Citrus Sinensis ID: 013005
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 451 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SUL7 | 426 | CBL-interacting serine/th | yes | no | 0.924 | 0.978 | 0.620 | 1e-142 | |
| Q9XIW0 | 429 | CBL-interacting serine/th | no | no | 0.922 | 0.969 | 0.583 | 1e-139 | |
| Q75GK4 | 447 | CBL-interacting protein k | yes | no | 0.915 | 0.923 | 0.503 | 1e-112 | |
| Q2QMI0 | 454 | CBL-interacting protein k | no | no | 0.911 | 0.905 | 0.5 | 1e-107 | |
| Q9LWM4 | 461 | CBL-interacting protein k | no | no | 0.860 | 0.841 | 0.497 | 1e-106 | |
| P92937 | 421 | CBL-interacting serine/th | no | no | 0.917 | 0.983 | 0.489 | 1e-106 | |
| Q7X996 | 443 | CBL-interacting protein k | no | no | 0.909 | 0.925 | 0.467 | 1e-105 | |
| Q5W736 | 457 | CBL-interacting protein k | no | no | 0.915 | 0.903 | 0.453 | 1e-103 | |
| Q5JLQ9 | 476 | CBL-interacting protein k | no | no | 0.935 | 0.886 | 0.453 | 1e-103 | |
| Q9LEU7 | 445 | CBL-interacting serine/th | no | no | 0.904 | 0.916 | 0.456 | 1e-101 |
| >sp|Q9SUL7|CIPK4_ARATH CBL-interacting serine/threonine-protein kinase 4 OS=Arabidopsis thaliana GN=CIPK4 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 505 bits (1301), Expect = e-142, Method: Compositional matrix adjust.
Identities = 273/440 (62%), Positives = 329/440 (74%), Gaps = 23/440 (5%)
Query: 14 PPPPPPSKKIPT-LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAM 72
P P P K T LL +Y+LG LG GSFAKVH A+SI+ G +VAIK I+K K +D+ M
Sbjct: 4 PYPKSPEKITGTVLLGKYELGRRLGSGSFAKVHVARSISTGELVAIKIIDKQ-KTIDSGM 62
Query: 73 EDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAA 131
E RI+RE+ AMRRL NHPNVLKI EVMATK+KIYLV+EYAAGGELF KL R GRL ESAA
Sbjct: 63 EPRIIREIEAMRRLHNHPNVLKIHEVMATKSKIYLVVEYAAGGELFTKLIRFGRLNESAA 122
Query: 132 RRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ-IKNGMLHTA 190
RRYFQQL SAL FCH++G+AHRDVKPQNLLLD+ GNLKVSDFGLSALPE NG+LHTA
Sbjct: 123 RRYFQQLASALSFCHRDGIAHRDVKPQNLLLDKQGNLKVSDFGLSALPEHRSNNGLLHTA 182
Query: 191 CGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQF 250
CGTPAYTAPEV+A+RGYDGA ADAWSCGV LFVLLAGY+PFDD+N++AMY+K+++RDY+F
Sbjct: 183 CGTPAYTAPEVIAQRGYDGAKADAWSCGVFLFVLLAGYVPFDDANIVAMYRKIHKRDYRF 242
Query: 251 PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSLFELGVVGNN 310
PS++SKPARS+IY+LLDPNP+TRMSIE +M WFQKSL+ +SS+FEL +
Sbjct: 243 PSWISKPARSIIYKLLDPNPETRMSIEAVMGTVWFQKSLEISE---FQSSVFEL-----D 294
Query: 311 KYILKEKIPDIVSMNAFDIISLSSGLDLSGLFEAKKRKEKRFTTKEKTERVVEKVKEVGE 370
+++ KE ++ AFD+ISLSSGLDLSGLFE +KRKEKRFT + ERVVEK +GE
Sbjct: 295 RFLEKEA-KSSNAITAFDLISLSSGLDLSGLFERRKRKEKRFTARVSAERVVEKAGMIGE 353
Query: 371 RLGYVVEKG-KGDVVGLGKLGKMVLLVEVLMEIAPETFVVGV--KVVDNSVCGRVALEFD 427
+LG+ VEK + VVGLGK G+ + + F G+ V V G E
Sbjct: 354 KLGFRVEKKEETKVVGLGK-GRTA------VVVEVVEFAEGLVVADVKVVVEGEEEEEEV 406
Query: 428 EGDWNELQAGLGDIVLSWHT 447
E W+EL L +IVLSWH
Sbjct: 407 ESHWSELIVELEEIVLSWHN 426
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9XIW0|CIPK7_ARATH CBL-interacting serine/threonine-protein kinase 7 OS=Arabidopsis thaliana GN=CIPK7 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 493 bits (1270), Expect = e-139, Method: Compositional matrix adjust.
Identities = 261/447 (58%), Positives = 320/447 (71%), Gaps = 31/447 (6%)
Query: 12 PPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAA 71
P P + LL +Y+LG LG GSFAKVH A+SI +VA+K IEK K +++
Sbjct: 7 PQNQSSPATTPAKILLGKYELGRRLGSGSFAKVHLARSIESDELVAVKIIEKK-KTIESG 65
Query: 72 MEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGK-LRRGRLTESA 130
ME RI+RE+ AMRRL++HPN+LKI EVMATK+KIYLVME A+GGELF K LRRGRL ES
Sbjct: 66 MEPRIIREIDAMRRLRHHPNILKIHEVMATKSKIYLVMELASGGELFSKVLRRGRLPEST 125
Query: 131 ARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTA 190
ARRYFQQL SAL F HQ+GVAHRDVKPQNLLLD GNLKVSDFGLSALPE ++NG+LHTA
Sbjct: 126 ARRYFQQLASALRFSHQDGVAHRDVKPQNLLLDEQGNLKVSDFGLSALPEHLQNGLLHTA 185
Query: 191 CGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQF 250
CGTPAYTAPEV++RRGYDGA ADAWSCGVILFVLL G +PFDDSN+ AMY+K++RRDY+F
Sbjct: 186 CGTPAYTAPEVISRRGYDGAKADAWSCGVILFVLLVGDVPFDDSNIAAMYRKIHRRDYRF 245
Query: 251 PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSLFELGVVGNN 310
PS++SK A+S+IYQ+LDPNP TRMSIE +M +WF+KSL E+S F V +
Sbjct: 246 PSWISKQAKSIIYQMLDPNPVTRMSIETVMKTNWFKKSL--------ETSEFHRNVFDSE 297
Query: 311 KYILKEKIPDIVSMNAFDIISLSSGLDLSGLFEAKKRKEKRFTTKEKTERVVEKVKEVGE 370
E + S+ AFD+ISLSSGLDLSGLFEAKK+KE+RFT K V EK K +GE
Sbjct: 298 ----VEMKSSVNSITAFDLISLSSGLDLSGLFEAKKKKERRFTAKVSGVEVEEKAKMIGE 353
Query: 371 RLGY------VVEKGKGDVVGLGKLGKMVLLVEVLMEIAPETFVVGVKVVDNSVCGRVAL 424
+LGY + ++G+ VVGLG+ G+ V++VE + V
Sbjct: 354 KLGYVVKKKMMKKEGEVKVVGLGR-GRTVIVVEAVELTVDVV---------VVEVKVVEG 403
Query: 425 EFDEGDWNELQAGLGDIVLSWHTSDVM 451
E D+ W++L L DIVLSWH +D+M
Sbjct: 404 EEDDSRWSDLITELEDIVLSWH-NDIM 429
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner (By similarity). Phosphorylates the rice sucrose synthase (SuSy) in vitro in an allosteric manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75GK4|CIPK7_ORYSJ CBL-interacting protein kinase 7 OS=Oryza sativa subsp. japonica GN=CIPK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 404 bits (1038), Expect = e-112, Method: Compositional matrix adjust.
Identities = 218/433 (50%), Positives = 300/433 (69%), Gaps = 20/433 (4%)
Query: 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGS-IVAIKTIEKNN-KFLDAAMEDRIVREVSAM 83
LL +Y+LG LLGRG+FAKV+ A+S+A G+ VA+K ++K + A M R++REV+AM
Sbjct: 15 LLGKYELGRLLGRGTFAKVYHARSLAPGADPVAVKVLDKPDLAAAGAGMATRVLREVAAM 74
Query: 84 RRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVS 140
RRL+ HPNVL++ EV+AT++K+YLVME A GG+L +L RL E AA+R F QLVS
Sbjct: 75 RRLR-HPNVLRLHEVLATRSKVYLVMELAPGGDLLSRLASLPSRRLPEHAAQRVFLQLVS 133
Query: 141 ALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAP 199
AL +CH GV+HRDVKPQN+LLD GNLKVSDFGL+ALP+ +++ G LHTACGTPA+ AP
Sbjct: 134 ALIYCHARGVSHRDVKPQNVLLDAHGNLKVSDFGLAALPDSLRDDGRLHTACGTPAFAAP 193
Query: 200 EVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPAR 259
EV+ R+ YDGA ADAWSCGVILFVLLAG+LPFDDSN+ M +K +RR+Y P +VS+PAR
Sbjct: 194 EVLRRKAYDGAKADAWSCGVILFVLLAGHLPFDDSNIADMCRKAHRREYALPRWVSQPAR 253
Query: 260 SLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSLFELGVVGNNKYILKEKIP 319
L+ +LLDPNP TR+++ ++ + WF++SL + G LG + + P
Sbjct: 254 RLVSRLLDPNPATRLAVAELATHPWFKRSLSLDSQLGS-----LLGGQPERELAFQAPPP 308
Query: 320 DIVSMNAFDIISLSSGLDLSGLF-EAKKRKEKRFTTKEKTERVVEKVKEVGERLGYVVEK 378
+NAFDIIS+S GLDLSGLF E+K+R+EKRF T ER VE++ + G +LGY +
Sbjct: 309 ----LNAFDIISMSPGLDLSGLFGESKRRREKRFVTTASPERTVERLGQAGAKLGYFMVG 364
Query: 379 GKG-DVVGLGKLGKMVLLVEVLMEIAPETFVVGVKVVDNSVCGRVALEFDEGDWNELQAG 437
KG + + LG L +V + + E++P +V ++ ++ G +E W EL+A
Sbjct: 365 KKGVERLPLGGLSGLVAMSMEMSEVSPSMMLVELR-LEGGDDGDGDGGAEEFGWEELRAE 423
Query: 438 LG-DIVLSWHTSD 449
LG D+V++WH D
Sbjct: 424 LGDDVVMAWHGCD 436
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QMI0|CIPK4_ORYSJ CBL-interacting protein kinase 4 OS=Oryza sativa subsp. japonica GN=CIPK4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 389 bits (999), Expect = e-107, Method: Compositional matrix adjust.
Identities = 221/442 (50%), Positives = 294/442 (66%), Gaps = 31/442 (7%)
Query: 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR 85
LL +Y+LG +LGRG+FAKV+ A+++A G VA+K I+K A M R++REV+AMRR
Sbjct: 21 LLGKYELGRMLGRGTFAKVYLARAVAGGEAVAVKVIDKAEVMGTAGMAPRVLREVAAMRR 80
Query: 86 LQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR---RGRLTESAARRYFQQLVSAL 142
L+ HP+VL++ EV+AT+ +IYLVME A GG+L +L R RL ESAARR F QLV AL
Sbjct: 81 LR-HPHVLRLHEVLATRARIYLVMELATGGDLLSRLAALPRRRLPESAARRVFVQLVDAL 139
Query: 143 HFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEV 201
+CH GVAHRDVKPQN+LLD DGNLKVSDFGL+ALP+ +++ G LHTACGTPAY APEV
Sbjct: 140 SYCHARGVAHRDVKPQNVLLDGDGNLKVSDFGLAALPDTLRDDGRLHTACGTPAYAAPEV 199
Query: 202 VARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSL 261
+ RR YDGA ADAWSCGVILFVLLAG+LPFDDSN+ M +K +RR+Y+ P +VS+PAR L
Sbjct: 200 LRRRAYDGAKADAWSCGVILFVLLAGHLPFDDSNIADMCRKAHRREYELPRWVSQPARRL 259
Query: 262 IYQLLDPNPKTRMSIEKIMSIS-WFQKSLQQQRKRGQESSLFELGVVGNNKYILKEKIPD 320
+ +LLDPNP TR+++E + + WF++SL +S L L + G + + +
Sbjct: 260 VSRLLDPNPDTRVAVESLAAHHPWFKRSLS------VDSQLDGL-LNGEPERAVAFQAAP 312
Query: 321 IVSMNAFDIISLSSGLDLSGLF--EAKKRKEKRFTTKEKTERVVEKVKEVGERLGYVVEK 378
+NAFDIIS+S GLDLSGLF K +EKRFTT E+ +E++ G +LGYVV
Sbjct: 313 PPPLNAFDIISMSPGLDLSGLFGEHDKSLREKRFTTTASPEKTLEQLGLAGGKLGYVVVV 372
Query: 379 GKGDVVGL----GKLGKMVLLVEVLMEIAPETFVVGVKVVDNSVCGRVALEFDEGD---- 430
GK V L G+L + + V M + V ++ A + D GD
Sbjct: 373 GKKGVECLPLAGGRLSSGIAAMSVEM-----SEVAPPLLLVELRLEVAAGDVDGGDGEVK 427
Query: 431 ---WNELQAGLGDIVLSWHTSD 449
W +L+ LGD+V +WH+ +
Sbjct: 428 GFGWEQLRMELGDVVRAWHSCE 449
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LWM4|CIPK5_ORYSJ CBL-interacting protein kinase 5 OS=Oryza sativa subsp. japonica GN=CIPK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 386 bits (991), Expect = e-106, Method: Compositional matrix adjust.
Identities = 204/410 (49%), Positives = 277/410 (67%), Gaps = 22/410 (5%)
Query: 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREV 80
KK L+NRY+LG +LG+G+FAKV+ A+++A VAIK I+K K L M D+I RE+
Sbjct: 3 KKASILMNRYELGRMLGQGTFAKVYHARNLASNQSVAIKVIDKE-KVLRVGMIDQIKREI 61
Query: 81 SAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVS 140
S MR L HPN++++ EVMA+K+KIY MEY GGELF ++ RGRL E AAR+YFQQL+
Sbjct: 62 SIMR-LVRHPNIVQLHEVMASKSKIYFAMEYVRGGELFSRVARGRLKEDAARKYFQQLIG 120
Query: 141 ALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE-QIKNGMLHTACGTPAYTAP 199
A+ FCH GV HRD+KP+NLL+D +GNLKVSDFGLSA E Q ++G+LHT CGTPAY AP
Sbjct: 121 AVDFCHSRGVYHRDLKPENLLVDENGNLKVSDFGLSAFKECQKQDGLLHTTCGTPAYVAP 180
Query: 200 EVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPAR 259
E++ +RGYDGA AD WSCGVILFVLLAGYLPF DSNL+ MY+K+++ D +FP + + R
Sbjct: 181 EIINKRGYDGAKADIWSCGVILFVLLAGYLPFHDSNLMEMYRKISKGDVKFPQWFTTDVR 240
Query: 260 SLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSLFELGVVG--------NNK 311
L+ +LLDPNP R+++EK++ WF+K + Q + L V +N+
Sbjct: 241 RLLSRLLDPNPNIRITVEKLVEHPWFKKGYKPAVMLSQPNESNNLKDVHTAFSADHKDNE 300
Query: 312 YILKEKIPDI--VSMNAFDIISLSSGLDLSGLFEAKK--RKEKRFTTKEKTERVVEKVKE 367
KE + VS+NAFDIISLS G DLSGLFE K + + RF T++ +V K+++
Sbjct: 301 GKAKEPASSLKPVSLNAFDIISLSKGFDLSGLFENDKEQKADSRFMTQKPASAIVSKLEQ 360
Query: 368 VGERLGYVVEKGKGDVVGL-----GKLGKMVLLVEVLMEIAPETFVVGVK 412
+ E + V+K G +V L G+ G++ + E+ E+ P FVV VK
Sbjct: 361 IAETESFKVKKQDG-LVKLQGSKEGRKGQLAIDAEIF-EVTPSFFVVEVK 408
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P92937|CIPKF_ARATH CBL-interacting serine/threonine-protein kinase 15 OS=Arabidopsis thaliana GN=CIPK15 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 385 bits (990), Expect = e-106, Method: Compositional matrix adjust.
Identities = 211/431 (48%), Positives = 287/431 (66%), Gaps = 17/431 (3%)
Query: 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREV 80
KK L+ RY++G LG+G+FAKV+ A+ + G VAIK I+K + L M ++I RE+
Sbjct: 3 KKGSVLMLRYEVGKFLGQGTFAKVYHARHLKTGDSVAIKVIDKE-RILKVGMTEQIKREI 61
Query: 81 SAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVS 140
SAMR L+ HPN++++ EVMATK+KIY VME+ GGELF K+ G+L E AR+YFQQLV
Sbjct: 62 SAMRLLR-HPNIVELHEVMATKSKIYFVMEHVKGGELFNKVSTGKLREDVARKYFQQLVR 120
Query: 141 ALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE-QIKNGMLHTACGTPAYTAP 199
A+ FCH GV HRD+KP+NLLLD GNLK+SDFGLSAL + + ++G+LHT CGTPAY AP
Sbjct: 121 AVDFCHSRGVCHRDLKPENLLLDEHGNLKISDFGLSALSDSRRQDGLLHTTCGTPAYVAP 180
Query: 200 EVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPAR 259
EV++R GYDG AD WSCGVILFVLLAGYLPF DSNL+ +YKK+ + + +FP++++ A+
Sbjct: 181 EVISRNGYDGFKADVWSCGVILFVLLAGYLPFRDSNLMELYKKIGKAEVKFPNWLAPGAK 240
Query: 260 SLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSLFELGVVGNNKYILKEKIP 319
L+ ++LDPNP TR+S EKIM SWF+K LQ++ K E N KEK
Sbjct: 241 RLLKRILDPNPNTRVSTEKIMKSSWFRKGLQEEVKESVEEETEVDAEAEGNASAEKEK-K 299
Query: 320 DIVSMNAFDIISLSSGLDLSGLFEAKKRKEK-RFTTKEKTERVVEKVKEVGERLGYVVEK 378
+++NAF+IISLS+G DLSGLFE + KE+ RFT+ + + EK+ E+G+ L V K
Sbjct: 300 RCINLNAFEIISLSTGFDLSGLFEKGEEKEEMRFTSNREASEITEKLVEIGKDLKMKVRK 359
Query: 379 GKGDVVGLGKLGKMVLLVEV-LMEIAPETFVVGVKVV--DNSVCGRVALEFDEGDWNELQ 435
+ + K+ +VE + EIAP +V +K D + RV E ++
Sbjct: 360 KEHE--WRVKMSAEATVVEAEVFEIAPSYHMVVLKKSGGDTAEYKRVMKE-------SIR 410
Query: 436 AGLGDIVLSWH 446
L D VL+WH
Sbjct: 411 PALIDFVLAWH 421
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7X996|CIPK2_ORYSJ CBL-interacting protein kinase 2 OS=Oryza sativa subsp. japonica GN=CIPK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 381 bits (979), Expect = e-105, Method: Compositional matrix adjust.
Identities = 202/432 (46%), Positives = 285/432 (65%), Gaps = 22/432 (5%)
Query: 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR 85
L+ +Y++G LLG+G+FAKV+ A++ VAIK I+K K L + D+I RE+S M+
Sbjct: 9 LMKKYEMGKLLGQGTFAKVYHARNTETSESVAIKMIDKE-KVLKGGLMDQIKREISVMK- 66
Query: 86 LQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFC 145
L HPN++++ EVMATKTKIY V+E+ GGELF K++RGRL E AAR+YFQQL+ A+ FC
Sbjct: 67 LVRHPNIVQLYEVMATKTKIYFVLEHVKGGELFNKVQRGRLKEDAARKYFQQLICAVDFC 126
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE-QIKNGMLHTACGTPAYTAPEVVAR 204
H GV HRD+KP+NLLLD + NLKVSDFGLSAL + + ++G+LHT CGTPAY APEV+ R
Sbjct: 127 HSRGVYHRDLKPENLLLDENSNLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPEVINR 186
Query: 205 RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQ 264
RGYDGA AD WSCGVILFVLLAGYLPF D NL+ MYKK+ + +++ PS+ + R L+ +
Sbjct: 187 RGYDGAKADIWSCGVILFVLLAGYLPFHDKNLMDMYKKIGKAEFKCPSWFNTDVRRLLLR 246
Query: 265 LLDPNPKTRMSIEKIMSISWFQKSLQQQ--RKRGQESSLFELGVVGN----NKYILKEKI 318
+LDPNP TR+S++KIM WF+K L + R Q + + + N EK
Sbjct: 247 ILDPNPSTRISMDKIMENPWFRKGLDAKLLRYNLQPKDAIPVDMSTDFDSFNSAPTLEKK 306
Query: 319 PDIVSMNAFDIISLSSGLDLSGLFEAKKRKEKRFTTKEKTERVVEKVKEVGERLGYVVEK 378
P ++NAFDIISLS+GLDLSG+FE +KE +FT+ ++ K++++ + L + K
Sbjct: 307 PS--NLNAFDIISLSTGLDLSGMFEESDKKESKFTSTSTASTIISKIEDIAKGLRLKLTK 364
Query: 379 GKGDVVGL-----GKLGKMVLLVEVLMEIAPETFVVGVKVVDNSVCGRVALEFDEGDWNE 433
G ++ + G+ G M + E+ E+ P +V +K + LE+ + E
Sbjct: 365 KDGGLLKMEGSKPGRKGVMGIDAEIF-EVTPNFHLVELKKTNGDT-----LEYRKVLNQE 418
Query: 434 LQAGLGDIVLSW 445
++ L DIV +W
Sbjct: 419 MRPALKDIVWAW 430
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5W736|CIPKI_ORYSJ CBL-interacting protein kinase 18 OS=Oryza sativa subsp. japonica GN=CIPK18 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 377 bits (968), Expect = e-103, Method: Compositional matrix adjust.
Identities = 200/441 (45%), Positives = 287/441 (65%), Gaps = 28/441 (6%)
Query: 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR 85
LL RY++G LLG+G+FAKV+ ++I VAIK I+K+ K + D+I RE+S M+
Sbjct: 11 LLRRYEIGKLLGQGTFAKVYHGRNIVTSQSVAIKVIDKD-KIFKVGLMDQIKREISVMK- 68
Query: 86 LQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFC 145
L HPN++++ EVMATK+KIY V+EY GGELF K+ +GRL E AAR+YFQQLVSA+ FC
Sbjct: 69 LVRHPNIVQLYEVMATKSKIYFVLEYVKGGELFNKVAKGRLKEDAARKYFQQLVSAVDFC 128
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE-QIKNGMLHTACGTPAYTAPEVVAR 204
H GV HRD+KP+NLL+D +GNLK++DFGLSAL E + ++G+LHT CGTPAY APEV++R
Sbjct: 129 HSRGVYHRDLKPENLLVDENGNLKITDFGLSALAESRRQDGLLHTTCGTPAYVAPEVISR 188
Query: 205 RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQ 264
+GYDG D WSCGVILFVL+AGYLPF DSNL+ MY+K+ + +++ P++ S R L+ +
Sbjct: 189 KGYDGVKVDTWSCGVILFVLMAGYLPFQDSNLMEMYRKIGKAEFKCPAWFSSDVRKLVSR 248
Query: 265 LLDPNPKTRMSIEKIMSISWFQKSLQQQ------RKRGQESSLFELGVV-------GNNK 311
+LDPNP++RM I KIM WF+K L + ++L ++ VV + K
Sbjct: 249 ILDPNPRSRMPITKIMETYWFKKGLDSKLILKNVETNEPVTALADVNVVFSSMGSSSSKK 308
Query: 312 YILKEKIPDIVSMNAFDIISLSSGLDLSGLF-EAKKRKEKRFTTKEKTERVVEKVKEVGE 370
K+ + ++NAFDIISLS G DLSGLF E K+KE RFT+ + ++ K+++V
Sbjct: 309 TEEKQDAGKLTNLNAFDIISLSEGFDLSGLFEETDKKKEARFTSSQSASAIISKLEDVAS 368
Query: 371 RLGYVVEKGKGDVVGL-----GKLGKMVLLVEVLMEIAPETFVVGVKVVDNSVCGRVALE 425
V+K +G V+ + G+ G + + E+ E+ P +V +K + LE
Sbjct: 369 CSKLTVKKKEGGVLKMEGASEGRKGVLAIDAEIF-EVTPSFHLVEIKKNNGD-----TLE 422
Query: 426 FDEGDWNELQAGLGDIVLSWH 446
+ +++ L DIV +W
Sbjct: 423 YQHLWKEDMKPALKDIVWAWQ 443
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5JLQ9|CIPKU_ORYSJ CBL-interacting protein kinase 30 OS=Oryza sativa subsp. japonica GN=CIPK30 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 375 bits (963), Expect = e-103, Method: Compositional matrix adjust.
Identities = 209/461 (45%), Positives = 295/461 (63%), Gaps = 39/461 (8%)
Query: 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVRE 79
S+ ++ RY+LG LLGRG+FAKV+KA +A G VAIK +K +E ++ RE
Sbjct: 7 SQDSQVIMGRYKLGRLLGRGTFAKVYKAYKLATGEAVAIKVFDKEAVQRSGTVE-QVKRE 65
Query: 80 VSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRG-RLTESAARRYFQQL 138
V MRR+ +H +V+++ EVMAT+++IY VMEYA+GGELF +L R R E ARRYFQQL
Sbjct: 66 VDVMRRV-HHRHVIRLHEVMATRSRIYFVMEYASGGELFTRLSRSPRFPEPVARRYFQQL 124
Query: 139 VSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK-NGMLHTACGTPAYT 197
++A+ FCH GV HRD+KP+NLLLD G+LKV+DFGLSAL ++ +G+LHT CGTPAY
Sbjct: 125 ITAVEFCHSRGVYHRDLKPENLLLDARGDLKVTDFGLSALDGGLRGDGLLHTTCGTPAYV 184
Query: 198 APEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKP 257
APEV+ +RGYDGA AD WSCGVILFVLLAGYLPF+++NL+ +Y+ + +Y+ P + S
Sbjct: 185 APEVLLKRGYDGAKADIWSCGVILFVLLAGYLPFNETNLVILYRNITESNYRCPPWFSVE 244
Query: 258 ARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL---------------------QQQRKRG 296
AR L+ +LLDPNPKTR++I KIM WFQ++ Q+
Sbjct: 245 ARKLLARLLDPNPKTRITISKIMDRPWFQQATCPLGDMSLVASAPSVLLARKEASQQHDD 304
Query: 297 QESSLFELGVVGNNKYILKEKIPDI--VSMNAFDIISLSSGLDLSGLFEAKKRK-EKRFT 353
+E F + I+ + D+ SMNAFDIIS S GLDLS +F+A++R+ E RF+
Sbjct: 305 EEDDGFAREKKKRSNVIMSSPVIDVRPSSMNAFDIISRSRGLDLSKMFDAEERRSEARFS 364
Query: 354 TKEKTERVVEKVKEVGE--RLGY-VVEKGKGDVVGL--GKLGKMVLLVEVLMEIAPETFV 408
T+E T +V K++E+ E R + + EKG+ ++ G G+ G + + E+ ++APE V
Sbjct: 365 TRETTTAIVSKLEEIAEAGRFSFKLKEKGRVELEGSQDGRKGALAIEAEIF-KVAPEVHV 423
Query: 409 VGVKVVDNSVCGRVALEFDEGDWNELQAGLGDIVLSWHTSD 449
V V+ G + +F + EL+ LGD+V +W D
Sbjct: 424 VEVRKT-----GGDSPDFRDFYKQELKPSLGDMVWAWQGGD 459
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LEU7|CIPK5_ARATH CBL-interacting serine/threonine-protein kinase 5 OS=Arabidopsis thaliana GN=CIPK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 370 bits (949), Expect = e-101, Method: Compositional matrix adjust.
Identities = 201/440 (45%), Positives = 279/440 (63%), Gaps = 32/440 (7%)
Query: 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR 85
L +Y++G LLG+G+FAKV+ K I G VAIK I K+ M ++I RE+S M+
Sbjct: 8 LFGKYEMGRLLGKGTFAKVYYGKEIIGGECVAIKVINKDQVMKRPGMMEQIKREISIMK- 66
Query: 86 LQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFC 145
L HPN+++++EVMATKTKI+ VME+ GGELF K+ +G+L E AARRYFQQL+SA+ +C
Sbjct: 67 LVRHPNIVELKEVMATKTKIFFVMEFVKGGELFCKISKGKLHEDAARRYFQQLISAVDYC 126
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI-KNGMLHTACGTPAYTAPEVVAR 204
H GV+HRD+KP+NLLLD +G+LK+SDFGLSALPEQI ++G+LHT CGTPAY APEV+ +
Sbjct: 127 HSRGVSHRDLKPENLLLDENGDLKISDFGLSALPEQILQDGLLHTQCGTPAYVAPEVLKK 186
Query: 205 RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQ 264
+GYDGA AD WSCGV+L+VLLAG LPF D NL+ MY+K+ R D++FP + S AR LI +
Sbjct: 187 KGYDGAKADIWSCGVVLYVLLAGCLPFQDENLMNMYRKIFRADFEFPPWFSPEARRLISK 246
Query: 265 LLDPNPKTRMSIEKIMSISWFQKSLQ------------QQRKRGQESSLFELGVVGNNKY 312
LL +P R+SI IM W +K+ Q + E + G N
Sbjct: 247 LLVVDPDRRISIPAIMRTPWLRKNFTPPLAFKIDEPICSQSSKNNEEEEED-GDCENQTE 305
Query: 313 ILKEKIPDIVSMNAFDII-SLSSGLDLSGLFEAKKRKEKRFTTKEKTERVVEKVKEVGER 371
+ K NAF+ I S+SSG DLS LFE+K++ + FT++ V+EK++ V +
Sbjct: 306 PISPKF-----FNAFEFISSMSSGFDLSSLFESKRKVQSVFTSRSSATEVMEKIETVTKE 360
Query: 372 LGYVVEKGKGDVVGL-----GKLGKMVLLVEVLMEIAPETFVVGVKVVDNSVCGRVALEF 426
+ V++ K V + G+ G++ + EV E+APE + VV+ LE+
Sbjct: 361 MNMKVKRTKDFKVKMEGKTEGRKGRLSMTAEVF-EVAPE-----ISVVEFCKSAGDTLEY 414
Query: 427 DEGDWNELQAGLGDIVLSWH 446
D E++ L DIV SWH
Sbjct: 415 DRLYEEEVRPALNDIVWSWH 434
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 451 | ||||||
| 449467251 | 430 | PREDICTED: CBL-interacting serine/threon | 0.906 | 0.951 | 0.667 | 1e-156 | |
| 255551977 | 430 | CBL-interacting serine/threonine-protein | 0.929 | 0.974 | 0.623 | 1e-143 | |
| 15233500 | 426 | CBL-interacting serine/threonine-protein | 0.924 | 0.978 | 0.620 | 1e-140 | |
| 225432868 | 420 | PREDICTED: CBL-interacting serine/threon | 0.902 | 0.969 | 0.615 | 1e-139 | |
| 297800784 | 423 | cbl-interacting protein kinase 4 [Arabid | 0.926 | 0.988 | 0.609 | 1e-137 | |
| 15228920 | 429 | CBL-interacting serine/threonine-protein | 0.922 | 0.969 | 0.583 | 1e-137 | |
| 9798601 | 429 | serine/threonine protein kinase [Arabido | 0.922 | 0.969 | 0.581 | 1e-136 | |
| 297831018 | 428 | cbl-interacting protein kinase 7 [Arabid | 0.922 | 0.971 | 0.593 | 1e-136 | |
| 15451212 | 429 | SNF1 related protein kinase [Arabidopsis | 0.922 | 0.969 | 0.581 | 1e-135 | |
| 388496936 | 436 | unknown [Medicago truncatula] | 0.895 | 0.926 | 0.602 | 1e-135 |
| >gi|449467251|ref|XP_004151337.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 7-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 557 bits (1435), Expect = e-156, Method: Compositional matrix adjust.
Identities = 285/427 (66%), Positives = 338/427 (79%), Gaps = 18/427 (4%)
Query: 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR 85
LL +YQLG LGRGSFAKV++A+S+AD SIVA+K I+KN K +DAAME IVRE+S MRR
Sbjct: 21 LLGKYQLGRFLGRGSFAKVYQARSLADNSIVAVKIIDKN-KTIDAAMEPCIVREISVMRR 79
Query: 86 LQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLVSALHF 144
LQ+HP++LKI EVMATKTKIYLV++YA+GGELF KL RRGRLTES ARRYFQQL+SALHF
Sbjct: 80 LQHHPSILKIHEVMATKTKIYLVVDYASGGELFAKLLRRGRLTESTARRYFQQLISALHF 139
Query: 145 CHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVAR 204
CHQNGVAHRD+KPQNLLLD DGNLKVSDFGLSALPEQIK+GMLHTACGTPAYTAPEVV+R
Sbjct: 140 CHQNGVAHRDIKPQNLLLDEDGNLKVSDFGLSALPEQIKDGMLHTACGTPAYTAPEVVSR 199
Query: 205 RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQ 264
RGYDGA ADAWSCGVILFVLL+G+LPF D+NL+AMYKKV RR+YQFP +SKPAR LI+Q
Sbjct: 200 RGYDGAKADAWSCGVILFVLLSGHLPFSDNNLVAMYKKVYRREYQFPDSISKPARHLIFQ 259
Query: 265 LLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSLFELGVVGNNKYILKEKIPDIVSM 324
LLDPNP TRMSIE +M SW++KSL R + Q S+ +GN K L + +
Sbjct: 260 LLDPNPHTRMSIEALMQHSWYKKSL---RSKPQISNRSLFDSLGNYKSEL-----GVSGL 311
Query: 325 NAFDIISLSSGLDLSGLFEAKKRKEKRFTTKEKTERVVEKVKEVGERLGYVVEKGKGDVV 384
NAFDIIS+SSGLDLSGLFE +KRFTT E+V E+V+E+G LGY VEKGK +
Sbjct: 312 NAFDIISMSSGLDLSGLFETTDCNKKRFTTGVGMEKVEERVREIGGELGYRVEKGKSGAI 371
Query: 385 GLGKLGKMVLLVEVLMEIAPETFVVGVKVVDNSVCGRVALEFDEGDWNELQAGLGDIVLS 444
GLGK G+M+L+VE L EI +V VKV ++ +EF+ W +L+A L DIV S
Sbjct: 372 GLGK-GRMILVVEAL-EITSNLLMVEVKVAESK------MEFERMHWGDLKAKLQDIVDS 423
Query: 445 WHTSDVM 451
WHT++ M
Sbjct: 424 WHTNEGM 430
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255551977|ref|XP_002517033.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] gi|223543668|gb|EEF45196.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 516 bits (1328), Expect = e-143, Method: Compositional matrix adjust.
Identities = 280/449 (62%), Positives = 342/449 (76%), Gaps = 30/449 (6%)
Query: 12 PPPPPPPPSKKIP-----TLLNRYQLGPLLGRGSFAKVHKAKSIADGS-IVAIKTIEKNN 65
PPP PP S+ TLLN+Y+LG LLGRGSFAKV+ A+S+AD + +VAIK I+K
Sbjct: 3 PPPRGPPLSRTTSNTLPTTLLNKYELGKLLGRGSFAKVYAARSLADNNKLVAIKIIDKT- 61
Query: 66 KFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRG 124
+ +DAAME RI+ E+SAMRRLQ+HPN+LKI EVMATKTKIYLVME A GGELF K+ +RG
Sbjct: 62 RTIDAAMEPRIICEISAMRRLQHHPNILKIHEVMATKTKIYLVMELALGGELFSKVFQRG 121
Query: 125 RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184
+L+ES ARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLD +GNLKVSDFGLSAL E +
Sbjct: 122 KLSESKARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDANGNLKVSDFGLSALAEAQND 181
Query: 185 G--MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKK 242
G +L TACGTPA+TAPEV+ARRGYDGA +DAWSCGVILF LL+ LPFDD+NL MYKK
Sbjct: 182 GSTVLQTACGTPAFTAPEVMARRGYDGAQSDAWSCGVILFFLLSAQLPFDDTNLAVMYKK 241
Query: 243 VNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSLF 302
+++RDYQ PS SK A+S+I QLLDPNP TRMSIE++M SWF K+ + ++S+F
Sbjct: 242 IHKRDYQMPS-ASKSAKSIIMQLLDPNPSTRMSIEQLMKHSWFLKNYELP----TQNSMF 296
Query: 303 ELGVVGNNKYILKEKIPDIVSMNAFDIISLSSGLDLSGLFEAKKRKEKRFTTKEKTERVV 362
EL K+ D ++ AFDIISLSSGLDLSGLFEA R+EKRFT+ EK ER++
Sbjct: 297 ELEQTKCCKF-------DTSTVTAFDIISLSSGLDLSGLFEATNRREKRFTSMEKVERIM 349
Query: 363 EKVKEVGERLGYVVEKGKGDVVGLGKLGKMVLLVEVLMEIAPETFVVGVKVVDNSVCGRV 422
E+V+EVG RLGY +E+GK +GLGK G++ L+ E L EIA + VV VKVV+
Sbjct: 350 ERVREVGGRLGYRIEEGKSGAIGLGK-GRVALMFEAL-EIAEQLMVVEVKVVEGG----- 402
Query: 423 ALEFDEGDWNELQAGLGDIVLSWHTSDVM 451
+EF+E W EL+ GL D+VL+WH +D M
Sbjct: 403 GVEFEEVQWVELKDGLQDVVLNWH-NDAM 430
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15233500|ref|NP_193194.1| CBL-interacting serine/threonine-protein kinase 4 [Arabidopsis thaliana] gi|75337678|sp|Q9SUL7.1|CIPK4_ARATH RecName: Full=CBL-interacting serine/threonine-protein kinase 4; AltName: Full=SNF1-related kinase 3.3; AltName: Full=SOS2-like protein kinase PKS9 gi|5302772|emb|CAB46060.1| SNF1 like protein kinase [Arabidopsis thaliana] gi|7268164|emb|CAB78500.1| SNF1 like protein kinase [Arabidopsis thaliana] gi|13249503|gb|AAG01367.1| CBL-interacting protein kinase 4 [Arabidopsis thaliana] gi|332658062|gb|AEE83462.1| CBL-interacting serine/threonine-protein kinase 4 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 505 bits (1301), Expect = e-140, Method: Compositional matrix adjust.
Identities = 273/440 (62%), Positives = 329/440 (74%), Gaps = 23/440 (5%)
Query: 14 PPPPPPSKKIPT-LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAM 72
P P P K T LL +Y+LG LG GSFAKVH A+SI+ G +VAIK I+K K +D+ M
Sbjct: 4 PYPKSPEKITGTVLLGKYELGRRLGSGSFAKVHVARSISTGELVAIKIIDKQ-KTIDSGM 62
Query: 73 EDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAA 131
E RI+RE+ AMRRL NHPNVLKI EVMATK+KIYLV+EYAAGGELF KL R GRL ESAA
Sbjct: 63 EPRIIREIEAMRRLHNHPNVLKIHEVMATKSKIYLVVEYAAGGELFTKLIRFGRLNESAA 122
Query: 132 RRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ-IKNGMLHTA 190
RRYFQQL SAL FCH++G+AHRDVKPQNLLLD+ GNLKVSDFGLSALPE NG+LHTA
Sbjct: 123 RRYFQQLASALSFCHRDGIAHRDVKPQNLLLDKQGNLKVSDFGLSALPEHRSNNGLLHTA 182
Query: 191 CGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQF 250
CGTPAYTAPEV+A+RGYDGA ADAWSCGV LFVLLAGY+PFDD+N++AMY+K+++RDY+F
Sbjct: 183 CGTPAYTAPEVIAQRGYDGAKADAWSCGVFLFVLLAGYVPFDDANIVAMYRKIHKRDYRF 242
Query: 251 PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSLFELGVVGNN 310
PS++SKPARS+IY+LLDPNP+TRMSIE +M WFQKSL+ +SS+FEL +
Sbjct: 243 PSWISKPARSIIYKLLDPNPETRMSIEAVMGTVWFQKSLEISE---FQSSVFEL-----D 294
Query: 311 KYILKEKIPDIVSMNAFDIISLSSGLDLSGLFEAKKRKEKRFTTKEKTERVVEKVKEVGE 370
+++ KE ++ AFD+ISLSSGLDLSGLFE +KRKEKRFT + ERVVEK +GE
Sbjct: 295 RFLEKEA-KSSNAITAFDLISLSSGLDLSGLFERRKRKEKRFTARVSAERVVEKAGMIGE 353
Query: 371 RLGYVVEKG-KGDVVGLGKLGKMVLLVEVLMEIAPETFVVGV--KVVDNSVCGRVALEFD 427
+LG+ VEK + VVGLGK G+ + + F G+ V V G E
Sbjct: 354 KLGFRVEKKEETKVVGLGK-GRTA------VVVEVVEFAEGLVVADVKVVVEGEEEEEEV 406
Query: 428 EGDWNELQAGLGDIVLSWHT 447
E W+EL L +IVLSWH
Sbjct: 407 ESHWSELIVELEEIVLSWHN 426
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225432868|ref|XP_002283973.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 7 [Vitis vinifera] gi|229609841|gb|ACQ83536.1| CBL-interacting protein kinase 20 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 502 bits (1293), Expect = e-139, Method: Compositional matrix adjust.
Identities = 262/426 (61%), Positives = 331/426 (77%), Gaps = 19/426 (4%)
Query: 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR 85
+L +Y+LG LLGRGSFAKV++A SI DG+ VA+K ++K + ++A ME RIVREV+AMR
Sbjct: 9 ILGKYKLGRLLGRGSFAKVYQAHSITDGTAVAVKIMDKA-RSVEAGMESRIVREVTAMRS 67
Query: 86 LQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLVSALHF 144
LQ HPN+LKI E+MATK+KIYL++E A GGELF K+ RRGRLTE+AARRYFQQLVSAL F
Sbjct: 68 LQ-HPNILKIYEIMATKSKIYLIIELAKGGELFTKISRRGRLTEAAARRYFQQLVSALLF 126
Query: 145 CHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVAR 204
CHQNGVAHRD+KPQNLLLD+DGNLKVSDFGLSALP+Q+KNG+LHTACGTPAYTAPEVV+R
Sbjct: 127 CHQNGVAHRDMKPQNLLLDQDGNLKVSDFGLSALPDQLKNGLLHTACGTPAYTAPEVVSR 186
Query: 205 RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQ 264
+GYDGA ADAWSCGVILFV L+G+LPFDDSNL+ MY+K++RRDYQFPS++S+PARS+I Q
Sbjct: 187 KGYDGAKADAWSCGVILFVFLSGFLPFDDSNLVTMYRKIHRRDYQFPSWISRPARSVISQ 246
Query: 265 LLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSLFELGVVGNNKYILKEKIPDIVSM 324
LLDPNP RMSIE +M +WF+KS K+ + +S F+ + + E ++M
Sbjct: 247 LLDPNPNKRMSIEALMESAWFKKSTPA--KKLEHASSFDSDM---ESMKVCEYGSAPLTM 301
Query: 325 NAFDIISLSSGLDLSGLF--EAKKRKEKRFTTKEKTERVVEKVKEVGERLGYVVEKGKGD 382
NAFDIIS+SSGLDLSGLF A ++EKRF ++ E VEK++EVGE+LGY VE+GK
Sbjct: 302 NAFDIISMSSGLDLSGLFFEAAANKREKRFMSRASAEITVEKMREVGEKLGYGVERGK-- 359
Query: 383 VVGLGKLGKMVLLVEVLMEIAPETFVVGVKVVDNSVCGRVALEFDEGDWNELQAGLGDIV 442
V + + V+L+ + E+AP +V V+VVD EF+E W ++AGL DIV
Sbjct: 360 VGSIRREAGRVVLLVEVSEVAPSLLLVEVQVVDGG-------EFEELKWEIVKAGLEDIV 412
Query: 443 LSWHTS 448
+SW S
Sbjct: 413 VSWEGS 418
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297800784|ref|XP_002868276.1| cbl-interacting protein kinase 4 [Arabidopsis lyrata subsp. lyrata] gi|297314112|gb|EFH44535.1| cbl-interacting protein kinase 4 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 495 bits (1275), Expect = e-137, Method: Compositional matrix adjust.
Identities = 269/441 (60%), Positives = 329/441 (74%), Gaps = 23/441 (5%)
Query: 10 APPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLD 69
+P P P PS + LL +Y+LG LG GSFAKVH A+SI+ G +VAIK I+K +D
Sbjct: 3 SPNPKSPEKPSGTV--LLGKYELGRRLGSGSFAKVHVARSISTGELVAIKIIDKKKT-ID 59
Query: 70 AAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTE 128
+ ME RI+RE+ AMRRL +HPNVLKI EVMATK+KIYLV+EYAAGGELF KL R GRL E
Sbjct: 60 SGMEPRIIREIEAMRRLHHHPNVLKIHEVMATKSKIYLVVEYAAGGELFSKLNRFGRLNE 119
Query: 129 SAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK-NGML 187
SAARRYFQQL SAL FCH++G+AHRDVKPQNLLLD+ GNLKVSDFGLSALPE +G+L
Sbjct: 120 SAARRYFQQLASALSFCHRDGIAHRDVKPQNLLLDKQGNLKVSDFGLSALPEHRNSDGLL 179
Query: 188 HTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD 247
HTACGTPAYTAPEV+A+RGYDGA ADAWSCGV LFVLLAGY+PFDDSN+++MY+K++RRD
Sbjct: 180 HTACGTPAYTAPEVIAQRGYDGAKADAWSCGVFLFVLLAGYVPFDDSNIVSMYRKIHRRD 239
Query: 248 YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSLFELGVV 307
Y+FPS++SKPARS+IY+LLDPNP+TRMSIE + WFQKSL E S F+ V
Sbjct: 240 YRFPSWISKPARSIIYKLLDPNPETRMSIEAVTGTVWFQKSL--------EISEFQTSVF 291
Query: 308 GNNKYILKEKIPDIVSMNAFDIISLSSGLDLSGLFEAKKRKEKRFTTKEKTERVVEKVKE 367
++++ KE ++ AFD+ISLSSGLDLSGLFE +KRKEKRFT + ERVVEK +
Sbjct: 292 DLDRFLEKEA-KSSNAITAFDLISLSSGLDLSGLFERRKRKEKRFTARVSAERVVEKAET 350
Query: 368 VGERLGYVVEKG-KGDVVGLGKLGKMVLLVEVLMEIAPETFVVGVKVVDNSVCGRVALEF 426
+GE+LG+ VEK + VVGLGK G+ +V ++E+A V VKV +
Sbjct: 351 IGEKLGFRVEKKEEARVVGLGK-GRTA-VVVEVVELAEGLVVAEVKVAEGEEEEEET--- 405
Query: 427 DEGDWNELQAGLGDIVLSWHT 447
W+EL L +IVLSWH
Sbjct: 406 ---HWSELIVELEEIVLSWHN 423
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15228920|ref|NP_188940.1| CBL-interacting serine/threonine-protein kinase 7 [Arabidopsis thaliana] gi|75338665|sp|Q9XIW0.1|CIPK7_ARATH RecName: Full=CBL-interacting serine/threonine-protein kinase 7; AltName: Full=SNF1-related kinase 3.10; AltName: Full=SOS2-like protein kinase PKS7; AltName: Full=Serine/threonine-protein kinase SR2; Short=AtSR2; Short=AtSRPK1 gi|13249113|gb|AAK16682.1|AF290192_1 CBL-interacting protein kinase 7 [Arabidopsis thaliana] gi|13448039|gb|AAK26846.1|AF339148_1 SOS2-like protein kinase PKS7 [Arabidopsis thaliana] gi|5478791|dbj|BAA77716.2| SNF1 related protein kinase [Arabidopsis thaliana] gi|9294189|dbj|BAB02091.1| SNF1 related protein kinase [Arabidopsis thaliana] gi|57222172|gb|AAW38993.1| At3g23000 [Arabidopsis thaliana] gi|114213519|gb|ABI54342.1| At3g23000 [Arabidopsis thaliana] gi|332643183|gb|AEE76704.1| CBL-interacting serine/threonine-protein kinase 7 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 493 bits (1270), Expect = e-137, Method: Compositional matrix adjust.
Identities = 261/447 (58%), Positives = 320/447 (71%), Gaps = 31/447 (6%)
Query: 12 PPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAA 71
P P + LL +Y+LG LG GSFAKVH A+SI +VA+K IEK K +++
Sbjct: 7 PQNQSSPATTPAKILLGKYELGRRLGSGSFAKVHLARSIESDELVAVKIIEKK-KTIESG 65
Query: 72 MEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGK-LRRGRLTESA 130
ME RI+RE+ AMRRL++HPN+LKI EVMATK+KIYLVME A+GGELF K LRRGRL ES
Sbjct: 66 MEPRIIREIDAMRRLRHHPNILKIHEVMATKSKIYLVMELASGGELFSKVLRRGRLPEST 125
Query: 131 ARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTA 190
ARRYFQQL SAL F HQ+GVAHRDVKPQNLLLD GNLKVSDFGLSALPE ++NG+LHTA
Sbjct: 126 ARRYFQQLASALRFSHQDGVAHRDVKPQNLLLDEQGNLKVSDFGLSALPEHLQNGLLHTA 185
Query: 191 CGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQF 250
CGTPAYTAPEV++RRGYDGA ADAWSCGVILFVLL G +PFDDSN+ AMY+K++RRDY+F
Sbjct: 186 CGTPAYTAPEVISRRGYDGAKADAWSCGVILFVLLVGDVPFDDSNIAAMYRKIHRRDYRF 245
Query: 251 PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSLFELGVVGNN 310
PS++SK A+S+IYQ+LDPNP TRMSIE +M +WF+KSL E+S F V +
Sbjct: 246 PSWISKQAKSIIYQMLDPNPVTRMSIETVMKTNWFKKSL--------ETSEFHRNVFDSE 297
Query: 311 KYILKEKIPDIVSMNAFDIISLSSGLDLSGLFEAKKRKEKRFTTKEKTERVVEKVKEVGE 370
E + S+ AFD+ISLSSGLDLSGLFEAKK+KE+RFT K V EK K +GE
Sbjct: 298 ----VEMKSSVNSITAFDLISLSSGLDLSGLFEAKKKKERRFTAKVSGVEVEEKAKMIGE 353
Query: 371 RLGY------VVEKGKGDVVGLGKLGKMVLLVEVLMEIAPETFVVGVKVVDNSVCGRVAL 424
+LGY + ++G+ VVGLG+ G+ V++VE + V
Sbjct: 354 KLGYVVKKKMMKKEGEVKVVGLGR-GRTVIVVEAVELTVDVV---------VVEVKVVEG 403
Query: 425 EFDEGDWNELQAGLGDIVLSWHTSDVM 451
E D+ W++L L DIVLSWH +D+M
Sbjct: 404 EEDDSRWSDLITELEDIVLSWH-NDIM 429
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|9798601|dbj|BAB11738.1| serine/threonine protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 492 bits (1266), Expect = e-136, Method: Compositional matrix adjust.
Identities = 260/447 (58%), Positives = 320/447 (71%), Gaps = 31/447 (6%)
Query: 12 PPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAA 71
P P + LL +++LG LG GSFAKVH A+SI +VA+K IEK K +++
Sbjct: 7 PQNQSSPATTPAKILLGKHELGRRLGSGSFAKVHLARSIESDELVAVKIIEKK-KTIESG 65
Query: 72 MEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGK-LRRGRLTESA 130
ME RI+RE+ AMRRL++HPN+LKI EVMATK+KIYLVME A+GGELF K LRRGRL ES
Sbjct: 66 MEPRIIREIDAMRRLRHHPNILKIHEVMATKSKIYLVMELASGGELFSKVLRRGRLPEST 125
Query: 131 ARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTA 190
ARRYFQQL SAL F HQ+GVAHRDVKPQNLLLD GNLKVSDFGLSALPE ++NG+LHTA
Sbjct: 126 ARRYFQQLASALRFSHQDGVAHRDVKPQNLLLDEQGNLKVSDFGLSALPEHLQNGLLHTA 185
Query: 191 CGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQF 250
CGTPAYTAPEV++RRGYDGA ADAWSCGVILFVLL G +PFDDSN+ AMY+K++RRDY+F
Sbjct: 186 CGTPAYTAPEVISRRGYDGAKADAWSCGVILFVLLVGDVPFDDSNIAAMYRKIHRRDYRF 245
Query: 251 PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSLFELGVVGNN 310
PS++SK A+S+IYQ+LDPNP TRMSIE +M +WF+KSL E+S F V +
Sbjct: 246 PSWISKQAKSIIYQMLDPNPVTRMSIETVMKTNWFKKSL--------ETSEFHRNVFDSE 297
Query: 311 KYILKEKIPDIVSMNAFDIISLSSGLDLSGLFEAKKRKEKRFTTKEKTERVVEKVKEVGE 370
E + S+ AFD+ISLSSGLDLSGLFEAKK+KE+RFT K V EK K +GE
Sbjct: 298 ----VEMKSSVNSITAFDLISLSSGLDLSGLFEAKKKKERRFTAKVSGVEVEEKAKMIGE 353
Query: 371 RLGY------VVEKGKGDVVGLGKLGKMVLLVEVLMEIAPETFVVGVKVVDNSVCGRVAL 424
+LGY + ++G+ VVGLG+ G+ V++VE + V
Sbjct: 354 KLGYVVKKKMMKKEGEVKVVGLGR-GRTVIVVEAVELTVDVV---------VVEVKVVEG 403
Query: 425 EFDEGDWNELQAGLGDIVLSWHTSDVM 451
E D+ W++L L DIVLSWH +D+M
Sbjct: 404 EEDDSRWSDLITELEDIVLSWH-NDIM 429
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297831018|ref|XP_002883391.1| cbl-interacting protein kinase 7 [Arabidopsis lyrata subsp. lyrata] gi|297329231|gb|EFH59650.1| cbl-interacting protein kinase 7 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 490 bits (1262), Expect = e-136, Method: Compositional matrix adjust.
Identities = 266/448 (59%), Positives = 322/448 (71%), Gaps = 32/448 (7%)
Query: 12 PPPPPPPPSKKIP--TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLD 69
PPP S P TLL +Y+LG LG GSFAKVH A+SI +VAIK IEK ++
Sbjct: 5 PPPQNQTSSATTPAKTLLGKYELGRRLGSGSFAKVHLARSIESDELVAIKIIEKKKT-IE 63
Query: 70 AAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGK-LRRGRLTE 128
+ ME RI+RE+ AMRRL++HPN+LKI EVMATK+KIYLVME A+GGELF K LRRGRL E
Sbjct: 64 SGMEPRIIREIDAMRRLRHHPNILKIHEVMATKSKIYLVMELASGGELFSKVLRRGRLPE 123
Query: 129 SAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLH 188
S ARRYFQQL SAL F HQ+GVAHRDVKPQNLLLD+ GNLKVSDFGLSALPE ++NG+LH
Sbjct: 124 STARRYFQQLASALRFSHQDGVAHRDVKPQNLLLDQQGNLKVSDFGLSALPEHLQNGLLH 183
Query: 189 TACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY 248
TACGTPAYTAPEV++RRGYDGA ADAWSCGVILFVLL G +PFDDSN+ AMY+K++RRDY
Sbjct: 184 TACGTPAYTAPEVISRRGYDGAKADAWSCGVILFVLLVGNVPFDDSNIAAMYRKIHRRDY 243
Query: 249 QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSLFELGVVG 308
+FPS++SK A+S+IYQ+LDPNP TRMSIE +M +WF+KSL E+S F +
Sbjct: 244 RFPSWISKQAKSIIYQMLDPNPVTRMSIETVMKTNWFKKSL--------ETSEFHRNIFD 295
Query: 309 NNKYILKEKIPDIVSMNAFDIISLSSGLDLSGLFEAKKRKEKRFTTKEKTERVVEKVKEV 368
+ E + S+ AFD+ISLSSGLDLSGLFE KK+KE+RFT K V EK K +
Sbjct: 296 SE----PEMKSSVNSITAFDLISLSSGLDLSGLFEVKKKKERRFTAKVSAVEVEEKAKMI 351
Query: 369 GERLGYVVEK-----GKGDVVGLGKLGKMVLLVEVLMEIAPETFVVGVKVVDNSVCGRVA 423
GE+LGYVV+K G+ VVGLG+ G+ V++VE + V
Sbjct: 352 GEKLGYVVKKKMKKEGEAKVVGLGR-GRTVIVVEAVELTVDVV---------VVEVKVVE 401
Query: 424 LEFDEGDWNELQAGLGDIVLSWHTSDVM 451
E D+ W +L L DIVLSWH +D+M
Sbjct: 402 GEEDDSRWFDLITELEDIVLSWH-NDIM 428
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15451212|gb|AAK96877.1| SNF1 related protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 489 bits (1259), Expect = e-135, Method: Compositional matrix adjust.
Identities = 260/447 (58%), Positives = 318/447 (71%), Gaps = 31/447 (6%)
Query: 12 PPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAA 71
P P + LL +Y+LG LG GSFAKVH A+SI +VA+K IEK K +++
Sbjct: 7 PQNQSSPATTPAKILLGKYELGRRLGSGSFAKVHLARSIESDELVAVKIIEKK-KTIESG 65
Query: 72 MEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGK-LRRGRLTESA 130
ME RI+RE+ AMRRL++HPN+LKI EVMATK+KIYLVME A+GGELF K LRRGRL ES
Sbjct: 66 MEPRIIREIDAMRRLRHHPNILKIHEVMATKSKIYLVMELASGGELFSKVLRRGRLPEST 125
Query: 131 ARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTA 190
ARRYFQQL SAL F HQ+GVAHRDVKPQNLLLD GNLKVSDFGLSALPE ++NG+LHTA
Sbjct: 126 ARRYFQQLASALRFSHQDGVAHRDVKPQNLLLDEQGNLKVSDFGLSALPEHLQNGLLHTA 185
Query: 191 CGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQF 250
CGTPAYTAPEV++RRGYDGA ADAWSCGVILFVLL G PFDDSN+ AMY+K++RRDY+F
Sbjct: 186 CGTPAYTAPEVISRRGYDGAKADAWSCGVILFVLLVGDAPFDDSNIAAMYRKIHRRDYRF 245
Query: 251 PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSLFELGVVGNN 310
PS++SK A+S+IYQ+LDPNP TRMSIE +M +WF+KSL E+S F V +
Sbjct: 246 PSWISKQAKSIIYQMLDPNPVTRMSIETVMKTNWFKKSL--------ETSEFHRNVFDSE 297
Query: 311 KYILKEKIPDIVSMNAFDIISLSSGLDLSGLFEAKKRKEKRFTTKEKTERVVEKVKEVGE 370
E + S+ AFD+ISLSSGLDLSGLFEAKK+KE+RF K V EK K +GE
Sbjct: 298 ----VEMKSSVNSITAFDLISLSSGLDLSGLFEAKKKKERRFPAKVSGVEVEEKAKMIGE 353
Query: 371 RLGY------VVEKGKGDVVGLGKLGKMVLLVEVLMEIAPETFVVGVKVVDNSVCGRVAL 424
+LGY + ++G+ VVGLG+ G+ V++VE + V
Sbjct: 354 KLGYVVKKKMMKKEGEVKVVGLGR-GRTVIVVEAVELTVDVV---------VVEVKVVEG 403
Query: 425 EFDEGDWNELQAGLGDIVLSWHTSDVM 451
E D+ W++L L DIVLSWH +D+M
Sbjct: 404 EEDDSRWSDLITELEDIVLSWH-NDIM 429
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388496936|gb|AFK36534.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 486 bits (1251), Expect = e-135, Method: Compositional matrix adjust.
Identities = 256/425 (60%), Positives = 326/425 (76%), Gaps = 21/425 (4%)
Query: 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR 85
+L +YQL LGRG+FAKV++A+S+ DGS VA+K I+K+ K +DA+ME RIVRE+ AMRR
Sbjct: 20 ILGKYQLTKFLGRGNFAKVYQARSLIDGSTVAVKVIDKS-KTVDASMEPRIVREIDAMRR 78
Query: 86 LQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLVSALHF 144
LQNHPN+LKI EV+ATKTKIYL++++A GGELF KL RR + E+ ARRYFQQLVSAL F
Sbjct: 79 LQNHPNILKIHEVLATKTKIYLIVDFAGGGELFLKLARRRKFPEALARRYFQQLVSALCF 138
Query: 145 CHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVAR 204
CH+NG+AHRD+KPQNLLLD +GNLKVS FGLSALPEQ+KNG+LHTACGTPAYTAPE++ R
Sbjct: 139 CHRNGIAHRDLKPQNLLLDAEGNLKVSGFGLSALPEQLKNGLLHTACGTPAYTAPEILGR 198
Query: 205 RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQ 264
GYDG+ ADAWSCGVIL+VLLAG+LPFDDSN+ AM K++ RRDYQFP +SKPAR LIYQ
Sbjct: 199 TGYDGSKADAWSCGVILYVLLAGHLPFDDSNIPAMCKRITRRDYQFPEGISKPARYLIYQ 258
Query: 265 LLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSLFELGVVGNNKYILKEKIPDIVSM 324
LLDPNPKTR+ +E + +WF+KSL+++ E LF+ +KY + +
Sbjct: 259 LLDPNPKTRIRLENVFGNNWFKKSLREE----PEEKLFD------DKYSFDGYKKLELGV 308
Query: 325 NAFDIISLSSGLDLSGLFEAKK-RKEKRFTTKEKTERVVEKVKEVGERLGYVVEKGKGDV 383
+AFDIISLSSGL+LSGLFE R EKRFT+ E+ V EKVKE+G RLG+ VE GK
Sbjct: 309 SAFDIISLSSGLNLSGLFETTTLRSEKRFTSSEEVGVVEEKVKEIGVRLGFRVEIGKNGA 368
Query: 384 VGLGKLGKMVLLVEVLMEIAPETFVVGVKVVDNSVCGRVALEFDEGDWNELQAGLGDIVL 443
+GLGK GK+ ++VEV +I + +V +K+ + LEF++ WN+ + GL D+VL
Sbjct: 369 IGLGK-GKVTMVVEVF-KIVDDLLLVALKLENG------GLEFEDVLWNDWKIGLQDVVL 420
Query: 444 SWHTS 448
SWH +
Sbjct: 421 SWHNN 425
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 451 | ||||||
| TAIR|locus:2129930 | 426 | CIPK4 "CBL-interacting protein | 0.902 | 0.955 | 0.553 | 2.9e-110 | |
| TAIR|locus:2094553 | 429 | CIPK7 "CBL-interacting protein | 0.895 | 0.941 | 0.542 | 3.5e-107 | |
| TAIR|locus:2181047 | 421 | CIPK15 "CBL-interacting protei | 0.707 | 0.757 | 0.523 | 4.3e-86 | |
| TAIR|locus:2183720 | 445 | CIPK5 "CBL-interacting protein | 0.580 | 0.588 | 0.571 | 1.5e-83 | |
| TAIR|locus:2126749 | 441 | SIP3 "SOS3-interacting protein | 0.660 | 0.675 | 0.531 | 5e-83 | |
| TAIR|locus:2152380 | 439 | CIPK20 "CBL-interacting protei | 0.603 | 0.619 | 0.536 | 2.5e-81 | |
| TAIR|locus:2179260 | 488 | CIPK25 "CBL-interacting protei | 0.592 | 0.547 | 0.540 | 2.5e-81 | |
| UNIPROTKB|Q84XC0 | 516 | Q84XC0 "Calcineurin B-like-int | 0.627 | 0.548 | 0.544 | 1.1e-80 | |
| TAIR|locus:2169444 | 456 | CIPK2 "CBL-interacting protein | 0.669 | 0.662 | 0.488 | 7.4e-80 | |
| TAIR|locus:2161273 | 479 | SIP1 "SOS3-interacting protein | 0.634 | 0.597 | 0.523 | 9.7e-80 |
| TAIR|locus:2129930 CIPK4 "CBL-interacting protein kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1089 (388.4 bits), Expect = 2.9e-110, P = 2.9e-110
Identities = 234/423 (55%), Positives = 282/423 (66%)
Query: 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR 85
LL +Y+LG LG GSFAKVH A+SI+ G +VAIK I+K K +D+ ME RI+RE+ AMRR
Sbjct: 17 LLGKYELGRRLGSGSFAKVHVARSISTGELVAIKIIDKQ-KTIDSGMEPRIIREIEAMRR 75
Query: 86 LQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHF 144
L NHPNVLKI EVMATK+KIYLV+EYAAGGELF KL R GRL ESAARRYFQQL SAL F
Sbjct: 76 LHNHPNVLKIHEVMATKSKIYLVVEYAAGGELFTKLIRFGRLNESAARRYFQQLASALSF 135
Query: 145 CHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE-QIKNGMLHTACGTPAYTAPEVVA 203
CH++G+AHRDVKPQNLLLD+ GNLKVSDFGLSALPE + NG+LHTACGTPAYTAPEV+A
Sbjct: 136 CHRDGIAHRDVKPQNLLLDKQGNLKVSDFGLSALPEHRSNNGLLHTACGTPAYTAPEVIA 195
Query: 204 RRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIY 263
+RGYDGA ADAWSCGV LFVLLAGY+PFDD+N++AMY+K+++RDY+FPS++SKPARS+IY
Sbjct: 196 QRGYDGAKADAWSCGVFLFVLLAGYVPFDDANIVAMYRKIHKRDYRFPSWISKPARSIIY 255
Query: 264 QLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSLFELGVVGNNKYILKEKIPDIVS 323
+LLDPNP+TRMSIE +M WFQKSL+ +SS+FEL ++++ KE +
Sbjct: 256 KLLDPNPETRMSIEAVMGTVWFQKSLEISEF---QSSVFEL-----DRFLEKEA-KSSNA 306
Query: 324 MNAFXXXXXXXXXXXXXXFEAXXXXXXXXXXXXXXXXXXXXXXXXGERLGYXXXXXXXXX 383
+ AF FE GE+LG+
Sbjct: 307 ITAFDLISLSSGLDLSGLFERRKRKEKRFTARVSAERVVEKAGMIGEKLGFRVEKKEETK 366
Query: 384 XXXXXXXXXXXXXXXXXXIAPETFVVGVKVVDNSVCGRVALEFDEGDWNELQAGLGDIVL 443
A V VKVV V G E E W+EL L +IVL
Sbjct: 367 VVGLGKGRTAVVVEVVE-FAEGLVVADVKVV---VEGEEEEEEVESHWSELIVELEEIVL 422
Query: 444 SWH 446
SWH
Sbjct: 423 SWH 425
|
|
| TAIR|locus:2094553 CIPK7 "CBL-interacting protein kinase 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1060 (378.2 bits), Expect = 3.5e-107, P = 3.5e-107
Identities = 229/422 (54%), Positives = 276/422 (65%)
Query: 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR 85
LL +Y+LG LG GSFAKVH A+SI +VA+K IEK K +++ ME RI+RE+ AMRR
Sbjct: 21 LLGKYELGRRLGSGSFAKVHLARSIESDELVAVKIIEKK-KTIESGMEPRIIREIDAMRR 79
Query: 86 LQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGK-LRRGRLTESAARRYFQQLVSALHF 144
L++HPN+LKI EVMATK+KIYLVME A+GGELF K LRRGRL ES ARRYFQQL SAL F
Sbjct: 80 LRHHPNILKIHEVMATKSKIYLVMELASGGELFSKVLRRGRLPESTARRYFQQLASALRF 139
Query: 145 CHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVAR 204
HQ+GVAHRDVKPQNLLLD GNLKVSDFGLSALPE ++NG+LHTACGTPAYTAPEV++R
Sbjct: 140 SHQDGVAHRDVKPQNLLLDEQGNLKVSDFGLSALPEHLQNGLLHTACGTPAYTAPEVISR 199
Query: 205 RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQ 264
RGYDGA ADAWSCGVILFVLL G +PFDDSN+ AMY+K++RRDY+FPS++SK A+S+IYQ
Sbjct: 200 RGYDGAKADAWSCGVILFVLLVGDVPFDDSNIAAMYRKIHRRDYRFPSWISKQAKSIIYQ 259
Query: 265 LLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSLFELGVVGNNKYILKEKIPDIVSM 324
+LDPNP TRMSIE +M +WF+KSL E+S F V +++ +K + S+
Sbjct: 260 MLDPNPVTRMSIETVMKTNWFKKSL--------ETSEFHRNVF-DSEVEMKSSVN---SI 307
Query: 325 NAFXXXXXXXXXXXXXXFEAXXXXXXXXXXXXXXXXXXXXXXXXGERLGYXXXXXXXXXX 384
AF FEA GE+LGY
Sbjct: 308 TAFDLISLSSGLDLSGLFEAKKKKERRFTAKVSGVEVEEKAKMIGEKLGYVVKKKMMKKE 367
Query: 385 XXXXXXXXXXXXXXXXXIAPETFVVGVKVVDNSVCGRVALEFDEGDWNELQAGLGDIVLS 444
A E V V VV+ V V E D+ W++L L DIVLS
Sbjct: 368 GEVKVVGLGRGRTVIVVEAVE-LTVDVVVVEVKV---VEGEEDDSRWSDLITELEDIVLS 423
Query: 445 WH 446
WH
Sbjct: 424 WH 425
|
|
| TAIR|locus:2181047 CIPK15 "CBL-interacting protein kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 861 (308.1 bits), Expect = 4.3e-86, P = 4.3e-86
Identities = 170/325 (52%), Positives = 227/325 (69%)
Query: 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREV 80
KK L+ RY++G LG+G+FAKV+ A+ + G VAIK I+K + L M ++I RE+
Sbjct: 3 KKGSVLMLRYEVGKFLGQGTFAKVYHARHLKTGDSVAIKVIDKE-RILKVGMTEQIKREI 61
Query: 81 SAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVS 140
SAMR L+ HPN++++ EVMATK+KIY VME+ GGELF K+ G+L E AR+YFQQLV
Sbjct: 62 SAMRLLR-HPNIVELHEVMATKSKIYFVMEHVKGGELFNKVSTGKLREDVARKYFQQLVR 120
Query: 141 ALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK-NGMLHTACGTPAYTAP 199
A+ FCH GV HRD+KP+NLLLD GNLK+SDFGLSAL + + +G+LHT CGTPAY AP
Sbjct: 121 AVDFCHSRGVCHRDLKPENLLLDEHGNLKISDFGLSALSDSRRQDGLLHTTCGTPAYVAP 180
Query: 200 EVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPAR 259
EV++R GYDG AD WSCGVILFVLLAGYLPF DSNL+ +YKK+ + + +FP++++ A+
Sbjct: 181 EVISRNGYDGFKADVWSCGVILFVLLAGYLPFRDSNLMELYKKIGKAEVKFPNWLAPGAK 240
Query: 260 SLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRG-QESSLFELGVVGNNKYILKEKI 318
L+ ++LDPNP TR+S EKIM SWF+K LQ++ K +E + + GN KEK
Sbjct: 241 RLLKRILDPNPNTRVSTEKIMKSSWFRKGLQEEVKESVEEETEVDAEAEGNAS-AEKEK- 298
Query: 319 PDIVSMNAFXXXXXXXXXXXXXXFE 343
+++NAF FE
Sbjct: 299 KRCINLNAFEIISLSTGFDLSGLFE 323
|
|
| TAIR|locus:2183720 CIPK5 "CBL-interacting protein kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 800 (286.7 bits), Expect = 1.5e-83, Sum P(2) = 1.5e-83
Identities = 151/264 (57%), Positives = 200/264 (75%)
Query: 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR 85
L +Y++G LLG+G+FAKV+ K I G VAIK I K+ M ++I RE+S M+
Sbjct: 8 LFGKYEMGRLLGKGTFAKVYYGKEIIGGECVAIKVINKDQVMKRPGMMEQIKREISIMK- 66
Query: 86 LQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFC 145
L HPN+++++EVMATKTKI+ VME+ GGELF K+ +G+L E AARRYFQQL+SA+ +C
Sbjct: 67 LVRHPNIVELKEVMATKTKIFFVMEFVKGGELFCKISKGKLHEDAARRYFQQLISAVDYC 126
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI-KNGMLHTACGTPAYTAPEVVAR 204
H GV+HRD+KP+NLLLD +G+LK+SDFGLSALPEQI ++G+LHT CGTPAY APEV+ +
Sbjct: 127 HSRGVSHRDLKPENLLLDENGDLKISDFGLSALPEQILQDGLLHTQCGTPAYVAPEVLKK 186
Query: 205 RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQ 264
+GYDGA AD WSCGV+L+VLLAG LPF D NL+ MY+K+ R D++FP + S AR LI +
Sbjct: 187 KGYDGAKADIWSCGVVLYVLLAGCLPFQDENLMNMYRKIFRADFEFPPWFSPEARRLISK 246
Query: 265 LLDPNPKTRMSIEKIMSISWFQKS 288
LL +P R+SI IM W +K+
Sbjct: 247 LLVVDPDRRISIPAIMRTPWLRKN 270
|
|
| TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 832 (297.9 bits), Expect = 5.0e-83, P = 5.0e-83
Identities = 161/303 (53%), Positives = 216/303 (71%)
Query: 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR 85
L RY+LG LLG G+FAKV+ A++I G VA+K + K K + M D+I RE+S MR
Sbjct: 20 LHGRYELGRLLGHGTFAKVYHARNIQTGKSVAMKVVGKE-KVVKVGMVDQIKREISVMRM 78
Query: 86 LQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFC 145
++ HPN++++ EVMA+K+KIY ME GGELF K+ +GRL E AR YFQQL+SA+ FC
Sbjct: 79 VK-HPNIVELHEVMASKSKIYFAMELVRGGELFAKVAKGRLREDVARVYFQQLISAVDFC 137
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK-NGMLHTACGTPAYTAPEVVAR 204
H GV HRD+KP+NLLLD +GNLKV+DFGLSA E +K +G+LHT CGTPAY APEV+ +
Sbjct: 138 HSRGVYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTPAYVAPEVILK 197
Query: 205 RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQ 264
+GYDGA AD WSCGVILFVLLAGYLPF D NL+ MY+K+ R D++ P ++S AR L+ +
Sbjct: 198 KGYDGAKADLWSCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWLSSDARRLVTK 257
Query: 265 LLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSLFELGVVGNNKYILKEKIPDIVSM 324
LLDPNP TR++IEK+M WF+K Q R R + + + +++ + + ++
Sbjct: 258 LLDPNPNTRITIEKVMDSPWFKK--QATRSRNEPVAATITTTEEDVDFLVHKSKEETETL 315
Query: 325 NAF 327
NAF
Sbjct: 316 NAF 318
|
|
| TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 798 (286.0 bits), Expect = 2.5e-81, Sum P(2) = 2.5e-81
Identities = 148/276 (53%), Positives = 207/276 (75%)
Query: 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR 85
L+ +Y+LG LLG+G+FAKV+ A++I G VAIK I+K K + D+I RE+S MR
Sbjct: 8 LMRKYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQ-KVAKVGLIDQIKREISVMR- 65
Query: 86 LQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFC 145
L HP+V+ + EVMA+KTKIY MEY GGELF K+ +G+L E+ AR+YFQQL+ A+ +C
Sbjct: 66 LVRHPHVVFLHEVMASKTKIYFAMEYVKGGELFDKVSKGKLKENIARKYFQQLIGAIDYC 125
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE-QIKNGMLHTACGTPAYTAPEVVAR 204
H GV HRD+KP+NLLLD +G+LK+SDFGLSAL E + ++G+LHT CGTPAY APEV+ +
Sbjct: 126 HSRGVYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAPEVIGK 185
Query: 205 RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQ 264
+GYDGA AD WSCGV+L+VLLAG+LPF + NL+ MY+K+ + +++ P++ + L+ +
Sbjct: 186 KGYDGAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVKKLLSR 245
Query: 265 LLDPNPKTRMSIEKIMSISWFQKSLQQ-QRKRGQES 299
+LDPNP +R+ IEKIM SWFQK ++ + + ES
Sbjct: 246 ILDPNPNSRIKIEKIMENSWFQKGFKKIETPKSPES 281
|
|
| TAIR|locus:2179260 CIPK25 "CBL-interacting protein kinase 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 790 (283.2 bits), Expect = 2.5e-81, Sum P(2) = 2.5e-81
Identities = 146/270 (54%), Positives = 205/270 (75%)
Query: 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREV 80
+++ L +Y++G LLG+G+F KV+ K I G VAIK I K+ + ME +I RE+
Sbjct: 34 QQLRVLFAKYEMGRLLGKGTFGKVYYGKEITTGESVAIKIINKDQVKREGMME-QIKREI 92
Query: 81 SAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVS 140
S MR L HPN+++++EVMATKTKI+ +MEY GGELF K+ +G+L E +AR+YFQQL+S
Sbjct: 93 SIMR-LVRHPNIVELKEVMATKTKIFFIMEYVKGGELFSKIVKGKLKEDSARKYFQQLIS 151
Query: 141 ALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI-KNGMLHTACGTPAYTAP 199
A+ FCH GV+HRD+KP+NLL+D +G+LKVSDFGLSALPEQI ++G+LHT CGTPAY AP
Sbjct: 152 AVDFCHSRGVSHRDLKPENLLVDENGDLKVSDFGLSALPEQILQDGLLHTQCGTPAYVAP 211
Query: 200 EVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPAR 259
EV+ ++GYDGA D WSCG+IL+VLLAG+LPF D NL+ MY+K+ + ++++P + S ++
Sbjct: 212 EVLRKKGYDGAKGDIWSCGIILYVLLAGFLPFQDENLMKMYRKIFKSEFEYPPWFSPESK 271
Query: 260 SLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289
LI +LL +P R+SI IM WF+K++
Sbjct: 272 RLISKLLVVDPNKRISIPAIMRTPWFRKNI 301
|
|
| UNIPROTKB|Q84XC0 Q84XC0 "Calcineurin B-like-interacting protein kinase" [Pisum sativum (taxid:3888)] | Back alignment and assigned GO terms |
|---|
Score = 810 (290.2 bits), Expect = 1.1e-80, P = 1.1e-80
Identities = 158/290 (54%), Positives = 213/290 (73%)
Query: 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR 85
LL R++LG LLG G+FAKVH AK+I G VAIK I K+ K L + + I RE+S +RR
Sbjct: 22 LLGRFELGKLLGHGTFAKVHLAKNIKTGEAVAIKIISKD-KILKSGLVSHIKREISILRR 80
Query: 86 LQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFC 145
++ HPN++++ EVMATKTKIY VMEY GGELF K+ +GRL E AR+YFQQL+ A+ FC
Sbjct: 81 VR-HPNIVQLFEVMATKTKIYFVMEYVRGGELFNKVAKGRLKEEVARKYFQQLICAVEFC 139
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK-NGMLHTACGTPAYTAPEVVAR 204
H GV HRD+KP+NLLLD +GNLKVSDFGLSA+ ++IK +G+ HT CGTPAY APEV++R
Sbjct: 140 HARGVFHRDIKPENLLLDENGNLKVSDFGLSAVSDEIKQDGLFHTFCGTPAYVAPEVLSR 199
Query: 205 RGYDGAVADAWSCGVILFVLLAGYLPFDD-SNLLAMYKKVNRRDYQFPSFVSKPARSLIY 263
+GYDG D WSCGV+LFVL+AGYLPF D +N++ MYKK+ + D++ P + S +L+
Sbjct: 200 KGYDGGKVDIWSCGVVLFVLMAGYLPFHDPNNVMVMYKKIYKGDFRCPRWFSPELVNLLT 259
Query: 264 QLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQES---SLFELGVVGNN 310
+LLD P+TR+SI +IM WF+ ++ + ++ +L LG+ GNN
Sbjct: 260 RLLDTKPQTRISIPEIMENRWFKIGFKRIKFYVEDDVVCNLDSLGLDGNN 309
|
|
| TAIR|locus:2169444 CIPK2 "CBL-interacting protein kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 783 (280.7 bits), Expect = 7.4e-80, Sum P(2) = 7.4e-80
Identities = 154/315 (48%), Positives = 222/315 (70%)
Query: 24 PTLLN-RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSA 82
P++L RY++G LLG+G+FAKV+ +S VAIK I+K+ K + + +I RE+S
Sbjct: 5 PSVLTERYEVGRLLGQGTFAKVYFGRSNHTNESVAIKMIDKD-KVMRVGLSQQIKREISV 63
Query: 83 MRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSAL 142
MR + HPNV+++ EVMATK++IY V+EY GGELF K+ +G+L E A +YF QL+SA+
Sbjct: 64 MR-IAKHPNVVELYEVMATKSRIYFVIEYCKGGELFNKVAKGKLKEDVAWKYFYQLISAV 122
Query: 143 HFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE-QIKNGMLHTACGTPAYTAPEV 201
FCH GV HRD+KP+NLLLD + NLKVSDFGLSAL + + ++G+LHT CGTPAY APEV
Sbjct: 123 DFCHSRGVYHRDIKPENLLLDDNDNLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPEV 182
Query: 202 VARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSL 261
+ R+GY+G AD WSCGV+LFVLLAGYLPF D+NL+ MY+K+ + D++ PS+ + + L
Sbjct: 183 INRKGYEGTKADIWSCGVVLFVLLAGYLPFHDTNLMEMYRKIGKADFKCPSWFAPEVKRL 242
Query: 262 IYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQE---------SSLFELGVVGNNKY 312
+ ++LDPN +TR++I KI SWF+K L ++K+ ++ ++ E G G N+
Sbjct: 243 LCKMLDPNHETRITIAKIKESSWFRKGLHLKQKKMEKMEKQQVREATNPMEAGGSGQNEN 302
Query: 313 ILKEKIPDIVSMNAF 327
+ P + ++NAF
Sbjct: 303 GENHEPPRLATLNAF 317
|
|
| TAIR|locus:2161273 SIP1 "SOS3-interacting protein 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 801 (287.0 bits), Expect = 9.7e-80, P = 9.7e-80
Identities = 154/294 (52%), Positives = 214/294 (72%)
Query: 24 PTLL-NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSA 82
P++L ++Y +G LLG+G+FAKV+ +SI VAIK I+K K + + ++I RE+S
Sbjct: 5 PSVLTDKYDVGRLLGQGTFAKVYYGRSILTNQSVAIKMIDKE-KVMKVGLIEQIKREISV 63
Query: 83 MRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSAL 142
MR + HPNV+++ EVMATKT+IY VMEY GGELF K+ +G+L + A +YF QL++A+
Sbjct: 64 MR-IARHPNVVELYEVMATKTRIYFVMEYCKGGELFNKVAKGKLRDDVAWKYFYQLINAV 122
Query: 143 HFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE-QIKNGMLHTACGTPAYTAPEV 201
FCH V HRD+KP+NLLLD + NLKVSDFGLSAL + + ++G+LHT CGTPAY APEV
Sbjct: 123 DFCHSREVYHRDIKPENLLLDDNENLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPEV 182
Query: 202 VARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSL 261
+ R+GYDG AD WSCGV+LFVLLAGYLPF DSNL+ MY+K+ + D++ PS+ + R L
Sbjct: 183 INRKGYDGTKADIWSCGVVLFVLLAGYLPFHDSNLMEMYRKIGKADFKAPSWFAPEVRRL 242
Query: 262 IYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRK----RGQESSLFELGVVGNNK 311
+ ++LDPNP+TR++I +I SWF+K L ++K R +E + E G G N+
Sbjct: 243 LCKMLDPNPETRITIARIRESSWFRKGLHMKQKKMEKRVKEINSVEAGTAGTNE 296
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q75GK4 | CIPK7_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.5034 | 0.9157 | 0.9239 | yes | no |
| Q9SUL7 | CIPK4_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6204 | 0.9246 | 0.9788 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 451 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-99 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-84 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-74 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-66 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-65 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-65 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-62 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-57 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-57 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-55 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-55 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-52 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-50 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-49 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-48 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-48 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-47 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-46 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-45 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-45 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-45 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-44 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-44 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-44 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-44 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-43 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-42 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-42 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-42 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-42 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-42 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-41 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-41 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-41 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-41 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-40 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-40 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-40 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-40 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-40 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-40 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-40 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-39 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-39 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-39 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-39 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-39 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-38 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-38 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-38 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-38 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-38 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-37 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-37 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-37 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-36 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-36 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-36 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-36 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-36 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-36 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-36 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-35 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-35 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-35 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-35 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-34 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-34 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-34 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-34 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-34 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-34 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-34 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-34 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-33 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-33 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-33 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-33 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-33 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-33 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-32 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-32 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-32 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-32 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-32 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-31 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-31 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-31 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-31 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-31 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-30 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-30 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-30 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-30 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-29 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-29 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-29 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-29 | |
| cd12195 | 116 | cd12195, CIPK_C, C-terminal regulatory domain of C | 6e-29 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-28 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-28 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-28 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-28 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-28 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-28 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-28 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-28 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-27 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-27 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-27 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-27 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-27 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-27 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-27 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-26 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-26 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-26 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-26 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-26 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-25 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-25 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-25 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-25 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-25 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-25 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-25 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-24 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-24 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-24 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-24 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-24 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-24 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-24 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-24 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-24 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-24 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-24 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-23 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-23 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-23 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-23 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-23 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-23 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-23 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-23 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-23 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-22 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-22 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-22 | |
| pfam03822 | 58 | pfam03822, NAF, NAF domain | 8e-22 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-21 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-21 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-21 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-21 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-21 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-21 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-21 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-21 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-21 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-21 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-21 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-21 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-20 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-20 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-20 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-20 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-20 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-20 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-20 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-20 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-19 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-19 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-19 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-19 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-19 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-19 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-18 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-18 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-18 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-18 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-17 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-17 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-17 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-16 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-16 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-16 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-16 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-16 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-16 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-14 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-14 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-14 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-14 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-13 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-11 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-10 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-10 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 6e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-08 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-05 | |
| PRK09188 | 365 | PRK09188, PRK09188, serine/threonine protein kinas | 2e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-05 | |
| PRK12274 | 218 | PRK12274, PRK12274, serine/threonine protein kinas | 5e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 4e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 0.002 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.003 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.003 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 297 bits (764), Expect = 1e-99
Identities = 111/261 (42%), Positives = 164/261 (62%), Gaps = 12/261 (4%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89
Y++ LG GSF KV+ A+ G +VAIK I+K D +RI+RE+ +++L H
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD---RERILREIKILKKL-KH 56
Query: 90 PNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQN 148
PN++++ +V + K+YLVMEY GG+LF L+ RGRL+E AR Y +Q++SAL + H
Sbjct: 57 PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSK 116
Query: 149 GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYD 208
G+ HRD+KP+N+LLD DG++K++DFGL+ + L T GTP Y APEV+ +GY
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLAR--QLDPGEKLTTFVGTPEYMAPEVLLGKGYG 174
Query: 209 GAVADAWSCGVILFVLLAGYLPF-DDSNLLAMYKKVNRRDYQFPSF---VSKPARSLIYQ 264
AV D WS GVIL+ LL G PF D LL ++KK+ + FP +S A+ LI +
Sbjct: 175 KAV-DIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRK 233
Query: 265 LLDPNPKTRMSIEKIMSISWF 285
LL +P+ R++ E+ + +F
Sbjct: 234 LLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 259 bits (663), Expect = 3e-84
Identities = 101/264 (38%), Positives = 148/264 (56%), Gaps = 12/264 (4%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89
Y+L LG GSF V+KAK G IVA+K ++K + + + RE+ +RRL +H
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKK--RSEKSKKDQTARREIRILRRL-SH 57
Query: 90 PNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQN 148
PN++++ + K +YLVMEY GG+LF L R G L+E A++ Q++ L + H N
Sbjct: 58 PNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 149 GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYD 208
G+ HRD+KP+N+LLD +G +K++DFGL+ + L T GTP Y APEV+
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLL-KSSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 209 GAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR-------DYQFPSFVSKPARSL 261
G D WS GVIL+ LL G PF N+L + + R D S S+ A+ L
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDL 236
Query: 262 IYQLLDPNPKTRMSIEKIMSISWF 285
I + L+ +P R + E+I+ WF
Sbjct: 237 IKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 233 bits (597), Expect = 2e-74
Identities = 102/259 (39%), Positives = 152/259 (58%), Gaps = 18/259 (6%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK- 94
LG+GSF KV + G + A+K ++K K + + + E + + R+ NHP ++K
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKK-KIIKRKEVEHTLTERNILSRI-NHPFIVKL 58
Query: 95 ---IQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGV 150
Q T+ K+YLV+EYA GGELF L + GR +E AR Y ++V AL + H G+
Sbjct: 59 HYAFQ----TEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGI 114
Query: 151 AHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML-HTACGTPAYTAPEVVARRGYDG 209
+RD+KP+N+LLD DG++K++DFGL+ E G +T CGTP Y APEV+ +GY
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAK--ELSSEGSRTNTFCGTPEYLAPEVLLGKGYGK 172
Query: 210 AVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPN 269
AV D WS GV+L+ +L G PF + +Y+K+ + +FP F+S AR LI LL +
Sbjct: 173 AV-DWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKD 231
Query: 270 PKTRM---SIEKIMSISWF 285
P R+ E+I + +F
Sbjct: 232 PTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 5e-66
Identities = 87/249 (34%), Positives = 134/249 (53%), Gaps = 39/249 (15%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
LG G F V+ A+ G VAIK I+K + +++ + ++RE+ +++L NHPN++K+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS---SSLLEELLREIEILKKL-NHPNIVKL 56
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHR 153
V + +YLVMEY GG L L+ G+L+E R Q++ L + H NG+ HR
Sbjct: 57 YGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116
Query: 154 DVKPQNLLLD-RDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVA 212
D+KP+N+LLD +G +K++DFGLS L K+ +L T GTPAY APEV+ +GY +
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 213 DAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKT 272
D WS GVIL+ L + LI ++L +P+
Sbjct: 176 DIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEK 204
Query: 273 RMSIEKIMS 281
R S ++I+
Sbjct: 205 RPSAKEILE 213
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 212 bits (541), Expect = 1e-65
Identities = 94/263 (35%), Positives = 146/263 (55%), Gaps = 13/263 (4%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89
++ LG GSF +V + G A+K + K K + + ++ E ++ + H
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKA-KIVKLKQVEHVLNEKRILQSI-RH 60
Query: 90 PNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQN 148
P ++ + + +YLVMEY GGELF LR+ GR E AR Y Q+V AL + H
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 149 GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYD 208
+ +RD+KP+NLLLD DG +K++DFG + +++K +T CGTP Y APE++ +GY
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFA---KRVKGRT-YTLCGTPEYLAPEIILSKGYG 176
Query: 209 GAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDP 268
AV D W+ G++++ +LAGY PF D N + +Y+K+ +FPSF S A+ LI LL
Sbjct: 177 KAV-DWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQV 235
Query: 269 NPKTRM-----SIEKIMSISWFQ 286
+ R+ + I + WF
Sbjct: 236 DLTKRLGNLKNGVNDIKNHPWFA 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 2e-65
Identities = 84/254 (33%), Positives = 136/254 (53%), Gaps = 11/254 (4%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94
+G+GSF KV+ + +DG + +K I + + + + EV +++L NHPN++K
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEI--DLSNMSEKEREDALNEVKILKKL-NHPNIIK 63
Query: 95 IQEVMATKTKIYLVMEYAAGGELFGKLRRGR-----LTESAARRYFQQLVSALHFCHQNG 149
E K K+ +VMEYA GG+L K+++ + E +F QL AL + H
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK 123
Query: 150 VAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDG 209
+ HRD+KPQN+ L +G +K+ DFG+S + + + T GTP Y +PE+ + Y+
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD-LAKTVVGTPYYLSPELCQNKPYN- 181
Query: 210 AVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY-QFPSFVSKPARSLIYQLLDP 268
+D WS G +L+ L PF+ NLL + K+ + Y PS S R+L+ LL
Sbjct: 182 YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQK 241
Query: 269 NPKTRMSIEKIMSI 282
+P+ R SI +I+
Sbjct: 242 DPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 5e-62
Identities = 92/263 (34%), Positives = 140/263 (53%), Gaps = 16/263 (6%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
+ +G++ +V AK + G I AIK I+K + D+++ E + + Q+ P V+K+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKN-QVDQVLTERDILSQAQS-PYVVKL 58
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRD 154
K +YLVMEY GG+L L G L E AR Y ++V AL + H NG+ HRD
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRD 118
Query: 155 VKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML-------HTACGTPAYTAPEVVARRGY 207
+KP N+L+D +G+LK++DFGLS + + L GTP Y APEV+ +G+
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178
Query: 208 DGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSF--VSKPARSLIYQL 265
D WS G IL+ L G PF +++ + ++P VS A LI +L
Sbjct: 179 -SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKL 237
Query: 266 LDPNPKTRM---SIEKIMSISWF 285
L P+P+ R+ SIE+I + +F
Sbjct: 238 LVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 2e-57
Identities = 81/271 (29%), Positives = 135/271 (49%), Gaps = 24/271 (8%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAM-EDRIVREVSAMRRL 86
+ ++ G ++G GSF+ V AK AIK ++K + L + E + RL
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDK--RQLIKEKKVKYVKIEKEVLTRL 58
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFC 145
HP ++K+ + +Y V+EYA GEL +R+ G L E R Y +++ AL +
Sbjct: 59 NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYL 118
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS------ALPEQIKNGMLHTA--------- 190
H G+ HRD+KP+N+LLD+D ++K++DFG + + PE K +
Sbjct: 119 HSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 191 ----CGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR 246
GT Y +PE++ G +D W+ G I++ +L G PF SN ++K+ +
Sbjct: 179 FASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237
Query: 247 DYQFPSFVSKPARSLIYQLLDPNPKTRMSIE 277
+Y FP A+ LI +LL +P+ R+ +
Sbjct: 238 EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVN 268
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 3e-57
Identities = 79/259 (30%), Positives = 135/259 (52%), Gaps = 15/259 (5%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN 88
+ G LLGRGSF V+ A G ++A+K++E + + + + RE+ + LQ
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEEL--EALEREIRILSSLQ- 57
Query: 89 HPNVLKIQ----EVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALH 143
HPN+ ++ E K + + +EY +GG L L++ G+L E R+Y +Q++ L
Sbjct: 58 HPNI--VRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLA 115
Query: 144 FCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA-LPEQIKNGMLHTACGTPAYTAPEVV 202
+ H NG+ HRD+K N+L+D DG +K++DFG + L + + GTP + APEV+
Sbjct: 116 YLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 203 ARRGYDGAVADAWSCGVILFVLLAGYLPFDD-SNLLAMYKKVNRRDY--QFPSFVSKPAR 259
R G AD WS G + + G P+ + N +A K+ + P +S+ A+
Sbjct: 176 -RGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAK 234
Query: 260 SLIYQLLDPNPKTRMSIEK 278
+ + L +PK R + ++
Sbjct: 235 DFLRKCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 183 bits (468), Expect = 2e-55
Identities = 82/260 (31%), Positives = 136/260 (52%), Gaps = 9/260 (3%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN 88
YQLG L+GRG+F V+K ++ G VAIK I +A I++E+ ++ L
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKS--IMQEIDLLKNL-K 57
Query: 89 HPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQ 147
HPN++K + T +Y+++EYA G L +++ G ES Y Q++ L + H+
Sbjct: 58 HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHE 117
Query: 148 NGVAHRDVKPQNLLLDRDGNLKVSDFGLSA-LPEQIKNGMLHTACGTPAYTAPEVVARRG 206
GV HRD+K N+L +DG +K++DFG++ L + K+ + GTP + APEV+ G
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSG 175
Query: 207 YDGAVADAWSCGVILFVLLAGYLPFDDSN-LLAMYKKVNRRDYQFPSFVSKPARSLIYQL 265
A +D WS G + LL G P+ D N + A+++ V P +S + + Q
Sbjct: 176 ASTA-SDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQC 234
Query: 266 LDPNPKTRMSIEKIMSISWF 285
+P R + ++++ W
Sbjct: 235 FQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 5e-55
Identities = 95/263 (36%), Positives = 146/263 (55%), Gaps = 17/263 (6%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
LG G F +V K + A+K ++K + + ++ I E + NHP ++K+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV-ETGQQEHIFSEKEILEEC-NHPFIVKL 58
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQNGVAHRD 154
K IY++MEY GGEL+ LR RG E AR Y +V A + H G+ +RD
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRD 118
Query: 155 VKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML-HTACGTPAYTAPEVVARRGYDGAVAD 213
+KP+NLLLD +G +K+ DFG + +++K+G T CGTP Y APE++ +GYD +V D
Sbjct: 119 LKPENLLLDSNGYVKLVDFGFA---KKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSV-D 174
Query: 214 AWSCGVILFVLLAGYLPF--DDSNLLAMYKKVNRRDYQ--FPSFVSKPARSLIYQLLDPN 269
WS G++L+ LL G PF DD + + +Y + + + + FP+++ K A+ LI QLL N
Sbjct: 175 YWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN 234
Query: 270 PKTRM-----SIEKIMSISWFQK 287
P+ R+ I+ I WF
Sbjct: 235 PEERLGNLKGGIKDIKKHKWFNG 257
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 1e-52
Identities = 82/266 (30%), Positives = 138/266 (51%), Gaps = 22/266 (8%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89
Y++ +G+GSF V K + +DG I+ K I+ N + + ++V EV+ +R L+ H
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN--MTEKEKQQLVSEVNILRELK-H 58
Query: 90 PNVLKI--QEVMATKTKIYLVMEYAAGGELFGKLRR-----GRLTESAARRYFQQLVSAL 142
PN+++ + + + +Y+VMEY GG+L +++ + E R QL+ AL
Sbjct: 59 PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118
Query: 143 HFCH-----QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYT 197
+ CH N V HRD+KP N+ LD + N+K+ DFGL+ + + T GTP Y
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH-DSSFAKTYVGTPYYM 177
Query: 198 APEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQF---PSFV 254
+PE + YD +D WS G +++ L A PF N L + K+ ++ +F P
Sbjct: 178 SPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKI--KEGKFRRIPYRY 234
Query: 255 SKPARSLIYQLLDPNPKTRMSIEKIM 280
S +I +L+ +P R S E+++
Sbjct: 235 SSELNEVIKSMLNVDPDKRPSTEELL 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 1e-50
Identities = 91/301 (30%), Positives = 138/301 (45%), Gaps = 52/301 (17%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
+ +++ ++GRG+F +V + G + A+K + K D I R A R +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRK---------SDMIKRNQIAHVRAE 51
Query: 88 -------NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLV 139
+ P ++K+ + +YLVMEY GG+L L R+ E AR Y +LV
Sbjct: 52 RDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV 111
Query: 140 SALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA---------------------- 177
AL H+ G HRD+KP N+L+D DG++K++DFGL
Sbjct: 112 LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 178 ------LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPF 231
+ + ++ GTP Y APEV+ Y D WS GVIL+ +L G+ PF
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLEC-DWWSLGVILYEMLYGFPPF 230
Query: 232 DDSNLLAMYKKV--NRRDYQFPSF--VSKPARSLIYQLLDPNPKTRM-SIEKIMSISWFQ 286
L Y K+ + +FP VS A LI +LL P+ R+ S E+I S +F+
Sbjct: 231 YSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCD-PEDRLGSFEEIKSHPFFK 289
Query: 287 K 287
Sbjct: 290 G 290
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 172 bits (436), Expect = 2e-49
Identities = 93/282 (32%), Positives = 141/282 (50%), Gaps = 29/282 (10%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89
Y++ LG GSF +V+ A+ +VA+K + K + +E R +RE+ + L +
Sbjct: 2 YRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVE-RFLREIQILASLNHP 57
Query: 90 PNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR----RGRLTESAARRYFQQLVSALHFC 145
PN++K+ + + +YLVMEY GG L L+ +G L+ES A Q++SAL +
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 146 HQNGVAHRDVKPQNLLLDRDGN-LKVSDFGLSAL-----PEQIKNGMLHTACGTPAYTAP 199
H G+ HRD+KP+N+LLDRDG +K+ DFGL+ L + T+ GTP Y AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 200 EVV--ARRGYDGAVADAWSCGVILFVLLAGYLPFD----DSNLLAMYKKVNRRDYQ---- 249
EV+ Y + +D WS G+ L+ LL G PF+ S K +
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 250 -----FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQ 286
P +SK A L+ +LL +PK R+S +S
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 1e-48
Identities = 88/250 (35%), Positives = 140/250 (56%), Gaps = 10/250 (4%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
L+ +++G LG GSF +V AK G AIK ++K + L + +E S + L
Sbjct: 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKR-EILKMKQVQHVAQEKSILMEL 75
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFC 145
+HP ++ + + ++Y ++E+ GGELF LR+ GR A+ Y +LV A +
Sbjct: 76 -SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYL 134
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA-LPEQIKNGMLHTACGTPAYTAPEVVAR 204
H + +RD+KP+NLLLD G++KV+DFG + +P++ T CGTP Y APEV+
Sbjct: 135 HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQS 189
Query: 205 RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQ 264
+G+ AV D W+ GV+L+ +AGY PF D +Y+K+ +FP++ AR L+
Sbjct: 190 KGHGKAV-DWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKG 248
Query: 265 LLDPNPKTRM 274
LL + R+
Sbjct: 249 LLQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 3e-48
Identities = 80/259 (30%), Positives = 136/259 (52%), Gaps = 17/259 (6%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89
+++ +G+G F +V+KA+ G VAIK I+ +K +++I+ E+ +++ H
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKC-KH 56
Query: 90 PNVLKIQEVMATKTKIYLVMEYAAGG---ELFGKLRRGRLTESAARRYFQQLVSALHFCH 146
PN++K K ++++VME+ +GG +L K LTES ++L+ L + H
Sbjct: 57 PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLL-KSTNQTLTESQIAYVCKELLKGLEYLH 115
Query: 147 QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML-HTACGTPAYTAPEVVARR 205
NG+ HRD+K N+LL DG +K+ DFGLSA Q+ + +T GTP + APEV+ +
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGK 172
Query: 206 GYDGAVADAWSCGVILFVLLAGYLPFDDSN-LLAMYKKVNRRDYQF--PSFVSKPARSLI 262
YD AD WS G+ L G P+ + + A++K P S + +
Sbjct: 173 PYDYK-ADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFL 231
Query: 263 YQLLDPNPKTRMSIEKIMS 281
+ L NP+ R + E+++
Sbjct: 232 KKCLQKNPEKRPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 6e-47
Identities = 79/264 (29%), Positives = 144/264 (54%), Gaps = 13/264 (4%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89
+ +G G+F +VH + A+K + + + E + E ++ + +H
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALK-VMAIPEVIRLKQEQHVHNEKRVLKEV-SH 60
Query: 90 PNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQN 148
P ++++ + +Y++MEY GGELF LR GR + S Y ++V AL + H
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 149 GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYD 208
+ +RD+KP+N+LLD++G++K++DFG + +++++ T CGTP Y APEV+ +G++
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFA---KKLRD-RTWTLCGTPEYLAPEVIQSKGHN 176
Query: 209 GAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDP 268
AV D W+ G++++ +L GY PF D N +Y+K+ +FP + A+ LI +LL
Sbjct: 177 KAV-DWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVV 235
Query: 269 NPKTRMSIEK-----IMSISWFQK 287
+ R+ K + + WF+
Sbjct: 236 DRTRRLGNMKNGADDVKNHRWFKS 259
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 7e-46
Identities = 94/244 (38%), Positives = 141/244 (57%), Gaps = 11/244 (4%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN--HPNV 92
LLG+G+F KV + A G A+K + K +D + V+ R LQN HP +
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEV----IIAKDEVAHTVTESRVLQNTRHPFL 57
Query: 93 LKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRL-TESAARRYFQQLVSALHFCHQNGVA 151
++ T ++ VMEYA GGELF L R R+ TE AR Y ++VSAL + H V
Sbjct: 58 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 117
Query: 152 HRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG-MLHTACGTPAYTAPEVVARRGYDGA 210
+RD+K +NL+LD+DG++K++DFGL E I +G + T CGTP Y APEV+ Y A
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 211 VADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNP 270
V D W GV+++ ++ G LPF + + +++ + + +FP +S A+SL+ LL +P
Sbjct: 176 V-DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 234
Query: 271 KTRM 274
K R+
Sbjct: 235 KQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 1e-45
Identities = 92/244 (37%), Positives = 142/244 (58%), Gaps = 11/244 (4%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN--HPNV 92
LLG+G+F KV + A G A+K ++K +D + ++ R LQN HP +
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEV----IIAKDEVAHTLTESRVLQNTRHPFL 57
Query: 93 LKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRL-TESAARRYFQQLVSALHFCHQNGVA 151
++ T ++ VMEYA GGELF L R R+ +E AR Y ++VSAL + H V
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVV 117
Query: 152 HRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG-MLHTACGTPAYTAPEVVARRGYDGA 210
+RD+K +NL+LD+DG++K++DFGL E I +G + T CGTP Y APEV+ Y A
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 211 VADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNP 270
V D W GV+++ ++ G LPF + + +++ + + +FP +S A+SL+ LL +P
Sbjct: 176 V-DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 234
Query: 271 KTRM 274
K R+
Sbjct: 235 KQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 3e-45
Identities = 90/310 (29%), Positives = 138/310 (44%), Gaps = 94/310 (30%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRI----VREVSAMRRLQNHPN 91
LG G++ V+KA+ G IVA+K I +N+ E+ I +RE+S ++ L HPN
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNE------EEGIPSTALREISLLKEL-KHPN 59
Query: 92 VLKIQEVMATKTKIYLVMEYAAGGEL----FGKLRRGRLTESAARRYFQQLVSALHFCHQ 147
++K+ +V+ T+ K+YLV EY ++ + R G L+ + + QL+ L +CH
Sbjct: 60 IVKLLDVIHTERKLYLVFEYC---DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 148 NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP--AYT-------- 197
+ + HRD+KPQN+L++RDG LK++DFGL+ A G P YT
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLA------------RAFGIPLRTYTHEVVTLWY 164
Query: 198 -APEV-VARRGYDGAVADAWSCGVIL------FVLLAGYLPFDDSNL------------- 236
APE+ + + Y AV D WS G I L G DS +
Sbjct: 165 RAPEILLGSKHYSTAV-DIWSVGCIFAEMITGKPLFPG-----DSEIDQLFKIFQILGTP 218
Query: 237 ----------LAMYKKVNRRDYQFPSFVSKP-----------ARSLIYQLLDPNPKTRMS 275
L YK FP F K L+ ++L NP R+S
Sbjct: 219 TEESWPGVTKLPDYKPT------FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRIS 272
Query: 276 IEKIMSISWF 285
++ + +F
Sbjct: 273 AKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 3e-45
Identities = 88/259 (33%), Positives = 137/259 (52%), Gaps = 19/259 (7%)
Query: 38 RGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH-PNVLKIQ 96
+G+F V+ AK + G AIK ++K++ + A + V+ A+ +Q P V K+
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSD--MIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 97 EVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDV 155
+K +YLVMEY GG+ ++ G L E A++Y ++V + HQ G+ HRD+
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123
Query: 156 KPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTA-CGTPAYTAPEVVARRGYDGAVADA 214
KP+NLL+D+ G+LK++DFGLS +NG+ + GTP Y APE + G D D
Sbjct: 124 KPENLLIDQTGHLKLTDFGLS------RNGLENKKFVGTPDYLAPETILGVGDDKMS-DW 176
Query: 215 WSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFV----SKPARSLIYQLLDPNP 270
WS G ++F L GY PF A++ + R +P V S A LI +LL +P
Sbjct: 177 WSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP 236
Query: 271 KTRMS---IEKIMSISWFQ 286
R+ ++I S +F+
Sbjct: 237 AKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 2e-44
Identities = 72/203 (35%), Positives = 107/203 (52%), Gaps = 10/203 (4%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN 88
RY++ +G G+ V KAK G VA+K + + L+ + ++ +RE+ A++ Q
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKV--ALRRLEGGIPNQALREIKALQACQ- 57
Query: 89 HPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGR--LTESAARRYFQQLVSALHFCH 146
HP V+K+ +V + LVMEY L LR L E+ + Y + L+ + + H
Sbjct: 58 HPYVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 147 QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL-PEQIKNGMLHTACGTPAYTAPEVV-AR 204
NG+ HRD+KP NLL+ DG LK++DFGL+ L E+ H T Y APE++
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH-QVATRWYRAPELLYGA 175
Query: 205 RGYDGAVADAWSCGVILFVLLAG 227
R YD V D W+ G I LL G
Sbjct: 176 RKYDPGV-DLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 4e-44
Identities = 85/247 (34%), Positives = 142/247 (57%), Gaps = 16/247 (6%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIV-REVSAMRRLQNHPNVL 93
+LG+GSF KV A+ + A+K ++K+ D +E + + V A+ HP +
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG--KHPFLT 59
Query: 94 KIQEVMATKTKIYLVMEYAAGGEL-FGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAH 152
++ TK +++ VMEY GG+L F R GR E AR Y ++V L F H+ G+ +
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIY 119
Query: 153 RDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLH-----TACGTPAYTAPEVVARRGY 207
RD+K N+LLD +G++K++DFG+ K G+L T CGTP Y APE+++ + Y
Sbjct: 120 RDLKLDNVLLDSEGHIKIADFGMC------KEGILGGVTTSTFCGTPDYIAPEILSYQPY 173
Query: 208 DGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLD 267
AV D W+ GV+L+ +LAG PF+ + +++ + + ++P ++SK A+S++ L
Sbjct: 174 GPAV-DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLT 232
Query: 268 PNPKTRM 274
NP+ R+
Sbjct: 233 KNPEKRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 6e-44
Identities = 80/265 (30%), Positives = 130/265 (49%), Gaps = 21/265 (7%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIE----KNNKFLDAAMEDRIVREVSAMR 84
+++ LG+GS+ V+K K ++D A+K ++ + DA E RI+ V
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV---- 56
Query: 85 RLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGR-----LTESAARRYFQQLV 139
NHPN++ +E K+ +VMEYA G+L + + + + E R F QL+
Sbjct: 57 ---NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113
Query: 140 SALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAP 199
L H+ + HRD+K N+LL + +K+ D G+S + +K M T GTP Y AP
Sbjct: 114 RGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKV---LKKNMAKTQIGTPHYMAP 170
Query: 200 EVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY-QFPSFVSKPA 258
EV R Y +D WS G +L+ + PF+ ++ + KV R Y P S+
Sbjct: 171 EVWKGRPYSYK-SDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDL 229
Query: 259 RSLIYQLLDPNPKTRMSIEKIMSIS 283
++ I +L PK R + +KI++
Sbjct: 230 QNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 7e-44
Identities = 94/245 (38%), Positives = 144/245 (58%), Gaps = 12/245 (4%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN--HPNV 92
LLG+G+F KV K A G A+K ++K +D + ++ R LQN HP +
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEV----IVAKDEVAHTLTENRVLQNSRHPFL 57
Query: 93 LKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRL-TESAARRYFQQLVSALHFCH-QNGV 150
++ T ++ VMEYA GGELF L R R+ +E AR Y ++VSAL + H + V
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV 117
Query: 151 AHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG-MLHTACGTPAYTAPEVVARRGYDG 209
+RD+K +NL+LD+DG++K++DFGL E IK+G + T CGTP Y APEV+ Y
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175
Query: 210 AVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPN 269
AV D W GV+++ ++ G LPF + + +++ + + +FP +S A+SL+ LL +
Sbjct: 176 AV-DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKD 234
Query: 270 PKTRM 274
PK R+
Sbjct: 235 PKQRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 4e-43
Identities = 86/251 (34%), Positives = 134/251 (53%), Gaps = 15/251 (5%)
Query: 36 LGRGSFAKVHKAKSIA---DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNV 92
LG G++ KV + + G + A+K ++K A + E + ++ P +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 93 LKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLVSALHFCHQNGVA 151
+ + T TK++L+++Y GGELF L +R TES R Y ++V AL HQ G+
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGII 127
Query: 152 HRDVKPQNLLLDRDGNLKVSDFGLSA--LPEQIKNGMLHTACGTPAYTAPEVVAR--RGY 207
+RD+K +N+LLD +G++ ++DFGLS L E+ + ++ CGT Y APEV+ G+
Sbjct: 128 YRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA--YSFCGTIEYMAPEVIRGGSGGH 185
Query: 208 DGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR----DYQFPSFVSKPARSLIY 263
D AV D WS GV+ F LL G PF +++RR FP +S AR I
Sbjct: 186 DKAV-DWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQ 244
Query: 264 QLLDPNPKTRM 274
+LL+ +PK R+
Sbjct: 245 KLLEKDPKKRL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 1e-42
Identities = 86/240 (35%), Positives = 136/240 (56%), Gaps = 5/240 (2%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
+G+GSF KV + + I A+KTI K + + + + E + + ++ N P ++ +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAH-IVSRSEVTHTLAERTVLAQV-NCPFIVPL 58
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRD 154
+ + K+YLV+ + GGELF L+R GR S AR Y +L+ AL H+ V +RD
Sbjct: 59 KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 155 VKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADA 214
+KP+N+LLD G++ + DFGL L + +T CGTP Y APE++ GY AV D
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLAPELLLGHGYTKAV-DW 176
Query: 215 WSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRM 274
W+ GV+L+ +L G PF D N+ MY+K+ + +FP + A+ L+ LL +P R+
Sbjct: 177 WTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRL 236
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 1e-42
Identities = 86/251 (34%), Positives = 132/251 (52%), Gaps = 25/251 (9%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKN----NKFLDAAM-EDRIVREVSAMRRLQNHP 90
LGRG F KV A+ G + AIK ++K +++ M E RI ++ R HP
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER----HP 62
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGV 150
++ + T+ + VMEYAAGG+L + +E A Y +V L + H+N +
Sbjct: 63 FLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKI 122
Query: 151 AHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLH-----TACGTPAYTAPEVVARR 205
+RD+K NLLLD +G +K++DFGL K GM T CGTP + APEV+
Sbjct: 123 VYRDLKLDNLLLDTEGFVKIADFGLC------KEGMGFGDRTSTFCGTPEFLAPEVLTET 176
Query: 206 GYDGAVADAWSCGVILFVLLAGYLPF--DDSNLLAMYKKVNRRDYQFPSFVSKPARSLIY 263
Y AV D W GV+++ +L G PF DD ++ + + ++P F+S+ A S++
Sbjct: 177 SYTRAV-DWWGLGVLIYEMLVGESPFPGDDEE--EVFDSIVNDEVRYPRFLSREAISIMR 233
Query: 264 QLLDPNPKTRM 274
+LL NP+ R+
Sbjct: 234 RLLRRNPERRL 244
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 2e-42
Identities = 86/245 (35%), Positives = 130/245 (53%), Gaps = 14/245 (5%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
+G+GSF KV AK ADG A+K ++K L + I+ E + + + HP ++ +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKA-ILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRRGR-LTESAARRYFQQLVSALHFCHQNGVAHRD 154
T K+Y V++Y GGELF L+R R E AR Y ++ SAL + H + +RD
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRD 121
Query: 155 VKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLH-----TACGTPAYTAPEVVARRGYDG 209
+KP+N+LLD G++ ++DFGL K G+ H T CGTP Y APEV+ ++ YD
Sbjct: 122 LKPENILLDSQGHVVLTDFGLC------KEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDR 175
Query: 210 AVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPN 269
V D W G +L+ +L G PF + MY + + + +S AR L+ LL +
Sbjct: 176 TV-DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKD 234
Query: 270 PKTRM 274
R+
Sbjct: 235 RTKRL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 3e-42
Identities = 83/246 (33%), Positives = 137/246 (55%), Gaps = 14/246 (5%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL----QNHP 90
+LG+GSF KV A+ + AIK ++K D ++D V +R+ HP
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKK-----DVILQDDDVDCTMTEKRILALAAKHP 56
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGR-LTESAARRYFQQLVSALHFCHQNG 149
+ + TK +++ VMEY GG+L +++R R E +R Y ++ AL F H++G
Sbjct: 57 FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG 116
Query: 150 VAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTA-CGTPAYTAPEVVARRGYD 208
V +RD+K N+LLD +G+ K++DFG+ E I NG+ T CGTP Y APE++ Y
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELEYG 174
Query: 209 GAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDP 268
+V D W+ GV+++ ++AG PF+ N +++ + D +P ++SK A S++ +
Sbjct: 175 PSV-DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTK 233
Query: 269 NPKTRM 274
NP R+
Sbjct: 234 NPNKRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 3e-42
Identities = 80/266 (30%), Positives = 128/266 (48%), Gaps = 13/266 (4%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN 88
R+Q G +G G+F KV+ A ++ G ++A+K I + D I E+ + L
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEI--RIQDNDPKTIKEIADEMKVLELL-K 57
Query: 89 HPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGR-LTESAARRYFQQLVSALHFCHQ 147
HPN++K V + K+Y+ MEY +GG L L GR L E R Y QL+ L + H
Sbjct: 58 HPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS 117
Query: 148 NGVAHRDVKPQNLLLDRDGNLKVSDFGLS---ALPEQIKNGMLHTACGTPAYTAPEVVAR 204
+G+ HRD+KP N+ LD +G +K+ DFG + + + GTPAY APEV+
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 205 RGYDGAV--ADAWSCGVILFVLLAGYLPFD--DSNLLAMYKKVNRRDYQFPS--FVSKPA 258
G AD WS G ++ + G P+ D+ M+ P +S
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEG 237
Query: 259 RSLIYQLLDPNPKTRMSIEKIMSISW 284
+ + + L+ +PK R + +++ +
Sbjct: 238 KDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 1e-41
Identities = 70/264 (26%), Positives = 135/264 (51%), Gaps = 15/264 (5%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89
++L ++G+G+F KV + + A+K + K K ++ ++ E ++ L NH
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ-KCVEKGSVRNVLNERRILQEL-NH 59
Query: 90 PNVLKIQEVMATKTKIYLVMEYAAGGEL-FGKLRRGRLTESAARRYFQQLVSALHFCHQN 148
P ++ + + +YLV++ GG+L + ++ + +E + + ++V AL + H
Sbjct: 60 PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK 119
Query: 149 GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYD 208
G+ HRD+KP N+LLD G++ ++DF ++ + + + GTP Y APEV+ R+GY
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIATKVT--PDTLTTSTSGTPGYMAPEVLCRQGYS 177
Query: 209 GAVADAWSCGVILFVLLAGYLPFD-----DSNLLAMYKKVNRRDYQFPSFVSKPARSLIY 263
AV D WS GV + L G P+ + + ++ Y P+ S A I
Sbjct: 178 VAV-DWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLY--PATWSTEAIDAIN 234
Query: 264 QLLDPNPKTRMS--IEKIMSISWF 285
+LL+ +P+ R+ ++ + + +F
Sbjct: 235 KLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-41
Identities = 92/260 (35%), Positives = 146/260 (56%), Gaps = 16/260 (6%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN--HPNV 92
LLG+G+F KV + A G A+K ++K +D + ++ R L+N HP +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEV----IIAKDEVAHTLTESRVLKNTRHPFL 57
Query: 93 LKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRL-TESAARRYFQQLVSALHFCHQNGVA 151
++ TK ++ VMEY GGELF L R R+ +E R Y ++VSAL + H +
Sbjct: 58 TSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIV 117
Query: 152 HRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGA 210
+RD+K +NL+LD+DG++K++DFGL E I + + T CGTP Y APEV+ Y A
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 211 VADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNP 270
V D W GV+++ ++ G LPF + + +++ + D +FP +S A+SL+ LL +P
Sbjct: 176 V-DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDP 234
Query: 271 KTRM-----SIEKIMSISWF 285
R+ ++IM S+F
Sbjct: 235 NKRLGGGPDDAKEIMRHSFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 6e-41
Identities = 80/246 (32%), Positives = 137/246 (55%), Gaps = 14/246 (5%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL----QNHP 90
+LG+GSF KV A+ G + A+K ++K D ++D V +R+ +NHP
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKK-----DVILQDDDVECTMTEKRILSLARNHP 56
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGR-LTESAARRYFQQLVSALHFCHQNG 149
+ ++ T +++ VME+ GG+L +++ R E+ AR Y ++ SAL F H G
Sbjct: 57 FLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG 116
Query: 150 VAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML-HTACGTPAYTAPEVVARRGYD 208
+ +RD+K N+LLD +G+ K++DFG+ E I NG T CGTP Y APE++ Y
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLY- 173
Query: 209 GAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDP 268
G D W+ GV+L+ +L G+ PF+ N +++ + + +P+++S+ A ++ +
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTK 233
Query: 269 NPKTRM 274
NP R+
Sbjct: 234 NPTMRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 7e-41
Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 49/290 (16%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNK---FLDAAMEDRIVREVSAMRRLQNHPNV 92
+G G++ +V+KA++ G +VA+K I N+ F A+ RE+ +++L+ HPN+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAI-----REIKLLQKLR-HPNI 60
Query: 93 LKIQEVMATKTK--IYLVMEYAAGGELFGKLRRG--RLTESAARRYFQQLVSALHFCHQN 148
++++E++ +K K IY+V EY +L G L + TES + Y +QL+ L + H N
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN 119
Query: 149 GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVV--ARRG 206
G+ HRD+K N+L++ DG LK++DFGL+ + + T Y PE++ A R
Sbjct: 120 GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATR- 178
Query: 207 YDGAVADAWSCGVILFVLLAGYLPF---DDSNLLAM------------------------ 239
Y V D WS G IL L G F + L
Sbjct: 179 YGPEV-DMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237
Query: 240 ----YKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285
R F + A L+ +LL +PK R+S ++ + +F
Sbjct: 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 1e-40
Identities = 91/253 (35%), Positives = 135/253 (53%), Gaps = 25/253 (9%)
Query: 35 LLGRGSFAKVHKAKSIA---DGSIVAIK-----TIEKNNKFLDAA---MEDRIVREVSAM 83
+LG+G + KV + + + G I A+K TI +N K D A E I+ V
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQK--DTAHTKAERNILEAV--- 57
Query: 84 RRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSAL 142
HP ++ + T K+YL++EY +GGELF L R G E A Y ++ AL
Sbjct: 58 ----KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLAL 113
Query: 143 HFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG-MLHTACGTPAYTAPEV 201
HQ G+ +RD+KP+N+LLD G++K++DFGL E I G + HT CGT Y APE+
Sbjct: 114 EHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEI 171
Query: 202 VARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSL 261
+ R G+ AV D WS G +++ +L G PF N K+ + P +++ AR L
Sbjct: 172 LMRSGHGKAV-DWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDL 230
Query: 262 IYQLLDPNPKTRM 274
+ +LL NP +R+
Sbjct: 231 LKKLLKRNPSSRL 243
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 1e-40
Identities = 89/248 (35%), Positives = 137/248 (55%), Gaps = 17/248 (6%)
Query: 35 LLGRGSFAKVHKAKSIA---DGSIVAIKTIEKNN-KFLD---AAMEDRIVREVSAMRRLQ 87
+LG+GSF KV + I G + A+K ++K K D ME I+ EV
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------- 55
Query: 88 NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRL-TESAARRYFQQLVSALHFCH 146
NHP ++K+ T+ K+YL++++ GG+LF +L + + TE + Y +L AL H
Sbjct: 56 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 115
Query: 147 QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRG 206
G+ +RD+KP+N+LLD +G++K++DFGLS + ++ CGT Y APEVV RRG
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA-YSFCGTVEYMAPEVVNRRG 174
Query: 207 YDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLL 266
+ + AD WS GV++F +L G LPF + + + P F+S A+SL+ L
Sbjct: 175 HTQS-ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALF 233
Query: 267 DPNPKTRM 274
NP R+
Sbjct: 234 KRNPANRL 241
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-40
Identities = 89/273 (32%), Positives = 129/273 (47%), Gaps = 18/273 (6%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94
L+GRG F +V + A G I A+K ++K L A E + + N P + +
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKK--SVLLAQETVSFFEEERDILSISNSPWIPQ 65
Query: 95 IQEVMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAH 152
+Q K +YLVMEY GG+L L R + E A+ Y +LV A+H HQ G H
Sbjct: 66 LQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVH 125
Query: 153 RDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVV-ARRGYDGAV 211
RD+KP+N+L+DR G++K++DFG +A K GTP Y APEV+ G
Sbjct: 126 RDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGT 185
Query: 212 ----ADAWSCGVILFVLLAGYLPFDDSNLLAMYKKV--NRRDYQFPS--FVSKPARSLIY 263
D WS GVI + ++ G PF + Y + +R +FP VS LI
Sbjct: 186 YGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQ 245
Query: 264 QLLDPNPKTRMSIEKIMSISWFQK----SLQQQ 292
LL K R+ E + +F K +++
Sbjct: 246 SLL-CGQKERLGYEGLCCHPFFSKIDWNNIRNS 277
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (367), Expect = 3e-40
Identities = 82/290 (28%), Positives = 138/290 (47%), Gaps = 41/290 (14%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89
Y++ LG G+F V+ A++ G +VAIK ++K + M +REV ++R+L H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN---LREVKSLRKLNEH 57
Query: 90 PNVLKIQEVMATKTKIYLVMEYAAGGELFG--KLRRGR-LTESAARRYFQQLVSALHFCH 146
PN++K++EV ++Y V EY G L+ K R+G+ +ES R Q++ L H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 147 QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTA-CGTPAYTAPEVVARR 205
++G HRD+KP+NLL+ +K++DFGL+ +I++ +T T Y APE++ R
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLA---REIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 206 GYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAM-------------------YKKVNRR 246
+ D W+ G I+ L F S+ + YK ++
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233
Query: 247 DYQFPSFVSKP-----------ARSLIYQLLDPNPKTRMSIEKIMSISWF 285
++FP F A LI +L +PK R + + + +F
Sbjct: 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 5e-40
Identities = 86/242 (35%), Positives = 131/242 (54%), Gaps = 6/242 (2%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94
++G+GSF KV A+ A+ A+K ++K L E I+ E + + + HP ++
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKK-AILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 95 IQEVMATKTKIYLVMEYAAGGELFGKLRRGR-LTESAARRYFQQLVSALHFCHQNGVAHR 153
+ T K+Y V++Y GGELF L+R R E AR Y ++ SAL + H + +R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 154 DVKPQNLLLDRDGNLKVSDFGLSALPEQIK-NGMLHTACGTPAYTAPEVVARRGYDGAVA 212
D+KP+N+LLD G++ ++DFGL E I+ NG T CGTP Y APEV+ ++ YD V
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTV- 177
Query: 213 DAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKT 272
D W G +L+ +L G PF N MY + + Q ++ AR L+ LL +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237
Query: 273 RM 274
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 7e-40
Identities = 86/275 (31%), Positives = 130/275 (47%), Gaps = 37/275 (13%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
+G G++ V+KA+ G IVAIK I+ +F + +RE+ ++ L NHPN++K+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKL--RFESEGIPKTALREIKLLKEL-NHPNIIKL 63
Query: 96 QEVMATKTKIYLVMEYA-AGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRD 154
+V K +YLV E+ K R+ L ES + Y QL+ L FCH +G+ HRD
Sbjct: 64 LDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRD 123
Query: 155 VKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVAR-RGYDGAVAD 213
+KP+NLL++ +G LK++DFGL A T Y APE++ +GY V D
Sbjct: 124 LKPENLLINTEGVLKLADFGL-ARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPV-D 181
Query: 214 AWSCGVILFVLLAGYLPF-DDSNLLAMYK----------------KVNRRDY--QFPSFV 254
WS G I LL+ F S + ++K R+Y FP
Sbjct: 182 IWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKA 241
Query: 255 -----------SKPARSLIYQLLDPNPKTRMSIEK 278
S A L+ Q+L +P R++ E+
Sbjct: 242 GMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQ 276
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 8e-40
Identities = 69/249 (27%), Positives = 122/249 (48%), Gaps = 17/249 (6%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
+G G+ +V+KA A G VAIK + + ++ I+ E+ M+ HPN++
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDC-KHPNIVDY 80
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHR 153
+ ++++VMEY GG L + R+ E ++++ L + H V HR
Sbjct: 81 YDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHR 140
Query: 154 DVKPQNLLLDRDGNLKVSDFGLSALPEQI--KNGMLHTACGTPAYTAPEVVARRGYDGAV 211
D+K N+LL +DG++K++DFG +A Q+ + ++ GTP + APEV+ R+ Y V
Sbjct: 141 DIKSDNILLSKDGSVKLADFGFAA---QLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKV 197
Query: 212 ADAWSCGVILFVLLAGYLP-FDDSNLLAMYKKVNRR--DYQFPSFVSKPARSLIYQLLDP 268
D WS G++ + G P + L A++ + + P S + + + L
Sbjct: 198 -DIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVK 256
Query: 269 NPKTRMSIE 277
+P+ R S E
Sbjct: 257 DPEKRPSAE 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 3e-39
Identities = 86/296 (29%), Positives = 137/296 (46%), Gaps = 66/296 (22%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
+G G+F++V KA+S G AIK ++K+ K L+ +RE+ A+RRL HPN+L++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN---LREIQALRRLSPHPNILRL 63
Query: 96 QEVMATKT--KIYLVME------YAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQ 147
EV+ + ++ LV E Y EL K R+ L E + Y QL+ +L H+
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLY----ELI-KGRKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 148 NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYT---------A 198
NG+ HRD+KP+N+L+ D LK++DFG S P YT A
Sbjct: 119 NGIFHRDIKPENILIKDD-ILKLADFG-SC----------RGIYSKPPYTEYISTRWYRA 166
Query: 199 PEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN------------------LLAMY 240
PE + GY G D W+ G + F +L+ + F +N +L +
Sbjct: 167 PECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF 226
Query: 241 KKVNRRDYQFPS-----------FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285
+K +Y FPS S L+ +LL +P R++ ++ + +F
Sbjct: 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 4e-39
Identities = 79/246 (32%), Positives = 131/246 (53%), Gaps = 12/246 (4%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKN----NKFLDAAMEDRIVREVSAMRRLQNHPN 91
+G+G+F +V++ + I A+K + K K + + +R + + + P
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLL---DESPF 57
Query: 92 VLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGV 150
++ ++ T + +YLV +Y +GGELF L++ GR +E A+ Y +LV AL H+ +
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDI 117
Query: 151 AHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEV-VARRGYDG 209
+RD+KP+N+LLD G++ + DFGLS N +T CGT Y APEV + +GY
Sbjct: 118 VYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-T 175
Query: 210 AVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFV-SKPARSLIYQLLDP 268
D WS GV++F + G+ PF + MY+ + +FP V S R + LL+
Sbjct: 176 KHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNR 235
Query: 269 NPKTRM 274
NP+ R+
Sbjct: 236 NPQHRL 241
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 5e-39
Identities = 91/299 (30%), Positives = 137/299 (45%), Gaps = 55/299 (18%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL---QNHPN 91
++GRG+F +V + G I A+K + K+ E V V A R + ++P
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-----EKEQVAHVRAERDILAEADNPW 62
Query: 92 VLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLVSALHFCHQNGV 150
V+K+ + +YL+MEY GG++ L ++ TE R Y + + A+ H+ G
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122
Query: 151 AHRDVKPQNLLLDRDGNLKVSDFGL---------------------SALPEQIKNGML-- 187
HRD+KP NLLLD G++K+SDFGL S + I M
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 188 --------------HTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDD 233
++ GTP Y APEV + GY D WS GVI++ +L GY PF
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCS 241
Query: 234 SNLLAMYKKV-NRRDY-QFPSFV--SKPARSLIYQLLDPNPKTRM---SIEKIMSISWF 285
N Y+K+ N ++ QFP V S A+ LI +L + R+ + +I S +F
Sbjct: 242 DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPFF 299
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 5e-39
Identities = 84/246 (34%), Positives = 132/246 (53%), Gaps = 14/246 (5%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94
++G+GSF KV AK +DGS A+K ++K L ++ I+ E + + + HP ++
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKT-ILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 95 IQEVMATKTKIYLVMEYAAGGELFGKLRRGR-LTESAARRYFQQLVSALHFCHQNGVAHR 153
+ T K+Y V++Y GGELF L+R R E AR Y ++ SA+ + H + +R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 154 DVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM-----LHTACGTPAYTAPEVVARRGYD 208
D+KP+N+LLD G++ ++DFGL K G+ T CGTP Y APEV+ + YD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC------KEGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 209 GAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDP 268
V D W G +L+ +L G PF ++ MY + + Q P + A L+ LL
Sbjct: 175 RTV-DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHK 233
Query: 269 NPKTRM 274
+ + R+
Sbjct: 234 DQRRRL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 7e-39
Identities = 82/247 (33%), Positives = 132/247 (53%), Gaps = 12/247 (4%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL----QNHP 90
+LG+GSF KV A+ AIK ++K D +ED V RR+ HP
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKK-----DVVLEDDDVECTMVERRVLALAWEHP 56
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNG 149
+ + TK ++ VMEY GG+L ++ GR E+ AR Y +++ L F H+ G
Sbjct: 57 FLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116
Query: 150 VAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDG 209
+ +RD+K N+LLD+DG++K++DFG+ G T CGTP Y APE++ + Y+
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKASTFCGTPDYIAPEILKGQKYNE 175
Query: 210 AVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPN 269
+V D WS GV+L+ +L G PF + ++ + FP ++SK A+ + +L + +
Sbjct: 176 SV-DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERD 234
Query: 270 PKTRMSI 276
P R+ +
Sbjct: 235 PTKRLGV 241
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-38
Identities = 80/276 (28%), Positives = 129/276 (46%), Gaps = 42/276 (15%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMR---RLQNHPN 91
LLG+G +V + G + A+K ++K ++ V+ V + +HP
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKK-----EMIKRNKVKRVLTEQEILATLDHPF 62
Query: 92 VLKIQEVMATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQN 148
+ + T+T + LVM+Y GGELF L+R L+E AR Y +++ AL + H
Sbjct: 63 LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL 122
Query: 149 GVAHRDVKPQNLLLDRDGNLKVSDFGLS-------ALPEQIKNGMLHT-----------A 190
G+ +RD+KP+N+LL G++ +SDF LS + +
Sbjct: 123 GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182
Query: 191 C----------GTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMY 240
GT Y APEV++ G+ AV D W+ G++L+ +L G PF SN +
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKGSNRDETF 241
Query: 241 KKVNRRDYQFPS--FVSKPARSLIYQLLDPNPKTRM 274
+ +++ FP VS AR LI +LL +P R+
Sbjct: 242 SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRL 277
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-38
Identities = 84/254 (33%), Positives = 137/254 (53%), Gaps = 21/254 (8%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94
++GRGS+AKV + I A+K I+K D D + E NHP ++
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKE-LVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 95 IQEVMATKTKIYLVMEYAAGGEL-FGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHR 153
+ T+++++ V+E+ +GG+L F R+ +L E AR Y ++ AL+F H+ G+ +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 154 DVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG-MLHTACGTPAYTAPEVVARRGYDGAVA 212
D+K N+LLD +G++K++D+G+ E I+ G T CGTP Y APE++ Y +V
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV- 177
Query: 213 DAWSCGVILFVLLAGYLPFDDSNLLAM--YKKVNRRDYQF----------PSFVSKPARS 260
D W+ GV++F ++AG PFD ++ M N DY F P +S A S
Sbjct: 178 DWWALGVLMFEMMAGRSPFD---IVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASS 234
Query: 261 LIYQLLDPNPKTRM 274
++ L+ +PK R+
Sbjct: 235 VLKGFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 3e-38
Identities = 82/267 (30%), Positives = 142/267 (53%), Gaps = 15/267 (5%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
L +++ +G+G F+ V+KA + DG +VA+K + + + +DA ++E+ +++L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKV-QIFEMMDAKARQDCLKEIDLLKQL 59
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGEL------FGKLRRGRLTESAARRYFQQLVS 140
+HPNV+K ++ +V+E A G+L F K +R + E +YF QL S
Sbjct: 60 -DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKR-LIPERTIWKYFVQLCS 117
Query: 141 ALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPE 200
AL H + HRD+KP N+ + G +K+ D GL K H+ GTP Y +PE
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPE 176
Query: 201 VVARRGYDGAVADAWSCGVILFVLLAGYLPF--DDSNLLAMYKKVNRRDYQ-FPS-FVSK 256
+ GY+ +D WS G +L+ + A PF D NL ++ KK+ + DY P+ S+
Sbjct: 177 RIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSE 235
Query: 257 PARSLIYQLLDPNPKTRMSIEKIMSIS 283
R L+ + ++P+P+ R I ++ ++
Sbjct: 236 ELRDLVSRCINPDPEKRPDISYVLQVA 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 9e-38
Identities = 87/276 (31%), Positives = 128/276 (46%), Gaps = 27/276 (9%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTI--EKNNKFLDAAMEDRIVREVSAMRR 85
+ Y+L ++G G+ A V+ A + + VAIK I EK +D +EV AM
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELR-----KEVQAMS- 54
Query: 86 LQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFG----KLRRGRLTESAARRYFQQLVSA 141
NHPNV+K +++LVM Y +GG L RG L E+ ++++
Sbjct: 55 QCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKG 114
Query: 142 LHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL---PEQIKNGMLHTACGTPAYTA 198
L + H NG HRD+K N+LL DG++K++DFG+SA + T GTP + A
Sbjct: 115 LEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 199 PEVVA-RRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSF---- 253
PEV+ GYD AD WS G+ L G P+ S M + PS
Sbjct: 175 PEVMEQVHGYD-FKADIWSFGITAIELATGAAPY--SKYPPMKVLMLTLQNDPPSLETGA 231
Query: 254 ----VSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285
SK R +I L +P R + E+++ +F
Sbjct: 232 DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 9e-38
Identities = 89/268 (33%), Positives = 137/268 (51%), Gaps = 30/268 (11%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL---QNHPNV 92
+G+G + +V AK G IVA+K ++K L E VR V R + +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKK--SLLFKLNE---VRHVLTERDILTTTKSEWL 63
Query: 93 LKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLVSALHFCHQNGVA 151
+K+ +YL MEY GG+ L G L+E AR Y ++ A+ H+ G
Sbjct: 64 VKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYI 123
Query: 152 HRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML---HTACGTPAYTAPEVVARRGYD 208
HRD+KP+N L+D G++K++DFGLS G++ ++ G+P Y APEV+ +GYD
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLSK-------GIVTYANSVVGSPDYMAPEVLRGKGYD 176
Query: 209 GAVADAWSCGVILFVLLAGYLPFDDSNL------LAMYKKVNRR-DYQFPSF-VSKPARS 260
V D WS G +L+ L G+ PF S L +K+ +R Y P F +S A
Sbjct: 177 FTV-DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD 235
Query: 261 LIYQLLDPNPKTRM-SIEKIMSISWFQK 287
LI +L++ +P R S+E I + +F++
Sbjct: 236 LITKLIN-DPSRRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-37
Identities = 89/304 (29%), Positives = 131/304 (43%), Gaps = 66/304 (21%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRI----VREVSAMR 84
RY+ G LG G++A V+KA+ G IVAIK I K + +A D I +RE+ ++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKI-KLGERKEAK--DGINFTALREIKLLQ 57
Query: 85 RLQNHPNVLKIQEVMATKTKIYLVMEYAAGG-ELFGKLRRGRLTESAARRYFQQLVSALH 143
L+ HPN++ + +V K+ I LV E+ E K + LT + + Y + L
Sbjct: 58 ELK-HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLE 116
Query: 144 FCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP--AYTAPEV 201
+ H N + HRD+KP NLL+ DG LK++DFGL+ + G+P T +V
Sbjct: 117 YLHSNWILHRDLKPNNLLIASDGVLKLADFGLA------------RSFGSPNRKMT-HQV 163
Query: 202 VAR-----------RGYDGAVADAWSCGVILFVLLAG--YLPFD---------------- 232
V R R Y V D WS G I LL +LP D
Sbjct: 164 VTRWYRAPELLFGARHYGVGV-DMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTP 222
Query: 233 ------DSNLLAMYKKVNRR-----DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281
L Y + FP+ S A L+ +LL NP R++ + +
Sbjct: 223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPA-ASDDALDLLQRLLTLNPNKRITARQALE 281
Query: 282 ISWF 285
+F
Sbjct: 282 HPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 3e-37
Identities = 71/259 (27%), Positives = 118/259 (45%), Gaps = 13/259 (5%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
LG+GS V+K + G I A+K I + D +++RE+ +R P V+K
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKI---HVDGDEEFRKQLLRELKTLRS-CESPYVVKC 64
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQN-GVAHR 153
+ +I +V+EY GG L L++ G++ E +Q++ L + H + HR
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHR 124
Query: 154 DVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVAD 213
D+KP NLL++ G +K++DFG+S + E +T GT Y +PE + + AD
Sbjct: 125 DIKPSNLLINSKGEVKIADFGISKVLENTL-DQCNTFVGTVTYMSPERI-QGESYSYAAD 182
Query: 214 AWSCGVILFVLLAGYLPFDDSNLL---AMYKKVNRRD-YQFPS-FVSKPARSLIYQLLDP 268
WS G+ L G PF + + + P+ S R I L
Sbjct: 183 IWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQK 242
Query: 269 NPKTRMSIEKIMSISWFQK 287
+PK R S +++ + +K
Sbjct: 243 DPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 4e-37
Identities = 85/267 (31%), Positives = 140/267 (52%), Gaps = 15/267 (5%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
L +++ +GRG F++V++A + DG VA+K ++ + +DA ++E+ +++L
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFD-LMDAKARADCIKEIDLLKQL 59
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGEL------FGKLRRGRLTESAARRYFQQLVS 140
NHPNV+K ++ +V+E A G+L F K +R + E +YF QL S
Sbjct: 60 -NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR-LIPEKTVWKYFVQLCS 117
Query: 141 ALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPE 200
AL H V HRD+KP N+ + G +K+ D GL K H+ GTP Y +PE
Sbjct: 118 ALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPE 176
Query: 201 VVARRGYDGAVADAWSCGVILFVLLAGYLPF--DDSNLLAMYKKVNRRDY-QFPS-FVSK 256
+ GY+ +D WS G +L+ + A PF D NL ++ KK+ + DY PS S+
Sbjct: 177 RIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 235
Query: 257 PARSLIYQLLDPNPKTRMSIEKIMSIS 283
R L+ ++P+P+ R I + ++
Sbjct: 236 ELRQLVNMCINPDPEKRPDITYVYDVA 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 137 bits (345), Expect = 1e-36
Identities = 80/241 (33%), Positives = 130/241 (53%), Gaps = 4/241 (1%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94
++G+GSF KV AK DG A+K ++K L+ + I+ E + + + HP ++
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKK-IVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 95 IQEVMATKTKIYLVMEYAAGGELFGKLRRGR-LTESAARRYFQQLVSALHFCHQNGVAHR 153
+ T K+Y V+++ GGELF L+R R E AR Y ++ SAL + H + +R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 154 DVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVAD 213
D+KP+N+LLD G++ ++DFGL + T CGTP Y APEV+ ++ YD V D
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT-TFCGTPEYLAPEVIRKQPYDNTV-D 178
Query: 214 AWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTR 273
W G +L+ +L G PF ++ MY + + S A S++ +LL+ + + R
Sbjct: 179 WWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRR 238
Query: 274 M 274
+
Sbjct: 239 L 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 1e-36
Identities = 75/264 (28%), Positives = 135/264 (51%), Gaps = 8/264 (3%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAME-DRIVREVSAMRRL 86
++ G LLG+G+F +V+ + G +A+K + + + E + + E+ ++ L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFC 145
Q H +++ + + + MEY GG + +L+ G LTE+ R+Y +Q++ + +
Sbjct: 62 Q-HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYL 120
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI--KNGMLHTACGTPAYTAPEVVA 203
H N + HRD+K N+L D GN+K+ DFG S + I + + GTP + +PEV++
Sbjct: 121 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180
Query: 204 RRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR--DYQFPSFVSKPARSL 261
GY G AD WS G + +L P+ + +A K+ + + Q PS VS AR+
Sbjct: 181 GEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNF 239
Query: 262 IYQLLDPNPKTRMSIEKIMSISWF 285
+ + N K R S E+++ +
Sbjct: 240 LRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 78/242 (32%), Positives = 134/242 (55%), Gaps = 6/242 (2%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94
+LG+GSF KV A+ + AIK ++K+ D +E +V E + P + +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMV-EKRVLALQDKPPFLTQ 65
Query: 95 IQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHR 153
+ T ++Y VMEY GG+L +++ G+ E A Y ++ L F H+ G+ +R
Sbjct: 66 LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYR 125
Query: 154 DVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM-LHTACGTPAYTAPEVVARRGYDGAVA 212
D+K N++LD +G++K++DFG+ E + +G+ T CGTP Y APE++A + Y G
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSV 182
Query: 213 DAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKT 272
D W+ GV+L+ +LAG PFD + +++ + + +P +SK A S+ L+ +P
Sbjct: 183 DWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSK 242
Query: 273 RM 274
R+
Sbjct: 243 RL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 6e-36
Identities = 74/248 (29%), Positives = 123/248 (49%), Gaps = 9/248 (3%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89
+++ +G+GSF V K AD + A+K I+ + ++ + + E + +L +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK--MNRREREEAIDEARVLAKL-DS 58
Query: 90 PNVLKIQEVMATKTKIYLVMEYAAGGEL--FGKLRRGR-LTESAARRYFQQLVSALHFCH 146
+++ E K K+ +VMEYA G+L K++RGR L E R+F Q++ L H
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH 118
Query: 147 QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRG 206
+ HRD+K NL LD N+K+ D G++ L +T GTP Y +PE+ +
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD-NTNFANTIVGTPYYLSPELCEDKP 177
Query: 207 YDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQ-FPSFVSKPARSLIYQL 265
Y+ +D W+ GV+L+ G PFD +N A+ K+ R + S+ LI Q
Sbjct: 178 YN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236
Query: 266 LDPNPKTR 273
L + + R
Sbjct: 237 LTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 7e-36
Identities = 77/253 (30%), Positives = 138/253 (54%), Gaps = 8/253 (3%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIA---DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
++L +LG G++ KV + + G + A+K ++K A + E + + +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLVSALHFC 145
+ P ++ + T+ K++L+++Y +GGE+F L +R +E R Y +++ AL
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARR 205
H+ G+ +RD+K +N+LLD +G++ ++DFGLS + ++ CGT Y APE++ +
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK 181
Query: 206 GYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR----DYQFPSFVSKPARSL 261
G G D WS G+++F LL G PF +V+RR D FPSF+ A+ L
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDL 241
Query: 262 IYQLLDPNPKTRM 274
+++LL +PK R+
Sbjct: 242 LHKLLRKDPKKRL 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 7e-36
Identities = 83/244 (34%), Positives = 134/244 (54%), Gaps = 10/244 (4%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIV-REVSAMRRLQNHPNVL 93
+LG+GSF KV A+ + AIK ++K+ D +E +V + V A L P L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLA---LPGKPPFL 63
Query: 94 -KIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVA 151
++ T ++Y VMEY GG+L +++ G+ E A Y ++ L F H G+
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGII 123
Query: 152 HRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG-MLHTACGTPAYTAPEVVARRGYDGA 210
+RD+K N++LD +G++K++DFG+ E I G T CGTP Y APE++A + Y +
Sbjct: 124 YRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKS 181
Query: 211 VADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNP 270
V D W+ GV+L+ +LAG PFD + +++ + + +P +SK A S+ LL +P
Sbjct: 182 V-DWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHP 240
Query: 271 KTRM 274
R+
Sbjct: 241 AKRL 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 9e-36
Identities = 72/244 (29%), Positives = 131/244 (53%), Gaps = 4/244 (1%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94
+LG+GSF KV A+ AIK ++K+ +D +E +V E + HP +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMV-EKRVLSLAWEHPFLTH 60
Query: 95 IQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHR 153
+ TK ++ VMEY GG+L ++ + A Y +++ L F H G+ +R
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 154 DVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVAD 213
D+K N+LLD DG++K++DFG+ + + T CGTP Y APE++ + Y+ +V D
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCK-ENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV-D 178
Query: 214 AWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTR 273
WS GV+L+ +L G PF + +++ + + +P ++++ A+ ++ +L P+ R
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERR 238
Query: 274 MSIE 277
+ ++
Sbjct: 239 LGVK 242
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 1e-35
Identities = 76/255 (29%), Positives = 141/255 (55%), Gaps = 11/255 (4%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIA---DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
++L +LG G++ KV + ++ G + A+K ++K A + E + +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLVSALHFC 145
+ P ++ + T TK++L+++Y GGELF L +R R E + Y ++V AL
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVA-- 203
H+ G+ +RD+K +N+LLD +G++ ++DFGLS + + ++ CGT Y AP++V
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGG 181
Query: 204 RRGYDGAVADAWSCGVILFVLLAGYLPF----DDSNLLAMYKKVNRRDYQFPSFVSKPAR 259
G+D AV D WS GV+++ LL G PF + ++ + +++ + + +P +S A+
Sbjct: 182 DGGHDKAV-DWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 240
Query: 260 SLIYQLLDPNPKTRM 274
+I +LL +PK R+
Sbjct: 241 DIIQRLLMKDPKKRL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 89/275 (32%), Positives = 138/275 (50%), Gaps = 29/275 (10%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAM----RR 85
+ + ++GRG+F +V + + + A+K + +KF + I R SA R
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLL---SKF------EMIKRSDSAFFWEERD 95
Query: 86 LQNHPN---VLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSAL 142
+ H N ++++ +Y+VMEY GG+L + + E AR Y ++V AL
Sbjct: 96 IMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLAL 155
Query: 143 HFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLH--TACGTPAYTAPE 200
H G HRDVKP N+LLD+ G+LK++DFG + NGM+ TA GTP Y +PE
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD--ANGMVRCDTAVGTPDYISPE 213
Query: 201 VVARRGYDGAVA---DAWSCGVILFVLLAGYLPFDDSNLLAMYKKV--NRRDYQFPS--F 253
V+ +G DG D WS GV L+ +L G PF +L+ Y K+ ++ FP
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIE 273
Query: 254 VSKPARSLIYQLLDPNPKT--RMSIEKIMSISWFQ 286
+SK A+ LI L R +++I S +F+
Sbjct: 274 ISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFK 308
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 134 bits (337), Expect = 1e-35
Identities = 83/253 (32%), Positives = 139/253 (54%), Gaps = 21/253 (8%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94
++GRGS+AKV + + I A+K ++K D + D + E + ++P ++
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDI-DWVQTEKHVFEQASSNPFLVG 60
Query: 95 IQEVMATKTKIYLVMEYAAGGELFGKLRRGR-LTESAARRYFQQLVSALHFCHQNGVAHR 153
+ T ++++LV+EY GG+L ++R R L E AR Y ++ AL+F H+ G+ +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 154 DVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG-MLHTACGTPAYTAPEVVARRGYD-GAV 211
D+K N+LLD DG++K++D+G+ E + G T CGTP Y APE++ RG + G
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEIL--RGEEYGFS 176
Query: 212 ADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQF----------PSFVSKPARSL 261
D W+ GV++F ++AG PFD ++ +N DY F P F+S A +
Sbjct: 177 VDWWALGVLMFEMMAGRSPFD---IITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHV 233
Query: 262 IYQLLDPNPKTRM 274
+ L+ +PK R+
Sbjct: 234 LKGFLNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 80/290 (27%), Positives = 139/290 (47%), Gaps = 40/290 (13%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMED--RIVREVSAMRR 85
+ L +G+GSF +V+KA +VAIK I+ L+ A ++ I +E+ + +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID-----LEEAEDEIEDIQQEIQFLSQ 55
Query: 86 LQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFC 145
++ P + K +K++++MEY GG L+ G+L E+ ++++ L +
Sbjct: 56 CRS-PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYL 114
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML--HTACGTPAYTAPEVVA 203
H+ G HRD+K N+LL +G++K++DFG+S Q+ + M +T GTP + APEV+
Sbjct: 115 HEEGKIHRDIKAANILLSEEGDVKLADFGVSG---QLTSTMSKRNTFVGTPFWMAPEVIK 171
Query: 204 RRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMY----------KKVNRRDYQFPSF 253
+ GYD AD WS G+ L G P S+L M + +
Sbjct: 172 QSGYDEK-ADIWSLGITAIELAKGEPPL--SDLHPMRVLFLIPKNNPPSLEGNKF----- 223
Query: 254 VSKPARSLIYQLLDPNPKTRMSIE--------KIMSISWFQKSLQQQRKR 295
SKP + + L+ +PK R S + K + + L ++ K+
Sbjct: 224 -SKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKTSYLTLLIERIKK 272
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 74/249 (29%), Positives = 124/249 (49%), Gaps = 9/249 (3%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
LG+G+F + + D S+V K + N L + E+ + LQ HPN++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEV--NLTRLSEKERRDALNEIVILSLLQ-HPNIIAY 64
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRRGR---LTESAARRYFQQLVSALHFCHQNGVAH 152
+ + MEYA GG L+ K+ R + E Y Q+VSA+ + H+ G+ H
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILH 124
Query: 153 RDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVA 212
RD+K N+ L + G +K+ DFG+S + + M T GTP Y +PE+ Y+ +
Sbjct: 125 RDIKTLNIFLTKAGLIKLGDFGISKILGS-EYSMAETVVGTPYYMSPELCQGVKYN-FKS 182
Query: 213 DAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQ-FPSFVSKPARSLIYQLLDPNPK 271
D W+ G +L+ LL FD +N L + K+ + +Y S S SL++ LL +P+
Sbjct: 183 DIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPE 242
Query: 272 TRMSIEKIM 280
R + ++++
Sbjct: 243 KRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-34
Identities = 84/267 (31%), Positives = 138/267 (51%), Gaps = 15/267 (5%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
L +Q+ +GRG F++V++A + D VA+K ++ + +DA V+E+ +++L
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIF-EMMDAKARQDCVKEIDLLKQL 59
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGEL------FGKLRRGRLTESAARRYFQQLVS 140
NHPNV+K + ++ +V+E A G+L F K +R + E +YF QL S
Sbjct: 60 -NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKR-LIPERTVWKYFVQLCS 117
Query: 141 ALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPE 200
A+ H V HRD+KP N+ + G +K+ D GL K H+ GTP Y +PE
Sbjct: 118 AVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPE 176
Query: 201 VVARRGYDGAVADAWSCGVILFVLLAGYLPF--DDSNLLAMYKKVNRRDY-QFPS-FVSK 256
+ GY+ +D WS G +L+ + A PF D NL ++ +K+ + DY P+ S+
Sbjct: 177 RIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSE 235
Query: 257 PARSLIYQLLDPNPKTRMSIEKIMSIS 283
R L+ + P+P R I + I+
Sbjct: 236 KLRELVSMCIYPDPDQRPDIGYVHQIA 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 70/257 (27%), Positives = 137/257 (53%), Gaps = 9/257 (3%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIK--TIEKNNKFLDAAMEDRIVREVSAMRRL 86
R++ G LLG GSF V++ ++ DG A+K ++ + + A++ ++ +E++ + +L
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVK-QLEQEIALLSKL 59
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFC 145
Q HPN+++ + +Y+ +E GG L L++ G E R Y +Q++ L +
Sbjct: 60 Q-HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYL 118
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARR 205
H HRD+K N+L+D +G +K++DFG++ + ++ + G+P + APEV+A++
Sbjct: 119 HDRNTVHRDIKGANILVDTNGVVKLADFGMAK--QVVEFSFAKSFKGSPYWMAPEVIAQQ 176
Query: 206 GYDGAVADAWSCGVILFVLLAGYLPFDD-SNLLAMYKKVNRRDY-QFPSFVSKPARSLIY 263
G G AD WS G + + G P+ + A++K ++ P +S A+ I
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFIL 236
Query: 264 QLLDPNPKTRMSIEKIM 280
+ L +P R + +++
Sbjct: 237 KCLQRDPSLRPTAAELL 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 4e-34
Identities = 72/208 (34%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIV-----REVSA 82
N+Y++ ++G G++ V K ++ A G IVAIK KF ++ +D V REV
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIK------KFKESE-DDEDVKKTALREVKV 53
Query: 83 MRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGG--ELFGKLRRGRLTESAARRYFQQLVS 140
+R+L+ H N++ ++E K ++YLV EY EL G L A R Y QL+
Sbjct: 54 LRQLR-HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGG-LPPDAVRSYIWQLLQ 111
Query: 141 ALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPE 200
A+ +CH + + HRD+KP+N+L+ G LK+ DFG + L T Y APE
Sbjct: 112 AIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE 171
Query: 201 V-VARRGYDGAVADAWSCGVILFVLLAG 227
+ V Y V D W+ G I+ LL G
Sbjct: 172 LLVGDTNYGKPV-DVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 4e-34
Identities = 77/258 (29%), Positives = 124/258 (48%), Gaps = 11/258 (4%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN 88
+Y+ ++GRG+F VH + AD +V IK I + + E ++ L
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQI--PVEQMTKDERLAAQNECQVLKLLS- 57
Query: 89 HPNVLKIQEVMATKTKIYLVMEYAAGG---ELFGKLRRGRLTESAARRYFQQLVSALHFC 145
HPN+++ E + +VMEYA GG E K L E +F Q++ ALH
Sbjct: 58 HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV 117
Query: 146 HQNGVAHRDVKPQNLLLDRDGN-LKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVAR 204
H + HRD+K QN+LLD+ +K+ DFG+S +T GTP Y +PE+
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISK--ILSSKSKAYTVVGTPCYISPELCEG 175
Query: 205 RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQ-FPSFVSKPARSLIY 263
+ Y+ +D W+ G +L+ L + F+ +NL A+ K+ + S R LI
Sbjct: 176 KPYNQK-SDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLIL 234
Query: 264 QLLDPNPKTRMSIEKIMS 281
+L+ +P R + +IM+
Sbjct: 235 SMLNLDPSKRPQLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 5e-34
Identities = 77/242 (31%), Positives = 134/242 (55%), Gaps = 6/242 (2%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94
+LG+GSF KV A+ + AIK ++K+ D +E +V E + P + +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMV-EKRVLALSGKPPFLTQ 65
Query: 95 IQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHR 153
+ T ++Y VMEY GG+L ++++ GR E A Y ++ L F H G+ +R
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYR 125
Query: 154 DVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM-LHTACGTPAYTAPEVVARRGYDGAVA 212
D+K N++LD +G++K++DFG+ E + +G+ T CGTP Y APE++A + Y G
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSV 182
Query: 213 DAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKT 272
D W+ GV+L+ +LAG PF+ + +++ + + +P +SK A ++ L+ +P
Sbjct: 183 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGK 242
Query: 273 RM 274
R+
Sbjct: 243 RL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 5e-34
Identities = 82/262 (31%), Positives = 136/262 (51%), Gaps = 14/262 (5%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMED--RIVREVSAMRRLQ 87
YQ L+GRG++ V++ K + G +VA+K I LD +D I REV+ + +L+
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIIN-----LDTPDDDVSDIQREVALLSQLR 57
Query: 88 NH--PNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFC 145
PN+ K +++++MEYA GG + ++ G + E ++++ AL +
Sbjct: 58 QSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYI 117
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVAR- 204
H+ GV HRD+K N+L+ GN+K+ DFG++AL + T GTP + APEV+
Sbjct: 118 HKVGVIHRDIKAANILVTNTGNVKLCDFGVAAL-LNQNSSKRSTFVGTPYWMAPEVITEG 176
Query: 205 RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL-AMYKKVNRRDYQFP-SFVSKPARSLI 262
+ YD AD WS G+ ++ + G P+ D + AM + + + SK R +
Sbjct: 177 KYYD-TKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFV 235
Query: 263 YQLLDPNPKTRMSIEKIMSISW 284
LD PK R+S E+++ W
Sbjct: 236 AACLDEEPKERLSAEELLKSKW 257
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 7e-34
Identities = 73/224 (32%), Positives = 113/224 (50%), Gaps = 27/224 (12%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
++L ++G G++ KV+KA+ G +VAIK ++ + E+ I E + +R+
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD-----IIEDEEEEIKEEYNILRKYS 60
Query: 88 NHPNVLKIQEVMATKT------KIYLVMEYAAGG---ELFGKLRR--GRLTESAARRYFQ 136
NHPN+ K +++LVME GG +L LR+ RL E +
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 137 QLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK--NGMLHTACGTP 194
+ + L + H+N V HRD+K QN+LL ++ +K+ DFG+SA Q+ G +T GTP
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA---QLDSTLGRRNTFIGTP 177
Query: 195 AYTAPEVVA-----RRGYDGAVADAWSCGVILFVLLAGYLPFDD 233
+ APEV+A YD A +D WS G+ L G P D
Sbjct: 178 YWMAPEVIACDEQPDASYD-ARSDVWSLGITAIELADGKPPLCD 220
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 1e-33
Identities = 76/257 (29%), Positives = 138/257 (53%), Gaps = 6/257 (2%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94
+LG+GSF KV A+ G A+K ++K+ +D +E +V E + +P +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMV-EKRVLALAWENPFLTH 60
Query: 95 IQEVMATKTKIYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQNGVAHR 153
+ TK ++ VME+ GG+L ++ +GR A Y ++V L F H G+ +R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 154 DVKPQNLLLDRDGNLKVSDFGLSALPEQI-KNGMLHTACGTPAYTAPEVVARRGYDGAVA 212
D+K N++LDRDG++K++DFG+ E + + T CGTP Y APE++ Y +V
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV- 177
Query: 213 DAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKT 272
D WS GV+L+ +L G PF + +++ + +P +++K ++ ++ +L + +P
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237
Query: 273 RMSIEKIMSISWFQKSL 289
R+ + + F K++
Sbjct: 238 RLGVVGNIRGHPFFKTI 254
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 2e-33
Identities = 61/189 (32%), Positives = 96/189 (50%), Gaps = 15/189 (7%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94
LG GS+ V+KA G +VAIK + + I++E+S +++ + P ++K
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE------IIKEISILKQCDS-PYIVK 62
Query: 95 IQEVMATKTKIYLVMEYAAGGELFG--KLRRGRLTESAARRYFQQLVSALHFCHQNGVAH 152
T +++VMEY G + K+ LTE Q + L + H N H
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIH 122
Query: 153 RDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML--HTACGTPAYTAPEVVARRGYDGA 210
RD+K N+LL+ +G K++DFG+S Q+ + M +T GTP + APEV+ GY+
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSG---QLTDTMAKRNTVIGTPFWMAPEVIQEIGYN-N 178
Query: 211 VADAWSCGV 219
AD WS G+
Sbjct: 179 KADIWSLGI 187
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 3e-33
Identities = 74/265 (27%), Positives = 129/265 (48%), Gaps = 18/265 (6%)
Query: 33 GPLLGRGSFAKVHKAKSIADGSIVAIKTIE------KNNKFLDAAMEDRIVREVSAMRRL 86
G L+G+G++ +V+ A ++ G ++A+K +E + M + E+ ++ L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFC 145
H N+++ T+ + + +EY GG + LR GR E R + +Q++ L +
Sbjct: 66 D-HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI-KNGMLHTACGTPAYTAPEVV-- 202
H G+ HRD+K NLL+D DG K+SDFG+S + I N + G+ + APEV+
Sbjct: 125 HSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS 184
Query: 203 ARRGYDGAVADAWSCGVILFVLLAGYLPF-DDSNLLAMYKKVNRRDY-----QFPSFVSK 256
+GY V D WS G ++ + AG P+ D+ + AM+K N+R +S
Sbjct: 185 YSQGYSAKV-DIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSP 243
Query: 257 PARSLIYQLLDPNPKTRMSIEKIMS 281
A + NP R + +++
Sbjct: 244 VALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-33
Identities = 88/288 (30%), Positives = 138/288 (47%), Gaps = 49/288 (17%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDA--AMEDRIVREVSAMRRLQNHPNVL 93
LG G++A V+K ++ G IVA+K I LDA +RE+S M+ L+ H N++
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIH-----LDAEEGTPSTAIREISLMKELK-HENIV 61
Query: 94 KIQEVMATKTKIYLVMEYAAGG-----ELFGKLRRGRLTESAARRYFQQLVSALHFCHQN 148
++ +V+ T+ K+ LV EY + G RG L + + + QL+ + FCH+N
Sbjct: 62 RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 149 GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVV-ARRGY 207
V HRD+KPQNLL+++ G LK++DFGL A I T Y AP+V+ R Y
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGL-ARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTY 178
Query: 208 DGAVADAWSCGVILFVLLAGYLPFDDSN----LLAMYK---------------------- 241
++ D WS G I+ ++ G F +N LL +++
Sbjct: 179 STSI-DIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237
Query: 242 --KVNRRDYQ--FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285
+ +D Q FP L+++LL NP+ R+S + WF
Sbjct: 238 FPRYPPQDLQQLFPHA-DPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 4e-33
Identities = 80/252 (31%), Positives = 140/252 (55%), Gaps = 17/252 (6%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94
++GRGS+AKV + I A+K ++K D + D + E + NHP ++
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDI-DWVQTEKHVFEQASNHPFLVG 60
Query: 95 IQEVMATKTKIYLVMEYAAGGELFGKLRRGR-LTESAARRYFQQLVSALHFCHQNGVAHR 153
+ T+++++ V+EY GG+L ++R R L E AR Y ++ AL++ H+ G+ +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 154 DVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTA-CGTPAYTAPEVVARRGYD-GAV 211
D+K N+LLD +G++K++D+G+ E ++ G + CGTP Y APE++ RG D G
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEIL--RGEDYGFS 176
Query: 212 ADAWSCGVILFVLLAGYLPFD--------DSNLLA-MYKKVNRRDYQFPSFVSKPARSLI 262
D W+ GV++F ++AG PFD D N +++ + + + P +S A S++
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVL 236
Query: 263 YQLLDPNPKTRM 274
L+ +PK R+
Sbjct: 237 KSFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 85/250 (34%), Positives = 131/250 (52%), Gaps = 21/250 (8%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNN--KFLDAAM--EDRIVREVSAMRR 85
Y + ++GRG+F +V + + + A+K + K K D+A E+R + +
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA---- 100
Query: 86 LQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFC 145
N P V+++ +Y+VMEY GG+L + + E A+ Y ++V AL
Sbjct: 101 --NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAI 158
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLH--TACGTPAYTAPEVVA 203
H G+ HRDVKP N+LLD+ G+LK++DFG ++ GM+ TA GTP Y +PEV+
Sbjct: 159 HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE--TGMVRCDTAVGTPDYISPEVLK 216
Query: 204 RRGYDGAVA---DAWSCGVILFVLLAGYLPFDDSNLLAMYKKV--NRRDYQFP--SFVSK 256
+G DG D WS GV LF +L G PF +L+ Y K+ ++ FP +SK
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISK 276
Query: 257 PARSLIYQLL 266
A++LI L
Sbjct: 277 HAKNLICAFL 286
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 81/256 (31%), Positives = 128/256 (50%), Gaps = 9/256 (3%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN 88
+Y +G GSF K KS DG IK I + E R +EV+ + ++
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESR--KEVAVLSNMK- 57
Query: 89 HPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL--RRGRL-TESAARRYFQQLVSALHFC 145
HPN+++ QE +Y+VM+Y GG+L+ K+ +RG L E +F Q+ AL
Sbjct: 58 HPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHV 117
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARR 205
H + HRD+K QN+ L +DG +K+ DFG++ + + T GTP Y +PE+ R
Sbjct: 118 HDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-LARTCIGTPYYLSPEICENR 176
Query: 206 GYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY-QFPSFVSKPARSLIYQ 264
Y+ +D W+ G +L+ + F+ N+ + K+ R Y S S R+L+ Q
Sbjct: 177 PYNNK-SDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQ 235
Query: 265 LLDPNPKTRMSIEKIM 280
L NP+ R S+ I+
Sbjct: 236 LFKRNPRDRPSVNSIL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 78/233 (33%), Positives = 122/233 (52%), Gaps = 9/233 (3%)
Query: 36 LGRGSFAKVHKAK-SIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94
LG GSF +V A D VAIK EK+ K + D + E + + NHP +
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKS-KIIKQKQVDHVFSERKILNYI-NHPFCVN 95
Query: 95 IQEVMATKTKIYLVMEYAAGGELFGKLRRG-RLTESAARRYFQQLVSALHFCHQNGVAHR 153
+ ++ +YLV+E+ GGE F LRR R Y Q+V + + +R
Sbjct: 96 LYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYR 155
Query: 154 DVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVAD 213
D+KP+NLLLD+DG +K++DFG + ++ + +T CGTP Y APE++ G+ G AD
Sbjct: 156 DLKPENLLLDKDGFIKMTDFGFA----KVVDTRTYTLCGTPEYIAPEILLNVGH-GKAAD 210
Query: 214 AWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLL 266
W+ G+ ++ +L G PF + L +Y+K+ FP F+ + L+ +LL
Sbjct: 211 WWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLL 263
|
Length = 340 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 2e-32
Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 20/207 (9%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ-- 87
Y+ +G G++ V+KA+ + G VA+K + + + +RE++ +++L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLSTLREIALLKQLESF 58
Query: 88 NHPNVLKIQEVMATK-----TKIYLVMEYAAGGELFGKLRR----GRLTESAARRYFQQL 138
HPN++++ +V K+ LV E+ +L L + G L + +QL
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPG-LPPETIKDLMRQL 116
Query: 139 VSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTAC-GTPAYT 197
+ + F H + + HRD+KPQN+L+ DG +K++DFGL+ + M T+ T Y
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI---YSFEMALTSVVVTLWYR 173
Query: 198 APEVVARRGYDGAVADAWSCGVILFVL 224
APEV+ + Y V D WS G I L
Sbjct: 174 APEVLLQSSYATPV-DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 6e-32
Identities = 72/209 (34%), Positives = 107/209 (51%), Gaps = 50/209 (23%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIV-----REVSAMRRLQNHP 90
+G G++ V+KA+ G IVA+K I L+ ED V RE+S ++ L NHP
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIR-----LET--EDEGVPSTAIREISLLKEL-NHP 58
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-------GRLTESAARRYFQQLVSALH 143
N++++ +V+ ++ K+YLV E+ L L++ L + Y QL+ +
Sbjct: 59 NIVRLLDVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 144 FCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP--AYT---- 197
+CH + V HRD+KPQNLL+DR+G LK++DFGL+ A G P YT
Sbjct: 114 YCHSHRVLHRDLKPQNLLIDREGALKLADFGLA------------RAFGVPVRTYTHEVV 161
Query: 198 -----APEV-VARRGYDGAVADAWSCGVI 220
APE+ + R Y V D WS G I
Sbjct: 162 TLWYRAPEILLGSRQYSTPV-DIWSIGCI 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 9e-32
Identities = 86/250 (34%), Positives = 132/250 (52%), Gaps = 21/250 (8%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNN--KFLDAAM--EDRIVREVSAMRR 85
Y++ ++GRG+F +V + + + A+K + K K D+A E+R + +
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA---- 100
Query: 86 LQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFC 145
N P V+++ +Y+VMEY GG+L + + E AR Y ++V AL
Sbjct: 101 --NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAI 158
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLH--TACGTPAYTAPEVVA 203
H G HRDVKP N+LLD+ G+LK++DFG + K GM+ TA GTP Y +PEV+
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM--KMNKEGMVRCDTAVGTPDYISPEVLK 216
Query: 204 RRGYDGAVA---DAWSCGVILFVLLAGYLPFDDSNLLAMYKKV--NRRDYQFP--SFVSK 256
+G DG D WS GV L+ +L G PF +L+ Y K+ ++ FP + +SK
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK 276
Query: 257 PARSLIYQLL 266
A++LI L
Sbjct: 277 EAKNLICAFL 286
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 81/266 (30%), Positives = 134/266 (50%), Gaps = 23/266 (8%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN 88
Y+L +G G++ V+KA+ IA G +VAIK I K + I +E+S ++
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVI----KLEPGDDFEIIQQEISMLKEC-R 58
Query: 89 HPNVLKIQEVMATKTKIYLVMEYAAGGEL--FGKLRRGRLTESAARRYFQQLVSALHFCH 146
HPN++ + K+++VMEY GG L ++ RG L+E ++ + L + H
Sbjct: 59 HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH 118
Query: 147 QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML--HTACGTPAYTAPEVVA- 203
+ G HRD+K N+LL DG++K++DFG+SA Q+ + + GTP + APEV A
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGVSA---QLTATIAKRKSFIGTPYWMAPEVAAV 175
Query: 204 --RRGYDGAVADAWSCGVILFVLLAGYLP-FDDSNLLAMYKKVNRRDYQFPSFV-----S 255
+ GYDG D W+ G+ L P FD + A++ +++ ++ P S
Sbjct: 176 ERKGGYDGK-CDIWALGITAIELAELQPPMFDLHPMRALF-LISKSNFPPPKLKDKEKWS 233
Query: 256 KPARSLIYQLLDPNPKTRMSIEKIMS 281
I + L +PK R + K++
Sbjct: 234 PVFHDFIKKCLTKDPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 4e-31
Identities = 81/259 (31%), Positives = 126/259 (48%), Gaps = 23/259 (8%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIV-REVSAMRRLQNHPNVL 93
L+ G++ V+ + A+K I K N L ++ V R++ +P V+
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTF---AENPFVV 64
Query: 94 KIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAH 152
+ TK + +VMEY GG+ L+ G L AR YF + V AL + H G+ H
Sbjct: 65 SMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVH 124
Query: 153 RDVKPQNLLLDRDGNLKVSDFGLSA--------------LPEQIKNGMLHTACGTPAYTA 198
RD+KP NLL+ G++K++DFGLS + + + + CGTP Y A
Sbjct: 125 RDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIA 184
Query: 199 PEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP---SFVS 255
PEV+ R+GY V D W+ G+IL+ L G +PF ++ +V D ++P +
Sbjct: 185 PEVILRQGYGKPV-DWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALP 243
Query: 256 KPARSLIYQLLDPNPKTRM 274
A+ LI +LL NP R+
Sbjct: 244 ADAQDLISRLLRQNPLERL 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-31
Identities = 80/260 (30%), Positives = 136/260 (52%), Gaps = 16/260 (6%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN 88
RY++ +G GSF K++ AK+ +D IK I + + ++ +EV + +++
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEI--DLTKMPVKEKEASKKEVILLAKMK- 57
Query: 89 HPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGR---LTESAARRYFQQLVSALHFC 145
HPN++ ++++VMEY GG+L ++ R R +E +F Q+ L
Sbjct: 58 HPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHI 117
Query: 146 HQNGVAHRDVKPQNLLLDRDGNL-KVSDFGLSALPEQIKNGM--LHTACGTPAYTAPEVV 202
H + HRD+K QN+ L ++G + K+ DFG++ Q+ + M +T GTP Y +PE+
Sbjct: 118 HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIA---RQLNDSMELAYTCVGTPYYLSPEIC 174
Query: 203 ARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQ--FPSFVSKPARS 260
R Y+ D WS G +L+ L PF+ +NL + K+ + + P+F S+ RS
Sbjct: 175 QNRPYNNK-TDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNF-SRDLRS 232
Query: 261 LIYQLLDPNPKTRMSIEKIM 280
LI QL +P+ R SI I+
Sbjct: 233 LISQLFKVSPRDRPSITSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 8e-31
Identities = 81/262 (30%), Positives = 131/262 (50%), Gaps = 19/262 (7%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
LG G+F KV+KA+ G A K I+ + + +ED +V E+ + + HPN++ +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMV-EIDILSECK-HPNIVGL 67
Query: 96 QEVMATKTKIYLVMEYAAGGEL---FGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAH 152
E + K+++++E+ GG L +L RG LTE R +Q++ AL+F H + V H
Sbjct: 68 YEAYFYENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLHSHKVIH 126
Query: 153 RDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVA-----RRGY 207
RD+K N+LL DG++K++DFG+SA + T GTP + APEVVA Y
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR-DTFIGTPYWMAPEVVACETFKDNPY 185
Query: 208 DGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD---YQFPSFVSKPARSLIYQ 264
D AD WS G+ L L P + N + + K+ + + PS S +
Sbjct: 186 D-YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKS 244
Query: 265 LLDPNPKTRMSIEKIMSISWFQ 286
L +P R + +++ +
Sbjct: 245 CLVKDPDDRPTAAELLKHPFVS 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 88/304 (28%), Positives = 137/304 (45%), Gaps = 60/304 (19%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL---QNHPNV 92
+G G+F +V + + ++ A+KT+ K D M ++ V A R + ++ V
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRK----ADVLMRNQ-AAHVKAERDILAEADNEWV 63
Query: 93 LKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLVSALHFCHQNGVA 151
+K+ K +Y VM+Y GG++ L R G E AR Y +L A+ H+ G
Sbjct: 64 VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFI 123
Query: 152 HRDVKPQNLLLDRDGNLKVSDFGL------------------------------SAL--- 178
HRD+KP N+L+DRDG++K++DFGL S +
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRC 183
Query: 179 ---PEQIKNGMLHTAC------GTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYL 229
P + + H C GTP Y APEV+ R GY + D WS GVIL+ +L G
Sbjct: 184 RLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQP 242
Query: 230 PF-DDSNLLAMYKKVN-RRDYQFPSF--VSKPARSLIYQLLDPNPKTRM---SIEKIMSI 282
PF D+ K +N PS +S+ A LI +L + R+ ++I +
Sbjct: 243 PFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301
Query: 283 SWFQ 286
+F+
Sbjct: 302 PFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-30
Identities = 72/263 (27%), Positives = 121/263 (46%), Gaps = 18/263 (6%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
LG G+ V K G I+A+KTI ++ A++ +I+RE+ + + N P ++
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLE---INEAIQKQILRELDILHKC-NSPYIVGF 64
Query: 96 QEVMATKTKIYLVMEYAAGGEL--FGKLRRGRLTESAARRYFQQLVSAL-HFCHQNGVAH 152
I + MEY GG L K +GR+ E + ++ L + ++ + H
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIH 124
Query: 153 RDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVA 212
RDVKP N+L++ G +K+ DFG+S Q+ N + T GT +Y APE + Y +
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSG---QLVNSLAKTFVGTSSYMAPERIQGNDY-SVKS 180
Query: 213 DAWSCGVILFVLLAGYLPFDDSNLLA------MYKKVNRRDYQFPSFV-SKPARSLIYQL 265
D WS G+ L L G P+ N + VN + PS S + +
Sbjct: 181 DIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLC 240
Query: 266 LDPNPKTRMSIEKIMSISWFQKS 288
L +P+ R S ++++ + +K
Sbjct: 241 LIKDPRERPSYKELLEHPFIKKY 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 76/268 (28%), Positives = 134/268 (50%), Gaps = 18/268 (6%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADG-SIVAIKTIEKNNKFLDAAMEDR------IVREVSA 82
Y + LG G+F V+K + +G +++A+K I +N +R IV EV+
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 83 MRRLQNHPNVLKIQEVMATKTKIYLVMEYAAG---GELFGKLR--RGRLTESAARRYFQQ 137
++ HPN+++ + ++Y+VM+ G GE F L+ + R TE F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 138 LVSALHFCH-QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAY 196
+V AL + H + + HRD+ P N++L D + ++DFGL+ ++ L + GT Y
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILY 179
Query: 197 TAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQ-FPSFV- 254
+ PE+V Y G AD W+ G IL+ + PF +N+L++ K+ Y+ P +
Sbjct: 180 SCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238
Query: 255 SKPARSLIYQLLDPNPKTRMSIEKIMSI 282
S+ +I L P+ + R I ++ ++
Sbjct: 239 SEDVTDVITSCLTPDAEARPDIIQVSAM 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 3e-30
Identities = 88/271 (32%), Positives = 142/271 (52%), Gaps = 29/271 (10%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAM----EDRIVREVSAMRRLQNHP 90
++GRG+F +V K G + A+K + K A E+R V V+ RR
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVL-VNGDRRW---- 62
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQN 148
+ + + +YLVM+Y GG+L L + RL E AR Y ++V A+ HQ
Sbjct: 63 -ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL 121
Query: 149 GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHT--ACGTPAYTAPEVVAR-- 204
G HRD+KP N+LLD++G+++++DFG S L + +G + + A GTP Y +PE++
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFG-SCL-RLLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 205 --RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKV-NRRD-YQFPSF---VSKP 257
+G G D WS GV ++ +L G PF +L+ Y K+ N ++ +QFP VS+
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239
Query: 258 ARSLIYQLLDPNPKTRM---SIEKIMSISWF 285
A+ LI +L+ P+TR+ ++ +F
Sbjct: 240 AKDLIRRLICS-PETRLGRNGLQDFKDHPFF 269
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 7e-30
Identities = 87/313 (27%), Positives = 134/313 (42%), Gaps = 60/313 (19%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKF-LDAAMEDRIVREVSAMRRL 86
+ ++G+G+F +V + G I A+KT+ K+ F D + R+V A
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE--- 57
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRL-TESAARRYFQQLVSALHFC 145
+ P V+ + +YL+ME+ GG+L L + +E R Y + V A+
Sbjct: 58 SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAV 117
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA---------------------LPEQIKN 184
H+ G HRD+KP N+L+DR G++K+SDFGLS +N
Sbjct: 118 HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177
Query: 185 G-------------------------MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGV 219
M ++ GTP Y APE+ ++GY G D WS G
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGA 236
Query: 220 ILFVLLAGYLPFDDSNLLAMYKKVN--RRDYQFPS--FVSKPARSLIYQLLDPNPKTRM- 274
I+F L G+ PF N Y+K+ R FP +S A LI +L+ N + R+
Sbjct: 237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLG 295
Query: 275 --SIEKIMSISWF 285
+I S +F
Sbjct: 296 RGGAHEIKSHPFF 308
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-29
Identities = 80/264 (30%), Positives = 130/264 (49%), Gaps = 26/264 (9%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDR---IVREVSAMRRLQNHPNV 92
+G GS V A + G VA+K +D + R + EV MR Q HPN+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKK-------MDLRKQQRRELLFNEVVIMRDYQ-HPNI 78
Query: 93 LKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAH 152
+++ ++++VME+ GG L + R+ E ++ AL F H GV H
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIH 138
Query: 153 RDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM--LHTACGTPAYTAPEVVARRGYDGA 210
RD+K ++LL DG +K+SDFG A Q+ + + GTP + APEV++R Y G
Sbjct: 139 RDIKSDSILLTSDGRVKLSDFGFCA---QVSKEVPRRKSLVGTPYWMAPEVISRLPY-GT 194
Query: 211 VADAWSCGVILFVLLAGYLP-FDDSNLLAMYKKVNRRDYQFPSF-----VSKPARSLIYQ 264
D WS G+++ ++ G P F++ L AM K++ RD P VS RS + +
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPYFNEPPLQAM-KRI--RDNLPPKLKNLHKVSPRLRSFLDR 251
Query: 265 LLDPNPKTRMSIEKIMSISWFQKS 288
+L +P R + ++++ + K+
Sbjct: 252 MLVRDPAQRATAAELLNHPFLAKA 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-29
Identities = 79/250 (31%), Positives = 128/250 (51%), Gaps = 14/250 (5%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
+G+G+ V+ A +A G VAIK + ++ I+ E+ MR + HPN++
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQM----NLQQQPKKELIINEILVMRENK-HPNIVNY 81
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDV 155
+ ++++VMEY AGG L + + E ++ + AL F H N V HRD+
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDI 141
Query: 156 KPQNLLLDRDGNLKVSDFGLSA--LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVAD 213
K N+LL DG++K++DFG A PEQ K T GTP + APEVV R+ Y G D
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRS---TMVGTPYWMAPEVVTRKAY-GPKVD 197
Query: 214 AWSCGVILFVLLAGYLPFDDSN-LLAMY--KKVNRRDYQFPSFVSKPARSLIYQLLDPNP 270
WS G++ ++ G P+ + N L A+Y + Q P +S R + + L+ +
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDV 257
Query: 271 KTRMSIEKIM 280
+ R S ++++
Sbjct: 258 EKRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 73/261 (27%), Positives = 130/261 (49%), Gaps = 14/261 (5%)
Query: 33 GPLLGRGSFAKVHKAKSIADGSIVAIKTIE-----KNNKFLDAAMEDRIVREVSAMRRLQ 87
G L+G GSF V+ + + G ++A+K +E ++K +M D + RE++ ++ LQ
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 88 NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCH 146
H N+++ + + +EY GG + L G E+ R + +Q++ L++ H
Sbjct: 65 -HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH 123
Query: 147 QNGVAHRDVKPQNLLLDRDGNLKVSDFGLS-ALPEQIKNGMLHTA----CGTPAYTAPEV 201
G+ HRD+K N+L+D G +K+SDFG+S L + + A G+ + APEV
Sbjct: 124 NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV 183
Query: 202 VARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN-LLAMYKKVNRRDYQFPSFVSKPARS 260
V + Y AD WS G ++ +L G PF D L A++K + PS +S A
Sbjct: 184 VKQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAID 242
Query: 261 LIYQLLDPNPKTRMSIEKIMS 281
+ + + + R + +++
Sbjct: 243 FLEKTFEIDHNKRPTAAELLK 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-29
Identities = 73/252 (28%), Positives = 119/252 (47%), Gaps = 24/252 (9%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKN----NKFLDAAMEDRIVREVSAMRRLQNHPN 91
LG+G F +V + A G + A K ++K K A+ ++ + E +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILE------KVSSRF 54
Query: 92 VLKIQEVMATKTKIYLVMEYAAGGELFGKL----RRGRLTESAARRYFQQLVSALHFCHQ 147
++ + TK + LVM GG+L + G E+ A Y Q++ L HQ
Sbjct: 55 IVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHLHQ 113
Query: 148 NGVAHRDVKPQNLLLDRDGNLKVSDFGLSA-LPEQIKNGMLHTACGTPAYTAPEVVARRG 206
+ +RD+KP+N+LLD GN+++SD GL+ L K + GTP Y APEV+
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGEV 170
Query: 207 YDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQ----FPSFVSKPARSLI 262
YD +V D ++ G L+ ++AG PF +++ RR + +P S A+ L
Sbjct: 171 YDFSV-DWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLC 229
Query: 263 YQLLDPNPKTRM 274
LL +P+ R+
Sbjct: 230 EALLQKDPEKRL 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 6e-29
Identities = 48/122 (39%), Positives = 71/122 (58%), Gaps = 13/122 (10%)
Query: 325 NAFDIISLSSGLDLSGLFEA--KKRKEKRFTTKEKTERVVEKVKEVGERLGYVVEKGKGD 382
NAFD+ISLSSGLDLSGLFE + ++E RFT+++ E ++EK++E ++LG+ V K K
Sbjct: 1 NAFDLISLSSGLDLSGLFEEEDEVKRETRFTSRKPAEEIIEKLEEAAKKLGFRVRKKKEG 60
Query: 383 VVGL-----GKLGKMVLLVEVLMEIAPETFVVGVKVVDNSVCGRVALEFDEGDWNELQAG 437
V L G+ G++ + VEV E+ P VV VK LE+ + + L+
Sbjct: 61 GVKLEGQKGGRKGRLAVSVEV-FEVTPSLVVVEVKKS-----AGDTLEYHKFWKDLLRPL 114
Query: 438 LG 439
L
Sbjct: 115 LK 116
|
CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 1e-28
Identities = 76/259 (29%), Positives = 126/259 (48%), Gaps = 14/259 (5%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN 88
+Y + ++G GSF + + + A+K I + ++ M+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMK---- 56
Query: 89 HPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR--RGRL-TESAARRYFQQLVSALHFC 145
HPN++ +E +Y+VMEY GG+L K++ RG+L E ++F Q+ +
Sbjct: 57 HPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI 116
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLH--TACGTPAYTAPEVVA 203
H+ V HRD+K +N+ L ++G +K+ DFG + L + + + T GTP Y PE+
Sbjct: 117 HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL---LTSPGAYACTYVGTPYYVPPEIWE 173
Query: 204 RRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQ-FPSFVSKPARSLI 262
Y+ +D WS G IL+ L PF ++ + KV + Y+ PS S RSLI
Sbjct: 174 NMPYNNK-SDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLI 232
Query: 263 YQLLDPNPKTRMSIEKIMS 281
Q+ NP++R S I+S
Sbjct: 233 KQMFKRNPRSRPSATTILS 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 89/295 (30%), Positives = 133/295 (45%), Gaps = 46/295 (15%)
Query: 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAM 83
+L +Y++ LG+G++ V KA +VA+K I + F +A R RE+ +
Sbjct: 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKI--FDAFRNATDAQRTFREIMFL 60
Query: 84 RRLQNHPNVLKIQEVM--ATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRY-FQQLVS 140
+ L +HPN++K+ V+ IYLV EY +L +R L E +RY QL+
Sbjct: 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRANIL-EDVHKRYIMYQLLK 118
Query: 141 ALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGL----SALPEQIKNGMLHTACGTPAY 196
AL + H V HRD+KP N+LL+ D +K++DFGL S L E +N +L T Y
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWY 178
Query: 197 TAPEV-VARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL------------------ 237
APE+ + Y V D WS G IL +L G F ++ L
Sbjct: 179 RAPEILLGSTRYTKGV-DMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237
Query: 238 ---------AMYKKVNRRDYQ-----FPSFVSKPARSLIYQLLDPNPKTRMSIEK 278
M + R + P S A L+ +LL NP R++ E+
Sbjct: 238 ESIKSPFAATMLDSLPSRPRKPLDELLPK-ASDDALDLLKKLLVFNPNKRLTAEE 291
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 78/250 (31%), Positives = 129/250 (51%), Gaps = 14/250 (5%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
+G+G+ V+ A +A G VAI+ + + ++ I+ E+ MR +N PN++
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKN-PNIVNY 82
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDV 155
+ ++++VMEY AGG L + + E ++ + AL F H N V HRD+
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDI 142
Query: 156 KPQNLLLDRDGNLKVSDFGLSA--LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVAD 213
K N+LL DG++K++DFG A PEQ K + GTP + APEVV R+ Y G D
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMAPEVVTRKAY-GPKVD 198
Query: 214 AWSCGVILFVLLAGYLPFDDSN-LLAMYKKVNR--RDYQFPSFVSKPARSLIYQLLDPNP 270
WS G++ ++ G P+ + N L A+Y + Q P +S R + + LD +
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDV 258
Query: 271 KTRMSIEKIM 280
+ R S ++++
Sbjct: 259 EKRGSAKELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 67/206 (32%), Positives = 103/206 (50%), Gaps = 44/206 (21%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAME---DRIVREVSAMRRLQNHPNV 92
+G G++ V+KA++ G +VA+K I LD E +RE+S ++ L NHPN+
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHPNI 61
Query: 93 LKIQEVMATKTKIYLVMEYAAGGELFGKLRR-------GRLTESAARRYFQQLVSALHFC 145
+K+ +V+ T+ K+YLV E+ L L++ + + Y QL+ L FC
Sbjct: 62 VKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPA---------- 195
H + V HRD+KPQNLL++ +G +K++DFGL+ A G P
Sbjct: 117 HSHRVLHRDLKPQNLLINTEGAIKLADFGLA------------RAFGVPVRTYTHEVVTL 164
Query: 196 -YTAPEVVARRGYDGAVADAWSCGVI 220
Y APE++ Y D WS G I
Sbjct: 165 WYRAPEILLGCKYYSTAVDIWSLGCI 190
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 81/250 (32%), Positives = 130/250 (52%), Gaps = 17/250 (6%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89
+++ ++GRG+F +V K I A+K + K A E RE + +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRA--ETACFREERNVLVNGDC 60
Query: 90 PNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQ 147
+ + + +YLVM+Y GG+L L + RL E AR Y ++V A+H HQ
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 148 NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHT--ACGTPAYTAPEVVAR- 204
HRD+KP N+LLD +G+++++DFG S L + ++G + + A GTP Y +PE++
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFG-SCL-KMNQDGTVQSSVAVGTPDYISPEILQAM 178
Query: 205 ---RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKV--NRRDYQFPSF---VSK 256
G G D WS GV ++ +L G PF +L+ Y K+ + +QFPS VS+
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE 238
Query: 257 PARSLIYQLL 266
A+ LI +L+
Sbjct: 239 EAKDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 14/208 (6%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN 88
RY+L +G G++ V A G VAIK I +N F D RI+RE+ +R L
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNVFDDLIDAKRILREIKLLRHL-R 57
Query: 89 HPNVLKIQEVMATKTK-----IYLVMEYAAGGELFGKLRRGR-LTESAARRYFQQLVSAL 142
H N++ + +++ + +Y+V E +L ++ + LT+ + + Q++ L
Sbjct: 58 HENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGL 116
Query: 143 HFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS--ALPEQIKNGMLHTACGTPAYTAPE 200
+ H V HRD+KP N+L++ + +LK+ DFGL+ P++ + G L T Y APE
Sbjct: 117 KYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPE 176
Query: 201 VV-ARRGYDGAVADAWSCGVILFVLLAG 227
++ + Y A+ D WS G I LL
Sbjct: 177 LLLSSSRYTKAI-DIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 80/250 (32%), Positives = 128/250 (51%), Gaps = 14/250 (5%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
+G+G+ V+ A IA G VAIK + + ++ I+ E+ MR +N PN++
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQ----PKKELIINEILVMRENKN-PNIVNY 81
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDV 155
+ ++++VMEY AGG L + + E ++ + AL F H N V HRD+
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDI 141
Query: 156 KPQNLLLDRDGNLKVSDFGLSA--LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVAD 213
K N+LL DG++K++DFG A PEQ K T GTP + APEVV R+ Y G D
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRS---TMVGTPYWMAPEVVTRKAY-GPKVD 197
Query: 214 AWSCGVILFVLLAGYLPFDDSN-LLAMYKKVNR--RDYQFPSFVSKPARSLIYQLLDPNP 270
WS G++ ++ G P+ + N L A+Y + Q P +S R + + L+ +
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDV 257
Query: 271 KTRMSIEKIM 280
R S ++++
Sbjct: 258 DRRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-28
Identities = 80/250 (32%), Positives = 130/250 (52%), Gaps = 14/250 (5%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
+G+G+ V A +A G VAIK I + ++ I+ E+ M+ L+N PN++
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQ----PKKELIINEILVMKELKN-PNIVNF 81
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDV 155
+ ++++VMEY AGG L + + E+ ++ + AL F H N V HRD+
Sbjct: 82 LDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDI 141
Query: 156 KPQNLLLDRDGNLKVSDFGLSA--LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVAD 213
K N+LL DG++K++DFG A PEQ K T GTP + APEVV R+ Y G D
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS---TMVGTPYWMAPEVVTRKAY-GPKVD 197
Query: 214 AWSCGVILFVLLAGYLPFDDSN-LLAMYKKVNR--RDYQFPSFVSKPARSLIYQLLDPNP 270
WS G++ ++ G P+ + N L A+Y + Q P +S R + + L+ +
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDV 257
Query: 271 KTRMSIEKIM 280
+ R S ++++
Sbjct: 258 EKRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 83/273 (30%), Positives = 126/273 (46%), Gaps = 48/273 (17%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN--- 91
++GRG+F +V + G + A+K + K + +E V + A R + +
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKAD-----MLEKEQVGHIRAERDILVEADSLW 62
Query: 92 VLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLVSALHFCHQNGV 150
V+K+ K +YL+ME+ GG++ L ++ LTE + Y + V A+ HQ G
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 151 AHRDVKPQNLLLDRDGNLKVSDFGLS-----------------ALPEQI----------- 182
HRD+KP NLLLD G++K+SDFGL +LP
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 183 ------KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNL 236
+ + + GTP Y APEV + GY+ + D WS GVI++ +L GY PF
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 237 LAMYKKVN--RRDYQFPSFV--SKPARSLIYQL 265
YKKV + FP V S+ A+ LI +
Sbjct: 242 QETYKKVMNWKETLIFPPEVPISEKAKDLILRF 274
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 73/260 (28%), Positives = 129/260 (49%), Gaps = 22/260 (8%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIE--KNNKFLDAAMEDRIVREVSAMRRLQ 87
+ G LG G+F+ ++A+ + G+++A+K + +N + + + +E+ M RL
Sbjct: 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL- 60
Query: 88 NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCH 146
NHP+++++ + L +E+ AGG + L + G E+ Y +QL+ L + H
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH 120
Query: 147 QNGVAHRDVKPQNLLLDRDGN-LKVSDFGLSA-LPEQI------KNGMLHTACGTPAYTA 198
+N + HRDVK NLL+D G L+++DFG +A L + + +L GT A+ A
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL----GTIAFMA 176
Query: 199 PEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDD---SNLLAMYKKVNRRDY--QFPSF 253
PEV+ Y G D WS G ++ + P++ SN LA+ K+ P
Sbjct: 177 PEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH 235
Query: 254 VSKPARSLIYQLLDPNPKTR 273
+S R + + L+ P+ R
Sbjct: 236 LSPGLRDVTLRCLELQPEDR 255
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 77/250 (30%), Positives = 133/250 (53%), Gaps = 17/250 (6%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89
+++ ++GRG+F +V K + A+K + K A E RE + ++
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRA--ETACFREERDVLVNGDN 60
Query: 90 PNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQ 147
+ + + +YLVM+Y GG+L L + RL E AR Y ++V A+ HQ
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 148 NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHT--ACGTPAYTAPEVVAR- 204
HRD+KP N+L+D +G+++++DFG S L + +++G + + A GTP Y +PE++
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFG-SCL-KLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 205 ---RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKV--NRRDYQFPSF---VSK 256
+G G D WS GV ++ +L G PF +L+ Y K+ ++ +QFP+ VS+
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE 238
Query: 257 PARSLIYQLL 266
A+ LI +L+
Sbjct: 239 DAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 89/296 (30%), Positives = 136/296 (45%), Gaps = 50/296 (16%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN--- 91
++GRG+F +V + G I A+K + K + +E V + A R + +
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKILRKAD-----MLEKEQVAHIRAERDILVEADGAW 62
Query: 92 VLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLVSALHFCHQNGV 150
V+K+ K +YL+ME+ GG++ L ++ L+E A + Y + V A+ HQ G
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 151 AHRDVKPQNLLLDRDGNLKVSDFGL---------------------SALPEQIKNG---- 185
HRD+KP NLLLD G++K+SDFGL S Q N
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 186 ---------MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNL 236
+ ++ GTP Y APEV + GY+ + D WS GVI++ +L GY PF
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 237 LAMYKKVN--RRDYQFPSFV--SKPARSLIYQLL--DPNPKTRMSIEKIMSISWFQ 286
Y+KV + FP V S+ A+ LI + N +E+I S +F+
Sbjct: 242 QETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFE 297
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 7e-27
Identities = 73/260 (28%), Positives = 136/260 (52%), Gaps = 11/260 (4%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVR-EVSAMRRLQN 88
++ G LLG+G+F +V+ + G +A K ++ + + + + E + E+ ++ LQ
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ- 62
Query: 89 HPNVLKIQEVMATKTK--IYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFC 145
H +++ + + + + + MEY GG + +L+ G LTES R+Y +Q++ + +
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYL 122
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI--KNGMLHTACGTPAYTAPEVVA 203
H N + HRD+K N+L D GN+K+ DFG S + I + + GTP + +PEV++
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 204 RRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR--DYQFPSFVSKPARSL 261
GY G AD WS G + +L P+ + +A K+ + + Q PS +S+ AR
Sbjct: 183 GEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241
Query: 262 IYQLLDPNPKTRMSIEKIMS 281
+ + + R S E+++
Sbjct: 242 LGCIF-VEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 7e-27
Identities = 70/266 (26%), Positives = 124/266 (46%), Gaps = 25/266 (9%)
Query: 31 QLGPLLGRGSFAKVHKAK---SIADGSI-VAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
LG LG G+F +V+K K + VA+KT+ K + E +RE MR+L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEE--FLREARIMRKL 58
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGEL--FGKLRRGRLTESAARRYFQQLVSALHF 144
HPNV+K+ V + +Y+VMEY GG+L + + R +L+ S + Q+ + +
Sbjct: 59 D-HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117
Query: 145 CHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP---AYTAPEV 201
HRD+ +N L+ + +K+SDFGLS + + + G + APE
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLS---RDLYDDDYYRKRGGKLPIRWMAPES 174
Query: 202 VARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARS 260
+ + D WS GV+L+ + G P+ + + + + + Y+ P + P
Sbjct: 175 LKEGKFTSKS-DVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYL-KNGYRLPQPPNCPPE- 231
Query: 261 LIYQLL----DPNPKTRMSIEKIMSI 282
+Y L+ +P+ R + +++ I
Sbjct: 232 -LYDLMLQCWAEDPEDRPTFSELVEI 256
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 75/246 (30%), Positives = 110/246 (44%), Gaps = 56/246 (22%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN---V 92
LG G+F +V A+ + ++ A+KT+ K + L V V A R + + V
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQ-----VAHVKAERDILAEADNEWV 63
Query: 93 LKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLVSALHFCHQNGVA 151
+++ K +Y VM+Y GG++ L R G E AR Y +L A+ H+ G
Sbjct: 64 VRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFI 123
Query: 152 HRDVKPQNLLLDRDGNLKVSDFGLSA-----------------------------LPEQI 182
HRD+KP N+L+DRDG++K++DFGL P
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANC 183
Query: 183 KNG-----------------MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLL 225
+ G + H+ GTP Y APEV+ R GY + D WS GVIL+ +L
Sbjct: 184 RCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEML 242
Query: 226 AGYLPF 231
G PF
Sbjct: 243 VGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 72/221 (32%), Positives = 110/221 (49%), Gaps = 36/221 (16%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNK---FLDAAMEDRIVREVSAM 83
L Y++ LG G+F +V+KA+ I G +VA+K I +N+ F A+ RE+ +
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL-----REIKIL 61
Query: 84 RRLQNHPNVLKIQEVMA---------TKTKIYLVMEYAAGGELFGKLR--RGRLTESAAR 132
++L HPNV+ + + MA + +Y+V Y +L G L +LTES +
Sbjct: 62 KKL-KHPNVVPLID-MAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIK 118
Query: 133 RYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALP--EQIKNGMLHTA 190
Y QL+ +++ H+N + HRD+K N+L+D G LK++DFGL A P N
Sbjct: 119 CYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL-ARPYDGPPPNPKGGGG 177
Query: 191 CGTPAYT---------APEVVA-RRGYDGAVADAWSCGVIL 221
GT YT PE++ R Y AV D W G +
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAV-DIWGIGCVF 217
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 63/193 (32%), Positives = 110/193 (56%), Gaps = 17/193 (8%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
+G G++ V+K ++ G IVA+K I ++ + + +RE+S ++ LQ HPN++ +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQ-HPNIVCL 64
Query: 96 QEVMATKTKIYLVMEYAAGG--ELFGKLRRGRLTESA-ARRYFQQLVSALHFCHQNGVAH 152
Q+V+ ++++YL+ E+ + + L +G+ ++ + Y Q++ + FCH V H
Sbjct: 65 QDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLH 124
Query: 153 RDVKPQNLLLDRDGNLKVSDFGLS---ALPEQIKNGMLHTACGTPAYTAPEVV--ARRGY 207
RD+KPQNLL+D G +K++DFGL+ +P ++ H T Y APEV+ + R Y
Sbjct: 125 RDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT---HEVV-TLWYRAPEVLLGSPR-Y 179
Query: 208 DGAVADAWSCGVI 220
V D WS G I
Sbjct: 180 STPV-DIWSIGTI 191
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 81/257 (31%), Positives = 134/257 (52%), Gaps = 21/257 (8%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
LG G+F KV+KAK+ G++ A K IE + + +ED +V E+ + NHP ++K+
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMV-EIEILATC-NHPYIVKL 74
Query: 96 QEVMATKTKIYLVMEYAAGGELFG---KLRRGRLTESAARRYFQQLVSALHFCHQNGVAH 152
K+++++E+ GG + +L RG LTE + +Q++ AL + H + H
Sbjct: 75 LGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVICRQMLEALQYLHSMKIIH 133
Query: 153 RDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTA-CGTPAYTAPEVV-----ARRG 206
RD+K N+LL DG++K++DFG+SA + +K + GTP + APEVV
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSA--KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191
Query: 207 YDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD---YQFPSFVSKPARSLIY 263
YD AD WS G+ L + P + N + + K+ + + PS S R +
Sbjct: 192 YDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLK 250
Query: 264 QLLDPNPKTRMSIEKIM 280
LD +P+TR S +++
Sbjct: 251 TALDKHPETRPSAAQLL 267
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 9e-26
Identities = 72/258 (27%), Positives = 114/258 (44%), Gaps = 29/258 (11%)
Query: 36 LGRGSFAKVHKAK--SIADGSI-VAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNV 92
LG G+F +V+K K + VA+KT+ K + + +D ++E M++L HPNV
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDA-SEEERKD-FLKEARVMKKL-GHPNV 58
Query: 93 LKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQ--NGV 150
+++ V + +YLV+EY GG+L LR+ R + + L L F Q G+
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 151 A--------HRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPA-YTAPEV 201
HRD+ +N L+ D +K+SDFGLS T P + APE
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178
Query: 202 VARRGYDGAVADAWSCGVIL---FVLLAGYLPF---DDSNLLAMYKKVNRRDYQFPSFVS 255
+ + +D WS GV+L F L G P+ + +L +K R P +
Sbjct: 179 LKDGIFTSK-SDVWSFGVLLWEIFTL--GATPYPGLSNEEVLEYLRKGYR--LPKPEYCP 233
Query: 256 KPARSLIYQLLDPNPKTR 273
L+ +P+ R
Sbjct: 234 DELYELMLSCWQLDPEDR 251
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 9e-26
Identities = 77/283 (27%), Positives = 132/283 (46%), Gaps = 39/283 (13%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
+G G++ V KAK+ IVA+K + ++ D + +RE+ ++ L+ H N++++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELK-HKNIVRL 64
Query: 96 QEVMATKTKIYLVMEYAAGG--ELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHR 153
+V+ + K+ LV EY + F G + + + QL+ L FCH + V HR
Sbjct: 65 YDVLHSDKKLTLVFEYCDQDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHR 123
Query: 154 DVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVV-ARRGYDGAVA 212
D+KPQNLL++++G LK++DFGL A I T Y P+V+ + Y ++
Sbjct: 124 DLKPQNLLINKNGELKLADFGL-ARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI- 181
Query: 213 DAWSCGVILFVLLAGYLP-FDDSNLLAMYKKVNR----------------RDYQ-FPSF- 253
D WS G I L P F +++ K++ R DY+ +P +
Sbjct: 182 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYP 241
Query: 254 -----------VSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285
++ R L+ LL NP R+S E+ + +F
Sbjct: 242 ATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 1e-25
Identities = 75/267 (28%), Positives = 138/267 (51%), Gaps = 27/267 (10%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAM----RR 85
++LG LLG+G+F +V+ G +A+K ++ + + + + +EV+A+ +
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETS------KEVNALECEIQL 57
Query: 86 LQN--HPNVLK----IQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQL 138
L+N H +++ +++ M I+ ME+ GG + +L+ G LTE+ R+Y +Q+
Sbjct: 58 LKNLLHERIVQYYGCLRDPMERTLSIF--MEHMPGGSIKDQLKSYGALTENVTRKYTRQI 115
Query: 139 VSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI---KNGMLHTACGTPA 195
+ + + H N + HRD+K N+L D GN+K+ DFG S + I GM + GTP
Sbjct: 116 LEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMK-SVTGTPY 174
Query: 196 YTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR--DYQFPSF 253
+ +PEV++ GY G AD WS G + +L P+ + +A K+ + + P
Sbjct: 175 WMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPH 233
Query: 254 VSKPARSLIYQLLDPNPKTRMSIEKIM 280
VS R + ++ K R S ++++
Sbjct: 234 VSDHCRDFLKRIF-VEAKLRPSADELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 75/246 (30%), Positives = 110/246 (44%), Gaps = 56/246 (22%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN---V 92
LG G+F +V A + ++ A+KT+ K + + V V A R + + V
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKD-----VLNRNQVAHVKAERDILAEADNEWV 63
Query: 93 LKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLVSALHFCHQNGVA 151
+K+ K +Y VM+Y GG++ L R E AR Y +L A+ H+ G
Sbjct: 64 VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFI 123
Query: 152 HRDVKPQNLLLDRDGNLKVSDFGL----------------------SALP---------- 179
HRD+KP N+L+D DG++K++DFGL S P
Sbjct: 124 HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNC 183
Query: 180 --------------EQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLL 225
+Q + + H+ GTP Y APEV+ R+GY + D WS GVILF +L
Sbjct: 184 RCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEML 242
Query: 226 AGYLPF 231
G PF
Sbjct: 243 VGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 61/229 (26%), Positives = 107/229 (46%), Gaps = 14/229 (6%)
Query: 31 QLGPLLGRGSFAKVHKAKSIADGS----IVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
+LG LG G+F +V+K DG VA+KT+++ + E+ + E S M++L
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGAS--EEEREE-FLEEASIMKKL 58
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHF 144
HPN++++ V +Y+V EY GG+L LR+ +LT + Q+ + +
Sbjct: 59 S-HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 145 CHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP-AYTAPEVVA 203
HRD+ +N L+ + +K+SDFGLS + P + APE +
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 204 RRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRDYQFP 251
+ +D WS GV+L+ + G P+ + + + + Y+ P
Sbjct: 178 DGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-EDGYRLP 224
|
Length = 258 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 89/310 (28%), Positives = 140/310 (45%), Gaps = 73/310 (23%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRI----VREVSA 82
LNR +G G++ V++A+ G IVA+K + +N+ D I +RE++
Sbjct: 12 LNR------IGEGTYGIVYRARDTTSGEIVALKKVRMDNE------RDGIPISSLREITL 59
Query: 83 MRRLQNHPNVLKIQEVMATK--TKIYLVMEYAAG--GELFGKLRRGRLTESAARRYFQQL 138
+ L+ HPN+++++EV+ K I+LVMEY L + +ES + QL
Sbjct: 60 LLNLR-HPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPT-PFSESQVKCLMLQL 117
Query: 139 VSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPA--- 195
+ L + H+N + HRD+K NLLL G LK++DFGL+ M TP
Sbjct: 118 LRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM------TPKVVT 171
Query: 196 --YTAPEVV-ARRGYDGAVADAWSCGVILFVLLAG--YLP-------------------- 230
Y APE++ Y A+ D W+ G IL LLA LP
Sbjct: 172 LWYRAPELLLGCTTYTTAI-DMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNE 230
Query: 231 -----FDDSNLLAMYKKV-------NRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEK 278
F D L + K N ++FP ++S+ L+ LL +PK R + E+
Sbjct: 231 SIWPGFSD---LPLVGKFTLPKQPYNNLKHKFP-WLSEAGLRLLNFLLMYDPKKRATAEE 286
Query: 279 IMSISWFQKS 288
+ S+F++
Sbjct: 287 ALESSYFKEK 296
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 24/261 (9%)
Query: 36 LGRGSFAKVHKAKSIADGSI----VAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN 91
LG G+F +V+K G VA+KT+ K + E +RE MR+L HPN
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEE--FLREARIMRKLD-HPN 62
Query: 92 VLKIQEVMATKTKIYLVMEYAAGGEL---FGKLRRGRLTESAARRYFQQLVSALHFCHQN 148
++K+ V + + +VMEY GG+L K R L+ S + Q+ + +
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122
Query: 149 GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP---AYTAPEVVARR 205
HRD+ +N L+ + +K+SDFGLS + + + G + APE +
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLS---RDLYDDDYYKVKGGKLPIRWMAPESLKEG 179
Query: 206 GYDGAVADAWSCGVILFVLLAG----YLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSL 261
+ D WS GV+L+ + Y ++ +L KK R P L
Sbjct: 180 KFTSKS-DVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLP--KPPNCPPELYKL 236
Query: 262 IYQLLDPNPKTRMSIEKIMSI 282
+ Q +P+ R + +++ I
Sbjct: 237 MLQCWAEDPEDRPTFSELVEI 257
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 25/211 (11%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNK---FLDAAMEDRIVREVSAMR 84
++Y+ +G+G+F +V KA+ IVA+K + N+ F A+ RE+ ++
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITAL-----REIKILQ 66
Query: 85 RLQNHPNVLKIQEVMATKTK--------IYLVMEYAAGGELFGKLRRG--RLTESAARRY 134
L H NV+ + E+ TK YLV E+ +L G L + T S ++
Sbjct: 67 LL-KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKV 124
Query: 135 FQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS---ALPEQIKNGMLHTAC 191
+ L++ L++ H+N + HRD+K N+L+ +DG LK++DFGL+ +L + K
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV 184
Query: 192 GTPAYTAPEV-VARRGYDGAVADAWSCGVIL 221
T Y PE+ + R Y G D W G I+
Sbjct: 185 VTLWYRPPELLLGERDY-GPPIDMWGAGCIM 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 78/255 (30%), Positives = 125/255 (49%), Gaps = 27/255 (10%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNN----KFLDAAM-EDRIVREVSAMRRLQNHP 90
LG+G F +V + A G + A K + K K + AM E RI+ +V + R
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHS--RF---- 54
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKL-----RRGRLTESAARRYFQQLVSALHFC 145
++ + TKT + LVM GG+L + E A Y Q++S L
Sbjct: 55 -IVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTA--CGTPAYTAPEVVA 203
HQ + +RD+KP+N+LLD DGN+++SD GL+ ++K+G T GTP + APE++
Sbjct: 114 HQRRIIYRDLKPENVLLDNDGNVRISDLGLAV---ELKDGQSKTKGYAGTPGFMAPELLQ 170
Query: 204 RRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR----DYQFPSFVSKPAR 259
YD +V D ++ GV L+ ++A PF K++ +R +P S ++
Sbjct: 171 GEEYDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASK 229
Query: 260 SLIYQLLDPNPKTRM 274
S LL +P+ R+
Sbjct: 230 SFCEALLAKDPEKRL 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 71/225 (31%), Positives = 116/225 (51%), Gaps = 24/225 (10%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFL---DAAMEDRI-VREVSAM 83
+Y+ L+G GS+ V K K G IVAIK KFL D M +I +RE+ +
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIK------KFLESEDDKMVKKIAMREIRML 54
Query: 84 RRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSA 141
++L+ H N++ + EV K ++YLV E+ + L + L ES R+Y Q++
Sbjct: 55 KQLR-HENLVNLIEVFRRKKRLYLVFEFV-DHTVLDDLEKYPNGLDESRVRKYLFQILRG 112
Query: 142 LHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS---ALPEQIKNGMLHTACGTPAYTA 198
+ FCH + + HRD+KP+N+L+ + G +K+ DFG + A P ++ + T Y A
Sbjct: 113 IEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV----ATRWYRA 168
Query: 199 PEVVARRGYDGAVADAWSCGVILFVLLAG--YLPFDDSNLLAMYK 241
PE++ G D W+ G ++ +L G P DS++ +Y
Sbjct: 169 PELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP-GDSDIDQLYH 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 81/305 (26%), Positives = 139/305 (45%), Gaps = 56/305 (18%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNK---FLDAAMEDRIVREVSAM 83
++++ + +G G++ +V+KA+ G +VA+K + +N+ F A +RE+ +
Sbjct: 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITA-----IREIKIL 60
Query: 84 RRLQNHPNVLKIQEVMATKTK----------IYLVMEYAAGGELFGKLRRGRLT--ESAA 131
R+L NH N++ ++E++ K YLV EY +L G L G + E
Sbjct: 61 RQL-NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGLVHFSEDHI 118
Query: 132 RRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTAC 191
+ + +QL+ L++CH+ HRD+K N+LL+ G +K++DFGL+ L ++
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178
Query: 192 GTPAYTAPEVVARRGYDGAVADAWSCGVILFVL---------------------LAGY-- 228
T Y PE++ G D WSCG IL L L G
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238
Query: 229 ---------LPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKI 279
LP+ N + K+ RR + SF+ PA L+ +L +P R + E+
Sbjct: 239 PAVWPDVIKLPY--FNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEA 296
Query: 280 MSISW 284
++ W
Sbjct: 297 LNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 1e-24
Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 16/198 (8%)
Query: 86 LQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHF 144
++++PN +K+ + T L+M+Y G+LF L++ G+L+E+ ++ +QLV AL+
Sbjct: 65 MKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALND 124
Query: 145 CHQNGVAHRDVKPQNLLLDR-DGNLKVSDFGLSALPEQIKNGMLHTAC--GTPAYTAPEV 201
H++ + H D+K +N+L DR + + D+GL +I +C GT Y +PE
Sbjct: 125 LHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC----KIIG---TPSCYDGTLDYFSPEK 177
Query: 202 VARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN----LLAMYKKVNRRDYQFPSFVSKP 257
+ YD + D W+ GV+ + LL G PF + L K ++ F VSK
Sbjct: 178 IKGHNYDVSF-DWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKN 236
Query: 258 ARSLIYQLLDPNPKTRMS 275
A + +L N R++
Sbjct: 237 ANDFVQSMLKYNINYRLT 254
|
Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 67/244 (27%), Positives = 119/244 (48%), Gaps = 8/244 (3%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89
++LG LLGRG+F +V+ G +A+K + + + + E + + + H
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 90 PNVLKIQEVM--ATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCH 146
+++ + + K+ + +EY GG + +L+ G LTE+ RRY +Q++ + + H
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123
Query: 147 QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI--KNGMLHTACGTPAYTAPEVVAR 204
N + HRD+K N+L D GN+K+ DFG S + I + + GTP + +PEV++
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 205 RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR--DYQFPSFVSKPARSLI 262
GY G AD WS + +L P+ + +A K+ + P VS R +
Sbjct: 184 EGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFL 242
Query: 263 YQLL 266
Q+
Sbjct: 243 KQIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 81/271 (29%), Positives = 134/271 (49%), Gaps = 23/271 (8%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN 88
+Y + +LG G+ V AK ++DG A+K ++ ++ E R + + L N
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVD-----MEGMSEADKNRAQAEVCCLLN 87
Query: 89 --HPNVLKIQEVMATKTK--------IYLVMEYAAGGELFGKLRRGRLTESAARRY---- 134
+++K E A K I LV++YA G+L +++ T R +
Sbjct: 88 CDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL 147
Query: 135 -FQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL-PEQIKNGMLHTACG 192
F Q++ A+H H + HRD+K N+LL +G +K+ DFG S + + + + T CG
Sbjct: 148 LFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCG 207
Query: 193 TPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL-AMYKKVNRRDYQFP 251
TP Y APE+ R+ Y AD +S GV+L+ LL PFD N+ M+K + R P
Sbjct: 208 TPYYVAPEIWRRKPYSKK-ADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP 266
Query: 252 SFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282
+S + ++ LL +PK R S K++++
Sbjct: 267 PSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 2e-24
Identities = 75/226 (33%), Positives = 116/226 (51%), Gaps = 24/226 (10%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
+G+G++ KV+K + DGS+ A+K ++ + +++ I E + ++ L NHPNV+K
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISD-----VDEEIEAEYNILQSLPNHPNVVKF 84
Query: 96 QEVMATKTK-----IYLVMEYAAGG---ELF-GKLRRG-RLTESAARRYFQQLVSALHFC 145
+ K ++LV+E GG EL G L G RL E+ + L
Sbjct: 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL 144
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML--HTACGTPAYTAPEVVA 203
H N + HRDVK N+LL +G +K+ DFG+SA Q+ + L +T+ GTP + APEV+A
Sbjct: 145 HNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA---QLTSTRLRRNTSVGTPFWMAPEVIA 201
Query: 204 -RRGYD---GAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNR 245
+ YD A D WS G+ L G P D + + K+ R
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR 247
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 81/298 (27%), Positives = 128/298 (42%), Gaps = 71/298 (23%)
Query: 39 GSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRI-------VREVSAMRRLQNHPN 91
G++ V++A+ G IVA+K ++ ME +RE++ + +LQ HPN
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLK---------MEKEKEGFPITSLREINILLKLQ-HPN 65
Query: 92 VLKIQEVMATKT--KIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQ 147
++ ++EV+ KIY+VMEY +L + + +S + QL+S + H
Sbjct: 66 IVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD 124
Query: 148 NGVAHRDVKPQNLLLDRDGNLKVSDFGL-----SALPEQIKNGMLHTACGTPAYTAPEVV 202
N + HRD+K NLLL+ G LK+ DFGL S L + + T Y APE++
Sbjct: 125 NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV------TLWYRAPELL 178
Query: 203 -ARRGYDGAVADAWSCGVI----------------------LFVLLAGYLPFDDS----N 235
+ Y A+ D WS G I +F LL P + +
Sbjct: 179 LGAKEYSTAI-DMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLG--TPTEKIWPGFS 235
Query: 236 LLAMYKKVNRRDYQ-------FPS-FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285
L KK Y FP+ +S L+ +LL +P R+S E + +F
Sbjct: 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN 88
RYQ +G G++ V A G VAIK I R +RE+ +RR
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQ---RTLREIKILRRF-K 61
Query: 89 HPNVLKIQEVMATKT-----KIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALH 143
H N++ I +++ + +Y+V E +L+ ++ L+ + + Q++ L
Sbjct: 62 HENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLK 120
Query: 144 FCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGL--SALPEQIKNGMLHTACGTPAYTAPEV 201
+ H V HRD+KP NLLL+ + +LK+ DFGL A PE G L T Y APE+
Sbjct: 121 YIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180
Query: 202 -VARRGYDGAVADAWSCGVILFVLLAG 227
+ +GY A+ D WS G IL +L+
Sbjct: 181 MLNSKGYTKAI-DIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 80/309 (25%), Positives = 137/309 (44%), Gaps = 30/309 (9%)
Query: 8 PSAPPPPPPPPPSKKIPTLLNRYQLGPL--------LGRGSFAKVHKAKSIADGSIVAIK 59
P PP S + L +G G+ V+K G + A+K
Sbjct: 46 PLPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALK 105
Query: 60 TIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFG 119
I N+ + + +I RE+ +R + NHPNV+K ++ +I +++E+ GG L G
Sbjct: 106 VIYGNH---EDTVRRQICREIEILRDV-NHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG 161
Query: 120 -KLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178
+ + AR Q++S + + H+ + HRD+KP NLL++ N+K++DFG+S +
Sbjct: 162 THIADEQFLADVAR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRI 217
Query: 179 PEQIKNGMLHTACGTPAYTAPEVV----ARRGYDGAVADAWSCGVILFVLLAGYLPF--- 231
Q + +++ GT AY +PE + YDG D WS GV + G PF
Sbjct: 218 LAQTMDP-CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276
Query: 232 ---DDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288
D ++L M + + P+ S+ R I L P R S +++ + ++
Sbjct: 277 RQGDWASL--MCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334
Query: 289 LQQQRKRGQ 297
Q + G
Sbjct: 335 QPGQGQGGP 343
|
Length = 353 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 73/235 (31%), Positives = 128/235 (54%), Gaps = 25/235 (10%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
LG G+F KV+KA++ G + A K I+ + + +ED +V E+ + +HPN++K+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMV-EIDILASC-DHPNIVKL 67
Query: 96 QEVMATKTKIYLVMEYAAGGELFG---KLRRGRLTESAARRYFQQLVSALHFCHQNGVAH 152
+ + +++++E+ AGG + +L R LTE R +Q + AL++ H+N + H
Sbjct: 68 LDAFYYENNLWILIEFCAGGAVDAVMLELERP-LTEPQIRVVCKQTLEALNYLHENKIIH 126
Query: 153 RDVKPQNLLLDRDGNLKVSDFGLSALPE---QIKNGMLHTACGTPAYTAPEVV-----AR 204
RD+K N+L DG++K++DFG+SA Q ++ + GTP + APEVV
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI----GTPYWMAPEVVMCETSKD 182
Query: 205 RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPAR 259
R YD AD WS G+ L + P + N + + K+ + + P +++P+R
Sbjct: 183 RPYDYK-ADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE---PPTLAQPSR 233
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
LG G+ V K + G I A+KTI + + ++ +I+RE+ + + P ++K
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQKQILRELEINKSCK-SPYIVKY 64
Query: 96 QEVMATK--TKIYLVMEYAAGGEL---FGKLRR--GRLTESAARRYFQQLVSALHFCHQN 148
+ + I + MEY GG L + K+++ GR+ E + + ++ L + H
Sbjct: 65 YGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124
Query: 149 GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYD 208
+ HRD+KP N+LL R G +K+ DFG+S ++ N + T GT Y APE + + Y
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSG---ELVNSLAGTFTGTSFYMAPERIQGKPYS 181
Query: 209 GAVADAWSCGVILFVLLAGYLPF 231
+D WS G+ L + PF
Sbjct: 182 -ITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 62/196 (31%), Positives = 106/196 (54%), Gaps = 7/196 (3%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
N++++ ++G G++ V K + IVAIK + + + + +++ +RE+ +R L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE--NEEVKETTLRELKMLRTLK 58
Query: 88 NHPNVLKIQEVMATKTKIYLVMEYAAGG--ELFGKLRRGRLTESAARRYFQQLVSALHFC 145
N+++++E + K+YLV EY EL ++ G E R Y QL+ A+H+C
Sbjct: 59 QE-NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKV-RSYIYQLIKAIHWC 116
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARR 205
H+N + HRD+KP+NLL+ + LK+ DFG + + N T Y +PE++
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176
Query: 206 GYDGAVADAWSCGVIL 221
Y AV D WS G IL
Sbjct: 177 PYGKAV-DMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 86/315 (27%), Positives = 131/315 (41%), Gaps = 63/315 (20%)
Query: 29 RY-QLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDR-----------I 76
RY Q G LG G++ KV KA G IVAIK + K + + +DR
Sbjct: 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKV-KIIEISNDVTKDRQLVGMCGIHFTT 67
Query: 77 VREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL--RRGRLTESAARRY 134
+RE+ M + H N++ + +V I LVM+ A K+ R+ RLTES +
Sbjct: 68 LRELKIMNEI-KHENIMGLVDVYVEGDFINLVMDIMASD--LKKVVDRKIRLTESQVKCI 124
Query: 135 FQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS------------ALPEQI 182
Q+++ L+ H+ HRD+ P N+ ++ G K++DFGL+ + E +
Sbjct: 125 LLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 183 KNGMLHTA-CGTPAYTAPEVV-ARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN----- 235
+ T+ T Y APE++ Y AV D WS G I LL G F N
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAV-DMWSVGCIFAELLTGKPLFPGENEIDQL 243
Query: 236 ----------------------LLAMYKKVNRRDYQ--FPSFVSKPARSLIYQLLDPNPK 271
L + +D + FP S A L+ LL NP
Sbjct: 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFP-NASDDAIDLLQSLLKLNPL 302
Query: 272 TRMSIEKIMSISWFQ 286
R+S ++ + +F+
Sbjct: 303 ERISAKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 1e-23
Identities = 72/253 (28%), Positives = 126/253 (49%), Gaps = 16/253 (6%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSA--MRRLQNHPNVL 93
+G+GS+ +V + DG IK + N A+ +R E A + +L+ HPN++
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRN----ASRRERKAAEQEAQLLSQLK-HPNIV 62
Query: 94 KIQEVM-ATKTKIYLVMEYAAGGELFGKLRRGR---LTESAARRYFQQLVSALHFCHQNG 149
+E +Y+VM + GG+L+ KL+ + L E+ +F Q+ AL + H+
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122
Query: 150 VAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDG 209
+ HRD+K QN+ L R +KV D G++ + E + M T GTP Y +PE+ + + Y+
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN-QCDMASTLIGTPYYMSPELFSNKPYNY 181
Query: 210 AVADAWSCGVILFVLLAGYLPFD--DSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLD 267
+D W+ G ++ + F+ D N L +Y+ + + P S LI +L
Sbjct: 182 K-SDVWALGCCVYEMATLKHAFNAKDMNSL-VYRIIEGKLPPMPKDYSPELGELIATMLS 239
Query: 268 PNPKTRMSIEKIM 280
P+ R S++ I+
Sbjct: 240 KRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 2e-23
Identities = 77/252 (30%), Positives = 126/252 (50%), Gaps = 19/252 (7%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTI-EKNNKFLDAAMEDRIVREVSAMRRLQNHPNVL 93
+LG+G++ V+ A+ ++ +AIK I E++++++ E E++ L+ H N++
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE-----EIALHSYLK-HRNIV 68
Query: 94 KIQEVMATKTKIYLVMEYAAGGELFGKLRR--GRLT--ESAARRYFQQLVSALHFCHQNG 149
+ + + ME GG L LR G L E Y +Q++ L + H N
Sbjct: 69 QYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128
Query: 150 VAHRDVKPQNLLLDR-DGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVAR--RG 206
+ HRD+K N+L++ G +K+SDFG S I N T GT Y APEV+ + RG
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI-NPCTETFTGTLQYMAPEVIDKGPRG 187
Query: 207 YDGAVADAWSCGVILFVLLAGYLPFDD--SNLLAMYKKVNRRDY-QFPSFVSKPARSLIY 263
Y GA AD WS G + + G PF + AM+K + + + P +S A++ I
Sbjct: 188 Y-GAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFIL 246
Query: 264 QLLDPNPKTRMS 275
+ +P+P R S
Sbjct: 247 RCFEPDPDKRAS 258
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 3e-23
Identities = 80/277 (28%), Positives = 135/277 (48%), Gaps = 29/277 (10%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
+G GS V A+ G VA+K ++ + + + EV MR Q H NV+++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRDYQ-HQNVVEM 83
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDV 155
+ +++++ME+ GG L + + RL E + ++ AL + H GV HRD+
Sbjct: 84 YKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDI 143
Query: 156 KPQNLLLDRDGNLKVSDFGLSALPEQIKNGM--LHTACGTPAYTAPEVVARRGYDGAVAD 213
K ++LL DG +K+SDFG A QI + + GTP + APEV++R Y G D
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCA---QISKDVPKRKSLVGTPYWMAPEVISRTPY-GTEVD 199
Query: 214 AWSCGVILFVLLAGYLP-FDDSNLLAMYKKVNRRDYQFPSF-----VSKPARSLIYQLLD 267
WS G+++ ++ G P F DS + AM + RD P +S R + ++L
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSPVQAMKR---LRDSPPPKLKNAHKISPVLRDFLERMLT 256
Query: 268 PNPKTRMSIEKIMSISWFQKS---------LQQQRKR 295
P+ R + ++++ + ++ +QQ RKR
Sbjct: 257 REPQERATAQELLDHPFLLQTGLPECLVPLIQQYRKR 293
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 3e-23
Identities = 70/250 (28%), Positives = 126/250 (50%), Gaps = 15/250 (6%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
+G+GSF +V+K +VAIK I+ + +ED I +E++ + + + P + +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIED-IQQEITVLSQC-DSPYITRY 67
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDV 155
TK++++MEY GG L+ G L E+ ++++ L + H HRD+
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDI 127
Query: 156 KPQNLLLDRDGNLKVSDFGLSA--LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVAD 213
K N+LL G++K++DFG++ QIK +T GTP + APEV+ + YD AD
Sbjct: 128 KAANVLLSEQGDVKLADFGVAGQLTDTQIKR---NTFVGTPFWMAPEVIKQSAYDFK-AD 183
Query: 214 AWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSF---VSKPARSLIYQLLDPNP 270
WS G+ L G P D + + + + + P+ SKP + + L+ +P
Sbjct: 184 IWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP--PTLEGQYSKPFKEFVEACLNKDP 241
Query: 271 KTRMSIEKIM 280
+ R + ++++
Sbjct: 242 RFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 5e-23
Identities = 72/261 (27%), Positives = 127/261 (48%), Gaps = 18/261 (6%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89
++L +G G++ V+KA+++ G + AIK I+ L+ + +V++ M + H
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK-----LEPGEDFAVVQQEIIMMKDCKH 65
Query: 90 PNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQN 148
N++ + K+++ ME+ GG L G L+ES ++ + L++ H
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK 125
Query: 149 GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML--HTACGTPAYTAPEVVA--R 204
G HRD+K N+LL +G++K++DFG+SA QI + + GTP + APEV A R
Sbjct: 126 GKMHRDIKGANILLTDNGHVKLADFGVSA---QITATIAKRKSFIGTPYWMAPEVAAVER 182
Query: 205 RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARS---- 260
+G + D W+ G+ L P D + + + + ++Q P K S
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242
Query: 261 -LIYQLLDPNPKTRMSIEKIM 280
+ L NPK R + EK++
Sbjct: 243 HFVKMALTKNPKKRPTAEKLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 6e-23
Identities = 74/276 (26%), Positives = 130/276 (47%), Gaps = 37/276 (13%)
Query: 29 RYQLGPLLGRGSFAKVH---KAKSIADGSIVAIKTIE----KNNKFLDAAMEDRIVREVS 81
RY L LG+GSF V+ K++A+ + +K I N+ + A E +++ ++
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 82 AMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGR-----LTESAARRYFQ 136
HP ++K + ++ EY G +L KL + L+E+ +F
Sbjct: 61 -------HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFI 113
Query: 137 QLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTAC----- 191
QL+ +H+ HQ + HRD+K +N+ L ++ LK+ DFG+S L L +C
Sbjct: 114 QLLLGVHYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRL--------LMGSCDLATT 164
Query: 192 --GTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY- 248
GTP Y +PE + +GYD +D WS G IL+ + F+ N L++ ++
Sbjct: 165 FTGTPYYMSPEALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTP 223
Query: 249 QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISW 284
P S+ S++ +L+ +P R S +I+ +
Sbjct: 224 SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 8e-23
Identities = 65/201 (32%), Positives = 104/201 (51%), Gaps = 21/201 (10%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRI----VREVSAMRRLQNHPN 91
+G GS+ V K ++ G IVAIK KF+++ + I +RE+ +++L+ HPN
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIK------KFVESEDDPVIKKIALREIRMLKQLK-HPN 61
Query: 92 VLKIQEVMATKTKIYLVMEYAAGGEL--FGKLRRGRLTESAARRYFQQLVSALHFCHQNG 149
++ + EV K K++LV EY L K RG + E ++ Q + A++FCH++
Sbjct: 62 LVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-VPEHLIKKIIWQTLQAVNFCHKHN 120
Query: 150 VAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG---MLHTACGTPAYTAPEVVARRG 206
HRDVKP+N+L+ + G +K+ DFG + +I G T Y APE++
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFA----RILTGPGDDYTDYVATRWYRAPELLVGDT 176
Query: 207 YDGAVADAWSCGVILFVLLAG 227
G D W+ G + LL G
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 8e-23
Identities = 78/296 (26%), Positives = 131/296 (44%), Gaps = 56/296 (18%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIV-----REVSAMRRLQNHP 90
+G G++ KV+KA+ G +VA+K M++ + RE+S ++ L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTR-------LEMDEEGIPPTALREISLLQMLSESI 61
Query: 91 NVLKIQEVMATKTK-----IYLVMEYAAGG-----ELFGKLRRGRLTESAARRYFQQLVS 140
++++ +V + K +YLV EY + G+ L + + QL+
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 141 ALHFCHQNGVAHRDVKPQNLLLDRDGN-LKVSDFGLS-ALPEQIKNGMLHTACGTPAYTA 198
+ CH++GV HRD+KPQNLL+D+ LK++D GL A +K+ H T Y A
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS-YTHEIV-TLWYRA 179
Query: 199 PEV-VARRGYDGAVADAWSCGVILFVLLAGYLPF-DDS---NLLAMYKKV---------- 243
PEV + Y V D WS G I + F DS LL ++K +
Sbjct: 180 PEVLLGSTHYSTPV-DIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238
Query: 244 --NRRDY-QFPSF-----------VSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285
RD+ +FP + +S L+ ++L +P R+S + ++ +F
Sbjct: 239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 8e-23
Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 10/200 (5%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
+G+GSF +V K +VAIK I+ + +ED I +E++ + + + P V K
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIED-IQQEITVLSQC-DSPYVTKY 67
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDV 155
TK++++MEY GG LR G E ++++ L + H HRD+
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDI 127
Query: 156 KPQNLLLDRDGNLKVSDFGLSA--LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVAD 213
K N+LL G++K++DFG++ QIK +T GTP + APEV+ + YD AD
Sbjct: 128 KAANVLLSEQGDVKLADFGVAGQLTDTQIKR---NTFVGTPFWMAPEVIQQSAYDSK-AD 183
Query: 214 AWSCGVILFVLLAGYLPFDD 233
WS G+ L G P D
Sbjct: 184 IWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-22
Identities = 73/246 (29%), Positives = 122/246 (49%), Gaps = 33/246 (13%)
Query: 17 PPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRI 76
P PS + +++ +G+G++ KV K + +GS A+K ++ + +++ I
Sbjct: 14 PDPS-------DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-----IDEEI 61
Query: 77 VREVSAMRRLQNHPNVLKI-----QEVMATKTKIYLVMEYAAGGELF----GKLRRG-RL 126
E + ++ L +HPNV+K ++ + +++LV+E GG + G L+RG R+
Sbjct: 62 EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM 121
Query: 127 TESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM 186
E + + L H N HRDVK N+LL +G +K+ DFG+SA Q+ +
Sbjct: 122 EEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA---QLTSTR 178
Query: 187 L--HTACGTPAYTAPEVVA-----RRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAM 239
L +T+ GTP + APEV+A YD A D WS G+ L G P D + +
Sbjct: 179 LRRNTSVGTPFWMAPEVIACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPMRA 237
Query: 240 YKKVNR 245
K+ R
Sbjct: 238 LFKIPR 243
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 66/203 (32%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 28 NRY-QLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
NRY L P+ G G+F V A+ G VAIK I K F + R RE+ ++ L
Sbjct: 10 NRYVDLQPV-GMGAFGLVCSARDQLTGQNVAIKKIMK--PFSTPVLAKRTYRELKLLKHL 66
Query: 87 QNHPNVLKIQEV-MATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFC 145
+ H N++ + ++ ++ IY V E G +L L L + + + Q++ L +
Sbjct: 67 R-HENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYV 124
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVAR- 204
H GV HRD+KP N+L++ + +LK+ DFGL+ + + G + T Y APE++
Sbjct: 125 HSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTR----YYRAPEIMLTW 180
Query: 205 RGYDGAVADAWSCGVILFVLLAG 227
+ YD V D WS G I +L G
Sbjct: 181 QKYDVEV-DIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 3e-22
Identities = 63/217 (29%), Positives = 109/217 (50%), Gaps = 11/217 (5%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMED--RIVREVSAMRRLQ 87
+ G +LG+G++ V+ G ++A+K +E + + AA ++ ++ EV ++ L+
Sbjct: 2 WTKGEVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 88 NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCH 146
H N+++ I + ME+ GG + L R G L E +Y +Q++ + + H
Sbjct: 61 -HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH 119
Query: 147 QNGVAHRDVKPQNLLLDRDGNLKVSDFGLS-----ALPEQIKNGMLHTACGTPAYTAPEV 201
N V HRD+K N++L +G +K+ DFG + + ML + GTP + APEV
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 202 VARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLA 238
+ GY G +D WS G +F + G P + LA
Sbjct: 180 INESGY-GRKSDIWSIGCTVFEMATGKPPLASMDRLA 215
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 8e-22
Identities = 69/248 (27%), Positives = 118/248 (47%), Gaps = 11/248 (4%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
+G+GSF +V K +VAIK I+ + +ED I +E++ + + + P V K
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIED-IQQEITVLSQC-DSPYVTKY 67
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDV 155
TK++++MEY GG L G L E+ ++++ L + H HRD+
Sbjct: 68 YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDI 127
Query: 156 KPQNLLLDRDGNLKVSDFGLSA--LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVAD 213
K N+LL G +K++DFG++ QIK GTP + APEV+ + YD AD
Sbjct: 128 KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF---VGTPFWMAPEVIKQSAYDSK-AD 183
Query: 214 AWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD-YQFPSFVSKPARSLIYQLLDPNPKT 272
WS G+ L G P + + + + + + + SKP + + L+ P
Sbjct: 184 IWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSF 243
Query: 273 RMSIEKIM 280
R + ++++
Sbjct: 244 RPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|217748 pfam03822, NAF, NAF domain | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 8e-22
Identities = 30/58 (51%), Positives = 45/58 (77%), Gaps = 3/58 (5%)
Query: 324 MNAFDIISLSSGLDLSGLFEAKK---RKEKRFTTKEKTERVVEKVKEVGERLGYVVEK 378
+NAFD+ISLSSGLDLSGLFE +K +KE RFT+++ ++ K++E+ + LG+ V+K
Sbjct: 1 LNAFDLISLSSGLDLSGLFEEEKKSKKKETRFTSRKPASEIISKLEEIAKELGFKVKK 58
|
Length = 58 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 1e-21
Identities = 63/233 (27%), Positives = 107/233 (45%), Gaps = 34/233 (14%)
Query: 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVRE 79
+K P LN + +G G+ +V+K + G ++A+K + + + RI+ +
Sbjct: 7 GQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG---NKEENKRILMD 63
Query: 80 VSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-----------GRLTE 128
+ + + + P ++K T + +++ ME + KL + G++T
Sbjct: 64 LDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTV 121
Query: 129 SAARRYFQQLVSALHFCHQN-GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML 187
+ V ALH+ + GV HRDVKP N+LLD GN+K+ DFG+S ++ +
Sbjct: 122 AI--------VKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG---RLVDSKA 170
Query: 188 HT-ACGTPAYTAPEVV----ARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN 235
T + G AY APE + YD AD WS G+ L L G P+ +
Sbjct: 171 KTRSAGCAAYMAPERIDPPDPNPKYD-IRADVWSLGISLVELATGQFPYKNCK 222
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 2e-21
Identities = 69/249 (27%), Positives = 122/249 (48%), Gaps = 16/249 (6%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDA----AMEDRIVREVSAMRRLQNHP 90
++GRG F +V+ + G + A+K ++K + A+ +RI+ + + + P
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST---GDCP 57
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLVSALHFCHQNG 149
++ + T K+ +++ GG+L L + G +E+ R Y +++ L H
Sbjct: 58 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF 117
Query: 150 VAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVAR-RGYD 208
V +RD+KP N+LLD G++++SD GL+ + K H + GT Y APEV+ + YD
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVLQKGVAYD 174
Query: 209 GAVADAWSCGVILFVLLAGYLPF---DDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQL 265
+ AD +S G +LF LL G+ PF + + + + P S RSL+ L
Sbjct: 175 SS-ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 233
Query: 266 LDPNPKTRM 274
L + R+
Sbjct: 234 LQRDVNRRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 3e-21
Identities = 65/201 (32%), Positives = 104/201 (51%), Gaps = 10/201 (4%)
Query: 88 NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTES------AARRYFQQLVSA 141
+H ++K + + K+ L+MEY +GG+L ++++ RL E F Q+V A
Sbjct: 123 DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQ-RLKEHLPFQEYEVGLLFYQIVLA 181
Query: 142 LHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA-LPEQIKNGMLHTACGTPAYTAPE 200
L H + HRD+K N+ L G +K+ DFG S + + + + CGTP Y APE
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241
Query: 201 VVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQ-FPSFVSKPAR 259
+ R+ Y AD WS GVIL+ LL + PF + + ++V Y FP VS +
Sbjct: 242 LWERKRYSKK-ADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMK 300
Query: 260 SLIYQLLDPNPKTRMSIEKIM 280
+L+ LL NP R + ++++
Sbjct: 301 ALLDPLLSKNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 4e-21
Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ- 87
+Y+ +G G++ V+KA+ G VA+K++ + + VREV+ ++RL+
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN--EDGLPLSTVREVALLKRLEA 58
Query: 88 -NHPNVLKIQEVMAT-----KTKIYLVMEYAAGG--ELFGKLRRGRLTESAARRYFQQLV 139
+HPN++++ +V AT +TK+ LV E+ K+ L + +Q +
Sbjct: 59 FDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFL 118
Query: 140 SALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAP 199
L F H N + HRD+KP+N+L+ G +K++DFGL+ + L T Y AP
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC--QMALTPVVVTLWYRAP 176
Query: 200 EVVARRGYDGAVADAWSCGVIL 221
EV+ + Y V D WS G I
Sbjct: 177 EVLLQSTYATPV-DMWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 4e-21
Identities = 73/253 (28%), Positives = 117/253 (46%), Gaps = 24/253 (9%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKN--NKFLDAAM---EDRIVREVSAMRRLQNH 89
+LG+G F +V + A G + A K +EK K AM E +I+ +V N
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-------NS 59
Query: 90 PNVLKIQEVMATKTKIYLVMEYAAGGEL---FGKLRRGRLTESAARRYFQQLVSALHFCH 146
V+ + TK + LV+ GG+L + E A Y ++ L H
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH 119
Query: 147 QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG-MLHTACGTPAYTAPEVVARR 205
+ + +RD+KP+N+LLD G++++SD GL+ +I G + GT Y APEVV
Sbjct: 120 RERIVYRDLKPENILLDDYGHIRISDLGLAV---EIPEGETIRGRVGTVGYMAPEVVKNE 176
Query: 206 GYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR----DYQFPSFVSKPARSL 261
Y + D W G +++ ++ G PF ++V RR ++ S+ ARS+
Sbjct: 177 RYTFSP-DWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSI 235
Query: 262 IYQLLDPNPKTRM 274
QLL +P R+
Sbjct: 236 CRQLLTKDPGFRL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 82/299 (27%), Positives = 133/299 (44%), Gaps = 54/299 (18%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSI--ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
RY+L LG+G++ V A++ ++ VAIK I N F + R +RE+ +R
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKI--TNVFSKKILAKRALRELKLLRHF 58
Query: 87 QNHPNVLKIQEV----MATKTKIYL---VMEYAAGGELFGKLRRG-RLTESAARRYFQQL 138
+ H N+ + ++ ++YL +ME +L +R G LT++ + + Q+
Sbjct: 59 RGHKNITCLYDMDIVFPGNFNELYLYEELMEA----DLHQIIRSGQPLTDAHFQSFIYQI 114
Query: 139 VSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGL----SALPEQIKNGMLHTACGTP 194
+ L + H V HRD+KP NLL++ D LK+ DFGL S P + G + T
Sbjct: 115 LCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE-NAGFMTEYVATR 173
Query: 195 AYTAPEV-VARRGYDGAVADAWSCGVILFVLLAG------------------YLPFDDSN 235
Y APE+ ++ + Y A+ D WS G IL LL L D
Sbjct: 174 WYRAPEIMLSFQSYTKAI-DVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232
Query: 236 LLAMYKKVNRRDY--QFPSFVSKP-----------ARSLIYQLLDPNPKTRMSIEKIMS 281
L+ ++Y P+ KP A L+ +LL +P R+S+E+ +
Sbjct: 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 4e-21
Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 21/205 (10%)
Query: 90 PNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLVSALHFCHQN 148
PN++ + + + ++ ++LV+++A GG+L+ + + + E +R+ ++V AL H+
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104
Query: 149 GVAHRDVKPQNLLLDRDGNLKVSDFG-LSALPEQIKNGMLHTACGTPAYTAPEVVARRGY 207
G+ RD+ P N+LLD G+++++ F S + + + Y APEV
Sbjct: 105 GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVEN-----MYCAPEVGG-ISE 158
Query: 208 DGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKK-VNRR-DYQFPSFVSKPARSLIYQL 265
+ D WS G ILF LL G L+ + +N P +VS+ ARSL+ QL
Sbjct: 159 ETEACDWWSLGAILFELLTG------KTLVECHPSGINTHTTLNIPEWVSEEARSLLQQL 212
Query: 266 LDPNPKTRM-----SIEKIMSISWF 285
L NP R+ +E I S +F
Sbjct: 213 LQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 4e-21
Identities = 79/290 (27%), Positives = 126/290 (43%), Gaps = 51/290 (17%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
LG GS+A V+K +S G +VA+K I + + +RE S ++ L+ H N++ +
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEH---EEGAPFTAIREASLLKDLK-HANIVTL 68
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRR------GRLTESAARRYFQQLVSALHFCHQNG 149
+++ TK + LV EY L L++ G L+ R + QL+ L +CHQ
Sbjct: 69 HDIIHTKKTLTLVFEY-----LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR 123
Query: 150 VAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVV-ARRGYD 208
V HRD+KPQNLL+ G LK++DFGL A + + + T Y P+V+ Y
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGL-ARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 209 GAVADAWSCGVILFVLLAGYLPFDDSN-----LLAMYK---------------KVNRRDY 248
++ D W G I + + G F S L +++ + Y
Sbjct: 183 TSL-DMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY 241
Query: 249 QFPSFVSKP-------------ARSLIYQLLDPNPKTRMSIEKIMSISWF 285
FP + +P L + L PK R+S + M +F
Sbjct: 242 SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 5e-21
Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 43/215 (20%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
+++Y+ +G G++ V+KA+ +A+K I + D + +RE+S ++ +
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPSTAIREISLLKEM 58
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEY--------AAGGELFGKLRRGRLTESAARRYFQQL 138
Q H N++++Q+V+ ++ ++YLV EY F K R + Y Q+
Sbjct: 59 Q-HGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPR------LIKTYLYQI 111
Query: 139 VSALHFCHQNGVAHRDVKPQNLLLDRDGN-LKVSDFGLSALPEQIKNGMLHTACGTPA-- 195
+ + +CH + V HRD+KPQNLL+DR N LK++DFGL+ A G P
Sbjct: 112 LRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA------------RAFGIPVRT 159
Query: 196 ---------YTAPEV-VARRGYDGAVADAWSCGVI 220
Y APE+ + R Y V D WS G I
Sbjct: 160 FTHEVVTLWYRAPEILLGSRHYSTPV-DIWSVGCI 193
|
Length = 294 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 5e-21
Identities = 72/252 (28%), Positives = 123/252 (48%), Gaps = 22/252 (8%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDA----AMEDRIVREVSAMRRLQNHP 90
++GRG F +V+ + G + A+K ++K + A+ +RI+ + + + P
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST---GDCP 57
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLVSALHFCHQNG 149
++ + T K+ +++ GG+L L + G +E R Y +++ L H
Sbjct: 58 FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF 117
Query: 150 VAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVAR-RGYD 208
V +RD+KP N+LLD G++++SD GL+ + K H + GT Y APEV+ + YD
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVLQKGTAYD 174
Query: 209 GAVADAWSCGVILFVLLAGYLPF------DDSNLLAMYKKVNRRDYQFPSFVSKPARSLI 262
+ AD +S G +LF LL G+ PF D + M VN + P S +SL+
Sbjct: 175 SS-ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVN---VELPDSFSPELKSLL 230
Query: 263 YQLLDPNPKTRM 274
LL + R+
Sbjct: 231 EGLLQRDVSKRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 6e-21
Identities = 58/191 (30%), Positives = 95/191 (49%), Gaps = 18/191 (9%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
+G GSF V+ A+ + +VAIK + + K + +D I++EV +++L HPN ++
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQQL-RHPNTIEY 80
Query: 96 QEVMATKTKIYLVMEYAAG--GELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHR 153
+ + +LVMEY G ++ ++ L E + L + H + HR
Sbjct: 81 KGCYLREHTAWLVMEYCLGSASDILEVHKKP-LQEVEIAAICHGALQGLAYLHSHERIHR 139
Query: 154 DVKPQNLLLDRDGNLKVSDFGLSAL--PEQIKNGMLHTACGTPAYTAPEVVARRG---YD 208
D+K N+LL G +K++DFG ++L P + GTP + APEV+ YD
Sbjct: 140 DIKAGNILLTEPGTVKLADFGSASLVSPAN-------SFVGTPYWMAPEVILAMDEGQYD 192
Query: 209 GAVADAWSCGV 219
G V D WS G+
Sbjct: 193 GKV-DVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 7e-21
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN 88
RY+ +G G++ V A G VAIK I + F + R +RE+ +R
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI--PHAFDVPTLAKRTLRELKILRHF-K 62
Query: 89 HPNVLKIQEVMATKTK----IYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALH 143
H N++ I++++ +Y+VM+ +L + LTE R + QL+ L
Sbjct: 63 HDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLK 121
Query: 144 FCHQNGVAHRDVKPQNLLLDRDGNLKVSDFG----LSALPEQIKNGML-HTACGTPAYTA 198
+ H V HRD+KP NLL++ D L++ DFG LS+ P + K M + A T Y A
Sbjct: 122 YIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA--TRWYRA 179
Query: 199 PEVV-ARRGYDGAVADAWSCGVIL 221
PE++ + Y A+ D WS G I
Sbjct: 180 PELLLSLPEYTTAI-DMWSVGCIF 202
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 8e-21
Identities = 68/212 (32%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN 88
RY++ ++G+GS+ V A G VAIK I N+ F + RI+RE+ +R L+
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI--NDVFEHVSDATRILREIKLLRLLR- 57
Query: 89 HPNVLKIQEVMATKTK-----IYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSAL 142
HP++++I+ +M ++ IY+V E +L ++ LT + + QL+ AL
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 143 HFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL-----PEQIKNGMLHTACGTPAYT 197
+ H V HRD+KP+N+L + D LK+ DFGL+ + P I T Y
Sbjct: 117 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI---FWTDYVATRWYR 173
Query: 198 APEVVAR--RGYDGAVADAWSCGVILFVLLAG 227
APE+ Y A+ D WS G I +L G
Sbjct: 174 APELCGSFFSKYTPAI-DIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 69/252 (27%), Positives = 120/252 (47%), Gaps = 14/252 (5%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94
+LG+G F +V + A G + A K +EK + E + E + ++ N V+
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKK-RIKKRKGESMALNEKQILEKV-NSQFVVN 64
Query: 95 IQEVMATKTKIYLVMEYAAGGEL-FGKLRRGR--LTESAARRYFQQLVSALHFCHQNGVA 151
+ TK + LV+ GG+L F G E A Y +++ L H+
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTV 124
Query: 152 HRDVKPQNLLLDRDGNLKVSDFGLSA-LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGA 210
+RD+KP+N+LLD G++++SD GL+ +PE + GT Y APEV+ + Y
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLAVKIPE---GESIRGRVGTVGYMAPEVLNNQRY-TL 180
Query: 211 VADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR----DYQFPSFVSKPARSLIYQLL 266
D W G +++ ++ G PF ++V+RR + + + S+ A+S+ LL
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLL 240
Query: 267 DPNPKTRMSIEK 278
+PK R+ ++
Sbjct: 241 TKDPKQRLGCQE 252
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-20
Identities = 77/286 (26%), Positives = 126/286 (44%), Gaps = 46/286 (16%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
LG G++A V K +S ++VA+K I + + +REVS ++ L+ H N++ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEH---EEGAPCTAIREVSLLKNLK-HANIVTL 68
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRR-----GRLTESAARRYFQ-QLVSALHFCHQNG 149
+++ T+ + LV EY L L++ G L + F QL+ L +CH+
Sbjct: 69 HDIIHTERCLTLVFEY-----LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK 123
Query: 150 VAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDG 209
+ HRD+KPQNLL++ G LK++DFGL A + + T Y P+V+
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGL-ARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 210 AVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNR-------------------RDYQF 250
D W G IL+ + G F S + + R R Y F
Sbjct: 183 TPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLF 242
Query: 251 PSFVSKPARS-----------LIYQLLDPNPKTRMSIEKIMSISWF 285
P + ++P + L+ LL K+R+S E + S+F
Sbjct: 243 PQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-20
Identities = 77/286 (26%), Positives = 123/286 (43%), Gaps = 43/286 (15%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
LG GS+A V+K KS +G +VA+K I + +RE S ++ L+ H N++ +
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQE---EEGTPFTAIREASLLKGLK-HANIVLL 68
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHR 153
+++ TK + LV EY +L + + G L + + QL+ L + HQ + HR
Sbjct: 69 HDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHR 127
Query: 154 DVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVAD 213
D+KPQNLL+ G LK++DFGL A + + + T Y P+V+ D
Sbjct: 128 DLKPQNLLISDTGELKLADFGL-ARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLD 186
Query: 214 AWSCGVILFVLLAGY---------------------------------LPFDDSNLLAMY 240
W G I ++ G LP +Y
Sbjct: 187 MWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLY 246
Query: 241 KKVN-RRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285
N R+ + S+V+ A L +LL PK R+S + +S +F
Sbjct: 247 SPKNLRQAWNKLSYVNH-AEDLASKLLQCFPKNRLSAQAALSHEYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 33/213 (15%)
Query: 37 GRGSFAKVHKAKSIA--DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94
GRG++ +V+KAK DG AIK K +K + RE++ +R L+ H NV+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKF-KGDKEQYTGISQSACREIALLRELK-HENVVS 66
Query: 95 IQEVMATKT--KIYLVMEYAAGGELFGKLRRGRLTESAARRYFQ---------QLVSALH 143
+ EV +YL+ +YA +L+ ++ R A R Q+++ +H
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHR---QAKRVSIPPSMVKSLLWQILNGVH 122
Query: 144 FCHQNGVAHRDVKPQNLLLDRDGN----LKVSDFGLSALPEQIKNGMLHTACGTPA---- 195
+ H N V HRD+KP N+L+ +G +K+ D GL+ L + P
Sbjct: 123 YLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD---LDPVVVTI 179
Query: 196 -YTAPEVV-ARRGYDGAVADAWSCGVILFVLLA 226
Y APE++ R Y A+ D W+ G I LL
Sbjct: 180 WYRAPELLLGARHYTKAI-DIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 4e-20
Identities = 71/268 (26%), Positives = 125/268 (46%), Gaps = 25/268 (9%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89
++L L+G G++ +V+K + + G + AIK ++ + E+ I +E++ +++ +H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-----VTGDEEEEIKQEINMLKKYSHH 62
Query: 90 PNVLKIQEVMATKT------KIYLVMEYAAGG---ELFGKLRRGRLTESAARRYFQQLVS 140
N+ K +++LVME+ G +L + L E ++++
Sbjct: 63 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 122
Query: 141 ALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPE 200
L HQ+ V HRD+K QN+LL + +K+ DFG+SA ++ G +T GTP + APE
Sbjct: 123 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPE 181
Query: 201 VVARRGYDGAV----ADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFV-- 254
V+A A +D WS G+ + G P D + + + R P
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA--PRLKSK 239
Query: 255 --SKPARSLIYQLLDPNPKTRMSIEKIM 280
SK +S I L N R + E++M
Sbjct: 240 KWSKKFQSFIESCLVKNHSQRPTTEQLM 267
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 4e-20
Identities = 77/254 (30%), Positives = 119/254 (46%), Gaps = 26/254 (10%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94
+LG+G F +V + A G + A K +EK + E + E + ++ N V+
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKK-RIKKRKGESMALNEKQILEKV-NSRFVVS 64
Query: 95 IQEVMATKTKIYLVMEYAAGGEL-FGKLRRGR--LTESAARRYFQQLVSALHFCHQNGVA 151
+ TK + LV+ GG+L F G E A Y ++ L HQ +
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIV 124
Query: 152 HRDVKPQNLLLDRDGNLKVSDFGLSA-LPE-QIKNGMLHTACGTPAYTAPEVVARRGYDG 209
+RD+KP+N+LLD G++++SD GL+ +PE Q G + GT Y APEVV Y
Sbjct: 125 YRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV----GTVGYMAPEVVKNERYTF 180
Query: 210 AVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY---------QFPSFVSKPARS 260
+ D W+ G +L+ ++AG PF KK+ R + ++ S ARS
Sbjct: 181 S-PDWWALGCLLYEMIAGQSPFQQRK-----KKIKREEVERLVKEVQEEYSEKFSPDARS 234
Query: 261 LIYQLLDPNPKTRM 274
L LL +PK R+
Sbjct: 235 LCKMLLCKDPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 5e-20
Identities = 72/260 (27%), Positives = 123/260 (47%), Gaps = 18/260 (6%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
+G GS V A + G +VA+K ++ + + + EV MR Q H NV+++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQ-HENVVEM 82
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDV 155
++++VME+ GG L + R+ E ++ AL H GV HRD+
Sbjct: 83 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDI 142
Query: 156 KPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLH--TACGTPAYTAPEVVARRGYDGAVAD 213
K ++LL DG +K+SDFG A Q+ + + GTP + APE+++R Y G D
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCA---QVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVD 198
Query: 214 AWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSF-----VSKPARSLIYQLLDP 268
WS G+++ ++ G P+ + L K + RD P VS + + +LL
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--RDNLPPKLKNLHKVSPSLKGFLDRLLVR 256
Query: 269 NPKTRMSIEKIMSISWFQKS 288
+P R + +++ + K+
Sbjct: 257 DPAQRATAAELLKHPFLAKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 8e-20
Identities = 68/254 (26%), Positives = 118/254 (46%), Gaps = 21/254 (8%)
Query: 35 LLGRGSFAKVHKAKSIADGSI---VAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN 91
LG GSF V + + G VA+K ++ + L M+D + +E + M L +H N
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDK--LSDIMDDFL-KEAAIMHSL-DHEN 57
Query: 92 VLKIQEVMATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQN 148
++++ V+ T + +V E A G L +LR+ G S Y Q+ + + +
Sbjct: 58 LIRLYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 149 GVAHRDVKPQNLLLDRDGNLKVSDFGLS-ALPEQIKNGMLHTACGTP-AYTAPEVVARRG 206
HRD+ +N+LL D +K+ DFGL ALP+ + ++ P A+ APE + R
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 207 YDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQL 265
+ A +D W GV L+ + G P+ + + KK+++ + + P IY +
Sbjct: 177 FSHA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQD--IYNV 233
Query: 266 L----DPNPKTRMS 275
+ NP R +
Sbjct: 234 MLQCWAHNPADRPT 247
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 8e-20
Identities = 70/255 (27%), Positives = 119/255 (46%), Gaps = 24/255 (9%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
+G GS V A G VA+K ++ + + + EV MR +H NV+ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ----QRRELLFNEVVIMRDY-HHENVVDM 84
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDV 155
++++VME+ GG L + R+ E ++ AL + H GV HRD+
Sbjct: 85 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDI 144
Query: 156 KPQNLLLDRDGNLKVSDFGLSA-----LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGA 210
K ++LL DG +K+SDFG A +P++ + GTP + APEV++R Y G
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPKR------KSLVGTPYWMAPEVISRLPY-GT 197
Query: 211 VADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSF-----VSKPARSLIYQL 265
D WS G+++ ++ G P+ + L +++ RD P VS R + +
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI--RDNLPPRVKDSHKVSSVLRGFLDLM 255
Query: 266 LDPNPKTRMSIEKIM 280
L P R + ++++
Sbjct: 256 LVREPSQRATAQELL 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 8e-20
Identities = 70/264 (26%), Positives = 125/264 (47%), Gaps = 22/264 (8%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTI--EKNNKFLDAAMEDRIVREVSAMRRLQ 87
Y+L +G G++ V+KA+++ G + A+K I E + F E +V+E
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECK------ 64
Query: 88 NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCH 146
H N++ ++ K+++ MEY GG L G L+E ++ + L + H
Sbjct: 65 -HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH 123
Query: 147 QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML--HTACGTPAYTAPEVVA- 203
G HRD+K N+LL +G++K++DFG++A +I + + GTP + APEV A
Sbjct: 124 SKGKMHRDIKGANILLTDNGDVKLADFGVAA---KITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 204 -RRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLI 262
+ G + D W+ G+ L P D + + +++ ++Q P K S
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST 240
Query: 263 YQ-----LLDPNPKTRMSIEKIMS 281
+ L NPK R + E++++
Sbjct: 241 FHNFVKISLTKNPKKRPTAERLLT 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 1e-19
Identities = 86/287 (29%), Positives = 133/287 (46%), Gaps = 48/287 (16%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
LN Y++ +G G F +V K K I + + L + ++V EV+ MR L
Sbjct: 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAI--SYRGLKEREKSQLVIEVNVMREL 69
Query: 87 QNHPNVLKIQEVMATKT--KIYLVMEYAAGGELFGKLRR-----GRLTESAARRYFQQLV 139
+ H N+++ + K K+Y++ME+ G+L +++ G++ E A +QL+
Sbjct: 70 K-HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128
Query: 140 SALHFCHQ-----NG--VAHRDVKPQNLLLD-----------RDGNL------KVSDFGL 175
AL +CH NG V HRD+KPQN+ L + NL K+ DFGL
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 176 SALPEQIKN----GMLHTACGTPAYTAPEVVAR--RGYDGAVADAWSCGVILFVLLAGYL 229
S KN M H+ GTP Y +PE++ + YD +D W+ G I++ L +G
Sbjct: 189 S------KNIGIESMAHSCVGTPYYWSPELLLHETKSYDDK-SDMWALGCIIYELCSGKT 241
Query: 230 PFDDSNLLAMYKKVNRRDYQFP-SFVSKPARSLIYQLLDPNPKTRMS 275
PF +N + +R P SK LI LL+ + K R S
Sbjct: 242 PFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPS 288
|
Length = 1021 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 18/224 (8%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
+RYQ +G G++ +V A G VAIK + + F A R RE +R L+
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL--SRPFQSAIHAKRTYRE---LRLLK 69
Query: 88 --NHPNVLKIQEVMATKT------KIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLV 139
+H NV+ + +V + +YLV G +L ++ +L++ + Q++
Sbjct: 70 HMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQIL 128
Query: 140 SALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAP 199
L + H G+ HRD+KP N+ ++ D LK+ DFGL+ + G + T Y AP
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAP 184
Query: 200 EVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKV 243
E++ + D WS G I+ LL G F S+ + K++
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-19
Identities = 44/140 (31%), Positives = 81/140 (57%), Gaps = 3/140 (2%)
Query: 38 RGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQE 97
RG+F KV+ + + + A+K ++K + ++ M ++ E A+ L P ++ +
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKAD-MINKNMVHQVQAERDALA-LSKSPFIVHLYY 71
Query: 98 VMATKTKIYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVK 156
+ + +YLVMEY GG++ L G E A +Y ++ AL + H++G+ HRD+K
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLK 131
Query: 157 PQNLLLDRDGNLKVSDFGLS 176
P N+L+ +G++K++DFGLS
Sbjct: 132 PDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 76/253 (30%), Positives = 118/253 (46%), Gaps = 24/253 (9%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKN--NKFLDAAM---EDRIVREVSAMRRLQNH 89
+LG+G F +V + A G + A K +EK K AM E RI+ +V N
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-------NS 59
Query: 90 PNVLKIQEVMATKTKIYLVMEYAAGGEL-FGKLRRGR--LTESAARRYFQQLVSALHFCH 146
V+ + TK + LV+ GG+L F G E A Y +L L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 147 QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG-MLHTACGTPAYTAPEVVARR 205
+ + +RD+KP+N+LLD G++++SD GL+ QI G + GT Y APEV+
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGLAV---QIPEGETVRGRVGTVGYMAPEVINNE 176
Query: 206 GYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR----DYQFPSFVSKPARSL 261
Y + D W G +++ ++ G PF ++V+RR ++ S+ A+S+
Sbjct: 177 KYTFS-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSI 235
Query: 262 IYQLLDPNPKTRM 274
LL NPK R+
Sbjct: 236 CRMLLTKNPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-19
Identities = 59/218 (27%), Positives = 107/218 (49%), Gaps = 21/218 (9%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89
++L ++G G++ +V+K + + G + AIK ++ + E+ I E++ +++ +H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD-----VTEDEEEEIKLEINMLKKYSHH 72
Query: 90 PNVLKIQEVMATKT------KIYLVMEYAAGG---ELFGKLRRGRLTESAARRYFQQLVS 140
N+ K+ +++LVME+ G +L + L E ++++
Sbjct: 73 RNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILR 132
Query: 141 ALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPE 200
L H + V HRD+K QN+LL + +K+ DFG+SA ++ G +T GTP + APE
Sbjct: 133 GLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPE 191
Query: 201 VVA-----RRGYDGAVADAWSCGVILFVLLAGYLPFDD 233
V+A YD +D WS G+ + G P D
Sbjct: 192 VIACDENPDATYD-YRSDIWSLGITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-19
Identities = 79/306 (25%), Positives = 134/306 (43%), Gaps = 48/306 (15%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
LG G++A V K +S ++VA+K I + + +REVS ++ L+ H N++ +
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEH---EEGAPCTAIREVSLLKDLK-HANIVTL 69
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRR------GRLTESAARRYFQQLVSALHFCHQNG 149
+++ T + LV EY L L++ ++ + + Q++ L +CH+
Sbjct: 70 HDIVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK 124
Query: 150 VAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDG 209
V HRD+KPQNLL++ G LK++DFGL A + + T Y P+V+
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGL-ARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYS 183
Query: 210 AVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNR-------------------RDYQF 250
D W G I F + +G F S + + R ++Y F
Sbjct: 184 TQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF 243
Query: 251 PSFVSKP-----------ARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQES 299
P + +P L+ + L K R+S E+ M ++F +SL + ES
Sbjct: 244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF-RSLGTRIHSLPES 302
Query: 300 -SLFEL 304
S+F L
Sbjct: 303 ISIFSL 308
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 4e-19
Identities = 69/257 (26%), Positives = 119/257 (46%), Gaps = 33/257 (12%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLD-------AAMEDRIVREVSAMRRLQN 88
LG+G F +V + G + A K ++K K L A +E I+ +V N
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDK--KRLKKKSGEKMALLEKEILEKV-------N 51
Query: 89 HPNVLKIQEVMATKTKIYLVMEYAAGGEL----FGKLRRGRLTESAARRYFQQLVSALHF 144
P ++ + +KT + LVM GG+L + RG L Y Q+ +
Sbjct: 52 SPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-LEMERVIHYSAQITCGILH 110
Query: 145 CHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTA-CGTPAYTAPEVVA 203
H + +RD+KP+N+LLD GN ++SD GL+ ++K+G T GT Y APE++
Sbjct: 111 LHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTNGYMAPEILK 167
Query: 204 RRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR------DYQFPSFVSKP 257
Y V D ++ G ++ ++AG PF D +++ RR ++ +F ++
Sbjct: 168 EEPYSYPV-DWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNF-TEE 225
Query: 258 ARSLIYQLLDPNPKTRM 274
++ + L P+ R+
Sbjct: 226 SKDICRLFLAKKPEDRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 4e-19
Identities = 75/259 (28%), Positives = 120/259 (46%), Gaps = 30/259 (11%)
Query: 36 LGRGSFAKVHKAKSIADGSI-VAIKTIEKNNKFLDAAM-EDRIVREVSAMRRLQNHPNVL 93
LG G F VH K G I VAIK I + AM ED + E M +L HPN++
Sbjct: 12 LGSGQFGVVHLGK--WRGKIDVAIKMIR------EGAMSEDDFIEEAKVMMKLS-HPNLV 62
Query: 94 KIQEVMATKTKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVA 151
++ V + I++V EY A G L LR +G+L + A+ + NG
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI 122
Query: 152 HRDVKPQNLLLDRDGNLKVSDFGLS--ALPEQIKNGMLHTACGTPAY----TAPEVVARR 205
HRD+ +N L+ D +KVSDFGL+ L +Q +T+ + PEV
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ------YTSSQGTKFPVKWAPPEVFDYS 176
Query: 206 GYDGAVADAWSCGVILF-VLLAGYLPFDDSNLLAMYKKVNR--RDYQFPSFVSKPARSLI 262
+ +D WS GV+++ V G +P++ + + + V+ R Y+ P +++
Sbjct: 177 RFSSK-SDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR-PKLAPTEVYTIM 234
Query: 263 YQLLDPNPKTRMSIEKIMS 281
Y P+ R + +K++S
Sbjct: 235 YSCWHEKPEDRPAFKKLLS 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 86/291 (29%), Positives = 123/291 (42%), Gaps = 45/291 (15%)
Query: 29 RYQ-LGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFL-DAAMEDRIVREVSAMRRL 86
RY L PL G GS V A VA+K I L D +RE+ +RRL
Sbjct: 6 RYMDLRPL-GCGSNGLVFSAVDSDCDKRVAVKKI-----VLTDPQSVKHALREIKIIRRL 59
Query: 87 QNHPNVLKIQEVMATKTK--------------IYLVMEYAAGGELFGKLRRGRLTESAAR 132
H N++K+ EV+ +Y+V EY +L L +G L+E AR
Sbjct: 60 D-HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHAR 117
Query: 133 RYFQQLVSALHFCHQNGVAHRDVKPQNLLLD-RDGNLKVSDFGLSAL--PEQIKNGMLHT 189
+ QL+ L + H V HRD+KP N+ ++ D LK+ DFGL+ + P G L
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177
Query: 190 ACGTPAYTAPEVVAR-RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYK------K 242
T Y +P ++ Y A D W+ G I +L G F ++ L +
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKA-IDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236
Query: 243 VNRR-DYQ-----FPSFVSK----PARSLIYQLLDPNPKTRMSIEKIMSIS 283
V R D PSFV P R L L NP+ +E+I++ +
Sbjct: 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFN 287
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 8e-19
Identities = 70/287 (24%), Positives = 124/287 (43%), Gaps = 46/287 (16%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
LG G++A V+K +S ++VA+K I + + +REVS ++ L+ H N++ +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEH---EEGAPCTAIREVSLLKDLK-HANIVTL 69
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRR------GRLTESAARRYFQQLVSALHFCHQNG 149
+++ T+ + LV EY L L++ + + + QL+ L++CH+
Sbjct: 70 HDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK 124
Query: 150 VAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDG 209
V HRD+KPQNLL++ G LK++DFGL A + I T Y P+++
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGL-ARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183
Query: 210 AVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNR-------------------RDYQF 250
D W G I + + G F S + + R + Y +
Sbjct: 184 TQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNY 243
Query: 251 PSFVSKPARS-----------LIYQLLDPNPKTRMSIEKIMSISWFQ 286
P + + + L+ +LL + R+S E+ M +F
Sbjct: 244 PKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-18
Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 27/200 (13%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTI------EKNNKFLDAAMEDRIVREVSAMRRLQN 88
+G+G+F V+K + + VA+KT + KFL E I+++ +
Sbjct: 2 KIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQ---EAEILKQY-------D 50
Query: 89 HPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCH 146
HPN++K+ V K IY+VME GG L LR+ RLT + + + +
Sbjct: 51 HPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE 110
Query: 147 QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP----AYTAPEVV 202
HRD+ +N L+ + LK+SDFG+S + + G+ + G +TAPE +
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMS---REEEGGIYTVSDGLKQIPIKWTAPEAL 167
Query: 203 ARRGYDGAVADAWSCGVILF 222
G + +D WS G++L+
Sbjct: 168 -NYGRYTSESDVWSYGILLW 186
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 63/199 (31%), Positives = 91/199 (45%), Gaps = 26/199 (13%)
Query: 31 QLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP 90
+LG +G+G F V G VA+K ++ D+ + E S M L+ HP
Sbjct: 9 KLGATIGKGEFGDVMLG--DYRGQKVAVKCLKD-----DSTAAQAFLAEASVMTTLR-HP 60
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFC---- 145
N++++ V+ +Y+V EY A G L LR RGR A QQL AL C
Sbjct: 61 NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGR----AVITLAQQLGFALDVCEGME 116
Query: 146 --HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPA-YTAPEVV 202
+ HRD+ +N+L+ D KVSDFGL+ Q + P +TAPE +
Sbjct: 117 YLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-----QDSGKLPVKWTAPEAL 171
Query: 203 ARRGYDGAVADAWSCGVIL 221
R +D WS G++L
Sbjct: 172 -REKKFSTKSDVWSFGILL 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-18
Identities = 66/255 (25%), Positives = 118/255 (46%), Gaps = 20/255 (7%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
LG G F VH K A VAIK I + A E+ + E M +L +HP ++++
Sbjct: 12 LGSGQFGVVHLGKWRAQIK-VAIKAINEG-----AMSEEDFIEEAKVMMKL-SHPKLVQL 64
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHR 153
V + +Y+V E+ G L LR +G+L++ Q + + + +N HR
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124
Query: 154 DVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP---AYTAPEVVARRGYDGA 210
D+ +N L+ G +KVSDFG++ + + ++ G ++ PEV Y
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMT---RYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 211 VADAWSCGVILF-VLLAGYLPFDDSNLLAMYKKVNR--RDYQFPSFVSKPARSLIYQLLD 267
+D WS GV+++ V G +PF+ + + + ++R R Y+ P S ++Y
Sbjct: 182 -SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR-PKLASMTVYEVMYSCWH 239
Query: 268 PNPKTRMSIEKIMSI 282
P+ R + +++
Sbjct: 240 EKPEGRPTFAELLRA 254
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 14/204 (6%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDA--AMEDRIVREVSAMRRLQNHPNVL 93
LG G+ V K K I G+++A K + + A ++ +I+RE+ M ++ P ++
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVV-----HIGAKSSVRKQILRELQIMHECRS-PYIV 66
Query: 94 KIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCH-QNGVA 151
+ I + ME+ G L ++ G + + +V L + + + +
Sbjct: 67 SFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIM 126
Query: 152 HRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAV 211
HRD+KP N+L++ G +K+ DFG+S ++ N + T GT Y +PE + Y
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSG---ELINSIADTFVGTSTYMSPERIQGGKYT-VK 182
Query: 212 ADAWSCGVILFVLLAGYLPFDDSN 235
+D WS G+ + L G PF SN
Sbjct: 183 SDVWSLGISIIELALGKFPFAFSN 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 65/199 (32%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKF---LDAAMEDRIVREVSAMRRLQNHPNV 92
+GRG++ V AK+ VAIK I N F +DA R +RE+ +R L H NV
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKI--ANAFDNRIDAK---RTLREIKLLRHLD-HENV 66
Query: 93 LKIQEVMATKTK-----IYLVMEYAAGGELFGKLRRGR-LTESAARRYFQQLVSALHFCH 146
+ I+++M + +Y+V E +L +R + L++ + + QL+ L + H
Sbjct: 67 IAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 147 QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRG 206
V HRD+KP NLLL+ + +LK+ DFGL A K + T Y APE++
Sbjct: 126 SANVLHRDLKPSNLLLNANCDLKICDFGL-ARTTSEKGDFMTEYVVTRWYRAPELLLNCS 184
Query: 207 YDGAVADAWSCGVILFVLL 225
D WS G I LL
Sbjct: 185 EYTTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 66/205 (32%), Positives = 105/205 (51%), Gaps = 19/205 (9%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGS-IVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
+Y+ +G G++ KV KA+ + +G VA+K + + M +REV+ +R L+
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG--EEGMPLSTIREVAVLRHLE 59
Query: 88 N--HPNVLKIQEVMAT-----KTKIYLVMEYAAGGELFGKLRR----GRLTESAARRYFQ 136
HPNV+++ +V +TK+ LV E+ +L L + G TE+ +
Sbjct: 60 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETI-KDMMF 117
Query: 137 QLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAY 196
QL+ L F H + V HRD+KPQN+L+ G +K++DFGL+ + L + T Y
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTLWY 175
Query: 197 TAPEVVARRGYDGAVADAWSCGVIL 221
APEV+ + Y V D WS G I
Sbjct: 176 RAPEVLLQSSYATPV-DLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 8e-18
Identities = 58/189 (30%), Positives = 97/189 (51%), Gaps = 14/189 (7%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
+G GSF V+ A+ + + +VAIK + + K + +D I++EV +++L+ HPN ++
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKLR-HPNTIQY 80
Query: 96 QEVMATKTKIYLVMEYAAGG--ELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHR 153
+ + +LVMEY G +L ++ + L E + L + H + + HR
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLL-EVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 154 DVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRG---YDGA 210
DVK N+LL G +K+ DFG +++ + GTP + APEV+ YDG
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAPA-----NXFVGTPYWMAPEVILAMDEGQYDGK 194
Query: 211 VADAWSCGV 219
V D WS G+
Sbjct: 195 V-DVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 9e-18
Identities = 69/239 (28%), Positives = 113/239 (47%), Gaps = 24/239 (10%)
Query: 56 VAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGG 115
VAIKT++ + + E S M + HPN+++++ V+ + ++ EY G
Sbjct: 35 VAIKTLKAGSS---DKQRLDFLTEASIMGQFD-HPNIIRLEGVVTKSRPVMIITEYMENG 90
Query: 116 ELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDF 173
L LR G+ T + + S + + + HRD+ +N+L++ + KVSDF
Sbjct: 91 SLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDF 150
Query: 174 GLSALPEQIKNGMLHTACG-TPA-YTAPEVVARRGYDGAVADAWSCGVILF-VLLAGYLP 230
GLS E T G P +TAPE +A R + A +D WS G++++ V+ G P
Sbjct: 151 GLSRRLED-SEATYTTKGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERP 208
Query: 231 FDD-SNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLL------DPNPKTRMSIEKIMSI 282
+ D SN + K V Y+ P + P S +YQL+ D N R + +I+S
Sbjct: 209 YWDMSNQDVI-KAVE-DGYRLPPPMDCP--SALYQLMLDCWQKDRN--ERPTFSQIVST 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 59/193 (30%), Positives = 93/193 (48%), Gaps = 6/193 (3%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
LG GS+A V+K S +G +VA+K I + + +RE S ++ L+ H N++ +
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKT---EEGVPFTAIREASLLKGLK-HANIVLL 68
Query: 96 QEVMATKTKIYLVMEYAAGG-ELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRD 154
+++ TK + V EY + G L R + QL+ L + H + HRD
Sbjct: 69 HDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRD 128
Query: 155 VKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADA 214
+KPQNLL+ G LK++DFGL A + I + + T Y P+V+ + D
Sbjct: 129 LKPQNLLISYLGELKLADFGL-ARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDI 187
Query: 215 WSCGVILFVLLAG 227
W G I +L G
Sbjct: 188 WGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 62/211 (29%), Positives = 107/211 (50%), Gaps = 15/211 (7%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
+G GSF V+ A+ + +VAIK + + K + +D I++EV ++R++ HPN ++
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD-IIKEVKFLQRIK-HPNSIEY 90
Query: 96 QEVMATKTKIYLVMEYAAGG--ELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHR 153
+ + +LVMEY G +L ++ + L E + L + H + + HR
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLL-EVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 149
Query: 154 DVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRG---YDGA 210
D+K N+LL G +K++DFG +++ ++ GTP + APEV+ YDG
Sbjct: 150 DIKAGNILLTEPGQVKLADFGSASIASPA-----NSFVGTPYWMAPEVILAMDEGQYDGK 204
Query: 211 VADAWSCGVILFVLLAGYLP-FDDSNLLAMY 240
V D WS G+ L P F+ + + A+Y
Sbjct: 205 V-DVWSLGITCIELAERKPPLFNMNAMSALY 234
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 1e-17
Identities = 67/266 (25%), Positives = 118/266 (44%), Gaps = 21/266 (7%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
LG+G++ V+K G +A+K I LD + ++I+ E+ + + P ++
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLE---LDESKFNQIIMELDILHKA-VSPYIVDF 64
Query: 96 QEVMATKTKIYLVMEYAAGGEL----FGKLRRGRLTESAARRYFQQLVSALHFC-HQNGV 150
+ +Y+ MEY G L G + + E RR +V L F ++ +
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI 124
Query: 151 AHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGA 210
HRDVKP N+L++ +G +K+ DFG+S + + T G +Y APE + G +
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSG---NLVASLAKTNIGCQSYMAPERIKSGGPNQN 181
Query: 211 V-----ADAWSCGVILFVLLAG---YLPFDDSNLLAMYKKVNRRD-YQFPSFVSKPARSL 261
+D WS G+ + + G Y P +N+ A + D PS S A+
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDF 241
Query: 262 IYQLLDPNPKTRMSIEKIMSISWFQK 287
+ + L+ P R + +++ W K
Sbjct: 242 VAKCLNKIPNRRPTYAQLLEHPWLVK 267
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 3e-17
Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 15/198 (7%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAME--DRIVREVSAMRRLQNHPNVL 93
LG G+ V+KA + I+A+K I LD +E +I+ E+ + + + P ++
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIP-----LDITVELQKQIMSELEILYKCDS-PYII 62
Query: 94 KIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHR 153
+ +I + E+ GG L ++ E R +V L + + HR
Sbjct: 63 GFYGAFFVENRISICTEFMDGGSLD---VYRKIPEHVLGRIAVAVVKGLTYLWSLKILHR 119
Query: 154 DVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVAD 213
DVKP N+L++ G +K+ DFG+S Q+ N + T GT AY APE ++ Y G +D
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYVGTNAYMAPERISGEQY-GIHSD 175
Query: 214 AWSCGVILFVLLAGYLPF 231
WS G+ L G P+
Sbjct: 176 VWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 5e-17
Identities = 55/188 (29%), Positives = 96/188 (51%), Gaps = 20/188 (10%)
Query: 79 EVSAMRRLQNHPNVLKIQEVMATKTKIYLVME--------YAAGGELFGKLRRGRLTESA 130
E+ A+ RL NH N+LKI+E++ ++ Y++ + + K R L ++
Sbjct: 213 EILALGRL-NHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWK-DRPLLKQT- 269
Query: 131 ARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTA 190
R +QL+ A+ + H + HRD+K +N+ L+ DG + + DFG + E+ + +
Sbjct: 270 -RAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGW 328
Query: 191 CGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDS------NLLAMYKKV 243
GT A +PE++A GY + D WSCG+IL +L+ + P D LL + +
Sbjct: 329 VGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL 387
Query: 244 NRRDYQFP 251
+ D +FP
Sbjct: 388 SVCDEEFP 395
|
Length = 501 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 61/217 (28%), Positives = 107/217 (49%), Gaps = 14/217 (6%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
+G GSF V+ A + +VA+K + + K + +D I++EV +++L+ HPN ++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQD-IIKEVKFLQQLK-HPNTIEY 86
Query: 96 QEVMATKTKIYLVMEYAAGG--ELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHR 153
+ + +LVMEY G +L ++ + L E + L + H + + HR
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASDLL-EVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 145
Query: 154 DVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRG---YDGA 210
D+K N+LL G +K++DFG ++ K+ ++ GTP + APEV+ YDG
Sbjct: 146 DIKAGNILLTEPGQVKLADFGSAS-----KSSPANSFVGTPYWMAPEVILAMDEGQYDGK 200
Query: 211 VADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD 247
V D WS G+ L P + N ++ + + D
Sbjct: 201 V-DVWSLGITCIELAERKPPLFNMNAMSALYHIAQND 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 6e-17
Identities = 67/280 (23%), Positives = 124/280 (44%), Gaps = 36/280 (12%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
LGRG++ V K + + G+I+A+K I +++ + R++ ++ R + P +
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRAT---VNSQEQKRLLMDLDISMRSVDCPYTVTF 65
Query: 96 QEVMATKTKIYLVMEYAAGG--ELFGK--LRRGRLTESAARRYFQQLVSALHFCHQN-GV 150
+ + +++ ME + + K + + E + +V AL + H V
Sbjct: 66 YGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSV 125
Query: 151 AHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTA-CGTPAYTAPEVV----ARR 205
HRDVKP N+L++R+G +K+ DFG+S + + + T G Y APE + ++
Sbjct: 126 IHRDVKPSNVLINRNGQVKLCDFGISG---YLVDSVAKTIDAGCKPYMAPERINPELNQK 182
Query: 206 GYDGAVADAWSCGVILFVLLAGYLPFDD-SNLLAMYKKV----------NRRDYQFPSFV 254
GYD +D WS G+ + L G P+D K+V + +F FV
Sbjct: 183 GYD-VKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFV 241
Query: 255 SKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRK 294
+K L N K R + +++ +F+ L +
Sbjct: 242 NK--------CLKKNYKERPNYPELLQHPFFELHLSKNTD 273
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 7e-17
Identities = 60/243 (24%), Positives = 113/243 (46%), Gaps = 19/243 (7%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89
+ L LG G F +V + + VAIK ++ ++ + +EV A++RL+ H
Sbjct: 8 FTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLL----KQQDFQKEVQALKRLR-H 61
Query: 90 PNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQ-QLVSALHFCH 146
+++ + V + +Y++ E G L LR G++ A+ Q+ + +
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 147 QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAY--TAPEVVAR 204
+ HRD+ +N+L+ D KV+DFGL+ L IK + ++ Y TAPE +
Sbjct: 122 EQNSIHRDLAARNILVGEDLVCKVADFGLARL---IKEDVYLSSDKKIPYKWTAPEAASH 178
Query: 205 RGYDGAVADAWSCGVILF-VLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIY 263
+ +D WS G++L+ + G +P+ N +Y ++ Y+ P P IY
Sbjct: 179 GTFSTK-SDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQE--IY 234
Query: 264 QLL 266
+++
Sbjct: 235 KIM 237
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 8e-17
Identities = 72/272 (26%), Positives = 114/272 (41%), Gaps = 47/272 (17%)
Query: 32 LGPLLGRGSF--AKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVR---EVSAMRRL 86
L L+G+ VH AK ++VA+K I LD+ ++ + E+ R+L
Sbjct: 2 LLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKI-----NLDSCSKEDLKLLQQEIITSRQL 56
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR----GRLTESAARRYFQQLVSAL 142
Q HPN+L +++Y+V A G L+ G L E A + +++AL
Sbjct: 57 Q-HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNAL 114
Query: 143 HFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTAC-GTPAY----- 196
+ H G HR VK ++LL DG + +S GL IK+G P
Sbjct: 115 DYIHSKGFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNL 172
Query: 197 --TAPEVVAR--RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMY-KKVNRRDYQFP 251
+PEV+ + +GY+ +D +S G+ L G++PF D M +KV
Sbjct: 173 PWLSPEVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQMLLEKV-------- 223
Query: 252 SFVSKPARSLIYQLLDPN--PKTRMSIEKIMS 281
R + LLD + P S+ + S
Sbjct: 224 -------RGTVPCLLDKSTYPLYEDSMSQSRS 248
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 9e-17
Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 17/211 (8%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94
+GRG+F V+K G+I+A+K I D + R++ ++ + R + P ++K
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV---DEKEQKRLLMDLDVVMRSSDCPYIVK 67
Query: 95 IQEVMATKTKIYLVMEYAAGG-ELFGKL----RRGRLTESAARRYFQQLVSALHFCHQN- 148
+ + ++ ME + F K + + E + V AL++ +
Sbjct: 68 FYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL 127
Query: 149 GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTA-CGTPAYTAPEVVA---R 204
+ HRDVKP N+LLDR+GN+K+ DFG+S Q+ + + T G Y APE + R
Sbjct: 128 KIIHRDVKPSNILLDRNGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPSAR 184
Query: 205 RGYDGAVADAWSCGVILFVLLAGYLPFDDSN 235
GYD +D WS G+ L+ + G P+ N
Sbjct: 185 DGYD-VRSDVWSLGITLYEVATGKFPYPKWN 214
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 9e-17
Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 26/199 (13%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTI------EKNNKFLDAAMEDRIVREVSAMRRLQNH 89
+GRG+F +V + AD + VA+K+ + KFL E RI+++ S H
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFL---QEARILKQYS-------H 52
Query: 90 PNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQ 147
PN++++ V K IY+VME GG+ LR RL + + + + +
Sbjct: 53 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES 112
Query: 148 NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP----AYTAPEVVA 203
HRD+ +N L+ LK+SDFG+S + ++G+ + G +TAPE +
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFGMS---REEEDGVYASTGGMKQIPVKWTAPEALN 169
Query: 204 RRGYDGAVADAWSCGVILF 222
Y +D WS G++L+
Sbjct: 170 YGRYSSE-SDVWSFGILLW 187
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 50/213 (23%), Positives = 93/213 (43%), Gaps = 16/213 (7%)
Query: 15 PPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMED 74
P ++++ L Y + L GS +V A V +K +K ++A +
Sbjct: 54 PTKQKAREVVASLG-YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQ 112
Query: 75 RIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVM-EYAAGGELFGKLRRGRLTESAARR 133
+ NHP+V+++++ + + +V+ Y++ + R L A
Sbjct: 113 NV-----------NHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALI 161
Query: 134 YFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGT 193
+Q++ L + H + HRDVK +N+ ++ + + D G + P + GT
Sbjct: 162 IEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFP--VVAPAFLGLAGT 219
Query: 194 PAYTAPEVVARRGYDGAVADAWSCGVILFVLLA 226
APEV+AR Y+ D WS G++LF +LA
Sbjct: 220 VETNAPEVLARDKYNSKA-DIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 2e-16
Identities = 66/256 (25%), Positives = 117/256 (45%), Gaps = 24/256 (9%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
LG G F V K VAIK I++ + ED + E M +L +H ++++
Sbjct: 12 LGTGQFGVVKYGKWRGQYD-VAIKMIKEG-----SMSEDEFIEEAKVMMKL-SHEKLVQL 64
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRRG--RLTESAARRYFQQLVSALHFCHQNGVAHR 153
V + IY+V EY + G L LR R S + + + + HR
Sbjct: 65 YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHR 124
Query: 154 DVKPQNLLLDRDGNLKVSDFGLS--ALPEQIKNGMLHTACGTP---AYTAPEVVARRGYD 208
D+ +N L+D G +KVSDFGLS L ++ + + G+ ++ PEV+ +
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV-----GSKFPVRWSPPEVLLYSKFS 179
Query: 209 GAVADAWSCGVILF-VLLAGYLPFDDSNLLAMYKKVN--RRDYQFPSFVSKPARSLIYQL 265
+D W+ GV+++ V G +P++ N +KV+ R Y+ P S+ +++Y
Sbjct: 180 SK-SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR-PHLASEKVYAIMYSC 237
Query: 266 LDPNPKTRMSIEKIMS 281
+ R + ++++S
Sbjct: 238 WHEKAEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN 88
RY +G G++ V A G VAIK + + F R RE++ ++ +Q
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR--PFQSEIFAKRAYRELTLLKHMQ- 72
Query: 89 HPNVLKIQEVMATKT------KIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSAL 142
H NV+ + +V + YLVM Y K+ L+E + Q++ L
Sbjct: 73 HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQMLCGL 130
Query: 143 HFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVV 202
+ H G+ HRD+KP NL ++ D LK+ DFGL+ + G + T Y APEV+
Sbjct: 131 KYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW----YRAPEVI 186
Query: 203 ARRGYDGAVADAWSCGVILFVLLAG 227
+ D WS G I+ +L G
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 52/194 (26%), Positives = 102/194 (52%), Gaps = 16/194 (8%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94
LLG+G+F +V K ++ D + VA+KT +++ L ++ + + E +++ +HPN++K
Sbjct: 2 LLGKGNFGEVFKG-TLKDKTPVAVKTCKED---LPQELKIKFLSEARILKQY-DHPNIVK 56
Query: 95 IQEVMATKTKIYLVMEYAAGGELFGKLRRGR--LTESAARRYFQQLVSALHFCHQNGVAH 152
+ V + IY+VME GG+ LR+ + L ++ + + + H
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 153 RDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP----AYTAPEVVARRGYD 208
RD+ +N L+ + LK+SDFG+S + ++ ++++ G +TAPE + Y
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMS----RQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 209 GAVADAWSCGVILF 222
+D WS G++L+
Sbjct: 173 SE-SDVWSYGILLW 185
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 67/266 (25%), Positives = 116/266 (43%), Gaps = 23/266 (8%)
Query: 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVRE 79
+K I + RYQ +G G++ V A G VA+K + + F R RE
Sbjct: 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--PFQSIIHAKRTYRE 66
Query: 80 VSAMRRLQNHPNVLKIQEVMATKTK------IYLVMEYAAGGELFGKLRRGRLTESAARR 133
+ ++ ++ H NV+ + +V +YLV + G +L ++ +LT+ +
Sbjct: 67 LRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHVQF 124
Query: 134 YFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGT 193
Q++ L + H + HRD+KP NL ++ D LK+ DFGL+ + G + T
Sbjct: 125 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----AT 180
Query: 194 PAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSF 253
Y APE++ + D WS G I+ LL G F ++ + K + R
Sbjct: 181 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR-------L 233
Query: 254 VSKPARSLIYQLLDPNPKTRMSIEKI 279
V P L+ ++ + R I+ +
Sbjct: 234 VGTPGAELLKKI--SSESARNYIQSL 257
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 58/209 (27%), Positives = 107/209 (51%), Gaps = 18/209 (8%)
Query: 32 LGPLLGRGSFAKVHKA--KSIADGSI-VAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN 88
LG +G G F V++ S + I VA+KT + ++ ++ ++E MR+ +
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC---TSPSVREKFLQEAYIMRQF-D 65
Query: 89 HPNVLKIQEVMATKTKIYLVMEYAAGGEL--FGKLRRGRLTESAARRYFQQLVSALHFCH 146
HP+++K+ V+ T+ +++VME A GEL + ++ + L ++ Y QL +AL +
Sbjct: 66 HPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 147 QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP---AYTAPEVVA 203
HRD+ +N+L+ +K+ DFGLS +++ + A + APE +
Sbjct: 125 SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRY---LEDESYYKASKGKLPIKWMAPESIN 181
Query: 204 RRGYDGAVADAWSCGVILF-VLLAGYLPF 231
R + A +D W GV ++ +L+ G PF
Sbjct: 182 FRRFTSA-SDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 5e-16
Identities = 65/231 (28%), Positives = 107/231 (46%), Gaps = 16/231 (6%)
Query: 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVRE 79
+K I + +RY+ +G G++ V A G+ VAIK + + F R RE
Sbjct: 7 NKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYR--PFQSELFAKRAYRE 64
Query: 80 VSAMRRLQNHPNVLKIQEVMATKTKI------YLVMEYAAGGELFGKL-RRGRLTESAAR 132
+ ++ ++ H NV+ + +V + YLVM + G GKL + +L+E +
Sbjct: 65 LRLLKHMK-HENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQ 121
Query: 133 RYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACG 192
Q++ L + H G+ HRD+KP NL ++ D LK+ DFGL+ + G + T
Sbjct: 122 FLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRW- 180
Query: 193 TPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKV 243
Y APEV+ + D WS G I+ +L G F + L ++
Sbjct: 181 ---YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEI 228
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 5e-16
Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 14/221 (6%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN 88
RYQ +G G++ V A VA+K + + F R RE+ ++ ++
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSR--PFQSLIHARRTYRELRLLKHMK- 72
Query: 89 HPNVLKIQEVMATKT------KIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSAL 142
H NV+ + +V T ++YLV G +L ++ +L++ + QL+ L
Sbjct: 73 HENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGL 131
Query: 143 HFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVV 202
+ H G+ HRD+KP N+ ++ D L++ DFGL+ + G + T Y APE++
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYV----ATRWYRAPEIM 187
Query: 203 ARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKV 243
+ D WS G I+ LL G F ++ + K++
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 71/300 (23%), Positives = 125/300 (41%), Gaps = 54/300 (18%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
LG G+ V K G I+A K I K A+ ++I+RE+ + N P ++
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIK---PAIRNQIIRELKVLHEC-NSPYIVGF 64
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQN-GVAHR 153
+ +I + ME+ GG L L++ GR+ E+ + ++ L + + + HR
Sbjct: 65 YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHR 124
Query: 154 DVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVAD 213
DVKP N+L++ G +K+ DFG+S Q+ + M ++ GT +Y +PE + Y +D
Sbjct: 125 DVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFVGTRSYMSPERLQGTHY-TVQSD 180
Query: 214 AWSCGVILFVLLAGYLPF---DDSNLLAMY----------KKVNRRDYQFPSFVSKPARS 260
WS G+ L + G P D L AM+ + P P
Sbjct: 181 IWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP---DSPRPM 237
Query: 261 LIYQLLD----------------------------PNPKTRMSIEKIMSISWFQKSLQQQ 292
I++LLD NPK R ++++ + +++ ++
Sbjct: 238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELEE 297
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 5e-16
Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 36 LGRGSFAKVHKAK----SIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN 91
LG G F KV + G VA+K++ N+ + D RE+ +R L H N
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSD-FEREIEILRTLD-HEN 67
Query: 92 VLKIQEVM--ATKTKIYLVMEYAAGGELFGKLRRGRLTESAAR--RYFQQLVSALHFCHQ 147
++K + V + L+MEY G L L+R R + R + Q+ + +
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 148 NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACG-TPA-YTAPEVVARR 205
HRD+ +N+L++ + +K+SDFGL+ + + K+ G +P + APE +
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS 187
Query: 206 GYDGAVADAWSCGVILFVLL 225
+ A +D WS GV L+ L
Sbjct: 188 KFSSA-SDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 77/304 (25%), Positives = 126/304 (41%), Gaps = 56/304 (18%)
Query: 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMR 84
T+L RYQ +G G+ V A G VA+K + + F + R RE+ ++
Sbjct: 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR--PFQNQTHAKRAYRELVLLK 75
Query: 85 RLQNHPNVLKI------QEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQL 138
+ NH N++ + Q+ + +YLVME ++ L Q+
Sbjct: 76 CV-NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQM 132
Query: 139 VSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTA 198
+ + H G+ HRD+KP N+++ D LK+ DFGL+ N M+ T Y A
Sbjct: 133 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC--TNFMMTPYVVTRYYRA 190
Query: 199 PEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKV--------------- 243
PEV+ GY V D WS G I+ L+ G + F ++ + + KV
Sbjct: 191 PEVILGMGYKENV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249
Query: 244 ---------NR------------RDYQFPS------FVSKPARSLIYQLLDPNPKTRMSI 276
NR D+ FPS + AR L+ ++L +P R+S+
Sbjct: 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISV 309
Query: 277 EKIM 280
++ +
Sbjct: 310 DEAL 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 17/204 (8%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
+G G F V + VAIKTI + A E+ + E M +L +HP ++++
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-VAIKTIREG-----AMSEEDFIEEAQVMMKL-SHPKLVQL 64
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHR 153
V ++ I LV E+ G L LR RG+ ++ + + + + V HR
Sbjct: 65 YGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124
Query: 154 DVKPQNLLLDRDGNLKVSDFGLS--ALPEQIKNGMLHTACGTPA-YTAPEVVARRGYDGA 210
D+ +N L+ + +KVSDFG++ L +Q + T P +++PEV + Y
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS---TGTKFPVKWSSPEVFSFSKYSSK 181
Query: 211 VADAWSCGVILF-VLLAGYLPFDD 233
+D WS GV+++ V G P+++
Sbjct: 182 -SDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 4e-15
Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 50/218 (22%)
Query: 36 LGRGSFAKVHK--AKSIADGSI---VAIKTIEKNNKFLDAAMEDRI--VREVSAMRRLQN 88
LG+GSF V++ AK + G VAIKT+ +N A+M +RI + E S M+ N
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-----ASMRERIEFLNEASVMKEF-N 67
Query: 89 HPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAAR--------RYFQ---Q 137
+V+++ V++T +VME A G+L LR R ++ Q +
Sbjct: 68 CHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 138 L------VSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ------IKNG 185
+ ++A F H RD+ +N ++ D +K+ DFG++ + G
Sbjct: 128 IADGMAYLAAKKFVH------RDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKG 181
Query: 186 MLHTACGTPA-YTAPEVVARRGYDGAVADAWSCGVILF 222
+L P + APE + + G +D WS GV+L+
Sbjct: 182 LL------PVRWMAPESL-KDGVFTTKSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 70/284 (24%), Positives = 112/284 (39%), Gaps = 42/284 (14%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
+G G+F V DG VA+K + N F + R+ RE+ M H NVL
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMP--NVFQNLVSCKRVFRELK-MLCFFKHDNVLSA 64
Query: 96 QEVMATK-----TKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGV 150
+++ +IY+V E + L+ + + Q++ L + H G+
Sbjct: 65 LDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGI 124
Query: 151 AHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEV-VARRGYDG 209
HRD+KP NLL++ + LK+ DFGL+ + E ++ + T Y APE+ + R Y
Sbjct: 125 LHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTS 184
Query: 210 AVADAWSCGVILFVLLAGYLPFD----------------DSNLLAM-YKKVNRRDYQFPS 252
AV D WS G I LL + F +L AM R +
Sbjct: 185 AV-DIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRG 243
Query: 253 FVSKPARSLIYQLLDP---------------NPKTRMSIEKIMS 281
P+ ++Y L +P R+S ++
Sbjct: 244 PHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 5e-15
Identities = 73/257 (28%), Positives = 123/257 (47%), Gaps = 17/257 (6%)
Query: 35 LLGRGSFAKVHKAKSIADGS---IVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN 91
++G G F +V + G VAIKT++ + + D + E S M + +HPN
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG--YTEKQRRD-FLSEASIMGQF-DHPN 66
Query: 92 VLKIQEVMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNG 149
++ ++ V+ + +V EY G L LR+ G+ T + + S + + G
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG 126
Query: 150 VAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGT-PA-YTAPEVVARRGY 207
HRD+ +N+L++ + KVSDFGLS + E T G P +TAPE +A R +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186
Query: 208 DGAVADAWSCGVILF-VLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQL- 265
A +D WS G++++ V+ G P+ + + + K + Y+ P+ + PA ++QL
Sbjct: 187 TSA-SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYRLPAPMDCPA--ALHQLM 242
Query: 266 LDPNPKTRMSIEKIMSI 282
LD K R K I
Sbjct: 243 LDCWQKDRNERPKFEQI 259
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 7e-15
Identities = 68/247 (27%), Positives = 103/247 (41%), Gaps = 29/247 (11%)
Query: 36 LGRGSFAKV--HKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVL 93
+G G F KV +A + V +K + + + ++EV R L NHPNVL
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASA---TPDEQLLFLQEVQPYREL-NHPNVL 58
Query: 94 KIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAA------RRYFQQLVSALHFCHQ 147
+ LV+E+ G+L LR R + +R ++ S L + HQ
Sbjct: 59 QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 148 NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTA--CGTP-AYTAPEVVAR 204
H D+ +N L D ++K+ D+GL+ EQ T P + APE+V
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLAL--EQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 205 RGYDGAVAD------AWSCGVILFVLL-AGYLPFDD-SNLLAMYKKVNRRDYQFPSFVSK 256
RG D D WS GV ++ L A P+ D S+ + + V +D + P K
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP----K 232
Query: 257 PARSLIY 263
P L Y
Sbjct: 233 PQLDLKY 239
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 57/197 (28%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
LG G+ V K + G I+A K I K A+ ++I+RE+ + N P ++
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIK---PAIRNQIIRELQVLHEC-NSPYIVGF 68
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRRG-RLTESAARRYFQQLVSALHFCHQ-NGVAHR 153
+ +I + ME+ GG L L+ R+ E + ++ L + + + + HR
Sbjct: 69 YGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHR 128
Query: 154 DVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVAD 213
DVKP N+L++ G +K+ DFG+S Q+ + M ++ GT +Y +PE + Y +D
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFVGTRSYMSPERLQGTHYS-VQSD 184
Query: 214 AWSCGVILFVLLAGYLP 230
WS G+ L L G P
Sbjct: 185 IWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 4e-14
Identities = 63/243 (25%), Positives = 119/243 (48%), Gaps = 20/243 (8%)
Query: 35 LLGRGSFAKVHKAKSIADG---SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN 91
++G G F +V + + G VAIKT++ + + D + E S M + +HPN
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRD-FLSEASIMGQF-DHPN 66
Query: 92 VLKIQEVMATKTKIYLVMEYAAGGEL--FGKLRRGRLTESAARRYFQQLVSALHFCHQNG 149
++ ++ V+ + ++ E+ G L F + G+ T + + + + + +
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN 126
Query: 150 VAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTAC---GTPA-YTAPEVVARR 205
HRD+ +N+L++ + KVSDFGLS E + +T+ P +TAPE +A R
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 206 GYDGAVADAWSCGVILF-VLLAGYLPF-DDSNLLAMYKKVNRRDYQFPSFVSKPARSLIY 263
+ A +D WS G++++ V+ G P+ D SN + +DY+ P + P + ++
Sbjct: 187 KFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVI--NAIEQDYRLPPPMDCP--TALH 241
Query: 264 QLL 266
QL+
Sbjct: 242 QLM 244
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 4e-14
Identities = 63/234 (26%), Positives = 108/234 (46%), Gaps = 16/234 (6%)
Query: 53 GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK-IQEVMATKTKIYLVMEY 111
G VAIK + + + + R RE + RL HPN++ + A ++ V EY
Sbjct: 3 GHEVAIKLL-RTDAPEEEHQRARFRRETALCARLY-HPNIVALLDSGEAPPGLLFAVFEY 60
Query: 112 AAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG---N 167
G L L G L R Q++ AL H G+ HRD+KPQN+++ + G +
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 168 LKVSDFGLSALPEQIKNGMLHTAC------GTPAYTAPEVVARRGYDGAVADAWSCGVIL 221
KV DFG+ L +++ + T GTP Y APE + R +D ++ G+I
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL-RGEPVTPNSDLYAWGLIF 179
Query: 222 FVLLAGYLPFDDSNLL-AMYKKVNRRDYQFPSFV-SKPARSLIYQLLDPNPKTR 273
L G +++ +Y++++ D P ++ P ++ + L+ +P+ R
Sbjct: 180 LECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 5e-14
Identities = 64/240 (26%), Positives = 117/240 (48%), Gaps = 16/240 (6%)
Query: 35 LLGRGSFAKVHKAKSIADG---SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN 91
++G G F +V + G VAIKT++ + + +D + E S M + +H N
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQD-FLSEASIMGQF-SHHN 67
Query: 92 VLKIQEVMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNG 149
+++++ V+ ++ EY G L LR G + + + + + +
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN 127
Query: 150 VAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPA--YTAPEVVARRGY 207
HRD+ +N+L++ + KVSDFGLS + E G T+ G +TAPE +A R +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187
Query: 208 DGAVADAWSCGVILF-VLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLL 266
A +D WS G++++ V+ G P+ D + + K +N ++ P+ + P S +YQL+
Sbjct: 188 TSA-SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-DGFRLPAPMDCP--SAVYQLM 243
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 30/214 (14%)
Query: 33 GPLLGRGSFAKVHKA--KSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP 90
G +GRG++ V+KA K D A+K IE + A RE++ +R L+ HP
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC------REIALLRELK-HP 58
Query: 91 NVLKIQEVMATKT--KIYLVMEYAAGGELFGKLRRGR----------LTESAARRYFQQL 138
NV+ +Q+V + + K++L+ +YA +L+ ++ R L S + Q+
Sbjct: 59 NVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI 117
Query: 139 VSALHFCHQNGVAHRDVKPQNLLL----DRDGNLKVSDFGLSALPEQIKNGM--LHTACG 192
+ +H+ H N V HRD+KP N+L+ G +K++D G + L + L
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 193 TPAYTAPE-VVARRGYDGAVADAWSCGVILFVLL 225
T Y APE ++ R Y A+ D W+ G I LL
Sbjct: 178 TFWYRAPELLLGARHYTKAI-DIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 7e-14
Identities = 57/219 (26%), Positives = 106/219 (48%), Gaps = 21/219 (9%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAME-DRIVREVSAMRRLQNHPNVLK 94
LG G + +V++ VA+KT++++ ME + ++E + M+ ++ HPN+++
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDT------MEVEEFLKEAAVMKEIK-HPNLVQ 66
Query: 95 IQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQ---QLVSALHFCHQNGVA 151
+ V + Y++ E+ G L LR E A Q+ SA+ + +
Sbjct: 67 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 126
Query: 152 HRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAY----TAPEVVARRGY 207
HRD+ +N L+ + +KV+DFGLS L G +TA + TAPE +A +
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRL----MTGDTYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 208 DGAVADAWSCGVILF-VLLAGYLPFDDSNLLAMYKKVNR 245
+D W+ GV+L+ + G P+ +L +Y+ + +
Sbjct: 183 S-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 220
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 43/171 (25%), Positives = 81/171 (47%), Gaps = 6/171 (3%)
Query: 59 KTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVM-EYAAGGEL 117
KT E + + A E +R + NHP++++++ L++ Y
Sbjct: 115 KTCE--HVVIKAGQRGGTATEAHILRAI-NHPSIIQLKGTFTYNKFTCLILPRYKTDLYC 171
Query: 118 FGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177
+ +R + + ++ A+ + H+N + HRD+K +N+ ++ G++ + DFG +
Sbjct: 172 YLAAKR-NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAAC 230
Query: 178 LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGY 228
P I + GT A APE++AR Y AV D WS G++LF + +
Sbjct: 231 FPVDINANKYYGWAGTIATNAPELLARDPYGPAV-DIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 14/225 (6%)
Query: 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMR 84
T+L RYQ +G G+ V A VAIK + + F + R RE+ M+
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR--PFQNQTHAKRAYRELVLMK 78
Query: 85 RLQNHPNVLKIQEVMATKTK------IYLVMEYAAGGELFGKLRRGRLTESAARRYFQQL 138
+ NH N++ + V + +Y+VME ++ + L Q+
Sbjct: 79 CV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQM 135
Query: 139 VSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTA 198
+ + H G+ HRD+KP N+++ D LK+ DFGL+ + M+ T Y A
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRA 193
Query: 199 PEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKV 243
PEV+ GY V D WS G I+ ++ G + F ++ + + KV
Sbjct: 194 PEVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 1e-13
Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 30/214 (14%)
Query: 33 GPLLGRGSFAKVHKAKSI--ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP 90
G +GRG++ V+KAK D A+K IE + A RE++ +R L+ HP
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC------REIALLRELK-HP 58
Query: 91 NVLKIQEVMATKT--KIYLVMEYAAGGELFGKLRRGR----------LTESAARRYFQQL 138
NV+ +Q+V + K++L+ +YA +L+ ++ R L + Q+
Sbjct: 59 NVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 117
Query: 139 VSALHFCHQNGVAHRDVKPQNLLL----DRDGNLKVSDFGLSALPEQIKNGM--LHTACG 192
+ +H+ H N V HRD+KP N+L+ G +K++D G + L + L
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 193 TPAYTAPE-VVARRGYDGAVADAWSCGVILFVLL 225
T Y APE ++ R Y A+ D W+ G I LL
Sbjct: 178 TFWYRAPELLLGARHYTKAI-DIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 71/263 (26%), Positives = 118/263 (44%), Gaps = 30/263 (11%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKN---NKFLDAAMEDRIVREVSAM 83
L + LG ++G G F V + + G VA+K I+ + FL+ E + M
Sbjct: 5 LQKLTLGEIIGEGEFGAVLQGEYT--GQKVAVKNIKCDVTAQAFLE---------ETAVM 53
Query: 84 RRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR-RGRLTESAAR--RYFQQLVS 140
+L H N++++ V+ +Y+VME + G L LR RGR S + ++ +
Sbjct: 54 TKLH-HKNLVRLLGVI-LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAE 111
Query: 141 ALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGL-SALPEQIKNGMLHTACGTPAYTAP 199
+ + + HRD+ +N+L+ DG KVSDFGL + N L +TAP
Sbjct: 112 GMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAP 166
Query: 200 EVVARRGYDGAVADAWSCGVILF-VLLAGYLPFDDSNLLAMYKKVNRRDYQF--PSFVSK 256
E + + + +D WS GV+L+ V G P+ +L + + V + Y+ P
Sbjct: 167 EALKHKKFSSK-SDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV-EKGYRMEPPEGCPA 224
Query: 257 PARSLIYQLLDPNPKTRMSIEKI 279
L+ + PK R S K+
Sbjct: 225 DVYVLMTSCWETEPKKRPSFHKL 247
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 10/197 (5%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
LG G+ V K G I+A K I K A+ ++I+RE+ + N P ++
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIK---PAIRNQIIRELQVLHEC-NSPYIVGF 68
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQ-NGVAHR 153
+ +I + ME+ GG L L++ GR+ E + ++ L + + + + HR
Sbjct: 69 YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 128
Query: 154 DVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVAD 213
DVKP N+L++ G +K+ DFG+S Q+ + M ++ GT +Y +PE + Y +D
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFVGTRSYMSPERLQGTHYS-VQSD 184
Query: 214 AWSCGVILFVLLAGYLP 230
WS G+ L + G P
Sbjct: 185 IWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 14/225 (6%)
Query: 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMR 84
T+L RYQ +G G+ V A VAIK + + F + R RE+ M+
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR--PFQNQTHAKRAYRELVLMK 71
Query: 85 RLQNHPNVLKI------QEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQL 138
+ NH N++ + Q+ + +YLVME ++ + L Q+
Sbjct: 72 CV-NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQM 128
Query: 139 VSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTA 198
+ + H G+ HRD+KP N+++ D LK+ DFGL+ + M+ T Y A
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRA 186
Query: 199 PEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKV 243
PEV+ GY V D WS G I+ ++ + F + + + KV
Sbjct: 187 PEVILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 26/209 (12%)
Query: 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMR 84
T+L RYQ +G G+ V A G VAIK + + F + R RE+ M+
Sbjct: 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSR--PFQNVTHAKRAYRELVLMK 70
Query: 85 RLQNHPNVLKI------QEVMATKTKIYLVMEY--AAGGELFG-KLRRGRLTESAARRYF 135
L NH N++ + Q+ + +YLVME A ++ L R++ Y
Sbjct: 71 -LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS------YL 123
Query: 136 -QQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG--MLHTACG 192
Q++ + H G+ HRD+KP N+++ D LK+ DFGL+ + M+
Sbjct: 124 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTSFMMTPYVV 179
Query: 193 TPAYTAPEVVARRGYDGAVADAWSCGVIL 221
T Y APEV+ GY V D WS G I+
Sbjct: 180 TRYYRAPEVILGMGYKENV-DIWSVGCIM 207
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-13
Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
+G+G F V G+ VA+K I KN+ A + E S M +L+ H N++++
Sbjct: 14 IGKGEFGDVMLGDY--RGNKVAVKCI-KND-----ATAQAFLAEASVMTQLR-HSNLVQL 64
Query: 96 QEVMAT-KTKIYLVMEYAAGGELFGKLR-RGR--LTESAARRYFQQLVSALHFCHQNGVA 151
V+ K +Y+V EY A G L LR RGR L ++ + A+ + N
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFV 124
Query: 152 HRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAV 211
HRD+ +N+L+ D KVSDFGL+ ++ T +TAPE + + +
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD----TGKLPVKWTAPEALREKKFSTK- 179
Query: 212 ADAWSCGVILFVLLA-GYLPF 231
+D WS G++L+ + + G +P+
Sbjct: 180 SDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-13
Identities = 55/198 (27%), Positives = 96/198 (48%), Gaps = 13/198 (6%)
Query: 36 LGRGSFAKV----HKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN 91
LG G F KV + + G +VA+KT+++ +E++ ++ L H N
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTL-YHEN 67
Query: 92 VLKIQEVMATKTK--IYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNG 149
++K + + + + L+MEY G L L + +L + + QQ+ + + H
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH 127
Query: 150 VAHRDVKPQNLLLDRDGNLKVSDFGLS-ALPEQIKNGMLHTACGTPAY-TAPEVVARRGY 207
HRD+ +N+LLD D +K+ DFGL+ A+PE + + +P + A E + +
Sbjct: 128 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKF 187
Query: 208 DGAVADAWSCGVILFVLL 225
A +D WS GV L+ LL
Sbjct: 188 SYA-SDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 5e-13
Identities = 68/276 (24%), Positives = 118/276 (42%), Gaps = 36/276 (13%)
Query: 28 NRYQLGPLLGRGSFAKVHKAK----SIADGSI-VAIKTIEKNNKFLDAAMEDRIVREVSA 82
N G LG G+F KV +A S +D + VA+K ++ ++ + ++ E+
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT---AHSSEREALMSELKI 91
Query: 83 MRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSAL 142
M L NH N++ + I ++ EY G+L LRR R F L L
Sbjct: 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRR-------KRESFLTLEDLL 144
Query: 143 HFCHQ--NGVA--------HRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACG 192
F +Q G+A HRD+ +N+LL +K+ DFGL+ I N + G
Sbjct: 145 SFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA---RDIMNDSNYVVKG 201
Query: 193 TP----AYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRD 247
+ APE + Y +D WS G++L+ + + G P+ + + + K+ +
Sbjct: 202 NARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG 260
Query: 248 YQF--PSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281
Y+ P ++ D +P R + ++I+
Sbjct: 261 YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 71/289 (24%), Positives = 116/289 (40%), Gaps = 48/289 (16%)
Query: 31 QLGPLLGRGSFAKVHKA-----KSIADGSIVAIKTIEKN---NKFLDAAMEDRIVREVSA 82
LG LG G F KV KA K A + VA+K +++N ++ D E ++++V
Sbjct: 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-- 60
Query: 83 MRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGR----------------- 125
NHP+V+K+ + + L++EYA G L LR R
Sbjct: 61 -----NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 126 --------LTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177
LT + Q+ + + + + HRD+ +N+L+ +K+SDFGLS
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 178 LPEQIKNGMLHTACGTPA-YTAPEVVARRGYDGAVADAWSCGVILF--VLLAG--YLPFD 232
+ + + + P + A E + Y +D WS GV+L+ V L G Y
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIA 234
Query: 233 DSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281
L + K R + P S+ +L+ P R + I
Sbjct: 235 PERLFNLLKTGYRMER--PENCSEEMYNLMLTCWKQEPDKRPTFADISK 281
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 66/233 (28%), Positives = 105/233 (45%), Gaps = 35/233 (15%)
Query: 16 PPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSI-----ADGSIVAIKTIEKNNKFLDA 70
P P ++P +R LG LG G+F +V KA+++ + S VA+K ++ +
Sbjct: 2 PLDPEWELP--RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD------ 53
Query: 71 AMEDRI---VREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLT 127
A E + V E+ M+ + H N++ + V + +Y+V+EYAA G L LR R
Sbjct: 54 ATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPP 113
Query: 128 ESAARRY----------FQQLVS-------ALHFCHQNGVAHRDVKPQNLLLDRDGNLKV 170
A + LVS + F HRD+ +N+L+ D +K+
Sbjct: 114 GEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKI 173
Query: 171 SDFGLSALPEQIKNGMLHTACGTPA-YTAPEVVARRGYDGAVADAWSCGVILF 222
+DFGL+ I T P + APE + R Y +D WS GV+L+
Sbjct: 174 ADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLW 225
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 33/231 (14%)
Query: 21 KKIPTLLNR-----YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDR 75
K I +NR Y+LG ++G GSF V++A I VAIK + ++ ++ +
Sbjct: 54 KMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN------ 107
Query: 76 IVREVSAMRRLQNHPNVLKIQEVMATKT------KIYL--VMEYAAGGELFGKLRRGRLT 127
RE+ M+ L NH N++ +++ T+ I+L VME+ + K +
Sbjct: 108 --RELLIMKNL-NHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP--QTVHKYMKHYAR 162
Query: 128 ESAA------RRYFQQLVSALHFCHQNGVAHRDVKPQNLLLD-RDGNLKVSDFGLSALPE 180
+ A + Y QL AL + H + HRD+KPQNLL+D LK+ DFG SA
Sbjct: 163 NNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG-SAKNL 221
Query: 181 QIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPF 231
+ C + Y APE++ D WS G I+ ++ GY F
Sbjct: 222 LAGQRSVSYIC-SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271
|
Length = 440 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 47/213 (22%), Positives = 93/213 (43%), Gaps = 14/213 (6%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGS----IVAIKTIEKNNKFLDAAMEDRIVREVSAMR 84
+ +LG G+F V+K I +G VAIK + + I+ E M
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET---SPKANKEILDEAYVMA 64
Query: 85 RLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSAL 142
+ HP+V+++ + + + L+ + G L +R + + + Q+ +
Sbjct: 65 SVD-HPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGM 122
Query: 143 HFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP-AYTAPEV 201
+ + + HRD+ +N+L+ ++K++DFGL+ L + + P + A E
Sbjct: 123 SYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 202 VARRGYDGAVADAWSCGVILFVLLA-GYLPFDD 233
+ R Y +D WS GV ++ L+ G P++
Sbjct: 183 ILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 4e-12
Identities = 71/309 (22%), Positives = 125/309 (40%), Gaps = 64/309 (20%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKN---NKFLDAAMEDRIVREVSAM 83
+ RY + L+G+G +V+ A VA+K I ++ N L + R +RE
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLL----KKRFLREAKIA 56
Query: 84 RRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAAR----------- 132
L HP ++ + + + +Y M Y G L L+ ES ++
Sbjct: 57 ADLI-HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115
Query: 133 -RYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ---------- 181
F ++ + + + H GV HRD+KP N+LL G + + D+G + +
Sbjct: 116 LSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 182 -IKNGMLHT------ACGTPAYTAPEVVARRGYDGAVA-DAWSCGVILFVLLAGYLPFDD 233
+N + GTP Y APE + G + + D ++ GVIL+ +L P+
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERL--LGVPASESTDIYALGVILYQMLTLSFPYRR 233
Query: 234 SNLLAMYKKVNRRDY-----------QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282
+K++ RD + P F+S+ A + L +P R S S+
Sbjct: 234 KK----GRKISYRDVILSPIEVAPYREIPPFLSQIA----MKALAVDPAERYS-----SV 280
Query: 283 SWFQKSLQQ 291
++ L+
Sbjct: 281 QELKQDLEP 289
|
Length = 932 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 17/149 (11%)
Query: 36 LGRGSFAKVHK-------AKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN 88
LG G+F V K K + VA+KT+++ + AA + +RE S M +L +
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVE----VAVKTLKQEH---IAAGKKEFLREASVMAQL-D 54
Query: 89 HPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQ 147
HP ++++ V + LVME A G L L+ R + S + Q+ + +
Sbjct: 55 HPCIVRLIGV-CKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLES 113
Query: 148 NGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176
HRD+ +N+LL K+SDFG+S
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMS 142
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 49/215 (22%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 36 LGRG--SFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDR--IVREVSAMRRLQNHPN 91
+GRG + V+ A+ G++V ++ + L+ E+ ++ + HPN
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITD-----LENCTEEHLKALQNEVVLSHFFRHPN 60
Query: 92 VLKIQEVMATKTKIYLV---MEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQN 148
++ V T + ++++ M Y + L ++E+ + L++ HQN
Sbjct: 61 IMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN 120
Query: 149 GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTAC-GTPAYT-------APE 200
G HR++K ++L+ DG + +S GLS L ++NG P ++ +PE
Sbjct: 121 GYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178
Query: 201 VVAR--RGYDGAVADAWSCGVILFVLLAGYLPFDD 233
++ + GY+ +D +S G+ L G +PF D
Sbjct: 179 LLRQDLYGYN-VKSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 51/200 (25%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
LG G F +V + + VA+KT++ + A +E E + M+ LQ H ++++
Sbjct: 14 LGAGQFGEVWMG-YYNNSTKVAVKTLKPGTMSVQAFLE-----EANLMKTLQ-HDKLVRL 66
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAH 152
V+ + IY++ EY A G L L+ G++ + Q+ + + + H
Sbjct: 67 YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIH 126
Query: 153 RDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVA 212
RD++ N+L+ K++DFGL+ + E + A +TAPE + G +
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI-NFGSFTIKS 185
Query: 213 DAWSCGVILF-VLLAGYLPF 231
D WS G++L+ ++ G +P+
Sbjct: 186 DVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 29/203 (14%)
Query: 31 QLGPLLGRGSFAKVHKAKSIADGSI-VAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89
+L LG G F +V +G+ VA+KT++ +A ++E M++L+ H
Sbjct: 9 KLERKLGAGQFGEVWMGT--WNGTTKVAVKTLKPGTMSPEA-----FLQEAQIMKKLR-H 60
Query: 90 PNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRG--------RLTESAARRYFQQLVSA 141
++++ V + + IY+V EY + G L L+ G +L + AA Q+
Sbjct: 61 DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA-----QIAEG 115
Query: 142 LHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP---AYTA 198
+ + HRD+ +N+L+ + K++DFGL+ L I++ G +TA
Sbjct: 116 MAYLESRNYIHRDLAARNILVGENLVCKIADFGLARL---IEDDEYTAREGAKFPIKWTA 172
Query: 199 PEVVARRGYDGAVADAWSCGVIL 221
PE A G +D WS G++L
Sbjct: 173 PE-AANYGRFTIKSDVWSFGILL 194
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 69/262 (26%), Positives = 121/262 (46%), Gaps = 26/262 (9%)
Query: 31 QLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP 90
QL LG G F +V + + VA+KT++ ++ +E E M++L+ H
Sbjct: 9 QLIKKLGNGQFGEVWMG-TWNGNTKVAVKTLKPGTMSPESFLE-----EAQIMKKLR-HD 61
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRG--------RLTESAARRYFQQLVSAL 142
++++ V+ ++ IY+V EY + G L L+ G L + AA Q+ + +
Sbjct: 62 KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAA-----QVAAGM 115
Query: 143 HFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVV 202
+ + HRD++ N+L+ K++DFGL+ L E + A +TAPE
Sbjct: 116 AYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE-A 174
Query: 203 ARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPA--R 259
A G +D WS G++L L+ G +P+ N + ++V R Y+ P P
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV-ERGYRMPCPQDCPISLH 233
Query: 260 SLIYQLLDPNPKTRMSIEKIMS 281
L+ Q +P+ R + E + S
Sbjct: 234 ELMLQCWKKDPEERPTFEYLQS 255
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 35 LLGRGSFAKVHKAK--SIAD--GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP 90
LG+G+F V + + D G +VA+K ++ + + D RE+ ++ LQ H
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA---EHLRD-FEREIEILKSLQ-HD 65
Query: 91 NVLKIQEVM--ATKTKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCH 146
N++K + V A + + LVMEY G L L+ R RL Y Q+ + +
Sbjct: 66 NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125
Query: 147 QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACG-TPAY-TAPEVVAR 204
HRD+ +N+L++ + +K+ DFGL+ + Q K G +P + APE +
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE 185
Query: 205 RGYDGAVADAWSCGVILFVL 224
+ A +D WS GV+L+ L
Sbjct: 186 SKFSVA-SDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 56/192 (29%), Positives = 95/192 (49%), Gaps = 10/192 (5%)
Query: 36 LGRGSFAKVHKA--KSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVL 93
LG G+F V K K VA+K ++ +N D A++D ++RE + M++L N P ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN--DPALKDELLREANVMQQLDN-PYIV 59
Query: 94 KIQEVMATKTKIYLVMEYAAGGELFGKLRRGR-LTESAARRYFQQLVSALHFCHQNGVAH 152
++ + ++ + LVME A G L L++ + +TE Q+ + + + H
Sbjct: 60 RMIGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVH 118
Query: 153 RDVKPQNLLLDRDGNLKVSDFGLS-ALPEQIKNGMLHTACGTPA-YTAPEVVARRGYDGA 210
RD+ +N+LL K+SDFGLS AL T P + APE + +
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSK 178
Query: 211 VADAWSCGVILF 222
+D WS GV+++
Sbjct: 179 -SDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 9e-11
Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 39/225 (17%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIA-------DGSIVAIKTIEKNNKFLDAAMEDRIVREV 80
+R LG LG G F +V +A++ VA+K ++ N D A ++ E+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLA---DLISEM 68
Query: 81 SAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGR---------LTESAA 131
M+ + H N++ + V + +Y+++EYAA G L LR R +T+
Sbjct: 69 ELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPE 128
Query: 132 RRY-FQQLVS-------ALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI- 182
+ F+ LVS + + HRD+ +N+L+ D +K++DFGL+ I
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188
Query: 183 -----KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILF 222
NG L + APE + R Y +D WS G++++
Sbjct: 189 YYKKTSNGRLPV-----KWMAPEALFDRVYTHQ-SDVWSFGILMW 227
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 34/233 (14%)
Query: 35 LLGRGSFAKVHKAKSIADG-----SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89
++G G+F +V +A DG +I +K N D A E+ + +L +H
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFA------GELEVLCKLGHH 62
Query: 90 PNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTE----------SAARRYFQQLV 139
PN++ + + +Y+ +EYA G L LR+ R+ E +A+ QQL+
Sbjct: 63 PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 140 -------SALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE-QIKNGMLHTAC 191
+ + + + HRD+ +N+L+ + K++DFGLS E +K M
Sbjct: 123 QFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPV 182
Query: 192 GTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKV 243
+ A E + Y +D WS GV+L+ +++ G P+ +Y+K+
Sbjct: 183 ---RWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 51/185 (27%), Positives = 91/185 (49%), Gaps = 22/185 (11%)
Query: 56 VAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGG 115
VAIK++++ + +A + E + M++LQ HP ++++ V+ T+ IY++ EY G
Sbjct: 33 VAIKSLKQGSMSPEAFLA-----EANLMKQLQ-HPRLVRLYAVV-TQEPIYIITEYMENG 85
Query: 116 ELFG--------KLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN 167
L KL +L + AA Q+ + F + HRD++ N+L+
Sbjct: 86 SLVDFLKTPEGIKLTINKLIDMAA-----QIAEGMAFIERKNYIHRDLRAANILVSETLC 140
Query: 168 LKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILF-VLLA 226
K++DFGL+ L E + A +TAPE + G +D WS G++L ++
Sbjct: 141 CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTY 199
Query: 227 GYLPF 231
G +P+
Sbjct: 200 GRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 62/239 (25%), Positives = 111/239 (46%), Gaps = 32/239 (13%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIV--AIKTIEKNNKFLDAAMEDR--IVREVSAM 83
N + ++G G+F +V KA+ DG + AIK +++ A+ +D E+ +
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-----ASKDDHRDFAGELEVL 61
Query: 84 RRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTE----------SAARR 133
+L +HPN++ + + +YL +EYA G L LR+ R+ E +A+
Sbjct: 62 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121
Query: 134 YFQQLVS-------ALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE-QIKNG 185
QQL+ + + Q HRD+ +N+L+ + K++DFGLS E +K
Sbjct: 122 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 181
Query: 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKV 243
M + A E + Y +D WS GV+L+ +++ G P+ +Y+K+
Sbjct: 182 MGRLPV---RWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 48/153 (31%), Positives = 77/153 (50%), Gaps = 14/153 (9%)
Query: 77 VREVSAMRRLQNHPNVLKIQEVMATKTKIYLVM-EYAAGGELFGKLRR-----GRLTESA 130
V E +RRL +HP VL + +V LV+ +Y + +L+ L G +A
Sbjct: 208 VHEARLLRRL-SHPAVLALLDVRVVGGLTCLVLPKYRS--DLYTYLGARLRPLGLAQVTA 264
Query: 131 ARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTA 190
R QL+SA+ + H G+ HRD+K +N+L++ ++ + DFG + + H
Sbjct: 265 VAR---QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 191 -CGTPAYTAPEVVARRGYDGAVADAWSCGVILF 222
GT APEV+A Y +V D WS G+++F
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSV-DIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 76/277 (27%), Positives = 125/277 (45%), Gaps = 44/277 (15%)
Query: 32 LGPLLGRGSFAKVHKAKSIADGSI--VAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89
LG LG G F V + + D SI VA+KT+ K + MED + E M+ +H
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTM-KIAICTRSEMED-FLSEAVCMKEF-DH 59
Query: 90 PNVLKIQEV--MATKTKIY----LVMEYAAGGELFGKLRRGRLTESAARRYFQQLV---- 139
PNV+++ V +++ Y +++ + G+L L RL + Q LV
Sbjct: 60 PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119
Query: 140 ---SALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLH----TACG 192
S + + HRD+ +N +L+ + N+ V+DFGLS ++I NG + A
Sbjct: 120 DIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS---KKIYNGDYYRQGRIAKM 176
Query: 193 TPAYTAPEVVARRGYDGAVADAWSCGVILF-VLLAGYLPF---DDSNLLAMYKKVNRRDY 248
+ A E +A R Y +D WS GV ++ + G P+ ++S + ++ NR
Sbjct: 177 PVKWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR--- 232
Query: 249 QFPSFVSKPARSL--IYQLLDP----NPKTRMSIEKI 279
+ +P L +Y L+ NPK R S E +
Sbjct: 233 -----LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETL 264
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 53/220 (24%), Positives = 96/220 (43%), Gaps = 29/220 (13%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIA-------DGSIVAIKTIEKNNKFLDAAMEDRIVREV 80
++ LG LG G F +V A+++ + VA+K ++ + D + +V E+
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLS---DLVSEM 71
Query: 81 SAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTE----------SA 130
M+ + H N++ + +Y+++EYA+ G L LR R
Sbjct: 72 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPD 131
Query: 131 ARRYFQQLVS-------ALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183
+ F+ LVS + + HRD+ +N+L+ + +K++DFGL+ I
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 184 NGMLHTACGTPA-YTAPEVVARRGYDGAVADAWSCGVILF 222
T P + APE + R Y +D WS GV+++
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMW 230
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 59/230 (25%), Positives = 95/230 (41%), Gaps = 29/230 (12%)
Query: 18 PPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSI-------ADGSIVAIKTIEKNNKFLDA 70
P K R LG LG G F +V A++I VA+K ++ + D
Sbjct: 2 PADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT--DK 59
Query: 71 AMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGR----- 125
+ D +V E+ M+ + H N++ + +Y+++EYA+ G L LR R
Sbjct: 60 DLSD-LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMD 118
Query: 126 ------------LTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDF 173
LT Q+ + + HRD+ +N+L+ D +K++DF
Sbjct: 119 YSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADF 178
Query: 174 GLSALPEQIKNGMLHTACGTPA-YTAPEVVARRGYDGAVADAWSCGVILF 222
GL+ I T P + APE + R Y +D WS GV+L+
Sbjct: 179 GLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLW 227
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 12/193 (6%)
Query: 36 LGRGSFAKVHKA--KSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVL 93
LG G+F V K K VAIK ++ N + ++ D ++RE M +L N P ++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN---EKSVRDEMMREAEIMHQLDN-PYIV 58
Query: 94 KIQEVMATKTKIYLVMEYAAGGEL--FGKLRRGRLTESAARRYFQQLVSALHFCHQNGVA 151
++ V + + LVME A+GG L F ++ +T S Q+ + +
Sbjct: 59 RMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFV 117
Query: 152 HRDVKPQNLLLDRDGNLKVSDFGLS-ALPEQIKNGMLHTACGTP-AYTAPEVVARRGYDG 209
HRD+ +N+LL K+SDFGLS AL +A P + APE + R +
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS- 176
Query: 210 AVADAWSCGVILF 222
+ +D WS G+ ++
Sbjct: 177 SRSDVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 30/209 (14%)
Query: 36 LGRGSFAKVHKAKSIADGSI-VAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94
LG G F +V + + + + VA+KT++ + E M++L+ HP +++
Sbjct: 14 LGAGQFGEVWEG--LWNNTTPVAVKTLKP-----GTMDPKDFLAEAQIMKKLR-HPKLIQ 65
Query: 95 IQEVMATKTKIYLVMEYAAGGELFGKLRRG--------RLTESAARRYFQQLVSALHFCH 146
+ V + IY+V E G L L+ G +L + AA Q+ S + +
Sbjct: 66 LYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA-----QVASGMAYLE 120
Query: 147 QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP---AYTAPEVVA 203
HRD+ +N+L+ + KV+DFGL+ + IK + G +TAPE A
Sbjct: 121 AQNYIHRDLAARNVLVGENNICKVADFGLARV---IKEDIYEAREGAKFPIKWTAPE-AA 176
Query: 204 RRGYDGAVADAWSCGVILFVLLA-GYLPF 231
+D WS G++L ++ G +P+
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 5e-10
Identities = 56/233 (24%), Positives = 104/233 (44%), Gaps = 34/233 (14%)
Query: 35 LLGRGSFAKVHKAKSIADG-----SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89
++G G+F +V KA+ DG +I +K + D A E+ + +L +H
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA------GELEVLCKLGHH 55
Query: 90 PNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTES--------------AAR--- 132
PN++ + + +YL +EYA G L LR+ R+ E+ +++
Sbjct: 56 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 133 RYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE-QIKNGMLHTAC 191
+ + + + Q HRD+ +N+L+ + K++DFGLS E +K M
Sbjct: 116 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 175
Query: 192 GTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKV 243
+ A E + Y +D WS GV+L+ +++ G P+ +Y+K+
Sbjct: 176 ---RWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 224
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 27/221 (12%)
Query: 31 QLGPLLGRG--SFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN 88
+L ++GRG V+ A+ G V ++ I N + M + E+ + +L N
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRI--NLEACTNEMVTFLQGELH-VSKLFN 57
Query: 89 HPNVLKIQEVMATKTKIYLV---MEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFC 145
HPN++ + ++++V M Y + +L ++E A Q ++ AL +
Sbjct: 58 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYI 117
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG----MLHTACGTPAYTA--- 198
H G HR VK ++L+ DG + +S GL + I +G ++H P Y+
Sbjct: 118 HHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHD---FPKYSVKVL 172
Query: 199 ----PEVVAR--RGYDGAVADAWSCGVILFVLLAGYLPFDD 233
PEV+ + +GYD A +D +S G+ L G++PF D
Sbjct: 173 PWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 7e-10
Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 28/221 (12%)
Query: 32 LGPLLGRGSFAKVHKAK-SIADGSI--VAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN 88
LG +LG G F V + + S DGS VA+KT++ + + +E+ + E + M+ +
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEE-FLSEAACMKDF-D 59
Query: 89 HPNVLKIQEV---MATKTKI---YLVMEYAAGGELFGKLRRGRLTESAARRYFQQLV--- 139
HPNV+K+ V ++ KI +++ + G+L L RL + Q L+
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 140 ----SALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG----MLHTAC 191
+ + HRD+ +N +L D + V+DFGLS ++I +G A
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS---KKIYSGDYYRQGRIAK 176
Query: 192 GTPAYTAPEVVARRGYDGAVADAWSCGVILF-VLLAGYLPF 231
+ A E +A R Y + +D W+ GV ++ + G P+
Sbjct: 177 MPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 8e-10
Identities = 49/202 (24%), Positives = 95/202 (47%), Gaps = 15/202 (7%)
Query: 33 GPLLGRGSFAKVHKAKSIADGSI----VAIKTIE-KNNKFLDAAMEDRIVREVSAMRRLQ 87
LLG G F VHK I +G VAIKTI+ ++ + + D ++ AM L
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHML----AMGSL- 66
Query: 88 NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFC 145
+H ++++ + + LV + + G L +R R L + Q+ +++
Sbjct: 67 DHAYIVRLLGI-CPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYL 125
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP-AYTAPEVVAR 204
++ + HR++ +N+LL D ++++DFG++ L ++ TP + A E +
Sbjct: 126 EEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF 185
Query: 205 RGYDGAVADAWSCGVILFVLLA 226
Y +D WS GV ++ +++
Sbjct: 186 GRYTHQ-SDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 65/273 (23%), Positives = 107/273 (39%), Gaps = 34/273 (12%)
Query: 36 LGRGSFAKVHKAK-----SIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP 90
LG G+F KV + D +VA+KT+++ + A +D RE + Q H
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKD-FEREAELLTNFQ-HE 68
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR---------------GRLTESAARRYF 135
N++K V +V EY G+L LR G LT S +
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 136 QQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPA 195
Q+ S + + HRD+ +N L+ D +K+ DFG+S + + G
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS---RDVYTTDYYRVGGHTM 185
Query: 196 ----YTAPEVVARRGYDGAVADAWSCGVILF-VLLAGYLP-FDDSNLLAMYKKVNRRDYQ 249
+ PE + R + +D WS GV+L+ + G P + SN + R Q
Sbjct: 186 LPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQ 244
Query: 250 FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282
P ++ +P+ R++I+ I
Sbjct: 245 RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHER 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 37/151 (24%), Positives = 72/151 (47%), Gaps = 8/151 (5%)
Query: 88 NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFC 145
+H N+++++ V+ + +V EY + G L LR+ G+L L S + +
Sbjct: 64 DHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL 123
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACG-TPA-YTAPEVVA 203
+ G H+ + +L++ D K+S F L E + T G +P + APE +
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQ 181
Query: 204 RRGYDGAVADAWSCGVILFVLLA-GYLPFDD 233
+ A +D WS G++++ +++ G P+ D
Sbjct: 182 YHHFSSA-SDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 63/253 (24%), Positives = 118/253 (46%), Gaps = 16/253 (6%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
LG G F +V A + + VA+KT++ + ++A + E + M+ LQ H ++K+
Sbjct: 14 LGAGQFGEVWMA-TYNKHTKVAVKTMKPGSMSVEAFLA-----EANVMKTLQ-HDKLVKL 66
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAH 152
V+ TK IY++ E+ A G L L+ + + Q+ + F Q H
Sbjct: 67 HAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 125
Query: 153 RDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVA 212
RD++ N+L+ K++DFGL+ + E + A +TAPE + G +
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI-NFGSFTIKS 184
Query: 213 DAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPAR--SLIYQLLDPN 269
D WS G++L ++ G +P+ + + + + R Y+ P + P +++ +
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYRMPRPENCPEELYNIMMRCWKNR 243
Query: 270 PKTRMSIEKIMSI 282
P+ R + E I S+
Sbjct: 244 PEERPTFEYIQSV 256
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-09
Identities = 66/257 (25%), Positives = 116/257 (45%), Gaps = 26/257 (10%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
LG+G F +V + + VAIKT++ +A ++ E M++L+ H ++ +
Sbjct: 14 LGQGCFGEVWMG-TWNGTTKVAIKTLKPGTMMPEAFLQ-----EAQIMKKLR-HDKLVPL 66
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRRG--------RLTESAARRYFQQLVSALHFCHQ 147
V+ ++ IY+V E+ G L L+ G +L + AA Q+ + + +
Sbjct: 67 YAVV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAA-----QIADGMAYIER 120
Query: 148 NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGY 207
HRD++ N+L+ + K++DFGL+ L E + A +TAPE A G
Sbjct: 121 MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE-AALYGR 179
Query: 208 DGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPA--RSLIYQ 264
+D WS G++L L+ G +P+ + ++V R Y+ P P L+
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESLHELMKL 238
Query: 265 LLDPNPKTRMSIEKIMS 281
+P R + E I S
Sbjct: 239 CWKKDPDERPTFEYIQS 255
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-09
Identities = 70/253 (27%), Positives = 117/253 (46%), Gaps = 26/253 (10%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
LG+G F +V + + VAIKT++ +A ++ E M++L+ H ++++
Sbjct: 14 LGQGCFGEVWMG-TWNGTTRVAIKTLKPGTMSPEAFLQ-----EAQVMKKLR-HEKLVQL 66
Query: 96 QEVMATKTKIYLVMEYAAGGEL-------FGK-LRRGRLTESAARRYFQQLVSALHFCHQ 147
V+ ++ IY+V EY + G L GK LR +L + AA Q+ S + + +
Sbjct: 67 YAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA-----QIASGMAYVER 120
Query: 148 NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGY 207
HRD++ N+L+ + KV+DFGL+ L E + A +TAPE A G
Sbjct: 121 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE-AALYGR 179
Query: 208 DGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPA--RSLIYQ 264
+D WS G++L L G +P+ + +V R Y+ P P L+ Q
Sbjct: 180 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPESLHDLMCQ 238
Query: 265 LLDPNPKTRMSIE 277
P+ R + E
Sbjct: 239 CWRKEPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 62/237 (26%), Positives = 102/237 (43%), Gaps = 41/237 (17%)
Query: 16 PPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIA-------DGSIVAIKTIEKNNKFL 68
P P ++P +R LG LG G F +V A++I + VA+K ++
Sbjct: 8 PEDPRWEVPR--DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKS----- 60
Query: 69 DAAMED--RIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRL 126
DA +D ++ E+ M+ + H N++ + +Y+++EYA+ G L LR R
Sbjct: 61 DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR- 119
Query: 127 TESAARRY-------------FQQLVS-------ALHFCHQNGVAHRDVKPQNLLLDRDG 166
Y F+ LVS + + HRD+ +N+L+ D
Sbjct: 120 --PPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 177
Query: 167 NLKVSDFGLSALPEQIKNGMLHTACGTPA-YTAPEVVARRGYDGAVADAWSCGVILF 222
+K++DFGL+ I T P + APE + R Y +D WS GV+L+
Sbjct: 178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLW 233
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 47/163 (28%), Positives = 72/163 (44%), Gaps = 27/163 (16%)
Query: 35 LLGRGSFAKVHK--AKSI-ADGS---IVAIKTIEKNNKFLDAAMEDRI--VREVSAMRRL 86
LG G+F +V++ A I GS VA+KT+ K A +++ ++E M
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG-----ATDQEKKEFLKEAHLMSNF 56
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGR--------LTESAARRYFQQL 138
NHPN++K+ V Y++ME GG+L LR R LT +
Sbjct: 57 -NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDV 115
Query: 139 VSALHFCHQNGVAHRDVKPQNLLL-----DRDGNLKVSDFGLS 176
+ Q HRD+ +N L+ D D +K+ DFGL+
Sbjct: 116 AKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 74/270 (27%), Positives = 127/270 (47%), Gaps = 33/270 (12%)
Query: 30 YQLGPLLGRGSFAKVHKAK-SIADGSI--VAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
+ LG +LG+G F V +A+ DGS VA+K + K + F + +E+ +RE + M+
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEE-FLREAACMKEF 58
Query: 87 QNHPNVLKIQEV-MATKTKIYL-----VMEYAAGGELFGKLRRGRLTESAARRYFQQLV- 139
+HPNV+K+ V + ++ K L ++ + G+L L R+ E Q LV
Sbjct: 59 -DHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117
Query: 140 ------SALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLH---TA 190
S + + HRD+ +N +L+ + + V+DFGLS ++I +G + A
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS---KKIYSGDYYRQGCA 174
Query: 191 CGTPA-YTAPEVVARRGYDGAVADAWSCGVILF-VLLAGYLPF---DDSNLLAMYKKVNR 245
P + A E +A Y +D W+ GV ++ ++ G P+ ++S + K NR
Sbjct: 175 SKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR 233
Query: 246 RDYQFPSFVSKPARSLIYQLLDPNPKTRMS 275
+ P + L+ Q P PK R S
Sbjct: 234 --LKQPPDCLEDVYELMCQCWSPEPKCRPS 261
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 71/277 (25%), Positives = 117/277 (42%), Gaps = 29/277 (10%)
Query: 27 LNRYQLGPL--LGRGSFAKVH--KAKSIADGS---IVAIKTIEKNNKFLDAAMEDRIVRE 79
R L + LGRG F +V KAK I + +V +K ++K K + E R RE
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFR--RE 58
Query: 80 VSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLV 139
+ R+L +H NV+++ + Y+++EY G+L LR + + +
Sbjct: 59 LDMFRKL-SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTK 117
Query: 140 SALHFCHQ----------NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHT 189
+ C Q HRD+ +N L+ +KVS LS + L
Sbjct: 118 QKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRN 177
Query: 190 ACGTPAYTAPEVVARRGYDGAVADAWSCGVILF-VLLAGYLPFDDSNLLAMYKKVNRRDY 248
A + APE V + +D WS GV+++ V G LPF + + ++
Sbjct: 178 ALIPLRWLAPEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL 236
Query: 249 QFPSFVSKPARSLIYQLL----DPNPKTRMSIEKIMS 281
+ P P+R +Y+L+ NPK R S +++S
Sbjct: 237 ELPVPEGCPSR--LYKLMTRCWAVNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 7e-09
Identities = 31/95 (32%), Positives = 46/95 (48%), Gaps = 2/95 (2%)
Query: 138 LVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA-LPEQIKNGMLHTACGTPAY 196
L+ AL + H G+ HRDVK +N+ LD N + DFG + L + GT
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253
Query: 197 TAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPF 231
+PE++A Y A D WS G++LF + +
Sbjct: 254 NSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 9e-09
Identities = 63/269 (23%), Positives = 106/269 (39%), Gaps = 38/269 (14%)
Query: 36 LGRGSFAKVHKA--KSIADGSIVA-IKTIEKNNKFLDAAMEDRI--VREVSAMRRLQNHP 90
LG+G+F ++K + +D IV + + K L + D + S M +L H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLS-HK 61
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYF--QQLVSALHFCHQN 148
+++K+ V I +V EY G L L R + S + +QL SALH+
Sbjct: 62 HLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK 120
Query: 149 GVAHRDVKPQNLLLDRDGN-------LKVSDFG--LSALPEQIKNGMLHTACGTPA-YTA 198
+ H +V +N+L+ R G +K+SD G ++ L + + A
Sbjct: 121 KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE--------RVERIPWIA 172
Query: 199 PEVVARRGYDGAV-----ADAWSCGVILF-VLLAGYLPFDDSNLLAMYKKVNRRDYQFPS 252
PE + +G AD WS G L + G P + ++ + ++ P
Sbjct: 173 PECIR----NGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-ERFYQDQHRLPM 227
Query: 253 FVSKPARSLIYQLLDPNPKTRMSIEKIMS 281
+LI Q +P R S I+
Sbjct: 228 PDCAELANLINQCWTYDPTKRPSFRAILR 256
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 57/233 (24%), Positives = 102/233 (43%), Gaps = 31/233 (13%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSI-ADGSI---VAIKTIEKNNKFLDAAMEDRIVREVSAMR 84
R L LL G+F ++ I V +KT++ + + + +++E +
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL---LLQESCLLY 63
Query: 85 RLQNHPNVLKIQEVMATKTKIYLVME-YAAGGELFGKLRRGRLTESAARRYF--QQLV-- 139
L +H N+L I V + V+ Y G L L++ RL E+ + QQLV
Sbjct: 64 GL-SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHM 122
Query: 140 -----SALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTAC--- 191
+ + H+ GV H+D+ +N ++D + +K++D +AL + H C
Sbjct: 123 AIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD---NALSRDLFPMDYH--CLGD 177
Query: 192 --GTP-AYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMY 240
P + A E + + Y A +D WS GV+L+ L+ G P+ + + M
Sbjct: 178 NENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFEMA 229
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 51/200 (25%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 36 LGRGSFAKV----HKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN 91
LG G F KV + + G VA+K+++ + A + +E+ +R L H N
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA---DLKKEIEILRNLY-HEN 67
Query: 92 VLKIQEVMATK--TKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQ 147
++K + + I L+ME+ G L L R ++ +Y Q+ + +
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 148 NGVAHRDVKPQNLLLDRDGNLKVSDFGLS-ALPEQIKNGMLHTACGTPAY-TAPEVVARR 205
HRD+ +N+L++ + +K+ DFGL+ A+ + + +P + APE + +
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187
Query: 206 GYDGAVADAWSCGVILFVLL 225
+ A +D WS GV L+ LL
Sbjct: 188 KFYIA-SDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 72/289 (24%), Positives = 111/289 (38%), Gaps = 74/289 (25%)
Query: 31 QLGPLLGRGSFAKVHKAKSIA-DGSI----VAIKTIE---KNNKFLDAAMEDRIVREVSA 82
L LG G+F +V++ DG VA+KT+ D ME I+ +
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-- 66
Query: 83 MRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSAL 142
NH N++++ V + ++++E AGG+L LR R R + L
Sbjct: 67 -----NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPE---RPSSLTMKDL 118
Query: 143 HFC-----------HQNGVAHRDVKPQNLLLDRDGN---LKVSDFGLSALPEQI------ 182
FC +N HRD+ +N LL G K++DFG++ I
Sbjct: 119 LFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA---RDIYRASYY 175
Query: 183 -KNG--MLHTACGTPAYTAPEVVARRGYDG---AVADAWSCGVILF-VLLAGYLPFDDSN 235
K G ML + PE DG + D WS GV+L+ + GY+P+
Sbjct: 176 RKGGRAMLPI-----KWMPPEAF----LDGIFTSKTDVWSFGVLLWEIFSLGYMPYP--- 223
Query: 236 LLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISW 284
R + + FV+ R LDP + +IM+ W
Sbjct: 224 --------GRTNQEVMEFVTGGGR------LDPPKGCPGPVYRIMTDCW 258
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 41/169 (24%), Positives = 77/169 (45%), Gaps = 32/169 (18%)
Query: 36 LGRGSFAKVHKAKSIA-----DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP 90
+G+G+F +V +A++ ++VA+K +++ A M+ RE + M +HP
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS---ADMQADFQREAALMAEF-DHP 68
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYF------------- 135
N++K+ V A + L+ EY A G+L LR R S +
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 136 --------QQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176
+Q+ + + + + HRD+ +N L+ + +K++DFGLS
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 177
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 68/286 (23%), Positives = 112/286 (39%), Gaps = 43/286 (15%)
Query: 36 LGRGSFAKVHKAKSIADGSI--VAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVL 93
+G G F KV + + + V +K + + + + + + E R LQ H N+L
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQE---QMKFLEEAQPYRSLQ-HSNLL 58
Query: 94 KIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAA------RRYFQQLVSALHFCHQ 147
+ T LVME+ G+L G LR R E +R ++ L H+
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 148 NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP-AYTAPEVVARRG 206
N H D+ +N LL D +K+ D+GLS + + P + APE+V
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 207 YDGAVAD------AWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPAR 259
+ V D WS GV ++ L G P+ + D Q ++ +
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQPYR-----------HLSDEQVLTYTVREQ- 226
Query: 260 SLIYQLLDPNPKTRMSIE----KIMSISWFQKSLQQQRKRGQESSL 301
QL P P+ ++ + ++M W Q +QR +E L
Sbjct: 227 ----QLKLPKPRLKLPLSDRWYEVMQFCWLQP---EQRPSAEEVHL 265
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 54/223 (24%), Positives = 96/223 (43%), Gaps = 35/223 (15%)
Query: 36 LGRGSFAKVHKAKSIADG-----SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP 90
LG G+F KV+K + + VAIKT+++N + ++ +E M LQ HP
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA---EPKVQQEFRQEAELMSDLQ-HP 68
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR------------GRLTESA--ARRYFQ 136
N++ + V + ++ EY A G+L L R +S+ +
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 137 ---QLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG----MLHT 189
Q+ + + + + HRD+ +N L+ +K+SDFGLS I + +
Sbjct: 129 IAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD---IYSADYYRVQSK 185
Query: 190 ACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPF 231
+ + PE + G +D WS GV+L+ + + G P+
Sbjct: 186 SLLPVRWMPPEAIL-YGKFTTESDIWSFGVVLWEIFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 67/275 (24%), Positives = 110/275 (40%), Gaps = 37/275 (13%)
Query: 36 LGRGSFAKVHKAK-----SIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP 90
LG G+F KV A+ D +VA+K ++ AA +D RE + LQ H
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKD-FQREAELLTNLQ-HE 67
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKLR-----------------RGRLTESAARR 133
+++K V + +V EY G+L LR +G L S
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 134 YFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGT 193
Q+ S + + HRD+ +N L+ + +K+ DFG+S + + + G
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS---RDVYSTDYYRVGGH 184
Query: 194 PA----YTAPEVVARRGYDGAVADAWSCGVILF-VLLAGYLP-FDDSNLLAMYKKVNRRD 247
+ PE + R + +D WS GVIL+ + G P F SN + R
Sbjct: 185 TMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRV 243
Query: 248 YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282
+ P K ++ P+ R++I++I I
Sbjct: 244 LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 35 LLGRGSFAKVHKAKSIADGS----IVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP 90
+LG G+F V+K I DG VAIK + +N I+ E M + + P
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS---PKANKEILDEAYVMAGVGS-P 69
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQN 148
V ++ + T T + LV + G L +R + R+ + Q+ + + +
Sbjct: 70 YVCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV 128
Query: 149 GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACG-TP-AYTAPEVVARRG 206
+ HRD+ +N+L+ ++K++DFGL+ L + I H G P + A E + R
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLD-IDETEYHADGGKVPIKWMALESILHRR 187
Query: 207 YDGAVADAWSCGVILFVLLA-GYLPFD 232
+ +D WS GV ++ L+ G P+D
Sbjct: 188 FTHQ-SDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 68/269 (25%), Positives = 111/269 (41%), Gaps = 28/269 (10%)
Query: 36 LGRGSFAKVHKAKSI-----ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP 90
LG G+F KV A+ D +VA+KT++ + D A +D RE + LQ H
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKD-FHREAELLTNLQ-HE 67
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR--------------GRLTESAARRYFQ 136
+++K V + +V EY G+L LR LT+S Q
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 137 QLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPA- 195
Q+ + + + HRD+ +N L+ + +K+ DFG+S + P
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 196 YTAPEVVARRGYDGAVADAWSCGVILF-VLLAGYLP-FDDSNLLAMYKKVNRRDYQFPSF 253
+ PE + R + +D WS GV+L+ + G P + SN + R Q P
Sbjct: 188 WMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRT 246
Query: 254 VSKPARSLIYQLLDPNPKTRMSIEKIMSI 282
K L+ P R++I++I S+
Sbjct: 247 CPKEVYDLMLGCWQREPHMRLNIKEIHSL 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 70/273 (25%), Positives = 114/273 (41%), Gaps = 49/273 (17%)
Query: 36 LGRGSFAKVHKA--KSIADG-----SIVAIKTIEKNNK-----FLDAAMEDRIVREVSAM 83
LG+G+F K+ K + + D + V +K ++K+++ F +AA S M
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAA---------SMM 53
Query: 84 RRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGR--LTESAARRYFQQLVSA 141
+L + VL + I +V EY G L L++ + + S +QL A
Sbjct: 54 SQLSHKHLVLNYGVCVCGDESI-MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWA 112
Query: 142 LHFCHQNGVAHRDVKPQNLLLDRDGN--------LKVSDFGLS--ALPEQIKNGMLHTAC 191
LHF G+ H +V +N+LL R+ + +K+SD G+S LP++I +
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI---- 168
Query: 192 GTPAYTAPEVVARRGYDGAVADAWSCGVILF-VLLAGYLP---FDDSNLLAMYKKVNRRD 247
+ PE + AD WS G L+ + G P D L Y+
Sbjct: 169 ---PWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED----R 221
Query: 248 YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIM 280
+Q P+ +LI Q +D P R S I+
Sbjct: 222 HQLPAPKWTELANLINQCMDYEPDFRPSFRAII 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 40/213 (18%)
Query: 36 LGRGSFAKVHKAKSIADGSI-------VAIKTIEKNNKFLDAAMEDRI--VREVSAMRRL 86
LG+GSF V++ IA G + VAIKT+ + A+M +RI + E S M+
Sbjct: 14 LGQGSFGMVYEG--IAKGVVKDEPETRVAIKTVNEA-----ASMRERIEFLNEASVMKEF 66
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAA--------RRYFQ-- 136
H +V+++ V++ ++ME G+L LR R ++ Q
Sbjct: 67 NCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMA 125
Query: 137 -QLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA------LPEQIKNGMLHT 189
++ + + + N HRD+ +N ++ D +K+ DFG++ + G+L
Sbjct: 126 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 190 ACGTPAYTAPEVVARRGYDGAVADAWSCGVILF 222
+ +PE + + G +D WS GV+L+
Sbjct: 186 -----RWMSPESL-KDGVFTTYSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 61/259 (23%), Positives = 113/259 (43%), Gaps = 18/259 (6%)
Query: 35 LLGRGSFAKVHKAKSIADGSI---VAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN 91
++G+G F V+ I A+K++ N+ D ++ ++E M+ +HPN
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSL---NRITDLEEVEQFLKEGIIMKDF-SHPN 57
Query: 92 VLKIQEVMATKTKIYLV-MEYAAGGELFGKLRRGRL--TESAARRYFQQLVSALHFCHQN 148
VL + + LV + Y G+L +R T + Q+ + +
Sbjct: 58 VLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK 117
Query: 149 GVAHRDVKPQNLLLDRDGNLKVSDFGLS--ALPEQIKNGMLHTACGTPA-YTAPEVVARR 205
HRD+ +N +LD +KV+DFGL+ ++ + HT P + A E + +
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 206 GYDGAVADAWSCGVILFVLLA-GYLPFDDSNL--LAMYKKVNRRDYQFPSFVSKPARSLI 262
+ +D WS GV+L+ L+ G P+ D + + +Y RR Q P + P ++
Sbjct: 178 KFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ-PEYCPDPLYEVM 235
Query: 263 YQLLDPNPKTRMSIEKIMS 281
P P+ R + +++S
Sbjct: 236 LSCWHPKPEMRPTFSELVS 254
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 36/178 (20%), Positives = 71/178 (39%), Gaps = 35/178 (19%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADG----------------SIVAIKTIEKNNKFLDAA 71
+ +L LG G F +VH + A+G +VA+K + + +
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCE--AEGLAEFLGEGAPEFDGQPVLVAVKMLRAD---VTKT 59
Query: 72 MEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGG---------ELFGKLR 122
+ ++E+ M RL +PN++++ V + + ++ EY G E+
Sbjct: 60 ARNDFLKEIKIMSRL-KNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFT 118
Query: 123 RGRLTESAARRYF----QQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176
S + Q+ S + + HRD+ +N L+ +K++DFG+S
Sbjct: 119 HANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 25/203 (12%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94
++ RG +K KSI +G +K I N + E++ M +LQ HPN++K
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS--------EIADMGKLQ-HPNIVK 747
Query: 95 IQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQN---GVA 151
+ + ++ YL+ EY G L LR L+ R+ + AL F H V
Sbjct: 748 LIGLCRSEKGAYLIHEYIEGKNLSEVLR--NLSWERRRKIAIGIAKALRFLHCRCSPAVV 805
Query: 152 HRDVKPQNLLLD--RDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDG 209
++ P+ +++D + +L++S LP + + AY APE +
Sbjct: 806 VGNLSPEKIIIDGKDEPHLRLS------LPGLL--CTDTKCFISSAYVAPETRETKDITE 857
Query: 210 AVADAWSCGVILFVLLAGYLPFD 232
+D + G+IL LL G P D
Sbjct: 858 K-SDIYGFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 65/273 (23%), Positives = 113/273 (41%), Gaps = 36/273 (13%)
Query: 36 LGRGSFAKVHKAKSI-----ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP 90
LG G+F KV A+ D +VA+K +++ + ++A +D RE + LQ H
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQD-FQREAELLTVLQ-HQ 67
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR----------------GRLTESAARRY 134
++++ V + +V EY G+L LR G+LT
Sbjct: 68 HIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 135 FQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP 194
Q+ S + + HRD+ +N L+ + +K+ DFG+S I + + G
Sbjct: 128 ASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMS---RDIYSTDYYRVGGRT 184
Query: 195 A----YTAPEVVARRGYDGAVADAWSCGVILF-VLLAGYLP-FDDSNLLAMYKKVNRRDY 248
+ PE + R + +D WS GV+L+ + G P + SN A+ R+
Sbjct: 185 MLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGREL 243
Query: 249 QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281
+ P +++ P+ RM I+ I S
Sbjct: 244 ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 30/85 (35%), Positives = 45/85 (52%), Gaps = 4/85 (4%)
Query: 192 GTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP 251
GTP Y APE++ + + AV D W+ GV LF L G PF+D +++ + RD +P
Sbjct: 542 GTPDYLAPELLLGKPHGPAV-DWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 252 ---SFVSKPARSLIYQLLDPNPKTR 273
+S A++ I LL +P R
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKR 625
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 48/203 (23%), Positives = 92/203 (45%), Gaps = 8/203 (3%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIK-TIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVL 93
+LG G+F V+K I +G V I I++ + I+ E M + +P+V
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVC 72
Query: 94 KIQEVMATKTKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVA 151
++ + T T + L+ + G L +R + + + Q+ +++ + +
Sbjct: 73 RLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLV 131
Query: 152 HRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP-AYTAPEVVARRGYDGA 210
HRD+ +N+L+ ++K++DFGL+ L + P + A E + R Y
Sbjct: 132 HRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQ 191
Query: 211 VADAWSCGVILFVLLA-GYLPFD 232
+D WS GV ++ L+ G P+D
Sbjct: 192 -SDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 43/170 (25%), Positives = 74/170 (43%), Gaps = 34/170 (20%)
Query: 36 LGRGSFAKVHKAK----------------SIADGSIVAIKTI-EKNNKFLDAAMEDRIVR 78
LG G F +VH + S +VA+K + E NK A D ++
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK---NARND-FLK 68
Query: 79 EVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAA------- 131
E+ M RL++ PN++++ V T + ++ EY G+L L R E+A
Sbjct: 69 EIKIMSRLKD-PNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127
Query: 132 -----RRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176
Q+ S + + HRD+ +N L+ ++ +K++DFG+S
Sbjct: 128 SYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 38/212 (17%)
Query: 36 LGRGSFAKVHK--AKSIADGSI---VAIKTIEKNNKFLDAAMEDRI--VREVSAMRRLQN 88
LG+GSF V++ A+ I G VA+KT+ ++ A++ +RI + E S M+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES-----ASLRERIEFLNEASVMKGFTC 68
Query: 89 HPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR---------RGRLTESAARRYFQ--- 136
H +V+++ V++ +VME A G+L LR GR + + Q
Sbjct: 69 H-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL-QEMIQMAA 126
Query: 137 QLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA------LPEQIKNGMLHTA 190
++ + + + HRD+ +N ++ D +K+ DFG++ + G+L
Sbjct: 127 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV- 185
Query: 191 CGTPAYTAPEVVARRGYDGAVADAWSCGVILF 222
+ APE + + G +D WS GV+L+
Sbjct: 186 ----RWMAPESL-KDGVFTTSSDMWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 54/233 (23%), Positives = 97/233 (41%), Gaps = 30/233 (12%)
Query: 36 LGRGSFAKVHKAKSIADG----SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN 91
LG +F K++K G +VAIKT++ N + +E S M L +HPN
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN---NPQQWGEFQQEASLMAEL-HHPN 68
Query: 92 VLKIQEVMATKTKIYLVMEYAAGGEL--FGKLRR------------GRLTESAARRYFQ- 136
++ + V+ + + ++ EY G+L F +R G + S F
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 137 ---QLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGT 193
Q+ + + + + H+D+ +N+L+ ++K+SD GLS +
Sbjct: 129 IAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 194 PAYTAPEVVARRGYDGAVADAWSCGVILFVL----LAGYLPFDDSNLLAMYKK 242
P P G + +D WS GV+L+ + L Y F + ++ M +K
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 5e-06
Identities = 50/212 (23%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 35 LLGRGSFAKVHKAKSIADGSIV----AIKTIEK------NNKFLDAAMEDRIVREVSAMR 84
+LG G+F V+K + +G V AIK + + N +F+D A+ +
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL----------IM 63
Query: 85 RLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSAL 142
+HP+++++ V + T I LV + G L + + + + Q+ +
Sbjct: 64 ASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGM 122
Query: 143 HFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP-AYTAPEV 201
+ + + HRD+ +N+L+ ++K++DFGL+ L E + P + A E
Sbjct: 123 MYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 202 VARRGYDGAVADAWSCGVILFVLLA-GYLPFD 232
+ R + +D WS GV ++ L+ G P+D
Sbjct: 183 IHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 8e-06
Identities = 49/207 (23%), Positives = 86/207 (41%), Gaps = 24/207 (11%)
Query: 36 LGRGSFAKVHKAKSIADGSI--VAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVL 93
+G G F KV ++ D + V +K ++ N + ++ +++ R LQ HPN+L
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKAN---ASSKEQNEFLQQGDPYRILQ-HPNIL 58
Query: 94 KIQEVMATKTKIYLVMEYAAGGELFGKLR-----RGRLTESAARRYFQQLVSALHFCHQN 148
+ LV EY G+L L R +R ++ + + H++
Sbjct: 59 QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH 118
Query: 149 GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHT---ACGTPAYTAPEVVARR 205
H D+ +N L D +KV D+G+ P + K + T C + APE+V
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGIG--PSRYKEDYIETEDDKCVPLRWLAPELVGEF 176
Query: 206 GYDGAVA-------DAWSCGVILFVLL 225
+ G + + W+ GV L+ L
Sbjct: 177 -HGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 26/108 (24%), Positives = 43/108 (39%), Gaps = 10/108 (9%)
Query: 75 RIVREVSAMRRLQNHPN-VLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARR 133
REV+ ++ L V K+ + YL+ME+ G L ++E
Sbjct: 37 DREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL------DEVSEEEKED 90
Query: 134 YFQQLVSALHFCHQ---NGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178
+QL L HQ + H D+ P N+L+D L + D+ +
Sbjct: 91 IAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|236400 PRK09188, PRK09188, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 50/185 (27%), Positives = 69/185 (37%), Gaps = 45/185 (24%)
Query: 12 PPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAA 71
P P P +IP L R+ +L R F+ V + F
Sbjct: 2 PNIDVPLPGDQIPALSARFVETAVLKRDVFSTVERGY------------------FAGDP 43
Query: 72 MEDRIVREVSAMRRLQNHP-------NVLKIQEVMATKT--KIYLVMEYAAGGELFGKLR 122
R VR RR+ P L +E+ A KT I +V + A G+ L
Sbjct: 44 GTARAVR-----RRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATGK--DGLV 96
Query: 123 RGRLTESAA---------RRYFQQLVSALHFCHQNGVAHRDV-KPQNLLLDRDGNLKVSD 172
RG TE +F+ AL H+ G+ H D+ KPQN L+ DG V D
Sbjct: 97 RG-WTEGVPLHLARPHGDPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVID 155
Query: 173 FGLSA 177
F L++
Sbjct: 156 FQLAS 160
|
Length = 365 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 50/185 (27%), Positives = 77/185 (41%), Gaps = 46/185 (24%)
Query: 97 EVMATKTKIYLVMEYAAGGELFGK---LRRGRLTESA-ARRYFQQLVSALHFCHQNGVAH 152
++M +K Y V Y L GK L +G E+ + +Q++ AL H G+ H
Sbjct: 224 DLMQSKEFPYNVEPY-----LLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVH 278
Query: 153 RDVKPQNLLLD-RDGNLKVSDFGLSA-----LPEQIKNGMLHTACGTPAYTAPE--VVAR 204
RDVKPQN++ G+ K+ D G +A + K +L P Y APE +++
Sbjct: 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLL-----DPRYAAPEQYIMST 333
Query: 205 RGYDGAVA-------------------DAWSCGVILFVLLAGYLPF--DDSNLLAMYKKV 243
+ A D +S G+I L P DSNL+ +++
Sbjct: 334 QTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI---FLQMAFPNLRSDSNLIQFNRQL 390
Query: 244 NRRDY 248
R DY
Sbjct: 391 KRNDY 395
|
Length = 566 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 18/39 (46%), Positives = 29/39 (74%)
Query: 136 QQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFG 174
+Q+++ L H+ G+ HRD+KP+NLL+ DG +K+ DFG
Sbjct: 316 RQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 51/225 (22%), Positives = 93/225 (41%), Gaps = 39/225 (17%)
Query: 36 LGRGSFAKVHKAK--SIADG---SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP 90
LG F KV+K A G VAIKT++ + + + E RLQ HP
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK---AEGPLREEFKHEAMMRSRLQ-HP 68
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGEL------------FGKLRRGRLTESAAR-----R 133
N++ + V+ + + ++ Y + +L G + +S
Sbjct: 69 NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128
Query: 134 YFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGL------SALPEQIKNGML 187
Q+ + + F + V H+D+ +N+L+ N+K+SD GL + + + N +L
Sbjct: 129 IVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 188 HTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPF 231
+ +PE + G +D WS GV+L+ + + G P+
Sbjct: 189 PI-----RWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 43/170 (25%), Positives = 73/170 (42%), Gaps = 34/170 (20%)
Query: 36 LGRGSFAKVH-------KAKSIADGSI---------VAIKTIEKNNKFLDAAMEDRIVRE 79
LG G F +VH + S + VA+K + + D A ED + +E
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFL-KE 69
Query: 80 VSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLV 139
V + RL PN+ ++ V + ++MEY G+L L++ S + L
Sbjct: 70 VKILSRLS-DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 140 SA--LHFCHQ-----------NGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176
+ L+ Q N V HRD+ +N L+ ++ +K++DFG+S
Sbjct: 129 FSTLLYMATQIASGMRYLESLNFV-HRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|237032 PRK12274, PRK12274, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 5e-05
Identities = 35/101 (34%), Positives = 48/101 (47%), Gaps = 13/101 (12%)
Query: 78 REVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTE-SAARRYFQ 136
RE A+R+L P + + +L Y AG ++ + RG L AARR Q
Sbjct: 50 REALALRQLDGLPRTPR----LLHWDGRHLDRSYLAGAAMYQRPPRGDLAYFRAARRLLQ 105
Query: 137 QLVSALHFCHQNGVAHRDV-KPQNLLLDRDGNLKVSDFGLS 176
QL H+ GVAH D+ K N L+ DG+ V DF L+
Sbjct: 106 QL-------HRCGVAHNDLAKEANWLVQEDGSPAVIDFQLA 139
|
Length = 218 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 44/170 (25%), Positives = 72/170 (42%), Gaps = 19/170 (11%)
Query: 79 EVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGG--ELFGKLRRGRLTESAARRYFQ 136
E ++M R +H +++ + V + +V E+ G +LF + LT + +
Sbjct: 53 ETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAK 112
Query: 137 QLVSALHFCHQNGVAHRDVKPQNLLLDRDG-------NLKVSDFG--LSALPEQIKNGML 187
QL SAL + + H +V +N+LL R+G +K+SD G ++ L Q
Sbjct: 113 QLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ------ 166
Query: 188 HTACGTPAYTAPEVVARRGYDGAVADAWSCGVILF-VLLAGYLPFDDSNL 236
+ APE V AD WS G L+ + G +P D L
Sbjct: 167 -ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 64/260 (24%), Positives = 105/260 (40%), Gaps = 49/260 (18%)
Query: 15 PPPPPSKKIPTLL----------------------NRYQLGPLLGRGSFAKVHKAKSIAD 52
PPP KK+ L R+++ LLG G+F KV +A
Sbjct: 94 APPPKKKKVTYALPNQSREEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKR 153
Query: 53 GSIVAIKTIEKNNKFL-DAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT-KIYLVME 110
A+K + K+ DA +E + + +V P ++KIQ +T + +VM
Sbjct: 154 KEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFP-LMKIQRYFQNETGHMCIVMP 212
Query: 111 YAAGGELFGKLRRGRLTESAARRYFQQLV----SALHFCHQN-GVAHRDVKPQNLLLDRD 165
L ++ G + R+ Q++ AL + H + H D+KP+N+L++
Sbjct: 213 KYGPCLLDWIMKHGPFSH----RHLAQIIFQTGVALDYFHTELHLMHTDLKPENILME-T 267
Query: 166 GNLKVSDFGLSALPE---QIKNGMLHTAC----------GTPAYTAPEVVARRGYDGAVA 212
+ V ALP +++ L C T Y +PEVV G+ +
Sbjct: 268 SDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYS-T 326
Query: 213 DAWSCGVILFVLLAGYLPFD 232
D WS G I++ L G L +D
Sbjct: 327 DMWSMGCIIYELYTGKLLYD 346
|
Length = 467 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 49/186 (26%), Positives = 76/186 (40%), Gaps = 20/186 (10%)
Query: 107 LVMEYAAGGELFGKLRRGRLTESAARRYF--QQLVSALHFCHQNGVAHRDVKPQNLLLDR 164
+V E+ G L LR+ + A + QQL SAL + + H +V +N+LL R
Sbjct: 93 MVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLAR 152
Query: 165 DG-------NLKVSDFGLS--ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAW 215
G +K+SD G+S AL + + + + APE V AD W
Sbjct: 153 LGLAEGTSPFIKLSDPGVSFTALSREERVERI-------PWIAPECVPGGNSLSTAADKW 205
Query: 216 SCGVILF-VLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRM 274
S G L + G +P + ++ + ++ P K +LI Q L P R
Sbjct: 206 SFGTTLLEICFDGEVPL-KERTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRP 264
Query: 275 SIEKIM 280
S I+
Sbjct: 265 SFRTIL 270
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 30/103 (29%), Positives = 50/103 (48%), Gaps = 9/103 (8%)
Query: 134 YFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS----ALPEQIKNGMLHT 189
Y Q+ + F HRD+ +N+LL + +K+ DFGL+ P+ ++ G
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG---D 240
Query: 190 ACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPF 231
A + APE + R Y +D WS GV+L+ + + G P+
Sbjct: 241 ARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 36/174 (20%), Positives = 69/174 (39%), Gaps = 34/174 (19%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIK---TIEKNNKFL--------DAAMEDR--IVREVSA 82
LG G F +VH + + + ++ + K L DA R ++EV
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 83 MRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAAR---------- 132
+ RL++ PN++++ V + + ++ EY G+L L L +
Sbjct: 73 LSRLKD-PNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 133 ----------RYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176
Q+ S + + HRD+ +N L+ + +K++DFG+S
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.003
Identities = 42/147 (28%), Positives = 63/147 (42%), Gaps = 13/147 (8%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKT-IEKN--NKFLDAAM-EDRIVREVSAMRR-LQNH 89
L+ RG+ A+++ + G IK I K + LD + +R RE M R +
Sbjct: 3 LIKRGAEAEIYLGDFL--GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAG 60
Query: 90 PNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNG 149
NV + V I VMEY G L + + E R +LV LH G
Sbjct: 61 VNVPAVYFVDPENFII--VMEYIEGEPLKDLINSNGMEELELSREIGRLVGKLH---SAG 115
Query: 150 VAHRDVKPQNLLLDRDGNLKVSDFGLS 176
+ H D+ N++L G + + DFGL+
Sbjct: 116 IIHGDLTTSNMIL-SGGKIYLIDFGLA 141
|
Length = 211 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.003
Identities = 26/101 (25%), Positives = 43/101 (42%), Gaps = 15/101 (14%)
Query: 137 QLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAY 196
Q + AL H+ + + + LL DG++ PEQ + P +
Sbjct: 25 QCLGALRELHRQAKSGNILLTWDGLLKLDGSVAFKT------PEQSR--------PDPYF 70
Query: 197 TAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL 237
APEV+ + Y AD +S G+ L+ L LP+++ L
Sbjct: 71 MAPEVIQGQSYTEK-ADIYSLGITLYEALDYELPYNEEREL 110
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 27/93 (29%), Positives = 46/93 (49%), Gaps = 8/93 (8%)
Query: 134 YFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS----ALPEQIKNGMLHT 189
Y Q+ + F HRD+ +N+LL + +K+ DFGL+ P+ ++ G +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG---S 235
Query: 190 ACGTPAYTAPEVVARRGYDGAVADAWSCGVILF 222
A + APE + + Y +D WS GV+L+
Sbjct: 236 ARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLW 267
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 451 | |||
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.75 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.74 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.72 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.62 | |
| PF03822 | 63 | NAF: NAF domain; InterPro: IPR004041 The NAF domai | 99.62 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.53 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.49 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.48 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.46 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.46 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.24 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.22 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.13 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.09 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.06 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.04 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.95 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.95 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.89 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.69 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.63 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.61 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.55 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.52 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.48 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.45 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.4 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.4 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.37 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.24 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.2 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.17 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.13 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.02 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.96 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.96 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.93 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.91 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.85 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.76 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.76 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.69 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.68 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.65 | |
| PF02149 | 47 | KA1: Kinase associated domain 1; InterPro: IPR0017 | 97.59 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.56 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.56 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.31 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.21 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.21 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.19 | |
| PLN02236 | 344 | choline kinase | 96.99 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.74 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.68 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.63 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.35 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.11 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.08 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.06 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.87 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.6 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.56 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.48 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.28 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.24 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.42 |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-62 Score=492.42 Aligned_cols=333 Identities=47% Similarity=0.810 Sum_probs=274.9
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhh-HHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLD-AAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
.....++|.+++.||+|+||+|++|.+..+++.||+|++++...... ....+.+.+|+.+++++..||||+++++++..
T Consensus 12 ~~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 12 LQLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT 91 (370)
T ss_pred cccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence 45778999999999999999999999999999999998877521111 24567788999999999779999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCC-CCeEEEeccCCCcc
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD-GNLKVSDFGLSALP 179 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~-~~lkl~DFGls~~~ 179 (451)
..++|+|||||.||+|++++.+ ++++|.+++++|+||++||+|||++||+||||||||||+|.+ +++||+|||++...
T Consensus 92 ~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 92 PTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred CCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 9999999999999999999986 899999999999999999999999999999999999999999 99999999999876
Q ss_pred hhhhcCcccccCCCCccccceeeeccC-CCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCC-CHh
Q 013005 180 EQIKNGMLHTACGTPAYTAPEVVARRG-YDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFV-SKP 257 (451)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~APEvl~~~~-~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~-s~~ 257 (451)
. .....+.+.|||+.|+|||++.+.+ |.+.++|||||||+||.|++|+.||++.+...++.+|.++.+.+|.++ |++
T Consensus 172 ~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~ 250 (370)
T KOG0583|consen 172 P-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPE 250 (370)
T ss_pred C-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHH
Confidence 4 3457889999999999999999988 999999999999999999999999999999999999999999999999 999
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHcCccccc-hhHHh--hhhccCCc---chhc--cccCCchhhhhccCC------CCCC
Q 013005 258 ARSLIYQLLDPNPKTRMSIEKIMSISWFQK-SLQQQ--RKRGQESS---LFEL--GVVGNNKYILKEKIP------DIVS 323 (451)
Q Consensus 258 ~~~li~~~L~~dP~~Rpt~~eil~hp~f~~-~~~~~--~~~~~~~~---~~~~--~~~~~~~~~~~~~~~------~~~~ 323 (451)
+.+||.+||.+||.+|+|+.+|+.||||+. ..... ........ .... ..............+ .+..
T Consensus 251 ~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (370)
T KOG0583|consen 251 ARSLIEKMLVPDPSTRITLLEILEHPWFQKENPLPSDELPSEVAPSAPSAPSAKDSVSPVETEDEKPLSPTSTPESLPLS 330 (370)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhhChhhccCCCCCccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999999999999999998 32211 00000000 0000 000000000000000 2457
Q ss_pred CChhhhhc-cCCCC--CCCCcccccc-ccccceeeCC
Q 013005 324 MNAFDIIS-LSSGL--DLSGLFEAKK-RKEKRFTTKE 356 (451)
Q Consensus 324 ~~~~~~~~-~s~~~--~~~~~~~~~~-~~~~rf~~~~ 356 (451)
+++++.++ ++.+. +++.+++... ....+|.+..
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (370)
T KOG0583|consen 331 LNAYDLGSSLSTGINEALSGLFENEKEKEEPRFASLT 367 (370)
T ss_pred cChhhhcccccccccccccccccccccchhhhhhhcc
Confidence 88888887 78888 8888887554 4455665544
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-61 Score=490.19 Aligned_cols=262 Identities=42% Similarity=0.774 Sum_probs=246.6
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
..-++-|+++++||.|+.|.|.+|++..||+.+|||++.+. ..........+.+||.+|+.+. |||++++|++++++.
T Consensus 8 ~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~-~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe~~~ 85 (786)
T KOG0588|consen 8 KNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKR-SELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWENKQ 85 (786)
T ss_pred cccccceeccccccCCCCceehhhhcccccceeEEEeeccc-cccccccccchhhhhHHHHHhc-CCCeeeeeeeeccCc
Confidence 34578899999999999999999999999999999999886 2344555678999999999995 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 104 KIYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~-~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
++|+|+||++||+||+++. +|++++.++.+||.||+.|+.|||..+|+||||||||+|||.++++||+|||+|.+..
T Consensus 86 ~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-- 163 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV-- 163 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc--
Confidence 9999999999999999886 6999999999999999999999999999999999999999999999999999998643
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHH
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLI 262 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 262 (451)
...++.+.||+|.|.|||++.+.+|++.++||||||||||+||+|++||++.|...++.++.++.+..|..+|.++++||
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLL 243 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLL 243 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHH
Confidence 35788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHcCccccchh
Q 013005 263 YQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 263 ~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
++||+.||.+|+|.++|++|||+.+..
T Consensus 244 r~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 244 RRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHHhccCccccccHHHHhhCchhhcCC
Confidence 999999999999999999999998653
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-61 Score=468.91 Aligned_cols=262 Identities=34% Similarity=0.636 Sum_probs=232.4
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhh---HHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLD---AAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
...+.|.+.+.||+|+||.|.+|.++.||+.||||++.+...... .+....+.+|+++|++|. |||||+++++|+.
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRIKDFFEV 247 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEEeeeeec
Confidence 477788999999999999999999999999999999987632211 123345789999999995 9999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCC---CCeEEEeccCCC
Q 013005 102 KTKIYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD---GNLKVSDFGLSA 177 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~-~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~---~~lkl~DFGls~ 177 (451)
.+..||||||++||+|++++. ++.+.|...+.+++||+.||.|||++||+||||||||||+..+ ..+||+|||+|.
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 999999999999999999986 5789999999999999999999999999999999999999766 679999999998
Q ss_pred cchhhhcCcccccCCCCccccceeeeccCC--CCccchhhhhhHHHHHHHhcCCCCCCCcHHH-HHHHhhccCCCCCC--
Q 013005 178 LPEQIKNGMLHTACGTPAYTAPEVVARRGY--DGAVADAWSCGVILFVLLAGYLPFDDSNLLA-MYKKVNRRDYQFPS-- 252 (451)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~--~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~-~~~~i~~~~~~~p~-- 252 (451)
... ....+.+.||||.|+|||++.+.++ ++.+.||||+||+||.+|+|++||.+..... +..+|.++.+.+-+
T Consensus 328 ~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 328 VSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred ccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 654 3467889999999999999987664 4557899999999999999999999876665 89999999887643
Q ss_pred --CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 253 --FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 253 --~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
.++.++++||.+||..||+.|||++++|+||||+...
T Consensus 406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 3899999999999999999999999999999998643
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-60 Score=483.31 Aligned_cols=261 Identities=34% Similarity=0.667 Sum_probs=243.7
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
.+|+.+++||+|+|++||.+++..+|+.||+|++++. ........+.+.+||++.+.|+ |||||++|++|++.+++||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~-~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FEDs~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKK-LLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFEDSNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehH-HhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEeecCCceEE
Confidence 5699999999999999999999999999999999986 4556677889999999999996 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCc
Q 013005 108 VMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM 186 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~ 186 (451)
|+|+|..++|-.++++ +.++|.+++.|++||+.||.|||+++|+|||||..||+|+++-++||+|||||+..+... ..
T Consensus 96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-Er 174 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-ER 174 (592)
T ss_pred EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc-cc
Confidence 9999999999999974 789999999999999999999999999999999999999999999999999999776432 34
Q ss_pred ccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhcc
Q 013005 187 LHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLL 266 (451)
Q Consensus 187 ~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 266 (451)
..+.||||+|+|||++.+.++ +..+||||+|||+|.||.|++||...+..+.|.+|...++.+|..+|.++++||.+||
T Consensus 175 k~TlCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL 253 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLL 253 (592)
T ss_pred cceecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHh
Confidence 568999999999999998877 5669999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHHcCccccchhHHh
Q 013005 267 DPNPKTRMSIEKIMSISWFQKSLQQQ 292 (451)
Q Consensus 267 ~~dP~~Rpt~~eil~hp~f~~~~~~~ 292 (451)
++||.+|||+++|+.|+||.+++.+.
T Consensus 254 ~~~P~~Rpsl~~vL~h~Ff~~g~~p~ 279 (592)
T KOG0575|consen 254 RPNPSERPSLDEVLDHPFFKSGFTPA 279 (592)
T ss_pred cCCcccCCCHHHHhcCHhhhCCCcCC
Confidence 99999999999999999997766544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-56 Score=428.95 Aligned_cols=264 Identities=34% Similarity=0.656 Sum_probs=240.9
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
..-.++|++++.||+|+||+|++++.+.|++.+|+|++++. +.......+....|..+|..++ ||.||+++-.|.+..
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~-~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQt~~ 98 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKK-KIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQTEE 98 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhh-HhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecccCC
Confidence 45578999999999999999999999999999999999987 5556667788999999999995 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 104 KIYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~-~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
++|+|+||+.||+|+..++ .+.|+|..++.|+..|+.||.|||++||+||||||||||||.+|+++|+||||++....
T Consensus 99 kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~- 177 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK- 177 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc-
Confidence 9999999999999999998 58999999999999999999999999999999999999999999999999999985332
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCC-CCCCHhHHHH
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP-SFVSKPARSL 261 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p-~~~s~~~~~l 261 (451)
......+.|||+.|||||++.+.+|+.. +|.||||+++|+|++|.+||.+.+...++.+|.......+ ..++.+++++
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~-vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardl 256 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKA-VDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDL 256 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcc-cchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHH
Confidence 2245567899999999999999999654 8999999999999999999999999999999999985544 4599999999
Q ss_pred HHhccCCCCCCCC----CHHHHHcCccccchhHH
Q 013005 262 IYQLLDPNPKTRM----SIEKIMSISWFQKSLQQ 291 (451)
Q Consensus 262 i~~~L~~dP~~Rp----t~~eil~hp~f~~~~~~ 291 (451)
|+++|..||.+|. ++.+|.+||||..-...
T Consensus 257 l~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~ 290 (357)
T KOG0598|consen 257 LKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWE 290 (357)
T ss_pred HHHHhccCHHHhcCCCCChHHhhcCcccccCCHH
Confidence 9999999999995 79999999999875443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-56 Score=447.75 Aligned_cols=263 Identities=32% Similarity=0.635 Sum_probs=241.3
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
..-..+|.+++.||+|+|++|++|+++.+++.||||++++. ....+.....+.+|-.+|.+|.+||.|++||-.|.+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~-~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~ 147 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKR-YIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE 147 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHH-HHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc
Confidence 45577999999999999999999999999999999999987 55666667788899999999988999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 104 KIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
.+|+|+||+++|+|.++|.+ |.|++.-+|.|+.||+.||+|||++|||||||||||||||.++++||+|||.|......
T Consensus 148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 99999999999999999986 99999999999999999999999999999999999999999999999999999765432
Q ss_pred hcC------------cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCC
Q 013005 183 KNG------------MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQF 250 (451)
Q Consensus 183 ~~~------------~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~ 250 (451)
... ...+.+||..|++||+|.+.. .+..+|||+||||||.|++|.+||.+.+..-.+++|..-.+.|
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~f 306 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEF 306 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccC
Confidence 111 114578999999999997654 4677999999999999999999999999999999999999999
Q ss_pred CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 251 PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 251 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
|+.+++.+.+||+++|..||.+|+|+++|.+||||...
T Consensus 307 p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 307 PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred CCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 99999999999999999999999999999999999864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-56 Score=418.70 Aligned_cols=259 Identities=36% Similarity=0.686 Sum_probs=242.6
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
.-.++|+..++||.|+||+|.+++.+.+|..+|+|++++. +..+....+...+|..+|+.+. ||+++++++.+.+.+.
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~-~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~ 118 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQ-KVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSN 118 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHH-HHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCe
Confidence 5578899999999999999999999999999999999987 5667777888999999999996 9999999999999999
Q ss_pred EEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 105 IYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
+||||||++||+|+.++++ ++|++..++.|+.|++.||+|||+++|++|||||||||||.+|.+||+|||+|....
T Consensus 119 lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~--- 195 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS--- 195 (355)
T ss_pred EEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec---
Confidence 9999999999999999987 899999999999999999999999999999999999999999999999999997542
Q ss_pred cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHH
Q 013005 184 NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIY 263 (451)
Q Consensus 184 ~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 263 (451)
+...+.||||.|+|||++..++|. ..+|.|+|||++|||++|++||.+.+...+|.+|..+...||+.+++.+++||+
T Consensus 196 -~rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~ 273 (355)
T KOG0616|consen 196 -GRTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLK 273 (355)
T ss_pred -CcEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHH
Confidence 346789999999999999999985 558999999999999999999999999999999999999999999999999999
Q ss_pred hccCCCCCCCC-----CHHHHHcCccccchhH
Q 013005 264 QLLDPNPKTRM-----SIEKIMSISWFQKSLQ 290 (451)
Q Consensus 264 ~~L~~dP~~Rp-----t~~eil~hp~f~~~~~ 290 (451)
++|+.|-.+|. ...+|..||||+....
T Consensus 274 ~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W 305 (355)
T KOG0616|consen 274 KLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDW 305 (355)
T ss_pred HHHhhhhHhhhcCcCCCccccccCcccccccH
Confidence 99999999994 5789999999986543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-55 Score=418.36 Aligned_cols=256 Identities=29% Similarity=0.506 Sum_probs=231.8
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE-
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK- 104 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~- 104 (451)
..++.+.++.||+|+.|+||+++++.|++.+|+|++... .+.....++.+|+.+++.. +|||||.+|+.|..+..
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~---~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN---IDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc---CCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCce
Confidence 344778889999999999999999999999999999543 3567788999999999999 59999999999999995
Q ss_pred EEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 105 IYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQ-NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~-~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
++|+||||+||+|.+++.. |+++|...-+++.++++||.|||+ ++|+||||||+|||++..|.+||||||.|...-
T Consensus 153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv-- 230 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV-- 230 (364)
T ss_pred EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh--
Confidence 9999999999999999986 899999999999999999999996 899999999999999999999999999997543
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCC-----cHHHHHHHhhcc-CCCCCCC-CC
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS-----NLLAMYKKVNRR-DYQFPSF-VS 255 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~-----~~~~~~~~i~~~-~~~~p~~-~s 255 (451)
+....+.+||..|||||.+.+..| +.++||||||+.++|+++|+.||... +..+++..|..+ ...+|.. +|
T Consensus 231 -nS~a~tfvGT~~YMsPERi~g~~Y-s~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS 308 (364)
T KOG0581|consen 231 -NSIANTFVGTSAYMSPERISGESY-SVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFS 308 (364)
T ss_pred -hhhcccccccccccChhhhcCCcC-CcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCC
Confidence 246789999999999999999888 45599999999999999999999875 667888888874 4567775 99
Q ss_pred HhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 256 KPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 256 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
+++++||..||.+||.+|||+.|+++|||+++..
T Consensus 309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 309 PEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 9999999999999999999999999999998754
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-54 Score=417.41 Aligned_cols=261 Identities=39% Similarity=0.691 Sum_probs=236.3
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
.....++|.+.+.||+|+||+||+|+++.++..||||.+.+.+ ......+.+..||.+|+.++ |||||+++++....
T Consensus 5 ~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~--l~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~ 81 (429)
T KOG0595|consen 5 SMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKK--LNKKLVELLLSEIKILKELK-HPNIVRLLDCIEDD 81 (429)
T ss_pred cccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhc--cCHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecC
Confidence 4566889999999999999999999999999999999998753 35667888999999999996 99999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCC------CCeEEEeccC
Q 013005 103 TKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD------GNLKVSDFGL 175 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~------~~lkl~DFGl 175 (451)
+.+|||||||+||+|.+++++ ++++|..++.+++||+.||++||+++|+||||||+||||+.. -.+||+|||+
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 999999999999999999985 799999999999999999999999999999999999999875 3589999999
Q ss_pred CCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCC---CCC
Q 013005 176 SALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQ---FPS 252 (451)
Q Consensus 176 s~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~---~p~ 252 (451)
|+.... .....+.||+|.|||||++....|+ .|+|+||+|+|||+|++|+.||+..+..++...+.++... ++.
T Consensus 162 AR~L~~--~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~ 238 (429)
T KOG0595|consen 162 ARFLQP--GSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPA 238 (429)
T ss_pred hhhCCc--hhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhh
Confidence 997653 4677899999999999999888886 5599999999999999999999999999998888776543 345
Q ss_pred CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 253 FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 253 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
..+.+..+|+...|..||..|.+..+-+.|++.....
T Consensus 239 ~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 239 ELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 6888889999999999999999999999999987654
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-54 Score=416.19 Aligned_cols=261 Identities=42% Similarity=0.741 Sum_probs=243.9
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
-..+--+|++.++||+|.||+|.+|+....|+.||||.|+++ +..+....-.+++||.||..| |||||+++|++|+++
T Consensus 48 khnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKd-kIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENk 125 (668)
T KOG0611|consen 48 KHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKD-KIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENK 125 (668)
T ss_pred ccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhh-hcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCC
Confidence 345677999999999999999999999999999999999988 666777778899999999999 599999999999999
Q ss_pred CEEEEEEEecCCCchhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 103 TKIYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~-~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
+++.|||||..+|+|++++. .+.++|.+++.+|+||.+|+.|||.++++|||||.||||||.++++||+||||+.++..
T Consensus 126 dKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 126 DKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred ceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999999999997 58999999999999999999999999999999999999999999999999999987754
Q ss_pred hhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHH
Q 013005 182 IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSL 261 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 261 (451)
...+.+.||+|-|.+||++.+.+|.++..|-|||||+||.|+.|..||++.+...+.++|.++.+.-|. -+..+.-|
T Consensus 206 --~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-~PSdA~gL 282 (668)
T KOG0611|consen 206 --KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-TPSDASGL 282 (668)
T ss_pred --ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-CCchHHHH
Confidence 467889999999999999999999999999999999999999999999999999999999999887666 46778899
Q ss_pred HHhccCCCCCCCCCHHHHHcCccccch
Q 013005 262 IYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 262 i~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
|+.||..||.+|.|+++|..|=|..-+
T Consensus 283 IRwmLmVNP~RRATieDiAsHWWvNwg 309 (668)
T KOG0611|consen 283 IRWMLMVNPERRATIEDIASHWWVNWG 309 (668)
T ss_pred HHHHHhcCcccchhHHHHhhhheeecc
Confidence 999999999999999999999887533
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-53 Score=422.65 Aligned_cols=261 Identities=35% Similarity=0.608 Sum_probs=231.8
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
.-.++|+++..||+|+||.||+|+.+.||+.+|+|++++.. .......+.++.|-.+|... ++|+||++|-.|.+..+
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~-M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~ 215 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSE-MLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEY 215 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHH-HHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCe
Confidence 45789999999999999999999999999999999999873 34556677889999999996 59999999999999999
Q ss_pred EEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh--
Q 013005 105 IYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ-- 181 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~-- 181 (451)
+||||||++||++..++.+ +.|+++.++.|+.+++.|++.+|+.|++||||||+|+|||..|++||+||||++-...
T Consensus 216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 9999999999999999875 8999999999999999999999999999999999999999999999999999852111
Q ss_pred -------------h-------------------------------hcCcccccCCCCccccceeeeccCCCCccchhhhh
Q 013005 182 -------------I-------------------------------KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSC 217 (451)
Q Consensus 182 -------------~-------------------------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSl 217 (451)
. ........+|||.|+|||++.+.+| +..+|.|||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY-~~~cDwWSL 374 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY-GKECDWWSL 374 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC-CccccHHHH
Confidence 0 0011235679999999999999998 456999999
Q ss_pred hHHHHHHHhcCCCCCCCcHHHHHHHhhccC--CCCCCC--CCHhHHHHHHhccCCCCCCCC---CHHHHHcCccccchh
Q 013005 218 GVILFVLLAGYLPFDDSNLLAMYKKVNRRD--YQFPSF--VSKPARSLIYQLLDPNPKTRM---SIEKIMSISWFQKSL 289 (451)
Q Consensus 218 Gvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~--~s~~~~~li~~~L~~dP~~Rp---t~~eil~hp~f~~~~ 289 (451)
|||+||||.|++||...+..+.+.+|..-. +.+|.. ++++++|||.+||. ||.+|. .++||.+||||+...
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD 452 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence 999999999999999999999999998654 667764 78999999999999 999998 499999999998743
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-53 Score=416.92 Aligned_cols=263 Identities=36% Similarity=0.634 Sum_probs=232.1
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchh----------hHHHHHHHHHHHHHHHHhcCCCCceE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFL----------DAAMEDRIVREVSAMRRLQNHPNVLK 94 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~----------~~~~~~~~~~Ei~il~~L~~HpnIv~ 94 (451)
..++.|++.+.||+|.||+|.+|++..+++.||||++++..... .....+.+++||.+|++|. |||||+
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~nVV~ 172 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPNVVK 172 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcCeeE
Confidence 45789999999999999999999999999999999998753211 0112468999999999996 999999
Q ss_pred EEEEEEe--CCEEEEEEEecCCCchhHHhhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEE
Q 013005 95 IQEVMAT--KTKIYLVMEYAAGGELFGKLRRGR-LTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVS 171 (451)
Q Consensus 95 l~~~~~~--~~~~~lV~E~~~gg~L~~~l~~~~-l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~ 171 (451)
|+++..+ .+++|||+|||..|.+...-.... +++.++|+|+++++.||+|||.+||+||||||.|+||+++|++||+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 9999976 468999999999998865554555 9999999999999999999999999999999999999999999999
Q ss_pred eccCCCcchhh----hcCcccccCCCCccccceeeec---cCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhh
Q 013005 172 DFGLSALPEQI----KNGMLHTACGTPAYTAPEVVAR---RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVN 244 (451)
Q Consensus 172 DFGls~~~~~~----~~~~~~~~~gt~~y~APEvl~~---~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~ 244 (451)
|||.+...... ....+...+|||.|+|||.+.. ..+.+.+.||||+||+||.|+.|++||.+....+++.+|.
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv 332 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV 332 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence 99998754221 1123445889999999999877 5678899999999999999999999999999999999999
Q ss_pred ccCCCCCCC--CCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 245 RRDYQFPSF--VSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 245 ~~~~~~p~~--~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.....||.. +.+.+++||.+||.+||++|+++.+|..|||....
T Consensus 333 n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 333 NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 999999875 79999999999999999999999999999998765
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-54 Score=393.51 Aligned_cols=259 Identities=35% Similarity=0.683 Sum_probs=232.1
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
-.+.+.|++.+.||+|+|+.||++.+..||+.+|+|+++.. +. +...-+.+.+|+.|-+.|+ ||||+++++.+.+..
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~-k~-~~~~~e~l~rEarIC~~Lq-HP~IvrL~~ti~~~~ 83 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK-KL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEES 83 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhh-hh-ccccHHHHHHHHHHHHhcC-CCcEeehhhhhcccc
Confidence 34678899999999999999999999999999999999865 32 2335678999999999997 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCC---CCeEEEeccCCCcc
Q 013005 104 KIYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD---GNLKVSDFGLSALP 179 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~-~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~---~~lkl~DFGls~~~ 179 (451)
..|||+|++.|++|..-+- +--++|..+-.+++||+++|.|||.+||+|||+||+|+|+-.. .-+||+|||+|...
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred eeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999999999976554 4568999999999999999999999999999999999999543 35999999999755
Q ss_pred hhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCC----CCC
Q 013005 180 EQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS----FVS 255 (451)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s 255 (451)
. .........|||.|+|||++.+.+|. .++|||+||||||.||.|++||.+.+...+|..|..+.+.+|+ .++
T Consensus 164 ~--~g~~~~G~~GtP~fmaPEvvrkdpy~-kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is 240 (355)
T KOG0033|consen 164 N--DGEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVT 240 (355)
T ss_pred C--CccccccccCCCcccCHHHhhcCCCC-CcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCC
Confidence 4 34556778999999999999988885 5599999999999999999999999999999999999888765 489
Q ss_pred HhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 256 KPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 256 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+++++|+++||..||.+|+|+.|.|+|||+.+.
T Consensus 241 ~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 241 PEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 999999999999999999999999999999764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-52 Score=424.09 Aligned_cols=265 Identities=32% Similarity=0.577 Sum_probs=244.6
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
...-+++|.+.+.||+|+||+|+++..+.+++.+|||+++|. .....+..+....|-.|+....+||.+++++..|.++
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~-~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~ 441 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKG-DILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK 441 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeecc-ceeccccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence 456688999999999999999999999999999999999998 4566677788999999999998899999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 103 TKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
+++|+||||+.||++..+.+.+.|++..++.|+..++.||.|||++|||+||||.+|||||.+|++||+|||+++-.-.
T Consensus 442 ~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~- 520 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG- 520 (694)
T ss_pred CeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC-
Confidence 9999999999999977777779999999999999999999999999999999999999999999999999999974321
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHH
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLI 262 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 262 (451)
......|.||||.|+|||++....| +...|.|||||+||+||.|..||.+.+.++.+..|...++.+|.|+|.++.+++
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Y-t~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il 599 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSY-TRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIM 599 (694)
T ss_pred CCCccccccCChhhcChhhhccCcc-cchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHH
Confidence 2245678999999999999999888 566999999999999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCC-----HHHHHcCccccchhH
Q 013005 263 YQLLDPNPKTRMS-----IEKIMSISWFQKSLQ 290 (451)
Q Consensus 263 ~~~L~~dP~~Rpt-----~~eil~hp~f~~~~~ 290 (451)
+++|..||++|.- +++|..||||+.-..
T Consensus 600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w 632 (694)
T KOG0694|consen 600 RRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDW 632 (694)
T ss_pred HHHhccCcccccCCCCCCchhhhhCCccccCCH
Confidence 9999999999985 689999999987543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-53 Score=393.41 Aligned_cols=260 Identities=27% Similarity=0.487 Sum_probs=221.7
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
+++|+.+..+|+|+||.||+++++.||+.||||.+... ..+....+...|||.+|++|+ |||+|.++++|..+...+
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es--edd~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrrkrklh 77 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES--EDDPVVKKIALREIRMLKQLK-HENLVNLIEVFRRKRKLH 77 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC--CccHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHhcceeE
Confidence 57899999999999999999999999999999999653 234556677889999999996 999999999999999999
Q ss_pred EEEEecCCCchhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 107 LVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~-~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
+|+|||+..-|.++-+ ...++++.+++|+.|++.|+.|||+++++|||||||||||+.+|.+||||||+|+.... ...
T Consensus 78 LVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd 156 (396)
T KOG0593|consen 78 LVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGD 156 (396)
T ss_pred EEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccc
Confidence 9999998755544433 36799999999999999999999999999999999999999999999999999987654 335
Q ss_pred cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc--------------C----
Q 013005 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR--------------D---- 247 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~--------------~---- 247 (451)
.....+.|.+|.|||++.+...++.+.|||++||++.||++|.+.|.+.+..+....|... +
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 5667889999999999998666688899999999999999999999987766554444321 1
Q ss_pred -CCCC------------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchhH
Q 013005 248 -YQFP------------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQ 290 (451)
Q Consensus 248 -~~~p------------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 290 (451)
..+| +.++..+.+|+++||..||.+|++.+|++.||+|.....
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e 292 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE 292 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence 1122 125677899999999999999999999999999965443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=401.63 Aligned_cols=258 Identities=30% Similarity=0.572 Sum_probs=221.5
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC--E
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT--K 104 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~--~ 104 (451)
..+|..++.||+|+||.||++.+.++|+..|||.+...+. ...+.+.+|+.+|++|+ |||||+++|...... .
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~----~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~ 90 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS----PTSESLEREIRILSRLN-HPNIVQYYGSSSSRENDE 90 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc----hhHHHHHHHHHHHHhCC-CCCEEeeCCccccccCee
Confidence 5679999999999999999999999999999999987622 12677999999999997 999999999855444 6
Q ss_pred EEEEEEecCCCchhHHhhc-C-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC-CCCeEEEeccCCCcchh
Q 013005 105 IYLVMEYAAGGELFGKLRR-G-RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR-DGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~-~-~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~-~~~lkl~DFGls~~~~~ 181 (451)
++++|||++||+|.+++.+ + +++|..++.|.+|+++||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999999999986 4 7999999999999999999999999999999999999999 79999999999986553
Q ss_pred --hhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCC-CcHHHHHHHhhcc--CCCCCCCCCH
Q 013005 182 --IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDD-SNLLAMYKKVNRR--DYQFPSFVSK 256 (451)
Q Consensus 182 --~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~-~~~~~~~~~i~~~--~~~~p~~~s~ 256 (451)
..........|||.|||||++.+.....+++||||+||++.||+||..||.. .......-.+... .+.+|.++|+
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~ 250 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSD 250 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCH
Confidence 1123344678999999999998633334579999999999999999999987 3444444444433 3578889999
Q ss_pred hHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 257 PARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
++++||.+||..||++|||++++|.|||.+...
T Consensus 251 ~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 251 EAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 999999999999999999999999999997653
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-52 Score=409.56 Aligned_cols=260 Identities=40% Similarity=0.706 Sum_probs=241.6
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
.+.+=|.+.++||+|.|+.|.+|++.-||+.||||++++.+ .+......+.+|+..|+.++ |||||++|++..+..+
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTK--lD~~st~hlfqEVRCMKLVQ-HpNiVRLYEViDTQTK 91 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTK--LDTLSTGHLFQEVRCMKLVQ-HPNIVRLYEVIDTQTK 91 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccc--cchhhhhHHHHHHHHHHHhc-CcCeeeeeehhcccce
Confidence 45677999999999999999999999999999999999873 34455567889999999997 9999999999999999
Q ss_pred EEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC-CCCeEEEeccCCCcchh
Q 013005 105 IYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR-DGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~-~~~lkl~DFGls~~~~~ 181 (451)
+|||+|+-++|+|+++|.+ ..++|+.+++||.||+.|+.|||+..++||||||||+.+-+ -|-+||+|||++..+..
T Consensus 92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999999999999999975 67999999999999999999999999999999999998754 58999999999986654
Q ss_pred hhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHH
Q 013005 182 IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSL 261 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 261 (451)
...+.+.||++.|-|||++.+..|+.++.||||||||||.|++|++||...+..+....|....|..|..++.++++|
T Consensus 172 --G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdL 249 (864)
T KOG4717|consen 172 --GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDL 249 (864)
T ss_pred --cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHH
Confidence 356789999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 262 IYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 262 i~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
|..||.-||++|.|.++|..++|++...
T Consensus 250 I~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 250 IQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred HHHHHhcCchhhccHHHHhccccccCCC
Confidence 9999999999999999999999998653
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-52 Score=414.25 Aligned_cols=258 Identities=33% Similarity=0.602 Sum_probs=238.8
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
+++|.+.+.||+|+||.||+|+.+.|.+.||+|.+++..+ .......+.+|+.+++.|+ |||||.++++|++..+.|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr--~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfEt~~~~~ 77 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR--NEKELKNLRQEVRILRSLK-HPNIVEMLESFETSAHLW 77 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC--chHHHHHHHHHHHHHHhcC-CcchhhHHHhhcccceEE
Confidence 5789999999999999999999999999999999998743 4456778999999999996 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 107 LVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
+|.|||.| +|+.++.. +.++|+.++.++.||+.||.|||+++|.|||+||.|||++..|.+|+||||+|+.... ...
T Consensus 78 vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~ 155 (808)
T KOG0597|consen 78 VVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTS 155 (808)
T ss_pred EEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc-Cce
Confidence 99999988 99999985 8999999999999999999999999999999999999999999999999999986543 235
Q ss_pred cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhc
Q 013005 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQL 265 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 265 (451)
.+....|||.|||||++.+.+|+ ..+|+||+|||+|||++|++||.......+.+.|...+...|...+..+.+|++.+
T Consensus 156 vltsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gL 234 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGL 234 (808)
T ss_pred eeeeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHH
Confidence 56677899999999999988886 44899999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCHHHHHcCccccchhH
Q 013005 266 LDPNPKTRMSIEKIMSISWFQKSLQ 290 (451)
Q Consensus 266 L~~dP~~Rpt~~eil~hp~f~~~~~ 290 (451)
|..||.+|.|+.+++.|||.+....
T Consensus 235 L~kdP~~RltW~~Ll~HpF~k~~~~ 259 (808)
T KOG0597|consen 235 LIKDPAQRLTWTDLLGHPFWKGKIN 259 (808)
T ss_pred hhcChhhcccHHHHhcChHHhhhhh
Confidence 9999999999999999999987544
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-53 Score=390.40 Aligned_cols=253 Identities=34% Similarity=0.618 Sum_probs=224.2
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEE-EE-EeC
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQE-VM-ATK 102 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~-~~-~~~ 102 (451)
....+|++.+.||.|+||+||++++..+|..||.|.+.-. ..+....+.+..|+.+|++|+ |||||++|+ .+ +++
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~--~md~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG--MMDAKARQDCVKEISLLKQLN-HPNIVQYYAHSFIEDN 92 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh--hccHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhhccc
Confidence 3456799999999999999999999999999999999743 356667788999999999995 999999998 33 445
Q ss_pred CEEEEEEEecCCCchhHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH--CC--ceecCCCCCeEEeCCCCCeEEEec
Q 013005 103 TKIYLVMEYAAGGELFGKLRR-----GRLTESAARRYFQQLVSALHFCHQ--NG--VAHRDVKPQNLLLDRDGNLKVSDF 173 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~-----~~l~e~~~~~~~~ql~~gL~yLH~--~g--iiHrDLKpeNILld~~~~lkl~DF 173 (451)
.-++||||||.+|+|..+++. ..++|..+|+||.||+.||..||+ .. |+||||||.||+||.+|.+||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 559999999999999999852 469999999999999999999999 45 999999999999999999999999
Q ss_pred cCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCC-CC-
Q 013005 174 GLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQ-FP- 251 (451)
Q Consensus 174 Gls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p- 251 (451)
||++.... .....++.+|||+||+||++...+| ..+|||||+||++|||++-+.||.+.+..++.++|..++++ +|
T Consensus 173 GL~r~l~s-~~tfA~S~VGTPyYMSPE~i~~~~Y-~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~ 250 (375)
T KOG0591|consen 173 GLGRFLSS-KTTFAHSLVGTPYYMSPERIHESGY-NFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD 250 (375)
T ss_pred hhHhHhcc-hhHHHHhhcCCCcccCHHHHhcCCC-CcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH
Confidence 99987654 2345678899999999999999998 57799999999999999999999999999999999999875 66
Q ss_pred CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 252 SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 252 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
...|..+..||..|+.+||.+||+. +|+++.
T Consensus 251 ~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~d 281 (375)
T KOG0591|consen 251 EHYSTDLRELINMCIAVDPEQRPDT-----VPYVQD 281 (375)
T ss_pred HHhhhHHHHHHHHHccCCcccCCCc-----chHHHH
Confidence 5689999999999999999999996 555543
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-52 Score=377.53 Aligned_cols=256 Identities=38% Similarity=0.683 Sum_probs=239.1
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
.+++|++++.||+|-||.||+|+.++++-.||+|++-++ .........++.+|++|...|+ ||||+++|++|-+...+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKs-qi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKS-QILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFHDSKRI 97 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHH-HHHHhcchhhhhheeEeecccC-CccHHhhhhheecccee
Confidence 467899999999999999999999999999999999887 3566677889999999999996 99999999999999999
Q ss_pred EEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 106 YLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
|+++||..+|+|+..+.. .++++..+..|..|++.|+.|||.++|+||||||||+|++.+|.+||+|||.|-...
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 999999999999999983 569999999999999999999999999999999999999999999999999987543
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHH
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLI 262 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 262 (451)
.+.-.+.|||..|.|||...+.+++.. .|+|++|++.|+++.|.+||...+..+.|++|.+.++.+|..++.++.+||
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~-Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI 253 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKF-VDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLI 253 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccch-hhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHH
Confidence 234467899999999999999888655 899999999999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHcCccccc
Q 013005 263 YQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 263 ~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
.+||..+|.+|.+..|++.|||+..
T Consensus 254 ~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 254 SRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHhccCccccccHHHHhhhHHHHh
Confidence 9999999999999999999999865
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-50 Score=405.36 Aligned_cols=263 Identities=35% Similarity=0.662 Sum_probs=237.2
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
........|++++.||.|.||.||+++++.||+.+|+|++.+.. .......+.+.+|+.+|+++.+|||||.+++++++
T Consensus 29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~-~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~ 107 (382)
T KOG0032|consen 29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRK-LRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED 107 (382)
T ss_pred ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhh-ccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc
Confidence 44566778999999999999999999999999999999998863 33333557899999999999889999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCC----CCeEEEeccCCC
Q 013005 102 KTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD----GNLKVSDFGLSA 177 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~----~~lkl~DFGls~ 177 (451)
...+|+|||+|.||+|++.+....++|..+..++.|++.++.|||+.||+||||||||+|+... +.+|++|||+|.
T Consensus 108 ~~~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 108 PDSVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred CCeEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 9999999999999999999976469999999999999999999999999999999999999643 479999999998
Q ss_pred cchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCC--C--
Q 013005 178 LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS--F-- 253 (451)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~-- 253 (451)
.... ...+...||||.|+|||++...+|. ..+||||+|+++|.|++|..||.+.+......++..+.+.|+. |
T Consensus 188 ~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~ 264 (382)
T KOG0032|consen 188 FIKP--GERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDD 264 (382)
T ss_pred EccC--CceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccc
Confidence 7665 5678899999999999999888884 5589999999999999999999999998888899988876653 3
Q ss_pred CCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 254 VSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 254 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
++..+++||++||..||.+|+|+.++|+|||++..
T Consensus 265 is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 265 ISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred cCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 79999999999999999999999999999998764
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-52 Score=382.23 Aligned_cols=268 Identities=32% Similarity=0.611 Sum_probs=238.0
Q ss_pred CCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcc----hhhHHHHHHHHHHHHHHHHhcCCCCceEE
Q 013005 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNK----FLDAAMEDRIVREVSAMRRLQNHPNVLKI 95 (451)
Q Consensus 20 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~~~~~~~~~Ei~il~~L~~HpnIv~l 95 (451)
...-....++|+--+.||.|..+.|.++.++.||..+|+|+++.... .....+.+.-.+|+.||+++.+||||+++
T Consensus 9 ~~aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l 88 (411)
T KOG0599|consen 9 KDAAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDL 88 (411)
T ss_pred hhhHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEe
Confidence 34445667889999999999999999999999999999999975421 11335667788999999999999999999
Q ss_pred EEEEEeCCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEecc
Q 013005 96 QEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFG 174 (451)
Q Consensus 96 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFG 174 (451)
.++|+++...++|+|.|+.|+|++++.. -.++|...+++++||++|++|||.++|+||||||||||+|++-++||+|||
T Consensus 89 ~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 89 QDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred eeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccc
Confidence 9999999999999999999999999975 789999999999999999999999999999999999999999999999999
Q ss_pred CCCcchhhhcCcccccCCCCccccceeeecc------CCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC
Q 013005 175 LSALPEQIKNGMLHTACGTPAYTAPEVVARR------GYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY 248 (451)
Q Consensus 175 ls~~~~~~~~~~~~~~~gt~~y~APEvl~~~------~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~ 248 (451)
+|+..+. ...+...||||.|+|||.+... +| +...|+|+||||+|.|++|.+||-.....-+...|..+.+
T Consensus 169 Fa~~l~~--GekLrelCGTPgYLAPEtikC~m~e~~pGY-s~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGky 245 (411)
T KOG0599|consen 169 FACQLEP--GEKLRELCGTPGYLAPETIKCSMYENHPGY-SKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKY 245 (411)
T ss_pred eeeccCC--chhHHHhcCCCcccChhheeeecccCCCCc-cchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccc
Confidence 9986644 3456788999999999998542 34 5568999999999999999999999988999999999988
Q ss_pred CC--CCC--CCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchhH
Q 013005 249 QF--PSF--VSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQ 290 (451)
Q Consensus 249 ~~--p~~--~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 290 (451)
+| |.| +|...++||.+||+.||.+|+|++|+|.||||..-..
T Consensus 246 qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~ 291 (411)
T KOG0599|consen 246 QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ 291 (411)
T ss_pred ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence 76 445 7899999999999999999999999999999976543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-52 Score=406.55 Aligned_cols=261 Identities=31% Similarity=0.501 Sum_probs=227.8
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
-.++++|.+.+.||.|+||.||+|+.+.+|+.||||.+.+.- .. ...-.-.||+..|++|..|||||++.+++.+.+
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf--~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF--YS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDND 82 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh--cc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence 467899999999999999999999999999999999997642 22 223345689999999966999999999998887
Q ss_pred -EEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 104 -KIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 104 -~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
.+|+|||||+. +|+++++. ..|++..++.|+.||++||+|+|.+|++|||+||||||+..+..+||+|||||+...
T Consensus 83 ~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 83 RILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred ceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence 99999999965 99999974 569999999999999999999999999999999999999988899999999998654
Q ss_pred hhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhc---------------
Q 013005 181 QIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNR--------------- 245 (451)
Q Consensus 181 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~--------------- 245 (451)
. .......+.|.+|+|||+|.+.++++.+.|||++|||++|+.+-++.|.+.+..+...+|..
T Consensus 162 S--kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 162 S--KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred c--CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 3 45677889999999999999999999999999999999999999999999887766655532
Q ss_pred ----cCCCCC-----------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchhH
Q 013005 246 ----RDYQFP-----------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQ 290 (451)
Q Consensus 246 ----~~~~~p-----------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 290 (451)
-++.+| +..+.++.++|.+||..||.+|||++|+++||||+....
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 123333 226889999999999999999999999999999987544
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-50 Score=400.85 Aligned_cols=257 Identities=34% Similarity=0.668 Sum_probs=231.5
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
...++|++.+.||+|+||.||+|++..+++.||+|++.+. ........+.+.+|+.+++++. ||||+++++++.+.+.
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 92 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKR-EILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQDENR 92 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH-HHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEcCCE
Confidence 3468999999999999999999999999999999999764 2223344567889999999995 9999999999999999
Q ss_pred EEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 105 IYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
.|+||||+.||+|.+.+.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~-- 170 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-- 170 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC--
Confidence 9999999999999999875 7899999999999999999999999999999999999999999999999999875422
Q ss_pred cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHH
Q 013005 184 NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIY 263 (451)
Q Consensus 184 ~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 263 (451)
...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+......+|.+++..+.+||.
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 247 (329)
T PTZ00263 171 --RTFTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVK 247 (329)
T ss_pred --CcceecCChhhcCHHHHcCCCC-CCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHH
Confidence 2235689999999999987776 5679999999999999999999999888888888888888899999999999999
Q ss_pred hccCCCCCCCCC-----HHHHHcCccccch
Q 013005 264 QLLDPNPKTRMS-----IEKIMSISWFQKS 288 (451)
Q Consensus 264 ~~L~~dP~~Rpt-----~~eil~hp~f~~~ 288 (451)
+||..||.+||+ +++++.||||...
T Consensus 248 ~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 248 GLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 999999999997 8999999999864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-51 Score=403.55 Aligned_cols=260 Identities=30% Similarity=0.539 Sum_probs=228.8
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC-
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK- 102 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~- 102 (451)
+...+.|+.++.||+|.||.||+|++..||+.||+|.+..++. +.....-..|||.||++|. ||||++|.+...+.
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~--~~~~~~t~~REI~ILr~l~-HpNIikL~eivt~~~ 189 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE--KEGFPITAIREIKILRRLD-HPNIIKLEEIVTSKL 189 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC--CCcchHHHHHHHHHHHhcC-CCcccceeeEEEecC
Confidence 4557788999999999999999999999999999999987642 2334455679999999995 99999999998876
Q ss_pred -CEEEEEEEecCCCchhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcc
Q 013005 103 -TKIYLVMEYAAGGELFGKLRRG--RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALP 179 (451)
Q Consensus 103 -~~~~lV~E~~~gg~L~~~l~~~--~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~ 179 (451)
..+|||+|||+. +|.-++... +|++.+++.|++||+.||+|||++||.|||||..|||||.+|++||+|||||+++
T Consensus 190 ~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 190 SGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred CceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeec
Confidence 789999999986 888888764 7999999999999999999999999999999999999999999999999999988
Q ss_pred hhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc----------CCC
Q 013005 180 EQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR----------DYQ 249 (451)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~----------~~~ 249 (451)
.......+...+-|++|.|||+|.+...++...|+||+||||.||++|++.|.+.+..+...+|.+- ...
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 7776677888899999999999999888888899999999999999999999999888777766431 001
Q ss_pred CC-------------------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 250 FP-------------------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 250 ~p-------------------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
+| ..++..+.+|+..||..||.+|.|+.++|+++||..
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 11 125788999999999999999999999999999943
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-50 Score=391.98 Aligned_cols=255 Identities=30% Similarity=0.602 Sum_probs=228.9
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+.+|+.+++++. ||||+++++++.+....|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPE-VIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEHDQRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHH-HhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhccCCeEEE
Confidence 47999999999999999999999999999999997542 222334567889999999995 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCc
Q 013005 108 VMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM 186 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~ 186 (451)
||||+.+|+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++..... .
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~----~ 154 (291)
T cd05612 79 LMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD----R 154 (291)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC----C
Confidence 9999999999999875 6799999999999999999999999999999999999999999999999999875422 2
Q ss_pred ccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhcc
Q 013005 187 LHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLL 266 (451)
Q Consensus 187 ~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 266 (451)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+......+|..++..+.+||++||
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l 233 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLL 233 (291)
T ss_pred cccccCChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHc
Confidence 234679999999999987766 5679999999999999999999999988888899888888899999999999999999
Q ss_pred CCCCCCCCC-----HHHHHcCccccchh
Q 013005 267 DPNPKTRMS-----IEKIMSISWFQKSL 289 (451)
Q Consensus 267 ~~dP~~Rpt-----~~eil~hp~f~~~~ 289 (451)
..||.+||+ ++++++||||+...
T Consensus 234 ~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 261 (291)
T cd05612 234 VVDRTRRLGNMKNGADDVKNHRWFKSVD 261 (291)
T ss_pred CCCHHHccCCccCCHHHHhcCccccCCC
Confidence 999999995 99999999998643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=393.77 Aligned_cols=252 Identities=34% Similarity=0.606 Sum_probs=223.7
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecC
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAA 113 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ 113 (451)
+.||+|+||.||+|.+..+|+.||+|++.+. ..........+.+|+.+++.+. ||||+++++++...+..|+||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKE-VIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHH-HhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEcCCEEEEEEeCCC
Confidence 4699999999999999999999999999764 2223344556788999999995 9999999999999999999999999
Q ss_pred CCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCC
Q 013005 114 GGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACG 192 (451)
Q Consensus 114 gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~g 192 (451)
||+|.+.+.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~-~~~~~~~~~g 157 (323)
T cd05571 79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFCG 157 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc-CCCcccceec
Confidence 9999998875 6799999999999999999999999999999999999999999999999999864221 1223345689
Q ss_pred CCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccCCCCCC
Q 013005 193 TPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKT 272 (451)
Q Consensus 193 t~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 272 (451)
|+.|+|||++.+..+ +.++||||+||++|+|++|..||...+....+..+......+|..+++.+.+||.+||..||++
T Consensus 158 t~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 236 (323)
T cd05571 158 TPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQ 236 (323)
T ss_pred CccccChhhhcCCCC-CccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 999999999987766 5669999999999999999999999888888888888888899999999999999999999999
Q ss_pred CC-----CHHHHHcCccccchh
Q 013005 273 RM-----SIEKIMSISWFQKSL 289 (451)
Q Consensus 273 Rp-----t~~eil~hp~f~~~~ 289 (451)
|| ++.++++||||....
T Consensus 237 R~~~~~~~~~~ll~h~~f~~~~ 258 (323)
T cd05571 237 RLGGGPEDAKEIMEHRFFASIN 258 (323)
T ss_pred cCCCCCCCHHHHHcCCCcCCCC
Confidence 99 899999999998743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-49 Score=384.21 Aligned_cols=270 Identities=30% Similarity=0.496 Sum_probs=230.6
Q ss_pred CCCCCCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceE
Q 013005 15 PPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94 (451)
Q Consensus 15 ~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~ 94 (451)
....+...++.-.+.|++...||.|..++||+|+...+++.||||+++.++. ....+.+.+|+..|+.+. ||||++
T Consensus 13 ~~~~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc---~~~ld~l~kE~~~msl~~-HPNIv~ 88 (516)
T KOG0582|consen 13 SASSSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC---NNDLDALRKEVQTMSLID-HPNIVT 88 (516)
T ss_pred ccccccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh---hhhHHHHHHHHHHhhhcC-CCCcce
Confidence 3445677888999999999999999999999999999999999999998742 233688999999999995 999999
Q ss_pred EEEEEEeCCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEE
Q 013005 95 IQEVMATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVS 171 (451)
Q Consensus 95 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~ 171 (451)
++..|..+..+|+||.|+.+|++.++++. ..++|..+..+++++++||.|||++|.+|||||+.|||||.+|.+||+
T Consensus 89 ~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLa 168 (516)
T KOG0582|consen 89 YHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLA 168 (516)
T ss_pred EEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEc
Confidence 99999999999999999999999999974 569999999999999999999999999999999999999999999999
Q ss_pred eccCCCcchhhhc--C-cccccCCCCccccceeeec--cCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHH-HHHhhc
Q 013005 172 DFGLSALPEQIKN--G-MLHTACGTPAYTAPEVVAR--RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAM-YKKVNR 245 (451)
Q Consensus 172 DFGls~~~~~~~~--~-~~~~~~gt~~y~APEvl~~--~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~-~~~i~~ 245 (451)
|||.+...-.... . ...+.+|||+|||||++.. .+| ..|+||||||++..||.+|..||.......+ ..++..
T Consensus 169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GY-dfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn 247 (516)
T KOG0582|consen 169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGY-DFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQN 247 (516)
T ss_pred CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCc-cchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 9998764332222 1 1167799999999999532 456 5679999999999999999999988766654 444444
Q ss_pred cCC-----CCC----CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 246 RDY-----QFP----SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 246 ~~~-----~~p----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
..+ .++ ..++..++.+|..||..||.+|||++++++|+||++..
T Consensus 248 ~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 248 DPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred CCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 333 111 23677899999999999999999999999999998653
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-49 Score=395.03 Aligned_cols=263 Identities=31% Similarity=0.574 Sum_probs=233.3
Q ss_pred CCCCcccccCCeEEcceEcccCceEEEEEEEcCCC-cEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEE
Q 013005 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADG-SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQE 97 (451)
Q Consensus 19 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~ 97 (451)
+........++|++.+.||+|+||.||+|.+..++ ..||+|++.+. ........+.+.+|+.+++.+. ||||+++++
T Consensus 21 ~~~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~ 98 (340)
T PTZ00426 21 PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKS-KIIKQKQVDHVFSERKILNYIN-HPFCVNLYG 98 (340)
T ss_pred cccCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHH-HhhhhhhHHHHHHHHHHHHhCC-CCCCcceEE
Confidence 44555667889999999999999999999876654 68999999764 2223344567889999999995 999999999
Q ss_pred EEEeCCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCC
Q 013005 98 VMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176 (451)
Q Consensus 98 ~~~~~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls 176 (451)
++.+....|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 99 ~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a 178 (340)
T PTZ00426 99 SFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFA 178 (340)
T ss_pred EEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCC
Confidence 99999999999999999999999975 68999999999999999999999999999999999999999999999999998
Q ss_pred CcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCH
Q 013005 177 ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSK 256 (451)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 256 (451)
..... ...+.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+....+..+......+|..+++
T Consensus 179 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~ 253 (340)
T PTZ00426 179 KVVDT----RTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDN 253 (340)
T ss_pred eecCC----CcceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCH
Confidence 75422 2345689999999999987666 567999999999999999999999998888899998888889999999
Q ss_pred hHHHHHHhccCCCCCCCC-----CHHHHHcCccccch
Q 013005 257 PARSLIYQLLDPNPKTRM-----SIEKIMSISWFQKS 288 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~Rp-----t~~eil~hp~f~~~ 288 (451)
.+.++|++||..||.+|+ |++++++||||...
T Consensus 254 ~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 254 NCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred HHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999999999995 89999999999864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=400.40 Aligned_cols=257 Identities=27% Similarity=0.495 Sum_probs=229.4
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
.....|.....||+|+.|.||.|+...+++.||||.++.... ...+.+.+|+.+|+.++ |+|||++++.|...+.
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q----~~keLilnEi~Vm~~~~-H~NiVnfl~Sylv~de 344 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ----PKKELLLNEILVMRDLH-HPNIVNFLDSYLVGDE 344 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC----CchhhhHHHHHHHHhcc-chHHHHHHHHhcccce
Confidence 445688889999999999999999999999999999987632 33567899999999996 9999999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 105 IYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
+|.||||++||+|.+.+....++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||++.......
T Consensus 345 LWVVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~- 423 (550)
T KOG0578|consen 345 LWVVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ- 423 (550)
T ss_pred eEEEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccccc-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998654422
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc---CCCCCCCCCHhHHHH
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR---DYQFPSFVSKPARSL 261 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~l 261 (451)
..-.+.+|||+|||||++....| +.+.||||||++++||+-|++||-..+.......|... .+..|..+|+.+++|
T Consensus 424 ~KR~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdF 502 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDF 502 (550)
T ss_pred CccccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHH
Confidence 23457799999999999999888 57799999999999999999999977766555555443 346677899999999
Q ss_pred HHhccCCCCCCCCCHHHHHcCccccch
Q 013005 262 IYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 262 i~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+.+||..||.+|+++.+||+||||+..
T Consensus 503 L~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 503 LDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred HHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 999999999999999999999999653
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=389.34 Aligned_cols=260 Identities=29% Similarity=0.549 Sum_probs=223.4
Q ss_pred CeEEcceEcccCceEEEEEEEc---CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSI---ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
+|++.+.||+|+||.||++++. .+++.||+|++.+..........+.+.+|+.+++.+.+||||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999864 4789999999976432223344567889999999997799999999999999999
Q ss_pred EEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 106 YLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
|+||||+.||+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 999999999999998864 6799999999999999999999999999999999999999999999999999875433222
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCC----cHHHHHHHhhccCCCCCCCCCHhHHH
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS----NLLAMYKKVNRRDYQFPSFVSKPARS 260 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~~ 260 (451)
......+||+.|+|||++.+....+.++|||||||++|+|++|..||... ........+......+|..+++.+.+
T Consensus 161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (332)
T cd05614 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD 240 (332)
T ss_pred CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 33345689999999999987655577899999999999999999999642 33445555666667778889999999
Q ss_pred HHHhccCCCCCCCC-----CHHHHHcCccccch
Q 013005 261 LIYQLLDPNPKTRM-----SIEKIMSISWFQKS 288 (451)
Q Consensus 261 li~~~L~~dP~~Rp-----t~~eil~hp~f~~~ 288 (451)
+|.+||..||++|| +++++++||||+..
T Consensus 241 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 99999999999999 89999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=402.60 Aligned_cols=265 Identities=41% Similarity=0.736 Sum_probs=246.9
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
.-+...+.|.+.++||+|.|++|.+|++..|+..||||++++.. .+......+.+|+.+|+.|. |||||++++++..
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~--ln~~~~~k~~rev~imk~l~-HPnIvkl~~v~~t 126 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQ--LNPSKRQKLGREVDIMKSLN-HPNIVKLFSVIET 126 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcc--cChHHHHHHHHHHHHHHhcC-Ccceeeeeeeeee
Confidence 44566789999999999999999999999999999999999873 33444455999999999995 9999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
...+|+||||+.+|++++++.+ +++.+..++.+|.|+.+|++|||+++|+|||||++|||||.+-++||+|||+|..+.
T Consensus 127 ~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 127 EATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred cceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999999999985 899999999999999999999999999999999999999999999999999999876
Q ss_pred hhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHH
Q 013005 181 QIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARS 260 (451)
Q Consensus 181 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 260 (451)
. ...+.+.||++.|.|||++.+..|+++.+|+||+|++||.|+.|.+||++.+...+......+.+.+|-.++.+..+
T Consensus 207 ~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~ 284 (596)
T KOG0586|consen 207 Y--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCED 284 (596)
T ss_pred c--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHH
Confidence 3 56788999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHcCccccchhHH
Q 013005 261 LIYQLLDPNPKTRMSIEKIMSISWFQKSLQQ 291 (451)
Q Consensus 261 li~~~L~~dP~~Rpt~~eil~hp~f~~~~~~ 291 (451)
+|+++|.+||.+|++++++++|+|.......
T Consensus 285 lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 285 LLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred HHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 9999999999999999999999998765544
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-49 Score=364.10 Aligned_cols=256 Identities=29% Similarity=0.500 Sum_probs=221.5
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
.+|...+.||+|.||.||+|++.+||+.||||.+...+. .........|||+.|+.++ ||||+.+.++|...+.+.|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~--kdGi~~talREIK~Lqel~-h~nIi~LiD~F~~~~~l~l 78 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA--KDGINRTALREIKLLQELK-HPNIIELIDVFPHKSNLSL 78 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc--ccCccHHHHHHHHHHHHcc-CcchhhhhhhccCCCceEE
Confidence 578899999999999999999999999999999987632 2334456789999999996 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 108 VMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
|+||++. +|...++. -.++..+++.|+.+++.||+|||++.|+||||||+|+|++.+|.+||+|||+|+.+.....
T Consensus 79 VfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~- 156 (318)
T KOG0659|consen 79 VFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR- 156 (318)
T ss_pred EEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc-
Confidence 9999975 89999985 4689999999999999999999999999999999999999999999999999998765333
Q ss_pred cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc-------------------
Q 013005 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR------------------- 246 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~------------------- 246 (451)
.....+-|.+|.|||++.+...++...||||.|||+.||+.|.+-|.+.+..+....|.+.
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 3333478999999999988877788899999999999999999999988877766655331
Q ss_pred CC-CCC--------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 247 DY-QFP--------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 247 ~~-~~p--------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.+ .+| +..+.++.+|+.+||.+||.+|+|+.|+++|+||...
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 00 011 1257788999999999999999999999999999863
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=386.21 Aligned_cols=249 Identities=34% Similarity=0.624 Sum_probs=222.0
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecCCC
Q 013005 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGG 115 (451)
Q Consensus 36 LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~gg 115 (451)
||+|+||.||+|.+..+++.||+|++.+. ..........+.+|+.+++++. ||||+++++++.+....|+||||+.||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~-~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKA-HIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFSFQSPEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHH-HhhhhhHHHHHHHHHHHHHhCC-CCcEeceeeEEecCCeEEEEEcCCCCC
Confidence 69999999999999999999999999754 2223344567789999999995 999999999999999999999999999
Q ss_pred chhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCCCC
Q 013005 116 ELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP 194 (451)
Q Consensus 116 ~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~gt~ 194 (451)
+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+||+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~ 157 (312)
T cd05585 79 ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTFCGTP 157 (312)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC-CCccccccCCc
Confidence 99999864 78999999999999999999999999999999999999999999999999998753221 12334568999
Q ss_pred ccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccCCCCCCCC
Q 013005 195 AYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRM 274 (451)
Q Consensus 195 ~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rp 274 (451)
.|+|||++.+..+ +.++||||+||++|+|++|..||...+....+..+......+|..+++.+.+||.+||..||.+||
T Consensus 158 ~y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 236 (312)
T cd05585 158 EYLAPELLLGHGY-TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRL 236 (312)
T ss_pred ccCCHHHHcCCCC-CCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcC
Confidence 9999999987766 566999999999999999999999988888888888888889999999999999999999999997
Q ss_pred ---CHHHHHcCccccch
Q 013005 275 ---SIEKIMSISWFQKS 288 (451)
Q Consensus 275 ---t~~eil~hp~f~~~ 288 (451)
++.+++.||||...
T Consensus 237 ~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 237 GYNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCCHHHHHcCCCcCCC
Confidence 58999999999874
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-48 Score=391.99 Aligned_cols=258 Identities=32% Similarity=0.540 Sum_probs=220.3
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|++.+.||+|+||+||+|.+..+++.||+|++.+. ..........+.+|+.++.++. ||||+++++.+.+....|+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~~~~~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKA-DMLEKEQVGHIRAERDILVEAD-SLWVVKMFYSFQDKLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHH-HHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCeEEE
Confidence 5799999999999999999999999999999999764 2223344567889999999995 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh---
Q 013005 108 VMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK--- 183 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~--- 183 (451)
||||++||+|.+++.+ +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 79 IMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 9999999999999874 789999999999999999999999999999999999999999999999999986432110
Q ss_pred -------------------------------cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCC
Q 013005 184 -------------------------------NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFD 232 (451)
Q Consensus 184 -------------------------------~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~ 232 (451)
.......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCC
Confidence 0112346899999999999887774 56999999999999999999999
Q ss_pred CCcHHHHHHHhhc--cCCCCCCC--CCHhHHHHHHhccCCCCC---CCCCHHHHHcCccccchh
Q 013005 233 DSNLLAMYKKVNR--RDYQFPSF--VSKPARSLIYQLLDPNPK---TRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 233 ~~~~~~~~~~i~~--~~~~~p~~--~s~~~~~li~~~L~~dP~---~Rpt~~eil~hp~f~~~~ 289 (451)
+.+....+.++.. ....+|+. +++++.+||.+|+. +|. .||++++|++||||+...
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~ 300 (363)
T cd05628 238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVD 300 (363)
T ss_pred CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCC
Confidence 9888888877765 33455553 68999999999765 444 568999999999998753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=393.77 Aligned_cols=265 Identities=31% Similarity=0.521 Sum_probs=229.1
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
......++|++.+.||+|+||.||+|.+..+++.||+|++.+.. .........+.+|+.+++.+. ||||+++++++.+
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~il~~~~-h~~iv~~~~~~~~ 114 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFE-MIKRSDSAFFWEERDIMAHAN-SEWIVQLHYAFQD 114 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH-hhhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEec
Confidence 34456789999999999999999999999999999999997642 222334456788999999995 9999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 102 KTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
....|+||||++||+|.+++....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 115 DKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999999875433
Q ss_pred hhcCcccccCCCCccccceeeeccC---CCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC--CCCCC--CC
Q 013005 182 IKNGMLHTACGTPAYTAPEVVARRG---YDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD--YQFPS--FV 254 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~~~---~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~ 254 (451)
.......+.+||+.|+|||++.+.. +.+.++|||||||++|+|++|..||...+....+.++.... ..+|. .+
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 274 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEI 274 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCC
Confidence 2222234568999999999986543 35678999999999999999999999988888888876533 45555 47
Q ss_pred CHhHHHHHHhccCCCCCC--CCCHHHHHcCccccch
Q 013005 255 SKPARSLIYQLLDPNPKT--RMSIEKIMSISWFQKS 288 (451)
Q Consensus 255 s~~~~~li~~~L~~dP~~--Rpt~~eil~hp~f~~~ 288 (451)
|..+.+||++||..+|.+ |+|++++++||||+..
T Consensus 275 s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 275 SKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred CHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 999999999999999998 9999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=385.34 Aligned_cols=253 Identities=30% Similarity=0.571 Sum_probs=223.1
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecC
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAA 113 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ 113 (451)
+.||+|+||.||+|.+..+++.||+|++.+.. .......+.+.+|+.++..+.+||||+++++++.+.+.+|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDV-ILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHH-HhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence 46999999999999999999999999997642 22233445677888888887679999999999999999999999999
Q ss_pred CCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCC
Q 013005 114 GGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACG 192 (451)
Q Consensus 114 gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~g 192 (451)
||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 80 ~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~-~~~~~~~~~g 158 (320)
T cd05590 80 GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF-NGKTTSTFCG 158 (320)
T ss_pred CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc-CCCccccccc
Confidence 9999998864 6899999999999999999999999999999999999999999999999999864221 1223345689
Q ss_pred CCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccCCCCCC
Q 013005 193 TPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKT 272 (451)
Q Consensus 193 t~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 272 (451)
|+.|+|||++.+..+ +.++||||+||++|+|++|+.||...+....+..+......+|.+++..+.+||.+||..||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 159 TPDYIAPEILQEMLY-GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred CccccCHHHHcCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence 999999999987666 5669999999999999999999999998888998888888889999999999999999999999
Q ss_pred CCCH------HHHHcCccccchh
Q 013005 273 RMSI------EKIMSISWFQKSL 289 (451)
Q Consensus 273 Rpt~------~eil~hp~f~~~~ 289 (451)
||++ +++++||||....
T Consensus 238 R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 238 RLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred CCCCCCCCCHHHHHcCCCcCCCC
Confidence 9998 9999999998643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=385.40 Aligned_cols=257 Identities=30% Similarity=0.553 Sum_probs=226.9
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
+|++.+.||+|+||.||+|.+..+++.||+|++.+.. .......+.+..|+.++..+.+|++|+++++++...+..|+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV-IIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence 5899999999999999999999999999999997642 223344566788999999997566799999999999999999
Q ss_pred EEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcc
Q 013005 109 MEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML 187 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~ 187 (451)
|||++||+|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~-~~~~~ 158 (324)
T cd05587 80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF-GGKTT 158 (324)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC-CCCce
Confidence 999999999998864 6799999999999999999999999999999999999999999999999999863211 12233
Q ss_pred cccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccC
Q 013005 188 HTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLD 267 (451)
Q Consensus 188 ~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 267 (451)
...+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...+....+..+......+|..+++.+.+++.+||.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred eeecCCccccChhhhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 45689999999999987766 56699999999999999999999999888888888888888899999999999999999
Q ss_pred CCCCCCCCH-----HHHHcCccccch
Q 013005 268 PNPKTRMSI-----EKIMSISWFQKS 288 (451)
Q Consensus 268 ~dP~~Rpt~-----~eil~hp~f~~~ 288 (451)
.||.+|++. +++++||||...
T Consensus 238 ~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 238 KHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred cCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999986 899999999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=386.07 Aligned_cols=251 Identities=34% Similarity=0.606 Sum_probs=222.6
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecC
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAA 113 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ 113 (451)
+.||+|+||.||++.+..+++.||+|++.+. ..........+.+|+.+++.+. ||||+++++++...+..|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~-~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKE-VIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQTKDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHH-HhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCEEEEEEeCCC
Confidence 4699999999999999999999999999764 2223344567888999999995 9999999999999999999999999
Q ss_pred CCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCC
Q 013005 114 GGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACG 192 (451)
Q Consensus 114 gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~g 192 (451)
+|+|...+.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .......+|
T Consensus 79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~g 157 (328)
T cd05593 79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFCG 157 (328)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccccccC
Confidence 9999988865 67999999999999999999999999999999999999999999999999998643221 123345689
Q ss_pred CCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccCCCCCC
Q 013005 193 TPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKT 272 (451)
Q Consensus 193 t~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 272 (451)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|..+++.+.+||.+||..||.+
T Consensus 158 t~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 236 (328)
T cd05593 158 TPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNK 236 (328)
T ss_pred CcCccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHH
Confidence 999999999987766 5679999999999999999999998888888888887888899999999999999999999999
Q ss_pred CC-----CHHHHHcCccccch
Q 013005 273 RM-----SIEKIMSISWFQKS 288 (451)
Q Consensus 273 Rp-----t~~eil~hp~f~~~ 288 (451)
|+ ++.++++||||...
T Consensus 237 R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 237 RLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred cCCCCCCCHHHHhcCCCcCCC
Confidence 97 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=385.20 Aligned_cols=252 Identities=31% Similarity=0.571 Sum_probs=223.1
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecC
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAA 113 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ 113 (451)
+.||+|+||.||+|.+..+++.||+|++.+. ........+.+..|..++..+.+||||+++++++.+...+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKD-VILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHH-HhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence 4699999999999999999999999999764 222334445677888888887679999999999999999999999999
Q ss_pred CCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCC
Q 013005 114 GGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACG 192 (451)
Q Consensus 114 gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~g 192 (451)
||+|...+.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~-~~~~~~~~~g 158 (321)
T cd05591 80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL-NGVTTTTFCG 158 (321)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc-CCcccccccc
Confidence 9999988864 6799999999999999999999999999999999999999999999999999864322 1223345679
Q ss_pred CCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccCCCCCC
Q 013005 193 TPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKT 272 (451)
Q Consensus 193 t~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 272 (451)
|+.|+|||++.+..+ +.++||||+||++|+|++|+.||...+....+..+......+|.+++.++.++|.+||..||++
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 159 TPDYIAPEILQELEY-GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred CccccCHHHHcCCCC-CCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 999999999987766 5669999999999999999999999998899999988888899999999999999999999999
Q ss_pred CC-------CHHHHHcCccccch
Q 013005 273 RM-------SIEKIMSISWFQKS 288 (451)
Q Consensus 273 Rp-------t~~eil~hp~f~~~ 288 (451)
|| +++++++||||...
T Consensus 238 R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 238 RLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred cCCCCCCCCCHHHHhcCCccCCC
Confidence 99 99999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-48 Score=392.32 Aligned_cols=265 Identities=32% Similarity=0.532 Sum_probs=227.0
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
......++|++.+.||+|+||.||++.+..+++.||+|++.+.. .........+.+|+.+++.+. ||||+++++++.+
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~ 114 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFE-MIKRSDSAFFWEERDIMAFAN-SPWVVQLFCAFQD 114 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH-hhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEc
Confidence 34455789999999999999999999999999999999997642 222334456788999999995 9999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 102 KTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
....|+||||++||+|.+++....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999999975433
Q ss_pred hhcCcccccCCCCccccceeeeccC---CCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc--CCCCCC--CC
Q 013005 182 IKNGMLHTACGTPAYTAPEVVARRG---YDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR--DYQFPS--FV 254 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~~~---~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~ 254 (451)
.......+.+||+.|+|||++.+.+ +.+.++||||+||++|+|++|..||...+....+.++... ...+|. .+
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 274 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEI 274 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccC
Confidence 2222334678999999999987643 3467799999999999999999999998888777777653 345555 46
Q ss_pred CHhHHHHHHhccCCCCCC--CCCHHHHHcCccccch
Q 013005 255 SKPARSLIYQLLDPNPKT--RMSIEKIMSISWFQKS 288 (451)
Q Consensus 255 s~~~~~li~~~L~~dP~~--Rpt~~eil~hp~f~~~ 288 (451)
+..++++|.+||..+|.+ |+|++++++||||+..
T Consensus 275 s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 275 SKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred CHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 999999999999866654 8999999999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-48 Score=384.20 Aligned_cols=256 Identities=30% Similarity=0.556 Sum_probs=224.6
Q ss_pred eEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhc--CCCCceEEEEEEEeCCEEEE
Q 013005 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ--NHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 30 y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~--~HpnIv~l~~~~~~~~~~~l 107 (451)
|++.+.||+|+||.||+|.+..+++.||||++.+.. .......+.+.+|+.++..+. +||||+++++++.+....|+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGD-IIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence 678999999999999999999999999999997642 222334556777776654332 49999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcc
Q 013005 108 VMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML 187 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~ 187 (451)
||||+.||+|...+..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 80 v~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~ 158 (324)
T cd05589 80 VMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-GDRT 158 (324)
T ss_pred EEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-CCcc
Confidence 999999999999998889999999999999999999999999999999999999999999999999998643221 1233
Q ss_pred cccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccC
Q 013005 188 HTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLD 267 (451)
Q Consensus 188 ~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 267 (451)
...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|..++..+.++|.+||.
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~ 237 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLR 237 (324)
T ss_pred cccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhh
Confidence 45689999999999987766 56699999999999999999999998888888888888888898999999999999999
Q ss_pred CCCCCCC-----CHHHHHcCccccch
Q 013005 268 PNPKTRM-----SIEKIMSISWFQKS 288 (451)
Q Consensus 268 ~dP~~Rp-----t~~eil~hp~f~~~ 288 (451)
.||.+|| ++.++++||||+..
T Consensus 238 ~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 238 RNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred cCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 9999999 79999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-48 Score=384.24 Aligned_cols=252 Identities=35% Similarity=0.612 Sum_probs=222.5
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecC
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAA 113 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ 113 (451)
+.||+|+||.||++.+..+|..||+|++.+.. .........+.+|+.+++.+. ||||+++++.+...+..|+||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEV-IIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH-hhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCEEEEEEeCCC
Confidence 46999999999999999999999999997642 223344556778999999995 9999999999999999999999999
Q ss_pred CCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCC
Q 013005 114 GGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACG 192 (451)
Q Consensus 114 gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~g 192 (451)
||+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~-~~~~~~~~~g 157 (323)
T cd05595 79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFCG 157 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC-CCCccccccC
Confidence 9999988865 6799999999999999999999999999999999999999999999999999864211 1122345679
Q ss_pred CCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccCCCCCC
Q 013005 193 TPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKT 272 (451)
Q Consensus 193 t~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 272 (451)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|..+++.+.+||.+||..||.+
T Consensus 158 t~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 236 (323)
T cd05595 158 TPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQ 236 (323)
T ss_pred CcCcCCcccccCCCC-CchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 999999999987766 5679999999999999999999999888888888888888889999999999999999999999
Q ss_pred CC-----CHHHHHcCccccchh
Q 013005 273 RM-----SIEKIMSISWFQKSL 289 (451)
Q Consensus 273 Rp-----t~~eil~hp~f~~~~ 289 (451)
|+ ++.++++||||....
T Consensus 237 R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 237 RLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred hCCCCCCCHHHHHcCCCcCCCC
Confidence 98 899999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=374.77 Aligned_cols=257 Identities=25% Similarity=0.412 Sum_probs=218.8
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
.|++.+.||+|+||+||+|.+..+++.||+|.+.+.. .........+.+|+.+++++. |+||+++++++.+.+..|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR-IKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhh-hhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEccCCeEEEE
Confidence 3788999999999999999999999999999997652 222233456788999999995 99999999999999999999
Q ss_pred EEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 109 MEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
|||+.+|+|.+.+.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++..... ..
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~--~~ 156 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE--GE 156 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC--CC
Confidence 999999999887753 3689999999999999999999999999999999999999999999999999875422 12
Q ss_pred cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcH----HHHHHHhhccCCCCCCCCCHhHHHH
Q 013005 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNL----LAMYKKVNRRDYQFPSFVSKPARSL 261 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~l 261 (451)
.....+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...+. ......+......++..++..+.+|
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 235 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKY-TFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSI 235 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCC-CcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHH
Confidence 2345679999999999987766 4669999999999999999999987543 2333344445556777899999999
Q ss_pred HHhccCCCCCCCCC-----HHHHHcCccccchhH
Q 013005 262 IYQLLDPNPKTRMS-----IEKIMSISWFQKSLQ 290 (451)
Q Consensus 262 i~~~L~~dP~~Rpt-----~~eil~hp~f~~~~~ 290 (451)
|++||..||.+||+ ++++++||||.....
T Consensus 236 i~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 236 CRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred HHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 99999999999997 999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-48 Score=384.12 Aligned_cols=254 Identities=30% Similarity=0.530 Sum_probs=221.6
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|++.+.||+|+||.||+|++..+++.||+|++.+.. .........+.+|+.+++.+. ||||+++++++......|+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSL-LFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHH-HhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCCEEEE
Confidence 47999999999999999999999999999999997642 222334567889999999996 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCc
Q 013005 108 VMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM 186 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~ 186 (451)
||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 79 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~ 154 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----Y 154 (333)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----c
Confidence 9999999999999975 6799999999999999999999999999999999999999999999999999875432 3
Q ss_pred ccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC--CCCCC------CCCHhH
Q 013005 187 LHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD--YQFPS------FVSKPA 258 (451)
Q Consensus 187 ~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~------~~s~~~ 258 (451)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+.... ...|. .++.++
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~ 233 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEA 233 (333)
T ss_pred cCCcccCccccChhHhcCCCC-CCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHH
Confidence 346689999999999987766 566999999999999999999999888777766654322 22222 358999
Q ss_pred HHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 259 RSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 259 ~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.+||.+||..+|.+|||++++++||||...
T Consensus 234 ~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 234 WDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-48 Score=375.97 Aligned_cols=254 Identities=28% Similarity=0.489 Sum_probs=212.3
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.+. ||||+++++++...+..|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 77 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE--NEEVKETTLRELKMLRTLK-QENIVELKEAFRRRGKLYL 77 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc--cccchhhHHHHHHHHHhCC-CccccchhhhEecCCEEEE
Confidence 579999999999999999999999999999999976421 2234567789999999995 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCc
Q 013005 108 VMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM 186 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~ 186 (451)
||||+.++.+..+... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 9999999877665543 579999999999999999999999999999999999999999999999999997653322233
Q ss_pred ccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc-------------------C
Q 013005 187 LHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR-------------------D 247 (451)
Q Consensus 187 ~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~-------------------~ 247 (451)
....+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...+.......+... .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred ccccccccccCCcHHHcCCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 345679999999999987776 56799999999999999999999876544332221110 0
Q ss_pred CCC-------------CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 248 YQF-------------PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 248 ~~~-------------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
..+ ...+|..+.+||++||..||++|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 011 12367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-48 Score=389.07 Aligned_cols=257 Identities=32% Similarity=0.580 Sum_probs=220.6
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|++.+.||+|+||+||+|++..+++.||||++.+.. .........+.+|+.+++.+. ||||+++++++.+...+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSE-MLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQDENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCeEEE
Confidence 47999999999999999999999999999999997642 223344567889999999995 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc--
Q 013005 108 VMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN-- 184 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~-- 184 (451)
||||+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++........
T Consensus 79 v~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred EECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999999999999875 6799999999999999999999999999999999999999999999999999864321100
Q ss_pred -----------------------------------CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCC
Q 013005 185 -----------------------------------GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYL 229 (451)
Q Consensus 185 -----------------------------------~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~ 229 (451)
....+.+||+.|+|||++.+.++ +.++|||||||++|+|++|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC-CCeeeeecchhHHHHhhcCCC
Confidence 01124579999999999987776 567999999999999999999
Q ss_pred CCCCCcHHHHHHHhhcc--CCCCCC--CCCHhHHHHHHhccCCCCCCCCC---HHHHHcCccccch
Q 013005 230 PFDDSNLLAMYKKVNRR--DYQFPS--FVSKPARSLIYQLLDPNPKTRMS---IEKIMSISWFQKS 288 (451)
Q Consensus 230 Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~~Rpt---~~eil~hp~f~~~ 288 (451)
||...+....+..+... ...+|. .+++.+.+||.+||. +|.+|++ ++++++||||+..
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 99988877776666543 234444 368999999999997 9999998 9999999999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=382.04 Aligned_cols=258 Identities=29% Similarity=0.535 Sum_probs=227.4
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
+|.+.+.||+|+||.||+|.+..+++.||+|++.+.. .......+.+..|..++..+.+||+|+++++++.+.+..|+|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV-VIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence 5889999999999999999999999999999998652 222334455677888888887799999999999999999999
Q ss_pred EEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcc
Q 013005 109 MEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML 187 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~ 187 (451)
|||++||+|.+.+.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~-~~~~~ 158 (323)
T cd05616 80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW-DGVTT 158 (323)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC-CCCcc
Confidence 999999999998864 7899999999999999999999999999999999999999999999999999864321 11233
Q ss_pred cccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccC
Q 013005 188 HTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLD 267 (451)
Q Consensus 188 ~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 267 (451)
...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+......+|..++.++.+++.+||.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred ccCCCChhhcCHHHhcCCCC-CCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcc
Confidence 45689999999999987776 56699999999999999999999999988888988888888899999999999999999
Q ss_pred CCCCCCCC-----HHHHHcCccccchh
Q 013005 268 PNPKTRMS-----IEKIMSISWFQKSL 289 (451)
Q Consensus 268 ~dP~~Rpt-----~~eil~hp~f~~~~ 289 (451)
.||.+|++ ..++++||||+...
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 238 KHPGKRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred cCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence 99999998 48999999998643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-48 Score=381.76 Aligned_cols=253 Identities=28% Similarity=0.536 Sum_probs=220.5
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecC
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAA 113 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ 113 (451)
+.||+|+||.||+|.+..+|+.||+|++.+... ...........|..++..+.+||||+++++++.+.+..|+||||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVV-LIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence 469999999999999999999999999976421 1122344567788888776579999999999999999999999999
Q ss_pred CCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCC
Q 013005 114 GGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACG 192 (451)
Q Consensus 114 gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~g 192 (451)
||+|...+.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..... ........+|
T Consensus 80 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~g 158 (316)
T cd05620 80 GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF-GDNRASTFCG 158 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc-CCCceeccCC
Confidence 9999988875 6899999999999999999999999999999999999999999999999999863211 1223446789
Q ss_pred CCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccCCCCCC
Q 013005 193 TPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKT 272 (451)
Q Consensus 193 t~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 272 (451)
|+.|+|||++.+..+ +.++||||+||++|+|++|..||...+.......+......+|.+++.++.+||.+||..||++
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 159 TPDYIAPEILQGLKY-TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred CcCccCHHHHcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 999999999987766 5669999999999999999999999888888888887788889999999999999999999999
Q ss_pred CCCH-HHHHcCccccchh
Q 013005 273 RMSI-EKIMSISWFQKSL 289 (451)
Q Consensus 273 Rpt~-~eil~hp~f~~~~ 289 (451)
||++ +++++||||....
T Consensus 238 R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 238 RLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred cCCChHHHHcCCCcCCCC
Confidence 9998 5899999998743
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=379.66 Aligned_cols=253 Identities=31% Similarity=0.580 Sum_probs=219.7
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecC
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAA 113 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ 113 (451)
+.||+|+||+||+|.+..+++.||+|++.+.. .......+.+..|..++..+.+||||+++++++......|+||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDV-VLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH-hhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 46999999999999999999999999997642 22223344556677777766579999999999999999999999999
Q ss_pred CCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCC
Q 013005 114 GGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACG 192 (451)
Q Consensus 114 gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~g 192 (451)
||+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+|
T Consensus 80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~-~~~~~~~~g 158 (316)
T cd05592 80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG-EGKASTFCG 158 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC-CCccccccC
Confidence 9999998864 78999999999999999999999999999999999999999999999999998643221 133345689
Q ss_pred CCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccCCCCCC
Q 013005 193 TPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKT 272 (451)
Q Consensus 193 t~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 272 (451)
|+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+......+|.+++..+.+||.+||..||++
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 159 TPDYIAPEILKGQKY-NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred CccccCHHHHcCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 999999999987766 5669999999999999999999999888888888887777888899999999999999999999
Q ss_pred CCCH-HHHHcCccccchh
Q 013005 273 RMSI-EKIMSISWFQKSL 289 (451)
Q Consensus 273 Rpt~-~eil~hp~f~~~~ 289 (451)
||++ ++++.||||....
T Consensus 238 R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 238 RLGVDGDIRQHPFFRGID 255 (316)
T ss_pred cCCChHHHHcCcccCCCC
Confidence 9986 5899999998643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=382.34 Aligned_cols=259 Identities=34% Similarity=0.550 Sum_probs=221.7
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|.+.+.||+|+||+||+|.+..+++.||+|++.+.. .........+.+|+.+++.+. ||||+++++++.+....|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~i~~~~~-~~~i~~~~~~~~~~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSV-LLAQETVSFFEEERDILSISN-SPWIPQLQYAFQDKDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCeEEE
Confidence 47999999999999999999999999999999997642 223345567889999999985 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 108 VMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
||||++||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 9999999999999975 67999999999999999999999999999999999999999999999999999754432222
Q ss_pred cccccCCCCccccceeeec-----cCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC--CCCCC--CCCH
Q 013005 186 MLHTACGTPAYTAPEVVAR-----RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD--YQFPS--FVSK 256 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~-----~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~ 256 (451)
.....+||+.|+|||++.. ....+.++|||||||++|+|++|..||...+....+.++.... ..+|. .++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS 238 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCH
Confidence 2344579999999999863 2334567999999999999999999999888777777665432 33343 5789
Q ss_pred hHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 257 PARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
.+.+||.+||. ||.+|||++++++||||....
T Consensus 239 ~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~ 270 (330)
T cd05601 239 DFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID 270 (330)
T ss_pred HHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence 99999999998 999999999999999998643
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=388.68 Aligned_cols=258 Identities=31% Similarity=0.493 Sum_probs=217.6
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
.|++++.||+|+||+||+|++..+++.||+|++.+. ..........+.+|+.+++.+. ||||+++++++.+.+.+|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~-~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKK-DVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHH-HhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEecCCEEEEE
Confidence 689999999999999999999999999999999765 2233445567899999999995 99999999999999999999
Q ss_pred EEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh----
Q 013005 109 MEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK---- 183 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~---- 183 (451)
|||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 999999999999875 679999999999999999999999999999999999999999999999999975321000
Q ss_pred ------------------------------------------cCcccccCCCCccccceeeeccCCCCccchhhhhhHHH
Q 013005 184 ------------------------------------------NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVIL 221 (451)
Q Consensus 184 ------------------------------------------~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil 221 (451)
.....+.+||+.|+|||++.+..+ +.++||||+||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlG~il 238 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY-TQLCDWWSVGVIL 238 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCC-CCccceeehhhHH
Confidence 001134579999999999988776 4669999999999
Q ss_pred HHHHhcCCCCCCCcHHHHHHHhhc--cCCCCCC--CCCHhHHHHHHhcc--CCCCCCCCCHHHHHcCccccchh
Q 013005 222 FVLLAGYLPFDDSNLLAMYKKVNR--RDYQFPS--FVSKPARSLIYQLL--DPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 222 ~~Ll~G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L--~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
|+|++|..||...+.......+.. ....+|. .+++++.+||.+|+ ..+|..|+++++++.||||....
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~ 312 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD 312 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence 999999999988776655555542 2344444 47899999999955 55666699999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=382.32 Aligned_cols=252 Identities=31% Similarity=0.566 Sum_probs=217.8
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecC
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAA 113 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ 113 (451)
+.||+|+||.||+|.+..+++.||+|++.+. ..........+.+|+.+++.+.+||||+++++++.+....|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~-~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKE-LVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHH-HhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 4699999999999999999999999999864 222334456688999999999779999999999999999999999999
Q ss_pred CCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCC
Q 013005 114 GGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACG 192 (451)
Q Consensus 114 gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~g 192 (451)
||+|..++.+ +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ......+.+|
T Consensus 80 ~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-~~~~~~~~~g 158 (329)
T cd05588 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR-PGDTTSTFCG 158 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc-CCCccccccC
Confidence 9999988864 7899999999999999999999999999999999999999999999999999863211 1223345689
Q ss_pred CCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCC---------cHHHHHHHhhccCCCCCCCCCHhHHHHHH
Q 013005 193 TPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS---------NLLAMYKKVNRRDYQFPSFVSKPARSLIY 263 (451)
Q Consensus 193 t~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~---------~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 263 (451)
|+.|+|||++.+..+ +.++||||+||++|+|++|..||... .....++.+......+|..++..+.++|.
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 237 (329)
T cd05588 159 TPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237 (329)
T ss_pred CccccCHHHHcCCCC-CCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999987766 46699999999999999999999631 22335566677778889999999999999
Q ss_pred hccCCCCCCCCC------HHHHHcCccccch
Q 013005 264 QLLDPNPKTRMS------IEKIMSISWFQKS 288 (451)
Q Consensus 264 ~~L~~dP~~Rpt------~~eil~hp~f~~~ 288 (451)
+||..||.+|+| ++++++||||...
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred HHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 999999999997 8999999999763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=385.37 Aligned_cols=257 Identities=34% Similarity=0.606 Sum_probs=224.3
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|++.+.||+|+||+||+|++..+++.||||++.+.. .........+.+|+.++..+. ||||+++++++.+.+..|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSD-MIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQDEEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHH-HhhccHHHHHHHHHHHHHhcC-CCCccchhhheecCCeEEE
Confidence 57999999999999999999999999999999997642 222244567889999999995 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh---
Q 013005 108 VMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK--- 183 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~--- 183 (451)
||||+.|++|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 9999999999999875 689999999999999999999999999999999999999999999999999987543322
Q ss_pred -------------------------cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHH
Q 013005 184 -------------------------NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLA 238 (451)
Q Consensus 184 -------------------------~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~ 238 (451)
........||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCC-CCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 112345679999999999987766 567999999999999999999999988777
Q ss_pred HHHHhhc--cCCCCCCC--CCHhHHHHHHhccCCCCCCCCC-HHHHHcCccccch
Q 013005 239 MYKKVNR--RDYQFPSF--VSKPARSLIYQLLDPNPKTRMS-IEKIMSISWFQKS 288 (451)
Q Consensus 239 ~~~~i~~--~~~~~p~~--~s~~~~~li~~~L~~dP~~Rpt-~~eil~hp~f~~~ 288 (451)
.+.++.. ....+|.. +++.+.+||.+||. ||.+||+ ++++++||||+..
T Consensus 238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 7777765 44455544 59999999999997 9999999 9999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=389.00 Aligned_cols=257 Identities=32% Similarity=0.559 Sum_probs=218.3
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|++.+.||+|+||+||+|.+..+++.||||++.+.. .........+.+|+.+++++. ||||+++++++.+....|+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSE-MFKKDQLAHVKAERDVLAESD-SPWVVSLYYSFQDAQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH-HHHhHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCeeEE
Confidence 47999999999999999999999999999999997642 223344567889999999995 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc--
Q 013005 108 VMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN-- 184 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~-- 184 (451)
||||+.||+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9999999999999875 6799999999999999999999999999999999999999999999999999853211000
Q ss_pred --------------------------------------------CcccccCCCCccccceeeeccCCCCccchhhhhhHH
Q 013005 185 --------------------------------------------GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVI 220 (451)
Q Consensus 185 --------------------------------------------~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvi 220 (451)
......+||+.|+|||++.+..+ +.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvi 237 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAI 237 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC-CCceeeEecchh
Confidence 00113579999999999987776 567999999999
Q ss_pred HHHHHhcCCCCCCCcHHHHHHHhhc--cCCCCCC--CCCHhHHHHHHhccCCCCCCC---CCHHHHHcCccccch
Q 013005 221 LFVLLAGYLPFDDSNLLAMYKKVNR--RDYQFPS--FVSKPARSLIYQLLDPNPKTR---MSIEKIMSISWFQKS 288 (451)
Q Consensus 221 l~~Ll~G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~dP~~R---pt~~eil~hp~f~~~ 288 (451)
+|+|++|..||...+....+..+.. ....+|. .++.++.+||.+||. +|.+| +|+.+++.||||+..
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9999999999998877777766654 2344554 478999999999998 67665 599999999999853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=374.14 Aligned_cols=253 Identities=29% Similarity=0.480 Sum_probs=211.5
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
+++|++.+.||+|+||.||+|++..++..||+|++..... ......+.+|+.+++++. ||||+++++++.+....|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 79 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKNLK-HANIVTLHDIIHTERCLT 79 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc---CCcchhHHHHHHHHHhCC-CCCEeeEEEEEcCCCeEE
Confidence 5789999999999999999999999999999999975421 122345678999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 107 LVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
+||||+.+ +|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 80 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~-~ 157 (288)
T cd07871 80 LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP-T 157 (288)
T ss_pred EEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC-C
Confidence 99999986 88888864 35899999999999999999999999999999999999999999999999998643221 2
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc------------------
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR------------------ 246 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~------------------ 246 (451)
.......||+.|+|||++.+....+.++||||+||++|+|++|+.||...+..+....+...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 23345678999999999876555567799999999999999999999887665544333210
Q ss_pred -CCCCC-----------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 247 -DYQFP-----------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 247 -~~~~p-----------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
...+| +.++.++.+||++||..||.+|||++|+++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 00111 2357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=382.24 Aligned_cols=252 Identities=35% Similarity=0.609 Sum_probs=221.9
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecC
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAA 113 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ 113 (451)
+.||+|+||+||++.+..+++.||+|++.+.. .........+.+|+.+++.+. ||||+++++++......|+||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEV-IVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEEcCCEEEEEEeCCC
Confidence 46999999999999999999999999997642 223334556778999999995 9999999999999999999999999
Q ss_pred CCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccC
Q 013005 114 GGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQ-NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTAC 191 (451)
Q Consensus 114 gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~-~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~ 191 (451)
||+|..++.. +.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++...... .......+
T Consensus 79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 157 (325)
T cd05594 79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTFC 157 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Cccccccc
Confidence 9999998865 679999999999999999999997 79999999999999999999999999998642211 12334567
Q ss_pred CCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccCCCCC
Q 013005 192 GTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPK 271 (451)
Q Consensus 192 gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~ 271 (451)
||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|..+++.+.+||.+||..||+
T Consensus 158 gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~ 236 (325)
T cd05594 158 GTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPK 236 (325)
T ss_pred CCcccCCHHHHccCCC-CCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHH
Confidence 9999999999977766 567999999999999999999999988888888888888888999999999999999999999
Q ss_pred CCC-----CHHHHHcCccccchh
Q 013005 272 TRM-----SIEKIMSISWFQKSL 289 (451)
Q Consensus 272 ~Rp-----t~~eil~hp~f~~~~ 289 (451)
+|+ ++.++++||||....
T Consensus 237 ~R~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 237 QRLGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred HhCCCCCCCHHHHhcCCCcCCCC
Confidence 997 999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=379.59 Aligned_cols=253 Identities=32% Similarity=0.610 Sum_probs=221.7
Q ss_pred cceEcccCceEEEEEEEc---CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEE
Q 013005 33 GPLLGRGSFAKVHKAKSI---ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVM 109 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~ 109 (451)
.+.||+|+||.||++.+. .+++.||+|++.+............+.+|+.+++.+. ||||+++++++..++..|+||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEecCCeEEEEE
Confidence 367999999999999864 4788999999976422223334456789999999995 999999999999999999999
Q ss_pred EecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCccc
Q 013005 110 EYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLH 188 (451)
Q Consensus 110 E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~ 188 (451)
||+.|++|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~ 158 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH-EGTVTH 158 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc-CCCccc
Confidence 99999999999875 6789999999999999999999999999999999999999999999999999863221 122334
Q ss_pred ccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccCC
Q 013005 189 TACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDP 268 (451)
Q Consensus 189 ~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 268 (451)
..+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|+.+++.+.+||.+||..
T Consensus 159 ~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 237 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKR 237 (323)
T ss_pred ccCCCccccChhhccCCCC-CCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccc
Confidence 5689999999999987666 567999999999999999999999988888888888888888999999999999999999
Q ss_pred CCCCCC-----CHHHHHcCccccch
Q 013005 269 NPKTRM-----SIEKIMSISWFQKS 288 (451)
Q Consensus 269 dP~~Rp-----t~~eil~hp~f~~~ 288 (451)
||++|| +++++++||||...
T Consensus 238 ~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 238 NPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred CHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999 89999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=378.21 Aligned_cols=253 Identities=32% Similarity=0.607 Sum_probs=223.3
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecC
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAA 113 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ 113 (451)
+.||+|+||+||+|.+..+++.||+|++.+.. .........+.+|+.+++.+.+||||+++++++.+...+|+||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDV-ILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH-HhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 47999999999999999999999999997642 22333455677888899888679999999999999999999999999
Q ss_pred CCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCC
Q 013005 114 GGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACG 192 (451)
Q Consensus 114 gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~g 192 (451)
||+|...+.+ +.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~g 158 (318)
T cd05570 80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL-GGVTTSTFCG 158 (318)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc-CCCcccceec
Confidence 9999998875 5899999999999999999999999999999999999999999999999999864211 1122345679
Q ss_pred CCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccCCCCCC
Q 013005 193 TPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKT 272 (451)
Q Consensus 193 t~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 272 (451)
|+.|+|||++.+..+ +.++||||+||++|+|++|..||...+....+..+......+|..++..+.+||.+||..||.+
T Consensus 159 ~~~y~aPE~~~~~~~-~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 159 TPDYIAPEILSYQPY-GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred CccccCHHHhcCCCC-CcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 999999999987766 4669999999999999999999999888888888888888888899999999999999999999
Q ss_pred CCCH-----HHHHcCccccchh
Q 013005 273 RMSI-----EKIMSISWFQKSL 289 (451)
Q Consensus 273 Rpt~-----~eil~hp~f~~~~ 289 (451)
|||+ .++++||||+...
T Consensus 238 R~s~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 238 RLGCLPTGEQDIKGHPFFREID 259 (318)
T ss_pred cCCCCCCCHHHHhcCCCcCCCC
Confidence 9999 9999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=387.25 Aligned_cols=257 Identities=32% Similarity=0.553 Sum_probs=218.3
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
.+|++++.||+|+||+||+|++..+++.||+|++.+. ..........+.+|+.+++++. ||||+++++.+.+....|+
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~-~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~~~~~~~~~l 78 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKK-DVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYF 78 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHH-HhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEEEEeCCEEEE
Confidence 3689999999999999999999999999999999764 2223345567889999999995 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh----
Q 013005 108 VMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI---- 182 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~---- 182 (451)
||||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 79 VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 9999999999999875 67999999999999999999999999999999999999999999999999997532100
Q ss_pred ------------------------------------------hcCcccccCCCCccccceeeeccCCCCccchhhhhhHH
Q 013005 183 ------------------------------------------KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVI 220 (451)
Q Consensus 183 ------------------------------------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvi 220 (451)
......+.+||+.|+|||++.+.+|. .++||||+||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvi 237 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVI 237 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHH
Confidence 00011245799999999999888775 66999999999
Q ss_pred HHHHHhcCCCCCCCcHHHHHHHhhc--cCCCCC--CCCCHhHHHHHHhccCCCCCCCCC---HHHHHcCccccch
Q 013005 221 LFVLLAGYLPFDDSNLLAMYKKVNR--RDYQFP--SFVSKPARSLIYQLLDPNPKTRMS---IEKIMSISWFQKS 288 (451)
Q Consensus 221 l~~Ll~G~~Pf~~~~~~~~~~~i~~--~~~~~p--~~~s~~~~~li~~~L~~dP~~Rpt---~~eil~hp~f~~~ 288 (451)
+|+|++|+.||...+......++.. ....+| ..+++++.++|.+|+ .||.+|++ ++++++||||+..
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 9999999999998877666655543 223344 357999999999976 59999997 9999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-47 Score=378.15 Aligned_cols=252 Identities=30% Similarity=0.571 Sum_probs=217.2
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecC
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAA 113 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ 113 (451)
+.||+|+||+||+|.+..+++.||+|++.+. ..........+.+|+.++.++.+||||+++++++...+..|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKE-LVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhh-HhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence 4799999999999999999999999999865 222334456688899998888679999999999999999999999999
Q ss_pred CCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCC
Q 013005 114 GGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACG 192 (451)
Q Consensus 114 gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~g 192 (451)
+|+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~-~~~~~~~~~g 158 (329)
T cd05618 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGDTTSTFCG 158 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC-CCCccccccC
Confidence 9999988864 6899999999999999999999999999999999999999999999999999864321 1123345689
Q ss_pred CCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCC---------CcHHHHHHHhhccCCCCCCCCCHhHHHHHH
Q 013005 193 TPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDD---------SNLLAMYKKVNRRDYQFPSFVSKPARSLIY 263 (451)
Q Consensus 193 t~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~---------~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 263 (451)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.. ......+..+......+|..++..+.+||.
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 159 TPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237 (329)
T ss_pred CccccCHHHHcCCCC-CCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 999999999987766 5669999999999999999999952 122345566667777889999999999999
Q ss_pred hccCCCCCCCCC------HHHHHcCccccch
Q 013005 264 QLLDPNPKTRMS------IEKIMSISWFQKS 288 (451)
Q Consensus 264 ~~L~~dP~~Rpt------~~eil~hp~f~~~ 288 (451)
+||..||.+||| ++++++||||+..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 238 SFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 999999999998 6899999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=378.47 Aligned_cols=258 Identities=29% Similarity=0.542 Sum_probs=226.8
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
+|++.+.||+|+||.||+|.+..+++.||+|++.+.. .......+.+..|..++..+.+|++|+++++++.+.+..|+|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV-VIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence 4788899999999999999999999999999997642 222334456778888898887678899999999999999999
Q ss_pred EEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcc
Q 013005 109 MEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML 187 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~ 187 (451)
|||++||+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~-~~~~ 158 (323)
T cd05615 80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-GVTT 158 (323)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC-Cccc
Confidence 999999999999875 78999999999999999999999999999999999999999999999999998643211 1223
Q ss_pred cccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccC
Q 013005 188 HTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLD 267 (451)
Q Consensus 188 ~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 267 (451)
...+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+....+..+......+|..++..+.+++.+||.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred cCccCCccccCHHHHcCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence 45679999999999987766 56799999999999999999999998888888888888888899999999999999999
Q ss_pred CCCCCCCC-----HHHHHcCccccchh
Q 013005 268 PNPKTRMS-----IEKIMSISWFQKSL 289 (451)
Q Consensus 268 ~dP~~Rpt-----~~eil~hp~f~~~~ 289 (451)
.||.+|++ .+++++||||+...
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 238 KHPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred cCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 99999997 57999999998753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=385.49 Aligned_cols=266 Identities=31% Similarity=0.519 Sum_probs=226.9
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
.......++|++.+.||+|+||.||+|++..+++.||+|++.+.. .........+.+|+.+++.+. ||||+++++++.
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~-~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~ 113 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE-MIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQ 113 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHH-hhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEE
Confidence 344556789999999999999999999999999999999997542 223334456788999999995 999999999999
Q ss_pred eCCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
+....|+||||++||+|.+++....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 99999999999999999999988889999999999999999999999999999999999999999999999999987543
Q ss_pred hhhcCcccccCCCCccccceeeeccC---CCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC--CCCCC--C
Q 013005 181 QIKNGMLHTACGTPAYTAPEVVARRG---YDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD--YQFPS--F 253 (451)
Q Consensus 181 ~~~~~~~~~~~gt~~y~APEvl~~~~---~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~--~ 253 (451)
........+.+||+.|+|||++.... +.+.++|||||||++|+|++|..||...+....+.++.... ..+|. .
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 273 (371)
T cd05622 194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 273 (371)
T ss_pred cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCC
Confidence 32222334678999999999987543 34677999999999999999999999998888888876533 34443 5
Q ss_pred CCHhHHHHHHhccCCCCCC--CCCHHHHHcCccccch
Q 013005 254 VSKPARSLIYQLLDPNPKT--RMSIEKIMSISWFQKS 288 (451)
Q Consensus 254 ~s~~~~~li~~~L~~dP~~--Rpt~~eil~hp~f~~~ 288 (451)
++..+.++|.+||..++.+ |++++++++||||+..
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 274 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred CCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 8999999999999854543 7899999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=371.86 Aligned_cols=267 Identities=30% Similarity=0.457 Sum_probs=234.0
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
....-.+.|++++.||.|.-|+||++....++..+|+|++++. .........+...|-.||..+. ||.++.||..++.
T Consensus 71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~-~l~~rkKl~Ra~tE~eIL~~lD-HPFlPTLYa~fet 148 (459)
T KOG0610|consen 71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKE-SLASRKKLKRAQTEREILSLLD-HPFLPTLYASFET 148 (459)
T ss_pred CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHH-HHhhhhHHHHHHHHHHHHHhcC-CCccchhhheeec
Confidence 3445567889999999999999999999999999999999987 3344455667888888999995 9999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
....|++||||+||+|..+.++ ..|++..++.|+..++.||+|||-.||+.||||||||||-++|++-|+||.||..
T Consensus 149 ~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 149 DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecccccc
Confidence 9999999999999999998875 4699999999999999999999999999999999999999999999999999742
Q ss_pred ch-------h---------------------------hhc---------------------CcccccCCCCccccceeee
Q 013005 179 PE-------Q---------------------------IKN---------------------GMLHTACGTPAYTAPEVVA 203 (451)
Q Consensus 179 ~~-------~---------------------------~~~---------------------~~~~~~~gt~~y~APEvl~ 203 (451)
.. . ... .-....+||-.|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 10 0 000 0112457999999999999
Q ss_pred ccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCC--CCCHhHHHHHHhccCCCCCCCCC----HH
Q 013005 204 RRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS--FVSKPARSLIYQLLDPNPKTRMS----IE 277 (451)
Q Consensus 204 ~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~Rpt----~~ 277 (451)
+.+.. .+.|.|.|||.+|||+.|..||.+.+..+.+..|...+..||. .++..++|||+++|.+||++|.. +.
T Consensus 309 G~GHg-sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~ 387 (459)
T KOG0610|consen 309 GEGHG-SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAA 387 (459)
T ss_pred cCCCC-chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchH
Confidence 99885 5589999999999999999999999999999999999988886 47899999999999999999998 99
Q ss_pred HHHcCccccchhHH
Q 013005 278 KIMSISWFQKSLQQ 291 (451)
Q Consensus 278 eil~hp~f~~~~~~ 291 (451)
||.+||||+.....
T Consensus 388 eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 388 EIKRHPFFEGVNWA 401 (459)
T ss_pred HhhcCccccCCChh
Confidence 99999999875443
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=387.09 Aligned_cols=257 Identities=32% Similarity=0.538 Sum_probs=217.3
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|++.+.||+|+||.||+|++..+++.||+|++.+.. .........+.+|+.+++.+. ||||+++++.+.+++.+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~-~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKAD-VLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHH-HHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCEEEE
Confidence 47999999999999999999999999999999997542 222334566889999999995 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh----
Q 013005 108 VMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI---- 182 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~---- 182 (451)
||||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 79 v~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 9999999999999875 67899999999999999999999999999999999999999999999999997522100
Q ss_pred --------------------------------------hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHH
Q 013005 183 --------------------------------------KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVL 224 (451)
Q Consensus 183 --------------------------------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~L 224 (451)
........+||+.|+|||++.+..+ +.++|||||||++|+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyel 237 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEM 237 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC-Ccceeeeeccceeeeh
Confidence 0001123579999999999987776 5679999999999999
Q ss_pred HhcCCCCCCCcHHHHHHHhhcc--CCCCCC--CCCHhHHHHHHhccCCCCCCCC---CHHHHHcCccccch
Q 013005 225 LAGYLPFDDSNLLAMYKKVNRR--DYQFPS--FVSKPARSLIYQLLDPNPKTRM---SIEKIMSISWFQKS 288 (451)
Q Consensus 225 l~G~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~~Rp---t~~eil~hp~f~~~ 288 (451)
++|+.||...+.......+... ...+|. .+++.+.++|.+|+ .+|.+|+ |++++++||||+..
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 9999999988776665555432 223333 57899999999976 5999999 99999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=376.62 Aligned_cols=253 Identities=28% Similarity=0.541 Sum_probs=219.6
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecC
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAA 113 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ 113 (451)
+.||+|+||+||+|.+..+++.||+|++.+.. ............|..++..+.+||||+++++++.+.+..|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDV-VLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH-hhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 46999999999999999999999999997642 11122334566777788776569999999999999999999999999
Q ss_pred CCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCC
Q 013005 114 GGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACG 192 (451)
Q Consensus 114 gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~g 192 (451)
||+|.+.+.. ..+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~g 158 (316)
T cd05619 80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML-GDAKTCTFCG 158 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC-CCCceeeecC
Confidence 9999999975 6799999999999999999999999999999999999999999999999999863211 1123345679
Q ss_pred CCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccCCCCCC
Q 013005 193 TPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKT 272 (451)
Q Consensus 193 t~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 272 (451)
|+.|+|||++.+..+ +.++||||+||++|+|++|..||...+....+..+......+|.+++..+.+||.+||..||++
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 159 TPDYIAPEILLGQKY-NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred CccccCHHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhh
Confidence 999999999987766 5669999999999999999999999888888888877777788899999999999999999999
Q ss_pred CCCHH-HHHcCccccchh
Q 013005 273 RMSIE-KIMSISWFQKSL 289 (451)
Q Consensus 273 Rpt~~-eil~hp~f~~~~ 289 (451)
||++. ++++||||+...
T Consensus 238 R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 238 RLGVKGDIRQHPFFREID 255 (316)
T ss_pred cCCChHHHHcCcccCCCC
Confidence 99996 999999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-47 Score=373.79 Aligned_cols=256 Identities=28% Similarity=0.456 Sum_probs=208.6
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.+. ||||+++++++.+....|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 79 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE---EGTPFTAIREASLLKGLK-HANIVLLHDIIHTKETLT 79 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc---cccchhHHHHHHHHhhCC-CCCcCeEEEEEecCCeEE
Confidence 4789999999999999999999999999999999975421 122345678999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 107 LVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
+||||+. ++|.+.+.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~ 157 (303)
T cd07869 80 LVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP-S 157 (303)
T ss_pred EEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC-C
Confidence 9999996 577777654 67999999999999999999999999999999999999999999999999998643221 2
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcH-HHHHHHhhc---cC-------------
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNL-LAMYKKVNR---RD------------- 247 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~-~~~~~~i~~---~~------------- 247 (451)
......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+... ......+.. ..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 2334567899999999987665556779999999999999999999986432 222221110 00
Q ss_pred -----CC--CCC---------CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 248 -----YQ--FPS---------FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 248 -----~~--~p~---------~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+. .|. ..++.+.+||.+||+.||.+|||++++++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 00 000 134678999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-48 Score=362.02 Aligned_cols=252 Identities=34% Similarity=0.637 Sum_probs=221.3
Q ss_pred cccCCeEEc-ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe--
Q 013005 25 TLLNRYQLG-PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT-- 101 (451)
Q Consensus 25 ~~~~~y~~~-~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~-- 101 (451)
.+.++|.+. +.||-|-.|+|..+.++.||+.+|+|++... ...++|+...-+...|||||+++++|++
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds---------~KARrEVeLHw~~s~h~~iV~IidVyeNs~ 128 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS---------PKARREVELHWMASGHPHIVSIIDVYENSY 128 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC---------HHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence 467888874 5799999999999999999999999998654 2456888888788889999999999854
Q ss_pred --CCEEEEEEEecCCCchhHHhhc-C--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCC---CCeEEEec
Q 013005 102 --KTKIYLVMEYAAGGELFGKLRR-G--RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD---GNLKVSDF 173 (451)
Q Consensus 102 --~~~~~lV~E~~~gg~L~~~l~~-~--~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~---~~lkl~DF 173 (451)
..++.+|||.++||+|++.+.. | .|+|.++..+++||..|+.|||+.+|.||||||||+|...+ ..+||+||
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence 5678899999999999999974 3 49999999999999999999999999999999999999754 46999999
Q ss_pred cCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCc----HHHHHHHhhccCCC
Q 013005 174 GLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN----LLAMYKKVNRRDYQ 249 (451)
Q Consensus 174 Gls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~----~~~~~~~i~~~~~~ 249 (451)
|+|.... .+..+.+.|-||+|+|||++....|+ ..+|+||+|||+|.||+|++||.... ...+..+|..+.+.
T Consensus 209 GFAK~t~--~~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~ 285 (400)
T KOG0604|consen 209 GFAKETQ--EPGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYE 285 (400)
T ss_pred ccccccC--CCccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCcc
Confidence 9998543 25678899999999999999888886 45899999999999999999997643 24677889999998
Q ss_pred CCC--C--CCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 250 FPS--F--VSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 250 ~p~--~--~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
||. | +|+.++++|+.+|..+|.+|.|+++++.|||+...
T Consensus 286 FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 286 FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 885 3 79999999999999999999999999999999754
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=376.92 Aligned_cols=251 Identities=33% Similarity=0.586 Sum_probs=217.0
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHH-HHHHhcCCCCceEEEEEEEeCCEEEEEEEec
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVS-AMRRLQNHPNVLKIQEVMATKTKIYLVMEYA 112 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~-il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~ 112 (451)
+.||+|+||+||+|++..+|+.||+|++.+.. .........+.+|.. +++.+ +||||+++++.+.+.+..|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKA-ILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH-HhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEeCCEEEEEEcCC
Confidence 46999999999999999999999999997642 122223344555555 45667 5999999999999999999999999
Q ss_pred CCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccC
Q 013005 113 AGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTAC 191 (451)
Q Consensus 113 ~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~ 191 (451)
.||+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~ 157 (323)
T cd05575 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE-HSKTTSTFC 157 (323)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc-CCCcccccc
Confidence 99999998875 6799999999999999999999999999999999999999999999999999864321 122334568
Q ss_pred CCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccCCCCC
Q 013005 192 GTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPK 271 (451)
Q Consensus 192 gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~ 271 (451)
||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+......+++.++..+.++|.+||..||.
T Consensus 158 gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (323)
T cd05575 158 GTPEYLAPEVLRKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRT 236 (323)
T ss_pred CChhhcChhhhcCCCC-CccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHH
Confidence 9999999999987766 466999999999999999999999998888888888888888888999999999999999999
Q ss_pred CCCCH----HHHHcCccccch
Q 013005 272 TRMSI----EKIMSISWFQKS 288 (451)
Q Consensus 272 ~Rpt~----~eil~hp~f~~~ 288 (451)
+||++ .++++||||...
T Consensus 237 ~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 237 KRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred hCCCCCCCHHHHHcCCCcCCC
Confidence 99987 699999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=367.21 Aligned_cols=261 Identities=28% Similarity=0.470 Sum_probs=222.5
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe--
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT-- 101 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~-- 101 (451)
-.+..+|...+.||+|+||.|..|.++.||+.||||.+.. .+.+....++..||+..|+.++ |+||+.+++++..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~--~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~~ 94 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN--PFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPPS 94 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhh--hhhchHHHHHHHHHHHHHHHhc-CCCcceEEeeccccc
Confidence 3455667778999999999999999999999999999863 3445667788999999999997 9999999999865
Q ss_pred ---CCEEEEEEEecCCCchhHHhhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 102 ---KTKIYLVMEYAAGGELFGKLRRGR-LTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 102 ---~~~~~lV~E~~~gg~L~~~l~~~~-l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
-..+|+|+|++ +.+|...++.++ ++++.++.++.||+.||+|+|+.||+||||||.|+|++.+..+||+|||+|+
T Consensus 95 ~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 95 RDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred ccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEecccccee
Confidence 45799999999 559999999877 9999999999999999999999999999999999999999999999999998
Q ss_pred cchhh-hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhc-----------
Q 013005 178 LPEQI-KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNR----------- 245 (451)
Q Consensus 178 ~~~~~-~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~----------- 245 (451)
..... ....+...+-|.+|.|||++.....++...||||+|||+.||++|++.|.+.+....+..|..
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 76432 224556788999999999998776667889999999999999999999988766554443321
Q ss_pred ------------cCCCCC--------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 246 ------------RDYQFP--------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 246 ------------~~~~~p--------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.....| +..++.+.+|+.+||..||.+|+|++|+|+|||+...
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 011111 2478999999999999999999999999999999764
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=374.11 Aligned_cols=253 Identities=31% Similarity=0.571 Sum_probs=219.3
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecC
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAA 113 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ 113 (451)
+.||+|+||+||+|.+..+++.||+|++.+. ........+.+.+|+.++.++.+||||+++++++.+.+.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKE-LVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHH-HhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence 4799999999999999999999999999865 233344556788999999999779999999999999999999999999
Q ss_pred CCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCC
Q 013005 114 GGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACG 192 (451)
Q Consensus 114 gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~g 192 (451)
||+|...+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~g 158 (327)
T cd05617 80 GGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG-PGDTTSTFCG 158 (327)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC-CCCceecccC
Confidence 9999988864 6899999999999999999999999999999999999999999999999999864221 1223346789
Q ss_pred CCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCC-------CcHHHHHHHhhccCCCCCCCCCHhHHHHHHhc
Q 013005 193 TPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDD-------SNLLAMYKKVNRRDYQFPSFVSKPARSLIYQL 265 (451)
Q Consensus 193 t~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~-------~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 265 (451)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.. ......+..+......+|..++..+.++|.+|
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 237 (327)
T cd05617 159 TPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237 (327)
T ss_pred CcccCCHHHHCCCCC-CchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 999999999987766 5679999999999999999999953 22345566666777788888999999999999
Q ss_pred cCCCCCCCCC------HHHHHcCccccchh
Q 013005 266 LDPNPKTRMS------IEKIMSISWFQKSL 289 (451)
Q Consensus 266 L~~dP~~Rpt------~~eil~hp~f~~~~ 289 (451)
|..||.+|++ ++++++||||....
T Consensus 238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 238 LNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred hccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 9999999998 57999999998754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-47 Score=377.85 Aligned_cols=252 Identities=31% Similarity=0.557 Sum_probs=216.6
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhc--CCCCceEEEEEEEeCCEEEEEEEecC
Q 013005 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ--NHPNVLKIQEVMATKTKIYLVMEYAA 113 (451)
Q Consensus 36 LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~--~HpnIv~l~~~~~~~~~~~lV~E~~~ 113 (451)
||+|+||+||+|++..+++.||+|++.+.. ............|..++..+. +||||+++++++.+....|+||||+.
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKE-IVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHH-HhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence 699999999999999999999999997542 122223334556666766654 69999999999999999999999999
Q ss_pred CCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCC
Q 013005 114 GGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACG 192 (451)
Q Consensus 114 gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~g 192 (451)
+|+|...+.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..... ........+|
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~-~~~~~~~~~g 158 (330)
T cd05586 80 GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT-DNKTTNTFCG 158 (330)
T ss_pred CChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC-CCCCccCccC
Confidence 9999988864 7899999999999999999999999999999999999999999999999999864322 1233446789
Q ss_pred CCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCC-CCCHhHHHHHHhccCCCCC
Q 013005 193 TPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS-FVSKPARSLIYQLLDPNPK 271 (451)
Q Consensus 193 t~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~-~~s~~~~~li~~~L~~dP~ 271 (451)
|+.|+|||++.+....+.++|||||||++|+|++|..||...+....+..+......+|. .+++.+.+||++||..||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 238 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQ 238 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHH
Confidence 999999999876554567799999999999999999999999888888888877777775 4799999999999999999
Q ss_pred CCC----CHHHHHcCccccchh
Q 013005 272 TRM----SIEKIMSISWFQKSL 289 (451)
Q Consensus 272 ~Rp----t~~eil~hp~f~~~~ 289 (451)
+|| +++++++||||....
T Consensus 239 ~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 239 HRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred HCCCCCCCHHHHhcCccccCCC
Confidence 998 799999999998643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-47 Score=381.70 Aligned_cols=257 Identities=33% Similarity=0.584 Sum_probs=220.4
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|++.+.||+|+||+||+|.+..+++.||+|++.+.. .........+.+|+.++..+. ||||+++++.+.+.+..|+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKAD-MLEKEQVAHIRAERDILVEAD-GAWVVKMFYSFQDKRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH-HhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEE
Confidence 47999999999999999999999999999999997542 223344567889999999995 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh---
Q 013005 108 VMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK--- 183 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~--- 183 (451)
||||++||+|.+++.+ +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.++|+|||++.......
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 79 IMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 9999999999999865 789999999999999999999999999999999999999999999999999986432110
Q ss_pred -------------------------------cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCC
Q 013005 184 -------------------------------NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFD 232 (451)
Q Consensus 184 -------------------------------~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~ 232 (451)
.....+.+||+.|+|||++.+.++. .++|||||||++|+|++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCC
Confidence 0112245899999999999887774 56999999999999999999999
Q ss_pred CCcHHHHHHHhhc--cCCCCCCC--CCHhHHHHHHhccCCCCCCCC---CHHHHHcCccccch
Q 013005 233 DSNLLAMYKKVNR--RDYQFPSF--VSKPARSLIYQLLDPNPKTRM---SIEKIMSISWFQKS 288 (451)
Q Consensus 233 ~~~~~~~~~~i~~--~~~~~p~~--~s~~~~~li~~~L~~dP~~Rp---t~~eil~hp~f~~~ 288 (451)
..+....+.++.. ....+|+. +++.+.+||.+|+ .||.+|+ +++++++||||+..
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence 8888777777664 23445543 6899999999977 4999998 58999999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=362.38 Aligned_cols=260 Identities=25% Similarity=0.400 Sum_probs=220.6
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe--
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT-- 101 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~-- 101 (451)
-..++.|+.+..|++|+||.||+|+|+.|++.||+|.++.+. . ....--.-.|||.+|.+.+ |||||.+-++...
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-e-k~GFPItsLREIniLl~~~-H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-E-KEGFPITSLREINILLKAR-HPNIVEVKEVVVGSN 148 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-c-cCCCcchhHHHHHHHHhcC-CCCeeeeEEEEeccc
Confidence 345678999999999999999999999999999999997763 1 1122223468999999996 9999999998764
Q ss_pred CCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcc
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALP 179 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~ 179 (451)
-+.+|||||||+. +|...+.. .+|...+++.++.|+++|++|||.+.|+||||||+|+|++..|.+||+|||+|+.+
T Consensus 149 ~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 149 MDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred cceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhh
Confidence 4679999999976 89988875 68999999999999999999999999999999999999999999999999999976
Q ss_pred hhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc-------------
Q 013005 180 EQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR------------- 246 (451)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~------------- 246 (451)
.... ..+...+-|.+|.|||++.+...++.+.|+||+|||+.+|+++.+.|.+........+|..-
T Consensus 228 gsp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 228 GSPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred cCCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 5532 34556677999999999998877778899999999999999999999998877666665321
Q ss_pred ------CCCCC------------CC-CCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 247 ------DYQFP------------SF-VSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 247 ------~~~~p------------~~-~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
...++ .. .+....+|++.+|.+||.+|.|+++.|+|+||...
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 11111 11 45788999999999999999999999999999874
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=381.95 Aligned_cols=255 Identities=28% Similarity=0.482 Sum_probs=225.2
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
..|...+.||+|+||.||+|++..|++.||+|+++.+. .....+.+.+|+.++.++. ++||.++|+.+..+..+|+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~---~~deIediqqei~~Ls~~~-~~~it~yygsyl~g~~Lwi 88 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE---AEDEIEDIQQEISVLSQCD-SPNITEYYGSYLKGTKLWI 88 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh---cchhhHHHHHHHHHHHhcC-cchHHhhhhheeecccHHH
Confidence 45777799999999999999999999999999998763 3455678999999999996 9999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCC-CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCc
Q 013005 108 VMEYAAGGELFGKLRRGRL-TESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM 186 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~~~l-~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~ 186 (451)
+||||.||++.+.++.+.+ .|.++..++++++.|+.|||.++.+|||||+.|||+..+|.+||+|||.+..........
T Consensus 89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 9999999999999998765 999999999999999999999999999999999999999999999999997654433333
Q ss_pred ccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhHHHHHHhc
Q 013005 187 LHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPARSLIYQL 265 (451)
Q Consensus 187 ~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~ 265 (451)
.+.+|||.|||||++...+|+. ++||||||++.+||++|.+||...........|.+. +..+...+++.+++|+..|
T Consensus 169 -~tfvGTPfwMAPEVI~~~~Y~~-KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~C 246 (467)
T KOG0201|consen 169 -KTFVGTPFWMAPEVIKQSGYDT-KADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEAC 246 (467)
T ss_pred -ccccccccccchhhhccccccc-hhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHH
Confidence 7889999999999999888864 589999999999999999999887665444444333 3344456899999999999
Q ss_pred cCCCCCCCCCHHHHHcCccccch
Q 013005 266 LDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 266 L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
|+.||+.|||+.++++|+|++..
T Consensus 247 L~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 247 LDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred hhcCcccCcCHHHHhhhHHHHhc
Confidence 99999999999999999999874
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=373.79 Aligned_cols=251 Identities=35% Similarity=0.611 Sum_probs=220.4
Q ss_pred cceEcccCceEEEEEEEc---CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEE
Q 013005 33 GPLLGRGSFAKVHKAKSI---ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVM 109 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~ 109 (451)
++.||+|+||.||++.+. .+|+.||+|++.+.. ........+.+|+.+++++. ||||+++++++.+....|+||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 77 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT--LKVRDRVRTKMERDILAEVN-HPFIVKLHYAFQTEGKLYLIL 77 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCEEEEEE
Confidence 367999999999999863 578999999997642 12223456778999999995 999999999999999999999
Q ss_pred EecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCccc
Q 013005 110 EYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLH 188 (451)
Q Consensus 110 E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~ 188 (451)
||+.+|+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .....
T Consensus 78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-~~~~~ 156 (318)
T cd05582 78 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-EKKAY 156 (318)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC-CCcee
Confidence 99999999999874 67999999999999999999999999999999999999999999999999998754321 12334
Q ss_pred ccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccCC
Q 013005 189 TACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDP 268 (451)
Q Consensus 189 ~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 268 (451)
..+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+......+|..+++.+.+||++||..
T Consensus 157 ~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~ 235 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKR 235 (318)
T ss_pred cccCChhhcCHHHHcCCCC-CCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhc
Confidence 5689999999999987666 567999999999999999999999988888888888888888999999999999999999
Q ss_pred CCCCCCC-----HHHHHcCccccch
Q 013005 269 NPKTRMS-----IEKIMSISWFQKS 288 (451)
Q Consensus 269 dP~~Rpt-----~~eil~hp~f~~~ 288 (451)
||++||| +++++.||||...
T Consensus 236 ~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 236 NPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred CHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 9999999 8889999999864
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=372.48 Aligned_cols=259 Identities=30% Similarity=0.531 Sum_probs=217.8
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|++.+.||+|+||+||++++..+++.||+|++.+.. .......+.+.+|+.+++.+. ||||+++++++.+....|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWE-MLKRAETACFREERDVLVNGD-RRWITNLHYAFQDENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH-HhhhhhHHHHHHHHHHHHhCC-CCCCCceEEEEecCCeEEE
Confidence 57999999999999999999999999999999997642 223344566888999999984 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 108 VMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
||||+.||+|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 9999999999999964 57999999999999999999999999999999999999999999999999998643322222
Q ss_pred cccccCCCCccccceeeec----cCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC--CCCCC---CCCH
Q 013005 186 MLHTACGTPAYTAPEVVAR----RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD--YQFPS---FVSK 256 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~----~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~---~~s~ 256 (451)
.....+||+.|+|||++.. ....+.++||||+||++|+|++|+.||...+....+..+.... ..+|. .++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 238 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE 238 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence 2233579999999999863 2344677999999999999999999999888777777665432 33333 4789
Q ss_pred hHHHHHHhccCCCCCC--CCCHHHHHcCccccch
Q 013005 257 PARSLIYQLLDPNPKT--RMSIEKIMSISWFQKS 288 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~--Rpt~~eil~hp~f~~~ 288 (451)
.+.+||++||..++.+ |++++++++||||...
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 239 EAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred HHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 9999999988764443 8899999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=373.79 Aligned_cols=251 Identities=31% Similarity=0.565 Sum_probs=216.5
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHH-HHHhcCCCCceEEEEEEEeCCEEEEEEEec
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSA-MRRLQNHPNVLKIQEVMATKTKIYLVMEYA 112 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~i-l~~L~~HpnIv~l~~~~~~~~~~~lV~E~~ 112 (451)
+.||+|+||+||+|.+..+|+.||+|++.+.. .........+.+|..+ ++.+ +||||+++++++...+..|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKI-VLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTTEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEecCCEEEEEEcCC
Confidence 46999999999999999999999999997642 2222333455566554 5566 5999999999999999999999999
Q ss_pred CCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccC
Q 013005 113 AGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTAC 191 (451)
Q Consensus 113 ~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~ 191 (451)
.||+|...+.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .......+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~ 157 (325)
T cd05604 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTTFC 157 (325)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCccccc
Confidence 99999988865 68999999999999999999999999999999999999999999999999998643211 12334568
Q ss_pred CCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccCCCCC
Q 013005 192 GTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPK 271 (451)
Q Consensus 192 gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~ 271 (451)
||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+...++..+......+++..+..+.++|.+||..||.
T Consensus 158 gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~ 236 (325)
T cd05604 158 GTPEYLAPEVIRKQPY-DNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQ 236 (325)
T ss_pred CChhhCCHHHHcCCCC-CCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHH
Confidence 9999999999987776 466999999999999999999999988888888888877777778999999999999999999
Q ss_pred CCCCH----HHHHcCccccch
Q 013005 272 TRMSI----EKIMSISWFQKS 288 (451)
Q Consensus 272 ~Rpt~----~eil~hp~f~~~ 288 (451)
+||++ .++++||||...
T Consensus 237 ~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 237 RRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred hcCCCCCCHHHHhcCCCcCCC
Confidence 99976 599999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-46 Score=374.23 Aligned_cols=257 Identities=27% Similarity=0.470 Sum_probs=214.3
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
....++|+..+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.+. |+||+++++++...+
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 145 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---EDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNG 145 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cHHHHHHHHHHHHHHHhCC-CCCcceeeeEeccCC
Confidence 344678999999999999999999999999999999996542 2345567899999999995 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 104 KIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
..|+||||+.+|+|... ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 146 ~~~lv~e~~~~~~L~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 146 EIQVLLEFMDGGSLEGT---HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred eEEEEEecCCCCccccc---ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 99999999999998653 345788889999999999999999999999999999999999999999999987543221
Q ss_pred cCcccccCCCCccccceeeec----cCCCCccchhhhhhHHHHHHHhcCCCCCCCcH---HHHHHHhh-ccCCCCCCCCC
Q 013005 184 NGMLHTACGTPAYTAPEVVAR----RGYDGAVADAWSCGVILFVLLAGYLPFDDSNL---LAMYKKVN-RRDYQFPSFVS 255 (451)
Q Consensus 184 ~~~~~~~~gt~~y~APEvl~~----~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~---~~~~~~i~-~~~~~~p~~~s 255 (451)
.......||+.|+|||++.. ..+.+.++|||||||++|+|++|+.||..... ......+. ......+..++
T Consensus 223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (353)
T PLN00034 223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS 301 (353)
T ss_pred -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccC
Confidence 22345679999999998743 23556689999999999999999999974322 22222222 22334556789
Q ss_pred HhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 256 KPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 256 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
..+.+||.+||..||++|||+.|+++||||.+.
T Consensus 302 ~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 302 REFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 999999999999999999999999999999875
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-47 Score=362.46 Aligned_cols=258 Identities=28% Similarity=0.477 Sum_probs=219.2
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCC-ceEEEEEEEeCC--
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN-VLKIQEVMATKT-- 103 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~Hpn-Iv~l~~~~~~~~-- 103 (451)
+..|+.++.||+|+||+||+|+++.+|+.||+|.+..+.. .+..-....+|+.+++.|+ |+| ||++++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~--~EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~~ 86 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFE--EEGVPSTAIREISLLKRLS-HANHIVRLHDVIHTSNNH 86 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccc--ccCCCchhhHHHHHHHHhC-CCcceEEEEeeeeecccc
Confidence 6778888999999999999999999999999999987632 1223445679999999996 999 999999998877
Q ss_pred ----EEEEEEEecCCCchhHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEecc
Q 013005 104 ----KIYLVMEYAAGGELFGKLRR-----GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFG 174 (451)
Q Consensus 104 ----~~~lV~E~~~gg~L~~~l~~-----~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFG 174 (451)
..|+|+||++. +|..++.. ..++...++.++.||+.||+|||++||+||||||+||||+++|.+||+|||
T Consensus 87 ~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 87 RGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred cccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccc
Confidence 89999999965 89888874 257888999999999999999999999999999999999999999999999
Q ss_pred CCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc--------
Q 013005 175 LSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR-------- 246 (451)
Q Consensus 175 ls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~-------- 246 (451)
+|+.... ......+.++|.+|.|||++.+...++...||||+|||++||++++..|.+.+..+....|..-
T Consensus 166 lAra~~i-p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 166 LARAFSI-PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred hHHHhcC-CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 9985432 2234667789999999999999866677799999999999999999999998887766665321
Q ss_pred ----------CCCCCCC------------CCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 247 ----------DYQFPSF------------VSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 247 ----------~~~~p~~------------~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
...++.+ .++...+++.+||+.+|.+|.|+..++.||||....
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 1122222 234789999999999999999999999999998753
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=372.04 Aligned_cols=251 Identities=33% Similarity=0.596 Sum_probs=215.8
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHH-HHHHhcCCCCceEEEEEEEeCCEEEEEEEec
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVS-AMRRLQNHPNVLKIQEVMATKTKIYLVMEYA 112 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~-il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~ 112 (451)
+.||+|+||+||+|++..+++.||+|++.+.. .........+.+|.. +++.+ +||||+++++++...+..|+||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKA-ILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH-HHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcCCeEEEEEeCC
Confidence 46999999999999999999999999997642 112222334444544 45667 5999999999999999999999999
Q ss_pred CCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccC
Q 013005 113 AGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTAC 191 (451)
Q Consensus 113 ~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~ 191 (451)
.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+
T Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~-~~~~~~~~~ 157 (325)
T cd05602 79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE-HNGTTSTFC 157 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc-CCCCccccc
Confidence 99999999875 6799999999999999999999999999999999999999999999999999864321 123344668
Q ss_pred CCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccCCCCC
Q 013005 192 GTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPK 271 (451)
Q Consensus 192 gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~ 271 (451)
||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+......+++.+++.+.++|.+||..||.
T Consensus 158 gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (325)
T cd05602 158 GTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRT 236 (325)
T ss_pred CCccccCHHHHcCCCC-CCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHH
Confidence 9999999999987766 466999999999999999999999988888888888877788888999999999999999999
Q ss_pred CCCCHH----HHHcCccccch
Q 013005 272 TRMSIE----KIMSISWFQKS 288 (451)
Q Consensus 272 ~Rpt~~----eil~hp~f~~~ 288 (451)
+|+++. ++++|+||...
T Consensus 237 ~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 237 KRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred HCCCCCCCHHHHhcCcccCCC
Confidence 999865 89999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=371.44 Aligned_cols=256 Identities=29% Similarity=0.463 Sum_probs=206.5
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC-----C
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK-----T 103 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~-----~ 103 (451)
+|++.+.||+|+||.||+|++..+++.||||.+.... ........+.+|+.++++++ ||||+++++++... .
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~ 77 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFK 77 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh--ccchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCCCc
Confidence 6999999999999999999999999999999986431 12223456889999999995 99999999988543 3
Q ss_pred EEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 104 KIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
..|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 78 DIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred eEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 5899999995 688888864 67999999999999999999999999999999999999999999999999998753221
Q ss_pred hc--CcccccCCCCccccceeeecc-CCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhh---------------
Q 013005 183 KN--GMLHTACGTPAYTAPEVVARR-GYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVN--------------- 244 (451)
Q Consensus 183 ~~--~~~~~~~gt~~y~APEvl~~~-~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~--------------- 244 (451)
.. ......+||+.|+|||++.+. ...+.++|||||||++|+|++|+.||...+.......+.
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 11 222456799999999998652 334667999999999999999999998765433221110
Q ss_pred ------------cc-CCCC---CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 245 ------------RR-DYQF---PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 245 ------------~~-~~~~---p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.. ...+ .+..++.+.++|.+||..||++|||++++++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 00 0000 02357788999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=361.84 Aligned_cols=255 Identities=26% Similarity=0.444 Sum_probs=217.3
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
.|++.+.||+|+||+||++.+..+++.||+|++.... .........+.+|+.+++.+. ||||+++++.+...+..|+|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR-IKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhh-hhhhhhHHHHHHHHHHHHhcC-CCCEeeeeeeecCCCeEEEE
Confidence 4889999999999999999999999999999997642 222233456778999999995 99999999999999999999
Q ss_pred EEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 109 MEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
|||+.||+|.+.+.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++..... ..
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~--~~ 156 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE--GE 156 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC--CC
Confidence 999999999988753 4699999999999999999999999999999999999999999999999999875432 12
Q ss_pred cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHH----HHHHhhccCCCCCCCCCHhHHHH
Q 013005 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLA----MYKKVNRRDYQFPSFVSKPARSL 261 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~----~~~~i~~~~~~~p~~~s~~~~~l 261 (451)
.....+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+... ....+......++..++..+.+|
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSI 235 (285)
T ss_pred ccccccCCCCccCcHHhcCCCC-CccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHH
Confidence 2235589999999999977665 566999999999999999999998765432 22333444456667789999999
Q ss_pred HHhccCCCCCCCC-----CHHHHHcCccccch
Q 013005 262 IYQLLDPNPKTRM-----SIEKIMSISWFQKS 288 (451)
Q Consensus 262 i~~~L~~dP~~Rp-----t~~eil~hp~f~~~ 288 (451)
|.+||..||.+|| +++++++||||...
T Consensus 236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 236 CRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred HHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 9999999999999 99999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=370.21 Aligned_cols=251 Identities=33% Similarity=0.585 Sum_probs=216.6
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHH-HHHHhcCCCCceEEEEEEEeCCEEEEEEEec
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVS-AMRRLQNHPNVLKIQEVMATKTKIYLVMEYA 112 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~-il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~ 112 (451)
+.||+|+||.||+|++..+++.||+|++.+.. .........+.+|.. +++.+ +||||+++++++.+.+..|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKT-ILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTAEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH-HHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCEEEEEEcCC
Confidence 46999999999999999999999999997642 222233344555554 56677 5999999999999999999999999
Q ss_pred CCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccC
Q 013005 113 AGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTAC 191 (451)
Q Consensus 113 ~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~ 191 (451)
+||+|...+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ........+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~ 157 (321)
T cd05603 79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE-PEETTSTFC 157 (321)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC-CCCcccccc
Confidence 99999988864 6799999999999999999999999999999999999999999999999999874321 122334568
Q ss_pred CCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccCCCCC
Q 013005 192 GTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPK 271 (451)
Q Consensus 192 gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~ 271 (451)
||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+......+|...+..+.++|.+||..||.
T Consensus 158 gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (321)
T cd05603 158 GTPEYLAPEVLRKEPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQR 236 (321)
T ss_pred CCcccCCHHHhcCCCC-CCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHh
Confidence 9999999999987766 456999999999999999999999998888888888888888888999999999999999999
Q ss_pred CCCCH----HHHHcCccccch
Q 013005 272 TRMSI----EKIMSISWFQKS 288 (451)
Q Consensus 272 ~Rpt~----~eil~hp~f~~~ 288 (451)
+||++ .++++||||...
T Consensus 237 ~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 237 RRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred hcCCCCCCHHHHhCCCCcCCC
Confidence 99875 599999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-46 Score=370.30 Aligned_cols=259 Identities=29% Similarity=0.508 Sum_probs=218.7
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|++.+.||+|+||.||++++..+++.+|+|++.+.. .........+.+|+.++..+. ||||+++++.+.+....|+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE-MLKRAETACFREERDVLVNGD-NQWITTLHYAFQDENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHH-HHHhhHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCEEEE
Confidence 47999999999999999999999999999999997542 223334456788999999985 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 108 VMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
||||+.||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 9999999999999975 67999999999999999999999999999999999999999999999999998643222222
Q ss_pred cccccCCCCccccceeeec----cCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC--CCCCC---CCCH
Q 013005 186 MLHTACGTPAYTAPEVVAR----RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD--YQFPS---FVSK 256 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~----~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~---~~s~ 256 (451)
.....+||+.|+|||++.. ....+.++|||||||++|+|++|+.||...+....+.++.... ..+|. .+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 238 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE 238 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence 2334689999999999863 3334677999999999999999999999988888887776543 33343 4789
Q ss_pred hHHHHHHhccCCCCCC--CCCHHHHHcCccccch
Q 013005 257 PARSLIYQLLDPNPKT--RMSIEKIMSISWFQKS 288 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~--Rpt~~eil~hp~f~~~ 288 (451)
.+.+||++||..++.+ |++++++++||||...
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 239 DAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred HHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 9999999999765544 7899999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=361.94 Aligned_cols=249 Identities=26% Similarity=0.437 Sum_probs=211.1
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecCCC
Q 013005 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGG 115 (451)
Q Consensus 36 LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~gg 115 (451)
||+|+||+||++.+..+++.||+|.+.+.. .......+.+..|+.+++.+. ||||+++++++......|+||||++||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKR-LKKRKGYEGAMVEKRILAKVH-SRFIVSLAYAFQTKTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHH-HhhhHHHHHHHHHHHHHHhCC-CCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence 699999999999999999999999997642 222233456788999999994 999999999999999999999999999
Q ss_pred chhHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCccccc
Q 013005 116 ELFGKLR-----RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTA 190 (451)
Q Consensus 116 ~L~~~l~-----~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~ 190 (451)
+|...+. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... .......
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~ 157 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG-QSKTKGY 157 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC-Ccccccc
Confidence 9988763 246999999999999999999999999999999999999999999999999998654321 1223345
Q ss_pred CCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcH----HHHHHHhhccCCCCCCCCCHhHHHHHHhcc
Q 013005 191 CGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNL----LAMYKKVNRRDYQFPSFVSKPARSLIYQLL 266 (451)
Q Consensus 191 ~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 266 (451)
.||+.|+|||++.+..+ +.++||||+||++|+|++|+.||..... ......+......+|..++..+.+++.+||
T Consensus 158 ~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (280)
T cd05608 158 AGTPGFMAPELLQGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL 236 (280)
T ss_pred CCCcCccCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence 79999999999987766 4669999999999999999999976432 233444444556677788999999999999
Q ss_pred CCCCCCCC-----CHHHHHcCccccch
Q 013005 267 DPNPKTRM-----SIEKIMSISWFQKS 288 (451)
Q Consensus 267 ~~dP~~Rp-----t~~eil~hp~f~~~ 288 (451)
+.||++|| |++++++||||+..
T Consensus 237 ~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 237 AKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred cCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 99999999 88999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=368.05 Aligned_cols=255 Identities=24% Similarity=0.412 Sum_probs=216.6
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
..++|++.+.||+|+||.||++++..++..+|+|++.... .....+.+.+|+.+++++. ||||+++++++...+..
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 78 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEI 78 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEE
Confidence 3589999999999999999999999999999999997542 2345567999999999995 99999999999999999
Q ss_pred EEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 106 YLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQN-GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~-giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
|+||||++||+|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 156 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 156 (331)
T ss_pred EEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc--
Confidence 999999999999999975 6799999999999999999999986 699999999999999999999999999874422
Q ss_pred cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc-----------------
Q 013005 184 NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR----------------- 246 (451)
Q Consensus 184 ~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~----------------- 246 (451)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+...+...+...
T Consensus 157 -~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 157 -SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred -cccccCCCCcCcCCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 23345679999999999987665 56799999999999999999999876554433221110
Q ss_pred ------------------------------CCCCC-CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 247 ------------------------------DYQFP-SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 247 ------------------------------~~~~p-~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
....+ ..+++++.+||.+||..||++|||+++|++||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 01111 1367889999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=359.07 Aligned_cols=265 Identities=32% Similarity=0.585 Sum_probs=238.6
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
.+-+++|..+++||+|.||+|.+++.+.+++.+|||+++++ -.........-..|-.+|+..+ ||.+..+.-.|...+
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKe-viiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKE-VIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQTQD 241 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhh-heeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhccCc
Confidence 35689999999999999999999999999999999999887 3444444555667888899985 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 104 KIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
.+|+||||+.||+|+-.+.+ ..++|+.+|.|-..|+.||.|||+++|+.||||.||+|+|.+|++||+||||+.-.-.
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~- 320 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK- 320 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc-
Confidence 99999999999999888865 6799999999999999999999999999999999999999999999999999863211
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHH
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLI 262 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 262 (451)
......+.||||.|+|||++....| +...|.|.+||++|+|++|++||...+...++..|.-....||..++++++.|+
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLL 399 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLL 399 (516)
T ss_pred ccceeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHH
Confidence 2245678999999999999998888 566999999999999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCC-----CHHHHHcCccccchhHHh
Q 013005 263 YQLLDPNPKTRM-----SIEKIMSISWFQKSLQQQ 292 (451)
Q Consensus 263 ~~~L~~dP~~Rp-----t~~eil~hp~f~~~~~~~ 292 (451)
..+|..||.+|. .+.+|..|+||.....+.
T Consensus 400 sGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~ 434 (516)
T KOG0690|consen 400 SGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA 434 (516)
T ss_pred HHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence 999999999998 589999999998765443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=371.19 Aligned_cols=254 Identities=30% Similarity=0.450 Sum_probs=215.2
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEcCCCcE-EEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSI-VAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~-vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~ 99 (451)
........+..+.+.||+|+||+||+|.. .|+. ||+|++..... +....+.+.+|+.+|.+|+ |||||+++|++
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~--~~~~~~~f~~E~~il~~l~-HpNIV~f~G~~ 108 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDF--DDESRKAFRREASLLSRLR-HPNIVQFYGAC 108 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhc--ChHHHHHHHHHHHHHHhCC-CCCeeeEEEEE
Confidence 44455566777888899999999999986 4455 99999986532 2222778999999999996 99999999999
Q ss_pred EeCC-EEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCCCeEEeCCCC-CeEEEec
Q 013005 100 ATKT-KIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNG-VAHRDVKPQNLLLDRDG-NLKVSDF 173 (451)
Q Consensus 100 ~~~~-~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~g-iiHrDLKpeNILld~~~-~lkl~DF 173 (451)
.... ..++||||+++|+|.+++.. +.++...+..++.||++||+|||+++ |+||||||+|||++.++ ++||+||
T Consensus 109 ~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DF 188 (362)
T KOG0192|consen 109 TSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADF 188 (362)
T ss_pred cCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCC
Confidence 9887 79999999999999999964 68999999999999999999999999 99999999999999998 9999999
Q ss_pred cCCCcchhhhcCcccccCCCCccccceeeec--cCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhh--ccCCC
Q 013005 174 GLSALPEQIKNGMLHTACGTPAYTAPEVVAR--RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVN--RRDYQ 249 (451)
Q Consensus 174 Gls~~~~~~~~~~~~~~~gt~~y~APEvl~~--~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~--~~~~~ 249 (451)
|+++...... .......||+.|||||++.+ ..| +.++||||||++||||+||..||.+.........+. .....
T Consensus 189 Glsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~-~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~ 266 (362)
T KOG0192|consen 189 GLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPY-TEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP 266 (362)
T ss_pred ccceeecccc-ccccCCCCCccccChhhhcCCCCcC-CccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 9998544321 22333689999999999984 455 677999999999999999999999877654444443 34456
Q ss_pred CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 250 FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 250 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+|...++.+..|+.+||..||.+||+..+|+.
T Consensus 267 ~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 267 IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 67779999999999999999999999999876
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=369.32 Aligned_cols=259 Identities=31% Similarity=0.516 Sum_probs=218.9
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|++.+.||+|+||.||++++..+++.||+|++.+. ..........+.+|+.++..+. ||||+++++++.+.+..|+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~~~~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKW-EMLKRAETACFREERNVLVNGD-CQWITTLHYAFQDENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHH-HHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEE
Confidence 5799999999999999999999999999999999764 2223344556788999998885 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 108 VMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
||||+.||+|.+++.+ +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 9999999999999975 67999999999999999999999999999999999999999999999999998654332222
Q ss_pred cccccCCCCccccceeeecc----CCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC--CCCCC---CCCH
Q 013005 186 MLHTACGTPAYTAPEVVARR----GYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD--YQFPS---FVSK 256 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~----~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~---~~s~ 256 (451)
.....+||+.|+|||++.+. +..+.++||||+||++|+|++|+.||...+....+.++.... ..+|. .++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 238 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE 238 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence 22346799999999998652 234567999999999999999999999888777777776533 33443 3689
Q ss_pred hHHHHHHhccCCCCCC--CCCHHHHHcCccccch
Q 013005 257 PARSLIYQLLDPNPKT--RMSIEKIMSISWFQKS 288 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~--Rpt~~eil~hp~f~~~ 288 (451)
.+.++|.+||..++.+ |++++++++||||+..
T Consensus 239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 239 EAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred HHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 9999999999976655 5799999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-46 Score=383.66 Aligned_cols=251 Identities=27% Similarity=0.394 Sum_probs=205.1
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC---
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK--- 102 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~--- 102 (451)
..++|++++.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.+. ||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~-h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLN-HINIIFLKDYYYTECFK 134 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------chHHHHHHHHHhcC-CCCCcceeeeEeecccc
Confidence 4568999999999999999999999999999999986542 12347999999995 99999999887432
Q ss_pred -----CEEEEEEEecCCCchhHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC-CeEEE
Q 013005 103 -----TKIYLVMEYAAGGELFGKLR-----RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG-NLKVS 171 (451)
Q Consensus 103 -----~~~~lV~E~~~gg~L~~~l~-----~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~-~lkl~ 171 (451)
..+++||||+++ +|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 135 ~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred cCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeee
Confidence 257799999986 5665553 35799999999999999999999999999999999999999765 69999
Q ss_pred eccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc-----
Q 013005 172 DFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR----- 246 (451)
Q Consensus 172 DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~----- 246 (451)
|||+|..... .......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+......++...
T Consensus 214 DFGla~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 214 DFGSAKNLLA--GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291 (440)
T ss_pred ccccchhccC--CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9999975432 122335678999999999877655577899999999999999999999887655443333210
Q ss_pred ------------CC------------CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 247 ------------DY------------QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 247 ------------~~------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.. .+|...++++.+||.+||..||.+|||+.|+++||||...
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 11 1344567899999999999999999999999999999753
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-46 Score=376.02 Aligned_cols=256 Identities=24% Similarity=0.405 Sum_probs=213.5
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC-----
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT----- 103 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~----- 103 (451)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... .+......+.+|+.+++.++ ||||+++++++....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 77 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF--QNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDPFE 77 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc--cchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccccc
Confidence 4788999999999999999999999999999986531 22334567889999999995 999999999998776
Q ss_pred EEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 104 KIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
..|+||||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 78 EIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred eEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 8999999997 477777754 67999999999999999999999999999999999999999999999999999764433
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhc-----------------
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNR----------------- 245 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~----------------- 245 (451)
.........+|+.|+|||++.+....+.++||||+||++|+|++|+.||...+.......+..
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 333344557899999999988766557779999999999999999999987765544333321
Q ss_pred ------cCC---------CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 246 ------RDY---------QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 246 ------~~~---------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
... .+....++++.+||.+||..||.+|||++++++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 111 1223457889999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=360.98 Aligned_cols=252 Identities=29% Similarity=0.478 Sum_probs=205.4
Q ss_pred CCeEEcceEcccCceEEEEEEEcC-CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhc--CCCCceEEEEEEE----
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIA-DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ--NHPNVLKIQEVMA---- 100 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~--~HpnIv~l~~~~~---- 100 (451)
.+|++.+.||+|+||+||+|.+.. ++..||+|.+..... .......+.+|+.+++.+. +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~ 78 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG--EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 78 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC--CCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence 479999999999999999999865 468899999875421 1122334567787777764 4999999999885
Q ss_pred -eCCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCC
Q 013005 101 -TKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176 (451)
Q Consensus 101 -~~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls 176 (451)
.....++||||+. ++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 79 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 79 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 3456999999997 588888864 45899999999999999999999999999999999999999999999999998
Q ss_pred CcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC--------
Q 013005 177 ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY-------- 248 (451)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~-------- 248 (451)
...... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+.++.....
T Consensus 158 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 158 RIYSFQ--MALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred EeccCC--cccccccccccccChHHHhCCCC-CCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 754321 23345679999999999977666 4569999999999999999999998776665555432100
Q ss_pred -------------------CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 249 -------------------QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 249 -------------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
.+.+.+++.+.+||.+||..||++|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0113467888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=362.86 Aligned_cols=256 Identities=27% Similarity=0.487 Sum_probs=212.0
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
+++|.+.+.||+|+||.||+|++..+++.||+|.+..... ......+.+|+.++++++ ||||+++++++...+..|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 80 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKDLK-HANIVTLHDIVHTDKSLT 80 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc---CCcchhHHHHHHHHHhCC-CCCcceEEEEEeeCCeEE
Confidence 5789999999999999999999999999999999975421 122345678999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 107 LVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
+||||+.+ +|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~ 158 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP-T 158 (309)
T ss_pred EEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC-c
Confidence 99999976 78777754 45899999999999999999999999999999999999999999999999998643221 1
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhc-------------------
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNR------------------- 245 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~------------------- 245 (451)
.......+|+.|+|||++.+....+.++||||+||++|+|++|..||...+..+....+..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 2233457899999999987655557789999999999999999999987665443322211
Q ss_pred cCCCCC-----------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 246 RDYQFP-----------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 246 ~~~~~p-----------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
....+| +.+++++.+||.+||..||.+|||++++++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 001111 2367889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=349.44 Aligned_cols=256 Identities=29% Similarity=0.520 Sum_probs=218.6
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcch-hhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKF-LDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
++|.+.+.||+|++|.||.|.+..+++.||+|.+...... ........+.+|+.+++++. ||||+++++++......|
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEccCCeEE
Confidence 5799999999999999999999999999999998754211 11223457889999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 107 LVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
+|+||++|++|.+.+.. +.+++..++.++.|++.||.|||+.|++||||+|+||++++++.++|+|||++.........
T Consensus 81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 99999999999998875 67899999999999999999999999999999999999999999999999998654322111
Q ss_pred c--ccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc--CCCCCCCCCHhHHHH
Q 013005 186 M--LHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR--DYQFPSFVSKPARSL 261 (451)
Q Consensus 186 ~--~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~l 261 (451)
. .....|++.|+|||.+.+..+ +.++||||+|+++|+|++|+.||...+.......+... ...+|..++..+.++
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNF 239 (263)
T ss_pred cccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHH
Confidence 1 134568899999999987664 57799999999999999999999876665554444332 345677789999999
Q ss_pred HHhccCCCCCCCCCHHHHHcCccc
Q 013005 262 IYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 262 i~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
|.+||..+|++|||+.++++||||
T Consensus 240 i~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 240 LRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHhhcCcccCCCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=375.03 Aligned_cols=251 Identities=20% Similarity=0.335 Sum_probs=205.8
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
...++|++.+.||+|+||.||+|++..+++.||+|.... ..+.+|+.++++|. ||||+++++++.....
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~----------~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~ 157 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR----------GGTATEAHILRAIN-HPSIIQLKGTFTYNKF 157 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh----------hhhHHHHHHHHhCC-CCCCCCEeEEEEECCe
Confidence 445789999999999999999999999999999997532 23578999999995 9999999999999999
Q ss_pred EEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 105 IYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
.++|||++. ++|..++.. ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 158 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 158 TCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred eEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 999999995 688887764 679999999999999999999999999999999999999999999999999997543322
Q ss_pred cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCc-------HHHHHHHh-------------
Q 013005 184 NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN-------LLAMYKKV------------- 243 (451)
Q Consensus 184 ~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~-------~~~~~~~i------------- 243 (451)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.... .......+
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred ccccccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 233445689999999999987766 567999999999999999998874321 01111111
Q ss_pred -------------hccCC----CCCC-----CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 244 -------------NRRDY----QFPS-----FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 244 -------------~~~~~----~~p~-----~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
..... ..|. .++.++.+||.+||..||.+|||++|+++||||+..
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 00000 1111 145678999999999999999999999999999763
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=354.33 Aligned_cols=263 Identities=33% Similarity=0.612 Sum_probs=227.6
Q ss_pred ccccCCeEE-cceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 24 PTLLNRYQL-GPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 24 ~~~~~~y~~-~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
+.+.+-|.+ .+.||+|+|+.|--+.+..||..||||++++.. .....++.+|+.++.+.++|+||++++++|+++
T Consensus 73 g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~----gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 73 GKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP----GHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred chHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC----chHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 344555665 567999999999999999999999999999863 345578999999999999999999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCC---eEEEeccCCCc
Q 013005 103 TKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN---LKVSDFGLSAL 178 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~---lkl~DFGls~~ 178 (451)
+..|||||-+.||.|...|.+ ..|+|.++.++.++|+.||+|||.+||.||||||||||-..... +|||||.|..-
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg 228 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSG 228 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccc
Confidence 999999999999999988875 67999999999999999999999999999999999999865544 79999999753
Q ss_pred ch------hhhcCcccccCCCCccccceeee----ccCCCCccchhhhhhHHHHHHHhcCCCCCCC--------------
Q 013005 179 PE------QIKNGMLHTACGTPAYTAPEVVA----RRGYDGAVADAWSCGVILFVLLAGYLPFDDS-------------- 234 (451)
Q Consensus 179 ~~------~~~~~~~~~~~gt~~y~APEvl~----~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~-------------- 234 (451)
.. ......+.++||+..|||||+.. ...++..++|.||||||||.||+|++||.+.
T Consensus 229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr 308 (463)
T KOG0607|consen 229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR 308 (463)
T ss_pred cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence 22 12234567889999999999863 2345567799999999999999999999642
Q ss_pred -cHHHHHHHhhccCCCCCC----CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchhH
Q 013005 235 -NLLAMYKKVNRRDYQFPS----FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQ 290 (451)
Q Consensus 235 -~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 290 (451)
....++..|..+.+.||. .+|.+++++|+.+|..|+..|.++.++++|||++....
T Consensus 309 ~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 309 VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence 245788899999999996 38999999999999999999999999999999987543
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=383.84 Aligned_cols=265 Identities=30% Similarity=0.489 Sum_probs=226.2
Q ss_pred CCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE
Q 013005 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 20 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~ 99 (451)
........++|++.+.||+|+||+||+|.+..+++.||||+++... .+......+.+|+.++..+. |+||+++++.+
T Consensus 24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~--~~~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~ 100 (496)
T PTZ00283 24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG--MSEADKNRAQAEVCCLLNCD-FFSIVKCHEDF 100 (496)
T ss_pred cccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEeccc--CCHHHHHHHHHHHHHHhcCC-CCcEEEeecce
Confidence 3444556689999999999999999999999999999999997653 23344567889999999995 99999998877
Q ss_pred EeCC--------EEEEEEEecCCCchhHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC
Q 013005 100 ATKT--------KIYLVMEYAAGGELFGKLRR-----GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG 166 (451)
Q Consensus 100 ~~~~--------~~~lV~E~~~gg~L~~~l~~-----~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~ 166 (451)
.... .+++||||+.+|+|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++
T Consensus 101 ~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 101 AKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG 180 (496)
T ss_pred ecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC
Confidence 5432 47899999999999998853 4689999999999999999999999999999999999999999
Q ss_pred CeEEEeccCCCcchhhh-cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhc
Q 013005 167 NLKVSDFGLSALPEQIK-NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNR 245 (451)
Q Consensus 167 ~lkl~DFGls~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~ 245 (451)
.+||+|||++....... .....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+..
T Consensus 181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~ 259 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY-SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA 259 (496)
T ss_pred CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 99999999987543321 233456789999999999987766 5679999999999999999999999888777776665
Q ss_pred cCC-CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 246 RDY-QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 246 ~~~-~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
... .+|+.+++.+.+++.+||..||.+|||+.+++.|||++..
T Consensus 260 ~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 260 GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 443 4677889999999999999999999999999999998754
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=353.07 Aligned_cols=252 Identities=37% Similarity=0.649 Sum_probs=212.9
Q ss_pred eEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEE
Q 013005 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVM 109 (451)
Q Consensus 30 y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~ 109 (451)
|++++.||+|+||+||++++..+++.||+|++..... .........+|+.+++++ +||||+++++++......++||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~v~ 77 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI--EEEEREENIREIKILRRL-RHPNIVQILDVFQDDNYLYIVM 77 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH--HHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEESSEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc--cccccchhhhhhhccccc-cccccccccccccccccccccc
Confidence 8899999999999999999999999999999987632 222333445699999999 5999999999999999999999
Q ss_pred EecCCCchhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCccc
Q 013005 110 EYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLH 188 (451)
Q Consensus 110 E~~~gg~L~~~l~-~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~ 188 (451)
||+.+++|.+++. .+.+++.++..++.||++||++||++|++|+||||+||+++.++.++|+|||.+... ........
T Consensus 78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~~~~~ 156 (260)
T PF00069_consen 78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL-SENNENFN 156 (260)
T ss_dssp EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES-TSTTSEBS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence 9999999999997 689999999999999999999999999999999999999999999999999998643 11234455
Q ss_pred ccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCc---HHHHHHHhhccCCCC----CCCCCHhHHHH
Q 013005 189 TACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN---LLAMYKKVNRRDYQF----PSFVSKPARSL 261 (451)
Q Consensus 189 ~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~---~~~~~~~i~~~~~~~----p~~~s~~~~~l 261 (451)
..++|+.|.|||++......+.++||||||+++|+|++|..||...+ ......+........ ....+..+.++
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDL 236 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHH
Confidence 67899999999998744555778999999999999999999999873 333333333221111 11224899999
Q ss_pred HHhccCCCCCCCCCHHHHHcCccc
Q 013005 262 IYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 262 i~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
|.+||+.||++|||+.++++||||
T Consensus 237 i~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 237 IKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHccCChhHCcCHHHHhcCCCC
Confidence 999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=369.05 Aligned_cols=256 Identities=24% Similarity=0.413 Sum_probs=212.8
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC--
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK-- 102 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~-- 102 (451)
.+.++|++.+.||+|+||+||+|.+..+++.||+|++.... ........+.+|+.+++++. ||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF--QSLIHARRTYRELRLLKHMK-HENVIGLLDVFTPATS 88 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh--hhhHHHHHHHHHHHHHHhcC-CCchhhhhhhhccccc
Confidence 45689999999999999999999999999999999987542 22233456778999999995 99999999987543
Q ss_pred ----CEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 103 ----TKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 103 ----~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
...|+++|++ +++|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcccee
Confidence 4578999988 77999888888899999999999999999999999999999999999999999999999999875
Q ss_pred chhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC-----------
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD----------- 247 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~----------- 247 (451)
... .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||...+.......+....
T Consensus 168 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07878 168 ADD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243 (343)
T ss_pred cCC----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 422 23456799999999998775556778999999999999999999998766544433322100
Q ss_pred ------------CCCC--------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 248 ------------YQFP--------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 248 ------------~~~p--------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
...+ ...++.+.+||.+||..||.+|||+.++++||||...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 0011 1246678999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=367.55 Aligned_cols=257 Identities=28% Similarity=0.462 Sum_probs=209.2
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC-
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT- 103 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~- 103 (451)
.+.++|++.+.||+|+||.||++.+..+|+.||+|++.... ........+.+|+.+++.+. ||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 94 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF--QNQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQKS 94 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc--cchhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCC
Confidence 56799999999999999999999999999999999997542 22344567789999999995 999999999986543
Q ss_pred -----EEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 104 -----KIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 104 -----~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
..|+||||+.+ +|...+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 95 LEEFQDVYLVMELMDA-NLCQVIH-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred ccccceeEEEEeCCCc-CHHHHHh-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 57999999976 5555553 4589999999999999999999999999999999999999999999999999874
Q ss_pred chhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhc-------------
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNR------------- 245 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~------------- 245 (451)
... ........||+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+..
T Consensus 173 ~~~--~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 173 ACT--NFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccc--CccCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 322 2233456789999999999887774 569999999999999999999987654332221110
Q ss_pred ---------cCCC---------CC-----------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 246 ---------RDYQ---------FP-----------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 246 ---------~~~~---------~p-----------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
.... ++ ...++.+.+||.+||..||++|||+.|+++||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 322 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY 322 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence 0000 11 12357789999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=354.46 Aligned_cols=255 Identities=36% Similarity=0.692 Sum_probs=227.8
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|++.+.||+|+||.||++.+..+++.||+|++.+. ........+.+.+|+.+++++. ||||+++++++.+....|+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKA-KIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHH-HhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCeEEE
Confidence 4799999999999999999999999999999999764 2233345577889999999996 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCc
Q 013005 108 VMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM 186 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~ 186 (451)
||||+++++|.+++.+ +.+++..+..++.||+.||.|||++|++||||+|.||+++.++.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 79 VMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 9999999999999875 77999999999999999999999999999999999999999999999999998754322
Q ss_pred ccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhcc
Q 013005 187 LHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLL 266 (451)
Q Consensus 187 ~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 266 (451)
....+|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+....+..+......+|..++..+.++|.+||
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 233 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLL 233 (290)
T ss_pred CCCCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHc
Confidence 345578999999999876654 5669999999999999999999998887777888777778888889999999999999
Q ss_pred CCCCCCCC-----CHHHHHcCccccchh
Q 013005 267 DPNPKTRM-----SIEKIMSISWFQKSL 289 (451)
Q Consensus 267 ~~dP~~Rp-----t~~eil~hp~f~~~~ 289 (451)
..||.+|+ +++++++||||+...
T Consensus 234 ~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 234 QVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred cCCHHHccCcccCCHHHHHcCcccccCC
Confidence 99999999 999999999997643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=377.68 Aligned_cols=256 Identities=29% Similarity=0.453 Sum_probs=221.6
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCC-CcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIAD-GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~-~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
...|.+.+.||+|+||.||+|.+..+ ++.||+|.+... .......+.+|+.+++.+. |||||++++++...+..
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~ 140 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAAYARSELHCLAACD-HFGIVKHFDDFKSDDKL 140 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEECCEE
Confidence 44599999999999999999998877 788999987543 2234456788999999995 99999999999999999
Q ss_pred EEEEEecCCCchhHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 106 YLVMEYAAGGELFGKLRR-----GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~-----~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
|+||||++||+|.+.+.. ..+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 999999999999887742 468999999999999999999999999999999999999999999999999997543
Q ss_pred hhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC-CCCCCCCHhH
Q 013005 181 QIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY-QFPSFVSKPA 258 (451)
Q Consensus 181 ~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~ 258 (451)
.... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...+.......+..... .+|..++..+
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 299 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGM 299 (478)
T ss_pred CccccccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHH
Confidence 3211 23456689999999999987666 5679999999999999999999998888777777665544 4566789999
Q ss_pred HHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 259 RSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 259 ~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.++|.+||..||++|||+++++.|||++..
T Consensus 300 ~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 300 KALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred HHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 999999999999999999999999999753
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=355.15 Aligned_cols=251 Identities=28% Similarity=0.478 Sum_probs=203.8
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhc--CCCCceEEEEEEEe-----
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ--NHPNVLKIQEVMAT----- 101 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~--~HpnIv~l~~~~~~----- 101 (451)
+|++.+.||+|+||+||+|.+..+++.||+|.+..... .......+.+|+.+++.+. +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~ 78 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN--EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR 78 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC--CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence 58999999999999999999999999999999875421 1112234556777777664 59999999998864
Q ss_pred CCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
....+++|||+.+ +|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 79 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 79 ETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred CceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 3468999999985 88887764 3589999999999999999999999999999999999999999999999999875
Q ss_pred chhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc-----------C
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR-----------D 247 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~-----------~ 247 (451)
... ........||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+......++... .
T Consensus 158 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 158 YSC--QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred ccC--cccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 432 222345678999999999977665 56699999999999999999999877665444433210 0
Q ss_pred C----------------CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 248 Y----------------QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 248 ~----------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
. .+.+.++..+.+||.+||.+||++|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0112467788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=361.17 Aligned_cols=256 Identities=24% Similarity=0.409 Sum_probs=214.7
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
..++|++.+.||+|+||.||+|.+..++..+|+|++.... .....+.+.+|+.+++++. ||||+++++++.+.+..
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 78 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEI 78 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCC-CCcccceeEEEEECCEE
Confidence 4579999999999999999999999999999999987542 2344567899999999995 99999999999999999
Q ss_pred EEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 106 YLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQN-GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~-giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
|+||||+.||+|.+++.. +.+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++.....
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-- 156 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 156 (333)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh--
Confidence 999999999999999875 6799999999999999999999985 799999999999999999999999999864422
Q ss_pred cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHh--------------------
Q 013005 184 NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKV-------------------- 243 (451)
Q Consensus 184 ~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i-------------------- 243 (451)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........+
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 157 -SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred -hccccCCCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 22334579999999999977655 56699999999999999999999765443322111
Q ss_pred ------------------------hc-cCCCCC-CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 244 ------------------------NR-RDYQFP-SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 244 ------------------------~~-~~~~~p-~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
.. ....++ ..++.++.+||.+||..||++|||+++++.||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 00 011111 13578899999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=355.68 Aligned_cols=251 Identities=29% Similarity=0.472 Sum_probs=210.8
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC---
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT--- 103 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~--- 103 (451)
.=.|+..+++|.|+||.||+|...++++.||||.+-.+.+.. .+|+.+|+++. |||||++.-+|....
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k--------nrEl~im~~l~-HpNIV~L~~~f~~~~~~d 93 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK--------NRELQIMRKLD-HPNIVRLLYFFSSSTESD 93 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC--------cHHHHHHHhcC-CcCeeeEEEEEEecCCCc
Confidence 346888999999999999999999999999999987664322 37899999995 999999988875432
Q ss_pred --EEEEEEEecCCCchhHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCC-CCeEEEeccC
Q 013005 104 --KIYLVMEYAAGGELFGKLR-----RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD-GNLKVSDFGL 175 (451)
Q Consensus 104 --~~~lV~E~~~gg~L~~~l~-----~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~-~~lkl~DFGl 175 (451)
+..+||||++. +|...++ +.+++...++-|..||++||.|||+.||+||||||+|||+|.+ |.+||||||.
T Consensus 94 ~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGS 172 (364)
T KOG0658|consen 94 EVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGS 172 (364)
T ss_pred hhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCc
Confidence 34589999976 8888887 4679999999999999999999999999999999999999987 8999999999
Q ss_pred CCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc---------
Q 013005 176 SALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR--------- 246 (451)
Q Consensus 176 s~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~--------- 246 (451)
|......... .+..-|..|.|||++.+...++.+.||||+||++.||+.|++.|.+.+.......|.+-
T Consensus 173 AK~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 173 AKVLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred ceeeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9876553332 45556899999999999887888899999999999999999999988776655544220
Q ss_pred --------CCC------------CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 247 --------DYQ------------FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 247 --------~~~------------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
... +....++++.+|+.++|.++|.+|.++.|++.||||..-.
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 111 2234689999999999999999999999999999998643
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=369.51 Aligned_cols=259 Identities=27% Similarity=0.496 Sum_probs=235.2
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE-
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK- 104 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~- 104 (451)
.+++|+.++.+|+|+||.+++++++..++.+++|.++.... .....+...+|+.++++++ |||||.+++.|..++.
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~--t~~~r~~A~~E~~lis~~~-hP~iv~y~ds~~~~~~~ 78 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKL--TEPERRSAIQEMDLLSKLL-HPNIVEYKDSFEEDGQL 78 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEecccc--CchhhHHHHHHHHHHHhcc-CCCeeeeccchhcCCce
Confidence 36789999999999999999999999999999999987643 2333447789999999996 9999999999998888
Q ss_pred EEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 105 IYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
.+|||+||+||++.+.+.+ .-++|+.+..||.|++.||.|||+++|.|||||+.||+++.++.+||+|||+|+....
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999999999974 3599999999999999999999999999999999999999999999999999987654
Q ss_pred hhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC-CCCCCCCCHhHHH
Q 013005 182 IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD-YQFPSFVSKPARS 260 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 260 (451)
.. ....+.+|||.|+.||++.+.+| +.++|||||||++|+|++-+++|...+...+..+|.... .+.|...+.+++.
T Consensus 159 ~~-~~a~tvvGTp~YmcPEil~d~pY-n~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~ 236 (426)
T KOG0589|consen 159 ED-SLASTVVGTPYYMCPEILSDIPY-NEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRS 236 (426)
T ss_pred ch-hhhheecCCCcccCHHHhCCCCC-CccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHH
Confidence 22 36678899999999999999998 567999999999999999999999999999999999887 5677889999999
Q ss_pred HHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 261 LIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 261 li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
+|..||..+|..||++.++|.+|..+...
T Consensus 237 lv~~~l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 237 LVKSMLRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred HHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence 99999999999999999999999987655
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=378.47 Aligned_cols=253 Identities=23% Similarity=0.372 Sum_probs=201.4
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhc-----CCCCceEEEEEEE
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ-----NHPNVLKIQEVMA 100 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~-----~HpnIv~l~~~~~ 100 (451)
..++|++.+.||+|+||+||+|.+..+++.||||+++.... .......|+.+++.+. +|++++++++++.
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 45789999999999999999999999999999999965321 2234556777777664 2456899999887
Q ss_pred eC-CEEEEEEEecCCCchhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCeEEeCCCC-----------
Q 013005 101 TK-TKIYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQ-NGVAHRDVKPQNLLLDRDG----------- 166 (451)
Q Consensus 101 ~~-~~~~lV~E~~~gg~L~~~l~-~~~l~e~~~~~~~~ql~~gL~yLH~-~giiHrDLKpeNILld~~~----------- 166 (451)
.. .+.|+|||++ |++|.+++. .+.+++..++.++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 64 5789999988 678888776 4789999999999999999999998 5999999999999998765
Q ss_pred -----CeEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHH
Q 013005 167 -----NLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYK 241 (451)
Q Consensus 167 -----~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~ 241 (451)
.+||+|||++.... ......+||+.|+|||++.+..| +.++|||||||++|+|++|+.||...+......
T Consensus 281 ~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGW-MYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred CCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 49999999876322 22345689999999999988777 466999999999999999999998766544333
Q ss_pred HhhccCCCCC-----------------------------------------C-CCCHhHHHHHHhccCCCCCCCCCHHHH
Q 013005 242 KVNRRDYQFP-----------------------------------------S-FVSKPARSLIYQLLDPNPKTRMSIEKI 279 (451)
Q Consensus 242 ~i~~~~~~~p-----------------------------------------~-~~s~~~~~li~~~L~~dP~~Rpt~~ei 279 (451)
.+......+| . ..++.+.+||.+||..||.+|||++|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 2211100000 0 013557799999999999999999999
Q ss_pred HcCccccchh
Q 013005 280 MSISWFQKSL 289 (451)
Q Consensus 280 l~hp~f~~~~ 289 (451)
++||||++..
T Consensus 436 L~Hp~~~~~~ 445 (467)
T PTZ00284 436 TTHPYVLKYY 445 (467)
T ss_pred hcCccccccC
Confidence 9999998643
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=364.49 Aligned_cols=257 Identities=26% Similarity=0.424 Sum_probs=209.1
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC--
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK-- 102 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~-- 102 (451)
...++|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.+. ||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 90 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKS 90 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc--cChHHHHHHHHHHHHHHHhC-CCchhceeeeeecccc
Confidence 56789999999999999999999999999999999997542 23344567788999999995 99999999998643
Q ss_pred ----CEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 103 ----TKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 103 ----~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
...|+||||+++ +|.+.+. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 91 ~~~~~~~~lv~e~~~~-~l~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 91 LEEFQDVYLVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred ccccceeEEEhhhhcc-cHHHHHh-hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 357999999976 5665554 3589999999999999999999999999999999999999999999999999975
Q ss_pred chhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhc-------------
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNR------------- 245 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~------------- 245 (451)
... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 169 ~~~--~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 169 AGT--SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred CCC--ccccCCccccCCccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 422 223345679999999999987776 4569999999999999999999987664433222110
Q ss_pred ---------cC-----CC---------------CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 246 ---------RD-----YQ---------------FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 246 ---------~~-----~~---------------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
.. .. .+...+..+.+||.+||..||++|||++|+++||||....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 00 00 1112356789999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=352.10 Aligned_cols=255 Identities=27% Similarity=0.441 Sum_probs=213.6
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
.|+..+.||+|+||.||++.+..+++.||+|.+.+.. .........+.+|+.+++++. |+||+.+++.+.+.+..|+|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR-IKKRKGESMALNEKQILEKVN-SRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhh-ccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEecCCEEEEE
Confidence 4788899999999999999999999999999987642 222333456778999999995 99999999999999999999
Q ss_pred EEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 109 MEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
|||+.|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ..
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~--~~ 156 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQ 156 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC--Cc
Confidence 999999999988853 3599999999999999999999999999999999999999999999999999865322 12
Q ss_pred cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH----HHHHHhhccCCCCCCCCCHhHHHH
Q 013005 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL----AMYKKVNRRDYQFPSFVSKPARSL 261 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~----~~~~~i~~~~~~~p~~~s~~~~~l 261 (451)
.....+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...... ............++..+++.+.+|
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSL 235 (285)
T ss_pred cccCCCCCccccChHHHcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHH
Confidence 2234579999999999987766 56699999999999999999999864321 111111222334566789999999
Q ss_pred HHhccCCCCCCCCC-----HHHHHcCccccch
Q 013005 262 IYQLLDPNPKTRMS-----IEKIMSISWFQKS 288 (451)
Q Consensus 262 i~~~L~~dP~~Rpt-----~~eil~hp~f~~~ 288 (451)
+.+||..||.+||| ++++++||||+..
T Consensus 236 i~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 236 CKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred HHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 99999999999999 9999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=365.39 Aligned_cols=256 Identities=26% Similarity=0.428 Sum_probs=209.5
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC--
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK-- 102 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~-- 102 (451)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.+. ||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~~ 97 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKS 97 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc--cCchhHHHHHHHHHHHHhcC-CCCccccceeeccccc
Confidence 46789999999999999999999999999999999997532 22334456788999999995 99999999987543
Q ss_pred ----CEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 103 ----TKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 103 ----~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
...|+||||+.+ +|...+. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 98 ~~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 98 LEEFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred ccccCeEEEEEeCCCC-CHHHHHH-hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 468999999976 6666664 3588999999999999999999999999999999999999999999999999975
Q ss_pred chhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc------------
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR------------ 246 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~------------ 246 (451)
... ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+.++...
T Consensus 176 ~~~--~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 176 AGT--SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred cCC--CCcccCCcccCCcCCHHHHhCCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 432 223345679999999999987766 45699999999999999999999877665544433210
Q ss_pred ----------CCC--------------C------CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 247 ----------DYQ--------------F------PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 247 ----------~~~--------------~------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
... + +...+..+++||.+||..||.+|||++++++||||...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 000 0 01134678999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=353.82 Aligned_cols=258 Identities=27% Similarity=0.461 Sum_probs=213.7
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
-+++|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++ ||||+++++++......
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~ 79 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSL 79 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc---cCchhHHHHHHHHHHhcC-CCCcceEEEEEecCCeE
Confidence 36789999999999999999999999999999999875421 122345678999999995 99999999999999999
Q ss_pred EEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 106 YLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
|+||||+.+ +|..++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~- 157 (301)
T cd07873 80 TLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP- 157 (301)
T ss_pred EEEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC-
Confidence 999999974 88887764 56899999999999999999999999999999999999999999999999998643221
Q ss_pred cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc-----------------
Q 013005 184 NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR----------------- 246 (451)
Q Consensus 184 ~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~----------------- 246 (451)
........+++.|+|||++.+....+.++|||||||++|+|++|+.||...+.......+...
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 122334567999999999877665677899999999999999999999887665443322110
Q ss_pred --CCCCC-----------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 247 --DYQFP-----------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 247 --~~~~p-----------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
...+| ..+++.+.+||.+||..||.+|||++++++||||+.-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 01111 24678899999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=360.53 Aligned_cols=254 Identities=22% Similarity=0.382 Sum_probs=205.4
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEc-----CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSI-----ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
....++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.+.+||||++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA---TASEHKALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc---chHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence 445679999999999999999999752 345789999986532 223346788999999999669999999998
Q ss_pred EEeC-CEEEEEEEecCCCchhHHhhc------------------------------------------------------
Q 013005 99 MATK-TKIYLVMEYAAGGELFGKLRR------------------------------------------------------ 123 (451)
Q Consensus 99 ~~~~-~~~~lV~E~~~gg~L~~~l~~------------------------------------------------------ 123 (451)
+... ..+|++|||+++|+|.+++..
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 8654 468999999999999988863
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc-CcccccCCC
Q 013005 124 ---------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGT 193 (451)
Q Consensus 124 ---------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt 193 (451)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .......++
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 1377888999999999999999999999999999999999999999999999975422111 112234567
Q ss_pred CccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHH-HHHHhhcc-CCCCCCCCCHhHHHHHHhccCCCC
Q 013005 194 PAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLA-MYKKVNRR-DYQFPSFVSKPARSLIYQLLDPNP 270 (451)
Q Consensus 194 ~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP 270 (451)
+.|+|||++.+..+ +.++|||||||++|+|++ |..||....... ....+... ....|...++.+.+++.+||..||
T Consensus 240 ~~y~aPE~~~~~~~-~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 318 (338)
T cd05102 240 LKWMAPESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDP 318 (338)
T ss_pred ccccCcHHhhcCCC-CcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 88999999987766 567999999999999997 999998754332 33333332 344566789999999999999999
Q ss_pred CCCCCHHHHHc
Q 013005 271 KTRMSIEKIMS 281 (451)
Q Consensus 271 ~~Rpt~~eil~ 281 (451)
.+|||+.++++
T Consensus 319 ~~RPs~~el~~ 329 (338)
T cd05102 319 KERPTFSALVE 329 (338)
T ss_pred hhCcCHHHHHH
Confidence 99999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=348.30 Aligned_cols=248 Identities=23% Similarity=0.420 Sum_probs=205.3
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecCCC
Q 013005 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGG 115 (451)
Q Consensus 36 LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~gg 115 (451)
||+|+||.||++.+..+|+.||+|.+.... .........+..|+.+++++. ||||+++++++.+....|+||||+.|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~~~E~~il~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKR-LKKKSGEKMALLEKEILEKVN-SPFIVNLAYAFESKTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHH-hhcchhhHHHHHHHHHHHhcC-CCcEEEEEEEEecCCeEEEEEecCCCC
Confidence 699999999999999999999999997532 111223345567999999995 999999999999999999999999999
Q ss_pred chhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCC
Q 013005 116 ELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACG 192 (451)
Q Consensus 116 ~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~g 192 (451)
+|.+.+.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++...... .......|
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~ 156 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRAG 156 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeeccCC
Confidence 99888753 35899999999999999999999999999999999999999999999999998754321 22234679
Q ss_pred CCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcH----HHHHHHhhccCCCCC-CCCCHhHHHHHHhccC
Q 013005 193 TPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNL----LAMYKKVNRRDYQFP-SFVSKPARSLIYQLLD 267 (451)
Q Consensus 193 t~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~----~~~~~~i~~~~~~~p-~~~s~~~~~li~~~L~ 267 (451)
|+.|+|||++.+..+ +.++||||+||++|+|++|..||..... .............++ ..++.++.+||.+||.
T Consensus 157 ~~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 235 (277)
T cd05607 157 TNGYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLA 235 (277)
T ss_pred CCCccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhc
Confidence 999999999987775 5679999999999999999999976432 233333333333332 3578999999999999
Q ss_pred CCCCCCCCH----HHHHcCccccch
Q 013005 268 PNPKTRMSI----EKIMSISWFQKS 288 (451)
Q Consensus 268 ~dP~~Rpt~----~eil~hp~f~~~ 288 (451)
.||++||++ ++++.||||+..
T Consensus 236 ~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 236 KKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred cCHhhCCCCccchhhhhcChhhcCC
Confidence 999999999 778899999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=339.73 Aligned_cols=252 Identities=26% Similarity=0.493 Sum_probs=216.1
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe-CCEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT-KTKIYL 107 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~-~~~~~l 107 (451)
+|++.+.||+|++|.||++.+..+++.||+|.+.... ......+.+.+|+.++++++ |||++++++.+.. ....|+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~l 77 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN--ASRRERKAAEQEAQLLSQLK-HPNIVAYRESWEGEDGLLYI 77 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh--cCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecCCCCEEEE
Confidence 5899999999999999999999999999999997542 22334566889999999995 9999999998764 456899
Q ss_pred EEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 108 VMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
+|||+++++|.+++.. ..+++.+++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++...... .
T Consensus 78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~-~ 156 (257)
T cd08223 78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ-C 156 (257)
T ss_pred EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc-C
Confidence 9999999999998864 35899999999999999999999999999999999999999999999999998755332 2
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC-CCCCCCCHhHHHHHH
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY-QFPSFVSKPARSLIY 263 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~ 263 (451)
.......|++.|+|||++.+..+ +.++||||+|+++|+|++|..||...+.......+..... ..+..+++.+.+++.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPY-NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIA 235 (257)
T ss_pred CccccccCCcCccChhHhcCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHH
Confidence 23345678999999999877665 4669999999999999999999988777666555544433 456678999999999
Q ss_pred hccCCCCCCCCCHHHHHcCccc
Q 013005 264 QLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 264 ~~L~~dP~~Rpt~~eil~hp~f 285 (451)
+||..||++|||+.++++||||
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 236 TMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=346.27 Aligned_cols=255 Identities=25% Similarity=0.432 Sum_probs=216.5
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
.|+..+.||+|+||+||+|.+..+++.+|+|.+.+. ..........+.+|+.++++++ |+||+.+++.+..++..|++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKK-RIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehh-hhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEecCCEEEEE
Confidence 377889999999999999999999999999999764 2223334456788999999995 99999999999999999999
Q ss_pred EEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 109 MEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
|||+.+++|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ..
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~--~~ 156 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE--GE 156 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC--CC
Confidence 999999999887753 3699999999999999999999999999999999999999999999999999864322 12
Q ss_pred cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHH----HHHhhccCCCCCCCCCHhHHHH
Q 013005 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAM----YKKVNRRDYQFPSFVSKPARSL 261 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~l 261 (451)
......|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||........ ...+......++..++..+.+|
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSI 235 (285)
T ss_pred cccCCCCCcCccChHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHH
Confidence 2245679999999999977665 5669999999999999999999987654432 2333333445666788999999
Q ss_pred HHhccCCCCCCCCC-----HHHHHcCccccch
Q 013005 262 IYQLLDPNPKTRMS-----IEKIMSISWFQKS 288 (451)
Q Consensus 262 i~~~L~~dP~~Rpt-----~~eil~hp~f~~~ 288 (451)
+.+||..||++||| +++++.||||+..
T Consensus 236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 236 CKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 99999999999999 8999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=346.70 Aligned_cols=252 Identities=27% Similarity=0.455 Sum_probs=207.3
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
+|++.+.||+|++|.||+|.+..+++.||+|.+.... .+......+.+|+.+++.+. ||||+++++++.+....|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 77 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES--EEEGVPSTAIREISLLKELQ-HPNIVCLQDVLMQESRLYLI 77 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc--ccCCchHHHHHHHHHHHhcC-CCCEeeeEEEEeeCCeEEEE
Confidence 5899999999999999999999999999999986542 12223456788999999996 99999999999999999999
Q ss_pred EEecCCCchhHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 109 MEYAAGGELFGKLRR----GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~----~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
|||+. ++|.+++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++...... .
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~ 155 (285)
T cd07861 78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-V 155 (285)
T ss_pred EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC-c
Confidence 99997 578887753 56899999999999999999999999999999999999999999999999998643221 1
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc------------------
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR------------------ 246 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~------------------ 246 (451)
.......+++.|+|||++.+....+.++|||||||++|+|++|+.||...+.......+...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 22334567899999999876555567799999999999999999999876543222111000
Q ss_pred -----C------CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 247 -----D------YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 247 -----~------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
. ......+++++.++|++||..||.+|||+.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0 00122368899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=345.39 Aligned_cols=254 Identities=31% Similarity=0.496 Sum_probs=214.5
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
+|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++++. ||||+++++++......|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v 77 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRR--LEGGIPNQALREIKALQACQ-HPYVVKLLDVFPHGSGFVLV 77 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccc--ccchhhHHHHHHHHHHHhCC-CCCCcceeeEEecCCeeEEE
Confidence 5899999999999999999999999999999997642 12344567889999999996 99999999999999999999
Q ss_pred EEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCc
Q 013005 109 MEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM 186 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~ 186 (451)
+||+ +++|.+++.. ..+++.+++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..........
T Consensus 78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9999 9999998864 569999999999999999999999999999999999999999999999999987654432223
Q ss_pred ccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc-------------------C
Q 013005 187 LHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR-------------------D 247 (451)
Q Consensus 187 ~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~-------------------~ 247 (451)
.....|+..|+|||.+.+....+.++||||+|+++|+|++|.+||...+....+..+... .
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence 445679999999999876666677899999999999999999888776654443332210 0
Q ss_pred CCC-----------CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCcccc
Q 013005 248 YQF-----------PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQ 286 (451)
Q Consensus 248 ~~~-----------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~ 286 (451)
..+ .+..+..+.+||.+||..||++|||+++++.||||.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 001 123568899999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=347.58 Aligned_cols=260 Identities=28% Similarity=0.476 Sum_probs=220.8
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
.......+|++.+.||+|+||.||+|++..+++.||+|.+..... ...+.+.+|+.+++.+. ||||+++++.+..
T Consensus 14 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~----~~~~~~~~e~~~l~~~~-h~~v~~~~~~~~~ 88 (296)
T cd06654 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENK-NPNIVNYLDSYLV 88 (296)
T ss_pred ccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc----chHHHHHHHHHHHHhCC-CCCEeeEEEEEEe
Confidence 345566899999999999999999999999999999999976422 22456889999999995 9999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 102 KTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
....|+||||++|++|.+++..+.+++.++..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 89 GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred CCEEEEeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999999875332
Q ss_pred hhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc---CCCCCCCCCHhH
Q 013005 182 IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR---DYQFPSFVSKPA 258 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~ 258 (451)
. ........|++.|+|||.+.+..+ +.++||||+||++|+|++|+.||...+.......+... ....+..++..+
T Consensus 169 ~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (296)
T cd06654 169 E-QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246 (296)
T ss_pred c-ccccCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHH
Confidence 1 122234578999999999876655 56799999999999999999999877654333222222 223455688999
Q ss_pred HHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 259 RSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 259 ~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.++|.+||.+||++|||+.+++.||||...
T Consensus 247 ~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 999999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=349.28 Aligned_cols=253 Identities=25% Similarity=0.429 Sum_probs=213.4
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|+.++++++ ||||+++++.+.+.+..|+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 76 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI---KPAIRNQIIRELKVLHECN-SPYIVGFYGAFYSDGEISI 76 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc---CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCEEEE
Confidence 47999999999999999999999999999999986542 2344567889999999995 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 108 VMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQ-NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~-~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
||||++|++|.+++.+ +.+++..++.++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++..... .
T Consensus 77 v~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~ 153 (308)
T cd06615 77 CMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---S 153 (308)
T ss_pred EeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc---c
Confidence 9999999999999975 779999999999999999999998 5999999999999999999999999999864322 2
Q ss_pred cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC------------------
Q 013005 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD------------------ 247 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~------------------ 247 (451)
.....+|++.|+|||.+.+..+ +.++||||+||++|+|++|..||...+.......+....
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred ccccCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence 2345678999999999876655 567999999999999999999997655433332221110
Q ss_pred -------------------CCCCC-CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 248 -------------------YQFPS-FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 248 -------------------~~~p~-~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
...|. .++.++.+|+.+||..||++|||+.++++||||.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 11111 257789999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=350.21 Aligned_cols=258 Identities=32% Similarity=0.561 Sum_probs=222.9
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+.. .........+.+|+.+++.+. ||||+++++.+......|+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKE-MIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQTETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccc-cchHHHHHHHHHHHHHHHhCC-CCCchhheeeeecCCEEEE
Confidence 47999999999999999999999999999999998652 222334567889999999996 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 108 VMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
||||+.|++|.+++.. ..+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 9999999999999864 4699999999999999999999999999999999999999999999999999764322110
Q ss_pred ----------------------------CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcH
Q 013005 185 ----------------------------GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNL 236 (451)
Q Consensus 185 ----------------------------~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~ 236 (451)
.......||..|+|||++.+..+ +.++||||||+++|+|++|..||...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 01123468999999999977665 5679999999999999999999998887
Q ss_pred HHHHHHhhccCCCCCCC--CCHhHHHHHHhccCCCCCCCCC----HHHHHcCccccch
Q 013005 237 LAMYKKVNRRDYQFPSF--VSKPARSLIYQLLDPNPKTRMS----IEKIMSISWFQKS 288 (451)
Q Consensus 237 ~~~~~~i~~~~~~~p~~--~s~~~~~li~~~L~~dP~~Rpt----~~eil~hp~f~~~ 288 (451)
...+..+......++.. ++..+.++|.+||..||++||| +++++.||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 238 DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 77777776666666554 6899999999999999999999 9999999999763
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=347.60 Aligned_cols=258 Identities=29% Similarity=0.488 Sum_probs=221.0
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
.....+|++.+.||.|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.++ ||||+++++.+....
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 89 (296)
T cd06655 15 GDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK----QPKKELIINEILVMKELK-NPNIVNFLDSFLVGD 89 (296)
T ss_pred CCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc----CchHHHHHHHHHHHHhcC-CCceeeeeeeEecCc
Confidence 445567999999999999999999999999999999986542 123456789999999995 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 104 KIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
..|+|+||+.+++|..++....+++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred eEEEEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999987543221
Q ss_pred cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc---CCCCCCCCCHhHHH
Q 013005 184 NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR---DYQFPSFVSKPARS 260 (451)
Q Consensus 184 ~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~ 260 (451)
......+|++.|+|||.+.+..+ +.++|||||||++|+|++|..||...+.......+... ....+..+++.+.+
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (296)
T cd06655 170 -SKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRD 247 (296)
T ss_pred -ccCCCcCCCccccCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHH
Confidence 22234578999999999877655 56699999999999999999999887665444333322 23345568899999
Q ss_pred HHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 261 LIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 261 li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+|.+||..||++|||+.++++||||+..
T Consensus 248 li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 248 FLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred HHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 9999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=340.08 Aligned_cols=255 Identities=28% Similarity=0.516 Sum_probs=217.0
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcch-----hhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKF-----LDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
+|.++..||+|++|.||+|.+..+++.+|+|.+...... ......+.+.+|+.+++++. ||||+++++++....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSLDAD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCC
Confidence 588999999999999999999889999999988654221 12234567899999999995 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 104 KIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
..+++|||+++++|.+++.. +.+++..++.++.|++.||+|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 99999999999999999975 67999999999999999999999999999999999999999999999999998755421
Q ss_pred hc-----CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc-CCCCCCCCCH
Q 013005 183 KN-----GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR-DYQFPSFVSK 256 (451)
Q Consensus 183 ~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 256 (451)
.. .......|++.|+|||.+.+..+ +.++|+||+||++|+|++|+.||...+.......+... ...+|..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSY-TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISS 238 (267)
T ss_pred cccCCccccccccCCCcCccChhHhccCCC-CchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCH
Confidence 11 11123468899999999877665 46699999999999999999999876655544444332 3456667899
Q ss_pred hHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 257 PARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
.+.++|.+||.+||.+||++.++++||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 239 EAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=352.90 Aligned_cols=245 Identities=28% Similarity=0.441 Sum_probs=192.6
Q ss_pred cceEcccCceEEEEEEEc--CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe--CCEEEEE
Q 013005 33 GPLLGRGSFAKVHKAKSI--ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT--KTKIYLV 108 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~--~~~~~lV 108 (451)
+..||+|+||.||+|++. .+++.||+|.+..... ...+.+|+.+++++. ||||+++++++.. ....|++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI------SMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC------cHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEE
Confidence 578999999999999965 4678999999865421 234678999999995 9999999999854 4678999
Q ss_pred EEecCCCchhHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEe----CCCCCeEEEecc
Q 013005 109 MEYAAGGELFGKLRR----------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL----DRDGNLKVSDFG 174 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~----------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILl----d~~~~lkl~DFG 174 (451)
|||+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 79 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 999865 78777642 248999999999999999999999999999999999999 456789999999
Q ss_pred CCCcchhhhc--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH---------HHHHHh
Q 013005 175 LSALPEQIKN--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL---------AMYKKV 243 (451)
Q Consensus 175 ls~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~---------~~~~~i 243 (451)
++........ ......+||+.|+|||++.+....+.++||||+||++|+|++|..||...... .....+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 9976543211 23345689999999999987665677899999999999999999999643210 111111
Q ss_pred hc----------------------------cCCCC----------CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 244 NR----------------------------RDYQF----------PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 244 ~~----------------------------~~~~~----------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
.. ..... ....+..+.+||.+||..||.+|||++|+++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 00000 01134578899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=345.77 Aligned_cols=256 Identities=29% Similarity=0.429 Sum_probs=219.2
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
.++|++.+.||.|+||.||++.+..++..+|+|.+... .....+.+.+|+.+++++. ||||+++++.+......|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECK-HPNIVGLYEAYFYENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEecCCeEE
Confidence 46799999999999999999999889999999998654 2334567889999999996 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 107 LVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
+||||+++++|.+++.+ ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (280)
T cd06611 79 ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL- 157 (280)
T ss_pred EEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence 99999999999999865 569999999999999999999999999999999999999999999999999986543211
Q ss_pred CcccccCCCCccccceeeecc----CCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC---CCCCCCCCHh
Q 013005 185 GMLHTACGTPAYTAPEVVARR----GYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD---YQFPSFVSKP 257 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~----~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~ 257 (451)
.......||+.|+|||++... ...+.++||||+|+++|+|++|..||...+......++.... ...|..++..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSS 237 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHH
Confidence 122345689999999997532 223457999999999999999999998877766666665543 2345568899
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 258 ARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 258 ~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+.++|.+||..||.+|||++++++||||.+.
T Consensus 238 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 238 FNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 9999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=341.27 Aligned_cols=255 Identities=26% Similarity=0.418 Sum_probs=211.9
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe---
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT--- 101 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~--- 101 (451)
...+.|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++++.+||||+++++.+..
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 77 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence 34578999999999999999999999999999999997542 1234678899999999679999999999865
Q ss_pred ---CCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccC
Q 013005 102 ---KTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGL 175 (451)
Q Consensus 102 ---~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGl 175 (451)
...+|++|||+.+++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||+
T Consensus 78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 78 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred CCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCC
Confidence 3468999999999999998874 3589999999999999999999999999999999999999999999999999
Q ss_pred CCcchhhhcCcccccCCCCccccceeeecc----CCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC--C
Q 013005 176 SALPEQIKNGMLHTACGTPAYTAPEVVARR----GYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY--Q 249 (451)
Q Consensus 176 s~~~~~~~~~~~~~~~gt~~y~APEvl~~~----~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~--~ 249 (451)
+...... ........|++.|+|||++... ...+.++||||+||++|+|++|..||...........+..... .
T Consensus 158 ~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd06637 158 SAQLDRT-VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL 236 (272)
T ss_pred ceecccc-cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCC
Confidence 8754321 1223456799999999998632 1235679999999999999999999987655544444333222 1
Q ss_pred CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 250 FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 250 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
.+..++..+.+|+.+||..||.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 237 KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 223478899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=344.12 Aligned_cols=258 Identities=31% Similarity=0.548 Sum_probs=219.7
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|++.+.||+|+||.||++.+..+++.||+|.+.... .........+.+|+.+++.+. ||||+++++.+...+..|+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQN-LILRNQIQQVFVERDILTFAE-NPFVVSMFCSFETKRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhh-hhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEecCCEEEE
Confidence 47999999999999999999999999999999987652 222334567889999999995 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh----
Q 013005 108 VMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI---- 182 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~---- 182 (451)
||||++|++|.+++.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 79 VMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 9999999999999975 77999999999999999999999999999999999999999999999999998631110
Q ss_pred ----------hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCC
Q 013005 183 ----------KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS 252 (451)
Q Consensus 183 ----------~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~ 252 (451)
.........|++.|+|||.+.+..+ +.++|||||||++|+|++|..||.+.+.......+.......|.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 0011123468889999999877665 57799999999999999999999988777777776655443332
Q ss_pred ---CCCHhHHHHHHhccCCCCCCCCC---HHHHHcCccccch
Q 013005 253 ---FVSKPARSLIYQLLDPNPKTRMS---IEKIMSISWFQKS 288 (451)
Q Consensus 253 ---~~s~~~~~li~~~L~~dP~~Rpt---~~eil~hp~f~~~ 288 (451)
.++..+.++|.+||..||++||+ +.++++||||...
T Consensus 238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 47889999999999999999998 8999999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=342.59 Aligned_cols=254 Identities=28% Similarity=0.501 Sum_probs=210.5
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+.+|+.+++++. ||||+++++++......|+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~ 77 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLKQLK-HPNLVNLIEVFRRKRKLHL 77 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc--CccccHHHHHHHHHHHhCC-CCCEeeeeeEEeeCCEEEE
Confidence 579999999999999999999999999999999865421 1223355788999999996 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCc
Q 013005 108 VMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM 186 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~ 186 (451)
||||++++.|..++.. ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++....... ..
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~ 156 (286)
T cd07847 78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG-DD 156 (286)
T ss_pred EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc-cc
Confidence 9999999988887764 579999999999999999999999999999999999999999999999999987543321 12
Q ss_pred ccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc-------------------C
Q 013005 187 LHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR-------------------D 247 (451)
Q Consensus 187 ~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~-------------------~ 247 (451)
.....++..|+|||.+.+....+.++||||+|+++|+|++|..||.+.+..+....+... .
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 234467899999999876555567899999999999999999999876544322222110 0
Q ss_pred CCCC------------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 248 YQFP------------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 248 ~~~p------------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
...| +.++..+.+||.+||.+||++|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0001 2357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=364.24 Aligned_cols=253 Identities=28% Similarity=0.447 Sum_probs=212.9
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCC-----CCceEEEEEE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH-----PNVLKIQEVM 99 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~H-----pnIv~l~~~~ 99 (451)
.+..+|++.+.||+|+||.|-+|.+.+|++.||||+++... ....+-..|+.+|..|..| -|+|+++++|
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 44558999999999999999999999999999999998763 3345566799999999733 5899999999
Q ss_pred EeCCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC--CeEEEecc
Q 013005 100 ATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG--NLKVSDFG 174 (451)
Q Consensus 100 ~~~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~--~lkl~DFG 174 (451)
...++.|||+|.+. -+|+++++. ..++...++.+++||+.||.+||+.||||+|||||||||.+.+ .+||+|||
T Consensus 258 ~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 258 YFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred ccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecc
Confidence 99999999999985 499999985 4689999999999999999999999999999999999996544 69999999
Q ss_pred CCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhc---------
Q 013005 175 LSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNR--------- 245 (451)
Q Consensus 175 ls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~--------- 245 (451)
.|+.... ...+.+-+..|.|||++.+.+|.++ .||||||||++||++|.+.|.+.+..+.+..|..
T Consensus 337 SSc~~~q----~vytYiQSRfYRAPEVILGlpY~~~-IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m 411 (586)
T KOG0667|consen 337 SSCFESQ----RVYTYIQSRFYRAPEVILGLPYDTA-IDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM 411 (586)
T ss_pred cccccCC----cceeeeeccccccchhhccCCCCCc-cceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9986433 3338888999999999999999765 8999999999999999999988877665544411
Q ss_pred -------------------------------------------cCCCCCC-----------CCCHhHHHHHHhccCCCCC
Q 013005 246 -------------------------------------------RDYQFPS-----------FVSKPARSLIYQLLDPNPK 271 (451)
Q Consensus 246 -------------------------------------------~~~~~p~-----------~~s~~~~~li~~~L~~dP~ 271 (451)
.....|+ .....+.+||++||..||.
T Consensus 412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~ 491 (586)
T KOG0667|consen 412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA 491 (586)
T ss_pred HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence 0011120 1124578999999999999
Q ss_pred CCCCHHHHHcCccccch
Q 013005 272 TRMSIEKIMSISWFQKS 288 (451)
Q Consensus 272 ~Rpt~~eil~hp~f~~~ 288 (451)
+|+|+.++++||||...
T Consensus 492 ~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 492 ERITPAQALNHPFLTGT 508 (586)
T ss_pred hcCCHHHHhcCcccccc
Confidence 99999999999999853
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=340.77 Aligned_cols=253 Identities=26% Similarity=0.416 Sum_probs=210.2
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++++. ||||+++++++......
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~~~~~ 81 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG----DDFSLIQQEIFMVKECK-HCNIVAYFGSYLSREKL 81 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc----chHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCEE
Confidence 35689999999999999999999999999999999975421 22346788999999995 99999999999999999
Q ss_pred EEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 106 YLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
|+||||+.+++|.+++.. +.+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.......
T Consensus 82 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06646 82 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI- 160 (267)
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence 999999999999998864 689999999999999999999999999999999999999999999999999987543211
Q ss_pred CcccccCCCCccccceeeec--cCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCC-----CCCCHh
Q 013005 185 GMLHTACGTPAYTAPEVVAR--RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP-----SFVSKP 257 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~--~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~ 257 (451)
.......|++.|+|||.+.. ....+.++|+||+||++|+|++|..||...+.......+....+..+ ..++..
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST 240 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence 12234578999999998753 22235679999999999999999999976544433333333222222 236789
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHcCcc
Q 013005 258 ARSLIYQLLDPNPKTRMSIEKIMSISW 284 (451)
Q Consensus 258 ~~~li~~~L~~dP~~Rpt~~eil~hp~ 284 (451)
+.+||++||..||++|||+++|++|+|
T Consensus 241 ~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 241 FHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=347.81 Aligned_cols=260 Identities=28% Similarity=0.471 Sum_probs=220.5
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
......+|.+.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.+. ||||+++++.+...
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~ 88 (297)
T cd06656 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ----PKKELIINEILVMRENK-NPNIVNYLDSYLVG 88 (297)
T ss_pred cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc----chHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence 34566899999999999999999999999999999999975422 22456788999999995 99999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 103 TKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
...|+||||++|++|.+++.+..+++.++..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++......
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred CEEEEeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999998653321
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc---CCCCCCCCCHhHH
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR---DYQFPSFVSKPAR 259 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~ 259 (451)
........|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+... ....|..++..+.
T Consensus 169 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (297)
T cd06656 169 -QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFR 246 (297)
T ss_pred -ccCcCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHH
Confidence 122334578999999999877655 56799999999999999999999876543332222221 2234556788999
Q ss_pred HHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 260 SLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 260 ~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
+|+.+||..||++|||++++++||||+...
T Consensus 247 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 247 DFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred HHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 999999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=384.71 Aligned_cols=264 Identities=29% Similarity=0.481 Sum_probs=218.5
Q ss_pred CCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE
Q 013005 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 19 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
.....+...++|++++.||+|+||+||+|.+..++..||+|++.... ........+..|+.++++|. |||||+++++
T Consensus 4 ~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~--l~e~~~~~~~~EI~IL~~L~-HPNIVrl~d~ 80 (1021)
T PTZ00266 4 KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRG--LKEREKSQLVIEVNVMRELK-HKNIVRYIDR 80 (1021)
T ss_pred cccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccc--cCHHHHHHHHHHHHHHHHcC-CCCcCeEEEE
Confidence 45566788899999999999999999999999999999999997642 23344567889999999996 9999999998
Q ss_pred EEe--CCEEEEEEEecCCCchhHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-------CceecCCCCCeEEeCC
Q 013005 99 MAT--KTKIYLVMEYAAGGELFGKLRR-----GRLTESAARRYFQQLVSALHFCHQN-------GVAHRDVKPQNLLLDR 164 (451)
Q Consensus 99 ~~~--~~~~~lV~E~~~gg~L~~~l~~-----~~l~e~~~~~~~~ql~~gL~yLH~~-------giiHrDLKpeNILld~ 164 (451)
+.+ ...+||||||+.+|+|.+++.. +.+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 854 4679999999999999998863 5799999999999999999999994 4999999999999964
Q ss_pred -----------------CCCeEEEeccCCCcchhhhcCcccccCCCCccccceeeecc-CCCCccchhhhhhHHHHHHHh
Q 013005 165 -----------------DGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARR-GYDGAVADAWSCGVILFVLLA 226 (451)
Q Consensus 165 -----------------~~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~sDIwSlGvil~~Ll~ 226 (451)
.+.+||+|||++..... .......+||+.|+|||++.+. ...+.++||||||||||+|++
T Consensus 161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~--~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT 238 (1021)
T PTZ00266 161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI--ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238 (1021)
T ss_pred CccccccccccccccCCCCceEEccCCccccccc--cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH
Confidence 23589999999975432 2233456799999999998643 334677999999999999999
Q ss_pred cCCCCCCCcHH-HHHHHhhccCCCCC-CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 227 GYLPFDDSNLL-AMYKKVNRRDYQFP-SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 227 G~~Pf~~~~~~-~~~~~i~~~~~~~p-~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
|..||...+.. .+...+... ..+| ...+..+.+||.+||..+|.+|||+.|+|.|||++..
T Consensus 239 Gk~PF~~~~~~~qli~~lk~~-p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 239 GKTPFHKANNFSQLISELKRG-PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCCCCCcCCcHHHHHHHHhcC-CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 99999765443 444444433 2333 3478999999999999999999999999999999743
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=344.10 Aligned_cols=254 Identities=24% Similarity=0.443 Sum_probs=215.6
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|++.+.||+|+||.||++.+..++..||+|.+.... .......+.+|+.+++++. ||||+++++.+...+..|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~l 76 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQIIMELDILHKAV-SPYIVDFYGAFFIEGAVYM 76 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHhcC-CCcHHhhhhheecCCeEEE
Confidence 47899999999999999999999999999999986431 2334467889999999995 9999999999999999999
Q ss_pred EEEecCCCchhHHhhcC----CCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 108 VMEYAAGGELFGKLRRG----RLTESAARRYFQQLVSALHFCHQ-NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~~----~l~e~~~~~~~~ql~~gL~yLH~-~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
||||++|++|..++..+ .+++..++.++.||+.||.|||+ .||+||||||+||+++.++.++|+|||++.....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~- 155 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA- 155 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC-
Confidence 99999999999888764 79999999999999999999997 5999999999999999999999999999864322
Q ss_pred hcCcccccCCCCccccceeeeccCC-----CCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHH---Hhhc-cCCCCCCC
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGY-----DGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYK---KVNR-RDYQFPSF 253 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~-----~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~---~i~~-~~~~~p~~ 253 (451)
.......|++.|+|||.+.+... .+.++||||+||++|+|++|..||.......... .+.. ....+|..
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd06622 156 --SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG 233 (286)
T ss_pred --CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence 23345678999999999854332 3567999999999999999999997654443332 2222 23456667
Q ss_pred CCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 254 VSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 254 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
++.++.+||.+||..+|++||++++++.||||...
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 89999999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=341.22 Aligned_cols=252 Identities=27% Similarity=0.429 Sum_probs=209.8
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.+. ||||+++++.+......|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~~~~l~-h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAVVQQEIIMMKDCK-HSNIVAYFGSYLRRDKLW 82 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEE
Confidence 468999999999999999999999999999999987542 123356788999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 107 LVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
+||||+++++|.+++.. +.+++.+++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...... ..
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~ 161 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IA 161 (267)
T ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc-cc
Confidence 99999999999998864 78999999999999999999999999999999999999999999999999998644221 12
Q ss_pred cccccCCCCccccceeeec--cCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCC-----CCCCHhH
Q 013005 186 MLHTACGTPAYTAPEVVAR--RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP-----SFVSKPA 258 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~--~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~ 258 (451)
......|++.|+|||++.. ....+.++|+||+||++|+|++|..||...................+ ..++..+
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF 241 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHH
Confidence 2234578999999998742 22335679999999999999999999976544333322222222221 2357889
Q ss_pred HHHHHhccCCCCCCCCCHHHHHcCcc
Q 013005 259 RSLIYQLLDPNPKTRMSIEKIMSISW 284 (451)
Q Consensus 259 ~~li~~~L~~dP~~Rpt~~eil~hp~ 284 (451)
.++|.+||..||++|||+++|++|||
T Consensus 242 ~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 242 HHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhcCCC
Confidence 99999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=351.69 Aligned_cols=254 Identities=21% Similarity=0.328 Sum_probs=204.4
Q ss_pred EcceEccc--CceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEE
Q 013005 32 LGPLLGRG--SFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVM 109 (451)
Q Consensus 32 ~~~~LG~G--~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~ 109 (451)
++++||+| +|++||++.+..+|+.||+|.++... ......+.+.+|+.+++.+. ||||+++++++..++..|+||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEA--CTNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhh--ccHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCEEEEEE
Confidence 56789999 78999999999999999999997642 12344567888999999995 999999999999999999999
Q ss_pred EecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc--
Q 013005 110 EYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN-- 184 (451)
Q Consensus 110 E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~-- 184 (451)
||+++|+|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.++++||+.+........
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 99999999999853 4589999999999999999999999999999999999999999999999986543211110
Q ss_pred ----CcccccCCCCccccceeeecc-CCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC-----------
Q 013005 185 ----GMLHTACGTPAYTAPEVVARR-GYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY----------- 248 (451)
Q Consensus 185 ----~~~~~~~gt~~y~APEvl~~~-~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~----------- 248 (451)
.......++..|+|||++.+. ...+.++||||+||++|+|++|..||.................
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 111234578889999998753 2235679999999999999999999986544332222211110
Q ss_pred -----------------------------------CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 249 -----------------------------------QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 249 -----------------------------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.....+++.+.+||.+||..||++|||++++++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 0111246789999999999999999999999999999763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=340.56 Aligned_cols=260 Identities=27% Similarity=0.435 Sum_probs=215.6
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
..+....++|++.+.||+|+||.||++.+..+++.+|+|++.... .....+.+|+.+++++.+||||+++++++.
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 455567899999999999999999999999999999999986532 223567789999999967999999999986
Q ss_pred eC-----CEEEEEEEecCCCchhHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEE
Q 013005 101 TK-----TKIYLVMEYAAGGELFGKLR-----RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKV 170 (451)
Q Consensus 101 ~~-----~~~~lV~E~~~gg~L~~~l~-----~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl 170 (451)
.. ...|+||||++|++|.+++. ...+++..++.++.|++.||+|||++|++||||||+||+++.++.+||
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEE
Confidence 53 36899999999999998874 256899999999999999999999999999999999999999999999
Q ss_pred EeccCCCcchhhhcCcccccCCCCccccceeeeccC----CCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc
Q 013005 171 SDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRG----YDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR 246 (451)
Q Consensus 171 ~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~----~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~ 246 (451)
+|||++....... .......|++.|+|||++.... ..+.++||||+||++|+|++|+.||...+.......+...
T Consensus 170 ~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 248 (291)
T cd06639 170 VDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN 248 (291)
T ss_pred eecccchhccccc-ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC
Confidence 9999987543211 1123457899999999976433 1357799999999999999999999877655544444433
Q ss_pred C---CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCcccc
Q 013005 247 D---YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQ 286 (451)
Q Consensus 247 ~---~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~ 286 (451)
. ...+...+..+.++|.+||..||++||++.+|++||||+
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 249 PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 2 223445678899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=340.00 Aligned_cols=250 Identities=26% Similarity=0.418 Sum_probs=209.6
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|++.+.||+|+||.||+|++..+++.||+|++.... .......+.+|+.+++++. ||||+++++.+......++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 76 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQKQIMSELEILYKCD-SPYIIGFYGAFFVENRISI 76 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEECCEEEE
Confidence 46889999999999999999999999999999987542 2334567889999999995 9999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcc
Q 013005 108 VMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML 187 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~ 187 (451)
||||+++++|..+ ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++..... ...
T Consensus 77 v~e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~---~~~ 150 (279)
T cd06619 77 CTEFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN---SIA 150 (279)
T ss_pred EEecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc---ccc
Confidence 9999999998654 4678999999999999999999999999999999999999999999999999874322 233
Q ss_pred cccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcH-------HHHHHHhhccC-CCC-CCCCCHhH
Q 013005 188 HTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNL-------LAMYKKVNRRD-YQF-PSFVSKPA 258 (451)
Q Consensus 188 ~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~-------~~~~~~i~~~~-~~~-p~~~s~~~ 258 (451)
...+||+.|+|||++.+..+ +.++|+||+|+++|+|++|..||..... ......+.... ... ....++.+
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF 229 (279)
T ss_pred cCCCCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHH
Confidence 45689999999999987765 5679999999999999999999964221 12222222221 222 23478899
Q ss_pred HHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 259 RSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 259 ~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.++|.+||..||.+||++++++.||||+..
T Consensus 230 ~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 230 VHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=349.90 Aligned_cols=267 Identities=28% Similarity=0.520 Sum_probs=234.1
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
-+...+|.++..||+|+||+|.+|..+.|.+.+|||+++++--..+ +..+--..|-.+|......|.+++++.+|.+-+
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd-DDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD-DDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeec-CcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 4556789999999999999999999999999999999988743332 222333345556666656899999999999999
Q ss_pred EEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 104 KIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
.+|+||||+.||+|-..+++ |++.|..|..|+..|+-||-|||++||+.||||.+|||||.+|++||+|||++.-. ..
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn-i~ 502 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN-IF 502 (683)
T ss_pred heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc-cc
Confidence 99999999999999888876 99999999999999999999999999999999999999999999999999998631 22
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHH
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLI 262 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 262 (451)
......+.||||.|+|||++..++| +..+|.||+||+||||++|++||++.+..++++.|...+..+|..+|.++.++.
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ic 581 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAIC 581 (683)
T ss_pred CCcceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHH
Confidence 2345678999999999999999988 566999999999999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCC-----HHHHHcCccccchhHHhh
Q 013005 263 YQLLDPNPKTRMS-----IEKIMSISWFQKSLQQQR 293 (451)
Q Consensus 263 ~~~L~~dP~~Rpt-----~~eil~hp~f~~~~~~~~ 293 (451)
+..|...|.+|.. -.+|..||||+.......
T Consensus 582 kg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~ 617 (683)
T KOG0696|consen 582 KGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKL 617 (683)
T ss_pred HHHhhcCCccccCCCCccccchhhCcchhhccHHHH
Confidence 9999999999974 468999999987655443
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=336.85 Aligned_cols=254 Identities=30% Similarity=0.489 Sum_probs=216.4
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|++++.||.|+||+||+|.+..++..+|+|++..... ......+.+|+.+++.+. ||||+++++.+......|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~i 76 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC---QTSVDELRKEVQAMSQCN-HPNVVKYYTSFVVGDELWL 76 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc---chHHHHHHHHHHHHHhcC-CCCEEEEEEEEeeCCEEEE
Confidence 579999999999999999999988999999999975422 124567899999999995 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 108 VMEYAAGGELFGKLRR----GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~----~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
+||++.|++|.+++.. +.+++..++.++.||+.||.|||++|++||||+|+||++++++.++|+|||++.......
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 9999999999999864 468999999999999999999999999999999999999999999999999986543322
Q ss_pred cC---cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC-CCC-----CCC
Q 013005 184 NG---MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY-QFP-----SFV 254 (451)
Q Consensus 184 ~~---~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p-----~~~ 254 (451)
.. .....+|++.|+|||.+......+.++|+|||||++|+|++|+.||...+....+.+...... .++ ..+
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKY 236 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccc
Confidence 21 223456899999999987764556779999999999999999999988766655555444322 122 246
Q ss_pred CHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 255 SKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 255 s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
+..+.+++.+||..||++|||+++|++||||
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 237 SKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 7889999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=340.44 Aligned_cols=255 Identities=28% Similarity=0.504 Sum_probs=220.6
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|++.+.||.|++|.||+|.+..+++.||+|.+.... .......+.+|+.+++.+. ||||+++++.+.+....|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 76 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCR-SPYITKYYGSFLKGSKLWI 76 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHHHHHHHHHHHcC-CCCeeeeeEEEEECCeEEE
Confidence 47999999999999999999999999999999997542 2233456789999999996 9999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcc
Q 013005 108 VMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML 187 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~ 187 (451)
|+||+.+++|.+++..+++++..++.++.|++.|+.|||++|++||||+|+||++++++.++|+|||++....... ...
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~ 155 (274)
T cd06609 77 IMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKR 155 (274)
T ss_pred EEEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-ccc
Confidence 9999999999999988899999999999999999999999999999999999999999999999999987654321 222
Q ss_pred cccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC-CCCCCC-CCHhHHHHHHhc
Q 013005 188 HTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD-YQFPSF-VSKPARSLIYQL 265 (451)
Q Consensus 188 ~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~-~s~~~~~li~~~ 265 (451)
....|++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+.......+.... ...+.. ++..+.+++.+|
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 234 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLC 234 (274)
T ss_pred ccccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHH
Confidence 34578899999999987664 577999999999999999999998776655555444432 233444 788999999999
Q ss_pred cCCCCCCCCCHHHHHcCccccch
Q 013005 266 LDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 266 L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
|..||++|||++++++||||++.
T Consensus 235 l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 235 LNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred hhCChhhCcCHHHHhhChhhcCC
Confidence 99999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=346.86 Aligned_cols=252 Identities=29% Similarity=0.507 Sum_probs=206.9
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
+|++.+.||+|+||.||+|++..+|+.||+|.+..... .......+.+|+.+++++. ||||+++++++.+....|++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~lv 77 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELK-HKNIVRLYDVLHSDKKLTLV 77 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc--cccCccchhHHHHHHHhcC-CCCeeeHHHHhccCCceEEE
Confidence 58999999999999999999999999999999975421 2223356778999999995 99999999999999999999
Q ss_pred EEecCCCchhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCc
Q 013005 109 MEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM 186 (451)
Q Consensus 109 ~E~~~gg~L~~~l~--~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~ 186 (451)
+||+.+ +|.+++. .+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++...... ...
T Consensus 78 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~-~~~ 155 (284)
T cd07839 78 FEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP-VRC 155 (284)
T ss_pred EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC-CCC
Confidence 999975 7777665 367999999999999999999999999999999999999999999999999998754321 122
Q ss_pred ccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCC-CCcHHHHHHHhhcc----------------C--
Q 013005 187 LHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFD-DSNLLAMYKKVNRR----------------D-- 247 (451)
Q Consensus 187 ~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~-~~~~~~~~~~i~~~----------------~-- 247 (451)
.....+++.|+|||.+.+....+.++||||+||++|+|++|..||. ..+....+..+... .
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence 3445678999999998776655677999999999999999988854 44433333332110 0
Q ss_pred -C----------CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 248 -Y----------QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 248 -~----------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
. ...+.+++.+.+||.+||..||.+|||+++++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0112367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=338.73 Aligned_cols=256 Identities=30% Similarity=0.471 Sum_probs=213.9
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
+...++|++.+.||+|++|.||+|.+..+++.+++|++.... ...+.+.+|+.+++++.+||||+++++++....
T Consensus 2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (275)
T cd06608 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKN 76 (275)
T ss_pred CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence 455789999999999999999999998899999999987652 234578899999999967999999999996644
Q ss_pred ------EEEEEEEecCCCchhHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEe
Q 013005 104 ------KIYLVMEYAAGGELFGKLRR-----GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSD 172 (451)
Q Consensus 104 ------~~~lV~E~~~gg~L~~~l~~-----~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~D 172 (451)
..|+||||+++++|.+++.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECC
Confidence 58999999999999988753 5799999999999999999999999999999999999999999999999
Q ss_pred ccCCCcchhhhcCcccccCCCCccccceeeeccC----CCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC
Q 013005 173 FGLSALPEQIKNGMLHTACGTPAYTAPEVVARRG----YDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY 248 (451)
Q Consensus 173 FGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~----~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~ 248 (451)
||++....... .......|++.|+|||++.... ..+.++||||||+++|+|++|..||...+.......+.....
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 235 (275)
T cd06608 157 FGVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP 235 (275)
T ss_pred Cccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCC
Confidence 99986433211 2233456899999999875432 235679999999999999999999987665555555544322
Q ss_pred ---CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 249 ---QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 249 ---~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
..+..++..+.+||.+||..||++|||++++++|||+
T Consensus 236 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 236 PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2223367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=337.03 Aligned_cols=254 Identities=26% Similarity=0.491 Sum_probs=214.0
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcc--hhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNK--FLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
+|++++.||+|+||.||+|.+ .+++.+|+|.+..... .........+.+|+.+++++. |+||+++++++.+....|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLDDNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeecCCeEE
Confidence 588999999999999999986 5889999999875421 112334467899999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh---
Q 013005 107 LVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI--- 182 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~--- 182 (451)
+++||+.|++|.+++.+ +.+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 99999999999999975 77999999999999999999999999999999999999999999999999998643211
Q ss_pred --hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc---CCCCCCCCCHh
Q 013005 183 --KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR---DYQFPSFVSKP 257 (451)
Q Consensus 183 --~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~ 257 (451)
.........|++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+... ....+..++..
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA 237 (265)
T ss_pred ccccccccccCCCccccChhhhcCCCC-cchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHH
Confidence 1122334568999999999877665 46699999999999999999999876554443333322 23456668999
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 258 ARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 258 ~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
+.++|.+||..+|.+|||+.++++||||
T Consensus 238 ~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 238 AIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=340.64 Aligned_cols=254 Identities=26% Similarity=0.433 Sum_probs=215.1
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
-|++.+.||+|+||.||+|.+..++..+++|.+.... ....+.+.+|+.+++.+. ||||+++++.+......|+|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~~v 80 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS----EEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWIL 80 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC----HHHHHHHHHHHHHHHHCC-CCCeeeEEEEEeeCCEEEEE
Confidence 3788899999999999999999999999999986542 234566888999999995 99999999999999999999
Q ss_pred EEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCc
Q 013005 109 MEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM 186 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~ 186 (451)
+||+.+++|...+.+ +.+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...... ...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-~~~ 159 (282)
T cd06643 81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQR 159 (282)
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc-ccc
Confidence 999999999888753 67999999999999999999999999999999999999999999999999998643221 122
Q ss_pred ccccCCCCccccceeeec----cCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC---CCCCCCCCHhHH
Q 013005 187 LHTACGTPAYTAPEVVAR----RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD---YQFPSFVSKPAR 259 (451)
Q Consensus 187 ~~~~~gt~~y~APEvl~~----~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~ 259 (451)
.....||+.|+|||++.. ....+.++||||+||++|+|++|..||...+.......+.... ...|..++..+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFK 239 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHH
Confidence 334578999999999842 2223467999999999999999999998877665555554332 234556789999
Q ss_pred HHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 260 SLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 260 ~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+||.+||..||.+|||++++++||||+..
T Consensus 240 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 240 DFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 99999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=341.57 Aligned_cols=257 Identities=28% Similarity=0.415 Sum_probs=216.7
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
..+.|++.+.||.|+||.||+|.+..+++.+|+|.+... +....+.+.+|+.+++.+. ||||+++++.+......
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 84 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCN-HPYIVKLLGAFYWDGKL 84 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEeCCeE
Confidence 447799999999999999999999999999999998654 2344567888999999996 99999999999999999
Q ss_pred EEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 106 YLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
|+||||++|++|...+.+ ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 85 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~- 163 (292)
T cd06644 85 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT- 163 (292)
T ss_pred EEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc-
Confidence 999999999999887753 57899999999999999999999999999999999999999999999999998643221
Q ss_pred cCcccccCCCCccccceeeecc----CCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC---CCCCCCCCH
Q 013005 184 NGMLHTACGTPAYTAPEVVARR----GYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD---YQFPSFVSK 256 (451)
Q Consensus 184 ~~~~~~~~gt~~y~APEvl~~~----~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~ 256 (451)
........+++.|+|||++... ...+.++|||||||++|+|++|..||...+....+.++.... ...+..++.
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSM 243 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCH
Confidence 1222345688999999998532 222556999999999999999999998776665555554332 233456788
Q ss_pred hHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 257 PARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.+.++|.+||..||++||+++++++||||...
T Consensus 244 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 244 EFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 99999999999999999999999999999753
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=342.02 Aligned_cols=250 Identities=26% Similarity=0.432 Sum_probs=202.7
Q ss_pred eEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHh--cCCCCceEEEEEEEeCCEEEEEEEec
Q 013005 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL--QNHPNVLKIQEVMATKTKIYLVMEYA 112 (451)
Q Consensus 35 ~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L--~~HpnIv~l~~~~~~~~~~~lV~E~~ 112 (451)
.||+|+||.||++.+..+++.+|+|.+.+... ..........+|..+++.+ .+||||+.+++.+...+..|+||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEcccc-ccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence 48999999999999999999999999976422 1112222333444444333 25999999999999999999999999
Q ss_pred CCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccC
Q 013005 113 AGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTAC 191 (451)
Q Consensus 113 ~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~ 191 (451)
.||+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++..... .......
T Consensus 80 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~ 156 (279)
T cd05633 80 NGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK---KKPHASV 156 (279)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccc---cCccCcC
Confidence 99999998864 7799999999999999999999999999999999999999999999999999864322 1223457
Q ss_pred CCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCc---HHHHHHHhhccCCCCCCCCCHhHHHHHHhccCC
Q 013005 192 GTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN---LLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDP 268 (451)
Q Consensus 192 gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 268 (451)
||+.|+|||.+.+....+.++||||+||++|+|++|..||.... ..............+|..++..+.++|.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 99999999998654444667999999999999999999996532 222222223334566777899999999999999
Q ss_pred CCCCCC-----CHHHHHcCccccch
Q 013005 269 NPKTRM-----SIEKIMSISWFQKS 288 (451)
Q Consensus 269 dP~~Rp-----t~~eil~hp~f~~~ 288 (451)
||.+|| |+.++++||||+..
T Consensus 237 ~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 237 DVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred CHHHhcCCCCCCHHHHHhCccccCC
Confidence 999999 69999999999873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=359.14 Aligned_cols=253 Identities=23% Similarity=0.355 Sum_probs=204.9
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEc--CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSI--ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
.....+|++++.||+|+||.||+|... .++..||+|.+.... ...+|+.+++++. ||||+++++++..
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~---------~~~~E~~il~~l~-h~~iv~~~~~~~~ 157 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK---------TPGREIDILKTIS-HRAIINLIHAYRW 157 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc---------cHHHHHHHHHhcC-CCCccceeeeEee
Confidence 345668999999999999999999764 356789999886531 2457999999995 9999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 102 KTKIYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~-~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
....|++||++. ++|.+++. .+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 158 ~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 158 KSTVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred CCEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 999999999996 57888875 4789999999999999999999999999999999999999999999999999987543
Q ss_pred hhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcH---HHHHHHhh----cc------
Q 013005 181 QIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNL---LAMYKKVN----RR------ 246 (451)
Q Consensus 181 ~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~---~~~~~~i~----~~------ 246 (451)
.... ......+||+.|+|||++....| +.++||||+||++|+|++|..||.+... ...+..+. ..
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 3221 22234679999999999987776 4669999999999999999999965421 11111111 00
Q ss_pred -------------------CCCCCC-----CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 247 -------------------DYQFPS-----FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 247 -------------------~~~~p~-----~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.+..|. .++.++.++|.+||..||++|||+.+++.||||++.
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 111111 245678899999999999999999999999999764
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=333.35 Aligned_cols=252 Identities=28% Similarity=0.475 Sum_probs=218.7
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
+|++.+.||+|++|.||+|.+..+++.|++|.+.... ........+.+|+.+++.++ ||||+++++.+...+..|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK--MNRREREEAIDEARVLAKLD-SSYIIRYYESFLDKGKLNIV 77 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhh--CCHHHHHHHHHHHHHHHhcC-CCCeehheeeeccCCEEEEE
Confidence 5889999999999999999999999999999987542 22345567889999999995 99999999999999999999
Q ss_pred EEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 109 MEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
|||+.|++|.+++.. ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....... .
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-~ 156 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-N 156 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc-c
Confidence 999999999999864 468999999999999999999999999999999999999999999999999987543321 2
Q ss_pred cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC-CCCCCCCHhHHHHHHh
Q 013005 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY-QFPSFVSKPARSLIYQ 264 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 264 (451)
.....+|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+..... .++..++..+.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPY-NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQ 235 (256)
T ss_pred hhhccccCccccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHH
Confidence 2334578999999999887665 5669999999999999999999998887776666655443 3444678999999999
Q ss_pred ccCCCCCCCCCHHHHHcCccc
Q 013005 265 LLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 265 ~L~~dP~~Rpt~~eil~hp~f 285 (451)
||..+|++||++.++++|||+
T Consensus 236 ~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 236 CLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HccCCcccCcCHHHHhhCCCC
Confidence 999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=339.83 Aligned_cols=252 Identities=27% Similarity=0.532 Sum_probs=220.2
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
+|++.+.||.|+||.||+|.+..+++.||+|++.+. ........+.+.+|+.+++++. ||||+++++.+.+....|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ-KCVEKGSVRNVLNERRILQELN-HPFLVNLWYSFQDEENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehh-hhcchhHHHHHHHHHHHHHhCC-CCChHHHHHhhcCCCeEEEE
Confidence 589999999999999999999999999999999865 2233345678999999999995 99999999999999999999
Q ss_pred EEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcc
Q 013005 109 MEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML 187 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~ 187 (451)
+||+.|++|.+.+.. +.+++..+..++.||++||.|||++|++|+||+|+||++++++.++|+|||++...... ...
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~--~~~ 156 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD--TLT 156 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC--ccc
Confidence 999999999999976 48999999999999999999999999999999999999999999999999998754332 233
Q ss_pred cccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCc---HHHHHHHhhccCCCCCCCCCHhHHHHHHh
Q 013005 188 HTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN---LLAMYKKVNRRDYQFPSFVSKPARSLIYQ 264 (451)
Q Consensus 188 ~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 264 (451)
....|+..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+ ..............+|...+..+.++|.+
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINK 235 (258)
T ss_pred cccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHH
Confidence 45678999999999877664 567999999999999999999998766 33444444435567777889999999999
Q ss_pred ccCCCCCCCCCH--HHHHcCccc
Q 013005 265 LLDPNPKTRMSI--EKIMSISWF 285 (451)
Q Consensus 265 ~L~~dP~~Rpt~--~eil~hp~f 285 (451)
||..||.+||++ +++++||||
T Consensus 236 ~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 236 LLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HccCChhHcCCccHHHHhcCCCC
Confidence 999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=367.91 Aligned_cols=254 Identities=27% Similarity=0.445 Sum_probs=224.1
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
.+-|+++..||.|+||+||+|.++.++-..|-|+|.-. +....+.+.-||.||..+. ||+||++++.|...+++|
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk----seEELEDylVEIeILa~Cd-HP~ivkLl~ayy~enkLw 105 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK----SEEELEDYLVEIEILAECD-HPVIVKLLSAYYFENKLW 105 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc----chhHHhhhhhhhhhhhcCC-ChHHHHHHHHHhccCceE
Confidence 35688999999999999999999999999999999643 3456677889999999996 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 107 LVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
|.+|||.||-...++-. ..+++.+++.+++|++.||.|||+++|+|||||..|||++-+|.++|+|||.|.......
T Consensus 106 iliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~- 184 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR- 184 (1187)
T ss_pred EEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHH-
Confidence 99999999999887753 679999999999999999999999999999999999999999999999999987543321
Q ss_pred CcccccCCCCccccceeee-----ccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCC---CCCCCCH
Q 013005 185 GMLHTACGTPAYTAPEVVA-----RRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQ---FPSFVSK 256 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~-----~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~ 256 (451)
..-.+..|||+|||||++. +.+|+ .++||||||++|.+|..+.+|-..-+.....-+|.+...+ -|..++.
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~ 263 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSR 263 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhh
Confidence 2345778999999999975 35565 5599999999999999999999999988888888776542 3667899
Q ss_pred hHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 257 PARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
.+.+|+.+||..||..||++.+|++||||++
T Consensus 264 ~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 264 SFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred HHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence 9999999999999999999999999999985
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=355.95 Aligned_cols=253 Identities=25% Similarity=0.400 Sum_probs=216.1
Q ss_pred CCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE
Q 013005 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 20 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~ 99 (451)
...+..--..+.+++.||+|.||.||+|... ....||+|.+.... ...+.+.+|+.+|++|+ |+|||++++++
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~-----m~~~~f~~Ea~iMk~L~-H~~lV~l~gV~ 270 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGS-----MSPEAFLREAQIMKKLR-HEKLVKLYGVC 270 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccc-----cChhHHHHHHHHHHhCc-ccCeEEEEEEE
Confidence 4455555566678889999999999999973 34479999996542 22356779999999996 99999999999
Q ss_pred EeCCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCC
Q 013005 100 ATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176 (451)
Q Consensus 100 ~~~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls 176 (451)
.....+||||||+..|+|.++++. +.+...+...++.||++||+||+++++|||||-..||||+++..+||+|||||
T Consensus 271 ~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLA 350 (468)
T KOG0197|consen 271 TKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLA 350 (468)
T ss_pred ecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccc
Confidence 998899999999999999999985 56999999999999999999999999999999999999999999999999999
Q ss_pred CcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCC
Q 013005 177 ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFV 254 (451)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~ 254 (451)
+.............--..-|.|||.+....+ +.+||||||||+|+||+| |+.||...+..+....+.++ ..+.|..+
T Consensus 351 r~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~F-S~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~C 429 (468)
T KOG0197|consen 351 RLIGDDEYTASEGGKFPIKWTAPEALNYGKF-SSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGC 429 (468)
T ss_pred cccCCCceeecCCCCCCceecCHHHHhhCCc-ccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCC
Confidence 9544322222223333568999999987777 566999999999999998 99999999999988888776 45778889
Q ss_pred CHhHHHHHHhccCCCCCCCCCHHHHH
Q 013005 255 SKPARSLIYQLLDPNPKTRMSIEKIM 280 (451)
Q Consensus 255 s~~~~~li~~~L~~dP~~Rpt~~eil 280 (451)
|+.+-+++..||..+|++|||.+.+.
T Consensus 430 P~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 430 PDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 99999999999999999999998654
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=340.97 Aligned_cols=255 Identities=30% Similarity=0.537 Sum_probs=214.9
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|++.+.||+|+||.||+|.+..+++.||+|.++... ......+.+.+|+.+++++. ||||+++++++...+..|+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~i 77 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE--DDEDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGRLYL 77 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc--ccccchhHHHHHHHHHHhcC-CCCeeehhheEEECCEEEE
Confidence 47999999999999999999999999999999986532 12334567899999999996 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCc
Q 013005 108 VMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM 186 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~ 186 (451)
+|||+.++.+..+..+ ..+++.++..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++..........
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 78 VFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 9999998777766654 669999999999999999999999999999999999999999999999999987654433323
Q ss_pred ccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc-------------------C
Q 013005 187 LHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR-------------------D 247 (451)
Q Consensus 187 ~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~-------------------~ 247 (451)
.....+++.|+|||++......+.++||||+|+++|+|++|..||...+.......+... .
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 445678999999999987745567899999999999999999999876554333222110 0
Q ss_pred -------------CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 248 -------------YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 248 -------------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
..++..++..+.+||++||..||++|||++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 01233458889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=339.60 Aligned_cols=260 Identities=26% Similarity=0.440 Sum_probs=214.6
Q ss_pred CCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE
Q 013005 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 20 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~ 99 (451)
....+...++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+.+||||+++++++
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-----DIDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-----chHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 3556778899999999999999999999999999999999986432 12356778999999996699999999987
Q ss_pred E-----eCCEEEEEEEecCCCchhHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeE
Q 013005 100 A-----TKTKIYLVMEYAAGGELFGKLR-----RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLK 169 (451)
Q Consensus 100 ~-----~~~~~~lV~E~~~gg~L~~~l~-----~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lk 169 (451)
. .....|+||||++|++|.+++. ...+++..++.++.|++.||.|||+++++||||||+||+++.++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEE
Confidence 3 4467999999999999998764 25689999999999999999999999999999999999999999999
Q ss_pred EEeccCCCcchhhhcCcccccCCCCccccceeeecc----CCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhc
Q 013005 170 VSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARR----GYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNR 245 (451)
Q Consensus 170 l~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~----~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~ 245 (451)
|+|||++...... ........|++.|+|||++... ...+.++||||+||++|+|++|..||...+.......+..
T Consensus 165 l~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 243 (286)
T cd06638 165 LVDFGVSAQLTST-RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR 243 (286)
T ss_pred EccCCceeecccC-CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc
Confidence 9999998754321 1223345799999999987532 2235679999999999999999999987665444443332
Q ss_pred c---CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 246 R---DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 246 ~---~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
. ....|..++..+.+||.+||..||++|||+.++++|+||
T Consensus 244 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 244 NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 2 122344567889999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=339.81 Aligned_cols=250 Identities=26% Similarity=0.420 Sum_probs=205.9
Q ss_pred eEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHH---HHHHhcCCCCceEEEEEEEeCCEEEEEEEe
Q 013005 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVS---AMRRLQNHPNVLKIQEVMATKTKIYLVMEY 111 (451)
Q Consensus 35 ~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~---il~~L~~HpnIv~l~~~~~~~~~~~lV~E~ 111 (451)
.||+|+||.||+|.+..+++.||+|.+.+.... ..........|.. .++.. +||||+++++.+...+..|+||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-MKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccc-cchhHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCEEEEEEec
Confidence 489999999999999999999999999764211 1111122333333 33334 599999999999999999999999
Q ss_pred cCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCccccc
Q 013005 112 AAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTA 190 (451)
Q Consensus 112 ~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~ 190 (451)
+.||+|..++.+ +.+++..++.++.|++.||.|||+++|+||||||+||+++.++.++|+|||++..... ......
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~---~~~~~~ 155 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK---KKPHAS 155 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc---cCCcCc
Confidence 999999988864 6799999999999999999999999999999999999999999999999999874422 222356
Q ss_pred CCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCC---cHHHHHHHhhccCCCCCCCCCHhHHHHHHhccC
Q 013005 191 CGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS---NLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLD 267 (451)
Q Consensus 191 ~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 267 (451)
+|++.|+|||++.+....+.++||||+|+++|+|++|..||... ........+......+|...+..+.+++.+||.
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~ 235 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQ 235 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhh
Confidence 79999999999875544457799999999999999999999865 334444444445566777789999999999999
Q ss_pred CCCCCCC-----CHHHHHcCccccchh
Q 013005 268 PNPKTRM-----SIEKIMSISWFQKSL 289 (451)
Q Consensus 268 ~dP~~Rp-----t~~eil~hp~f~~~~ 289 (451)
.||.+|| ++.++++||||+...
T Consensus 236 ~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 236 RDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred cCHHhccCCCCCCHHHHHhCccccCCC
Confidence 9999999 999999999998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=341.21 Aligned_cols=256 Identities=30% Similarity=0.622 Sum_probs=224.9
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|.+.+.||+|+||.||+|.+..+++.||+|++.+.. .........+.+|..+++++.+||||+++++++.+.+..|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQ-LIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHh-ccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence 47999999999999999999999999999999997642 22334456788999999999669999999999999999999
Q ss_pred EEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc--
Q 013005 108 VMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN-- 184 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~-- 184 (451)
||||+.+++|.+++.+ +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 80 VLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 9999999999999976 5899999999999999999999999999999999999999999999999999875433221
Q ss_pred -----------------CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC
Q 013005 185 -----------------GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD 247 (451)
Q Consensus 185 -----------------~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~ 247 (451)
.......|+..|+|||++.... .+.++||||||++++++++|..||...+....+..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE 238 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC
Confidence 1223346789999999887655 4667999999999999999999999888777777777777
Q ss_pred CCCCCCCCHhHHHHHHhccCCCCCCCCCH----HHHHcCccc
Q 013005 248 YQFPSFVSKPARSLIYQLLDPNPKTRMSI----EKIMSISWF 285 (451)
Q Consensus 248 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~----~eil~hp~f 285 (451)
..+|..+++.+.+||.+||+.||++|||+ +++++||||
T Consensus 239 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 239 YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 78888899999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=337.24 Aligned_cols=251 Identities=19% Similarity=0.313 Sum_probs=210.7
Q ss_pred ccCCeEEcceEcccCceEEEEEEEc---CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSI---ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
..++|++.+.||+|+||.||+|.+. ..+..||+|.++... .......+.+|+.+++++. ||||+++++++...
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 78 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC---SDKQRRGFLAEALTLGQFD-HSNIVRLEGVITRG 78 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC---CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEecC
Confidence 3567999999999999999999764 456799999997542 2334567889999999995 99999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 103 TKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
+..|+||||+++|+|.+++.. +.+++.+++.++.||+.||+|||++|++||||||+|||++.++.++++|||.+....
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 999999999999999998864 579999999999999999999999999999999999999999999999999876432
Q ss_pred hhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhH
Q 013005 181 QIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPA 258 (451)
Q Consensus 181 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 258 (451)
...........+++.|+|||++.+..+ +.++||||+||++|++++ |..||...+.......+... ..+.|..++..+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLL 237 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence 211111123345678999999877665 567999999999999775 99999988777766666544 334566788999
Q ss_pred HHHHHhccCCCCCCCCCHHHHHc
Q 013005 259 RSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 259 ~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.+++.+||..+|.+|||+++|++
T Consensus 238 ~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 238 HQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHcCCCchhCCCHHHHHH
Confidence 99999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=335.01 Aligned_cols=256 Identities=29% Similarity=0.508 Sum_probs=213.0
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcc-hhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe--CCE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNK-FLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT--KTK 104 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~--~~~ 104 (451)
.+|++.+.||+|+||.||+|.+..++..||+|.+..... .........+.+|+.++++++ ||||+++++++.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCCCCE
Confidence 479999999999999999999999999999999875421 112234567899999999995 9999999998865 467
Q ss_pred EEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 105 IYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
.++++||+.+++|.+++.. +.+++...+.++.|++.||+|||++||+||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 8999999999999999875 678999999999999999999999999999999999999999999999999986432211
Q ss_pred --cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc--CCCCCCCCCHhHH
Q 013005 184 --NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR--DYQFPSFVSKPAR 259 (451)
Q Consensus 184 --~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~ 259 (451)
........++..|+|||.+.+..+ +.++||||+||++|+|++|+.||..........++... ...+|..+++.+.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHAR 239 (266)
T ss_pred ccCCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHH
Confidence 111233468899999999877655 56699999999999999999999876655444433322 3455667889999
Q ss_pred HHHHhccCCCCCCCCCHHHHHcCcccc
Q 013005 260 SLIYQLLDPNPKTRMSIEKIMSISWFQ 286 (451)
Q Consensus 260 ~li~~~L~~dP~~Rpt~~eil~hp~f~ 286 (451)
++| +||..+|++|||++++++||||+
T Consensus 240 ~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 240 DFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 999 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=342.36 Aligned_cols=254 Identities=27% Similarity=0.458 Sum_probs=212.3
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+... .....+.+.+|+.+++.+. ||||+++++++......|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 77 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLR-HENLVNLIEVFRRKKRLYL 77 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC--cchhhHHHHHHHHHHHhcC-CcchhhHHHhcccCCeEEE
Confidence 579999999999999999999988999999999865422 2234566788999999995 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCc
Q 013005 108 VMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM 186 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~ 186 (451)
|+||++++.|..+... +.+++.++..++.|++.||.|||++|++|+||+|+||++++++.++|+|||++....... ..
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~ 156 (286)
T cd07846 78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EV 156 (286)
T ss_pred EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cc
Confidence 9999999999887764 569999999999999999999999999999999999999999999999999987543322 22
Q ss_pred ccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC-------------------
Q 013005 187 LHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD------------------- 247 (451)
Q Consensus 187 ~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~------------------- 247 (451)
.....++..|+|||++.+....+.++||||+|+++|+|++|..||...........+....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 3345688999999998765555678999999999999999999998665443333222100
Q ss_pred CC------------CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 248 YQ------------FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 248 ~~------------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
.. .++.++..+.+|+.+||..||++|||+.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 00 123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=356.58 Aligned_cols=260 Identities=23% Similarity=0.370 Sum_probs=211.3
Q ss_pred CCCCCcccccCCeEEcceEcccCceEEEEEEEcCC-----CcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCc
Q 013005 18 PPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIAD-----GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNV 92 (451)
Q Consensus 18 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnI 92 (451)
|-...+....++|++++.||+|+||.||+|++..+ +..||+|++.... .....+.+.+|+.+++.+.+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~~h~nI 104 (374)
T cd05106 28 PYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDEREALMSELKILSHLGQHKNI 104 (374)
T ss_pred cccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHHHHHHHHHHHHhhccCCce
Confidence 33455566778999999999999999999986544 3589999997542 223356788999999999569999
Q ss_pred eEEEEEEEeCCEEEEEEEecCCCchhHHhhc-------------------------------------------------
Q 013005 93 LKIQEVMATKTKIYLVMEYAAGGELFGKLRR------------------------------------------------- 123 (451)
Q Consensus 93 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~------------------------------------------------- 123 (451)
+++++.+......|+||||+.+|+|.+++..
T Consensus 105 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (374)
T cd05106 105 VNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEM 184 (374)
T ss_pred eeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccccccc
Confidence 9999999999999999999999999988742
Q ss_pred ----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 124 ----------------------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 124 ----------------------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
.++++.++++++.|++.||.|||++||+||||||+|||+++++.+||+|||++.....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~ 264 (374)
T cd05106 185 RPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264 (374)
T ss_pred CCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence 1378889999999999999999999999999999999999999999999999875432
Q ss_pred hhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc--CCCCCCCCCHh
Q 013005 182 IKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR--DYQFPSFVSKP 257 (451)
Q Consensus 182 ~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~ 257 (451)
... ....+..+++.|+|||++.+..+ +.++||||+||++|+|++ |..||........+...... ....|...+++
T Consensus 265 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (374)
T cd05106 265 DSNYVVKGNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPE 343 (374)
T ss_pred CcceeeccCCCCccceeCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHH
Confidence 211 11122345678999999877665 567999999999999997 99999876544333333222 33456678999
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHc
Q 013005 258 ARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 258 ~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+.+++.+||..||.+|||++++++
T Consensus 344 l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 344 IYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-45 Score=386.05 Aligned_cols=263 Identities=32% Similarity=0.504 Sum_probs=232.0
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
.-.++|++++.||+|+||.|.+++.+.|++.||+|++++.. ........-|+.|-.+|.-- +.+-|++++-.|.++.+
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~e-MlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWE-MLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDERY 149 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHH-HhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCccc
Confidence 34578999999999999999999999999999999998752 22334455688888888766 58899999999999999
Q ss_pred EEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 105 IYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
+|+||||++||+|..++.+ +++|++.|++|+..|+.||+-+|+.|+|||||||+|||||..|++||+|||.+-.....+
T Consensus 150 LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence 9999999999999999986 679999999999999999999999999999999999999999999999999876555444
Q ss_pred cCcccccCCCCccccceeeec----cCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc--CCCCC--CCCC
Q 013005 184 NGMLHTACGTPAYTAPEVVAR----RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR--DYQFP--SFVS 255 (451)
Q Consensus 184 ~~~~~~~~gt~~y~APEvl~~----~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s 255 (451)
.-.....+|||-|++||+|.. .+.++..+|.||+||++|+|+.|..||...+..+.|.+|... .+.|| ..+|
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VS 309 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVS 309 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccC
Confidence 455678899999999999853 255688899999999999999999999999999999999876 67888 4689
Q ss_pred HhHHHHHHhccCCCCCCCCC---HHHHHcCccccchhH
Q 013005 256 KPARSLIYQLLDPNPKTRMS---IEKIMSISWFQKSLQ 290 (451)
Q Consensus 256 ~~~~~li~~~L~~dP~~Rpt---~~eil~hp~f~~~~~ 290 (451)
+++++||.+++. +|..|.. ++++..||||.....
T Consensus 310 eeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 310 EEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred HHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 999999999775 6888988 999999999987544
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=354.48 Aligned_cols=262 Identities=26% Similarity=0.416 Sum_probs=215.6
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
.-+.+-...|++++.||+|+.++||++..- ..+.||+|.+.. ...+......+.+||..|.+|++|.+||++|++-.
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~--~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv 430 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVL--LEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV 430 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHH--hhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence 344555678999999999999999999864 445566665543 23466778899999999999999999999999999
Q ss_pred eCCEEEEEEEecCCCchhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRRG--RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~~--~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
.++.+||||||- ..+|..+++++ .++...++.|..|++.++.++|.+||+|.||||.|+|+ -.|.+||+|||.|..
T Consensus 431 ~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 431 TDGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANA 508 (677)
T ss_pred cCceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcc
Confidence 999999999985 45899999863 35546899999999999999999999999999999999 678999999999976
Q ss_pred chhhhc-CcccccCCCCccccceeeeccCCC----------CccchhhhhhHHHHHHHhcCCCCCCC-cHHHHHHHhhcc
Q 013005 179 PEQIKN-GMLHTACGTPAYTAPEVVARRGYD----------GAVADAWSCGVILFVLLAGYLPFDDS-NLLAMYKKVNRR 246 (451)
Q Consensus 179 ~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~----------~~~sDIwSlGvil~~Ll~G~~Pf~~~-~~~~~~~~i~~~ 246 (451)
...... -...+.|||+.|||||.+....+. ++++||||||||||+|+.|+.||..- +...-+..|...
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P 588 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDP 588 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCC
Confidence 544332 344678999999999998655443 66799999999999999999999753 344445555543
Q ss_pred --CCCCCCCCCHh-HHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 247 --DYQFPSFVSKP-ARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 247 --~~~~p~~~s~~-~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
.+.||..-+.. +.++++.||..||.+|||+.++|+|||.+-
T Consensus 589 ~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 589 NHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred CccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 34666654444 999999999999999999999999999975
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=338.27 Aligned_cols=255 Identities=25% Similarity=0.394 Sum_probs=210.8
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE----
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA---- 100 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~---- 100 (451)
...+.|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+..|+.+++++.+||||+++++++.
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 35589999999999999999999999999999999986542 233567889999999977999999999984
Q ss_pred --eCCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccC
Q 013005 101 --TKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGL 175 (451)
Q Consensus 101 --~~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGl 175 (451)
.....|++|||+.+|+|.+++.. ..+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||+
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~ 167 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGV 167 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcc
Confidence 34678999999999999998864 4589999999999999999999999999999999999999999999999999
Q ss_pred CCcchhhhcCcccccCCCCccccceeeecc----CCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC-C-
Q 013005 176 SALPEQIKNGMLHTACGTPAYTAPEVVARR----GYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY-Q- 249 (451)
Q Consensus 176 s~~~~~~~~~~~~~~~gt~~y~APEvl~~~----~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~-~- 249 (451)
+...... ........|++.|+|||.+... ...+.++|||||||++|+|++|..||...........+..... .
T Consensus 168 ~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 246 (282)
T cd06636 168 SAQLDRT-VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246 (282)
T ss_pred hhhhhcc-ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC
Confidence 8754321 1223456789999999998632 2234569999999999999999999977654443333332221 1
Q ss_pred CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 250 FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 250 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
.+..++..+.+||.+||..||.+|||+.+|++||||
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 123478899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=334.46 Aligned_cols=247 Identities=35% Similarity=0.685 Sum_probs=215.7
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecCCC
Q 013005 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGG 115 (451)
Q Consensus 36 LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~gg 115 (451)
||.|++|.||+|.+..+++.||+|++.+. ........+.+.+|+.+++.+. ||||+++++.+.+....|+++||++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKR-HIVETGQQEHIFSEKEILEECN-HPFIVKLYRTFKDKKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehh-cchhhhHHHHHHHHHHHHHhCC-CCCEeeeeeeEEcCCccEEEEecCCCC
Confidence 69999999999999999999999999765 2233345578999999999995 999999999999999999999999999
Q ss_pred chhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCCCC
Q 013005 116 ELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP 194 (451)
Q Consensus 116 ~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~gt~ 194 (451)
+|.+++.+ ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... .....+|++
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~ 156 (262)
T cd05572 79 ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTP 156 (262)
T ss_pred cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCc
Confidence 99999975 578999999999999999999999999999999999999999999999999987543321 223457899
Q ss_pred ccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCc--HHHHHHHhh--ccCCCCCCCCCHhHHHHHHhccCCCC
Q 013005 195 AYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN--LLAMYKKVN--RRDYQFPSFVSKPARSLIYQLLDPNP 270 (451)
Q Consensus 195 ~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~--~~~~~~~i~--~~~~~~p~~~s~~~~~li~~~L~~dP 270 (451)
.|+|||.+.+..+ +.++|+||+|+++|+|++|..||.... ....+.++. .....+|...+..+.++|.+||..||
T Consensus 157 ~~~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 235 (262)
T cd05572 157 EYVAPEIILNKGY-DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNP 235 (262)
T ss_pred CccChhHhcCCCC-CChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCCh
Confidence 9999999876665 566999999999999999999998766 566666665 44566777789999999999999999
Q ss_pred CCCCC-----HHHHHcCccccc
Q 013005 271 KTRMS-----IEKIMSISWFQK 287 (451)
Q Consensus 271 ~~Rpt-----~~eil~hp~f~~ 287 (451)
++||| ++|+++||||+.
T Consensus 236 ~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 236 EERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred hhCcCCcccCHHHHhcChhhhC
Confidence 99999 999999999975
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=336.65 Aligned_cols=256 Identities=26% Similarity=0.489 Sum_probs=213.7
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcch--hhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKF--LDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
+|+.++.||+|+||.||++.+..+++.||+|++...... ......+.+.+|+.++++++ ||||+++++++.+.+..+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCEDSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceeccCCeEE
Confidence 588899999999999999999999999999999754211 11234578899999999996 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC-CeEEEeccCCCcchhhhc
Q 013005 107 LVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG-NLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~-~lkl~DFGls~~~~~~~~ 184 (451)
+|+||+.|++|.+++.+ +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++........
T Consensus 80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 99999999999999875 6799999999999999999999999999999999999998876 599999999865433211
Q ss_pred ---CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHH---HHHHhh--ccCCCCCCCCCH
Q 013005 185 ---GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLA---MYKKVN--RRDYQFPSFVSK 256 (451)
Q Consensus 185 ---~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~---~~~~i~--~~~~~~p~~~s~ 256 (451)
.......||..|+|||.+.+..+ +.++||||+|+++|+|++|..||....... ....+. .....+|..+++
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238 (268)
T ss_pred cCCccccccccccceeCHhHhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCH
Confidence 11233468899999999877655 566999999999999999999997544322 222221 223455667889
Q ss_pred hHHHHHHhccCCCCCCCCCHHHHHcCcccc
Q 013005 257 PARSLIYQLLDPNPKTRMSIEKIMSISWFQ 286 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~Rpt~~eil~hp~f~ 286 (451)
.+.+++.+||..||.+|||+.++++||||+
T Consensus 239 ~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 999999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=339.70 Aligned_cols=240 Identities=17% Similarity=0.237 Sum_probs=205.4
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe----CCEEEEEE
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT----KTKIYLVM 109 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~----~~~~~lV~ 109 (451)
..||+|+++.||+|.. +|+.||||.+.... .......+.+.+|+.+|++++ ||||+++++++.+ ....++||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~lv~ 101 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFH-KGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSLIL 101 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccc-cccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEEEE
Confidence 5789999999999986 78999999997652 233344577889999999996 9999999999876 45789999
Q ss_pred EecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcc
Q 013005 110 EYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQN-GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML 187 (451)
Q Consensus 110 E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~-giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~ 187 (451)
||++||+|.+++.+ +.+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||++..... ..
T Consensus 102 Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~----~~ 177 (283)
T PHA02988 102 EYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS----PP 177 (283)
T ss_pred EeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc----cc
Confidence 99999999999975 6799999999999999999999985 999999999999999999999999999874322 12
Q ss_pred cccCCCCccccceeeecc-CCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc--CCCCCCCCCHhHHHHHHh
Q 013005 188 HTACGTPAYTAPEVVARR-GYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR--DYQFPSFVSKPARSLIYQ 264 (451)
Q Consensus 188 ~~~~gt~~y~APEvl~~~-~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~ 264 (451)
....||+.|+|||++.+. ...+.++|||||||++|+|++|..||...+....+..+... ...+|...++.+.+|+.+
T Consensus 178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 345789999999998652 33467799999999999999999999988877777776433 345565789999999999
Q ss_pred ccCCCCCCCCCHHHHHc
Q 013005 265 LLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 265 ~L~~dP~~Rpt~~eil~ 281 (451)
||+.||++|||++++++
T Consensus 258 cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 258 CTSHDSIKRPNIKEILY 274 (283)
T ss_pred HhcCCcccCcCHHHHHH
Confidence 99999999999999985
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=332.25 Aligned_cols=252 Identities=30% Similarity=0.558 Sum_probs=218.0
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
+|++.+.||+|+||.||.+.+..+++.||+|.+..... .......+.+|+.+++++. ||||+++++++......|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMK-HPNIVQYQESFEENGNLYIV 77 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHHHHHHHHHHHhCC-CCCeeeeEeeecCCCeEEEE
Confidence 68999999999999999999999999999999875421 2334467889999999995 99999999999999999999
Q ss_pred EEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 109 MEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
+||+.+++|.+.+.. ..+++.+++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-~ 156 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-E 156 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-h
Confidence 999999999998864 358999999999999999999999999999999999999999999999999987543321 1
Q ss_pred cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC-CCCCCCCHhHHHHHHh
Q 013005 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY-QFPSFVSKPARSLIYQ 264 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 264 (451)
......|++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+.......+..+.. ..+..++..+.++|.+
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 235 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQ 235 (256)
T ss_pred hhhhccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHH
Confidence 1234468899999999876654 5679999999999999999999998877777666655443 3566789999999999
Q ss_pred ccCCCCCCCCCHHHHHcCccc
Q 013005 265 LLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 265 ~L~~dP~~Rpt~~eil~hp~f 285 (451)
||..+|.+||++.++++||||
T Consensus 236 ~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 236 LFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HhhCChhhCcCHHHHhhCcCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=337.50 Aligned_cols=256 Identities=30% Similarity=0.545 Sum_probs=217.7
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhc--CCCCceEEEEEEEeCCEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ--NHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~--~HpnIv~l~~~~~~~~~~~ 106 (451)
.|++.+.||+|+||.||+|.+..+++.||+|.++... .......+.+|+.+++++. .|||++++++++......|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT---PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEE
Confidence 5888999999999999999999999999999986542 2233456888999999995 4999999999999999999
Q ss_pred EEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCc
Q 013005 107 LVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM 186 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~ 186 (451)
+||||+.|++|.+++..+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 79 lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~ 157 (277)
T cd06917 79 IIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-SK 157 (277)
T ss_pred EEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-cc
Confidence 99999999999999988899999999999999999999999999999999999999999999999999987543322 22
Q ss_pred ccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC-CCCCCC-CCHhHHHHHHh
Q 013005 187 LHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD-YQFPSF-VSKPARSLIYQ 264 (451)
Q Consensus 187 ~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~-~s~~~~~li~~ 264 (451)
.....|++.|+|||.+.+....+.++|+||||+++|+|++|..||...........+.... ..++.. ++..+.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAA 237 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHH
Confidence 3345789999999988665555678999999999999999999998876655444433322 223332 78899999999
Q ss_pred ccCCCCCCCCCHHHHHcCccccch
Q 013005 265 LLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 265 ~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
||..||++|||+.+++.||||+..
T Consensus 238 ~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 238 CLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred HcCCCcccCcCHHHHhhChHhhcc
Confidence 999999999999999999999764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=338.10 Aligned_cols=249 Identities=31% Similarity=0.536 Sum_probs=205.5
Q ss_pred eEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC--CEEEE
Q 013005 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK--TKIYL 107 (451)
Q Consensus 30 y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~--~~~~l 107 (451)
|++.+.||+|+||.||+|.+..+++.||+|.+.+... .. ......+|+.+++++.+||||+++++++.+. +..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC--Cc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence 6788999999999999999999999999999865421 11 1223457888999997799999999999887 89999
Q ss_pred EEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 108 VMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
||||+.+ +|.+.+.. +.+++..++.++.|++.||.|||++|++||||+|+||+++. +.+||+|||++...... .
T Consensus 78 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~--~ 153 (282)
T cd07831 78 VFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK--P 153 (282)
T ss_pred EEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC--C
Confidence 9999975 77777764 56899999999999999999999999999999999999999 99999999998754321 2
Q ss_pred cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhc------------------cC
Q 013005 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNR------------------RD 247 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~------------------~~ 247 (451)
......+++.|+|||.+....+.+.++||||+||++|+|++|..||...+..+....+.. ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 223456899999999876666667789999999999999999999987765544333321 11
Q ss_pred CCCC-----------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 248 YQFP-----------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 248 ~~~p-----------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
+.+| +.++..+.++|.+||.+||++|||++++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1122 2357899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=355.14 Aligned_cols=262 Identities=23% Similarity=0.375 Sum_probs=211.7
Q ss_pred CCCCCCcccccCCeEEcceEcccCceEEEEEEE-----cCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCC
Q 013005 17 PPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKS-----IADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN 91 (451)
Q Consensus 17 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~Hpn 91 (451)
-|.........++|++++.||+|+||+||+|.+ ..++..||+|++.... .....+.+.+|+.+++.+.+|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~il~~l~~Hpn 100 (375)
T cd05104 24 LPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHIN 100 (375)
T ss_pred CCCccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc---CcHHHHHHHHHHHHHHHhcCCcc
Confidence 344455566677999999999999999999974 3467789999986542 12334678899999999966999
Q ss_pred ceEEEEEEEeCCEEEEEEEecCCCchhHHhhcC-----------------------------------------------
Q 013005 92 VLKIQEVMATKTKIYLVMEYAAGGELFGKLRRG----------------------------------------------- 124 (451)
Q Consensus 92 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----------------------------------------------- 124 (451)
|+++++++......|+||||++||+|.+++...
T Consensus 101 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 180 (375)
T cd05104 101 IVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVP 180 (375)
T ss_pred eeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccc
Confidence 999999999999999999999999999888531
Q ss_pred -----------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccC
Q 013005 125 -----------------------------RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGL 175 (451)
Q Consensus 125 -----------------------------~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGl 175 (451)
.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~ 260 (375)
T cd05104 181 TKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGL 260 (375)
T ss_pred cccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCcc
Confidence 367888999999999999999999999999999999999999999999999
Q ss_pred CCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHH-HHHHHhhcc-CCCCC
Q 013005 176 SALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLL-AMYKKVNRR-DYQFP 251 (451)
Q Consensus 176 s~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~-~~~~~i~~~-~~~~p 251 (451)
+........ .......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...... ...+.+... ....|
T Consensus 261 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 339 (375)
T cd05104 261 ARDIRNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSP 339 (375)
T ss_pred ceeccCcccccccCCCCCCcceeChhHhcCCCC-CCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCC
Confidence 875432221 11122345678999999977666 567999999999999998 89999876544 333333332 22345
Q ss_pred CCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 252 SFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 252 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
...+.++.+||.+||..||++|||+.+|++.
T Consensus 340 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 5678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=353.46 Aligned_cols=246 Identities=24% Similarity=0.378 Sum_probs=197.9
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
..+|++.+.||+|+||.||+|.+..+++.||+|+.... ....|+.+++++. ||||+++++++......|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 133 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVN-HPSVIRMKDTLVSGAITC 133 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCC-CCCCcChhheEEeCCeeE
Confidence 34799999999999999999999999999999986443 1245888999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 107 LVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~--~ 210 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV--A 210 (357)
T ss_pred EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc--C
Confidence 9999996 578877753 5799999999999999999999999999999999999999999999999999874322 1
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCC-CCCcH----------HHHHHHhh---ccCCCC
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPF-DDSNL----------LAMYKKVN---RRDYQF 250 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf-~~~~~----------~~~~~~i~---~~~~~~ 250 (451)
.......||+.|+|||++.+..+ +.++||||+||++|+|+++..|+ ..... ..+...+. .....+
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 289 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKY-NSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF 289 (357)
T ss_pred cccccccccccccCCeecCCCCC-CchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence 22334579999999999987776 56699999999999999855444 32111 01111110 001111
Q ss_pred C------------------------------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 251 P------------------------------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 251 p------------------------------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
| ..++..+.+||.+||..||.+|||+.|+++||||++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 1 124667788999999999999999999999999975
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=344.62 Aligned_cols=258 Identities=28% Similarity=0.460 Sum_probs=212.0
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC--C
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK--T 103 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~--~ 103 (451)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.++++++ ||||+++++++... +
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 81 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE--RDGIPISSLREITLLLNLR-HPNIVELKEVVVGKHLD 81 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC--CCCCcchhhHHHHHHHhCC-CCCCcceEEEEecCCCC
Confidence 56789999999999999999999999999999999875421 1122234567999999996 99999999998755 5
Q ss_pred EEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 104 KIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
..|+||||+.+ +|.+++.. ..+++.+++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 82 SIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred eEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 78999999975 78777764 6799999999999999999999999999999999999999999999999999875543
Q ss_pred hhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc---------------
Q 013005 182 IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR--------------- 246 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~--------------- 246 (451)
.. .......+++.|+|||++.+....+.++||||+||++|+|++|..||...+....+..+...
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 161 PA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred cc-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 22 22233456888999999876555567799999999999999999999887766655444321
Q ss_pred ----CCCCC-----------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 247 ----DYQFP-----------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 247 ----~~~~p-----------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.+..+ .+.++.+.+||.+||..||++|||+++++.||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 01111 2257889999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=361.22 Aligned_cols=248 Identities=23% Similarity=0.307 Sum_probs=201.8
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
..+|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.++++|. |||||++++++......|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~-HpnIv~l~~~~~~~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLS-HPAVLALLDVRVVGGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCC-CCCCCcEEEEEEECCEEE
Confidence 4579999999999999999999999999999996432 23467999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 107 LVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
+|||++. ++|..++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 237 lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred EEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 9999995 588887754 5699999999999999999999999999999999999999999999999999975433221
Q ss_pred -CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCC--------cHHHHHHHhhccCC-------
Q 013005 185 -GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS--------NLLAMYKKVNRRDY------- 248 (451)
Q Consensus 185 -~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~--------~~~~~~~~i~~~~~------- 248 (451)
......+||+.|+|||++.+..+ +.++|||||||+||+|++|..|+... ........+.....
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~-~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPY-TPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCC-CchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 12234579999999999987776 56699999999999999987665321 11222222221110
Q ss_pred ----------------------CCCC-----CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 249 ----------------------QFPS-----FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 249 ----------------------~~p~-----~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
..+. .++..+.+||.+||..||.+|||+.|+|+||||+.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0111 24568899999999999999999999999999974
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=334.33 Aligned_cols=256 Identities=27% Similarity=0.495 Sum_probs=213.2
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcch------hhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKF------LDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
+|.+.+.||+|+||.||+|.+..+++.+|+|.+...... ......+.+.+|+.+++.+. ||||+++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEeccC
Confidence 689999999999999999999889999999998643111 11223457889999999995 99999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 103 TKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
...++||||+.|++|.+.+++ +.+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 999999999999999999976 7899999999999999999999999999999999999999999999999999875432
Q ss_pred hhc-CcccccCCCCccccceeeeccC-CCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc--CCCCCC----C
Q 013005 182 IKN-GMLHTACGTPAYTAPEVVARRG-YDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR--DYQFPS----F 253 (451)
Q Consensus 182 ~~~-~~~~~~~gt~~y~APEvl~~~~-~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~----~ 253 (451)
... .......|+..|+|||++.... ..+.++|+||||+++|+|++|..||...........+... ...++. .
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMN 240 (272)
T ss_pred cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccccc
Confidence 211 1223456899999999987654 3467799999999999999999999766555444333222 222332 3
Q ss_pred CCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 254 VSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 254 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
++..+.++|.+||.++|++|||++++++||||
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 241 LSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 58899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=340.42 Aligned_cols=255 Identities=26% Similarity=0.422 Sum_probs=207.9
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE---
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK--- 104 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~--- 104 (451)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+.+||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 78 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD--EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK 78 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc--ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence 579999999999999999999999999999999865421 122335678899999999778999999999877665
Q ss_pred --EEEEEEecCCCchhHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC-CCCeEEEeccC
Q 013005 105 --IYLVMEYAAGGELFGKLRR------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR-DGNLKVSDFGL 175 (451)
Q Consensus 105 --~~lV~E~~~gg~L~~~l~~------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~-~~~lkl~DFGl 175 (451)
.|+||||+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||+
T Consensus 79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccc
Confidence 8999999986 78877742 24799999999999999999999999999999999999998 88999999999
Q ss_pred CCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC-----C--
Q 013005 176 SALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD-----Y-- 248 (451)
Q Consensus 176 s~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~-----~-- 248 (451)
+....... .......+++.|+|||.+.+....+.++||||+|+++|+|++|..||...+......++.... .
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 158 GRAFSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred ceecCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 87442211 222334678999999988665555677999999999999999999998766554443332110 0
Q ss_pred ----------CC-----------CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCcccc
Q 013005 249 ----------QF-----------PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQ 286 (451)
Q Consensus 249 ----------~~-----------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~ 286 (451)
.+ .+.++..+.+||.+||.+||.+|||+++++.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00 123688899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=333.20 Aligned_cols=256 Identities=27% Similarity=0.495 Sum_probs=213.3
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcch-hhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe--CCE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKF-LDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT--KTK 104 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~--~~~ 104 (451)
.+|++.+.||+|+||.||.|.+..++..||+|.+...... ......+.+.+|+.+++++. ||||+++++++.+ ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccCCCce
Confidence 5799999999999999999999999999999998643221 12234567889999999995 9999999998865 357
Q ss_pred EEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 105 IYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
+|++|||++|++|.+++.+ +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 8899999999999999875 678999999999999999999999999999999999999999999999999987543211
Q ss_pred c--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc--CCCCCCCCCHhHH
Q 013005 184 N--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR--DYQFPSFVSKPAR 259 (451)
Q Consensus 184 ~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~ 259 (451)
. .......|+..|+|||++.+..+ +.++|||||||++|+|++|+.||...+......++... ....|..++..+.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCR 239 (265)
T ss_pred ccccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHH
Confidence 1 12334568999999999877665 56799999999999999999999876555444444332 2334566788899
Q ss_pred HHHHhccCCCCCCCCCHHHHHcCcccc
Q 013005 260 SLIYQLLDPNPKTRMSIEKIMSISWFQ 286 (451)
Q Consensus 260 ~li~~~L~~dP~~Rpt~~eil~hp~f~ 286 (451)
++|.+|+. +|++|||++++++|||+.
T Consensus 240 ~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 240 DFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 99999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=330.67 Aligned_cols=254 Identities=28% Similarity=0.531 Sum_probs=216.6
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcc-hhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNK-FLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
+|+..+.||+|+||+||+|.+..+++.|++|.+..... .......+.+.+|+.+++.+. ||||+++++++.+....|+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeEecCCeEEE
Confidence 58888999999999999999988999999999865421 122345567899999999995 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCc
Q 013005 108 VMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM 186 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~ 186 (451)
++||+++++|.+++.+ +.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++....... .
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~ 157 (258)
T cd06632 80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--F 157 (258)
T ss_pred EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--c
Confidence 9999999999999976 569999999999999999999999999999999999999999999999999987543221 2
Q ss_pred ccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhc--cCCCCCCCCCHhHHHHHHh
Q 013005 187 LHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNR--RDYQFPSFVSKPARSLIYQ 264 (451)
Q Consensus 187 ~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~ 264 (451)
.....|++.|+|||.+......+.++|+||+|+++|+|++|..||...........+.. ....+|..+++.+.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 34567899999999987655346779999999999999999999987665444444333 2334566789999999999
Q ss_pred ccCCCCCCCCCHHHHHcCccc
Q 013005 265 LLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 265 ~L~~dP~~Rpt~~eil~hp~f 285 (451)
||..+|.+|||+++++.|||+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 238 CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=338.52 Aligned_cols=261 Identities=29% Similarity=0.525 Sum_probs=219.2
Q ss_pred CeEEcceEcccCceEEEEEEEc---CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSI---ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
+|++.+.||+|+||.||+|.+. .+|..||+|++............+.+.+|+.+++++.+||||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999875 4789999999976422222334567889999999997799999999999999999
Q ss_pred EEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 106 YLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
|+||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+|||++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 999999999999999864 6789999999999999999999999999999999999999999999999999875433222
Q ss_pred CcccccCCCCccccceeeecc-CCCCccchhhhhhHHHHHHHhcCCCCCCCc----HHHHHHHhhccCCCCCCCCCHhHH
Q 013005 185 GMLHTACGTPAYTAPEVVARR-GYDGAVADAWSCGVILFVLLAGYLPFDDSN----LLAMYKKVNRRDYQFPSFVSKPAR 259 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~-~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~~ 259 (451)
......+|+..|+|||.+... ...+.++||||+|+++|+|++|..||...+ .......+......+|..+++.+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 240 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHH
Confidence 333456789999999998653 234567999999999999999999997432 234444444455566777899999
Q ss_pred HHHHhccCCCCCCCC-----CHHHHHcCccccchh
Q 013005 260 SLIYQLLDPNPKTRM-----SIEKIMSISWFQKSL 289 (451)
Q Consensus 260 ~li~~~L~~dP~~Rp-----t~~eil~hp~f~~~~ 289 (451)
+++.+||..||.+|| ++++++.||||++..
T Consensus 241 ~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 999999999999997 899999999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=332.42 Aligned_cols=247 Identities=34% Similarity=0.563 Sum_probs=207.9
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecC
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAA 113 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ 113 (451)
+.||+|+||.||+|.+..+++.||+|++.+... ........+..|..++....+||||+++++++...+..|+|+||+.
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDM-IAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhh-hHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 568999999999999999999999999976422 1122233445555555544469999999999999999999999999
Q ss_pred CCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCC
Q 013005 114 GGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACG 192 (451)
Q Consensus 114 gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~g 192 (451)
|++|.+++.. +.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++..... .....|
T Consensus 81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~~ 155 (260)
T cd05611 81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFVG 155 (260)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccCCC
Confidence 9999999975 6799999999999999999999999999999999999999999999999999864322 234568
Q ss_pred CCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCC----CCCCHhHHHHHHhccCC
Q 013005 193 TPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP----SFVSKPARSLIYQLLDP 268 (451)
Q Consensus 193 t~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~ 268 (451)
++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+....+..+......++ ..+++.+.++|.+||..
T Consensus 156 ~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 156 TPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 899999999877664 6779999999999999999999998887777766655443332 34789999999999999
Q ss_pred CCCCCC---CHHHHHcCccccc
Q 013005 269 NPKTRM---SIEKIMSISWFQK 287 (451)
Q Consensus 269 dP~~Rp---t~~eil~hp~f~~ 287 (451)
||++|| +++|++.||||++
T Consensus 235 ~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 235 DPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred CHHHccCCCcHHHHHcChHhhc
Confidence 999999 5589999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=329.31 Aligned_cols=252 Identities=29% Similarity=0.514 Sum_probs=219.3
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
+|++.+.||.|+||.||.+++..+++.+++|.++... .+......+.+|+.+++++. |+||+++++++.+....+++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~~ 77 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR--LSEKERRDALNEIVILSLLQ-HPNIIAYYNHFMDDNTLLIE 77 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecc--cchhHHHHHHHHHHHHHhCC-CCCeeEEEeEEecCCeEEEE
Confidence 5899999999999999999999999999999987542 22344567889999999995 99999999999999999999
Q ss_pred EEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 109 MEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
|||+++++|.+++.+ ..+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....... .
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~-~ 156 (256)
T cd08221 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY-S 156 (256)
T ss_pred EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc-c
Confidence 999999999999965 368999999999999999999999999999999999999999999999999987543322 2
Q ss_pred cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCC-CCCCCCHhHHHHHHh
Q 013005 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQ-FPSFVSKPARSLIYQ 264 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~ 264 (451)
......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+...... .+..++..+.++|.+
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKY-NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHS 235 (256)
T ss_pred cccccCCCccccCHhhcCCCCC-CCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHH
Confidence 3345678999999999877654 46699999999999999999999988877777776655443 345578999999999
Q ss_pred ccCCCCCCCCCHHHHHcCccc
Q 013005 265 LLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 265 ~L~~dP~~Rpt~~eil~hp~f 285 (451)
||..||.+|||+.++++|||+
T Consensus 236 ~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 236 LLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HcccCcccCCCHHHHhhCcCC
Confidence 999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=338.21 Aligned_cols=252 Identities=29% Similarity=0.505 Sum_probs=208.7
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
+|++.+.||.|++|.||+|++..+++.||||.+..... .......+.+|+.++++++ ||||+++++++.+....|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 77 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLV 77 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc--ccccchHHHHHHHHHHhcC-CCCCcchhhhcccCCcEEEE
Confidence 48899999999999999999999999999999865421 2223456889999999995 99999999999999999999
Q ss_pred EEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 109 MEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
|||+. ++|..++.. +.+++..++.++.|++.||+|||++|++||||+|+||+++.++.+||+|||++...... ..
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~-~~ 155 (284)
T cd07860 78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VR 155 (284)
T ss_pred eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC-cc
Confidence 99996 578887753 56899999999999999999999999999999999999999999999999998654321 12
Q ss_pred cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc------------------C
Q 013005 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR------------------D 247 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~------------------~ 247 (451)
......+++.|+|||.+.+....+.++||||||+++|+|++|..||...+......++... .
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 2334567899999999877666677799999999999999999999876554332222110 0
Q ss_pred CCC-----------CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 248 YQF-----------PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 248 ~~~-----------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
..+ .+.+++.+.++|.+||..||.+|||++++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 011 12367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=344.79 Aligned_cols=253 Identities=26% Similarity=0.447 Sum_probs=220.9
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
.+-|.++..||+|+||.||+|+++++|+.+|||.+..+. ....+.+||.+|+++. .|++|++|+.|.....+|
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s------DLQEIIKEISIMQQC~-S~yVVKYYGSYFK~sDLW 104 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT------DLQEIIKEISIMQQCK-SKYVVKYYGSYFKHSDLW 104 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc------hHHHHHHHHHHHHHcC-CchhhhhhhhhccCCceE
Confidence 445778999999999999999999999999999986652 3456889999999996 999999999999999999
Q ss_pred EEEEecCCCchhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 107 LVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~--~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
+|||||..|++.+.++ +..++|.++..+++..+.||+|||...-+|||||..|||++.+|..||+|||.+......-
T Consensus 105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM- 183 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM- 183 (502)
T ss_pred eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH-
Confidence 9999999999999997 4679999999999999999999999999999999999999999999999999986433211
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC---CCCCCCCHhHHHH
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY---QFPSFVSKPARSL 261 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~l 261 (451)
..-.+..|||.|||||++..-+|++. +||||||++..+|..|++||.+-......-.|-..+. .-|...|.++.+|
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~-ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DF 262 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTK-ADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDF 262 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchh-hhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHH
Confidence 12357789999999999999999765 8999999999999999999988776655545544322 2345578999999
Q ss_pred HHhccCCCCCCCCCHHHHHcCccccch
Q 013005 262 IYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 262 i~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+++||..+|++|-|+.++++|||.++.
T Consensus 263 i~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 263 IRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred HHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 999999999999999999999999864
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=336.44 Aligned_cols=257 Identities=26% Similarity=0.441 Sum_probs=219.2
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
...|+..+.||.|+||.||+|.+..+++.||+|++.... .......+.+|+.+++++. ||||+++++++.+....|
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 78 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKGTKLW 78 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEE
Confidence 356888999999999999999999999999999987542 1234567889999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCc
Q 013005 107 LVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM 186 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~ 186 (451)
+||||++|++|.+++..+++++.++..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 79 lv~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~ 157 (277)
T cd06640 79 IIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IK 157 (277)
T ss_pred EEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-cc
Confidence 99999999999999988899999999999999999999999999999999999999999999999999986543211 12
Q ss_pred ccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhHHHHHHhc
Q 013005 187 LHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPARSLIYQL 265 (451)
Q Consensus 187 ~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~ 265 (451)
.....++..|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+... ....+..++..+.+++.+|
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDAC 236 (277)
T ss_pred cccccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHH
Confidence 233468899999999876655 56799999999999999999999877655544444322 2334445788999999999
Q ss_pred cCCCCCCCCCHHHHHcCccccchh
Q 013005 266 LDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 266 L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
|..+|++||+++++++||||.+..
T Consensus 237 l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 237 LNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred cccCcccCcCHHHHHhChHhhhcc
Confidence 999999999999999999997643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=329.24 Aligned_cols=251 Identities=30% Similarity=0.506 Sum_probs=217.0
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
+|++.+.||+|+||.||+|.+..+++.+|+|.++... ........+.+|+.++++++ ||||+++++.+......++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQ--MTKDERLAAQNECQVLKLLS-HPNIIEYYENFLEDKALMIV 77 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccc--cccHHHHHHHHHHHHHhhCC-CCchhheeeeEecCCEEEEE
Confidence 6899999999999999999999999999999997652 23344677899999999995 99999999999999999999
Q ss_pred EEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC-CeEEEeccCCCcchhhhc
Q 013005 109 MEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG-NLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~-~lkl~DFGls~~~~~~~~ 184 (451)
|||++|++|.+++.. ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~-- 155 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-- 155 (256)
T ss_pred EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC--
Confidence 999999999999974 2489999999999999999999999999999999999998654 5799999998754322
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC-CCCCCCCCHhHHHHHH
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD-YQFPSFVSKPARSLIY 263 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~ 263 (451)
.......|++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+.......+.... ..++..++..+.+++.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 234 (256)
T cd08220 156 SKAYTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLIL 234 (256)
T ss_pred ccccccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHH
Confidence 22234568999999999876654 567999999999999999999999887776666655443 3456678999999999
Q ss_pred hccCCCCCCCCCHHHHHcCccc
Q 013005 264 QLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 264 ~~L~~dP~~Rpt~~eil~hp~f 285 (451)
+||..||.+|||+.++++||||
T Consensus 235 ~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 235 SMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHccCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=347.43 Aligned_cols=262 Identities=26% Similarity=0.459 Sum_probs=229.3
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
.+.-.+.|...+.||+|+||.||-++...||+.+|+|.+++. +...........+|-.+|.++. .+.||.+--.|+++
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KK-RiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAfeTk 257 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKK-RIKKRKGETMALNEKQILEKVS-SPFIVSLAYAFETK 257 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHH-HHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeeecCC
Confidence 566778899999999999999999999999999999999876 3444445556778888999995 89999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc-C--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcc
Q 013005 103 TKIYLVMEYAAGGELFGKLRR-G--RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALP 179 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~-~--~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~ 179 (451)
+.+++||..|+||+|.-.|.+ | .|+|..++.|+.+|+.||++||+++|+.|||||+|||||+.|+++|+|+|||.-.
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEec
Confidence 999999999999999877754 4 7999999999999999999999999999999999999999999999999999854
Q ss_pred hhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCc----HHHHHHHhhccCCCCCCCCC
Q 013005 180 EQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN----LLAMYKKVNRRDYQFPSFVS 255 (451)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s 255 (451)
.. .......+||..|||||++.+..|+ ...|.|||||+||+|+.|+.||.... .++.-+.+......+|..+|
T Consensus 338 ~~--g~~~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS 414 (591)
T KOG0986|consen 338 PE--GKPIRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFS 414 (591)
T ss_pred CC--CCccccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccC
Confidence 33 3445566999999999999998875 45899999999999999999997533 23455566667778889999
Q ss_pred HhHHHHHHhccCCCCCCCC-----CHHHHHcCccccchh
Q 013005 256 KPARSLIYQLLDPNPKTRM-----SIEKIMSISWFQKSL 289 (451)
Q Consensus 256 ~~~~~li~~~L~~dP~~Rp-----t~~eil~hp~f~~~~ 289 (451)
+++++|.+.+|..||.+|. .++++.+||||+.-.
T Consensus 415 ~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ln 453 (591)
T KOG0986|consen 415 EEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLN 453 (591)
T ss_pred HHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCC
Confidence 9999999999999999997 588999999998743
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=347.89 Aligned_cols=258 Identities=26% Similarity=0.465 Sum_probs=210.4
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC---
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK--- 102 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~--- 102 (451)
+.++|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.++++++ ||||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 78 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE---HQTFCQRTLREIKILRRFK-HENIIGILDIIRPPSFE 78 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc---cchhHHHHHHHHHHHHhCC-CCCcCchhheeeccccc
Confidence 4578999999999999999999999999999999986432 2234456778999999996 99999999987544
Q ss_pred --CEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 103 --TKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 103 --~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
...|+++||+.+ +|...+..+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 79 ~~~~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 79 SFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred ccceEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 358999999975 88888888889999999999999999999999999999999999999999999999999987543
Q ss_pred hhhc--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhc-------------
Q 013005 181 QIKN--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNR------------- 245 (451)
Q Consensus 181 ~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~------------- 245 (451)
.... ......+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 2211 2223457899999999876655456789999999999999999999977654332221110
Q ss_pred --c---------C--CC-----CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 246 --R---------D--YQ-----FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 246 --~---------~--~~-----~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
. . .. ..+..+..+.++|.+||..||++|||+.++++||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 0 0 00 112357889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=335.76 Aligned_cols=248 Identities=27% Similarity=0.471 Sum_probs=210.4
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecCCC
Q 013005 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGG 115 (451)
Q Consensus 36 LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~gg 115 (451)
||+|+||+||+|.+..+|+.||+|++.+.. .........+.+|+.++++++ ||||+++++++...+..|+||||++|+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKR-LKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhh-hhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecCCeEEEEEecCCCC
Confidence 699999999999999999999999997642 222233456678999999996 999999999999999999999999999
Q ss_pred chhHHhhc-C--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCC
Q 013005 116 ELFGKLRR-G--RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACG 192 (451)
Q Consensus 116 ~L~~~l~~-~--~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~g 192 (451)
+|.+++.+ + .+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..... ........+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~~ 156 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGRAG 156 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCccccccC
Confidence 99998864 3 699999999999999999999999999999999999999999999999999865432 222334568
Q ss_pred CCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcH----HHHHHHhhccCCCCCCCCCHhHHHHHHhccCC
Q 013005 193 TPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNL----LAMYKKVNRRDYQFPSFVSKPARSLIYQLLDP 268 (451)
Q Consensus 193 t~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 268 (451)
+..|+|||.+.+..+ +.++||||+|+++|+|++|+.||..... ......+.......|..+++.+.++|.+||..
T Consensus 157 ~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 235 (277)
T cd05577 157 TPGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQK 235 (277)
T ss_pred CCCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccC
Confidence 889999999877664 5669999999999999999999976543 33334444445566777899999999999999
Q ss_pred CCCCCC-----CHHHHHcCccccch
Q 013005 269 NPKTRM-----SIEKIMSISWFQKS 288 (451)
Q Consensus 269 dP~~Rp-----t~~eil~hp~f~~~ 288 (451)
||.+|| ++.+++.||||...
T Consensus 236 ~p~~R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 236 DPEKRLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred ChhHccCCCcccHHHHHhChhhhcC
Confidence 999999 89999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=343.80 Aligned_cols=246 Identities=28% Similarity=0.450 Sum_probs=191.8
Q ss_pred EcceEcccCceEEEEEEEcC--CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE--eCCEEEE
Q 013005 32 LGPLLGRGSFAKVHKAKSIA--DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA--TKTKIYL 107 (451)
Q Consensus 32 ~~~~LG~G~~g~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~--~~~~~~l 107 (451)
.+..||+|+||+||+|.+.. ++..||+|.+..... ...+.+|+.++++++ ||||+++++++. .....|+
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~------~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI------SMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWL 77 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC------cHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEE
Confidence 35689999999999998654 568999999865421 234678999999995 999999999885 4567899
Q ss_pred EEEecCCCchhHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEe----CCCCCeEEEec
Q 013005 108 VMEYAAGGELFGKLRR----------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL----DRDGNLKVSDF 173 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~----------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILl----d~~~~lkl~DF 173 (451)
||||+.+ +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 78 LFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred EEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 9999875 77766531 248999999999999999999999999999999999999 56678999999
Q ss_pred cCCCcchhhhc--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH---------HH---
Q 013005 174 GLSALPEQIKN--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL---------AM--- 239 (451)
Q Consensus 174 Gls~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~---------~~--- 239 (451)
|++........ ......+||+.|+|||++.+....+.++||||+||++|+|++|..||...... ..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence 99975433221 22345678999999999877665677899999999999999999999643211 00
Q ss_pred ------------HHHhhc-------------cCC----------CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCcc
Q 013005 240 ------------YKKVNR-------------RDY----------QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISW 284 (451)
Q Consensus 240 ------------~~~i~~-------------~~~----------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 284 (451)
+..+.. ... ......+..+.+||.+||..||.+|||++|+++|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07867 237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY 316 (317)
T ss_pred HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCC
Confidence 000000 000 001123556889999999999999999999999999
Q ss_pred c
Q 013005 285 F 285 (451)
Q Consensus 285 f 285 (451)
|
T Consensus 317 f 317 (317)
T cd07867 317 F 317 (317)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=343.00 Aligned_cols=256 Identities=26% Similarity=0.429 Sum_probs=216.6
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
.+.|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.+. ||||+++++.+...+..|
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~ 95 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK----QQRRELLFNEVVIMRDYH-HENVVDMYNSYLVGDELW 95 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch----HHHHHHHHHHHHHHHhCC-CCcHHHHHHheecCCeEE
Confidence 345555678999999999999998999999999986532 234566889999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCc
Q 013005 107 LVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM 186 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~ 186 (451)
+||||+++++|.+++..+++++.+++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... ...
T Consensus 96 lv~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-~~~ 174 (292)
T cd06658 96 VVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE-VPK 174 (292)
T ss_pred EEEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc-ccc
Confidence 9999999999999998888999999999999999999999999999999999999999999999999998643221 122
Q ss_pred ccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC---CCCCCCCCHhHHHHHH
Q 013005 187 LHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD---YQFPSFVSKPARSLIY 263 (451)
Q Consensus 187 ~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~ 263 (451)
.....|++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+.......+.... .......+..+.+++.
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 253 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLD 253 (292)
T ss_pred CceeecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHH
Confidence 334578999999999877665 466999999999999999999998876655554443321 1222346889999999
Q ss_pred hccCCCCCCCCCHHHHHcCccccchh
Q 013005 264 QLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 264 ~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
+||..||++|||++++++||||+...
T Consensus 254 ~~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 254 LMLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred HHccCChhHCcCHHHHhhChhhhccC
Confidence 99999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=328.83 Aligned_cols=254 Identities=31% Similarity=0.569 Sum_probs=214.6
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
+|.+.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+. ||||+++++...+.+..++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN--DPKTIKEIADEMKVLELLK-HPNLVKYYGVEVHREKVYIF 77 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc--chHHHHHHHHHHHHHHhCC-CCChhheeeeEecCCEEEEE
Confidence 68999999999999999999988999999999976532 2345678999999999995 99999999999999999999
Q ss_pred EEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCc-
Q 013005 109 MEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM- 186 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~- 186 (451)
+||+.+++|.+++.+ +.+++..++.++.|++.||.|||++|++|+||+|+||++++++.+||+|||++..........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 999999999999976 468999999999999999999999999999999999999999999999999987643322211
Q ss_pred --ccccCCCCccccceeeeccC--CCCccchhhhhhHHHHHHHhcCCCCCCCc-HHHHHHHhh-ccCCCCCCCC--CHhH
Q 013005 187 --LHTACGTPAYTAPEVVARRG--YDGAVADAWSCGVILFVLLAGYLPFDDSN-LLAMYKKVN-RRDYQFPSFV--SKPA 258 (451)
Q Consensus 187 --~~~~~gt~~y~APEvl~~~~--~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~-~~~~~~~i~-~~~~~~p~~~--s~~~ 258 (451)
.....+++.|+|||.+.... ..+.++||||+|+++|+|++|+.||.... .......+. .....+|.+. +..+
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEG 237 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHH
Confidence 22457889999999987654 24667999999999999999999997542 222222222 2334555554 8999
Q ss_pred HHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 259 RSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 259 ~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
.++|.+||..+|++|||+++++.|||+
T Consensus 238 ~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 238 KDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=368.88 Aligned_cols=257 Identities=28% Similarity=0.443 Sum_probs=213.0
Q ss_pred CCCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEE
Q 013005 18 PPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQE 97 (451)
Q Consensus 18 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~ 97 (451)
.....+.+---++++.+.|.+|+|+.||+|.+...|..||+|.+-.. +....+.+.+||.+|++|++|+|||.+++
T Consensus 27 ~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~v~~EI~~MK~L~gh~nIV~yid 102 (738)
T KOG1989|consen 27 FVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNAVKREIDIMKLLSGHKNIVSYID 102 (738)
T ss_pred CCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHHHHHHHHHHHHhcCCCceeeEec
Confidence 34444555566778999999999999999999888899999998433 55677889999999999999999999999
Q ss_pred E-EEe------CCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCeEEeCCC
Q 013005 98 V-MAT------KTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNG--VAHRDVKPQNLLLDRD 165 (451)
Q Consensus 98 ~-~~~------~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~g--iiHrDLKpeNILld~~ 165 (451)
. ... .-.++|.||||.||.|-+++.. .+|+|.++.+||.|+++||.+||... |||||||-|||||+.+
T Consensus 103 ss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~ 182 (738)
T KOG1989|consen 103 SSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSAD 182 (738)
T ss_pred cccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCC
Confidence 3 211 1257799999999999999973 67999999999999999999999997 9999999999999999
Q ss_pred CCeEEEeccCCCcchhhhc-----Cc---ccccCCCCccccceeee---ccCCCCccchhhhhhHHHHHHHhcCCCCCCC
Q 013005 166 GNLKVSDFGLSALPEQIKN-----GM---LHTACGTPAYTAPEVVA---RRGYDGAVADAWSCGVILFVLLAGYLPFDDS 234 (451)
Q Consensus 166 ~~lkl~DFGls~~~~~~~~-----~~---~~~~~gt~~y~APEvl~---~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~ 234 (451)
|+.||||||.++..-.... .. --...-|+.|+|||.+. +.+. +.|+|||+|||+||-|+....||+..
T Consensus 183 g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 183 GNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred CCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 9999999999874221110 00 01223589999999863 3333 67899999999999999999999876
Q ss_pred cHHHHHHHhhccCCCCCC--CCCHhHHHHHHhccCCCCCCCCCHHHHHcCc
Q 013005 235 NLLAMYKKVNRRDYQFPS--FVSKPARSLIYQLLDPNPKTRMSIEKIMSIS 283 (451)
Q Consensus 235 ~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 283 (451)
.. -.|..+.|.||+ .++..+.+||+.||++||.+||++-|++.+-
T Consensus 262 g~----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 262 GK----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI 308 (738)
T ss_pred cc----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence 42 346778888887 5899999999999999999999999998753
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=334.03 Aligned_cols=256 Identities=24% Similarity=0.417 Sum_probs=205.0
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|++.+.||+|+||.||+|.+..+|+.||+|.++.... ......+..|+..+.+..+||||+++++++......|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN---SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC---cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEE
Confidence 479999999999999999999999999999999876421 12234455666664444469999999999999999999
Q ss_pred EEEecCCCchhHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 108 VMEYAAGGELFGKLRR-----GRLTESAARRYFQQLVSALHFCHQN-GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~-----~~l~e~~~~~~~~ql~~gL~yLH~~-giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
+|||++ |+|.+++.. ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 999997 577666542 4689999999999999999999998 999999999999999999999999999875422
Q ss_pred hhcCcccccCCCCccccceeeecc---CCCCccchhhhhhHHHHHHHhcCCCCCCCc--HHHHHHHhhccCCCCCC-CCC
Q 013005 182 IKNGMLHTACGTPAYTAPEVVARR---GYDGAVADAWSCGVILFVLLAGYLPFDDSN--LLAMYKKVNRRDYQFPS-FVS 255 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~~---~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~--~~~~~~~i~~~~~~~p~-~~s 255 (451)
. .......|+..|+|||.+.+. ...+.++|+||+||++|+|++|..||.... .......+......+|. .+|
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd06617 157 S--VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFS 234 (283)
T ss_pred c--cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccC
Confidence 1 112235689999999988542 123567999999999999999999997532 22232223323334443 478
Q ss_pred HhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 256 KPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 256 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
.++.++|.+||..+|++|||++++++||||++..
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 9999999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=340.15 Aligned_cols=259 Identities=26% Similarity=0.425 Sum_probs=207.1
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
....+++|++.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 83 (310)
T cd07865 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE--KEGFPITALREIKILQLLK-HENVVNLIEICRTK 83 (310)
T ss_pred ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC--cCCchhHHHHHHHHHHhCC-CCCccceEEEEecc
Confidence 45677899999999999999999999999999999999865421 1122334568999999995 99999999998654
Q ss_pred C--------EEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEe
Q 013005 103 T--------KIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSD 172 (451)
Q Consensus 103 ~--------~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~D 172 (451)
. ..|+||||+.+ +|.+.+.. ..+++.+++.++.|++.||.|||++|++|+||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 84 ATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred cccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECc
Confidence 3 46999999965 78777764 3799999999999999999999999999999999999999999999999
Q ss_pred ccCCCcchhhhc---CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC--
Q 013005 173 FGLSALPEQIKN---GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD-- 247 (451)
Q Consensus 173 FGls~~~~~~~~---~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~-- 247 (451)
||++........ .......++..|+|||.+.+....+.++||||+|+++|+|++|..||...+.......+....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999875432211 122345678899999988765544677999999999999999999998766543322221100
Q ss_pred -----------------CCCC-------------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 248 -----------------YQFP-------------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 248 -----------------~~~p-------------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
..+| ...+..+.+||.+||..||.+|||++++++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0011 1135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=329.12 Aligned_cols=251 Identities=29% Similarity=0.468 Sum_probs=214.3
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
.++|++.+.||.|+||.||+|.+..+++.+|+|++..... ...+.+.+|+.++++++ ||||+++++.+......|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG----DDFEIIQQEISMLKECR-HPNIVAYFGSYLRRDKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch----hhHHHHHHHHHHHHhCC-CCChhceEEEEEeCCEEE
Confidence 4689999999999999999999999999999999976522 24567889999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 107 LVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
++|||+.+++|.+++.. ..+++.+++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred EEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 99999999999998864 689999999999999999999999999999999999999999999999999987543321
Q ss_pred CcccccCCCCccccceeeecc---CCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCC-----CCCCCCH
Q 013005 185 GMLHTACGTPAYTAPEVVARR---GYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQ-----FPSFVSK 256 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~---~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~ 256 (451)
.......++..|+|||.+.+. .+ +.++||||||+++|+|++|..||...+.......+....+. .+..++.
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~-~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGY-DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSP 234 (262)
T ss_pred hccccccCCccccCchhhcccccCCc-CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhH
Confidence 122345789999999998765 45 46699999999999999999999876655444444433222 2234578
Q ss_pred hHHHHHHhccCCCCCCCCCHHHHHcCcc
Q 013005 257 PARSLIYQLLDPNPKTRMSIEKIMSISW 284 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~Rpt~~eil~hp~ 284 (451)
++.+++.+||..||..|||+++++.|+|
T Consensus 235 ~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 235 VFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 8999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=337.26 Aligned_cols=253 Identities=30% Similarity=0.507 Sum_probs=204.9
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
.++|++.+.||+|++|.||+|.+..+++.||+|.+..... ......+.+|+.+++++. ||||+++++++.+....|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 79 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE---EGAPFTAIREASLLKDLK-HANIVTLHDIIHTKKTLT 79 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc---cCCchhHHHHHHHHhhCC-CcceeeEEEEEecCCeEE
Confidence 5789999999999999999999988999999999875421 111234568999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 107 LVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
+||||+.+ +|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus 80 lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-~ 157 (291)
T cd07844 80 LVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP-S 157 (291)
T ss_pred EEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC-C
Confidence 99999985 89888864 56899999999999999999999999999999999999999999999999998643221 1
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCc-HHHHHHHhhcc-----------------
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN-LLAMYKKVNRR----------------- 246 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~-~~~~~~~i~~~----------------- 246 (451)
.......+++.|+|||++.+....+.++||||+|+++|+|++|..||.... .......+...
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 122234578899999998765545677999999999999999999997654 22222211100
Q ss_pred --CCCC-----------CCCCC--HhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 247 --DYQF-----------PSFVS--KPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 247 --~~~~-----------p~~~s--~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
...+ ...++ ..+.++|.+||..||.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 01233 778899999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=336.24 Aligned_cols=252 Identities=24% Similarity=0.365 Sum_probs=213.9
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCC-----cEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADG-----SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
..++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.+. ||||+++++++.
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~ 78 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA---EPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCT 78 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC---CHHHHHHHHHHHHHHHhcC-CcccceEEEEEc
Confidence 3568999999999999999999876554 689999986542 2344567899999999995 999999999999
Q ss_pred eCCEEEEEEEecCCCchhHHhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeC
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRR-----------------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLD 163 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~-----------------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld 163 (451)
.....|++|||+++++|.+++.. ..+++.+++.++.|++.||.|||++|++||||||+||+++
T Consensus 79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG 158 (283)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence 99999999999999999998863 3578899999999999999999999999999999999999
Q ss_pred CCCCeEEEeccCCCcchhhh-cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHH
Q 013005 164 RDGNLKVSDFGLSALPEQIK-NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYK 241 (451)
Q Consensus 164 ~~~~lkl~DFGls~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~ 241 (451)
+++.++|+|||++....... ........+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..+...
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF-TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC-chhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999999999987432211 122334567889999999877665 567999999999999998 999999888777777
Q ss_pred HhhccC-CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 242 KVNRRD-YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 242 ~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
.+.... ...|..++..+.+|+.+||+.||.+|||+.+|+++
T Consensus 238 ~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 238 MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 766543 34566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=339.10 Aligned_cols=258 Identities=29% Similarity=0.437 Sum_probs=213.5
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchh-hHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFL-DAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
+|++.+.||+|+||.||+|.+..+++.||+|.+....... .......+..|+.++++++ ||||+++++++.+....|+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeecCCEEEE
Confidence 5889999999999999999999999999999997653210 1234456778999999996 9999999999999999999
Q ss_pred EEEecCCCchhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 108 VMEYAAGGELFGKLRRG--RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~~--~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
||||+ +++|.+++... .+++..++.++.||++||.|||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~ 157 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-R 157 (298)
T ss_pred EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC-c
Confidence 99999 88999999763 69999999999999999999999999999999999999999999999999987543321 2
Q ss_pred cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC------------------
Q 013005 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD------------------ 247 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~------------------ 247 (451)
......+++.|+|||.+.+....+.++||||+||++|+|++|.+||...+....+.++....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 22334578899999988665555778999999999999999988887766544443332110
Q ss_pred -----CC-----CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 248 -----YQ-----FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 248 -----~~-----~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
.. .....+..+.++|.+||..||++|||+.+++.||||++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 00 1123467899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=329.88 Aligned_cols=250 Identities=27% Similarity=0.449 Sum_probs=214.1
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
.++|++.+.||+|+||.||+|++..++..+++|.+.... ..+.+.+|+.+++++ +||||+++++.+.+....|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~ 74 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQEIIKEISILKQC-DSPYIVKYYGSYFKNTDLW 74 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------HHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCcEE
Confidence 468999999999999999999998889999999986541 156889999999999 5999999999999999999
Q ss_pred EEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 107 LVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
+++||+.+++|.+++.. ..+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 75 l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~- 153 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM- 153 (256)
T ss_pred EEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc-
Confidence 99999999999999863 568999999999999999999999999999999999999999999999999987543321
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc---CCCCCCCCCHhHHHH
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR---DYQFPSFVSKPARSL 261 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~l 261 (451)
.......|+..|+|||++.+..+ +.++||||+|+++|+|++|..||...........+... ....+..++..+.++
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDF 232 (256)
T ss_pred cccccccCCccccCHHHHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHH
Confidence 12234458899999999877765 56799999999999999999999876554433333221 223344578899999
Q ss_pred HHhccCCCCCCCCCHHHHHcCccc
Q 013005 262 IYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 262 i~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
|.+||..||++|||+.++++||||
T Consensus 233 i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 233 VKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHhcChhhCcCHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=347.22 Aligned_cols=257 Identities=27% Similarity=0.455 Sum_probs=209.7
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC--
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK-- 102 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~-- 102 (451)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+.+.. .+......+.+|+.+++++. ||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 89 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF--QNVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQKS 89 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc--cChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCCC
Confidence 46789999999999999999999999999999999986532 12334456778999999995 99999999988543
Q ss_pred ----CEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 103 ----TKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 103 ----~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
...|+||||+.+ +|.+.+... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++..
T Consensus 90 ~~~~~~~~lv~e~~~~-~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 90 LEEFQDVYLVMELMDA-NLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred ccccCcEEEEEeccCC-CHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 357999999965 787777644 99999999999999999999999999999999999999999999999999875
Q ss_pred chhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc------------
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR------------ 246 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~------------ 246 (451)
... ........||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||...+....+.++...
T Consensus 168 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 168 AGT--SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred CCC--CCCCCCCcccccccCHHHHhCCCC-CCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 432 122345578999999999988776 46699999999999999999999876654433332110
Q ss_pred ----------CC--------------CC-------CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 247 ----------DY--------------QF-------PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 247 ----------~~--------------~~-------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
.. .+ +...++.+.++|.+||..||++|||+.+++.||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~ 318 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWY 318 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhcc
Confidence 00 00 112356789999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=358.38 Aligned_cols=246 Identities=33% Similarity=0.546 Sum_probs=218.3
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
...+.|++...+|.|+|+.|..+.+..+++..++|++.+.. ....+|+.++....+||||+++++++.+...
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~--------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~ 390 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA--------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKE 390 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheeccccc--------cccccccchhhhhcCCCcceeecceecCCce
Confidence 34678999999999999999999999999999999998752 2345678788888889999999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEe-CCCCCeEEEeccCCCcchhhh
Q 013005 105 IYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL-DRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILl-d~~~~lkl~DFGls~~~~~~~ 183 (451)
.|+|||++.|+.+.+.+...+....++..|+.||+.|+.|||++||+||||||+|||+ ++.|+++|+|||.++..+..
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred eeeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999999999999999987665558888999999999999999999999999999999 58999999999999854432
Q ss_pred cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH-HHHHHhhccCCCCCCCCCHhHHHHH
Q 013005 184 NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL-AMYKKVNRRDYQFPSFVSKPARSLI 262 (451)
Q Consensus 184 ~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~-~~~~~i~~~~~~~p~~~s~~~~~li 262 (451)
+.+.|-|..|+|||++...+|+ ..+||||||++||+||+|+.||...... +++..+....+. .++|..+++||
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl 543 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLL 543 (612)
T ss_pred ---hcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHH
Confidence 5677889999999999988885 5599999999999999999999865444 777777655443 88999999999
Q ss_pred HhccCCCCCCCCCHHHHHcCccc
Q 013005 263 YQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 263 ~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
+.||+.||.+|+++++++.||||
T Consensus 544 ~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 544 QQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHhccCChhhCcChhhhccCcch
Confidence 99999999999999999999999
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=327.58 Aligned_cols=248 Identities=29% Similarity=0.529 Sum_probs=214.4
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
+|++.+.||+|+||.||++.+..+++.+|+|.++... .....+.+.+|+.+++.+. ||||+++++.+.+.+..|++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 76 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK---SSSAVEDSRKEAVLLAKMK-HPNIVAFKESFEADGHLYIV 76 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc---chHHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEE
Confidence 5899999999999999999999999999999987542 1234567888999999995 99999999999999999999
Q ss_pred EEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 109 MEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
|||+++++|.+++.. ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...... ..
T Consensus 77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-~~ 155 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-GA 155 (255)
T ss_pred EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc-cc
Confidence 999999999998853 45899999999999999999999999999999999999999999999999998754321 12
Q ss_pred cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC-CCCCCCCHhHHHHHHh
Q 013005 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY-QFPSFVSKPARSLIYQ 264 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 264 (451)
......|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+..... ..|..++..+.+||.+
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 234 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQ 234 (255)
T ss_pred ccccccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHH
Confidence 2234568999999999877665 5679999999999999999999998887776666655543 3566788999999999
Q ss_pred ccCCCCCCCCCHHHHHcC
Q 013005 265 LLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 265 ~L~~dP~~Rpt~~eil~h 282 (451)
||..||++|||+.+++.-
T Consensus 235 ~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 235 MFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHhCCcccCCCHHHHhhc
Confidence 999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=327.67 Aligned_cols=252 Identities=32% Similarity=0.587 Sum_probs=217.5
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE--eCCEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA--TKTKIY 106 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~--~~~~~~ 106 (451)
+|++.+.||.|+||.||+|.+..+++.||+|.+.... ......+.+.+|+.+++.+. ||||+++++.+. .....|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN--MTEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEeccc--CCHHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCEEE
Confidence 5899999999999999999999999999999987542 23444567889999999996 999999999775 356789
Q ss_pred EEEEecCCCchhHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH-----HCCceecCCCCCeEEeCCCCCeEEEeccCC
Q 013005 107 LVMEYAAGGELFGKLRR-----GRLTESAARRYFQQLVSALHFCH-----QNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~-----~~l~e~~~~~~~~ql~~gL~yLH-----~~giiHrDLKpeNILld~~~~lkl~DFGls 176 (451)
++|||+++++|.+++.. +++++..++.++.||+.||.||| +.+++|+||+|+||+++.++.+||+|||++
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence 99999999999998853 57899999999999999999999 889999999999999999999999999998
Q ss_pred CcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC-CCCCCCC
Q 013005 177 ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY-QFPSFVS 255 (451)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s 255 (451)
....... .......|++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+..... .++...+
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd08217 158 KILGHDS-SFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYS 235 (265)
T ss_pred ccccCCc-ccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccC
Confidence 8654322 11344578999999999877654 5669999999999999999999998887777777665544 4566788
Q ss_pred HhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 256 KPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 256 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
..+.+++.+||..+|.+|||+.+|++|||+
T Consensus 236 ~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 236 SELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=338.75 Aligned_cols=260 Identities=28% Similarity=0.470 Sum_probs=219.5
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
.+...++|++.+.||+|+||.||++.+..++..||+|.+.... ....+.+.+|+.+++.+. ||||+++++.+...
T Consensus 14 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~ 88 (293)
T cd06647 14 VGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKELIINEILVMRENK-HPNIVNYLDSYLVG 88 (293)
T ss_pred ccCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc----chHHHHHHHHHHHHhhcC-CCCeeehhheeeeC
Confidence 3455689999999999999999999998899999999986432 223466889999999996 99999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 103 TKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
...|+|+||+++++|.+++.+..+++.++..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 89 DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred CcEEEEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999998654332
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhc-cC--CCCCCCCCHhHH
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNR-RD--YQFPSFVSKPAR 259 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~-~~--~~~p~~~s~~~~ 259 (451)
. .......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+.. .. ...+..++..+.
T Consensus 169 ~-~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 246 (293)
T cd06647 169 Q-SKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 246 (293)
T ss_pred c-cccccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHH
Confidence 1 22234568999999999877655 5679999999999999999999987665443332222 11 222334678899
Q ss_pred HHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 260 SLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 260 ~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
++|.+||..+|++||++++++.||||+...
T Consensus 247 ~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 247 DFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 999999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=332.17 Aligned_cols=253 Identities=26% Similarity=0.465 Sum_probs=215.7
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|++.+.||+|+||.||++.+..+++.+|+|.+.... .......+.+|+.+++.+. ||||+++++.+......|+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~l 76 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDISI 76 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc---ChHHHHHHHHHHHHHHHCC-CCchhhhheeeecCCEEEE
Confidence 47889999999999999999999999999999997652 2245567889999999996 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 108 VMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQ-NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~-~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
++||+.+++|.+++.. ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||++........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 77 CMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred EEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 9999999999999974 679999999999999999999999 9999999999999999999999999999875433211
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCC-----cHHHHHHHhhcc-CCCCCCC-CCHh
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS-----NLLAMYKKVNRR-DYQFPSF-VSKP 257 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~-----~~~~~~~~i~~~-~~~~p~~-~s~~ 257 (451)
....|+..|+|||.+.+..+ +.++||||+|+++|+|++|..||... ........+... ....+.. ++..
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPD 232 (265)
T ss_pred ---hcccCChhccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence 22678999999999877755 56699999999999999999999754 233333333332 2334444 7889
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 258 ARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 258 ~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+.++|.+||..||.+|||+.+++.||||++.
T Consensus 233 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 233 FQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 9999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=356.01 Aligned_cols=260 Identities=30% Similarity=0.570 Sum_probs=237.1
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
.....+.+.+.+||-|+||.|-++........+|+|++++. ...+...++.+..|-.+|..++ .|.||++|..|.+..
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~-hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~k 493 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKK-HIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSK 493 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHh-hccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccch
Confidence 34566788899999999999999986555556999999886 5667777888999999999996 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 104 KIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
.+|+.||-|-||+|+..++. |.|.+..++.|+..+++|++|||++||+.|||||||++||.+|-+||.|||+|.....
T Consensus 494 yvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~- 572 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS- 572 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc-
Confidence 99999999999999999985 8999999999999999999999999999999999999999999999999999986544
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc--CCCCCCCCCHhHHH
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR--DYQFPSFVSKPARS 260 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 260 (451)
.....+.||||.|+|||++.+++.+-. +|.||||+++|||++|.+||.+.+....|..|.++ .+.+|..++..+.+
T Consensus 573 -g~KTwTFcGTpEYVAPEIILnKGHD~a-vDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~ 650 (732)
T KOG0614|consen 573 -GRKTWTFCGTPEYVAPEIILNKGHDRA-VDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATD 650 (732)
T ss_pred -CCceeeecCCcccccchhhhccCcchh-hHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHH
Confidence 355678999999999999999998755 89999999999999999999999999999999886 46889999999999
Q ss_pred HHHhccCCCCCCCCC-----HHHHHcCccccch
Q 013005 261 LIYQLLDPNPKTRMS-----IEKIMSISWFQKS 288 (451)
Q Consensus 261 li~~~L~~dP~~Rpt-----~~eil~hp~f~~~ 288 (451)
||+++...+|.+|.. +.+|.+|.||..-
T Consensus 651 Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 651 LIKKLCRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred HHHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 999999999999985 9999999999764
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=338.06 Aligned_cols=251 Identities=20% Similarity=0.313 Sum_probs=202.7
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcC----------------CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCC
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIA----------------DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~----------------~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~H 89 (451)
..++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.++.+++ |
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~-h 78 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---NKNARNDFLKEVKILSRLK-D 78 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---CHHHHHHHHHHHHHHhhcC-C
Confidence 34689999999999999999997532 34579999987542 2334567889999999995 9
Q ss_pred CCceEEEEEEEeCCEEEEEEEecCCCchhHHhhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCC
Q 013005 90 PNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRG--------------------RLTESAARRYFQQLVSALHFCHQNG 149 (451)
Q Consensus 90 pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--------------------~l~e~~~~~~~~ql~~gL~yLH~~g 149 (451)
|||+++++++.+.+..|+||||+.+|+|.+++... .+++..+..++.||+.||.|||++|
T Consensus 79 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 158 (304)
T cd05096 79 PNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN 158 (304)
T ss_pred CCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999999999999999999999999999988532 3677889999999999999999999
Q ss_pred ceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh--
Q 013005 150 VAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-- 226 (451)
Q Consensus 150 iiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-- 226 (451)
|+||||||+|||++.++.+||+|||++........ .......+++.|+|||++....+ +.++||||||+++|+|++
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHcc
Confidence 99999999999999999999999999874322111 12234456889999999876655 567999999999999986
Q ss_pred cCCCCCCCcHHHHHHHhhc--------cCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 227 GYLPFDDSNLLAMYKKVNR--------RDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 227 G~~Pf~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+..||...+.......+.. .....|+.++..+.+|+.+||..||++|||+++|.+
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 6788877655444333211 112335567899999999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=330.84 Aligned_cols=249 Identities=36% Similarity=0.631 Sum_probs=217.2
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecCCC
Q 013005 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGG 115 (451)
Q Consensus 36 LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~gg 115 (451)
||.|+||.||++.+..+++.+|+|++.... .......+.+.+|+.+++++. ||||+++++.+......|+++||+.|+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD-MIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchh-hhhhhHHHHHHHHHHHHHhCC-CcchhHHHHheecCcEEEEEEecCCCC
Confidence 689999999999998899999999997652 223455677899999999996 999999999999999999999999999
Q ss_pred chhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc-------Ccc
Q 013005 116 ELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN-------GML 187 (451)
Q Consensus 116 ~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~-------~~~ 187 (451)
+|.+++.+ +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++........ ...
T Consensus 79 ~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 79 DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence 99999975 7899999999999999999999999999999999999999999999999999874322111 122
Q ss_pred cccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCC--CHhHHHHHHhc
Q 013005 188 HTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFV--SKPARSLIYQL 265 (451)
Q Consensus 188 ~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~--s~~~~~li~~~ 265 (451)
....+++.|+|||.+....+ +.++|+||||+++|+|++|..||...........+......+|... +..+.+++.+|
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 237 (265)
T cd05579 159 KRIVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKL 237 (265)
T ss_pred cCcccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHH
Confidence 34568899999999876664 6679999999999999999999998888888877777666666655 89999999999
Q ss_pred cCCCCCCCCCH---HHHHcCccccc
Q 013005 266 LDPNPKTRMSI---EKIMSISWFQK 287 (451)
Q Consensus 266 L~~dP~~Rpt~---~eil~hp~f~~ 287 (451)
|..+|.+|||+ .++++||||.+
T Consensus 238 l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 238 LVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred hcCCHhhcCCCccHHHHhcCccccC
Confidence 99999999999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=338.02 Aligned_cols=255 Identities=25% Similarity=0.441 Sum_probs=216.5
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
+.|+..+.||+|+||.||+|.+..+++.||+|.++... .....+.+.+|+.+++++. ||||+++++++......|+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEIEDIQQEITVLSQCD-SPYITRYYGSYLKGTKLWI 79 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHHHHHHHHHHHHHcCC-CCccHhhhcccccCCceEE
Confidence 45778889999999999999998999999999987542 2234567899999999995 9999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcc
Q 013005 108 VMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML 187 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~ 187 (451)
||||+++++|.+++..+.+++..++.++.|++.|+.|||++|++|+||+|+||++++++.++|+|||++....... ...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06642 80 IMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred EEEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc-hhh
Confidence 9999999999999988889999999999999999999999999999999999999999999999999987543211 112
Q ss_pred cccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhHHHHHHhcc
Q 013005 188 HTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPARSLIYQLL 266 (451)
Q Consensus 188 ~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L 266 (451)
....|+..|+|||.+.+..+ +.++|+||+||++|+|++|..||...........+... ....+...+..+.++|.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAY-DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACL 237 (277)
T ss_pred hcccCcccccCHHHhCcCCC-chhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHc
Confidence 23468899999999877665 56799999999999999999999866554444333322 22344457889999999999
Q ss_pred CCCCCCCCCHHHHHcCccccch
Q 013005 267 DPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 267 ~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
..+|.+|||+.++++||||...
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 238 NKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred cCCcccCcCHHHHHHhHHHHHH
Confidence 9999999999999999999764
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=329.59 Aligned_cols=250 Identities=23% Similarity=0.374 Sum_probs=213.2
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
....+|.+.+.||+|+||.||+|.+..+++.||+|++..+. .....+.+|+.+++.+. ||||+++++++.....
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 76 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPP 76 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-----hHHHHHHHHHHHHHhCC-CCChhheEEEEcCCCC
Confidence 44567999999999999999999999999999999986542 22456888999999995 9999999999999999
Q ss_pred EEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 105 IYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
.+++|||+++++|.+++.. ..+++..++.++.|++.||+|||++|++||||||+||++++++.+||+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 77 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999999999999998864 3589999999999999999999999999999999999999999999999999875433
Q ss_pred hhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhHH
Q 013005 182 IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPAR 259 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 259 (451)
..........+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...+....+..+... ....|..++..+.
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVY 235 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 22111122334668999998877665 466999999999999998 99999988877777766553 3456677899999
Q ss_pred HHHHhccCCCCCCCCCHHHHHc
Q 013005 260 SLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 260 ~li~~~L~~dP~~Rpt~~eil~ 281 (451)
++|.+||..||++|||+.++++
T Consensus 236 ~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 236 ELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHccCCcccCCCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=337.35 Aligned_cols=254 Identities=28% Similarity=0.451 Sum_probs=211.2
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC--CE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK--TK 104 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~--~~ 104 (451)
.++|++.+.||+|+||.||+|.+..+++.+|+|.+..... .......+.+|+.+++++. ||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~ 80 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE--KEGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLDK 80 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccc--cccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCCc
Confidence 4689999999999999999999999999999999975422 1223345678999999996 99999999998877 89
Q ss_pred EEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 105 IYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
.|+||||+.+ +|.+++.. ..+++.+++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 81 IYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred EEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 9999999975 88888864 45899999999999999999999999999999999999999999999999998754332
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc----------------
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR---------------- 246 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~---------------- 246 (451)
. .......+++.|+|||.+.+....+.++||||+|+++|+|++|..||...+......++...
T Consensus 160 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 L-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred c-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 1 22334567899999999876655567799999999999999999999877655444333210
Q ss_pred ---------------CCCCCCC-CCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 247 ---------------DYQFPSF-VSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 247 ---------------~~~~p~~-~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
...++.. +++.+.++|++||..||++|||+.|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0112332 58889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=331.85 Aligned_cols=255 Identities=25% Similarity=0.443 Sum_probs=218.5
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
+-|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++++. ||||+++++.+......|+
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 79 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWI 79 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHHHhcC-CCCEeEEEEEEEeCCeEEE
Confidence 34778899999999999999998999999999986542 1234467889999999995 9999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcc
Q 013005 108 VMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML 187 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~ 187 (451)
||||+++++|.+++.++.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 80 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06641 80 IMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred EEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhh
Confidence 9999999999999988899999999999999999999999999999999999999999999999999986543211 112
Q ss_pred cccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhHHHHHHhcc
Q 013005 188 HTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPARSLIYQLL 266 (451)
Q Consensus 188 ~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L 266 (451)
....|+..|+|||.+.+... +.++|+||+||++|+|++|..||...+.......+... ...++..++..+.++|.+||
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 237 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACL 237 (277)
T ss_pred ccccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHc
Confidence 33568899999999876554 56799999999999999999999877665555555433 23455668899999999999
Q ss_pred CCCCCCCCCHHHHHcCccccch
Q 013005 267 DPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 267 ~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
..+|.+||++.++++||||.+.
T Consensus 238 ~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 238 NKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred cCChhhCcCHHHHHhCHHHhhh
Confidence 9999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=333.49 Aligned_cols=253 Identities=28% Similarity=0.415 Sum_probs=203.5
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
.++|.+.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.+. |+||+++++++......|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~ 79 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE---EGVPFTAIREASLLKGLK-HANIVLLHDIIHTKETLT 79 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc---CCCcHHHHHHHHHHHhcC-CCCEeEEEEEEecCCeEE
Confidence 3789999999999999999999999999999999865421 122335678999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 107 LVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
+||||+. ++|.+.+.. +.+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++...... .
T Consensus 80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-~ 157 (291)
T cd07870 80 FVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP-S 157 (291)
T ss_pred EEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC-C
Confidence 9999996 566666543 56889999999999999999999999999999999999999999999999998753221 1
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH-HHHHHhhc---------------cC-
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL-AMYKKVNR---------------RD- 247 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~-~~~~~i~~---------------~~- 247 (451)
.......+++.|+|||.+.+....+.++|||||||++|+|++|..||...+.. +...++.. ..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 22344567999999999876554466799999999999999999999765432 22111100 00
Q ss_pred -------CCCCC---------CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 248 -------YQFPS---------FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 248 -------~~~p~---------~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
...+. ..+..+.+++.+||..||.+|||+++++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000 125678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=343.57 Aligned_cols=257 Identities=25% Similarity=0.404 Sum_probs=214.8
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
-.+.++|++.+.||+|+||.||+|.+..++..||+|.+.+.. ........+.+|+.+++++. ||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 87 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPDL 87 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHHHHHHhcC-CCCccceeeeecCCc
Confidence 346789999999999999999999999999999999986532 22334556889999999995 999999999987543
Q ss_pred ------EEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 104 ------KIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 104 ------~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
..|+||||+ |++|.+++....+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++.
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 468999999 7799988888899999999999999999999999999999999999999999999999999987
Q ss_pred cchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC---------
Q 013005 178 LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY--------- 248 (451)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~--------- 248 (451)
.... ......+++.|+|||.+.+....+.++|+||+|+++|+|++|..||...+....+.++.....
T Consensus 167 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 167 QTDS----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred cccc----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 5422 223456789999999987654557789999999999999999999987665444433322110
Q ss_pred ----------------------CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 249 ----------------------QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 249 ----------------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
...+.+++.+.++|.+||..||++|||+.+++.||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 1123467889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=334.90 Aligned_cols=255 Identities=24% Similarity=0.426 Sum_probs=215.2
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
.++|++.+.||+|+||+||++.+..+++.||+|++.... .....+.+.+|+.+++.+. ||||+++++.+......|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 79 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA---KSSVRKQILRELQIMHECR-SPYIVSFYGAFLNENNIC 79 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC---cchHHHHHHHHHHHHHHcC-CCCcceEeeeEecCCEEE
Confidence 468999999999999999999999999999999986542 2344577899999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 107 LVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQ-NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~-~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
+||||+++++|.+++.+ +.+++..++.++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++.....
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~--- 156 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN--- 156 (284)
T ss_pred EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh---
Confidence 99999999999998875 679999999999999999999997 5999999999999999999999999999864322
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH-----------HHHHHhhcc-CCCCCC
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL-----------AMYKKVNRR-DYQFPS 252 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~-----------~~~~~i~~~-~~~~p~ 252 (451)
......+|+..|+|||++.+..+ +.++||||+||++|+|++|..||...... .....+... ...++.
T Consensus 157 ~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd06620 157 SIADTFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235 (284)
T ss_pred hccCccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc
Confidence 22234679999999999876655 56699999999999999999999864431 222333222 223333
Q ss_pred C-CCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 253 F-VSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 253 ~-~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
. ++..+.+||.+||.+||.+|||++++++||||.+..
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 3 778899999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=331.88 Aligned_cols=249 Identities=27% Similarity=0.439 Sum_probs=205.1
Q ss_pred ccccCCeEEcceE--cccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 24 PTLLNRYQLGPLL--GRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 24 ~~~~~~y~~~~~L--G~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
....++|++.+.+ |+|+||.||++.+..++..+|+|++..... .. .|+.....+.+||||+++++.+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~-------~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF--NA-------IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc--ch-------hhHHHHHHhhcCCCEEEEEEEEec
Confidence 3456778887776 999999999999999999999999875421 10 122233334469999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC-CeEEEeccCCCcc
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG-NLKVSDFGLSALP 179 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~-~lkl~DFGls~~~ 179 (451)
.+..|+||||++|++|.+++.. +.+++.+++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++...
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 9999999999999999999976 5899999999999999999999999999999999999999998 9999999998643
Q ss_pred hhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHH----HHHHhhccCCCCCCCCC
Q 013005 180 EQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLA----MYKKVNRRDYQFPSFVS 255 (451)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~----~~~~i~~~~~~~p~~~s 255 (451)
.. .....|++.|+|||++.+..+ +.++||||+|+++|+|++|..||....... ............++.++
T Consensus 161 ~~-----~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T PHA03390 161 GT-----PSCYDGTLDYFSPEKIKGHNY-DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVS 234 (267)
T ss_pred CC-----CccCCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccC
Confidence 22 123468999999999987776 466999999999999999999997543221 11111233445556789
Q ss_pred HhHHHHHHhccCCCCCCCCC-HHHHHcCccccc
Q 013005 256 KPARSLIYQLLDPNPKTRMS-IEKIMSISWFQK 287 (451)
Q Consensus 256 ~~~~~li~~~L~~dP~~Rpt-~~eil~hp~f~~ 287 (451)
+.+.+||.+||++||.+||+ ++++++||||++
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 235 KNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 99999999999999999996 699999999963
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=332.08 Aligned_cols=251 Identities=30% Similarity=0.512 Sum_probs=208.7
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
+|++.+.||.|++|.||+|.+..+|+.||+|.+..... ......+.+|+.+++++. ||||+++++.+.+.+..|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 76 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELK-HENIVRLHDVIHTENKLMLV 76 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc---ccchHHHHHHHHHHHhhc-CCCEeeeeeeEeeCCcEEEE
Confidence 58999999999999999999999999999999976422 122345678999999995 99999999999999999999
Q ss_pred EEecCCCchhHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 109 MEYAAGGELFGKLRR----GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~----~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
|||+.+ +|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++.......
T Consensus 77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~- 154 (284)
T cd07836 77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV- 154 (284)
T ss_pred EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-
Confidence 999986 78887753 358999999999999999999999999999999999999999999999999986443211
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc------------------
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR------------------ 246 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~------------------ 246 (451)
.......+++.|+|||.+.+....+.++|||||||++|+|++|..||.+.+..+...++...
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 22234567899999999876555567799999999999999999999877655444433211
Q ss_pred CCC-----------CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 247 DYQ-----------FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 247 ~~~-----------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
... +.+..+..+.++|.+||+.||.+|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 000 112357788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=343.88 Aligned_cols=257 Identities=28% Similarity=0.418 Sum_probs=209.6
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC---
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK--- 102 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~--- 102 (451)
+.++|.+.+.||.|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.++++++ ||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~ 77 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSD 77 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHHHHHHHHHHHHhcC-CCcchhhHhhhcccccc
Confidence 45899999999999999999999999999999999866432 33456788999999995 99999999876543
Q ss_pred -----------CEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC-CCCeEE
Q 013005 103 -----------TKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR-DGNLKV 170 (451)
Q Consensus 103 -----------~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~-~~~lkl 170 (451)
...|+||||+. ++|.+.+..+.+++..++.++.||+.||.|||++|++||||||+||+++. ++.++|
T Consensus 78 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 78 LTEDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccccccccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEE
Confidence 35899999997 58988888888999999999999999999999999999999999999974 557899
Q ss_pred EeccCCCcchhhhc--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC-
Q 013005 171 SDFGLSALPEQIKN--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD- 247 (451)
Q Consensus 171 ~DFGls~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~- 247 (451)
+|||++........ .......|+..|+|||.+......+.++||||+||++|+|++|..||...+.......+....
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999875432111 222334688999999987665555677999999999999999999998765544333322110
Q ss_pred ------------------------C-----CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 248 ------------------------Y-----QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 248 ------------------------~-----~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
. .+.+.++.++.+||.+||..||.+|||+++++.||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 0 0123467889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=338.17 Aligned_cols=254 Identities=26% Similarity=0.459 Sum_probs=216.0
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
..|.....||+|+||.||+|.+..+++.||+|.++.... ...+.+.+|+.+++.+. ||||+++++.+......|+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~i 95 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRDYQ-HQNVVEMYKSYLVGEELWV 95 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc----chHHHHHHHHHHHHhCC-CCchhhhhhheeeCCeEEE
Confidence 345566789999999999999988999999999965421 23456789999999995 9999999999999999999
Q ss_pred EEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcc
Q 013005 108 VMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML 187 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~ 187 (451)
++||+++++|..++....+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++....... ...
T Consensus 96 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~ 174 (297)
T cd06659 96 LMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKR 174 (297)
T ss_pred EEecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccc
Confidence 9999999999998887889999999999999999999999999999999999999999999999999986432211 222
Q ss_pred cccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC---CCCCCCCHhHHHHHHh
Q 013005 188 HTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY---QFPSFVSKPARSLIYQ 264 (451)
Q Consensus 188 ~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~ 264 (451)
...+|++.|+|||++.+..+ +.++||||+||++|+|++|+.||...+.......+..... ..+..++..+.++|.+
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~ 253 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLER 253 (297)
T ss_pred cceecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHH
Confidence 34678999999999877665 5679999999999999999999987776655555543322 2234578899999999
Q ss_pred ccCCCCCCCCCHHHHHcCccccch
Q 013005 265 LLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 265 ~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
||..+|++|||++++++||||.+.
T Consensus 254 ~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 254 MLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred HhcCCcccCcCHHHHhhChhhccC
Confidence 999999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=331.24 Aligned_cols=254 Identities=28% Similarity=0.452 Sum_probs=216.1
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
.|...+.||+|++|.||++.+..+++.+|+|.++... ....+.+.+|+.+++.+. ||||+++++++......|++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK----QQRRELLFNEVVIMRDYQ-HPNIVEMYSSYLVGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc----hhHHHHHHHHHHHHHHcC-CCChheEEEEEEcCCeEEEE
Confidence 3445579999999999999998899999999986432 233456789999999995 99999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCccc
Q 013005 109 MEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLH 188 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~ 188 (451)
+||+.|++|.+++..+++++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++....... ....
T Consensus 95 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~~ 173 (285)
T cd06648 95 MEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRK 173 (285)
T ss_pred EeccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC-cccc
Confidence 999999999999988889999999999999999999999999999999999999999999999999876432211 1223
Q ss_pred ccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCC---CCCCCHhHHHHHHhc
Q 013005 189 TACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQF---PSFVSKPARSLIYQL 265 (451)
Q Consensus 189 ~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~---p~~~s~~~~~li~~~ 265 (451)
...|++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+.......+....... +..++..+.+++.+|
T Consensus 174 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM 252 (285)
T ss_pred cccCCccccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHH
Confidence 4568999999999877665 566999999999999999999998877666666555443222 233788999999999
Q ss_pred cCCCCCCCCCHHHHHcCccccchh
Q 013005 266 LDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 266 L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
|..||++|||+.++++||||++..
T Consensus 253 l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 253 LVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred cccChhhCcCHHHHccCcccccCC
Confidence 999999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=335.89 Aligned_cols=251 Identities=24% Similarity=0.393 Sum_probs=208.3
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcE--EEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSI--VAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~--vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
-.++|++.+.||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.++.++.+||||+++++++...+
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc---CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 357899999999999999999998877765 566665432 223445678899999999966999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC
Q 013005 104 KIYLVMEYAAGGELFGKLRRG-----------------RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG 166 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~~-----------------~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~ 166 (451)
.+|+||||+++++|.+++... .+++..++.++.||+.||+|||++|++||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 999999999999999988632 478999999999999999999999999999999999999999
Q ss_pred CeEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhc
Q 013005 167 NLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNR 245 (451)
Q Consensus 167 ~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~ 245 (451)
.+||+|||++........ .....++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+.+..+..
T Consensus 162 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 238 (303)
T cd05088 162 VAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 238 (303)
T ss_pred cEEeCccccCcccchhhh--cccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence 999999999864322111 112234667999998866654 567999999999999998 9999988777776666644
Q ss_pred c-CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 246 R-DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 246 ~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
. ....+..+++.+.+||.+||..+|++|||+++++.+
T Consensus 239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3 223455578999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=332.36 Aligned_cols=261 Identities=31% Similarity=0.526 Sum_probs=217.0
Q ss_pred CeEEcceEcccCceEEEEEEEc---CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSI---ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
+|++.+.||+|++|.||++.+. .+++.||+|++.+..........+.+.+|+.++.++.+||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 4678999999976432223344567889999999997799999999999999999
Q ss_pred EEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 106 YLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
|+||||+.+|+|.+.+.. +.+++..++.++.|++.||.|||+.|++||||+|.||+++.++.++|+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 999999999999998875 6799999999999999999999999999999999999999999999999999875433222
Q ss_pred CcccccCCCCccccceeeeccC-CCCccchhhhhhHHHHHHHhcCCCCCCCc----HHHHHHHhhccCCCCCCCCCHhHH
Q 013005 185 GMLHTACGTPAYTAPEVVARRG-YDGAVADAWSCGVILFVLLAGYLPFDDSN----LLAMYKKVNRRDYQFPSFVSKPAR 259 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~-~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~~ 259 (451)
......+|++.|+|||.+.+.. ..+.++||||+|+++|+|++|..||.... .....+.+.......|..++..+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 240 (288)
T cd05583 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEAR 240 (288)
T ss_pred cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHH
Confidence 2223456899999999986543 34667999999999999999999996432 233344444555566777899999
Q ss_pred HHHHhccCCCCCCCCC---HHHHHcCccccchh
Q 013005 260 SLIYQLLDPNPKTRMS---IEKIMSISWFQKSL 289 (451)
Q Consensus 260 ~li~~~L~~dP~~Rpt---~~eil~hp~f~~~~ 289 (451)
++|.+||..||++||| +.++++||||+...
T Consensus 241 ~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 241 DFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred HHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 9999999999999998 57889999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=322.58 Aligned_cols=252 Identities=33% Similarity=0.604 Sum_probs=219.8
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
+|.+.+.||.|+||.||++.+..+++.||+|.+.... ........+.+|+.+++.++ |||++++++.+......++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~lv 77 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN--MSEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLCIV 77 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeeccc--CChHHHHHHHHHHHHHHhcC-CCChhheEEEEecCCEEEEE
Confidence 5899999999999999999999899999999997642 22345567889999999996 99999999999999999999
Q ss_pred EEecCCCchhHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 109 MEYAAGGELFGKLRR-----GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~-----~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
+||+++++|.+.+.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999998864 569999999999999999999999999999999999999999999999999987643322
Q ss_pred cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC-CCCCCCCCHhHHHHH
Q 013005 184 NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD-YQFPSFVSKPARSLI 262 (451)
Q Consensus 184 ~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 262 (451)
......+|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+............ ..+|..++..+.+++
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLV 235 (258)
T ss_pred -ceecceeeeecccChhHhccCCC-CccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 23345678999999999877665 566999999999999999999998887776666655443 345567889999999
Q ss_pred HhccCCCCCCCCCHHHHHcCccc
Q 013005 263 YQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 263 ~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
.+||..+|++|||+.++++||||
T Consensus 236 ~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 236 SSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHcCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=324.49 Aligned_cols=254 Identities=28% Similarity=0.501 Sum_probs=218.6
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|++.+.||+|++|.||+|.+..+++.||+|++..... ......+.+|+.++.+++ ||||+++++++......|+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l 76 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD---EEFRKQLLRELKTLRSCE-SPYVVKCYGAFYKEGEISI 76 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc---hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEccCCeEEE
Confidence 478999999999999999999999999999999976532 144567899999999996 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 108 VMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQ-NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~-~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
||||+++++|.+++.. +.+++..+..++.|++.|+.|||+ .|++||||+|+||+++.++.++|+|||++....... .
T Consensus 77 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~-~ 155 (264)
T cd06623 77 VLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL-D 155 (264)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC-C
Confidence 9999999999999975 789999999999999999999999 999999999999999999999999999987543322 1
Q ss_pred cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCC---cHHHHHHHhhcc-CCCCCCC-CCHhHHH
Q 013005 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS---NLLAMYKKVNRR-DYQFPSF-VSKPARS 260 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~---~~~~~~~~i~~~-~~~~p~~-~s~~~~~ 260 (451)
......++..|+|||.+.+..+ +.++|+||||+++|+|++|..||... ........+... ....+.. ++..+.+
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 234 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRD 234 (264)
T ss_pred cccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence 2234568899999999876644 56799999999999999999999776 444455554433 2344455 7899999
Q ss_pred HHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 261 LIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 261 li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
+|.+||.++|++|||+.++++||||+.
T Consensus 235 li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 235 FISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=325.24 Aligned_cols=247 Identities=25% Similarity=0.439 Sum_probs=208.0
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
.++|++.+.||+|+||.||++.+. ++..+|+|.+..... ..+.+.+|+.+++.+. ||||+++++++......|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~-----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM-----SEEDFIEEAKVMMKLS-HPKLVQLYGVCTQQKPLY 75 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc-----cHHHHHHHHHHHHHCC-CCCceeEEEEEccCCCEE
Confidence 357899999999999999999864 566899998864421 2356788999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 107 LVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
+||||+++|+|.+++.. +.+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++........
T Consensus 76 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 76 IVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 99999999999999864 5689999999999999999999999999999999999999999999999999875422111
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhccC-CCCCCCCCHhHHHHH
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRD-YQFPSFVSKPARSLI 262 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 262 (451)
.......++..|+|||.+....+ +.++||||+|+++|+|++ |+.||...+.......+.... ...|...+..+.+++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li 234 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKY-SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVM 234 (256)
T ss_pred eccCCCCCchhhCChhhcccCcc-chhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence 11122235568999999876665 567999999999999999 999999888777777776543 334556788999999
Q ss_pred HhccCCCCCCCCCHHHHHc
Q 013005 263 YQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 263 ~~~L~~dP~~Rpt~~eil~ 281 (451)
.+||..||++|||++++++
T Consensus 235 ~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 235 YSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHccCCcccCcCHHHHHH
Confidence 9999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=343.80 Aligned_cols=259 Identities=25% Similarity=0.410 Sum_probs=215.8
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
...+.++|++.+.||+|++|.||+|++..+++.||+|++.... .+......+.+|+.+++++. ||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 86 (343)
T cd07851 10 VWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF--QSAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPA 86 (343)
T ss_pred eecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc--chhhHHHHHHHHHHHHHhcc-CCCHHHHHHHhhcc
Confidence 3456789999999999999999999999999999999986531 12234456778999999995 99999999887655
Q ss_pred CE------EEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCC
Q 013005 103 TK------IYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176 (451)
Q Consensus 103 ~~------~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls 176 (451)
.. .|+|+||+ |++|.+++..+++++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++
T Consensus 87 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 87 SSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccccccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 44 89999998 669999998889999999999999999999999999999999999999999999999999998
Q ss_pred CcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC--------
Q 013005 177 ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY-------- 248 (451)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~-------- 248 (451)
..... ......+++.|+|||++.+....+.++||||+||++|+|++|+.||...+....+..+.....
T Consensus 166 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 166 RHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred ccccc----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence 75422 234457889999999986654557789999999999999999999987766554444322100
Q ss_pred -----------------------CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 249 -----------------------QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 249 -----------------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
......+..+.+||.+||.+||++|||+.+|++||||++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 00123588999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=325.78 Aligned_cols=252 Identities=31% Similarity=0.572 Sum_probs=210.4
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
.++|++.+.||+|+||.||+|++..+++.||||.+.... ..+......+.+|+.+++.++ ||||+++++++.+.+..|
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 78 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFE-MMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIEDNELN 78 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccc-cCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEECCeEE
Confidence 368999999999999999999999999999999886542 223445567889999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 107 LVMEYAAGGELFGKLR-----RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~-----~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
+++||+++|+|.+++. ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999998874 24589999999999999999999999999999999999999999999999999876433
Q ss_pred hhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCc--HHHHHHHhhccCC-CCC-CCCCHh
Q 013005 182 IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN--LLAMYKKVNRRDY-QFP-SFVSKP 257 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~--~~~~~~~i~~~~~-~~p-~~~s~~ 257 (451)
.. .......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||.... .......+..... ..+ ...+..
T Consensus 159 ~~-~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08228 159 KT-TAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEK 236 (267)
T ss_pred hh-HHHhcCCCCccccChhhhccCCC-CchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence 22 22234578999999999877666 466999999999999999999996543 2344444433222 222 346788
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 258 ARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 258 ~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
+.+++.+||..+|++|||+.++++.
T Consensus 237 ~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 237 LRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHCCCCcccCcCHHHHHHH
Confidence 9999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=331.15 Aligned_cols=251 Identities=28% Similarity=0.486 Sum_probs=207.6
Q ss_pred eEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEE
Q 013005 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVM 109 (451)
Q Consensus 30 y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~ 109 (451)
|++.+.||.|++|.||+|.+..+|..||+|++..... .......+.+|+.+++.++ ||||+++++++.+.+..|++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~~~~~~~iv~ 77 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPSTAIREISLLKELN-HPNIVRLLDVVHSENKLYLVF 77 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc--cccchhHHHHHHHHHHhcC-CCCccCHhheeccCCeEEEEE
Confidence 6788999999999999999999999999999975421 2223356778999999996 999999999999999999999
Q ss_pred EecCCCchhHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCc
Q 013005 110 EYAAGGELFGKLRRG---RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM 186 (451)
Q Consensus 110 E~~~gg~L~~~l~~~---~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~ 186 (451)
||+. ++|.+++... .+++..+..++.|++.||+|||+++++||||+|+||+++.++.++|+|||++...... ...
T Consensus 78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~ 155 (283)
T cd07835 78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP-VRT 155 (283)
T ss_pred eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC-ccc
Confidence 9995 5899888653 5999999999999999999999999999999999999999999999999998644321 122
Q ss_pred ccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc--------------------
Q 013005 187 LHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR-------------------- 246 (451)
Q Consensus 187 ~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~-------------------- 246 (451)
.....+++.|+|||++.+....+.++||||+|+++|+|++|..||...+......++...
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 233467899999999876555567799999999999999999999876654433322110
Q ss_pred -----C----CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 247 -----D----YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 247 -----~----~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
. ....+.++..+.++|.+||++||.+|||+++++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0 01123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=325.20 Aligned_cols=252 Identities=30% Similarity=0.539 Sum_probs=214.3
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
+|++.+.||+|+||.||++.+..+|..+|+|.+..... .....+.+.+|+.+++.++ ||||+++++.+......|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~~~~~~lv 77 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM--PVKEKEASKKEVILLAKMK-HPNIVTFFASFQENGRLFIV 77 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc--cchhhHHHHHHHHHHHhCC-CCChhhhhheeccCCeEEEE
Confidence 58999999999999999999999999999999976421 2233457789999999995 99999999999999999999
Q ss_pred EEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCC-eEEEeccCCCcchhhhc
Q 013005 109 MEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN-LKVSDFGLSALPEQIKN 184 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~-lkl~DFGls~~~~~~~~ 184 (451)
+||+.+++|.+++.. ..+++..+..++.|++.||.|||+++++|+||||+||++++++. ++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM- 156 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence 999999999998864 25899999999999999999999999999999999999998864 6999999987543221
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC-CCCCCCCHhHHHHHH
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY-QFPSFVSKPARSLIY 263 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~ 263 (451)
.......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+..... ..++.++..+.++|.
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 235 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLIS 235 (257)
T ss_pred ccccccCCCccccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Confidence 22234568999999998876655 5669999999999999999999988776665555544332 344567889999999
Q ss_pred hccCCCCCCCCCHHHHHcCccc
Q 013005 264 QLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 264 ~~L~~dP~~Rpt~~eil~hp~f 285 (451)
+||..+|++|||+.++++||||
T Consensus 236 ~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 236 QLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHhccChhhCcCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=330.54 Aligned_cols=259 Identities=21% Similarity=0.281 Sum_probs=212.3
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcC-----CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIA-----DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
....++|++.+.||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.+++.+. ||||++++++
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~ 77 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA---SLRERIEFLNEASVMKGFT-CHHVVRLLGV 77 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC---CHHHHHHHHHHHHHHHhCC-CCCeeeEEEE
Confidence 4556899999999999999999997542 35589999986542 1223345788999999995 9999999999
Q ss_pred EEeCCEEEEEEEecCCCchhHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCC
Q 013005 99 MATKTKIYLVMEYAAGGELFGKLRR-----------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN 167 (451)
Q Consensus 99 ~~~~~~~~lV~E~~~gg~L~~~l~~-----------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~ 167 (451)
+......|+||||+.+|+|.+++.+ ..++...++.++.|++.||.|||++||+||||||+|||++.++.
T Consensus 78 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 78 VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred EcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc
Confidence 9999999999999999999999863 12466788999999999999999999999999999999999999
Q ss_pred eEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhc
Q 013005 168 LKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNR 245 (451)
Q Consensus 168 lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~ 245 (451)
++|+|||++........ .......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...........+..
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD 236 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 99999999874322111 11123345778999999876655 567999999999999998 7999988777766665554
Q ss_pred c-CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc------Cccccc
Q 013005 246 R-DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS------ISWFQK 287 (451)
Q Consensus 246 ~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~------hp~f~~ 287 (451)
. ....+...++.+.+++.+||+.||++|||+.++++ ||||..
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 237 GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 3 33456667899999999999999999999999987 888864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=326.07 Aligned_cols=249 Identities=29% Similarity=0.461 Sum_probs=206.2
Q ss_pred EEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEE
Q 013005 31 QLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVME 110 (451)
Q Consensus 31 ~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E 110 (451)
.....||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++ ||||+++++++...+..|+|+|
T Consensus 11 ~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD----SRYVQPLHEEIALHSYLK-HRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred CceEEEecCCceEEEEeEecCCCcEEEEEEecCCC----HHHHHHHHHHHHHHHhcC-CCCeeeeeeeeccCCEEEEEEe
Confidence 33458999999999999999999999999986542 234567889999999995 9999999999999999999999
Q ss_pred ecCCCchhHHhhc--CCC--CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC-CCCeEEEeccCCCcchhhhcC
Q 013005 111 YAAGGELFGKLRR--GRL--TESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR-DGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 111 ~~~gg~L~~~l~~--~~l--~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~-~~~lkl~DFGls~~~~~~~~~ 185 (451)
|+.+++|.+++.. +.+ ++..+..++.|++.||.|||++||+||||||+||+++. ++.++|+|||++...... ..
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-~~ 164 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI-NP 164 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC-CC
Confidence 9999999999874 455 88999999999999999999999999999999999986 679999999998654321 12
Q ss_pred cccccCCCCccccceeeeccC-CCCccchhhhhhHHHHHHHhcCCCCCCCcHH--HHHHH-hhccCCCCCCCCCHhHHHH
Q 013005 186 MLHTACGTPAYTAPEVVARRG-YDGAVADAWSCGVILFVLLAGYLPFDDSNLL--AMYKK-VNRRDYQFPSFVSKPARSL 261 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~-~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~--~~~~~-i~~~~~~~p~~~s~~~~~l 261 (451)
......|++.|+|||.+.+.. ..+.++||||+|+++|+|++|..||...... ..+.. .......+|..+++.+.+|
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF 244 (268)
T ss_pred ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHH
Confidence 223446899999999986543 2456799999999999999999999754321 22221 2233345677789999999
Q ss_pred HHhccCCCCCCCCCHHHHHcCccc
Q 013005 262 IYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 262 i~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
+.+||.++|++|||+.+++.||||
T Consensus 245 i~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 245 ILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHcCCCchhCCCHHHHHhCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=332.63 Aligned_cols=257 Identities=25% Similarity=0.453 Sum_probs=209.0
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
+++|++.+.||+|++|.||+|.+..+++.||+|.+..... .....+.+.+|+.+++++. ||||+++++++.+....|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 77 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKRLY 77 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc--cccchHHHHHHHHHHHhcc-CCCEeeEEEEEecCCeEE
Confidence 4689999999999999999999999999999999865421 2233456788999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc-C--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC-CCCeEEEeccCCCcchhh
Q 013005 107 LVMEYAAGGELFGKLRR-G--RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR-DGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~-~--~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~-~~~lkl~DFGls~~~~~~ 182 (451)
+||||+++ +|.+.+.. . .+++..++.++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++......
T Consensus 78 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 78 LVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred EEEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 99999964 77777653 2 3688999999999999999999999999999999999985 457999999998654321
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc---C------------
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR---D------------ 247 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~---~------------ 247 (451)
........+++.|+|||.+.+....+.++||||+||++|+|++|..||...+......++... .
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 157 -VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred -ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence 122234567899999999876555567799999999999999999999876655444332210 0
Q ss_pred --------C------CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 248 --------Y------QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 248 --------~------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
. ...+.+++.+.+++.+||+.||++||+++++++||||...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 0 0123467889999999999999999999999999999764
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=328.83 Aligned_cols=254 Identities=20% Similarity=0.280 Sum_probs=209.6
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcC-----CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIA-----DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
....++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.+. ||||++++++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~ 77 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFN-CHHVVRLLGV 77 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCC-CCCeeeEEEE
Confidence 4567889999999999999999998642 45689999986432 1223456889999999995 9999999999
Q ss_pred EEeCCEEEEEEEecCCCchhHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCC
Q 013005 99 MATKTKIYLVMEYAAGGELFGKLRRG-----------RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN 167 (451)
Q Consensus 99 ~~~~~~~~lV~E~~~gg~L~~~l~~~-----------~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~ 167 (451)
+......++||||+++++|.+++.+. .++...+..++.|++.||.|||++|++||||||+||++++++.
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 78 VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred EcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC
Confidence 99999999999999999999988641 2567889999999999999999999999999999999999999
Q ss_pred eEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhc
Q 013005 168 LKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNR 245 (451)
Q Consensus 168 lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~ 245 (451)
++|+|||++........ .......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999864322111 11123456788999999876655 567999999999999998 7999988877766665554
Q ss_pred cC-CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 246 RD-YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 246 ~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
.. ...+...+..+.+++.+||..||++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 237 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 43 35566788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=347.74 Aligned_cols=249 Identities=32% Similarity=0.611 Sum_probs=217.2
Q ss_pred cceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEec
Q 013005 33 GPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYA 112 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~ 112 (451)
.+.||+|.||+||-|+++.||+.||||+|++. ++.. ....++++|+.||+.+. ||.||.+--.+++.+.++.|||-+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKl-rFp~-kqesqlR~EVaILq~l~-HPGiV~le~M~ET~ervFVVMEKl 645 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKL-RFPT-KQESQLRNEVAILQNLH-HPGIVNLECMFETPERVFVVMEKL 645 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecc-cCCC-chHHHHHHHHHHHHhcC-CCCeeEEEEeecCCceEEEEehhh
Confidence 56899999999999999999999999999987 3332 33478999999999995 999999999999999999999999
Q ss_pred CCCchhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCC---CCeEEEeccCCCcchhhhcCcc
Q 013005 113 AGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD---GNLKVSDFGLSALPEQIKNGML 187 (451)
Q Consensus 113 ~gg~L~~~l~--~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~---~~lkl~DFGls~~~~~~~~~~~ 187 (451)
.|.-|.-++. +|++++.....++.||+.||.|||.++|+|.||||||||+... -++||||||+|+.... ...-
T Consensus 646 ~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--ksFR 723 (888)
T KOG4236|consen 646 HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--KSFR 723 (888)
T ss_pred cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch--hhhh
Confidence 8866666664 5999999999999999999999999999999999999999655 3699999999997654 2344
Q ss_pred cccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCC--C--CCHhHHHHHH
Q 013005 188 HTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS--F--VSKPARSLIY 263 (451)
Q Consensus 188 ~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~--~s~~~~~li~ 263 (451)
.+.+|||.|+|||++.+++|.. .-|+||.|||+|.-|.|..||.... +...+|.+..+-+|+ | ++.++.+||.
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNr-SLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~AidlIn 800 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNR-SLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAIDLIN 800 (888)
T ss_pred hhhcCCccccCHHHHhhccccc-cccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHHHHHH
Confidence 5789999999999999999964 4899999999999999999997653 344556666666654 3 8999999999
Q ss_pred hccCCCCCCCCCHHHHHcCccccchh
Q 013005 264 QLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 264 ~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
.+|+..-.+|.|+++.+.|||++...
T Consensus 801 ~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 801 NLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred HHHHHHHHHhcchHhhccchhhhcch
Confidence 99999999999999999999998753
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=331.45 Aligned_cols=258 Identities=25% Similarity=0.382 Sum_probs=214.3
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
.....+|.+.+.||+|+||.||+|.+..+++.||+|.+..... ........+.+|+.+++.++ ||||+++++++.+..
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~ 88 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLREH 88 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEecccc-CcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEeCC
Confidence 3445679999999999999999999988999999999865422 23344567889999999995 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 104 KIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~--~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
..|+|+||+.| +|.+.+. .+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 89 ~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 89 TAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred eEEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99999999975 6666654 36799999999999999999999999999999999999999999999999999865322
Q ss_pred hhcCcccccCCCCccccceeeec--cCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc-CCCC-CCCCCHh
Q 013005 182 IKNGMLHTACGTPAYTAPEVVAR--RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR-DYQF-PSFVSKP 257 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~--~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~-~~~~-p~~~s~~ 257 (451)
.....|++.|+|||++.+ ....+.++||||+|+++|+|++|..||...+.......+... .... +..++..
T Consensus 168 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (307)
T cd06607 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDY 242 (307)
T ss_pred -----CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHH
Confidence 234568899999999853 233456799999999999999999999887766554444332 2222 2246788
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 258 ARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 258 ~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
+.++|.+||..||++|||+.+++.||||....
T Consensus 243 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 243 FRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 99999999999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=328.74 Aligned_cols=252 Identities=31% Similarity=0.540 Sum_probs=210.1
Q ss_pred eEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC--CEEEE
Q 013005 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK--TKIYL 107 (451)
Q Consensus 30 y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~--~~~~l 107 (451)
|++.+.||+|+||.||+|.+..+++.+|+|.+.... ........+.+|+.+++++. |||++++++++... ...|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcEEE
Confidence 678899999999999999999999999999998652 12233456778999999996 99999999999888 89999
Q ss_pred EEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 108 VMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
|+||+++ +|.+.+.+ ..+++..++.++.|++.||+|||++|++|+||+|+||++++++.++|+|||++.........
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 78 VFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred Eeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 9999975 88888865 47999999999999999999999999999999999999999999999999998765443322
Q ss_pred cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC-----------------
Q 013005 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY----------------- 248 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~----------------- 248 (451)
......++..|+|||.+.+....+.++||||+|+++|+|++|+.||...+.......+.....
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence 334456788999999887655557789999999999999999999988776554443322100
Q ss_pred ------C--------CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 249 ------Q--------FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 249 ------~--------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
. +....++.+.++|.+||..||++|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0 011137889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=340.13 Aligned_cols=262 Identities=30% Similarity=0.464 Sum_probs=213.7
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC-
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK- 102 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~- 102 (451)
..+.++|++.+.||+|+||.||+|.+..+++.+|+|.+.+.. ........+.+|+.+++++.+||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~ 80 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF--RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN 80 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc--CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC
Confidence 356789999999999999999999998899999999886431 12223345778999999995599999999988643
Q ss_pred -CEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 103 -TKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 103 -~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
...|+||||+.+ +|..++..+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 81 DKDIYLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred CceEEEEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 468999999974 999988877889999999999999999999999999999999999999999999999999875433
Q ss_pred hhc----CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc-----------
Q 013005 182 IKN----GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR----------- 246 (451)
Q Consensus 182 ~~~----~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~----------- 246 (451)
... .......||+.|+|||++.+....+.++||||||+++|+|++|+.||..........++...
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 221 22334568999999999877666677899999999999999999999865544333222111
Q ss_pred ----------------CC----CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 247 ----------------DY----QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 247 ----------------~~----~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.. ...+.++..+.++|.+||..||++|||+.++++||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 00 1112368899999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=331.75 Aligned_cols=250 Identities=22% Similarity=0.379 Sum_probs=208.1
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCc--EEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGS--IVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
.++|++.+.||+|+||.||+|.+..++. .+++|.+... ......+.+.+|+.++.++.+||||+++++++.....
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 77 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF---ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY 77 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc---CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence 3689999999999999999999877765 4688887532 1233456788999999999669999999999999999
Q ss_pred EEEEEEecCCCchhHHhhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCC
Q 013005 105 IYLVMEYAAGGELFGKLRRG-----------------RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN 167 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~~-----------------~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~ 167 (451)
.|++|||+++++|.+++... .+++..++.++.|++.||+|||++||+||||||+|||+++++.
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe
Confidence 99999999999999998642 4889999999999999999999999999999999999999999
Q ss_pred eEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc
Q 013005 168 LKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR 246 (451)
Q Consensus 168 lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~ 246 (451)
+||+|||++........ ......+..|+|||.+....+ +.++|||||||++|+|++ |..||...+......++...
T Consensus 158 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~ 234 (297)
T cd05089 158 SKIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVY-TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 234 (297)
T ss_pred EEECCcCCCccccceec--cCCCCcCccccCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence 99999999864221111 111223557999999877665 567999999999999997 99999988877777666543
Q ss_pred -CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 247 -DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 247 -~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
....|..++..+.+|+.+||..||.+|||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 235 YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 234556689999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=320.10 Aligned_cols=252 Identities=31% Similarity=0.586 Sum_probs=218.3
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
+|++.+.||+|++|.||++.+..+++.||+|.+..... .....+.+.+|+.+++++. |||++++++++.+....|++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v 77 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLYII 77 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc--CHHHHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEEEE
Confidence 58999999999999999999999999999999976532 2345568999999999995 99999999999999999999
Q ss_pred EEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcc
Q 013005 109 MEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML 187 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~ 187 (451)
|||+++++|.+++.. +.+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++....... ...
T Consensus 78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~ 156 (254)
T cd06627 78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS-KDD 156 (254)
T ss_pred EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc-ccc
Confidence 999999999999875 789999999999999999999999999999999999999999999999999987554322 223
Q ss_pred cccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHh-hccCCCCCCCCCHhHHHHHHhcc
Q 013005 188 HTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKV-NRRDYQFPSFVSKPARSLIYQLL 266 (451)
Q Consensus 188 ~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i-~~~~~~~p~~~s~~~~~li~~~L 266 (451)
....|+..|+|||.+.+.. .+.++||||+|+++|+|++|..||...+......+. ......++..++..+.+++.+||
T Consensus 157 ~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 235 (254)
T cd06627 157 ASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCF 235 (254)
T ss_pred cccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHH
Confidence 4456899999999987666 467799999999999999999999876554433333 34445566778999999999999
Q ss_pred CCCCCCCCCHHHHHcCccc
Q 013005 267 DPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 267 ~~dP~~Rpt~~eil~hp~f 285 (451)
..+|++|||+.+++.||||
T Consensus 236 ~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 236 QKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred hCChhhCcCHHHHhcCCCC
Confidence 9999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=330.15 Aligned_cols=249 Identities=25% Similarity=0.380 Sum_probs=209.8
Q ss_pred cCCeEEcceEcccCceEEEEEEEc-----CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSI-----ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
..+|.+.+.||+|+||+||++.+. .++..+|+|.+.... ......+.+|+.+++++. ||||+++++++..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 78 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS----DNARKDFHREAELLTNLQ-HEHIVKFYGVCVE 78 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC----HHHHHHHHHHHHHHHhCC-CCCcceEEEEEec
Confidence 467999999999999999999852 345679999986542 344567889999999995 9999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhc-C-------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCC
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR-G-------------RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN 167 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~-~-------------~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~ 167 (451)
....|+||||+.+++|.+++.. + .+++..++.++.|++.||+|||++|++||||||+|||+++++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 9999999999999999998863 2 3899999999999999999999999999999999999999999
Q ss_pred eEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhc
Q 013005 168 LKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNR 245 (451)
Q Consensus 168 lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~ 245 (451)
++|+|||++........ .......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~ 237 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 99999999874422111 12233456788999999876655 567999999999999998 9999988877777777766
Q ss_pred cC-CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 246 RD-YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 246 ~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.. ...+..++..+.+|+.+||..||.+|||+++++.
T Consensus 238 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 238 GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 54 3445568899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=329.87 Aligned_cols=259 Identities=25% Similarity=0.401 Sum_probs=215.3
Q ss_pred CCCcccccCCeEEcceEcccCceEEEEEEEcCC-----CcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceE
Q 013005 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIAD-----GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94 (451)
Q Consensus 20 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~ 94 (451)
...+....++|++.+.||+|+||.||++.+... ...+|+|.+.... .......+.+|+.+++++.+||||++
T Consensus 4 ~~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~ 80 (293)
T cd05053 4 DPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIIN 80 (293)
T ss_pred CcccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC---CHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 344556678899999999999999999987643 3789999987542 22334568899999999966999999
Q ss_pred EEEEEEeCCEEEEEEEecCCCchhHHhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 013005 95 IQEVMATKTKIYLVMEYAAGGELFGKLRR-----------------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKP 157 (451)
Q Consensus 95 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-----------------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKp 157 (451)
+++++......|++|||+.+|+|..++.. +.+++..+..++.|++.||+|||++||+||||||
T Consensus 81 ~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp 160 (293)
T cd05053 81 LLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAA 160 (293)
T ss_pred EEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccce
Confidence 99999999999999999999999998852 3588999999999999999999999999999999
Q ss_pred CeEEeCCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCc
Q 013005 158 QNLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSN 235 (451)
Q Consensus 158 eNILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~ 235 (451)
+|||++.++.+||+|||++........ .......++..|+|||++.+..+ +.++||||+||++|+|++ |..||...+
T Consensus 161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 161 RNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred eeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCc-CcccceeehhhHHHHHhcCCCCCCCCCC
Confidence 999999999999999999975433211 11122335678999999876655 566999999999999997 999999888
Q ss_pred HHHHHHHhhccC-CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 236 LLAMYKKVNRRD-YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 236 ~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
....+..+.... ...|...+..+.+|+.+||..||++|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 240 VEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 777777665543 34566678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=329.12 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=211.3
Q ss_pred cCCeEEcceEcccCceEEEEEEEcC-----CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIA-----DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
.++|.+.+.||+|+||.||+|.+.. ++..||+|++.... .....+.+.+|+.+++.+. ||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 79 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA---SNDARKDFEREAELLTNFQ-HENIVKFYGVCTE 79 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC---CHHHHHHHHHHHHHHHhcC-CCCchheeeEEec
Confidence 4678999999999999999998743 46789999986542 2334578899999999995 9999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR---------------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG 166 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~---------------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~ 166 (451)
....|+||||++|++|.+++.. ..+++.++..++.|++.|+.|||++|++||||||+||+++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL 159 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC
Confidence 9999999999999999999863 2478899999999999999999999999999999999999999
Q ss_pred CeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhh
Q 013005 167 NLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVN 244 (451)
Q Consensus 167 ~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~ 244 (451)
.++|+|||++........ .......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+.
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCc-chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 999999999864322111 11233456789999999977666 566999999999999998 999998887777777776
Q ss_pred ccCCC-CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 245 RRDYQ-FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 245 ~~~~~-~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
..... .+..++..+.+++.+||..||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 239 QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 55443 34568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=340.10 Aligned_cols=258 Identities=25% Similarity=0.389 Sum_probs=211.7
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC-
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK- 102 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~- 102 (451)
....++|++.+.||+|+||.||+|.+..+++.||+|.+.+.. ......+.+.+|+.++++++ ||||+++++++...
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~~ 89 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPAR 89 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHHHHHHcC-CCcccceeeeeeecc
Confidence 456689999999999999999999999999999999997542 12233456788999999995 99999999988543
Q ss_pred -----CEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 103 -----TKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 103 -----~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
...|++++++ |++|.+++....+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccc
Confidence 3478888887 7799988887889999999999999999999999999999999999999999999999999987
Q ss_pred cchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC----------
Q 013005 178 LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD---------- 247 (451)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~---------- 247 (451)
... .......|++.|+|||++.+....+.++||||+||++|+|++|..||...+.......+....
T Consensus 169 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T cd07877 169 HTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 244 (345)
T ss_pred ccc----ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 432 223345789999999998764445677999999999999999999998765544333221100
Q ss_pred -------------CCC--------CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 248 -------------YQF--------PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 248 -------------~~~--------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
... ....++.+.++|.+||..||.+|||+.+++.||||++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 000 112578899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=341.48 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=210.4
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE----eC
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA----TK 102 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~----~~ 102 (451)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++++. ||||+++++++. ..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 80 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF--DVPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGADF 80 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc--ccccchHHHHHHHHHHHhcC-CCCccCHHHhccccCCCC
Confidence 478999999999999999999999999999999987542 12234556778999999996 999999999875 34
Q ss_pred CEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 103 TKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
...|+||||+. ++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 81 KDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred ceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 57899999996 588888864 6799999999999999999999999999999999999999999999999999865432
Q ss_pred hhc---CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhc-------------
Q 013005 182 IKN---GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNR------------- 245 (451)
Q Consensus 182 ~~~---~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~------------- 245 (451)
... ......+|+..|+|||.+.+....+.++||||+||++|+|++|+.||...+.......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 211 2223457899999999987655557779999999999999999999987654332221111
Q ss_pred -----------c--CCCC-----CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 246 -----------R--DYQF-----PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 246 -----------~--~~~~-----p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
. .... .+..+..+.++|.+||+.+|.+|||+++++.||||.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 0 0011 13368899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=332.74 Aligned_cols=259 Identities=22% Similarity=0.377 Sum_probs=214.1
Q ss_pred CCCcccccCCeEEcceEcccCceEEEEEEEcC-------CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCc
Q 013005 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIA-------DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNV 92 (451)
Q Consensus 20 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnI 92 (451)
...+....++|.+++.||+|+||.||+|.+.. +...+|+|.+.... .......+.+|+.+++.+.+||||
T Consensus 10 ~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~~i 86 (307)
T cd05098 10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNI 86 (307)
T ss_pred CCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC---ChHHHHHHHHHHHHHHHhcCCCCE
Confidence 33455667899999999999999999998643 23579999997542 223345688899999999669999
Q ss_pred eEEEEEEEeCCEEEEEEEecCCCchhHHhhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q 013005 93 LKIQEVMATKTKIYLVMEYAAGGELFGKLRRG-----------------RLTESAARRYFQQLVSALHFCHQNGVAHRDV 155 (451)
Q Consensus 93 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-----------------~l~e~~~~~~~~ql~~gL~yLH~~giiHrDL 155 (451)
+++++++......|+||||+.+|+|.+++... .+++.++..++.|++.||+|||++|++||||
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dl 166 (307)
T cd05098 87 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDL 166 (307)
T ss_pred eeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccc
Confidence 99999999999999999999999999998642 4788999999999999999999999999999
Q ss_pred CCCeEEeCCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCC
Q 013005 156 KPQNLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDD 233 (451)
Q Consensus 156 KpeNILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~ 233 (451)
||+||+++.++.+||+|||++........ .......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||..
T Consensus 167 kp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~ 245 (307)
T cd05098 167 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPG 245 (307)
T ss_pred cHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 99999999999999999999875432111 11112234578999999877655 567999999999999998 9999988
Q ss_pred CcHHHHHHHhhccC-CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 234 SNLLAMYKKVNRRD-YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 234 ~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
.+.......+.... ...|..++..+.+||.+||..+|++|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 246 VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred CCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 88777766665543 35566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=332.97 Aligned_cols=258 Identities=28% Similarity=0.548 Sum_probs=210.4
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
....++|++.+.||+|+||.||+|.+..+++.||+|.++.... .......+.+|+.+++.++ ||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~ 79 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE--KEGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQ 79 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc--ccCchHHHHHHHHHHHhCC-CCCeeeeeheecCcc
Confidence 3567899999999999999999999999999999999975421 1222346678999999995 999999999987654
Q ss_pred ----------EEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEE
Q 013005 104 ----------KIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVS 171 (451)
Q Consensus 104 ----------~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~ 171 (451)
..|+|+||+++ ++...+.. ..+++..++.++.|++.||.|||+.||+||||||+||++++++.+||+
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 80 DALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred hhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeC
Confidence 89999999986 66666654 479999999999999999999999999999999999999999999999
Q ss_pred eccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc---CC
Q 013005 172 DFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR---DY 248 (451)
Q Consensus 172 DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~---~~ 248 (451)
|||++...............+++.|+|||.+.+....+.++||||+||++|+|++|+.||...+.......+... ..
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999987654322222233456889999998876555567899999999999999999999876655444333221 00
Q ss_pred ---------------------------CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 249 ---------------------------QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 249 ---------------------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
.....++..+.+++.+||..||.+|||+++++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0012367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=318.85 Aligned_cols=253 Identities=30% Similarity=0.559 Sum_probs=217.4
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC--CEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK--TKIY 106 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~--~~~~ 106 (451)
+|.+.+.||+|++|.||+|.+..++..|++|++..... .....+.+.+|+.+++++. ||||+++++.+... ...+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD--SEEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCeEE
Confidence 58889999999999999999998999999999976532 2345678899999999996 99999999999988 8999
Q ss_pred EEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc-
Q 013005 107 LVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN- 184 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~- 184 (451)
+++||+++++|.+++.+ ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 99999999999999976 4899999999999999999999999999999999999999999999999999875543221
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCc-HHHHHHHhh--ccCCCCCCCCCHhHHHH
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN-LLAMYKKVN--RRDYQFPSFVSKPARSL 261 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~-~~~~~~~i~--~~~~~~p~~~s~~~~~l 261 (451)
.......++..|+|||.+.... .+.++||||+|+++|+|++|..||.... .......+. .....+|...+..+.++
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF 236 (260)
T ss_pred ccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHH
Confidence 1134567899999999987665 4667999999999999999999998765 333333333 23445667789999999
Q ss_pred HHhccCCCCCCCCCHHHHHcCccc
Q 013005 262 IYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 262 i~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
|.+||..||++||++.+++.||||
T Consensus 237 i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 237 LRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHhCcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=323.97 Aligned_cols=251 Identities=24% Similarity=0.386 Sum_probs=210.8
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCC---CcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIAD---GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
.++|++.+.||+|+||.||+|.+..+ ...||+|.+.... .......+.+|+.++++++ ||||+++++.+....
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 78 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFD-HPNIIRLEGVVTKSR 78 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC---ChHHHHHHHHHHHHHHhCC-CCCcceEeEEEecCC
Confidence 46799999999999999999988644 4589999986542 2334567888999999995 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 104 KIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
..|++|||+.+++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||+++++.++|+|||++.....
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 79 PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999999999864 5799999999999999999999999999999999999999999999999999986542
Q ss_pred hhcC-cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhH
Q 013005 182 IKNG-MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPA 258 (451)
Q Consensus 182 ~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 258 (451)
.... ......+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+... ....+...+..+
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSAL 237 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCC-ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 1111 1112345678999999877665 566999999999999997 99999877777666666543 234455678999
Q ss_pred HHHHHhccCCCCCCCCCHHHHHcC
Q 013005 259 RSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 259 ~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
.+++.+||..+|++||++++++++
T Consensus 238 ~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 238 YQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=340.39 Aligned_cols=257 Identities=26% Similarity=0.443 Sum_probs=209.5
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC---
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK--- 102 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~--- 102 (451)
+.++|.+.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.+++.+. ||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~ 79 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD--NRIDAKRTLREIKLLRHLD-HENVIAIKDIMPPPHRE 79 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc--ccchhHHHHHHHHHHHhcC-CCCccchHHheeccccc
Confidence 45789999999999999999999999999999999875321 2223446678999999995 99999999987544
Q ss_pred --CEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcc
Q 013005 103 --TKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALP 179 (451)
Q Consensus 103 --~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~ 179 (451)
...|+++||+. ++|.+++.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus 80 ~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 80 AFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred ccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 35899999996 588888865 78999999999999999999999999999999999999999999999999998754
Q ss_pred hhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhc--------------
Q 013005 180 EQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNR-------------- 245 (451)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~-------------- 245 (451)
.... .......++..|+|||.+.+....+.++||||+||++|+|++|+.||...+....+..+..
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 159 SEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred CCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 3321 2234557899999999987644456789999999999999999999987654332221110
Q ss_pred -------------c-CC---CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 246 -------------R-DY---QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 246 -------------~-~~---~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
. .. ...+.+++.+.+||++||..||++|||++++++||||..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 0 00 012347889999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=349.93 Aligned_cols=251 Identities=26% Similarity=0.420 Sum_probs=217.6
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
.|.=++.||.|+||-||.|++..|.+.||||.+.-..+ ....--..|.+|+..|++|. |||+|.+.++|......|+|
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGK-Qs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeecccccc-ccHHHHHHHHHHHHHHHhcc-CCCcccccceeeccchHHHH
Confidence 46668899999999999999999999999999987644 33344457889999999996 99999999999999999999
Q ss_pred EEecCCCchhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCc
Q 013005 109 MEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM 186 (451)
Q Consensus 109 ~E~~~gg~L~~~l~--~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~ 186 (451)
||||-| +-.+++. +.++.+.++..++.+.+.||+|||+.+.||||||..|||+++.|.+||+|||.|.+. .+
T Consensus 105 MEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~-----~P 178 (948)
T KOG0577|consen 105 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM-----AP 178 (948)
T ss_pred HHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc-----Cc
Confidence 999965 6667664 578999999999999999999999999999999999999999999999999998754 34
Q ss_pred ccccCCCCccccceeeec---cCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC-CCCC-CCCCHhHHHH
Q 013005 187 LHTACGTPAYTAPEVVAR---RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD-YQFP-SFVSKPARSL 261 (451)
Q Consensus 187 ~~~~~gt~~y~APEvl~~---~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p-~~~s~~~~~l 261 (451)
..+.+|||+||||||+.. ..|++. +||||||+++.+|...++|+...|.......|..+. +.++ +.+|..+.+|
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgk-vDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~F 257 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 257 (948)
T ss_pred hhcccCCccccchhHheeccccccCCc-cceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHH
Confidence 567899999999999853 346554 899999999999999999999888876666665543 3333 3479999999
Q ss_pred HHhccCCCCCCCCCHHHHHcCccccch
Q 013005 262 IYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 262 i~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+..||.+-|+.|||.++++.|+|....
T Consensus 258 vd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 258 VDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred HHHHHhhCcccCCcHHHHhhcchhccC
Confidence 999999999999999999999998653
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=321.83 Aligned_cols=243 Identities=23% Similarity=0.425 Sum_probs=201.8
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecC
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAA 113 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ 113 (451)
+.||+|+||.||+|++..+++.+|+|.+.... .......+.+|+.+++++. ||||+++++++......|+||||+.
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL---PPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQ 76 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC---CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcCCCCeEEEEeecc
Confidence 46899999999999999999999999886432 2344567889999999995 9999999999999999999999999
Q ss_pred CCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCc-cccc
Q 013005 114 GGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM-LHTA 190 (451)
Q Consensus 114 gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~-~~~~ 190 (451)
+++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......... ....
T Consensus 77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 9999999864 458999999999999999999999999999999999999999999999999986432211100 1111
Q ss_pred CCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhc-cCCCCCCCCCHhHHHHHHhccCC
Q 013005 191 CGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNR-RDYQFPSFVSKPARSLIYQLLDP 268 (451)
Q Consensus 191 ~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~-~~~~~p~~~s~~~~~li~~~L~~ 268 (451)
.++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...+.......+.. .....+...+..+.+|+.+||..
T Consensus 157 ~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 235 (252)
T cd05084 157 QIPVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEY 235 (252)
T ss_pred CCceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCC
Confidence 23457999999877665 566999999999999997 9999987665554444433 23455667889999999999999
Q ss_pred CCCCCCCHHHHHc
Q 013005 269 NPKTRMSIEKIMS 281 (451)
Q Consensus 269 dP~~Rpt~~eil~ 281 (451)
||++|||+.++++
T Consensus 236 ~p~~Rps~~~~~~ 248 (252)
T cd05084 236 DPGQRPSFSTVHQ 248 (252)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=345.36 Aligned_cols=260 Identities=22% Similarity=0.374 Sum_probs=211.1
Q ss_pred CCCCCcccccCCeEEcceEcccCceEEEEEEEcCC-----CcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCc
Q 013005 18 PPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIAD-----GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNV 92 (451)
Q Consensus 18 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnI 92 (451)
|-...+....++|.+++.||+|+||.||+|.+... +..||||++.... .....+.+.+|+.+++++..||||
T Consensus 27 ~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~~l~~l~~HpnI 103 (400)
T cd05105 27 PYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA---RSSEKQALMSELKIMTHLGPHLNI 103 (400)
T ss_pred CCCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCCe
Confidence 33456666788999999999999999999987533 3479999996542 233446788999999999669999
Q ss_pred eEEEEEEEeCCEEEEEEEecCCCchhHHhhc-------------------------------------------------
Q 013005 93 LKIQEVMATKTKIYLVMEYAAGGELFGKLRR------------------------------------------------- 123 (451)
Q Consensus 93 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~------------------------------------------------- 123 (451)
+++++++......|+|||||++|+|.+++..
T Consensus 104 v~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (400)
T cd05105 104 VNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQA 183 (400)
T ss_pred eeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccc
Confidence 9999999999999999999999999988743
Q ss_pred ------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q 013005 124 ------------------------------------------------GRLTESAARRYFQQLVSALHFCHQNGVAHRDV 155 (451)
Q Consensus 124 ------------------------------------------------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDL 155 (451)
..+++.++..++.|++.||+|||++||+||||
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~di 263 (400)
T cd05105 184 DTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDL 263 (400)
T ss_pred cccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 13778888999999999999999999999999
Q ss_pred CCCeEEeCCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCC
Q 013005 156 KPQNLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDD 233 (451)
Q Consensus 156 KpeNILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~ 233 (451)
||+|||++.++.+||+|||++........ .......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||..
T Consensus 264 kp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~ 342 (400)
T cd05105 264 AARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPG 342 (400)
T ss_pred ChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcc
Confidence 99999999999999999999875432111 12223456788999999877665 567999999999999997 9999987
Q ss_pred CcHH-HHHHHhhcc-CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 234 SNLL-AMYKKVNRR-DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 234 ~~~~-~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.... ..+..+... ....+..++..+.+++.+||..||++|||+.++.+
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 343 MIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred cchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 5443 333333332 23455678899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=323.47 Aligned_cols=250 Identities=21% Similarity=0.360 Sum_probs=208.9
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
....++|++.+.||+|+||.||+|.+ .++..||+|.+.... ...+.+.+|+.+++.+. ||||+++++.+....
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 74 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQ-HDKLVRLYAVVTKEE 74 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCc-----hhHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCC
Confidence 34567899999999999999999986 456789999886532 12467889999999995 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 104 KIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
..|++|||+.+++|.+++.. ..+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++....
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05072 75 PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIE 154 (261)
T ss_pred CcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecC
Confidence 99999999999999999864 468999999999999999999999999999999999999999999999999997643
Q ss_pred hhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhH
Q 013005 181 QIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPA 258 (451)
Q Consensus 181 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 258 (451)
...........++..|+|||.+....+ +.++|||||||++|+|++ |..||...........+... ....+..++..+
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (261)
T cd05072 155 DNEYTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDEL 233 (261)
T ss_pred CCceeccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 322111223345678999999876655 567999999999999998 99999887766666655543 223344578999
Q ss_pred HHHHHhccCCCCCCCCCHHHHHc
Q 013005 259 RSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 259 ~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.+++.+||..||++|||++++.+
T Consensus 234 ~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 234 YDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=358.62 Aligned_cols=263 Identities=23% Similarity=0.369 Sum_probs=196.9
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCC-CcEEEEEEeecCc-------------chhhHHHHHHHHHHHHHHHHhcCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIAD-GSIVAIKTIEKNN-------------KFLDAAMEDRIVREVSAMRRLQNH 89 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-~~~vAiK~i~~~~-------------~~~~~~~~~~~~~Ei~il~~L~~H 89 (451)
....++|++++.||+|+||+||++..... +...+.|.+.... ..........+.+|+.+++++. |
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~-H 222 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN-H 222 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC-C
Confidence 45678999999999999999999875432 2223333111000 0011234456889999999995 9
Q ss_pred CCceEEEEEEEeCCEEEEEEEecCCCchhHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeC
Q 013005 90 PNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRG------RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLD 163 (451)
Q Consensus 90 pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~------~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld 163 (451)
|||+++++++...+..|+|+|++. ++|..++..+ ......++.++.||+.||.|||++||+||||||+|||++
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 999999999999999999999985 4677766432 345677889999999999999999999999999999999
Q ss_pred CCCCeEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCC-CCCC--cHHHHH
Q 013005 164 RDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLP-FDDS--NLLAMY 240 (451)
Q Consensus 164 ~~~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~P-f~~~--~~~~~~ 240 (451)
.++.+||+|||++..............+||+.|+|||++.+..+ +.++|||||||++|+|++|..| |... +....+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 99999999999997654333333345689999999999988776 5669999999999999998754 4322 111111
Q ss_pred HHhhc----------------------cCC-----CCC-----CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 241 KKVNR----------------------RDY-----QFP-----SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 241 ~~i~~----------------------~~~-----~~p-----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.++.. ..+ .++ ..++..+.++|.+||..||++|||+.|++.||||...
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 11110 000 001 1245677888999999999999999999999999765
Q ss_pred h
Q 013005 289 L 289 (451)
Q Consensus 289 ~ 289 (451)
.
T Consensus 461 ~ 461 (501)
T PHA03210 461 E 461 (501)
T ss_pred C
Confidence 3
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=325.59 Aligned_cols=253 Identities=23% Similarity=0.301 Sum_probs=212.1
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCC-----CcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIAD-----GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
....++|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++.+. ||||++++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~ 77 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA---SMRERIEFLNEASVMKEFN-CHHVVRLLGV 77 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc---CHHHHHHHHHHHHHHHhCC-CCceeEEEEE
Confidence 35568999999999999999999987643 4789999986442 2233456788999999995 9999999999
Q ss_pred EEeCCEEEEEEEecCCCchhHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCC
Q 013005 99 MATKTKIYLVMEYAAGGELFGKLRR-----------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN 167 (451)
Q Consensus 99 ~~~~~~~~lV~E~~~gg~L~~~l~~-----------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~ 167 (451)
+......|+||||+.+|+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.
T Consensus 78 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~ 157 (277)
T cd05032 78 VSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT 157 (277)
T ss_pred EcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC
Confidence 9999999999999999999998853 23678899999999999999999999999999999999999999
Q ss_pred eEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhc
Q 013005 168 LKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNR 245 (451)
Q Consensus 168 lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~ 245 (451)
+||+|||++........ .......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+..
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence 99999999875432211 22334567889999999876655 567999999999999998 9999988777766666554
Q ss_pred c-CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 246 R-DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 246 ~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
. ....|...+..+.++|.+||..+|++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 237 GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 3 34567778999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=330.88 Aligned_cols=255 Identities=23% Similarity=0.366 Sum_probs=206.4
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|+..+.||+|+||.||++.+..+++.||+|.+..... ......+.+|+.++.++.+||||+++++++......++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD---EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC---hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 467778899999999999999999999999999875422 23456788999999999679999999999999999999
Q ss_pred EEEecCCCchhH---Hhh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 108 VMEYAAGGELFG---KLR---RGRLTESAARRYFQQLVSALHFCHQN-GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 108 V~E~~~gg~L~~---~l~---~~~l~e~~~~~~~~ql~~gL~yLH~~-giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
+|||+.+ ++.+ .+. .+.+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++....
T Consensus 81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9999865 4433 322 36799999999999999999999985 99999999999999999999999999986432
Q ss_pred hhhcCcccccCCCCccccceeeecc--CCCCccchhhhhhHHHHHHHhcCCCCCCCcH-HHHHHHhhccC-CCC----CC
Q 013005 181 QIKNGMLHTACGTPAYTAPEVVARR--GYDGAVADAWSCGVILFVLLAGYLPFDDSNL-LAMYKKVNRRD-YQF----PS 252 (451)
Q Consensus 181 ~~~~~~~~~~~gt~~y~APEvl~~~--~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~-~~~~~~i~~~~-~~~----p~ 252 (451)
. ........|++.|+|||++.+. ...+.++||||+||++|+|++|+.||..... ......+.... ... +.
T Consensus 160 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd06616 160 D--SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237 (288)
T ss_pred c--CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence 2 1222345689999999998766 2446679999999999999999999976542 12222222221 122 22
Q ss_pred CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 253 FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 253 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.++..+.+||.+||..||++|||+++|+.||||+..
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 378899999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=327.29 Aligned_cols=252 Identities=21% Similarity=0.327 Sum_probs=209.4
Q ss_pred ccCCeEEcceEcccCceEEEEEEEc----CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSI----ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~----~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
.+.+|++.+.||+|+||+||+|.+. .++..+|+|.+.... .......+.+|+.+++.+. ||||+++++++..
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 78 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN---NPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQ 78 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEec
Confidence 3578999999999999999999853 456789999986532 2334467889999999995 9999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhc------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeC
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR------------------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLD 163 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~------------------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld 163 (451)
....|++|||+.+++|.+++.. ..+++.++..++.|++.||+|||++|++||||||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~ 158 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG 158 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence 9999999999999999998842 2378889999999999999999999999999999999999
Q ss_pred CCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHH
Q 013005 164 RDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYK 241 (451)
Q Consensus 164 ~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~ 241 (451)
+++.+||+|||++........ .......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+......
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999999875422111 12234456778999999876655 567999999999999998 999998876665555
Q ss_pred Hhhcc-CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 242 KVNRR-DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 242 ~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
.+... ....+..+++.+.+++.+||+.||.+||++.+|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 238 MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 55443 344566789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=326.62 Aligned_cols=255 Identities=25% Similarity=0.456 Sum_probs=209.4
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe--CCEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT--KTKI 105 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~--~~~~ 105 (451)
++|+..+.||.|++|.||++.+..+++.+|+|.+.... .......+.+|+.+++++. ||||+++++++.. ...+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC---chHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCCeE
Confidence 57999999999999999999999999999999997542 2244567899999999995 9999999998854 4479
Q ss_pred EEEEEecCCCchhHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 106 YLVMEYAAGGELFGKLR-----RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~-----~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
|+||||++|++|.+++. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999999999988764 2568999999999999999999999999999999999999999999999999986432
Q ss_pred hhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCC-----cHHHHHHHhhcc-CCCCC---
Q 013005 181 QIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS-----NLLAMYKKVNRR-DYQFP--- 251 (451)
Q Consensus 181 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~-----~~~~~~~~i~~~-~~~~p--- 251 (451)
. .......++..|+|||.+.+..+ +.++|||||||++|+|++|..||... ...+....+... ...++
T Consensus 157 ~---~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd06621 157 N---SLAGTFTGTSFYMAPERIQGKPY-SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEP 232 (287)
T ss_pred c---cccccccCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCC
Confidence 2 12234567899999999877665 56699999999999999999999865 222333333321 11111
Q ss_pred ---CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchhH
Q 013005 252 ---SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQ 290 (451)
Q Consensus 252 ---~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 290 (451)
...++.+.++|.+||..||.+|||+.|++.||||++...
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 274 (287)
T cd06621 233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274 (287)
T ss_pred CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence 124678999999999999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=321.37 Aligned_cols=255 Identities=28% Similarity=0.496 Sum_probs=214.1
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcc-hhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC--CE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNK-FLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK--TK 104 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~--~~ 104 (451)
.+|++.+.||+|+||.||+|.+..+++.||+|.+..... .........+.+|+.++++++ ||||+++++.+.+. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCCCCE
Confidence 579999999999999999999999999999999864311 112344567899999999995 99999999998664 56
Q ss_pred EEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 105 IYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
.++++||+++++|.+.+.. +.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 8999999999999999875 679999999999999999999999999999999999999999999999999987543211
Q ss_pred c--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc--CCCCCCCCCHhHH
Q 013005 184 N--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR--DYQFPSFVSKPAR 259 (451)
Q Consensus 184 ~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~ 259 (451)
. .......|+..|+|||.+.+..+ +.++|+|||||++|+|++|+.||..........++... ...+|..+++.+.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 239 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACR 239 (264)
T ss_pred ccCccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHH
Confidence 1 11234568999999999877655 56699999999999999999999877655554444432 3456778899999
Q ss_pred HHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 260 SLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 260 ~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
++|.+||. +|.+|||+.+++.|||.
T Consensus 240 ~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 240 DFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHhc-CcccCccHHHHhcCCCC
Confidence 99999999 57999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=383.30 Aligned_cols=260 Identities=32% Similarity=0.573 Sum_probs=223.9
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
.+.-+|.-+.+||.|.||+||-|.|..||+..|+|-+.-... .......+.+|..++..+. |||+|++|++-.+.+.
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~--~~k~~~~i~eEm~vlE~ln-HpNlV~YyGVEvHRek 1308 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDS--DHKTFKLIAEEMKVLEGLN-HPNLVRYYGVEVHREK 1308 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCcc--ccccCcchHHHHHHHHhcc-CccccccCceeecHHH
Confidence 344578889999999999999999999999999999865532 2445567899999999995 9999999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 105 IYLVMEYAAGGELFGKLRRGR-LTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~~~-l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
.||.||||.||+|.+.++.|+ .+|...+.|..|++.|+.|||++||+||||||+||+||.+|.+|++|||.|.......
T Consensus 1309 v~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 999999999999999999765 6778888999999999999999999999999999999999999999999987544322
Q ss_pred ---cCcccccCCCCccccceeeeccC--CCCccchhhhhhHHHHHHHhcCCCCCCCc--HHHHHHHhhccCCCCCCCCCH
Q 013005 184 ---NGMLHTACGTPAYTAPEVVARRG--YDGAVADAWSCGVILFVLLAGYLPFDDSN--LLAMYKKVNRRDYQFPSFVSK 256 (451)
Q Consensus 184 ---~~~~~~~~gt~~y~APEvl~~~~--~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~--~~~~~~~i~~~~~~~p~~~s~ 256 (451)
++.+....|||.|||||++.+.. -.+.++|||||||++.||+||+.||..-+ ..-+|+--....+++|..+|.
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~ 1468 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSS 1468 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhH
Confidence 24456778999999999997643 12445899999999999999999997543 334555555567889999999
Q ss_pred hHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 257 PARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
+..+||.+||..||.+|.++.||++|.|-+.
T Consensus 1469 ~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1469 EGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred hHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 9999999999999999999999999988654
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=334.63 Aligned_cols=254 Identities=26% Similarity=0.459 Sum_probs=203.1
Q ss_pred CeEEcceEcccCceEEEEEEEcC--CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC--CE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIA--DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK--TK 104 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~--~~ 104 (451)
+|++.+.||+|+||.||+|.+.. ++..||+|.+..... ......+.+.+|+.+++++. ||||+++++++.+. ..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 78 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKS 78 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCce
Confidence 58899999999999999999988 899999999976421 11223456778999999995 99999999999888 88
Q ss_pred EEEEEEecCCCchhHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC----CCCeEEEecc
Q 013005 105 IYLVMEYAAGGELFGKLRR------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR----DGNLKVSDFG 174 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~----~~~lkl~DFG 174 (451)
.|+||||+.+ +|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999999975 56665531 36899999999999999999999999999999999999999 8999999999
Q ss_pred CCCcchhhhc--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHH---------HHHHh
Q 013005 175 LSALPEQIKN--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLA---------MYKKV 243 (451)
Q Consensus 175 ls~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~---------~~~~i 243 (451)
++........ ......++|+.|+|||++.+....+.++|||||||++|+|++|+.||....... ....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9876433222 122345789999999988765555677999999999999999999997543221 00000
Q ss_pred --------------------------hccCCCCC-----------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 244 --------------------------NRRDYQFP-----------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 244 --------------------------~~~~~~~p-----------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
......++ ...+..+.++|.+||..||++|||+.++++||||
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00001111 1456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=302.89 Aligned_cols=255 Identities=30% Similarity=0.541 Sum_probs=215.3
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
.+|.-.+.||+|.||+||+|++..|++.||+|.++.+.. +...-....+||.+++.|+ |.|||+++++...+.+.-+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd--degvpssalreicllkelk-hknivrl~dvlhsdkkltl 78 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTL 78 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC--CCCCcHHHHHHHHHHHHhh-hcceeehhhhhccCceeEE
Confidence 467778899999999999999999999999999977632 3334456779999999996 9999999999999999999
Q ss_pred EEEecCCCchhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 108 VMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 108 V~E~~~gg~L~~~l~--~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
|+|||.. +|..+.. +|.++.+.++.++.|+++||.|||++++.||||||+|+|++.+|.+|++|||+++.+.... .
T Consensus 79 vfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv-r 156 (292)
T KOG0662|consen 79 VFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-R 156 (292)
T ss_pred eHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce-E
Confidence 9999965 7877776 4889999999999999999999999999999999999999999999999999998654322 2
Q ss_pred cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc----------------CC
Q 013005 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR----------------DY 248 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~----------------~~ 248 (451)
.....+-|.+|.+|.++.+...++...|+||.|||+.|+.. |++.|.+.+..+..++|.+. ++
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 23344569999999999888777777999999999999975 78889998888777776431 00
Q ss_pred ----CCCC---------CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 249 ----QFPS---------FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 249 ----~~p~---------~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
.+|. ..+..-++|++++|.-||.+|++++..++||||..
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 1111 13445689999999999999999999999999964
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=320.45 Aligned_cols=246 Identities=39% Similarity=0.722 Sum_probs=218.0
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecCCC
Q 013005 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGG 115 (451)
Q Consensus 36 LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~gg 115 (451)
||+|+||.||++.+..+++.+|+|++.+. ........+.+.+|+.+++++. ||||+++++.+..+...|++|||+.++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKK-KIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehh-hhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHeecCCeeEEEEecCCCC
Confidence 69999999999999889999999999775 3333445678899999999996 999999999999999999999999999
Q ss_pred chhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCCCC
Q 013005 116 ELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP 194 (451)
Q Consensus 116 ~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~gt~ 194 (451)
+|.+++.. +.+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++....... .......++.
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~ 157 (250)
T cd05123 79 ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTP 157 (250)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCc
Confidence 99999975 578999999999999999999999999999999999999999999999999987543321 2234567899
Q ss_pred ccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccCCCCCCCC
Q 013005 195 AYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRM 274 (451)
Q Consensus 195 ~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rp 274 (451)
.|+|||.+.+... +.++|+||||+++|+|++|..||...+.......+......+|...+..+.++|.+||..||+.||
T Consensus 158 ~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~ 236 (250)
T cd05123 158 EYLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRL 236 (250)
T ss_pred cccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCC
Confidence 9999999876554 566999999999999999999998888777777777777788888899999999999999999999
Q ss_pred CH---HHHHcCccc
Q 013005 275 SI---EKIMSISWF 285 (451)
Q Consensus 275 t~---~eil~hp~f 285 (451)
|+ +++++||||
T Consensus 237 ~~~~~~~l~~~~~f 250 (250)
T cd05123 237 GSGGAEEIKAHPFF 250 (250)
T ss_pred CcccHHHHHhCCCC
Confidence 99 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=323.68 Aligned_cols=247 Identities=26% Similarity=0.438 Sum_probs=206.3
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
.+|++.+.||+|+||.||++.+. ++..+|+|++.+... ..+.+.+|+.+++++. ||||+++++++......|+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l 76 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-----SEDDFIEEAKVMMKLS-HPNLVQLYGVCTKQRPIFI 76 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC-----CHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCceEE
Confidence 46899999999999999999875 567899999865421 1245778999999995 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 108 VMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
||||++|++|.+++.. +.+++..++.++.|++.|+.|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 77 VTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred EEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 9999999999999864 56899999999999999999999999999999999999999999999999998754321111
Q ss_pred cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhHHHHHH
Q 013005 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPARSLIY 263 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~ 263 (451)
......++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...+.......+... ....|...+..+.+++.
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRF-SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMY 235 (256)
T ss_pred ccCCCCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence 1111223457999999877666 566999999999999998 89999877766666666543 34556668999999999
Q ss_pred hccCCCCCCCCCHHHHHcC
Q 013005 264 QLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 264 ~~L~~dP~~Rpt~~eil~h 282 (451)
+||..+|++|||+.++++.
T Consensus 236 ~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 236 SCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHhcCChhhCcCHHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=333.78 Aligned_cols=250 Identities=20% Similarity=0.339 Sum_probs=207.2
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcE----EEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSI----VAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
..+|++.+.||+|+||.||+|.+..+++. ||+|++.... .......+.+|+.+++.+. ||||+++++++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~~ 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVD-NPHVCRLLGICLTS 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC---CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcCC
Confidence 46799999999999999999998766654 8999986432 2344567889999999995 99999999998764
Q ss_pred CEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 103 TKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
..++++||+.+|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 57899999999999999975 468999999999999999999999999999999999999999999999999998654
Q ss_pred hhhcC-cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHh
Q 013005 181 QIKNG-MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKP 257 (451)
Q Consensus 181 ~~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 257 (451)
..... ......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.........+... ....|...+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 239 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence 32221 1122345678999999877666 566999999999999997 99999887766554444332 23455678899
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 258 ARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 258 ~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
+.+++.+||..||.+|||+.+++.+
T Consensus 240 ~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 240 VYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=326.51 Aligned_cols=252 Identities=22% Similarity=0.329 Sum_probs=209.6
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcC-----CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIA-----DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
..++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.+. ||||+++++++.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~ 79 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC---SEQDESDFLMEALIMSKFN-HQNIVRLIGVSF 79 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEc
Confidence 34789999999999999999999877 77899999886442 2334456888999999995 999999999999
Q ss_pred eCCEEEEEEEecCCCchhHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC---CeE
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRRG--------RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG---NLK 169 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~~--------~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~---~lk 169 (451)
+....|+||||+.|++|.+++... .+++..+..++.||+.||+|||++|++||||||+||+++.++ .+|
T Consensus 80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceE
Confidence 999999999999999999998642 489999999999999999999999999999999999998765 599
Q ss_pred EEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhc-c
Q 013005 170 VSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNR-R 246 (451)
Q Consensus 170 l~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~-~ 246 (451)
|+|||++........ .......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+.. .
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~ 238 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG 238 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999875422111 11122334568999999977665 567999999999999997 9999998776666555543 2
Q ss_pred CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 247 DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 247 ~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
....|..++..+.+++.+||..||++|||+.++++|
T Consensus 239 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 239 RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 345567789999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=337.27 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=215.6
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC-----
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT----- 103 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~----- 103 (451)
+|++.+.||.|++|.||+|++..+++.||+|.+.... ........+.+|+.+++.+. ||||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~ 77 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF--DDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPEDFN 77 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc--ccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCccccc
Confidence 6899999999999999999999899999999987532 12344567889999999995 999999999987765
Q ss_pred EEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 104 KIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
..|++|||+.+ +|.+.+.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 78 ~~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 78 DVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred ceEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 79999999974 88888875 58999999999999999999999999999999999999999999999999999865432
Q ss_pred hc--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC------------
Q 013005 183 KN--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY------------ 248 (451)
Q Consensus 183 ~~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~------------ 248 (451)
.. .......+|+.|+|||.+.+....+.++||||+|+++|+|++|..||...+....+..+.....
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 21 2234456899999999998774557779999999999999999999988776655554432100
Q ss_pred -------------------CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 249 -------------------QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 249 -------------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
...+.++..+.++|.+||..||.+|||+++++.||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 01123578899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=324.11 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=204.2
Q ss_pred eEEcceEcccCceEEEEEEEcCCCc--EEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe------
Q 013005 30 YQLGPLLGRGSFAKVHKAKSIADGS--IVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT------ 101 (451)
Q Consensus 30 y~~~~~LG~G~~g~Vy~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~------ 101 (451)
+.+++.||+|+||.||+|.+..++. .+|+|.+.... ......+.+.+|+.+++.++ ||||+++++++..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 77 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI--CTRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEG 77 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc--CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccC
Confidence 3578899999999999999877765 69999986542 23344567889999999995 9999999997642
Q ss_pred CCEEEEEEEecCCCchhHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEecc
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR-------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFG 174 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~-------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFG 174 (451)
....+++|||+.+|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCC
Confidence 2357899999999999887731 348899999999999999999999999999999999999999999999999
Q ss_pred CCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhccC-CCCC
Q 013005 175 LSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRD-YQFP 251 (451)
Q Consensus 175 ls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p 251 (451)
++........ .......+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||........+..+.... ...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQP 236 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 9875432211 11123346778999999877655 567999999999999999 899998877777766666543 3456
Q ss_pred CCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 252 SFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 252 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
..++..+.++|.+||..||++|||+++|+++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 237 PDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 6788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=338.64 Aligned_cols=256 Identities=23% Similarity=0.392 Sum_probs=205.8
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcC-----CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEE
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIA-----DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQE 97 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~ 97 (451)
+....++|++.+.||+|+||.||+|.... +++.||+|++.... .......+.+|+.+++++.+||||+++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~~~~l~~h~niv~~~~ 78 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA---TASEYKALMTELKILIHIGHHLNVVNLLG 78 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC---CHHHHHHHHHHHHHHHhhccCcchhheee
Confidence 45566799999999999999999997543 45789999986532 22334567889999999966999999999
Q ss_pred EEEe-CCEEEEEEEecCCCchhHHhhc-----------------------------------------------------
Q 013005 98 VMAT-KTKIYLVMEYAAGGELFGKLRR----------------------------------------------------- 123 (451)
Q Consensus 98 ~~~~-~~~~~lV~E~~~gg~L~~~l~~----------------------------------------------------- 123 (451)
++.. ...+|++|||+++++|.+++..
T Consensus 79 ~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (337)
T cd05054 79 ACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEE 158 (337)
T ss_pred eEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhccc
Confidence 8764 4678999999999999988742
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc-CcccccCCC
Q 013005 124 ---------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGT 193 (451)
Q Consensus 124 ---------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt 193 (451)
..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++........ .......++
T Consensus 159 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 159 DEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred chhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 2578999999999999999999999999999999999999999999999999975422111 112234567
Q ss_pred CccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHH-HHHHhhcc-CCCCCCCCCHhHHHHHHhccCCCC
Q 013005 194 PAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLA-MYKKVNRR-DYQFPSFVSKPARSLIYQLLDPNP 270 (451)
Q Consensus 194 ~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP 270 (451)
..|+|||++.+..+ +.++|||||||++|+|++ |..||......+ ....+... ....|...++.+.+++.+||+.+|
T Consensus 239 ~~y~aPE~~~~~~~-~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p 317 (337)
T cd05054 239 LKWMAPESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNP 317 (337)
T ss_pred ccccCcHHhcCCCC-CccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCCh
Confidence 78999999988776 456999999999999998 999997644332 22333222 234456678999999999999999
Q ss_pred CCCCCHHHHHcC
Q 013005 271 KTRMSIEKIMSI 282 (451)
Q Consensus 271 ~~Rpt~~eil~h 282 (451)
++|||++++++|
T Consensus 318 ~~RPs~~ell~~ 329 (337)
T cd05054 318 EDRPTFSELVEI 329 (337)
T ss_pred hhCcCHHHHHHH
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=324.04 Aligned_cols=251 Identities=30% Similarity=0.573 Sum_probs=209.4
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
+++|++.+.||+|+||.||+|++..++..+|||.+.... ..+......+.+|+.+++.+. ||||+++++++...+..+
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~ 78 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFD-LMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELN 78 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehh-hhhHHHHHHHHHHHHHHHHcc-CCchhhhhheeEeCCeEE
Confidence 368999999999999999999999999999999887542 223344567889999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 107 LVMEYAAGGELFGKLRR-----GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~-----~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
++|||+.|++|.+++.. ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999998752 4689999999999999999999999999999999999999999999999999875433
Q ss_pred hhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcH--HHHHHHhhccCC-CC-CCCCCHh
Q 013005 182 IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNL--LAMYKKVNRRDY-QF-PSFVSKP 257 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~--~~~~~~i~~~~~-~~-p~~~s~~ 257 (451)
.. ......+|++.|+|||.+.+..+ +.++|+||||+++|+|++|..||..... ......+..... .. +..++..
T Consensus 159 ~~-~~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08229 159 KT-TAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 236 (267)
T ss_pred CC-cccccccCCcCccCHHHhcCCCc-cchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHH
Confidence 21 22345678999999999877665 4669999999999999999999975433 233344433222 12 2357889
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHc
Q 013005 258 ARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 258 ~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+.+++.+||..||++|||+.+|++
T Consensus 237 ~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 237 LRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHhcCCCcccCCCHHHHHH
Confidence 999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=329.65 Aligned_cols=250 Identities=27% Similarity=0.453 Sum_probs=212.5
Q ss_pred cceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEec
Q 013005 33 GPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYA 112 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~ 112 (451)
...||+|+||.||++.+..+++.||+|.+.... ......+.+|+.+++.+. ||||+++++.+...+..|+||||+
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK----QQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc----hhHHHHHHHHHHHHHhcC-CcchhheeeEEEeCCEEEEEEecC
Confidence 467999999999999999999999999985431 234567889999999995 999999999999999999999999
Q ss_pred CCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCC
Q 013005 113 AGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACG 192 (451)
Q Consensus 113 ~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~g 192 (451)
++++|.+++..+++++..++.++.|++.||+|||++|++||||+|+||+++.++.++|+|||++....... ......+|
T Consensus 100 ~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~ 178 (292)
T cd06657 100 EGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVG 178 (292)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccccc
Confidence 99999999888889999999999999999999999999999999999999999999999999876432211 12234568
Q ss_pred CCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc---CCCCCCCCCHhHHHHHHhccCCC
Q 013005 193 TPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR---DYQFPSFVSKPARSLIYQLLDPN 269 (451)
Q Consensus 193 t~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~~~L~~d 269 (451)
++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...........+... .......++..+.+++.+||..|
T Consensus 179 ~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 257 (292)
T cd06657 179 TPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257 (292)
T ss_pred CccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCC
Confidence 999999998876555 56799999999999999999999877665554444322 12223457889999999999999
Q ss_pred CCCCCCHHHHHcCccccchh
Q 013005 270 PKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 270 P~~Rpt~~eil~hp~f~~~~ 289 (451)
|.+||++.+++.||||.+..
T Consensus 258 P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 258 PAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred cccCcCHHHHhcChHHhccC
Confidence 99999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=319.06 Aligned_cols=244 Identities=24% Similarity=0.421 Sum_probs=210.9
Q ss_pred ceEcccCceEEEEEEEcCC---CcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEE
Q 013005 34 PLLGRGSFAKVHKAKSIAD---GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVME 110 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E 110 (451)
+.||+|+||.||+|.+... +..||+|.+..... ....+.+.+|+..++.+. |+||+++++++......+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e 76 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS---EEERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLE 76 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc---hhHHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEE
Confidence 4689999999999998765 89999999976532 224678899999999996 9999999999999999999999
Q ss_pred ecCCCchhHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 111 YAAGGELFGKLRR----------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 111 ~~~gg~L~~~l~~----------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
|+++++|.+++.. ..+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||.+....
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 9999999999974 568999999999999999999999999999999999999999999999999997654
Q ss_pred hhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHh
Q 013005 181 QIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKP 257 (451)
Q Consensus 181 ~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 257 (451)
.... .......+++.|+|||.+....+ +.++||||||+++|+|++ |..||...........+... ....|..++..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDE 235 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChH
Confidence 3221 22334567899999999877655 567999999999999999 69999988877777776643 34567778999
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 258 ARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 258 ~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
+.+++.+||..||++|||+++++++
T Consensus 236 ~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 236 LYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHh
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=319.51 Aligned_cols=251 Identities=30% Similarity=0.592 Sum_probs=210.1
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+.... ..+....+.+.+|+.+++++. |+||+++++.+......+
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~~~~~~~~~ 78 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFE-MMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFIENNELN 78 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccc-ccchhhHHHHHHHHHHHHhCC-CCCeeeeeeeeecCCeEE
Confidence 368999999999999999999998899999999987542 223344667899999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 107 LVMEYAAGGELFGKLRR-----GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~-----~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
+||||+++++|..++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999988852 4589999999999999999999999999999999999999999999999999865432
Q ss_pred hhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCc--HHHHHHHhhccCC-CCCC-CCCHh
Q 013005 182 IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN--LLAMYKKVNRRDY-QFPS-FVSKP 257 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~--~~~~~~~i~~~~~-~~p~-~~s~~ 257 (451)
. ........|++.|+|||.+.+..+ +.++||||+||++|+|++|..||.... .......+..... ..|. .++..
T Consensus 159 ~-~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08224 159 K-TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE 236 (267)
T ss_pred C-CcccceecCCccccCHHHhccCCC-CchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHH
Confidence 1 122334578999999999877666 456999999999999999999996543 2334444433322 2343 57889
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHc
Q 013005 258 ARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 258 ~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+.++|.+||..+|++|||+.+|++
T Consensus 237 ~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 237 LRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHH
Confidence 999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=320.66 Aligned_cols=248 Identities=23% Similarity=0.347 Sum_probs=207.6
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
..++|++.+.||+|++|.||+|.+. +++.||+|.+..... ..+.+.+|+.+++++. ||||+++++++...+..
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 76 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM-----DPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEPI 76 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc-----cHHHHHHHHHHHHHCC-CCCccceeEEEecCCCe
Confidence 4567999999999999999999864 557899999865421 2356788999999996 99999999999999999
Q ss_pred EEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 106 YLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
|++|||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 999999999999999975 25999999999999999999999999999999999999999999999999998754321
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhHHH
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPARS 260 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 260 (451)
.........++..|+|||.+.+..+ +.++||||||+++|+|++ |+.||...+.......+... ....+...+..+.+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYD 235 (261)
T ss_pred cccccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 1111111223457999999876655 566999999999999999 99999887777666666543 23445667899999
Q ss_pred HHHhccCCCCCCCCCHHHHHc
Q 013005 261 LIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 261 li~~~L~~dP~~Rpt~~eil~ 281 (451)
++.+||..+|++||+++++.+
T Consensus 236 li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 236 IMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHhhcCcccCCCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=323.73 Aligned_cols=249 Identities=22% Similarity=0.386 Sum_probs=211.7
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
....+|++.+.||.|+||.||+|.+.. +..+|+|++.... ......+.+|+.+++.++ ||||+++++++.....
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 76 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD----LLKQQDFQKEVQALKRLR-HKHLISLFAVCSVGEP 76 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc----hhhHHHHHHHHHHHhcCC-CcchhheeeeEecCCC
Confidence 345679999999999999999999876 8999999987652 223456889999999995 9999999999999999
Q ss_pred EEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 105 IYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
.|+||||+++++|.+++.+ ..+++..++.++.||+.||.|||++|++||||||+||++++++.+||+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 9999999999999999974 4689999999999999999999999999999999999999999999999999875432
Q ss_pred hhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhHH
Q 013005 182 IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPAR 259 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 259 (451)
.. .......+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...+....+..+... ....+...++.+.
T Consensus 157 ~~-~~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (261)
T cd05148 157 DV-YLSSDKKIPYKWTAPEAASHGTF-STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIY 234 (261)
T ss_pred cc-ccccCCCCceEecCHHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHH
Confidence 11 11123346778999999877655 566999999999999998 89999887776666666543 3345667899999
Q ss_pred HHHHhccCCCCCCCCCHHHHHc
Q 013005 260 SLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 260 ~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+++.+||..||++|||+.+|++
T Consensus 235 ~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 235 KIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHcCCCchhCcCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=328.88 Aligned_cols=257 Identities=24% Similarity=0.365 Sum_probs=211.8
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEc-----CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEE
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSI-----ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l 95 (451)
.+++...++|.+.+.||+|+||.||+|.+. .++..||+|.+.... .....+.+.+|+.+++++.+||||+++
T Consensus 28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~ 104 (302)
T cd05055 28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA---HSSEREALMSELKIMSHLGNHENIVNL 104 (302)
T ss_pred ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC---ChHHHHHHHHHHHHHHhccCCCCcceE
Confidence 456777889999999999999999999752 345689999987542 223456788999999999669999999
Q ss_pred EEEEEeCCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEe
Q 013005 96 QEVMATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSD 172 (451)
Q Consensus 96 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~D 172 (451)
++.+...+..|++|||+.+|+|.+++.. ..+++.++..++.|++.||.|||++|++|+||||+|||++.++.++|+|
T Consensus 105 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~d 184 (302)
T cd05055 105 LGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICD 184 (302)
T ss_pred EEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECC
Confidence 9999999999999999999999999864 2389999999999999999999999999999999999999999999999
Q ss_pred ccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc--CC
Q 013005 173 FGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR--DY 248 (451)
Q Consensus 173 FGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~--~~ 248 (451)
||++........ .......+++.|+|||.+....+ +.++||||+||++|+|++ |..||...+......+.... ..
T Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 263 (302)
T cd05055 185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM 263 (302)
T ss_pred CcccccccCCCceeecCCCCcccccCCHhhhccCCC-CcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC
Confidence 999875432211 11223346788999999877665 567999999999999998 99999876655444333322 22
Q ss_pred CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 249 QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 249 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
..+...++.+.+++.+||.++|++|||+.++++
T Consensus 264 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 264 AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 345567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=314.85 Aligned_cols=248 Identities=31% Similarity=0.524 Sum_probs=211.9
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
+|++.+.||+|++|.||++.+..+++.+++|++..... .....+.+|+.+++++. ||||+++++++......+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEEEE
Confidence 48899999999999999999988999999999976521 34567889999999996 99999999999999999999
Q ss_pred EEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCc
Q 013005 109 MEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM 186 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~ 186 (451)
+||++|++|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+........
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999999999875 4799999999999999999999999999999999999999999999999999875543221
Q ss_pred ccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc-CCCCCC--CCCHhHHHHHH
Q 013005 187 LHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR-DYQFPS--FVSKPARSLIY 263 (451)
Q Consensus 187 ~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~-~~~~p~--~~s~~~~~li~ 263 (451)
.....|+..|+|||.+.... .+.++|+||+|+++|+|++|..||...+........... ....+. .++..+.++|.
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 232 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLK 232 (253)
T ss_pred ccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHH
Confidence 34567899999999987655 466799999999999999999999877444333333322 222222 24889999999
Q ss_pred hccCCCCCCCCCHHHHHcCcc
Q 013005 264 QLLDPNPKTRMSIEKIMSISW 284 (451)
Q Consensus 264 ~~L~~dP~~Rpt~~eil~hp~ 284 (451)
+||..||++|||+.++++|||
T Consensus 233 ~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 233 KCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHccCChhhCCCHHHHhcCCC
Confidence 999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=327.59 Aligned_cols=251 Identities=22% Similarity=0.347 Sum_probs=211.5
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCC-----CcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIAD-----GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
..+|++.+.||+|+||.||+|.+..+ +..||+|++.... .....+.+.+|+.++..++ ||||+++++++..
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~ 79 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVTK 79 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcC
Confidence 45688999999999999999987543 5789999997542 2344567889999999995 9999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR-----------------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR 164 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~-----------------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~ 164 (451)
....++++||+.+++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||++++
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 9999999999999999988742 34788899999999999999999999999999999999999
Q ss_pred CCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHH
Q 013005 165 DGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKK 242 (451)
Q Consensus 165 ~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~ 242 (451)
++.+||+|||++........ .......+++.|+|||.+....+ +.++||||+||++|+|++ |..||.+.........
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999875432211 22334456789999999876655 566999999999999998 8999988877777777
Q ss_pred hhccCC-CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 243 VNRRDY-QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 243 i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
+..... ..|..++..+.+|+.+||+.+|.+||++.+|+..
T Consensus 239 i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 239 IRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 766543 4566789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=331.51 Aligned_cols=255 Identities=26% Similarity=0.470 Sum_probs=204.4
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC----
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK---- 102 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~---- 102 (451)
.++|++.+.||+|+||.||+|.+..+++.+|+|.+..... .......+.+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE--KDGFPITALREIKILKKLK-HPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC--CCCcchhHHHHHHHHHhcC-CCCccchhhheecccccc
Confidence 6899999999999999999999999999999999865421 1112235678999999995 99999999987443
Q ss_pred ----CEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCC
Q 013005 103 ----TKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176 (451)
Q Consensus 103 ----~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls 176 (451)
..+|+|+||+.+ +|...+.. ..+++..++.++.|+++||.|||++|++||||||+||++++++.++|+|||++
T Consensus 84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 357999999975 66666653 57999999999999999999999999999999999999999999999999998
Q ss_pred CcchhhhcC----------cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc
Q 013005 177 ALPEQIKNG----------MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR 246 (451)
Q Consensus 177 ~~~~~~~~~----------~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~ 246 (451)
......... ......|++.|+|||.+.+....+.++||||+||++|+|++|+.||.+.+.......+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 754322111 1123357889999998876554567799999999999999999999887765544433211
Q ss_pred C-----------------------CCCC-------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 247 D-----------------------YQFP-------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 247 ~-----------------------~~~p-------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
. ...+ ...++.+.++|.+||..||.+|||+.+++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0 0001 1234678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=328.91 Aligned_cols=256 Identities=23% Similarity=0.394 Sum_probs=211.9
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEcC-------CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceE
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIA-------DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~ 94 (451)
.+....++|.+++.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++++.+||||++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA---TDKDLADLISEMELMKLIGKHKNIIN 82 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC---ChHHHHHHHHHHHHHHhccCCCCeee
Confidence 345556899999999999999999998642 34579999987532 22345668899999999966999999
Q ss_pred EEEEEEeCCEEEEEEEecCCCchhHHhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 013005 95 IQEVMATKTKIYLVMEYAAGGELFGKLRR-----------------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKP 157 (451)
Q Consensus 95 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-----------------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKp 157 (451)
+++++......|++|||+.+|+|.+++.. ..+++.++..++.||+.||.|||++|++||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 162 (314)
T cd05099 83 LLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAA 162 (314)
T ss_pred EEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 99999999999999999999999998853 2478899999999999999999999999999999
Q ss_pred CeEEeCCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCc
Q 013005 158 QNLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSN 235 (451)
Q Consensus 158 eNILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~ 235 (451)
+|||++.++.+||+|||++........ .......+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...+
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999975432211 11222334568999999877655 567999999999999999 999998887
Q ss_pred HHHHHHHhhccC-CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 236 LLAMYKKVNRRD-YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 236 ~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
....+..+.... ...|..++..+.+++.+||..||++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 242 VEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 777776665543 3456678889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=331.83 Aligned_cols=257 Identities=26% Similarity=0.459 Sum_probs=211.5
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe-CC
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT-KT 103 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~-~~ 103 (451)
...++|++.+.||.|+||.||+|.+..+++.||+|.+.+... .......+.+|+.+++.+. ||||+++++++.. ..
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 83 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS--TPVLAKRTYRELKLLKHLR-HENIISLSDIFISPLE 83 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc--ccchhHHHHHHHHHHHhcC-CCCeeeEeeeEecCCC
Confidence 457899999999999999999999999999999999865421 2234466788999999995 9999999999865 56
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 104 KIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
..|+++||+ +++|..++..+.+++..+..++.|++.||.|||++||+||||+|.||+++.++.++|+|||++.....
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~-- 160 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP-- 160 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--
Confidence 799999998 56898888888899999999999999999999999999999999999999999999999999874321
Q ss_pred cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhc------------------
Q 013005 184 NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNR------------------ 245 (451)
Q Consensus 184 ~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~------------------ 245 (451)
......+++.|+|||.+.+....+.++||||+|+++|+|++|..||...+....+..+..
T Consensus 161 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 161 --QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred --CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence 223456789999999987644456789999999999999999999977654322211110
Q ss_pred --------cCCCCC-----CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 246 --------RDYQFP-----SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 246 --------~~~~~p-----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
.....| +.++..+.++|.+||..+|++|||+++++.||||....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 000111 24678899999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=324.94 Aligned_cols=257 Identities=27% Similarity=0.482 Sum_probs=219.3
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
....+.|++...||+|++|.||+|.+..++..|++|+++.... ..+.+.+|+..++.+. ||||+++++.+....
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 88 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCK-HPNIVDYYDSYLVGD 88 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCC-CCCeeEEEEEEEECC
Confidence 4567789999999999999999999988899999999976532 4567889999999995 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 104 KIYLVMEYAAGGELFGKLRRG--RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~~--~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
..|+++||++|++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 89 ELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 999999999999999999864 799999999999999999999999999999999999999999999999998764332
Q ss_pred hhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC-C--CCCCCCHhH
Q 013005 182 IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY-Q--FPSFVSKPA 258 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~-~--~p~~~s~~~ 258 (451)
.. .......+++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+..... . .+..++..+
T Consensus 169 ~~-~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (286)
T cd06614 169 EK-SKRNSVVGTPYWMAPEVIKRKDY-GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEF 246 (286)
T ss_pred ch-hhhccccCCcccCCHhHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHH
Confidence 11 12234457899999999877665 5679999999999999999999988766554444433222 2 223378899
Q ss_pred HHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 259 RSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 259 ~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.++|.+||..+|.+|||+.+++.||||.+.
T Consensus 247 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 247 KDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred HHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=334.67 Aligned_cols=262 Identities=28% Similarity=0.399 Sum_probs=212.3
Q ss_pred cccCCeEE-cceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhH----------HHHHHHHHHHHHHHHhcCCCCce
Q 013005 25 TLLNRYQL-GPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDA----------AMEDRIVREVSAMRRLQNHPNVL 93 (451)
Q Consensus 25 ~~~~~y~~-~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~----------~~~~~~~~Ei~il~~L~~HpnIv 93 (451)
.+.++|.. .+.||+|+||+||+|.+..+++.||+|++......... .....+.+|+.+++.+. ||||+
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv 83 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HENIM 83 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Cccee
Confidence 45678864 57799999999999999999999999998654221100 01124778999999995 99999
Q ss_pred EEEEEEEeCCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEe
Q 013005 94 KIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSD 172 (451)
Q Consensus 94 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~D 172 (451)
++++++......|+||||+. |+|.+++.. ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 84 GLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred eeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECC
Confidence 99999999999999999997 588888864 6799999999999999999999999999999999999999999999999
Q ss_pred ccCCCcchhh-------------hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHH
Q 013005 173 FGLSALPEQI-------------KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAM 239 (451)
Q Consensus 173 FGls~~~~~~-------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~ 239 (451)
||++...... .........+++.|+|||.+.+....+.++|||||||++|+|++|..||...+....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~ 242 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ 242 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9998754310 111223445788999999987665557789999999999999999999988776554
Q ss_pred HHHhhcc---C--C-----------------------CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 240 YKKVNRR---D--Y-----------------------QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 240 ~~~i~~~---~--~-----------------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+..+... . . ......+..+.++|.+||..+|++|||+++++.||||+..
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 4433210 0 0 0012357789999999999999999999999999999864
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=321.87 Aligned_cols=249 Identities=22% Similarity=0.366 Sum_probs=205.5
Q ss_pred eEEcceEcccCceEEEEEEEcC---CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE--
Q 013005 30 YQLGPLLGRGSFAKVHKAKSIA---DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK-- 104 (451)
Q Consensus 30 y~~~~~LG~G~~g~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~-- 104 (451)
|.+++.||+|+||.||+|.... ++..||+|.+..... .....+.+.+|+..++.+. ||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 77 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH--TYSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQ 77 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccCCccc
Confidence 5788999999999999998754 347899999875422 2344567899999999995 9999999998865543
Q ss_pred ----EEEEEEecCCCchhHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEec
Q 013005 105 ----IYLVMEYAAGGELFGKLRR-------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDF 173 (451)
Q Consensus 105 ----~~lV~E~~~gg~L~~~l~~-------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DF 173 (451)
.++++||+.+|+|..++.. ..+++..++.++.|++.||.|||++|++||||||+||++++++.+||+||
T Consensus 78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCc
Confidence 8999999999999888742 35899999999999999999999999999999999999999999999999
Q ss_pred cCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCC
Q 013005 174 GLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQF 250 (451)
Q Consensus 174 Gls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~ 250 (451)
|++........ .......++..|+|||.+.+..+ +.++||||+||++|+|++ |..||.+.+....+..+... ....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQ 236 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99875432211 11222345678999999876655 567999999999999999 99999887776666665543 4456
Q ss_pred CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 251 PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 251 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
|..++..+.+++.+||..||++|||+.+++++
T Consensus 237 ~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 237 PEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=321.72 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=206.4
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
...++|++.+.||+|+||.||+|.+. ++..+|+|.+..... ..+.+.+|+.+++++. ||||+++++++. ...
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~-~~~ 74 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-----SPESFLEEAQIMKKLR-HDKLVQLYAVVS-EEP 74 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-----CHHHHHHHHHHHHhcC-CCceEEEEeEEC-CCC
Confidence 45678999999999999999999864 567799999875422 1246889999999995 999999999875 456
Q ss_pred EEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 105 IYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
.|++|||+.+++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||++++++.++|+|||++.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 8999999999999999864 3589999999999999999999999999999999999999999999999999875433
Q ss_pred hhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhHH
Q 013005 182 IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPAR 259 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 259 (451)
..........++..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.+.......+... ..+.+...+..+.
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLH 233 (260)
T ss_pred cccccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 22222222345668999998866555 567999999999999999 99999887776666666543 3445667889999
Q ss_pred HHHHhccCCCCCCCCCHHHHHc
Q 013005 260 SLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 260 ~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+|+.+||.+||++|||++++.+
T Consensus 234 ~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 234 ELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHH
Confidence 9999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=321.40 Aligned_cols=248 Identities=25% Similarity=0.394 Sum_probs=206.6
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
.++|++.+.||+|+||.||+|.+. .+..+|+|.+..... ..+.+.+|+.+++++. ||||+++++++......|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~-----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-----SEDEFIEEAKVMMKLS-HEKLVQLYGVCTKQRPIY 75 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc-----cHHHHHHHHHHHhcCC-CCCeeeEEEEEccCCCcE
Confidence 457999999999999999999864 455699999865421 2356889999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 107 LVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
++|||+.+|+|.+++.. ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++........
T Consensus 76 lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 76 IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 99999999999999864 4689999999999999999999999999999999999999999999999999875432211
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhccCC-CCCCCCCHhHHHHH
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRDY-QFPSFVSKPARSLI 262 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li 262 (451)
.......++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...+.......+..... ..+...+..+.+++
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 234 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKF-SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIM 234 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 11112235678999999876655 567999999999999998 9999988777666666655433 33555789999999
Q ss_pred HhccCCCCCCCCCHHHHHcC
Q 013005 263 YQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 263 ~~~L~~dP~~Rpt~~eil~h 282 (451)
.+||..||.+|||+.+|+.+
T Consensus 235 ~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 235 YSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHcCCCcccCCCHHHHHHh
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=321.59 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=206.1
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
...++|++.+.||+|+||.||+|.+..+ ..||+|.+..... ..+.+.+|+.+++.+. ||||+++++++. ...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~-~~~ 74 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-----SPEAFLQEAQVMKKLR-HEKLVQLYAVVS-EEP 74 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-----CHHHHHHHHHHHHhCC-CCCcceEEEEEC-CCC
Confidence 3457899999999999999999988655 4699999975421 1246889999999995 999999999875 456
Q ss_pred EEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 105 IYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
.|+||||+.+|+|.+++.+ ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 8999999999999999974 3589999999999999999999999999999999999999999999999999875433
Q ss_pred hhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhHH
Q 013005 182 IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPAR 259 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 259 (451)
..........++..|+|||.+.+..+ +.++||||+|+++|+|++ |..||........+..+... ....+..++..+.
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 233 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH 233 (262)
T ss_pred cccccccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHH
Confidence 22222233456778999998876665 566999999999999999 89999887766666655443 2344566889999
Q ss_pred HHHHhccCCCCCCCCCHHHHHc
Q 013005 260 SLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 260 ~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+++.+||..||++|||++++++
T Consensus 234 ~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 234 DLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHccCCcccCCCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=327.15 Aligned_cols=256 Identities=21% Similarity=0.374 Sum_probs=213.4
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEc-------CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEE
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSI-------ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l 95 (451)
+....++|.+.+.||+|+||.||+|+.. .++..||+|.+.... .......+.+|+.+++.+.+||||+++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~ 86 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINL 86 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc---chHHHHHHHHHHHHHHhhccCCCchhe
Confidence 4567889999999999999999999753 234579999986431 233456788999999999669999999
Q ss_pred EEEEEeCCEEEEEEEecCCCchhHHhhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 013005 96 QEVMATKTKIYLVMEYAAGGELFGKLRRG-----------------RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQ 158 (451)
Q Consensus 96 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-----------------~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpe 158 (451)
++++......|++|||+.+|+|.+++.+. .++..++..++.|++.||.|||++|++||||||+
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 99999999999999999999999998642 3678889999999999999999999999999999
Q ss_pred eEEeCCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcH
Q 013005 159 NLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNL 236 (451)
Q Consensus 159 NILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~ 236 (451)
||+++.++.+||+|||++........ .......+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 99999999999999999875432211 11223456778999999877665 566999999999999998 8999998888
Q ss_pred HHHHHHhhccC-CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 237 LAMYKKVNRRD-YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 237 ~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
......+.... ...+..++..+.+|+.+||..+|++|||+.++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 246 EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 77777765443 34456688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=333.49 Aligned_cols=255 Identities=20% Similarity=0.304 Sum_probs=202.6
Q ss_pred ceEccc--CceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEe
Q 013005 34 PLLGRG--SFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEY 111 (451)
Q Consensus 34 ~~LG~G--~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~ 111 (451)
..||.| +||+||+|.+..+|+.||+|++..... .....+.+.+|+.+++.+. ||||+++++++...+..|+|+||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~~v~e~ 80 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC--TEEHLKALQNEVVLSHFFR-HPNIMTSWTVFTTGSWLWVISPF 80 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCcceEeeeEecCCceEEEEec
Confidence 356666 999999999999999999999876422 2344578899999998885 99999999999999999999999
Q ss_pred cCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc--C-
Q 013005 112 AAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN--G- 185 (451)
Q Consensus 112 ~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~--~- 185 (451)
+.+++|.+++.+ ..+++..++.++.|++.||+|||++|++||||||+|||++.++.++++||+.+........ .
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 999999998874 3589999999999999999999999999999999999999999999999986532211100 0
Q ss_pred ---cccccCCCCccccceeeeccC-CCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC-------------
Q 013005 186 ---MLHTACGTPAYTAPEVVARRG-YDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY------------- 248 (451)
Q Consensus 186 ---~~~~~~gt~~y~APEvl~~~~-~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~------------- 248 (451)
......++..|+|||++.+.. ..+.++||||+||++|+|++|..||.................
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 011123567799999987642 235779999999999999999999987654433322221110
Q ss_pred ----------------------------------CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchhHH
Q 013005 249 ----------------------------------QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQ 291 (451)
Q Consensus 249 ----------------------------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~~ 291 (451)
..+..+++.+.+||++||..||++|||++++++||||....+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 0112256778999999999999999999999999999876543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=350.88 Aligned_cols=248 Identities=31% Similarity=0.523 Sum_probs=213.7
Q ss_pred eEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecCC
Q 013005 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAG 114 (451)
Q Consensus 35 ~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~g 114 (451)
.||+|.||+||.|+|..|...+|||-+...+ ....+-+..||...+.|+ |.|||++.|.+..++.+-|+||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd----sr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD----SREVQPLHEEIALHSTLR-HKNIVRYLGSVSENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc----chhhccHHHHHHHHHHHh-hHhHHHHhhccCCCCeEEEEeecCCC
Confidence 5999999999999999999999999996542 233455778999999997 99999999999999999999999999
Q ss_pred CchhHHhhc--CCC--CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC-CCCeEEEeccCCCcchhhhcCcccc
Q 013005 115 GELFGKLRR--GRL--TESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR-DGNLKVSDFGLSALPEQIKNGMLHT 189 (451)
Q Consensus 115 g~L~~~l~~--~~l--~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~-~~~lkl~DFGls~~~~~~~~~~~~~ 189 (451)
|+|.++++. |++ +|..+-.|.+||++||.|||++.|+|||||-+|+|++. .|.+||+|||-+...-.. +....+
T Consensus 657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TET 735 (1226)
T KOG4279|consen 657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTET 735 (1226)
T ss_pred CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC-Cccccc
Confidence 999999986 777 89999999999999999999999999999999999964 689999999998643322 344567
Q ss_pred cCCCCccccceeeecc--CCCCccchhhhhhHHHHHHHhcCCCCCC--CcHHHHHHH-hhccCCCCCCCCCHhHHHHHHh
Q 013005 190 ACGTPAYTAPEVVARR--GYDGAVADAWSCGVILFVLLAGYLPFDD--SNLLAMYKK-VNRRDYQFPSFVSKPARSLIYQ 264 (451)
Q Consensus 190 ~~gt~~y~APEvl~~~--~~~~~~sDIwSlGvil~~Ll~G~~Pf~~--~~~~~~~~~-i~~~~~~~p~~~s~~~~~li~~ 264 (451)
.-||..|||||++... +| ++++|||||||++.||.||++||.. .....+++- ..+...++|..++.+++.||.+
T Consensus 736 FTGTLQYMAPEvIDqG~RGY-G~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filr 814 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGY-GKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILR 814 (1226)
T ss_pred cccchhhhChHhhccCCcCC-CchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHH
Confidence 7899999999999643 45 6779999999999999999999975 333444442 2334567888899999999999
Q ss_pred ccCCCCCCCCCHHHHHcCccccchh
Q 013005 265 LLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 265 ~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
|+.+||..||++.++|.+||++...
T Consensus 815 cFepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 815 CFEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred HcCCCcccCccHHHhccCcccccCC
Confidence 9999999999999999999998763
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=317.13 Aligned_cols=250 Identities=30% Similarity=0.511 Sum_probs=217.3
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
+|++.+.||+|+||.||++.+..+++.+|+|.+..... .......+.+|+.+++.++ ||||+++++++.+....|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM--SQKEREDAVNEIRILASVN-HPNIISYKEAFLDGNKLCIV 77 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc--cHHHHHHHHHHHHHHHhCC-CCCchhhhhhhccCCEEEEE
Confidence 58999999999999999999999999999999976421 2334556778999999996 99999999999999999999
Q ss_pred EEecCCCchhHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 109 MEYAAGGELFGKLRR-----GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~-----~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
+||+++++|.+++.+ ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999998865 56899999999999999999999999999999999999999999999999998765432
Q ss_pred cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC-CCCCCCCHhHHHHH
Q 013005 184 NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY-QFPSFVSKPARSLI 262 (451)
Q Consensus 184 ~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li 262 (451)
......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|+.||...+.......+....+ ..+...+.++.+++
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 233 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPY-SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFI 233 (256)
T ss_pred --CcccccCCccccCHHHHCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHH
Confidence 3344678999999999877665 4569999999999999999999998887766666555443 34456789999999
Q ss_pred HhccCCCCCCCCCHHHHHcCccc
Q 013005 263 YQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 263 ~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
.+||..+|++|||+.++++||+.
T Consensus 234 ~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 234 RSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHcCCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=325.45 Aligned_cols=251 Identities=31% Similarity=0.525 Sum_probs=209.9
Q ss_pred eEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEE
Q 013005 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVM 109 (451)
Q Consensus 30 y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~ 109 (451)
|++.+.||+|++|.||+|.+..+++.+++|.+..... .......+.+|+.+++++. ||||+++++++......|+|+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~ 77 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE--SEGIPKTALREIKLLKELN-HPNIIKLLDVFRHKGDLYLVF 77 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc--cchhHHHHHHHHHHHHHhc-CCCcchHHHhhccCCCEEEEE
Confidence 6778899999999999999988999999999876422 2234567888999999996 999999999999999999999
Q ss_pred EecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcc
Q 013005 110 EYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML 187 (451)
Q Consensus 110 E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~ 187 (451)
||+.+ +|.+.+.. +.+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||.+....... ...
T Consensus 78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~ 155 (283)
T cd05118 78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPY 155 (283)
T ss_pred eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccc
Confidence 99976 88877764 589999999999999999999999999999999999999999999999999987543322 123
Q ss_pred cccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc-------------------CC
Q 013005 188 HTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR-------------------DY 248 (451)
Q Consensus 188 ~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~-------------------~~ 248 (451)
....++..|+|||.+.+....+.++|+||+|+++|+|++|+.||...+..+.+.++... ..
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence 34568889999999877645577899999999999999999999887765544433211 00
Q ss_pred CC-----------CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 249 QF-----------PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 249 ~~-----------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
.+ .+.++..+.++|.+||.+||.+||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 11 12357889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=319.47 Aligned_cols=249 Identities=24% Similarity=0.384 Sum_probs=207.3
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
....++|++.+.||+|+||.||+|.+ .+++.||+|.+..... ..+.+.+|+.+++++. ||||+++++++. .+
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~-----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~ 73 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSM-----SPEAFLAEANLMKQLQ-HPRLVRLYAVVT-QE 73 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCC-----cHHHHHHHHHHHHhcC-CcCeeeEEEEEc-cC
Confidence 35568899999999999999999985 5678899999875422 1346888999999995 999999999874 56
Q ss_pred EEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 104 KIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
..|++|||+.+++|.+++.. ..+++.++..++.|++.||+|||++|++||||||+||+++.++.++|+|||++....
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 74 PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 78999999999999998863 468999999999999999999999999999999999999999999999999987543
Q ss_pred hhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhH
Q 013005 181 QIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPA 258 (451)
Q Consensus 181 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 258 (451)
...........++..|+|||.+....+ +.++||||||+++|+|++ |+.||.+.+.......+... ....+...+..+
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T cd05067 154 DNEYTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEEL 232 (260)
T ss_pred CCCcccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHH
Confidence 221112223345678999999876655 567999999999999998 99999887776666655443 234455678899
Q ss_pred HHHHHhccCCCCCCCCCHHHHHc
Q 013005 259 RSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 259 ~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.+++.+||..||++|||++++++
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 233 YELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHccCChhhCCCHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=361.62 Aligned_cols=252 Identities=23% Similarity=0.384 Sum_probs=204.9
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
+++|++.+.||+|+||.||+|++..+++.||+|++... ........+++.+|+.+++++. ||||+++++++.+.+..|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~-l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d~~~ly 78 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIRED-LSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSDGDPVY 78 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcc-cccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEeeCCEEE
Confidence 47999999999999999999999999999999999754 2223445667899999999996 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEecc
Q 013005 107 LVMEYAAGGELFGKLRR------------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFG 174 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~------------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFG 174 (451)
++|||++||+|.+++.. ..++...+..++.||+.||+|||++||+||||||+|||++.++.++|+|||
T Consensus 79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999998853 234567788999999999999999999999999999999999999999999
Q ss_pred CCCcchhhhc-----------------CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH
Q 013005 175 LSALPEQIKN-----------------GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL 237 (451)
Q Consensus 175 ls~~~~~~~~-----------------~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~ 237 (451)
++........ ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9975421100 01123579999999999877766 56799999999999999999999875543
Q ss_pred HHHHH-hhccCCCCC--CCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 238 AMYKK-VNRRDYQFP--SFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 238 ~~~~~-i~~~~~~~p--~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
..... ......... ..+++.+.+++.+||..||++||+..+.+.
T Consensus 238 ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 238 KISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 32221 111111111 347889999999999999999987655443
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=324.63 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=208.7
Q ss_pred cCCeEEcceEcccCceEEEEEEEc-----CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSI-----ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
.++|.+.+.||+|+||.||+|.+. .++..+++|.+.... ......+.+|+.+++++. ||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 78 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT----LAARKDFQREAELLTNLQ-HEHIVKFYGVCGD 78 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc----HHHHHHHHHHHHHHhcCC-CCCcceEEEEEcc
Confidence 467999999999999999999854 345679999885432 233456889999999995 9999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR-----------------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR 164 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~-----------------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~ 164 (451)
....++||||+++++|.+++.. +.+++..++.++.||+.||+|||++|++||||||+|||++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 9999999999999999999853 23789999999999999999999999999999999999999
Q ss_pred CCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHH
Q 013005 165 DGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKK 242 (451)
Q Consensus 165 ~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~ 242 (451)
++.++|+|||++........ .......+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||...+.......
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999874332211 12234557889999999877665 566999999999999998 9999988777776666
Q ss_pred hhccCC-CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 243 VNRRDY-QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 243 i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+..... ..+...+..+.+++.+||..||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 238 ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 655443 344557899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=334.17 Aligned_cols=255 Identities=26% Similarity=0.428 Sum_probs=207.7
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC--
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK-- 102 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~-- 102 (451)
.+.++|.+.+.||+|+||.||+|++..+++.||+|.+.+.. ........+.+|+.+++.+. ||||+++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 88 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF--QSEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAVS 88 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc--ccccchhHHHHHHHHHHhcC-CCCccchhheeccccc
Confidence 45689999999999999999999999999999999987532 12233456788999999995 99999999998654
Q ss_pred ----CEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 103 ----TKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 103 ----~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
...|+|+||+.. +|.... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..
T Consensus 89 ~~~~~~~~lv~e~~~~-~l~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 89 GDEFQDFYLVMPYMQT-DLQKIM-GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred CCCCceEEEEeccccc-CHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 356999999964 666554 34789999999999999999999999999999999999999999999999999874
Q ss_pred chhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc------------
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR------------ 246 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~------------ 246 (451)
... ......+|+.|+|||.+.+....+.++||||+||++|+|++|+.||...+....+..+...
T Consensus 167 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 167 ADA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred CCC----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 322 2234567899999999876544567799999999999999999999887654443332210
Q ss_pred -----------CCCC--------CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 247 -----------DYQF--------PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 247 -----------~~~~--------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
...+ .+..++.+.+||.+||+.||.+|||+++++.||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0001 12357789999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=318.56 Aligned_cols=242 Identities=23% Similarity=0.354 Sum_probs=202.1
Q ss_pred eEcccCceEEEEEEE--cCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEec
Q 013005 35 LLGRGSFAKVHKAKS--IADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYA 112 (451)
Q Consensus 35 ~LG~G~~g~Vy~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~ 112 (451)
.||+|+||.||+|.+ ..++..+|+|++.... .+....+.+.+|+.+++.+. ||||+++++++. ....++||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-~~~~~lv~e~~ 77 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLD-NPYIVRMIGICE-AESWMLVMELA 77 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC--CcHHHHHHHHHHHHHHHhCC-CCCcceEEEEEc-CCCcEEEEecC
Confidence 589999999999964 4678899999986542 23445677899999999995 999999999875 45679999999
Q ss_pred CCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC--cccc
Q 013005 113 AGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG--MLHT 189 (451)
Q Consensus 113 ~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~--~~~~ 189 (451)
.+|+|.+++.. +.+++..+..++.|++.||+|||++||+||||||.||+++.++.+||+|||++......... ....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 99999999865 67999999999999999999999999999999999999999999999999998754322211 1122
Q ss_pred cCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhccC-CCCCCCCCHhHHHHHHhccC
Q 013005 190 ACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRD-YQFPSFVSKPARSLIYQLLD 267 (451)
Q Consensus 190 ~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~ 267 (451)
..+++.|+|||.+....+ +.++|||||||++|+|++ |..||...+.......+.... ...|..+++++.++|.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~ 236 (257)
T cd05116 158 GKWPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWT 236 (257)
T ss_pred CCCCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhc
Confidence 344679999998865554 567999999999999998 999998877766666666543 45677789999999999999
Q ss_pred CCCCCCCCHHHHHc
Q 013005 268 PNPKTRMSIEKIMS 281 (451)
Q Consensus 268 ~dP~~Rpt~~eil~ 281 (451)
+||+.||++++|.+
T Consensus 237 ~~p~~Rp~~~~i~~ 250 (257)
T cd05116 237 YGVDERPGFAVVEL 250 (257)
T ss_pred cCchhCcCHHHHHH
Confidence 99999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=330.76 Aligned_cols=258 Identities=23% Similarity=0.374 Sum_probs=213.4
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEcCC-------CcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCce
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIAD-------GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVL 93 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv 93 (451)
..+.....+|.+++.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++++.+||||+
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv 81 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA---TDKDLSDLVSEMEMMKMIGKHKNII 81 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc---CHHHHHHHHHHHHHHHhhcCCCCee
Confidence 45566667899999999999999999986432 2379999886431 2334567889999999996699999
Q ss_pred EEEEEEEeCCEEEEEEEecCCCchhHHhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q 013005 94 KIQEVMATKTKIYLVMEYAAGGELFGKLRR-----------------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVK 156 (451)
Q Consensus 94 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-----------------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLK 156 (451)
++++++......|+++||+.+|+|.+++.+ ..++..++..++.|++.||.|||++|++|||||
T Consensus 82 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlk 161 (334)
T cd05100 82 NLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLA 161 (334)
T ss_pred eeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence 999999999999999999999999998863 136778899999999999999999999999999
Q ss_pred CCeEEeCCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCC
Q 013005 157 PQNLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDS 234 (451)
Q Consensus 157 peNILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~ 234 (451)
|+|||++.++.+||+|||++........ .......++..|+|||++.+..+ +.++||||||+++|+|++ |..||...
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred cceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCc-CchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999999875432211 11122334568999999977666 456999999999999998 89999988
Q ss_pred cHHHHHHHhhccC-CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 235 NLLAMYKKVNRRD-YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 235 ~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
+....+..+.... ...+...+..+.+++.+||..+|.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 241 PVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 8887777765543 34566678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=325.31 Aligned_cols=255 Identities=24% Similarity=0.369 Sum_probs=211.2
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
.+.|...+.||+|+||+||+|++..+++.||+|.+..... ........+.+|+.+++.++ |||++++++++.+....|
T Consensus 20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 97 (313)
T cd06633 20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKEHTAW 97 (313)
T ss_pred HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc-CchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEEE
Confidence 3446777889999999999999999999999999976522 23344557888999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 107 LVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
+||||+.| +|.+.+.. ..+++.++..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++...
T Consensus 98 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~----- 171 (313)
T cd06633 98 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS----- 171 (313)
T ss_pred EEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCccc-----
Confidence 99999964 77776653 57899999999999999999999999999999999999999999999999998632
Q ss_pred CcccccCCCCccccceeeec--cCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC-C-CCCCCCHhHHH
Q 013005 185 GMLHTACGTPAYTAPEVVAR--RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY-Q-FPSFVSKPARS 260 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~--~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~-~-~p~~~s~~~~~ 260 (451)
.......|+..|+|||.+.. .+..+.++|||||||++|+|++|..||...+.......+..... . ....++..+.+
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 251 (313)
T cd06633 172 SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRG 251 (313)
T ss_pred CCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHH
Confidence 22234578999999999853 23345679999999999999999999987765554444433322 1 12346788999
Q ss_pred HHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 261 LIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 261 li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
|+.+||..+|.+||++.+++.||||+...
T Consensus 252 li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 252 FVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred HHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 99999999999999999999999998743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=331.12 Aligned_cols=257 Identities=27% Similarity=0.416 Sum_probs=205.7
Q ss_pred CeEEcceEcccCceEEEEEEEcCC--CcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe----C
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIAD--GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT----K 102 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~----~ 102 (451)
+|++.+.||+|+||.||++.+..+ +..||+|.+.... ........+.+|+.+++++.+||||+++++.... .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 78 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF--SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF 78 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc--ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence 589999999999999999999888 8999999986431 1223345677899999999779999999987532 2
Q ss_pred CEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 103 TKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
...|+++||+. ++|.+.+.. ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 79 ~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 79 NELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred CcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 46889999986 588888864 6799999999999999999999999999999999999999999999999999875432
Q ss_pred hhc---CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc------------
Q 013005 182 IKN---GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR------------ 246 (451)
Q Consensus 182 ~~~---~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~------------ 246 (451)
... .......||+.|+|||++.+....+.++||||+||++|+|++|..||...+.......+...
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 111 12234578999999998765444467799999999999999999999876543322221110
Q ss_pred ----------------CCCC---CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 247 ----------------DYQF---PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 247 ----------------~~~~---p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
...+ .+..+..+.+|+.+||..||++|||+.+++.||||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 0011 12357889999999999999999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=318.62 Aligned_cols=248 Identities=24% Similarity=0.378 Sum_probs=204.9
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
...++|.+.+.||+|++|.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.+. ||||+++++++. ...
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~ 74 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM-----MPEAFLQEAQIMKKLR-HDKLVPLYAVVS-EEP 74 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc-----cHHHHHHHHHHHHhCC-CCCeeeEEEEEc-CCC
Confidence 3457899999999999999999987554 4699998865421 2356788999999995 999999999875 456
Q ss_pred EEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 105 IYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
.|++|||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 8999999999999999964 2489999999999999999999999999999999999999999999999999875433
Q ss_pred hhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhHH
Q 013005 182 IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPAR 259 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 259 (451)
..........++..|+|||.+.+..+ +.++||||+|+++|+|++ |..||.+.........+... ....+...+..+.
T Consensus 155 ~~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd05069 155 NEYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLH 233 (260)
T ss_pred CcccccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHH
Confidence 22222223345678999998866554 567999999999999999 99999887776666665543 2345566889999
Q ss_pred HHHHhccCCCCCCCCCHHHHHc
Q 013005 260 SLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 260 ~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+++.+||..||++||+++++++
T Consensus 234 ~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 234 ELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=339.28 Aligned_cols=261 Identities=21% Similarity=0.360 Sum_probs=212.6
Q ss_pred CCCCCcccccCCeEEcceEcccCceEEEEEEEc-----CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCc
Q 013005 18 PPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSI-----ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNV 92 (451)
Q Consensus 18 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnI 92 (451)
+....+....++|.+++.||+|+||.||+|++. .++..||+|++.... .....+.+.+|+.++.++..||||
T Consensus 27 ~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~~H~ni 103 (401)
T cd05107 27 PYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA---RSSEKQALMSELKIMSHLGPHLNI 103 (401)
T ss_pred CCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC---ChhHHHHHHHHHHHHHhcCCCCCe
Confidence 444557778889999999999999999999864 345689999997542 122345688999999999669999
Q ss_pred eEEEEEEEeCCEEEEEEEecCCCchhHHhhcC------------------------------------------------
Q 013005 93 LKIQEVMATKTKIYLVMEYAAGGELFGKLRRG------------------------------------------------ 124 (451)
Q Consensus 93 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~------------------------------------------------ 124 (451)
+++++.+...+..|+||||+.+|+|.++++..
T Consensus 104 v~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (401)
T cd05107 104 VNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSK 183 (401)
T ss_pred EEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCC
Confidence 99999999999999999999999999988531
Q ss_pred ---------------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 013005 125 ---------------------------------------------------RLTESAARRYFQQLVSALHFCHQNGVAHR 153 (451)
Q Consensus 125 ---------------------------------------------------~l~e~~~~~~~~ql~~gL~yLH~~giiHr 153 (451)
.+++..++.++.||+.||.|||++|++||
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr 263 (401)
T cd05107 184 DESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHR 263 (401)
T ss_pred ccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcc
Confidence 25667788999999999999999999999
Q ss_pred CCCCCeEEeCCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCC
Q 013005 154 DVKPQNLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPF 231 (451)
Q Consensus 154 DLKpeNILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf 231 (451)
||||+|||++.++.+||+|||++........ .......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||
T Consensus 264 dlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~ 342 (401)
T cd05107 264 DLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPY 342 (401)
T ss_pred cCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999875422111 11233467889999999877655 567999999999999998 89999
Q ss_pred CCCcHHHHH-HHhhcc-CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 232 DDSNLLAMY-KKVNRR-DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 232 ~~~~~~~~~-~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
......+.. ..+... ....|..++..+.+|+.+||..+|.+||++++|+..
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 343 PELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 875544433 333332 234566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=321.26 Aligned_cols=264 Identities=30% Similarity=0.528 Sum_probs=233.5
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
...-.++|.+++.||+|+|++|.+++.++|.+.+|+|+++++ ...+....+-++.|-.+..+..+||.+|-++.+|.+.
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkke-l~nddedidwvqtek~vfe~asn~pflvglhscfqte 323 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKE-LVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE 323 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHH-hcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence 345578999999999999999999999999999999999876 4455566677888888999999999999999999999
Q ss_pred CEEEEEEEecCCCchhHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 103 TKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l-~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
+.+++|.||++||+|--.+ ++.+++|+.++.|...|+-||.|||++||+.||||..|+|+|..|++||+|+|+..-.-
T Consensus 324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l- 402 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL- 402 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC-
Confidence 9999999999999985555 45789999999999999999999999999999999999999999999999999986321
Q ss_pred hhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCC--------CcHHHHHHHhhccCCCCCCC
Q 013005 182 IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDD--------SNLLAMYKKVNRRDYQFPSF 253 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~--------~~~~~~~~~i~~~~~~~p~~ 253 (451)
.......+.||||+|+|||++.+..| +...|.|+|||++++|++|+.||+- .+...+++-|....+.+|..
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprs 481 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRS 481 (593)
T ss_pred CCCcccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccce
Confidence 12356678999999999999998888 6779999999999999999999962 23346788888889999999
Q ss_pred CCHhHHHHHHhccCCCCCCCC------CHHHHHcCccccchh
Q 013005 254 VSKPARSLIYQLLDPNPKTRM------SIEKIMSISWFQKSL 289 (451)
Q Consensus 254 ~s~~~~~li~~~L~~dP~~Rp------t~~eil~hp~f~~~~ 289 (451)
+|-.+..+++.-|++||.+|. ...++..|+||+...
T Consensus 482 lsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id 523 (593)
T KOG0695|consen 482 LSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID 523 (593)
T ss_pred eehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence 999999999999999999997 478999999998643
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=325.67 Aligned_cols=253 Identities=25% Similarity=0.407 Sum_probs=213.0
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
..|...+.||+|+||.||+|.+..++..||+|.+..... ........+.+|+.+++++. |||++++++++......|+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLREHTAWL 102 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-CchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCeEEE
Confidence 448889999999999999999999999999999976522 23345567889999999995 9999999999999999999
Q ss_pred EEEecCCCchhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 108 VMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 108 V~E~~~gg~L~~~l~--~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
||||+.| +|.+.+. ...+++.++..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++....
T Consensus 103 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~----- 176 (317)
T cd06635 103 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS----- 176 (317)
T ss_pred EEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC-----
Confidence 9999975 6767664 4679999999999999999999999999999999999999999999999999986432
Q ss_pred cccccCCCCccccceeeec--cCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC-CC-CCCCCHhHHHH
Q 013005 186 MLHTACGTPAYTAPEVVAR--RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY-QF-PSFVSKPARSL 261 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~--~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~-~~-p~~~s~~~~~l 261 (451)
......|++.|+|||.+.. .+..+.++||||+||++|+|++|..||...+.......+..... .. +..+++.+.++
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 256 (317)
T cd06635 177 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 256 (317)
T ss_pred CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHH
Confidence 2234578999999999742 23346679999999999999999999988766655555544332 22 23468889999
Q ss_pred HHhccCCCCCCCCCHHHHHcCccccch
Q 013005 262 IYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 262 i~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+.+||..+|.+|||+.++++|+|+...
T Consensus 257 i~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 257 VDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred HHHHccCCcccCcCHHHHHhChhhhcc
Confidence 999999999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=334.16 Aligned_cols=255 Identities=22% Similarity=0.367 Sum_probs=204.5
Q ss_pred ccccCCeEEcceEcccCceEEEEEEE-----cCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKS-----IADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
....++|++.+.||+|+||+||+|.+ ..+++.||||+++... .......+.+|+.++.++.+||||++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGA 79 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence 34457899999999999999999984 3467899999997542 123345688999999999779999999998
Q ss_pred EEe-CCEEEEEEEecCCCchhHHhhc------------------------------------------------------
Q 013005 99 MAT-KTKIYLVMEYAAGGELFGKLRR------------------------------------------------------ 123 (451)
Q Consensus 99 ~~~-~~~~~lV~E~~~gg~L~~~l~~------------------------------------------------------ 123 (451)
+.. ....+++|||+++|+|.+++..
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 754 4568999999999999988853
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc-Cccc
Q 013005 124 --------------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN-GMLH 188 (451)
Q Consensus 124 --------------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~-~~~~ 188 (451)
..++...+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........ ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 1267788899999999999999999999999999999999999999999999875422111 1122
Q ss_pred ccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHH-HHHHHhhc-cCCCCCCCCCHhHHHHHHhc
Q 013005 189 TACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLL-AMYKKVNR-RDYQFPSFVSKPARSLIYQL 265 (451)
Q Consensus 189 ~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~-~~~~~i~~-~~~~~p~~~s~~~~~li~~~ 265 (451)
...+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...... .....+.. .....|.+.++.+.+++.+|
T Consensus 240 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c 318 (343)
T cd05103 240 DARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 318 (343)
T ss_pred CCCCCcceECcHHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence 3345678999999877666 566999999999999996 99999765432 22222222 23445667889999999999
Q ss_pred cCCCCCCCCCHHHHHcC
Q 013005 266 LDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 266 L~~dP~~Rpt~~eil~h 282 (451)
|..||++|||+.+|++|
T Consensus 319 l~~~p~~Rps~~eil~~ 335 (343)
T cd05103 319 WHGEPSQRPTFSELVEH 335 (343)
T ss_pred ccCChhhCcCHHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=323.86 Aligned_cols=263 Identities=25% Similarity=0.429 Sum_probs=211.5
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
.......++|++.+.||+|+||.||+|.+..+++.||||.+.+... ......+.+|+.++.++.+||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 84 (296)
T cd06618 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN---KEENKRILMDLDVVLKSHDCPYIVKCYGYFI 84 (296)
T ss_pred eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC---hHHHHHHHHHHHHHHhccCCCchHhhheeee
Confidence 3445667899999999999999999999988899999999975421 2233456667777777767999999999999
Q ss_pred eCCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQ-NGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~-~giiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
+....|++|||+.+ +|.+.+.. +.+++..+..++.|++.||.|||+ .||+||||+|+||++++++.+||+|||++.
T Consensus 85 ~~~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~ 163 (296)
T cd06618 85 TDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG 163 (296)
T ss_pred cCCeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccch
Confidence 99999999999854 67666643 679999999999999999999997 599999999999999999999999999986
Q ss_pred cchhhhcCcccccCCCCccccceeeeccC---CCCccchhhhhhHHHHHHHhcCCCCCCCcH-HHHHHHhhccC-CCCCC
Q 013005 178 LPEQIKNGMLHTACGTPAYTAPEVVARRG---YDGAVADAWSCGVILFVLLAGYLPFDDSNL-LAMYKKVNRRD-YQFPS 252 (451)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~---~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~-~~~~~~i~~~~-~~~p~ 252 (451)
..... .......+++.|+|||.+.+.. ..+.++||||||+++|+|++|+.||..... .+.+..+.... ...+.
T Consensus 164 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T cd06618 164 RLVDS--KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPP 241 (296)
T ss_pred hccCC--CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCC
Confidence 54221 1122345788999999986543 235679999999999999999999976332 23333333322 22222
Q ss_pred --CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 253 --FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 253 --~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
.++.++.+|+.+||..||++|||+++++.||||+...
T Consensus 242 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 242 NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 3688999999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=316.56 Aligned_cols=250 Identities=24% Similarity=0.379 Sum_probs=210.3
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
+...++|++.+.||+|+||.||+|.+. ++..+|+|.+..... ..+.+.+|+.+++++. ||||+++++++....
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 74 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM-----SPEAFLQEAQIMKKLR-HDKLVQLYAVCSEEE 74 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc-----CHHHHHHHHHHHhhCC-CCCEeeeeeeeecCC
Confidence 456789999999999999999999974 567899999875421 2356889999999996 999999999999989
Q ss_pred EEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 104 KIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
..|+||||+++++|.+++.. ..+++..++.++.|++.|+.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus 75 ~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 75 PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceecc
Confidence 99999999999999999964 368999999999999999999999999999999999999999999999999987543
Q ss_pred hhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhH
Q 013005 181 QIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPA 258 (451)
Q Consensus 181 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 258 (451)
...........++..|+|||.+.+..+ +.++||||+|+++|+|++ |+.||.+.+.......+... ....|...+..+
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (261)
T cd05034 155 DDEYTAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEEL 233 (261)
T ss_pred chhhhhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 211111122234678999999876554 667999999999999998 99999887777777666544 234455678999
Q ss_pred HHHHHhccCCCCCCCCCHHHHHc
Q 013005 259 RSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 259 ~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.+++.+||..||++||+++++.+
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 234 YDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHcccCcccCCCHHHHHH
Confidence 99999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=323.35 Aligned_cols=251 Identities=21% Similarity=0.311 Sum_probs=207.3
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCC----------------cEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCC
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADG----------------SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~----------------~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~H 89 (451)
..++|++.+.||+|+||.||+|.+..++ ..||+|.+.... .....+.+.+|+.++++++ |
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~-~ 78 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNAREDFLKEVKILSRLS-D 78 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhcC-C
Confidence 3568999999999999999999876544 468999987542 2345677899999999996 9
Q ss_pred CCceEEEEEEEeCCEEEEEEEecCCCchhHHhhc-C-----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 013005 90 PNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-G-----------RLTESAARRYFQQLVSALHFCHQNGVAHRDVKP 157 (451)
Q Consensus 90 pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~-----------~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKp 157 (451)
|||+++++++..+...+++|||+.+++|.+++.. . .+++..++.++.|++.||.|||++|++||||||
T Consensus 79 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp 158 (296)
T cd05051 79 PNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLAT 158 (296)
T ss_pred CCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccch
Confidence 9999999999999999999999999999999865 2 589999999999999999999999999999999
Q ss_pred CeEEeCCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh--cCCCCCCC
Q 013005 158 QNLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA--GYLPFDDS 234 (451)
Q Consensus 158 eNILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~--G~~Pf~~~ 234 (451)
+||+++.++.++|+|||++........ .......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999999999999999999874322111 22234556789999999876554 567999999999999998 78899876
Q ss_pred cHHHHHHHhhcc--------CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 235 NLLAMYKKVNRR--------DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 235 ~~~~~~~~i~~~--------~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+....+...... ....+..++.++.+++.+||..||++|||+.+|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 655554443321 12334557899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=318.82 Aligned_cols=250 Identities=24% Similarity=0.422 Sum_probs=207.7
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCc---EEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGS---IVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
.++|++.+.||+|+||.||+|.+..++. .+|+|.++... .....+.+.+|+.+++++. ||||+++++++....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 78 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSK 78 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC---CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCC
Confidence 4689999999999999999998865543 79999986532 2334567889999999995 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 104 KIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
..|+||||+++++|.+++.. +.+++.++..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999999999874 5689999999999999999999999999999999999999999999999999875433
Q ss_pred hhcCcc--cccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHh
Q 013005 182 IKNGML--HTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKP 257 (451)
Q Consensus 182 ~~~~~~--~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 257 (451)
...... ....++..|+|||.+.+..+ +.++|+||||+++|++++ |..||...+.......+... ..+.+..+++.
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAA 237 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHH
Confidence 222111 11223568999999977665 567999999999999886 99999887766666655543 22334457889
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHc
Q 013005 258 ARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 258 ~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+.+++.+||..+|.+|||+.++++
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 238 LHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHHHcccCchhCCCHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=343.75 Aligned_cols=255 Identities=21% Similarity=0.356 Sum_probs=217.6
Q ss_pred CCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE
Q 013005 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 20 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~ 99 (451)
...+.+..+...++..||+|+||+||+|++.+ .||||+++.+.. ..+..+.|++|+.++++-+ |-||+-+.|++
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p--t~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~ 457 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP--TPEQLQAFKNEVAVLKKTR-HENILLFMGAC 457 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCC--CHHHHHHHHHHHHHHhhcc-hhhheeeehhh
Confidence 46677888888999999999999999999754 599999988743 4457889999999999997 99999999999
Q ss_pred EeCCEEEEEEEecCCCchhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 100 ATKTKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 100 ~~~~~~~lV~E~~~gg~L~~~l~--~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
..... .||+.+|+|.+|+.+++ +.+|.....+.|++|+++||.|||.++|+|||||..||+|++++++||+||||++
T Consensus 458 ~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 458 MNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred cCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEeccccee
Confidence 87777 99999999999999997 3679999999999999999999999999999999999999999999999999997
Q ss_pred cchhhh-cCcccccCCCCccccceeeeccC--CCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCC-----
Q 013005 178 LPEQIK-NGMLHTACGTPAYTAPEVVARRG--YDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQ----- 249 (451)
Q Consensus 178 ~~~~~~-~~~~~~~~gt~~y~APEvl~~~~--~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~----- 249 (451)
...... ...+...-|...|||||++.... ..+..+|||||||++|||++|.+||...+.+..+-.+.++...
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~ 616 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSK 616 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchh
Confidence 644332 24455667899999999985322 2367799999999999999999999977777766666655321
Q ss_pred CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 250 FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 250 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.-...++++++|+..||.+++++||+..+|+.
T Consensus 617 ~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 617 IRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred hhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 12346779999999999999999999999986
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=321.31 Aligned_cols=250 Identities=30% Similarity=0.468 Sum_probs=206.2
Q ss_pred eEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEE
Q 013005 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVM 109 (451)
Q Consensus 30 y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~ 109 (451)
|++.+.||+|++|+||+|.+..+++.||||.+..... ........+|+..++++.+||||+++++++..++..|+||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY---SWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc---chhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEE
Confidence 6789999999999999999988999999999865421 1122345578899999966999999999999999999999
Q ss_pred EecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCc
Q 013005 110 EYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM 186 (451)
Q Consensus 110 E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~ 186 (451)
||+ +|+|.+.+.. ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 78 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~--~~ 154 (283)
T cd07830 78 EYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR--PP 154 (283)
T ss_pred ecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC--CC
Confidence 999 7789888864 36899999999999999999999999999999999999999999999999998754321 22
Q ss_pred ccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc-------------------C
Q 013005 187 LHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR-------------------D 247 (451)
Q Consensus 187 ~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~-------------------~ 247 (451)
.....|+..|+|||++.+....+.++|+||||+++++|++|+.||...+....+.++... .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 334568999999999866555577899999999999999999999876655443332210 0
Q ss_pred CC-----------CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 248 YQ-----------FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 248 ~~-----------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
.. ..+..+..+.++|++||..||++|||++|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00 011236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=312.41 Aligned_cols=256 Identities=26% Similarity=0.440 Sum_probs=211.9
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
.++.+.+..||.|+.|.|++++.+.+|...|||.+.+.. +.....++...+.++.+..++|+||+.+|+|..+...+
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~---Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF 167 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC---CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence 445566778999999999999999999999999998763 45566788889998888766899999999999999999
Q ss_pred EEEEecCCCchhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 107 LVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQ-NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~--~~~l~e~~~~~~~~ql~~gL~yLH~-~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
+.||.+.. .+..+++ +++++|..+-++...++.||.||.. +||+|||+||+|||+|+.|++|+||||.|...-.
T Consensus 168 IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd-- 244 (391)
T KOG0983|consen 168 ICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD-- 244 (391)
T ss_pred HHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec--
Confidence 99999843 4555554 4789999999999999999999976 5899999999999999999999999999964322
Q ss_pred cCcccccCCCCccccceeeecc---CCCCccchhhhhhHHHHHHHhcCCCCCCCcH-HHHHHHhhccCC-CCCC--CCCH
Q 013005 184 NGMLHTACGTPAYTAPEVVARR---GYDGAVADAWSCGVILFVLLAGYLPFDDSNL-LAMYKKVNRRDY-QFPS--FVSK 256 (451)
Q Consensus 184 ~~~~~~~~gt~~y~APEvl~~~---~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~-~~~~~~i~~~~~-~~p~--~~s~ 256 (451)
........|.+.|||||.+.-. .| ...+||||||+.|++|.||..||.+.+. .+...++.+... .+|. .+|+
T Consensus 245 SkAhtrsAGC~~YMaPERidp~~~~kY-DiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp 323 (391)
T KOG0983|consen 245 SKAHTRSAGCAAYMAPERIDPPDKPKY-DIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSP 323 (391)
T ss_pred ccccccccCCccccCccccCCCCCCcc-chhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCH
Confidence 1222345689999999998533 34 4559999999999999999999988543 356666655433 3333 3799
Q ss_pred hHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 257 PARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
.+++|+..||..|+.+||...++|+|||+....
T Consensus 324 ~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 324 DFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred HHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 999999999999999999999999999997643
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=319.56 Aligned_cols=249 Identities=21% Similarity=0.347 Sum_probs=206.2
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCc----EEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGS----IVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
..+|++.+.||+|+||+||+|.+..+++ .||+|++.... .......+.+|+.+++.+. ||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~- 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEILDEAYVMAGVG-SPYVCRLLGICLT- 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC---CHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcC-
Confidence 4679999999999999999999877776 48999986542 2344567889999999995 9999999999875
Q ss_pred CEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 103 TKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
...++++||+++|+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||+++++.+||+|||++....
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 457899999999999999864 569999999999999999999999999999999999999999999999999987553
Q ss_pred hhhcC-cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHh
Q 013005 181 QIKNG-MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKP 257 (451)
Q Consensus 181 ~~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 257 (451)
..... ......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...........+... ....+...+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRF-THQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTID 239 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHH
Confidence 22111 1122335678999999877666 466999999999999998 99999877666555555443 23445668899
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHc
Q 013005 258 ARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 258 ~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+.+++.+||..||++|||+.+++.
T Consensus 240 ~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 240 VYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=320.01 Aligned_cols=250 Identities=26% Similarity=0.454 Sum_probs=205.1
Q ss_pred eEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhc--CCCCceEEEEEEEeCCE---
Q 013005 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ--NHPNVLKIQEVMATKTK--- 104 (451)
Q Consensus 30 y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~--~HpnIv~l~~~~~~~~~--- 104 (451)
|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++++. +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc--cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 6789999999999999999988899999999975422 2223345667888887774 49999999999987776
Q ss_pred --EEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcc
Q 013005 105 --IYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALP 179 (451)
Q Consensus 105 --~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~ 179 (451)
.|++|||+.+ +|.+++.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 79 ~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 79 LKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred ceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 9999999975 78887764 35899999999999999999999999999999999999999999999999998754
Q ss_pred hhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC-----CC-----
Q 013005 180 EQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD-----YQ----- 249 (451)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~-----~~----- 249 (451)
... .......+++.|+|||++.+..+ +.++|+||+||++|+|++|..||...+..+.+.++.... ..
T Consensus 158 ~~~--~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 158 SFE--MALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred cCC--cccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 322 22234457899999999877665 567999999999999999999998877665555443210 00
Q ss_pred ------C-----------CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 250 ------F-----------PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 250 ------~-----------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
+ .+.++..+.++|.+||..||.+||++++++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 01245778899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=320.18 Aligned_cols=250 Identities=23% Similarity=0.349 Sum_probs=200.5
Q ss_pred cCCe-EEcceEcccCceEEEEEE----EcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 27 LNRY-QLGPLLGRGSFAKVHKAK----SIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 27 ~~~y-~~~~~LG~G~~g~Vy~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
.++| ++.+.||+|+||+||++. ...++..||+|++.... .......+.+|+.+++.+. ||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~ 77 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTLY-HENIVKYKGCCSE 77 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec
Confidence 3566 899999999999998764 34578899999987542 1234467889999999995 9999999998765
Q ss_pred --CCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcc
Q 013005 102 --KTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALP 179 (451)
Q Consensus 102 --~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~ 179 (451)
....|++|||+.+++|.+++....+++.+++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 78 ~~~~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 78 QGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred CCCceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 346899999999999999998888999999999999999999999999999999999999999999999999998754
Q ss_pred hhhhc--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH--HHH-------------HH
Q 013005 180 EQIKN--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL--AMY-------------KK 242 (451)
Q Consensus 180 ~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~--~~~-------------~~ 242 (451)
..... .......++..|+|||.+.+..+ +.++||||||+++|+|++|..||...... ... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence 32211 11223346678999999876555 56799999999999999999998653211 110 00
Q ss_pred hh-ccCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 243 VN-RRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 243 i~-~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+. ......|...+..+.+++.+||.+||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 10 1112345567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=321.15 Aligned_cols=249 Identities=23% Similarity=0.337 Sum_probs=207.7
Q ss_pred cCCeEEcceEcccCceEEEEEEE-----cCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKS-----IADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
..+|.+.+.||+|+||.||++.. ..++..+|+|.+... .....+.+.+|+.+++.+. ||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 78 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTVLQ-HQHIVRFYGVCTE 78 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC----CHHHHHHHHHHHHHHhcCC-CCCCceEEEEEec
Confidence 46788999999999999999964 235678999988653 2344567899999999995 9999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCC
Q 013005 102 KTKIYLVMEYAAGGELFGKLRRG----------------RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD 165 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~~----------------~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~ 165 (451)
....|++|||+.+++|.+++... .+++..++.++.||+.||+|||++|++||||||+|||++++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence 99999999999999999988642 47899999999999999999999999999999999999999
Q ss_pred CCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHh
Q 013005 166 GNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKV 243 (451)
Q Consensus 166 ~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i 243 (451)
+.+||+|||++........ .......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...........+
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 9999999999864322111 11223345788999999877766 566999999999999998 99999877666655555
Q ss_pred hcc-CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 244 NRR-DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 244 ~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
... ....|..+++.+.++|.+||..||++||++++|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 238 TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 443 34556678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=317.57 Aligned_cols=242 Identities=24% Similarity=0.407 Sum_probs=200.8
Q ss_pred ceEcccCceEEEEEEEcCCCc--EEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEe
Q 013005 34 PLLGRGSFAKVHKAKSIADGS--IVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEY 111 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~ 111 (451)
+.||+|+||.||+|.+..++. .+|+|.+... ......+.+.+|+.++.++.+||||+++++++...+..|++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 77 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 77 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc---CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEe
Confidence 368999999999999888776 4688887642 12344567889999999996799999999999999999999999
Q ss_pred cCCCchhHHhhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEecc
Q 013005 112 AAGGELFGKLRRG-----------------RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFG 174 (451)
Q Consensus 112 ~~gg~L~~~l~~~-----------------~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFG 174 (451)
+++|+|.+++... .+++.+++.++.|++.||+|||++|++||||||+|||+++++.+||+|||
T Consensus 78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCC
Confidence 9999999998642 37899999999999999999999999999999999999999999999999
Q ss_pred CCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCC
Q 013005 175 LSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPS 252 (451)
Q Consensus 175 ls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~ 252 (451)
++......... .....++.|+|||++....+ +.++|||||||++|+|++ |..||...+....+..+... ....+.
T Consensus 158 l~~~~~~~~~~--~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05047 158 LSRGQEVYVKK--TMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234 (270)
T ss_pred Cccccchhhhc--cCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence 98632221111 12234667999999876655 567999999999999997 99999887777766666543 234455
Q ss_pred CCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 253 FVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 253 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.++..+.+++.+||..||.+|||+++++.
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 67899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=314.28 Aligned_cols=242 Identities=24% Similarity=0.367 Sum_probs=201.1
Q ss_pred ceEcccCceEEEEEEEcCCC---cEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEE
Q 013005 34 PLLGRGSFAKVHKAKSIADG---SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVME 110 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E 110 (451)
+.||+|+||.||+|....++ ..+|+|.+..... ....+.+.+|+.+++.+. ||||+++++++. ....++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~~~~~v~e 75 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI---AAGKKEFLREASVMAQLD-HPCIVRLIGVCK-GEPLMLVME 75 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccc---hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEc-CCceEEEEE
Confidence 46999999999999876554 7899999976532 134567889999999995 999999999876 456899999
Q ss_pred ecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCccc-
Q 013005 111 YAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLH- 188 (451)
Q Consensus 111 ~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~- 188 (451)
|+.+|+|.+++.+ +.+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++............
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred eCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 9999999999976 56999999999999999999999999999999999999999999999999998755332221111
Q ss_pred -ccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhHHHHHHhc
Q 013005 189 -TACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPARSLIYQL 265 (451)
Q Consensus 189 -~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~ 265 (451)
...++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...+.......+... ....|..++..+.++|.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 234 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSC 234 (257)
T ss_pred cCccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHH
Confidence 1223467999999876665 567999999999999998 99999887776666665544 2355667899999999999
Q ss_pred cCCCCCCCCCHHHHHc
Q 013005 266 LDPNPKTRMSIEKIMS 281 (451)
Q Consensus 266 L~~dP~~Rpt~~eil~ 281 (451)
|.+||++|||+.++++
T Consensus 235 l~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 235 WKYRPEDRPTFSELES 250 (257)
T ss_pred hcCChhhCcCHHHHHH
Confidence 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=321.30 Aligned_cols=248 Identities=24% Similarity=0.374 Sum_probs=205.9
Q ss_pred CeEEcceEcccCceEEEEEEEcC-----CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIA-----DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++.+. ||||+++++.+...+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA---SSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC---CHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCC
Confidence 58899999999999999998753 23579999886542 2233467889999999995 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 013005 104 KIYLVMEYAAGGELFGKLRR-------------------------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQ 158 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~-------------------------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpe 158 (451)
..|+++||+.+++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ 156 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR 156 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhh
Confidence 99999999999999998753 24788999999999999999999999999999999
Q ss_pred eEEeCCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcH
Q 013005 159 NLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNL 236 (451)
Q Consensus 159 NILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~ 236 (451)
|||+++++.+||+|||++........ ......+++..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+...
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc-chHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999999874322111 11233456778999998876655 567999999999999998 9999988877
Q ss_pred HHHHHHhhcc-CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 237 LAMYKKVNRR-DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 237 ~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
......+... ....|..++..+.+++.+||..||++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 236 ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 7666655443 23446668899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=312.04 Aligned_cols=242 Identities=24% Similarity=0.435 Sum_probs=202.3
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecC
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAA 113 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ 113 (451)
+.||+|+||.||+|.. .++..+|+|.+.... .......+.+|+.+++.+. ||||+++++++......++||||++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL---PQELKIKFLSEARILKQYD-HPNIVKLIGVCTQRQPIYIVMELVP 75 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC---CHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEecCCccEEEEECCC
Confidence 4689999999999985 578899999986542 2334456889999999995 9999999999999999999999999
Q ss_pred CCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccC
Q 013005 114 GGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTAC 191 (451)
Q Consensus 114 gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~ 191 (451)
+++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...............
T Consensus 76 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 76 GGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 9999998864 46899999999999999999999999999999999999999999999999998643221111112234
Q ss_pred CCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhHHHHHHhccCCC
Q 013005 192 GTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPARSLIYQLLDPN 269 (451)
Q Consensus 192 gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~d 269 (451)
+++.|+|||++....+ +.++||||+|+++|++++ |..||...........+... ....+..++..+.+++.+||..+
T Consensus 156 ~~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (250)
T cd05085 156 IPIKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYK 234 (250)
T ss_pred CcccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccC
Confidence 4678999999866554 567999999999999998 99999887776665555543 33556678999999999999999
Q ss_pred CCCCCCHHHHHc
Q 013005 270 PKTRMSIEKIMS 281 (451)
Q Consensus 270 P~~Rpt~~eil~ 281 (451)
|++|||+.++++
T Consensus 235 p~~Rp~~~~l~~ 246 (250)
T cd05085 235 PENRPKFSELQK 246 (250)
T ss_pred cccCCCHHHHHH
Confidence 999999999976
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=313.29 Aligned_cols=243 Identities=24% Similarity=0.448 Sum_probs=208.5
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
..++|++.+.||.|+||.||+|.+ .|+.||+|.+.... ....++.+|+.+++.+. |+||+++++++.+....
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 75 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDS-----TAAQAFLAEASVMTTLR-HPNLVQLLGVVLQGNPL 75 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccch-----hHHHHHHHHHHHHHhcC-CcceeeeEEEEcCCCCe
Confidence 457899999999999999999985 48899999997542 14567889999999995 99999999999999999
Q ss_pred EEEEEecCCCchhHHhhc-C--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 106 YLVMEYAAGGELFGKLRR-G--RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~-~--~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
|+||||+++++|.+++.. . .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 999999999999999975 2 6999999999999999999999999999999999999999999999999998754221
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhHHH
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPARS 260 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 260 (451)
.....++..|+|||.+....+ +.++||||||+++|+|++ |..||...+.......+... ....|..+++.+.+
T Consensus 156 ----~~~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd05039 156 ----QDSGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYK 230 (256)
T ss_pred ----cccCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHH
Confidence 113345667999999876555 567999999999999997 99999888777666655543 33456668899999
Q ss_pred HHHhccCCCCCCCCCHHHHHc
Q 013005 261 LIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 261 li~~~L~~dP~~Rpt~~eil~ 281 (451)
+|.+||..+|++|||++++++
T Consensus 231 li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 231 VMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHhccChhhCcCHHHHHH
Confidence 999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=318.26 Aligned_cols=250 Identities=25% Similarity=0.378 Sum_probs=209.8
Q ss_pred CCeEEcceEcccCceEEEEEEEcC-----CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIA-----DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
++|++.+.||+|+||.||+|++.. +.+.+++|.+.... .....+.+.+|+.+++++. ||||+++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK---DENLQSEFRRELDMFRKLS-HKNVVRLLGLCREA 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc---chHHHHHHHHHHHHHHhcC-CcceeeeEEEECCC
Confidence 689999999999999999999754 35689999886542 2234567889999999995 99999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc-C---------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEe
Q 013005 103 TKIYLVMEYAAGGELFGKLRR-G---------RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSD 172 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~-~---------~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~D 172 (451)
...|+||||+++|+|.+++.. . .+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence 999999999999999999864 3 589999999999999999999999999999999999999999999999
Q ss_pred ccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhccCC--C
Q 013005 173 FGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRDY--Q 249 (451)
Q Consensus 173 FGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~~~--~ 249 (451)
||++...............+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+..... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC
Confidence 99986432222222334456788999998876655 566999999999999998 8999987666666666654443 3
Q ss_pred CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 250 FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 250 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
.+..++..+.+++.+||..||++|||+.+++.+
T Consensus 240 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 355688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=355.75 Aligned_cols=149 Identities=29% Similarity=0.591 Sum_probs=137.0
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
+++|.+.+.||+|+||+||+|.+..+++.||||++... ..........+.+|+.+++.++ ||||+++++++.....+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~-~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKA-DMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQSANNVY 80 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehh-hccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEEECCEEE
Confidence 58899999999999999999999999999999999765 2234455677889999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 107 LVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
+||||+.|++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999975 678999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=322.50 Aligned_cols=250 Identities=20% Similarity=0.318 Sum_probs=203.0
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCC--------------cEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCc
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADG--------------SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNV 92 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~--------------~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnI 92 (451)
.++|++.+.||+|+||.||++.+..++ ..||+|.+.... .....+.+.+|+.+++++. ||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~ei~~l~~l~-h~~i 79 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV---TKTARNDFLKEIKIMSRLK-NPNI 79 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhCC-CCCc
Confidence 468999999999999999999875432 359999987542 2344567899999999995 9999
Q ss_pred eEEEEEEEeCCEEEEEEEecCCCchhHHhhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCe
Q 013005 93 LKIQEVMATKTKIYLVMEYAAGGELFGKLRRG-------------RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQN 159 (451)
Q Consensus 93 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-------------~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeN 159 (451)
+++++++......|+||||+.+++|.+++... .+++..+..++.|++.||.|||++|++||||||+|
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N 159 (295)
T cd05097 80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN 159 (295)
T ss_pred CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhh
Confidence 99999999999999999999999999988532 36888899999999999999999999999999999
Q ss_pred EEeCCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh--cCCCCCCCcH
Q 013005 160 LLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA--GYLPFDDSNL 236 (451)
Q Consensus 160 ILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~--G~~Pf~~~~~ 236 (451)
|+++.++.+||+|||++........ .......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 9999999999999999874322111 12223445778999999876655 677999999999999988 7788887665
Q ss_pred HHHHHHhhc--------cCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 237 LAMYKKVNR--------RDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 237 ~~~~~~i~~--------~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
......+.. .....++.+++.+.+|+.+||..||++|||+++|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 544433321 112334557899999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=321.20 Aligned_cols=251 Identities=31% Similarity=0.518 Sum_probs=209.5
Q ss_pred eEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEE
Q 013005 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVM 109 (451)
Q Consensus 30 y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~ 109 (451)
|++.+.||+|++|.||+|.+..+++.||+|++.... ......+.+.+|+.+++++. ||||+++++++.+....|+|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~ 77 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN--EEEGIPSTALREISLLKELK-HPNIVKLLDVIHTERKLYLVF 77 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc--ccccccHHHHHHHHHHHhcC-CCCHHHHHhhhhcCCceEEEe
Confidence 677889999999999999999999999999997652 12333456778999999996 999999999999999999999
Q ss_pred EecCCCchhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcc
Q 013005 110 EYAAGGELFGKLRRG--RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML 187 (451)
Q Consensus 110 E~~~gg~L~~~l~~~--~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~ 187 (451)
||+.+ +|.+++.+. .+++..++.++.|++.||.|||++||+||||+|+||++++++.++|+|||++....... ...
T Consensus 78 e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~-~~~ 155 (282)
T cd07829 78 EYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL-RTY 155 (282)
T ss_pred cCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc-ccc
Confidence 99984 899999764 79999999999999999999999999999999999999999999999999987543321 123
Q ss_pred cccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc------------------CCC
Q 013005 188 HTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR------------------DYQ 249 (451)
Q Consensus 188 ~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~------------------~~~ 249 (451)
....++..|+|||.+.+....+.++||||+|+++|+|++|..||...+....+.++... ...
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence 34556889999999877645577899999999999999999999887655444333210 001
Q ss_pred CC-----------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 250 FP-----------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 250 ~p-----------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
++ +..+..+.++|.+||..||++||++++++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 11 1247789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=314.82 Aligned_cols=241 Identities=24% Similarity=0.357 Sum_probs=199.6
Q ss_pred eEcccCceEEEEEEEc--CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEec
Q 013005 35 LLGRGSFAKVHKAKSI--ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYA 112 (451)
Q Consensus 35 ~LG~G~~g~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~ 112 (451)
.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++++. ||||+++++++. ....++||||+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~-~~~~~lv~e~~ 76 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN---EKSVRDEMMREAEIMHQLD-NPYIVRMIGVCE-AEALMLVMEMA 76 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc---ChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEc-CCCeEEEEEeC
Confidence 3899999999999765 445679999986542 2344567899999999995 999999999875 45789999999
Q ss_pred CCCchhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCc--cc
Q 013005 113 AGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM--LH 188 (451)
Q Consensus 113 ~gg~L~~~l~--~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~--~~ 188 (451)
++++|.+++. .+.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......... ..
T Consensus 77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 9999999886 3679999999999999999999999999999999999999999999999999987543222111 11
Q ss_pred ccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhHHHHHHhcc
Q 013005 189 TACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPARSLIYQLL 266 (451)
Q Consensus 189 ~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L 266 (451)
...+++.|+|||.+....+ +.++|||||||++|+|++ |..||...........+... ...+|...++++.++|.+||
T Consensus 157 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~ 235 (257)
T cd05115 157 AGKWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCW 235 (257)
T ss_pred CCCCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHc
Confidence 2233578999999876655 567999999999999996 99999887766666555443 34667778999999999999
Q ss_pred CCCCCCCCCHHHHHc
Q 013005 267 DPNPKTRMSIEKIMS 281 (451)
Q Consensus 267 ~~dP~~Rpt~~eil~ 281 (451)
..||++||++.+|.+
T Consensus 236 ~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 236 IYKWEDRPNFAKVEE 250 (257)
T ss_pred CCChhhCcCHHHHHH
Confidence 999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=318.29 Aligned_cols=249 Identities=20% Similarity=0.336 Sum_probs=203.3
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcE----EEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSI----VAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
.++|++.+.||+|+||+||+|.+..+++. +++|.+... ........+..|+.+++.+. ||||+++++++. .
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~~-~ 80 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR---SGRQTFQEITDHMLAMGSLD-HAYIVRLLGICP-G 80 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc---cchHHHHHHHHHHHHHhcCC-CCCcceEEEEEC-C
Confidence 46889999999999999999998877764 677776432 12233456778888888995 999999999875 4
Q ss_pred CEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 103 TKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
...++++||+.+|+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+|||+++++.+||+|||++....
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 567899999999999999964 578999999999999999999999999999999999999999999999999997543
Q ss_pred hhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhccC-CCCCCCCCHh
Q 013005 181 QIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRD-YQFPSFVSKP 257 (451)
Q Consensus 181 ~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 257 (451)
.... .......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.........+.... ...+...+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTID 239 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHH
Confidence 2221 12234457788999999877665 567999999999999998 999998876665555444433 2334456788
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHc
Q 013005 258 ARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 258 ~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+.+++.+||..||.+|||+.++++
T Consensus 240 ~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 240 VYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHH
Confidence 999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=318.97 Aligned_cols=238 Identities=25% Similarity=0.335 Sum_probs=196.7
Q ss_pred ceEcccCceEEEEEEEcCCCc-------EEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 34 PLLGRGSFAKVHKAKSIADGS-------IVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~-------~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
+.||+|+||.||+|.+..++. .+|+|.+.... ....+.+.+|+.+++.+. ||||+++++++......+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH----RNYSESFFEAASMMSQLS-HKHLVLNYGVCVCGDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh----HHHHHHHHHHHHHHHhCC-CCChhheeeEEEeCCCcE
Confidence 368999999999999866544 48888876432 234567788999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCC--------eEEEeccCC
Q 013005 107 LVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN--------LKVSDFGLS 176 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~--------lkl~DFGls 176 (451)
+||||+.+|+|..++.. ..+++..+..++.||+.||+|||++||+||||||+||+++.++. ++++|||++
T Consensus 76 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred EEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999999999975 35899999999999999999999999999999999999987765 699999998
Q ss_pred CcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhc-CCCCCCCcHHHHHHHhhccCCCCCCCCC
Q 013005 177 ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAG-YLPFDDSNLLAMYKKVNRRDYQFPSFVS 255 (451)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s 255 (451)
..... .....+++.|+|||++.+....+.++||||||+++|+|++| ..||...+...... .......+|...+
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 229 (258)
T cd05078 156 ITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLPAPKW 229 (258)
T ss_pred cccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCCCCCc
Confidence 64321 23356889999999998755557789999999999999998 56666554443322 2334456677778
Q ss_pred HhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 256 KPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 256 ~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
..+.+|+.+||+.||++|||+++|++.
T Consensus 230 ~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 230 TELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=313.45 Aligned_cols=243 Identities=26% Similarity=0.444 Sum_probs=205.0
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE-EeCC
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM-ATKT 103 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~-~~~~ 103 (451)
....+|++.+.||+|+||.||++.. .+..+|+|.+.... ..+.+.+|+.+++++. |||++++++++ ....
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~------~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 73 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA------TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKG 73 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc------hHHHHHHHHHHHHhCC-CCCeeeEEEEEEcCCC
Confidence 3467899999999999999999975 47889999986442 2356889999999995 99999999975 4566
Q ss_pred EEEEEEEecCCCchhHHhhc-C--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 104 KIYLVMEYAAGGELFGKLRR-G--RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~-~--~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
..|++|||+++++|.+++.. + .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++....
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 153 (256)
T cd05082 74 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 153 (256)
T ss_pred ceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecc
Confidence 89999999999999999864 2 48899999999999999999999999999999999999999999999999986432
Q ss_pred hhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhH
Q 013005 181 QIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPA 258 (451)
Q Consensus 181 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 258 (451)
. ......++..|+|||++....+ +.++|||||||++|+|++ |..||...+.......+... ....+..+++.+
T Consensus 154 ~----~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (256)
T cd05082 154 S----TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVV 228 (256)
T ss_pred c----cCCCCccceeecCHHHHccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHH
Confidence 2 1223445678999999876665 566999999999999997 99999888777766666543 334556789999
Q ss_pred HHHHHhccCCCCCCCCCHHHHHc
Q 013005 259 RSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 259 ~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.+++.+||..||++|||+.++++
T Consensus 229 ~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 229 YDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=323.73 Aligned_cols=255 Identities=24% Similarity=0.382 Sum_probs=210.5
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
....|...+.||+|+||.||+|++..+++.+|+|.+.... .........+.+|+.+++.+. |||++++++++......
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 90 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTA 90 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccc-ccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCee
Confidence 3445888899999999999999999999999999987542 122334456788999999995 99999999999999999
Q ss_pred EEEEEecCCCchhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 106 YLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~--~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
|+||||+. |+|.+.+. ...+++.+++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 91 ~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-- 167 (308)
T cd06634 91 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (308)
T ss_pred EEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC--
Confidence 99999997 47777664 35689999999999999999999999999999999999999999999999999865322
Q ss_pred cCcccccCCCCccccceeeec--cCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC-CC-CCCCCHhHH
Q 013005 184 NGMLHTACGTPAYTAPEVVAR--RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY-QF-PSFVSKPAR 259 (451)
Q Consensus 184 ~~~~~~~~gt~~y~APEvl~~--~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~-~~-p~~~s~~~~ 259 (451)
.....|++.|+|||.+.+ ....+.++|||||||++|+|++|..||...+.......+..... .. +..++..+.
T Consensus 168 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (308)
T cd06634 168 ---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR 244 (308)
T ss_pred ---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHH
Confidence 234568999999999753 23345679999999999999999999987655444433333322 22 235788999
Q ss_pred HHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 260 SLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 260 ~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+||.+||..+|++||+++++++|||+...
T Consensus 245 ~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 99999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=319.95 Aligned_cols=246 Identities=30% Similarity=0.495 Sum_probs=201.4
Q ss_pred EEcceEcccCceEEEEEEEc----CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 31 QLGPLLGRGSFAKVHKAKSI----ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 31 ~~~~~LG~G~~g~Vy~a~~~----~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
.+.+.||.|+||.||+|... ..+..|+||.+... ......+.+.+|+..++++ +||||+++++++...+..+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~---~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS---SSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT---SSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc---cccccceeeeecccccccc-ccccccccccccccccccc
Confidence 46789999999999999987 35678999999543 2334467889999999999 5999999999999888899
Q ss_pred EEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 107 LVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
+|+||+++|+|.+++.. ..+++.....++.|++.||.|||+++++|+||+|.|||++.++.+||+|||++.......
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999975 479999999999999999999999999999999999999999999999999987542111
Q ss_pred -cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhccC-CCCCCCCCHhHHH
Q 013005 184 -NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRD-YQFPSFVSKPARS 260 (451)
Q Consensus 184 -~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 260 (451)
........+...|+|||.+.+..+ +.++||||||+++|+|++ |..||...+......++.... ...|..++..+.+
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYS 236 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHH
T ss_pred ccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHH
Confidence 122234457789999999877665 677999999999999999 789999888777766664433 3456678999999
Q ss_pred HHHhccCCCCCCCCCHHHHHc
Q 013005 261 LIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 261 li~~~L~~dP~~Rpt~~eil~ 281 (451)
+|.+||..||++|||+.+|++
T Consensus 237 li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 237 LIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHh
Confidence 999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=319.40 Aligned_cols=251 Identities=23% Similarity=0.348 Sum_probs=209.0
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcC-----CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIA-----DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
..++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++++. ||||+++++++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~ei~~l~~l~-h~~iv~~~~~~~ 78 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFD-HPNIVKLLGVCA 78 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc---CHHHHHHHHHHHHHHHhcC-CCchheEEEEEc
Confidence 45789999999999999999998743 67899999987542 2334567889999999995 999999999999
Q ss_pred eCCEEEEEEEecCCCchhHHhhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRRG-----------------------RLTESAARRYFQQLVSALHFCHQNGVAHRDVKP 157 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~~-----------------------~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKp 157 (451)
.....|++|||+.+|+|.+++... .+++..+..++.|++.||.|||++|++||||||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p 158 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLAT 158 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence 999999999999999999988631 367888999999999999999999999999999
Q ss_pred CeEEeCCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCc
Q 013005 158 QNLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSN 235 (451)
Q Consensus 158 eNILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~ 235 (451)
+||+++.++.++|+|||++........ .......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999864322111 11222344678999999877665 567999999999999997 889998877
Q ss_pred HHHHHHHhhccCC-CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 236 LLAMYKKVNRRDY-QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 236 ~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
..+....+..... ..|...+..+.+||.+||..||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 238 HEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7776666655443 345668899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=314.06 Aligned_cols=250 Identities=23% Similarity=0.390 Sum_probs=207.8
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCc---EEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGS---IVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
.++|+..+.||+|+||.||+|.+..++. .+|+|.+.... .....+.+.+|+.+++++. ||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 79 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY---TEKQRQDFLSEASIMGQFS-HHNIIRLEGVVTKFK 79 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEccCC
Confidence 4578999999999999999999876654 79999986542 2334567889999999995 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 104 KIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
..|+||||+++++|.+++.. +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999999999864 6799999999999999999999999999999999999999999999999999875432
Q ss_pred hhcCccc--ccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHh
Q 013005 182 IKNGMLH--TACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKP 257 (451)
Q Consensus 182 ~~~~~~~--~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 257 (451)
....... ....++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+... ..+.+...+..
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 238 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSA 238 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHH
Confidence 2221111 1223457999999877665 567999999999999997 99999887776666666543 22334457889
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHc
Q 013005 258 ARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 258 ~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+.+++.+||..+|++||++.++++
T Consensus 239 ~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 239 VYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHH
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=314.98 Aligned_cols=250 Identities=22% Similarity=0.416 Sum_probs=208.1
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCc---EEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGS---IVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
.+.|++.+.||+|+||.||+|.+..++. .||+|++.... .......+..|+.+++.+. ||||+++++++.+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~ 78 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSR 78 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCC-CcCcceEEEEECCCC
Confidence 4579999999999999999999877664 69999986531 2344567899999999995 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 104 KIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
..++||||+.+++|.+++.. +.+++.+++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 99999999999999999864 5689999999999999999999999999999999999999999999999999875432
Q ss_pred hhcC--cccccC--CCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCC
Q 013005 182 IKNG--MLHTAC--GTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVS 255 (451)
Q Consensus 182 ~~~~--~~~~~~--gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s 255 (451)
.... ...... .+..|+|||.+.+..+ +.++||||+||++|+|++ |..||...+.......+... ..+.+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 237 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCP 237 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcc-cchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCC
Confidence 2111 111111 2457999999877666 556999999999999886 99999887776666665432 234455678
Q ss_pred HhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 256 KPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 256 ~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
..+.+++.+||..+|++||++++++.
T Consensus 238 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 238 TALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 89999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=324.87 Aligned_cols=246 Identities=24% Similarity=0.360 Sum_probs=195.3
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecCCCchhH
Q 013005 40 SFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFG 119 (451)
Q Consensus 40 ~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~ 119 (451)
+++.||.+++..+++.||+|++.... ......+.+.+|+.+++.++ ||||+++++++......|++|||+.+|+|.+
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDS--CSKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVDSELYVVSPLMAYGSCED 88 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccc--cchhHHHHHHHHHHHHHhcC-CcchhhhhheeecCCeEEEEEeccCCCCHHH
Confidence 44556666666799999999997642 23345678999999999996 9999999999999999999999999999999
Q ss_pred Hhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc------Cccccc
Q 013005 120 KLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN------GMLHTA 190 (451)
Q Consensus 120 ~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~------~~~~~~ 190 (451)
++.. ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||.+........ ......
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~ 168 (314)
T cd08216 89 LLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS 168 (314)
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccc
Confidence 9874 4689999999999999999999999999999999999999999999999998754321111 122344
Q ss_pred CCCCccccceeeecc-CCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHH-HHhhccC---------------------
Q 013005 191 CGTPAYTAPEVVARR-GYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMY-KKVNRRD--------------------- 247 (451)
Q Consensus 191 ~gt~~y~APEvl~~~-~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~-~~i~~~~--------------------- 247 (451)
.++..|+|||++... ...+.++||||+||++|+|++|..||......... .++....
T Consensus 169 ~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (314)
T cd08216 169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRS 248 (314)
T ss_pred cccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccc
Confidence 578899999998653 22356799999999999999999999875543322 2221100
Q ss_pred ------------CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 248 ------------YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 248 ------------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
...+..++..+.+|+.+||..||++|||++++++||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 249 SNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred cccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 00111234678899999999999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=312.22 Aligned_cols=248 Identities=23% Similarity=0.391 Sum_probs=207.7
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
..+|++.+.||+|+||.||+|.+. ++..+|+|.+..... ....+.+|+.+++++. ||||+++++++......|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-----SEEDFIEEAQVMMKLS-HPKLVQLYGVCTERSPIC 75 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-----CHHHHHHHHHHHHhCC-CCCeeeEEEEEccCCceE
Confidence 357999999999999999999874 577899999865421 1245788999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 107 LVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
++|||+.+++|.+++.. +.+++..++.++.|++.|+.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 76 LVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 99999999999999864 5689999999999999999999999999999999999999999999999999864322111
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhccC-CCCCCCCCHhHHHHH
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRD-YQFPSFVSKPARSLI 262 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 262 (451)
.......++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+.... ...|...+..+.+|+
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKY-SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELM 234 (256)
T ss_pred cccCCCccchhhcCHhHhccCCc-ChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence 11122335678999999876655 566999999999999998 999999888777777766542 233555789999999
Q ss_pred HhccCCCCCCCCCHHHHHcC
Q 013005 263 YQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 263 ~~~L~~dP~~Rpt~~eil~h 282 (451)
.+||..+|++|||+.+++++
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 235 QHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHcccChhhCCCHHHHHHh
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=311.82 Aligned_cols=249 Identities=23% Similarity=0.391 Sum_probs=206.4
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
....++|++.+.||+|+||.||++.+ ..+..+|+|.+.... ...+.+.+|+.+++++. |+||+++++++.. .
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~-----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~ 73 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK-E 73 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCCh-----hHHHHHHHHHHHHHhcC-CCCcceEEEEEcC-C
Confidence 45678999999999999999999985 456679999886431 23457888999999995 9999999999887 7
Q ss_pred EEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 104 KIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
..|++|||+++++|.+++.+ ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 88999999999999999864 357889999999999999999999999999999999999999999999999987543
Q ss_pred hhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhH
Q 013005 181 QIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPA 258 (451)
Q Consensus 181 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 258 (451)
...........++..|+|||++....+ +.++|+|||||++|++++ |..||...+.......+... ....+...+..+
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL 232 (260)
T ss_pred CCCcccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHH
Confidence 222111222345677999999876554 567999999999999998 99999887776666655543 223455688999
Q ss_pred HHHHHhccCCCCCCCCCHHHHHc
Q 013005 259 RSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 259 ~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.+++.+||.+||++||++.++++
T Consensus 233 ~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 233 YNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHcccCcccCcCHHHHHH
Confidence 99999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=310.28 Aligned_cols=247 Identities=26% Similarity=0.423 Sum_probs=208.5
Q ss_pred eEEcceEcccCceEEEEEEEcCCC----cEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 30 YQLGPLLGRGSFAKVHKAKSIADG----SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 30 y~~~~~LG~G~~g~Vy~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
+++.+.||.|+||.||++.+..++ ..||+|.+.... .......+..|+..++.+ +||||+++++++.+.+..
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 76 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA---DEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPL 76 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC---ChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCee
Confidence 357789999999999999998766 899999996542 222556788999999999 599999999999999999
Q ss_pred EEEEEecCCCchhHHhhcC--C-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 106 YLVMEYAAGGELFGKLRRG--R-LTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~~--~-l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
|++|||+++++|.+++... . +++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 9999999999999999752 2 999999999999999999999999999999999999999999999999998754432
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhccC-CCCCCCCCHhHHH
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRD-YQFPSFVSKPARS 260 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 260 (451)
.........+++.|+|||.+....+ +.++||||+|+++|+|++ |..||...+.......+.... ...+...+..+.+
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYK 235 (258)
T ss_pred cccccccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHH
Confidence 1111112236789999998855444 677999999999999998 899998887777777665543 3455668999999
Q ss_pred HHHhccCCCCCCCCCHHHHHc
Q 013005 261 LIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 261 li~~~L~~dP~~Rpt~~eil~ 281 (451)
++.+||..||++|||+.++++
T Consensus 236 ~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 236 LMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHCcCChhhCcCHHHHHh
Confidence 999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=313.63 Aligned_cols=228 Identities=28% Similarity=0.438 Sum_probs=190.6
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecCCCchh
Q 013005 39 GSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELF 118 (451)
Q Consensus 39 G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~ 118 (451)
|.+|+||++++..+++.||+|.+.+... ..+|...+... .||||+++++++.+....|++|||++||+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~---------~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE---------YSRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh---------hhhHHHHHHhc-CCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence 8999999999999999999999976421 22333334444 4999999999999999999999999999999
Q ss_pred HHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCCCCccc
Q 013005 119 GKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYT 197 (451)
Q Consensus 119 ~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~ 197 (451)
+++.+ ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++++|||++..... ......++..|+
T Consensus 74 ~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~----~~~~~~~~~~y~ 149 (237)
T cd05576 74 SHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED----SCDGEAVENMYC 149 (237)
T ss_pred HHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc----ccccCCcCcccc
Confidence 98864 6799999999999999999999999999999999999999999999999998754322 123445678899
Q ss_pred cceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccCCCCCCCCCH-
Q 013005 198 APEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSI- 276 (451)
Q Consensus 198 APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~- 276 (451)
|||.+....+ +.++|+||+|+++|+|++|..||........ ......+|.++++.+.++|.+||+.||++|||+
T Consensus 150 aPE~~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 150 APEVGGISEE-TEACDWWSLGAILFELLTGKTLVECHPSGIN----THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred CCcccCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchhcc----cccccCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 9999876655 5679999999999999999998865432110 112345778899999999999999999999985
Q ss_pred ----HHHHcCccc
Q 013005 277 ----EKIMSISWF 285 (451)
Q Consensus 277 ----~eil~hp~f 285 (451)
+++++||||
T Consensus 225 ~~~~~~~~~h~~~ 237 (237)
T cd05576 225 VAGVEDIKSHPFF 237 (237)
T ss_pred ccchHHHHcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=314.83 Aligned_cols=249 Identities=19% Similarity=0.364 Sum_probs=209.6
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCc----EEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGS----IVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
.++|++.+.||+|+||.||+|.+..+++ .+|+|.+.... .......+.+|+.+++++. ||||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET---SPKANKEILDEAYVMASVD-HPHVVRLLGICLS- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC---CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEec-
Confidence 4689999999999999999999877665 68999886552 2344567889999999995 9999999999887
Q ss_pred CEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 103 TKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
...++||||+.+|+|.+.+.. +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++....
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 789999999999999999875 569999999999999999999999999999999999999999999999999997654
Q ss_pred hhhcCc-ccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHh
Q 013005 181 QIKNGM-LHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKP 257 (451)
Q Consensus 181 ~~~~~~-~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 257 (451)
...... .....++..|+|||.+....+ +.++||||||+++|+|++ |..||...........+... ....|...+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIY-THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTID 239 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCc-CchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence 322211 112234678999998876655 466999999999999998 99999988777766666554 34556668899
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHc
Q 013005 258 ARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 258 ~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+.+++.+||..||+.|||+.++++
T Consensus 240 ~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 240 VYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHHcCCChhhCCCHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=338.13 Aligned_cols=257 Identities=31% Similarity=0.519 Sum_probs=214.4
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
.-|..++.||-|+||+|.+++..+|...||+|.+++.+ .........++.|-.||..-. .+-||+||-.|.+++++|+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaD-Vl~rnQvaHVKAERDILAEAD-n~WVVrLyySFQDkdnLYF 706 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKAD-VLMRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYF 706 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHH-HHhhhhhhhhhhhhhhHhhcC-CcceEEEEEEeccCCceEE
Confidence 34678899999999999999999999999999998763 344455567888999999885 8999999999999999999
Q ss_pred EEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh-----
Q 013005 108 VMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ----- 181 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~----- 181 (451)
||+|++||++-.++.+ |-|.|+.+|.|+..|..|+++.|..|+|||||||+|||||.+|++||+||||++-+.-
T Consensus 707 VMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred EEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 9999999999887765 8999999999999999999999999999999999999999999999999999753210
Q ss_pred ------------------------------------hhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHH
Q 013005 182 ------------------------------------IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLL 225 (451)
Q Consensus 182 ------------------------------------~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll 225 (451)
......+..+||+.|+|||++.+.+|. ..+|.||.|||||+|+
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVILYEML 865 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHHHHHHh
Confidence 001123456799999999999999995 5599999999999999
Q ss_pred hcCCCCCCCcHHHHHHHhhc--cCCCCC--CCCCHhHHHHHHhccCCCCCCCC---CHHHHHcCccccch
Q 013005 226 AGYLPFDDSNLLAMYKKVNR--RDYQFP--SFVSKPARSLIYQLLDPNPKTRM---SIEKIMSISWFQKS 288 (451)
Q Consensus 226 ~G~~Pf~~~~~~~~~~~i~~--~~~~~p--~~~s~~~~~li~~~L~~dP~~Rp---t~~eil~hp~f~~~ 288 (451)
.|+.||.+....+...++.+ .-+.+| ..+|+++.++|.++ .-+++.|. -++++..||||+..
T Consensus 866 ~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kL-c~sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKL-CCSADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred hCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHH-hcChhhhhcccchhhhhcCcccccc
Confidence 99999987765544433322 223333 46899999999884 45677887 47789999999864
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=308.35 Aligned_cols=256 Identities=26% Similarity=0.421 Sum_probs=207.5
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE-
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA- 100 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~- 100 (451)
.+-+-.++|++.+.||+|+|+.||++.+..++..+|+|.+.-. +....+...+|+...+++. |||+++++++..
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~----~~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~ 89 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH----SQEDIEEALREIDNHRKFN-SPNVLRLVDHQLR 89 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc----chHHHHHHHHHHHHHHhhC-CcchHHHHHHHHH
Confidence 3445567999999999999999999999999999999999654 3456778899999999995 999999987653
Q ss_pred ----eCCEEEEEEEecCCCchhHHhhc----C-CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCeEEeCCCCCeE
Q 013005 101 ----TKTKIYLVMEYAAGGELFGKLRR----G-RLTESAARRYFQQLVSALHFCHQNG--VAHRDVKPQNLLLDRDGNLK 169 (451)
Q Consensus 101 ----~~~~~~lV~E~~~gg~L~~~l~~----~-~l~e~~~~~~~~ql~~gL~yLH~~g--iiHrDLKpeNILld~~~~lk 169 (451)
.+...||+++|...|+|.+.++. | .++|.++.+||.++++||++||+.. ++||||||.|||+++.+.++
T Consensus 90 ~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~v 169 (302)
T KOG2345|consen 90 EEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPV 169 (302)
T ss_pred hhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceE
Confidence 34459999999999999998863 3 5999999999999999999999998 99999999999999999999
Q ss_pred EEeccCCCcchhhhc--------CcccccCCCCccccceeeeccCC--CCccchhhhhhHHHHHHHhcCCCCCCCcH--H
Q 013005 170 VSDFGLSALPEQIKN--------GMLHTACGTPAYTAPEVVARRGY--DGAVADAWSCGVILFVLLAGYLPFDDSNL--L 237 (451)
Q Consensus 170 l~DFGls~~~~~~~~--------~~~~~~~gt~~y~APEvl~~~~~--~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~--~ 237 (451)
|.|||.++...-.-. .......-|..|.|||++.-+.+ .+.++|||||||+||+|+.|..||+..-. .
T Consensus 170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg 249 (302)
T KOG2345|consen 170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG 249 (302)
T ss_pred EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC
Confidence 999999875321110 00112234889999999865443 35679999999999999999999963211 0
Q ss_pred HHHHHhhccCCCCCC--CCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 238 AMYKKVNRRDYQFPS--FVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 238 ~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
.+.-.+..+.+.+|. .+|+.+.++|+.||+.||.+||++.+++.+
T Consensus 250 SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 250 SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 111223444566664 389999999999999999999999999864
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=319.57 Aligned_cols=250 Identities=21% Similarity=0.356 Sum_probs=201.7
Q ss_pred cCCeEEcceEcccCceEEEEEEEcC----------------CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCC
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIA----------------DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP 90 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~----------------~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~Hp 90 (451)
.++|++.+.||+|+||.||++.+.. ++..+|+|++.... .......+.+|+.+++.++ ||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~E~~~l~~l~-~~ 79 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---NKNARNDFLKEIKIMSRLK-DP 79 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCC-CC
Confidence 4689999999999999999986432 34579999986531 2344567889999999995 99
Q ss_pred CceEEEEEEEeCCEEEEEEEecCCCchhHHhhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 013005 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRG------------RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQ 158 (451)
Q Consensus 91 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~------------~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpe 158 (451)
||+++++++......|++|||+.+++|.+++... .+++..++.++.|++.||+|||++|++||||||+
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~ 159 (296)
T cd05095 80 NIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATR 159 (296)
T ss_pred CcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChh
Confidence 9999999999999999999999999999988642 3667889999999999999999999999999999
Q ss_pred eEEeCCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh--cCCCCCCCc
Q 013005 159 NLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA--GYLPFDDSN 235 (451)
Q Consensus 159 NILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~--G~~Pf~~~~ 235 (451)
|||++.++.++|+|||++........ .......+++.|+|||......+ +.++|||||||++|+|++ |..||...+
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 99999999999999999874322111 11223345678999998766555 567999999999999998 789997665
Q ss_pred HHHHHHHhh--------ccCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 236 LLAMYKKVN--------RRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 236 ~~~~~~~i~--------~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
......... ......+..+++.+.+|+.+||..||.+|||+.+|.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 239 DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 544333221 1112334567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=313.92 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=206.6
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCC---CcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIAD---GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
..++|.+.+.||+|+||.||+|.+..+ ...||+|...... .....+.+.+|+.+++.+. ||||+++++++.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~- 78 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFD-HPHIVKLIGVITE- 78 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC---CHHHHHHHHHHHHHHHhCC-CCchhceeEEEcC-
Confidence 346789999999999999999987544 3579999886542 2344567889999999995 9999999998875
Q ss_pred CEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 103 TKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
...|+||||+++|+|.+++.. ..+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++....
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 457899999999999999975 358999999999999999999999999999999999999999999999999987543
Q ss_pred hhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhH
Q 013005 181 QIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPA 258 (451)
Q Consensus 181 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 258 (451)
...........+++.|+|||.+....+ +.++||||||+++|+|++ |..||...+.......+... ....|..++..+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 237 (270)
T ss_pred cccceecCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHH
Confidence 321111122334568999999876655 567999999999999986 99999887766665555543 345667789999
Q ss_pred HHHHHhccCCCCCCCCCHHHHHcC
Q 013005 259 RSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 259 ~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
.+++.+|+..+|.+|||+.+++..
T Consensus 238 ~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 238 YSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=310.85 Aligned_cols=242 Identities=26% Similarity=0.436 Sum_probs=202.9
Q ss_pred ceEcccCceEEEEEEEcC-CC--cEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEE
Q 013005 34 PLLGRGSFAKVHKAKSIA-DG--SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVME 110 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~-~~--~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E 110 (451)
+.||+|++|.||+|.+.. ++ ..||+|.+..... . ...+.+.+|+.++++++ ||||+++++.+.. ...++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~--~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e 75 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--S-DIMDDFLKEAAIMHSLD-HENLIRLYGVVLT-HPLMMVTE 75 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCccc--H-HHHHHHHHHHHHHhhcC-CCCccceeEEEcC-CeEEEEEE
Confidence 468999999999998755 33 3699999976532 1 56678999999999996 9999999999988 89999999
Q ss_pred ecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc--C
Q 013005 111 YAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN--G 185 (451)
Q Consensus 111 ~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~--~ 185 (451)
|+++++|.+.+.+ ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++........ .
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 9999999999975 3589999999999999999999999999999999999999999999999999876533221 1
Q ss_pred cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc--CCCCCCCCCHhHHHHH
Q 013005 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR--DYQFPSFVSKPARSLI 262 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li 262 (451)
......++..|+|||.+....+ +.++|||||||++|+|++ |..||...+..+....+... ....+...+..+.+++
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 234 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTF-SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVM 234 (257)
T ss_pred cccCCCCCceecCHHHhcccCc-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHH
Confidence 1123457889999999877666 556999999999999998 99999887777666665532 2334456789999999
Q ss_pred HhccCCCCCCCCCHHHHHc
Q 013005 263 YQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 263 ~~~L~~dP~~Rpt~~eil~ 281 (451)
.+||..+|.+|||+.++++
T Consensus 235 ~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 235 LQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHCCCCcccCCCHHHHHH
Confidence 9999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=338.22 Aligned_cols=245 Identities=25% Similarity=0.429 Sum_probs=211.1
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
+.+.+.++...-++-||.|+.|-||+|+ -.++.||||.++.. -..+|+-|++|+ ||||+.+.|+|.
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Gr--l~netVAVKKV~el-----------kETdIKHLRkLk-H~NII~FkGVCt 182 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGR--LHNETVAVKKVREL-----------KETDIKHLRKLK-HPNIITFKGVCT 182 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeee--ccCceehhHHHhhh-----------hhhhHHHHHhcc-CcceeeEeeeec
Confidence 4455555666667889999999999998 46789999987532 235778899996 999999999999
Q ss_pred eCCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcc
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALP 179 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~ 179 (451)
...++|||||||..|.|...++. ..++......|..+|+.|+.|||.+.|||||||.-||||+.+..+||+|||.+...
T Consensus 183 qsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 183 QSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred CCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhh
Confidence 99999999999999999999986 56899999999999999999999999999999999999999999999999999765
Q ss_pred hhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc--CCCCCCCCCHh
Q 013005 180 EQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR--DYQFPSFVSKP 257 (451)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~ 257 (451)
... ...-..+||..|||||++.+.+. ..|.|||||||+|||||||..||.+-+...++.-+..+ .+..|..+++.
T Consensus 263 ~~~--STkMSFaGTVaWMAPEvIrnePc-sEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~G 339 (904)
T KOG4721|consen 263 SDK--STKMSFAGTVAWMAPEVIRNEPC-SEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDG 339 (904)
T ss_pred hhh--hhhhhhhhhHhhhCHHHhhcCCc-ccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchH
Confidence 443 34456799999999999988776 57799999999999999999999876655544433333 34567789999
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 258 ARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 258 ~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
++-||+.||.-.|..||++.+|+.|
T Consensus 340 fklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 340 FKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred HHHHHHHHHhcCCCCCccHHHHHHH
Confidence 9999999999999999999999999
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=340.62 Aligned_cols=257 Identities=24% Similarity=0.472 Sum_probs=220.9
Q ss_pred cccCCe-EEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 25 TLLNRY-QLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 25 ~~~~~y-~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
...++| +....||+|+|-+||+|.|..+|-.||--.+...+...+....+++..|+.+|+.|+ |||||++|..+.+..
T Consensus 36 ~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~ 114 (632)
T KOG0584|consen 36 DPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTD 114 (632)
T ss_pred CCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCC
Confidence 445666 456789999999999999999999999766554444455667789999999999996 999999999997755
Q ss_pred E--EEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCeEEeCCC-CCeEEEeccCCC
Q 013005 104 K--IYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNG--VAHRDVKPQNLLLDRD-GNLKVSDFGLSA 177 (451)
Q Consensus 104 ~--~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~g--iiHrDLKpeNILld~~-~~lkl~DFGls~ 177 (451)
. +-+|+|.+.+|+|+.+.++ ++++...++.|++||+.||.|||++. |+|||||-+||+|+.+ |.+||+|+|||+
T Consensus 115 n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAt 194 (632)
T KOG0584|consen 115 NKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLAT 194 (632)
T ss_pred CceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHH
Confidence 4 8899999999999999986 88999999999999999999999994 9999999999999865 899999999998
Q ss_pred cchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCC-CcHHHHHHHhhccCC--CCCCCC
Q 013005 178 LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDD-SNLLAMYKKVNRRDY--QFPSFV 254 (451)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~ 254 (451)
+... .......|||.|||||++. ..|+ ...||||||+.+.||+|+..||.. .+....|+++..+.. .+..--
T Consensus 195 l~r~---s~aksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~ 269 (632)
T KOG0584|consen 195 LLRK---SHAKSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK 269 (632)
T ss_pred Hhhc---cccceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC
Confidence 7543 3334578999999999886 5564 559999999999999999999975 678899999987643 233335
Q ss_pred CHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 255 SKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 255 s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
++++++||.+||.. ...|+|+.|||.||||...
T Consensus 270 dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 270 DPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred CHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 78999999999999 9999999999999999874
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=316.83 Aligned_cols=237 Identities=24% Similarity=0.322 Sum_probs=192.5
Q ss_pred eEcccCceEEEEEEEcCC------------------------CcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCC
Q 013005 35 LLGRGSFAKVHKAKSIAD------------------------GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP 90 (451)
Q Consensus 35 ~LG~G~~g~Vy~a~~~~~------------------------~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~Hp 90 (451)
.||+|+||.||+|....+ ...||+|+++... ......+.+|+.+++.+. ||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~~~~l~-h~ 76 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH----RDIALAFFETASLMSQVS-HI 76 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH----HHHHHHHHHHHHHHhcCC-CC
Confidence 689999999999975321 2468999886432 234456788899999995 99
Q ss_pred CceEEEEEEEeCCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC--
Q 013005 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG-- 166 (451)
Q Consensus 91 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~-- 166 (451)
||+++++++......|+||||+++|+|..++.. +.+++..+..++.|++.||+|||++||+||||||+|||++..+
T Consensus 77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence 999999999999999999999999999998864 6799999999999999999999999999999999999997654
Q ss_pred -----CeEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHH-HhcCCCCCCCcHHHHH
Q 013005 167 -----NLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVL-LAGYLPFDDSNLLAMY 240 (451)
Q Consensus 167 -----~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~L-l~G~~Pf~~~~~~~~~ 240 (451)
.+|++|||++..... .....+++.|+|||.+.+....+.++|||||||++|+| ++|..||.........
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~-----~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 231 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALS-----REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231 (274)
T ss_pred cCccceeeecCCcccccccc-----ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 389999998753211 12345788999999887655557789999999999998 4799999876544332
Q ss_pred HHhhccCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 241 KKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 241 ~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
.. ......+|...++.+.++|.+||..+|++|||+.+++++
T Consensus 232 ~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 232 RF-YEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HH-HHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 22 223344555567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=313.01 Aligned_cols=238 Identities=23% Similarity=0.304 Sum_probs=193.1
Q ss_pred ceEcccCceEEEEEEEcCC------------CcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 34 PLLGRGSFAKVHKAKSIAD------------GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~------------~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
+.||+|+||.||+|+...+ ...||+|+++... ......+.+|+.+++.+. ||||+++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH----RDISLAFFETASMMRQVS-HKHIVLLYGVCVR 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh----hhHHHHHHHHHHHHHhCC-CCCEeeEEEEEec
Confidence 4689999999999985322 2358889876532 234557888999999995 9999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCC-------eEEEe
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN-------LKVSD 172 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~-------lkl~D 172 (451)
+...+++|||+++|+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++. ++++|
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999999999888863 56999999999999999999999999999999999999987664 89999
Q ss_pred ccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHH-hcCCCCCCCcHHHHHHHhhccCCCCC
Q 013005 173 FGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLL-AGYLPFDDSNLLAMYKKVNRRDYQFP 251 (451)
Q Consensus 173 FGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll-~G~~Pf~~~~~~~~~~~i~~~~~~~p 251 (451)
||++..... .....|+..|+|||.+......+.++||||+||++|+|+ .|..||.......... .........
T Consensus 156 ~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~~ 229 (262)
T cd05077 156 PGIPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCMLV 229 (262)
T ss_pred CCCCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccCC
Confidence 999864321 234568899999999875555567799999999999997 5899987765443322 222333333
Q ss_pred CCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 252 SFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 252 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
...+.++.+||.+||..||.+||++.+|+.+
T Consensus 230 ~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 230 TPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 4456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=314.46 Aligned_cols=253 Identities=20% Similarity=0.317 Sum_probs=209.1
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcC----CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIA----DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~ 99 (451)
....++|++.+.||+|+||.||+|.+.. ++..|++|.+... ......+.+.+|+.+++++. ||||+++++++
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~ 77 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH---ASEIQVTLLLQESCLLYGLS-HQNILPILHVC 77 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC---CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEE
Confidence 3456789999999999999999999865 3688999988643 23444677889999999995 99999999987
Q ss_pred Ee-CCEEEEEEEecCCCchhHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeE
Q 013005 100 AT-KTKIYLVMEYAAGGELFGKLRR---------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLK 169 (451)
Q Consensus 100 ~~-~~~~~lV~E~~~gg~L~~~l~~---------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lk 169 (451)
.. ....++++||+.+++|.+++.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 78 IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred ecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEE
Confidence 65 5778999999999999998854 3489999999999999999999999999999999999999999999
Q ss_pred EEeccCCCcchhhhcC-cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-
Q 013005 170 VSDFGLSALPEQIKNG-MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR- 246 (451)
Q Consensus 170 l~DFGls~~~~~~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~- 246 (451)
|+|||+++........ ......++..|+|||.+.+..+ +.++||||||+++|++++ |..||...+.......+...
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 236 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY 236 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC
Confidence 9999999754221111 1122345778999999877665 566999999999999998 99999887776666655543
Q ss_pred CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 247 DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 247 ~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
....+..+++.+.+++.+||..||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 237 RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 22344567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=315.13 Aligned_cols=253 Identities=28% Similarity=0.478 Sum_probs=209.9
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcc-hhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNK-FLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
+|.+.+.||+|+||.||++.+..++..+++|++..... .........+.+|+.+++.++ ||||+++++.+.+....++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHhcCCceEE
Confidence 68999999999999999999988888788877754311 111223345667899999995 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 108 VMEYAAGGELFGKLRR-----GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~-----~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
|+||+.+++|.+.+.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++. +.++|+|||++......
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 9999999999988752 56999999999999999999999999999999999999975 57999999998654321
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhHHHH
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPARSL 261 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 261 (451)
........|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+... ....+..++..+.++
T Consensus 159 -~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 159 -CDLATTFTGTPYYMSPEALKHQGY-DSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236 (260)
T ss_pred -cccccCCCCCcCccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHH
Confidence 122334568899999999876665 45699999999999999999999877766666655443 334455678999999
Q ss_pred HHhccCCCCCCCCCHHHHHcCccc
Q 013005 262 IYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 262 i~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
|.+||..||++||+++++++||||
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=308.42 Aligned_cols=242 Identities=25% Similarity=0.411 Sum_probs=203.1
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecC
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAA 113 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~ 113 (451)
+.||+|+||.||+|.+.. ++.||+|.+..... ......+.+|+.+++++. ||||+++++++.+....|+||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~ 75 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYD-HPNIVKLIGVCVQKQPIYIVMELVP 75 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC---HHHHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCCeEEEEEcCC
Confidence 468999999999999877 99999999876422 234567899999999995 9999999999999999999999999
Q ss_pred CCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC-ccccc
Q 013005 114 GGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG-MLHTA 190 (451)
Q Consensus 114 gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~-~~~~~ 190 (451)
|++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......... .....
T Consensus 76 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 76 GGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 9999999864 56899999999999999999999999999999999999999999999999998754321111 11123
Q ss_pred CCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhHHHHHHhccCC
Q 013005 191 CGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPARSLIYQLLDP 268 (451)
Q Consensus 191 ~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~ 268 (451)
.++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+... ....|...+..+.+++.+||..
T Consensus 156 ~~~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 234 (251)
T cd05041 156 QIPIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAY 234 (251)
T ss_pred cceeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhcc
Confidence 34667999999876655 567999999999999998 89999887766666555443 3345567889999999999999
Q ss_pred CCCCCCCHHHHHc
Q 013005 269 NPKTRMSIEKIMS 281 (451)
Q Consensus 269 dP~~Rpt~~eil~ 281 (451)
+|++|||++++++
T Consensus 235 ~p~~Rp~~~ell~ 247 (251)
T cd05041 235 DPENRPSFSEIYN 247 (251)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=319.70 Aligned_cols=255 Identities=26% Similarity=0.444 Sum_probs=208.0
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCC-CC----ceEEEE
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH-PN----VLKIQE 97 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~H-pn----Iv~l~~ 97 (451)
.+.+.++|++..++|+|.||+|-.+.+.+++..||||+++... ...+...-|+.+++++..+ |+ +|++.+
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-----KYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 3567899999999999999999999999999999999996543 2345566789999999433 33 788899
Q ss_pred EEEeCCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC----------
Q 013005 98 VMATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR---------- 164 (451)
Q Consensus 98 ~~~~~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~---------- 164 (451)
+|+-.+++|||+|.+ |.++++++.. -+++-.+++.+..||+++|+|||+.+++|-||||||||+..
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccC
Confidence 999999999999988 6699999986 36999999999999999999999999999999999999832
Q ss_pred ----------CCCeEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCC
Q 013005 165 ----------DGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS 234 (451)
Q Consensus 165 ----------~~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~ 234 (451)
+..++|+|||.|+.... .-.+.+.|..|.|||++.+-++. .++||||+||||+||.+|...|...
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e----~hs~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHE----HHSTIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred CccceeccCCCcceEEEecCCcceecc----CcceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccceecccC
Confidence 23589999999986433 23567889999999999999995 5599999999999999999999865
Q ss_pred cHHH---HHHHhhcc------------------CCCCCC-------------------------CCCHhHHHHHHhccCC
Q 013005 235 NLLA---MYKKVNRR------------------DYQFPS-------------------------FVSKPARSLIYQLLDP 268 (451)
Q Consensus 235 ~~~~---~~~~i~~~------------------~~~~p~-------------------------~~s~~~~~li~~~L~~ 268 (451)
+..+ +.+.|... ....|. ....++.+||++||.+
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 5333 44333210 111110 0123578999999999
Q ss_pred CCCCCCCHHHHHcCccccch
Q 013005 269 NPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 269 dP~~Rpt~~eil~hp~f~~~ 288 (451)
||.+|+|+.|++.||||...
T Consensus 393 DP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 393 DPARRITLREALSHPFFARL 412 (415)
T ss_pred CccccccHHHHhcCHHhhcC
Confidence 99999999999999999753
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=310.52 Aligned_cols=244 Identities=23% Similarity=0.310 Sum_probs=191.1
Q ss_pred ceEcccCceEEEEEEEcC--CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEe
Q 013005 34 PLLGRGSFAKVHKAKSIA--DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEY 111 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~ 111 (451)
+.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.+. ||||+++++.+......|+||||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~-h~nii~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA---TPDEQLLFLQEVQPYRELN-HPNVLQCLGQCIESIPYLLVLEF 76 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC---ChHHHHHHHHHHHHHHhCC-CCCcceEEEEECCCCceEEEEEe
Confidence 468999999999996432 34578888775432 2334556788999999995 99999999999999999999999
Q ss_pred cCCCchhHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc-
Q 013005 112 AAGGELFGKLRRG------RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN- 184 (451)
Q Consensus 112 ~~gg~L~~~l~~~------~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~- 184 (451)
+++|+|.+++... ..++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 9999999998642 246788899999999999999999999999999999999999999999999864322111
Q ss_pred CcccccCCCCccccceeeecc------CCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHh-hccCCC-----CC
Q 013005 185 GMLHTACGTPAYTAPEVVARR------GYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKV-NRRDYQ-----FP 251 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~------~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i-~~~~~~-----~p 251 (451)
.......+++.|+|||++... ...+.++||||+||++|+|++ |..||............ ...... .+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLD 236 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccc
Confidence 112334567789999987532 233667999999999999999 88999876655444433 332222 23
Q ss_pred CCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 252 SFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 252 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
..++....+++..|+ .||.+|||++++++.
T Consensus 237 ~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 237 LKYSDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred ccCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 357788899999998 599999999999863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=312.86 Aligned_cols=249 Identities=21% Similarity=0.355 Sum_probs=199.4
Q ss_pred CeEEcceEcccCceEEEEEEE----cCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC--
Q 013005 29 RYQLGPLLGRGSFAKVHKAKS----IADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK-- 102 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~-- 102 (451)
-|++.+.||+|+||.||++.. ..++..||+|.+.... .......+.+|+.+++++. ||||+++++++...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc---cHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCC
Confidence 368899999999999999974 4578899999986542 2334567899999999995 99999999998765
Q ss_pred CEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 103 TKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
...|+||||++|++|.+++.+ ..+++.++..++.|++.||+|||++|++||||||+||+++.++.++|+|||++....
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 678999999999999999864 358999999999999999999999999999999999999999999999999987543
Q ss_pred hhhc--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCc---------------HHHHHHHh
Q 013005 181 QIKN--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN---------------LLAMYKKV 243 (451)
Q Consensus 181 ~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~---------------~~~~~~~i 243 (451)
.... .......|+..|+|||.+.+..+ +.++||||+||++|+|+++..|+.... .......+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCC-CccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 2211 11234567788999999877655 567999999999999999877653211 01111111
Q ss_pred hc-cCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 244 NR-RDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 244 ~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
.. ...+.+..++..+.+|+.+||..||++|||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 240 EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 11 1233455688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=310.84 Aligned_cols=243 Identities=24% Similarity=0.374 Sum_probs=200.7
Q ss_pred ceEcccCceEEEEEEEcCCC------cEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 34 PLLGRGSFAKVHKAKSIADG------SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~------~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
+.||+|+||.||+|.+.... ..+|+|.+.+.. .......+.+|+.+++.+. ||||+++++++......|+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 76 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA---TDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLLNEPQYI 76 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc---chhhHHHHHHHHHHHHhcC-CCCeeeEeeeecCCCCeEE
Confidence 46899999999999876544 689999886431 1233457888999999995 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC-----CeEEEecc
Q 013005 108 VMEYAAGGELFGKLRR--------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG-----NLKVSDFG 174 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~--------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~-----~lkl~DFG 174 (451)
||||+++++|.+++.. ..+++.++..++.|++.||.|||+++++|+||||+||+++.++ .++|+|||
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 9999999999998853 2378899999999999999999999999999999999999887 89999999
Q ss_pred CCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCC
Q 013005 175 LSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFP 251 (451)
Q Consensus 175 ls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p 251 (451)
++........ .......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+... ....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKP 235 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCc
Confidence 9864322111 11223456788999999876655 677999999999999998 99999887766666555432 34556
Q ss_pred CCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 252 SFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 252 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
..++..+.++|.+||..+|++|||++++++
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 236 ENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 678999999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=308.66 Aligned_cols=243 Identities=23% Similarity=0.298 Sum_probs=191.7
Q ss_pred ceEcccCceEEEEEEEc--CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEe
Q 013005 34 PLLGRGSFAKVHKAKSI--ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEY 111 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~ 111 (451)
+.||+|+||.||+|... .++..+|+|.+.... .......+.+|+.++++++ ||||+++++.+.+....|+||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA---SVQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEVTPYLLVMEF 76 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCCcEEEEEC
Confidence 46899999999999754 355789999986542 1233456888999999995 99999999999999999999999
Q ss_pred cCCCchhHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc-
Q 013005 112 AAGGELFGKLRR------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN- 184 (451)
Q Consensus 112 ~~gg~L~~~l~~------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~- 184 (451)
+++|+|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 999999999863 1356778889999999999999999999999999999999999999999999864322111
Q ss_pred CcccccCCCCccccceeeeccC------CCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHH-hhccCCCCC-----
Q 013005 185 GMLHTACGTPAYTAPEVVARRG------YDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKK-VNRRDYQFP----- 251 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~------~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~-i~~~~~~~p----- 251 (451)
......+|++.|+|||++.+.. ..+.++||||+|+++|+|++ |..||........... +......++
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLK 236 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccC
Confidence 1122346788999999986432 13567999999999999996 9999987655543332 222222222
Q ss_pred CCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 252 SFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 252 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
...++.+.+++.+|+ .+|++|||+++|..
T Consensus 237 ~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 237 LPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 235788999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=310.68 Aligned_cols=248 Identities=23% Similarity=0.373 Sum_probs=197.7
Q ss_pred CCeEEcceEcccCceEEEEEE----EcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe--
Q 013005 28 NRYQLGPLLGRGSFAKVHKAK----SIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT-- 101 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~-- 101 (451)
.+|++.+.||+|+||.||++. +..++..||+|.+.... ......+.+|+.++++++ ||||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST----AEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAG 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC----HHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCC
Confidence 478999999999999999997 45678899999986542 344567889999999995 9999999998643
Q ss_pred CCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcc
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALP 179 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~ 179 (451)
....|+||||+++++|.+++.+ +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 4568999999999999999864 46899999999999999999999999999999999999999999999999998754
Q ss_pred hhhhcCc--ccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHH----------------HHH
Q 013005 180 EQIKNGM--LHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLA----------------MYK 241 (451)
Q Consensus 180 ~~~~~~~--~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~----------------~~~ 241 (451)
....... .....++..|+|||.+.+..+ +.++||||+||++|+|++|..|+....... +..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 3321111 112234456999999876655 567999999999999999987765432111 111
Q ss_pred Hhhc-cCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 242 KVNR-RDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 242 ~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.+.. .....+..++..+.+|+.+||..+|++|||+.+|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1111 122334567899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=306.71 Aligned_cols=244 Identities=22% Similarity=0.361 Sum_probs=196.3
Q ss_pred ceEcccCceEEEEEEEcC---CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE-eCCEEEEEE
Q 013005 34 PLLGRGSFAKVHKAKSIA---DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA-TKTKIYLVM 109 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~-~~~~~~lV~ 109 (451)
+.||+|+||.||+|.+.. ++..+|+|.+.... .....+.+.+|+.+++.++ ||||+++++++. .++..|++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT---DLEEVEQFLKEGIIMKDFS-HPNVLSLLGICLPSEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC---CHHHHHHHHHHHHHHccCC-CCCcceEEEEeecCCCCcEEEE
Confidence 468999999999998654 34579999885431 2334567888999999995 999999999765 466789999
Q ss_pred EecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc---
Q 013005 110 EYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN--- 184 (451)
Q Consensus 110 E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~--- 184 (451)
||+.+|+|.+++.+ ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++........
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 99999999999874 4577888899999999999999999999999999999999999999999999874322111
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhHHHHH
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPARSLI 262 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li 262 (451)
.......+++.|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+.......+... ....+..+++.+.+++
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 235 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVM 235 (262)
T ss_pred cccccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHH
Confidence 11123346778999999877665 567999999999999999 56778776666655555443 2344556789999999
Q ss_pred HhccCCCCCCCCCHHHHHcC
Q 013005 263 YQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 263 ~~~L~~dP~~Rpt~~eil~h 282 (451)
.+||.++|++||++.++++.
T Consensus 236 ~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 236 LSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHcCCChhhCCCHHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=315.07 Aligned_cols=261 Identities=27% Similarity=0.434 Sum_probs=208.1
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCc----EEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGS----IVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
+....|++...||+|.||.||+|....++. .+|||.++.+.. ........-||+..++.|+ |||++.+..++.
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd--~tGiS~SAcREiaL~REl~-h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD--GTGISMSACREIALLRELK-HPNVISLVKVFL 97 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC--CCCcCHHHHHHHHHHHHhc-CCcchhHHHHHh
Confidence 445679999999999999999996555433 789999876522 1123345678999999996 999999999997
Q ss_pred e-CCEEEEEEEecCCCchhHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCC----CCeE
Q 013005 101 T-KTKIYLVMEYAAGGELFGKLRR------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD----GNLK 169 (451)
Q Consensus 101 ~-~~~~~lV~E~~~gg~L~~~l~~------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~----~~lk 169 (451)
+ +.++|+++||.+. +|++.|+- ..++...++.++.||+.|+.|||++-|+||||||.|||+..+ |.+|
T Consensus 98 ~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeE
Confidence 7 8899999999976 88888852 358999999999999999999999999999999999999887 8999
Q ss_pred EEeccCCCcchhhhcC--cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcH---------HH
Q 013005 170 VSDFGLSALPEQIKNG--MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNL---------LA 238 (451)
Q Consensus 170 l~DFGls~~~~~~~~~--~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~---------~~ 238 (451)
|+|||+++.+...-.. .....+-|.+|.|||++.+...++++.|||+.|||+.||++-.+.|.+... ..
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 9999999987654332 234566799999999999988888999999999999999998887753211 01
Q ss_pred HHHHhhc---------------------------cCCC----CCCC------CCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 239 MYKKVNR---------------------------RDYQ----FPSF------VSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 239 ~~~~i~~---------------------------~~~~----~p~~------~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
...+|.. ..+. ++.| -++.+.+|+.+||.+||-+|+|+++.++
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 1111100 0000 1111 3556889999999999999999999999
Q ss_pred Cccccchh
Q 013005 282 ISWFQKSL 289 (451)
Q Consensus 282 hp~f~~~~ 289 (451)
|+||.+..
T Consensus 337 h~yF~~d~ 344 (438)
T KOG0666|consen 337 HPYFTEDP 344 (438)
T ss_pred ccccccCC
Confidence 99998764
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=307.43 Aligned_cols=251 Identities=28% Similarity=0.514 Sum_probs=208.8
Q ss_pred CeEEcceEcccCceEEEEEEEcC-CCcEEEEEEeecCcc------hhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIA-DGSIVAIKTIEKNNK------FLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~-~~~~vAiK~i~~~~~------~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... .........+.+|+.++.+..+||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999887 688999999864321 12233445677888888764469999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCeEEeCCCCCeEEEeccC
Q 013005 102 KTKIYLVMEYAAGGELFGKLR-----RGRLTESAARRYFQQLVSALHFCHQ-NGVAHRDVKPQNLLLDRDGNLKVSDFGL 175 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~-----~~~l~e~~~~~~~~ql~~gL~yLH~-~giiHrDLKpeNILld~~~~lkl~DFGl 175 (451)
.+..|++|||+.|++|.+.+. ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 999999999999999988773 2469999999999999999999996 7899999999999999999999999999
Q ss_pred CCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCC-CC-C
Q 013005 176 SALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQF-PS-F 253 (451)
Q Consensus 176 s~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~-p~-~ 253 (451)
+....... ......|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+....... +. .
T Consensus 161 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd08528 161 AKQKQPES--KLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237 (269)
T ss_pred eeeccccc--ccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCccc
Confidence 87543322 3345678999999999976554 677999999999999999999998877766666655444332 22 5
Q ss_pred CCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 254 VSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 254 ~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
+++.+.++|.+||..||++|||+.++..+
T Consensus 238 ~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 238 YSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 78999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=328.95 Aligned_cols=256 Identities=28% Similarity=0.434 Sum_probs=215.2
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEcCCCc---E-EEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEE
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGS---I-VAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQ 96 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~---~-vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~ 96 (451)
..+...-++-.+.+.||+|+||.||+|.-...+. . ||+|..... ..........+.+|..+|++++ |||||++|
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~-~~~~~~~~~e~m~EArvMr~l~-H~NVVr~y 227 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGS-SELTKEQIKEFMKEARVMRQLN-HPNVVRFY 227 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccc-ccccHHHHHHHHHHHHHHHhCC-CCCEEEEE
Confidence 3444445555677899999999999998765422 3 899998753 2244566778999999999995 99999999
Q ss_pred EEEEeCCEEEEEEEecCCCchhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEecc
Q 013005 97 EVMATKTKIYLVMEYAAGGELFGKLRRG--RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFG 174 (451)
Q Consensus 97 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFG 174 (451)
|+.....-+|+|||+|.||+|.+++++. .++..+...++.+.+.||+|||+++++||||-.+|+|++.++.+||+|||
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccc
Confidence 9999999999999999999999999863 49999999999999999999999999999999999999999999999999
Q ss_pred CCCcchhhhcCccccc-CCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhccCC--CC
Q 013005 175 LSALPEQIKNGMLHTA-CGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRDY--QF 250 (451)
Q Consensus 175 ls~~~~~~~~~~~~~~-~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~~~--~~ 250 (451)
+|+..... ...... .-...|+|||.+....| +.++||||+||++||+++ |..||.+....+...++....+ +.
T Consensus 308 Ls~~~~~~--~~~~~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~ 384 (474)
T KOG0194|consen 308 LSRAGSQY--VMKKFLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI 384 (474)
T ss_pred cccCCcce--eeccccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC
Confidence 98754321 111112 24568999999988755 677999999999999999 8899999999999999855444 45
Q ss_pred CCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 251 PSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 251 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
|...+..+..++.+|+..||+.|||+.++.+
T Consensus 385 ~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 385 PSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred CCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 6677889999999999999999999999875
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=314.30 Aligned_cols=250 Identities=19% Similarity=0.330 Sum_probs=204.0
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCc----EEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGS----IVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
.++|+..+.||+|+||.||+|.+..++. .||+|.+.... .......+.+|+.+++.+. ||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~ 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT---GPKANVEFMDEALIMASMD-HPHLVRLLGVCLSP 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC---CHHHHHHHHHHHHHHHhCC-CCCcccEEEEEcCC
Confidence 4678899999999999999999887776 47888886542 2233446889999999995 99999999998654
Q ss_pred CEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 103 TKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
..++++||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 46799999999999999864 468999999999999999999999999999999999999999999999999997543
Q ss_pred hhhcC-cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHh
Q 013005 181 QIKNG-MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKP 257 (451)
Q Consensus 181 ~~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 257 (451)
..... ......++..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.........+... ....++..+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTID 239 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence 32211 1223445778999999876655 566999999999999997 99999876655544444332 23344567889
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 258 ARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 258 ~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
+.+++.+||..+|++||+++++++.
T Consensus 240 ~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 240 VYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=305.49 Aligned_cols=240 Identities=25% Similarity=0.465 Sum_probs=201.7
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
.++|++.+.||+|+||.||++. .+++.||+|.+.... ..+.+.+|+.+++.++ ||||+++++++... ..|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~------~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~-~~~ 74 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV------TAQAFLEETAVMTKLH-HKNLVRLLGVILHN-GLY 74 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc------hHHHHHHHHHHHHhCC-CCCcCeEEEEEcCC-CcE
Confidence 4689999999999999999986 578899999986531 2356788999999995 99999999998654 479
Q ss_pred EEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 107 LVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
++|||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~- 153 (254)
T cd05083 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG- 153 (254)
T ss_pred EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence 99999999999999874 35899999999999999999999999999999999999999999999999998643221
Q ss_pred cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhccC-CCCCCCCCHhHHHH
Q 013005 184 NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRD-YQFPSFVSKPARSL 261 (451)
Q Consensus 184 ~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 261 (451)
......+..|+|||.+.+..+ +.++|+||+|+++|+|++ |..||...+.......+.... ...+..++..+.++
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVL 229 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHH
Confidence 122334578999998876655 567999999999999997 999998887776666555432 23345678999999
Q ss_pred HHhccCCCCCCCCCHHHHHc
Q 013005 262 IYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 262 i~~~L~~dP~~Rpt~~eil~ 281 (451)
+.+||..+|++|||+++++.
T Consensus 230 i~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 230 MTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=306.41 Aligned_cols=235 Identities=23% Similarity=0.286 Sum_probs=191.7
Q ss_pred ceEcccCceEEEEEEEcCCC----------cEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 34 PLLGRGSFAKVHKAKSIADG----------SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~----------~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
+.||+|+||.||+|.+..++ ..+++|++.... .....+.+|+.+++++. ||||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RDSLAFFETASLMSQLS-HKHLVKLYGVCVR-D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hhHHHHHHHHHHHHcCC-CcchhheeeEEec-C
Confidence 46899999999999987776 357888775432 11567889999999995 9999999999887 7
Q ss_pred EEEEEEEecCCCchhHHhhc-C-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC-------CeEEEecc
Q 013005 104 KIYLVMEYAAGGELFGKLRR-G-RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG-------NLKVSDFG 174 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~-~-~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~-------~lkl~DFG 174 (451)
..++||||+.+|+|.+++.. + .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 78999999999999999975 3 689999999999999999999999999999999999999888 79999999
Q ss_pred CCCcchhhhcCcccccCCCCccccceeeecc-CCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhccCCCCCC
Q 013005 175 LSALPEQIKNGMLHTACGTPAYTAPEVVARR-GYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRDYQFPS 252 (451)
Q Consensus 175 ls~~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~~~~~p~ 252 (451)
++..... .....++..|+|||++... ...+.++||||||+++|+|++ |..||...+......... .....+.
T Consensus 154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~ 227 (259)
T cd05037 154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPM 227 (259)
T ss_pred ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCC
Confidence 9875322 2234577889999998765 345677999999999999999 688887665333322222 2222233
Q ss_pred CCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 253 FVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 253 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.....+.++|.+||..||.+|||+.++++
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 228 PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 33488999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=350.07 Aligned_cols=255 Identities=30% Similarity=0.524 Sum_probs=209.5
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe---
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT--- 101 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~--- 101 (451)
....+|+.++.||+|+||.||+++|+-+|..||||.|.... +......+.+|+..+.+| +|||||++|..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~ 551 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTA 551 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCC
Confidence 45678899999999999999999999999999999998652 455667899999999999 59999999532200
Q ss_pred --------------------------------------------------------------------------------
Q 013005 102 -------------------------------------------------------------------------------- 101 (451)
Q Consensus 102 -------------------------------------------------------------------------------- 101 (451)
T Consensus 552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S 631 (1351)
T KOG1035|consen 552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS 631 (1351)
T ss_pred ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence
Q ss_pred ----------------------------C--------CEEEEEEEecCCCchhHHhhcCCCC--HHHHHHHHHHHHHHHH
Q 013005 102 ----------------------------K--------TKIYLVMEYAAGGELFGKLRRGRLT--ESAARRYFQQLVSALH 143 (451)
Q Consensus 102 ----------------------------~--------~~~~lV~E~~~gg~L~~~l~~~~l~--e~~~~~~~~ql~~gL~ 143 (451)
+ ..+||-||||+...|.++++++.+. ...++++|+||++||.
T Consensus 632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLA 711 (1351)
T ss_pred cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHH
Confidence 0 1368999999998999999887764 7889999999999999
Q ss_pred HHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch----h-------------hhcCcccccCCCCccccceeeeccC
Q 013005 144 FCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE----Q-------------IKNGMLHTACGTPAYTAPEVVARRG 206 (451)
Q Consensus 144 yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~----~-------------~~~~~~~~~~gt~~y~APEvl~~~~ 206 (451)
|+|++|+|||||||.||++|+++++||+|||+|+... . ...+.....+||.-|+|||++.+..
T Consensus 712 YIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 712 YIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred HHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 9999999999999999999999999999999998621 0 0112345678999999999998877
Q ss_pred --CCCccchhhhhhHHHHHHHhcCCCCCCC-cHHHHHHHhhccCCCCCCC----CCHhHHHHHHhccCCCCCCCCCHHHH
Q 013005 207 --YDGAVADAWSCGVILFVLLAGYLPFDDS-NLLAMYKKVNRRDYQFPSF----VSKPARSLIYQLLDPNPKTRMSIEKI 279 (451)
Q Consensus 207 --~~~~~sDIwSlGvil~~Ll~G~~Pf~~~-~~~~~~~~i~~~~~~~p~~----~s~~~~~li~~~L~~dP~~Rpt~~ei 279 (451)
.+..|+|+||||||||||+. ||... ........+.++.+++|.. --+...++|+.||+.||.+|||+.|+
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eL 868 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATEL 868 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHH
Confidence 45678999999999999984 57543 3335566666666666522 23456789999999999999999999
Q ss_pred HcCcccc
Q 013005 280 MSISWFQ 286 (451)
Q Consensus 280 l~hp~f~ 286 (451)
|++.||.
T Consensus 869 L~s~llp 875 (1351)
T KOG1035|consen 869 LNSELLP 875 (1351)
T ss_pred hhccCCC
Confidence 9999997
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=322.76 Aligned_cols=255 Identities=29% Similarity=0.450 Sum_probs=201.2
Q ss_pred CCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE
Q 013005 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 19 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
+...+....++|.-.+.||+|+||.||+|.. .++..||||.+...... . ...|.+|+.++.+++ |||+|+|+|+
T Consensus 66 s~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~---~-~~eF~~Ei~~ls~l~-H~Nlv~LlGy 139 (361)
T KOG1187|consen 66 SYDELRKATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQ---G-EREFLNEVEILSRLR-HPNLVKLLGY 139 (361)
T ss_pred eHHHHHHHHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCc---c-hhHHHHHHHHHhcCC-CcCcccEEEE
Confidence 3455566778999999999999999999985 55699999988665321 1 344999999999997 9999999999
Q ss_pred EEeCC-EEEEEEEecCCCchhHHhhc--C-CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCCCeEEeCCCCCeEEE
Q 013005 99 MATKT-KIYLVMEYAAGGELFGKLRR--G-RLTESAARRYFQQLVSALHFCHQNG---VAHRDVKPQNLLLDRDGNLKVS 171 (451)
Q Consensus 99 ~~~~~-~~~lV~E~~~gg~L~~~l~~--~-~l~e~~~~~~~~ql~~gL~yLH~~g---iiHrDLKpeNILld~~~~lkl~ 171 (451)
|.+.+ ..+||+||+.+|+|.+.+.. + .++|....+|+.++++||+|||... |+||||||+|||||++.+.||+
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 99988 59999999999999999974 3 7899999999999999999999864 9999999999999999999999
Q ss_pred eccCCCcchhhhcCccccc-CCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCc------HHHH-HHHh
Q 013005 172 DFGLSALPEQIKNGMLHTA-CGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN------LLAM-YKKV 243 (451)
Q Consensus 172 DFGls~~~~~~~~~~~~~~-~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~------~~~~-~~~i 243 (451)
|||+|...... .....+. .||..|+|||.+.. +..+.++|||||||+|.||++|+.|.+... .... ...+
T Consensus 220 DFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCcc-ccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999654331 1112222 89999999998866 455778999999999999999999887532 1111 1122
Q ss_pred hccC------CCCC-CCCC--H---hHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 244 NRRD------YQFP-SFVS--K---PARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 244 ~~~~------~~~p-~~~s--~---~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.... ..+. ...+ . .+..+..+|+..+|..||++.|+.+
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 2211 1111 1222 2 2456788999999999999999754
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=305.65 Aligned_cols=243 Identities=21% Similarity=0.299 Sum_probs=190.5
Q ss_pred ceEcccCceEEEEEEEcCC--CcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEe
Q 013005 34 PLLGRGSFAKVHKAKSIAD--GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEY 111 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~ 111 (451)
+.||+|+||+||+|....+ ...+++|.+.... .....+.+.+|+.+++.+. ||||+++++.+......|+||||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 76 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA---SSKEQNEFLQQGDPYRILQ-HPNILQCLGQCVEAIPYLLVFEY 76 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC---ChHHHHHHHHHHHHHhccC-CcchhheEEEecCCCccEEEEec
Confidence 3699999999999975433 3356677765432 2234567889999999995 99999999999999999999999
Q ss_pred cCCCchhHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh-cC
Q 013005 112 AAGGELFGKLRR-----GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK-NG 185 (451)
Q Consensus 112 ~~gg~L~~~l~~-----~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~-~~ 185 (451)
+++|+|.+++.+ ..+++..++.++.|++.||+|||+++++||||||+|||++.++.++|+|||++....... ..
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 999999999864 236677888999999999999999999999999999999999999999999975321111 11
Q ss_pred cccccCCCCccccceeeeccC------CCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-C-----CCCCC
Q 013005 186 MLHTACGTPAYTAPEVVARRG------YDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-D-----YQFPS 252 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~------~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~-----~~~p~ 252 (451)
.....+|++.|+|||++.... ..+.++|||||||++|+|++ |..||...+..+.+..+... . ...+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLEL 236 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCC
Confidence 223457899999999985321 12567999999999999996 57788776665555543322 2 12334
Q ss_pred CCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 253 FVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 253 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.+++.+.+++..|+ .+|.+|||+++|++
T Consensus 237 ~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 237 PYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 47888999999999 67999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=295.83 Aligned_cols=255 Identities=24% Similarity=0.453 Sum_probs=209.7
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC--C
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK--T 103 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~--~ 103 (451)
-.++|++.+.+|+|-|+.||.|++..+++.++||+++... ...+++|+.||+.|++||||++++++..+. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk 108 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESK 108 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-------HHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence 4678999999999999999999999999999999997543 367999999999999999999999998654 4
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCC-CCeEEEeccCCCcchhh
Q 013005 104 KIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD-GNLKVSDFGLSALPEQI 182 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~-~~lkl~DFGls~~~~~~ 182 (451)
.+.+|+||+++.+...+. ..++..+++.|+.||+.||.|||++||+|||+||.|+++|.. ..++|+|+|||..+..
T Consensus 109 tpaLiFE~v~n~Dfk~ly--~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp- 185 (338)
T KOG0668|consen 109 TPSLIFEYVNNTDFKQLY--PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP- 185 (338)
T ss_pred CchhHhhhhccccHHHHh--hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC-
Confidence 678999999887765554 358889999999999999999999999999999999999965 4699999999987654
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCC-CcHHHHHHHhh-------------ccCC
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDD-SNLLAMYKKVN-------------RRDY 248 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~-~~~~~~~~~i~-------------~~~~ 248 (451)
......++.+..|..||++.+-..+...-|+|||||+|..|+..+.||.. .+..+...+|. +-..
T Consensus 186 -~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 186 -GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred -CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 23455677899999999998877777778999999999999999999853 22222211111 0000
Q ss_pred C-------------------C-----CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchhHH
Q 013005 249 Q-------------------F-----PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQ 291 (451)
Q Consensus 249 ~-------------------~-----p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~~ 291 (451)
. | ....++++.+|+.++|..|-++|+|+.|.+.||||......
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~ 331 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREA 331 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHH
Confidence 0 0 01257899999999999999999999999999999865443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=336.28 Aligned_cols=258 Identities=24% Similarity=0.374 Sum_probs=217.9
Q ss_pred CCCCcccccCCeEEcceEcccCceEEEEEEEcC-----CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCce
Q 013005 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIA-----DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVL 93 (451)
Q Consensus 19 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv 93 (451)
..........+-++.+.||+|+||+||+|.-.. ....||||.++... +..+...|+||+..+..|+ |||||
T Consensus 477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a---~~~~~~dF~REaeLla~l~-H~nIV 552 (774)
T KOG1026|consen 477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA---ENQARQDFRREAELLAELQ-HPNIV 552 (774)
T ss_pred ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc---cHHHHHHHHHHHHHHHhcc-CCCeE
Confidence 344444555667788999999999999997532 34689999997542 4557889999999999996 99999
Q ss_pred EEEEEEEeCCEEEEEEEecCCCchhHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 013005 94 KIQEVMATKTKIYLVMEYAAGGELFGKLRR---------------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQ 158 (451)
Q Consensus 94 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~---------------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpe 158 (451)
+++|++..++-.|||+||+..|+|.++++. .+++..+...++.||+.||.||-++.++||||-..
T Consensus 553 rLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATR 632 (774)
T KOG1026|consen 553 RLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATR 632 (774)
T ss_pred EEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhh
Confidence 999999999999999999999999999852 12788999999999999999999999999999999
Q ss_pred eEEeCCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcH
Q 013005 159 NLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNL 236 (451)
Q Consensus 159 NILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~ 236 (451)
|.||.++-.+||+||||++..-.... .......-...|||||.+....|. .+|||||+||+|||+++ |..||.+...
T Consensus 633 NCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT-teSDVWs~GVvLWEIFsyG~QPy~glSn 711 (774)
T KOG1026|consen 633 NCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT-TESDVWSFGVVLWEIFSYGKQPYYGLSN 711 (774)
T ss_pred hceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc-chhhhhhhhhhhhhhhccccCcccccch
Confidence 99999999999999999974322111 112223345789999999988885 55999999999999998 9999999988
Q ss_pred HHHHHHhhccC-CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 237 LAMYKKVNRRD-YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 237 ~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.+....+..+. ...|..+|.++.+|+..||+.+|++||++.||-.
T Consensus 712 ~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~ 757 (774)
T KOG1026|consen 712 QEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS 757 (774)
T ss_pred HHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 88888887765 5778889999999999999999999999999843
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=304.96 Aligned_cols=249 Identities=22% Similarity=0.371 Sum_probs=202.6
Q ss_pred eEEcceEcccCceEEEEEEEc---CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC---
Q 013005 30 YQLGPLLGRGSFAKVHKAKSI---ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT--- 103 (451)
Q Consensus 30 y~~~~~LG~G~~g~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~--- 103 (451)
|.+.+.||+|+||.||+|.+. .+++.||||++..+. ......+.+.+|+.+++.+. ||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 77 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI--FSSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKG 77 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc--CChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCC
Confidence 678899999999999999864 357899999986542 23344567889999999995 999999999875432
Q ss_pred ---EEEEEEEecCCCchhHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEec
Q 013005 104 ---KIYLVMEYAAGGELFGKLRR-------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDF 173 (451)
Q Consensus 104 ---~~~lV~E~~~gg~L~~~l~~-------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DF 173 (451)
..++++||+.+|+|.+++.. ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+||
T Consensus 78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcc
Confidence 35789999999999887632 24789999999999999999999999999999999999999999999999
Q ss_pred cCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCC
Q 013005 174 GLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQF 250 (451)
Q Consensus 174 Gls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~ 250 (451)
|++........ .......+++.|++||.+....+ +.++|||||||++|+|++ |..||...+....+..+... ....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVY-TTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ 236 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCcc-chhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 99875432111 11223345678999999876665 566999999999999999 89999887776666655543 3345
Q ss_pred CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 251 PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 251 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
+...+..+.+++.+||..+|+.|||+.++++.
T Consensus 237 ~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 237 PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 56788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=308.70 Aligned_cols=254 Identities=14% Similarity=0.195 Sum_probs=190.4
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCC---CcEEEEEEeecCcchhhHHH-------HHHHHHHHHHHHHhcCCCCce
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIAD---GSIVAIKTIEKNNKFLDAAM-------EDRIVREVSAMRRLQNHPNVL 93 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~-------~~~~~~Ei~il~~L~~HpnIv 93 (451)
....++|++.+.||+|+||+||+|.+..+ +..+|+|+....+....... ......+...+..+ .|+||+
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~ 86 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIP 86 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCC
Confidence 34557999999999999999999998877 67788887544322110000 01122333344555 499999
Q ss_pred EEEEEEEeCC----EEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCe
Q 013005 94 KIQEVMATKT----KIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNL 168 (451)
Q Consensus 94 ~l~~~~~~~~----~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~l 168 (451)
+++++..... ..++++|++.. ++.+.+.. ...++..++.++.|++.||+|||++||+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 9998765443 45788887743 56566554 457899999999999999999999999999999999999999999
Q ss_pred EEEeccCCCcchhhhc------CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcH-HH---
Q 013005 169 KVSDFGLSALPEQIKN------GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNL-LA--- 238 (451)
Q Consensus 169 kl~DFGls~~~~~~~~------~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~-~~--- 238 (451)
+|+|||+|+....... .......||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+. ..
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 9999999975432111 12233579999999999887766 6779999999999999999999976522 11
Q ss_pred -----HHHHhhccCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 239 -----MYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 239 -----~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
....+......+ +..++.+.+++..|+..+|++||++++|++
T Consensus 245 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 245 AAKCDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HhHHHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 223333333333 345789999999999999999999999875
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=306.03 Aligned_cols=249 Identities=22% Similarity=0.372 Sum_probs=201.3
Q ss_pred CCeEEcceEcccCceEEEEEEEc----CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe--
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSI----ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT-- 101 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~----~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~-- 101 (451)
..|++.+.||+|+||.||+|... .++..+|+|++..... ....+.+.+|+.+++.+. ||||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~ 79 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE---EQHRSDFEREIEILRTLD-HENIVKYKGVCEKPG 79 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc---hHHHHHHHHHHHHHHhCC-CCChheEEeeeecCC
Confidence 46788899999999999999854 3588999999976532 135667999999999995 9999999999877
Q ss_pred CCEEEEEEEecCCCchhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcc
Q 013005 102 KTKIYLVMEYAAGGELFGKLRRG--RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALP 179 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~~--~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~ 179 (451)
....|++|||+++++|.+++... .+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++...
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 66899999999999999999753 4999999999999999999999999999999999999999999999999999765
Q ss_pred hhhhc--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHH---------------HHHH
Q 013005 180 EQIKN--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLA---------------MYKK 242 (451)
Q Consensus 180 ~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~---------------~~~~ 242 (451)
..... .......++..|+|||.+....+ +.++||||||+++|+|++|..||....... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 42111 11112345567999998876655 566999999999999999999986542211 1112
Q ss_pred hhc-cCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 243 VNR-RDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 243 i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+.. .....+..++..+.+++.+||.+||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 221 122334557889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=331.63 Aligned_cols=263 Identities=27% Similarity=0.451 Sum_probs=228.9
Q ss_pred CCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE
Q 013005 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 19 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
+....+...+.|++..+||.|.+|+||+++++.+++.+|+|+.+.+. ...+.+..|..+++.+.+|||++.+|++
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-----d~deEiE~eynil~~~~~hpnv~~fyg~ 84 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-----DEEEEIELEYNMLKKYSHHPNVATFYGA 84 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-----cccHHHHHHHHHHHhccCCCCcceEEEE
Confidence 34556777889999999999999999999999999999999987652 4456788899999999999999999999
Q ss_pred EEe-----CCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEE
Q 013005 99 MAT-----KTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKV 170 (451)
Q Consensus 99 ~~~-----~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl 170 (451)
+.- .+.+|||||||.||+..+++++ .++.|+.+..+++.++.|+.+||++.++|||||-.|||++.+|.+||
T Consensus 85 ~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 85 FIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred EEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEE
Confidence 853 5679999999999999999974 67999999999999999999999999999999999999999999999
Q ss_pred EeccCCCcchhhhcCcccccCCCCccccceeeeccC-----CCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhc
Q 013005 171 SDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRG-----YDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNR 245 (451)
Q Consensus 171 ~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~-----~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~ 245 (451)
+|||+|....... +.-.+..|||.|||||++.... | ...+|+||||++..||..|.+|+-+.......-+|.+
T Consensus 165 vDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~ty-d~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR 242 (953)
T KOG0587|consen 165 VDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATY-DYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 242 (953)
T ss_pred eeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCc-ccccchhhccceeehhcCCCCCccCcchhhhhccCCC
Confidence 9999998654432 3456789999999999996533 4 3458999999999999999999999888877777766
Q ss_pred cCCC---CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 246 RDYQ---FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 246 ~~~~---~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
++.+ -|...+..+.+||..||..|-.+||+..+++.|||+..+
T Consensus 243 NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 243 NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 5432 244578999999999999999999999999999999854
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=335.06 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=180.3
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCC----CcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE--
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIAD----GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV-- 98 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~----~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~-- 98 (451)
...++|++.+.||+|+||.||+|.+..+ +..||+|.+..... . +....+ .++... +.++..+...
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~-----e~~~~e--~l~~~~-~~~~~~~~~~~~ 199 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-V-----EIWMNE--RVRRAC-PNSCADFVYGFL 199 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-h-----HHHHHH--HHHhhc-hhhHHHHHHhhh
Confidence 4578999999999999999999999888 89999998864311 1 111111 111111 2222222111
Q ss_pred ----EEeCCEEEEEEEecCCCchhHHhhcCCC---------------------CHHHHHHHHHHHHHHHHHHHHCCceec
Q 013005 99 ----MATKTKIYLVMEYAAGGELFGKLRRGRL---------------------TESAARRYFQQLVSALHFCHQNGVAHR 153 (451)
Q Consensus 99 ----~~~~~~~~lV~E~~~gg~L~~~l~~~~l---------------------~e~~~~~~~~ql~~gL~yLH~~giiHr 153 (451)
.......++|+||+.+++|.+++....+ .+..++.++.||+.||.|||++||+||
T Consensus 200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR 279 (566)
T PLN03225 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR 279 (566)
T ss_pred cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 2456679999999999999998864321 234567899999999999999999999
Q ss_pred CCCCCeEEeCC-CCCeEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCC---------------------CCcc
Q 013005 154 DVKPQNLLLDR-DGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGY---------------------DGAV 211 (451)
Q Consensus 154 DLKpeNILld~-~~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~---------------------~~~~ 211 (451)
||||+|||++. ++.+||+|||+|+.............+||+.|+|||.+....+ .+.+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999999986 5799999999997554333333456789999999997643222 1234
Q ss_pred chhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCC---------------------CCCCCCHhHHHHHHhccCCCC
Q 013005 212 ADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQ---------------------FPSFVSKPARSLIYQLLDPNP 270 (451)
Q Consensus 212 sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~---------------------~p~~~s~~~~~li~~~L~~dP 270 (451)
+||||+||+||+|+++..|++.. .......+...... .....+....+||.+||.+||
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 69999999999999988776432 22222222111111 011123345689999999999
Q ss_pred CCCCCHHHHHcCccccch
Q 013005 271 KTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 271 ~~Rpt~~eil~hp~f~~~ 288 (451)
++|||+.++++||||+..
T Consensus 439 ~kR~ta~e~L~Hpff~~~ 456 (566)
T PLN03225 439 RQRISAKAALAHPYFDRE 456 (566)
T ss_pred ccCCCHHHHhCCcCcCCC
Confidence 999999999999999764
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=331.13 Aligned_cols=243 Identities=33% Similarity=0.536 Sum_probs=199.2
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC---
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT--- 103 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~--- 103 (451)
..-|...+.||+|+||.||+++|++||+.||||.+++.. .....+..-+|+++|++|. |||||+++++-++..
T Consensus 12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~---~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~ 87 (732)
T KOG4250|consen 12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES---SLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGL 87 (732)
T ss_pred CcceeehhhhcCCccceeeeecccccccchhHHhhhhhc---ccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCc
Confidence 377899999999999999999999999999999998753 3345678889999999996 999999999876544
Q ss_pred ---EEEEEEEecCCCchhHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC--CC--CeEEEe
Q 013005 104 ---KIYLVMEYAAGGELFGKLRR----GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR--DG--NLKVSD 172 (451)
Q Consensus 104 ---~~~lV~E~~~gg~L~~~l~~----~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~--~~--~lkl~D 172 (451)
...+|||||.||+|+..+++ ..++|.+.+.++.++..||.|||++||+||||||.||++-. +| ..||+|
T Consensus 88 ~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 88 VTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred ccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeec
Confidence 57899999999999999974 57999999999999999999999999999999999999842 23 479999
Q ss_pred ccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCC-----cHHHHHHHhhcc-
Q 013005 173 FGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS-----NLLAMYKKVNRR- 246 (451)
Q Consensus 173 FGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~-----~~~~~~~~i~~~- 246 (451)
||.|+-.++ +....+.+||+.|.+||++.++.+++..+|.||+||++|+++||.+||... +..-++..+.+.
T Consensus 168 fG~Arel~d--~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp 245 (732)
T KOG4250|consen 168 FGAARELDD--NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKP 245 (732)
T ss_pred ccccccCCC--CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCC
Confidence 999986554 457788899999999999987667778899999999999999999999642 222344433221
Q ss_pred -------------------CCCCCCCCCHhH----HHHHHhccCCCCCCCCC
Q 013005 247 -------------------DYQFPSFVSKPA----RSLIYQLLDPNPKTRMS 275 (451)
Q Consensus 247 -------------------~~~~p~~~s~~~----~~li~~~L~~dP~~Rpt 275 (451)
.+++|...+..+ ...+..+|.-||.+|..
T Consensus 246 ~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~ 297 (732)
T KOG4250|consen 246 SGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGH 297 (732)
T ss_pred CceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence 123344444443 45677889999999983
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.87 Aligned_cols=250 Identities=22% Similarity=0.380 Sum_probs=212.1
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCC-C----cEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIAD-G----SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~-~----~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
...-++.+.||+|+||.||.|.-... + -.||||.+.+. .+......|.+|..+|+.+. |||||+++|++-+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~---~~~~~~~~Fl~Ea~~m~~f~-HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL---SSEQEVSDFLKEALLMSKFD-HPNIVSLIGVCLD 766 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc---CCHHHHHHHHHHHHHHhcCC-CcceeeEEEeecC
Confidence 45678899999999999999976543 2 24899988754 35567788999999999995 9999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEec
Q 013005 102 KTKIYLVMEYAAGGELFGKLRRG--------RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDF 173 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~~--------~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DF 173 (451)
....+|++|||.||+|..++++. .++..+...++.|+++|++||++++++||||-..|+||++...+||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999753 3889999999999999999999999999999999999999999999999
Q ss_pred cCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHH-HhhccCCCC
Q 013005 174 GLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYK-KVNRRDYQF 250 (451)
Q Consensus 174 Gls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~-~i~~~~~~~ 250 (451)
|+|+....... ..-....-...|||||.+.+..+ +.++|||||||+|||+++ |..||.+.+..+... -...+..+.
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~ 925 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDP 925 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCC
Confidence 99983221111 11111122358999999988666 567999999999999998 999999987776665 445567788
Q ss_pred CCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 251 PSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 251 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
|..++..+.+++..||..+|+.||++..|++
T Consensus 926 P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 926 PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 8899999999999999999999999999987
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=300.73 Aligned_cols=264 Identities=25% Similarity=0.427 Sum_probs=213.9
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe--
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT-- 101 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~-- 101 (451)
-...+.|+-...||+|.||.||+|+...+|+.||+|++-.++. ....-....+|+.+|..|+ |+|++.+++++..
T Consensus 13 ~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene--KeGfpitalreikiL~~lk-Henv~nliEic~tk~ 89 (376)
T KOG0669|consen 13 CDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE--KEGFPITALREIKILQLLK-HENVVNLIEICRTKA 89 (376)
T ss_pred eecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc--ccCCcHHHHHHHHHHHHhc-chhHHHHHHHHhhcc
Confidence 3456788889999999999999999999999999987644321 1122234568999999996 9999999888743
Q ss_pred ------CCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEec
Q 013005 102 ------KTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDF 173 (451)
Q Consensus 102 ------~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DF 173 (451)
...+|+|+.+|+. +|+-++.. .+++..++.+++++|+.||.|+|+..|+|||+||+|+||+.+|.+||+||
T Consensus 90 Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred CCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecc
Confidence 3458999999976 88888864 68999999999999999999999999999999999999999999999999
Q ss_pred cCCCcchhhhc---CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc--C-
Q 013005 174 GLSALPEQIKN---GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR--D- 247 (451)
Q Consensus 174 Gls~~~~~~~~---~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~--~- 247 (451)
|+++.+....+ .-...++-|.+|.+||.+.+...++++.|||+.|||+.+|++|.+.+.+.+.......|..- .
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 99975543322 22445667999999999998888889999999999999999999999876655544443210 0
Q ss_pred ----------------C---CCCC-------------CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchhHH
Q 013005 248 ----------------Y---QFPS-------------FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQ 291 (451)
Q Consensus 248 ----------------~---~~p~-------------~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~~ 291 (451)
. +.|. --++++.+|+.++|..||.+|+++++++.|.||.+...+
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 0 0111 124578899999999999999999999999999876544
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=295.80 Aligned_cols=253 Identities=25% Similarity=0.407 Sum_probs=208.2
Q ss_pred eEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEE
Q 013005 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVM 109 (451)
Q Consensus 30 y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~ 109 (451)
.+-+..||.|+||+|++..++.+|+..|||.|...+ ....+.++..|.....+-.+.||||++||..-.++..||.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n---~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN---IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc---chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 344567999999999999999999999999998664 24566788999998888778999999999999999999999
Q ss_pred EecCCCchhHHh------hcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 110 EYAAGGELFGKL------RRGRLTESAARRYFQQLVSALHFCHQN-GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 110 E~~~gg~L~~~l------~~~~l~e~~~~~~~~ql~~gL~yLH~~-giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
|+++- +|..+. ++..++|...-++....+.||+||-.. .|+|||+||+|||+|..|.+||||||.+......
T Consensus 143 ELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 143 ELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred HHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 99964 443322 246799999999999999999999764 8999999999999999999999999998643221
Q ss_pred hcCcccccCCCCccccceeeec--cCCCCccchhhhhhHHHHHHHhcCCCCCCCcH-HHHHHHhhccCCC---CCC---C
Q 013005 183 KNGMLHTACGTPAYTAPEVVAR--RGYDGAVADAWSCGVILFVLLAGYLPFDDSNL-LAMYKKVNRRDYQ---FPS---F 253 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~--~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~-~~~~~~i~~~~~~---~p~---~ 253 (451)
-....-.|..+|||||.+.. .+|+ .+||+||||++|||+.||..|+..-+. .+....+..+.++ ++. .
T Consensus 222 --iAkT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~ 298 (361)
T KOG1006|consen 222 --IAKTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVH 298 (361)
T ss_pred --HHhhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccc
Confidence 12234568899999999864 3454 559999999999999999999987543 3555555555443 222 2
Q ss_pred CCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 254 VSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 254 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
++..+..+|.-||.+|-..||...+++++||++...
T Consensus 299 ~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 299 YSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred cCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 789999999999999999999999999999998654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=307.07 Aligned_cols=270 Identities=29% Similarity=0.479 Sum_probs=220.9
Q ss_pred CCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhH---HHHHHHHHHHHHHHHhcCCCCceEEE
Q 013005 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDA---AMEDRIVREVSAMRRLQNHPNVLKIQ 96 (451)
Q Consensus 20 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~~~Ei~il~~L~~HpnIv~l~ 96 (451)
....+.+.++|-++.+||+|+|+.||+|.|....+.||+|+-.....+.+. ......-+|..|.+.|. ||.||++|
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD-HpRIVKlY 533 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD-HPRIVKLY 533 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC-cceeeeee
Confidence 455678899999999999999999999999999999999997554333222 23345668999999995 99999999
Q ss_pred EEEE-eCCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCCCeEEeCC---CCCeE
Q 013005 97 EVMA-TKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQN--GVAHRDVKPQNLLLDR---DGNLK 169 (451)
Q Consensus 97 ~~~~-~~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~--giiHrDLKpeNILld~---~~~lk 169 (451)
+++. +.+..|-|+|||+|.+|.-+++. .-++|.+++.|+.||+.||.||... .|+|-||||.||||-. -|.+|
T Consensus 534 DyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 534 DYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred eeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeE
Confidence 9996 45678899999999999999986 5689999999999999999999986 5999999999999943 36799
Q ss_pred EEeccCCCcchhhhcC------cccccCCCCccccceeeec---cCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH-HH
Q 013005 170 VSDFGLSALPEQIKNG------MLHTACGTPAYTAPEVVAR---RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL-AM 239 (451)
Q Consensus 170 l~DFGls~~~~~~~~~------~~~~~~gt~~y~APEvl~~---~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~-~~ 239 (451)
|+||||+...+..... +.....||.+|++||.+.- .+..+.+.||||+|||+|..+.|+.||...-.. .+
T Consensus 614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI 693 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI 693 (775)
T ss_pred eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH
Confidence 9999999876654332 3345679999999998643 234467899999999999999999999865332 22
Q ss_pred HH--H-hhccCCCCCC--CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchhH
Q 013005 240 YK--K-VNRRDYQFPS--FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQ 290 (451)
Q Consensus 240 ~~--~-i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 290 (451)
.+ . ++.....||+ -++.++++||++||.+.-+.|....++..||+|.-...
T Consensus 694 LqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~r 749 (775)
T KOG1151|consen 694 LQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIR 749 (775)
T ss_pred HhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhh
Confidence 22 2 2334556775 48999999999999999999999999999999986543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=284.07 Aligned_cols=239 Identities=44% Similarity=0.799 Sum_probs=205.4
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecCCCchhH
Q 013005 40 SFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFG 119 (451)
Q Consensus 40 ~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~ 119 (451)
+||.||+|.+..+++.+|+|++...... ...+.+.+|+..++++ +|+||+++++.+......++++||+.+++|.+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~ 76 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK---KKRERILREISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD 76 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc---cHHHHHHHHHHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence 5899999999889999999999765321 1157889999999999 59999999999999999999999999999999
Q ss_pred HhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCCCCcccc
Q 013005 120 KLRRG-RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTA 198 (451)
Q Consensus 120 ~l~~~-~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~A 198 (451)
++... .+++..+..++.+++.++.|||+.|++|+||+|.||+++.++.++|+|||++...... .......+++.|+|
T Consensus 77 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~ 154 (244)
T smart00220 77 LLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPG--GLLTTFVGTPEYMA 154 (244)
T ss_pred HHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccc--cccccccCCcCCCC
Confidence 98764 4899999999999999999999999999999999999999999999999998754332 13445678999999
Q ss_pred ceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCC-CcHHHHHHHhhccCCCCCCC---CCHhHHHHHHhccCCCCCCCC
Q 013005 199 PEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDD-SNLLAMYKKVNRRDYQFPSF---VSKPARSLIYQLLDPNPKTRM 274 (451)
Q Consensus 199 PEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~-~~~~~~~~~i~~~~~~~p~~---~s~~~~~li~~~L~~dP~~Rp 274 (451)
||.+....+ +.++||||+|+++++|++|..||.. .+.......+.......+.. ++..+.+++.+||..||++||
T Consensus 155 pE~~~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp 233 (244)
T smart00220 155 PEVLLGKGY-GKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRL 233 (244)
T ss_pred HHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhcc
Confidence 999876666 4579999999999999999999987 55556666555554443332 788999999999999999999
Q ss_pred CHHHHHcCccc
Q 013005 275 SIEKIMSISWF 285 (451)
Q Consensus 275 t~~eil~hp~f 285 (451)
++.++++||||
T Consensus 234 ~~~~~~~~~~~ 244 (244)
T smart00220 234 TAEEALQHPFF 244 (244)
T ss_pred CHHHHhhCCCC
Confidence 99999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=312.68 Aligned_cols=262 Identities=21% Similarity=0.327 Sum_probs=191.1
Q ss_pred cccCCeEEcceEcccCceEEEEEEEc----------------CCCcEEEEEEeecCcchhhH----------HHHHHHHH
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSI----------------ADGSIVAIKTIEKNNKFLDA----------AMEDRIVR 78 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~----------------~~~~~vAiK~i~~~~~~~~~----------~~~~~~~~ 78 (451)
...++|++.+.||+|+||+||+|... ..++.||||.+......... ...+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 35789999999999999999999752 23567999998654211100 01123345
Q ss_pred HHHHHHHhcCCCC-----ceEEEEEEEe--------CCEEEEEEEecCCCchhHHhhc--C-------------------
Q 013005 79 EVSAMRRLQNHPN-----VLKIQEVMAT--------KTKIYLVMEYAAGGELFGKLRR--G------------------- 124 (451)
Q Consensus 79 Ei~il~~L~~Hpn-----Iv~l~~~~~~--------~~~~~lV~E~~~gg~L~~~l~~--~------------------- 124 (451)
|+.++.+++ |.+ ++++++++.. +...|+|+||+.+++|.+++.. +
T Consensus 222 E~~~l~~l~-~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 222 EAYMCAKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHhh-cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 777777775 444 3566666542 4568999999999999888752 1
Q ss_pred ----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCCCCccccce
Q 013005 125 ----RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPE 200 (451)
Q Consensus 125 ----~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APE 200 (451)
.+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++...............+|+.|+|||
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 2356778899999999999999999999999999999999999999999998643322111112234589999999
Q ss_pred eeeccC--------------------CC-CccchhhhhhHHHHHHHhcCC-CCCCCc-----------HHHHHHHhhccC
Q 013005 201 VVARRG--------------------YD-GAVADAWSCGVILFVLLAGYL-PFDDSN-----------LLAMYKKVNRRD 247 (451)
Q Consensus 201 vl~~~~--------------------~~-~~~sDIwSlGvil~~Ll~G~~-Pf~~~~-----------~~~~~~~i~~~~ 247 (451)
.+.... |. ..+.||||+||++|+|++|.+ ||.... ....+..+....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 985432 11 123699999999999999986 775321 122233333344
Q ss_pred CCCC--CCCCHhHHHHHHhccCCCC---CCCCCHHHHHcCccccc
Q 013005 248 YQFP--SFVSKPARSLIYQLLDPNP---KTRMSIEKIMSISWFQK 287 (451)
Q Consensus 248 ~~~p--~~~s~~~~~li~~~L~~dP---~~Rpt~~eil~hp~f~~ 287 (451)
+.++ ...++..++|+.+||..+| .+|+|++|+|+||||..
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 4454 3478999999999999866 68999999999999964
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=306.09 Aligned_cols=254 Identities=28% Similarity=0.471 Sum_probs=209.6
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcC-----CCCceEEEEE
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN-----HPNVLKIQEV 98 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~-----HpnIv~l~~~ 98 (451)
..+-++|.+....|+|-|++|..|.+..-|..||||+|... ..+...=.+|+.+|++|.. --|+++++..
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-----E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-----EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-----hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 46677999999999999999999999999999999999765 2455556789999999962 3589999999
Q ss_pred EEeCCEEEEEEEecCCCchhHHhhc-C---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC-CeEEEec
Q 013005 99 MATKTKIYLVMEYAAGGELFGKLRR-G---RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG-NLKVSDF 173 (451)
Q Consensus 99 ~~~~~~~~lV~E~~~gg~L~~~l~~-~---~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~-~lkl~DF 173 (451)
|...+++|||+|-+. .+|.+.+++ | .|....++.|++||+-||..|-..||+|.||||.|||+++.. .+|||||
T Consensus 503 F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred hhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccC
Confidence 999999999999874 589999975 3 588899999999999999999999999999999999998765 5899999
Q ss_pred cCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhc--------
Q 013005 174 GLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNR-------- 245 (451)
Q Consensus 174 Gls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~-------- 245 (451)
|.|..... ....+..-+..|.|||++.+.+|+.+ .|+||.||+||||.||+..|.+.+...|+.....
T Consensus 582 GSA~~~~e---neitPYLVSRFYRaPEIiLG~~yd~~-iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~K 657 (752)
T KOG0670|consen 582 GSASFASE---NEITPYLVSRFYRAPEIILGLPYDYP-IDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNK 657 (752)
T ss_pred cccccccc---ccccHHHHHHhccCcceeecCcccCC-ccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHH
Confidence 99875433 33444555678999999999999766 8999999999999999999998776655443211
Q ss_pred ----cCC---------------------------------------------CCCCC---CCHhHHHHHHhccCCCCCCC
Q 013005 246 ----RDY---------------------------------------------QFPSF---VSKPARSLIYQLLDPNPKTR 273 (451)
Q Consensus 246 ----~~~---------------------------------------------~~p~~---~s~~~~~li~~~L~~dP~~R 273 (451)
+.+ .+|.. +-..+.+||.+||..||++|
T Consensus 658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR 737 (752)
T KOG0670|consen 658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR 737 (752)
T ss_pred HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence 000 01110 11257899999999999999
Q ss_pred CCHHHHHcCccccc
Q 013005 274 MSIEKIMSISWFQK 287 (451)
Q Consensus 274 pt~~eil~hp~f~~ 287 (451)
.|+.|+|.||||+.
T Consensus 738 it~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 738 ITVNQALKHPFITE 751 (752)
T ss_pred CCHHHHhcCCcccC
Confidence 99999999999974
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=286.70 Aligned_cols=256 Identities=27% Similarity=0.448 Sum_probs=211.7
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC-
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK- 102 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~- 102 (451)
-+...+|.-++.+|.|+- .|-.|.|.-++++||+|.+-.. ..+.....+..+|...+..+. |+||++++.+|...
T Consensus 13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p--f~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP--FQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQK 88 (369)
T ss_pred eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc--cccCccchhhhhhhhhhhhhc-ccceeeeeeccCccc
Confidence 345668999999999999 8899999999999999988654 333445567889999999995 99999999998644
Q ss_pred -----CEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 103 -----TKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 103 -----~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
...|+|||+++. +|...+. -.++-..+..++.|++.|++|||+.||+||||||+||++..++.+||.|||+|.
T Consensus 89 ~l~~~~e~y~v~e~m~~-nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 89 TLEEFQEVYLVMELMDA-NLCQVIL-MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred cHHHHHhHHHHHHhhhh-HHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhc
Confidence 358999999965 7777665 457788899999999999999999999999999999999999999999999998
Q ss_pred cchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc-----------
Q 013005 178 LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR----------- 246 (451)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~----------- 246 (451)
..... -.+...+.|..|.|||++.+.+| ...+||||+|||+.+|++|...|.+.+..+.+.++...
T Consensus 167 ~e~~~--~~mtpyVvtRyyrapevil~~~~-ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 167 TEDTD--FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred ccCcc--cccCchhheeeccCchheeccCC-cccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 54332 35667889999999999999996 56699999999999999999999887766655544211
Q ss_pred -------------C---C----CCCC-----------CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 247 -------------D---Y----QFPS-----------FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 247 -------------~---~----~~p~-----------~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
. . .+|. .-+..+++++.+||..||++|.|++++|.||||+-+
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw 316 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVW 316 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeee
Confidence 0 0 1121 124568999999999999999999999999999843
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=285.20 Aligned_cols=261 Identities=25% Similarity=0.421 Sum_probs=214.2
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
+...-+.+-.+.||.|+||.||.+.|..+|+.||+|.+... +.+-...+++.+|+.++.-++ |.|++...++.....
T Consensus 49 Pqqq~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv--fq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph 125 (449)
T KOG0664|consen 49 PQQQQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV--FQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPAN 125 (449)
T ss_pred ccccccCCCCCcccccceeEEEeccCCCCccchhHhhcchH--HHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCC
Confidence 34455667789999999999999999999999999988643 344556678999999999996 999999988875443
Q ss_pred -----EEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 104 -----KIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 104 -----~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
.+|.++|++.. +|..++-. ..++.+.++-++.||++||+|||+.||.||||||.|+|++.+..+||||||+++
T Consensus 126 ~dfFqEiYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLAR 204 (449)
T KOG0664|consen 126 PSFFQELYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLAR 204 (449)
T ss_pred chHHHHHHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEeccccccc
Confidence 46778888754 77776654 779999999999999999999999999999999999999999999999999999
Q ss_pred cchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhh-------------
Q 013005 178 LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVN------------- 244 (451)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~------------- 244 (451)
..+......+...+-|-+|.|||++.+...++...||||.|||+.||+..+..|...+..+....|.
T Consensus 205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 205 TWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred ccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 8776555555566778999999999988777777999999999999999999998776655444332
Q ss_pred ----------ccCCCCC-----------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 245 ----------RRDYQFP-----------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 245 ----------~~~~~~p-----------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+....-| .....+...++..+|.+||.+|++.++.+.|++...+
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 1111111 1234567889999999999999999999999998654
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=300.57 Aligned_cols=246 Identities=26% Similarity=0.407 Sum_probs=204.7
Q ss_pred eEEcceEcccCceEEEEEEEcC--CCc--EEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 30 YQLGPLLGRGSFAKVHKAKSIA--DGS--IVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 30 y~~~~~LG~G~~g~Vy~a~~~~--~~~--~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
..+.+.||+|.||.||.|.-.. .|+ .||||.-+.+. ..+..+.|..|..+|+.+. |||||+++|++.+. ..
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~---t~d~tekflqEa~iMrnfd-HphIikLIGv~~e~-P~ 465 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC---TPDDTEKFLQEASIMRNFD-HPHIIKLIGVCVEQ-PM 465 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC---ChhhHHHHHHHHHHHHhCC-Ccchhheeeeeecc-ce
Confidence 3456789999999999997532 233 68888876542 3345788999999999995 99999999999754 58
Q ss_pred EEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 106 YLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
|||||+++-|+|..+++. ..++......|+.||+.||.|||+..++||||-..|||+.....+||+|||||+..+...
T Consensus 466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 999999999999999975 579999999999999999999999999999999999999999999999999999876644
Q ss_pred cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhHHHH
Q 013005 184 NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPARSL 261 (451)
Q Consensus 184 ~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 261 (451)
........-..-|||||.+.-..+. .++|||.|||.+||++. |..||.+-...+..-.+.++ ..+.|+.+++.+..|
T Consensus 546 yYkaS~~kLPIKWmaPESINfRrFT-tASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYsl 624 (974)
T KOG4257|consen 546 YYKASRGKLPIKWMAPESINFRRFT-TASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSL 624 (974)
T ss_pred hhhccccccceeecCccccchhccc-chhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHH
Confidence 3222223335679999999777674 45999999999998765 99999886655555555544 568899999999999
Q ss_pred HHhccCCCCCCCCCHHHHHc
Q 013005 262 IYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 262 i~~~L~~dP~~Rpt~~eil~ 281 (451)
+.+||+++|.+||+..+|..
T Consensus 625 mskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 625 MSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HHHHhccCcccCCcHHHHHH
Confidence 99999999999999888764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=289.09 Aligned_cols=132 Identities=23% Similarity=0.445 Sum_probs=114.2
Q ss_pred ccc-CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCC-------CCceEEE
Q 013005 25 TLL-NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH-------PNVLKIQ 96 (451)
Q Consensus 25 ~~~-~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~H-------pnIv~l~ 96 (451)
.+. ++|.+.+.||.|-|++||+|.|..+.+.||+|+.+... ...+....||.+|++++.+ .+||+|+
T Consensus 74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll 148 (590)
T KOG1290|consen 74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL 148 (590)
T ss_pred cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence 444 79999999999999999999999999999999986542 3345566799999998743 3699999
Q ss_pred EEEEe----CCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCeEEe
Q 013005 97 EVMAT----KTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQN-GVAHRDVKPQNLLL 162 (451)
Q Consensus 97 ~~~~~----~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~-giiHrDLKpeNILl 162 (451)
+.|.. ..++|||+|++ |.+|..+|.+ ..++...++.|++|++.||.|||.+ ||||-||||||||+
T Consensus 149 D~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 149 DHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred ccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 99964 56899999998 6688888864 5799999999999999999999976 99999999999998
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=301.65 Aligned_cols=266 Identities=25% Similarity=0.391 Sum_probs=223.0
Q ss_pred CCCCCCCCcccccCCeEEcceEcccCceEEEEEEEcCC-C--cEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCC
Q 013005 15 PPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIAD-G--SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN 91 (451)
Q Consensus 15 ~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-~--~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~Hpn 91 (451)
+.+....++-+-.++..+.++||+|.||.|++|.+... | -.||||++..+.. ......|.+|+.+|.+|+ |||
T Consensus 97 ~~p~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l---~~~mddflrEas~M~~L~-H~h 172 (1039)
T KOG0199|consen 97 ANPSIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSL---NAIMDDFLREASHMLKLQ-HPH 172 (1039)
T ss_pred CCcCCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCcc---chhHHHHHHHHHHHHhcc-Ccc
Confidence 33445566667778888999999999999999988643 3 3799999976532 226678999999999996 999
Q ss_pred ceEEEEEEEeCCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCe
Q 013005 92 VLKIQEVMATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNL 168 (451)
Q Consensus 92 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~l 168 (451)
+++|||+..+ ....||+|++..|+|.+.+++ +.|.......|+.||+.||.||.+++.|||||-..||||-....+
T Consensus 173 liRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtV 251 (1039)
T KOG0199|consen 173 LIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTV 251 (1039)
T ss_pred eeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheeccccee
Confidence 9999999887 778999999999999999975 568899999999999999999999999999999999999988899
Q ss_pred EEEeccCCCcchhhhcCc--ccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhc
Q 013005 169 KVSDFGLSALPEQIKNGM--LHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNR 245 (451)
Q Consensus 169 kl~DFGls~~~~~~~~~~--~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~ 245 (451)
||+||||.+-.......+ .....-...|+|||.|....+ +.++|+|++||+||||++ |+.||.+-+-....++|-.
T Consensus 252 KI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kF-ShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~ 330 (1039)
T KOG0199|consen 252 KICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKF-SHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA 330 (1039)
T ss_pred eeecccceeccCCCCcceEecCCCcCcccccCHhHhccccc-cccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc
Confidence 999999998654433321 112223568999999988777 456999999999999998 8999999998888888874
Q ss_pred c-CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCcccc
Q 013005 246 R-DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQ 286 (451)
Q Consensus 246 ~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~ 286 (451)
+ ...-|+.++..+.+++..||..+|+.|||+..|.+.-+.+
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 3 3566778999999999999999999999999997654443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=296.52 Aligned_cols=212 Identities=29% Similarity=0.514 Sum_probs=188.0
Q ss_pred CCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHH----HHHHHHHHHHHhc--CCCCc
Q 013005 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMED----RIVREVSAMRRLQ--NHPNV 92 (451)
Q Consensus 19 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~----~~~~Ei~il~~L~--~HpnI 92 (451)
.+++...-..+|...+.+|+|+||+|++|+++++...|+||.|.++.-..+..+.+ .+-.||+||..|. .|+||
T Consensus 552 ~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI 631 (772)
T KOG1152|consen 552 GCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI 631 (772)
T ss_pred cceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence 35555666778999999999999999999999999999999998874333333332 3668999999994 39999
Q ss_pred eEEEEEEEeCCEEEEEEEec-CCCchhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEE
Q 013005 93 LKIQEVMATKTKIYLVMEYA-AGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKV 170 (451)
Q Consensus 93 v~l~~~~~~~~~~~lV~E~~-~gg~L~~~l~-~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl 170 (451)
++++++|++++.+||+||-- +|.+|++++. +.+++|.++..+|+|++.|+++||++||+|||||-||+.+|.+|.+||
T Consensus 632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred hhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEE
Confidence 99999999999999999965 4669999998 478999999999999999999999999999999999999999999999
Q ss_pred EeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCC
Q 013005 171 SDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDD 233 (451)
Q Consensus 171 ~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~ 233 (451)
+|||.|.+.. ++...+.+||..|.|||++.+..|.+.+-|||++|++||.++....||..
T Consensus 712 idfgsaa~~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 712 IDFGSAAYTK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eeccchhhhc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9999998643 47788999999999999999999999999999999999999999999853
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=292.45 Aligned_cols=255 Identities=23% Similarity=0.363 Sum_probs=216.9
Q ss_pred CCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE
Q 013005 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 20 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~ 99 (451)
..++...-.+..+-..||.|.||.||.|.+++-.-.||||.++.+ ....+.|.+|..+|+.++ |||+|+++++|
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-----tMeveEFLkEAAvMKeik-HpNLVqLLGVC 332 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIK-HPNLVQLLGVC 332 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-----chhHHHHHHHHHHHHhhc-CccHHHHhhhh
Confidence 455555555566777899999999999999999999999998654 244678999999999996 99999999999
Q ss_pred EeCCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCC
Q 013005 100 ATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176 (451)
Q Consensus 100 ~~~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls 176 (451)
....-.|||+|||..|+|.++++. ..++.-....++.||..|++||..+++|||||-..|.|+.++..+|++||||+
T Consensus 333 T~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 333 THEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred ccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchh
Confidence 999999999999999999999985 34677777888899999999999999999999999999999999999999999
Q ss_pred CcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCC
Q 013005 177 ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFV 254 (451)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~ 254 (451)
++.............-..-|.|||.|....+ +.++|||+|||+|||+.| |-.||.+-+....|..+.++ ...-|..+
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtF-SiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGC 491 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGC 491 (1157)
T ss_pred hhhcCCceecccCccCcccccCccccccccc-ccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCC
Confidence 8764422211111223467999999987766 567999999999999987 99999999998888877665 34567889
Q ss_pred CHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 255 SKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 255 s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
++.+.+|++.||+.+|..||++.+|-+
T Consensus 492 PpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 492 PPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred CHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 999999999999999999999998743
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=305.47 Aligned_cols=247 Identities=28% Similarity=0.427 Sum_probs=197.2
Q ss_pred cceEcccCceE-EEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEe
Q 013005 33 GPLLGRGSFAK-VHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEY 111 (451)
Q Consensus 33 ~~~LG~G~~g~-Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~ 111 (451)
-+.+|.|+-|+ ||+|. -.|+.||||.+-.+ ......+||..|+.-..||||||+|+.-.+....||.+|.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e-------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGV--YEGREVAVKRLLEE-------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred HHHcccCCCCcEEEEEe--eCCceehHHHHhhH-------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 45689998875 79997 57889999987433 2356789999999999999999999999999999999999
Q ss_pred cCCCchhHHhhcC-C----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC---CC--CeEEEeccCCCcchh
Q 013005 112 AAGGELFGKLRRG-R----LTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR---DG--NLKVSDFGLSALPEQ 181 (451)
Q Consensus 112 ~~gg~L~~~l~~~-~----l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~---~~--~lkl~DFGls~~~~~ 181 (451)
|.. +|.++++.. . ......+....|++.||++||+.+|+||||||.||||+. ++ .++|+|||++.....
T Consensus 585 C~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 585 CAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 965 999999752 1 111456888999999999999999999999999999976 33 689999999986544
Q ss_pred hhc--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhc-CCCCCCCcHHHHHHHhhccCCCCC---CCCC
Q 013005 182 IKN--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAG-YLPFDDSNLLAMYKKVNRRDYQFP---SFVS 255 (451)
Q Consensus 182 ~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G-~~Pf~~~~~~~~~~~i~~~~~~~p---~~~s 255 (451)
... ....+..||-.|+|||++..... +.++||+|+||++|+.++| ..||.+.-.. ...|..+.+..- +...
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~~~d 740 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLEPLPD 740 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeeccCch
Confidence 333 23556789999999999976655 4568999999999988885 9999765322 233444444322 2222
Q ss_pred HhHHHHHHhccCCCCCCCCCHHHHHcCccccchhHHh
Q 013005 256 KPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQ 292 (451)
Q Consensus 256 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~~~ 292 (451)
.++.+||.+|+.++|+.||++.++|.||+|....++.
T Consensus 741 ~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL 777 (903)
T KOG1027|consen 741 CEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRL 777 (903)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHH
Confidence 3899999999999999999999999999999876544
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=327.15 Aligned_cols=238 Identities=24% Similarity=0.346 Sum_probs=186.7
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
...|...+.||+|+||.||+|.+..++..||+|.+..... ....|+.++++++ |||||++++++.+....|
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~l~~l~-HpnIv~~~~~~~~~~~~~ 759 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--------IPSSEIADMGKLQ-HPNIVKLIGLCRSEKGAY 759 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--------ccHHHHHHHhhCC-CCCcceEEEEEEcCCCCE
Confidence 3456667789999999999999989999999999865421 1124578899995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 107 LVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCH---QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH---~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
+||||+++|+|.++++. +++..+.+++.|++.||+||| +.+|+||||||+||+++.++..++. ||.+.....
T Consensus 760 lv~Ey~~~g~L~~~l~~--l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-- 834 (968)
T PLN00113 760 LIHEYIEGKNLSEVLRN--LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-- 834 (968)
T ss_pred EEEeCCCCCcHHHHHhc--CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence 99999999999999964 889999999999999999999 6699999999999999999888875 666543211
Q ss_pred cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcH----HHHHHHhhcc--------CCCC-
Q 013005 184 NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNL----LAMYKKVNRR--------DYQF- 250 (451)
Q Consensus 184 ~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~----~~~~~~i~~~--------~~~~- 250 (451)
.....||+.|+|||++.+..+ +.++||||+||++|||++|+.||+.... ...+...... +...
T Consensus 835 ---~~~~~~t~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (968)
T PLN00113 835 ---DTKCFISSAYVAPETRETKDI-TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIR 910 (968)
T ss_pred ---CCCccccccccCcccccCCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcccc
Confidence 123468999999999887766 5679999999999999999999964211 1111111000 0001
Q ss_pred -----CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 251 -----PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 251 -----p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
+.....++.+++.+||..||++|||+.++++.
T Consensus 911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 11112356789999999999999999999864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=302.06 Aligned_cols=252 Identities=24% Similarity=0.408 Sum_probs=217.5
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCC---cEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADG---SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
....-.+.+.||.|.||.|++|+.+..| ..||||.++... .+.....|..|..||-++. ||||++|-|+....
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy---tekqrrdFL~EAsIMGQFd-HPNIIrLEGVVTks 702 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY---TEKQRRDFLSEASIMGQFD-HPNIIRLEGVVTKS 702 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc---cHHHHhhhhhhhhhcccCC-CCcEEEEEEEEecC
Confidence 3445678899999999999999987665 479999997542 3455678999999999996 99999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 103 TKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
.-..||.|||++|+|..+++. |+|+..+...+++-|+.|++||-+.|++||||-..|||++.+-..|++|||||+..+
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 999999999999999999984 899999999999999999999999999999999999999999999999999999876
Q ss_pred hhhcCcccccCC--CCccccceeeeccCCCCccchhhhhhHHHHHHH-hcCCCCCCCcHHHHHHHhhccC-CCCCCCCCH
Q 013005 181 QIKNGMLHTACG--TPAYTAPEVVARRGYDGAVADAWSCGVILFVLL-AGYLPFDDSNLLAMYKKVNRRD-YQFPSFVSK 256 (451)
Q Consensus 181 ~~~~~~~~~~~g--t~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll-~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~ 256 (451)
........+..| ...|.|||.+....+. .++||||+||++||.+ .|..||=+.+..+..+.|..+. .+.|-.++.
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFT-sASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~ 861 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPA 861 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccC-chhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcH
Confidence 655444444444 3589999999888775 4599999999999755 5999998888888888887653 333446889
Q ss_pred hHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 257 PARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
.+..|+..||++|-.+||+++||+.+
T Consensus 862 aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 862 ALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 99999999999999999999999875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=303.21 Aligned_cols=259 Identities=27% Similarity=0.442 Sum_probs=223.9
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
...++|+++..+|.|+||.||+|+|+.+++..|+|+++.+. ......+..||-+++..+ |||||.+++.+-....
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep----~dd~~~iqqei~~~~dc~-h~nivay~gsylr~dk 86 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP----GDDFSGIQQEIGMLRDCR-HPNIVAYFGSYLRRDK 86 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccC----CccccccccceeeeecCC-CcChHHHHhhhhhhcC
Confidence 55679999999999999999999999999999999998763 234556788999999996 9999999999999999
Q ss_pred EEEEEEecCCCchhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 105 IYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~-~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
.|++||||.||+|.+..+ .|.++|.++...++..+.|++|||+.|-+|||||-.|||+++.|.+|++|||.+..+...-
T Consensus 87 lwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 87 LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred cEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh
Confidence 999999999999999887 5999999999999999999999999999999999999999999999999999987543221
Q ss_pred cCcccccCCCCccccceee--eccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCC-----CCCH
Q 013005 184 NGMLHTACGTPAYTAPEVV--ARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS-----FVSK 256 (451)
Q Consensus 184 ~~~~~~~~gt~~y~APEvl--~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~-----~~s~ 256 (451)
.......|||+|||||+- ...+-+...+|||++|+...+|---+.|-.+...........+..++.|. ..++
T Consensus 167 -~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~ 245 (829)
T KOG0576|consen 167 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSE 245 (829)
T ss_pred -hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchH
Confidence 122456899999999985 23333467799999999999999888888777777666666666666553 3688
Q ss_pred hHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 257 PARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
.+.+|++.+|..||.+|||++.+|.|||.....
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~l 278 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTL 278 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccch
Confidence 999999999999999999999999999987653
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=287.42 Aligned_cols=247 Identities=19% Similarity=0.323 Sum_probs=201.4
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
...+.+.||+|-||.|.++.- ..+..||+|+++... .......+.+||++|.+|+ |||||+++++|..++.+++|
T Consensus 539 ~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a---~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDA---TKNARNDFLKEIKILSRLK-HPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred heehhhhhcCcccceeEEEEe-cCceEEEEeecCccc---chhHHHHHHHHHHHHhccC-CCCeeEEEeeeecCCchHHH
Confidence 457889999999999999984 557899999997653 3344678999999999995 99999999999999999999
Q ss_pred EEecCCCchhHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh-hhc
Q 013005 109 MEYAAGGELFGKLRRGR---LTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ-IKN 184 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~~~---l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~-~~~ 184 (451)
+||++.|+|.+++.... +.-....+++.||+.|++||.+.+++||||.|.|+|+|.++++||+|||+|+-.-. ...
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 99999999999997542 23345666999999999999999999999999999999999999999999973221 111
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHH--hcCCCCCCCcHHHHHHHhhc---c-----CCCCCCCC
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLL--AGYLPFDDSNLLAMYKKVNR---R-----DYQFPSFV 254 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll--~G~~Pf~~~~~~~~~~~i~~---~-----~~~~p~~~ 254 (451)
......+-...|||||.+....+. .++|+|++|+++||++ +...||...+.++....... . ...-|+-+
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFt-taSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~c 772 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPAC 772 (807)
T ss_pred eeecceeeeeeehhHHHHHhcccc-chhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcC
Confidence 222233456799999999877774 5599999999999875 58899987666554443321 1 23456778
Q ss_pred CHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 255 SKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 255 s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+..+.+++-+||..+-.+|||.+++-.
T Consensus 773 p~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 773 PQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred cHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 999999999999999999999999854
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=281.03 Aligned_cols=260 Identities=28% Similarity=0.481 Sum_probs=209.3
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEcC---CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEE
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIA---DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQE 97 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~ 97 (451)
..++.+.+.|.....||+|+|+.||+|.+.. .++.||+|.+..... ..++.+|+.+|..+.++.||+.+.+
T Consensus 29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~------p~ri~~El~~L~~~gG~~ni~~~~~ 102 (418)
T KOG1167|consen 29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS------PSRILNELEMLYRLGGSDNIIKLNG 102 (418)
T ss_pred hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC------chHHHHHHHHHHHhccchhhhcchh
Confidence 4467888999999999999999999999877 788999999977643 2468899999999999999999999
Q ss_pred EEEeCCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCC-CCeEEEeccCC
Q 013005 98 VMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD-GNLKVSDFGLS 176 (451)
Q Consensus 98 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~-~~lkl~DFGls 176 (451)
++..++...+||||.+..+..++... ++..+++.|++.++.||.++|++||+||||||.|+|.+.. +.-.|+|||||
T Consensus 103 ~~rnnd~v~ivlp~~~H~~f~~l~~~--l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 103 CFRNNDQVAIVLPYFEHDRFRDLYRS--LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred hhccCCeeEEEecccCccCHHHHHhc--CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhH
Confidence 99999999999999998887777664 6688899999999999999999999999999999999864 67899999998
Q ss_pred Ccchhhh--------------------------------c-----------CcccccCCCCccccceeeeccCCCCccch
Q 013005 177 ALPEQIK--------------------------------N-----------GMLHTACGTPAYTAPEVVARRGYDGAVAD 213 (451)
Q Consensus 177 ~~~~~~~--------------------------------~-----------~~~~~~~gt~~y~APEvl~~~~~~~~~sD 213 (451)
...+... . ..-....||++|.|||++.+-+..+.+.|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 6211100 0 00113359999999999999888899999
Q ss_pred hhhhhHHHHHHHhcCCCCCCCcH-----HHH---------------------HH---------------Hh-----hccC
Q 013005 214 AWSCGVILFVLLAGYLPFDDSNL-----LAM---------------------YK---------------KV-----NRRD 247 (451)
Q Consensus 214 IwSlGvil~~Ll~G~~Pf~~~~~-----~~~---------------------~~---------------~i-----~~~~ 247 (451)
|||.|||+..++++..||..... .++ ++ .. .+..
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 99999999999999999942110 000 00 00 0000
Q ss_pred C------CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 248 Y------QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 248 ~------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
. ......+..+.+|+.+||..||.+|+|+++.|+||||...
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 0 0001245578999999999999999999999999999853
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=296.68 Aligned_cols=256 Identities=23% Similarity=0.429 Sum_probs=212.9
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEc---C----CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceE
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSI---A----DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~---~----~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~ 94 (451)
.+....++..+.+.||+|+||.|++|.-. . ....||||.+.... .....+.+..|+.+|+.+..||||+.
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~---~~~~~~~~~~El~~m~~~g~H~niv~ 366 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA---SSSEKKDLMSELNVLKELGKHPNIVN 366 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc---CcHHHHHHHHHHHHHHHhcCCcchhh
Confidence 44555555677789999999999999632 1 14579999987542 23566789999999999989999999
Q ss_pred EEEEEEeCCEEEEEEEecCCCchhHHhhcCC-----------------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 013005 95 IQEVMATKTKIYLVMEYAAGGELFGKLRRGR-----------------LTESAARRYFQQLVSALHFCHQNGVAHRDVKP 157 (451)
Q Consensus 95 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------------l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKp 157 (451)
+.+++...+..++|+||+..|+|.++++..+ ++..+...+..||+.|++||++..++||||-.
T Consensus 367 llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAa 446 (609)
T KOG0200|consen 367 LLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAA 446 (609)
T ss_pred heeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhh
Confidence 9999999999999999999999999998655 89999999999999999999999999999999
Q ss_pred CeEEeCCCCCeEEEeccCCCcchhhhcCcccccCCCC--ccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCC
Q 013005 158 QNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP--AYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDS 234 (451)
Q Consensus 158 eNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~gt~--~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~ 234 (451)
.|||+..+..+||+|||+|+..............|+. .|||||.+....| +.++||||+||+|||+++ |..||.+-
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 9999999999999999999854332222112223334 4999999988555 677999999999999998 89999874
Q ss_pred c-HHHHHHHhhccC-CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 235 N-LLAMYKKVNRRD-YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 235 ~-~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
. ..+++..+..+. ...|..++.++.++++.||..+|++||+..++.+
T Consensus 526 ~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 526 PPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 4 556666666654 4678889999999999999999999999999876
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=248.63 Aligned_cols=216 Identities=26% Similarity=0.483 Sum_probs=176.8
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
.....+...-+..||+|+||.|-+.++..+|...|+|.+... .+...+.++.+|+.+..+...+|.+|.+||.+...
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t---vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re 117 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT---VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE 117 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhh---cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence 344455666678899999999999999999999999999754 33556678889999887777899999999999999
Q ss_pred CEEEEEEEecCCCchhHHhh----c-CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCeEEeCCCCCeEEEeccCC
Q 013005 103 TKIYLVMEYAAGGELFGKLR----R-GRLTESAARRYFQQLVSALHFCHQN-GVAHRDVKPQNLLLDRDGNLKVSDFGLS 176 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~----~-~~l~e~~~~~~~~ql~~gL~yLH~~-giiHrDLKpeNILld~~~~lkl~DFGls 176 (451)
..+|+.||.++. +|..+.+ + +.++|..+-+++..++.||.|||++ .++|||+||.|||++.+|++|+||||.|
T Consensus 118 gdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 118 GDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred ccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccc
Confidence 999999999964 6654432 3 5799999999999999999999987 8999999999999999999999999999
Q ss_pred CcchhhhcCcccc-cCCCCccccceeeec----cCCCCccchhhhhhHHHHHHHhcCCCCCCC-cHHHHHHHhhcc
Q 013005 177 ALPEQIKNGMLHT-ACGTPAYTAPEVVAR----RGYDGAVADAWSCGVILFVLLAGYLPFDDS-NLLAMYKKVNRR 246 (451)
Q Consensus 177 ~~~~~~~~~~~~~-~~gt~~y~APEvl~~----~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~-~~~~~~~~i~~~ 246 (451)
..... ....+ ..|...|+|||.+.. .+| +.++||||||+.++||.+++.||+.- +..+..+++...
T Consensus 197 G~L~d---SiAkt~daGCkpYmaPEri~~e~n~~gY-~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 197 GYLVD---SIAKTMDAGCKPYMAPERINPELNQKGY-SVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred eeehh---hhHHHHhcCCCccCChhhcCcccCcccc-eeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 76533 22222 567889999999743 355 56799999999999999999999763 444555555443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=271.43 Aligned_cols=244 Identities=27% Similarity=0.389 Sum_probs=193.6
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHH--hcCCCCceEEEEEEEeCC-
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR--LQNHPNVLKIQEVMATKT- 103 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~--L~~HpnIv~l~~~~~~~~- 103 (451)
.....+.+.||+|.||.||+|.- +++.||||++.... .+.+..|-.|.+. + .|+||+++++.-...+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~-------kqs~~~Ek~Iy~lp~m-~h~nIl~Fi~~ekr~t~ 278 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE-------KQSFQNEKNIYSLPGM-KHENILQFIGAEKRGTA 278 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHH-------HHHHHhHHHHHhccCc-cchhHHHhhchhccCCc
Confidence 55677889999999999999984 67999999997543 2455666665554 4 4999999998865555
Q ss_pred ---EEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CceecCCCCCeEEeCCCCCeEEE
Q 013005 104 ---KIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQN---------GVAHRDVKPQNLLLDRDGNLKVS 171 (451)
Q Consensus 104 ---~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~---------giiHrDLKpeNILld~~~~lkl~ 171 (451)
.++||+||.+.|+|.+++....+++.+..+++..+++||+|||+. .|+|||||..||||.++++..|+
T Consensus 279 ~~~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 279 DRMEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred cccceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 799999999999999999999999999999999999999999973 49999999999999999999999
Q ss_pred eccCCCcchhhhc-CcccccCCCCccccceeeeccCCCC-----ccchhhhhhHHHHHHHhcC------------CCCC-
Q 013005 172 DFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDG-----AVADAWSCGVILFVLLAGY------------LPFD- 232 (451)
Q Consensus 172 DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~-----~~sDIwSlGvil~~Ll~G~------------~Pf~- 232 (451)
|||||..+..... +..+..+||..|||||+|.+.-... ...||||+|.+||||++.. +||.
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 9999976654333 5566789999999999986543222 3489999999999999753 3343
Q ss_pred ----CCcHHHHHHHhh--ccCCCCCCC-----CCHhHHHHHHhccCCCCCCCCCHHHHH
Q 013005 233 ----DSNLLAMYKKVN--RRDYQFPSF-----VSKPARSLIYQLLDPNPKTRMSIEKIM 280 (451)
Q Consensus 233 ----~~~~~~~~~~i~--~~~~~~p~~-----~s~~~~~li~~~L~~dP~~Rpt~~eil 280 (451)
.++.+++..... +....+|.. -...+.+.+..||+.||+-|.|+.=+.
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE 497 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence 234444444433 334455542 245678999999999999999976443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-31 Score=243.51 Aligned_cols=212 Identities=40% Similarity=0.723 Sum_probs=185.2
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecCCC
Q 013005 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGG 115 (451)
Q Consensus 36 LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~gg 115 (451)
||+|++|.||++.+..+++.+++|++...... ...+.+.+|+..++.+. |++|+++++++......++++||+.|+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~~~e~~~~~ 76 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS---SLLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCEGG 76 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccch---hHHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeEEEEEecCCCC
Confidence 68999999999999888999999999765321 14567899999999996 899999999999999999999999999
Q ss_pred chhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC-CCCeEEEeccCCCcchhhhcCcccccCC
Q 013005 116 ELFGKLRRG--RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR-DGNLKVSDFGLSALPEQIKNGMLHTACG 192 (451)
Q Consensus 116 ~L~~~l~~~--~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~-~~~lkl~DFGls~~~~~~~~~~~~~~~g 192 (451)
+|.+++... .++...++.++.+++.++.+||++|++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 77 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 77 SLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 999999764 7999999999999999999999999999999999999999 89999999999875433211 1334567
Q ss_pred CCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccCCCCCC
Q 013005 193 TPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKT 272 (451)
Q Consensus 193 t~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 272 (451)
+..|.+||.+......+.++|+|++|+++++| ..+.+++.+|+..||++
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~ 204 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEK 204 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCccc
Confidence 88999999986653446779999999999999 67899999999999999
Q ss_pred CCCHHHHHcCc
Q 013005 273 RMSIEKIMSIS 283 (451)
Q Consensus 273 Rpt~~eil~hp 283 (451)
||++.++++|+
T Consensus 205 R~~~~~l~~~~ 215 (215)
T cd00180 205 RPSAKEILEHL 215 (215)
T ss_pred CcCHHHHhhCC
Confidence 99999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=244.66 Aligned_cols=218 Identities=39% Similarity=0.689 Sum_probs=184.1
Q ss_pred eEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEE
Q 013005 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVM 109 (451)
Q Consensus 30 y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~ 109 (451)
|.+.+.||+|++|.||++.+..+++.+|+|.+...... ...+.+.+|+..++.+. |+|++++++.+......++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~v~ 76 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLK-HPNIVKLYGVFEDPEPLYLVM 76 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCC-CCChhhheeeeecCCceEEEE
Confidence 57789999999999999999888999999999765321 24578889999999995 999999999999999999999
Q ss_pred EecCCCchhHHhhc-CC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcc
Q 013005 110 EYAAGGELFGKLRR-GR-LTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML 187 (451)
Q Consensus 110 E~~~gg~L~~~l~~-~~-l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~ 187 (451)
||+.+++|.+++.. .. +++..+..++.|++.++.+||+++++|+||+|.||+++.++.++|+|||++...........
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 99999999999976 34 89999999999999999999999999999999999999999999999999876543221133
Q ss_pred cccCCCCccccceee-eccCCCCccchhhhhhHHHHHHHhcCCCCCC--CcHHHHHHHhhccCCCCCC
Q 013005 188 HTACGTPAYTAPEVV-ARRGYDGAVADAWSCGVILFVLLAGYLPFDD--SNLLAMYKKVNRRDYQFPS 252 (451)
Q Consensus 188 ~~~~gt~~y~APEvl-~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~--~~~~~~~~~i~~~~~~~p~ 252 (451)
....++..|++||.+ ....+ +.++|+||||+++++|++|+.||.. .+...+...+..+.....+
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~-~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGY-GEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLWE 223 (225)
T ss_pred cceeccCCcCCHhHhcCCCCC-CchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccccc
Confidence 456788999999988 44444 4579999999999999999999987 4445777777776544433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=254.04 Aligned_cols=257 Identities=25% Similarity=0.410 Sum_probs=204.4
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE-EEe
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV-MAT 101 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~-~~~ 101 (451)
.-.+.+.|.+.+.||+|-||++.++.++.+++.+++|.+.+.. .....+.+|...--.|..|.||+.-|++ |.+
T Consensus 19 kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt 93 (378)
T KOG1345|consen 19 KVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT 93 (378)
T ss_pred ccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-----hhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence 3467889999999999999999999999999999999997652 3456788998877777789999998887 566
Q ss_pred CCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC--CCCeEEEeccCCCcc
Q 013005 102 KTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR--DGNLKVSDFGLSALP 179 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~--~~~lkl~DFGls~~~ 179 (451)
.+.+.+++||++-|+|..-+....+.|....+++.|+++|+.|+|+++++|||||.+||||-. ...+||||||+++..
T Consensus 94 ~d~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 94 SDAYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred CceEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 778889999999999999999889999999999999999999999999999999999999932 237999999998743
Q ss_pred hhhhcCcccccCCCCccccceeeeccC---C-CCccchhhhhhHHHHHHHhcCCCCCCCcH----HHHHHHhhcc-CCCC
Q 013005 180 EQIKNGMLHTACGTPAYTAPEVVARRG---Y-DGAVADAWSCGVILFVLLAGYLPFDDSNL----LAMYKKVNRR-DYQF 250 (451)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~APEvl~~~~---~-~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~----~~~~~~i~~~-~~~~ 250 (451)
.. .....--+..|.|||++.... + ..+.+|||.||+++|.+++|.+||..... ...+.++..+ ....
T Consensus 174 g~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~ 249 (378)
T KOG1345|consen 174 GT----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL 249 (378)
T ss_pred Cc----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC
Confidence 22 112223467899999874332 1 13458999999999999999999974322 2233444333 3344
Q ss_pred CC---CCCHhHHHHHHhccCCCCCCC---CCHHHHHcCccccch
Q 013005 251 PS---FVSKPARSLIYQLLDPNPKTR---MSIEKIMSISWFQKS 288 (451)
Q Consensus 251 p~---~~s~~~~~li~~~L~~dP~~R---pt~~eil~hp~f~~~ 288 (451)
|. .+++.+..+.++-|.++|+.| .++.......|..+.
T Consensus 250 P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 250 PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence 43 378999999999999999999 556666666676543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=278.85 Aligned_cols=246 Identities=22% Similarity=0.362 Sum_probs=209.5
Q ss_pred eEEcceEcccCceEEEEEEEcCCCc----EEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 30 YQLGPLLGRGSFAKVHKAKSIADGS----IVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 30 y~~~~~LG~G~~g~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
....+.||+|+||+||+|.+...|+ +||||++.... .......+..|.-+|.+|. |||++|+++++.... +
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t---~~~~s~e~LdeAl~masld-Hpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT---SPKASIELLDEALRMASLD-HPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC---CchhhHHHHHHHHHHhcCC-CchHHHHhhhcccch-H
Confidence 3456789999999999999877665 78999987542 2334567888999999995 999999999997666 8
Q ss_pred EEEEEecCCCchhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 106 YLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~--~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
.||++|+++|.|.++++ ++.+.......|..||++||.|||.++++||||-..|+|+..-..+||.|||++.......
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 89999999999999997 4789999999999999999999999999999999999999999999999999999876654
Q ss_pred cCccccc-CCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhHHH
Q 013005 184 NGMLHTA-CGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPARS 260 (451)
Q Consensus 184 ~~~~~~~-~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 260 (451)
....... .-.+.|+|=|.+....| +.++||||+||++||++| |..|+++....+.-..+..+ ....|+..+-++..
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~-thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~ 931 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKY-THQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYM 931 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCC-CchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHH
Confidence 4333221 22467999998877777 567999999999999988 99999998888777776654 35678889999999
Q ss_pred HHHhccCCCCCCCCCHHHHHc
Q 013005 261 LIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 261 li~~~L~~dP~~Rpt~~eil~ 281 (451)
++.+||..|+..||+++++..
T Consensus 932 ~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 932 VMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHhccCcccCccHHHHHH
Confidence 999999999999999988764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=258.10 Aligned_cols=248 Identities=26% Similarity=0.417 Sum_probs=194.5
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHH--hcCCCCceEEEEEEEe
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR--LQNHPNVLKIQEVMAT 101 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~--L~~HpnIv~l~~~~~~ 101 (451)
..+..+..+.+.||+|.||.||+|.+ -|+.||||++... .+..+.+|.+|.+. | +|+||+.+++.-..
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~sr-------dE~SWfrEtEIYqTvmL-RHENILgFIaaD~~ 276 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSR-------DERSWFRETEIYQTVML-RHENILGFIAADNK 276 (513)
T ss_pred HhhhheeEEEEEecCccccceeeccc--cCCceEEEEeccc-------chhhhhhHHHHHHHHHh-ccchhhhhhhcccc
Confidence 35566788999999999999999986 6899999999643 23567778877764 5 49999999876422
Q ss_pred ----CCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCeEEeCCCCCeE
Q 013005 102 ----KTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQN--------GVAHRDVKPQNLLLDRDGNLK 169 (451)
Q Consensus 102 ----~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~--------giiHrDLKpeNILld~~~~lk 169 (451)
-+.+|||.+|.+.|+|+|++.+..++.+...+++..++.||++||-. .|.|||||..|||+..+|..-
T Consensus 277 ~~gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 277 DNGSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred CCCceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 24699999999999999999999999999999999999999999963 399999999999999999999
Q ss_pred EEeccCCCcchhhhc---CcccccCCCCccccceeeeccC----CC-CccchhhhhhHHHHHHHhc----------CCCC
Q 013005 170 VSDFGLSALPEQIKN---GMLHTACGTPAYTAPEVVARRG----YD-GAVADAWSCGVILFVLLAG----------YLPF 231 (451)
Q Consensus 170 l~DFGls~~~~~~~~---~~~~~~~gt~~y~APEvl~~~~----~~-~~~sDIwSlGvil~~Ll~G----------~~Pf 231 (451)
|+|+|||-......+ -..+..+||..|||||+|...- +. -..+||||||.++||++.. .+||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 999999965443322 2346789999999999985432 11 1348999999999999752 5788
Q ss_pred CC-----CcHHHHHHHhhc--cCCCCCC-CCCH----hHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 232 DD-----SNLLAMYKKVNR--RDYQFPS-FVSK----PARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 232 ~~-----~~~~~~~~~i~~--~~~~~p~-~~s~----~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.+ ++.+++.+-+.- -...+|+ |-+. .+..+++.||..||.-|.|+-.|.+
T Consensus 437 yd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 437 YDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred ccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 53 455555544332 2334444 4443 3467899999999999999987764
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=293.32 Aligned_cols=194 Identities=19% Similarity=0.241 Sum_probs=144.0
Q ss_pred CCceEEEEEE-------EeCCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeE
Q 013005 90 PNVLKIQEVM-------ATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNL 160 (451)
Q Consensus 90 pnIv~l~~~~-------~~~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNI 160 (451)
+||.++++.+ .....+++++||+ +++|.+++.. ..+++.+++.++.||+.||+|||++||+||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 5777777766 2334677888987 5699999974 4599999999999999999999999999999999999
Q ss_pred EeCC-------------------CCCeEEEeccCCCcchhhhc---------------CcccccCCCCccccceeeeccC
Q 013005 161 LLDR-------------------DGNLKVSDFGLSALPEQIKN---------------GMLHTACGTPAYTAPEVVARRG 206 (451)
Q Consensus 161 Lld~-------------------~~~lkl~DFGls~~~~~~~~---------------~~~~~~~gt~~y~APEvl~~~~ 206 (451)
||+. ++.+|++|||+++....... ......+||+.|+|||++.+..
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 191 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS 191 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence 9954 44566666776653211000 0011246899999999998877
Q ss_pred CCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCC-CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 207 YDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQ-FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 207 ~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
| +.++|||||||+||||++|..|+..... ....+.....+ .+....+...+++.+||.+||.+|||+.++++||||
T Consensus 192 ~-~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~ 268 (793)
T PLN00181 192 S-NCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFI 268 (793)
T ss_pred C-CchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhh
Confidence 7 5679999999999999999998764321 11112111111 111124567789999999999999999999999999
Q ss_pred cc
Q 013005 286 QK 287 (451)
Q Consensus 286 ~~ 287 (451)
..
T Consensus 269 ~~ 270 (793)
T PLN00181 269 NE 270 (793)
T ss_pred hh
Confidence 75
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=285.01 Aligned_cols=261 Identities=28% Similarity=0.501 Sum_probs=207.3
Q ss_pred ccCCe-EEcceEcccCceEEEEEEEcCCCcEEEEEEeecC--cchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 26 LLNRY-QLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKN--NKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 26 ~~~~y-~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
....| .....+|.|++|.|+.+......+.++.|..... ...........+..|..+-..|. |||++.....+.+.
T Consensus 315 ~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~~~ 393 (601)
T KOG0590|consen 315 FSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQEI 393 (601)
T ss_pred cccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHhhc
Confidence 34556 4577899999998888887766666666654311 01112223333778888888895 99998877776666
Q ss_pred CEEEEEEEecCCCchhHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 103 TKIYLVMEYAAGGELFGKLRRG-RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~~-~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
...+-+||||++ +|+.++... .++..++..+++||+.||+|+|+.|+.||||||+|++++.+|.+||+|||.+..+..
T Consensus 394 ~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 394 DGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred ccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeecc
Confidence 666666999999 999999874 999999999999999999999999999999999999999999999999999987654
Q ss_pred hhc---CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHH-HHHHh--------hccCCC
Q 013005 182 IKN---GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLA-MYKKV--------NRRDYQ 249 (451)
Q Consensus 182 ~~~---~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~-~~~~i--------~~~~~~ 249 (451)
... ......+|+.+|+|||++.+..|+....||||+|++++.|.+|+.||......+ .+... ..+...
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~ 552 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNR 552 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHH
Confidence 333 345678999999999999999999999999999999999999999997544331 11111 111122
Q ss_pred CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 250 FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 250 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+...++...+.+|.+||++||.+|.|+++|++.+||+..
T Consensus 553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 553 LLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred HHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 223467788999999999999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=222.44 Aligned_cols=158 Identities=24% Similarity=0.249 Sum_probs=127.6
Q ss_pred CchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCC
Q 013005 115 GELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACG 192 (451)
Q Consensus 115 g~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~g 192 (451)
|+|.+++.. +.+++.+++.++.|++.||.|||+++ ||+|||++.++.+|+ ||++..... ....|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~------~~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP------EQSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc------ccCCC
Confidence 688999874 46999999999999999999999999 999999999999999 999875432 12368
Q ss_pred CCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH-HHHHHhhccCCC-------CCCCCCH--hHHHHH
Q 013005 193 TPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL-AMYKKVNRRDYQ-------FPSFVSK--PARSLI 262 (451)
Q Consensus 193 t~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~-~~~~~i~~~~~~-------~p~~~s~--~~~~li 262 (451)
|+.|+|||++.+..| +.++||||+||++|+|++|..||...... .....+...... .+..++. .+.++|
T Consensus 67 ~~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 67 DPYFMAPEVIQGQSY-TEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred cccccChHHhcCCCC-cchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 999999999988777 46799999999999999999999765432 333333222111 1122333 689999
Q ss_pred HhccCCCCCCCCCHHHHHcCccccc
Q 013005 263 YQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 263 ~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
.+||..||.+|||+.++++|+|+..
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHH
Confidence 9999999999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=224.72 Aligned_cols=253 Identities=36% Similarity=0.596 Sum_probs=208.7
Q ss_pred eEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCC-CceEEEEEEEeCCEEEEE
Q 013005 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP-NVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 30 y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~Hp-nIv~l~~~~~~~~~~~lV 108 (451)
|.+.+.||.|+|+.||++.+. ..+++|.+..... ........+.+|+.++..+. |+ +|+++++.+......+++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~-~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~ 76 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLE-SKSKEVERFLREIQILASLN-HPPNIVKLYDFFQDEGSLYLV 76 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhc-cchhHHHHHHHHHHHHHHcc-CCcceeeEEEEEecCCEEEEE
Confidence 788999999999999999976 8899999976522 22235678899999999997 55 899999999888888999
Q ss_pred EEecCCCchhHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC-CeEEEeccCCCcchhhh
Q 013005 109 MEYAAGGELFGKLRRG----RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG-NLKVSDFGLSALPEQIK 183 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~~----~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~-~lkl~DFGls~~~~~~~ 183 (451)
++++.++++.+.+... .+++..+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||++.......
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 9999999999777653 799999999999999999999999999999999999999998 69999999987443322
Q ss_pred cC-----cccccCCCCccccceeeecc--CCCCccchhhhhhHHHHHHHhcCCCCCCCc----HHHHHHHhhccCCC-CC
Q 013005 184 NG-----MLHTACGTPAYTAPEVVARR--GYDGAVADAWSCGVILFVLLAGYLPFDDSN----LLAMYKKVNRRDYQ-FP 251 (451)
Q Consensus 184 ~~-----~~~~~~gt~~y~APEvl~~~--~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~----~~~~~~~i~~~~~~-~p 251 (451)
.. .....+||..|+|||.+... .+.....|+||+|++++++++|..||.... .......+...... ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 21 34678899999999999874 456677999999999999999999988765 34555555444433 22
Q ss_pred CCCC--------HhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 252 SFVS--------KPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 252 ~~~s--------~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
.... ..+.+++.+++..+|..|.+..+...++|...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 2221 47899999999999999999999998866654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=238.68 Aligned_cols=177 Identities=24% Similarity=0.341 Sum_probs=139.7
Q ss_pred CCCCCCcccccCCeEEcceEcccCceEEEEEEEcC-CCcEEEEEEeecCcc-hhhHHHHHHHHHHHHHHHHhcCCCCceE
Q 013005 17 PPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIA-DGSIVAIKTIEKNNK-FLDAAMEDRIVREVSAMRRLQNHPNVLK 94 (451)
Q Consensus 17 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-~~~~vAiK~i~~~~~-~~~~~~~~~~~~Ei~il~~L~~HpnIv~ 94 (451)
+.|....+.+.++|.+.+.||+|+||+||+|++.. +++.+|||.+..... .......+.+.+|+.+|++|. |+||+.
T Consensus 7 ~~~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~ 85 (365)
T PRK09188 7 PLPGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVP 85 (365)
T ss_pred CCcccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCc
Confidence 44667778899999999999999999999999876 678889998753211 012334567999999999996 999884
Q ss_pred -EEEEEEeCCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC-CCCeEEeCCCCCeEEEe
Q 013005 95 -IQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDV-KPQNLLLDRDGNLKVSD 172 (451)
Q Consensus 95 -l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDL-KpeNILld~~~~lkl~D 172 (451)
+++. ...|+||||++|++|... .. .. ...++.|+++||.|||++||+|||| ||+|||++.++.+||+|
T Consensus 86 ~l~~~----~~~~LVmE~~~G~~L~~~-~~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 86 QLLAT----GKDGLVRGWTEGVPLHLA-RP--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred EEEEc----CCcEEEEEccCCCCHHHh-Cc--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEE
Confidence 5542 458999999999999732 11 11 2568899999999999999999999 99999999999999999
Q ss_pred ccCCCcchhhhc-------CcccccCCCCccccceeeec
Q 013005 173 FGLSALPEQIKN-------GMLHTACGTPAYTAPEVVAR 204 (451)
Q Consensus 173 FGls~~~~~~~~-------~~~~~~~gt~~y~APEvl~~ 204 (451)
||+|........ ....+.++++.|.|||.+..
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999985433221 12246678999999999854
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=228.32 Aligned_cols=252 Identities=20% Similarity=0.279 Sum_probs=205.1
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCC-----cEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADG-----SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~ 99 (451)
.--.++++...+-+|.||.||+|++.+.. +.|-+|.+... .++-....+..|-..+.-+. |||+..+.++.
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~---AS~iQv~~~L~es~lly~~s-H~nll~V~~V~ 356 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH---ASQIQVNLLLQESMLLYGAS-HPNLLSVLGVS 356 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc---ccHHHHHHHHHHHHHHhcCc-CCCccceeEEE
Confidence 34567888889999999999999876533 34555655432 23445567778888888885 99999999987
Q ss_pred E-eCCEEEEEEEecCCCchhHHhh-----c----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeE
Q 013005 100 A-TKTKIYLVMEYAAGGELFGKLR-----R----GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLK 169 (451)
Q Consensus 100 ~-~~~~~~lV~E~~~gg~L~~~l~-----~----~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lk 169 (451)
. +....+.++.+..-|+|..++. + ..++..+...++.|+..|++|||++||+|.||-..|.+||+.-++|
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVk 436 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVK 436 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEE
Confidence 4 5667889999999999999986 1 2377788888999999999999999999999999999999999999
Q ss_pred EEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhccC
Q 013005 170 VSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRD 247 (451)
Q Consensus 170 l~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~~ 247 (451)
|+|=.+|+..-.... ..-..--....||+||.+.+..|.+. +|+|||||+||||+| |+.|+..-+..+++..++.+.
T Consensus 437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssa-sDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy 515 (563)
T KOG1024|consen 437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSA-SDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY 515 (563)
T ss_pred eccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcch-hhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc
Confidence 999999874322222 22222234568999999999888655 899999999999988 999999999999988887763
Q ss_pred -CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 248 -YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 248 -~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
..-|-.+++++..++.-||...|++||+.+|+..
T Consensus 516 RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 516 RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 4557789999999999999999999999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-28 Score=245.96 Aligned_cols=243 Identities=34% Similarity=0.571 Sum_probs=206.4
Q ss_pred eEcccCceEEEEEEEc---CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEe
Q 013005 35 LLGRGSFAKVHKAKSI---ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEY 111 (451)
Q Consensus 35 ~LG~G~~g~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~ 111 (451)
.+|+|+||+|++++.. ..|..+|+|+..+..-..... ..-..|-.++..+++||.+|+++..+..+.+.|+++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~--~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~ 78 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR--THTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDF 78 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccc--cccccHHHHHhhccCCCceeeeeeeeccccchhHhhhh
Confidence 4799999999987642 457789999987642211111 14455666777887799999999999999999999999
Q ss_pred cCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCccccc
Q 013005 112 AAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTA 190 (451)
Q Consensus 112 ~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~ 190 (451)
..||+|+..+.+ ..+.+...+.+...++-+++++|+.||+|||+|++||+++.+|++++.|||++...-... ..
T Consensus 79 ~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-----~~ 153 (612)
T KOG0603|consen 79 LRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-----IA 153 (612)
T ss_pred cccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh-----hc
Confidence 999999998875 678999999999999999999999999999999999999999999999999997543222 22
Q ss_pred CCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccCCCC
Q 013005 191 CGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNP 270 (451)
Q Consensus 191 ~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP 270 (451)
|||..|||||++. +.. ..+|.||+|++.|+|++|..||.. +....|.+....+|...+..+++++..++..+|
T Consensus 154 cgt~eymApEI~~--gh~-~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHL-SAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred ccchhhhhhHhhh--ccC-CcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCH
Confidence 9999999999987 443 448999999999999999999988 667778888889999999999999999999999
Q ss_pred CCCCC-----HHHHHcCccccchhHH
Q 013005 271 KTRMS-----IEKIMSISWFQKSLQQ 291 (451)
Q Consensus 271 ~~Rpt-----~~eil~hp~f~~~~~~ 291 (451)
..|.- +.++++|+||+.....
T Consensus 227 ~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 227 ENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred HHHhccCcchhHHHhccchheeeeHh
Confidence 99974 5899999999876554
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=221.47 Aligned_cols=248 Identities=23% Similarity=0.295 Sum_probs=193.4
Q ss_pred CeEEcceEcccCceEEEEEEEcCCC-cEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhc---CCCCceEEEEEE-EeCC
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADG-SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ---NHPNVLKIQEVM-ATKT 103 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~---~HpnIv~l~~~~-~~~~ 103 (451)
+|.+.+.||+|+||.||++.+..++ ..+|+|+........ ...+..|+.++..+. +.+++.++++.. ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~----~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK----PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC----CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence 8999999999999999999987774 689999887642211 115778888888886 246899999999 5788
Q ss_pred EEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCC-----CCeEEEeccC
Q 013005 104 KIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD-----GNLKVSDFGL 175 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~-----~~lkl~DFGl 175 (451)
..|+||+.+ |.+|.++... ++++..++..++.|++.+|+++|+.|++||||||+|+++... ..+.|.|||+
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 899999988 7799887742 689999999999999999999999999999999999999765 3699999999
Q ss_pred CCcch--hhhc------Cc-ccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH---HHHHHh
Q 013005 176 SALPE--QIKN------GM-LHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL---AMYKKV 243 (451)
Q Consensus 176 s~~~~--~~~~------~~-~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~---~~~~~i 243 (451)
++... .... .. .....||..|+++....+... +++.|+||++.++.+|+.|.+||...... ..+.+.
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 98322 1111 11 223459999999998876655 67799999999999999999999765432 222222
Q ss_pred hccCCC--CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 244 NRRDYQ--FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 244 ~~~~~~--~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
...... +....+..+..+...+-..+...+|....+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 253 PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 222221 233456778888888888999999999888765
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=199.35 Aligned_cols=247 Identities=23% Similarity=0.278 Sum_probs=198.7
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
--...++|.+++.||.|+||.+|+|.+..+|+.||||+-....+ ..++..|..+.+.|++...|..+..+..+.
T Consensus 10 ~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~------hpqL~yEskvY~iL~~g~GiP~i~~y~~e~ 83 (341)
T KOG1163|consen 10 ELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK------HPQLLYESKVYRILQGGVGIPHIRHYGTEK 83 (341)
T ss_pred hheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC------CcchhHHHHHHHHhccCCCCchhhhhcccc
Confidence 34668899999999999999999999999999999999765432 235677889999999888999999999999
Q ss_pred CEEEEEEEecCCCchhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCC---CCeEEEeccCCC
Q 013005 103 TKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD---GNLKVSDFGLSA 177 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~--~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~---~~lkl~DFGls~ 177 (451)
..-.+||+.. |-+|.++.. ...++..++.-++.|++.-++|+|.++++||||||+|+|..-+ ..+.++|||||.
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred ccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence 9999999988 779988886 4789999999999999999999999999999999999998533 469999999998
Q ss_pred cchhhhc------CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCC---cHHHHHHHhhccCC
Q 013005 178 LPEQIKN------GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS---NLLAMYKKVNRRDY 248 (451)
Q Consensus 178 ~~~~~~~------~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~---~~~~~~~~i~~~~~ 248 (451)
.+.+... ..-....||..|.+--...+... +...|+-|+|.+|..+.-|.+||.+- +...-|.+|.....
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~ 241 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM 241 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc
Confidence 6544322 12234568999988765554333 56689999999999999999999874 34456667766555
Q ss_pred CCC-----CCCCHhHHHHHHhccCCCCCCCCCHH
Q 013005 249 QFP-----SFVSKPARSLIYQLLDPNPKTRMSIE 277 (451)
Q Consensus 249 ~~p-----~~~s~~~~~li~~~L~~dP~~Rpt~~ 277 (451)
..| ..+|.++...+.-|-..--++-|...
T Consensus 242 s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 242 STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 544 34678888888888777666667643
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-23 Score=200.64 Aligned_cols=250 Identities=18% Similarity=0.280 Sum_probs=200.9
Q ss_pred CCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE
Q 013005 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 20 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~ 99 (451)
.......--.|.+++.||+|+||.+++|.|.-++++||||.-..... .-++.-|....+.|.+.++|..+|-+.
T Consensus 20 ~s~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~------APQLrdEYr~YKlL~g~~GIP~vYYFG 93 (449)
T KOG1165|consen 20 SSGVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE------APQLRDEYRTYKLLGGTEGIPQVYYFG 93 (449)
T ss_pred CCCceEecccceeccccccCcceeeecccccccCceEEEEeccccCC------cchHHHHHHHHHHHcCCCCCCceeeec
Confidence 33445666789999999999999999999999999999998765321 346788999999998899999999888
Q ss_pred EeCCEEEEEEEecCCCchhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC-----CeEEEe
Q 013005 100 ATKTKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG-----NLKVSD 172 (451)
Q Consensus 100 ~~~~~~~lV~E~~~gg~L~~~l~--~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~-----~lkl~D 172 (451)
.+..+-.||||++ |-+|.|+.. ..+|+..++..++.|++.-++|+|++..|.|||||+|+||..-+ .+.|+|
T Consensus 94 qeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiD 172 (449)
T KOG1165|consen 94 QEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIID 172 (449)
T ss_pred cccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEe
Confidence 8888889999988 778888886 36799999999999999999999999999999999999996543 589999
Q ss_pred ccCCCcchhhhc------CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCC---CcHHHHHHHh
Q 013005 173 FGLSALPEQIKN------GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDD---SNLLAMYKKV 243 (451)
Q Consensus 173 FGls~~~~~~~~------~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~---~~~~~~~~~i 243 (451)
||+|..+.+... .....-.||..||+-....+... +...|+-|||=+++..|-|.+||.+ .+...-|++|
T Consensus 173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred ccchhhhcCccccccCccccccccccceeeeEeeccccchh-hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence 999986544322 22345579999999888777655 5668999999999999999999986 5667788888
Q ss_pred hccCCCCC-----CCCCHhHHHHHHhccCCCCCCCCCHH
Q 013005 244 NRRDYQFP-----SFVSKPARSLIYQLLDPNPKTRMSIE 277 (451)
Q Consensus 244 ~~~~~~~p-----~~~s~~~~~li~~~L~~dP~~Rpt~~ 277 (451)
......-| ..++.++..-+.-.-..+-.+-|..+
T Consensus 252 Ge~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd 290 (449)
T KOG1165|consen 252 GETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYD 290 (449)
T ss_pred ccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence 76544333 23566666666655555555666654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.7e-25 Score=233.85 Aligned_cols=221 Identities=32% Similarity=0.551 Sum_probs=176.3
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
-...+|..+++|..|+||-||+.+++.+.+++|+ .+++++. +.|. ++... +.|.+|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l---------ilRn--ilt~a-~npfvv----------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL---------ILRN--ILTFA-GNPFVV----------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhh-cccccch---------hhhc--ccccc-CCccee-----------
Confidence 3456799999999999999999999999999999 4554421 1111 22222 344444
Q ss_pred EEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch---
Q 013005 105 IYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE--- 180 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~--- 180 (451)
|+-...++. |.++.+. +.+++|||+.||+|||+||+|++|+.-|++|++|||++...-
T Consensus 136 ----------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ----------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ----------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 455555554 5666554 778999999999999999999999999999999999986421
Q ss_pred ----------hhhcCcc-cccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCC
Q 013005 181 ----------QIKNGML-HTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQ 249 (451)
Q Consensus 181 ----------~~~~~~~-~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~ 249 (451)
....... ...||||.|.|||++..++| +.+.|.|++|+|+|+.+-|..||.+++.++++.........
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~ 276 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE 276 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence 1111222 23499999999999999999 56699999999999999999999999999999998887777
Q ss_pred CCCC---CCHhHHHHHHhccCCCCCCCC---CHHHHHcCccccch
Q 013005 250 FPSF---VSKPARSLIYQLLDPNPKTRM---SIEKIMSISWFQKS 288 (451)
Q Consensus 250 ~p~~---~s~~~~~li~~~L~~dP~~Rp---t~~eil~hp~f~~~ 288 (451)
+|.. .+++++++|.++|..+|..|. .+-++.+|+||+.-
T Consensus 277 wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 277 WPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred ccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 7753 688999999999999999996 57789999999864
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=193.07 Aligned_cols=141 Identities=23% Similarity=0.328 Sum_probs=111.3
Q ss_pred cceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhH----------------------HHHHHHHHHHHHHHHhcCCC
Q 013005 33 GPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDA----------------------AMEDRIVREVSAMRRLQNHP 90 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~----------------------~~~~~~~~Ei~il~~L~~Hp 90 (451)
...||+|+||.||+|.+. +|+.||||+++........ .......+|+.++.+|. ++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV-TA 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH-HC
Confidence 468999999999999986 8999999999764211000 01233456999999996 77
Q ss_pred CceEEEEEEEeCCEEEEEEEecCCCchhHH-hhcCCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCCCCeEEeCCCCCe
Q 013005 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGK-LRRGRLTESAARRYFQQLVSALHFC-HQNGVAHRDVKPQNLLLDRDGNL 168 (451)
Q Consensus 91 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~-l~~~~l~e~~~~~~~~ql~~gL~yL-H~~giiHrDLKpeNILld~~~~l 168 (451)
++.....+.. . ..+|||||++|+++... +..+.+++..+..++.|++.+|.|+ |+.||+||||||+|||++ ++.+
T Consensus 80 ~v~~p~~~~~-~-~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 80 GIPCPEPILL-K-SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCCCCcEEEe-c-CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcE
Confidence 7644433322 2 23899999999877654 4567899999999999999999999 799999999999999998 5789
Q ss_pred EEEeccCCCc
Q 013005 169 KVSDFGLSAL 178 (451)
Q Consensus 169 kl~DFGls~~ 178 (451)
+|+|||+|..
T Consensus 157 ~LiDFG~a~~ 166 (190)
T cd05147 157 YIIDVSQSVE 166 (190)
T ss_pred EEEEcccccc
Confidence 9999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-25 Score=238.19 Aligned_cols=260 Identities=32% Similarity=0.546 Sum_probs=219.3
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcC-CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIA-DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
....|.+.+.||+|+|+.|-++.+.. +...+|.|.+.... ......+.+..|..+-+.+.+|+|++.+++...+...
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~ 95 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS 95 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCccCCCcc
Confidence 56778899999999999999998744 34567777765542 2344556778888888888779999999999999999
Q ss_pred EEEEEEecCCCchhHHh-hcC--CCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCeEEeCCCC-CeEEEeccCCCcc
Q 013005 105 IYLVMEYAAGGELFGKL-RRG--RLTESAARRYFQQLVSALHFCH-QNGVAHRDVKPQNLLLDRDG-NLKVSDFGLSALP 179 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l-~~~--~l~e~~~~~~~~ql~~gL~yLH-~~giiHrDLKpeNILld~~~-~lkl~DFGls~~~ 179 (451)
.+++++|..|+++++.+ ... ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+ +++++|||+|+.+
T Consensus 96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999999999999 653 6888999999999999999999 99999999999999999999 9999999999876
Q ss_pred hh--hhcCcccccCC-CCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHH-HHHHhhcc----CCCCC
Q 013005 180 EQ--IKNGMLHTACG-TPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLA-MYKKVNRR----DYQFP 251 (451)
Q Consensus 180 ~~--~~~~~~~~~~g-t~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~-~~~~i~~~----~~~~p 251 (451)
.. .........|| ++.|.|||...+..|.+...|+||+|+++..+++|..||....... .+..+... .....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPW 255 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcc
Confidence 55 33356677899 9999999999988898999999999999999999999998654432 22222222 13334
Q ss_pred CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 252 SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 252 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
..++....+++.++|..+|..|.+.+++..+||+..
T Consensus 256 ~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 256 NSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccCChhhhhcccccccCCchhccccccccccccccc
Confidence 558899999999999999999999999999999987
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=195.90 Aligned_cols=175 Identities=15% Similarity=0.186 Sum_probs=134.1
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHH------HHHHHHHHHHhcCCCCceEEEEE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDR------IVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~------~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
.+.++|++.+.||.|+||.||++.+ ++..+|+|++..... ..+..... +.+|+..+.+|. ||+|..+.++
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~-~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~d~ 103 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVK-RTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLNDF 103 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcC-chHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcceEe
Confidence 5678999999999999999999654 567899999976532 22222233 689999999995 9999999988
Q ss_pred EEeC--------CEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEE
Q 013005 99 MATK--------TKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKV 170 (451)
Q Consensus 99 ~~~~--------~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl 170 (451)
+... +..+++|||++|.+|.+.. .+++ ....+++.+|..||+.|++|||+||+||+++.+| ++|
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~---~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMP---EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhh---hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEE
Confidence 6543 3589999999999998773 2333 2456999999999999999999999999999998 999
Q ss_pred EeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHH
Q 013005 171 SDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLL 225 (451)
Q Consensus 171 ~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll 225 (451)
+|||.+.......... .......|. .++||||||+++..+.
T Consensus 176 iDfg~~~~~~e~~a~d-------------~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 176 IDLSGKRCTAQRKAKD-------------RIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred EECCCcccccchhhHH-------------HHHHHhHhc-ccccccceeEeehHHH
Confidence 9999876432111100 023344565 6799999999887554
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.3e-23 Score=188.58 Aligned_cols=143 Identities=22% Similarity=0.292 Sum_probs=114.7
Q ss_pred EcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchh----------------------hHHHHHHHHHHHHHHHHhcCC
Q 013005 32 LGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFL----------------------DAAMEDRIVREVSAMRRLQNH 89 (451)
Q Consensus 32 ~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~----------------------~~~~~~~~~~Ei~il~~L~~H 89 (451)
+.+.||+|++|.||+|.+. +|+.||||+++...... .........+|...+.++. |
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~ 78 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY-E 78 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH-h
Confidence 3578999999999999986 89999999998652110 0111234578999999996 8
Q ss_pred CCceEEEEEEEeCCEEEEEEEecCCCchhH-HhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCeEEeCCCCC
Q 013005 90 PNVLKIQEVMATKTKIYLVMEYAAGGELFG-KLRRGRLTESAARRYFQQLVSALHFCHQ-NGVAHRDVKPQNLLLDRDGN 167 (451)
Q Consensus 90 pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~-~l~~~~l~e~~~~~~~~ql~~gL~yLH~-~giiHrDLKpeNILld~~~~ 167 (451)
++|.....+.... .|+||||++|+++.. .+..+++++.++..++.|++.++.++|+ +||+||||||+|||++ ++.
T Consensus 79 ~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 79 AGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence 8875554443332 489999999885543 4556788999999999999999999999 9999999999999998 889
Q ss_pred eEEEeccCCCcc
Q 013005 168 LKVSDFGLSALP 179 (451)
Q Consensus 168 lkl~DFGls~~~ 179 (451)
++|+|||++...
T Consensus 156 ~~liDFG~a~~~ 167 (190)
T cd05145 156 PYIIDVSQAVEL 167 (190)
T ss_pred EEEEEcccceec
Confidence 999999998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=187.31 Aligned_cols=192 Identities=20% Similarity=0.232 Sum_probs=143.2
Q ss_pred EEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEE
Q 013005 31 QLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVME 110 (451)
Q Consensus 31 ~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E 110 (451)
.+...|++|+||+||++.. .+..++.+.+..............+.+|+.+|++|.+|++|++++++ ...|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3567899999999998863 67788877776553222222233688999999999877999999886 44799999
Q ss_pred ecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC-CCCeEEeCCCCCeEEEeccCCCcchhhhc-----
Q 013005 111 YAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDV-KPQNLLLDRDGNLKVSDFGLSALPEQIKN----- 184 (451)
Q Consensus 111 ~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDL-KpeNILld~~~~lkl~DFGls~~~~~~~~----- 184 (451)
|+.|.+|......+ ...++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||+|........
T Consensus 79 yI~G~~L~~~~~~~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L 152 (218)
T PRK12274 79 YLAGAAMYQRPPRG------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLL 152 (218)
T ss_pred eecCccHHhhhhhh------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHH
Confidence 99999987543221 2357899999999999999999999 79999999999999999999974332111
Q ss_pred -------CcccccCCCCccccceeeeccCCCC-ccchhhhhhHHHHHHHhcCCCCCCC
Q 013005 185 -------GMLHTACGTPAYTAPEVVARRGYDG-AVADAWSCGVILFVLLAGYLPFDDS 234 (451)
Q Consensus 185 -------~~~~~~~gt~~y~APEvl~~~~~~~-~~sDIwSlGvil~~Ll~G~~Pf~~~ 234 (451)
-.......++.|++|+.-.-..-.+ ...+.++.|+-+|.++|+..|+-.+
T Consensus 153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 153 AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0112234688899998532221111 3357779999999999999887443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-23 Score=202.02 Aligned_cols=235 Identities=26% Similarity=0.353 Sum_probs=149.1
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcC---------CCCceEEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN---------HPNVLKIQEVM 99 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~---------HpnIv~l~~~~ 99 (451)
.+..++.||.|+++.||.+.+.+|++.+|+|+..... .......+.+++|.-....+.+ |-.++-.++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 4567889999999999999999999999999997654 2333445667766644443321 22333333332
Q ss_pred E---------eC---C-----EEEEEEEecCCCchhHHhh---c-CCC---CHHHH-HHHHHHHHHHHHHHHHCCceecC
Q 013005 100 A---------TK---T-----KIYLVMEYAAGGELFGKLR---R-GRL---TESAA-RRYFQQLVSALHFCHQNGVAHRD 154 (451)
Q Consensus 100 ~---------~~---~-----~~~lV~E~~~gg~L~~~l~---~-~~l---~e~~~-~~~~~ql~~gL~yLH~~giiHrD 154 (451)
. .. + +.+++|+-+ .++|.+++. . ... ....+ ..+..|+++.+++||+.|++|+|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd 170 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD 170 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence 2 11 1 235677776 457777653 1 222 12223 34458999999999999999999
Q ss_pred CCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCCCCccccceeeecc-------CCCCccchhhhhhHHHHHHHhc
Q 013005 155 VKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARR-------GYDGAVADAWSCGVILFVLLAG 227 (451)
Q Consensus 155 LKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~-------~~~~~~sDIwSlGvil~~Ll~G 227 (451)
|+|+|++++.+|.+.|+||+........ ......+..|.+||+.... -..+.+.|.|+||+++|.|++|
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999999999999999876432221 1113455789999976442 1235668999999999999999
Q ss_pred CCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccCCCCCCC
Q 013005 228 YLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTR 273 (451)
Q Consensus 228 ~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 273 (451)
.+||+.......... .+..-..++..++.||+.+|+.||.+|
T Consensus 247 ~lPf~~~~~~~~~~~----~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW----DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999986543211110 122222689999999999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.5e-23 Score=199.07 Aligned_cols=258 Identities=28% Similarity=0.439 Sum_probs=178.7
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCC-----------------------------------cEEEEEEeecCcc-hh
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADG-----------------------------------SIVAIKTIEKNNK-FL 68 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~-----------------------------------~~vAiK~i~~~~~-~~ 68 (451)
-.+++|+++..||+|.-+.||.|.-...| -+.|||.+=.-.. ..
T Consensus 154 FtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~ 233 (598)
T KOG4158|consen 154 FTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSG 233 (598)
T ss_pred cchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCc
Confidence 45678999999999999999998753311 1455665421111 11
Q ss_pred hHHHHHHHHHHHH--------------HHHH-------hcCCCCceEEEEEEEe--------------------------
Q 013005 69 DAAMEDRIVREVS--------------AMRR-------LQNHPNVLKIQEVMAT-------------------------- 101 (451)
Q Consensus 69 ~~~~~~~~~~Ei~--------------il~~-------L~~HpnIv~l~~~~~~-------------------------- 101 (451)
+........+|.. ..+. |..|||||++...|.+
T Consensus 234 ~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g 313 (598)
T KOG4158|consen 234 DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAG 313 (598)
T ss_pred hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccC
Confidence 1222222233321 1122 2359999999877632
Q ss_pred -CCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEe--CCCC--CeEEEeccCC
Q 013005 102 -KTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL--DRDG--NLKVSDFGLS 176 (451)
Q Consensus 102 -~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILl--d~~~--~lkl~DFGls 176 (451)
....|+||...+. +|..++-....+....+-++.|+++|+.|||++||.|||||.+|||+ |+++ .+.|+|||++
T Consensus 314 ~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc 392 (598)
T KOG4158|consen 314 EPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC 392 (598)
T ss_pred CCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee
Confidence 3468999987654 88898888888889999999999999999999999999999999998 4443 5899999986
Q ss_pred Ccchhhhc-----CcccccCCCCccccceeeeccCC-----CCccchhhhhhHHHHHHHhcCCCCCCCcHH----HHHHH
Q 013005 177 ALPEQIKN-----GMLHTACGTPAYTAPEVVARRGY-----DGAVADAWSCGVILFVLLAGYLPFDDSNLL----AMYKK 242 (451)
Q Consensus 177 ~~~~~~~~-----~~~~~~~gt~~y~APEvl~~~~~-----~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~----~~~~~ 242 (451)
--.+...- ...-...|....||||+....+- +-.++|.|++|.+.||++....||...... ..|++
T Consensus 393 LAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe 472 (598)
T KOG4158|consen 393 LADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE 472 (598)
T ss_pred eeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh
Confidence 42221000 11123458889999998754321 234589999999999999999999874322 11222
Q ss_pred hhccCCCCCCCCCHhHHHHHHhccCCCCCCCCCHH---HHHcCccc
Q 013005 243 VNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIE---KIMSISWF 285 (451)
Q Consensus 243 i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~---eil~hp~f 285 (451)
..-...|..+++.+++++..+|+.||++|++.. .+++...|
T Consensus 473 --~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw 516 (598)
T KOG4158|consen 473 --SQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLW 516 (598)
T ss_pred --hhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHh
Confidence 123456677999999999999999999999843 44444333
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.2e-24 Score=227.11 Aligned_cols=250 Identities=28% Similarity=0.389 Sum_probs=187.7
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
..+..+|...+.||.+.|=+|.+|++ ..|. |+||++-+.....+-....+..+|++ .... +|||.+.+.-+.....
T Consensus 19 sd~~~e~~~~~~LGstRFlKv~r~k~-~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~-~~pn~lPfqk~~~t~k 94 (1431)
T KOG1240|consen 19 SDLSVECHYVENLGSTRFLKVARAKD-REGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALM-KAPNCLPFQKVLVTDK 94 (1431)
T ss_pred hcCccceeeecccCchhhhhhhhccC-CCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhh-cCCcccchHHHHHhhH
Confidence 33344899999999999999999986 3455 99999977654444444444555665 3344 5999999999988888
Q ss_pred EEEEEEEecCCCchhHHhhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCC---cc
Q 013005 104 KIYLVMEYAAGGELFGKLRRGR-LTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA---LP 179 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~~~-l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~---~~ 179 (451)
..|||-+|... +|+|.+...+ +..-+.+.|+-||+.||.-||..||+|||||.|||||+.-.-+.|+||..-+ +.
T Consensus 95 AAylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 95 AAYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHHHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCC
Confidence 89999999965 8999998654 6778889999999999999999999999999999999999899999997643 11
Q ss_pred hhhhc---CcccccCCCCccccceeeeccC----------CCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhc
Q 013005 180 EQIKN---GMLHTACGTPAYTAPEVVARRG----------YDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNR 245 (451)
Q Consensus 180 ~~~~~---~~~~~~~gt~~y~APEvl~~~~----------~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~ 245 (451)
++... -...+...-.+|.|||.+.... ..+++.||||+||+++||++ |.+||.-..... | +.
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~a-Y---r~ 249 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLA-Y---RS 249 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHh-H---hc
Confidence 11111 1234555667899999875422 13567899999999999988 788885322111 1 11
Q ss_pred cCCCCC-----CCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 246 RDYQFP-----SFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 246 ~~~~~p-----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
+....+ .--+..++.+|..|++.||.+|.++++.|+.
T Consensus 250 ~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 250 GNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111111 1124578999999999999999999999986
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-21 Score=180.40 Aligned_cols=135 Identities=21% Similarity=0.248 Sum_probs=108.9
Q ss_pred cceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhc----CCCCceEEEEEEEeCC---EE
Q 013005 33 GPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ----NHPNVLKIQEVMATKT---KI 105 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~----~HpnIv~l~~~~~~~~---~~ 105 (451)
.+.||+|+|+.||. +..++.. +||++..... ...+.+.+|+.+++.|. .||||+++|+++.++. ..
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 46899999999995 6666665 6999876421 23467899999999994 3799999999998874 43
Q ss_pred E-EEEEe--cCCCchhHHhhcCCCCHHHHHHHHHHHHHHH-HHHHHCCceecCCCCCeEEeCCC----CCeEEEeccCC
Q 013005 106 Y-LVMEY--AAGGELFGKLRRGRLTESAARRYFQQLVSAL-HFCHQNGVAHRDVKPQNLLLDRD----GNLKVSDFGLS 176 (451)
Q Consensus 106 ~-lV~E~--~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL-~yLH~~giiHrDLKpeNILld~~----~~lkl~DFGls 176 (451)
+ +|+|| +.+|+|.+++.++.+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 4 78999 557999999988777776 35677888777 99999999999999999999743 47999995544
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-21 Score=181.25 Aligned_cols=243 Identities=19% Similarity=0.325 Sum_probs=192.0
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
+.+....+...|.+...|..|+|++.+ ..++.|++.... ........+..|.-.|+.+. ||||+.+++.+....+
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~--~t~risrdfneefp~lrifs-hpnilpvlgacnsppn 261 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQG--NDIVAKILNVRE--VTARISRDFNEEFPALRIFS-HPNILPVLGACNSPPN 261 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccC--cchhhhhhhhhh--cchhhcchhhhhCcceeeec-CCchhhhhhhccCCCC
Confidence 445555677789999999999999744 445668775432 22334456778888888885 9999999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCeEEeCCCCCeEEE--eccCCC
Q 013005 105 IYLVMEYAAGGELFGKLRRGR---LTESAARRYFQQLVSALHFCHQNG--VAHRDVKPQNLLLDRDGNLKVS--DFGLSA 177 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~~~---l~e~~~~~~~~ql~~gL~yLH~~g--iiHrDLKpeNILld~~~~lkl~--DFGls~ 177 (451)
+.++..|++-|+|+..++.+. .+..++.+++.++++|++|||+.. |----|....+++|++-+.+|+ |--+|.
T Consensus 262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf 341 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF 341 (448)
T ss_pred ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee
Confidence 999999999999999998643 678899999999999999999974 3344688999999999877664 322221
Q ss_pred cchhhhcCcccccCCCCccccceeeeccCCCC--ccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhh--ccCCCCCCC
Q 013005 178 LPEQIKNGMLHTACGTPAYTAPEVVARRGYDG--AVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVN--RRDYQFPSF 253 (451)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~--~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~ 253 (451)
. .....-.|.|++||.+++.+.+. ..+|+|||+++|+||.|...||.+-+..+.-.++. .-...+|+.
T Consensus 342 ----q----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippg 413 (448)
T KOG0195|consen 342 ----Q----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPG 413 (448)
T ss_pred ----e----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCC
Confidence 0 11223478999999998876553 45899999999999999999999877665544443 345678999
Q ss_pred CCHhHHHHHHhccCCCCCCCCCHHHHH
Q 013005 254 VSKPARSLIYQLLDPNPKTRMSIEKIM 280 (451)
Q Consensus 254 ~s~~~~~li~~~L~~dP~~Rpt~~eil 280 (451)
++..+..|+.-|+..||.+||..+.|.
T Consensus 414 is~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 414 ISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 999999999999999999999987664
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=178.34 Aligned_cols=144 Identities=20% Similarity=0.230 Sum_probs=114.7
Q ss_pred CeEEcceEcccCceEEEEEE-EcCCCcEEEEEEeecCcchh--------------------hHHHHHHHHHHHHHHHHhc
Q 013005 29 RYQLGPLLGRGSFAKVHKAK-SIADGSIVAIKTIEKNNKFL--------------------DAAMEDRIVREVSAMRRLQ 87 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~-~~~~~~~vAiK~i~~~~~~~--------------------~~~~~~~~~~Ei~il~~L~ 87 (451)
-|.+.+.||+|+||.||+|. +..+|+.||+|++....... .......+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 37889999999999999998 67899999999997542100 0112235678999999996
Q ss_pred CCC--CceEEEEEEEeCCEEEEEEEecCCCchhHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCCCeEEeC
Q 013005 88 NHP--NVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLVSALHFCHQNG-VAHRDVKPQNLLLD 163 (451)
Q Consensus 88 ~Hp--nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l-~~~~l~e~~~~~~~~ql~~gL~yLH~~g-iiHrDLKpeNILld 163 (451)
+. .+.++++. ...|+||||+.|++|.... ....+....+..++.|++.+|.+||++| ++||||||+||+++
T Consensus 109 -~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 109 -EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred -hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 42 33444442 2358999999998887655 3456777778899999999999999999 99999999999999
Q ss_pred CCCCeEEEeccCCCc
Q 013005 164 RDGNLKVSDFGLSAL 178 (451)
Q Consensus 164 ~~~~lkl~DFGls~~ 178 (451)
++.++|+|||.+..
T Consensus 184 -~~~i~LiDFg~a~~ 197 (237)
T smart00090 184 -DGKVVIIDVSQSVE 197 (237)
T ss_pred -CCCEEEEEChhhhc
Confidence 88999999999863
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.3e-19 Score=163.60 Aligned_cols=138 Identities=22% Similarity=0.285 Sum_probs=114.9
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcch----hhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEE
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKF----LDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVM 109 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~ 109 (451)
+.||+|++|.||+|.+ +|..+++|+....... ........+.+|+.++..+. |++|.....++.+....+++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEEeCCCCEEEE
Confidence 5799999999999986 7788999986532110 11122356889999999996 899887777777778899999
Q ss_pred EecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 110 EYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 110 E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
||++|++|.+.+..... ....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||++..
T Consensus 79 e~~~G~~L~~~~~~~~~---~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM---EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccH---HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999998865332 7889999999999999999999999999999998 78999999999874
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.2e-19 Score=194.39 Aligned_cols=246 Identities=21% Similarity=0.324 Sum_probs=183.4
Q ss_pred CCCCCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcch---hhHHHHHHHHHHHHHHHHhcCCCCc
Q 013005 16 PPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKF---LDAAMEDRIVREVSAMRRLQNHPNV 92 (451)
Q Consensus 16 ~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~~~~~Ei~il~~L~~HpnI 92 (451)
..-+......-..+|.|-+.||+|+||+||.|.... |+.||+|+-...+.+ ....+.++++ ... -+-|
T Consensus 686 ~l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-----~~~---~~~~ 756 (974)
T KOG1166|consen 686 KLNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-----PQM---LPSI 756 (974)
T ss_pred ccCccceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-----hhh---hcch
Confidence 334566677778899999999999999999999755 999999997655322 1222222232 111 2456
Q ss_pred eEEEEEEEeCCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeC-------C
Q 013005 93 LKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLD-------R 164 (451)
Q Consensus 93 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld-------~ 164 (451)
..++..+.-.+..++|+||.+-|+|.+++.. +-+++..+..+..|++..|+.||..+|||+||||+|.||. +
T Consensus 757 ~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~ 836 (974)
T KOG1166|consen 757 MHISSAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSD 836 (974)
T ss_pred HHHHHHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCc
Confidence 6666666667788999999999999999985 6799999999999999999999999999999999999993 2
Q ss_pred CCCeEEEeccCCCcchhhhcC-cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHh
Q 013005 165 DGNLKVSDFGLSALPEQIKNG-MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKV 243 (451)
Q Consensus 165 ~~~lkl~DFGls~~~~~~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i 243 (451)
..-++|+|||.|.-.....++ .....++|-.+--+|...+.++ +..+|.|+++.+++.||+|+.- +.+
T Consensus 837 ~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpW-tYq~DyfGlAa~~h~mLFG~y~----------q~~ 905 (974)
T KOG1166|consen 837 SKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPW-TYQIDYFGLAATVHVMLFGKYM----------EVK 905 (974)
T ss_pred ccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCC-chhhhhHHHHHHHHHHHHHHHH----------Hhc
Confidence 345999999998755444443 5566788999999999999888 5669999999999999999532 111
Q ss_pred hccCC----CCCCCCCH-hHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 244 NRRDY----QFPSFVSK-PARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 244 ~~~~~----~~p~~~s~-~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
..... .++..+.. ...+|+..+|+.|-.+=|.+.+|..
T Consensus 906 ~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~ 948 (974)
T KOG1166|consen 906 NGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRT 948 (974)
T ss_pred CCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHH
Confidence 11111 13333333 3457889999966666677666643
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.6e-18 Score=160.59 Aligned_cols=138 Identities=22% Similarity=0.276 Sum_probs=108.9
Q ss_pred eEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhh------------------HHHHHHHHHHHHHHHHhcCCCC
Q 013005 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLD------------------AAMEDRIVREVSAMRRLQNHPN 91 (451)
Q Consensus 30 y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~------------------~~~~~~~~~Ei~il~~L~~Hpn 91 (451)
|.+.+.||+|+||.||++.+ .+|+.||||+++....... ........+|+.++..+. |++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~ 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY-EEG 94 (198)
T ss_pred hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH-HcC
Confidence 78889999999999999986 4899999999875421000 011224678899999995 664
Q ss_pred --ceEEEEEEEeCCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeE
Q 013005 92 --VLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLK 169 (451)
Q Consensus 92 --Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lk 169 (451)
++..++ ....++||||++|++|...... .....++.+++.++.++|+.|++||||||+||++++++.++
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 444443 2456899999999998765431 44678899999999999999999999999999999999999
Q ss_pred EEeccCCCc
Q 013005 170 VSDFGLSAL 178 (451)
Q Consensus 170 l~DFGls~~ 178 (451)
|+|||++..
T Consensus 166 liDfg~~~~ 174 (198)
T cd05144 166 IIDWPQMVS 174 (198)
T ss_pred EEECCcccc
Confidence 999999863
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.7e-18 Score=158.70 Aligned_cols=134 Identities=21% Similarity=0.276 Sum_probs=107.3
Q ss_pred eEcccCceEEEEEEEcCCCcEEEEEEeecCcchh----hHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEE
Q 013005 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFL----DAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVME 110 (451)
Q Consensus 35 ~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~----~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E 110 (451)
.||+|+||.||+|. .++..+++|......... ......++.+|+.+++.+. |+++....-+.......+++||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEEECCCCEEEEE
Confidence 48999999999998 467889999865431111 1123467889999999996 7765554444556667799999
Q ss_pred ecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 111 YAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 111 ~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
|++|++|.+.+..... .++.|++.+|.+||+.|++|||++|.||+++ ++.++++|||++..
T Consensus 78 ~~~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999988754321 7899999999999999999999999999998 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.9e-18 Score=178.96 Aligned_cols=143 Identities=21% Similarity=0.302 Sum_probs=113.7
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCc-ch---hhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNN-KF---LDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~-~~---~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
.....|...+.||+|+||+||++.+... .+++|+..... .. ......+++.+|+.+++.++ |++|+..+.+..
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~ 406 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIYDV 406 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEEEE
Confidence 3344556788999999999999986443 34444432211 11 11123467889999999996 999998877777
Q ss_pred eCCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
.....++||||++|++|.+.+. ....++.|++.+|.|||+.|++||||||+|||+ .++.++|+|||++..
T Consensus 407 ~~~~~~lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 407 DPEEKTIVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred eCCCCEEEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 7778899999999999998875 467899999999999999999999999999999 678999999999874
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.3e-18 Score=176.33 Aligned_cols=197 Identities=25% Similarity=0.343 Sum_probs=154.7
Q ss_pred HHhcCCCCceEEEEEEEeCCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCc-eecCCCCCeE
Q 013005 84 RRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGV-AHRDVKPQNL 160 (451)
Q Consensus 84 ~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~gi-iHrDLKpeNI 160 (451)
+.+. |.|+.+++|...+....++|.+||..|+|.+.+.. -+++.--...+.++|+.||.|+|+..| +|+.|++.|.
T Consensus 2 ~~l~-h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 2 RQLD-HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred cccc-hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4564 99999999999999999999999999999999986 457777788889999999999999876 9999999999
Q ss_pred EeCCCCCeEEEeccCCCcchhhh-cCcccccCCCCccccceeeeccCC------CCccchhhhhhHHHHHHHhcCCCCCC
Q 013005 161 LLDRDGNLKVSDFGLSALPEQIK-NGMLHTACGTPAYTAPEVVARRGY------DGAVADAWSCGVILFVLLAGYLPFDD 233 (451)
Q Consensus 161 Lld~~~~lkl~DFGls~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~------~~~~sDIwSlGvil~~Ll~G~~Pf~~ 233 (451)
++|....+||+|||+........ ........-..-|.|||.+..... .+.++||||+|++++++++...||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 99999999999999987654211 111122234567999999876422 35669999999999999999999975
Q ss_pred C----cHHHHHHHhhc-cCCCCCC------CCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 234 S----NLLAMYKKVNR-RDYQFPS------FVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 234 ~----~~~~~~~~i~~-~~~~~p~------~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
. ...+....+.+ ....+-+ ...+.+..++.+||..+|..||+++++-.
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 2 22344444444 2221212 24457899999999999999999998864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3e-19 Score=180.02 Aligned_cols=245 Identities=22% Similarity=0.322 Sum_probs=164.9
Q ss_pred CCeEEcceEcccCceEEEEEEEcCC---CcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEE------EE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIAD---GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQ------EV 98 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~------~~ 98 (451)
..+.+.+-.+..+++.+....-..+ .+.+.-+..+.+ +........+++..+.....|++.+..- ..
T Consensus 244 ~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d----~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~ 319 (516)
T KOG1033|consen 244 GSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVD----SLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFES 319 (516)
T ss_pred ccccccccccccccCCchhhhhcccchhhhhccchhhhcc----chhhhhhhhhhhhheeccccCCcccccCCCCchhhh
Confidence 3444555566666666655543222 223333322222 1123334556666665555455443321 11
Q ss_pred EE-----eCCEEEEEEEecCCCchhHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeE
Q 013005 99 MA-----TKTKIYLVMEYAAGGELFGKLRR----GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLK 169 (451)
Q Consensus 99 ~~-----~~~~~~lV~E~~~gg~L~~~l~~----~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lk 169 (451)
+. ...+.||.|++|.-.+|.+++.. ...+......++.|+..|++| +|.+|||+||.||+...+..+|
T Consensus 320 ~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~k 396 (516)
T KOG1033|consen 320 SKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLK 396 (516)
T ss_pred ccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhh
Confidence 11 12358899999999999999974 246778899999999999999 9999999999999999999999
Q ss_pred EEeccCCCcchhhh-----cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHh
Q 013005 170 VSDFGLSALPEQIK-----NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKV 243 (451)
Q Consensus 170 l~DFGls~~~~~~~-----~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i 243 (451)
|.|||+.+...... ........||+.||+||.+.+..| +.++||||||+||++|+. =..+|. .......+
T Consensus 397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y-~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~ 472 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQY-SEKVDIYALGLILAELLIQFSTQFE---RIATLTDI 472 (516)
T ss_pred hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhh-hhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhh
Confidence 99999987544333 123345789999999999998888 577999999999999997 222221 11223333
Q ss_pred hccCCCCCC--C-CCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 244 NRRDYQFPS--F-VSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 244 ~~~~~~~p~--~-~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
..+. +|+ + -.+.-..|+..+|.+.|.+||++.+.--|+|.
T Consensus 473 r~g~--ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 473 RDGI--IPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hcCC--CChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 3333 332 1 13445689999999999999988777777764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-17 Score=152.05 Aligned_cols=140 Identities=24% Similarity=0.342 Sum_probs=101.0
Q ss_pred EcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHH--------------------HHHHHHHHHHHHhcCC-C
Q 013005 32 LGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAME--------------------DRIVREVSAMRRLQNH-P 90 (451)
Q Consensus 32 ~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~--------------------~~~~~Ei~il~~L~~H-p 90 (451)
+++.||+|+||+||+|.+. +++.||||++............ .....|...+..+..+ -
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999975 8999999998764221111000 1124666677776422 2
Q ss_pred CceEEEEEEEeCCEEEEEEEecCCCchhH-HhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCeEEeCCCCCe
Q 013005 91 NVLKIQEVMATKTKIYLVMEYAAGGELFG-KLRRGRLTESAARRYFQQLVSALHFCHQ-NGVAHRDVKPQNLLLDRDGNL 168 (451)
Q Consensus 91 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~-~l~~~~l~e~~~~~~~~ql~~gL~yLH~-~giiHrDLKpeNILld~~~~l 168 (451)
.+.+.++. ...++||||++|+.+.. .+...... .+++.++.+++.++.++|+ +||+||||||+||+++ ++.+
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 34455543 24689999999954432 12211111 6789999999999999999 9999999999999999 8899
Q ss_pred EEEeccCCCc
Q 013005 169 KVSDFGLSAL 178 (451)
Q Consensus 169 kl~DFGls~~ 178 (451)
+|+|||.+..
T Consensus 154 ~liDfg~a~~ 163 (187)
T cd05119 154 YIIDVPQAVE 163 (187)
T ss_pred EEEECccccc
Confidence 9999999863
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.3e-16 Score=152.19 Aligned_cols=139 Identities=19% Similarity=0.303 Sum_probs=107.1
Q ss_pred cceEc-ccCceEEEEEEEcCCCcEEEEEEeecCcc---hh------hHHHHHHHHHHHHHHHHhcCCCCc--eEEEEEEE
Q 013005 33 GPLLG-RGSFAKVHKAKSIADGSIVAIKTIEKNNK---FL------DAAMEDRIVREVSAMRRLQNHPNV--LKIQEVMA 100 (451)
Q Consensus 33 ~~~LG-~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~---~~------~~~~~~~~~~Ei~il~~L~~HpnI--v~l~~~~~ 100 (451)
...|| .|+.|+||.+.. .+..++||.+..... .. +.....++.+|+.++..|. |++| ++.+++..
T Consensus 36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~~~ 112 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIAARV 112 (239)
T ss_pred CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEeeee
Confidence 34577 788888888874 478899998864321 00 1123356889999999996 7775 67776643
Q ss_pred eC-C---EEEEEEEecCC-CchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccC
Q 013005 101 TK-T---KIYLVMEYAAG-GELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGL 175 (451)
Q Consensus 101 ~~-~---~~~lV~E~~~g-g~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGl 175 (451)
.. . ..++|||+++| .+|.+++..+.+++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||.
T Consensus 113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 113 VRHGLFYRADILIERIEGARDLVALLQEAPLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred eecCcceeeeEEEEecCCCCCHHHHHhcCCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 32 2 23599999998 6898888877777653 57899999999999999999999999999999999999999
Q ss_pred CCc
Q 013005 176 SAL 178 (451)
Q Consensus 176 s~~ 178 (451)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.1e-16 Score=136.52 Aligned_cols=133 Identities=24% Similarity=0.236 Sum_probs=113.3
Q ss_pred EcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCC-CCceEEEEEEEeCCEEEEEEE
Q 013005 32 LGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH-PNVLKIQEVMATKTKIYLVME 110 (451)
Q Consensus 32 ~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~H-pnIv~l~~~~~~~~~~~lV~E 110 (451)
+.+.||+|.++.||++.+. +..+++|....... ...+.+|+.+++.+.++ +++++++......+..|++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEE
Confidence 4578999999999999963 37899999865421 45688999999999744 689999998888889999999
Q ss_pred ecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 111 YAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQN---GVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 111 ~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~---giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
|+.|+.+... +......++.+++.++.++|.. +++|+|++|+||+++..+.++++|||++..
T Consensus 74 ~~~g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 74 WIEGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecCCeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9999877654 5567778899999999999985 799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.2e-16 Score=171.58 Aligned_cols=264 Identities=27% Similarity=0.400 Sum_probs=207.6
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
-..-.+.+.+.+-+-+|+++.++.+.-..+|...++|+..+..+... ...+.+.++-.++-.. .+|-+++..--+-..
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~-~~~~s~r~~s~~~i~p-~~P~v~~~~~s~~~r 876 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT-NDYESIRSKSNILITP-RSPAVVRSFPSFPCR 876 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhcc-ccccccCCccCccccC-CCCceecccCCCCCC
Confidence 44567788899999999999999998878887788877655432221 1122233333332222 245555554445567
Q ss_pred CEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch-
Q 013005 103 TKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE- 180 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~- 180 (451)
...+++++|..|++|...++. +..+++-++.+...+..+.+|||+..+.|||++|.|+|...+|..+++|||+.....
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence 789999999999999999986 668889999999999999999999999999999999999999999999998322100
Q ss_pred ---------------------hhhc--------CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCC
Q 013005 181 ---------------------QIKN--------GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPF 231 (451)
Q Consensus 181 ---------------------~~~~--------~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf 231 (451)
.... ...+...||+.|.|||.+.+... +..+|.|+.|+++++.++|..||
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCC
Confidence 0000 11334579999999999988766 45589999999999999999999
Q ss_pred CCCcHHHHHHHhhccCCCCCC---CCCHhHHHHHHhccCCCCCCCCCHH---HHHcCccccchh
Q 013005 232 DDSNLLAMYKKVNRRDYQFPS---FVSKPARSLIYQLLDPNPKTRMSIE---KIMSISWFQKSL 289 (451)
Q Consensus 232 ~~~~~~~~~~~i~~~~~~~p~---~~s~~~~~li~~~L~~dP~~Rpt~~---eil~hp~f~~~~ 289 (451)
........+..+.+.....|. ..+..+++++.+.|..+|.+|..+. ++..|+||+...
T Consensus 1036 na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred CCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence 999999999998888776654 4789999999999999999999888 999999998654
|
|
| >PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs) | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.3e-16 Score=114.35 Aligned_cols=58 Identities=57% Similarity=0.933 Sum_probs=47.7
Q ss_pred CCCCChhhhhccCCCCCCCCcccccc----ccccceeeCCCHHHHHHHHHHHHHHcCcEEEE
Q 013005 321 IVSMNAFDIISLSSGLDLSGLFEAKK----RKEKRFTTKEKTERVVEKVKEVGERLGYVVEK 378 (451)
Q Consensus 321 ~~~~~~~~~~~~s~~~~~~~~~~~~~----~~~~rf~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (451)
|.++||||+||+|+|+|||+||+... ++.+||+|+.++++|++|||++|+.+||.|+|
T Consensus 2 p~~lNAFdiIS~S~G~DLSgLFe~~~~~~~~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K 63 (63)
T PF03822_consen 2 PKSLNAFDIISLSSGFDLSGLFEEKDKSSVKRETRFTSKEPASEIIEKLEEIAKKLGFRVKK 63 (63)
T ss_dssp -EE--HHHHHCTSTTTSCGGGGGCG-S-SS---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred CccccHHHHHHhccCCChHHhcCccccccccccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence 56799999999999999999997653 46899999999999999999999999999985
|
Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.9e-14 Score=145.80 Aligned_cols=142 Identities=27% Similarity=0.383 Sum_probs=98.2
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchh-h-----------------------------HHHHH------HHH
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFL-D-----------------------------AAMED------RIV 77 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~-~-----------------------------~~~~~------~~~ 77 (451)
+.||.|++|.||+|+. .+|+.||||+.+..-... . ..... .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5799999999999985 589999999986531100 0 00001 234
Q ss_pred HHHHHHHHhc----CCCCceEEEEEE-EeCCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHH-HHHHHHHCC
Q 013005 78 REVSAMRRLQ----NHPNVLKIQEVM-ATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVS-ALHFCHQNG 149 (451)
Q Consensus 78 ~Ei~il~~L~----~HpnIv~l~~~~-~~~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~-gL~yLH~~g 149 (451)
+|...+.++. +++++ .+-.++ ...+..++||||++|++|.+.... ... ....++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCC
Confidence 4555555543 34443 322222 234457999999999999887642 222 23445666665 467899999
Q ss_pred ceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 150 VAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 150 iiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
++|+|++|.||+++.+|.++++|||++....
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999987543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=8.9e-15 Score=153.46 Aligned_cols=151 Identities=25% Similarity=0.391 Sum_probs=104.2
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcch------------------------------hhHH
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKF------------------------------LDAA 71 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~------------------------------~~~~ 71 (451)
.+......|+. +.||+|++|.||+|+...+|+.||||++++.-.. .-..
T Consensus 114 ~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e 192 (537)
T PRK04750 114 PVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAE 192 (537)
T ss_pred CHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHH
Confidence 34455667776 7899999999999998888999999999754100 0001
Q ss_pred HHHHH------HHHHHHHHHhc---CCCCceEEEEEEEe-CCEEEEEEEecCCCchhHH--hhc-C----CCCHHHHHHH
Q 013005 72 MEDRI------VREVSAMRRLQ---NHPNVLKIQEVMAT-KTKIYLVMEYAAGGELFGK--LRR-G----RLTESAARRY 134 (451)
Q Consensus 72 ~~~~~------~~Ei~il~~L~---~HpnIv~l~~~~~~-~~~~~lV~E~~~gg~L~~~--l~~-~----~l~e~~~~~~ 134 (451)
..+.+ .+|...+.++. .+.+.+.+-.++.+ .+..+|||||++|+.+.+. +.. + .+.+..+..+
T Consensus 193 ~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~ 272 (537)
T PRK04750 193 FEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVF 272 (537)
T ss_pred HHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHH
Confidence 12223 34444444442 13333444444432 4567899999999999764 332 3 3556666677
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCeEEeCCCC----CeEEEeccCCCcch
Q 013005 135 FQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG----NLKVSDFGLSALPE 180 (451)
Q Consensus 135 ~~ql~~gL~yLH~~giiHrDLKpeNILld~~~----~lkl~DFGls~~~~ 180 (451)
+.|++ ..|++|+|+||.||+++.+| .++++|||+.....
T Consensus 273 ~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 273 FTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 77765 48999999999999999988 99999999987543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=5.5e-13 Score=122.60 Aligned_cols=141 Identities=19% Similarity=0.257 Sum_probs=104.9
Q ss_pred cceEcccCceEEEEEEEcC------CCcEEEEEEeecCc--------------chh----hHHHHHH----HHHHHHHHH
Q 013005 33 GPLLGRGSFAKVHKAKSIA------DGSIVAIKTIEKNN--------------KFL----DAAMEDR----IVREVSAMR 84 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~------~~~~vAiK~i~~~~--------------~~~----~~~~~~~----~~~Ei~il~ 84 (451)
...||.|--+.||.|.... .+..+|||+..-.. +.. ....... ..+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4679999999999998643 35799999985321 000 0111223 348999999
Q ss_pred HhcCC-CCceEEEEEEEeCCEEEEEEEecCCCchh-HHhhcCCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCCCCeEE
Q 013005 85 RLQNH-PNVLKIQEVMATKTKIYLVMEYAAGGELF-GKLRRGRLTESAARRYFQQLVSALHFC-HQNGVAHRDVKPQNLL 161 (451)
Q Consensus 85 ~L~~H-pnIv~l~~~~~~~~~~~lV~E~~~gg~L~-~~l~~~~l~e~~~~~~~~ql~~gL~yL-H~~giiHrDLKpeNIL 161 (451)
++... -++.+++.+ ..-+|||||+.++.+. ..++...+++.++..++.|++.+|..+ |+.|++|+||+|.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 99643 466777764 4568999999876543 234445667777888899999999999 8999999999999999
Q ss_pred eCCCCCeEEEeccCCCc
Q 013005 162 LDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 162 ld~~~~lkl~DFGls~~ 178 (451)
++ ++.+.|+|||.+-.
T Consensus 158 ~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 158 WH-DGKVWFIDVSQSVE 173 (197)
T ss_pred EE-CCcEEEEECCCcee
Confidence 96 57899999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.2e-14 Score=149.33 Aligned_cols=253 Identities=20% Similarity=0.280 Sum_probs=190.2
Q ss_pred CeEEcceEcc--cCceEEEEEEE--cCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 29 RYQLGPLLGR--GSFAKVHKAKS--IADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 29 ~y~~~~~LG~--G~~g~Vy~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
.+-+...+|. |.+|.||.+.. ..++..+|+|.-..- ........+=.+|+...+.+..|+|.++.+..+...+.
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p--~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP--FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCC--CCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 4456778999 99999999988 888999999984321 11111222334677777788789999999999999999
Q ss_pred EEEEEEecCCCchhHHhhc-C-CCCHHHHHHHHHHHHH----HHHHHHHCCceecCCCCCeEEeCCC-CCeEEEeccCCC
Q 013005 105 IYLVMEYAAGGELFGKLRR-G-RLTESAARRYFQQLVS----ALHFCHQNGVAHRDVKPQNLLLDRD-GNLKVSDFGLSA 177 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~-~-~l~e~~~~~~~~ql~~----gL~yLH~~giiHrDLKpeNILld~~-~~lkl~DFGls~ 177 (451)
.|+-+|+|. .+|..+... . -+++..++.++.+... ||..+|+.+++|-|+||+||++..+ ...+++|||+..
T Consensus 193 lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred ceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 999999996 677777764 3 4899999999999999 9999999999999999999999999 889999999976
Q ss_pred cchhhhc----CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhc--cCCCCC
Q 013005 178 LPEQIKN----GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNR--RDYQFP 251 (451)
Q Consensus 178 ~~~~~~~----~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~--~~~~~p 251 (451)
......- ......-|..-|++||++.+ ..+..+||+++|.++.+-.+|..+....... .+..+.. ....+-
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~W~~~r~~~ip~e~~ 348 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNS-SWSQLRQGYIPLEFC 348 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCC-CccccccccCchhhh
Confidence 5433221 11122367889999998754 3466799999999998888776655322100 0111111 111222
Q ss_pred CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 252 SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 252 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
...+..+...+..|++.+|-.|++.+.++.|++...
T Consensus 349 ~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 349 EGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred cCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 334667777999999999999999999999999873
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=9e-15 Score=139.85 Aligned_cols=200 Identities=17% Similarity=0.298 Sum_probs=140.8
Q ss_pred HHHhcCCCCceEEEEEEEeC-----CEEEEEEEecCCCchhHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--c
Q 013005 83 MRRLQNHPNVLKIQEVMATK-----TKIYLVMEYAAGGELFGKLRR-----GRLTESAARRYFQQLVSALHFCHQNG--V 150 (451)
Q Consensus 83 l~~L~~HpnIv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~l~~-----~~l~e~~~~~~~~ql~~gL~yLH~~g--i 150 (451)
+-++- |.|||+++.++.+. ....++.||+..|++..++++ ..+.....++|+.||+.||.|||+.. |
T Consensus 121 llqlv-HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 121 LLQLV-HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHH-HHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 44453 99999999998654 458899999999999999974 35889999999999999999999984 9
Q ss_pred eecCCCCCeEEeCCCCCeEEEeccCCCcchhh---hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhc
Q 013005 151 AHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI---KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAG 227 (451)
Q Consensus 151 iHrDLKpeNILld~~~~lkl~DFGls~~~~~~---~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G 227 (451)
+|+++...-|++..+|-+|+.---....-... .........|-++|.|||.=..... +.++|||++|....+|..+
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHHh
Confidence 99999999999999998887532222111110 1111223346789999996433333 4458999999999999887
Q ss_pred CCCCCCCc-HHHHHHHhhccCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 228 YLPFDDSN-LLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 228 ~~Pf~~~~-~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
..--.... .......+.+..+.. -...-+.++.+||...|+.||++.+++-||..-+
T Consensus 279 Eiq~tnseS~~~~ee~ia~~i~~l---en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANVIIGL---ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred eeccCCCcceeehhhhhhhheeec---cCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 65532221 111111121111111 1223457899999999999999999999998644
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.5e-13 Score=120.89 Aligned_cols=128 Identities=18% Similarity=0.212 Sum_probs=97.1
Q ss_pred cceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEec
Q 013005 33 GPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYA 112 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~ 112 (451)
.+.|+.|.++.||++.. .+..|++|+...... ......+|+.+++.+.....+.+++.... +..++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE-----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc-----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEec
Confidence 35689999999999985 478899999755421 12345789999999863333456665533 3458999999
Q ss_pred CCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 113 AGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGV-----AHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 113 ~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~gi-----iHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
+|.++... ......++.+++++|..||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 74 ~G~~l~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 74 EGSELLTE-------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCCccccc-------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 99887643 11124567899999999999985 9999999999998 6789999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.46 E-value=8.9e-13 Score=137.01 Aligned_cols=219 Identities=19% Similarity=0.286 Sum_probs=150.3
Q ss_pred EEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecCCCchhHHhhcCC
Q 013005 46 KAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGR 125 (451)
Q Consensus 46 ~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~ 125 (451)
.|..+.++.+|.|.+.+..+. ...+.+.+-+..|+.|+ ||||+++++.++..+..|+|+|-+. .|..+++.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~----~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG----EVTELAKRAVKRLKTLR-HPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCc----hhhHHHHHHHHHhhhcc-CchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--
Confidence 355567888999999876542 33456778888899997 9999999999999999999999885 45555554
Q ss_pred CCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCCCCccccceeeec
Q 013005 126 LTESAARRYFQQLVSALHFCH-QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVAR 204 (451)
Q Consensus 126 l~e~~~~~~~~ql~~gL~yLH-~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~ 204 (451)
++......-+.||+.||.||| +.+++|++|.-..|++++.|..||++|-++........ ......---.|..|+.+..
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCc
Confidence 225666777899999999998 56899999999999999999999999998764333221 1111112234666765533
Q ss_pred cCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccCCCCCCCCCHH-----HH
Q 013005 205 RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIE-----KI 279 (451)
Q Consensus 205 ~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~-----ei 279 (451)
.. -..|.|.|||++++++.|..+-. .....+..+++....+..+-+.-.+..||... -.
T Consensus 180 s~---~s~D~~~Lg~li~el~ng~~~~~-------------~~~~~~~~ipk~~~~~~~k~~~~~~~~r~n~~~~~~~~~ 243 (690)
T KOG1243|consen 180 SE---WSIDSWGLGCLIEELFNGSLLTK-------------TDLSNTGKIPKALIELYCKKLGATELKRPNKLRFILECR 243 (690)
T ss_pred cc---cchhhhhHHHHHHHHhCcccCcc-------------hhhhccCccchhHHHHHHHHhccccccccchhhHHHHHH
Confidence 32 23699999999999999933311 12222333444444454444555555555422 22
Q ss_pred HcCccccchhH
Q 013005 280 MSISWFQKSLQ 290 (451)
Q Consensus 280 l~hp~f~~~~~ 290 (451)
+-|.||++.+-
T Consensus 244 ~~~gff~n~fv 254 (690)
T KOG1243|consen 244 LLGGFFRNDFV 254 (690)
T ss_pred hccccccchHH
Confidence 34788876543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.9e-13 Score=138.27 Aligned_cols=255 Identities=20% Similarity=0.171 Sum_probs=187.9
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEc-CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSI-ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
......+|.++..||.|.|+.|+...-. .++..|++|...+.-. .. .....-..|+.+...+.-|.++++.+..+..
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~-~~-~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~ 337 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA-TF-ASDIFSLGEVILEAILGSHLPSVGKNSSWSQ 337 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcccc-ch-HhhhcchhhhhHhhHhhcccccCCCCCCccc
Confidence 3456678889999999999999987644 6788899998765421 11 1112223566666666679999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCC-CCeEEEeccCCCcc
Q 013005 102 KTKIYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD-GNLKVSDFGLSALP 179 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~-~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~-~~lkl~DFGls~~~ 179 (451)
....|+=.|||+++++...+. ...+.+...++...|++.++.++|+..++|+|+||+||++..+ +..++.|||..+..
T Consensus 338 ~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 338 LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccc
Confidence 999999999999998876664 3568888999999999999999999999999999999999876 78899999998631
Q ss_pred hhhhcCcccccCCCCccc-cceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhH
Q 013005 180 EQIKNGMLHTACGTPAYT-APEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPA 258 (451)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~-APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 258 (451)
... .. ...++-.+. .+|++........++|++|||.-+.+..+|...-.. ......+..+.....+.....+
T Consensus 418 ~~~-~~---~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~---~~~~~~i~~~~~p~~~~~~~~~ 490 (524)
T KOG0601|consen 418 AFS-SG---VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES---GVQSLTIRSGDTPNLPGLKLQL 490 (524)
T ss_pred cee-cc---cccccccccccchhhccccccccccccccccccccccccCcccCcc---cccceeeecccccCCCchHHhh
Confidence 110 11 111222333 355555555557789999999999999888543211 1123334444444445555888
Q ss_pred HHHHHhccCCCCCCCCCHHHHHcCcccc
Q 013005 259 RSLIYQLLDPNPKTRMSIEKIMSISWFQ 286 (451)
Q Consensus 259 ~~li~~~L~~dP~~Rpt~~eil~hp~f~ 286 (451)
+.+.+.+..+++..|+.+.++..|+=|.
T Consensus 491 q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 491 QVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhhcCCccccchhhhhhcccchhh
Confidence 9999999999999999999998887654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.24 E-value=7.1e-11 Score=110.30 Aligned_cols=141 Identities=21% Similarity=0.269 Sum_probs=108.7
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcC-CCCceEEEEEEEeC---CEEEEEE
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN-HPNVLKIQEVMATK---TKIYLVM 109 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~-HpnIv~l~~~~~~~---~~~~lV~ 109 (451)
+.||.|..+.||++.. .+|+.+++|+....... .....+.+|..+++.+.. +.++.+++.+.... +..++||
T Consensus 4 ~~l~~G~~n~~~~v~~-~~g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTA-GGGRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEe-cCCcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 5689999999999986 34688999998654211 123467899999999963 23467777776554 3678999
Q ss_pred EecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 013005 110 EYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQ------------------------------------------ 147 (451)
Q Consensus 110 E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~------------------------------------------ 147 (451)
||++|.++.+.+..+.+++.+...++.+++.+|..||+
T Consensus 80 e~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 80 ERVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EEeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 99999988776544567778888888888888888884
Q ss_pred --------------CCceecCCCCCeEEeCC--CCCeEEEeccCCCc
Q 013005 148 --------------NGVAHRDVKPQNLLLDR--DGNLKVSDFGLSAL 178 (451)
Q Consensus 148 --------------~giiHrDLKpeNILld~--~~~lkl~DFGls~~ 178 (451)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23589999999999998 56689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.7e-10 Score=102.12 Aligned_cols=135 Identities=21% Similarity=0.280 Sum_probs=97.2
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEee-cCcch--hhH-HHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEE
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIE-KNNKF--LDA-AMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVM 109 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~-~~~~~--~~~-~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~ 109 (451)
..+++|+-+.+|.+.. -|..+++|.=- |.... .+. -..++..+|..++.++. --.|...+=+..+.....|+|
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCCEEEE
Confidence 4578999999999954 34456666432 21111 111 12346778999998886 334444443445566778999
Q ss_pred EecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 110 EYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 110 E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
||++|-.|.+.+... ...++..+-.-+.-||..||+|+||.++||++..+ ++.++||||+..
T Consensus 79 e~I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCcccc
Confidence 999999999888765 24566667777888999999999999999999655 599999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.4e-09 Score=97.27 Aligned_cols=144 Identities=21% Similarity=0.281 Sum_probs=105.6
Q ss_pred EcceEcccCceEEEEEEEcCCCcEEEEEEee-cCcch--hhH-HHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 32 LGPLLGRGSFAKVHKAKSIADGSIVAIKTIE-KNNKF--LDA-AMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 32 ~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~-~~~~~--~~~-~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
....|-+|+-+.|+++. ..|+...||.=- +..+. .+. -...+.++|+..+.++. --.|.-..=++.+...-.|
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCCCeE
Confidence 56688999999999998 478887887532 21111 111 23456789999999886 4455555555666667789
Q ss_pred EEEecCC-CchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCC---eEEEeccCCCc
Q 013005 108 VMEYAAG-GELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN---LKVSDFGLSAL 178 (451)
Q Consensus 108 V~E~~~g-g~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~---lkl~DFGls~~ 178 (451)
+|||++| .++.+++.. ..........+++++-+.+.-||.++|+|+||..+||+|..+|. +-++|||++..
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9999988 467777753 22233333788999999999999999999999999999976653 58999999864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.09 E-value=7e-10 Score=101.60 Aligned_cols=128 Identities=23% Similarity=0.364 Sum_probs=85.9
Q ss_pred EEEEEEEcCCCcEEEEEEeecCc--------------c--------hhhHHHHHHHHHHHHHHHHhcCC-CCceEEEEEE
Q 013005 43 KVHKAKSIADGSIVAIKTIEKNN--------------K--------FLDAAMEDRIVREVSAMRRLQNH-PNVLKIQEVM 99 (451)
Q Consensus 43 ~Vy~a~~~~~~~~vAiK~i~~~~--------------~--------~~~~~~~~~~~~Ei~il~~L~~H-pnIv~l~~~~ 99 (451)
.||.|.. .+|..+|+|+..... . ..........++|...|.++... -++.+++.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899986 678899999985421 0 01122345688999999999633 2567777553
Q ss_pred EeCCEEEEEEEecC--CCchhHHhhcCCCCHHHHHHHHHHHHHHHHH-HHHCCceecCCCCCeEEeCCCCCeEEEeccCC
Q 013005 100 ATKTKIYLVMEYAA--GGELFGKLRRGRLTESAARRYFQQLVSALHF-CHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176 (451)
Q Consensus 100 ~~~~~~~lV~E~~~--gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~y-LH~~giiHrDLKpeNILld~~~~lkl~DFGls 176 (451)
.-+|||||++ |..+.. +....++......++.+++..+.. +|+.|++|+||.+.|||++++ .+.|+|||.+
T Consensus 80 ----~~~ivME~I~~~G~~~~~-l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qa 153 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPR-LKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQA 153 (188)
T ss_dssp ----TTEEEEE--EETTEEGGC-HHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTE
T ss_pred ----CCEEEEEecCCCccchhh-HHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcc
Confidence 2369999998 555543 443333356677888899986666 579999999999999999877 9999999987
Q ss_pred C
Q 013005 177 A 177 (451)
Q Consensus 177 ~ 177 (451)
.
T Consensus 154 v 154 (188)
T PF01163_consen 154 V 154 (188)
T ss_dssp E
T ss_pred e
Confidence 5
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.8e-09 Score=108.28 Aligned_cols=228 Identities=21% Similarity=0.279 Sum_probs=159.9
Q ss_pred cccccCCeEEcceEc---ccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE
Q 013005 23 IPTLLNRYQLGPLLG---RGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG---~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~ 99 (451)
++.+...|.-+..+- .---.+.|++....+|..|++|.+.-+ +.... ...-.-+++++++. |+|+|++.+++
T Consensus 268 ~p~lv~~~~~L~pl~~~~~~~~~Ttyk~~s~~DG~~YvLkRlhg~-r~~~~---nk~t~lve~wkkl~-h~NvV~frevf 342 (655)
T KOG3741|consen 268 IPSLVESFVNLYPLELLNDLFSITTYKATSNVDGNAYVLKRLHGD-RDQST---NKDTSLVEAWKKLC-HTNVVPFREVF 342 (655)
T ss_pred CCcchhhhhceeecccccccccceeEeeeeccCCceeeeeeeccc-cccCc---ccchHHHHHHHHhc-cCceeehhhhh
Confidence 455555554433332 213467899999999999999999433 11111 11223456788895 99999999998
Q ss_pred Ee----CCEEEEEEEecCC-CchhHHhh----------------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 013005 100 AT----KTKIYLVMEYAAG-GELFGKLR----------------RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQ 158 (451)
Q Consensus 100 ~~----~~~~~lV~E~~~g-g~L~~~l~----------------~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpe 158 (451)
.+ +..+++|++|.++ ++|.++.- ..+.+|..+|.|+.||..||.++|+.|..-+-|.|.
T Consensus 343 ~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~ 422 (655)
T KOG3741|consen 343 LTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLK 422 (655)
T ss_pred hhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHh
Confidence 63 4578999999876 46665441 124789999999999999999999999999999999
Q ss_pred eEEeCCCCCeEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCC-CCCCcHH
Q 013005 159 NLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLP-FDDSNLL 237 (451)
Q Consensus 159 NILld~~~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~P-f~~~~~~ 237 (451)
+||++.+-+++|+..|...+..... . |.+... .+-|.=-||.+++.|.+|..- +......
T Consensus 423 kIlv~G~~RIriS~C~i~Dvl~~d~-------------~--~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~ 483 (655)
T KOG3741|consen 423 KILVTGKMRIRISGCGIMDVLQEDP-------------T--EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQ 483 (655)
T ss_pred HeEeeCcceEEEecccceeeecCCC-------------C--cchhHH----hhhhHHHHHHHHHHHhhcccccccccchH
Confidence 9999998889998777765432211 0 112221 236889999999999999544 2222222
Q ss_pred HH-HHHhhccCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 238 AM-YKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 238 ~~-~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
.. ...| -...+.+++++|.-+...++.+ -++.+++.+
T Consensus 484 ~s~~~~I-------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 484 SSHLTRI-------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHh-------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 21 2222 2336788999999999999987 788888876
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=7.9e-11 Score=123.14 Aligned_cols=150 Identities=18% Similarity=0.373 Sum_probs=112.6
Q ss_pred HHHHHHHHHHC-CceecCCCCCeEEeCCCCCeEEEeccCCCcchhh--------hcCcccccCCCCccccceeeeccCCC
Q 013005 138 LVSALHFCHQN-GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI--------KNGMLHTACGTPAYTAPEVVARRGYD 208 (451)
Q Consensus 138 l~~gL~yLH~~-giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~--------~~~~~~~~~gt~~y~APEvl~~~~~~ 208 (451)
...|+.|+|.. +++|+.|.|++|.++.+|.+||+.|+++...... ....-....-...|.|||.+... ..
T Consensus 108 v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~-~~ 186 (700)
T KOG2137|consen 108 VADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT-TN 186 (700)
T ss_pred ccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc-cc
Confidence 34899999987 8999999999999999999999999987543221 01111112346789999999774 44
Q ss_pred CccchhhhhhHHHHHHH-hcCCCCCCCcHHHHHHHh----hccCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCc
Q 013005 209 GAVADAWSCGVILFVLL-AGYLPFDDSNLLAMYKKV----NRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSIS 283 (451)
Q Consensus 209 ~~~sDIwSlGvil~~Ll-~G~~Pf~~~~~~~~~~~i----~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 283 (451)
+.++|++|+|+.+|.+. .|+.-+...+....+..- .......+..++.++++=+.++|..++..||++.+++..|
T Consensus 187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ 266 (700)
T KOG2137|consen 187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIP 266 (700)
T ss_pred cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhccc
Confidence 67799999999999999 566555544332222211 1123345577899999999999999999999999999999
Q ss_pred cccch
Q 013005 284 WFQKS 288 (451)
Q Consensus 284 ~f~~~ 288 (451)
||...
T Consensus 267 ff~D~ 271 (700)
T KOG2137|consen 267 FFSDP 271 (700)
T ss_pred ccCCc
Confidence 99764
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.5e-08 Score=96.59 Aligned_cols=140 Identities=16% Similarity=0.101 Sum_probs=96.7
Q ss_pred eEcccCceEEEEEEEcCCCcEEEEEEeecCcch--hhH-----HHHHHHHHHHHHHHHhcCCCCc--eEEEEEEEe----
Q 013005 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKF--LDA-----AMEDRIVREVSAMRRLQNHPNV--LKIQEVMAT---- 101 (451)
Q Consensus 35 ~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~-----~~~~~~~~Ei~il~~L~~HpnI--v~l~~~~~~---- 101 (451)
.+-+.....|.+.. -.|+.|.||........ ... .......+|...+.+|. .-+| +.+..+...
T Consensus 29 ~v~~~~~rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 29 VFRELEGRRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred EEecCCCceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCC
Confidence 34434444466654 35778999976432100 000 00113678888888874 2233 233334332
Q ss_pred -CCEEEEEEEecCCC-chhHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC-------CCCeE
Q 013005 102 -KTKIYLVMEYAAGG-ELFGKLR---RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR-------DGNLK 169 (451)
Q Consensus 102 -~~~~~lV~E~~~gg-~L~~~l~---~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~-------~~~lk 169 (451)
....++|+|++++. +|.+++. ....++.....++.+++..+.-||+.||+|+|++|.|||++. ++.+.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEE
Confidence 23578999999986 7888875 345677788899999999999999999999999999999975 46799
Q ss_pred EEeccCCC
Q 013005 170 VSDFGLSA 177 (451)
Q Consensus 170 l~DFGls~ 177 (451)
++||+.+.
T Consensus 186 LIDl~r~~ 193 (268)
T PRK15123 186 VIDLHRAQ 193 (268)
T ss_pred EEECCccc
Confidence 99999875
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=6.6e-09 Score=98.48 Aligned_cols=138 Identities=25% Similarity=0.330 Sum_probs=104.5
Q ss_pred EEcceEcccCceEEEEEEEcCCCcEEEEEEeecCc----------------chhh--HHHHHHHHHHHHHHHHhcCC-CC
Q 013005 31 QLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNN----------------KFLD--AAMEDRIVREVSAMRRLQNH-PN 91 (451)
Q Consensus 31 ~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~----------------~~~~--~~~~~~~~~Ei~il~~L~~H-pn 91 (451)
.++..||.|--|.||.|.+ ..|..+|||.=+... ...+ .......++|..+|.+|..+ -.
T Consensus 94 ~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 5778999999999999996 579999999643210 0011 11233567999999999633 25
Q ss_pred ceEEEEEEEeCCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEE
Q 013005 92 VLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVS 171 (451)
Q Consensus 92 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~ 171 (451)
+.+.+++ +...+||||++|-.|... +++...+..++..|++-+.-+-..||+|+|+.+-||+++++|.+.++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vI 244 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRL----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVI 244 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecc----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEE
Confidence 6666653 556899999999777543 33466677788888888887779999999999999999999999999
Q ss_pred eccCCC
Q 013005 172 DFGLSA 177 (451)
Q Consensus 172 DFGls~ 177 (451)
||--+.
T Consensus 245 DwPQ~v 250 (304)
T COG0478 245 DWPQAV 250 (304)
T ss_pred eCcccc
Confidence 996543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.6e-08 Score=99.11 Aligned_cols=233 Identities=19% Similarity=0.223 Sum_probs=149.1
Q ss_pred EcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE------EeCC-E
Q 013005 32 LGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM------ATKT-K 104 (451)
Q Consensus 32 ~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~------~~~~-~ 104 (451)
.++.||+|+.+.+|-.- +-+..|| |+...-.. ....+. +..|...-.||-+-.-..+- .+.+ .
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VA-KIYh~Ppp----a~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVA-KIYHAPPP----AAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCccccCCccceeeecc--hhhchhh-eeecCCCc----hHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 57889999999999664 2334455 88765422 111112 22233443455433211110 1222 3
Q ss_pred EEEEEEecCCCch-hHHhh----cC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCC
Q 013005 105 IYLVMEYAAGGEL-FGKLR----RG---RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176 (451)
Q Consensus 105 ~~lV~E~~~gg~L-~~~l~----~~---~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls 176 (451)
+-+.|..+.|-.= ..+.. +. ...++-+.+..+.|+.+.+.||..|..-+|+.++|+|+++++.+.|.|=..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 6788888887532 22332 11 2677888999999999999999999999999999999999999999885432
Q ss_pred CcchhhhcCcccccCCCCccccceeeeccCC----CCccchhhhhhHHHHHHHhc-CCCCCCC-------cHHHHHHHhh
Q 013005 177 ALPEQIKNGMLHTACGTPAYTAPEVVARRGY----DGAVADAWSCGVILFVLLAG-YLPFDDS-------NLLAMYKKVN 244 (451)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~----~~~~sDIwSlGvil~~Ll~G-~~Pf~~~-------~~~~~~~~i~ 244 (451)
.+- .........+|.+.|.+||.-.-... .+...|.|.||+++|+|+.| +.||.+- +..+ ..|.
T Consensus 165 qi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E--~~Ia 240 (637)
T COG4248 165 QIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE--TDIA 240 (637)
T ss_pred eec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch--hhhh
Confidence 211 12234456789999999997531111 13448999999999999886 9999642 1111 1111
Q ss_pred cc----------C-CCCC---CC--CCHhHHHHHHhccCC--CCCCCCCHHH
Q 013005 245 RR----------D-YQFP---SF--VSKPARSLIYQLLDP--NPKTRMSIEK 278 (451)
Q Consensus 245 ~~----------~-~~~p---~~--~s~~~~~li~~~L~~--dP~~Rpt~~e 278 (451)
.+ . .+-| ++ +++.++.|..+|+.. ++.-|||++.
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 11 1 1112 22 578899999999876 4678999754
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.1e-07 Score=88.62 Aligned_cols=105 Identities=24% Similarity=0.364 Sum_probs=82.8
Q ss_pred HHHHHHHHHHHHhcC-CCCceEEEEEEEeC----CEEEEEEEecCCC-chhHHhhc-CCCCHHHHHHHHHHHHHHHHHHH
Q 013005 74 DRIVREVSAMRRLQN-HPNVLKIQEVMATK----TKIYLVMEYAAGG-ELFGKLRR-GRLTESAARRYFQQLVSALHFCH 146 (451)
Q Consensus 74 ~~~~~Ei~il~~L~~-HpnIv~l~~~~~~~----~~~~lV~E~~~gg-~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH 146 (451)
.+..+|...+..|.. .=..++.+.+.... ...++|+|+++|. +|.+++.. ...+......++.++...+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 457788888777752 12234455554432 2468999999985 78888875 44777888999999999999999
Q ss_pred HCCceecCCCCCeEEeCCCC---CeEEEeccCCCc
Q 013005 147 QNGVAHRDVKPQNLLLDRDG---NLKVSDFGLSAL 178 (451)
Q Consensus 147 ~~giiHrDLKpeNILld~~~---~lkl~DFGls~~ 178 (451)
+.||+|+|++|.|||++.++ .+.++||+-+..
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999887 899999997753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.63 E-value=7.4e-07 Score=82.94 Aligned_cols=143 Identities=19% Similarity=0.260 Sum_probs=92.7
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHH-----HHHHHHHHHHHhc--CCCCceEEEE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMED-----RIVREVSAMRRLQ--NHPNVLKIQE 97 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~-----~~~~Ei~il~~L~--~HpnIv~l~~ 97 (451)
.+.++|.+.+.+-......|.+.. -+|..+++|......+........ ...+++..+.++. +-..+..++-
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 456788888888888888787775 467889999986543221111110 1223333333432 1223333333
Q ss_pred EEE-----eCCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEe
Q 013005 98 VMA-----TKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSD 172 (451)
Q Consensus 98 ~~~-----~~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~D 172 (451)
+.. -....+++|||++|..|.+... +++ .+...+.+++.-+|+.|++|+|..|.|++++++ .++++|
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID 177 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED---IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIID 177 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh---cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEE
Confidence 322 2234568999999988866532 333 244667788999999999999999999999855 599999
Q ss_pred ccCCC
Q 013005 173 FGLSA 177 (451)
Q Consensus 173 FGls~ 177 (451)
|+...
T Consensus 178 ~~~k~ 182 (229)
T PF06176_consen 178 TQGKR 182 (229)
T ss_pred Ccccc
Confidence 98754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.61 E-value=6.1e-07 Score=83.14 Aligned_cols=141 Identities=18% Similarity=0.176 Sum_probs=100.3
Q ss_pred eEcccCceEEEEEEEcCCCcEEEEEEeecC-cchhh-HHHHHHHHHHHHHHHHhcCC-CCceEEEEEEEe----CCEEEE
Q 013005 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKN-NKFLD-AAMEDRIVREVSAMRRLQNH-PNVLKIQEVMAT----KTKIYL 107 (451)
Q Consensus 35 ~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~-~~~~~-~~~~~~~~~Ei~il~~L~~H-pnIv~l~~~~~~----~~~~~l 107 (451)
--|+|+-+.|+.... .|+.+-+|..... ..... +.....+.+|+..+.+|... -.+.++...... .-..+|
T Consensus 25 N~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~L 102 (216)
T PRK09902 25 NYRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALL 102 (216)
T ss_pred CcCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEE
Confidence 347789999998753 3446888876421 11111 22346788999999988621 114444311111 224779
Q ss_pred EEEecCC-CchhHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCC--eEEEeccCCC
Q 013005 108 VMEYAAG-GELFGKLRRG---RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN--LKVSDFGLSA 177 (451)
Q Consensus 108 V~E~~~g-g~L~~~l~~~---~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~--lkl~DFGls~ 177 (451)
|+|-+.| -+|.+++..+ +.++.....++.++...+.-||+.|+.|+|+-+.||+++.+|. ++++||--++
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 9997765 4888888664 4577778899999999999999999999999999999987777 9999998664
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=7.1e-07 Score=93.62 Aligned_cols=149 Identities=26% Similarity=0.420 Sum_probs=97.3
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcch-------------------------hh-----HHH
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKF-------------------------LD-----AAM 72 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~-------------------------~~-----~~~ 72 (451)
+......|. -..|+.++-|.||+|+. .+|+.||||+.+..-.. .+ .+.
T Consensus 121 iee~F~eF~-~~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~ 198 (517)
T COG0661 121 IEELFSEFE-PEPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEF 198 (517)
T ss_pred HHHHHHHcC-CCchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHH
Confidence 333444443 26799999999999985 56999999998653100 00 011
Q ss_pred HH------HHHHHHHHHHHhc----CCCCceEEEEEEEeCCEEEEEEEecCCCchhHHh--hcCCCCH-----HHHHHHH
Q 013005 73 ED------RIVREVSAMRRLQ----NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL--RRGRLTE-----SAARRYF 135 (451)
Q Consensus 73 ~~------~~~~Ei~il~~L~----~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l--~~~~l~e-----~~~~~~~ 135 (451)
.+ .+.+|...+.+++ +.|++.-..=+++-.+...|+|||++|-.+.+.. +...++. .-++.++
T Consensus 199 ~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~ 278 (517)
T COG0661 199 EKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFL 278 (517)
T ss_pred HHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHH
Confidence 11 2345555555543 3455433333334456678999999999888774 4444553 3333344
Q ss_pred HHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 136 QQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 136 ~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
.|++ ..|++|.|.+|.||+++.+|.+-+.|||+....+
T Consensus 279 ~q~~-------~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 279 RQLL-------RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHH-------hcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 4443 3899999999999999999999999999986543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.52 E-value=2.1e-06 Score=80.88 Aligned_cols=139 Identities=20% Similarity=0.221 Sum_probs=98.4
Q ss_pred cceEcccCceEEEEEEEcCCCcEEEEEEeecCcch--------------------hhHHHHHHHHHHHHHHHHhcC-CCC
Q 013005 33 GPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKF--------------------LDAAMEDRIVREVSAMRRLQN-HPN 91 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~--------------------~~~~~~~~~~~Ei~il~~L~~-Hpn 91 (451)
...|+.|--+.||+|.. .++..+|+|+....... .......-..+|...|+++.+ +=.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34677888889999974 67899999998653210 001111234678888887752 234
Q ss_pred ceEEEEEEEeCCEEEEEEEecCCC-chhHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCeEEeCCCCCeE
Q 013005 92 VLKIQEVMATKTKIYLVMEYAAGG-ELFGKLRRGRLTESAARRYFQQLVSALHFCHQ-NGVAHRDVKPQNLLLDRDGNLK 169 (451)
Q Consensus 92 Iv~l~~~~~~~~~~~lV~E~~~gg-~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~-~giiHrDLKpeNILld~~~~lk 169 (451)
+.+.+.+.. -.|||||+... .-.-.+..-++...++..+..++++.+.-|-. .|++|+||+.-|||+. ++.+.
T Consensus 132 vP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 132 VPEPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred CCCceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence 445555543 36899999654 22223334445555899999999999999876 8999999999999998 88999
Q ss_pred EEeccCCC
Q 013005 170 VSDFGLSA 177 (451)
Q Consensus 170 l~DFGls~ 177 (451)
|+|||-|.
T Consensus 207 iID~~QaV 214 (268)
T COG1718 207 IIDVSQAV 214 (268)
T ss_pred EEECcccc
Confidence 99999875
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.48 E-value=3.3e-06 Score=79.93 Aligned_cols=134 Identities=16% Similarity=0.130 Sum_probs=84.9
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCC-CceEEEEEEEeCCEEEEEEEec
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP-NVLKIQEVMATKTKIYLVMEYA 112 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~Hp-nIv~l~~~~~~~~~~~lV~E~~ 112 (451)
..||+|..+.||+. .+..+++|...... ....+.+|..+++.+.... .+.+.+.+....+...+|||++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF------DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC------CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeec
Confidence 46899999999984 24467889876431 1234688999999986332 2577888888888889999999
Q ss_pred CCCc-hh--------------HH-------hhcC---CCCHHH-HHHHHHH----------HHHH-HHHHHH----CCce
Q 013005 113 AGGE-LF--------------GK-------LRRG---RLTESA-ARRYFQQ----------LVSA-LHFCHQ----NGVA 151 (451)
Q Consensus 113 ~gg~-L~--------------~~-------l~~~---~l~e~~-~~~~~~q----------l~~g-L~yLH~----~gii 151 (451)
+|.. +. .. ++.- ..+... ...+..+ +... ..+|.+ ..++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 9963 11 10 1110 111111 0111111 1111 222221 2478
Q ss_pred ecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 152 HRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 152 HrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
|+|+.|.||++++++ +.|+||+.+..
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.4e-06 Score=81.54 Aligned_cols=134 Identities=15% Similarity=0.122 Sum_probs=85.3
Q ss_pred EcccCc-eEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecCC
Q 013005 36 LGRGSF-AKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAG 114 (451)
Q Consensus 36 LG~G~~-g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~g 114 (451)
|-.|.. +.||+... .+..+.+|+..... ...+.+|+.+++.+..+--+.+++++....+..++|||+++|
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 444544 88999964 34678889875431 235678999999997665566888887777778999999999
Q ss_pred CchhHHh-------------------hcC-----CCCHH------HHHHHHH----------------HHHHHHHHHH--
Q 013005 115 GELFGKL-------------------RRG-----RLTES------AARRYFQ----------------QLVSALHFCH-- 146 (451)
Q Consensus 115 g~L~~~l-------------------~~~-----~l~e~------~~~~~~~----------------ql~~gL~yLH-- 146 (451)
..|.... +.- .+... .....+. .+...+..|-
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 7665321 110 01100 0000000 0111122221
Q ss_pred -----HCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 147 -----QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 147 -----~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
...++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 12389999999999999987789999998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.40 E-value=2.1e-06 Score=95.07 Aligned_cols=202 Identities=16% Similarity=0.196 Sum_probs=141.9
Q ss_pred HHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE----EEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC
Q 013005 74 DRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY----LVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQN 148 (451)
Q Consensus 74 ~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~----lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~ 148 (451)
....-|+..+.+.. |+|++.++.+-......- +..|+|..-++...+.. +..+....+.+..+++.|+.|+|+.
T Consensus 227 ~~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 227 QTTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 34455666777886 999999998875543322 34478888899888875 8899999999999999999999999
Q ss_pred CceecCCCCC---eEEeCCCCCeEEE--eccCCCcchhhhcCcccccCCCCccccceeeeccCCCC-ccchhhhhhHHHH
Q 013005 149 GVAHRDVKPQ---NLLLDRDGNLKVS--DFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDG-AVADAWSCGVILF 222 (451)
Q Consensus 149 giiHrDLKpe---NILld~~~~lkl~--DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~-~~sDIwSlGvil~ 222 (451)
...|.-|... +--.+..+...++ ||+.+........ .....-+..+.|||.+....+.. ...|+|++|..+.
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 6665555544 4444566667776 8887764433222 22333466788888876554432 2369999999999
Q ss_pred HHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 223 VLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 223 ~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
.+..|..+-...-.. ..+ .+........+++.+|+.-++++|+++.+++.|+|.+.
T Consensus 384 ~~~~~~~i~~~~~~~---~~~------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 384 QLSQGEDISEKSAVP---VSL------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred hhhhcCcccccccch---hhh------hccccchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence 998876553211110 000 11112226788999999999999999999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.7e-08 Score=102.44 Aligned_cols=237 Identities=19% Similarity=0.191 Sum_probs=163.7
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCC-ceEEEEEEEeCCEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN-VLKIQEVMATKTKIYL 107 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~Hpn-Iv~l~~~~~~~~~~~l 107 (451)
-|.....+++|+++++++.+...+...+ .+.+... ....-+++.|.++ +||| .++.++-+..+...++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~---------l~~rl~~eLLdK~-n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---------LSRRLAIELLDKV-NNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc---------hhhHHHHHHHHHc-cCCCCcccccccCCcccccch
Confidence 4556777899999999999876555444 5655332 3345577789999 5999 7777777788889999
Q ss_pred EEEecCCC-chhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 108 VMEYAAGG-ELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 108 V~E~~~gg-~L~~~l~--~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
.++++.++ +-..... .-.+.+.+.....+.-.++++|+|+.-=+||| ||+..+ +..+..||+........
T Consensus 312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~-- 384 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT-- 384 (829)
T ss_pred hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcc--
Confidence 99999887 2222211 12344555666677788899999998778999 888855 67899999987643321
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCC------CCCCHhH
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP------SFVSKPA 258 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p------~~~s~~~ 258 (451)
..-.+..+|+.++|||+.....++.. -|.|++|+--.++.-|-+|-..... ....+..+. ..| .|-+..-
T Consensus 385 ~~~~t~~~~~~~~~pev~~~~~~~~~-p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g~~p-~s~~L~~~~aw~~~~~ 460 (829)
T KOG0576|consen 385 MKPRTAIGTPEPLAPEVIQENTIDGC-PDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIGNGP-NSPMLTDKSAWSPVFH 460 (829)
T ss_pred cccccCCCCCCCCCchhhcccccccC-CCccCCCcchhhcCCCCCCCCCCcc--ccCCCCCCC-CccccchhhhcCcccc
Confidence 13456789999999999988888765 6999999887788778777543110 000011000 001 1111112
Q ss_pred HHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 259 RSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 259 ~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
.++...|+..-|..|++.-..+-|.+|..
T Consensus 461 ~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 461 RDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred cCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 24677899999999999999998888864
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.37 E-value=7.8e-06 Score=76.45 Aligned_cols=137 Identities=23% Similarity=0.317 Sum_probs=83.0
Q ss_pred cceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCC-CCceEEEEEE---EeCCEEEEE
Q 013005 33 GPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH-PNVLKIQEVM---ATKTKIYLV 108 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~H-pnIv~l~~~~---~~~~~~~lV 108 (451)
++.|+.|..+.||+..... ..+++|..... .....+.+|..+++.|..+ ..+.+++... ......+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEE
Confidence 4678999999999998643 58999997432 3456778899999988644 2356677643 334468999
Q ss_pred EEecCCCchhH----------------Hhh---cC--C---CCHHH------HHHH---------------HHHHHH-HH
Q 013005 109 MEYAAGGELFG----------------KLR---RG--R---LTESA------ARRY---------------FQQLVS-AL 142 (451)
Q Consensus 109 ~E~~~gg~L~~----------------~l~---~~--~---l~e~~------~~~~---------------~~ql~~-gL 142 (451)
|++++|..+.. .+. .. . +.... .... ...+.. .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 99999987766 111 11 1 11000 0000 111222 33
Q ss_pred HHHHH-------CCceecCCCCCeEEeC-CCCCeEEEeccCCC
Q 013005 143 HFCHQ-------NGVAHRDVKPQNLLLD-RDGNLKVSDFGLSA 177 (451)
Q Consensus 143 ~yLH~-------~giiHrDLKpeNILld-~~~~lkl~DFGls~ 177 (451)
..+++ ..++|+|+.|.|||++ +++.+.|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 34432 3599999999999999 66667899999875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.24 E-value=4.7e-05 Score=70.13 Aligned_cols=131 Identities=27% Similarity=0.372 Sum_probs=91.1
Q ss_pred cCCeEEcceEcccCc-eEEEEEEEcCCCcEEEEEEeec---Ccc------hhh--------HHHHHHHHHHHHHHHHhc-
Q 013005 27 LNRYQLGPLLGRGSF-AKVHKAKSIADGSIVAIKTIEK---NNK------FLD--------AAMEDRIVREVSAMRRLQ- 87 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~-g~Vy~a~~~~~~~~vAiK~i~~---~~~------~~~--------~~~~~~~~~Ei~il~~L~- 87 (451)
..+++.++.||.|.. |.||++. -+|..+|+|++.. ... ... ....+-+..|..+..+|+
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 478999999999999 9999998 4778999999321 100 000 012235778888777775
Q ss_pred -CCCCc--eEEEEEEEeC------------------CEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHH
Q 013005 88 -NHPNV--LKIQEVMATK------------------TKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCH 146 (451)
Q Consensus 88 -~HpnI--v~l~~~~~~~------------------~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH 146 (451)
++.++ |+.+|+..-. ....||-||+.... .++. .-+.++.+-|..+|
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccch----hHHHHHHHHHHHHH
Confidence 24455 8999997322 12357777776533 2223 33456777778899
Q ss_pred HCCceecCCCCCeEEeCCCCCeEEEeccCC
Q 013005 147 QNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176 (451)
Q Consensus 147 ~~giiHrDLKpeNILld~~~~lkl~DFGls 176 (451)
..||+-+|+++.|.. .-+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999985 3489999864
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.1e-05 Score=88.19 Aligned_cols=146 Identities=19% Similarity=0.339 Sum_probs=92.3
Q ss_pred cceEcccCceEEEEEEEcCCC--cEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCc--eEEEEEEEeC---CEE
Q 013005 33 GPLLGRGSFAKVHKAKSIADG--SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNV--LKIQEVMATK---TKI 105 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~~~--~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnI--v~l~~~~~~~---~~~ 105 (451)
.+.++.|.+..+|+......+ ..+++|........ .....+.+|..+|+.|.+|+++ .+++.++.+. +..
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~---~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL---QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC---ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 567899999999998754332 46777876543111 1234678999999999656664 7778777654 468
Q ss_pred EEEEEecCCCchhH--------------------Hh---hcCC-----C---------CHHHHHHHHHH-----------
Q 013005 106 YLVMEYAAGGELFG--------------------KL---RRGR-----L---------TESAARRYFQQ----------- 137 (451)
Q Consensus 106 ~lV~E~~~gg~L~~--------------------~l---~~~~-----l---------~e~~~~~~~~q----------- 137 (451)
|+||||++|..+.+ .+ +.-. + ...++..|..+
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 99999999864321 11 1100 0 01122222221
Q ss_pred ----HHHHHHHHHH-----------CCceecCCCCCeEEeCCC-CC-eEEEeccCCCcchh
Q 013005 138 ----LVSALHFCHQ-----------NGVAHRDVKPQNLLLDRD-GN-LKVSDFGLSALPEQ 181 (451)
Q Consensus 138 ----l~~gL~yLH~-----------~giiHrDLKpeNILld~~-~~-lkl~DFGls~~~~~ 181 (451)
+...+.+|.. ..++|+|++|.|||++.+ +. .-|.||.+++..+.
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdP 260 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQ 260 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCCh
Confidence 2233556633 249999999999999853 33 58999999986544
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.8e-05 Score=70.80 Aligned_cols=130 Identities=18% Similarity=0.236 Sum_probs=92.9
Q ss_pred EEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEE
Q 013005 31 QLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVME 110 (451)
Q Consensus 31 ~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E 110 (451)
...+.||+|.+|.||++.. .|..+|+|+-..+. ....+..|..++..+..----.++|.+-. .++.||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds------~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me 92 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDS------PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRME 92 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEecCCc------chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhh
Confidence 4567899999999999985 56799999876553 24578899999999974434456665543 345599
Q ss_pred ecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC-CCeEEeCCCCCeEEEeccCCCc
Q 013005 111 YAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVK-PQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 111 ~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLK-peNILld~~~~lkl~DFGls~~ 178 (451)
|+.|-+|.+.-..+ + ++-...+++.---|-..||-|+.|. |...+|-.++.+.|+||.-|+.
T Consensus 93 ~i~G~~L~~~~~~~--~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 93 YIDGRPLGKLEIGG--D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhcCcchhhhhhcc--c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 99998887654432 1 3333445555445677899999885 6666665666999999998874
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.13 E-value=6.2e-05 Score=69.58 Aligned_cols=133 Identities=21% Similarity=0.305 Sum_probs=96.5
Q ss_pred cceEcccCceEEEEEEEcCCCcEEEEEEeecCcc------------hhhHHHHHHHHHHHHHHHHhc-----CCCCceEE
Q 013005 33 GPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNK------------FLDAAMEDRIVREVSAMRRLQ-----NHPNVLKI 95 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~------------~~~~~~~~~~~~Ei~il~~L~-----~HpnIv~l 95 (451)
...||+|+.-.||.- .......||+...... ........+..+|+.....+. .+.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 357899999998864 4566678999977640 001122355667777666653 37889999
Q ss_pred EEEEEeCCEEEEEEEecCC------CchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC---
Q 013005 96 QEVMATKTKIYLVMEYAAG------GELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG--- 166 (451)
Q Consensus 96 ~~~~~~~~~~~lV~E~~~g------g~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~--- 166 (451)
||+.+++.-.-+|+|.+.. -+|.+++..+.+++ ..+ ..|-+-..||-+.+|+.+||+|.||++...+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 9999999999999998743 26788888888877 333 3444556688999999999999999996432
Q ss_pred -CeEEEe
Q 013005 167 -NLKVSD 172 (451)
Q Consensus 167 -~lkl~D 172 (451)
.+.|+|
T Consensus 159 ~~lvlID 165 (199)
T PF10707_consen 159 FRLVLID 165 (199)
T ss_pred eEEEEEe
Confidence 467776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.02 E-value=2.8e-05 Score=71.37 Aligned_cols=101 Identities=22% Similarity=0.237 Sum_probs=82.5
Q ss_pred HHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecCCCchhHH----hhcCCCCHHHHHHHHHHHHHHHHHHHH---CC
Q 013005 77 VREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGK----LRRGRLTESAARRYFQQLVSALHFCHQ---NG 149 (451)
Q Consensus 77 ~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~----l~~~~l~e~~~~~~~~ql~~gL~yLH~---~g 149 (451)
..|.-+++.+.+.+++++++|.+. .+++.||...+++... .+-...++..+.+++.++++.++++++ ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888999986689999999984 3678999987766532 122457899999999999999999988 35
Q ss_pred ceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 150 VAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 150 iiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
+.-.|++|+|+-++++|++|++|.........
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~~ 114 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVEDK 114 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhHH
Confidence 77899999999999999999999998765443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.96 E-value=7.8e-05 Score=78.33 Aligned_cols=143 Identities=22% Similarity=0.292 Sum_probs=89.2
Q ss_pred cceEcccCceEEEEEEEcCCCcEEEEEEeecCcch---------------------------hhHHHHHHHH------HH
Q 013005 33 GPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKF---------------------------LDAAMEDRIV------RE 79 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~---------------------------~~~~~~~~~~------~E 79 (451)
-+.||.-+.|.||+|+. .+|+.||||+-+..-+. .-.+..+.+. +|
T Consensus 166 ~~piaaASlaQVhrA~L-~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARL-KNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEe-cCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 36799999999999986 45999999997543110 0011122222 33
Q ss_pred HHHHHHhc---CCCC------ceEEEEEEEeCCEEEEEEEecCCCchhH--HhhcCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013005 80 VSAMRRLQ---NHPN------VLKIQEVMATKTKIYLVMEYAAGGELFG--KLRRGRLTESAARRYFQQLVSALHFCHQN 148 (451)
Q Consensus 80 i~il~~L~---~Hpn------Iv~l~~~~~~~~~~~lV~E~~~gg~L~~--~l~~~~l~e~~~~~~~~ql~~gL~yLH~~ 148 (451)
.+...+.+ .|-+ |.++|- ...+...|+|||++|..+.+ .+.+..++...+.....+...-+ +=..
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~q--If~~ 320 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQ--IFKT 320 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHH--HHhc
Confidence 33222221 1444 333332 22456789999999987755 44566666664443333222211 2246
Q ss_pred CceecCCCCCeEEeCC----CCCeEEEeccCCCcch
Q 013005 149 GVAHRDVKPQNLLLDR----DGNLKVSDFGLSALPE 180 (451)
Q Consensus 149 giiHrDLKpeNILld~----~~~lkl~DFGls~~~~ 180 (451)
|++|.|=+|-||+++. ++.+.+-|||+.....
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 8999999999999984 5689999999986543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.96 E-value=5.4e-05 Score=71.87 Aligned_cols=73 Identities=11% Similarity=0.087 Sum_probs=45.8
Q ss_pred ceEcccCce-EEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCC--CceEEEEEEEeC---CEEEE
Q 013005 34 PLLGRGSFA-KVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP--NVLKIQEVMATK---TKIYL 107 (451)
Q Consensus 34 ~~LG~G~~g-~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~Hp--nIv~l~~~~~~~---~~~~l 107 (451)
+.|+.|+.. .||+.. ..+++|+.... .....+.+|..+++.|.++- .+.++++..... ...|+
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~------~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAA------GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCcc------chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 456766665 588762 35777875432 12347889999999886431 344455443322 24589
Q ss_pred EEEecCCCch
Q 013005 108 VMEYAAGGEL 117 (451)
Q Consensus 108 V~E~~~gg~L 117 (451)
+|++++|.++
T Consensus 72 l~~~i~G~~l 81 (235)
T cd05155 72 VYRWLEGETA 81 (235)
T ss_pred EEEeecCCCC
Confidence 9999999665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.93 E-value=5.3e-07 Score=101.50 Aligned_cols=213 Identities=14% Similarity=0.100 Sum_probs=146.0
Q ss_pred HHHHHHHHHHHHHHHhcCCCCceEEEEEEE--eCCEEEEEEEecCCCchhHHhhcC-----CCCHHHHHHHHHHHHHHHH
Q 013005 71 AMEDRIVREVSAMRRLQNHPNVLKIQEVMA--TKTKIYLVMEYAAGGELFGKLRRG-----RLTESAARRYFQQLVSALH 143 (451)
Q Consensus 71 ~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~--~~~~~~lV~E~~~gg~L~~~l~~~-----~l~e~~~~~~~~ql~~gL~ 143 (451)
...+....|..-++... |+++...+.-.. +....|..++|+.+|.+++.+-+| .+.+.-+....++.+.+..
T Consensus 1271 Plkemll~e~de~~~~~-h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~ 1349 (2724)
T KOG1826|consen 1271 PLKEMLLSERDELREAK-HYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRN 1349 (2724)
T ss_pred HHHHhhhhhhhhhhhhh-ceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccc
Confidence 34445555555556665 999888766553 345678999999999999999754 2344444444555577777
Q ss_pred HHHHCC-----ceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhh
Q 013005 144 FCHQNG-----VAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCG 218 (451)
Q Consensus 144 yLH~~g-----iiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlG 218 (451)
-+|++. .+|++||+-|.+|+.+.++|+.++|+.+.... .........+++.|++|++...-.+. .++|+|+.|
T Consensus 1350 ~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s 1427 (2724)
T KOG1826|consen 1350 VILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRS 1427 (2724)
T ss_pred hhhhcccCCccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHH
Confidence 888752 78999999999999999999999999983222 12334556788999999988776664 449999999
Q ss_pred HHHHHHHhcCCCCCCCcHHHHHHHhhccC-CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCcccc
Q 013005 219 VILFVLLAGYLPFDDSNLLAMYKKVNRRD-YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQ 286 (451)
Q Consensus 219 vil~~Ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~ 286 (451)
+-+|.+..|..+|-......+...+.... ...+...|.++......+|-..-..||.-..++.-+.|.
T Consensus 1428 ~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1428 LSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HHHHHHhcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 99999999988874333222222222222 223333445555555556666667788777777766664
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00015 Score=68.52 Aligned_cols=136 Identities=15% Similarity=0.198 Sum_probs=81.7
Q ss_pred cceEcccCceEEEEEEEcC-CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEe
Q 013005 33 GPLLGRGSFAKVHKAKSIA-DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEY 111 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~ 111 (451)
.+.|..|-...+|+..... .++.|++|+...... ......+|+.+++.+..+.-.++++.... + .++|||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-----LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-----ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEe
Confidence 3567888889999997432 357899998754321 11123478888888864444556665433 2 379999
Q ss_pred cCCCchhH--------------Hh---hcC--CCC-----------HHHHHHHHHH----------------------HH
Q 013005 112 AAGGELFG--------------KL---RRG--RLT-----------ESAARRYFQQ----------------------LV 139 (451)
Q Consensus 112 ~~gg~L~~--------------~l---~~~--~l~-----------e~~~~~~~~q----------------------l~ 139 (451)
++|.++.. .+ +.. ... ...+..+... +.
T Consensus 74 i~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 153 (235)
T cd05157 74 IPGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLR 153 (235)
T ss_pred eCCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHH
Confidence 99866521 11 110 110 1122222211 11
Q ss_pred HHHHHH----HH----CCceecCCCCCeEEeCC-CCCeEEEeccCCC
Q 013005 140 SALHFC----HQ----NGVAHRDVKPQNLLLDR-DGNLKVSDFGLSA 177 (451)
Q Consensus 140 ~gL~yL----H~----~giiHrDLKpeNILld~-~~~lkl~DFGls~ 177 (451)
..+..| .. .+++|+|+.|.|||+++ ++.+.++||..|.
T Consensus 154 ~~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 154 DEISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 111111 11 25899999999999998 5789999999876
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00027 Score=72.17 Aligned_cols=82 Identities=18% Similarity=0.181 Sum_probs=56.1
Q ss_pred cceEcccCceEEEEEEEcCCCcEEEEEEeecCcchh-h--HHHHHHHHHHHHHHHHhcCC--CCceEEEEEEEeCCEEEE
Q 013005 33 GPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFL-D--AAMEDRIVREVSAMRRLQNH--PNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~-~--~~~~~~~~~Ei~il~~L~~H--pnIv~l~~~~~~~~~~~l 107 (451)
.+.||.|.+..||++.+...++.++||.-....+.. . ....++...|...|+.+..+ .++++++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 367999999999999975433689999854221110 1 12345677788888876433 457788876 4466789
Q ss_pred EEEecCCCc
Q 013005 108 VMEYAAGGE 116 (451)
Q Consensus 108 V~E~~~gg~ 116 (451)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998743
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00059 Score=67.28 Aligned_cols=78 Identities=12% Similarity=0.046 Sum_probs=56.1
Q ss_pred EcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCC--CCceEEEEEEEe---CCEEE
Q 013005 32 LGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH--PNVLKIQEVMAT---KTKIY 106 (451)
Q Consensus 32 ~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~H--pnIv~l~~~~~~---~~~~~ 106 (451)
-.+.||.|..+.||.... .++ .+.+|..+.. .....+..|...++.|..+ -.+.++++++.. .+..+
T Consensus 18 ~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~------~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 18 RVECISEQPYAALWALYD-SQG-NPMPLMARSF------STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred eeeecCCccceeEEEEEc-CCC-CEEEEEeccc------ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 356799999999999863 233 4666774321 0124688999999999654 367888887754 36689
Q ss_pred EEEEecCCCch
Q 013005 107 LVMEYAAGGEL 117 (451)
Q Consensus 107 lV~E~~~gg~L 117 (451)
+|||+++|+++
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998754
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00017 Score=69.35 Aligned_cols=133 Identities=20% Similarity=0.202 Sum_probs=79.1
Q ss_pred eEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecCC
Q 013005 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAG 114 (451)
Q Consensus 35 ~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~g 114 (451)
.+..|-...+|+.. .++..+++|+...... ...-...+|..+++.+..+.-..+++.... -++||||++|
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~----~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G 72 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCK----ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEG 72 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccc----cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccC
Confidence 35678888999886 4567888898654321 110124678888988864422344554432 3689999998
Q ss_pred CchhH--------------H---hhcCC-----CCH-HHHHHHHHHH---------HHHHHHHHHC--------CceecC
Q 013005 115 GELFG--------------K---LRRGR-----LTE-SAARRYFQQL---------VSALHFCHQN--------GVAHRD 154 (451)
Q Consensus 115 g~L~~--------------~---l~~~~-----l~e-~~~~~~~~ql---------~~gL~yLH~~--------giiHrD 154 (451)
..+.. . ++... ++. ..+..+..++ ...+..+-.. .++|+|
T Consensus 73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 66531 1 11111 111 1222332222 1112222221 489999
Q ss_pred CCCCeEEeCCCCCeEEEeccCCCc
Q 013005 155 VKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 155 LKpeNILld~~~~lkl~DFGls~~ 178 (451)
+.|.||++++++ +.|+||..+..
T Consensus 153 l~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 153 VHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CCcCcEEEeCCC-CEEEeccccCc
Confidence 999999999877 79999998874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00056 Score=68.05 Aligned_cols=141 Identities=28% Similarity=0.355 Sum_probs=100.4
Q ss_pred EcceEcccCceEEEEEEEcCCCcEEEEEEeecC--------c-------------chhhHHHH-HHHHHHHHHHHHhcCC
Q 013005 32 LGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKN--------N-------------KFLDAAME-DRIVREVSAMRRLQNH 89 (451)
Q Consensus 32 ~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~--------~-------------~~~~~~~~-~~~~~Ei~il~~L~~H 89 (451)
+...|..|--+.||+|.. .+|..+|||++.-. . +.....+. --..+|+..|++|. .
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~-~ 225 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN-N 225 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH-h
Confidence 556788999999999984 68889999998431 0 00111222 23467888888885 4
Q ss_pred CCceEEEEEEEeCCEEEEEEEecCC-CchhHHhhcCCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCCCCeEEeCCCCC
Q 013005 90 PNVLKIQEVMATKTKIYLVMEYAAG-GELFGKLRRGRLTESAARRYFQQLVSALHFC-HQNGVAHRDVKPQNLLLDRDGN 167 (451)
Q Consensus 90 pnIv~l~~~~~~~~~~~lV~E~~~g-g~L~~~l~~~~l~e~~~~~~~~ql~~gL~yL-H~~giiHrDLKpeNILld~~~~ 167 (451)
..|.-.--+. - ....|||+++.+ |--.-.++...++...++.+.+|++.-+.-| |..+.+|.||.--|+|+ .+|.
T Consensus 226 aGIP~PePIl-L-k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~ 302 (520)
T KOG2270|consen 226 AGIPCPEPIL-L-KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGK 302 (520)
T ss_pred cCCCCCCcee-e-ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCE
Confidence 4443221111 1 234689999964 2234455667899999999999999999988 56799999999999999 6779
Q ss_pred eEEEeccCCC
Q 013005 168 LKVSDFGLSA 177 (451)
Q Consensus 168 lkl~DFGls~ 177 (451)
+.|+|-+-|-
T Consensus 303 lyiIDVSQSV 312 (520)
T KOG2270|consen 303 LYIIDVSQSV 312 (520)
T ss_pred EEEEEccccc
Confidence 9999987664
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00048 Score=67.52 Aligned_cols=136 Identities=18% Similarity=0.135 Sum_probs=83.1
Q ss_pred cceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCC-CceEEEEE------EEeCCEE
Q 013005 33 GPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP-NVLKIQEV------MATKTKI 105 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~Hp-nIv~l~~~------~~~~~~~ 105 (451)
.+.|..|....+|+... ++..+++|+.... ..+.+..|+.++..|..+- .+.+++.. ....+..
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~-------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV-------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCC-------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 45677888889999864 3457888987532 1245677888888885331 24455432 2334567
Q ss_pred EEEEEecCCCchhH-----------Hh---hc--CCCCH--------H--H--HH--------HHHHHHHHHHHHHHH--
Q 013005 106 YLVMEYAAGGELFG-----------KL---RR--GRLTE--------S--A--AR--------RYFQQLVSALHFCHQ-- 147 (451)
Q Consensus 106 ~lV~E~~~gg~L~~-----------~l---~~--~~l~e--------~--~--~~--------~~~~ql~~gL~yLH~-- 147 (451)
+++++|++|..+.. .+ +. ..+.. . . .. .....+..++.++.+
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 89999999866421 00 10 00100 0 0 00 011112334444443
Q ss_pred -----CCceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 148 -----NGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 148 -----~giiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
.+++|+|+.|.||++++++...|+||+.+.
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 369999999999999988777899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.65 E-value=7.6e-05 Score=72.89 Aligned_cols=136 Identities=18% Similarity=0.214 Sum_probs=99.5
Q ss_pred eEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCc----------------chhhHHH--HHHHHHHHHHHHHhcCCCC
Q 013005 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNN----------------KFLDAAM--EDRIVREVSAMRRLQNHPN 91 (451)
Q Consensus 30 y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~----------------~~~~~~~--~~~~~~Ei~il~~L~~Hpn 91 (451)
+.+++.||-|--+.||.+-+ +.|.+.++|.=+... +..+.-. .-...+|...|+.|..|-.
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 56889999999999999986 678889988643210 0000011 1134688999999975533
Q ss_pred -ceEEEEEEEeCCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEE
Q 013005 92 -VLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKV 170 (451)
Q Consensus 92 -Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl 170 (451)
+.+.++ .+..++|||++.|-.|...-+ ...+..++..|+.-+--|-.+|+||+|..--||++++++.+++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~-----v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~v 243 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRH-----VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVV 243 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeee-----cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEE
Confidence 334443 356789999999987765432 2235567778888888899999999999999999999999999
Q ss_pred EeccC
Q 013005 171 SDFGL 175 (451)
Q Consensus 171 ~DFGl 175 (451)
+||--
T Consensus 244 IDFPQ 248 (465)
T KOG2268|consen 244 IDFPQ 248 (465)
T ss_pred eechH
Confidence 99963
|
|
| >PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00017 Score=50.30 Aligned_cols=43 Identities=12% Similarity=0.157 Sum_probs=36.8
Q ss_pred CcEEEEEEEEeeec-CCeEEEEEEecCCCCCCCcchhhHhhhHHHHhhhhc
Q 013005 390 GKMVLLVEVLMEIA-PETFVVGVKVVDNSVCGRVALEFDEGDWNELQAGLG 439 (451)
Q Consensus 390 ~~~~~~~~~~~~~~-~~~~~v~~~~~~g~~~~~~~~~~~~~~~~~~~~~l~ 439 (451)
..+.|.+||| .+. ++.+.|+|+|.+|| .+.|+++|. ++...|+
T Consensus 3 ~~v~fEieV~-kl~~~~l~Gv~~kRi~Gd-----~~~yk~lc~-~il~~l~ 46 (47)
T PF02149_consen 3 EVVKFEIEVC-KLPRLGLYGVDFKRISGD-----SWQYKDLCS-KILNELR 46 (47)
T ss_dssp C-EEEEEEEE-EECCCTCEEEEEEEEES------HHHHHHHHH-HHHHHTT
T ss_pred cceEEEEEEE-EecCCCeeEEEEEEeeCC-----HHHHHHHHH-HHHHHcc
Confidence 4689999999 997 89999999999999 999999998 7776664
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00094 Score=66.06 Aligned_cols=137 Identities=20% Similarity=0.165 Sum_probs=81.0
Q ss_pred cceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCC-CCceEEEEE------EEeCCEE
Q 013005 33 GPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH-PNVLKIQEV------MATKTKI 105 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~H-pnIv~l~~~------~~~~~~~ 105 (451)
.+.++.|....+|+... .++ .+++|+...... .+.+..|+.++..|..+ -.+++++.. ....+..
T Consensus 27 i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~~------~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~ 98 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT-DVG-RYILTLYEKRVK------AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP 98 (307)
T ss_pred ccccCCccccceEEEEe-CCC-cEEEEEecCCCC------HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence 55677888889999863 344 577898754311 12345667777777422 124444332 1224567
Q ss_pred EEEEEecCCCchh-----------HH---hhc--CCCCH-------HHHH----------------HHHHHHHHHHHHHH
Q 013005 106 YLVMEYAAGGELF-----------GK---LRR--GRLTE-------SAAR----------------RYFQQLVSALHFCH 146 (451)
Q Consensus 106 ~lV~E~~~gg~L~-----------~~---l~~--~~l~e-------~~~~----------------~~~~ql~~gL~yLH 146 (451)
++++||++|..+. .. ++. ..++. ...+ .....+...++++.
T Consensus 99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 8999999985431 11 111 11100 0000 00112333455554
Q ss_pred H-------CCceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 147 Q-------NGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 147 ~-------~giiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
. .+++|+|+.+.||++++++...|+||+.+.
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 3 579999999999999988777899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00071 Score=66.64 Aligned_cols=75 Identities=15% Similarity=0.119 Sum_probs=49.1
Q ss_pred ceEcccCceEEEEEEEcC------CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 34 PLLGRGSFAKVHKAKSIA------DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
+.|..|-...+|+..... +++.+++|+...... ......+|..+++.+..+.-..+++..... .+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-----LLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-----ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 456677788999887432 257899999754321 123456888888888644334466665542 35
Q ss_pred EEEecCCCch
Q 013005 108 VMEYAAGGEL 117 (451)
Q Consensus 108 V~E~~~gg~L 117 (451)
|+||++|..+
T Consensus 75 v~e~i~G~~l 84 (302)
T cd05156 75 IEEFIPSRTL 84 (302)
T ss_pred hhheeCCCcC
Confidence 8999988665
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0018 Score=65.08 Aligned_cols=87 Identities=21% Similarity=0.138 Sum_probs=53.7
Q ss_pred eEcccCceEEEEEEEcCCCcEEEEEEeecCcchh--h-HHHHHHHHHHHHHHHHhcCC-C-CceEEEEEEEeCCEEEEEE
Q 013005 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFL--D-AAMEDRIVREVSAMRRLQNH-P-NVLKIQEVMATKTKIYLVM 109 (451)
Q Consensus 35 ~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~--~-~~~~~~~~~Ei~il~~L~~H-p-nIv~l~~~~~~~~~~~lV~ 109 (451)
.||.|....||++.+...++.|+||.-...-+.. + .-..++...|...|+.+... | .++++|.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 5799999999999975444689999764321110 0 12345666777788776432 3 45566643 455566999
Q ss_pred EecCCC-chhHHhhc
Q 013005 110 EYAAGG-ELFGKLRR 123 (451)
Q Consensus 110 E~~~gg-~L~~~l~~ 123 (451)
|+++.. .|...+.+
T Consensus 80 EdL~~~~ilR~~Li~ 94 (370)
T TIGR01767 80 EDLSHHKIARKGLIE 94 (370)
T ss_pred hhCccchHHHHHHHc
Confidence 998653 23344433
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0044 Score=60.45 Aligned_cols=31 Identities=23% Similarity=0.448 Sum_probs=26.1
Q ss_pred CceecCCCCCeEEeCCCCC-eEEEeccCCCcc
Q 013005 149 GVAHRDVKPQNLLLDRDGN-LKVSDFGLSALP 179 (451)
Q Consensus 149 giiHrDLKpeNILld~~~~-lkl~DFGls~~~ 179 (451)
.++|+|++|.|||+++++. .-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 3899999999999997565 469999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0034 Score=62.12 Aligned_cols=146 Identities=16% Similarity=0.206 Sum_probs=86.2
Q ss_pred EcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcC-CCCceEEEEEEEeCC--EEEEE
Q 013005 32 LGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN-HPNVLKIQEVMATKT--KIYLV 108 (451)
Q Consensus 32 ~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~-HpnIv~l~~~~~~~~--~~~lV 108 (451)
+.+.+..|..-.+|...+ +++.++++ ... ............+|..+++.+.. ---+.+.++.+.+.. ..|.|
T Consensus 29 ~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~--~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 29 IVEEISGGWSNDTFRLGD--TGQKYVLR-KPP--RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred eeeeccCCcccceEEEec--CCceEEEe-cCC--ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 444444454455566553 38888888 321 11223445667889999998842 112334566665555 78999
Q ss_pred EEecCCCchhHHhhcCCCC---------------------------------HHHHHHHHH--------------HHHHH
Q 013005 109 MEYAAGGELFGKLRRGRLT---------------------------------ESAARRYFQ--------------QLVSA 141 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~~~l~---------------------------------e~~~~~~~~--------------ql~~g 141 (451)
|+|++|..+.+.......+ ..+...+.. .+..-
T Consensus 104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~ 183 (321)
T COG3173 104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL 183 (321)
T ss_pred EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence 9999984333222111111 011111111 12233
Q ss_pred HHHHHHC--------CceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 142 LHFCHQN--------GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 142 L~yLH~~--------giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
..+++.+ .++|+|+.+.||+++.++-+-|.||+++.+.+..
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~ 232 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL 232 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence 4455443 3899999999999999999999999999875543
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0066 Score=60.19 Aligned_cols=136 Identities=16% Similarity=0.127 Sum_probs=75.4
Q ss_pred cceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCC-CCceEEEE------EEEeCCEE
Q 013005 33 GPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH-PNVLKIQE------VMATKTKI 105 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~H-pnIv~l~~------~~~~~~~~ 105 (451)
.+.|+.|....+|+... .+| .+++|+.... . .+.+..|+..++.|..+ -.+.+++. +....+..
T Consensus 27 ~~~l~~G~~n~~y~v~t-~~g-~~vLK~~~~~----~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~ 97 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT-TQG-EYVLTLFERL----T---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKP 97 (319)
T ss_pred cchhccccccceEEEEe-CCC-cEEEEEeccC----C---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEE
Confidence 34567788889999864 334 6888987521 1 12334455666666421 11333332 12335678
Q ss_pred EEEEEecCCCchh-----------HHh---hc--CCCC----------H-HH-HHH-----------HHHHHH-HHHHHH
Q 013005 106 YLVMEYAAGGELF-----------GKL---RR--GRLT----------E-SA-ARR-----------YFQQLV-SALHFC 145 (451)
Q Consensus 106 ~lV~E~~~gg~L~-----------~~l---~~--~~l~----------e-~~-~~~-----------~~~ql~-~gL~yL 145 (451)
++++||++|..+. ..+ +. ..++ . .. ... .+.+.+ ..++.+
T Consensus 98 ~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 177 (319)
T PRK05231 98 AAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFL 177 (319)
T ss_pred EEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhh
Confidence 9999999986431 111 11 0110 0 00 011 111111 112233
Q ss_pred H-------HCCceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 146 H-------QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 146 H-------~~giiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
. ..|++|+|+.|.||+++.+...-|+||+.+.
T Consensus 178 ~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 178 ASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred hccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2 2379999999999999866556899999876
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0066 Score=61.19 Aligned_cols=137 Identities=13% Similarity=0.172 Sum_probs=82.2
Q ss_pred cceEcccCceEEEEEEEcC----CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 33 GPLLGRGSFAKVHKAKSIA----DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
...|-.|-...+|++.... +++.|++|+..... ....+ -.+|..+++.+.++.--.++++.+... .|
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t----~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v 111 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV----ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RV 111 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC----Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence 3455568889999986432 34689999875532 11222 267888888887554445667666432 57
Q ss_pred EEecCCCchhHH-----------------hhcCC------C-CHHHHHHHHHHH-----------------HHHHHHH--
Q 013005 109 MEYAAGGELFGK-----------------LRRGR------L-TESAARRYFQQL-----------------VSALHFC-- 145 (451)
Q Consensus 109 ~E~~~gg~L~~~-----------------l~~~~------l-~e~~~~~~~~ql-----------------~~gL~yL-- 145 (451)
.||++|.+|... +++.. . ....+..+..++ ...+..|
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 999987665311 11111 1 123333333222 1111122
Q ss_pred --H----HCCceecCCCCCeEEeCC-CCCeEEEeccCCCc
Q 013005 146 --H----QNGVAHRDVKPQNLLLDR-DGNLKVSDFGLSAL 178 (451)
Q Consensus 146 --H----~~giiHrDLKpeNILld~-~~~lkl~DFGls~~ 178 (451)
. ...++|+|+++.|||+++ ++.+.++||..+..
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 125899999999999986 46899999998863
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.013 Score=58.69 Aligned_cols=137 Identities=16% Similarity=0.194 Sum_probs=79.9
Q ss_pred cceEcccCceEEEEEEEcCC---CcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEE
Q 013005 33 GPLLGRGSFAKVHKAKSIAD---GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVM 109 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~ 109 (451)
.+.|..|-...+|+...... +..|++|+...... .. -.-.+|..+++.+..+.--.++++++. .+ +|.
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~----~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~ 89 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD----YV-IDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQ 89 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC----eE-echHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eee
Confidence 34455588888999865332 34789998754321 11 123578888888864433346666653 22 488
Q ss_pred EecCCCchhH--------------Hh---hcCC------C-CHHHHHHHHHHHH----------------------HHHH
Q 013005 110 EYAAGGELFG--------------KL---RRGR------L-TESAARRYFQQLV----------------------SALH 143 (451)
Q Consensus 110 E~~~gg~L~~--------------~l---~~~~------l-~e~~~~~~~~ql~----------------------~gL~ 143 (451)
+|++|..|.. .+ +... + ....+.+|+.++- .-+.
T Consensus 90 ~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 169 (330)
T PLN02421 90 SFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIV 169 (330)
T ss_pred hhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHH
Confidence 9988765421 11 1111 1 1233334433321 1122
Q ss_pred HH----HHCC----ceecCCCCCeEEeCC-CCCeEEEeccCCCc
Q 013005 144 FC----HQNG----VAHRDVKPQNLLLDR-DGNLKVSDFGLSAL 178 (451)
Q Consensus 144 yL----H~~g----iiHrDLKpeNILld~-~~~lkl~DFGls~~ 178 (451)
.+ .+.+ .+|.|+.|.|||+++ ++.++++||..|..
T Consensus 170 ~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 170 ELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 22 1122 799999999999975 47899999998863
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.035 Score=54.63 Aligned_cols=29 Identities=31% Similarity=0.532 Sum_probs=25.7
Q ss_pred CCceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 148 NGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 148 ~giiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.008 Score=62.34 Aligned_cols=162 Identities=20% Similarity=0.233 Sum_probs=102.7
Q ss_pred HHHHHHHHHHHhcCCCCceEEEEEEEeC-CEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 013005 75 RIVREVSAMRRLQNHPNVLKIQEVMATK-TKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHR 153 (451)
Q Consensus 75 ~~~~Ei~il~~L~~HpnIv~l~~~~~~~-~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHr 153 (451)
++.-...+++.+. |+|...+.++.... ....+|||++ +.+|.+.+..+.+-..... .+|+.|
T Consensus 28 ~ilgr~~~lktl~-~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~~s~~--------------~~~~~~- 90 (725)
T KOG1093|consen 28 QILGRFQYLKSLQ-HDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKDESLL--------------AHGVLH- 90 (725)
T ss_pred HHhhhhHHHHhhc-CccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccchhhhc--------------ccccce-
Confidence 3445567788886 99999999887653 3478899998 4588888775542211111 122221
Q ss_pred CCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCC
Q 013005 154 DVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDD 233 (451)
Q Consensus 154 DLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~ 233 (451)
-| .++++| -+++ .. .+. .++++||||+|.++.++..|...|..
T Consensus 91 ----~~-------~~~~td-~~~t------~~--~~~-----------------~~pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 91 ----LN-------IIYITD-HFLT------KY--PSP-----------------IGPKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred ----eh-------hhhccc-cccc------cC--CCC-----------------CCcchhhhhHHHHHHHHHHhhHHHHH
Confidence 11 233333 1111 00 111 12479999999999999999888765
Q ss_pred CcHHHHHHHhhccCCC------------CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchhH
Q 013005 234 SNLLAMYKKVNRRDYQ------------FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQ 290 (451)
Q Consensus 234 ~~~~~~~~~i~~~~~~------------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 290 (451)
....+....+.+-... +--..+.....+..+|+-..|..||...++.+++-|....+
T Consensus 134 ~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~~ 202 (725)
T KOG1093|consen 134 LTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVYK 202 (725)
T ss_pred HHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHHh
Confidence 5444443333321110 01124666788999999999999999999999999987654
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.047 Score=55.96 Aligned_cols=79 Identities=18% Similarity=0.135 Sum_probs=52.4
Q ss_pred EcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhH---HHHHHHHHHHHHHHHhcC--CCCceEEEEEEEeCCEEE
Q 013005 32 LGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDA---AMEDRIVREVSAMRRLQN--HPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 32 ~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~~~Ei~il~~L~~--HpnIv~l~~~~~~~~~~~ 106 (451)
..+.||.|....||+..+ .+..++||.-....+.... ...++...|...|+.+.. ..++++++.+.. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 366789999999999986 3456899986532111111 123455566777766642 247788888766 4467
Q ss_pred EEEEecCC
Q 013005 107 LVMEYAAG 114 (451)
Q Consensus 107 lV~E~~~g 114 (451)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999977
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.075 Score=52.56 Aligned_cols=30 Identities=13% Similarity=0.201 Sum_probs=27.7
Q ss_pred CceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 149 GVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 149 giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
+++|+|+.+.|+|+++++.+.++||..++.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 699999999999999999999999998763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.057 Score=55.18 Aligned_cols=77 Identities=14% Similarity=0.104 Sum_probs=48.0
Q ss_pred EcceEcccCceEEEEEEEcCC-CcE-----EEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 32 LGPLLGRGSFAKVHKAKSIAD-GSI-----VAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 32 ~~~~LG~G~~g~Vy~a~~~~~-~~~-----vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
..+.|..|-...+|++..... +.. |.+++.... ....-.-.+|+.+++.|..+..-.++++.+..
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-----~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~---- 124 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-----NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD---- 124 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-----CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----
Confidence 344566699999999975332 122 444442111 11111235688899999766666678887753
Q ss_pred EEEEEecCCCch
Q 013005 106 YLVMEYAAGGEL 117 (451)
Q Consensus 106 ~lV~E~~~gg~L 117 (451)
+++.||++|..|
T Consensus 125 g~l~efIeGr~l 136 (383)
T PTZ00384 125 FTIQEWVEGNTM 136 (383)
T ss_pred EEEEEEeccccC
Confidence 589999998765
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.016 Score=53.81 Aligned_cols=30 Identities=33% Similarity=0.728 Sum_probs=21.6
Q ss_pred CceecCCCCCeEEe-CCCCCeEEEeccCCCc
Q 013005 149 GVAHRDVKPQNLLL-DRDGNLKVSDFGLSAL 178 (451)
Q Consensus 149 giiHrDLKpeNILl-d~~~~lkl~DFGls~~ 178 (451)
-++|.||.|.|||+ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8889999999999864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.038 Score=56.36 Aligned_cols=80 Identities=18% Similarity=0.157 Sum_probs=52.5
Q ss_pred cceEcccCceEEEEEEEcCCCcEEEEEEeecCcchh-h-HHHHHHHHHHHHHHHHhcCC-C-CceEEEEEEEeCCEEEEE
Q 013005 33 GPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFL-D-AAMEDRIVREVSAMRRLQNH-P-NVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~-~-~~~~~~~~~Ei~il~~L~~H-p-nIv~l~~~~~~~~~~~lV 108 (451)
.+.||.|.-.-||++.+...+..|+||.-...-+.. + .-..++...|..+|+.+... | +++++|.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 567899999999999974335789999754321110 1 12345677788888876432 3 46666654 45556789
Q ss_pred EEecCC
Q 013005 109 MEYAAG 114 (451)
Q Consensus 109 ~E~~~g 114 (451)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998864
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.037 Score=55.36 Aligned_cols=85 Identities=22% Similarity=0.355 Sum_probs=60.5
Q ss_pred CCCceEEEEEE-EeCCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCeEEeCCCC
Q 013005 89 HPNVLKIQEVM-ATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQN-GVAHRDVKPQNLLLDRDG 166 (451)
Q Consensus 89 HpnIv~l~~~~-~~~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~-giiHrDLKpeNILld~~~ 166 (451)
.++..+.+-+- .+....|++|++- |++|.. +. -...+++..++.+.+..++-+..+ ..-|||+...||||| +|
T Consensus 284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~-ik--~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G 358 (488)
T COG5072 284 SVFLETLKVVSLDETLYLYLHFKDH-GTPISI-IK--ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG 358 (488)
T ss_pred chhhhcceEEecCCceEEEEEEecC-Cceeee-ee--cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC
Confidence 44444444444 3334567777764 434422 21 234577888999988888777765 689999999999999 99
Q ss_pred CeEEEeccCCCc
Q 013005 167 NLKVSDFGLSAL 178 (451)
Q Consensus 167 ~lkl~DFGls~~ 178 (451)
++.|+||-++++
T Consensus 359 nvtLIDfklsRl 370 (488)
T COG5072 359 NVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEeeeeec
Confidence 999999999984
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.062 Score=52.72 Aligned_cols=75 Identities=17% Similarity=0.228 Sum_probs=48.9
Q ss_pred EcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhc--CCCCceEEEEEEEeCCEEEEEE
Q 013005 32 LGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ--NHPNVLKIQEVMATKTKIYLVM 109 (451)
Q Consensus 32 ~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~--~HpnIv~l~~~~~~~~~~~lV~ 109 (451)
-.+.++.|....+|+.. .+++.+.+|+-.... ...+..|..-|+.|. ..-.+++++.+....+..||+|
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~-------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG-------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG-------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecChhh-------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 35678889999999987 678889999876321 245777888888883 2445778899888877889999
Q ss_pred EecCCC
Q 013005 110 EYAAGG 115 (451)
Q Consensus 110 E~~~gg 115 (451)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 998876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.37 Score=48.10 Aligned_cols=72 Identities=14% Similarity=0.129 Sum_probs=43.1
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCC-CceEEE---E--EEEeCCEEEEEEEec
Q 013005 39 GSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP-NVLKIQ---E--VMATKTKIYLVMEYA 112 (451)
Q Consensus 39 G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~Hp-nIv~l~---~--~~~~~~~~~lV~E~~ 112 (451)
+.-..||+... .++..+++|+.+... . ....+..|+..+..|..+. .++... + +...++..+.+++++
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~-~----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~ 109 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPER-W----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRR 109 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCccc-C----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeee
Confidence 45567898863 567789999985431 1 2345667777777775321 122211 1 123356788899999
Q ss_pred CCCc
Q 013005 113 AGGE 116 (451)
Q Consensus 113 ~gg~ 116 (451)
+|..
T Consensus 110 ~G~~ 113 (325)
T PRK11768 110 GGRA 113 (325)
T ss_pred CCCC
Confidence 8854
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.28 E-value=0.19 Score=57.91 Aligned_cols=137 Identities=18% Similarity=0.274 Sum_probs=76.7
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCC-CC--ceEEEE--------EEEe-
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH-PN--VLKIQE--------VMAT- 101 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~H-pn--Iv~l~~--------~~~~- 101 (451)
+.|+ |..-.+|+... .+|..+++|+.+.... ...+..|...|..|..+ +. +.+++- ....
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~~------~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~ 102 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSEP------RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDP 102 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCccc------hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecC
Confidence 4564 45677888863 5677899999975421 12334455566655432 22 223221 1111
Q ss_pred CC--EEEEEEEecCCCchhHH-----------------hhc--CC---------CCH-----------------HHHHHH
Q 013005 102 KT--KIYLVMEYAAGGELFGK-----------------LRR--GR---------LTE-----------------SAARRY 134 (451)
Q Consensus 102 ~~--~~~lV~E~~~gg~L~~~-----------------l~~--~~---------l~e-----------------~~~~~~ 134 (451)
.+ ..+-+++|++|..+.+. ++. .. +.+ ...+.+
T Consensus 103 ~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~ 182 (1013)
T PRK06148 103 DGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRAL 182 (1013)
T ss_pred CCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHH
Confidence 22 56778999999766441 000 00 111 112223
Q ss_pred HHHHHHHHHH-----HH--HCCceecCCCCCeEEeCCCC--CeE-EEeccCCCc
Q 013005 135 FQQLVSALHF-----CH--QNGVAHRDVKPQNLLLDRDG--NLK-VSDFGLSAL 178 (451)
Q Consensus 135 ~~ql~~gL~y-----LH--~~giiHrDLKpeNILld~~~--~lk-l~DFGls~~ 178 (451)
+.++++...- +. .++++|+|+.+.|||++.++ .+. |+|||.+..
T Consensus 183 l~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 183 VERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3333333221 11 14799999999999999875 554 999998864
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.24 E-value=0.062 Score=54.58 Aligned_cols=61 Identities=21% Similarity=0.278 Sum_probs=45.7
Q ss_pred EEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHH-HHHCCceecCCCCCeEEeCCC
Q 013005 105 IYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHF-CHQNGVAHRDVKPQNLLLDRD 165 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~y-LH~~giiHrDLKpeNILld~~ 165 (451)
..++-+|..|.++..++.....+|...++++.-..+|+-- +--.+++|.|+.|.||++-.+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhcccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 4566778889899888887667776777776666666543 345689999999999999543
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.42 E-value=0.098 Score=49.00 Aligned_cols=84 Identities=19% Similarity=0.295 Sum_probs=57.6
Q ss_pred HHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC--Ccee
Q 013005 75 RIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQN--GVAH 152 (451)
Q Consensus 75 ~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~--giiH 152 (451)
.++.+..++.++ | .|+++..- +.-.+-+++|+|..... ... .++.-=+..|.-.|+. +..|
T Consensus 104 ~y~nky~v~Arm--h-GilrL~ND--n~~~yGvIlE~Cy~~~i-----------~~~-N~i~agi~~L~~fH~~~~~~lH 166 (308)
T PF07387_consen 104 LYFNKYRVFARM--H-GILRLKND--NNYKYGVILERCYKIKI-----------NFS-NFITAGIKDLMDFHSENQHCLH 166 (308)
T ss_pred hhhhhhhHHHHh--h-heeEeecC--CCceeEEEEeeccCccc-----------chh-HHHHHhHHHHHHhhccCCCeec
Confidence 457778888887 3 78888732 44456799999954211 001 1111114556677843 6999
Q ss_pred cCCCCCeEEeCCCCCeEEEeccC
Q 013005 153 RDVKPQNLLLDRDGNLKVSDFGL 175 (451)
Q Consensus 153 rDLKpeNILld~~~~lkl~DFGl 175 (451)
+|-.|+||+-|..|.+||.|=+.
T Consensus 167 GD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 167 GDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred CCCChhheeecCCCCEEecChhh
Confidence 99999999999999999999664
|
The function of this family is unknown. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 451 | ||||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-58 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-58 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-58 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-58 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-57 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-56 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-56 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-56 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-56 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-56 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-56 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-56 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-55 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-55 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-54 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-53 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-53 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-53 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-51 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-48 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-48 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-47 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-47 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-47 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-47 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-47 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-44 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-43 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-43 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-43 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-43 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-43 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-42 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-41 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-41 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-41 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-41 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-41 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-41 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-41 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-41 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-41 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-41 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-41 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-41 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-41 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-41 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-41 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-41 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-40 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-40 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-40 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-40 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-40 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-40 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-40 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-40 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-40 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-40 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-40 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-40 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-40 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-40 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-40 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-40 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-40 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-40 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-40 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-40 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-39 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-39 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-39 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-39 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-39 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-39 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-39 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-39 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-39 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-39 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-39 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-39 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-39 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-39 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-39 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-39 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-39 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-39 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-39 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-39 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-38 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-38 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-38 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-38 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-38 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-38 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-38 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-38 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-38 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-38 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-38 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-37 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-37 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-37 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-37 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-37 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-37 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-37 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-37 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-37 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-37 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-37 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-37 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-36 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-36 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-36 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-36 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-36 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-36 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-36 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-36 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-36 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-36 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-36 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-36 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-36 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-36 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-36 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-36 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-36 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-36 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-36 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-36 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-36 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-36 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-36 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-36 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-36 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-36 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-36 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-36 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-36 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-36 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-36 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-36 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-36 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-36 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-36 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-36 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-36 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-36 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-36 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-36 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-36 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-36 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-36 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-36 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-36 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-36 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-36 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-36 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-36 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-36 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-36 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-36 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-36 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-36 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-36 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-36 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-36 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-36 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-36 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-36 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-36 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-35 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-35 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-35 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-35 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-35 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-35 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-35 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-35 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-35 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-35 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-35 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-35 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-35 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-35 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-35 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-35 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-35 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-35 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-35 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-34 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-34 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-34 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-34 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-34 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-34 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-34 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-34 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-34 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-34 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-34 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-34 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-34 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-34 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-33 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-33 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-33 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-33 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-33 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-33 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-33 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-33 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-33 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-33 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-33 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-33 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-33 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-33 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-33 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-33 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-33 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-33 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-33 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-33 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-33 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-33 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-33 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-33 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-33 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-33 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-33 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-33 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-33 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-33 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-33 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-33 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-33 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-33 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-33 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-32 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-32 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-32 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-32 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-32 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-32 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-31 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-31 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-31 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-31 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-31 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-31 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-31 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-31 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-31 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-31 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-31 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-30 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-30 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-30 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-30 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-30 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-30 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-30 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-30 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-30 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-30 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-30 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-30 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-30 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-30 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-30 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-30 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-30 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-30 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-30 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-30 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-30 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-30 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-30 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-30 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-30 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-29 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-29 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-29 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-29 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-29 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-29 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-29 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-29 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-29 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-29 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-29 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-29 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-29 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-29 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-29 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-29 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-29 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-29 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-29 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-29 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-29 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-29 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-29 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-29 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-29 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-29 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 9e-29 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 9e-29 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-28 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-28 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-28 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-28 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-28 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-28 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-28 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-28 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-28 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-28 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-28 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-28 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-28 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-27 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-27 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-27 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-27 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-27 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-27 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-26 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-26 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-26 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-26 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-26 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-26 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-26 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-26 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-26 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-25 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-25 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-25 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-25 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-25 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-25 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-24 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-24 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-24 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-24 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-24 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-24 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-24 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-24 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-24 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-24 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-24 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-24 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-24 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-24 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-24 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-24 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-24 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-24 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-24 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-24 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-24 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-24 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-24 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-24 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-24 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-24 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-24 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-24 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-24 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-24 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-24 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-24 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-24 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-23 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-23 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-23 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-23 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-23 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-23 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-23 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-23 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-23 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-22 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-22 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-22 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-22 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-22 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-22 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-22 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-22 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-22 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-22 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 8e-22 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-21 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-21 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-21 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-21 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-21 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-21 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-20 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-20 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-20 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-20 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-20 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-20 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-20 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-20 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-20 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-20 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-20 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-20 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-20 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-20 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-19 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-19 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-19 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-19 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-19 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-19 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-19 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-19 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-19 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-19 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-19 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-19 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-19 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-19 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-19 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-19 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-19 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-19 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 9e-19 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-18 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-18 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-18 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-18 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-18 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-18 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-18 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-18 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-18 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-18 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-18 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-18 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-18 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-17 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-17 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-17 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-17 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-17 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-17 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-17 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-17 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-17 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-17 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-17 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-17 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-17 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-17 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-17 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-17 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-17 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-17 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-17 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-17 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-17 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-17 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-17 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-17 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-17 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-17 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-17 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-17 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-17 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-17 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-17 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-17 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-17 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-17 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-16 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-16 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-16 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-16 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-16 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-16 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-16 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-16 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-16 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-16 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-16 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-16 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-16 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-16 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-16 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-16 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-16 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-16 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-16 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-16 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-16 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-16 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-16 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-16 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-16 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-16 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-16 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-16 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-16 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-16 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-16 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-16 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-16 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-16 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-16 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-16 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-16 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-16 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-16 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-16 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-16 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-16 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-16 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-16 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-16 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-16 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-15 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-15 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-15 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-15 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-15 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-15 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-15 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-15 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-15 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-15 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-15 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-15 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-15 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-15 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-15 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-15 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-15 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-15 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-15 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-15 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-15 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-15 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-15 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-15 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-15 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-15 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-15 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-15 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-15 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-15 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-15 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-15 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-15 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-15 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-15 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-15 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-15 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-15 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-15 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-15 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-15 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-15 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-15 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-15 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-15 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-15 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-15 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-15 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-15 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-15 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-15 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-15 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-15 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-15 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-15 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-15 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-15 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-15 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-15 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-15 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-15 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-15 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-15 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-14 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-14 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-14 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-14 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-14 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-14 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-14 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-14 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-14 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-14 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-14 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-14 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-14 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-14 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-14 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-13 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-13 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-13 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-13 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-13 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-13 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-13 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-13 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-13 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-13 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-13 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-13 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-13 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-13 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-13 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-13 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-13 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-13 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-13 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-12 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-12 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-12 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 7e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-11 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-11 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-11 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 8e-11 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-11 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 9e-11 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 9e-11 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 9e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-11 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 9e-11 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 9e-11 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 9e-11 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 9e-11 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-10 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-10 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-10 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-10 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-10 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-10 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-10 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-10 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-10 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-10 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-10 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-10 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-10 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-10 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-10 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-09 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-09 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-09 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-09 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-09 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 5e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-09 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 9e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-07 |
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 408 bits (1051), Expect = e-143
Identities = 103/272 (37%), Positives = 162/272 (59%), Gaps = 5/272 (1%)
Query: 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVR 78
+ Y LG LG G+F KV + G VA+K + + K + +I R
Sbjct: 2 SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQ-KIRSLDVVGKIKR 60
Query: 79 EVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQ 137
E+ ++ HP+++K+ +V++T T ++VMEY +GGELF + + GR+ E ARR FQQ
Sbjct: 61 EIQNLKLF-RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQ 119
Query: 138 LVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYT 197
++SA+ +CH++ V HRD+KP+N+LLD N K++DFGLS + L T+CG+P Y
Sbjct: 120 ILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRTSCGSPNYA 177
Query: 198 APEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKP 257
APEV++ R Y G D WSCGVIL+ LL G LPFDD ++ ++KK+ + P ++++
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRS 237
Query: 258 ARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289
+L+ +L +P R +I+ I WF++ L
Sbjct: 238 VATLLMHMLQVDPLKRATIKDIREHEWFKQDL 269
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 408 bits (1050), Expect = e-141
Identities = 113/360 (31%), Positives = 175/360 (48%), Gaps = 27/360 (7%)
Query: 12 PPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAA 71
P P I +RY +G G+F + +VA+K IE+
Sbjct: 4 APVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----- 58
Query: 72 MEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESA 130
+++ + RE+ R L HPN+++ +EV+ T T + ++MEYA+GGEL+ ++ GR +E
Sbjct: 59 IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDE 117
Query: 131 ARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD--GNLKVSDFGLSALPEQIKNGMLH 188
AR +FQQL+S + +CH + HRD+K +N LLD LK+ DFG S +
Sbjct: 118 ARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--HSQPK 175
Query: 189 TACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR-- 246
+ GTPAY APEV+ R+ YDG +AD WSCGV L+V+L G PF+D Y+K +R
Sbjct: 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRIL 235
Query: 247 --DYQFPS--FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL-------QQQRKR 295
Y P +S LI ++ +P TR+SI +I + SWF K+L +
Sbjct: 236 SVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQ 295
Query: 296 GQESSLFELGVVGNNKYILKEKIPDIVSMNAFDIISLSSGLDLSGLFEAKKRKEK-RFTT 354
QE + + I + IP + N ++ LDL + + + +
Sbjct: 296 FQEPEQPMQSLDTIMQIISEATIPAV--RNRCLDDFMTDNLDLDDDMDDFDSESEIDIDS 353
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 403 bits (1038), Expect = e-141
Identities = 88/275 (32%), Positives = 143/275 (52%), Gaps = 9/275 (3%)
Query: 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR 85
+ + L LG G++ +V A + VA+K ++ + I +E+ +
Sbjct: 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKM 61
Query: 86 LQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLVSALHF 144
L NH NV+K YL +EY +GGELF ++ + E A+R+F QL++ + +
Sbjct: 62 L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 145 CHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI-KNGMLHTACGTPAYTAPEVVA 203
H G+ HRD+KP+NLLLD NLK+SDFGL+ + + +L+ CGT Y APE++
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 204 RRGYDGAVADAWSCGVILFVLLAGYLPFDD-SNLLAMYKKVNRRDYQFPSF--VSKPARS 260
RR + D WSCG++L +LAG LP+D S+ Y + + + +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 261 LIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKR 295
L++++L NP R++I I W+ K L++ KR
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 275
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 404 bits (1040), Expect = e-141
Identities = 84/270 (31%), Positives = 133/270 (49%), Gaps = 7/270 (2%)
Query: 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR 85
L+ +Y +G LLG GS+ KV + A+K ++K E + +E+ +RR
Sbjct: 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 86 LQNHPNVLKIQEVM--ATKTKIYLVMEYAAGG--ELFGKLRRGRLTESAARRYFQQLVSA 141
L H NV+++ +V+ K K+Y+VMEY G E+ + R A YF QL+
Sbjct: 63 L-RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDG 121
Query: 142 LHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK-NGMLHTACGTPAYTAPE 200
L + H G+ H+D+KP NLLL G LK+S G++ + T+ G+PA+ PE
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 201 VVA-RRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPAR 259
+ + G D WS GV L+ + G PF+ N+ +++ + + Y P P
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241
Query: 260 SLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289
L+ +L+ P R SI +I SWF+K
Sbjct: 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 404 bits (1040), Expect = e-140
Identities = 90/283 (31%), Positives = 138/283 (48%), Gaps = 5/283 (1%)
Query: 6 SPPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNN 65
P+A PP P P RY G LG+G FAK + + A K + K+
Sbjct: 19 GAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKS- 77
Query: 66 KFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRG 124
L +++ E+S R L H +V+ +++V+E L RR
Sbjct: 78 LLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK 136
Query: 125 RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184
LTE AR Y +Q+V + H+N V HRD+K NL L+ D +K+ DFGL+ E
Sbjct: 137 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-DG 195
Query: 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVN 244
CGTP Y APEV++++G+ V D WS G I++ LL G PF+ S L Y ++
Sbjct: 196 ERKKVLCGTPNYIAPEVLSKKGHSFEV-DVWSIGCIMYTLLVGKPPFETSCLKETYLRIK 254
Query: 245 RRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287
+ +Y P ++ A SLI ++L +P R +I ++++ +F
Sbjct: 255 KNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 402 bits (1036), Expect = e-140
Identities = 94/319 (29%), Positives = 155/319 (48%), Gaps = 13/319 (4%)
Query: 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR 85
+ + L LG G++ +V A + VA+K ++ + I +E+ +
Sbjct: 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKM 61
Query: 86 LQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLVSALHF 144
L NH NV+K YL +EY +GGELF ++ + E A+R+F QL++ + +
Sbjct: 62 L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 145 CHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI-KNGMLHTACGTPAYTAPEVVA 203
H G+ HRD+KP+NLLLD NLK+SDFGL+ + + +L+ CGT Y APE++
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 204 RRGYDGAVADAWSCGVILFVLLAGYLPFDD-SNLLAMYKKVNRRDYQFPSF--VSKPARS 260
RR + D WSCG++L +LAG LP+D S+ Y + + + +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 261 LIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSLFELGVVGNNKYILKEKIPD 320
L++++L NP R++I I W+ K L K+G + G V + + I
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPL----KKGAKRPRVTSGGVSESPSGFSKHIQS 296
Query: 321 IVSMNAFDIISLSSGLDLS 339
+ + + S + G S
Sbjct: 297 NLDFSPVNSASRTPGSGWS 315
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 398 bits (1026), Expect = e-139
Identities = 86/274 (31%), Positives = 133/274 (48%), Gaps = 5/274 (1%)
Query: 15 PPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMED 74
P P RY G LG+G FAK + + A K + K+ L +
Sbjct: 2 KEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKS-LLLKPHQRE 60
Query: 75 RIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARR 133
++ E+S R L H +V+ +++V+E L RR LTE AR
Sbjct: 61 KMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY 119
Query: 134 YFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGT 193
Y +Q+V + H+N V HRD+K NL L+ D +K+ DFGL+ E CGT
Sbjct: 120 YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKVLCGT 178
Query: 194 PAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSF 253
P Y APEV++++G+ V D WS G I++ LL G PF+ S L Y ++ + +Y P
Sbjct: 179 PNYIAPEVLSKKGHSFEV-DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 237
Query: 254 VSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287
++ A SLI ++L +P R +I ++++ +F
Sbjct: 238 INPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 402 bits (1034), Expect = e-137
Identities = 104/277 (37%), Positives = 161/277 (58%), Gaps = 5/277 (1%)
Query: 14 PPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAME 73
P + Y LG LG G+F KV K G VA+K + + K +
Sbjct: 2 PMAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQ-KIRSLDVV 60
Query: 74 DRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAAR 132
+I RE+ ++ HP+++K+ +V++T + I++VMEY +GGELF + + GRL E +R
Sbjct: 61 GKIRREIQNLKLF-RHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESR 119
Query: 133 RYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACG 192
R FQQ++S + +CH++ V HRD+KP+N+LLD N K++DFGLS + L T+CG
Sbjct: 120 RLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRTSCG 177
Query: 193 TPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS 252
+P Y APEV++ R Y G D WS GVIL+ LL G LPFDD ++ ++KK+ + P
Sbjct: 178 SPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQ 237
Query: 253 FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289
+++ SL+ +L +P R +I+ I WF++ L
Sbjct: 238 YLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDL 274
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 394 bits (1015), Expect = e-137
Identities = 95/277 (34%), Positives = 151/277 (54%), Gaps = 6/277 (2%)
Query: 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVRE 79
+ I + +++G LLG+GSFA V++A+SI G VAIK I+K A M R+ E
Sbjct: 3 ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKK-AMYKAGMVQRVQNE 61
Query: 80 VSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL--RRGRLTESAARRYFQQ 137
V +L HP++L++ +YLV+E GE+ L R +E+ AR + Q
Sbjct: 62 VKIHCQL-KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ 120
Query: 138 LVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYT 197
+++ + + H +G+ HRD+ NLLL R+ N+K++DFGL+ + + +T CGTP Y
Sbjct: 121 IITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM-PHEKHYTLCGTPNYI 179
Query: 198 APEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKP 257
+PE+ R + D WS G + + LL G PFD + KV DY+ PSF+S
Sbjct: 180 SPEIATRSAHGLES-DVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIE 238
Query: 258 ARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRK 294
A+ LI+QLL NP R+S+ ++ + ++ + K
Sbjct: 239 AKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSK 275
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 392 bits (1008), Expect = e-135
Identities = 108/270 (40%), Positives = 165/270 (61%), Gaps = 6/270 (2%)
Query: 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREV 80
+ Y + LG GSF KV A VA+K I + + M R+ RE+
Sbjct: 2 AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQ-LLKKSDMHMRVEREI 60
Query: 81 SAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLV 139
S ++ L HP+++K+ +V+ T T I +V+EYA GGELF + + R+TE RR+FQQ++
Sbjct: 61 SYLKLL-RHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQII 118
Query: 140 SALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAP 199
A+ +CH++ + HRD+KP+NLLLD + N+K++DFGLS + L T+CG+P Y AP
Sbjct: 119 CAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD--GNFLKTSCGSPNYAAP 176
Query: 200 EVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPAR 259
EV+ + Y G D WSCG++L+V+L G LPFDD + ++KKVN Y P F+S A+
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQ 236
Query: 260 SLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289
SLI +++ +P R++I++I WF +L
Sbjct: 237 SLIRRMIVADPMQRITIQEIRRDPWFNVNL 266
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 388 bits (998), Expect = e-134
Identities = 85/275 (30%), Positives = 152/275 (55%), Gaps = 7/275 (2%)
Query: 18 PPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIV 77
K ++ + +G LG+G F V+ A+ + I+A+K + K+ + +E ++
Sbjct: 4 AEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKS-QLEKEGVEHQLR 62
Query: 78 REVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQ 136
RE+ L HPN+L++ + +IYL++E+A GEL+ +L++ GR E + + +
Sbjct: 63 REIEIQSHL-RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME 121
Query: 137 QLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAY 196
+L ALH+CH+ V HRD+KP+NLL+ G LK++DFG S ++ T CGT Y
Sbjct: 122 ELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---RRTMCGTLDY 178
Query: 197 TAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSK 256
PE++ + +D V D W GV+ + L G PFD + ++++ D +FP F+S
Sbjct: 179 LPPEMIEGKTHDEKV-DLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSD 237
Query: 257 PARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQ 291
++ LI +LL +P R+ ++ +M W + + ++
Sbjct: 238 GSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 385 bits (992), Expect = e-133
Identities = 82/296 (27%), Positives = 149/296 (50%), Gaps = 30/296 (10%)
Query: 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEK---------------- 63
S LN+Y L +G+GS+ V A + D + A+K + K
Sbjct: 5 SSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPR 64
Query: 64 ------NNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM--ATKTKIYLVMEYAAGG 115
+++ +E++ +++L +HPNV+K+ EV+ + +Y+V E G
Sbjct: 65 GTRPAPGGCIQPRGPIEQVYQEIAILKKL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQG 123
Query: 116 ELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGL 175
+ L+E AR YFQ L+ + + H + HRD+KP NLL+ DG++K++DFG+
Sbjct: 124 PVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 176 SALPEQIKNGMLHTACGTPAYTAPEVVA--RRGYDGAVADAWSCGVILFVLLAGYLPFDD 233
S + + +L GTPA+ APE ++ R+ + G D W+ GV L+ + G PF D
Sbjct: 184 SNEFKG-SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242
Query: 234 SNLLAMYKKVNRRDYQFPSF--VSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287
++ ++ K+ + +FP +++ + LI ++LD NP++R+ + +I W +
Sbjct: 243 ERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 383 bits (986), Expect = e-133
Identities = 93/282 (32%), Positives = 149/282 (52%), Gaps = 7/282 (2%)
Query: 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVRE 79
SKK L +++G LG+G F V+ A+ I+A+K + K + A +E ++ RE
Sbjct: 1 SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRRE 59
Query: 80 VSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQL 138
V L HPN+L++ T++YL++EYA G ++ +L++ + E Y +L
Sbjct: 60 VEIQSHL-RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 118
Query: 139 VSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTA 198
+AL +CH V HRD+KP+NLLL G LK++DFG S + CGT Y
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLP 175
Query: 199 PEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPA 258
PE++ R +D V D WS GV+ + L G PF+ + YK+++R ++ FP FV++ A
Sbjct: 176 PEMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 234
Query: 259 RSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESS 300
R LI +LL NP R + +++ W + + + S
Sbjct: 235 RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKES 276
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 381 bits (980), Expect = e-131
Identities = 93/299 (31%), Positives = 148/299 (49%), Gaps = 17/299 (5%)
Query: 1 MEPGCSPPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKT 60
+P PP+ P P PPP K Y+LGPLLG+G F V + D VAIK
Sbjct: 4 TKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKV 63
Query: 61 IEKN--NKFLDAAMEDRIVREVSAMRRL---QNHPNVLKIQEVMATKTKIYLVMEYAA-G 114
I +N + + EV+ + ++ HP V+++ + T+ LV+E
Sbjct: 64 IPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPA 123
Query: 115 GELFGKL-RRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD-GNLKVSD 172
+LF + +G L E +R +F Q+V+A+ CH GV HRD+K +N+L+D G K+ D
Sbjct: 124 QDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLID 183
Query: 173 FGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFD 232
FG AL + + GT Y+ PE ++R Y A WS G++L+ ++ G +PF+
Sbjct: 184 FGSGAL---LHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240
Query: 233 DSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQ 291
+++ + FP+ VS +LI + L P P +R S+E+I+ W Q +
Sbjct: 241 R------DQEILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAED 293
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 373 bits (959), Expect = e-128
Identities = 112/279 (40%), Positives = 162/279 (58%), Gaps = 6/279 (2%)
Query: 16 PPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDR 75
+ Y+L +G+G+FAKV A+ I G VAIK I+K L+ +
Sbjct: 3 SIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ--LNPTSLQK 60
Query: 76 IVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRY 134
+ REV M+ L NHPN++K+ EV+ T+ +YL+MEYA+GGE+F L GR+ E AR
Sbjct: 61 LFREVRIMKIL-NHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK 119
Query: 135 FQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP 194
F+Q+VSA+ +CHQ + HRD+K +NLLLD D N+K++DFG S G L CG P
Sbjct: 120 FRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV--GGKLDAFCGAP 177
Query: 195 AYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFV 254
Y APE+ + YDG D WS GVIL+ L++G LPFD NL + ++V R Y+ P ++
Sbjct: 178 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYM 237
Query: 255 SKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQR 293
S +L+ + L NP R ++E+IM W ++
Sbjct: 238 STDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDE 276
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 370 bits (952), Expect = e-127
Identities = 87/290 (30%), Positives = 141/290 (48%), Gaps = 15/290 (5%)
Query: 6 SPPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKN- 64
P P K+ L ++YQ+GPLLG G F V+ ++D VAIK +EK+
Sbjct: 21 MAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDR 80
Query: 65 -NKFLDAAMEDRIVREVSAMRRLQN-HPNVLKIQEVMATKTKIYLVMEYAAG-GELFGKL 121
+ + + R+ EV ++++ + V+++ + L++E +LF +
Sbjct: 81 ISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI 140
Query: 122 -RRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD-GNLKVSDFGLSALP 179
RG L E AR +F Q++ A+ CH GV HRD+K +N+L+D + G LK+ DFG AL
Sbjct: 141 TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200
Query: 180 EQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAM 239
K+ + GT Y+ PE + Y G A WS G++L+ ++ G +PF+
Sbjct: 201 ---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----- 252
Query: 240 YKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289
+++ R F VS + LI L P R + E+I + W Q L
Sbjct: 253 -EEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 363 bits (934), Expect = e-124
Identities = 82/299 (27%), Positives = 137/299 (45%), Gaps = 18/299 (6%)
Query: 9 SAPPPPPPPPPSKKIPT---LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKN- 64
+ PP +Y LG G+F V A V +K I+K
Sbjct: 2 ALEEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEK 61
Query: 65 ---NKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAA-GGELFGK 120
+ +++ ++ E++ + R+ H N++K+ ++ + LVME G +LF
Sbjct: 62 VLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAF 120
Query: 121 L-RRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALP 179
+ R RL E A F+QLVSA+ + + HRD+K +N+++ D +K+ DFG +A
Sbjct: 121 IDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180
Query: 180 EQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAM 239
E+ + +T CGT Y APEV+ Y G + WS GV L+ L+ PF +
Sbjct: 181 ER--GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------ 232
Query: 240 YKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQE 298
++ P VSK SL+ LL P P+ R ++EK+++ W + + +E
Sbjct: 233 LEETVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEE 291
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 345 bits (887), Expect = e-117
Identities = 65/331 (19%), Positives = 129/331 (38%), Gaps = 52/331 (15%)
Query: 1 MEPGCSPPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKT 60
M+ S S K +N Y++ L +G F K+ + D A+K
Sbjct: 6 MKDILSNYSNLIYLNKYVKEKDK--YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKK 61
Query: 61 IEK-------------NNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107
EK N+K + D E+ + + + L + ++ ++Y+
Sbjct: 62 YEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEYCLTCEGIITNYDEVYI 120
Query: 108 VMEYAAGGELFGKLRR---------GRLTESAARRYFQQLVSALHFCH-QNGVAHRDVKP 157
+ EY + + + + ++++ + H + + HRDVKP
Sbjct: 121 IYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKP 180
Query: 158 QNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRG-YDGAVADAWS 216
N+L+D++G +K+SDFG S + + + + GT + PE + Y+GA D WS
Sbjct: 181 SNILMDKNGRVKLSDFGESE---YMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWS 237
Query: 217 CGVILFVLLAGYLPFDD-SNLLAMYKKVNRRDYQFP-------------------SFVSK 256
G+ L+V+ +PF +L+ ++ + ++ ++P +F+S
Sbjct: 238 LGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSN 297
Query: 257 PARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287
+ L NP R++ E + W
Sbjct: 298 EDIDFLKLFLRKNPAERITSEDALKHEWLAD 328
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 305 bits (782), Expect = e-101
Identities = 73/298 (24%), Positives = 126/298 (42%), Gaps = 40/298 (13%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
+ ++ +LG+G+F +V KA++ D AIK I + I+ EV + L
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-----KLSTILSEVMLLASL 59
Query: 87 QNHPNVLKIQEV-------------MATKTKIYLVMEYAAGGELFGKLRRGRLT--ESAA 131
NH V++ + K+ +++ MEY G L+ + L
Sbjct: 60 -NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118
Query: 132 RRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ---------- 181
R F+Q++ AL + H G+ HRD+KP N+ +D N+K+ DFGL+ +
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 182 ---IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLA 238
+ L +A GT Y A EV+ G+ D +S G+I F ++ Y +
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVN 236
Query: 239 MYKKVNRRDYQFPSF----VSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQ 292
+ KK+ +FP K + +I L+D +P R +++ W Q +
Sbjct: 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDE 294
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = e-101
Identities = 87/294 (29%), Positives = 147/294 (50%), Gaps = 21/294 (7%)
Query: 18 PPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAA-----M 72
P S Y+ +LGRG + V + A+K I+ +A +
Sbjct: 7 PGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQEL 66
Query: 73 EDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAA 131
+ ++EV +R++ HPN++++++ T T +LV + GELF L + L+E
Sbjct: 67 REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET 126
Query: 132 RRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG-MLHTA 190
R+ + L+ + H+ + HRD+KP+N+LLD D N+K++DFG S Q+ G L
Sbjct: 127 RKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREV 183
Query: 191 CGTPAYTAPEVVA------RRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVN 244
CGTP+Y APE++ GY V D WS GVI++ LLAG PF + M + +
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEV-DMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 242
Query: 245 RRDYQFPS----FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRK 294
+YQF S S + L+ + L P+ R + E+ ++ +FQ+ + ++ +
Sbjct: 243 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR 296
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 303 bits (778), Expect = e-100
Identities = 88/302 (29%), Positives = 143/302 (47%), Gaps = 20/302 (6%)
Query: 2 EPGCSPPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTI 61
+ P P +Y ++GRG + V + A G A+K +
Sbjct: 68 GTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIM 127
Query: 62 EKNNKFLDA----AMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGEL 117
E + L + + RE +R++ HP+++ + + + + ++LV + GEL
Sbjct: 128 EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL 187
Query: 118 FGKL-RRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176
F L + L+E R + L+ A+ F H N + HRD+KP+N+LLD + +++SDFG S
Sbjct: 188 FDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFS 247
Query: 177 ALPEQIKNG-MLHTACGTPAYTAPEV------VARRGYDGAVADAWSCGVILFVLLAGYL 229
++ G L CGTP Y APE+ GY V D W+CGVILF LLAG
Sbjct: 248 C---HLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEV-DLWACGVILFTLLAGSP 303
Query: 230 PFDDSNLLAMYKKVNRRDYQFPS----FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285
PF + M + + YQF S S + LI +LL +P+ R++ E+ + +F
Sbjct: 304 PFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363
Query: 286 QK 287
++
Sbjct: 364 ER 365
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = 2e-99
Identities = 66/309 (21%), Positives = 132/309 (42%), Gaps = 21/309 (6%)
Query: 8 PSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKF 67
S + + Y + +G G +KV + + I AIK +
Sbjct: 8 SSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-- 64
Query: 68 LDAAMEDRIVREVSAMRRLQ-NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR-RGR 125
D D E++ + +LQ + ++++ + T IY+VME +L L+ +
Sbjct: 65 ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS 123
Query: 126 LTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS-ALPEQIKN 184
+ + Y++ ++ A+H HQ+G+ H D+KP N L+ DG LK+ DFG++ + +
Sbjct: 124 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 182
Query: 185 GMLHTACGTPAYTAPEVVARRGYD----------GAVADAWSCGVILFVLLAGYLPFDD- 233
+ + GT Y PE + +D WS G IL+ + G PF
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242
Query: 234 -SNLLAMYKKVNRR-DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQ 291
+ + ++ ++ + +FP K + ++ L +PK R+SI ++++ + Q
Sbjct: 243 INQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302
Query: 292 QRKRGQESS 300
+ + ++
Sbjct: 303 VNQMAKGTT 311
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = 2e-98
Identities = 95/286 (33%), Positives = 149/286 (52%), Gaps = 21/286 (7%)
Query: 18 PPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKN----NKFLDAAME 73
S L + Y + LG G+ +V A VAI+ I K +A
Sbjct: 125 DQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPA 184
Query: 74 DRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAAR 132
+ E+ +++L NHP ++KI+ + Y+V+E GGELF K+ RL E+ +
Sbjct: 185 LNVETEIEILKKL-NHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCK 242
Query: 133 RYFQQLVSALHFCHQNGVAHRDVKPQNLLL---DRDGNLKVSDFGLSALPEQIKNGMLHT 189
YF Q++ A+ + H+NG+ HRD+KP+N+LL + D +K++DFG S + + ++ T
Sbjct: 243 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRT 300
Query: 190 ACGTPAYTAPEVVA---RRGYDGAVADAWSCGVILFVLLAGYLPF-DDSNLLAMYKKVNR 245
CGTP Y APEV+ GY+ AV D WS GVILF+ L+GY PF + +++ ++
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAV-DCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 359
Query: 246 RDYQFPS----FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287
Y F VS+ A L+ +LL +PK R + E+ + W Q
Sbjct: 360 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = 1e-97
Identities = 96/284 (33%), Positives = 149/284 (52%), Gaps = 21/284 (7%)
Query: 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKN----NKFLDAAMEDR 75
S L + Y + LG G+ +V A VAIK I K +A
Sbjct: 2 SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN 61
Query: 76 IVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRY 134
+ E+ +++L NHP ++KI+ + Y+V+E GGELF K+ RL E+ + Y
Sbjct: 62 VETEIEILKKL-NHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLY 119
Query: 135 FQQLVSALHFCHQNGVAHRDVKPQNLLL---DRDGNLKVSDFGLSALPEQIKNGMLHTAC 191
F Q++ A+ + H+NG+ HRD+KP+N+LL + D +K++DFG S + + ++ T C
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLC 177
Query: 192 GTPAYTAPEVVA---RRGYDGAVADAWSCGVILFVLLAGYLPF-DDSNLLAMYKKVNRRD 247
GTP Y APEV+ GY+ AV D WS GVILF+ L+GY PF + +++ ++
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAV-DCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236
Query: 248 YQFPS----FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287
Y F VS+ A L+ +LL +PK R + E+ + W Q
Sbjct: 237 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 293 bits (753), Expect = 1e-97
Identities = 91/288 (31%), Positives = 154/288 (53%), Gaps = 16/288 (5%)
Query: 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR 85
+ Y + LG+G+F+ V + G A K I K L A ++ RE R+
Sbjct: 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT--KKLSARDFQKLEREARICRK 61
Query: 86 LQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLVSALHF 144
LQ HPN++++ + + ++ YLV + GGELF + R +E+ A QQ++ ++ +
Sbjct: 62 LQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 145 CHQNGVAHRDVKPQNLLL---DRDGNLKVSDFGLSALPEQIKNG-MLHTACGTPAYTAPE 200
CH NG+ HR++KP+NLLL + +K++DFGL+ ++ + H GTP Y +PE
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPE 177
Query: 201 VVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS----FVSK 256
V+ + Y V D W+CGVIL++LL GY PF D + +Y ++ Y +PS V+
Sbjct: 178 VLKKDPYSKPV-DIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 236
Query: 257 PARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSLFEL 304
A+SLI +L NPK R++ ++ + + W + ++ ++ L
Sbjct: 237 EAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCL 284
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 294 bits (754), Expect = 1e-97
Identities = 95/276 (34%), Positives = 159/276 (57%), Gaps = 17/276 (6%)
Query: 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVRE 79
S + + + +LG G+F++V K G + A+K I+K+ + + E
Sbjct: 1 SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA----FRDSSLENE 56
Query: 80 VSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGK-LRRGRLTESAARRYFQQL 138
++ ++++ H N++ ++++ + T YLVM+ +GGELF + L RG TE A QQ+
Sbjct: 57 IAVLKKI-KHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQV 115
Query: 139 VSALHFCHQNGVAHRDVKPQNLLL---DRDGNLKVSDFGLSALPEQIKNGMLHTACGTPA 195
+SA+ + H+NG+ HRD+KP+NLL + + + ++DFGLS + +NG++ TACGTP
Sbjct: 116 LSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTACGTPG 172
Query: 196 YTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS--- 252
Y APEV+A++ Y AV D WS GVI ++LL GY PF + +++K+ Y+F S
Sbjct: 173 YVAPEVLAQKPYSKAV-DCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFW 231
Query: 253 -FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287
+S+ A+ I LL+ +P R + EK +S W
Sbjct: 232 DDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 293 bits (752), Expect = 2e-96
Identities = 91/311 (29%), Positives = 154/311 (49%), Gaps = 16/311 (5%)
Query: 3 PGCSPPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIE 62
+ Y + LG+G+F+ V + G A K I
Sbjct: 4 MASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN 63
Query: 63 KNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL- 121
K L A ++ RE R+LQ HPN++++ + + ++ YLV + GGELF +
Sbjct: 64 T--KKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 122 RRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL---DRDGNLKVSDFGLSAL 178
R +E+ A QQ++ ++ +CH NG+ HR++KP+NLLL + +K++DFGL+
Sbjct: 121 AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI- 179
Query: 179 PEQIKNG-MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL 237
++ + H GTP Y +PEV+ + Y V D W+CGVIL++LL GY PF D +
Sbjct: 180 --EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPV-DIWACGVILYILLVGYPPFWDEDQH 236
Query: 238 AMYKKVNRRDYQFPS----FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQR 293
+Y ++ Y +PS V+ A+SLI +L NPK R++ ++ + + W +
Sbjct: 237 RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVAS 296
Query: 294 KRGQESSLFEL 304
++ ++ L
Sbjct: 297 AIHRQDTVDCL 307
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 290 bits (745), Expect = 2e-96
Identities = 83/291 (28%), Positives = 139/291 (47%), Gaps = 21/291 (7%)
Query: 10 APPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLD 69
T+ + + LG G+F VH + + G IKTI K+
Sbjct: 4 HHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--- 60
Query: 70 AAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-----RRG 124
++I E+ ++ L +HPN++KI EV +Y+VME GGEL ++ R
Sbjct: 61 QVPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK 119
Query: 125 RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL---DRDGNLKVSDFGLSALPEQ 181
L+E +Q+++AL + H V H+D+KP+N+L +K+ DFGL+ L
Sbjct: 120 ALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--- 176
Query: 182 IKNG-MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMY 240
K+ A GT Y APEV +R D WS GV+++ LL G LPF ++L +
Sbjct: 177 FKSDEHSTNAAGTALYMAPEVF-KRDVTFKC-DIWSAGVVMYFLLTGCLPFTGTSLEEVQ 234
Query: 241 KKVNRRDYQFPS---FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288
+K ++ + ++ A L+ Q+L +P+ R S +++ WF+++
Sbjct: 235 QKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 2e-96
Identities = 99/283 (34%), Positives = 142/283 (50%), Gaps = 19/283 (6%)
Query: 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREV 80
+ Y L +GRGS+ +V A A K I K DR +E+
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF----VEDVDRFKQEI 57
Query: 81 SAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGK-LRRGRLTESAARRYFQQLV 139
M+ L +HPN++++ E T IYLVME GGELF + + + ES A R + ++
Sbjct: 58 EIMKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL 116
Query: 140 SALHFCHQNGVAHRDVKPQNLLL---DRDGNLKVSDFGLSALPEQIKNG-MLHTACGTPA 195
SA+ +CH+ VAHRD+KP+N L D LK+ DFGL+A K G M+ T GTP
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRTKVGTPY 173
Query: 196 YTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS--- 252
Y +P+V+ Y D WS GV+++VLL GY PF + K+ + FP
Sbjct: 174 YVSPQVL-EGLYGPEC-DEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW 231
Query: 253 -FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRK 294
VS A SLI +LL +PK R++ + + WF+K L +
Sbjct: 232 LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPR 274
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 294 bits (753), Expect = 3e-96
Identities = 71/362 (19%), Positives = 148/362 (40%), Gaps = 21/362 (5%)
Query: 6 SPPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNN 65
+ ++ I Y + +G G +KV + + I AIK +
Sbjct: 34 DLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE 92
Query: 66 KFLDAAMEDRIVREVSAMRRLQ-NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR-R 123
D D E++ + +LQ + ++++ + T IY+VME +L L+ +
Sbjct: 93 --ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKK 149
Query: 124 GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS-ALPEQI 182
+ + Y++ ++ A+H HQ+G+ H D+KP N L+ DG LK+ DFG++ +
Sbjct: 150 KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208
Query: 183 KNGMLHTACGTPAYTAPEVVARRGYD----------GAVADAWSCGVILFVLLAGYLPFD 232
+ + + G Y PE + +D WS G IL+ + G PF
Sbjct: 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268
Query: 233 D--SNLLAMYKKVNRR-DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289
+ + ++ ++ + +FP K + ++ L +PK R+SI ++++ + Q
Sbjct: 269 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328
Query: 290 QQQRKRGQESSLFELGVVGNNKYILKEKIPDIVSMNAFDIISLSSGLDLSGLFEAKKRKE 349
+ + ++ V+G + + ++ S + S +K++
Sbjct: 329 HPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRG 388
Query: 350 KR 351
K+
Sbjct: 389 KK 390
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 2e-95
Identities = 95/277 (34%), Positives = 150/277 (54%), Gaps = 15/277 (5%)
Query: 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAM 83
T RY + +LG+GSF +V K K A+K I K I+REV +
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINK--ASAKNKDTSTILREVELL 75
Query: 84 RRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGK-LRRGRLTESAARRYFQQLVSAL 142
++L +HPN++K+ E++ + Y+V E GGELF + ++R R +E A R +Q+ S +
Sbjct: 76 KKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 143 HFCHQNGVAHRDVKPQNLLL---DRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAP 199
+ H++ + HRD+KP+N+LL ++D ++K+ DFGLS +Q N + GT Y AP
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRIGTAYYIAP 192
Query: 200 EVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS----FVS 255
EV+ R YD D WS GVIL++LL+G PF N + K+V Y F +S
Sbjct: 193 EVL-RGTYDEKC-DVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250
Query: 256 KPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQ 292
A+ LI ++L +P R++ + + W QK ++
Sbjct: 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 6e-95
Identities = 72/348 (20%), Positives = 148/348 (42%), Gaps = 21/348 (6%)
Query: 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVRE 79
++ I Y + +G G +KV + + I AIK + D D E
Sbjct: 1 NECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE--ADNQTLDSYRNE 57
Query: 80 VSAMRRLQ-NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQ 137
++ + +LQ + ++++ + T IY+VME +L L+ + + + Y++
Sbjct: 58 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKN 116
Query: 138 LVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS-ALPEQIKNGMLHTACGTPAY 196
++ A+H HQ+G+ H D+KP N L+ DG LK+ DFG++ + + + + GT Y
Sbjct: 117 MLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 175
Query: 197 TAPEVVARRGYD----------GAVADAWSCGVILFVLLAGYLPFDD--SNLLAMYKKVN 244
PE + +D WS G IL+ + G PF + + ++ ++
Sbjct: 176 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235
Query: 245 RR-DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSLFE 303
+ +FP K + ++ L +PK R+SI ++++ + Q + + ++
Sbjct: 236 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEM 295
Query: 304 LGVVGNNKYILKEKIPDIVSMNAFDIISLSSGLDLSGLFEAKKRKEKR 351
V+G + + ++ S + S +K++ K+
Sbjct: 296 KYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRGKK 343
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 284 bits (730), Expect = 2e-93
Identities = 92/305 (30%), Positives = 157/305 (51%), Gaps = 29/305 (9%)
Query: 2 EPGCSPPSAPPPPPPPPPSKKIP----------TLLNRYQLGPLLGRGSFAKVHKAKSIA 51
S+ P + +P L + +++ LGRG+ + V++ K
Sbjct: 17 NLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKG 76
Query: 52 DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEY 111
A+K ++K + + E+ + RL +HPN++K++E+ T T+I LV+E
Sbjct: 77 TQKPYALKVLKKTVD------KKIVRTEIGVLLRL-SHPNIIKLKEIFETPTEISLVLEL 129
Query: 112 AAGGELFGK-LRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL---DRDGN 167
GGELF + + +G +E A +Q++ A+ + H+NG+ HRD+KP+NLL D
Sbjct: 130 VTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAP 189
Query: 168 LKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAG 227
LK++DFGLS + E ++ T CGTP Y APE++ Y V D WS G+I ++LL G
Sbjct: 190 LKIADFGLSKIVE--HQVLMKTVCGTPGYCAPEILRGCAYGPEV-DMWSVGIITYILLCG 246
Query: 228 YLPF-DDSNLLAMYKKVNRRDYQFPS----FVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282
+ PF D+ M++++ +Y F S VS A+ L+ +L+ +PK R++ + +
Sbjct: 247 FEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306
Query: 283 SWFQK 287
W
Sbjct: 307 PWVTG 311
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 3e-92
Identities = 90/267 (33%), Positives = 142/267 (53%), Gaps = 13/267 (4%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN 88
YQL LG+G+F+ V + + G A I K L A ++ RE R L+
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINT--KKLSARDHQKLEREARICRLLK- 68
Query: 89 HPNVLKIQEVMATKTKIYLVMEYAAGGELFGK-LRRGRLTESAARRYFQQLVSALHFCHQ 147
HPN++++ + ++ + YL+ + GGELF + R +E+ A QQ++ A+ CHQ
Sbjct: 69 HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ 128
Query: 148 NGVAHRDVKPQNLLL---DRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVAR 204
GV HR++KP+NLLL + +K++DFGL+ E + GTP Y +PEV+ +
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-EQQAWFGFAGTPGYLSPEVLRK 187
Query: 205 RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS----FVSKPARS 260
Y V D W+CGVIL++LL GY PF D + +Y+++ Y FPS V+ A+
Sbjct: 188 DPYGKPV-DLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 246
Query: 261 LIYQLLDPNPKTRMSIEKIMSISWFQK 287
LI ++L NP R++ + + W
Sbjct: 247 LINKMLTINPSKRITAAEALKHPWISH 273
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 281 bits (722), Expect = 3e-92
Identities = 89/347 (25%), Positives = 155/347 (44%), Gaps = 35/347 (10%)
Query: 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREV 80
+ + Y++ +G GS++ + A A+K I+K+ + E+
Sbjct: 15 RNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------DPTEEI 66
Query: 81 SAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGK-LRRGRLTESAARRYFQQLV 139
+ R HPN++ +++V +Y+V E GGEL K LR+ +E A +
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTIT 126
Query: 140 SALHFCHQNGVAHRDVKPQNLLL-DRDGN---LKVSDFGLSALPEQIKNGMLHTACGTPA 195
+ + H GV HRD+KP N+L D GN +++ DFG + +NG+L T C T
Sbjct: 127 KTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA-ENGLLMTPCYTAN 185
Query: 196 YTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFD---DSNLLAMYKKVNRRDYQFPS 252
+ APEV+ R+GYD A D WS GV+L+ +L GY PF D + ++ +
Sbjct: 186 FVAPEVLERQGYDAAC-DIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG 244
Query: 253 ----FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSLFELGVVG 308
VS A+ L+ ++L +P R++ ++ W Q + +
Sbjct: 245 GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQ--------- 295
Query: 309 NNKYILKEKIPDIVS-MNAFDIISLSSGLDLSGLFEAKKRKEKRFTT 354
+ +++K + S +N L + S L A++R K+ T+
Sbjct: 296 DAPHLVKGAMAATYSALNRNQSPVLEP-VGRSTL--AQRRGIKKITS 339
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 291 bits (747), Expect = 4e-92
Identities = 85/333 (25%), Positives = 138/333 (41%), Gaps = 26/333 (7%)
Query: 15 PPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMED 74
P P++ +++ LG G F V + G VAIK + L +
Sbjct: 5 SPSLPTQTC----GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE---LSPKNRE 57
Query: 75 RIVREVSAMRRLQNHPNVLKIQEVMATKTKI------YLVMEYAAGGELFGKL----RRG 124
R E+ M++L NHPNV+ +EV K+ L MEY GG+L L
Sbjct: 58 RWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC 116
Query: 125 RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN---LKVSDFGLSALPEQ 181
L E R + SAL + H+N + HRD+KP+N++L K+ D G + +Q
Sbjct: 117 GLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176
Query: 182 IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPF-DDSNLLAMY 240
+ GT Y APE++ ++ Y V D WS G + F + G+ PF + + +
Sbjct: 177 --GELCTEFVGTLQYLAPELLEQKKYTVTV-DYWSFGTLAFECITGFRPFLPNWQPVQWH 233
Query: 241 KKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQ-QRKRGQES 299
KV + + ++ + + P P I W Q L QR+RG +
Sbjct: 234 GKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDP 293
Query: 300 SLFELGVVGNNKYILKEKIPDIVSMNAFDIISL 332
+G IL K+ +++M + + +
Sbjct: 294 QNPNVGCFQALDSILSLKLLSVMNMVSGRVHTY 326
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 6e-92
Identities = 92/284 (32%), Positives = 141/284 (49%), Gaps = 27/284 (9%)
Query: 22 KIPTLLNRYQLGPL---LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVR 78
K Y L LG GSF+ K A+K I K ME +
Sbjct: 2 KDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-------MEANTQK 54
Query: 79 EVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGK-LRRGRLTESAARRYFQQ 137
E++A++ + HPN++K+ EV + +LVME GGELF + ++ +E+ A ++
Sbjct: 55 EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRK 114
Query: 138 LVSALHFCHQNGVAHRDVKPQNLLL---DRDGNLKVSDFGLSALPEQIKNGMLHTACGTP 194
LVSA+ H GV HRD+KP+NLL + + +K+ DFG + L + N L T C T
Sbjct: 115 LVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL-KPPDNQPLKTPCFTL 173
Query: 195 AYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN-------LLAMYKKVNRRD 247
Y APE++ + GYD + D WS GVIL+ +L+G +PF + + + KK+ + D
Sbjct: 174 HYAAPELLNQNGYDESC-DLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232
Query: 248 YQFPS----FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287
+ F VS+ A+ LI LL +P R+ + + W Q
Sbjct: 233 FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 7e-92
Identities = 85/280 (30%), Positives = 140/280 (50%), Gaps = 17/280 (6%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDR--IVREVSAMRR 85
+ Y++G LG G FA V K + G A K I+K R I REV+ +R
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 86 LQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLVSALHF 144
+ HPN++ + ++ KT + L++E +GGELF L + LTE A ++ +Q++ +H+
Sbjct: 65 I-RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 123
Query: 145 CHQNGVAHRDVKPQNLLL----DRDGNLKVSDFGLSALPEQIKNG-MLHTACGTPAYTAP 199
H +AH D+KP+N++L + +K+ DFG++ I+ G GTP + AP
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK---IEAGNEFKNIFGTPEFVAP 180
Query: 200 EVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS----FVS 255
E+V D WS GVI ++LL+G PF ++ +Y F S
Sbjct: 181 EIVNYEPLGLEA-DMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 239
Query: 256 KPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKR 295
+ A+ I +LL +PK RM+I + + SW + ++ +
Sbjct: 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRG 279
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 8e-92
Identities = 92/343 (26%), Positives = 139/343 (40%), Gaps = 55/343 (16%)
Query: 5 CSPPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKN 64
+ + L +Y L +G+GS+ V A +I AIK + KN
Sbjct: 3 HHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN 62
Query: 65 N-KFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR 123
+ ++ +RI EV M++L +HPN+ ++ EV + I LVME GG L KL
Sbjct: 63 KIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNV 121
Query: 124 -----------------------------------------GRLTESAARRYFQQLVSAL 142
E +Q+ SAL
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181
Query: 143 HFCHQNGVAHRDVKPQNLLL--DRDGNLKVSDFGLSALPEQIKNG---MLHTACGTPAYT 197
H+ H G+ HRD+KP+N L ++ +K+ DFGLS ++ NG + T GTP +
Sbjct: 182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFV 241
Query: 198 APEVV--ARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS--- 252
APEV+ Y DAWS GV+L +LL G +PF N +V + F +
Sbjct: 242 APEVLNTTNESYGPKC-DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNY 300
Query: 253 -FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRK 294
+S AR L+ LL+ N R + + W + + K
Sbjct: 301 NVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYK 343
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 279 bits (717), Expect = 1e-91
Identities = 86/292 (29%), Positives = 144/292 (49%), Gaps = 18/292 (6%)
Query: 21 KKIPTLLNRYQL-GPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVRE 79
+ + N Y L LGRG FA V + S + G A K ++K + I+ E
Sbjct: 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKK--RRRGQDCRAEILHE 78
Query: 80 VSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL---RRGRLTESAARRYFQ 136
++ + ++ P V+ + EV ++I L++EYAAGGE+F ++E+ R +
Sbjct: 79 IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK 138
Query: 137 QLVSALHFCHQNGVAHRDVKPQNLLL---DRDGNLKVSDFGLSALPEQIKNG-MLHTACG 192
Q++ +++ HQN + H D+KPQN+LL G++K+ DFG+S +I + L G
Sbjct: 139 QILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR---KIGHACELREIMG 195
Query: 193 TPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS 252
TP Y APE++ A D W+ G+I ++LL PF + Y +++ + +
Sbjct: 196 TPEYLAPEILNYDPITTAT-DMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE 254
Query: 253 ----FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESS 300
VS+ A I LL NP+ R + E +S SW Q+ + +E+S
Sbjct: 255 ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETS 306
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 6e-91
Identities = 60/309 (19%), Positives = 111/309 (35%), Gaps = 52/309 (16%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
+ + L +LG+G+ A V + + G + AIK + D +RE +++L
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQMREFEVLKKL- 64
Query: 88 NHPNVLKIQEVMATKTK--IYLVMEYAAGGELFGKL----RRGRLTESAARRYFQQLVSA 141
NH N++K+ + T L+ME+ G L+ L L ES + +V
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 142 LHFCHQNGVAHRDVKPQNLLL----DRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYT 197
++ +NG+ HR++KP N++ D K++DFG + E + + GT Y
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED--DEQFVSLYGTEEYL 182
Query: 198 APEVVARRGYD-------GAVADAWSCGVILFVLLAGYLPFDDS----NLLAMYKKVNRR 246
P++ R GA D WS GV + G LPF + K+
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 247 DY-------------------------QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281
+ ++ +L+ + + ++ +
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302
Query: 282 ISWFQKSLQ 290
+
Sbjct: 303 ETSDILHRG 311
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 1e-90
Identities = 91/300 (30%), Positives = 142/300 (47%), Gaps = 32/300 (10%)
Query: 8 PSAPPPPPPPPPSKKIPTLLNRYQLG-PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNK 66
S+ P K + + YQL +LG G KV + G A+K + +
Sbjct: 8 HSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-- 65
Query: 67 FLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV----MATKTKIYLVMEYAAGGELFGK-L 121
+ +EV + P+++ I +V K + ++ME GGELF +
Sbjct: 66 -------PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ 118
Query: 122 RRG--RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL---DRDGNLKVSDFGLS 176
RG TE A + + +A+ F H + +AHRDVKP+NLL ++D LK++DFG +
Sbjct: 119 ERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178
Query: 177 ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN- 235
+ L T C TP Y APEV+ YD + D WS GVI+++LL G+ PF +
Sbjct: 179 K---ETTQNALQTPCYTPYYVAPEVLGPEKYDKSC-DMWSLGVIMYILLCGFPPFYSNTG 234
Query: 236 ---LLAMYKKVNRRDYQFPS----FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288
M +++ Y FP+ VS+ A+ LI LL +P R++I + M+ W +S
Sbjct: 235 QAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 1e-90
Identities = 92/278 (33%), Positives = 147/278 (52%), Gaps = 17/278 (6%)
Query: 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR 85
RY + +LG+GSF +V K K A+K I K + I+REV +++
Sbjct: 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS--AKNKDTSTILREVELLKK 77
Query: 86 LQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGK-LRRGRLTESAARRYFQQLVSALHF 144
L +HPN++K+ E++ + Y+V E GGELF + ++R R +E A R +Q+ S + +
Sbjct: 78 L-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 145 CHQNGVAHRDVKPQNLLL---DRDGNLKVSDFGLSALPEQIKNG-MLHTACGTPAYTAPE 200
H++ + HRD+KP+N+LL ++D ++K+ DFGLS + + GT Y APE
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYIAPE 193
Query: 201 VVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS----FVSK 256
V+ R YD D WS GVIL++LL+G PF N + K+V Y F +S
Sbjct: 194 VL-RGTYDEKC-DVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251
Query: 257 PARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRK 294
A+ LI ++L +P R++ + + W QK +
Sbjct: 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPT 289
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 2e-90
Identities = 90/278 (32%), Positives = 137/278 (49%), Gaps = 17/278 (6%)
Query: 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDR--IVRE 79
+ + + Y G LG G FA V K + + G A K I+K R I RE
Sbjct: 5 RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 80 VSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQL 138
VS ++ +Q HPNV+ + EV KT + L++E AGGELF L + LTE A + +Q+
Sbjct: 65 VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 139 VSALHFCHQNGVAHRDVKPQNLLL----DRDGNLKVSDFGLSALPEQIKNG-MLHTACGT 193
++ +++ H +AH D+KP+N++L +K+ DFGL+ +I G GT
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGT 180
Query: 194 PAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS- 252
P + APE+V D WS GVI ++LL+G PF V+ +Y+F
Sbjct: 181 PEFVAPEIVNYEPLGLEA-DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE 239
Query: 253 ---FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287
S A+ I +LL +PK RM+I+ + W +
Sbjct: 240 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 3e-90
Identities = 86/292 (29%), Positives = 142/292 (48%), Gaps = 17/292 (5%)
Query: 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDR--IVRE 79
K + + Y +G LG G FA V K + + G A K I+K R I RE
Sbjct: 6 KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 80 VSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQL 138
VS +R++ H NV+ + +V +T + L++E +GGELF L ++ L+E A + +Q+
Sbjct: 66 VSILRQV-LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 139 VSALHFCHQNGVAHRDVKPQNLLL----DRDGNLKVSDFGLSALPEQIKNG-MLHTACGT 193
+ +++ H +AH D+KP+N++L ++K+ DFGL+ +I++G GT
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFGT 181
Query: 194 PAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS- 252
P + APE+V D WS GVI ++LL+G PF + Y F
Sbjct: 182 PEFVAPEIVNYEPLGLEA-DMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEE 240
Query: 253 ---FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSL 301
S+ A+ I +LL + R++I++ + W QQ +ES +
Sbjct: 241 FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVV 292
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 7e-90
Identities = 86/295 (29%), Positives = 144/295 (48%), Gaps = 17/295 (5%)
Query: 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDR--I 76
+ K + + Y +G LG G FA V K + + G A K I+K R I
Sbjct: 3 ETFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEI 62
Query: 77 VREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYF 135
REVS +R++ HPN++ + +V +T + L++E +GGELF L ++ L+E A +
Sbjct: 63 EREVSILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 136 QQLVSALHFCHQNGVAHRDVKPQNLLL----DRDGNLKVSDFGLSALPEQIKNG-MLHTA 190
+Q++ +++ H +AH D+KP+N++L ++K+ DFGL+ +I++G
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNI 178
Query: 191 CGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQF 250
GTP + APE+V D WS GVI ++LL+G PF + Y F
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEA-DMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237
Query: 251 PS----FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSL 301
S+ A+ I +LL + R++I++ + W QQ +ES +
Sbjct: 238 DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVV 292
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 2e-89
Identities = 78/312 (25%), Positives = 151/312 (48%), Gaps = 17/312 (5%)
Query: 6 SPPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNN 65
SP + + + Y+L ++G+G F+ V + + G A+K ++
Sbjct: 2 SPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAK 61
Query: 66 -KFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL--- 121
+ + RE S L+ HP+++++ E ++ +Y+V E+ G +L ++
Sbjct: 62 FTSSPGLSTEDLKREASICHMLK-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKR 120
Query: 122 --RRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL---DRDGNLKVSDFGLS 176
+E+ A Y +Q++ AL +CH N + HRDVKP +LL + +K+ FG++
Sbjct: 121 ADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180
Query: 177 ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNL 236
+ + GTP + APEVV R Y V D W CGVILF+LL+G LPF +
Sbjct: 181 IQLGE-SGLVAGGRVGTPHFMAPEVVKREPYGKPV-DVWGCGVILFILLSGCLPFYGTK- 237
Query: 237 LAMYKKVNRRDYQFPS----FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQ 292
+++ + + Y+ +S+ A+ L+ ++L +P R+++ + ++ W ++ +
Sbjct: 238 ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYA 297
Query: 293 RKRGQESSLFEL 304
K ++ +L
Sbjct: 298 YKIHLPETVEQL 309
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 273 bits (701), Expect = 2e-89
Identities = 91/294 (30%), Positives = 133/294 (45%), Gaps = 40/294 (13%)
Query: 29 RYQLG-PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
YQL +LG G+ A+V ++ A+K IEK + R+ REV + + Q
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG----HIRSRVFREVEMLYQCQ 68
Query: 88 NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGK-LRRGRLTESAARRYFQQLVSALHFCH 146
H NVL++ E + + YLV E GG + +R E A Q + SAL F H
Sbjct: 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128
Query: 147 QNGVAHRDVKPQNLLL---DRDGNLKVSDFGLS------ALPEQIKNGMLHTACGTPAYT 197
G+AHRD+KP+N+L ++ +K+ DF L I L T CG+ Y
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 198 APEVV-----ARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLA-------------- 238
APEVV YD D WS GVIL++LL+GY PF
Sbjct: 189 APEVVEAFSEEASIYDKRC-DLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247
Query: 239 -MYKKVNRRDYQFPS----FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287
+++ + Y+FP +S A+ LI +LL + K R+S +++ W Q
Sbjct: 248 MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 3e-89
Identities = 98/280 (35%), Positives = 150/280 (53%), Gaps = 14/280 (5%)
Query: 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREV 80
+RY+ +LG+GSF +V K G A+K I K + ++ ++REV
Sbjct: 19 HSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR-QVKQKTDKESLLREV 77
Query: 81 SAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLV 139
+++L +HPN++K+ E K YLV E GGELF ++ R R +E A R +Q++
Sbjct: 78 QLLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVL 136
Query: 140 SALHFCHQNGVAHRDVKPQNLLL---DRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAY 196
S + + H+N + HRD+KP+NLLL +D N+++ DFGLS E + + GT Y
Sbjct: 137 SGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGTAYY 194
Query: 197 TAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS---- 252
APEV+ YD D WS GVIL++LL+G PF+ +N + KKV + Y F
Sbjct: 195 IAPEVL-HGTYDEKC-DVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK 252
Query: 253 FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQ 292
VS+ A+ LI ++L P R+S + W Q ++Q
Sbjct: 253 KVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQ 292
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 1e-88
Identities = 95/283 (33%), Positives = 152/283 (53%), Gaps = 15/283 (5%)
Query: 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVRE 79
+ K L YQ LG G++ +V + AIK I K + + + +++ E
Sbjct: 29 TSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS--VSTSSNSKLLEE 86
Query: 80 VSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQL 138
V+ ++ L +HPN++K+ + K YLVME GGELF ++ R + E A +Q+
Sbjct: 87 VAVLKLL-DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQV 145
Query: 139 VSALHFCHQNGVAHRDVKPQNLLL---DRDGNLKVSDFGLSALPEQIKNGMLHTACGTPA 195
+S + + H++ + HRD+KP+NLLL ++D +K+ DFGLSA+ E + GT
Sbjct: 146 LSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN--QKKMKERLGTAY 203
Query: 196 YTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS--- 252
Y APEV+ R+ YD D WS GVILF+LLAGY PF + +KV + Y F S
Sbjct: 204 YIAPEVL-RKKYDEKC-DVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEW 261
Query: 253 -FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRK 294
VS+ A+ LI Q+L + + R+S ++ + W ++ ++
Sbjct: 262 KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKES 304
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 2e-88
Identities = 91/313 (29%), Positives = 143/313 (45%), Gaps = 34/313 (10%)
Query: 7 PPSAPPPPPPPPPS----------KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIV 56
+ KK + Y LG G++ +V K S
Sbjct: 5 HHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEK 64
Query: 57 AIKTIEKNN---------KFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107
AIK I+K+ + I E+S ++ L +HPN++K+ +V K YL
Sbjct: 65 AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFDVFEDKKYFYL 123
Query: 108 VMEYAAGGELFGKL-RRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL---D 163
V E+ GGELF ++ R + E A +Q++S + + H++ + HRD+KP+N+LL +
Sbjct: 124 VTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN 183
Query: 164 RDGNLKVSDFGLSALPEQIKNG-MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILF 222
N+K+ DFGLS L GT Y APEV+ ++ Y+ D WSCGVI++
Sbjct: 184 SLLNIKIVDFGLS---SFFSKDYKLRDRLGTAYYIAPEVL-KKKYNEKC-DVWSCGVIMY 238
Query: 223 VLLAGYLPFDDSNLLAMYKKVNRRDYQFPS----FVSKPARSLIYQLLDPNPKTRMSIEK 278
+LL GY PF N + KKV + Y F +S A+ LI +L + R + E+
Sbjct: 239 ILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEE 298
Query: 279 IMSISWFQKSLQQ 291
++ W +K
Sbjct: 299 ALNSRWIKKYANN 311
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 273 bits (701), Expect = 2e-88
Identities = 110/390 (28%), Positives = 172/390 (44%), Gaps = 54/390 (13%)
Query: 3 PGCSPPSAPPPP--------PPPPPSKKIPTLLNR--------------YQLGPLLGRGS 40
P +PP PP P PPPPP ++ P + +LG G
Sbjct: 15 PAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGI 74
Query: 41 FAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV-- 98
KV + + A+K ++ + REV R P++++I +V
Sbjct: 75 NGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYE 125
Query: 99 --MATKTKIYLVMEYAAGGELFGK-LRRG--RLTESAARRYFQQLVSALHFCHQNGVAHR 153
A + + +VME GGELF + RG TE A + + A+ + H +AHR
Sbjct: 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 185
Query: 154 DVKPQNLLL---DRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGA 210
DVKP+NLL + LK++DFG + + L T C TP Y APEV+ YD +
Sbjct: 186 DVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPCYTPYYVAPEVLGPEKYDKS 243
Query: 211 VADAWSCGVILFVLLAGYLPFDDSNLLA----MYKKVNRRDYQFPS----FVSKPARSLI 262
D WS GVI+++LL GY PF ++ LA M ++ Y+FP+ VS+ + LI
Sbjct: 244 C-DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLI 302
Query: 263 YQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSLFELGVVGNNKYILKEKIPDIV 322
LL P RM+I + M+ W +S + + S + + + + +E +
Sbjct: 303 RNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE-RWEDVKEEMTSALA 361
Query: 323 SMNA-FDIISLSSGLDLSGLFEAKKRKEKR 351
+M ++ I + D S K+RK+ R
Sbjct: 362 TMRVDYEQIKIKKIEDASNPLLLKRRKKAR 391
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 4e-88
Identities = 60/309 (19%), Positives = 111/309 (35%), Gaps = 52/309 (16%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
+ + L +LG+G+ A V + + G + AIK + D +RE +++L
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQMREFEVLKKL- 64
Query: 88 NHPNVLKIQEVMATKTK--IYLVMEYAAGGELFGKL----RRGRLTESAARRYFQQLVSA 141
NH N++K+ + T L+ME+ G L+ L L ES + +V
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 142 LHFCHQNGVAHRDVKPQNLLL----DRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYT 197
++ +NG+ HR++KP N++ D K++DFG + E + + GT Y
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED--DEQFVSLYGTEEYL 182
Query: 198 APEVVARRGYD-------GAVADAWSCGVILFVLLAGYLPFDD----SNLLAMYKKVNRR 246
P++ R GA D WS GV + G LPF + K+
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 247 DY-------------------------QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281
+ ++ +L+ + + ++ +
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302
Query: 282 ISWFQKSLQ 290
+
Sbjct: 303 ETSDILHRM 311
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 8e-87
Identities = 83/362 (22%), Positives = 155/362 (42%), Gaps = 24/362 (6%)
Query: 12 PPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAA 71
P P K ++ + Y + LG G+F VH+ A G + K I
Sbjct: 35 KKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP----L 90
Query: 72 MEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL--RRGRLTES 129
+ + E+S M +L +HP ++ + + K ++ L++E+ +GGELF ++ +++E+
Sbjct: 91 DKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEA 149
Query: 130 AARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL--DRDGNLKVSDFGLSALPEQIKNG-M 186
Y +Q L H++ + H D+KP+N++ + ++K+ DFGL+ ++ +
Sbjct: 150 EVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEI 206
Query: 187 LHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR 246
+ T + APE+V R D W+ GV+ +VLL+G PF + L + V R
Sbjct: 207 VKVTTATAEFAAPEIVDREPVGFYT-DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC 265
Query: 247 DYQFPS----FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSLF 302
D++F VS A+ I LL P+ R+++ + W + R S
Sbjct: 266 DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYN 325
Query: 303 ELGVVGNNKYILKEKIPDIVSMNAFDIISLSSGLDLSGLFEAKKRKEKRFTTKEKTERVV 362
++ + +KEK D + + + + + F KE R
Sbjct: 326 KI------RQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIYDSYFDRKEAVPRFK 379
Query: 363 EK 364
+
Sbjct: 380 LR 381
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 3e-86
Identities = 89/312 (28%), Positives = 137/312 (43%), Gaps = 27/312 (8%)
Query: 2 EPGCSPPSAPPPPPPPPP---SKKIPTLLNRYQLGPL--LGRGSFAKVHKAKSIADGSIV 56
P PP P + K + + Y + LG G F +VHK + A G +
Sbjct: 58 RTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKL 117
Query: 57 AIKTIEKNNKFLDAAMEDR--IVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAG 114
A K I+ M+D+ + E+S M +L +H N++++ + +K I LVMEY G
Sbjct: 118 AAKIIKT------RGMKDKEEVKNEISVMNQL-DHANLIQLYDAFESKNDIVLVMEYVDG 170
Query: 115 GELFGKL--RRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL-DRDGN-LKV 170
GELF ++ LTE + +Q+ + HQ + H D+KP+N+L +RD +K+
Sbjct: 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKI 230
Query: 171 SDFGLSALPEQIKNG-MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYL 229
DFGL+ + K L GTP + APEVV D WS GVI ++LL+G
Sbjct: 231 IDFGLAR---RYKPREKLKVNFGTPEFLAPEVVNYDFVSFPT-DMWSVGVIAYMLLSGLS 286
Query: 230 PFDDSNLLAMYKKVNRRDYQFPS----FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285
PF N + + +S+ A+ I +LL R+S + + W
Sbjct: 287 PFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWL 346
Query: 286 QKSLQQQRKRGQ 297
R Q
Sbjct: 347 SDHKLHSRLSAQ 358
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 4e-86
Identities = 66/270 (24%), Positives = 120/270 (44%), Gaps = 19/270 (7%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
+Y + LGRG F VH+ + K ++ K D + + +E+S +
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV--KGTD---QVLVKKEISILNIA- 58
Query: 88 NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL--RRGRLTESAARRYFQQLVSALHFC 145
H N+L + E + ++ ++ E+ +G ++F ++ L E Y Q+ AL F
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 146 HQNGVAHRDVKPQNLLL--DRDGNLKVSDFGLSALPEQIKNG-MLHTACGTPAYTAPEVV 202
H + + H D++P+N++ R +K+ +FG + Q+K G P Y APEV
Sbjct: 119 HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR---QLKPGDNFRLLFTAPEYYAPEVH 175
Query: 203 ARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS----FVSKPA 258
A D WS G +++VLL+G PF + + + +Y F +S A
Sbjct: 176 QHDVVSTAT-DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 259 RSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288
+ +LL K+RM+ + + W ++
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQK 264
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 7e-86
Identities = 83/380 (21%), Positives = 145/380 (38%), Gaps = 23/380 (6%)
Query: 2 EPGCSPPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTI 61
P P K +L+ Y + LG G+F VH+ A G+ A K +
Sbjct: 131 NYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV 190
Query: 62 EKNNKFLDAAMEDR--IVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFG 119
D+ + +E+ M L+ HP ++ + + ++ ++ E+ +GGELF
Sbjct: 191 MT------PHESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFE 243
Query: 120 KL--RRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL--DRDGNLKVSDFGL 175
K+ +++E A Y +Q+ L H+N H D+KP+N++ R LK+ DFGL
Sbjct: 244 KVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL 303
Query: 176 SALPEQIKNG-MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS 234
+A + + GT + APEV + D WS GV+ ++LL+G PF
Sbjct: 304 TA---HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT-DMWSVGVLSYILLSGLSPFGGE 359
Query: 235 NLLAMYKKVNRRDYQFPS----FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQ 290
N + V D+ +S+ + I +LL +P TRM+I + + W
Sbjct: 360 NDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419
Query: 291 QQRKRGQESSLFELGVVGNNKYILKEKIPDIVSMNAFDIISLSSGLDLSGLFEAKKRKEK 350
R SS + + + K + + S ++
Sbjct: 420 PGRDSQIPSSRYTK-IRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAFWDR 478
Query: 351 RFTTKEKTERVVEKVKEVGE 370
+ G+
Sbjct: 479 SEAQPRFIVKPYGTEVGEGQ 498
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 260 bits (667), Expect = 8e-85
Identities = 81/282 (28%), Positives = 135/282 (47%), Gaps = 18/282 (6%)
Query: 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAM 83
P+ Y++ +G GS+ + K + +DG I+ K ++ + + A + +V EV+ +
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS--MTEAEKQMLVSEVNLL 59
Query: 84 RRLQNHPNVLKIQE--VMATKTKIYLVMEYAAGGELFGKLRRGR-----LTESAARRYFQ 136
R L HPN+++ + + T T +Y+VMEY GG+L + +G L E R
Sbjct: 60 REL-KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 137 QLVSALHFCHQ-----NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTAC 191
QL AL CH+ + V HRD+KP N+ LD N+K+ DFGL+ + T
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKTFV 177
Query: 192 GTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQF- 250
GTP Y +PE + R Y+ +D WS G +L+ L A PF + + K+ ++
Sbjct: 178 GTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI 236
Query: 251 PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQ 292
P S +I ++L+ R S+E+I+ +
Sbjct: 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHH 278
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 261 bits (668), Expect = 5e-84
Identities = 72/269 (26%), Positives = 127/269 (47%), Gaps = 9/269 (3%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
+ +Y +G GSF K KS DG IK I + + + + REV+ + +
Sbjct: 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR--MSSKEREESRREVAVLANM 80
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALH 143
HPN+++ +E +Y+VM+Y GG+LF ++ E +F Q+ AL
Sbjct: 81 -KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK 139
Query: 144 FCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVA 203
H + HRD+K QN+ L +DG +++ DFG++ + + GTP Y +PE+
Sbjct: 140 HVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-TVELARACIGTPYYLSPEICE 198
Query: 204 RRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQ-FPSFVSKPARSLI 262
+ Y+ +D W+ G +L+ L F+ ++ + K+ + S RSL+
Sbjct: 199 NKPYNNK-SDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLV 257
Query: 263 YQLLDPNPKTRMSIEKIMSISWFQKSLQQ 291
QL NP+ R S+ I+ + K +++
Sbjct: 258 SQLFKRNPRDRPSVNSILEKGFIAKRIEK 286
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 256 bits (655), Expect = 8e-82
Identities = 44/327 (13%), Positives = 100/327 (30%), Gaps = 57/327 (17%)
Query: 16 PPPPSKKIPTLLNR----YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAA 71
++ + L G +LG+ +A G + + +
Sbjct: 57 NTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSN 115
Query: 72 MEDRIVREVSAMRRL------------------------QNHPNVLKIQEVMATKT--KI 105
++ EV +R L +++++
Sbjct: 116 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR 175
Query: 106 YLVMEYAAG--GELFGKL-----RRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQ 158
+ + L L A + Q++ L H G+ H ++P
Sbjct: 176 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPV 235
Query: 159 NLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRG----------YD 208
+++LD+ G + ++ F +++G + + + PE+ ARR
Sbjct: 236 DIVLDQRGGVFLTGFEHL-----VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLM 290
Query: 209 GAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDP 268
DAW+ G++++ + LP L + + R P P R+L+ L
Sbjct: 291 TFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQ----PVRALLEGFLRY 346
Query: 269 NPKTRMSIEKIMSISWFQKSLQQQRKR 295
+ R+ + M +++ +
Sbjct: 347 PKEDRLLPLQAMETPEYEQLRTELSAA 373
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 8e-81
Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 12/285 (4%)
Query: 6 SPPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNN 65
S P PS+ +Q LG GS+ +V K +S DG + A+K
Sbjct: 35 GEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMS-- 92
Query: 66 KFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-- 123
F R + EV + ++ HP +++++ +YL E G L
Sbjct: 93 PFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWG 151
Query: 124 GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183
L E+ Y + + AL H G+ H DVKP N+ L G K+ DFGL
Sbjct: 152 ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG--T 209
Query: 184 NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGY-LPFDDSNLLAMYKK 242
G G P Y APE++ + Y A AD +S G+ + + LP + +
Sbjct: 210 AGAGEVQEGDPRYMAPELL-QGSYGTA-ADVFSLGLTILEVACNMELPHGGEGWQQLRQG 267
Query: 243 VNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287
+F + +S RS++ +L+P+PK R + E ++++ ++
Sbjct: 268 YLPP--EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 3e-80
Identities = 84/308 (27%), Positives = 144/308 (46%), Gaps = 13/308 (4%)
Query: 2 EPGCSPPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTI 61
+ PP P L +++ +GRG F++V++A + DG VA+K +
Sbjct: 6 QGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV 65
Query: 62 EKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL 121
+ + +DA ++E+ +++L NHPNV+K ++ +V+E A G+L +
Sbjct: 66 QIFDL-MDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIVLELADAGDLSRMI 123
Query: 122 RRGR-----LTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176
+ + + E +YF QL SAL H V HRD+KP N+ + G +K+ D GL
Sbjct: 124 KHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 183
Query: 177 ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPF--DDS 234
K H+ GTP Y +PE + GY+ +D WS G +L+ + A PF D
Sbjct: 184 RFFSS-KTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKM 241
Query: 235 NLLAMYKKVNRRDYQ-FPSFV-SKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQ 292
NL ++ KK+ + DY PS S+ R L+ ++P+P+ R + + ++ +
Sbjct: 242 NLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301
Query: 293 RKRGQESS 300
Sbjct: 302 SLEHHHHH 309
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 3e-80
Identities = 67/292 (22%), Positives = 121/292 (41%), Gaps = 37/292 (12%)
Query: 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAM 83
++ L+G G F +V KAK DG IK ++ NN ++ REV A+
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKAL 58
Query: 84 RRLQNHPNVLK----------------IQEVMATKTKIYLVMEYAAGGELFGKL---RRG 124
+L +H N++ + +++ ME+ G L + R
Sbjct: 59 AKL-DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 125 RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184
+L + A F+Q+ + + H + +RD+KP N+ L +K+ DFGL + +
Sbjct: 118 KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN--D 175
Query: 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKV 243
G + GT Y +PE ++ + Y V D ++ G+IL LL F+ S +
Sbjct: 176 GKRTRSKGTLRYMSPEQISSQDYGKEV-DLYALGLILAELLHVCDTAFETSKFFTDLRD- 233
Query: 244 NRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKR 295
K ++L+ +LL P+ R + +I+ K ++ +R
Sbjct: 234 ----GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER 281
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 5e-80
Identities = 62/304 (20%), Positives = 106/304 (34%), Gaps = 27/304 (8%)
Query: 7 PPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNK 66
+ + Y LG G F+ V + + DG A+K I + +
Sbjct: 8 HHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ 67
Query: 67 FLDAAMEDRIVREVSAMRRLQNHPNVLK----IQEVMATKTKIYLVMEYAAGGELFGKLR 122
+ RE R NHPN+L+ K + +L++ + G L+ ++
Sbjct: 68 ----QDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIE 122
Query: 123 R-----GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177
R LTE + L H G AHRD+KP N+LL +G + D G
Sbjct: 123 RLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182
Query: 178 LP--------EQIKNGMLHTACGTPAYTAPEVVARRGYD--GAVADAWSCGVILFVLLAG 227
+ + T +Y APE+ + + + D WS G +L+ ++ G
Sbjct: 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242
Query: 228 YLPFDDSNLLAM-YKKVNRRDYQFPSF--VSKPARSLIYQLLDPNPKTRMSIEKIMSISW 284
P+D + P S L+ ++ +P R I ++S
Sbjct: 243 EGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302
Query: 285 FQKS 288
+
Sbjct: 303 ALQP 306
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 2e-78
Identities = 78/331 (23%), Positives = 130/331 (39%), Gaps = 36/331 (10%)
Query: 1 MEPGCSPPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKT 60
M S A + + R ++ +L G FA V++A+ + G A+K
Sbjct: 1 MAGPGSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKR 60
Query: 61 IEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI-------QEVMATKTKIYLVMEYAA 113
+ N + I++EV M++L HPN+++ +E T +L++
Sbjct: 61 LLSNEE----EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC 116
Query: 114 GGELFGKL----RRGRLTESAARRYFQQLVSALHFCHQNG--VAHRDVKPQNLLLDRDGN 167
G+L L RG L+ + F Q A+ H+ + HRD+K +NLLL G
Sbjct: 117 KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT 176
Query: 168 LKVSDFGLSALPEQIKNG-----------MLHTACGTPAYTAPEVV--ARRGYDGAVADA 214
+K+ DFG + + T TP Y PE++ G D
Sbjct: 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDI 236
Query: 215 WSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSF--VSKPARSLIYQLLDPNPKT 272
W+ G IL++L PF+D L + Y P SLI +L NP+
Sbjct: 237 WALGCILYLLCFRQHPFEDGAKLR----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEE 292
Query: 273 RMSIEKIMSISWFQKSLQQQRKRGQESSLFE 303
R+SI +++ + + + + L E
Sbjct: 293 RLSIAEVVHQLQEIAAARNVNPKSPITELLE 323
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 5e-77
Identities = 84/290 (28%), Positives = 142/290 (48%), Gaps = 11/290 (3%)
Query: 6 SPPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNN 65
P A PP + ++ G +LG GSF+ V A+ +A AIK +EK
Sbjct: 8 PRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR- 66
Query: 66 KFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-G 124
+ + RE M RL +HP +K+ K+Y + YA GEL +R+ G
Sbjct: 67 HIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG 125
Query: 125 RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS-ALPEQIK 183
E+ R Y ++VSAL + H G+ HRD+KP+N+LL+ D +++++DFG + L + K
Sbjct: 126 SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 185
Query: 184 NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKV 243
++ GT Y +PE++ + + D W+ G I++ L+AG PF N +++K+
Sbjct: 186 QARANSFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 244
Query: 244 NRRDYQFPSFVSKPARSLIYQLLDPNPKTRM------SIEKIMSISWFQK 287
+ +Y FP AR L+ +LL + R+ + + +F+
Sbjct: 245 IKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 5e-76
Identities = 84/295 (28%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 12 PPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAA 71
P KK + + +LG G KV + + A+K ++ K
Sbjct: 2 PHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR--- 58
Query: 72 MEDRIVREVSAMRRLQNHPNVLKIQEV----MATKTKIYLVMEYAAGGELFGK-LRRG-- 124
REV R P++++I +V A + + +VME GGELF + RG
Sbjct: 59 ------REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 112
Query: 125 RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL---DRDGNLKVSDFGLSALPEQ 181
TE A + + A+ + H +AHRDVKP+NLL + LK++DFG
Sbjct: 113 AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------ 166
Query: 182 IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLA--- 238
A E YD + D WS GVI+++LL GY PF ++ LA
Sbjct: 167 ----------------AKETT-GEKYDKSC-DMWSLGVIMYILLCGYPPFYSNHGLAISP 208
Query: 239 -MYKKVNRRDYQFPS----FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288
M ++ Y+FP+ VS+ + LI LL P RM+I + M+ W +S
Sbjct: 209 GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 2e-75
Identities = 62/303 (20%), Positives = 108/303 (35%), Gaps = 51/303 (16%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
N +LG GS V + G VA+K + D + E+ +
Sbjct: 15 NLVVSEKILGYGSSGTV-VFQGSFQGRPVAVKRMLI-------DFCDIALMEIKLLTESD 66
Query: 88 NHPNVLKIQEVMATKTKIYLVMEYAAGGELF--------GKLRRGRLTESAARRYFQQLV 139
+HPNV++ T +Y+ +E L E +Q+
Sbjct: 67 DHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 140 SALHFCHQNGVAHRDVKPQNLLLD-------------RDGNLKVSDFGLSAL---PEQIK 183
S + H + HRD+KPQN+L+ + + +SDFGL +
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 184 NGMLHTACGTPAYTAPEV-------VARRGYDGAVADAWSCGVILFVLL-AGYLPFDDSN 235
L+ GT + APE+ +R ++ D +S G + + +L G PF D
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSI-DIFSMGCVFYYILSKGKHPFGDKY 244
Query: 236 LLAMYKKVNRRDYQFPSF-------VSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288
+ + R + + A LI Q++D +P R + K++ F
Sbjct: 245 --SRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302
Query: 289 LQQ 291
++
Sbjct: 303 SKK 305
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 1e-71
Identities = 50/326 (15%), Positives = 91/326 (27%), Gaps = 51/326 (15%)
Query: 16 PPPPSKKIPTLLNR----YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAA 71
P + +LL++ +L L G + V + + A+K +
Sbjct: 46 PQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMG-AENSRS 104
Query: 72 MEDRIVREVSAMRRL-----------------------QNHPNVLKIQEVMATKTK--IY 106
+R+ A RL Q+ P ++
Sbjct: 105 ELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYL 164
Query: 107 LVMEYAAG--GELFGKLRR-----GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQN 159
L+M A+ LF L G A QL+ G+ H P N
Sbjct: 165 LLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDN 224
Query: 160 LLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYD-GAVADAWSCG 218
L + DG L + D + Y E + +AW G
Sbjct: 225 LFIMPDGRLMLGDVSALWKV----GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLG 280
Query: 219 VILFVLLAGYLPFDDSN-------LLAMYKKVNRRDYQFPSF--VSKPARSLIYQLLDPN 269
+ ++ + +LPF + F S + ++LI + L+ +
Sbjct: 281 LSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFD 340
Query: 270 PKTRMSIEKIMSISWFQKSLQQQRKR 295
+ R+ + M F + +
Sbjct: 341 RRRRLLPLEAMETPEFLQLQNEISSS 366
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 3e-71
Identities = 62/304 (20%), Positives = 106/304 (34%), Gaps = 28/304 (9%)
Query: 4 GCSPPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEK 63
G SP + + + +LG G+ + + D VA+K I
Sbjct: 2 GSSPSLEQDDGDEETSVVIVGKI--SFCPKDVLGHGAEGTIVYRG-MFDNRDVAVKRILP 58
Query: 64 NNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-- 121
+ A REV +R HPNV++ + Y+ +E L +
Sbjct: 59 --ECFSFAD-----REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQ 110
Query: 122 RRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN-----LKVSDFGLS 176
+ QQ S L H + HRD+KP N+L+ +SDFGL
Sbjct: 111 KDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170
Query: 177 AL--PEQIKNGMLHTACGTPAYTAPEVV---ARRGYDGAVADAWSCGVILFVLLA-GYLP 230
+ GT + APE++ + V D +S G + + +++ G P
Sbjct: 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTV-DIFSAGCVFYYVISEGSHP 229
Query: 231 FDDSNLLAMYKKVNRRDYQFPSF---VSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287
F S + AR LI +++ +P+ R S + ++ +F
Sbjct: 230 FGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289
Query: 288 SLQQ 291
+Q
Sbjct: 290 LEKQ 293
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 2e-70
Identities = 47/326 (14%), Positives = 99/326 (30%), Gaps = 45/326 (13%)
Query: 15 PPPPPSKKIPTLLNRYQL---GPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAA 71
P + L R + G +LG+ +A G + + A
Sbjct: 62 NTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNA 121
Query: 72 MEDRIVREVSAMRRLQ---------------------NHPNVLKIQEVMATKTKI----- 105
++ ++ EV +R L+ P K+ V + +
Sbjct: 122 IK-QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR 180
Query: 106 YLVMEYAAG--GELFGKL-----RRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQ 158
+ + L L A + Q++ L H G+ H ++P
Sbjct: 181 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPV 240
Query: 159 NLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAV----ADA 214
+++LD+ G + ++ F + P TA ++ + + D
Sbjct: 241 DIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDT 300
Query: 215 WSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRM 274
W+ G+ ++ + LP D L + + R P P R+L+ L + R+
Sbjct: 301 WTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQ----PVRALLEGFLRYPKEDRL 356
Query: 275 SIEKIMSISWFQKSLQQQRKRGQESS 300
+ M +++ +
Sbjct: 357 LPLQAMETPEYEQLRTELSAALPLYQ 382
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 2e-70
Identities = 88/269 (32%), Positives = 142/269 (52%), Gaps = 19/269 (7%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR- 85
L+++ LG GSF +V K G+ A+K ++K ++ + + +R
Sbjct: 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 94
Query: 86 LQ--NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSAL 142
LQ N P ++K++ + +Y+VMEY AGGE+F LRR GR +E AR Y Q+V
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 143 HFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVV 202
+ H + +RD+KP+NLL+D+ G ++V+DFG + + G T CGTP APE++
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA----KRVKGRTWTLCGTPEALAPEII 210
Query: 203 ARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLI 262
+GY+ AV D W+ GV+++ + AGY PF + +Y+K+ +FPS S + L+
Sbjct: 211 LSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 263 YQLLDPNPKTRM-----SIEKIMSISWFQ 286
LL + R + I + WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 2e-70
Identities = 84/269 (31%), Positives = 151/269 (56%), Gaps = 19/269 (7%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR- 85
L +Q+ LG GSF +VH +S +G A+K ++K + + + V + R
Sbjct: 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK-----EIVVRLKQVEHTNDERLM 59
Query: 86 LQ--NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSAL 142
L HP ++++ +I+++M+Y GGELF LR+ R A+ Y ++ AL
Sbjct: 60 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL 119
Query: 143 HFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVV 202
+ H + +RD+KP+N+LLD++G++K++DFG + + + +T CGTP Y APEVV
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA----KYVPDVTYTLCGTPDYIAPEVV 175
Query: 203 ARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLI 262
+ + Y+ ++ D WS G++++ +LAGY PF DSN + Y+K+ + +FP F ++ + L+
Sbjct: 176 STKPYNKSI-DWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLL 234
Query: 263 YQLLDPNPKTRM-----SIEKIMSISWFQ 286
+L+ + R+ E + + WF+
Sbjct: 235 SRLITRDLSQRLGNLQNGTEDVKNHPWFK 263
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 2e-70
Identities = 76/304 (25%), Positives = 118/304 (38%), Gaps = 43/304 (14%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
L ++ LGRG F V +AK+ D AIK I N+ L ++++REV A+ +L
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA---REKVMREVKALAKL 60
Query: 87 QNHPNV------------LKIQEVMATKTKIYLVMEYAAGGELFGKLRRGR----LTESA 130
HP + + + + K +Y+ M+ L + S
Sbjct: 61 -EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 131 ARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA-----------LP 179
F Q+ A+ F H G+ HRD+KP N+ D +KV DFGL L
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 180 EQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFD-DSNLLA 238
GT Y +PE + Y V D +S G+ILF LL PF +
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKV-DIFSLGLILFELLY---PFSTQMERVR 235
Query: 239 MYKKVNRRDY-QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQ------KSLQQ 291
V + + ++ +L P+P R I+ + F+ K++ +
Sbjct: 236 TLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLR 295
Query: 292 QRKR 295
QR R
Sbjct: 296 QRSR 299
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 1e-68
Identities = 73/282 (25%), Positives = 130/282 (46%), Gaps = 19/282 (6%)
Query: 16 PPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDR 75
PP + + +++ +G+GSF KV + + A+K + K +E
Sbjct: 3 PPVFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNK-----QKCVERN 57
Query: 76 IVREVSAMRR-LQ--NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAA 131
VR V + +Q HP ++ + + +++V++ GG+L L++ E
Sbjct: 58 EVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV 117
Query: 132 RRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTAC 191
+ + +LV AL + + HRD+KP N+LLD G++ ++DF ++A + + T
Sbjct: 118 KLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA--MLPRETQITTMA 175
Query: 192 GTPAYTAPEVVARR---GYDGAVADAWSCGVILFVLLAGYLPF---DDSNLLAMYKKVNR 245
GT Y APE+ + R GY AV D WS GV + LL G P+ ++ +
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAV-DWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET 234
Query: 246 RDYQFPSFVSKPARSLIYQLLDPNPKTRM-SIEKIMSISWFQ 286
+PS S+ SL+ +LL+PNP R + + + +
Sbjct: 235 TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN 276
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 5e-68
Identities = 81/282 (28%), Positives = 141/282 (50%), Gaps = 15/282 (5%)
Query: 12 PPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEK----NNKF 67
P PS +I + + L +LG+GSF KV A+ AIK ++K +
Sbjct: 1 PELNKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD 60
Query: 68 LDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRL 126
++ M ++ V ++ HP + + TK ++ VMEY GG+L ++ +
Sbjct: 61 VECTMVEKRVLSLAW-----EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF 115
Query: 127 TESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG- 185
S A Y +++ L F H G+ +RD+K N+LLD+DG++K++DFG+ E +
Sbjct: 116 DLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDA 173
Query: 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNR 245
+T CGTP Y APE++ + Y+ +V D WS GV+L+ +L G PF + ++ +
Sbjct: 174 KTNTFCGTPDYIAPEILLGQKYNHSV-DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 232
Query: 246 RDYQFPSFVSKPARSLIYQLLDPNPKTRM-SIEKIMSISWFQ 286
+ +P ++ K A+ L+ +L P+ R+ I F+
Sbjct: 233 DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 274
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 9e-68
Identities = 96/306 (31%), Positives = 150/306 (49%), Gaps = 31/306 (10%)
Query: 4 GCSPPSAPP-----PPPPPPPSKKIPTLLNRY-QLGP-------LLGRGSFAKVHKAKSI 50
G S P P P PPP PS++I + P ++G+GSF KV A+
Sbjct: 1 GISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHK 60
Query: 51 ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL----QNHPNVLKIQEVMATKTKIY 106
A+ A+K ++K A ++ + + + + R + HP ++ + T K+Y
Sbjct: 61 AEEVFYAVKVLQK-----KAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115
Query: 107 LVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD 165
V++Y GGELF L+R E AR Y ++ SAL + H + +RD+KP+N+LLD
Sbjct: 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ 175
Query: 166 GNLKVSDFGLSALPEQIKNGML-HTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVL 224
G++ ++DFGL E I++ T CGTP Y APEV+ ++ YD V D W G +L+ +
Sbjct: 176 GHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTV-DWWCLGAVLYEM 232
Query: 225 LAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRM----SIEKIM 280
L G PF N MY + + Q ++ AR L+ LL + R+ +I
Sbjct: 233 LYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 292
Query: 281 SISWFQ 286
S +F
Sbjct: 293 SHVFFS 298
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 1e-66
Identities = 45/307 (14%), Positives = 100/307 (32%), Gaps = 38/307 (12%)
Query: 15 PPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIA-----DGSIVAIKTIEKNNKFLD 69
P P + + LLG G+FA+V++A + +K + N +
Sbjct: 52 PAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW-- 109
Query: 70 AAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELF------GKLRR 123
E I ++ + +K + LV E + G L
Sbjct: 110 ---EFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPE 166
Query: 124 GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL-----------DRDGNLKVSD 172
+ + + +++ + H + H D+KP N +L D L + D
Sbjct: 167 KVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALID 226
Query: 173 FGLSA-LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAG-YLP 230
G S + K + C T + E+++ + ++ + D + ++ +L G Y+
Sbjct: 227 LGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQI-DYFGVAATVYCMLFGTYMK 285
Query: 231 FDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI---SWFQK 287
+ + + RR + + +L+ + ++ FQ+
Sbjct: 286 VKNEGGECKPEGLFRRLPHLDMW-----NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340
Query: 288 SLQQQRK 294
+ +
Sbjct: 341 HYTNKIR 347
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 8e-66
Identities = 85/295 (28%), Positives = 153/295 (51%), Gaps = 22/295 (7%)
Query: 4 GCSPPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEK 63
G S S ++ ++ ++ +LG+GSF KV A+ G + A+K ++K
Sbjct: 1 GPKESSKEGNGIGVNSSNRLG--IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKK 58
Query: 64 NNKFLDAAMEDRIVREVSAMRRL----QNHPNVLKIQEVMATKTKIYLVMEYAAGGELFG 119
D ++D V +R+ +NHP + ++ T +++ VME+ GG+L
Sbjct: 59 -----DVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMF 113
Query: 120 KLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178
+++ R E+ AR Y +++SAL F H G+ +RD+K N+LLD +G+ K++DFG+
Sbjct: 114 HIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK- 172
Query: 179 PEQIKNGML-HTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL 237
E I NG+ T CGTP Y APE++ Y AV D W+ GV+L+ +L G+ PF+ N
Sbjct: 173 -EGICNGVTTATFCGTPDYIAPEILQEMLYGPAV-DWWAMGVLLYEMLCGHAPFEAENED 230
Query: 238 AMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRM------SIEKIMSISWFQ 286
+++ + + +P+++ + A ++ + NP R+ I+ +F+
Sbjct: 231 DLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK 285
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 2e-65
Identities = 92/267 (34%), Positives = 143/267 (53%), Gaps = 24/267 (8%)
Query: 35 LLGRGSFAKVHKAKSIAD---GSIVAIKTIEKN----NKFLDAAMEDRIVREVSAMRRLQ 87
+LG+GSF KV K I+ + A+K ++K + ME I+ EV
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV------- 83
Query: 88 NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCH 146
NHP ++K+ T+ K+YL++++ GG+LF +L + TE + Y +L AL H
Sbjct: 84 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 143
Query: 147 QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML-HTACGTPAYTAPEVVARR 205
G+ +RD+KP+N+LLD +G++K++DFGLS E I + ++ CGT Y APEVV RR
Sbjct: 144 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRR 201
Query: 206 GYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQL 265
G+ + D WS GV++F +L G LPF + + + P F+S A+SL+ L
Sbjct: 202 GHTQSA-DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRML 260
Query: 266 LDPNPKTRM-----SIEKIMSISWFQK 287
NP R+ +E+I S+F
Sbjct: 261 FKRNPANRLGAGPDGVEEIKRHSFFST 287
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 2e-65
Identities = 87/269 (32%), Positives = 143/269 (53%), Gaps = 26/269 (9%)
Query: 35 LLGRGSFAKVHKAKSIA---DGSIVAIKTIEKNN---KFLDAA---MEDRIVREVSAMRR 85
+LG+G + KV + + + G I A+K ++K D A E I+ EV
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV----- 78
Query: 86 LQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHF 144
HP ++ + T K+YL++EY +GGELF +L R G E A Y ++ AL
Sbjct: 79 --KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 145 CHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML-HTACGTPAYTAPEVVA 203
HQ G+ +RD+KP+N++L+ G++K++DFGL E I +G + HT CGT Y APE++
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAPEILM 194
Query: 204 RRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIY 263
R G++ AV D WS G +++ +L G PF N K+ + P ++++ AR L+
Sbjct: 195 RSGHNRAV-DWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLK 253
Query: 264 QLLDPNPKTRM-----SIEKIMSISWFQK 287
+LL N +R+ ++ + +F+
Sbjct: 254 KLLKRNAASRLGAGPGDAGEVQAHPFFRH 282
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 3e-65
Identities = 93/262 (35%), Positives = 141/262 (53%), Gaps = 18/262 (6%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR-LQ--NHPN 91
LLG+G+F KV + A G A+K + K + + V R LQ HP
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRK-----EVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 92 VLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGV 150
+ ++ T ++ VMEYA GGELF L R TE AR Y ++VSAL + H V
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 151 AHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML-HTACGTPAYTAPEVVARRGYDG 209
+RD+K +NL+LD+DG++K++DFGL E I +G T CGTP Y APEV+ Y
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 210 AVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPN 269
AV D W GV+++ ++ G LPF + + +++ + + +FP +S A+SL+ LL +
Sbjct: 185 AV-DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243
Query: 270 PKTRM-----SIEKIMSISWFQ 286
PK R+ +++M +F
Sbjct: 244 PKQRLGGGPSDAKEVMEHRFFL 265
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 6e-65
Identities = 82/263 (31%), Positives = 130/263 (49%), Gaps = 15/263 (5%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94
++GRG+F +V + + + A+K + K + + + E M N P V++
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKF-EMIKRSDSAFFWEERDIMAFA-NSPWVVQ 133
Query: 95 IQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRD 154
+ +Y+VMEY GG+L + + E AR Y ++V AL H G HRD
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRD 193
Query: 155 VKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRG----YDGA 210
VKP N+LLD+ G+LK++DFG + TA GTP Y +PEV+ +G Y
Sbjct: 194 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 253
Query: 211 VADAWSCGVILFVLLAGYLPFDDSNLLAMYKKV--NRRDYQFPS--FVSKPARSLIYQLL 266
D WS GV L+ +L G PF +L+ Y K+ ++ FP +SK A++LI L
Sbjct: 254 C-DWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL 312
Query: 267 DPNPKTRM---SIEKIMSISWFQ 286
+ + R+ +E+I +F+
Sbjct: 313 T-DREVRLGRNGVEEIKRHLFFK 334
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 3e-64
Identities = 77/263 (29%), Positives = 136/263 (51%), Gaps = 19/263 (7%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR----LQNHP 90
+LG+GSF KV ++ + A+K ++K D ++D V +R P
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKK-----DVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLVSALHFCHQNG 149
+ ++ T ++Y VMEY GG+L + + GR E A Y ++ L F G
Sbjct: 82 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 141
Query: 150 VAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML-HTACGTPAYTAPEVVARRGYD 208
+ +RD+K N++LD +G++K++DFG+ E I +G+ T CGTP Y APE++A + Y
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEIIAYQPYG 199
Query: 209 GAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDP 268
+V D W+ GV+L+ +LAG PF+ + +++ + + +P +SK A ++ L+
Sbjct: 200 KSV-DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTK 258
Query: 269 NPKTRM-----SIEKIMSISWFQ 286
+P R+ I ++F+
Sbjct: 259 HPGKRLGCGPEGERDIKEHAFFR 281
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 3e-63
Identities = 81/268 (30%), Positives = 144/268 (53%), Gaps = 16/268 (5%)
Query: 35 LLGRGSFAKVHKAKSIAD---GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN 91
+LG G++ KV + I+ G + A+K ++K A + E + ++ P
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 92 VLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGV 150
++ + T+TK++L+++Y GGELF L + R TE + Y ++V AL H+ G+
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI 180
Query: 151 AHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVV--ARRGYD 208
+RD+K +N+LLD +G++ ++DFGLS + + CGT Y AP++V G+D
Sbjct: 181 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHD 240
Query: 209 GAVADAWSCGVILFVLLAGYLPF----DDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQ 264
AV D WS GV+++ LL G PF + ++ + +++ + + +P +S A+ LI +
Sbjct: 241 KAV-DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQR 299
Query: 265 LLDPNPKTRM-----SIEKIMSISWFQK 287
LL +PK R+ ++I +FQK
Sbjct: 300 LLMKDPKKRLGCGPRDADEIKEHLFFQK 327
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 7e-63
Identities = 77/274 (28%), Positives = 131/274 (47%), Gaps = 33/274 (12%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNN--KFLDAA---MEDRIVREVSAMRRLQNH 89
++GRG+F +V K + A+K + K K + A E ++ +
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-------DS 133
Query: 90 PNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQ 147
+ + +YLVM+Y GG+L L + RL E AR Y ++V A+ HQ
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 148 NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML--HTACGTPAYTAPEVV--- 202
HRD+KP N+L+D +G+++++DFG + +++G + A GTP Y +PE++
Sbjct: 194 LHYVHRDIKPDNILMDMNGHIRLADFGSCL--KLMEDGTVQSSVAVGTPDYISPEILQAM 251
Query: 203 --ARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKV--NRRDYQFPSF---VS 255
+ Y D WS GV ++ +L G PF +L+ Y K+ ++ +QFP+ VS
Sbjct: 252 EGGKGRYGPEC-DWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVS 310
Query: 256 KPARSLIYQLLDPNPKTRM---SIEKIMSISWFQ 286
+ A+ LI +L+ R+ IE +F
Sbjct: 311 ENAKDLIRRLICSREH-RLGQNGIEDFKKHPFFS 343
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 1e-62
Identities = 97/296 (32%), Positives = 153/296 (51%), Gaps = 21/296 (7%)
Query: 2 EPGCSPPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTI 61
P + + P ++ +N ++ LLG+G+F KV K A G A+K +
Sbjct: 124 SPSDNSGAEEMEVSLAKPKHRVT--MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKIL 181
Query: 62 EKNNKFLDAAMEDRIVREVSAMRR-LQ--NHPNVLKIQEVMATKTKIYLVMEYAAGGELF 118
+K + + V R LQ HP + ++ T ++ VMEYA GGELF
Sbjct: 182 KK-----EVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 236
Query: 119 GKLRR-GRLTESAARRYFQQLVSALHFCH-QNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176
L R +E AR Y ++VSAL + H + V +RD+K +NL+LD+DG++K++DFGL
Sbjct: 237 FHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296
Query: 177 ALPEQIKNGML-HTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN 235
E IK+G T CGTP Y APEV+ Y AV D W GV+++ ++ G LPF + +
Sbjct: 297 K--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAV-DWWGLGVVMYEMMCGRLPFYNQD 353
Query: 236 LLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRM-----SIEKIMSISWFQ 286
+++ + + +FP + A+SL+ LL +PK R+ ++IM +F
Sbjct: 354 HEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 409
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 214 bits (545), Expect = 1e-62
Identities = 81/303 (26%), Positives = 144/303 (47%), Gaps = 26/303 (8%)
Query: 2 EPGCSPPSAPPPPPPPPPSKKIPTLLNRYQLGP-------LLGRGSFAKVHKAKSIADGS 54
+ P K NR ++ +LG+GSF KV ++
Sbjct: 308 RAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDE 367
Query: 55 IVAIKTIEKNNKFLDAAMEDRIVREVSAMRR----LQNHPNVLKIQEVMATKTKIYLVME 110
+ A+K ++K D ++D V +R P + ++ T ++Y VME
Sbjct: 368 LYAVKILKK-----DVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 422
Query: 111 YAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLK 169
Y GG+L +++ GR E A Y ++ L F G+ +RD+K N++LD +G++K
Sbjct: 423 YVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK 482
Query: 170 VSDFGLSALPEQIKNGML-HTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGY 228
++DFG+ E I +G+ T CGTP Y APE++A + Y +V D W+ GV+L+ +LAG
Sbjct: 483 IADFGMCK--ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSV-DWWAFGVLLYEMLAGQ 539
Query: 229 LPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRM-----SIEKIMSIS 283
PF+ + +++ + + +P +SK A ++ L+ +P R+ I +
Sbjct: 540 APFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 599
Query: 284 WFQ 286
+F+
Sbjct: 600 FFR 602
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 2e-62
Identities = 77/273 (28%), Positives = 142/273 (52%), Gaps = 29/273 (10%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL----QNHP 90
++GRGS+AKV + I A+K ++K + +D + V + + NHP
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKK-----ELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNG 149
++ + T+++++ V+EY GG+L ++R +L E AR Y ++ AL++ H+ G
Sbjct: 71 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 130
Query: 150 VAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML-HTACGTPAYTAPEVVARRGYD 208
+ +RD+K N+LLD +G++K++D+G+ E ++ G T CGTP Y APE++ Y
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYG 188
Query: 209 GAVADAWSCGVILFVLLAGYLPFDDSNLLA---------MYKKVNRRDYQFPSFVSKPAR 259
+V D W+ GV++F ++AG PFD +++ + + + P +S A
Sbjct: 189 FSV-DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 247
Query: 260 SLIYQLLDPNPKTRM------SIEKIMSISWFQ 286
S++ L+ +PK R+ I +F+
Sbjct: 248 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 1e-61
Identities = 53/291 (18%), Positives = 100/291 (34%), Gaps = 37/291 (12%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
+ +G G F V K DG I AIK +K + E +REV A L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKK--PLAGSVDEQNALREVYAHAVL 67
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-----GRLTESAARRYFQQLVSA 141
H +V++ A + + EY GG L + E+ + Q+
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 142 LHFCHQNGVAHRDVKPQNLLLDRDGNL-------------------KVSDFGLSALPEQI 182
L + H + H D+KP N+ + R K+ D G
Sbjct: 128 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT----- 182
Query: 183 KNGMLHTACGTPAYTAPEVVA-RRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYK 241
+ G + A EV+ + AD ++ + + + + +
Sbjct: 183 RISSPQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGD---QWH 238
Query: 242 KVNRRDY-QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQ 291
++ + + P +S+ L+ ++ P+P+ R S ++ S + ++
Sbjct: 239 EIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK 289
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 1e-61
Identities = 76/273 (27%), Positives = 142/273 (52%), Gaps = 29/273 (10%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL----QNHP 90
++GRGS+AKV + I A++ ++K + +D + V + + NHP
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKK-----ELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLVSALHFCHQNG 149
++ + T+++++ V+EY GG+L + R+ +L E AR Y ++ AL++ H+ G
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 173
Query: 150 VAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML-HTACGTPAYTAPEVVARRGYD 208
+ +RD+K N+LLD +G++K++D+G+ E ++ G T CGTP Y APE++ Y
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYG 231
Query: 209 GAVADAWSCGVILFVLLAGYLPFDDSNLLA---------MYKKVNRRDYQFPSFVSKPAR 259
+V D W+ GV++F ++AG PFD +++ + + + P +S A
Sbjct: 232 FSV-DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 290
Query: 260 SLIYQLLDPNPKTRM------SIEKIMSISWFQ 286
S++ L+ +PK R+ I +F+
Sbjct: 291 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 4e-61
Identities = 74/274 (27%), Positives = 122/274 (44%), Gaps = 31/274 (11%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR---LQNHPN 91
++GRG+F++V K G + A+K + K ++ V R +
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNK-----WDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 92 VLKIQEVMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNG 149
+ ++ + +YLVMEY GG+L L + R+ AR Y ++V A+ H+ G
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG 182
Query: 150 VAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML--HTACGTPAYTAPEVVARRG- 206
HRD+KP N+LLDR G+++++DFG + +G + A GTP Y +PE++ G
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCL--KLRADGTVRSLVAVGTPDYLSPEILQAVGG 240
Query: 207 ------YDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKV--NRRDYQFPSF---VS 255
Y D W+ GV + + G PF + Y K+ + P V
Sbjct: 241 GPGTGSYGPEC-DWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVP 299
Query: 256 KPARSLIYQLLDPNPKTRM---SIEKIMSISWFQ 286
+ AR I +LL P+TR+ + +F
Sbjct: 300 EEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF 332
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 8e-60
Identities = 71/284 (25%), Positives = 127/284 (44%), Gaps = 23/284 (8%)
Query: 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEK----NNKFLDAAM-E 73
I +N + + ++GRG F +V+ + G + A+K ++K + A+ E
Sbjct: 180 VELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE 239
Query: 74 DRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAAR 132
++ VS P ++ + T K+ +++ GG+L L + G +E+ R
Sbjct: 240 RIMLSLVSTGD----CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR 295
Query: 133 RYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACG 192
Y +++ L H V +RD+KP N+LLD G++++SD GL+ H + G
Sbjct: 296 FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASVG 352
Query: 193 TPAYTAPEVVARR-GYDGAVADAWSCGVILFVLLAGYLPFDDSN---LLAMYKKVNRRDY 248
T Y APEV+ + YD + D +S G +LF LL G+ PF + +
Sbjct: 353 THGYMAPEVLQKGVAYDSSA-DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 411
Query: 249 QFPSFVSKPARSLIYQLLDPNPKTRM-----SIEKIMSISWFQK 287
+ P S RSL+ LL + R+ +++ +F+
Sbjct: 412 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 1e-59
Identities = 72/271 (26%), Positives = 120/271 (44%), Gaps = 28/271 (10%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEK----NNKFLDAAMEDRIVREVSAMRRLQNHP 90
+LGRG F +V + A G + A K + K K AM ++ + +
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV------HSR 245
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELF-----GKLRRGRLTESAARRYFQQLVSALHFC 145
++ + TKT + LVM GG++ E A Y Q+VS L
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML-HTACGTPAYTAPEVVAR 204
HQ + +RD+KP+N+LLD DGN+++SD GL+ E GTP + APE++
Sbjct: 306 HQRNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 205 RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLA----MYKKVNRRDYQFPSFVSKPARS 260
YD +V D ++ GV L+ ++A PF + ++V + +P S ++
Sbjct: 364 EEYDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKD 422
Query: 261 LIYQLLDPNPKTRM-----SIEKIMSISWFQ 286
LL +P+ R+ S + + + F+
Sbjct: 423 FCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 4e-59
Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 27/269 (10%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEK----NNKFLDAAM-EDRIVREVSAMRRLQNH 89
+LG+G F +V + A G + A K +EK K A+ E +I+ +V N
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-------NS 243
Query: 90 PNVLKIQEVMATKTKIYLVMEYAAGGELF---GKLRRGRLTESAARRYFQQLVSALHFCH 146
V+ + TK + LV+ GG+L + + E+ A Y ++ L H
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 147 QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRG 206
+ + +RD+KP+N+LLD G++++SD GL+ + + GT Y APEVV
Sbjct: 304 RERIVYRDLKPENILLDDHGHIRISDLGLAV--HVPEGQTIKGRVGTVGYMAPEVVKNER 361
Query: 207 YDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR----DYQFPSFVSKPARSLI 262
Y + D W+ G +L+ ++AG PF ++V R ++ S ARSL
Sbjct: 362 YTFSP-DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLC 420
Query: 263 YQLLDPNPKTRM-----SIEKIMSISWFQ 286
QLL +P R+ S ++ F+
Sbjct: 421 SQLLCKDPAERLGCRGGSAREVKEHPLFK 449
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 6e-53
Identities = 70/332 (21%), Positives = 108/332 (32%), Gaps = 76/332 (22%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIK------------TIEKNNKFLDAAMED 74
L ++ +GRG F V +AK+ D AIK + + K L
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64
Query: 75 RIVREVSAMRRLQ-----------------------------------------NHPNVL 93
IVR +A + N +
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 94 KIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLT----ESAARRYFQQLVSALHFCHQNG 149
+ + K +Y+ M+ L + R F Q+ A+ F H G
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 150 VAHRDVKPQNLLLDRDGNLKVSDFGLS-----------ALPEQIKNGMLHTACGTPAYTA 198
+ HRD+KP N+ D +KV DFGL L GT Y +
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 199 PEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP---SFVS 255
PE + Y V D +S G+ILF LL Y + + V R+ +FP +
Sbjct: 245 PEQIHGNNYSHKV-DIFSLGLILFELL--YSFSTQMERVRIITDV--RNLKFPLLFTQKY 299
Query: 256 KPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287
++ +L P+P R I+ + F+
Sbjct: 300 PQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 3e-51
Identities = 73/281 (25%), Positives = 130/281 (46%), Gaps = 17/281 (6%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
+ +LG+G++ V+ + +++ +AIK I D+ + E++ + L
Sbjct: 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP----ERDSRYSQPLHEEIALHKHL 76
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR----RGRLTESAARRYFQQLVSAL 142
H N+++ + I + ME GG L LR + E Y +Q++ L
Sbjct: 77 -KHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 135
Query: 143 HFCHQNGVAHRDVKPQNLLLD-RDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEV 201
+ H N + HRD+K N+L++ G LK+SDFG S I N T GT Y APE+
Sbjct: 136 KYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI-NPCTETFTGTLQYMAPEI 194
Query: 202 V--ARRGYDGAVADAWSCGVILFVLLAGYLPFDD--SNLLAMYKKVNRRDY-QFPSFVSK 256
+ RGY A AD WS G + + G PF + AM+K + + + P +S
Sbjct: 195 IDKGPRGYGKA-ADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA 253
Query: 257 PARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQ 297
A++ I + +P+P R ++ + + S ++++ + +
Sbjct: 254 EAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPK 294
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 7e-51
Identities = 66/279 (23%), Positives = 104/279 (37%), Gaps = 22/279 (7%)
Query: 6 SPPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNN 65
P + ++ P +GRGSF +VH+ K G A+K +
Sbjct: 38 EGVLLTEKLKPVDYEYREE--VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--- 92
Query: 66 KFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-G 124
+E V E+ A L + P ++ + + + + ME GG L +++ G
Sbjct: 93 ------LEVFRVEELVACAGL-SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG 145
Query: 125 RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNL-KVSDFGLSALPEQIK 183
L E A Y Q + L + H + H DVK N+LL DG+ + DFG + +
Sbjct: 146 CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205
Query: 184 NGMLHTAC----GTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPF-DDSNLLA 238
G GT + APEVV + D D WS ++ +L G P+
Sbjct: 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPL 264
Query: 239 MYKKVNRR--DYQFPSFVSKPARSLIYQLLDPNPKTRMS 275
K + + P + I + L P R S
Sbjct: 265 CLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRAS 303
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-50
Identities = 64/269 (23%), Positives = 115/269 (42%), Gaps = 19/269 (7%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89
+ +GRGSF V+K VA ++ L + R E ++ LQ H
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--LTKSERQRFKEEAEMLKGLQ-H 84
Query: 90 PNVLKI----QEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHF 144
PN+++ + + K I LV E G L L+R + R + +Q++ L F
Sbjct: 85 PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 144
Query: 145 CHQNG--VAHRDVKPQNLLLD-RDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEV 201
H + HRD+K N+ + G++K+ D GL+ + GTP + APE+
Sbjct: 145 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKAVIGTPEFMAPEM 201
Query: 202 VARRGYDGAVADAWSCGVILFVLLAGYLPFDD-SNLLAMYKKVNRRD--YQFPSFVSKPA 258
YD +V D ++ G+ + + P+ + N +Y++V F
Sbjct: 202 Y-EEKYDESV-DVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259
Query: 259 RSLIYQLLDPNPKTRMSIEKIMSISWFQK 287
+ +I + N R SI+ +++ ++FQ+
Sbjct: 260 KEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-48
Identities = 71/260 (27%), Positives = 117/260 (45%), Gaps = 15/260 (5%)
Query: 31 QLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP 90
+ +G GSF VH+A+ GS VA+K + + + A + +REV+ M+RL HP
Sbjct: 40 NIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQD--FHAERVNEFLREVAIMKRL-RHP 94
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRG----RLTESAARRYFQQLVSALHFCH 146
N++ + + +V EY + G L+ L + +L E + +++ H
Sbjct: 95 NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 147 QNGVA--HRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVAR 204
HR++K NLL+D+ +KV DFGLS L +A GTP + APEV+
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS-KSAAGTPEWMAPEVLRD 213
Query: 205 RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQ--FPSFVSKPARSLI 262
+ D +S GVIL+ L P+ + N + V + + P ++ ++I
Sbjct: 214 EPSNEKS-DVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAII 272
Query: 263 YQLLDPNPKTRMSIEKIMSI 282
P R S IM +
Sbjct: 273 EGCWTNEPWKRPSFATIMDL 292
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 7e-48
Identities = 68/258 (26%), Positives = 115/258 (44%), Gaps = 15/258 (5%)
Query: 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMR 84
+ RY++ LG G + V+ A+ VAIK I R REV
Sbjct: 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSS 66
Query: 85 RLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALH 143
+L +H N++ + +V YLVMEY G L + G L+ A + Q++ +
Sbjct: 67 QL-SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125
Query: 144 FCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS-ALPEQIKNGMLHTAC--GTPAYTAPE 200
H + HRD+KPQN+L+D + LK+ DFG++ AL E + T GT Y +PE
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE---TSLTQTNHVLGTVQYFSPE 182
Query: 201 VVARRGYDGAVADAWSCGVILFVLLAGYLPFD-DSNLLAMYKKVNRRDYQFPSF----VS 255
A+ D +S G++L+ +L G PF+ ++ + K + + +
Sbjct: 183 -QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIP 241
Query: 256 KPARSLIYQLLDPNPKTR 273
+ ++I + + + R
Sbjct: 242 QSLSNVILRATEKDKANR 259
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 3e-47
Identities = 75/263 (28%), Positives = 113/263 (42%), Gaps = 27/263 (10%)
Query: 31 QLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP 90
++ ++GRG+F V KAK VAIK + + + E+ + R+ NHP
Sbjct: 11 EVEEVVGRGAFGVVCKAK--WRAKDVAIK------QIESESERKAFIVELRQLSRV-NHP 61
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGR----LTESAARRYFQQLVSA---LH 143
N++K+ A + LVMEYA GG L+ L T + A + Q LH
Sbjct: 62 NIVKL--YGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 144 FCHQNGVAHRDVKPQNLLLDRDGN-LKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVV 202
+ HRD+KP NLLL G LK+ DFG + + G+ A+ APEV
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNNKGSAAWMAPEVF 175
Query: 203 ARRGYDGAVADAWSCGVILFVLLAGYLPFDD-SNLLAMYKKVNRRDY--QFPSFVSKPAR 259
Y D +S G+IL+ ++ PFD+ + KP
Sbjct: 176 EGSNYSEKC-DVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE 234
Query: 260 SLIYQLLDPNPKTRMSIEKIMSI 282
SL+ + +P R S+E+I+ I
Sbjct: 235 SLMTRCWSKDPSQRPSMEEIVKI 257
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 3e-47
Identities = 84/264 (31%), Positives = 127/264 (48%), Gaps = 17/264 (6%)
Query: 23 IPTLL-NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVS 81
P+ L +RY+LG +LG G ++VH A+ + D VA+K + + + D + R RE
Sbjct: 6 TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQ 64
Query: 82 AMRRLQNHPNVLKI----QEVMATKTKIYLVMEYAAGGELFGKLR-RGRLTESAARRYFQ 136
L NHP ++ + + Y+VMEY G L + G +T A
Sbjct: 65 NAAAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA 123
Query: 137 QLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTAC--GTP 194
AL+F HQNG+ HRDVKP N+++ +KV DFG++ N + TA GT
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 195 AYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFD-DSNLLAMYKKVNRRDYQFPSF 253
Y +PE AR A +D +S G +L+ +L G PF DS + Y+ V D PS
Sbjct: 184 QYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-EDPIPPSA 241
Query: 254 ----VSKPARSLIYQLLDPNPKTR 273
+S +++ + L NP+ R
Sbjct: 242 RHEGLSADLDAVVLKALAKNPENR 265
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 4e-47
Identities = 83/314 (26%), Positives = 126/314 (40%), Gaps = 72/314 (22%)
Query: 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRI------ 76
+ + RY+ LG G FA V+KA+ IVAIK I+ L E +
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK-----LGHRSEAKDGINRTA 59
Query: 77 VREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGG-ELFGKLRRGRLTESAARRYF 135
+RE+ ++ L HPN++ + + K+ I LV ++ E+ K LT S + Y
Sbjct: 60 LREIKLLQELS-HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYM 118
Query: 136 QQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP- 194
+ L + HQ+ + HRD+KP NLLLD +G LK++DFGL+ + G+P
Sbjct: 119 LMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA------------KSFGSPN 166
Query: 195 -AYTAPEVVAR-----------RGYDGAVADAWSCGVILFVLLAG--YLP---------- 230
AYT +VV R R Y V D W+ G IL LL +LP
Sbjct: 167 RAYT-HQVVTRWYRAPELLFGARMYGVGV-DMWAVGCILAELLLRVPFLPGDSDLDQLTR 224
Query: 231 ------------------FDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKT 272
D + + F + LI L NP
Sbjct: 225 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHH-IFSAA-GDDLLDLIQGLFLFNPCA 282
Query: 273 RMSIEKIMSISWFQ 286
R++ + + + +F
Sbjct: 283 RITATQALKMKYFS 296
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 9e-47
Identities = 71/265 (26%), Positives = 117/265 (44%), Gaps = 20/265 (7%)
Query: 31 QLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP 90
L ++G G F KV++A G VA+K + + + + +E L HP
Sbjct: 10 TLEEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHP 66
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNG- 149
N++ ++ V + + LVME+A GG L L R+ + Q+ +++ H
Sbjct: 67 NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 150 --VAHRDVKPQNLLLDRDG--------NLKVSDFGLSALPEQIKNGMLHTACGTPAYTAP 199
+ HRD+K N+L+ + LK++DFGL+ +A G A+ AP
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE---WHRTTKMSAAGAYAWMAP 183
Query: 200 EVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY--QFPSFVSKP 257
EV+ + D WS GV+L+ LL G +PF + LA+ V PS +P
Sbjct: 184 EVIRASMFSKGS-DVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEP 242
Query: 258 ARSLIYQLLDPNPKTRMSIEKIMSI 282
L+ +P+P +R S I+
Sbjct: 243 FAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-46
Identities = 77/338 (22%), Positives = 133/338 (39%), Gaps = 77/338 (22%)
Query: 3 PGCSPPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIE 62
G P + T ++RY+ LG G++ +V+KA VAIK I
Sbjct: 9 MGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR 68
Query: 63 KNNKFLDAAMEDRI----VREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELF 118
L+ E+ + +REVS ++ LQ H N+++++ V+ +++L+ EYA +L
Sbjct: 69 -----LEHE-EEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNHRLHLIFEYAEN-DLK 120
Query: 119 GKL-RRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLD-----RDGNLKVSD 172
+ + ++ + + QL++ ++FCH HRD+KPQNLLL LK+ D
Sbjct: 121 KYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGD 180
Query: 173 FGLSALPEQIKNGMLHTACGTP--AYTAPEVVAR-----------RGYDGAVADAWSCGV 219
FGL+ A G P +T E++ R Y +V D WS
Sbjct: 181 FGLA------------RAFGIPIRQFT-HEIITLWYRPPEILLGSRHYSTSV-DIWSIAC 226
Query: 220 ILFVLLAG--YLPFDDSNL-----------------------LAMYKKV------NRRDY 248
I +L P DS + L +K+
Sbjct: 227 IWAEMLMKTPLFP-GDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKR 285
Query: 249 QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQ 286
+ + L+ +L+ +P R+S + + +F
Sbjct: 286 VLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS 323
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 4e-46
Identities = 64/270 (23%), Positives = 105/270 (38%), Gaps = 26/270 (9%)
Query: 31 QLGPLLGRGSFAKVHKAKSIADGSIVAIKTI---EKNNKFLDAAMEDRIVREVSAMRRLQ 87
+ +G+G F VHK + + D S+VAIK++ + + REV M L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL- 80
Query: 88 NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFC 145
NHPN++K+ +VME+ G+L+ +L + S R + + +
Sbjct: 81 NHPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 146 HQNGVA--HRDVKPQNLLLDRDG-----NLKVSDFGLSALPEQIKNGMLHTACGTPAYTA 198
HRD++ N+ L KV+DFGLS Q + G + A
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS----QQSVHSVSGLLGNFQWMA 194
Query: 199 PEVVARRG--YDGAVADAWSCGVILFVLLAGYLPFDDSNLLAM--YKKVNRRDY--QFPS 252
PE + Y D +S +IL+ +L G PFD+ + + + P
Sbjct: 195 PETIGAEEESYTEKA-DTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE 253
Query: 253 FVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282
R++I +PK R I+
Sbjct: 254 DCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 6e-46
Identities = 69/248 (27%), Positives = 101/248 (40%), Gaps = 11/248 (4%)
Query: 2 EPGCSPPSAPPPPPP-PPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKT 60
S P + T Y+L L+GRG V++A+ IVA+K
Sbjct: 7 HHHHSSGLVPRGSHMDGTAESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKL 66
Query: 61 IEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGK 120
+ D R+ RE RL P+V+ I + ++Y+ M G +L
Sbjct: 67 M-SETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAM 124
Query: 121 LRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGL-SAL 178
LRR G L A +Q+ SAL H G HRDVKP+N+L+ D + DFG+ SA
Sbjct: 125 LRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASAT 184
Query: 179 PEQIKNGMLHT--ACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNL 236
+ + GT Y APE + AD ++ +L+ L G P+ L
Sbjct: 185 TD---EKLTQLGNTVGTLYYMAPE-RFSESHATYRADIYALTCVLYECLTGSPPYQGDQL 240
Query: 237 LAMYKKVN 244
M +N
Sbjct: 241 SVMGAHIN 248
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 9e-46
Identities = 74/309 (23%), Positives = 130/309 (42%), Gaps = 68/309 (22%)
Query: 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR 85
++ +Y+ +G GS+ V K ++ G IVAIK D ++ +RE+ +++
Sbjct: 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF--LESEDDPVIKKIALREIRMLKQ 58
Query: 86 LQNHPNVLKIQEVMATKTKIYLVMEYAAG---GELFGKLRRGRLTESAARRYFQQLVSAL 142
L HPN++ + EV K +++LV EY EL + + E + Q + A+
Sbjct: 59 L-KHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHEL--DRYQRGVPEHLVKSITWQTLQAV 115
Query: 143 HFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP--AYT--- 197
+FCH++ HRDVKP+N+L+ + +K+ DFG + P Y
Sbjct: 116 NFCHKHNCIHRDVKPENILITKHSVIKLCDFGFA------------RLLTGPSDYYDDEV 163
Query: 198 ------APEV-VARRGYDGAVADAWSCGVILFVLLAG--YLPFDDSNL------------ 236
+PE+ V Y V D W+ G + LL+G P S++
Sbjct: 164 ATRWYRSPELLVGDTQYGPPV-DVWAIGCVFAELLSGVPLWP-GKSDVDQLYLIRKTLGD 221
Query: 237 -----------LAMYKKVNRRDYQ--------FPSFVSKPARSLIYQLLDPNPKTRMSIE 277
+ V D + FP+ +S PA L+ L +P R++ E
Sbjct: 222 LIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPN-ISYPALGLLKGCLHMDPTERLTCE 280
Query: 278 KIMSISWFQ 286
+++ +F+
Sbjct: 281 QLLHHPYFE 289
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-45
Identities = 56/268 (20%), Positives = 111/268 (41%), Gaps = 23/268 (8%)
Query: 31 QLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP 90
++G L+G+G F +V+ + + VAI+ I+ + REV A R+ H
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGE---VAIRLIDIER--DNEDQLKAFKREVMAYRQT-RHE 89
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGR--LTESAARRYFQQLVSALHFCHQN 148
NV+ + + ++ G L+ +R + L + R+ Q++V + + H
Sbjct: 90 NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK 149
Query: 149 GVAHRDVKPQNLLLDRDGNLKVSDFGLS----ALPEQIKNGMLHTACGTPAYTAPEVVAR 204
G+ H+D+K +N+ D +G + ++DFGL L + L G + APE++ +
Sbjct: 150 GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 205 RGYDGAV--------ADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNR--RDYQFPSFV 254
D +D ++ G I + L A PF A+ ++ + +
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGM 268
Query: 255 SKPARSLIYQLLDPNPKTRMSIEKIMSI 282
K ++ + R + K+M +
Sbjct: 269 GKEISDILLFCWAFEQEERPTFTKLMDM 296
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-45
Identities = 68/265 (25%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDR--IVREVSAMRRL 86
+ +G+GSF +V K +VAIK I+ L+ A ++ I +E++ + +
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-----LEEAEDEIEDIQQEITVLSQC 77
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCH 146
P V K TK++++MEY GG L G L E+ ++++ L + H
Sbjct: 78 D-SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLH 136
Query: 147 QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML--HTACGTPAYTAPEVVAR 204
HRD+K N+LL G +K++DFG++ Q+ + + +T GTP + APEV+ +
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQ 193
Query: 205 RGYDGAVADAWSCGVILFVLLAGYLPFDDSN-LLAMYKKVNRRDYQFPSFVSKPARSLIY 263
YD + AD WS G+ L G P + + + ++ SKP + +
Sbjct: 194 SAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE 252
Query: 264 QLLDPNPKTRMSIEKIMSISWFQKS 288
L+ P R + ++++ + ++
Sbjct: 253 ACLNKEPSFRPTAKELLKHKFILRN 277
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-45
Identities = 60/264 (22%), Positives = 108/264 (40%), Gaps = 20/264 (7%)
Query: 31 QLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP 90
+G +G GSF V+K K D VA+K + EV +R+ + H
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTA--PTPQQLQAFKNEVGVLRKTR-HV 80
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQN 148
N+L T ++ +V ++ G L+ L + +Q + + H
Sbjct: 81 NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK 139
Query: 149 GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTA-CGTPAYTAPEVVARRG- 206
+ HRD+K N+ L D +K+ DFGL+ + G+ + APEV+ +
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 207 --YDGAVADAWSCGVILFVLLAGYLPFDD-SNLLAMYKKVNR-----RDYQFPSFVSKPA 258
Y D ++ G++L+ L+ G LP+ + +N + + V R + S K
Sbjct: 200 NPYSFQS-DVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 258
Query: 259 RSLIYQLLDPNPKTRMSIEKIMSI 282
+ L+ + L R S +I++
Sbjct: 259 KRLMAECLKKKRDERPSFPRILAE 282
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-44
Identities = 80/329 (24%), Positives = 129/329 (39%), Gaps = 76/329 (23%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRI----VREVSA 82
+ Y LG G++A V+K KS ++VA+K I L+ E+ +REVS
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR-----LEH--EEGAPCTAIREVSL 53
Query: 83 MRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL--RRGRLTESAARRYFQQLVS 140
++ L+ H N++ + +++ T+ + LV EY +L L + + + QL+
Sbjct: 54 LKDLK-HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLR 111
Query: 141 ALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP--AYTA 198
L +CH+ V HRD+KPQNLL++ G LK++DFGL+ A P Y
Sbjct: 112 GLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLA------------RAKSIPTKTYD- 158
Query: 199 PEVVAR-----------RGYDGAVADAWSCGVILFVLLAG--YLPFDDSNL--------- 236
EVV Y + D W G I + + G P +
Sbjct: 159 NEVVTLWYRPPDILLGSTDYSTQI-DMWGVGCIFYEMATGRPLFP-GSTVEEQLHFIFRI 216
Query: 237 --------------LAMYKKVNRRDYQ-------FPSFVSKPARSLIYQLLDPNPKTRMS 275
+K N Y+ P L+ +LL + R+S
Sbjct: 217 LGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRL-DSDGADLLTKLLQFEGRNRIS 275
Query: 276 IEKIMSISWFQKSLQQQRKRGQESSLFEL 304
E M +F ++ K +S+F L
Sbjct: 276 AEDAMKHPFFLSLGERIHKLPDTTSIFAL 304
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-44
Identities = 72/313 (23%), Positives = 135/313 (43%), Gaps = 49/313 (15%)
Query: 13 PPPPPPPSKKIP-TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAA 71
++ + + +Y+ L+G GS+ V K ++ G IVAIK +++ D
Sbjct: 9 SSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD--DKM 66
Query: 72 MEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAG---GELFGKLRRGRLTE 128
++ +RE+ +++L H N++ + EV K + YLV E+ +L +L L
Sbjct: 67 VKKIAMREIKLLKQL-RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDL--ELFPNGLDY 123
Query: 129 SAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS-ALPEQIKNGML 187
++Y Q+++ + FCH + + HRD+KP+N+L+ + G +K+ DFG + L +
Sbjct: 124 QVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-YD 182
Query: 188 HTACGTPAYTAPEV-VARRGYDGAVADAWSCGVILFVLLAG--YLPFDDSNL-------- 236
T Y APE+ V Y AV D W+ G ++ + G P DS++
Sbjct: 183 DEVA-TRWYRAPELLVGDVKYGKAV-DVWAIGCLVTEMFMGEPLFP-GDSDIDQLYHIMM 239
Query: 237 ---------------LAMYKKVNRRDYQ--------FPSFVSKPARSLIYQLLDPNPKTR 273
++ V + + +P S+ L + L +P R
Sbjct: 240 CLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKL-SEVVIDLAKKCLHIDPDKR 298
Query: 274 MSIEKIMSISWFQ 286
+++ +FQ
Sbjct: 299 PFCAELLHHDFFQ 311
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-44
Identities = 61/277 (22%), Positives = 111/277 (40%), Gaps = 30/277 (10%)
Query: 3 PGCSPPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAK-SIADGSIVAIKTI 61
P C P + P P + +Y++ + G ++ A +G V +K +
Sbjct: 60 PYCGSPYSFLPQLNPGD-----IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGL 114
Query: 62 EKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI-----QEVMATKTKIYLVMEYAAGGE 116
+ DA + + E + + HP++++I Y+VMEY G
Sbjct: 115 VHSG---DAEAQAMAMAERQFLAEV-VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQS 170
Query: 117 LFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176
L + + +L + A Y +++ AL + H G+ + D+KP+N++L + LK+ D G
Sbjct: 171 L-KRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAV 228
Query: 177 ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNL 236
+ G L GTP + APE + R G A D ++ G L L + +
Sbjct: 229 SRINS--FGYL---YGTPGFQAPE-IVRTGPTVA-TDIYTVGRTLAALTLDLPTRNGRYV 281
Query: 237 LAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTR 273
+ D L+ + +DP+P+ R
Sbjct: 282 ----DGLPEDDPVLK--TYDSYGRLLRRAIDPDPRQR 312
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-44
Identities = 78/312 (25%), Positives = 127/312 (40%), Gaps = 77/312 (24%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRI----VREVSA 82
+ +Y+ +G G++ V KAK+ IVA+K + LD ++ + +RE+
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-----LDDD-DEGVPSSALREICL 54
Query: 83 MRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGEL----FGKLRRGRLTESAARRYFQQL 138
++ L+ H N++++ +V+ + K+ LV E+ + + G L + + QL
Sbjct: 55 LKELK-HKNIVRLHDVLHSDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVKSFLFQL 110
Query: 139 VSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP--AY 196
+ L FCH V HRD+KPQNLL++R+G LK+++FGL+ A G P Y
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA------------RAFGIPVRCY 158
Query: 197 TAPEVVAR-----------RGYDGAVADAWSCGVILFVLLAGYLP--------------F 231
+ EVV + Y ++ D WS G I L P F
Sbjct: 159 S-AEVVTLWYRPPDVLFGAKLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216
Query: 232 D-----------------DSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRM 274
D MY P + R L+ LL NP R+
Sbjct: 217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKL-NATGRDLLQNLLKCNPVQRI 275
Query: 275 SIEKIMSISWFQ 286
S E+ + +F
Sbjct: 276 SAEEALQHPYFS 287
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-43
Identities = 83/324 (25%), Positives = 142/324 (43%), Gaps = 74/324 (22%)
Query: 13 PPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAM 72
+ L+ +YQ +G G++ V+KAK + G IVA+K I LDA
Sbjct: 6 HHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIR-----LDAE- 58
Query: 73 EDRI----VREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGG-ELFGKLRRGRLT 127
++ I +RE+S ++ L HPN++ + +V+ ++ + LV E+ + + L
Sbjct: 59 DEGIPSTAIREISLLKELH-HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQ 117
Query: 128 ESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML 187
+S + Y QL+ + CHQ+ + HRD+KPQNLL++ DG LK++DFGL+
Sbjct: 118 DSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA----------- 166
Query: 188 HTACGTP--AYTAPEVVAR-----------RGYDGAVADAWSCGVILFVLLAG--YLPFD 232
A G P +YT EVV + Y +V D WS G I ++ G P
Sbjct: 167 -RAFGIPVRSYT-HEVVTLWYRAPDVLMGSKKYSTSV-DIWSIGCIFAEMITGKPLFP-G 222
Query: 233 DSNL-----------------------LAMYKKVNRRDYQ-------FPSFVSKPARSLI 262
++ L ++K+ + ++ P F + L+
Sbjct: 223 VTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGF-CQEGIDLL 281
Query: 263 YQLLDPNPKTRMSIEKIMSISWFQ 286
+L +P R+S M+ +F+
Sbjct: 282 SNMLCFDPNKRISARDAMNHPYFK 305
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-43
Identities = 74/285 (25%), Positives = 123/285 (43%), Gaps = 24/285 (8%)
Query: 6 SPPSAPPPPPPPPPSKKIPTLLN----------RYQLGPLLGRGSFAKVHKAKSIADGSI 55
++ L +G GS V A+ G
Sbjct: 13 LGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQ 72
Query: 56 VAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGG 115
VA+K ++ + + EV MR Q H NV+++ + +++++ME+ GG
Sbjct: 73 VAVKMMDLRK----QQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELWVLMEFLQGG 127
Query: 116 ELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGL 175
L + + RL E + ++ AL + H GV HRD+K ++LL DG +K+SDFG
Sbjct: 128 ALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGF 187
Query: 176 SALPEQIKNGML--HTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLP-FD 232
A QI + + GTP + APEV++R Y V D WS G+++ ++ G P F
Sbjct: 188 CA---QISKDVPKRKSLVGTPYWMAPEVISRSLYATEV-DIWSLGIMVIEMVDGEPPYFS 243
Query: 233 DSNLLAMYK--KVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMS 275
DS + AM + + VS R + ++L +P+ R +
Sbjct: 244 DSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERAT 288
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-43
Identities = 49/266 (18%), Positives = 101/266 (37%), Gaps = 28/266 (10%)
Query: 31 QLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP 90
L ++ K + G+ + +K ++ + E +R +HP
Sbjct: 13 NFLTKLNENHSGELWKGR--WQGNDIVVKVLKVRD--WSTRKSRDFNEECPRLRIF-SHP 67
Query: 91 NVLKIQEVMA-----TKTKIYLVMEYAAGGELFGKLRRGR---LTESAARRYFQQLVSAL 142
NVL V+ L+ + G L+ L G + +S A ++ + +
Sbjct: 68 NVLP---VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124
Query: 143 HFCH--QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPE 200
F H + + + +++++D D ++S + + PA+ APE
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK------FSFQSPGRMYAPAWVAPE 178
Query: 201 VVARRGYDGAV--ADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQ--FPSFVSK 256
+ ++ D AD WS V+L+ L+ +PF D + + + KV + P +S
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP 238
Query: 257 PARSLIYQLLDPNPKTRMSIEKIMSI 282
L+ ++ +P R + I+ I
Sbjct: 239 HVSKLMKICMNEDPAKRPKFDMIVPI 264
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 5e-43
Identities = 73/313 (23%), Positives = 121/313 (38%), Gaps = 70/313 (22%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRI------VREV 80
+RY+ +G G++ V+KA+ G VA+K++ + VREV
Sbjct: 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR-----VPNGGGGGGGLPISTVREV 62
Query: 81 SAMRRLQ--NHPNVLKIQEVMATK-----TKIYLVMEYAAG--GELFGKLRRGRLTESAA 131
+ +RRL+ HPNV+++ +V AT K+ LV E+ K L
Sbjct: 63 ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI 122
Query: 132 RRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTAC 191
+ +Q + L F H N + HRD+KP+N+L+ G +K++DFGL+
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA------------RIY 170
Query: 192 GTPA----------YTAPEVVARRGYDGAVADAWSCGVILFVLLAG--YLPFDD------ 233
Y APEV+ + Y V D WS G I + +
Sbjct: 171 SYQMALTPVVVTLWYRAPEVLLQSTYATPV-DMWSVGCIFAEMFRRKPLFCGNSEADQLG 229
Query: 234 --SNLL-----AMYKKVNR-RDYQFPSFVSKP-----------ARSLIYQLLDPNPKTRM 274
+L+ + + FP +P L+ ++L NP R+
Sbjct: 230 KIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRI 289
Query: 275 SIEKIMSISWFQK 287
S + + S+ K
Sbjct: 290 SAFRALQHSYLHK 302
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 6e-43
Identities = 77/317 (24%), Positives = 131/317 (41%), Gaps = 81/317 (25%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRI----VREVSAM 83
++++ LG G++A V+K + G VA+K ++ LD+ E+ +RE+S M
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK-----LDS--EEGTPSTAIREISLM 57
Query: 84 RRLQNHPNVLKIQEVMATKTKIYLVMEYAAG------GELFGKLRRGRLTESAARRYFQQ 137
+ L+ H N++++ +V+ T+ K+ LV E+ L + + + Q
Sbjct: 58 KELK-HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 138 LVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP--A 195
L+ L FCH+N + HRD+KPQNLL+++ G LK+ DFGL+ A G P
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA------------RAFGIPVNT 164
Query: 196 YTAPEVVAR-----------RGYDGAVADAWSCGVILFVLLAG----------------- 227
++ EVV R Y ++ D WSCG IL ++ G
Sbjct: 165 FS-SEVVTLWYRAPDVLMGSRTYSTSI-DIWSCGCILAEMITGKPLFPGTNDEEQLKLIF 222
Query: 228 ---------------YLPFDDSNLLAMYKKVNRRD---YQFPSFVSKPARSLIYQLLDPN 269
LP + + + R + ++ LL N
Sbjct: 223 DIMGTPNESLWPSVTKLP-KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLN 281
Query: 270 PKTRMSIEKIMSISWFQ 286
P R+S ++ + WF
Sbjct: 282 PDMRLSAKQALHHPWFA 298
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 7e-43
Identities = 79/296 (26%), Positives = 134/296 (45%), Gaps = 33/296 (11%)
Query: 18 PPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDR-- 75
+ + Y+L ++G G+ A V A VAIK I L+
Sbjct: 5 SSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN-----LEKCQTSMDE 59
Query: 76 IVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELF---------GKLRRGRL 126
+++E+ AM + +HPN++ K +++LVM+ +GG + G+ + G L
Sbjct: 60 LLKEIQAMSQC-HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVL 118
Query: 127 TESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM 186
ES ++++ L + H+NG HRDVK N+LL DG+++++DFG+SA +
Sbjct: 119 DESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDIT 178
Query: 187 L----HTACGTPAYTAPEVVAR-RGYDGAVADAWSCGVILFVLLAGYLPFDDSN-LLAMY 240
T GTP + APEV+ + RGYD AD WS G+ L G P+ + +
Sbjct: 179 RNKVRKTFVGTPCWMAPEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLM 237
Query: 241 K---------KVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287
+ +D + K R +I L +P+ R + +++ +FQK
Sbjct: 238 LTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-42
Identities = 75/252 (29%), Positives = 124/252 (49%), Gaps = 14/252 (5%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN 88
+Y +G+G+ V+ A +A G VAI+ + ++ I+ E+ MR +
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ----QPKKELIINEILVMRENK- 75
Query: 89 HPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQN 148
+PN++ + ++++VMEY AGG L + + E ++ + AL F H N
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 149 GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML--HTACGTPAYTAPEVVARRG 206
V HRD+K N+LL DG++K++DFG A QI T GTP + APEVV R+
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCA---QITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 207 YDGAVADAWSCGVILFVLLAGYLP-FDDSNLLAMYK--KVNRRDYQFPSFVSKPARSLIY 263
Y V D WS G++ ++ G P +++ L A+Y + Q P +S R +
Sbjct: 193 YGPKV-DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251
Query: 264 QLLDPNPKTRMS 275
+ L+ + + R S
Sbjct: 252 RCLEMDVEKRGS 263
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-42
Identities = 72/308 (23%), Positives = 132/308 (42%), Gaps = 71/308 (23%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAME---DRIVREVSAM 83
+ +Y +G G++ V+KA++ G A+K I L+ E +RE+S +
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIR-----LEKEDEGIPSTTIREISIL 54
Query: 84 RRLQNHPNVLKIQEVMATKTKIYLVMEYAAGG-ELFGKLRRGRLTESAARRYFQQLVSAL 142
+ L+ H N++K+ +V+ TK ++ LV E+ + + G L A+ + QL++ +
Sbjct: 55 KELK-HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 143 HFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP--AYTAPE 200
+CH V HRD+KPQNLL++R+G LK++DFGL+ A G P YT E
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGELKIADFGLA------------RAFGIPVRKYT-HE 160
Query: 201 VVAR-----------RGYDGAVADAWSCGVILFVLLAG--YLPFDD-------------- 233
+V + Y + D WS G I ++ G P
Sbjct: 161 IVTLWYRAPDVLMGSKKYSTTI-DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT 219
Query: 234 ---------SNL------LAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEK 278
+ L +Y+ + + L+ ++L +P R++ ++
Sbjct: 220 PNSKNWPNVTELPKYDPNFTVYEPLPWES-FLKGL-DESGIDLLSKMLKLDPNQRITAKQ 277
Query: 279 IMSISWFQ 286
+ ++F+
Sbjct: 278 ALEHAYFK 285
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 7e-42
Identities = 45/278 (16%), Positives = 86/278 (30%), Gaps = 42/278 (15%)
Query: 6 SPPSAPPPPPPPPPSKKIP---TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIE 62
PP + +P RY+L G + +A A VA+ ++
Sbjct: 6 LREPDRESSAPPDDVQLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVD 65
Query: 63 KNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR 122
L + + + R+ + P V ++ +V+ T+ +V E+ GG L ++
Sbjct: 66 PQGV-LPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHTRAGGLVVAEWIRGGSL-QEVA 122
Query: 123 RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182
+ A R Q L +A H+ GVA P + + DG++ +
Sbjct: 123 DTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVL------------ 170
Query: 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKK 242
PA D G L+ LL P ++ + +
Sbjct: 171 ---------AYPATMPDA--------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP 213
Query: 243 VNRRDYQFP-------SFVSKPARSLIYQLLDPNPKTR 273
R P + ++ + + + R
Sbjct: 214 AERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR 251
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-41
Identities = 70/276 (25%), Positives = 129/276 (46%), Gaps = 35/276 (12%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
++L L+G G++ +V+K + + G + AIK ++ + E+ I +E++ +++
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-----VTGDEEEEIKQEINMLKKYS 78
Query: 88 NHPNVLK------IQEVMATKTKIYLVMEYAAGG---ELFGKLRRGRLTESAARRYFQQL 138
+H N+ + +++LVME+ G +L + L E +++
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 138
Query: 139 VSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML--HTACGTPAY 196
+ L HQ+ V HRD+K QN+LL + +K+ DFG+SA Q+ + +T GTP +
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFIGTPYW 195
Query: 197 TAPEVVARR-----GYDGAVADAWSCGVILFVLLAGYLPFDDSN-LLAMYKKVNR----- 245
APEV+A YD +D WS G+ + G P D + + A++
Sbjct: 196 MAPEVIACDENPDATYDF-KSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL 254
Query: 246 RDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281
+ ++ SK +S I L N R + E++M
Sbjct: 255 KSKKW----SKKFQSFIESCLVKNHSQRPATEQLMK 286
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-41
Identities = 63/283 (22%), Positives = 122/283 (43%), Gaps = 25/283 (8%)
Query: 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREV 80
++ +N + +G G+ +V K + G ++A+K + ++ + RI+ ++
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS---GNKEENKRILMDL 74
Query: 81 SAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGG-ELFGKLRRGRLTESAARRYFQQLV 139
+ + + P +++ T T +++ ME E K +G + E + +V
Sbjct: 75 DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIV 134
Query: 140 SALHFCH-QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTA-CGTPAYT 197
AL++ ++GV HRDVKP N+LLD G +K+ DFG+S ++ + G AY
Sbjct: 135 KALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYM 191
Query: 198 APEVVARRGYDGAV----ADAWSCGVILFVLLAGYLPFDD--SNLLAMYKKVN------R 245
APE + AD WS G+ L L G P+ + ++ + K +
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP 251
Query: 246 RDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288
F S +S + L + + R K++ S+ ++
Sbjct: 252 GHMGF----SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-41
Identities = 74/254 (29%), Positives = 127/254 (50%), Gaps = 18/254 (7%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN 88
+ + LG GS+ V+KA G IVAIK + +++ +++ I++E+S M++
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-----VESDLQE-IIKEISIMQQCD- 82
Query: 89 HPNVLKIQEVMATKTKIYLVMEYAAGGELFG--KLRRGRLTESAARRYFQQLVSALHFCH 146
P+V+K T +++VMEY G + +LR LTE Q + L + H
Sbjct: 83 SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 147 QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML--HTACGTPAYTAPEVVAR 204
HRD+K N+LL+ +G+ K++DFG++ Q+ + M +T GTP + APEV+
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAG---QLTDTMAKRNTVIGTPFWMAPEVIQE 199
Query: 205 RGYDGAVADAWSCGVILFVLLAGYLPFDDSN-LLAMYK--KVNRRDYQFPSFVSKPARSL 261
GY+ VAD WS G+ + G P+ D + + A++ ++ P S
Sbjct: 200 IGYNC-VADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDF 258
Query: 262 IYQLLDPNPKTRMS 275
+ Q L +P+ R +
Sbjct: 259 VKQCLVKSPEQRAT 272
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 6e-41
Identities = 59/250 (23%), Positives = 108/250 (43%), Gaps = 12/250 (4%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
LG G+ V K G ++A K I A+ ++I+RE+ + N P ++
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHEC-NSPYIVGF 96
Query: 96 QEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNG-VAHR 153
+ +I + ME+ GG L L++ GR+ E + ++ L + + + HR
Sbjct: 97 YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 156
Query: 154 DVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVAD 213
DVKP N+L++ G +K+ DFG+S Q+ + M ++ GT +Y +PE + Y +D
Sbjct: 157 DVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFVGTRSYMSPERLQGTHYSVQ-SD 212
Query: 214 AWSCGVILFVLLAGYLPF--DDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPK 271
WS G+ L + G P D+ L + + + +
Sbjct: 213 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSR 272
Query: 272 TRMSIEKIMS 281
M+I +++
Sbjct: 273 PPMAIFELLD 282
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-41
Identities = 63/289 (21%), Positives = 121/289 (41%), Gaps = 26/289 (8%)
Query: 18 PPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIV 77
P + + +GRG++ V+K G I+A+K I +D + +++
Sbjct: 12 SPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST---VDEKEQKQLL 68
Query: 78 REVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGG-----ELFGKLRRGRLTESAAR 132
++ + R + P +++ + + ++ ME + + + + E
Sbjct: 69 MDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG 128
Query: 133 RYFQQLVSALHFCHQNG-VAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTAC 191
+ V AL+ +N + HRD+KP N+LLDR GN+K+ DFG+S Q+ + + T
Sbjct: 129 KITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRD 185
Query: 192 -GTPAYTAPEVVA----RRGYDGAVADAWSCGVILFVLLAGYLPFDDSN--LLAMYKKVN 244
G Y APE + R+GYD +D WS G+ L+ L G P+ N + + V
Sbjct: 186 AGCRPYMAPERIDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK 244
Query: 245 R-----RDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288
+ + F S + + L + R ++++ +
Sbjct: 245 GDPPQLSNSEEREF-SPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-40
Identities = 72/310 (23%), Positives = 124/310 (40%), Gaps = 70/310 (22%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIAD-GSIVAIKTIEKNNKFLDAAMEDRI----VREVSA 82
+Y+ +G G++ KV KA+ + + G VA+K + + E+ + +REV+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-----VQTG-EEGMPLSTIREVAV 64
Query: 83 MRRLQ--NHPNVLKIQEVMAT-----KTKIYLVMEYAAG--GELFGKLRRGRLTESAARR 133
+R L+ HPNV+++ +V +TK+ LV E+ K+ + +
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 124
Query: 134 YFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGT 193
QL+ L F H + V HRD+KPQN+L+ G +K++DFGL+
Sbjct: 125 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA------------RIYSF 172
Query: 194 PA----------YTAPEVVARRGYDGAVADAWSCGVILFVLLAG--YLPFDD-------- 233
Y APEV+ + Y V D WS G I +
Sbjct: 173 QMALTSVVVTLWYRAPEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 231
Query: 234 SNLL-----AMYKKVNR-RDYQFPSFVSKP-----------ARSLIYQLLDPNPKTRMSI 276
+++ + + F S ++P + L+ + L NP R+S
Sbjct: 232 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 291
Query: 277 EKIMSISWFQ 286
+S +FQ
Sbjct: 292 YSALSHPYFQ 301
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-40
Identities = 65/270 (24%), Positives = 111/270 (41%), Gaps = 24/270 (8%)
Query: 31 QLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP 90
G +LG+G F + K G ++ +K + + D + ++EV MR L+ HP
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR----FDEETQRTFLKEVKVMRCLE-HP 67
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQN 148
NVLK V+ ++ + EY GG L G ++ + S + + + S + + H
Sbjct: 68 NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM 127
Query: 149 GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN-------------GMLHTACGTPA 195
+ HRD+ N L+ + N+ V+DFGL+ L K +T G P
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 196 YTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL-AMYKKVNRRDY--QFPS 252
+ APE++ R YD V D +S G++L ++ D + R P
Sbjct: 188 WMAPEMINGRSYDEKV-DVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPP 246
Query: 253 FVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282
+ + D +P+ R S K+
Sbjct: 247 NCPPSFFPITVRCCDLDPEKRPSFVKLEHW 276
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-40
Identities = 75/259 (28%), Positives = 127/259 (49%), Gaps = 21/259 (8%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN 88
+++ LG G+F KV+KAK+ G++ A K IE + + +ED + E+ +
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELED-YIVEIEILATCD- 74
Query: 89 HPNVLKIQEVMATKTKIYLVMEYAAGGEL--FGKLRRGRLTESAARRYFQQLVSALHFCH 146
HP ++K+ K+++++E+ GG + LTE + +Q++ AL+F H
Sbjct: 75 HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH 134
Query: 147 QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML--HTACGTPAYTAPEVVAR 204
+ HRD+K N+L+ +G+++++DFG+SA + + + GTP + APEVV
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSA---KNLKTLQKRDSFIGTPYWMAPEVVMC 191
Query: 205 R-----GYDGAVADAWSCGVILFVLLAGYLPFDDSN-LLAMYK--KVNRRDYQFPSFVSK 256
YD AD WS G+ L + P + N + + K K + PS S
Sbjct: 192 ETMKDTPYDY-KADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSV 250
Query: 257 PARSLIYQLLDPNPKTRMS 275
R + LD NP+TR S
Sbjct: 251 EFRDFLKIALDKNPETRPS 269
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-39
Identities = 72/296 (24%), Positives = 124/296 (41%), Gaps = 34/296 (11%)
Query: 3 PGCSPPSAPPPPPPPPPSKKIPTLLN--------------RYQLGPLLGRGSFAKVHKAK 48
P P P + +L + + +G GSF V+ A+
Sbjct: 15 PTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFAR 74
Query: 49 SIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108
+ + +VAIK + + K + +D I++EV +++L+ HPN ++ + + +LV
Sbjct: 75 DVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKLR-HPNTIQYRGCYLREHTAWLV 132
Query: 109 MEYAAGGEL-FGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN 167
MEY G ++ + L E + L + H + + HRDVK N+LL G
Sbjct: 133 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL 192
Query: 168 LKVSDFGLSALPEQI--KNGMLHTACGTPAYTAPEVVA---RRGYDGAVADAWSCGVILF 222
+K+ DFG ++ + N + GTP + APEV+ YDG D WS G+
Sbjct: 193 VKLGDFGSAS---IMAPANSFV----GTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCI 244
Query: 223 VLLAGYLPFDDSN-LLAMYK--KVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMS 275
L P + N + A+Y + Q + S+ R+ + L P+ R +
Sbjct: 245 ELAERKPPLFNMNAMSALYHIAQNESPALQSGHW-SEYFRNFVDSCLQKIPQDRPT 299
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 7e-39
Identities = 63/266 (23%), Positives = 112/266 (42%), Gaps = 20/266 (7%)
Query: 36 LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95
LGRG++ V K + + G I+A+K I +++ + R++ ++ R + P +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRAT---VNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 96 QEVMATKTKIYLVMEYAAGG-ELFGKL---RRGRLTESAARRYFQQLVSALHFCHQNG-V 150
+ + +++ ME + F K + + E + +V AL H V
Sbjct: 72 YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131
Query: 151 AHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM-LHTACGTPAYTAPEVVA----RR 205
HRDVKP N+L++ G +K+ DFG+S + + + G Y APE + ++
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPERINPELNQK 188
Query: 206 GYDGAVADAWSCGVILFVLLAGYLPFDDSN--LLAMYKKVNRRDYQFPSFV-SKPARSLI 262
GY +D WS G+ + L P+D + + V Q P+ S
Sbjct: 189 GYSVK-SDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFT 247
Query: 263 YQLLDPNPKTRMSIEKIMSISWFQKS 288
Q L N K R + ++M +F
Sbjct: 248 SQCLKKNSKERPTYPELMQHPFFTLH 273
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-38
Identities = 77/331 (23%), Positives = 131/331 (39%), Gaps = 83/331 (25%)
Query: 17 PPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMED-R 75
+++Y+ +G+G+F +V KA+ G VA+K + ++ E
Sbjct: 6 DSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-----MENEKEGFP 60
Query: 76 I--VREVSAMRRLQNHPNVLKIQEVM--------ATKTKIYLVMEYAAGGELFGKL--RR 123
I +RE+ ++ L H NV+ + E+ K IYLV ++ +L G L
Sbjct: 61 ITALREIKILQLL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL 118
Query: 124 GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183
+ T S +R Q L++ L++ H+N + HRD+K N+L+ RDG LK++DFGL+
Sbjct: 119 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA------- 171
Query: 184 NGMLHTACGTPA------YTAPEVVAR-----------RGYDGAVADAWSCGVILFVLLA 226
A YT VV R Y + D W G I+ +
Sbjct: 172 -----RAFSLAKNSQPNRYT-NRVVTLWYRPPELLLGERDYGPPI-DLWGAGCIMAEMWT 224
Query: 227 G--YLPFDD--------SNL--------------LAMYKKVNRRDYQ-------FPSFVS 255
+ + S L +Y+K+ Q ++V
Sbjct: 225 RSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVR 284
Query: 256 KP-ARSLIYQLLDPNPKTRMSIEKIMSISWF 285
P A LI +LL +P R+ + ++ +F
Sbjct: 285 DPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 1e-38
Identities = 58/289 (20%), Positives = 110/289 (38%), Gaps = 22/289 (7%)
Query: 28 NRYQLGPLLGRG--SFAKVHKAKSIADGSIVAIKTI--EKNNKFLDAAMEDRIVREVSAM 83
Y+L ++G+G V+ A+ G V ++ I E + M + E+
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN----EMVTFLQGELHVS 80
Query: 84 RRLQNHPNVLKIQEVMATKTKIYLVMEYAAGG---ELFGKLRRGRLTESAARRYFQQLVS 140
+ NHPN++ + ++++V + A G +L + E A Q ++
Sbjct: 81 KLF-NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK 139
Query: 141 ALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA--LPEQIKNGMLHTAC----GTP 194
AL + H G HR VK ++L+ DG + +S + + + ++H
Sbjct: 140 ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 195 AYTAPEVVAR--RGYDGAVADAWSCGVILFVLLAGYLPFDDSN-LLAMYKKVNRRDYQFP 251
+ +PEV+ + +GYD +D +S G+ L G++PF D + +K+N
Sbjct: 200 PWLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258
Query: 252 SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESS 300
+ PA L + +S S + S
Sbjct: 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFS 307
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-38
Identities = 63/294 (21%), Positives = 112/294 (38%), Gaps = 50/294 (17%)
Query: 31 QLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP 90
L +G+G + +V + G VA+K ++ E E+ L+ H
Sbjct: 11 TLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDE-KSWFRE----TELYNTVMLR-HE 62
Query: 91 NVLK----IQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCH 146
N+L + T+++L+ Y G L+ L+ L + R + S L H
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLH 122
Query: 147 --------QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML---HTACGTPA 195
+ +AHRD+K +N+L+ ++G ++D GL+ + Q N + + GT
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 196 YTAPEVVARRGYDGAV-----ADAWSCGVILFVLLAGY----------LPFDDSN----- 235
Y APEV+ D W+ G++L+ + PF D
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242
Query: 236 LLAMYKKVNRRDY--QFPS-FVSKPARSLIYQLL----DPNPKTRMSIEKIMSI 282
M K V P+ + S P + + +L+ NP R++ +I
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-37
Identities = 66/303 (21%), Positives = 124/303 (40%), Gaps = 58/303 (19%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
+ YQL LGRG +++V +A +I + V +K ++ + +I RE+ + L+
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-------VKKKKIKREIKILENLR 88
Query: 88 NHPNVLKIQEVM--ATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFC 145
PN++ + +++ LV E+ + K LT+ R Y +++ AL +C
Sbjct: 89 GGPNIITLADIVKDPVSRTPALVFEHVNNTDF--KQLYQTLTDYDIRFYMYEILKALDYC 146
Query: 146 HQNGVAHRDVKPQNLLLDRD-GNLKVSDFGL--SALPEQIKNGMLHTACGTPAYTAPEV- 201
H G+ HRDVKP N+++D + L++ D+GL P Q N + + + PE+
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY----FKGPELL 202
Query: 202 VARRGYDGAVADAWSCGVILFVLLAGYLPF--------------------DDSNLLAMYK 241
V + YD ++ D WS G +L ++ PF D + + Y
Sbjct: 203 VDYQMYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261
Query: 242 KVNRRDY--QFPSFVSKPARSLI----YQLLDP------------NPKTRMSIEKIMSIS 283
+ K + L+ P + ++R++ + M
Sbjct: 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321
Query: 284 WFQ 286
+F
Sbjct: 322 YFY 324
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-36
Identities = 66/317 (20%), Positives = 119/317 (37%), Gaps = 53/317 (16%)
Query: 6 SPPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNN 65
S P + I + L +G+G F +V + K G VA+K
Sbjct: 23 MTTSGSGSGLPLLVQRTIARTI---VLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE 77
Query: 66 KFLDAAMEDRIVREVSAMRRLQNHPNVLK----IQEVMATKTKIYLVMEYAAGGELFGKL 121
+ E E+ L+ H N+L + T T+++LV +Y G LF L
Sbjct: 78 E-RSWFRE----AEIYQTVMLR-HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL 131
Query: 122 RRGRLTESAARRYFQQLVSALHFCHQN--------GVAHRDVKPQNLLLDRDGNLKVSDF 173
R +T + S L H +AHRD+K +N+L+ ++G ++D
Sbjct: 132 NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191
Query: 174 GLSALPEQIKNGM---LHTACGTPAYTAPEVVARRGYDGAV-----ADAWSCGVILFVLL 225
GL+ + + + + GT Y APEV+ AD ++ G++ + +
Sbjct: 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
Query: 226 AGY----------LPFD-----DSNLLAMYKKVNRRDY--QFPS-FVSKPARSLIYQLL- 266
LP+ D ++ M K V + P+ + S A ++ +++
Sbjct: 252 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR 311
Query: 267 ---DPNPKTRMSIEKIM 280
N R++ +I
Sbjct: 312 ECWYANGAARLTALRIK 328
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-36
Identities = 62/232 (26%), Positives = 105/232 (45%), Gaps = 31/232 (13%)
Query: 18 PPSKKIPTLLNRYQ-LGPLLGRGSFAKVHKA--KSIADGSIVAIKTIEKNNKFLDAAMED 74
S + + + ++ G +GRG++ V+KA K D A+K IE +A
Sbjct: 10 KLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSA--- 65
Query: 75 RIVREVSAMRRLQNHPNVLKIQEVMATKT--KIYLVMEYA---------AGGELFGKLRR 123
RE++ +R L+ HPNV+ +Q+V + K++L+ +YA +
Sbjct: 66 --CREIALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKP 122
Query: 124 GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN----LKVSDFGLSALP 179
+L + Q++ +H+ H N V HRD+KP N+L+ +G +K++D G + L
Sbjct: 123 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
Query: 180 EQIKNGMLHTACG--TPAYTAPEVV--ARRGYDGAVADAWSCGVILFVLLAG 227
+ T Y APE++ AR Y A+ D W+ G I LL
Sbjct: 183 NSPLKPLADLDPVVVTFWYRAPELLLGARH-YTKAI-DIWAIGCIFAELLTS 232
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-36
Identities = 71/330 (21%), Positives = 125/330 (37%), Gaps = 69/330 (20%)
Query: 1 MEPGCSPPSAPPPPPPPP--PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAI 58
+E S S P +K+I Q+ +G+G + +V K G VA+
Sbjct: 15 IEQSQSSGSGSGLPLLVQRTIAKQI-------QMVKQIGKGRYGEVWMGKW--RGEKVAV 65
Query: 59 KTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK----IQEVMATKTKIYLVMEYAAG 114
K + E E+ ++ H N+L + + T++YL+ +Y
Sbjct: 66 KVF-FTTEEASWFRE----TEIYQTVLMR-HENILGFIAADIKGTGSWTQLYLITDYHEN 119
Query: 115 GELFGKLRRGRLTESAARRYFQQLVSALHFCH--------QNGVAHRDVKPQNLLLDRDG 166
G L+ L+ L + + VS L H + +AHRD+K +N+L+ ++G
Sbjct: 120 GSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179
Query: 167 NLKVSDFGLSALPEQIKN---GMLHTACGTPAYTAPEVVARRGYDGAV----------AD 213
++D GL+ N +T GT Y PEV D ++ AD
Sbjct: 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV-----LDESLNRNHFQSYIMAD 234
Query: 214 AWSCGVIL---------FVLLAGY-LPFD-----DSNLLAMYKKVNRRDY--QFPSFVSK 256
+S G+IL ++ Y LP+ D + M + V + FP+ S
Sbjct: 235 MYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSS 294
Query: 257 PA-----RSLIYQLLDPNPKTRMSIEKIMS 281
L+ + NP +R++ ++
Sbjct: 295 DECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 78/302 (25%), Positives = 125/302 (41%), Gaps = 59/302 (19%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN 88
Y ++G GSF V++AK G +VAIK + D RE+ MR+L +
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDK---RFKNRELQIMRKL-D 105
Query: 89 HPNVLKIQEVMATKT------KIYLVMEYAAGGELFGKLR-----RGRLTESAARRYFQQ 137
H N+++++ + + LV++Y ++ R + L + Y Q
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQ 164
Query: 138 LVSALHFCHQNGVAHRDVKPQNLLLDRD-GNLKVSDFGLSALPEQIKNGMLHTACGTPAY 196
L +L + H G+ HRD+KPQNLLLD D LK+ DFG A + C + Y
Sbjct: 165 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS-AKQLVRGEPNVSYIC-SRYY 222
Query: 197 TAPEVVAR-RGYDGAVADAWSCGVILFVLLAGYLPF-------------------DDSNL 236
APE++ Y ++ D WS G +L LL G F +
Sbjct: 223 RAPELIFGATDYTSSI-DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281
Query: 237 LAMYKKVNRRDYQFPSFVSKP------------ARSLIYQLLDPNPKTRMSIEKIMSISW 284
M N +++FP + P A +L +LL+ P R++ + + S+
Sbjct: 282 REM--NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339
Query: 285 FQ 286
F
Sbjct: 340 FD 341
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-35
Identities = 84/333 (25%), Positives = 134/333 (40%), Gaps = 66/333 (19%)
Query: 6 SPPSAPPPPPPPPPSKKIPTLL----------NRYQLGPLLGRGSFAKVHKAKSIADGSI 55
+P + P P+K I L Y ++G GSF V +AK +
Sbjct: 8 APLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESD-E 66
Query: 56 VAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT------KTKIYLVM 109
VAIK + D RE+ MR + HPNV+ ++ + + + LV+
Sbjct: 67 VAIKKV-----LQDK---RFKNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNLVL 117
Query: 110 EYAAGGELFGKLR-----RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR 164
EY ++ R + + + Y QL+ +L + H G+ HRD+KPQNLLLD
Sbjct: 118 EYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP 176
Query: 165 D-GNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVAR-RGYDGAVADAWSCGVILF 222
G LK+ DFG A + C + Y APE++ Y + D WS G ++
Sbjct: 177 PSGVLKLIDFGS-AKILIAGEPNVSYIC-SRYYRAPELIFGATNYTTNI-DIWSTGCVMA 233
Query: 223 VLLAGYLPFD-DSNLLAMYK--KV--------------NRRDYQFPSFVSKP-------- 257
L+ G F +S + + + KV N +++FP P
Sbjct: 234 ELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPR 293
Query: 258 ----ARSLIYQLLDPNPKTRMSIEKIMSISWFQ 286
A LI +LL+ P R++ + + +F
Sbjct: 294 TPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 66/262 (25%), Positives = 108/262 (41%), Gaps = 47/262 (17%)
Query: 2 EPGCSPPSAPPPPPPPPPSKKIPT---------LLNRYQLGPLLGRGSFAKVHKAKSIAD 52
SK + + +RY++ L+G GS+ V +A +
Sbjct: 18 HTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLE 77
Query: 53 GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT-----KIYL 107
+VAIK I F D RI+RE++ + RL NH +V+K+ +++ K ++Y+
Sbjct: 78 KRVVAIKKI--LRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYV 134
Query: 108 VMEYAAGGELFGKLRRG-RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG 166
V+E A + R LTE + L+ + + H G+ HRD+KP N L+++D
Sbjct: 135 VLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC 193
Query: 167 NLKVSDFGLS-----------------ALPEQIKNGMLHTACGTPAYT---------APE 200
++KV DFGL+ + HT T APE
Sbjct: 194 SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPE 253
Query: 201 V-VARRGYDGAVADAWSCGVIL 221
+ + + Y A+ D WS G I
Sbjct: 254 LILLQENYTEAI-DVWSIGCIF 274
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-34
Identities = 59/300 (19%), Positives = 118/300 (39%), Gaps = 60/300 (20%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
QL + RG F V KA+ VA+K +K + EV ++ ++
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQ--LLNEYVAVKIFPIQDK-----QSWQNEYEVYSLPGMK 76
Query: 88 NHPNVLKI----QEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALH 143
H N+L+ + + ++L+ + G L L+ ++ + + + L
Sbjct: 77 -HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLA 135
Query: 144 FCHQN----------GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACG 192
+ H++ ++HRD+K +N+LL + ++DFGL+ E K+ G H G
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG 195
Query: 193 TPAYTAPEVVARRGYDGAV---------ADAWSCGVILFVLLAGYLPFD----------- 232
T Y APEV+ +GA+ D ++ G++L+ L + D
Sbjct: 196 TRRYMAPEVL-----EGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250
Query: 233 -----DSNLLAMYKKV--NRRDYQFPSFVSK-PARSLIYQLL----DPNPKTRMSIEKIM 280
+L M + V ++ + K +++ + + D + + R+S +
Sbjct: 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-34
Identities = 57/291 (19%), Positives = 106/291 (36%), Gaps = 47/291 (16%)
Query: 31 QLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNK--FLDAAMEDRIVREVSAMRRLQN 88
+L L+GRG + V+K D VA+K N+ F++ E + + + ++
Sbjct: 16 KLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFIN---E----KNIYRVPLME- 65
Query: 89 HPNVLK-----IQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALH 143
H N+ + + + + LVMEY G L L ++ R + L
Sbjct: 66 HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLA 125
Query: 144 FCH---------QNGVAHRDVKPQNLLLDRDGNLKVSDFGLS-------ALPEQIKNGML 187
+ H + ++HRD+ +N+L+ DG +SDFGLS + ++
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 188 HTACGTPAYTAPEV------VARRGYDGAVADAWSCGVILFVLLAG---YLPFDDSNLLA 238
+ GT Y APEV + D ++ G+I + + P +
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245
Query: 239 M-YKKVNRRDYQFPSF----VSKPARSLIYQLLDPNPKTRMSIEKIMSISW 284
M ++ F + R + N S+++ + W
Sbjct: 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 77/309 (24%), Positives = 124/309 (40%), Gaps = 59/309 (19%)
Query: 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVR 78
P + + + + +QL LLG G++ V A G IVAIK K F R +R
Sbjct: 2 PKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFDKPLFALRTLR 58
Query: 79 EVSAMRRLQNHPNVLKIQEVMATKTK-----IYLVMEYAAGGELFGKLRRGRLTESAARR 133
E+ ++ H N++ I + + +Y++ E +L + L++ +
Sbjct: 59 EIKILKHF-KHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSD-DHIQ 115
Query: 134 YFQ-QLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACG 192
YF Q + A+ H + V HRD+KP NLL++ + +LKV DFGL+ + ++
Sbjct: 116 YFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 193 TPA---------YTAPEVV-ARRGYDGAVADAWSCGVILFVLLAG--------YL----- 229
Y APEV+ Y A+ D WSCG IL L Y
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAM-DVWSCGCILAELFLRRPIFPGRDYRHQLLL 234
Query: 230 -------PFDDSNL--------------LAMYKKVNRRDYQFPSFVSKPARSLIYQLLDP 268
P D++L L MY FP V+ L+ ++L
Sbjct: 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKM-FPR-VNPKGIDLLQRMLVF 292
Query: 269 NPKTRMSIE 277
+P R++ +
Sbjct: 293 DPAKRITAK 301
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 77/310 (24%), Positives = 124/310 (40%), Gaps = 45/310 (14%)
Query: 7 PPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNK 66
+A P ++ + RY +G G++ V A + VAIK K +
Sbjct: 6 HMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK---KISP 62
Query: 67 FLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK-----IYLVMEYAAGGELFGKL 121
F R +RE+ + R H N++ I +++ T +Y+V + +L+ L
Sbjct: 63 FEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL 120
Query: 122 RRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGL--SALP 179
+ L+ + Q++ L + H V HRD+KP NLLL+ +LK+ DFGL A P
Sbjct: 121 KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180
Query: 180 EQIKNGMLHTACGTPAYTAPEVV-ARRGYDGAVADAWSCGVILFVLLAG----------- 227
+ G L T Y APE++ +GY ++ D WS G IL +L+
Sbjct: 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLD 239
Query: 228 -------YLPFDDSNLLAMYKKVNRRDY--QFPSFVSKP-----------ARSLIYQLLD 267
L L + R+Y P P A L+ ++L
Sbjct: 240 QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLT 299
Query: 268 PNPKTRMSIE 277
NP R+ +E
Sbjct: 300 FNPHKRIEVE 309
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 71/312 (22%), Positives = 128/312 (41%), Gaps = 53/312 (16%)
Query: 9 SAPPPPPPPPPSKKIP----TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKN 64
S+PPP +++ + Y+ +G G++ V A G+ VAIK +
Sbjct: 2 SSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL--Y 59
Query: 65 NKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK------IYLVMEYAAGGELF 118
F R RE+ ++ + H NV+ + +V YLVM + G +L
Sbjct: 60 RPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLG 117
Query: 119 GKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178
++ +L E + Q++ L + H G+ HRD+KP NL ++ D LK+ DFGL+
Sbjct: 118 KLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-- 175
Query: 179 PEQIKNGMLHTACGTPAYTAPEVV-ARRGYDGAVADAWSCGVILFVLLAG--------YL 229
+ + + T Y APEV+ Y V D WS G I+ ++ G +L
Sbjct: 176 --RQADSEMTGYVVTRWYRAPEVILNWMRYTQTV-DIWSVGCIMAEMITGKTLFKGSDHL 232
Query: 230 ------------PFDDS----------NLLAMYKKVNRRDYQ--FPSFVSKPARSLIYQL 265
P + N + ++ ++D+ + S A +L+ ++
Sbjct: 233 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTN-ASPLAVNLLEKM 291
Query: 266 LDPNPKTRMSIE 277
L + + R++
Sbjct: 292 LVLDAEQRVTAG 303
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-32
Identities = 65/251 (25%), Positives = 109/251 (43%), Gaps = 18/251 (7%)
Query: 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMR 84
T+L RYQ +G G+ V A VAIK + + F + R RE+ M+
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMK 79
Query: 85 RLQNHPNVLKIQEVMATKTK------IYLVMEYAAGGELFGKLRRGRLTESAARRYFQQL 138
+ NH N++ + V + +Y+VME L ++ + L Q+
Sbjct: 80 CV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQMELDHERMSYLLYQM 136
Query: 139 VSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTA 198
+ + H G+ HRD+KP N+++ D LK+ DFGL+ + M+ T Y A
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--RTAGTSFMMTPYVVTRYYRA 194
Query: 199 PEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR----DYQFPSFV 254
PEV+ GY V D WS G I+ ++ G + F ++ + + KV + +F +
Sbjct: 195 PEVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253
Query: 255 SKPARSLIYQL 265
R+ +
Sbjct: 254 QPTVRTYVENR 264
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 29/227 (12%)
Query: 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMR 84
+L +Y+L LG+G++ V K+ G +VA+K I + F ++ R RE+ +
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI--FDAFQNSTDAQRTFREIMILT 63
Query: 85 RLQNHPNVLKIQEVMATKTK--IYLVMEYAAGGELFGKLRRGRLTESAARRYFQ-QLVSA 141
L H N++ + V+ +YLV +Y +L +R L ++Y QL+
Sbjct: 64 ELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANILEP-VHKQYVVYQLIKV 121
Query: 142 LHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPA------ 195
+ + H G+ HRD+KP N+LL+ + ++KV+DFGLS I+ +
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 196 --------------YTAPEV-VARRGYDGAVADAWSCGVILFVLLAG 227
Y APE+ + Y + D WS G IL +L G
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGI-DMWSLGCILGEILCG 227
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 72/292 (24%), Positives = 120/292 (41%), Gaps = 50/292 (17%)
Query: 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMR 84
L Y +G G++ V A G VAIK + + F R RE+ ++
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLLK 78
Query: 85 RLQNHPNVLKIQEVMATKTK------IYLVMEYAAGGELFGKLRRGRLTESAARRYFQQL 138
+ H NV+ + +V + YLVM + +L K+ + +E + Q+
Sbjct: 79 HM-QHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDL-QKIMGLKFSEEKIQYLVYQM 135
Query: 139 VSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTA 198
+ L + H GV HRD+KP NL ++ D LK+ DFGL+ + + + T Y A
Sbjct: 136 LKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA----RHADAEMTGYVVTRWYRA 191
Query: 199 PEVV-ARRGYDGAVADAWSCGVILFVLLAG--------YL------------PFDDS--- 234
PEV+ + Y+ V D WS G I+ +L G YL P +
Sbjct: 192 PEVILSWMHYNQTV-DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250
Query: 235 -------NLLAMYKKVNRRDYQ--FPSFVSKPARSLIYQLLDPNPKTRMSIE 277
+ + + R+D+ FP S A L+ ++L+ + R++
Sbjct: 251 LNDKAAKSYIQSLPQTPRKDFTQLFPR-ASPQAADLLEKMLELDVDKRLTAA 301
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 14/209 (6%)
Query: 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMR 84
T+L RYQ +G G+ V A VAIK + + F + R RE+ M+
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMK 116
Query: 85 RLQNHPNVLKIQEVMATKTK------IYLVMEYAAGGELFGKLRRGRLTESAARRYFQQL 138
+ NH N++ + V + +YLVME L ++ + L Q+
Sbjct: 117 CV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-CQVIQMELDHERMSYLLYQM 173
Query: 139 VSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTA 198
+ + H G+ HRD+KP N+++ D LK+ DFGL+ + M+ T Y A
Sbjct: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRA 231
Query: 199 PEVVARRGYDGAVADAWSCGVILFVLLAG 227
PEV+ GY V D WS G I+ ++
Sbjct: 232 PEVILGMGYKENV-DIWSVGCIMGEMVRH 259
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 66/291 (22%), Positives = 114/291 (39%), Gaps = 47/291 (16%)
Query: 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMR 84
+ RYQ +G G++ V A G VA+K + + F R RE+ ++
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLK 83
Query: 85 RLQNHPNVLKIQEVMATKTK------IYLVMEYAAGGELFGKLRRGRLTESAARRYFQQL 138
+ H NV+ + +V +YLV G +L ++ +LT+ + Q+
Sbjct: 84 HM-KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 139 VSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTA 198
+ L + H + HRD+KP NL ++ D LK+ DFGL+ + + T Y A
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTADEMTGYVATRWYRA 197
Query: 199 PEVV-ARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKV-------------- 243
PE++ Y+ V D WS G I+ LL G F ++ + K +
Sbjct: 198 PEIMLNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256
Query: 244 ----NRRDY--QFPSFVSKP-----------ARSLIYQLLDPNPKTRMSIE 277
+ R+Y A L+ ++L + R++
Sbjct: 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 307
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-30
Identities = 76/301 (25%), Positives = 114/301 (37%), Gaps = 55/301 (18%)
Query: 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMR 84
L +RY LG G V A VAIK I D +RE+ +R
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI----VLTDPQSVKHALREIKIIR 63
Query: 85 RLQNHPNVLKIQEVMATKTK--------------IYLVMEYAAGGELFGKLRRGRLTESA 130
RL +H N++K+ E++ +Y+V EY +L L +G L E
Sbjct: 64 RL-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEH 121
Query: 131 ARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLD-RDGNLKVSDFGL--SALPEQIKNGML 187
AR + QL+ L + H V HRD+KP NL ++ D LK+ DFGL P G L
Sbjct: 122 ARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181
Query: 188 HTACGTPAYTAPEV-VARRGYDGAVADAWSCGVILFVLLAGYLPF--------------- 231
T Y +P + ++ Y A+ D W+ G I +L G F
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240
Query: 232 ----DDSNLLAMYKKVNRRDYQFPSFVSKP-----------ARSLIYQLLDPNPKTRMSI 276
+ + + + + KP A + Q+L +P R++
Sbjct: 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA 300
Query: 277 E 277
E
Sbjct: 301 E 301
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 33/231 (14%)
Query: 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMR 84
+ + Y + L+GRGS+ V+ A VAIK + N F D RI+RE++ +
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRILREITILN 80
Query: 85 RLQNHPNVLKIQEVMATKTK-----IYLVMEYAAGGELFGKLRRGRLTESAARRYFQ-QL 138
RL ++++ +++ +Y+V+E A +L + + L
Sbjct: 81 RL-KSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNL 138
Query: 139 VSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGL--SALPEQIKNGMLHTACGTPA- 195
+ +F H++G+ HRD+KP N LL++D ++KV DFGL + E+ N +
Sbjct: 139 LLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 196 ------------------YTAPEV-VARRGYDGAVADAWSCGVILFVLLAG 227
Y APE+ + + Y ++ D WS G I LL
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI-DIWSTGCIFAELLNM 248
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 68/306 (22%), Positives = 115/306 (37%), Gaps = 39/306 (12%)
Query: 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR 85
+ RY++ ++G+GSF +V KA VA+K + +F A E E+ +
Sbjct: 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE-----EIRILEH 149
Query: 86 LQNHP-----NVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGR---LTESAARRYFQQ 137
L+ NV+ + E + I + E L+ +++ + + R++
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRNHICMTFEL-LSMNLYELIKKNKFQGFSLPLVRKFAHS 208
Query: 138 LVSALHFCHQNGVAHRDVKPQNLLL--DRDGNLKVSDFGLSALPEQIKNGMLHTACGTPA 195
++ L H+N + H D+KP+N+LL +KV DFG S Q ++T +
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ----RVYTYIQSRF 264
Query: 196 YTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPF---DDSNLLA------------MY 240
Y APEV+ Y + D WS G IL LL GY D+ + LA +
Sbjct: 265 YRAPEVILGARYGMPI-DMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323
Query: 241 KKVNRRDYQFPSFVSKPARSLIYQLLDPNP--KTRMSIEKIMSISWFQKSLQQQRKRGQE 298
R S P + L D + S + + K +
Sbjct: 324 DASKRAKNFVSSK-GYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDD 382
Query: 299 SSLFEL 304
+
Sbjct: 383 PLFLDF 388
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-29
Identities = 71/309 (22%), Positives = 118/309 (38%), Gaps = 70/309 (22%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
++R+Q+ + G+G+F V K + G VAIK + D +R ++ M+ L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-----IQDPRFRNRELQI---MQDL 73
Query: 87 Q--NHPNVLKIQEVMATKTK-------IYLVMEYAAGGELFGKLR-----RGRLTESAAR 132
+HPN++++Q T + + +VMEY L R + +
Sbjct: 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIK 132
Query: 133 RYFQQLVSALHFCHQN--GVAHRDVKPQNLLLDR-DGNLKVSDFGL--SALPEQIKNGML 187
+ QL+ ++ H V HRD+KP N+L++ DG LK+ DFG P + +
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP---NV 189
Query: 188 HTACGTPAYTAPEVV-ARRGYDGAVADAWSCGVILFVLLAGYLPF--------------- 231
C + Y APE++ + Y AV D WS G I ++ G F
Sbjct: 190 AYIC-SRYYRAPELIFGNQHYTTAV-DIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247
Query: 232 ----DDSNLLAMYKKVNRRDYQFPSFVSKP---------------ARSLIYQLLDPNPKT 272
L + + D + P A L+ LL P+
Sbjct: 248 LGCPSREVLRKL--NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEE 305
Query: 273 RMSIEKIMS 281
RM + +
Sbjct: 306 RMKPYEALC 314
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 63/302 (20%), Positives = 117/302 (38%), Gaps = 57/302 (18%)
Query: 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEK-------NNKFLDAAMEDRIV 77
+ + Y + + GS+ V ++G VAIK + N D+ + R++
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 78 REVSAMRRLQNHPNVLKIQEVMATKTK-----IYLVMEYAAGGELFGKLRRGR--LTESA 130
RE+ + +HPN+L ++++ + +YLV E +L + R ++
Sbjct: 78 REIRLLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQH 135
Query: 131 ARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTA 190
+ + ++ LH H+ GV HRD+ P N+LL + ++ + DF L+ +
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTA--DANKTHY 193
Query: 191 CGTPAYTAPEVV-ARRGYDGAVADAWSCGVILFVLLAG--------YL------------ 229
Y APE+V +G+ V D WS G ++ + +
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLV-DMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252
Query: 230 PFDD--------------SNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMS 275
P + N L+ P+ A LI ++L+ NP+ R+S
Sbjct: 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAV-VPT-ADPVALDLIAKMLEFNPQRRIS 310
Query: 276 IE 277
E
Sbjct: 311 TE 312
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 75/336 (22%), Positives = 122/336 (36%), Gaps = 95/336 (28%)
Query: 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAM 83
T +Y LG LG GSF V + I G A+K + D RE+ M
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV-----LQDPR---YKNRELDIM 54
Query: 84 RRLQNHPNVLKIQEVMATKTK--------------------------------------I 105
+ L +H N++K+ + T +
Sbjct: 55 KVL-DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 106 YLVMEYAAGGELFGKLR-----RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNL 160
++MEY L L+ + + Y QL A+ F H G+ HRD+KPQNL
Sbjct: 114 NVIMEYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNL 172
Query: 161 LLD-RDGNLKVSDFGL--SALPEQIKNGMLHTACGTPAYTAPEVV-ARRGYDGAVADAWS 216
L++ +D LK+ DFG +P + + C + Y APE++ Y ++ D WS
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEP---SVAYIC-SRFYRAPELMLGATEYTPSI-DLWS 227
Query: 217 CGVILFVLLAGYLPF-------------------DDSNLLAMYKKVNRRDYQFPSFVSKP 257
G + L+ G F ++ M + + +FP+ +K
Sbjct: 228 IGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRM--NPHYTEVRFPTLKAKD 285
Query: 258 ------------ARSLIYQLLDPNPKTRMSIEKIMS 281
A L+ Q+L P R++ + M+
Sbjct: 286 WRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 65/291 (22%), Positives = 118/291 (40%), Gaps = 24/291 (8%)
Query: 2 EPGCSPPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTI 61
+P P + LG +GRG+F +V + AD ++VA+K+
Sbjct: 90 QPLTKKSGVVLHRAVPKDKWVLNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC 147
Query: 62 EKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL 121
+ ++ + ++E +++ HPN++++ V K IY+VME GG+ L
Sbjct: 148 RETL---PPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL 203
Query: 122 R--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALP 179
R RL + + + + HRD+ +N L+ LK+SDFG+S
Sbjct: 204 RTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS--- 260
Query: 180 EQIKNGMLHTACGTPAY----TAPEVVARRGYDGAVADAWSCGVILF-VLLAGYLPFDDS 234
+ +G+ + G TAPE + Y +D WS G++L+ G P+ +
Sbjct: 261 REEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE-SDVWSFGILLWETFSLGASPYPNL 319
Query: 235 NLLAMYKKVNRRDYQFPSFVSKPARSLIYQLL----DPNPKTRMSIEKIMS 281
+ + V + + P P +++L+ P R S I
Sbjct: 320 SNQQTREFV-EKGGRLPCPELCPDA--VFRLMEQCWAYEPGQRPSFSTIYQ 367
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 6e-26
Identities = 64/310 (20%), Positives = 129/310 (41%), Gaps = 33/310 (10%)
Query: 5 CSPPSAPPPPPPPPPSKK--IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIE 62
+ P P K + + LG G + +V++ VA+KT++
Sbjct: 197 APKRNKPTIYGVSPNYDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK 254
Query: 63 KNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR 122
+ D + ++E + M+ ++ HPN++++ V + Y++ E+ G L LR
Sbjct: 255 E-----DTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 308
Query: 123 RGR---LTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALP 179
++ Q+ SA+ + + HR++ +N L+ + +KV+DFGLS L
Sbjct: 309 ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368
Query: 180 EQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILF-VLLAGYLPFDDSNLLA 238
A +TAPE +A + +D W+ GV+L+ + G P+ +L
Sbjct: 369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQ 427
Query: 239 MYKKVNRRDYQFPSFVSKP--ARSLIYQLL----DPNPKTR-------MSIEKIMSISWF 285
+Y+ + +DY+ +P +Y+L+ NP R + E + S
Sbjct: 428 VYELL-EKDYRME----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 482
Query: 286 QKSLQQQRKR 295
++++ +
Sbjct: 483 SDEVEKELGK 492
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 71/341 (20%), Positives = 128/341 (37%), Gaps = 83/341 (24%)
Query: 26 LLNRYQLGPLLGRGSFAKVHKAK-SIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMR 84
L RY++ LG G+F KV + S VA+K I K+ +AA E++ ++
Sbjct: 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-----EINVLK 71
Query: 85 RLQ-----NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGR---LTESAARRYFQ 136
+++ N + + + + + E G F L+ R
Sbjct: 72 KIKEKDKENKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKENNFQPYPLPHVRHMAY 130
Query: 137 QLVSALHFCHQNGVAHRDVKPQNLLL-------------------DRDGNLKVSDFGLSA 177
QL AL F H+N + H D+KP+N+L ++ +++V+DFG SA
Sbjct: 131 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SA 189
Query: 178 LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPF---DDS 234
+ + T T Y PEV+ G+ D WS G ILF G+ F ++
Sbjct: 190 TFD---HEHHTTIVATRHYRPPEVILELGWAQPC-DVWSIGCILFEYYRGFTLFQTHENR 245
Query: 235 NLLA------------MYKKVNRRDY---------------QFPSFVSKPARS------- 260
L M + ++ Y ++ KP +S
Sbjct: 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSL 305
Query: 261 -------LIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRK 294
L+ ++L+ +P R+++ + + +F ++R
Sbjct: 306 EHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERS 346
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143 | Back alignment and structure |
|---|
Score = 98.9 bits (246), Expect = 6e-25
Identities = 31/132 (23%), Positives = 68/132 (51%), Gaps = 14/132 (10%)
Query: 322 VSMNAFDIISLSSGLDLSGLFEAKK---RKEKRFTTKEKTERVVEKVKEVGERLGYVVEK 378
+ MNAF++I+LS GL+LS LF+ ++ +++ RF ++ + ++ ++ V +G+
Sbjct: 5 LMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHT 64
Query: 379 GKGDV----VGLGKLGKMVLLVEVLMEIAPETFVVGVKVVDNSVCGRVALEFDEGDWNEL 434
+ K G++ +++E+ E+AP F+V V+ LE+ + + +L
Sbjct: 65 RNFKTRLEGLSSIKAGQLAVVIEIY-EVAPSLFMVDVRKAAGE-----TLEYHKF-YKKL 117
Query: 435 QAGLGDIVLSWH 446
+ L +I+
Sbjct: 118 CSKLENIIWRAT 129
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 60/229 (26%), Positives = 104/229 (45%), Gaps = 26/229 (11%)
Query: 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR 85
++RY++ L+G+GSF +V KA + VAIK I+ FL+ A EV +
Sbjct: 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ-----IEVRLLEL 106
Query: 86 LQNHP-----NVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGR---LTESAARRYFQQ 137
+ H ++ ++ + + LV E L+ LR ++ + R++ QQ
Sbjct: 107 MNKHDTEMKYYIVHLKRHFMFRNHLCLVFEM-LSYNLYDLLRNTNFRGVSLNLTRKFAQQ 165
Query: 138 LVSALHFCHQN--GVAHRDVKPQNLLLDRDGN--LKVSDFGLSALPEQIKNGMLHTACGT 193
+ +AL F + H D+KP+N+LL +K+ DFG S+ ++ +
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQL---GQRIYQYIQS 221
Query: 194 PAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPF---DDSNLLAM 239
Y +PEV+ YD A+ D WS G IL + G F ++ + +
Sbjct: 222 RFYRSPEVLLGMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNK 269
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 61/342 (17%), Positives = 115/342 (33%), Gaps = 95/342 (27%)
Query: 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR 85
L N + + +G G+F +V + I + A+K + K+ +A E +++
Sbjct: 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI-----EADILKK 87
Query: 86 LQNHP----NVLKIQEVMATKTKIYLVME------YAAGGELFGKLRRGRLTESAARRYF 135
+QN N++K + L+ E Y E+ + + Y
Sbjct: 88 IQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLY----EIITRNNYNGFHIEDIKLYC 143
Query: 136 QQLVSALHFCHQNGVAHRDVKPQNLLL-------------------------DRDGNLKV 170
+++ AL++ + + H D+KP+N+LL + +K+
Sbjct: 144 IEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 171 SDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLP 230
DFG A + + + T Y APEV+ G+D + D WS G +L L G L
Sbjct: 204 IDFG-CATFK---SDYHGSIINTRQYRAPEVILNLGWDVSS-DMWSFGCVLAELYTGSLL 258
Query: 231 F---DDSNLLA------------MYKKVNRRDYQF----------------------PSF 253
F + LA M + + +
Sbjct: 259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVK 318
Query: 254 VSKPAR---------SLIYQLLDPNPKTRMSIEKIMSISWFQ 286
P +Y +L +P R S +++ + +
Sbjct: 319 KCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 71/285 (24%), Positives = 121/285 (42%), Gaps = 24/285 (8%)
Query: 14 PPPPPPSKKIPTLLNRYQ--LGPLLGRGSFAKVHKA--KSIADGSI-VAIKTIEKNNKFL 68
P + + L+ L LG GSF V + + + ++ VA+K + K +
Sbjct: 2 SAGEGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL-KPDVLS 60
Query: 69 DAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR--RGRL 126
D +REV+AM L H N++++ V + +V E A G L +LR +G
Sbjct: 61 QPEAMDDFIREVNAMHSLD-HRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHF 118
Query: 127 TESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS-ALPEQIKNG 185
RY Q+ + + HRD+ +NLLL +K+ DFGL ALP+ +
Sbjct: 119 LLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 178
Query: 186 MLHTACGTP-AYTAPEVVARRGYDGAVADAWSCGVILF-VLLAGYLPFDDSNLLAMYKKV 243
++ P A+ APE + R + A +D W GV L+ + G P+ N + K+
Sbjct: 179 VMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237
Query: 244 NRRDYQFPSFVSKPAR--SLIYQLL----DPNPKTRMSIEKIMSI 282
++ + P +P IY ++ P+ R + +
Sbjct: 238 DKEGERLP----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123 | Back alignment and structure |
|---|
Score = 96.6 bits (240), Expect = 2e-24
Identities = 36/123 (29%), Positives = 61/123 (49%), Gaps = 9/123 (7%)
Query: 323 SMNAFDIISLSSGLDLSGLFE--AKKRKEKRFTTKEKTERVVEKVKEVGERLGYVVEKGK 380
MNAFDIIS S G +LSGLF K + +RF + ERVVE+++E+ V K +
Sbjct: 5 RMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVAKKE 64
Query: 381 GDVVGL-GKLGKMVLLVEVLMEIAPETFVVGVKVVDNSVCGRVALEFDEGDWNELQAGLG 439
+ + G+ G ++VE+ ++ E ++ V+ R A + + L+
Sbjct: 65 TWGMKIEGQKGNFAMVVEI-NQLTDELVMIEVR-----KRQRAAASGRDLWTDTLRPFFV 118
Query: 440 DIV 442
++V
Sbjct: 119 ELV 121
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-23
Identities = 58/228 (25%), Positives = 95/228 (41%), Gaps = 42/228 (18%)
Query: 9 SAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFL 68
S + + +L +G+G F V G+ VA+K I+ +
Sbjct: 4 SVAAQDEFYRSGWALN--MKELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKND---- 55
Query: 69 DAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK--IYLVMEYAAGGELFGKLR---R 123
A + E S M +L+ H N++++ V + K +Y+V EY A G L LR R
Sbjct: 56 --ATAQAFLAEASVMTQLR-HSNLVQLLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGR 111
Query: 124 GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS------- 176
L ++ + A+ + N HRD+ +N+L+ D KVSDFGL+
Sbjct: 112 SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171
Query: 177 ---ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVIL 221
LP +K +TAPE + + + +D WS G++L
Sbjct: 172 DTGKLP--VK------------WTAPEALREKKFSTK-SDVWSFGILL 204
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 42/232 (18%)
Query: 7 PPSAPPPPPPPPPSKKIPTLLNRY--QLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKN 64
P + LN +L +G+G F V G+ VA+K I KN
Sbjct: 170 PKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCI-KN 226
Query: 65 NKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK--IYLVMEYAAGGELFGKLR 122
+ A + E S M +L+ H N++++ V + K +Y+V EY A G L LR
Sbjct: 227 D-----ATAQAFLAEASVMTQLR-HSNLVQLLGV-IVEEKGGLYIVTEYMAKGSLVDYLR 279
Query: 123 ---RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS--- 176
R L ++ + A+ + N HRD+ +N+L+ D KVSDFGL+
Sbjct: 280 SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339
Query: 177 -------ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVIL 221
LP +K +TAPE + + + +D WS G++L
Sbjct: 340 SSTQDTGKLP--VK------------WTAPEALREKKFSTK-SDVWSFGILL 376
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 3e-23
Identities = 51/239 (21%), Positives = 107/239 (44%), Gaps = 20/239 (8%)
Query: 19 PSKKIPTLLNRYQL--GPLLGRGSFAKVHKAKSIADGS----IVAIKTIEKNNKFLDAAM 72
P++ + +L + +LG G+F V+K I +G VAIK + + A
Sbjct: 4 PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKAN 61
Query: 73 EDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR--RGRLTESA 130
++ I+ E M + ++P+V ++ + + + L+ + G L +R + +
Sbjct: 62 KE-ILDEAYVMASV-DNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 131 ARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTA 190
+ Q+ +++ + HRD+ +N+L+ ++K++DFGL+ L + + A
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHA 176
Query: 191 CGT--P-AYTAPEVVARRGYDGAVADAWSCGVILF-VLLAGYLPFDDSNLLAMYKKVNR 245
G P + A E + R Y +D WS GV ++ ++ G P+D + + +
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 8e-23
Identities = 48/224 (21%), Positives = 95/224 (42%), Gaps = 25/224 (11%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAME-----DRIVREVSA 82
RY L LG G F+ V AK + + + VA+K + + + +AA + R+ +
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNT 78
Query: 83 MRRLQNHPNVLKIQEV----MATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYF 135
++LK+ + + +V E G L +++ + ++
Sbjct: 79 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQIS 137
Query: 136 QQLVSALHFCHQN-GVAHRDVKPQNLLLDR------DGNLKVSDFGLSALPEQIKNGMLH 188
+QL+ L + H+ G+ H D+KP+N+L++ +K++D G + +
Sbjct: 138 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW----YDEHYT 193
Query: 189 TACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFD 232
+ T Y +PEV+ + D WS ++F L+ G F+
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGA-DIWSTACLIFELITGDFLFE 236
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 9e-23
Identities = 55/229 (24%), Positives = 101/229 (44%), Gaps = 18/229 (7%)
Query: 5 CSPPSAPPPPPPPPPSKKIPTLLNRYQL--GPLLGRGSFAKVHKAK----SIADGSIVAI 58
+ + PT L LG+G+F V + G +VA+
Sbjct: 16 TTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAV 75
Query: 59 KTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV--MATKTKIYLVMEYAAGGE 116
K ++ + + + D RE+ ++ LQ H N++K + V A + + L+MEY G
Sbjct: 76 KKLQHST---EEHLRD-FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 130
Query: 117 LFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFG 174
L L+ + R+ +Y Q+ + + HRD+ +N+L++ + +K+ DFG
Sbjct: 131 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 190
Query: 175 LS-ALPEQIKNGMLHTACGTP-AYTAPEVVARRGYDGAVADAWSCGVIL 221
L+ LP+ + + +P + APE + + A +D WS GV+L
Sbjct: 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVL 238
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 9e-23
Identities = 71/265 (26%), Positives = 120/265 (45%), Gaps = 30/265 (11%)
Query: 31 QLGPLLGRGSFAKVHKAKSIADGSI-VAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89
L LG G F V K G VA+K I++ + ED +E M +L H
Sbjct: 11 TLLKELGSGQFGVVKLGK--WKGQYDVAVKMIKE-----GSMSEDEFFQEAQTMMKLS-H 62
Query: 90 PNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQ 147
P ++K V + + IY+V EY + G L LR L S + + F
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES 122
Query: 148 NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGT--PA-YTAPEVVAR 204
+ HRD+ +N L+DRD +KVSDFG++ + + ++ GT P ++APEV
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRY---VLDDQYVSSVGTKFPVKWSAPEVFHY 179
Query: 205 RGYDGAVADAWSCGVILF-VLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPAR--SL 261
Y +D W+ G++++ V G +P+D + KV+ + ++ +P
Sbjct: 180 FKYSSK-SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLY----RPHLASDT 233
Query: 262 IYQLL----DPNPKTRMSIEKIMSI 282
IYQ++ P+ R + ++++S
Sbjct: 234 IYQIMYSCWHELPEKRPTFQQLLSS 258
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 9e-23
Identities = 71/335 (21%), Positives = 121/335 (36%), Gaps = 89/335 (26%)
Query: 26 LLNRYQLGPLLGRGSFAKVHKAK-SIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMR 84
L RY++ LG G+F KV + A G VA+K ++ +++ +AA E+ +
Sbjct: 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS-----EIQVLE 66
Query: 85 RLQ-----NHPNVLKIQEVMATKTKIYLVME------YAAGGELFGKLRRGRLTESAARR 133
L + +++ E I +V E Y + + R+
Sbjct: 67 HLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTY----DFIKENGFLPFRLDHIRK 122
Query: 134 YFQQLVSALHFCHQNGVAHRDVKPQNLLLD-------------------RDGNLKVSDFG 174
Q+ +++F H N + H D+KP+N+L + ++KV DFG
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
Query: 175 LSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPF--- 231
SA + + T T Y APEV+ G+ D WS G IL G+ F
Sbjct: 183 -SATYD---DEHHSTLVSTRHYRAPEVILALGWSQPC-DVWSIGCILIEYYLGFTVFPTH 237
Query: 232 DDSNLLA------------MYKKVNRRDYQFPSFVSKPARS------------------- 260
D LA M +K +R Y + S
Sbjct: 238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLS 297
Query: 261 ----------LIYQLLDPNPKTRMSIEKIMSISWF 285
LI ++L+ +P R+++ + + +F
Sbjct: 298 QDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-22
Identities = 62/264 (23%), Positives = 115/264 (43%), Gaps = 28/264 (10%)
Query: 31 QLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP 90
+G G F VH + VAIKTI + A E+ + E M +L HP
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIRE-----GAMSEEDFIEEAEVMMKLS-HP 63
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQN 148
++++ V + I LV E+ G L LR RG + + + +
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 123
Query: 149 GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGT--PA-YTAPEVVARR 205
V HRD+ +N L+ + +KVSDFG++ + + ++ GT P + +PEV +
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRF---VLDDQYTSSTGTKFPVKWASPEVFSFS 180
Query: 206 GYDGAVADAWSCGVILF-VLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPAR--SLI 262
Y +D WS GV+++ V G +P+++ + + + + ++ KP + +
Sbjct: 181 RYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-STGFRLY----KPRLASTHV 234
Query: 263 YQLL----DPNPKTRMSIEKIMSI 282
YQ++ P+ R + +++
Sbjct: 235 YQIMNHCWRERPEDRPAFSRLLRQ 258
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 59/248 (23%), Positives = 106/248 (42%), Gaps = 25/248 (10%)
Query: 7 PPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSI-VAIKTIEKNN 65
P S P + +IP +L LG+G F +V +G+ VAIKT++
Sbjct: 165 PTSKPQTQGLAKDAWEIP--RESLRLEVKLGQGCFGEVWMGT--WNGTTRVAIKTLKP-- 218
Query: 66 KFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGR 125
+ ++E M++L H ++++ V ++ IY+V EY + G L L+
Sbjct: 219 ---GTMSPEAFLQEAQVMKKL-RHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGET 273
Query: 126 ---LTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182
L Q+ S + + + HRD++ N+L+ + KV+DFGL+ ++
Sbjct: 274 GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA----RL 329
Query: 183 KNGMLHTACGTPAY----TAPEVVARRGYDGAVADAWSCGVILF-VLLAGYLPFDDSNLL 237
+TA + TAPE + +D WS G++L + G +P+
Sbjct: 330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNR 388
Query: 238 AMYKKVNR 245
+ +V R
Sbjct: 389 EVLDQVER 396
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 64/285 (22%), Positives = 127/285 (44%), Gaps = 35/285 (12%)
Query: 31 QLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP 90
+ LG G + +V++ VA+KT+++ D + ++E + M+ ++ HP
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-----DTMEVEEFLKEAAVMKEIK-HP 69
Query: 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKLR---RGRLTESAARRYFQQLVSALHFCHQ 147
N++++ V + Y++ E+ G L LR R ++ Q+ SA+ + +
Sbjct: 70 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 148 NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGT--PA-YTAPEVVAR 204
HRD+ +N L+ + +KV+DFGLS L + G P +TAPE +A
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 205 RGYDGAVADAWSCGVILF-VLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPAR--SL 261
+ +D W+ GV+L+ + G P+ +L +Y+ + +DY+ +P
Sbjct: 187 NKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRME----RPEGCPEK 240
Query: 262 IYQLL----DPNPKTR-------MSIEKIMSISWFQKSLQQQRKR 295
+Y+L+ NP R + E + S ++++ +
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGK 285
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 63/291 (21%), Positives = 116/291 (39%), Gaps = 32/291 (10%)
Query: 5 CSPPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSI-VAIKTIEK 63
+AP S +I LG G F V K G VAIK I++
Sbjct: 3 LGSKNAPSTAGLGYGSWEIDP--KDLTFLKELGTGQFGVVKYGK--WRGQYDVAIKMIKE 58
Query: 64 NNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR- 122
+ ED + E M L H ++++ V + I+++ EY A G L LR
Sbjct: 59 -----GSMSEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE 112
Query: 123 -RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181
R R + + A+ + HRD+ +N L++ G +KVSDFGLS
Sbjct: 113 MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY--- 169
Query: 182 IKNGMLHTACGT--PA-YTAPEVVARRGYDGAVADAWSCGVILF-VLLAGYLPFDDSNLL 237
+ + ++ G+ P ++ PEV+ + +D W+ GV+++ + G +P++
Sbjct: 170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNS 228
Query: 238 AMYKKVNRRDYQFPSFVSKPAR--SLIYQLL----DPNPKTRMSIEKIMSI 282
+ + + + +P +Y ++ R + + ++S
Sbjct: 229 ETAEHI-AQGLRLY----RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-22
Identities = 49/237 (20%), Positives = 104/237 (43%), Gaps = 16/237 (6%)
Query: 19 PSKKIPTLLNRYQ--LGPLLGRGSFAKVHKAKSIADGS----IVAIKTIEKNNKFLDAAM 72
P++ + +L + +LG G+F V+K I +G VAIK + + A
Sbjct: 4 PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKAN 61
Query: 73 EDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR--RGRLTESA 130
++ I+ E M + ++P+V ++ + + + L+ + G L +R + +
Sbjct: 62 KE-ILDEAYVMASV-DNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 131 ARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTA 190
+ Q+ +++ + HRD+ +N+L+ ++K++DFGL+ L +
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 191 CGTP-AYTAPEVVARRGYDGAVADAWSCGVILF-VLLAGYLPFDDSNLLAMYKKVNR 245
P + A E + R Y +D WS GV ++ ++ G P+D + + +
Sbjct: 179 GKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 6e-22
Identities = 59/254 (23%), Positives = 106/254 (41%), Gaps = 27/254 (10%)
Query: 5 CSPPSAPPPPPPPPPS--KKIPTLLNR--YQLGPLLGRGSFAKVHKAKSIADGSI-VAIK 59
C + P P K + R +L LG+G F +V +G+ VAIK
Sbjct: 240 CHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGT--WNGTTRVAIK 297
Query: 60 TIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFG 119
T++ + ++E M++L H ++++ V ++ IY+V EY + G L
Sbjct: 298 TLKP-----GTMSPEAFLQEAQVMKKL-RHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLD 350
Query: 120 KLRRGR---LTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176
L+ L Q+ S + + + HRD++ N+L+ + KV+DFGL+
Sbjct: 351 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 410
Query: 177 ALPEQIKNGMLHTACGTPAY----TAPEVVARRGYDGAVADAWSCGVILF-VLLAGYLPF 231
++ +TA + TAPE + +D WS G++L + G +P+
Sbjct: 411 ----RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPY 465
Query: 232 DDSNLLAMYKKVNR 245
+ +V R
Sbjct: 466 PGMVNREVLDQVER 479
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 7e-22
Identities = 61/245 (24%), Positives = 102/245 (41%), Gaps = 45/245 (18%)
Query: 7 PPSAPPPPPPPPPSKK--IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGS--IVAIKTIE 62
P P+ + N + ++G G+F +V KA+ DG AIK ++
Sbjct: 4 HHHHHHGKNNPDPTIYPVLD--WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK 61
Query: 63 KNNKFLDAAMEDRI--VREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGK 120
+ A+ +D E+ + +L +HPN++ + + +YL +EYA G L
Sbjct: 62 EY-----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 116
Query: 121 LRRGRLTESAARRYFQQLVSA-------LHFCHQNGVA------------HRDVKPQNLL 161
LR+ R+ E+ ++ LHF VA HRD+ +N+L
Sbjct: 117 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD--VARGMDYLSQKQFIHRDLAARNIL 174
Query: 162 LDRDGNLKVSDFGLSALPE---QIKNGMLHTACGTPA-YTAPEVVARRGYDGAVADAWSC 217
+ + K++DFGLS E + G L P + A E + Y +D WS
Sbjct: 175 VGENYVAKIADFGLSRGQEVYVKKTMGRL------PVRWMAIESLNYSVYTTN-SDVWSY 227
Query: 218 GVILF 222
GV+L+
Sbjct: 228 GVLLW 232
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 7e-22
Identities = 57/233 (24%), Positives = 106/233 (45%), Gaps = 21/233 (9%)
Query: 1 MEPGCSPPSAPPPPPPPPPSKKIPTLL----NRYQLGPLLGRGSFAKVHKA--KSIADGS 54
+ + A + R +LG +G G F VH+ S + +
Sbjct: 359 VSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPA 418
Query: 55 I-VAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAA 113
+ VAIKT + ++ ++ ++E MR+ +HP+++K+ V T+ ++++ME
Sbjct: 419 MAVAIKTCKNCT---SDSVREKFLQEALTMRQF-DHPHIVKLIGV-ITENPVWIIMELCT 473
Query: 114 GGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVS 171
GEL L+ + L ++ Y QL +AL + HRD+ +N+L+ + +K+
Sbjct: 474 LGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLG 533
Query: 172 DFGLSALPEQIKNGMLHTACGT--PA-YTAPEVVARRGYDGAVADAWSCGVIL 221
DFGLS +++ + A P + APE + R + A +D W GV +
Sbjct: 534 DFGLSRY---MEDSTYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCM 582
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 52/220 (23%), Positives = 97/220 (44%), Gaps = 17/220 (7%)
Query: 14 PPPPPPSKKIPTLLNRYQL--GPLLGRGSFAKVHKAK----SIADGSIVAIKTIEKNNKF 67
P ++ PT + L LG G F KV + G VA+K+++ +
Sbjct: 5 SEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-- 62
Query: 68 LDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK--IYLVMEYAAGGELFGKLR--R 123
+ D + +E+ +R L H N++K + + I L+ME+ G L L +
Sbjct: 63 GGNHIAD-LKKEIEILRNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK 120
Query: 124 GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS-ALPEQI 182
++ +Y Q+ + + HRD+ +N+L++ + +K+ DFGL+ A+
Sbjct: 121 NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180
Query: 183 KNGMLHTACGTP-AYTAPEVVARRGYDGAVADAWSCGVIL 221
+ + +P + APE + + + A +D WS GV L
Sbjct: 181 EYYTVKDDRDSPVFWYAPECLMQSKFYIA-SDVWSFGVTL 219
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 29/222 (13%)
Query: 31 QLGPLLGRGSFAKVHKAKSIADGSI----VAIKTI------EKNNKFLDAAMEDRIVREV 80
++G G F +V+K VAIKT+ ++ FL E
Sbjct: 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL---------GEA 97
Query: 81 SAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQL 138
M + H N+++++ V++ + ++ EY G L LR G + + +
Sbjct: 98 GIMGQFS-HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGI 156
Query: 139 VSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGT--PA- 195
+ + + HRD+ +N+L++ + KVSDFGLS + E +T G P
Sbjct: 157 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT-YTTSGGKIPIR 215
Query: 196 YTAPEVVARRGYDGAVADAWSCGVILF-VLLAGYLPFDD-SN 235
+TAPE ++ R + A +D WS G++++ V+ G P+ + SN
Sbjct: 216 WTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSN 256
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 27/230 (11%)
Query: 31 QLGPLLGRGSFAKVHKA--KSIADGSI-VAIKTI------EKNNKFLDAAMEDRIVREVS 81
+ ++G G +V + + VAIK + + FL E S
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL---------SEAS 102
Query: 82 AMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLV 139
M + HPN+++++ V+ +V EY G L LR G+ T + +
Sbjct: 103 IMGQFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVG 161
Query: 140 SALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGT--PA-Y 196
+ + + G HRD+ +N+L+D + KVSDFGLS + E +T G P +
Sbjct: 162 AGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED-DPDAAYTTTGGKIPIRW 220
Query: 197 TAPEVVARRGYDGAVADAWSCGVILF-VLLAGYLPFDDSNLLAMYKKVNR 245
TAPE +A R + A +D WS GV+++ VL G P+ + + V
Sbjct: 221 TAPEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 95.4 bits (237), Expect = 3e-21
Identities = 62/256 (24%), Positives = 101/256 (39%), Gaps = 20/256 (7%)
Query: 2 EPGCSPPSAPPPPPPPPPSKKIPTLLNRYQL---GPLLGRGSFAKVHKAK-SIADGSI-V 56
P P K L R L LG G+F V + + I V
Sbjct: 307 PMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDV 366
Query: 57 AIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGE 116
AIK +++ + A + ++RE M +L ++P ++++ V + LVME A GG
Sbjct: 367 AIKVLKQGT---EKADTEEMMREAQIMHQL-DNPYIVRLIGV-CQAEALMLVMEMAGGGP 421
Query: 117 LFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFG 174
L L R + S Q+ + + + HR++ +N+LL K+SDFG
Sbjct: 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFG 481
Query: 175 LS-ALPEQIKNGMLHTACGT--P-AYTAPEVVARRGYDGAVADAWSCGVILF-VLLAGYL 229
LS AL + P + APE + R + +D WS GV ++ L G
Sbjct: 482 LSKALGAD--DSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQK 538
Query: 230 PFDDSNLLAMYKKVNR 245
P+ + + +
Sbjct: 539 PYKKMKGPEVMAFIEQ 554
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 3e-21
Identities = 50/191 (26%), Positives = 88/191 (46%), Gaps = 10/191 (5%)
Query: 36 LGRGSFAKVHKAKSIADGSI--VAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVL 93
LG G+F V K + VA+K ++ D A++D ++ E + M++L +P ++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLD-NPYIV 81
Query: 94 KIQEVMATKTKIYLVMEYAAGGELFGKLRRGR-LTESAARRYFQQLVSALHFCHQNGVAH 152
++ + LVME A G L L++ R + + Q+ + + ++ H
Sbjct: 82 RMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 140
Query: 153 RDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGT-P-AYTAPEVVARRGYDGA 210
RD+ +N+LL K+SDFGLS +N G P + APE + +
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 200
Query: 211 VADAWSCGVIL 221
+D WS GV++
Sbjct: 201 -SDVWSFGVLM 210
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-21
Identities = 52/198 (26%), Positives = 93/198 (46%), Gaps = 20/198 (10%)
Query: 31 QLGPLLGRGSFAKVHKAKSIADGSI-VAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89
+L LG G F +V +G VA+K++++ + D + E + M++LQ H
Sbjct: 16 KLVERLGAGQFGEVWMGY--YNGHTKVAVKSLKQ-----GSMSPDAFLAEANLMKQLQ-H 67
Query: 90 PNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGR---LTESAARRYFQQLVSALHFCH 146
++++ V T+ IY++ EY G L L+ LT + Q+ + F
Sbjct: 68 QRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 147 QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGT--PA-YTAPEVVA 203
+ HRD++ N+L+ + K++DFGL+ L I++ G P +TAPE +
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARL---IEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 204 RRGYDGAVADAWSCGVIL 221
+ +D WS G++L
Sbjct: 184 YGTFTIK-SDVWSFGILL 200
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 5e-21
Identities = 62/249 (24%), Positives = 98/249 (39%), Gaps = 41/249 (16%)
Query: 4 GCSPPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAK-----SIADGSIVAI 58
G + P P + P NR G LG G+F KV +A VA+
Sbjct: 1 GNNYVYIDPTQLPYDHKWEFP--RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAV 58
Query: 59 KTIEKNNKFLDAAMEDRI--VREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGE 116
K ++ + A + +R + E+ + L NH N++ + ++ EY G+
Sbjct: 59 KMLKPS-----AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 113
Query: 117 LFGKLRRGRLTESAARRYFQQLVSA---------LHFCHQ--NGVA--------HRDVKP 157
L LRR R + ++ + L F +Q G+A HRD+
Sbjct: 114 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173
Query: 158 QNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGT---PA-YTAPEVVARRGYDGAVAD 213
+N+LL K+ DFGL+ IKN + G P + APE + Y +D
Sbjct: 174 RNILLTHGRITKICDFGLA---RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SD 229
Query: 214 AWSCGVILF 222
WS G+ L+
Sbjct: 230 VWSYGIFLW 238
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 5e-21
Identities = 57/224 (25%), Positives = 95/224 (42%), Gaps = 17/224 (7%)
Query: 5 CSPPSAPPPPP-PPPPSKKIPTLLNRY--QLGPLLGRGSFAKVHKAKSIADGSI-VAIKT 60
C S P P P +K + R +L LG G F +V A + VA+KT
Sbjct: 162 CQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMAT--YNKHTKVAVKT 219
Query: 61 IEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGK 120
++ + + + E + M+ L H ++K+ V TK IY++ E+ A G L
Sbjct: 220 MKP-----GSMSVEAFLAEANVMKTL-QHDKLVKLHAV-VTKEPIYIITEFMAKGSLLDF 272
Query: 121 LRRGR---LTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177
L+ + Q+ + F Q HRD++ N+L+ K++DFGL+
Sbjct: 273 LKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR 332
Query: 178 LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVIL 221
+ E + A +TAPE + + +D WS G++L
Sbjct: 333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILL 375
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 6e-21
Identities = 62/230 (26%), Positives = 108/230 (46%), Gaps = 30/230 (13%)
Query: 31 QLGPLLGRGSFAKVHKA--KSIADGSI-VAIKTI------EKNNKFLDAAMEDRIVREVS 81
+LG +G G F VH+ S + ++ VAIKT KFL +E
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL---------QEAL 68
Query: 82 AMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLV 139
MR+ +HP+++K+ V T+ ++++ME GEL L+ + L ++ Y QL
Sbjct: 69 TMRQF-DHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 126
Query: 140 SALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGT--PA-Y 196
+AL + HRD+ +N+L+ + +K+ DFGLS +++ + A P +
Sbjct: 127 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKW 183
Query: 197 TAPEVVARRGYDGAVADAWSCGVILF-VLLAGYLPFDDSNLLAMYKKVNR 245
APE + R + A +D W GV ++ +L+ G PF + ++
Sbjct: 184 MAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 232
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 7e-21
Identities = 51/223 (22%), Positives = 101/223 (45%), Gaps = 14/223 (6%)
Query: 31 QLGPLLGRGSFAKVHKAKSIADGS----IVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
+ +LG G F VHK I +G V IK I +K + + + + A+ L
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQA-VTDHMLAIGSL 72
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGEL--FGKLRRGRLTESAARRYFQQLVSALHF 144
H +++++ + + + LV +Y G L + RG L + Q+ +++
Sbjct: 73 D-HAHIVRLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 130
Query: 145 CHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP-AYTAPEVVA 203
++G+ HR++ +N+LL ++V+DFG++ L +L++ TP + A E +
Sbjct: 131 LEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 204 RRGYDGAVADAWSCGVILF-VLLAGYLPFDDSNLLAMYKKVNR 245
Y +D WS GV ++ ++ G P+ L + + +
Sbjct: 191 FGKYTHQ-SDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 8e-21
Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 17/199 (8%)
Query: 31 QLGPLLGRGSFAKVHKA--KSIADGSI-VAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
L +LG G F +V++ + I VA+KT +K+ +++ + E M+ L
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC---TLDNKEKFMSEAVIMKNL- 70
Query: 88 NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFC 145
+HP+++K+ ++ + +++ME GEL L + L Y Q+ A+ +
Sbjct: 71 DHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 129
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGT--P-AYTAPEVV 202
HRD+ +N+L+ +K+ DFGLS I++ + A T P + +PE +
Sbjct: 130 ESINCVHRDIAVRNILVASPECVKLGDFGLSRY---IEDEDYYKASVTRLPIKWMSPESI 186
Query: 203 ARRGYDGAVADAWSCGVIL 221
R + A +D W V +
Sbjct: 187 NFRRFTTA-SDVWMFAVCM 204
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 8e-21
Identities = 74/271 (27%), Positives = 124/271 (45%), Gaps = 34/271 (12%)
Query: 31 QLGPLLGRGSFAKVHKA--KSIADGSI-VAIKTI------EKNNKFLDAAMEDRIVREVS 81
+ ++G G F +V K + I VAIKT+ ++ FL E S
Sbjct: 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL---------GEAS 98
Query: 82 AMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLV 139
M + HPN+++++ V+ + +V EY G L LR + T + +
Sbjct: 99 IMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIA 157
Query: 140 SALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGT--PA-Y 196
S + + G HRD+ +N+L++ + KVSDFGL + E +T G P +
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA-YTTRGGKIPIRW 216
Query: 197 TAPEVVARRGYDGAVADAWSCGVILF-VLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVS 255
T+PE +A R + A +D WS G++L+ V+ G P+ + + + K V Y+ P +
Sbjct: 217 TSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV-DEGYRLPPPMD 274
Query: 256 KPARSLIYQLL----DPNPKTRMSIEKIMSI 282
PA +YQL+ + R E+I+SI
Sbjct: 275 CPAA--LYQLMLDCWQKDRNNRPKFEQIVSI 303
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 8e-21
Identities = 59/239 (24%), Positives = 94/239 (39%), Gaps = 40/239 (16%)
Query: 8 PSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSI---VAIKTIEKN 64
P I N LG +LG G F V + + VA+KT+ K
Sbjct: 16 PRGSEELQNKLEDVVID--RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KL 72
Query: 65 NKFLDAAMEDRIVREVSAMRRLQNHPNVLK-----IQEVMATKTKIYLVMEYAAGGELFG 119
+ +E+ + E + M+ +HPNV++ I+ K +++ + G+L
Sbjct: 73 DNSSQREIEE-FLSEAACMKDF-SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHT 130
Query: 120 KLRRGRLTESAARRYFQQLVSALHFCHQNGVA------------HRDVKPQNLLLDRDGN 167
L RL Q L L F +A HRD+ +N +L D
Sbjct: 131 YLLYSRLETGPKHIPLQTL---LKFMVD--IALGMEYLSNRNFLHRDLAARNCMLRDDMT 185
Query: 168 LKVSDFGLSALPEQIKNGMLHTACGTPA-----YTAPEVVARRGYDGAVADAWSCGVIL 221
+ V+DFGLS ++I +G + G A + A E +A R Y +D W+ GV +
Sbjct: 186 VCVADFGLS---KKIYSGDYYRQ-GRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTM 239
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 51/220 (23%), Positives = 89/220 (40%), Gaps = 39/220 (17%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGS---IVAIKTIEKNNKFLDAAMEDRIVREVSAMR 84
++ LG +LG+G F V +A+ + VA+K + K + + +E+ +RE + M+
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEE-FLREAACMK 80
Query: 85 RLQNHPNVLKI------QEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQL 138
+HP+V K+ +++ + G+L L R+ E+ Q L
Sbjct: 81 EF-DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139
Query: 139 VSALHFCHQ--NGVA--------HRDVKPQNLLLDRDGNLKVSDFGLSALPEQI------ 182
+ F G+ HRD+ +N +L D + V+DFGLS
Sbjct: 140 ---VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQG 196
Query: 183 KNGMLHTACGTPA-YTAPEVVARRGYDGAVADAWSCGVIL 221
L P + A E +A Y +D W+ GV +
Sbjct: 197 CASKL------PVKWLALESLADNLYTVH-SDVWAFGVTM 229
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 15/216 (6%)
Query: 16 PPPPSKKIPTLLNRYQL--GPLLGRGSFAKVHKAK----SIADGSIVAIKTIEKNNKFLD 69
PT+ ++ L LG G F KV + G +VA+K ++ +
Sbjct: 17 VLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG--P 74
Query: 70 AAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK--IYLVMEYAAGGELFGKLRRGRLT 127
+E+ +R L H +++K + + LVMEY G L L R +
Sbjct: 75 QHRSG-WKQEIDILRTLY-HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIG 132
Query: 128 ESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS-ALPEQIKNGM 186
+ + QQ+ + + H HRD+ +N+LLD D +K+ DFGL+ A+PE +
Sbjct: 133 LAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR 192
Query: 187 LHTACGTP-AYTAPEVVARRGYDGAVADAWSCGVIL 221
+ +P + APE + + A +D WS GV L
Sbjct: 193 VREDGDSPVFWYAPECLKEYKFYYA-SDVWSFGVTL 227
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-20
Identities = 51/201 (25%), Positives = 97/201 (48%), Gaps = 16/201 (7%)
Query: 31 QLGPLLGRGSFAKVHKAK----SIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
+ LG+G+F V + G +VA+K ++ + + + D RE+ ++ L
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRD-FEREIEILKSL 68
Query: 87 QNHPNVLKIQEVMATKTK--IYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSAL 142
Q H N++K + V + + + L+MEY G L L+ + R+ +Y Q+ +
Sbjct: 69 Q-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 143 HFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS-ALPEQIKNGMLHTACGTP-AYTAPE 200
+ HRD+ +N+L++ + +K+ DFGL+ LP+ + + +P + APE
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE 187
Query: 201 VVARRGYDGAVADAWSCGVIL 221
+ + A +D WS GV+L
Sbjct: 188 SLTESKFSVA-SDVWSFGVVL 207
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 3e-20
Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 17/219 (7%)
Query: 36 LGRGSFAKVHKAK-SIADGSI-VAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVL 93
LG G+F V + + I VAIK +++ + A + ++RE M +L +P ++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLD-NPYIV 73
Query: 94 KIQEVMATKTKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVA 151
++ V + LVME A GG L L R + S Q+ + + +
Sbjct: 74 RLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 152 HRDVKPQNLLLDRDGNLKVSDFGLS-ALPEQIKNGMLHTACGT--P-AYTAPEVVARRGY 207
HRD+ +N+LL K+SDFGLS AL + P + APE + R +
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGAD--DSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 208 DGAVADAWSCGVILF-VLLAGYLPFDDSNLLAMYKKVNR 245
+D WS GV ++ L G P+ + + +
Sbjct: 191 SSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 4e-20
Identities = 54/224 (24%), Positives = 98/224 (43%), Gaps = 20/224 (8%)
Query: 11 PPPPPPPPPSKKIPTLLNRYQL--GPLLGRGSFAKVHKAK----SIADGSIVAIKTIEKN 64
+ + PT+ L LG+G+F V + G++VA+K ++
Sbjct: 4 HHHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH- 62
Query: 65 NKFLDAAMEDR-IVREVSAMRRLQNHPNVLKIQEV-MATKTK-IYLVMEYAAGGELFGKL 121
+ R RE+ ++ L ++K + V + + LVMEY G L L
Sbjct: 63 ----SGPDQQRDFQREIQILKALH-SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL 117
Query: 122 R--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS-AL 178
+ R RL S Y Q+ + + HRD+ +N+L++ + ++K++DFGL+ L
Sbjct: 118 QRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177
Query: 179 PEQIKNGMLHTACGTP-AYTAPEVVARRGYDGAVADAWSCGVIL 221
P ++ +P + APE ++ + +D WS GV+L
Sbjct: 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQ-SDVWSFGVVL 220
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 6e-20
Identities = 60/283 (21%), Positives = 101/283 (35%), Gaps = 57/283 (20%)
Query: 31 QLGPLLGRGSFAKVHKAKSIADGSI-------VAIKTIEKNNKFLDAAMEDRI--VREVS 81
LG+G+F K+ K G V +K ++K A S
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK------AHRNYSESFFEAAS 64
Query: 82 AMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLV 139
M +L +H +++ V + LV E+ G L L+ + + +QL
Sbjct: 65 MMSKL-SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 140 SALHFCHQNGVAHRDVKPQNLLLDRDGNL--------KVSDFGLSALPEQ-------IKN 184
+A+HF +N + H +V +N+LL R+ + K+SD G+S I
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP- 182
Query: 185 GMLHTACGTPAYTAPEVVA-RRGYDGAVADAWSCGVILF-VLLAGYLPFDDSNLLAMYKK 242
+ PE + + + A D WS G L+ + G P + +
Sbjct: 183 -----------WVPPECIENPKNLNLA-TDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230
Query: 243 VNRRDYQFPSFVSKPARSLIYQLL----DPNPKTRMSIEKIMS 281
R +Q P P + + L+ D P R S I+
Sbjct: 231 YEDR-HQLP----APKAAELANLINNCMDYEPDHRPSFRAIIR 268
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 67/222 (30%), Positives = 100/222 (45%), Gaps = 36/222 (16%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94
+LGRG F KV+K + +ADG++VA+K +++ E + EV + H N+L+
Sbjct: 37 ILGRGGFGKVYKGR-LADGTLVAVKRLKEERT---QGGELQFQTEVEMISMAV-HRNLLR 91
Query: 95 IQEVMATKTKIYLVMEYAAGG----ELFGKL---------RRGRLTESAARRYFQQLVSA 141
++ T T+ LV Y A G L + +R R+ +AR
Sbjct: 92 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR--------G 143
Query: 142 LHFCHQNG---VAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLH--TA-CGTPA 195
L + H + + HRDVK N+LLD + V DFGL+ L + H TA GT
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL---MDYKDTHVTTAVRGTIG 200
Query: 196 YTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL 237
+ APE G D + GV+L L+ G FD + L
Sbjct: 201 HIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 44/188 (23%), Positives = 80/188 (42%), Gaps = 26/188 (13%)
Query: 7 PPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHK--AKSIADGS---IVAIKTI 61
P P ++ + + LG+GSF V++ AK + VAIKT+
Sbjct: 6 PEYFSAADVYVPDEWEVA--REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV 63
Query: 62 EKNNKFLDAAMEDRI--VREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFG 119
+ A+M +RI + E S M+ N +V+++ V++ ++ME G+L
Sbjct: 64 NE-----AASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 117
Query: 120 KLRRGRLTESAARRYFQ-QLVSALHFCHQ--NGVA--------HRDVKPQNLLLDRDGNL 168
LR R + L + + +G+A HRD+ +N ++ D +
Sbjct: 118 YLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177
Query: 169 KVSDFGLS 176
K+ DFG++
Sbjct: 178 KIGDFGMT 185
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 4e-19
Identities = 45/217 (20%), Positives = 85/217 (39%), Gaps = 48/217 (22%)
Query: 31 QLGPLLGRGSFAKVHKAKSIADGSI---VAIKTIEKNNKFLDAAMEDRI--VREVSAMRR 85
++GRG F V+ + + A+K++ + + + + E M+
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-----TDIGEVSQFLTEGIIMKD 82
Query: 86 LQNHPNVLKIQEVMA-TKTKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSAL 142
+HPNVL + + ++ +V+ Y G+L +R T + L+
Sbjct: 83 F-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPT-------VKDLIG-- 132
Query: 143 HFCHQNGVA------------HRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTA 190
F Q VA HRD+ +N +LD +KV+DFGL+ + + ++
Sbjct: 133 -FGLQ--VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA---RDMYDKEYYSV 186
Query: 191 CGTPA------YTAPEVVARRGYDGAVADAWSCGVIL 221
+ A E + + + +D WS GV+L
Sbjct: 187 HNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLL 222
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 47/204 (23%), Positives = 81/204 (39%), Gaps = 37/204 (18%)
Query: 1 MEPGCSPPSAPPPPPPPPPSK-KIPTLLNRYQLGPLLGRGSFAKVHKAK-----SIADGS 54
M+P P P SK + P +R +LG LGRG+F +V +A A
Sbjct: 1 MDPDELPLDEHCERLPYDASKWEFP--RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCR 58
Query: 55 IVAIKTIEKNNKFLDAAMEDRI--VREVSAMRRLQNHPNVLK-IQEVMATKTKIYLVMEY 111
VA+K +++ A + + E+ + + +H NV+ + + +++E+
Sbjct: 59 TVAVKMLKEG-----ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF 113
Query: 112 AAGGELFGKLRRGRLTESAARRYFQQLVSA-------LHFCHQNGVA------------H 152
G L LR R + + L + + Q VA H
Sbjct: 114 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQ--VAKGMEFLASRKCIH 171
Query: 153 RDVKPQNLLLDRDGNLKVSDFGLS 176
RD+ +N+LL +K+ DFGL+
Sbjct: 172 RDLAARNILLSEKNVVKICDFGLA 195
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 50/198 (25%), Positives = 77/198 (38%), Gaps = 35/198 (17%)
Query: 4 GCSPPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSI-----ADGSIVAI 58
G S P P + P N Q G LG G+F KV +A + VA+
Sbjct: 24 GNSYTFIDPTQLPYNEKWEFP--RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAV 81
Query: 59 KTIEKNNKFLDAAMEDRI--VREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGE 116
K ++ A +++ + E+ M L H N++ + + ++ EY G+
Sbjct: 82 KMLKS-----TAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 117 LFGKLRRGR--------LTESAARRYFQQLVSALHFCHQ--NGVA--------HRDVKPQ 158
L LRR + + + L LHF Q G+A HRDV +
Sbjct: 137 LLNFLRRKSRVLETDPAFAIANSTASTRDL---LHFSSQVAQGMAFLASKNCIHRDVAAR 193
Query: 159 NLLLDRDGNLKVSDFGLS 176
N+LL K+ DFGL+
Sbjct: 194 NVLLTNGHVAKIGDFGLA 211
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 59/225 (26%), Positives = 91/225 (40%), Gaps = 51/225 (22%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNK-----FLDAAMEDRIVREVSAMRRLQNH 89
L+G G F KV+K + DG+ VA+K + F E+ + + H
Sbjct: 46 LIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFE---------TEIETLSFCR-H 94
Query: 90 PNVLKI------QEVMATKTKIYLVMEYAAGGE----LFGKLR---------RGRLTESA 130
P+++ + + M L+ +Y G L+G R + A
Sbjct: 95 PHLVSLIGFCDERNEMI------LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 131 ARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTA 190
AR LH+ H + HRDVK N+LLD + K++DFG+S ++ L T
Sbjct: 149 AR--------GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV 200
Query: 191 C-GTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS 234
GT Y PE +G +D +S GV+LF +L S
Sbjct: 201 VKGTLGYIDPE-YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 49/245 (20%), Positives = 86/245 (35%), Gaps = 54/245 (22%)
Query: 6 SPPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSI---VAIKTIE 62
+ P I ++GRG F V+ + + A+K++
Sbjct: 67 DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 126
Query: 63 KNNKFLDAAMEDRI--VREVSAMRRLQNHPNVLKIQEVMA-TKTKIYLVMEYAAGGELFG 119
+ + + + E M+ +HPNVL + + ++ +V+ Y G+L
Sbjct: 127 RI-----TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 180
Query: 120 KLR--RGRLTESAARRYFQQLVSALHFCHQNGVA------------HRDVKPQNLLLDRD 165
+R T + L+ F Q VA HRD+ +N +LD
Sbjct: 181 FIRNETHNPT-------VKDLIG---FGLQ--VAKGMKFLASKKFVHRDLAARNCMLDEK 228
Query: 166 GNLKVSDFGLS--------ALPEQIKNGMLHTACGTPA-YTAPEVVARRGYDGAVADAWS 216
+KV+DFGL+ L P + A E + + + +D WS
Sbjct: 229 FTVKVADFGLARDMYDKEFDSVHNKTGAKL------PVKWMALESLQTQKFTTK-SDVWS 281
Query: 217 CGVIL 221
GV+L
Sbjct: 282 FGVLL 286
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 42/206 (20%), Positives = 77/206 (37%), Gaps = 41/206 (19%)
Query: 5 CSPPSAPPPPPPPPPSKKIPTLL------NRYQLGPLLGRGSFAKVHKAK-------SIA 51
+ ++P +R LG LG G+F +V A+
Sbjct: 40 TTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPN 99
Query: 52 DGSIVAIKTIEKNNKFLDAAMEDRI--VREVSAMRRLQNHPNVLKIQEVMATKTKIYLVM 109
+ VA+K ++ DA +D + E+ M+ + H N++ + +Y+++
Sbjct: 100 RVTKVAVKMLKS-----DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 154
Query: 110 EYAAGGELFGKLRRGRLTESAARRYFQQLVSA-------LHFCHQNGVA----------- 151
EYA+ G L L+ R + +Q VA
Sbjct: 155 EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ--VARGMEYLASKKC 212
Query: 152 -HRDVKPQNLLLDRDGNLKVSDFGLS 176
HRD+ +N+L+ D +K++DFGL+
Sbjct: 213 IHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 43/204 (21%), Positives = 80/204 (39%), Gaps = 41/204 (20%)
Query: 7 PPSAPPPPPPPPPSKKIPTLL------NRYQLGPLLGRGSFAKVHKAK-------SIADG 53
+A P ++P ++ LG LG G F +V A+ +
Sbjct: 54 SSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEA 113
Query: 54 SIVAIKTIEKNNKFLDAAMEDRI--VREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEY 111
VA+K ++ DA +D V E+ M+ + H N++ + +Y+++EY
Sbjct: 114 VTVAVKMLKD-----DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY 168
Query: 112 AAGGELFGKLRRGRLTESAARRYFQQLVSA-------LHFCHQNGVA------------H 152
A+ G L LR R ++ + +Q +A H
Sbjct: 169 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQ--LARGMEYLASQKCIH 226
Query: 153 RDVKPQNLLLDRDGNLKVSDFGLS 176
RD+ +N+L+ + +K++DFGL+
Sbjct: 227 RDLAARNVLVTENNVMKIADFGLA 250
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 52/250 (20%), Positives = 82/250 (32%), Gaps = 66/250 (26%)
Query: 12 PPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHK--AKSIADGS---IVAIKTIEKNNK 66
P I L LG G+F KV ++ +VA+K ++
Sbjct: 27 PQYFSDACVHHIK--RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK---- 80
Query: 67 FLDAAMEDRI--VREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRG 124
+A+ R RE + L H ++++ V + +V EY G+L LR
Sbjct: 81 --EASESARQDFQREAELLTML-QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH 137
Query: 125 RLTESAARRYFQQLVSAL------HFCHQNGVA------------HRDVKPQNLLLDRDG 166
L Q VA HRD+ +N L+ +
Sbjct: 138 GPDAKLLAGGEDVAPGPLGLGQLLAVASQ--VAAGMVYLAGLHFVHRDLATRNCLVGQGL 195
Query: 167 NLKVSDFGLS---------------ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAV 211
+K+ DFG+S LP I+ + PE + R +
Sbjct: 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLP--IR------------WMPPESILYRKFTTE- 240
Query: 212 ADAWSCGVIL 221
+D WS GV+L
Sbjct: 241 SDVWSFGVVL 250
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 42/198 (21%), Positives = 79/198 (39%), Gaps = 41/198 (20%)
Query: 13 PPPPPPPSKKIPTLL------NRYQLGPLLGRGSFAKVHKAK-------SIADGSIVAIK 59
P ++P ++ LG LG G+F +V A+ + VA+K
Sbjct: 14 PMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK 73
Query: 60 TIEKNNKFLDAAMEDRI--VREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGEL 117
++ DA +D V E+ M+ + H N++ + +Y+++EYA+ G L
Sbjct: 74 MLKD-----DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 118 FGKLRRGRLTESAARRYFQQLVSA-------LHFCHQNGVA------------HRDVKPQ 158
LR R ++ + +Q +A HRD+ +
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQ--LARGMEYLASQKCIHRDLAAR 186
Query: 159 NLLLDRDGNLKVSDFGLS 176
N+L+ + +K++DFGL+
Sbjct: 187 NVLVTENNVMKIADFGLA 204
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 45/201 (22%), Positives = 73/201 (36%), Gaps = 42/201 (20%)
Query: 9 SAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAK-----SIADGSIVAIKTIEK 63
+ P + G +LG G+F KV A VA+K +++
Sbjct: 28 YVDFREYEYDLKWEFP--RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE 85
Query: 64 NNKFLDAAMEDRI--VREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL 121
A +R + E+ M +L +H N++ + IYL+ EY G+L L
Sbjct: 86 K-----ADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL 140
Query: 122 RRGRLTESAARRYFQQLVSA--------------LHFCHQNGVA------------HRDV 155
R R S ++ L F +Q VA HRD+
Sbjct: 141 RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ--VAKGMEFLEFKSCVHRDL 198
Query: 156 KPQNLLLDRDGNLKVSDFGLS 176
+N+L+ +K+ DFGL+
Sbjct: 199 AARNVLVTHGKVVKICDFGLA 219
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 5e-18
Identities = 57/244 (23%), Positives = 102/244 (41%), Gaps = 44/244 (18%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94
+G G F V+K + + VA+K + ++ + +E+ M + Q H N+++
Sbjct: 38 KMGEGGFGVVYKG--YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVE 94
Query: 95 I-------QEVMATKTKIYLVMEYAAGG----ELFGKLRRGRLT--------ESAARRYF 135
+ ++ LV Y G L L+ + AA
Sbjct: 95 LLGFSSDGDDLC-------LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN--- 144
Query: 136 QQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTA-CGTP 194
++F H+N HRD+K N+LLD K+SDFGL+ E+ ++ + GT
Sbjct: 145 -----GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTT 199
Query: 195 AYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS----NLLAMYKKVNRRDYQF 250
AY APE + RG +D +S GV+L ++ G D+ LL + +++ +
Sbjct: 200 AYMAPEAL--RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTI 257
Query: 251 PSFV 254
++
Sbjct: 258 EDYI 261
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 46/202 (22%), Positives = 80/202 (39%), Gaps = 44/202 (21%)
Query: 9 SAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHK--AKSIADGS---IVAIKTIEK 63
P P S + P N + +G G+F +V + A + +VA+K +++
Sbjct: 30 RMPLLLNPKLLSLEYP--RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE 87
Query: 64 NNKFLDAAMEDRI--VREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL 121
+A+ + + RE + M ++PN++K+ V A + L+ EY A G+L L
Sbjct: 88 -----EASADMQADFQREAALMAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL 141
Query: 122 RRGRLTESAARRYFQQLVSA---------------LHFCHQNGVA------------HRD 154
R + + A L Q VA HRD
Sbjct: 142 RSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ--VAAGMAYLSERKFVHRD 199
Query: 155 VKPQNLLLDRDGNLKVSDFGLS 176
+ +N L+ + +K++DFGLS
Sbjct: 200 LATRNCLVGENMVVKIADFGLS 221
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-17
Identities = 56/218 (25%), Positives = 91/218 (41%), Gaps = 50/218 (22%)
Query: 31 QLGPLLGRGSFAKVHKA--KSIADGSI-VAIKTIEKNNKFLDAAMEDRI--VREVSAMRR 85
++G+G F V+ A I AIK++ + M+ +RE MR
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-----TEMQQVEAFLREGLLMRG 78
Query: 86 LQNHPNVLKIQEVMATKT-KIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSAL 142
L NHPNVL + +M ++++ Y G+L +R + T + L+S
Sbjct: 79 L-NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPT-------VKDLIS-- 128
Query: 143 HFCHQ--NGVA--------HRDVKPQNLLLDRDGNLKVSDFGLS--------ALPEQIKN 184
F Q G+ HRD+ +N +LD +KV+DFGL+ +Q ++
Sbjct: 129 -FGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRH 187
Query: 185 GMLHTACGTPA-YTAPEVVARRGYDGAVADAWSCGVIL 221
L P +TA E + + +D WS GV+L
Sbjct: 188 ARL------PVKWTALESLQTYRFTTK-SDVWSFGVLL 218
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 57/238 (23%), Positives = 87/238 (36%), Gaps = 38/238 (15%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
NRY+LG +G GSF ++ IA G VAIK E ++ E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVK-----TKHPQLHIESKIYKMMQ 62
Query: 88 NHPNVLKIQEVMATKTKIYLVMEYAAGG----ELFGKLRRGRLTESAARRYFQQLVSALH 143
+ I+ A +VME G +LF R + + Q++S +
Sbjct: 63 GGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIE 119
Query: 144 FCHQNGVAHRDVKPQNLLLDRDGN---LKVSDFGLSALPEQIKNGMLHTA-------CGT 193
+ H HRDVKP N L+ + + DFGL+ + H GT
Sbjct: 120 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ-HIPYRENKNLTGT 178
Query: 194 PAYTAPEVVARRGY-----DGAVADAWSCGVILFVLLAGYLP---FDDSNLLAMYKKV 243
Y + + G D D S G +L G LP + Y+++
Sbjct: 179 ARYAS--INTHLGIEQSRRD----DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 230
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 3e-17
Identities = 53/232 (22%), Positives = 83/232 (35%), Gaps = 65/232 (28%)
Query: 31 QLGPLLGRGSFAKVHK--AKSIADGS---IVAIKTIEKNNKFLDAAMEDRI--VREVSAM 83
L LG G+F KV +++ +VA+K ++ D + R RE +
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK------DPTLAARKDFQREAELL 71
Query: 84 RRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSA-- 141
LQ H +++K V + +V EY G+L LR +
Sbjct: 72 TNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 142 -----LHFCHQNGVA------------HRDVKPQNLLLDRDGNLKVSDFGLS-------- 176
LH Q +A HRD+ +N L+ + +K+ DFG+S
Sbjct: 131 GLSQMLHIASQ--IASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188
Query: 177 -------ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVIL 221
LP I+ + PE + R + +D WS GVIL
Sbjct: 189 YRVGGHTMLP--IR------------WMPPESIMYRKFTTE-SDVWSFGVIL 225
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 53/248 (21%), Positives = 88/248 (35%), Gaps = 66/248 (26%)
Query: 12 PPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHK--AKSIADGS---IVAIKTIEKNNK 66
K++P L LG G+F +V++ + + VA+KT+ +
Sbjct: 57 GKTSSISDLKEVP--RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-- 112
Query: 67 FLDAAMEDRI--VREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRG 124
+ +D + + E + + NH N+++ V ++++E AGG+L LR
Sbjct: 113 ---CSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET 168
Query: 125 RLTESAARRY-FQQLVSALHFCHQNGVA------------HRDVKPQNLLLDRDGN---L 168
R S L LH +A HRD+ +N LL G
Sbjct: 169 RPRPSQPSSLAMLDL---LHVARD--IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223
Query: 169 KVSDFGLS---------------ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVAD 213
K+ DFG++ LP +K + PE + D
Sbjct: 224 KIGDFGMARDIYRAGYYRKGGCAMLP--VK------------WMPPEAFMEGIFTSK-TD 268
Query: 214 AWSCGVIL 221
WS GV+L
Sbjct: 269 TWSFGVLL 276
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 54/245 (22%), Positives = 88/245 (35%), Gaps = 66/245 (26%)
Query: 15 PPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHK--AKSIADGS---IVAIKTIEKNNKFLD 69
K++P L LG G+F +V++ + + VA+KT+ +
Sbjct: 19 SSISDLKEVP--RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV----- 71
Query: 70 AAMEDRI--VREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLT 127
+ +D + + E + + NH N+++ V +++ME AGG+L LR R
Sbjct: 72 CSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPR 130
Query: 128 ESAARR-YFQQLVSALHFCHQNGVA------------HRDVKPQNLLLDRDGN---LKVS 171
S L LH +A HRD+ +N LL G K+
Sbjct: 131 PSQPSSLAMLDL---LHVARD--IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185
Query: 172 DFGLS---------------ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWS 216
DFG++ LP +K + PE + D WS
Sbjct: 186 DFGMARDIYRASYYRKGGCAMLP--VK------------WMPPEAFMEGIFTSK-TDTWS 230
Query: 217 CGVIL 221
GV+L
Sbjct: 231 FGVLL 235
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 7e-17
Identities = 54/232 (23%), Positives = 83/232 (35%), Gaps = 64/232 (27%)
Query: 31 QLGPLLGRGSFAKVHK--AKSIADGS---IVAIKTIEKNNKFLDAAMEDRI--VREVSAM 83
+ LG F KV+K A G VAIKT++ A R E
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD-----KAEGPLREEFRHEAMLR 66
Query: 84 RRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSA-- 141
RLQ HPNV+ + V+ + ++ Y + G+L L + V +
Sbjct: 67 ARLQ-HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 142 -----LHFCHQNGVA------------HRDVKPQNLLLDRDGNLKVSDFGLS-------- 176
+H Q +A H+D+ +N+L+ N+K+SD GL
Sbjct: 126 EPPDFVHLVAQ--IAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY 183
Query: 177 -------ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVIL 221
LP I+ + APE + + +D WS GV+L
Sbjct: 184 YKLLGNSLLP--IR------------WMAPEAIMYGKFSID-SDIWSYGVVL 220
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 7e-17
Identities = 53/269 (19%), Positives = 93/269 (34%), Gaps = 69/269 (25%)
Query: 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAM-EDRIVREVSAM 83
RY + LG G F+ V + I VA+K ++ + + A+ E R+++ V
Sbjct: 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNS 93
Query: 84 RRLQNHPNVLKIQEVM-------ATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARR 133
N PN + +++ T I +V E G L + + L ++
Sbjct: 94 D--PNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKK 150
Query: 134 YFQQLVSALHFCH-QNGVAHRDVKPQNLLL------------------------------ 162
QQ++ L + H + + H D+KP+N+LL
Sbjct: 151 IIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 163 -------------------DRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVA 203
+K++D G + + + T Y + EV+
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLI 266
Query: 204 RRGYDGAVADAWSCGVILFVLLAGYLPFD 232
GY+ AD WS + F L G F+
Sbjct: 267 GSGYNTP-ADIWSTACMAFELATGDYLFE 294
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 35/158 (22%), Positives = 66/158 (41%), Gaps = 18/158 (11%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
+++G +G G+F ++ K++ VAIK +E + ++ E ++L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMK-----SRAPQLHLEYRFYKQLG 62
Query: 88 NHPNVLKIQEVMATKTKIYLVMEYAAGG----ELFGKLRRGRLTESAARRYFQQLVSALH 143
+ + ++ +V+E G +LF R + QL+S +
Sbjct: 63 SGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDR-TFSLKTVLMIAIQLISRME 119
Query: 144 FCHQNGVAHRDVKPQNLLLDRDGNLKVS-----DFGLS 176
+ H + +RDVKP+N L+ R GN DF L+
Sbjct: 120 YVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 53/217 (24%), Positives = 83/217 (38%), Gaps = 25/217 (11%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
N+++LG +G GSF +++ +I VAIK K +++ E R LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------HPQLLYESKIYRILQ 60
Query: 88 NHPNVLKIQEVMATKTKIYLVMEYAAG---GELFGKLRRGRLTESAARRYFQQLVSALHF 144
+ ++ LVM+ G +LF R +L+ Q+++ + F
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEF 118
Query: 145 CHQNGVAHRDVKPQNLLLDRDGN---LKVSDFGLSALPEQIKNGMLHTA-------CGTP 194
H HRD+KP N L+ + + DFGL+ H GT
Sbjct: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ-HIPYRENKNLTGTA 177
Query: 195 AYTAPEVVARRGYD-GAVADAWSCGVILFVLLAGYLP 230
Y + V G + D S G +L L G LP
Sbjct: 178 RYAS--VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 4e-16
Identities = 51/206 (24%), Positives = 81/206 (39%), Gaps = 46/206 (22%)
Query: 7 PPSAPPPPPPPPPSKK--IPTLLNRYQLGPLLGRGSFAKVHKAK-----SIADGSIVAIK 59
P S K P LG LG G F KV KA A + VA+K
Sbjct: 2 PLSLSVDAFKILEDPKWEFP--RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK 59
Query: 60 TIEKNNKFLDAAMEDRI--VREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGEL 117
+++N A+ + + E + ++++ NHP+V+K+ + + L++EYA G L
Sbjct: 60 MLKEN-----ASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSL 113
Query: 118 FGKLRRGRLTESAARRYFQQLVSA---------------LHFCHQNGVA----------- 151
G LR R S+ + F Q ++
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQ--ISQGMQYLAEMKL 171
Query: 152 -HRDVKPQNLLLDRDGNLKVSDFGLS 176
HRD+ +N+L+ +K+SDFGLS
Sbjct: 172 VHRDLAARNILVAEGRKMKISDFGLS 197
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 8e-16
Identities = 52/262 (19%), Positives = 85/262 (32%), Gaps = 70/262 (26%)
Query: 15 PPPPPSKKIPTLL--NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAM 72
P P K+ + N++ LG +G G F ++ A A ++ ++
Sbjct: 22 SMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK-----VEYQE 76
Query: 73 EDRIVREVSAMRRLQNHPNVLKIQEVMATKT----KIY--------------LVMEYAAG 114
+ E+ +R+ + K E Y +VME
Sbjct: 77 NGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVME---- 132
Query: 115 GELFGK------LRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNL 168
G + G +S + +++ L + H+N H D+K NLLL
Sbjct: 133 --RLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD 190
Query: 169 KV--SDFGLS----------ALPEQIKNGMLHTACGTPAYT--------APEVVARRGYD 208
+V +D+GLS E + G H GT +T A +RR
Sbjct: 191 QVYLADYGLSYRYCPNGNHKQYQENPRKG--HN--GTIEFTSLDAHKGVAL---SRRS-- 241
Query: 209 GAVADAWSCGVILFVLLAGYLP 230
D G + L G LP
Sbjct: 242 ----DVEILGYCMLRWLCGKLP 259
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 76.1 bits (186), Expect = 2e-15
Identities = 40/204 (19%), Positives = 70/204 (34%), Gaps = 47/204 (23%)
Query: 16 PPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTI----------EKNN 65
P P S +PT + Q +G G F +V + IAD + VAIK I
Sbjct: 10 PVPFSHCLPT--EKLQRCEKIGEGVFGEVFQT--IADHTPVAIKIIAIEGPDLVNGSHQK 65
Query: 66 KFLDAAMEDRIVREVSAMR--RLQNHPNVLKIQEV------------------------- 98
F + E I +E+S + + + V
Sbjct: 66 TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125
Query: 99 -----MATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQN-GVAH 152
++++V+E+ GG ++R + + A+ QL ++L + H
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEH 185
Query: 153 RDVKPQNLLLDRDGNLKVSDFGLS 176
RD+ N+LL + K+
Sbjct: 186 RDLHWGNVLLKKTSLKKLHYTLNG 209
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-15
Identities = 42/218 (19%), Positives = 79/218 (36%), Gaps = 25/218 (11%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
Y++G +G GSF + + ++ + VAIK E + ++ E + L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRR-----SDAPQLRDEYRTYKLLA 63
Query: 88 NHPNVLKIQEVMATKTKIYLVMEYAAG---GELFGKLRRGRLTESAARRYFQQLVSALHF 144
+ + LV++ G +L R + + +Q+++ +
Sbjct: 64 GCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQS 121
Query: 145 CHQNGVAHRDVKPQNLLLDRDGNLK-----VSDFGLS------ALPEQIKNGMLHTACGT 193
H+ + +RD+KP N L+ R + V DFG+ + I GT
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181
Query: 194 PAYTAPEVVARRGYD-GAVADAWSCGVILFVLLAGYLP 230
Y + + G + D + G + L G LP
Sbjct: 182 ARYMS--INTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 32/203 (15%), Positives = 65/203 (32%), Gaps = 46/203 (22%)
Query: 6 SPPSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSF-----AKVHKAKSIADGSIVAIKT 60
S +++G +G+G F A ++ ++S+ + +K
Sbjct: 13 SSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKV 72
Query: 61 IEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT----KIY---------- 106
+N L E+ +R + K K K +
Sbjct: 73 EPSDNGPLF--------TELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGK 124
Query: 107 ----LVMEYAAGGELFGK-------LRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDV 155
++M+ FG R + + +++ L + H++ H D+
Sbjct: 125 SYRFMIMD------RFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDI 178
Query: 156 KPQNLLLDRDGNLKV--SDFGLS 176
K NLLL+ +V D+GL+
Sbjct: 179 KASNLLLNYKNPDQVYLVDYGLA 201
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 41/249 (16%), Positives = 85/249 (34%), Gaps = 69/249 (27%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSI--------VAIKTIEKNNKFLDAAMEDRIVRE 79
+++L R + +++A + + ++K ++ + R+ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDG--------RLFNE 92
Query: 80 VSAMRRLQNHPNVLKIQEVMATKT----KIY-----------LVMEYAAG---GELFGKL 121
+ +R V K +++ +T LV+ G
Sbjct: 93 QNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS 151
Query: 122 RRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKV--SDFGLS--- 176
+ L+E + + +L+ AL F H+N H +V +N+ +D + +V + +G +
Sbjct: 152 PKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
Query: 177 -------ALPEQIKNGMLHTACGTPAYT--------APEVVARRGYDGAVADAWSCGVIL 221
A E ++ H G + P +RR D S G +
Sbjct: 212 CPSGKHVAYVEGSRSP--HE--GDLEFISMDLHKGCGP---SRRS------DLQSLGYCM 258
Query: 222 FVLLAGYLP 230
L G+LP
Sbjct: 259 LKWLYGFLP 267
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 3e-09
Identities = 60/374 (16%), Positives = 107/374 (28%), Gaps = 114/374 (30%)
Query: 61 IEKNNKFLDAAMEDR-------IVREVSAMRRLQNHP------NVLKIQEVMATKTKI-- 105
+ N KFL + ++ + RL N NV ++Q + + +
Sbjct: 87 LRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLE 146
Query: 106 -----YLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSA-----LHFCHQNGVAHRDV 155
+++ G GK + Y Q L+ + N
Sbjct: 147 LRPAKNVLI-DGVLG--SGK---TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLE 200
Query: 156 KPQNLLLDRDGNLKVSDFGLSALP---EQIKNGMLHTACGTPAYTAPEVVARRGYDGA-- 210
Q LL D N S + I+ + ++ + Y+
Sbjct: 201 MLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR------------LLKSKPYENCLL 248
Query: 211 ----VADAW-------SC---------GVILFV------------LLAGYLPFDDSNLLA 238
V +A SC V F+ P + +LL
Sbjct: 249 VLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL 308
Query: 239 MYKKVNRRDYQFPSFVSK--P-ARSLIYQLLDPNPKT-----RMSIEKIMSISWFQKSLQ 290
K ++ R P V P S+I + + T ++ +K+ +I + SL
Sbjct: 309 --KYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTI--IESSLN 364
Query: 291 QQ-----RKRGQESSLFELGVVGNNKYILKEKIPDIV------SMNAFDIISLSSGLDLS 339
RK S+F IP I+ + D++ + + L
Sbjct: 365 VLEPAEYRKMFDRLSVFPPSA----------HIPTILLSLIWFDVIKSDVMVVVNKLHKY 414
Query: 340 GLFEAKKRKEKRFT 353
L E K+ KE +
Sbjct: 415 SLVE-KQPKESTIS 427
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 24/104 (23%), Positives = 46/104 (44%), Gaps = 9/104 (8%)
Query: 28 NRYQLGPLLGRGSFAKVHKAK-----SIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSA 82
+R +LG LGRG+F +V +A A VA+K +++ + + E+
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL---MSELKI 78
Query: 83 MRRLQNHPNVLK-IQEVMATKTKIYLVMEYAAGGELFGKLRRGR 125
+ + +H NV+ + + +++E+ G L LR R
Sbjct: 79 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 122
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 4e-05
Identities = 37/159 (23%), Positives = 61/159 (38%), Gaps = 9/159 (5%)
Query: 121 LRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180
L + LT Y Q+ + F HRD+ +N+LL +K+ DFGL+
Sbjct: 185 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 244
Query: 181 QIKNGMLHTACGTPA-YTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPF----DDS 234
+ + + P + APE + R Y +D WS GV+L+ + + G P+ D
Sbjct: 245 KDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDE 303
Query: 235 NLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTR 273
K+ R P + + + P R
Sbjct: 304 EFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQR 340
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 27/167 (16%), Positives = 53/167 (31%), Gaps = 30/167 (17%)
Query: 25 TLLNRY---QLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVR--- 78
L+ +G L+G G + V S +K + + E R
Sbjct: 84 RLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLH 142
Query: 79 -----------EVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLT 127
E A+++L V K+ ++ME EL+ R+
Sbjct: 143 FSVLAIRSARNEFRALQKL-QGLAVPKVYAWEGN----AVLMELIDAKELY------RVR 191
Query: 128 ESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFG 174
++ + + G+ H D+ N+L+ + + + DF
Sbjct: 192 VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFP 237
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 451 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 2ehb_D | 143 | CBL-interacting serine/threonine-protein kinase 2; | 100.0 | |
| 2zfd_B | 123 | Putative uncharacterized protein T20L15_90; calciu | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.46 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.17 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.1 | |
| 3ose_A | 120 | Serine/threonine-protein kinase MARK1; kinase asso | 99.02 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.83 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.68 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.67 | |
| 1v5s_A | 126 | MAP/microtubule affinity-regulating kinase 3; Ka1 | 98.6 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.42 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.32 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.27 | |
| 4eai_A | 106 | 5'-AMP-activated protein kinase catalytic subunit | 98.26 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.22 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.1 | |
| 2v8q_A | 157 | 5'-AMP-activated protein kinase catalytic subunit; | 98.02 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.92 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.86 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.86 | |
| 4eag_A | 130 | EG:132E8.2 protein; AMPK, transferase; HET: ATP TA | 97.75 | |
| 2y8l_A | 173 | 5'-AMP-activated protein kinase catalytic subunit; | 97.73 | |
| 2qrd_A | 137 | SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind | 97.61 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.61 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.57 | |
| 3t4n_A | 179 | Carbon catabolite-derepressing protein kinase; CBS | 97.44 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.42 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.38 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.28 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.23 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.15 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.14 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.05 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.92 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.41 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.08 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.07 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 87.96 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.56 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-67 Score=516.42 Aligned_cols=260 Identities=30% Similarity=0.570 Sum_probs=237.8
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
...++|++++.||+|+||+||+|+++.+|+.||||++++. ...+....+.+.+|+.+|++|+ |||||++++++.+.+.
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~-~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~ 106 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR-HIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEK 106 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHH-HHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHH-HCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCE
Confidence 4457899999999999999999999999999999999875 2223344578999999999995 9999999999999999
Q ss_pred EEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 105 IYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
+|||||||+||+|++++.+ +.++|.+++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999999999975 899999999999999999999999999999999999999999999999999998654332
Q ss_pred -cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHH
Q 013005 184 -NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLI 262 (451)
Q Consensus 184 -~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 262 (451)
.....+.|||+.|+|||++.+.+| +.++|||||||++|+|++|+.||.+.+...++.++....+.+|..+|+++++||
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli 265 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLV 265 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHH
T ss_pred CcccccCcccCcccCCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHH
Confidence 345667899999999999988877 567999999999999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHH------HHcCccccc
Q 013005 263 YQLLDPNPKTRMSIEK------IMSISWFQK 287 (451)
Q Consensus 263 ~~~L~~dP~~Rpt~~e------il~hp~f~~ 287 (451)
.+||..||++|||++| |++||||+.
T Consensus 266 ~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 266 EKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp HHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 9999999999999987 689999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-66 Score=504.60 Aligned_cols=259 Identities=43% Similarity=0.810 Sum_probs=221.3
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
..+++|++++.||+|+||+||+|++..+|+.||||++++. ...+....+.+.+|+.+|++|+ |||||++++++.+.+.
T Consensus 10 ~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~-~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~ 87 (275)
T 3hyh_A 10 AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKK-VLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIKSKDE 87 (275)
T ss_dssp ----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred CEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHH-HcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCE
Confidence 3468999999999999999999999999999999999875 2333445678999999999995 9999999999999999
Q ss_pred EEEEEEecCCCchhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 105 IYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~-~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
+|+||||| +|+|.+++. ++++++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+....
T Consensus 88 ~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-- 164 (275)
T 3hyh_A 88 IIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD-- 164 (275)
T ss_dssp EEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred EEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC--
Confidence 99999999 679999886 48899999999999999999999999999999999999999999999999999976433
Q ss_pred cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHH
Q 013005 184 NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIY 263 (451)
Q Consensus 184 ~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 263 (451)
.....+.|||+.|+|||++.+..|++.++||||+||++|+|++|+.||.+.+...++..+....+.+|..+|+++.+||.
T Consensus 165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 244 (275)
T 3hyh_A 165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIK 244 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 23455789999999999999999888889999999999999999999999999999999999999999999999999999
Q ss_pred hccCCCCCCCCCHHHHHcCccccch
Q 013005 264 QLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 264 ~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+||..||++|||++|+++||||+..
T Consensus 245 ~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 245 RMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp HHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred HHccCChhHCcCHHHHHcCcccccC
Confidence 9999999999999999999999764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-64 Score=501.86 Aligned_cols=256 Identities=27% Similarity=0.427 Sum_probs=229.8
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
...|++++.||+|+||+||+|+++.||+.||||++++... ...+.+.+|+.+|++|+ |||||++++++.+.+.+|
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~ 147 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELW 147 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC----SSGGGGHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch----hHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence 4679999999999999999999999999999999976532 12356789999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCc
Q 013005 107 LVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM 186 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~ 186 (451)
||||||+||+|.+++.++++++.+++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+..... ...
T Consensus 148 ivmEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~~ 226 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPR 226 (346)
T ss_dssp EEECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS-SCC
T ss_pred EEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC-CCc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999755332 234
Q ss_pred ccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC---CCCCCCCHhHHHHHH
Q 013005 187 LHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY---QFPSFVSKPARSLIY 263 (451)
Q Consensus 187 ~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~ 263 (451)
..+.|||+.|+|||++.+.+| +.++|||||||++|+|++|+.||.+.+....+..+..... ..+..+|+++.+||.
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~ 305 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 305 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHH
Confidence 567899999999999988888 5679999999999999999999999998888888876532 233458999999999
Q ss_pred hccCCCCCCCCCHHHHHcCccccchh
Q 013005 264 QLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 264 ~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
+||..||++|||++|+++||||++..
T Consensus 306 ~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 306 RLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp HHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 99999999999999999999998753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-64 Score=502.29 Aligned_cols=260 Identities=28% Similarity=0.537 Sum_probs=227.9
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
.+++|++++.||+|+||+||+|+++.+|+.||||++++.. ......+.+.+|+.+|++|+ |||||++++++.+.+.+
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~ 98 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR--MSSKEREESRREVAVLANMK-HPNIVQYRESFEENGSL 98 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTT--SCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHH--CCHHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEECCEE
Confidence 4689999999999999999999999999999999998753 23445678999999999995 99999999999999999
Q ss_pred EEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 106 YLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
|||||||+||+|.+++.. ..+++.+++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.....
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999999999963 35799999999999999999999999999999999999999999999999999865432
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC-CCCCCCCHhHHHH
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY-QFPSFVSKPARSL 261 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~l 261 (451)
. ....+.|||+.|+|||++.+.+|+ .++|||||||+||+|++|+.||.+.+..+++.++....+ ..+..+|+++.+|
T Consensus 179 ~-~~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~l 256 (350)
T 4b9d_A 179 V-ELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSL 256 (350)
T ss_dssp H-HHHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred c-ccccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence 2 234567899999999999988884 679999999999999999999999999998888887765 4566799999999
Q ss_pred HHhccCCCCCCCCCHHHHHcCccccchhH
Q 013005 262 IYQLLDPNPKTRMSIEKIMSISWFQKSLQ 290 (451)
Q Consensus 262 i~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 290 (451)
|.+||..||++|||++|+++||||++...
T Consensus 257 i~~~L~~dP~~R~s~~e~l~hp~~~~~~~ 285 (350)
T 4b9d_A 257 VSQLFKRNPRDRPSVNSILEKGFIAKRIE 285 (350)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSHHHHTTGG
T ss_pred HHHHccCChhHCcCHHHHhcCHHhhcCCC
Confidence 99999999999999999999999986543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-62 Score=502.73 Aligned_cols=255 Identities=27% Similarity=0.438 Sum_probs=230.0
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
.+.|++++.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|+.+|+.|+ |||||++++++.+.+.+|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~ 224 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELW 224 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC----SSGGGHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch----hHHHHHHHHHHHHHhCC-CCCCCceEEEEEECCEEE
Confidence 4679999999999999999999999999999999986532 12356889999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCc
Q 013005 107 LVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM 186 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~ 186 (451)
||||||+||+|.+++..+++++.+++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+..... ...
T Consensus 225 iVmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~-~~~ 303 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPR 303 (423)
T ss_dssp EEEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS-CCC
T ss_pred EEEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC-Ccc
Confidence 9999999999999999899999999999999999999999999999999999999999999999999999754332 234
Q ss_pred ccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC---CCCCCCCCHhHHHHHH
Q 013005 187 LHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD---YQFPSFVSKPARSLIY 263 (451)
Q Consensus 187 ~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~ 263 (451)
..+.|||+.|||||++.+..| +.++|||||||++|+|++|+.||.+.+....+..+.... ...+..+|+++.+||.
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~ 382 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 382 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHH
Confidence 567899999999999988888 567999999999999999999999999888888877653 2344568999999999
Q ss_pred hccCCCCCCCCCHHHHHcCccccch
Q 013005 264 QLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 264 ~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+||..||++|||++|+|+||||++.
T Consensus 383 ~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 383 RLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp HHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHcCCChhHCcCHHHHhcCHHhcCC
Confidence 9999999999999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-63 Score=489.30 Aligned_cols=257 Identities=34% Similarity=0.590 Sum_probs=224.7
Q ss_pred cCCeEEcceEcccCceEEEEEEEc---CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSI---ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
.++|++++.||+|+||+||+|++. .+++.||||++++.... .....++.+|+.+|++|+ |||||++++++.+.+
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK--VRDRVRTKMERDILVEVN-HPFIVKLHYAFQTEG 99 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEE--EEECC------CCCCCCC-CTTEECEEEEEEETT
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcC--hHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECC
Confidence 368999999999999999999874 46889999999765321 111235788999999995 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 104 KIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
.+|||||||+||+|.+++.+ +.+++.+++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 99999999999999999975 88999999999999999999999999999999999999999999999999999754332
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHH
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLI 262 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 262 (451)
.....+.|||+.|+|||++.+.+|+ .++|||||||++|+|++|+.||.+.+..+.+.++.+..+.+|..+|+++.+||
T Consensus 180 -~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 257 (304)
T 3ubd_A 180 -EKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLL 257 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred -CccccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 2345678999999999999888885 56999999999999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCC-----HHHHHcCccccch
Q 013005 263 YQLLDPNPKTRMS-----IEKIMSISWFQKS 288 (451)
Q Consensus 263 ~~~L~~dP~~Rpt-----~~eil~hp~f~~~ 288 (451)
.+||..||++||| ++|+++||||+.-
T Consensus 258 ~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 258 RMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp HHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 9999999999998 6899999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-61 Score=472.30 Aligned_cols=254 Identities=25% Similarity=0.464 Sum_probs=219.8
Q ss_pred ccCCe-EEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe---
Q 013005 26 LLNRY-QLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT--- 101 (451)
Q Consensus 26 ~~~~y-~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~--- 101 (451)
..++| ++.+.||+|+||+||+|++..++..||+|++.... ......+.+.+|+.+|++|+ |||||++++++.+
T Consensus 23 ~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~ 99 (290)
T 3fpq_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--LTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVK 99 (290)
T ss_dssp TTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEET
T ss_pred CCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh--CCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccC
Confidence 34566 77888999999999999999999999999997642 23445678999999999995 9999999999865
Q ss_pred -CCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCeEEeCC-CCCeEEEeccCC
Q 013005 102 -KTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNG--VAHRDVKPQNLLLDR-DGNLKVSDFGLS 176 (451)
Q Consensus 102 -~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~g--iiHrDLKpeNILld~-~~~lkl~DFGls 176 (451)
...+|||||||+||+|.+++.+ +.+++..++.|+.||+.||+|||++| |+||||||+||||+. +|.+||+|||+|
T Consensus 100 ~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla 179 (290)
T 3fpq_A 100 GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp TEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred CCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence 3568999999999999999975 78999999999999999999999998 999999999999984 799999999999
Q ss_pred CcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCC-cHHHHHHHhhccCC--CCCCC
Q 013005 177 ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS-NLLAMYKKVNRRDY--QFPSF 253 (451)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~-~~~~~~~~i~~~~~--~~p~~ 253 (451)
+... .....+.||||.|+|||++.+ .| +.++|||||||+||+|++|+.||.+. +...++..+..... .++..
T Consensus 180 ~~~~---~~~~~~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 254 (290)
T 3fpq_A 180 TLKR---ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 254 (290)
T ss_dssp GGCC---TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred EeCC---CCccCCcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCcc
Confidence 7532 244567899999999998864 46 56799999999999999999999764 55566666665433 34566
Q ss_pred CCHhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 254 VSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 254 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
.++++.+||.+||..||++|||++|+++||||++
T Consensus 255 ~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 8899999999999999999999999999999985
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-60 Score=474.49 Aligned_cols=252 Identities=26% Similarity=0.364 Sum_probs=219.5
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
...+.|++.+.||+|+||+||+|+++.+|+.||||+++++.. ..+|+.+|+.|+ |||||++++++.+.+.
T Consensus 55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---------~~~E~~il~~l~-HpnIV~l~~~~~~~~~ 124 (336)
T 4g3f_A 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---------RVEELVACAGLS-SPRIVPLYGAVREGPW 124 (336)
T ss_dssp BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------CTHHHHTTTTCC-CTTBCCEEEEEEETTE
T ss_pred cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---------HHHHHHHHHhCC-CCCCCcEEEEEEECCE
Confidence 345679999999999999999999999999999999987532 246999999995 9999999999999999
Q ss_pred EEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC-CeEEEeccCCCcchhh
Q 013005 105 IYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG-NLKVSDFGLSALPEQI 182 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~-~lkl~DFGls~~~~~~ 182 (451)
+|||||||+||+|.+++++ +.+++.+++.|+.||+.||+|||++||+||||||+||||+.+| .+||+|||+|+.....
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 9999999999999999975 8899999999999999999999999999999999999999998 5999999999865432
Q ss_pred hc----CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC---CCCCCCC
Q 013005 183 KN----GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY---QFPSFVS 255 (451)
Q Consensus 183 ~~----~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s 255 (451)
.. ....+.|||+.|+|||++.+.+|+ .++|||||||++|+|++|+.||.+.+...++.++..... .+|+.++
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s 283 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCA 283 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSC
T ss_pred CcccceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCC
Confidence 21 122346899999999999988875 569999999999999999999998776666677766553 4677899
Q ss_pred HhHHHHHHhccCCCCCCCCCHHHH-------------HcCccccc
Q 013005 256 KPARSLIYQLLDPNPKTRMSIEKI-------------MSISWFQK 287 (451)
Q Consensus 256 ~~~~~li~~~L~~dP~~Rpt~~ei-------------l~hp~f~~ 287 (451)
+.+.+||.+||..||.+|||+.|| ++|||+..
T Consensus 284 ~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 999999999999999999999998 46888765
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-59 Score=489.33 Aligned_cols=396 Identities=29% Similarity=0.541 Sum_probs=305.8
Q ss_pred CCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE
Q 013005 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 20 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~ 99 (451)
........++|.+++.||+|+||+||+|++..+|+.||||++.+.. .......+.+.+|+.+++.+. ||||+++++++
T Consensus 8 ~~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~ 85 (476)
T 2y94_A 8 KHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQK-IRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVI 85 (476)
T ss_dssp -CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHH-HHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEE
T ss_pred ccCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhh-ccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEE
Confidence 3445677899999999999999999999999999999999997642 222234567899999999995 99999999999
Q ss_pred EeCCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 100 ATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 100 ~~~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
.+.+..|+||||+.||+|.+++.+ +.+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||++..
T Consensus 86 ~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~ 165 (476)
T 2y94_A 86 STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 165 (476)
T ss_dssp ECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhh
Confidence 999999999999999999999975 7899999999999999999999999999999999999999999999999999976
Q ss_pred chhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhH
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPA 258 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 258 (451)
... .....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+....+.++....+..|..+++.+
T Consensus 166 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 243 (476)
T 2y94_A 166 MSD--GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSV 243 (476)
T ss_dssp CCT--TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHH
T ss_pred ccc--cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHH
Confidence 433 234567899999999999988888788899999999999999999999999888899999888888899999999
Q ss_pred HHHHHhccCCCCCCCCCHHHHHcCccccchhHHhhhh---ccCCcchh----------c-----cc----cCC---ch--
Q 013005 259 RSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKR---GQESSLFE----------L-----GV----VGN---NK-- 311 (451)
Q Consensus 259 ~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~~~~~~---~~~~~~~~----------~-----~~----~~~---~~-- 311 (451)
.+||.+||..||.+|||++++++||||+......... ........ . .+ ... +.
T Consensus 244 ~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 323 (476)
T 2y94_A 244 ISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLA 323 (476)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSCSSCSHHHHHHHHSCCCC----------------------
T ss_pred HHHHHHHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCcccccccCCHHHHHHHHHHcCCCHHHHHHHHhCCCCCCHHH
Confidence 9999999999999999999999999998643211000 00000000 0 00 000 00
Q ss_pred --hh--hhccCCCCCCCChh---------------------hhhccCC--C----CC--------CCCccccccccccce
Q 013005 312 --YI--LKEKIPDIVSMNAF---------------------DIISLSS--G----LD--------LSGLFEAKKRKEKRF 352 (451)
Q Consensus 312 --~~--~~~~~~~~~~~~~~---------------------~~~~~s~--~----~~--------~~~~~~~~~~~~~rf 352 (451)
|. ...+.. ......+ ..+..+. . .. ....+....++..++
T Consensus 324 ~~y~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~lgi 402 (476)
T 2y94_A 324 VAYHLIIDNRRI-MNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGI 402 (476)
T ss_dssp ---------CCT-TCCSSHHHHHHHHHHSCGGGTSCCCCSSCTTTTCSCCCCCCSTTCTTTSSSTTTCSCCCCCCEEESE
T ss_pred HHHHHHHhchhh-hhhhhccccccCCccccccccccccCCcccCCcccccCCcccccccccccccccccccccceeeecC
Confidence 00 000000 0000000 0000000 0 00 111122334667899
Q ss_pred eeCCCHHHHHHHHHHHHHHcCcEEEEecCe-EEeeecc----CcEEEEEEEEeeecCCeEEEEEEecCCCCCCCcchhh
Q 013005 353 TTKEKTERVVEKVKEVGERLGYVVEKGKGD-VVGLGKL----GKMVLLVEVLMEIAPETFVVGVKVVDNSVCGRVALEF 426 (451)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~~~v~~~~~~g~~~~~~~~~~ 426 (451)
.|+.++.+|+..|..+++.|||.|++.+.+ +.+++++ ..+.|.+++| ++.++.+|||||+..|+ .++|
T Consensus 403 ~s~~~p~~im~ev~~al~~lg~~Wk~~~~~~i~~r~~~~~~~~~~k~~lqly-~~~~~~~llDf~~~~~~-----~~~~ 475 (476)
T 2y94_A 403 RSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLY-QVDSRTYLLDFRSIDDE-----ILEV 475 (476)
T ss_dssp EECSCHHHHHHHHHHHHHTTTCBCCEEETTEEEEEEECTTTCCEEEEEEEEE-ECSSSCEEEEEEEECCC---------
T ss_pred ccCCCHHHHHHHHHHHHHHcCCeeccCCCEEEEEEECCCCCCceEEEEEEEE-EecCCcEEEEeeecCCC-----cccc
Confidence 999999999999999999999999987776 6665321 3467999999 99999999999999999 7766
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-59 Score=478.26 Aligned_cols=259 Identities=24% Similarity=0.366 Sum_probs=223.2
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe----
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT---- 101 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~---- 101 (451)
+.++|++++.||+|+||+||+|+++.||+.||||++++.. ......+.+.+|+.+|+.|+ |||||++++++..
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 128 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF--DVVTNAKRTLRELKILKHFK-HDNIIAIKDILRPTVPY 128 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT--SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSSCT
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc--cchHHHHHHHHHHHHHHhcC-CCCcceEeeeeeccccc
Confidence 3468999999999999999999999999999999997642 23344567889999999995 9999999999764
Q ss_pred --CCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 102 --KTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 102 --~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
.+.+|||||||+ |+|.+++.+ +.+++.+++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 129 ~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 129 GEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred ccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 367999999996 679998875 7899999999999999999999999999999999999999999999999999976
Q ss_pred chhh---hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCC-----
Q 013005 179 PEQI---KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQF----- 250 (451)
Q Consensus 179 ~~~~---~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~----- 250 (451)
.... ......+.|||+.|+|||++.+..+++.++||||+|||+|+|++|+.||.+.+....+..|.......
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 4332 22445678999999999999888787888999999999999999999999998887777664321111
Q ss_pred --------------------------CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 251 --------------------------PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 251 --------------------------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.+.+++++.+||.+||..||.+|||++|+|+||||++.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 12368899999999999999999999999999999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-58 Score=466.19 Aligned_cols=258 Identities=28% Similarity=0.464 Sum_probs=213.5
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEc---CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSI---ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
.++.+.++|++.+.||+|+||+||+|+++ .+++.||+|.+.+... ..++.+|+.+|+.+.+|||||+++++
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~------~~~~~~E~~~l~~~~~h~nIv~l~~~ 88 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH------PIRIAAELQCLTVAGGQDNVMGVKYC 88 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC------HHHHHHHHHHHHHTCSBTTBCCCSEE
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC------HHHHHHHHHHHHHhcCCCCCceEEEE
Confidence 35678899999999999999999999874 4678999999876532 24578999999999779999999999
Q ss_pred EEeCCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCC-CCeEEEeccCCC
Q 013005 99 MATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD-GNLKVSDFGLSA 177 (451)
Q Consensus 99 ~~~~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~-~~lkl~DFGls~ 177 (451)
+.+.+++|+|||||+||+|.+++. ++++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+
T Consensus 89 ~~~~~~~~lvmE~~~g~~L~~~~~--~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 89 FRKNDHVVIAMPYLEHESFLDILN--SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEETTEEEEEEECCCCCCHHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEECCEEEEEEeCCCcccHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 999999999999999999999984 69999999999999999999999999999999999999877 799999999996
Q ss_pred cchhh---------------------------hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCC
Q 013005 178 LPEQI---------------------------KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLP 230 (451)
Q Consensus 178 ~~~~~---------------------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~P 230 (451)
..... ......+.|||+.|+|||++.+..+++.++||||+|||+|+|++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 43221 112345678999999999998877667889999999999999999999
Q ss_pred CCCC-cHHHHHHHhhc--------------------------------------cCC----------------CCCCCCC
Q 013005 231 FDDS-NLLAMYKKVNR--------------------------------------RDY----------------QFPSFVS 255 (451)
Q Consensus 231 f~~~-~~~~~~~~i~~--------------------------------------~~~----------------~~p~~~s 255 (451)
|... +.......|.. ... .....+|
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 9543 33333222210 000 1123478
Q ss_pred HhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 256 KPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 256 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
+++.+||++||..||++|||++|+|+||||+.
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999999999999975
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-58 Score=490.00 Aligned_cols=263 Identities=26% Similarity=0.426 Sum_probs=227.5
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHH---HHHHHHhcCCCCceEEEEEE
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVRE---VSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~E---i~il~~L~~HpnIv~l~~~~ 99 (451)
.+.-+++|++++.||+|+||+||+|+++.||+.||||++++.. .........+.+| +.+++.+ +|||||++++++
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~-i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f 261 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR-IKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAF 261 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEE
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHH-cchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEE
Confidence 3566889999999999999999999999999999999998652 1111222233344 4555556 599999999999
Q ss_pred EeCCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 100 ATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 100 ~~~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
.+.+.+|||||||+||+|++++.+ +.+++..++.|+.||+.||+|||++||+||||||+|||||.+|++||+|||+|..
T Consensus 262 ~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 262 HTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999999999975 8899999999999999999999999999999999999999999999999999975
Q ss_pred chhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCC---cHHHHHHHhhccCCCCCCCCC
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS---NLLAMYKKVNRRDYQFPSFVS 255 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s 255 (451)
... ....+.||||.|+|||++.+...++.++|||||||+||+|++|..||.+. +...+...+......+|..+|
T Consensus 342 ~~~---~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S 418 (689)
T 3v5w_A 342 FSK---KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 418 (689)
T ss_dssp CSS---CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred cCC---CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCC
Confidence 432 34567899999999999975444467799999999999999999999753 455677788888889999999
Q ss_pred HhHHHHHHhccCCCCCCCCC-----HHHHHcCccccchhH
Q 013005 256 KPARSLIYQLLDPNPKTRMS-----IEKIMSISWFQKSLQ 290 (451)
Q Consensus 256 ~~~~~li~~~L~~dP~~Rpt-----~~eil~hp~f~~~~~ 290 (451)
+++++||.+||..||.+|++ +++|++||||+.-..
T Consensus 419 ~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 419 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 99999999999999999998 799999999987543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-58 Score=449.08 Aligned_cols=252 Identities=29% Similarity=0.458 Sum_probs=201.7
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC---
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT--- 103 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~--- 103 (451)
.++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+.+|+.+|++|+ |||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~ 79 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTTE 79 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS---SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC---
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCccc
Confidence 467999999999999999999999999999999997653 3345578899999999995 999999999987544
Q ss_pred ---------EEEEEEEecCCCchhHHhhc-CC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEE
Q 013005 104 ---------KIYLVMEYAAGGELFGKLRR-GR---LTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKV 170 (451)
Q Consensus 104 ---------~~~lV~E~~~gg~L~~~l~~-~~---l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl 170 (451)
.+|+|||||+||+|.+++.. +. .++..++.++.||+.||+|||++||+||||||+|||++.+|.+||
T Consensus 80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEE
Confidence 37999999999999999975 33 456779999999999999999999999999999999999999999
Q ss_pred EeccCCCcchhhhc-----------CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcH-HH
Q 013005 171 SDFGLSALPEQIKN-----------GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNL-LA 238 (451)
Q Consensus 171 ~DFGls~~~~~~~~-----------~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~-~~ 238 (451)
+|||+|+....... ....+.|||+.|+|||++.+..| +.++|||||||++|+|++ ||..... ..
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyell~---Pf~~~~~~~~ 235 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFELLY---PFSTQMERVR 235 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCC-CCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence 99999986543221 12245689999999999988877 567999999999999996 8865432 23
Q ss_pred HHHHhhccCCCCCC---CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 239 MYKKVNRRDYQFPS---FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 239 ~~~~i~~~~~~~p~---~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
....+.. ..+|+ ..++.+.+||.+||.+||++|||+.|+++||||+..
T Consensus 236 ~~~~~~~--~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 236 TLTDVRN--LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHHHHT--TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HHHHHhc--CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 3333333 33343 346778899999999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-57 Score=448.00 Aligned_cols=253 Identities=24% Similarity=0.357 Sum_probs=219.4
Q ss_pred cCCeEEcceEcccCceEEEEEEEc-----CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSI-----ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
.++|.+.+.||+|+||+||+|++. .++..||||+++.. +....+.+.+|+.+|++|+ |||||++++++.+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~ 86 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVE 86 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC----CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC----ChHHHHHHHHHHHHHHhCC-CCCCccEEEEEee
Confidence 468999999999999999999864 36789999999754 2345678999999999995 9999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCC
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR--------------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN 167 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~--------------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~ 167 (451)
.+.+|||||||+||+|.+++++ ..+++.++..++.|++.||+|||+++|+||||||+||||+.++.
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence 9999999999999999999964 35999999999999999999999999999999999999999999
Q ss_pred eEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhc
Q 013005 168 LKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNR 245 (451)
Q Consensus 168 lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~ 245 (451)
+||+|||+|+....... ......+||+.|+|||++.+..| +.++|||||||+||||+| |+.||.+.+..+....+..
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 245 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 245 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999975433222 22334579999999999988877 567999999999999998 9999999888888888876
Q ss_pred cC-CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 246 RD-YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 246 ~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
+. ...|..+|+++.+|+.+||+.||++|||+++| ++|+++
T Consensus 246 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 246 GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 54 46788899999999999999999999999999 557754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-57 Score=479.10 Aligned_cols=258 Identities=29% Similarity=0.568 Sum_probs=233.2
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
..++++|++++.||+|+||+||+|+++.+|+.||+|++.+.. ....+.+.+|+.+|+.|+ |||||++++++.+..
T Consensus 153 ~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~----~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 227 (573)
T 3uto_A 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDN 227 (573)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHHHTC-CTTBCCEEEEEECSS
T ss_pred CcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc----hhhHHHHHHHHHHHHhCC-CCCCCeEEEEEEECC
Confidence 456789999999999999999999999999999999997653 233567889999999995 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCC--CCeEEEeccCCCcc
Q 013005 104 KIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD--GNLKVSDFGLSALP 179 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~--~~lkl~DFGls~~~ 179 (451)
.+|||||||+||+|++++.. +.+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus 228 ~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp EEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred EEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 99999999999999999853 689999999999999999999999999999999999999854 89999999999865
Q ss_pred hhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCC----CCCC
Q 013005 180 EQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP----SFVS 255 (451)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 255 (451)
.. .....+.|||+.|+|||++.+.+| +.++|||||||++|+|++|..||.+.+....+..+....+.++ ..+|
T Consensus 308 ~~--~~~~~~~~GT~~y~APEv~~~~~y-~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 384 (573)
T 3uto_A 308 DP--KQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS 384 (573)
T ss_dssp CT--TSEEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSC
T ss_pred cC--CCceeeeEECccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCC
Confidence 43 344567899999999999998887 5679999999999999999999999999999999988777665 3589
Q ss_pred HhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 256 KPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 256 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
+++++||.+||..||.+|||++|+|+||||+...
T Consensus 385 ~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~ 418 (573)
T 3uto_A 385 EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 418 (573)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence 9999999999999999999999999999998654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-57 Score=442.03 Aligned_cols=257 Identities=23% Similarity=0.341 Sum_probs=208.7
Q ss_pred CCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE
Q 013005 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 19 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
+...+....+++++++.||+|+||+||+|+.. ..||||+++... .+....+.+.+|+.+|++|+ |||||+++++
T Consensus 27 ~~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~--~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~ 100 (307)
T 3omv_A 27 SSYYWEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD--PTPEQFQAFRNEVAVLRKTR-HVNILLFMGY 100 (307)
T ss_dssp --CCCBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS--CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEE
T ss_pred CCcCcEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC--CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEE
Confidence 34556777889999999999999999999853 359999997542 23455678999999999995 9999999998
Q ss_pred EEeCCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCC
Q 013005 99 MATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176 (451)
Q Consensus 99 ~~~~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls 176 (451)
+. .+.+|||||||+||+|.+++.. +++++.++..++.|++.||+|||++||+||||||+|||||+++++||+|||+|
T Consensus 101 ~~-~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 179 (307)
T 3omv_A 101 MT-KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLA 179 (307)
T ss_dssp EC-SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred EE-CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCc
Confidence 75 4568999999999999999963 67999999999999999999999999999999999999999999999999999
Q ss_pred Ccchhhh-cCcccccCCCCccccceeeeccC--CCCccchhhhhhHHHHHHHhcCCCCCCCcHH-HHHHHhhccC-----
Q 013005 177 ALPEQIK-NGMLHTACGTPAYTAPEVVARRG--YDGAVADAWSCGVILFVLLAGYLPFDDSNLL-AMYKKVNRRD----- 247 (451)
Q Consensus 177 ~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~--~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~-~~~~~i~~~~----- 247 (451)
+...... .....+.+||+.|+|||++.+.. ..+.++|||||||+||||+||+.||.+.+.. .....+....
T Consensus 180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~ 259 (307)
T 3omv_A 180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDL 259 (307)
T ss_dssp BC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCS
T ss_pred eecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCc
Confidence 8654322 23456679999999999986432 2467799999999999999999999875544 3333333321
Q ss_pred CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 248 YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 248 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
...+..+++.+.+|+.+||..||++|||+.+|+++
T Consensus 260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 12345689999999999999999999999998765
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-56 Score=443.37 Aligned_cols=252 Identities=21% Similarity=0.317 Sum_probs=213.2
Q ss_pred cccCCeEEcceEcccCceEEEEEEEc-----CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSI-----ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~ 99 (451)
...+++.+.+.||+|+||+||+|+.. .+++.||||+++.. +....+.+.+|+.+|++|+ |||||++++++
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~ 112 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTMLQ-HQHIVRFFGVC 112 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC----SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEE
Confidence 34568999999999999999999864 46889999999754 2345678999999999995 99999999999
Q ss_pred EeCCEEEEEEEecCCCchhHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeC
Q 013005 100 ATKTKIYLVMEYAAGGELFGKLRR----------------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLD 163 (451)
Q Consensus 100 ~~~~~~~lV~E~~~gg~L~~~l~~----------------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld 163 (451)
.+...+|||||||++|+|.+++++ +++++.++..++.|++.||.|||+++|+||||||+|||||
T Consensus 113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 999999999999999999999853 3589999999999999999999999999999999999999
Q ss_pred CCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHH
Q 013005 164 RDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYK 241 (451)
Q Consensus 164 ~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~ 241 (451)
+++.+||+|||+|+....... ......+||+.|+|||++.+..| +.++|||||||+||||+| |+.||.+.+..+...
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCC-CccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999999986543222 23345789999999999988777 567999999999999998 999999988888887
Q ss_pred Hhhcc-CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 242 KVNRR-DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 242 ~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
.+..+ ....|..+++++.+|+.+||..||++|||++||+++
T Consensus 272 ~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 272 CITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 77664 467788899999999999999999999999999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-56 Score=439.02 Aligned_cols=253 Identities=23% Similarity=0.349 Sum_probs=220.3
Q ss_pred cccCCeEEcceEcccCceEEEEEEEc-----CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSI-----ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~ 99 (451)
...+++++.+.||+|+||+||+|... .+++.||||+++... +....+.+.+|+.+|++|+ |||||++++++
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~---~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~ 98 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA---EGPLREEFRHEAMLRARLQ-HPNVVCLLGVV 98 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C---CC-CHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc---ChHHHHHHHHHHHHHHhCC-CCCCCCcceEE
Confidence 45678899999999999999999853 467899999996542 2334567999999999995 99999999999
Q ss_pred EeCCEEEEEEEecCCCchhHHhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEe
Q 013005 100 ATKTKIYLVMEYAAGGELFGKLRR-----------------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL 162 (451)
Q Consensus 100 ~~~~~~~lV~E~~~gg~L~~~l~~-----------------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILl 162 (451)
.+.+.+|||||||++|+|.+++.. +.+++.++..++.|++.||+|||+++|+||||||+||||
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 999999999999999999999852 358999999999999999999999999999999999999
Q ss_pred CCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHH
Q 013005 163 DRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMY 240 (451)
Q Consensus 163 d~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~ 240 (451)
|+++++||+|||+|+....... ....+.+||+.|+|||++.+..| +.++|||||||+||||+| |..||.+.+..+..
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~-s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~ 257 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 257 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999986544332 34556789999999999988777 577999999999999998 89999999888888
Q ss_pred HHhhccC-CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 241 KKVNRRD-YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 241 ~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
..+..+. .+.|..+++.+.+|+.+||..||++|||+.+|+++
T Consensus 258 ~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 258 EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8877654 46678899999999999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-55 Score=434.53 Aligned_cols=264 Identities=42% Similarity=0.752 Sum_probs=240.0
Q ss_pred CCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE
Q 013005 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 20 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~ 99 (451)
........++|++.+.||+|+||.||+|.+..+|+.||||++.+.. .+....+.+.+|+.+++.++ ||||+++++++
T Consensus 7 ~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~ 83 (328)
T 3fe3_A 7 CADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ--LNPTSLQKLFREVRIMKILN-HPNIVKLFEVI 83 (328)
T ss_dssp ----CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred ccccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhc--CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEE
Confidence 3444567889999999999999999999999999999999997652 23455677899999999995 99999999999
Q ss_pred EeCCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 100 ATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 100 ~~~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
.+.+..|+||||++||+|.+++.. +++++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||++..
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 163 (328)
T 3fe3_A 84 ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNE 163 (328)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred EECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence 999999999999999999999864 8899999999999999999999999999999999999999999999999999975
Q ss_pred chhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhH
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPA 258 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 258 (451)
... .......+||+.|+|||++.+..+.+.++||||+||++|+|++|..||.+.+.......+....+.+|..+++.+
T Consensus 164 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 241 (328)
T 3fe3_A 164 FTV--GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDC 241 (328)
T ss_dssp GSS--SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred cCC--CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Confidence 432 234567899999999999998888888899999999999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 259 RSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 259 ~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.+||.+||..||.+|||++|+++||||+..
T Consensus 242 ~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 242 ENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp HHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred HHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 999999999999999999999999999764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-54 Score=433.65 Aligned_cols=265 Identities=28% Similarity=0.541 Sum_probs=231.1
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
-....++|++.+.||+|+||+||+|++..+++.||||++.+. ........+.+.+|..+++.+.+||||+++++++.+.
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~-~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 96 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKD-VILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP 96 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHH-HHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHH-HhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence 345678999999999999999999999999999999999765 2223334567889999999987799999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 103 TKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
...|+||||+.||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.....
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 999999999999999999975 7899999999999999999999999999999999999999999999999999974322
Q ss_pred hhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHH
Q 013005 182 IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSL 261 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 261 (451)
......+.|||+.|+|||++.+..| +.++|||||||++|+|++|..||...+...++.++......+|.++++.+.+|
T Consensus 177 -~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 254 (353)
T 3txo_A 177 -NGVTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGI 254 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHC-TTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred -CCccccccCCCcCeEChhhcCCCCc-CCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 1233456799999999999988777 56799999999999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCH------HHHHcCccccchhH
Q 013005 262 IYQLLDPNPKTRMSI------EKIMSISWFQKSLQ 290 (451)
Q Consensus 262 i~~~L~~dP~~Rpt~------~eil~hp~f~~~~~ 290 (451)
|++||..||.+||++ +++++||||+....
T Consensus 255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w 289 (353)
T 3txo_A 255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW 289 (353)
T ss_dssp HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred HHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence 999999999999998 89999999987543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-55 Score=438.93 Aligned_cols=256 Identities=21% Similarity=0.353 Sum_probs=217.6
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCC-----CcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEE
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIAD-----GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQE 97 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~ 97 (451)
+....++|++++.||+|+||+||+|.+..+ ++.||||.+.... .....+.+.+|+.+|.++.+|||||++++
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~---~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---ChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 445678999999999999999999997654 3689999997642 23445679999999999986799999999
Q ss_pred EEEe-CCEEEEEEEecCCCchhHHhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCe
Q 013005 98 VMAT-KTKIYLVMEYAAGGELFGKLRR-----------------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQN 159 (451)
Q Consensus 98 ~~~~-~~~~~lV~E~~~gg~L~~~l~~-----------------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeN 159 (451)
++.. ...+|||||||++|+|.+++++ ..+++.++..|+.||+.||+|||+++|+||||||+|
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N 215 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 215 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence 9865 4578999999999999999963 238999999999999999999999999999999999
Q ss_pred EEeCCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcH-
Q 013005 160 LLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNL- 236 (451)
Q Consensus 160 ILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~- 236 (451)
||+++++.+||+|||+|+....... ....+.+||+.|+|||++.+..| +.++|||||||+||||+| |..||.+.+.
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y-~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC-CCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999986533222 22345689999999999988877 567999999999999998 9999987654
Q ss_pred HHHHHHhhcc-CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 237 LAMYKKVNRR-DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 237 ~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
......+..+ ....|..+++++.+|+.+||..||++|||+++|++|
T Consensus 295 ~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 295 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 3444444443 457788899999999999999999999999999987
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-53 Score=420.01 Aligned_cols=260 Identities=34% Similarity=0.601 Sum_probs=234.1
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
.+++|++.+.||+|+||+||+|++..+|+.||+|++.+.. .........+.+|+.+++.+. ||||+++++++.+.+..
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~ 80 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEV-IIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHH-hhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEEeCCEE
Confidence 4689999999999999999999999999999999997642 122233567889999999995 99999999999999999
Q ss_pred EEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 106 YLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
|+||||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++..... ..
T Consensus 81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-~~ 159 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DG 159 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-TT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc-CC
Confidence 999999999999999875 7899999999999999999999999999999999999999999999999999974322 12
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHh
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQ 264 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 264 (451)
....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||...+....+..+......+|..+++++.+||.+
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 238 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CcccccccChhhCChhhhcCCCC-CchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 34457789999999999987776 56799999999999999999999999999999999888899999999999999999
Q ss_pred ccCCCCCCCC-----CHHHHHcCccccchh
Q 013005 265 LLDPNPKTRM-----SIEKIMSISWFQKSL 289 (451)
Q Consensus 265 ~L~~dP~~Rp-----t~~eil~hp~f~~~~ 289 (451)
||..||.+|| +++++++||||+...
T Consensus 239 lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred HhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence 9999999999 999999999998643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=426.50 Aligned_cols=268 Identities=29% Similarity=0.531 Sum_probs=234.2
Q ss_pred CCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE
Q 013005 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 19 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
+........++|++.+.||+|+||+||+|++..+++.||||++.+.. .......+.+.+|..++..+.+||||++++++
T Consensus 8 ~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~ 86 (345)
T 1xjd_A 8 PSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDV-VLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT 86 (345)
T ss_dssp --------CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHH-HHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred CCccCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHH-hhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEE
Confidence 34455677899999999999999999999999999999999997642 11222345677899999887569999999999
Q ss_pred EEeCCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 99 MATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 99 ~~~~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
+.+....|+||||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 87 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 87 FQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 9999999999999999999999975 789999999999999999999999999999999999999999999999999997
Q ss_pred cchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHh
Q 013005 178 LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKP 257 (451)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 257 (451)
.... ......+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+....+..+......+|.++++.
T Consensus 167 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 244 (345)
T 1xjd_A 167 ENML-GDAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKE 244 (345)
T ss_dssp CCCC-TTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred hccc-CCCcccCCCCCcccCChhhhcCCCC-CChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHH
Confidence 4322 1233467799999999999988776 5679999999999999999999999999999999998888999999999
Q ss_pred HHHHHHhccCCCCCCCCCHH-HHHcCccccchh
Q 013005 258 ARSLIYQLLDPNPKTRMSIE-KIMSISWFQKSL 289 (451)
Q Consensus 258 ~~~li~~~L~~dP~~Rpt~~-eil~hp~f~~~~ 289 (451)
+.+||.+||..||.+||++. +|++||||+...
T Consensus 245 ~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 245 AKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp HHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred HHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 99999999999999999998 999999998654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-54 Score=428.84 Aligned_cols=261 Identities=41% Similarity=0.785 Sum_probs=232.7
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
....++|.+.+.||+|+||+||+|.+..+++.||+|++.+.. .........+.+|+.+++.++ ||||+++++++.+.+
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~ 82 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQL-LKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTPT 82 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH-HHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEECSS
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHH-ccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCC
Confidence 456899999999999999999999999999999999997541 122223457889999999995 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 104 KIYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~-~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
..|+||||+ +|+|.+++. .+++++.+++.++.||+.||.|||++||+||||||+|||++.++++||+|||++.....
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~- 160 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD- 160 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT-
T ss_pred EEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC-
Confidence 999999999 678888886 48899999999999999999999999999999999999999999999999999976533
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHH
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLI 262 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 262 (451)
.....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+......+.++....+.+|..+++.+.+||
T Consensus 161 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 239 (336)
T 3h4j_B 161 -GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLI 239 (336)
T ss_dssp -SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHH
T ss_pred -CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence 2345677999999999999888887888999999999999999999999877666666677777788899999999999
Q ss_pred HhccCCCCCCCCCHHHHHcCccccchh
Q 013005 263 YQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 263 ~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
.+||..||.+|||++|+++||||+...
T Consensus 240 ~~~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 240 RRMIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp HTTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred HHHcCCChhHCcCHHHHHhChhhccCC
Confidence 999999999999999999999998653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-52 Score=424.74 Aligned_cols=264 Identities=29% Similarity=0.541 Sum_probs=230.4
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
.....++|++++.||+|+||+||+|++..+++.||+|++.+. ........+.+.+|..+++++.+||||+++++++.+.
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~-~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 125 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKE-LVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 125 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGG-GTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhh-hccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC
Confidence 345678999999999999999999999999999999999875 2233344456888999999886799999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 103 TKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
+..|+||||+.||+|..++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.....
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999999999999875 7899999999999999999999999999999999999999999999999999974222
Q ss_pred hhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCC---------CcHHHHHHHhhccCCCCCC
Q 013005 182 IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDD---------SNLLAMYKKVNRRDYQFPS 252 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~---------~~~~~~~~~i~~~~~~~p~ 252 (451)
......+.|||+.|+|||++.+..| +.++|||||||++|+|++|..||.. .....++..+......+|.
T Consensus 206 -~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~ 283 (396)
T 4dc2_A 206 -PGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 283 (396)
T ss_dssp -TTCCBCCCCBCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT
T ss_pred -CCCccccccCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC
Confidence 1234567899999999999988777 5679999999999999999999963 2344577788888899999
Q ss_pred CCCHhHHHHHHhccCCCCCCCCCH------HHHHcCccccchh
Q 013005 253 FVSKPARSLIYQLLDPNPKTRMSI------EKIMSISWFQKSL 289 (451)
Q Consensus 253 ~~s~~~~~li~~~L~~dP~~Rpt~------~eil~hp~f~~~~ 289 (451)
.+++.+.+||++||..||.+||++ ++|++||||+...
T Consensus 284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~ 326 (396)
T 4dc2_A 284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326 (396)
T ss_dssp TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence 999999999999999999999984 8999999998643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=415.39 Aligned_cols=258 Identities=32% Similarity=0.647 Sum_probs=233.3
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
..++|++.+.||+|+||+||+|++..+|+.||+|++.+.. .......+.+.+|+.+++.+. ||||+++++++.+....
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~ 81 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEI-VVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQI 81 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHhhCC-CCCCceEeEEEEeCCEE
Confidence 4688999999999999999999999999999999997642 122233466789999999995 99999999999999999
Q ss_pred EEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 106 YLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
|+||||+.||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~---- 157 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---- 157 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS----
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC----
Confidence 999999999999999975 789999999999999999999999999999999999999999999999999997532
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHh
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQ 264 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 264 (451)
....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+.++......+|..+++++.+||.+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 236 (318)
T 1fot_A 158 DVTYTLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 236 (318)
T ss_dssp SCBCCCCSCTTTCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CccccccCCccccCHhHhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 23456789999999999987776 56699999999999999999999999999999999988899999999999999999
Q ss_pred ccCCCCCCCC-----CHHHHHcCccccchhH
Q 013005 265 LLDPNPKTRM-----SIEKIMSISWFQKSLQ 290 (451)
Q Consensus 265 ~L~~dP~~Rp-----t~~eil~hp~f~~~~~ 290 (451)
||..||.+|| +++++++||||+....
T Consensus 237 lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~ 267 (318)
T 1fot_A 237 LITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 267 (318)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred HhccCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence 9999999999 9999999999986543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=416.54 Aligned_cols=262 Identities=30% Similarity=0.545 Sum_probs=232.2
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
...++|++.+.||+|+||+||+|++..+++.||+|++.+. ........+.+.+|..+++++.+||||+++++++.+...
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKE-LVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGG-GSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhH-HhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 4578999999999999999999999999999999999875 233445567788999999998669999999999999999
Q ss_pred EEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 105 IYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
.|+||||+.||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++......
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~- 163 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP- 163 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT-
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC-
Confidence 9999999999999999975 78999999999999999999999999999999999999999999999999999743221
Q ss_pred cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCC---------CcHHHHHHHhhccCCCCCCCC
Q 013005 184 NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDD---------SNLLAMYKKVNRRDYQFPSFV 254 (451)
Q Consensus 184 ~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~---------~~~~~~~~~i~~~~~~~p~~~ 254 (451)
.....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.. .....++..+......+|..+
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~ 242 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 242 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTS
T ss_pred CCcccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCC
Confidence 234556799999999999988777 5679999999999999999999975 344566777778888899999
Q ss_pred CHhHHHHHHhccCCCCCCCCCH------HHHHcCccccchh
Q 013005 255 SKPARSLIYQLLDPNPKTRMSI------EKIMSISWFQKSL 289 (451)
Q Consensus 255 s~~~~~li~~~L~~dP~~Rpt~------~eil~hp~f~~~~ 289 (451)
+..+.+||.+||..||.+||++ +++++||||+...
T Consensus 243 s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 9999999999999999999995 8999999998643
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=422.88 Aligned_cols=266 Identities=32% Similarity=0.549 Sum_probs=227.1
Q ss_pred CCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHH-HHHhcCCCCceEEEEE
Q 013005 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSA-MRRLQNHPNVLKIQEV 98 (451)
Q Consensus 20 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~i-l~~L~~HpnIv~l~~~ 98 (451)
........++|++.+.||+|+||+||+|++..+++.||||++.+.. .........+.+|..+ ++.+ +||||++++++
T Consensus 30 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~-~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~ 107 (373)
T 2r5t_A 30 SSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKA-ILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFS 107 (373)
T ss_dssp TBCTTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGG-BC-------------CCBCCC-CCTTBCCEEEE
T ss_pred CCCCCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHH-hhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEE
Confidence 3444567889999999999999999999999999999999998763 2233344566677766 3556 59999999999
Q ss_pred EEeCCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 99 MATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 99 ~~~~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
+.+.+..|+||||+.||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.
T Consensus 108 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~ 187 (373)
T 2r5t_A 108 FQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK 187 (373)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccc
Confidence 9999999999999999999999975 789999999999999999999999999999999999999999999999999987
Q ss_pred cchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHh
Q 013005 178 LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKP 257 (451)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 257 (451)
.... ......+.|||+.|+|||++.+..| +.++|||||||++|+|++|..||...+...++..+......+|+.++..
T Consensus 188 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 265 (373)
T 2r5t_A 188 ENIE-HNSTTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNS 265 (373)
T ss_dssp GGBC-CCCCCCSBSCCCCCCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHH
T ss_pred cccc-CCCccccccCCccccCHHHhCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Confidence 4322 1234567799999999999988776 5669999999999999999999999999999999999888999999999
Q ss_pred HHHHHHhccCCCCCCCCCH----HHHHcCccccchh
Q 013005 258 ARSLIYQLLDPNPKTRMSI----EKIMSISWFQKSL 289 (451)
Q Consensus 258 ~~~li~~~L~~dP~~Rpt~----~eil~hp~f~~~~ 289 (451)
+.+||.+||..||.+||++ +++++||||+...
T Consensus 266 ~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 266 ARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp HHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence 9999999999999999986 6999999998643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=420.37 Aligned_cols=263 Identities=27% Similarity=0.515 Sum_probs=234.1
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
....++|++.+.||+|+||+||+|++..+++.||||++.+.. .......+.+.+|..++..+.+||||+++++++.+.+
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~-~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDV-VIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHH-HHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH-hhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 456789999999999999999999999999999999997652 2222334667889999988867999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 104 KIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
..|+||||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 173 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW- 173 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc-
Confidence 99999999999999999975 8899999999999999999999999999999999999999999999999999974322
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHH
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLI 262 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 262 (451)
......+.+||+.|+|||++.+.+| +.++|||||||++|+|++|..||.+.+...++..+......+|..+++.+.+||
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 252 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAIC 252 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCCccccChhhhcCCCc-CCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 1234557799999999999988777 567999999999999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCC-----CHHHHHcCccccchh
Q 013005 263 YQLLDPNPKTRM-----SIEKIMSISWFQKSL 289 (451)
Q Consensus 263 ~~~L~~dP~~Rp-----t~~eil~hp~f~~~~ 289 (451)
.+||..||.+|| ++++|++||||+...
T Consensus 253 ~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~ 284 (353)
T 2i0e_A 253 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 284 (353)
T ss_dssp HHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence 999999999999 479999999998643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=419.10 Aligned_cols=262 Identities=31% Similarity=0.559 Sum_probs=232.7
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhh--HHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLD--AAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
...+.++|++++.||+|+||+||+|++..+|+.||+|++.+...... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~ 85 (361)
T 2yab_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVYE 85 (361)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEEE
T ss_pred CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEEE
Confidence 45677899999999999999999999999999999999987532111 112467889999999996 999999999999
Q ss_pred eCCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC----CeEEEeccC
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG----NLKVSDFGL 175 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~----~lkl~DFGl 175 (451)
+....|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 99999999999999999999975 6899999999999999999999999999999999999998877 799999999
Q ss_pred CCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCC----
Q 013005 176 SALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP---- 251 (451)
Q Consensus 176 s~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p---- 251 (451)
+..... .......+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+....+..+....+.++
T Consensus 166 a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (361)
T 2yab_A 166 AHEIED--GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242 (361)
T ss_dssp CEECCT--TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred ceEcCC--CCccccCCCCccEECchHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 975433 233456789999999999987766 5679999999999999999999999999999999888877766
Q ss_pred CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 252 SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 252 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
..+++.+.+||.+||..||.+|||++++++||||+..
T Consensus 243 ~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 4689999999999999999999999999999999854
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-52 Score=415.71 Aligned_cols=259 Identities=32% Similarity=0.613 Sum_probs=234.9
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
....++|++.+.||+|+||+||+|++..+|+.||+|++.+.. .......+.+.+|+.+++.+. ||||+++++++.+..
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 114 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK-VVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNS 114 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSS
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHH-hccHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCC
Confidence 456789999999999999999999999999999999997642 222233567889999999995 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 104 KIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
..|+||||+.||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~- 193 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC-
Confidence 99999999999999999975 7899999999999999999999999999999999999999999999999999975432
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHH
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLI 262 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 262 (451)
...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+.++......+|..+++.+.+||
T Consensus 194 ---~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 269 (350)
T 1rdq_E 194 ---RTWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269 (350)
T ss_dssp ---CBCCCEECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHH
T ss_pred ---CcccccCCccccCHHHhcCCCC-CCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 2346789999999999988776 567999999999999999999999999999999999989999999999999999
Q ss_pred HhccCCCCCCCCC-----HHHHHcCccccchh
Q 013005 263 YQLLDPNPKTRMS-----IEKIMSISWFQKSL 289 (451)
Q Consensus 263 ~~~L~~dP~~Rpt-----~~eil~hp~f~~~~ 289 (451)
.+||..||.+||+ +++|++||||+...
T Consensus 270 ~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~ 301 (350)
T 1rdq_E 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred HHHhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence 9999999999998 99999999998643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-52 Score=405.17 Aligned_cols=259 Identities=28% Similarity=0.477 Sum_probs=227.4
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
+....++|++.+.||+|+||+||+|.+..+++.||+|++..... ...+.+.+|+.+++.+. ||||+++++++...
T Consensus 15 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 89 (297)
T 3fxz_A 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENK-NPNIVNYLDSYLVG 89 (297)
T ss_dssp SSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHHCC-CTTBCCEEEEEEET
T ss_pred cCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc----cHHHHHHHHHHHHhcCC-CCCCCeEeEEEEEC
Confidence 45567899999999999999999999999999999999976532 12356889999999995 99999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 103 TKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
+..|+||||+.||+|.+++....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CEEEEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 99999999999999999999889999999999999999999999999999999999999999999999999998754332
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc---CCCCCCCCCHhHH
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR---DYQFPSFVSKPAR 259 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~ 259 (451)
. ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+.......+... ....|..+++.+.
T Consensus 170 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (297)
T 3fxz_A 170 Q-SKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247 (297)
T ss_dssp T-CCBCCCCSCGGGCCHHHHHCSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHH
T ss_pred c-cccCCccCCcCccChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHH
Confidence 2 23456789999999999988776 56799999999999999999999988776555544332 3345667899999
Q ss_pred HHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 260 SLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 260 ~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+||.+||..||.+|||++++++||||+..
T Consensus 248 ~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 248 DFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 99999999999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=428.15 Aligned_cols=263 Identities=32% Similarity=0.517 Sum_probs=229.7
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
....++|++.+.||+|+||+||+|++..+++.||+|++.+.. .......+.+.+|+.+++.+. ||||+++++++.+..
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~-~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE-MIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDR 142 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-HHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhh-hhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEECC
Confidence 455789999999999999999999999999999999997631 111122335778999999995 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 104 KIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
..|+||||++||+|.+++..+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.......
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 99999999999999999998899999999999999999999999999999999999999999999999999997544322
Q ss_pred cCcccccCCCCccccceeeeccC---CCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc--CCCCCC--CCCH
Q 013005 184 NGMLHTACGTPAYTAPEVVARRG---YDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR--DYQFPS--FVSK 256 (451)
Q Consensus 184 ~~~~~~~~gt~~y~APEvl~~~~---~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~ 256 (451)
.....+.+||+.|+|||++.+.+ +.+.++|||||||++|+|++|..||.+.+....+.++... ...+|. .+++
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~ 302 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK 302 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCH
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccH
Confidence 22345789999999999997655 2457799999999999999999999999998888888754 245554 6899
Q ss_pred hHHHHHHhccCCCCCC--CCCHHHHHcCccccch
Q 013005 257 PARSLIYQLLDPNPKT--RMSIEKIMSISWFQKS 288 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~--Rpt~~eil~hp~f~~~ 288 (451)
.+++||.+||..+|.+ ||++++|++||||+..
T Consensus 303 ~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 303 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 9999999999999998 9999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=403.71 Aligned_cols=263 Identities=30% Similarity=0.594 Sum_probs=223.3
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchh----------------------hHHHHHHHHHHH
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFL----------------------DAAMEDRIVREV 80 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~----------------------~~~~~~~~~~Ei 80 (451)
.....++|++.+.||+|+||.||+|++..+++.||||++.+..... .....+.+.+|+
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 87 (298)
T 2zv2_A 8 DCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEI 87 (298)
T ss_dssp --CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHH
T ss_pred CceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHH
Confidence 3456789999999999999999999999999999999997653111 011235688999
Q ss_pred HHHHHhcCCCCceEEEEEEEe--CCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 013005 81 SAMRRLQNHPNVLKIQEVMAT--KTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQ 158 (451)
Q Consensus 81 ~il~~L~~HpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpe 158 (451)
.+++++. ||||+++++++.+ ....|+||||+++++|.+++..+.+++.+++.++.||+.||.|||++||+||||||+
T Consensus 88 ~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 88 AILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp HHHHTCC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HHHHhCC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 9999995 9999999999986 678999999999999999887789999999999999999999999999999999999
Q ss_pred eEEeCCCCCeEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCC--CCccchhhhhhHHHHHHHhcCCCCCCCcH
Q 013005 159 NLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGY--DGAVADAWSCGVILFVLLAGYLPFDDSNL 236 (451)
Q Consensus 159 NILld~~~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~--~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~ 236 (451)
|||++.++.+||+|||++...... .......+||+.|+|||++.+... .+.++|||||||++|+|++|..||...+.
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGS-DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSS-SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEECCCCCEEEecCCCccccccc-cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 999999999999999999754321 223445689999999999876542 46779999999999999999999999888
Q ss_pred HHHHHHhhccCCCCC--CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 237 LAMYKKVNRRDYQFP--SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 237 ~~~~~~i~~~~~~~p--~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
......+......+| ..+++.+.+||.+||..||++|||++++++||||++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 887777776666555 468999999999999999999999999999999963
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-52 Score=416.56 Aligned_cols=263 Identities=38% Similarity=0.694 Sum_probs=218.5
Q ss_pred CCCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEE
Q 013005 18 PPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQE 97 (451)
Q Consensus 18 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~ 97 (451)
|....+....++|++.+.||+|+||+||+|++..+++.||||++..... ..+.+.+|+.+++.++ ||||+++++
T Consensus 10 p~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~-hpniv~~~~ 83 (361)
T 3uc3_A 10 PLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-----IDENVQREIINHRSLR-HPNIVRFKE 83 (361)
T ss_dssp -CCCCCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-----SCHHHHHHHHHHHHCC-CTTBCCEEE
T ss_pred CCCccCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-----ccHHHHHHHHHHHhCC-CCCCCcEEE
Confidence 3344456678899999999999999999999999999999999976532 1245789999999995 999999999
Q ss_pred EEEeCCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCC--eEEEecc
Q 013005 98 VMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN--LKVSDFG 174 (451)
Q Consensus 98 ~~~~~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~--lkl~DFG 174 (451)
++.+.+..|+||||+.||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||
T Consensus 84 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg 163 (361)
T 3uc3_A 84 VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFG 163 (361)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCC
T ss_pred EEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecC
Confidence 99999999999999999999999864 78999999999999999999999999999999999999987765 9999999
Q ss_pred CCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCc----HHHHHHHhhccCCCC
Q 013005 175 LSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN----LLAMYKKVNRRDYQF 250 (451)
Q Consensus 175 ls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~----~~~~~~~i~~~~~~~ 250 (451)
++..... .......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+ .......+......+
T Consensus 164 ~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (361)
T 3uc3_A 164 YSKSSVL--HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSI 241 (361)
T ss_dssp CC-----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCC
T ss_pred ccccccc--cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCC
Confidence 9874322 2233456899999999999888887777999999999999999999998643 345555666666666
Q ss_pred CC--CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 251 PS--FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 251 p~--~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
|. .+++.+.+||.+||..||.+|||++++++||||.+.
T Consensus 242 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 242 PDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 65 479999999999999999999999999999999764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=407.80 Aligned_cols=256 Identities=23% Similarity=0.475 Sum_probs=229.4
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.+. ||||+++++++.+.+.
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~ 75 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIAR-HRNILHLHESFESMEE 75 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-----ccHHHHHHHHHHHHhCC-CCCCCeEeEEEecCCE
Confidence 46789999999999999999999999999999999997542 23456889999999995 9999999999999999
Q ss_pred EEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC--CCCeEEEeccCCCcch
Q 013005 105 IYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR--DGNLKVSDFGLSALPE 180 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~--~~~lkl~DFGls~~~~ 180 (451)
.|+||||++||+|.+++.. ..+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 9999999999999999975 46999999999999999999999999999999999999987 7899999999997543
Q ss_pred hhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCC----CCCCH
Q 013005 181 QIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP----SFVSK 256 (451)
Q Consensus 181 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 256 (451)
. .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+....+.++ +.++.
T Consensus 156 ~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T 1tki_A 156 P--GDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp T--TCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred C--CCccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCH
Confidence 3 233455689999999999876655 6779999999999999999999999998888888888777766 36899
Q ss_pred hHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 257 PARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
.+.+||.+||..||.+|||+.|+++||||+...
T Consensus 233 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 999999999999999999999999999998653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=407.42 Aligned_cols=262 Identities=30% Similarity=0.565 Sum_probs=222.9
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEc---CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSI---ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
....++|++.+.||+|+||.||+|++. .+++.||+|++.+............+.+|+.+++.+. ||||+++++++.
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~ 91 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQ 91 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEE
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEE
Confidence 456789999999999999999999985 6899999999986532222334556889999999995 999999999999
Q ss_pred eCCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcc
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALP 179 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~ 179 (451)
..+..|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999999999975 78999999999999999999999999999999999999999999999999998743
Q ss_pred hhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHH
Q 013005 180 EQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPAR 259 (451)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 259 (451)
... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|..+++.+.
T Consensus 172 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 249 (327)
T 3a62_A 172 IHD-GTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEAR 249 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHH
T ss_pred ccC-CccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 221 223456789999999999987766 567999999999999999999999999888888888888899999999999
Q ss_pred HHHHhccCCCCCCCC-----CHHHHHcCccccch
Q 013005 260 SLIYQLLDPNPKTRM-----SIEKIMSISWFQKS 288 (451)
Q Consensus 260 ~li~~~L~~dP~~Rp-----t~~eil~hp~f~~~ 288 (451)
+||.+||..||.+|| +++++++||||+..
T Consensus 250 ~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 250 DLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 999999999999999 89999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=424.68 Aligned_cols=262 Identities=34% Similarity=0.646 Sum_probs=230.4
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
....+.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++.+. ||||+++++++.+
T Consensus 5 ~~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~--~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~ 81 (444)
T 3soa_A 5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKK--LSARDHQKLEREARICRLLK-HPNIVRLHDSISE 81 (444)
T ss_dssp --CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCS--CHHHHHHHHHHHHHHHHHCC-BTTBCCEEEEEEC
T ss_pred ccccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEccc--CCHHHHHHHHHHHHHHHhCC-CcCCCeEEEEEEE
Confidence 34567789999999999999999999999999999999998753 23345667899999999995 9999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeC---CCCCeEEEeccCCC
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLD---RDGNLKVSDFGLSA 177 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld---~~~~lkl~DFGls~ 177 (451)
.+..|+||||+.||+|.+.+.. +.+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 82 EGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp SSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred CCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 9999999999999999998874 7899999999999999999999999999999999999998 45789999999997
Q ss_pred cchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCC----C
Q 013005 178 LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS----F 253 (451)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~ 253 (451)
..... .......+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+....+..+....+.+|. .
T Consensus 162 ~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (444)
T 3soa_A 162 EVEGE-QQAWFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDT 239 (444)
T ss_dssp CCCTT-CCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTT
T ss_pred EecCC-CceeecccCCcccCCHHHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcccccc
Confidence 65432 233456789999999999987766 56799999999999999999999999999999998888776653 5
Q ss_pred CCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 254 VSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 254 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+++.+.+||.+||..||.+|||+.|+++||||+..
T Consensus 240 ~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 240 VTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred CCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 79999999999999999999999999999999754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=417.04 Aligned_cols=266 Identities=25% Similarity=0.469 Sum_probs=233.5
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
.......++|++.+.||+|+||+||+|.+..+++.||+|++.+.. .........+.+|+.+++.+. ||||+++++++.
T Consensus 8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~-~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQK-CVERNEVRNVFKELQIMQGLE-HPFLVNLWYSFQ 85 (384)
T ss_dssp CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEE
T ss_pred CCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhh-cccHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEE
Confidence 345567899999999999999999999999999999999997652 222334567889999999995 999999999999
Q ss_pred eCCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcc
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALP 179 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~ 179 (451)
+....|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 86 DEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred eCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 99999999999999999999985 68999999999999999999999999999999999999999999999999999754
Q ss_pred hhhhcCcccccCCCCccccceeeecc--CCCCccchhhhhhHHHHHHHhcCCCCCC---CcHHHHHHHhhccCCCCCCCC
Q 013005 180 EQIKNGMLHTACGTPAYTAPEVVARR--GYDGAVADAWSCGVILFVLLAGYLPFDD---SNLLAMYKKVNRRDYQFPSFV 254 (451)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~APEvl~~~--~~~~~~sDIwSlGvil~~Ll~G~~Pf~~---~~~~~~~~~i~~~~~~~p~~~ 254 (451)
.. .....+.+||+.|+|||++... ...+.++|||||||++|+|++|..||.. .........+......+|..+
T Consensus 166 ~~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~ 243 (384)
T 4fr4_A 166 PR--ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAW 243 (384)
T ss_dssp CT--TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTS
T ss_pred cC--CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcC
Confidence 32 2445678999999999998642 2236679999999999999999999974 455667777777888899999
Q ss_pred CHhHHHHHHhccCCCCCCCCC-HHHHHcCccccchhH
Q 013005 255 SKPARSLIYQLLDPNPKTRMS-IEKIMSISWFQKSLQ 290 (451)
Q Consensus 255 s~~~~~li~~~L~~dP~~Rpt-~~eil~hp~f~~~~~ 290 (451)
++.+.+||.+||..||.+||+ ++++++||||+....
T Consensus 244 s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 244 SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred CHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 999999999999999999998 999999999987543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-52 Score=408.94 Aligned_cols=248 Identities=22% Similarity=0.303 Sum_probs=195.7
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC---
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT--- 103 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~--- 103 (451)
..+|.+.+.||+|+||+||+|++ +|+.||||+++... ........|+..+.+++ |||||++++++...+
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~-----~~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~~~ 73 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhhHHHHHHHHHHhcCC-CCCCCcEEEEEEecCCCc
Confidence 35799999999999999999986 68999999997542 11223445676677785 999999999997653
Q ss_pred -EEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCeEEeCCCCCeEEEecc
Q 013005 104 -KIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQN--------GVAHRDVKPQNLLLDRDGNLKVSDFG 174 (451)
Q Consensus 104 -~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~--------giiHrDLKpeNILld~~~~lkl~DFG 174 (451)
.+|||||||+||+|.++++..+++++.+.+++.|++.||+|||++ +|+||||||+|||||.++++||+|||
T Consensus 74 ~~~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 74 TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred eEEEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 689999999999999999999999999999999999999999987 99999999999999999999999999
Q ss_pred CCCcchhhhc---CcccccCCCCccccceeeeccC-----CCCccchhhhhhHHHHHHHhcCCCCCC-------------
Q 013005 175 LSALPEQIKN---GMLHTACGTPAYTAPEVVARRG-----YDGAVADAWSCGVILFVLLAGYLPFDD------------- 233 (451)
Q Consensus 175 ls~~~~~~~~---~~~~~~~gt~~y~APEvl~~~~-----~~~~~sDIwSlGvil~~Ll~G~~Pf~~------------- 233 (451)
+|+....... ......+||+.|+|||++.+.. ..+.++|||||||+||||+||..||..
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 9976543322 1233568999999999986542 235679999999999999999876632
Q ss_pred --CcHHHHHHHhhccCC--CCCCC-----CCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 234 --SNLLAMYKKVNRRDY--QFPSF-----VSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 234 --~~~~~~~~~i~~~~~--~~p~~-----~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
.....+...+..... .+|.. .+..+.+|+.+||..||++|||+.||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 123344444433322 33332 22467899999999999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=407.91 Aligned_cols=261 Identities=32% Similarity=0.609 Sum_probs=223.1
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
.+.++|++.+.||+|+||+||+|++..+++.||+|++..... ....+.+.+|+.+++.+. ||||+++++++.+.+.
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~ 79 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLN-HENVVKFYGHRREGNI 79 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc---cchHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCe
Confidence 357899999999999999999999999999999999976422 223467889999999995 9999999999999999
Q ss_pred EEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 105 IYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
.|+||||++||+|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 9999999999999999975 579999999999999999999999999999999999999999999999999997543222
Q ss_pred -cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH-HHHHHhhccCCCCC--CCCCHhHH
Q 013005 184 -NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL-AMYKKVNRRDYQFP--SFVSKPAR 259 (451)
Q Consensus 184 -~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~-~~~~~i~~~~~~~p--~~~s~~~~ 259 (451)
.......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+.. ..+..+.......+ ..+++.+.
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHH
Confidence 244556789999999999988887778899999999999999999999865443 33333333333333 35899999
Q ss_pred HHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 260 SLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 260 ~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
+||.+||..||.+|||++|+++||||++..
T Consensus 240 ~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 240 ALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 999999999999999999999999998653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-51 Score=411.60 Aligned_cols=260 Identities=33% Similarity=0.668 Sum_probs=230.9
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
...+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.|. ||||+++++++.+.
T Consensus 24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~ 100 (362)
T 2bdw_A 24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK--LSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEE 100 (362)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEccc--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeC
Confidence 3456789999999999999999999999999999999998653 23345567899999999995 99999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC---CeEEEeccCCCc
Q 013005 103 TKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG---NLKVSDFGLSAL 178 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~---~lkl~DFGls~~ 178 (451)
+..|+||||+.||+|.+.+.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 101 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp SEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred CEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999999999998874 6799999999999999999999999999999999999998654 599999999976
Q ss_pred chhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCC----CC
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS----FV 254 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~ 254 (451)
... .......+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+....+..+....+.+|. .+
T Consensus 181 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 257 (362)
T 2bdw_A 181 VND--SEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV 257 (362)
T ss_dssp CTT--CCSCCCSCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGS
T ss_pred ecC--CcccccCCCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCC
Confidence 543 233456789999999999987766 56799999999999999999999999988888888887776664 37
Q ss_pred CHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 255 SKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 255 s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
++.+.+||.+||..||.+|||+.++++||||...
T Consensus 258 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 258 TPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999999999754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=424.01 Aligned_cols=263 Identities=33% Similarity=0.588 Sum_probs=225.1
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
.....++|++.+.||+|+||.||+|.+..+++.||||++.+. ..........+.+|+.+++.+. ||||+++++++.+.
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~ 220 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKE-VIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTH 220 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHH-HHC-------------CCCCCS-CTTSCCEEEEEEET
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhh-hhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEeeC
Confidence 345678999999999999999999999999999999999764 2223344556788999999995 99999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 103 TKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQ-NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~-~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
+..|+||||++||+|.+++.. +.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||++....
T Consensus 221 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 221 DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp TEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred CEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999999999999875 789999999999999999999998 999999999999999999999999999997532
Q ss_pred hhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHH
Q 013005 181 QIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARS 260 (451)
Q Consensus 181 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 260 (451)
.. .......+||+.|+|||++.+..| +.++|||||||++|+|++|..||...+....+..+......+|..+++.+.+
T Consensus 301 ~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 378 (446)
T 4ejn_A 301 KD-GATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKS 378 (446)
T ss_dssp C------CCSSSCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred CC-CcccccccCCccccCHhhcCCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHH
Confidence 21 233456789999999999987776 5679999999999999999999999999999999988889999999999999
Q ss_pred HHHhccCCCCCCCC-----CHHHHHcCccccchh
Q 013005 261 LIYQLLDPNPKTRM-----SIEKIMSISWFQKSL 289 (451)
Q Consensus 261 li~~~L~~dP~~Rp-----t~~eil~hp~f~~~~ 289 (451)
||.+||..||.+|| |++++++||||+...
T Consensus 379 li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~ 412 (446)
T 4ejn_A 379 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV 412 (446)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence 99999999999999 999999999998753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=424.54 Aligned_cols=263 Identities=29% Similarity=0.488 Sum_probs=227.1
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
....++|++.+.||+|+||+||+|++..+++.||+|++.+.. .........+.+|+.++..+. ||||+++++++.+.+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE-MLKRAETACFREERDVLVNGD-SKWITTLHYAFQDDN 147 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHH-HHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEEECSS
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHH-hhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCC
Confidence 455689999999999999999999999999999999997642 111222334788999999995 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 104 KIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
..|+||||+.||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 99999999999999999975 6899999999999999999999999999999999999999999999999999975433
Q ss_pred hhcCcccccCCCCccccceeeec----cCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc--CCCCCC---
Q 013005 182 IKNGMLHTACGTPAYTAPEVVAR----RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR--DYQFPS--- 252 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~----~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~--- 252 (451)
.........+||+.|+|||++.. ....+.++|||||||++|+|++|+.||.+.+....+.++... .+.+|.
T Consensus 228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 307 (437)
T 4aw2_A 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVT 307 (437)
T ss_dssp TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCC
T ss_pred CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccc
Confidence 22223345789999999999862 333467799999999999999999999999988888887643 355554
Q ss_pred CCCHhHHHHHHhccCCCCCC--CCCHHHHHcCccccch
Q 013005 253 FVSKPARSLIYQLLDPNPKT--RMSIEKIMSISWFQKS 288 (451)
Q Consensus 253 ~~s~~~~~li~~~L~~dP~~--Rpt~~eil~hp~f~~~ 288 (451)
.+++.+.+||++||..+|++ |++++++++||||+..
T Consensus 308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 308 DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred cCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 38999999999999998888 9999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=395.12 Aligned_cols=258 Identities=28% Similarity=0.464 Sum_probs=216.4
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
+++|++.+.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.++++++ ||||+++++++.+.+..|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 77 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLT 77 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC--cCCcchHHHHHHHHHhcCC-CCCEeeEEeEEEeCCEEE
Confidence 4789999999999999999999999999999999986532 3344567889999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 107 LVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~-~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
+||||+.++.+..+.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 78 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~ 156 (292)
T 3o0g_A 78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVR 156 (292)
T ss_dssp EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS-CCS
T ss_pred EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC-ccc
Confidence 9999998744444433 47899999999999999999999999999999999999999999999999999975432 123
Q ss_pred cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCC-CCCCcHHHHHHHhhccC-----------------
Q 013005 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLP-FDDSNLLAMYKKVNRRD----------------- 247 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~P-f~~~~~~~~~~~i~~~~----------------- 247 (451)
.....+||+.|+|||++.+....+.++||||+||++|+|++|..| |...+.......+....
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 345668999999999998777667889999999999999988877 55555555555443210
Q ss_pred ------------CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 248 ------------YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 248 ------------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
....+.+++.+.+||.+||..||++|||++|+++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 01223478899999999999999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=415.15 Aligned_cols=262 Identities=27% Similarity=0.425 Sum_probs=212.7
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
..+.++|++.+.||+|+||.||+|.+..+++.||||++.+. .........+.+|+.+++.+.+||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA--FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN 82 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc--ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence 35678999999999999999999999999999999998653 2234456678899999999977999999999997544
Q ss_pred --EEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 104 --KIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 104 --~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
.+|+||||+. ++|..++..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 83 ~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 83 DRDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp SSCEEEEEECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred CCEEEEEecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 7999999997 5899999888999999999999999999999999999999999999999999999999999975321
Q ss_pred --------------------hhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHH
Q 013005 182 --------------------IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYK 241 (451)
Q Consensus 182 --------------------~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~ 241 (451)
.........+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+....+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 241 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 011234557899999999999875555778999999999999999999999888776665
Q ss_pred HhhccCC-----------------------------------------------CCCCCCCHhHHHHHHhccCCCCCCCC
Q 013005 242 KVNRRDY-----------------------------------------------QFPSFVSKPARSLIYQLLDPNPKTRM 274 (451)
Q Consensus 242 ~i~~~~~-----------------------------------------------~~p~~~s~~~~~li~~~L~~dP~~Rp 274 (451)
.+....- ..+..+++.+.+||.+||..||.+||
T Consensus 242 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 321 (388)
T 3oz6_A 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI 321 (388)
T ss_dssp HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence 5532100 01125688999999999999999999
Q ss_pred CHHHHHcCccccch
Q 013005 275 SIEKIMSISWFQKS 288 (451)
Q Consensus 275 t~~eil~hp~f~~~ 288 (451)
|++|+++||||+..
T Consensus 322 t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 322 SANDALKHPFVSIF 335 (388)
T ss_dssp CHHHHTTSTTTTTT
T ss_pred CHHHHhCCHHHHHh
Confidence 99999999999753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=402.83 Aligned_cols=262 Identities=34% Similarity=0.567 Sum_probs=229.6
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhh--HHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLD--AAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++.+...... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 85 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYEN 85 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEe
Confidence 3566789999999999999999999999999999999976532111 112467889999999995 9999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC----CeEEEeccCC
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG----NLKVSDFGLS 176 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~----~lkl~DFGls 176 (451)
....|+||||+.||+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 9999999999999999999975 6799999999999999999999999999999999999999887 8999999999
Q ss_pred CcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCC----C
Q 013005 177 ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP----S 252 (451)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~ 252 (451)
..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......++ .
T Consensus 166 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (326)
T 2y0a_A 166 HKIDF--GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242 (326)
T ss_dssp EECCT--TSCCCCCCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred eECCC--CCccccccCCcCcCCceeecCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc
Confidence 75432 223456789999999999977666 5679999999999999999999999888888877777666655 4
Q ss_pred CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 253 FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 253 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
.++..+.+||.+||..||.+|||++++++||||+...
T Consensus 243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 5789999999999999999999999999999998654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-51 Score=400.23 Aligned_cols=266 Identities=28% Similarity=0.443 Sum_probs=215.5
Q ss_pred CCCCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEE
Q 013005 17 PPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQ 96 (451)
Q Consensus 17 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~ 96 (451)
..+......+.++|++.+.||+|+||+||+|.+ .+++.||+|++.... ........+.+|+.++++++ ||||++++
T Consensus 10 ~~~~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~-hp~iv~~~ 85 (311)
T 3niz_A 10 GRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDA--EDEGIPSTAIREISLLKELH-HPNIVSLI 85 (311)
T ss_dssp -----CEECSSCEEEEEEEEEECSSCEEEEEEE-TTSCEEEEEEEC--------CHHHHHHHHHHHHHHCC-CTTBCCEE
T ss_pred cccceeecchHhhhHhhhhccCCCCeEEEEEEE-CCCCEEEEEEEeccc--ccchhhHHHHHHHHHHHHcC-CCCEeeee
Confidence 334556778999999999999999999999998 469999999997542 22334567889999999995 99999999
Q ss_pred EEEEeCCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEecc
Q 013005 97 EVMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFG 174 (451)
Q Consensus 97 ~~~~~~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFG 174 (451)
+++.+....|+||||+.+ +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 164 (311)
T 3niz_A 86 DVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFG 164 (311)
T ss_dssp EEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCc
Confidence 999999999999999985 77777764 469999999999999999999999999999999999999999999999999
Q ss_pred CCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhc---cC----
Q 013005 175 LSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNR---RD---- 247 (451)
Q Consensus 175 ls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~---~~---- 247 (451)
++...... .......+||+.|+|||++.+....+.++||||+||++|+|++|..||...+.......+.. ..
T Consensus 165 ~a~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 243 (311)
T 3niz_A 165 LARAFGIP-VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPRE 243 (311)
T ss_dssp TCEETTSC-CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTT
T ss_pred CceecCCC-cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHH
Confidence 99754321 23344568999999999987766557789999999999999999999987654443333321 00
Q ss_pred --------------CC---------CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 248 --------------YQ---------FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 248 --------------~~---------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.. ..+.+++++.+||.+||..||.+|||++|+++||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp SGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred hhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 00 113367899999999999999999999999999999863
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-51 Score=392.88 Aligned_cols=260 Identities=33% Similarity=0.650 Sum_probs=230.5
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
....+++|++.+.||+|+||.||+|.+..+++.||+|++.+.. .........+.+|+.+++++. ||||+++++++.+.
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 81 (279)
T 3fdn_A 4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDA 81 (279)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-HHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECS
T ss_pred ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccc-cchhhHHHHHHHHHHHHHcCC-CCCCcchhheEecC
Confidence 3556789999999999999999999999999999999997642 222233567889999999996 99999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 103 TKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
...|+||||+++|+|.+.+.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999999999999875 7899999999999999999999999999999999999999999999999999864332
Q ss_pred hhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHH
Q 013005 182 IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSL 261 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 261 (451)
......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+.......+......+|..+++.+.+|
T Consensus 162 ---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (279)
T 3fdn_A 162 ---SRRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 237 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred ---ccccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHH
Confidence 22345679999999999877655 56799999999999999999999999999999999888889999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHcCccccch
Q 013005 262 IYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 262 i~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
|.+||..||.+|||++++++||||+..
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHHhccChhhCCCHHHHhhCccccCC
Confidence 999999999999999999999999764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-51 Score=407.75 Aligned_cols=261 Identities=29% Similarity=0.597 Sum_probs=222.8
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhh-HHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLD-AAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
..+.++|++.+.||+|+||+||+|.+..+++.||||+++....... ....+.+.+|+.+++.++ ||||+++++++.+.
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~ 98 (351)
T 3c0i_A 20 VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYSSD 98 (351)
T ss_dssp CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEEET
T ss_pred CccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEEeC
Confidence 3556789999999999999999999999999999999975421110 112467899999999995 99999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCC---eEEEecc
Q 013005 103 TKIYLVMEYAAGGELFGKLRR-----GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN---LKVSDFG 174 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~-----~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~---lkl~DFG 174 (451)
+..|+||||++|++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 999999999999999887753 25899999999999999999999999999999999999987665 9999999
Q ss_pred CCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCC---
Q 013005 175 LSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP--- 251 (451)
Q Consensus 175 ls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p--- 251 (451)
++...... .......+||+.|+|||++.+..| +.++|||||||++|+|++|..||...+ ...+..+....+.++
T Consensus 179 ~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~ 255 (351)
T 3c0i_A 179 VAIQLGES-GLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQ 255 (351)
T ss_dssp TCEECCTT-SCBCCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHH
T ss_pred ceeEecCC-CeeecCCcCCcCccCHHHHcCCCC-CchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccc
Confidence 99754331 223456789999999999987766 567999999999999999999998754 456666666665554
Q ss_pred -CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 252 -SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 252 -~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
..+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 256 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 256 WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 4589999999999999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-51 Score=418.29 Aligned_cols=262 Identities=28% Similarity=0.461 Sum_probs=225.0
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
....++|++.+.||+|+||+||+|++..+++.||||++.+.. .......+.+.+|..++..+. ||||+++++++.+.+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~-~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWD-MLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQDEN 134 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-HHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEEECSS
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH-hhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeCC
Confidence 455789999999999999999999999999999999997642 122223345788999999995 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 104 KIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
..|+||||+.||+|.+++.+ ..+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||++.....
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 99999999999999999975 4799999999999999999999999999999999999999999999999999975433
Q ss_pred hhcCcccccCCCCccccceeeec------cCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc--CCCCC--
Q 013005 182 IKNGMLHTACGTPAYTAPEVVAR------RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR--DYQFP-- 251 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~------~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p-- 251 (451)
.........+||+.|+|||++.. ....+.++|||||||++|+|++|+.||...+....+.++... ...+|
T Consensus 215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 294 (412)
T 2vd5_A 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV 294 (412)
T ss_dssp TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC--
T ss_pred CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcc
Confidence 22222345689999999999873 223467799999999999999999999999988888887652 24444
Q ss_pred -CCCCHhHHHHHHhccCCCCCCC---CCHHHHHcCccccch
Q 013005 252 -SFVSKPARSLIYQLLDPNPKTR---MSIEKIMSISWFQKS 288 (451)
Q Consensus 252 -~~~s~~~~~li~~~L~~dP~~R---pt~~eil~hp~f~~~ 288 (451)
..+|+++.+||++||. +|.+| |+++++++||||+..
T Consensus 295 ~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 295 DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp --CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 5689999999999999 99998 599999999999764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=390.75 Aligned_cols=264 Identities=39% Similarity=0.771 Sum_probs=226.6
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
......++|.+++.||+|+||.||+|.+..+++.||+|++.... .......+.+.+|+.+++.+. ||||+++++++.+
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 82 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQK-IRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVIST 82 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccc-ccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEec
Confidence 44567899999999999999999999999999999999997542 122233567889999999995 9999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
.+..|+||||+.+++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 83 PTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 9999999999999999999974 789999999999999999999999999999999999999999999999999987543
Q ss_pred hhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHH
Q 013005 181 QIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARS 260 (451)
Q Consensus 181 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 260 (451)
. .......+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...+.......+......+|..++..+.+
T Consensus 163 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 240 (276)
T 2h6d_A 163 D--GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVAT 240 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred C--CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHH
Confidence 3 12334568999999999998777767789999999999999999999999988888888888888888889999999
Q ss_pred HHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 261 LIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 261 li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
+|.+||..||.+|||++++++||||++..
T Consensus 241 li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred HHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 99999999999999999999999997643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=413.06 Aligned_cols=253 Identities=34% Similarity=0.603 Sum_probs=209.5
Q ss_pred ccccCCeEEc-ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe-
Q 013005 24 PTLLNRYQLG-PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT- 101 (451)
Q Consensus 24 ~~~~~~y~~~-~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~- 101 (451)
....++|.+. +.||+|+||+||+|.+..+++.||||++... ..+.+|+.++.++.+||||+++++++..
T Consensus 57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~ 127 (400)
T 1nxk_A 57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENL 127 (400)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---------hhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence 4567889887 7899999999999999999999999999643 2456788888776679999999999876
Q ss_pred ---CCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC---CCCeEEEe
Q 013005 102 ---KTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR---DGNLKVSD 172 (451)
Q Consensus 102 ---~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~---~~~lkl~D 172 (451)
...+|+||||+.||+|.+++.. ..+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEe
Confidence 6679999999999999999975 25999999999999999999999999999999999999998 78999999
Q ss_pred ccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH----HHHHHhhccCC
Q 013005 173 FGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL----AMYKKVNRRDY 248 (451)
Q Consensus 173 FGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~----~~~~~i~~~~~ 248 (451)
||++..... .....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||...+.. .....+....+
T Consensus 208 FG~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~ 284 (400)
T 1nxk_A 208 FGFAKETTS--HNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284 (400)
T ss_dssp CTTCEECC-------------CTTCCGGGSCCCCS-SSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC
T ss_pred cccccccCC--CCccccCCCCCCccCHhhcCCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc
Confidence 999975432 233457789999999999987776 46699999999999999999999765432 23445555555
Q ss_pred CCC----CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 249 QFP----SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 249 ~~p----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.+| ..++..+.+||.+||..||.+|||++++++||||...
T Consensus 285 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 554 3589999999999999999999999999999999754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=407.06 Aligned_cols=259 Identities=25% Similarity=0.399 Sum_probs=216.7
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
..-.+.++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++ ||||+++++++..
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~ 95 (367)
T 1cm8_A 19 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTP 95 (367)
T ss_dssp SEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECS
T ss_pred ceeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEec
Confidence 33456789999999999999999999999999999999996542 23455678899999999996 9999999999976
Q ss_pred C------CEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccC
Q 013005 102 K------TKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGL 175 (451)
Q Consensus 102 ~------~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGl 175 (451)
. ..+|+||||+ |++|.+++..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 96 DETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CSSTTTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CCccccCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeec
Confidence 5 3569999999 88999999888999999999999999999999999999999999999999999999999999
Q ss_pred CCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC--------
Q 013005 176 SALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD-------- 247 (451)
Q Consensus 176 s~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~-------- 247 (451)
+.... ......+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+....
T Consensus 175 a~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 175 ARQAD----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp CEECC----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccccc----cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 97543 224456899999999998874555777999999999999999999999887766555443210
Q ss_pred -----------------------CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 248 -----------------------YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 248 -----------------------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
....+..++.+.+||.+||..||.+|||++++++||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 01224568999999999999999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=406.50 Aligned_cols=265 Identities=20% Similarity=0.309 Sum_probs=219.5
Q ss_pred CCcccccCCeEEcceEccc--CceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE
Q 013005 21 KKIPTLLNRYQLGPLLGRG--SFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G--~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
..+....++|++.+.||+| +||.||+|++..+++.||||++.... ......+.+.+|+.+++.+. ||||++++++
T Consensus 18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~ 94 (389)
T 3gni_B 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA--CSNEMVTFLQGELHVSKLFN-HPNIVPYRAT 94 (389)
T ss_dssp CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHHHHHHHHHHHHCC-CTTBCCEEEE
T ss_pred hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc--cChHHHHHHHHHHHHHHhCC-CCCCCcEeEE
Confidence 3344567899999999999 99999999999999999999998652 23456678899999999995 9999999999
Q ss_pred EEeCCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccC
Q 013005 99 MATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGL 175 (451)
Q Consensus 99 ~~~~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGl 175 (451)
+.+.+..|+||||+.+|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~ 174 (389)
T 3gni_B 95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRS 174 (389)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGG
T ss_pred EEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccc
Confidence 9999999999999999999999864 6799999999999999999999999999999999999999999999999998
Q ss_pred CCcchhhh------cCcccccCCCCccccceeeecc-CCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC-
Q 013005 176 SALPEQIK------NGMLHTACGTPAYTAPEVVARR-GYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD- 247 (451)
Q Consensus 176 s~~~~~~~------~~~~~~~~gt~~y~APEvl~~~-~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~- 247 (451)
+....... .......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 254 (389)
T 3gni_B 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254 (389)
T ss_dssp CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 75432111 1223345899999999999773 233667999999999999999999998754433332222111
Q ss_pred ---------------------------------------------CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 248 ---------------------------------------------YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 248 ---------------------------------------------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
..++..+++.+.+||.+||..||.+|||++++++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 12345578999999999999999999999999999
Q ss_pred ccccch
Q 013005 283 SWFQKS 288 (451)
Q Consensus 283 p~f~~~ 288 (451)
|||+..
T Consensus 335 p~f~~~ 340 (389)
T 3gni_B 335 SFFKQI 340 (389)
T ss_dssp GGGGGC
T ss_pred HHHHHH
Confidence 999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=385.06 Aligned_cols=258 Identities=34% Similarity=0.676 Sum_probs=228.9
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.++++++ ||||+++++++...+.
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 79 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK--LSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESF 79 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeeccc--CCHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEcCCE
Confidence 46789999999999999999999999999999999997652 23445577899999999995 9999999999999999
Q ss_pred EEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCC---eEEEeccCCCcch
Q 013005 105 IYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN---LKVSDFGLSALPE 180 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~---lkl~DFGls~~~~ 180 (451)
.|+||||+.|++|.+.+.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++....
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999999999888864 77999999999999999999999999999999999999987665 9999999996543
Q ss_pred hhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCC----CCCH
Q 013005 181 QIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS----FVSK 256 (451)
Q Consensus 181 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 256 (451)
. .......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+.......+......+|. .+++
T Consensus 160 ~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T 3kk8_A 160 D--SEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 236 (284)
T ss_dssp S--SCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred c--CccccCCCCCcCCcCchhhcCCCC-CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCH
Confidence 2 233345689999999999987766 56799999999999999999999999888888888777665553 5789
Q ss_pred hHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 257 PARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.+.+||.+||..||.+|||++++++||||+..
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 237 EAKSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 99999999999999999999999999999764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=405.40 Aligned_cols=255 Identities=29% Similarity=0.590 Sum_probs=222.1
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
..+.++|++.+.||+|+||+||+|.+..+++.||||++++... ...+|+.++.++.+||||+++++++.+..
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~ 89 (342)
T 2qr7_A 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------DPTEEIEILLRYGQHPNIITLKDVYDDGK 89 (342)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--------CCHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--------ChHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence 4577899999999999999999999999999999999987532 23468888888867999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCC-C---CeEEEeccCCCc
Q 013005 104 KIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD-G---NLKVSDFGLSAL 178 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~-~---~lkl~DFGls~~ 178 (451)
..|+||||+.||+|.+.+.. +.+++.+++.++.||+.||+|||++||+||||||+|||+..+ + .+||+|||++..
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999999999999875 679999999999999999999999999999999999998543 3 499999999975
Q ss_pred chhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCC---CcHHHHHHHhhccCCCCC----
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDD---SNLLAMYKKVNRRDYQFP---- 251 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~---~~~~~~~~~i~~~~~~~p---- 251 (451)
.... .....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.. .+.......+....+.++
T Consensus 170 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 247 (342)
T 2qr7_A 170 LRAE-NGLLMTPCYTANFVAPEVLERQGY-DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247 (342)
T ss_dssp CBCT-TCCBCCSSCCSSCCCHHHHHHHHH-HHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred CcCC-CCceeccCCCccccCHHHhcCCCC-CCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence 4332 234567899999999999987766 4669999999999999999999975 456677778877766654
Q ss_pred CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 252 SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 252 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
..+++.+.+||.+||..||.+|||+.++++||||...
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 4589999999999999999999999999999999653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=399.23 Aligned_cols=262 Identities=32% Similarity=0.571 Sum_probs=235.5
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
+...++|.+.+.||+|+||.||++.+..+++.||+|++.+. ........+.+.+|+.+++.+. ||||+++++++.+.+
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 114 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKS-LLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDND 114 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGG-GCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechh-hhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCC
Confidence 45577999999999999999999999999999999999765 2234456678899999999995 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 104 KIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
..|+||||+.+++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred eEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999999999998875 78999999999999999999999999999999999999999999999999999754322
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHH
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLI 262 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 262 (451)
.......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+....+..+......+|..+++.+.+||
T Consensus 195 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 272 (335)
T 2owb_A 195 -GERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLI 272 (335)
T ss_dssp -TCCBCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHH
T ss_pred -cccccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHH
Confidence 123345689999999999977666 567999999999999999999999998888888888888888999999999999
Q ss_pred HhccCCCCCCCCCHHHHHcCccccchh
Q 013005 263 YQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 263 ~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
.+||..||++|||++++++||||....
T Consensus 273 ~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 273 QKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp HHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HHHccCChhHCcCHHHHhcCccccCCC
Confidence 999999999999999999999998653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-50 Score=406.32 Aligned_cols=260 Identities=28% Similarity=0.571 Sum_probs=228.7
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
.....+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.+. ||||+++++++.
T Consensus 44 ~~~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~ 118 (387)
T 1kob_A 44 VKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLH-HPKLINLHDAFE 118 (387)
T ss_dssp CBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCC-STTBCCEEEEEE
T ss_pred ccCCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc----hhhHHHHHHHHHHHHhCC-CcCCCeEEEEEE
Confidence 344567789999999999999999999999999999999997652 223457889999999995 999999999999
Q ss_pred eCCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC--CCCeEEEeccCC
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR--DGNLKVSDFGLS 176 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~--~~~lkl~DFGls 176 (451)
+....|+||||+.||+|.+++.. ..+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 119 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a 198 (387)
T 1kob_A 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA 198 (387)
T ss_dssp CSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccc
Confidence 99999999999999999999975 47999999999999999999999999999999999999974 467999999999
Q ss_pred CcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCC----C
Q 013005 177 ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP----S 252 (451)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~ 252 (451)
..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......++ .
T Consensus 199 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 275 (387)
T 1kob_A 199 TKLNP--DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS 275 (387)
T ss_dssp EECCT--TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTT
T ss_pred eecCC--CcceeeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccc
Confidence 75433 233445689999999999987666 5679999999999999999999999888888888777665544 3
Q ss_pred CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 253 FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 253 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.+++.+.+||.+||..||.+|||++++++||||+..
T Consensus 276 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 276 SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 579999999999999999999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=421.62 Aligned_cols=265 Identities=35% Similarity=0.613 Sum_probs=227.8
Q ss_pred CCCCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEE
Q 013005 17 PPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQ 96 (451)
Q Consensus 17 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~ 96 (451)
.|+...-+.+.++|++.+.||+|+||+||+|.+..+++.||||++.+... .......+.+|+.+++++. ||||++++
T Consensus 11 ~~~~~~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~ 87 (486)
T 3mwu_A 11 RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA--KNKDTSTILREVELLKKLD-HPNIMKLF 87 (486)
T ss_dssp ---CTTCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH--BCSCHHHHHHHHHHHHHCC-CTTBCCEE
T ss_pred CccccccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHHHhCC-CCCcCeEE
Confidence 34444556788999999999999999999999999999999999975421 1123467889999999995 99999999
Q ss_pred EEEEeCCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeC---CCCCeEEEe
Q 013005 97 EVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLD---RDGNLKVSD 172 (451)
Q Consensus 97 ~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld---~~~~lkl~D 172 (451)
+++.+....|+||||+.||+|.+.+.. +.+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 167 (486)
T 3mwu_A 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIID 167 (486)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECS
T ss_pred EEEEcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEE
Confidence 999999999999999999999998864 7899999999999999999999999999999999999995 456799999
Q ss_pred ccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCC-
Q 013005 173 FGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP- 251 (451)
Q Consensus 173 FGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p- 251 (451)
||++..... .......+||+.|+|||++.+ .| +.++|||||||++|+|++|..||.+.+.......+....+.++
T Consensus 168 fg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (486)
T 3mwu_A 168 FGLSTCFQQ--NTKMKDRIGTAYYIAPEVLRG-TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL 243 (486)
T ss_dssp CSCTTTBCC--C----CCTTGGGGCCGGGGGS-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS
T ss_pred CCcCeECCC--CCccCCCcCCCCCCCHHHhCC-CC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 999976533 233456789999999999865 34 6779999999999999999999999998888888887766543
Q ss_pred ---CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 252 ---SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 252 ---~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
..+|+.+.+||.+||..||.+|||+.++++||||+..
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 2479999999999999999999999999999999753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=436.55 Aligned_cols=263 Identities=27% Similarity=0.515 Sum_probs=235.9
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
...++|++++.||+|+||+||+|++..+++.||||++.+.. .......+.+.+|..++..+.+||||+++++++.+.+.
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDV-VIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHH-HHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccc-cccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 45678999999999999999999999999999999997642 22223345678899999988779999999999999999
Q ss_pred EEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 105 IYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
+||||||+.||+|.+++.. +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||++..... .
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~-~ 495 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW-D 495 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC-T
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc-C
Confidence 9999999999999999975 8899999999999999999999999999999999999999999999999999974322 1
Q ss_pred cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHH
Q 013005 184 NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIY 263 (451)
Q Consensus 184 ~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 263 (451)
.....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+...++..|......+|..+++++.+||+
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 574 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 574 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTCCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCCCcccCHhhhcCCCC-CccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 234567899999999999988777 5679999999999999999999999999999999999999999999999999999
Q ss_pred hccCCCCCCCCCH-----HHHHcCccccchhH
Q 013005 264 QLLDPNPKTRMSI-----EKIMSISWFQKSLQ 290 (451)
Q Consensus 264 ~~L~~dP~~Rpt~-----~eil~hp~f~~~~~ 290 (451)
+||..||.+||++ ++|++||||+....
T Consensus 575 ~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w 606 (674)
T 3pfq_A 575 GLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 606 (674)
T ss_dssp HHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCH
T ss_pred HHccCCHHHCCCCCCCcHHHHhcCccccCCCH
Confidence 9999999999997 99999999987543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=391.18 Aligned_cols=259 Identities=26% Similarity=0.480 Sum_probs=215.1
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
++++|++.+.||+|+||+||+|.+..+++.||+|++.... ......+.+.+|+.+++++. ||||+++++++.+.+..
T Consensus 1 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 77 (311)
T 4agu_A 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKRRL 77 (311)
T ss_dssp --CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC--C-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred CcccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc--cchHHHHHHHHHHHHHHhCC-CCCccchhheeecCCeE
Confidence 3689999999999999999999999999999999987642 23445677889999999996 99999999999999999
Q ss_pred EEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 106 YLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
|+||||+++++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 156 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP-S 156 (311)
T ss_dssp EEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc-c
Confidence 999999999999998874 67999999999999999999999999999999999999999999999999999754322 2
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc------------------
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR------------------ 246 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~------------------ 246 (451)
......+||+.|+|||++.+....+.++||||+|+++|+|++|..||...+.......+...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 23456689999999999977555678899999999999999999999987766554433221
Q ss_pred -CCCCC------------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 247 -DYQFP------------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 247 -~~~~p------------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
....| +.++..+.+||.+||..||.+|||++++++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 00111 3478889999999999999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-50 Score=388.35 Aligned_cols=260 Identities=32% Similarity=0.651 Sum_probs=231.8
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
.....++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+.+|+.+++.+. ||||+++++++.+.
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 86 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQ-LEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDR 86 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHH-HHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccc-cchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEEcC
Confidence 3456789999999999999999999999999999999997542 112223467889999999995 99999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 103 TKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
...|+||||+++|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 87 KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999999999999875 7899999999999999999999999999999999999999999999999999864332
Q ss_pred hhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHH
Q 013005 182 IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSL 261 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 261 (451)
......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+......+|..++..+.+|
T Consensus 167 ---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 242 (284)
T 2vgo_A 167 ---LRRRTMCGTLDYLPPEMIEGKTH-DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDL 242 (284)
T ss_dssp ---SCBCCCCSCGGGCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHH
T ss_pred ---cccccccCCCCcCCHHHhccCCC-CcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHH
Confidence 22345689999999999987666 56799999999999999999999998888888888888888999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHcCccccch
Q 013005 262 IYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 262 i~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
|.+||..||.+|||++++++||||+..
T Consensus 243 i~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 243 ISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp HHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 999999999999999999999999753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=389.27 Aligned_cols=262 Identities=36% Similarity=0.648 Sum_probs=206.2
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
++...++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+.+|+.+++++. ||||+++++++.+.
T Consensus 6 ~g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 83 (278)
T 3cok_A 6 IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA-MYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDS 83 (278)
T ss_dssp HCSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEECS
T ss_pred cccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhh-hhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEccC
Confidence 4566789999999999999999999999999999999997542 122223467889999999995 99999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 103 TKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
+..|+||||+++++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 84 NYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp SEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 999999999999999999975 579999999999999999999999999999999999999999999999999987543
Q ss_pred hhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHH
Q 013005 181 QIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARS 260 (451)
Q Consensus 181 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 260 (451)
... ......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+.......+....+..|..++..+.+
T Consensus 164 ~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (278)
T 3cok_A 164 MPH-EKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKD 241 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHH
T ss_pred CCC-CcceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHH
Confidence 221 22335679999999999877655 5679999999999999999999988776666666666677788889999999
Q ss_pred HHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 261 LIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 261 li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
||.+||..||++|||++++++||||...
T Consensus 242 li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 242 LIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 9999999999999999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=391.51 Aligned_cols=255 Identities=27% Similarity=0.489 Sum_probs=212.5
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
+++|++.+.||+|+||+||+|.+ .+++.||+|++..... .....+.+.+|+.++++++ ||||+++++++.+.+..|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 76 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE--DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLV 76 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc--ccccchhHHHHHHHHHhcC-CCCEeeeeeEEccCCeEE
Confidence 47899999999999999999998 7899999999976522 2223356789999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 107 LVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
+||||+.+ +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 77 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 154 (288)
T 1ob3_A 77 LVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP-V 154 (288)
T ss_dssp EEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc-c
Confidence 99999986 88888864 67999999999999999999999999999999999999999999999999998644321 1
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc--C---------------
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR--D--------------- 247 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~--~--------------- 247 (451)
......+||+.|+|||++.+....+.++|||||||++|+|++|..||...+.......+... .
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 22345679999999999977655577899999999999999999999987766555544321 0
Q ss_pred ---C---------CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 248 ---Y---------QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 248 ---~---------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
. .+...+++.+.+||.+||..||++|||++++++||||+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0 012347889999999999999999999999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=387.62 Aligned_cols=263 Identities=32% Similarity=0.561 Sum_probs=235.6
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
.-+...++|.+.+.||+|+||.||+|.+..+++.||+|++.... .......+.+.+|+.+++.+. ||||+++++++.+
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 86 (294)
T 2rku_A 9 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL-LLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFED 86 (294)
T ss_dssp EETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG-CCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEC
T ss_pred eCCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhh-ccCHHHHHHHHHHHHHHHhCC-CCCEeeeeeeecc
Confidence 33567789999999999999999999999999999999997652 233455678899999999995 9999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
.+..|+||||+++++|.+++.. +.+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 87 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 87 NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 9999999999999999998875 789999999999999999999999999999999999999999999999999997543
Q ss_pred hhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHH
Q 013005 181 QIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARS 260 (451)
Q Consensus 181 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 260 (451)
.. .......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+....+..+......+|..+++.+.+
T Consensus 167 ~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (294)
T 2rku_A 167 YD-GERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAAS 244 (294)
T ss_dssp ST-TCCBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHH
T ss_pred cC-ccccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHH
Confidence 22 123345679999999999877655 5679999999999999999999999988888888888888889999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 261 LIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 261 li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+|.+||..||++|||++++++||||...
T Consensus 245 li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 245 LIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp HHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHHcccChhhCcCHHHHhhChheecC
Confidence 9999999999999999999999999764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-50 Score=400.09 Aligned_cols=258 Identities=34% Similarity=0.629 Sum_probs=209.2
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
.....+.++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.+++++. ||||+++++++.
T Consensus 46 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 118 (349)
T 2w4o_A 46 SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------DKKIVRTEIGVLLRLS-HPNIIKLKEIFE 118 (349)
T ss_dssp SBCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCC-CTTBCCEEEEEE
T ss_pred cccccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch------hHHHHHHHHHHHHhCC-CCCCcceeeeEe
Confidence 345667889999999999999999999999999999999997542 2356789999999996 999999999999
Q ss_pred eCCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC---CCCeEEEeccCC
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR---DGNLKVSDFGLS 176 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~---~~~lkl~DFGls 176 (451)
+....|+||||+.||+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 119 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 119 TPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp CSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred cCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 99999999999999999999875 67999999999999999999999999999999999999975 889999999999
Q ss_pred CcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH-HHHHHhhccCCCCC----
Q 013005 177 ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL-AMYKKVNRRDYQFP---- 251 (451)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~-~~~~~i~~~~~~~p---- 251 (451)
..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ..+..+......++
T Consensus 199 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 275 (349)
T 2w4o_A 199 KIVEH--QVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWW 275 (349)
T ss_dssp ----------------CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTT
T ss_pred cccCc--ccccccccCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchh
Confidence 76433 223456789999999999987666 56799999999999999999999765443 46666666554433
Q ss_pred CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 252 SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 252 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
..++..+.+||.+||..||++|||+.++++||||...
T Consensus 276 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 276 DEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred hhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 3578999999999999999999999999999999754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=418.72 Aligned_cols=263 Identities=34% Similarity=0.598 Sum_probs=228.4
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhh---------HHHHHHHHHHHHHHHHhcCCCC
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLD---------AAMEDRIVREVSAMRRLQNHPN 91 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~---------~~~~~~~~~Ei~il~~L~~Hpn 91 (451)
.....+.++|++++.||+|+||+||+|.+..+++.||+|++.+...... ....+.+.+|+.+++++. |||
T Consensus 29 ~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpn 107 (504)
T 3q5i_A 29 KKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPN 107 (504)
T ss_dssp EECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-CTT
T ss_pred ccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CCC
Confidence 4445678999999999999999999999999999999999976521100 123467889999999995 999
Q ss_pred ceEEEEEEEeCCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC---C
Q 013005 92 VLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG---N 167 (451)
Q Consensus 92 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~---~ 167 (451)
|+++++++.+....|+|||||.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999999999998864 7899999999999999999999999999999999999999876 6
Q ss_pred eEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC
Q 013005 168 LKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD 247 (451)
Q Consensus 168 lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~ 247 (451)
+||+|||++..... .......+||+.|+|||++.+ .| +.++||||+||++|+|++|..||.+.+.......+....
T Consensus 188 ~kl~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 263 (504)
T 3q5i_A 188 IKIVDFGLSSFFSK--DYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK 263 (504)
T ss_dssp EEECCCTTCEECCT--TSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred EEEEECCCCEEcCC--CCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999975533 234456789999999999863 34 677999999999999999999999999999999998887
Q ss_pred CCCC----CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 248 YQFP----SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 248 ~~~p----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+.++ ..+++.+.+||.+||..||.+|||++++++||||++.
T Consensus 264 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 264 YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred CCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 7665 4689999999999999999999999999999999764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-50 Score=385.58 Aligned_cols=258 Identities=38% Similarity=0.633 Sum_probs=228.9
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
...+.++|++.+.||+|+||.||+|.+..++..||+|++..... ...+.+.+|+.+++++. ||||+++++++.+.
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 78 (277)
T 3f3z_A 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV----EDVDRFKQEIEIMKSLD-HPNIIRLYETFEDN 78 (277)
T ss_dssp --CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred hhhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc----chHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence 34567899999999999999999999999999999999976422 12457889999999995 99999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEe---CCCCCeEEEeccCCCc
Q 013005 103 TKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL---DRDGNLKVSDFGLSAL 178 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILl---d~~~~lkl~DFGls~~ 178 (451)
...|+||||++|++|.+++.. +.+++.+++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 79 TDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred CeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 999999999999999998864 779999999999999999999999999999999999999 8889999999999875
Q ss_pred chhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCC----CC
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS----FV 254 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~ 254 (451)
... .......+||+.|+|||++.+. .+.++||||||+++|+|++|..||...+.......+......+|. .+
T Consensus 159 ~~~--~~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (277)
T 3f3z_A 159 FKP--GKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNV 234 (277)
T ss_dssp CCT--TSCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTS
T ss_pred ccC--ccchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcC
Confidence 433 2344567899999999988643 467799999999999999999999999888888888888777764 58
Q ss_pred CHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 255 SKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 255 s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
++.+.+||.+||..||.+|||+.++++||||++..
T Consensus 235 ~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 235 SPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 99999999999999999999999999999998754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=400.52 Aligned_cols=265 Identities=26% Similarity=0.422 Sum_probs=210.0
Q ss_pred CCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE
Q 013005 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 19 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
+........++|++.+.||+|+||+||+|++..+++.||||++.... ......+.+.+|+.++++++ ||||++++++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~ 101 (329)
T 3gbz_A 25 SAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH--EEEGVPGTAIREVSLLKELQ-HRNIIELKSV 101 (329)
T ss_dssp -------CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCC-CTTBCCEEEE
T ss_pred ccCCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc--cccccchhHHHHHHHHHHcC-CCCcceEEEE
Confidence 34445677889999999999999999999999999999999997652 23334566789999999995 9999999999
Q ss_pred EEeCCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeC-----CCCCeEEEe
Q 013005 99 MATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLD-----RDGNLKVSD 172 (451)
Q Consensus 99 ~~~~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld-----~~~~lkl~D 172 (451)
+.+....|+||||+.| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 102 ~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 102 IHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp EEETTEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred EecCCEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECc
Confidence 9999999999999985 99998875 6799999999999999999999999999999999999994 445599999
Q ss_pred ccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC----
Q 013005 173 FGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY---- 248 (451)
Q Consensus 173 FGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~---- 248 (451)
||++...... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||...+.......+.....
T Consensus 181 fg~a~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 181 FGLARAFGIP-IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD 259 (329)
T ss_dssp TTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred CCCccccCCc-ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCch
Confidence 9998754321 23345567899999999998766567889999999999999999999998877666555432100
Q ss_pred --------------CCC------------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 249 --------------QFP------------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 249 --------------~~p------------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.++ ..+++.+.+||.+||..||.+|||++|+++||||+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 000 1167899999999999999999999999999999863
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=399.17 Aligned_cols=254 Identities=35% Similarity=0.653 Sum_probs=202.8
Q ss_pred ccCCeEEc---ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 26 LLNRYQLG---PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 26 ~~~~y~~~---~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
..++|++. +.||+|+||.||+|.+..+++.||||++.+.. ...+.+|+.+++.+.+||||+++++++.+.
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~ 78 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM-------EANTQKEITALKLCEGHPNIVKLHEVFHDQ 78 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG-------HHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh-------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 45678875 78999999999999999999999999997542 346778999999997799999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC---CeEEEeccCCCc
Q 013005 103 TKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG---NLKVSDFGLSAL 178 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~---~lkl~DFGls~~ 178 (451)
...|+||||++||+|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 79 LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 999999999999999999975 6799999999999999999999999999999999999998766 799999999975
Q ss_pred chhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCc-------HHHHHHHhhccCCCCC
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN-------LLAMYKKVNRRDYQFP 251 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~-------~~~~~~~i~~~~~~~p 251 (451)
.... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+ .......+....+.++
T Consensus 159 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~ 236 (325)
T 3kn6_A 159 KPPD-NQPLKTPCFTLHYAAPELLNQNGY-DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236 (325)
T ss_dssp CCC-----------------------CCC-CHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred cCCC-CCcccccCCCcCccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence 4332 234456789999999999987776 567999999999999999999997643 3566777777776665
Q ss_pred C----CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 252 S----FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 252 ~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
. .+++.+.+||.+||..||.+|||++++++||||+..
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 3 479999999999999999999999999999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=390.91 Aligned_cols=261 Identities=33% Similarity=0.585 Sum_probs=217.1
Q ss_pred ccccCCeEEc-ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 24 PTLLNRYQLG-PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 24 ~~~~~~y~~~-~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
..+.++|++. +.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++++.+||||+++++++.+.
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~ 83 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG----HIRSRVFREVEMLYQCQGHRNVLELIEFFEEE 83 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS----CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 4567889995 789999999999999999999999999976522 22457889999999976799999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCC---eEEEeccCCCc
Q 013005 103 TKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN---LKVSDFGLSAL 178 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~---lkl~DFGls~~ 178 (451)
+..|+||||++||+|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 999999999999999999975 78999999999999999999999999999999999999998876 99999999875
Q ss_pred chhhh------cCcccccCCCCccccceeeecc----CCCCccchhhhhhHHHHHHHhcCCCCCCCc-------------
Q 013005 179 PEQIK------NGMLHTACGTPAYTAPEVVARR----GYDGAVADAWSCGVILFVLLAGYLPFDDSN------------- 235 (451)
Q Consensus 179 ~~~~~------~~~~~~~~gt~~y~APEvl~~~----~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~------------- 235 (451)
..... .......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||...+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 43211 1223456799999999998651 223567999999999999999999997653
Q ss_pred --HHHHHHHhhccCCCCC----CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 236 --LLAMYKKVNRRDYQFP----SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 236 --~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
....+..+......+| ..+++.+.+||.+||..||.+|||++++++||||+..
T Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 2345666666666666 3589999999999999999999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-50 Score=423.47 Aligned_cols=261 Identities=28% Similarity=0.438 Sum_probs=229.8
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
+...++|++.+.||+|+||+||+|++..+|+.||+|++.+.. .........+.+|+.+|+.+. ||||+++++++.+.+
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~-~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~ 257 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR-IKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKD 257 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHh-hhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEeeCC
Confidence 356788999999999999999999999999999999997642 222233456889999999995 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 104 KIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
..|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999999999875 249999999999999999999999999999999999999999999999999997543
Q ss_pred hhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCC----cHHHHHHHhhccCCCCCCCCCH
Q 013005 181 QIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS----NLLAMYKKVNRRDYQFPSFVSK 256 (451)
Q Consensus 181 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~ 256 (451)
. .......+||+.|+|||++.+..| +.++|||||||++|+|++|..||... ....+...+......+|..+++
T Consensus 338 ~--~~~~~~~~GT~~Y~APEvl~~~~~-~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~ 414 (576)
T 2acx_A 338 E--GQTIKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSP 414 (576)
T ss_dssp T--TCCEECCCSCGGGCCHHHHTTCEE-SSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred c--CccccccCCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCH
Confidence 2 233456799999999999987766 56699999999999999999999875 3456677777777888899999
Q ss_pred hHHHHHHhccCCCCCCCC-----CHHHHHcCccccchh
Q 013005 257 PARSLIYQLLDPNPKTRM-----SIEKIMSISWFQKSL 289 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~Rp-----t~~eil~hp~f~~~~ 289 (451)
.+.+||.+||..||.+|| +++++++||||+...
T Consensus 415 ~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred HHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence 999999999999999999 899999999998743
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=383.87 Aligned_cols=270 Identities=30% Similarity=0.541 Sum_probs=229.4
Q ss_pred CCCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcc-----hhhHHHHHHHHHHHHHHHHhcCCCCc
Q 013005 18 PPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNK-----FLDAAMEDRIVREVSAMRRLQNHPNV 92 (451)
Q Consensus 18 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~~~~Ei~il~~L~~HpnI 92 (451)
|+......+.++|++.+.||+|+||.||+|.+..+++.||||+++.... .......+.+.+|+.+++++.+||||
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i 86 (298)
T 1phk_A 7 PGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86 (298)
T ss_dssp --------CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred ccccCCcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCE
Confidence 4445556788999999999999999999999999999999999976421 11234456788999999999779999
Q ss_pred eEEEEEEEeCCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEE
Q 013005 93 LKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVS 171 (451)
Q Consensus 93 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~ 171 (451)
+++++++......|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 87 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEEC
T ss_pred eeeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEe
Confidence 9999999999999999999999999999975 689999999999999999999999999999999999999999999999
Q ss_pred eccCCCcchhhhcCcccccCCCCccccceeeec-----cCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc
Q 013005 172 DFGLSALPEQIKNGMLHTACGTPAYTAPEVVAR-----RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR 246 (451)
Q Consensus 172 DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~-----~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~ 246 (451)
|||++..... .......+||+.|+|||++.. ....+.++||||||+++|+|++|..||...+.......+...
T Consensus 167 dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (298)
T 1phk_A 167 DFGFSCQLDP--GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244 (298)
T ss_dssp CCTTCEECCT--TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred cccchhhcCC--CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence 9999875432 233456689999999999852 233466799999999999999999999998888887777776
Q ss_pred CCCCCC----CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 247 DYQFPS----FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 247 ~~~~p~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
...++. .++..+.+||.+||..||.+|||++++++||||++..
T Consensus 245 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 245 NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred CcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 655442 4789999999999999999999999999999998653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=401.24 Aligned_cols=258 Identities=30% Similarity=0.494 Sum_probs=219.9
Q ss_pred cccCCeEE--cceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 25 TLLNRYQL--GPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 25 ~~~~~y~~--~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
...+.|.+ .+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.++++++ ||||+++++++.+.
T Consensus 84 ~~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~ 158 (373)
T 2x4f_A 84 AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG----MKDKEEVKNEISVMNQLD-HANLIQLYDAFESK 158 (373)
T ss_dssp CGGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECS
T ss_pred ccccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc----cccHHHHHHHHHHHHhCC-CCCCCeEEEEEEEC
Confidence 34455665 668999999999999999999999999997652 234567899999999995 99999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEe--CCCCCeEEEeccCCCc
Q 013005 103 TKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL--DRDGNLKVSDFGLSAL 178 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILl--d~~~~lkl~DFGls~~ 178 (451)
+..|+||||++|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 159 ~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~ 238 (373)
T 2x4f_A 159 NDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARR 238 (373)
T ss_dssp SEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEE
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCcee
Confidence 999999999999999998864 469999999999999999999999999999999999999 5678899999999975
Q ss_pred chhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCC----CCC
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP----SFV 254 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~ 254 (451)
... .......+||+.|+|||++....+ +.++|||||||++|+|++|..||...+.......+....+.++ ..+
T Consensus 239 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 315 (373)
T 2x4f_A 239 YKP--REKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDI 315 (373)
T ss_dssp CCT--TCBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTS
T ss_pred cCC--ccccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccC
Confidence 533 233445689999999999876555 6679999999999999999999999988888888877665554 357
Q ss_pred CHhHHHHHHhccCCCCCCCCCHHHHHcCccccchhH
Q 013005 255 SKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQ 290 (451)
Q Consensus 255 s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 290 (451)
++.+.+||.+||..||.+|||++++++||||+....
T Consensus 316 ~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~~ 351 (373)
T 2x4f_A 316 SEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKL 351 (373)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCch
Confidence 999999999999999999999999999999987543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=385.60 Aligned_cols=259 Identities=31% Similarity=0.555 Sum_probs=219.9
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
..-+.+.++|.+.+.||+|+||.||+|.+..++..||+|++..... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~ 90 (285)
T 3is5_A 15 YFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS---QVPMEQIEAEIEVLKSLD-HPNIIKIFEVFE 90 (285)
T ss_dssp EESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---CSCHHHHHHHHHHHHTCC-CTTBCCEEEEEE
T ss_pred CCCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc---chhHHHHHHHHHHHHhCC-CchHHhHHHhee
Confidence 3334778999999999999999999999999999999999976532 223467889999999995 999999999999
Q ss_pred eCCEEEEEEEecCCCchhHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEe---CCCCCeEEEe
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRR-----GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL---DRDGNLKVSD 172 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~-----~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILl---d~~~~lkl~D 172 (451)
+....|+||||++||+|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~D 170 (285)
T 3is5_A 91 DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIID 170 (285)
T ss_dssp CSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECC
T ss_pred cCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEe
Confidence 99999999999999999998842 579999999999999999999999999999999999999 4567899999
Q ss_pred ccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCC-
Q 013005 173 FGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP- 251 (451)
Q Consensus 173 FGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p- 251 (451)
||++...... ......+||+.|+|||++.+ .+ +.++||||||+++|+|++|..||...+.......+......++
T Consensus 171 fg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (285)
T 3is5_A 171 FGLAELFKSD--EHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAV 246 (285)
T ss_dssp CCCCCC------------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC
T ss_pred eecceecCCc--ccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccc
Confidence 9999765432 23446689999999998753 34 6779999999999999999999999888877776665544433
Q ss_pred --CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 252 --SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 252 --~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
..+++.+.+||.+||..||.+|||+.|+++||||++
T Consensus 247 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 247 ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp --CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 237899999999999999999999999999999985
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=395.53 Aligned_cols=258 Identities=28% Similarity=0.454 Sum_probs=204.4
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.+++++. ||||+++++++.+.+..
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~ 78 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISLMKELK-HENIVRLYDVIHTENKL 78 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCST---TCSCHHHHHHHHHHTTCC-BTTBCCEEEEECCTTEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc---cccHHHHHHHHHHHHhcC-CCCcceEEEEEEECCeE
Confidence 35789999999999999999999999999999999976531 122356778999999995 99999999999999999
Q ss_pred EEEEEecCCCchhHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 106 YLVMEYAAGGELFGKLRR-------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~-------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
|+||||+. |+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 99999998 489888853 3599999999999999999999999999999999999999999999999999975
Q ss_pred chhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC-----------
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD----------- 247 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~----------- 247 (451)
.... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 158 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 158 FGIP-VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp TTSC-CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred cCCC-cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence 4321 2234566899999999999775555778999999999999999999999887766655543210
Q ss_pred -----------------------CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 248 -----------------------YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 248 -----------------------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
...+..++..+.+||.+||..||.+|||++|+++||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 001224688999999999999999999999999999998754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=397.11 Aligned_cols=257 Identities=23% Similarity=0.390 Sum_probs=220.0
Q ss_pred CCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhc----CCCCceE
Q 013005 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ----NHPNVLK 94 (451)
Q Consensus 19 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~----~HpnIv~ 94 (451)
+......+.++|++.+.||+|+||+||+|++..+++.||||++... ........+|+.+++.+. +||||++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-----KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-----hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 4566678889999999999999999999999999999999999753 233456778999999996 4999999
Q ss_pred EEEEEEeCCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC-------
Q 013005 95 IQEVMATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR------- 164 (451)
Q Consensus 95 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~------- 164 (451)
+++++...+..|+||||+ +++|.+++.. ..+++.+++.++.||+.||+|||++||+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEE
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccc
Confidence 999999999999999999 8999999975 35999999999999999999999999999999999999975
Q ss_pred ------------------CCCeEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh
Q 013005 165 ------------------DGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA 226 (451)
Q Consensus 165 ------------------~~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~ 226 (451)
++.+||+|||++.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~----~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS----DYHGSIINTRQYRAPEVILNLGW-DVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETT----SCCCSCCSCGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHH
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecC----CCCcCccCcccccCcHHHcCCCC-CCccchHHHHHHHHHHHH
Confidence 7899999999997532 23346789999999999988776 566999999999999999
Q ss_pred cCCCCCCCcHHHHHHHhhccCCCCC--------------------------C--------------------CCCHhHHH
Q 013005 227 GYLPFDDSNLLAMYKKVNRRDYQFP--------------------------S--------------------FVSKPARS 260 (451)
Q Consensus 227 G~~Pf~~~~~~~~~~~i~~~~~~~p--------------------------~--------------------~~s~~~~~ 260 (451)
|..||...+.......+......+| . ..++.+.+
T Consensus 255 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 334 (360)
T 3llt_A 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCD 334 (360)
T ss_dssp SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHH
T ss_pred CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHH
Confidence 9999998777666555443222221 1 12367789
Q ss_pred HHHhccCCCCCCCCCHHHHHcCcccc
Q 013005 261 LIYQLLDPNPKTRMSIEKIMSISWFQ 286 (451)
Q Consensus 261 li~~~L~~dP~~Rpt~~eil~hp~f~ 286 (451)
||.+||..||.+|||++|+++||||+
T Consensus 335 li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 335 FLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHhcCChhhCCCHHHHhcCcccC
Confidence 99999999999999999999999996
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=390.88 Aligned_cols=262 Identities=31% Similarity=0.548 Sum_probs=230.0
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhh--HHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLD--AAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++........ ....+.+.+|+.+++++. ||||+++++++.+
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVYEN 86 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEEec
Confidence 4567899999999999999999999999999999999976532111 112467889999999996 9999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC----CeEEEeccCC
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG----NLKVSDFGLS 176 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~----~lkl~DFGls 176 (451)
....|+||||+.|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999999999975 6799999999999999999999999999999999999999888 7999999999
Q ss_pred CcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCC----C
Q 013005 177 ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP----S 252 (451)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~ 252 (451)
..... .......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+......++ .
T Consensus 167 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (321)
T 2a2a_A 167 HEIED--GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243 (321)
T ss_dssp EECCT--TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred eecCc--cccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc
Confidence 75433 223355679999999999877666 5679999999999999999999999888888888877666655 4
Q ss_pred CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 253 FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 253 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
.++..+.+||.+||..||.+|||++++++||||+...
T Consensus 244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 6889999999999999999999999999999998643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=412.24 Aligned_cols=260 Identities=28% Similarity=0.432 Sum_probs=198.5
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe---
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT--- 101 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~--- 101 (451)
.+.++|++++.||+|+||+||+|++..+++.||||++.+. ..+....+++.+|+.+|+.+. ||||+++++++..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV--FEDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKDV 126 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECST--TSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh--hcCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCCc
Confidence 4568999999999999999999999999999999999653 234455678899999999995 9999999999843
Q ss_pred --CCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 102 --KTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 102 --~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
...+|+||||+. ++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..
T Consensus 127 ~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 127 EKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp TTCCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred ccCceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 357999999984 689998875 6799999999999999999999999999999999999999999999999999976
Q ss_pred chhhhc--------------------------CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh------
Q 013005 179 PEQIKN--------------------------GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA------ 226 (451)
Q Consensus 179 ~~~~~~--------------------------~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~------ 226 (451)
...... ......+||+.|+|||++......+.++|||||||++|+|++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 432111 134556899999999987655555778999999999999998
Q ss_pred -----cCCCCCCCcH--------------------HHHHHHhhc-----------------------c-----C---CCC
Q 013005 227 -----GYLPFDDSNL--------------------LAMYKKVNR-----------------------R-----D---YQF 250 (451)
Q Consensus 227 -----G~~Pf~~~~~--------------------~~~~~~i~~-----------------------~-----~---~~~ 250 (451)
|.+||.+.+. ......+.. . . ...
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 6777765431 111111100 0 0 001
Q ss_pred CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 251 PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 251 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.+..++.+.+||.+||..||.+|||++|+++||||+..
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 13468999999999999999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=382.87 Aligned_cols=261 Identities=32% Similarity=0.611 Sum_probs=224.3
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
..++|++.+.||+|+||.||+|.+..+++.||+|+++.... ....+.+.+|+.+++.+. ||||+++++++.+.+..
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 80 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQ 80 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC---TTHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc---hhhhHHHHHHHHHHHhcC-CCCceeeeeEEEcCCEE
Confidence 46789999999999999999999999999999999975422 234567889999999995 99999999999999999
Q ss_pred EEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh-
Q 013005 106 YLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK- 183 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~- 183 (451)
|+||||+++++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 999999999999999975 579999999999999999999999999999999999999999999999999997543222
Q ss_pred cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH-HHHHHhhccCCCCC--CCCCHhHHH
Q 013005 184 NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL-AMYKKVNRRDYQFP--SFVSKPARS 260 (451)
Q Consensus 184 ~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~-~~~~~i~~~~~~~p--~~~s~~~~~ 260 (451)
.......+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...+.. ..+..+.......+ ..+++.+.+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHH
Confidence 234456789999999999988777677899999999999999999999875432 33333333332222 358999999
Q ss_pred HHHhccCCCCCCCCCHHHHHcCccccchhH
Q 013005 261 LIYQLLDPNPKTRMSIEKIMSISWFQKSLQ 290 (451)
Q Consensus 261 li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 290 (451)
||.+||..||.+|||++++++||||+....
T Consensus 241 li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 241 LLHKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence 999999999999999999999999987543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=414.82 Aligned_cols=258 Identities=27% Similarity=0.454 Sum_probs=212.0
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC--
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK-- 102 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~-- 102 (451)
.+.++|++++.||+|+||+||+|++..+++.||||++.+. ........++.+|+.+++.+. ||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~ 135 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP--FQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKT 135 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG--GGSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCS
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc--ccChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccCCc
Confidence 4578999999999999999999999999999999999764 234455678899999999995 99999999999654
Q ss_pred ----CEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 103 ----TKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 103 ----~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
..+|+||||++++ |.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 136 ~~~~~~~~lv~E~~~~~-l~~~~~-~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 136 LEEFQDVYLVMELMDAN-LCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp TTTCCEEEEEEECCSEE-HHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred cccCCeEEEEEeCCCCC-HHHHHh-hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 4689999999874 655554 3599999999999999999999999999999999999999999999999999975
Q ss_pred chhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC-----------
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD----------- 247 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~----------- 247 (451)
... .......+||+.|+|||++.+..|. .++|||||||++|+|++|+.||.+.+....+.++....
T Consensus 214 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 214 AGT--SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp -----CCCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred cCC--CcccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 433 2345667999999999999888774 66999999999999999999999988776665553310
Q ss_pred ----------------CCCCCC---------------CCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchhH
Q 013005 248 ----------------YQFPSF---------------VSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQ 290 (451)
Q Consensus 248 ----------------~~~p~~---------------~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 290 (451)
..++.. .++.+.+||.+||..||++|||++|+++||||+....
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 364 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 364 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence 000100 1457899999999999999999999999999986543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=419.88 Aligned_cols=262 Identities=36% Similarity=0.632 Sum_probs=229.9
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
....+.++|++.+.||+|+||.||+|.+..+++.||||++.+.. .......+.+.+|+.+++++. ||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~ 97 (484)
T 3nyv_A 20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQ-VKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFED 97 (484)
T ss_dssp CCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEEEC
T ss_pred CCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhh-cccchHHHHHHHHHHHHHhCC-CCCCCcEEEEEEe
Confidence 34567889999999999999999999999999999999997652 122233567889999999995 9999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEe---CCCCCeEEEeccCCC
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL---DRDGNLKVSDFGLSA 177 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILl---d~~~~lkl~DFGls~ 177 (451)
....|+||||+.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 98 KGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 9999999999999999998864 789999999999999999999999999999999999999 567899999999986
Q ss_pred cchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCC----CC
Q 013005 178 LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP----SF 253 (451)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~ 253 (451)
.... .......+||+.|+|||++.+ .| +.++|||||||++|+|++|..||...+.......+....+.++ ..
T Consensus 178 ~~~~--~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 253 (484)
T 3nyv_A 178 HFEA--SKKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK 253 (484)
T ss_dssp HBCC--CCSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGG
T ss_pred Eccc--ccccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCccccc
Confidence 5432 233456689999999999865 34 5679999999999999999999999999888888888766554 34
Q ss_pred CCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 254 VSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 254 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
+++.+.+||.+||..||.+|||++++++||||+...
T Consensus 254 ~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 254 VSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 799999999999999999999999999999998643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=388.59 Aligned_cols=261 Identities=28% Similarity=0.434 Sum_probs=211.6
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcch-hhHHHHHHHHHHHHHHHHhc--CCCCceEEEEEEE
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKF-LDAAMEDRIVREVSAMRRLQ--NHPNVLKIQEVMA 100 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~~Ei~il~~L~--~HpnIv~l~~~~~ 100 (451)
..+.++|++.+.||+|+||+||+|++..+++.||+|++...... ........+.+|+.+++.+. +||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 45678999999999999999999999999999999999753211 01111234567777777664 4999999999998
Q ss_pred eCC-----EEEEEEEecCCCchhHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEe
Q 013005 101 TKT-----KIYLVMEYAAGGELFGKLRRG---RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSD 172 (451)
Q Consensus 101 ~~~-----~~~lV~E~~~gg~L~~~l~~~---~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~D 172 (451)
... ..++||||+. ++|.+++... .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEee
Confidence 765 5899999997 4999998753 399999999999999999999999999999999999999999999999
Q ss_pred ccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC----
Q 013005 173 FGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY---- 248 (451)
Q Consensus 173 FGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~---- 248 (451)
||++..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+......++.....
T Consensus 164 fg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 164 FGLARIYSY--QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp CSCTTTSTT--CCCSGGGGCCCSSCCHHHHHTSCC-CSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred CccccccCC--CcccCCccccccccCchHHcCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 999975432 233456789999999999987776 5679999999999999999999998887776665543110
Q ss_pred -C----------------------CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 249 -Q----------------------FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 249 -~----------------------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
. ..+.+++.+.+||.+||..||.+|||+.|+++||||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 0 113478899999999999999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=418.94 Aligned_cols=262 Identities=26% Similarity=0.405 Sum_probs=229.8
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
+...++|++.+.||+|+||+||+|++..+|+.||+|++.+.. .........+.+|+.+++++. ||||+++++++.+.+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~-~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~ 258 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKR-LKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFETKT 258 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHH-hhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEEeeCC
Confidence 456789999999999999999999999999999999997642 222233457889999999995 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 104 KIYLVMEYAAGGELFGKLRR-----GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~-----~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
..|+||||++||+|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||++..
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 99999999999999998864 3599999999999999999999999999999999999999999999999999975
Q ss_pred chhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCC----cHHHHHHHhhccCCCCCCCC
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS----NLLAMYKKVNRRDYQFPSFV 254 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~----~~~~~~~~i~~~~~~~p~~~ 254 (451)
.... .......+||+.|+|||++.+..| +.++|||||||++|+|++|..||... ....+...+......+|..+
T Consensus 339 ~~~~-~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~ 416 (543)
T 3c4z_A 339 LKAG-QTKTKGYAGTPGFMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKF 416 (543)
T ss_dssp CCTT-CCCBCCCCSCTTTSCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTS
T ss_pred ccCC-CcccccccCCccccChhhhcCCCC-ChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCccc
Confidence 4332 122345699999999999988777 56699999999999999999999865 45677778888888899999
Q ss_pred CHhHHHHHHhccCCCCCCCCC-----HHHHHcCccccchh
Q 013005 255 SKPARSLIYQLLDPNPKTRMS-----IEKIMSISWFQKSL 289 (451)
Q Consensus 255 s~~~~~li~~~L~~dP~~Rpt-----~~eil~hp~f~~~~ 289 (451)
++.+.+||.+||..||.+||+ +++|++||||+...
T Consensus 417 s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~ 456 (543)
T 3c4z_A 417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456 (543)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence 999999999999999999996 58999999998743
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=397.01 Aligned_cols=269 Identities=33% Similarity=0.533 Sum_probs=224.5
Q ss_pred CCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcch-hhHHHHHHHHHHHHHHHHhcCCCCceEEEE
Q 013005 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKF-LDAAMEDRIVREVSAMRRLQNHPNVLKIQE 97 (451)
Q Consensus 19 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~ 97 (451)
....+..+.++|++.+.||+|+||.||+|.+..+++.||+|++.+.... ......+.+.+|+.++++++ ||||+++++
T Consensus 17 q~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~ 95 (345)
T 3hko_A 17 QGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYE 95 (345)
T ss_dssp CCBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEE
T ss_pred cCchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeeh
Confidence 3445567789999999999999999999999999999999999764211 12334568899999999995 999999999
Q ss_pred EEEeCCEEEEEEEecCCCchhHHhhc-----------------------------------------CCCCHHHHHHHHH
Q 013005 98 VMATKTKIYLVMEYAAGGELFGKLRR-----------------------------------------GRLTESAARRYFQ 136 (451)
Q Consensus 98 ~~~~~~~~~lV~E~~~gg~L~~~l~~-----------------------------------------~~l~e~~~~~~~~ 136 (451)
++.+....|+||||++||+|.+++.. ..+++..++.++.
T Consensus 96 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 175 (345)
T 3hko_A 96 VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175 (345)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred hhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence 99999999999999999999998851 1246788999999
Q ss_pred HHHHHHHHHHHCCceecCCCCCeEEeCCCC--CeEEEeccCCCcchhhhc---CcccccCCCCccccceeeecc-CCCCc
Q 013005 137 QLVSALHFCHQNGVAHRDVKPQNLLLDRDG--NLKVSDFGLSALPEQIKN---GMLHTACGTPAYTAPEVVARR-GYDGA 210 (451)
Q Consensus 137 ql~~gL~yLH~~giiHrDLKpeNILld~~~--~lkl~DFGls~~~~~~~~---~~~~~~~gt~~y~APEvl~~~-~~~~~ 210 (451)
||+.||+|||++||+||||||+|||++.++ .+||+|||++........ ......+||+.|+|||++.+. ...+.
T Consensus 176 qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 176 QIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence 999999999999999999999999998776 899999999975433222 124567899999999998652 34467
Q ss_pred cchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCC----CCCHhHHHHHHhccCCCCCCCCCHHHHHcCcccc
Q 013005 211 VADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS----FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQ 286 (451)
Q Consensus 211 ~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~ 286 (451)
++|||||||++|+|++|..||...+.......+......++. .+++.+.+||.+||..||.+|||+.++++||||+
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~ 335 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWIS 335 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhc
Confidence 799999999999999999999998888777777666554442 3789999999999999999999999999999997
Q ss_pred ch
Q 013005 287 KS 288 (451)
Q Consensus 287 ~~ 288 (451)
..
T Consensus 336 ~~ 337 (345)
T 3hko_A 336 QF 337 (345)
T ss_dssp TT
T ss_pred cC
Confidence 63
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=399.57 Aligned_cols=264 Identities=30% Similarity=0.517 Sum_probs=225.2
Q ss_pred cccCCeEEcceEcccCceEEEEEEEc---CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSI---ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
...++|++.+.||+|+||.||+|++. .+++.||||++.+..........+.+.+|+.+++.+.+||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 44589999999999999999999984 589999999997542211122234567899999999779999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
....|+||||+.+|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 9999999999999999999975 789999999999999999999999999999999999999999999999999997544
Q ss_pred hhhcCcccccCCCCccccceeeecc-CCCCccchhhhhhHHHHHHHhcCCCCCCC----cHHHHHHHhhccCCCCCCCCC
Q 013005 181 QIKNGMLHTACGTPAYTAPEVVARR-GYDGAVADAWSCGVILFVLLAGYLPFDDS----NLLAMYKKVNRRDYQFPSFVS 255 (451)
Q Consensus 181 ~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s 255 (451)
..........+||+.|+|||++.+. ...+.++|||||||++|+|++|..||... ........+......+|..++
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 290 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccC
Confidence 3333344567899999999998753 23467799999999999999999999743 345556666666778888899
Q ss_pred HhHHHHHHhccCCCCCCCC-----CHHHHHcCccccch
Q 013005 256 KPARSLIYQLLDPNPKTRM-----SIEKIMSISWFQKS 288 (451)
Q Consensus 256 ~~~~~li~~~L~~dP~~Rp-----t~~eil~hp~f~~~ 288 (451)
..+.+||.+||..||.+|| |++++++||||+..
T Consensus 291 ~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 9999999999999999999 99999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=415.37 Aligned_cols=263 Identities=34% Similarity=0.591 Sum_probs=225.3
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
.....+.++|++++.||+|+||+||+|++..++..||+|++.+... .......+.+|+.+++.+. ||||+++++++.
T Consensus 30 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~ 106 (494)
T 3lij_A 30 SKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV--STSSNSKLLEEVAVLKLLD-HPNIMKLYDFFE 106 (494)
T ss_dssp CCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCC-CTTBCCEEEEEE
T ss_pred cCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEecccc--CchHHHHHHHHHHHHHhCC-CCCCCeEEEEEE
Confidence 3445667789999999999999999999999999999999976521 1122457889999999995 999999999999
Q ss_pred eCCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCC---CCeEEEeccCC
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD---GNLKVSDFGLS 176 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~---~~lkl~DFGls 176 (451)
+....|+|||||.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||++
T Consensus 107 ~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 107 DKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 99999999999999999998864 789999999999999999999999999999999999999764 45999999999
Q ss_pred CcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCC----C
Q 013005 177 ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP----S 252 (451)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~ 252 (451)
..... .......+||+.|+|||++.+ .| +.++||||+||++|+|++|..||.+.+.......+....+.++ .
T Consensus 187 ~~~~~--~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (494)
T 3lij_A 187 AVFEN--QKKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWK 262 (494)
T ss_dssp EECBT--TBCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGT
T ss_pred eECCC--CccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcc
Confidence 76543 233456789999999999853 44 6679999999999999999999999999988888888776654 3
Q ss_pred CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchhH
Q 013005 253 FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQ 290 (451)
Q Consensus 253 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 290 (451)
.+++.+.+||.+||..||.+|||+.++++||||+....
T Consensus 263 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 300 (494)
T 3lij_A 263 NVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCS 300 (494)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHH
T ss_pred cCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCcc
Confidence 47999999999999999999999999999999987543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=389.69 Aligned_cols=253 Identities=26% Similarity=0.439 Sum_probs=221.8
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
.|...+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+++.++ ||||+++++++...+..|+|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 120 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELWVL 120 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CSHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch----hHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEE
Confidence 48888899999999999999999999999999976532 22456889999999995 99999999999999999999
Q ss_pred EEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCccc
Q 013005 109 MEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLH 188 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~ 188 (451)
|||+.|++|.+++...++++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus 121 ~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 199 (321)
T 2c30_A 121 MEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRK 199 (321)
T ss_dssp ECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBC
T ss_pred EecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc-cccc
Confidence 999999999999988899999999999999999999999999999999999999999999999999987543321 2334
Q ss_pred ccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC---CCCCCCCHhHHHHHHhc
Q 013005 189 TACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY---QFPSFVSKPARSLIYQL 265 (451)
Q Consensus 189 ~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~~ 265 (451)
..+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+..... ..+..+++.+.+||.+|
T Consensus 200 ~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 278 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLY-ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM 278 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHH
T ss_pred cccCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHH
Confidence 5689999999999977665 5679999999999999999999998887777766655432 22335789999999999
Q ss_pred cCCCCCCCCCHHHHHcCccccch
Q 013005 266 LDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 266 L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
|..||++|||++++++||||...
T Consensus 279 l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 279 LVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp SCSSTTTSCCHHHHHTSGGGGGC
T ss_pred ccCChhhCcCHHHHhcChhhccC
Confidence 99999999999999999999753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=394.56 Aligned_cols=261 Identities=31% Similarity=0.579 Sum_probs=227.5
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcch----hhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKF----LDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++...... ......+.+.+|+.+++++.+||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 4457899999999999999999999989999999999765321 112345678899999999966999999999999
Q ss_pred eCCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcc
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALP 179 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~ 179 (451)
..+..|+||||++|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 99999999999999999999975 68999999999999999999999999999999999999999999999999998754
Q ss_pred hhhhcCcccccCCCCccccceeeecc-----CCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCC---
Q 013005 180 EQIKNGMLHTACGTPAYTAPEVVARR-----GYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP--- 251 (451)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~APEvl~~~-----~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p--- 251 (451)
.. .......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||...+.......+....+.++
T Consensus 251 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 328 (365)
T 2y7j_A 251 EP--GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE 328 (365)
T ss_dssp CT--TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred CC--CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 33 2334567899999999998632 2346679999999999999999999999888888777777666554
Q ss_pred -CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 252 -SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 252 -~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
..++..+.+||.+||..||.+|||++++++||||++
T Consensus 329 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 329 WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 357899999999999999999999999999999973
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=385.45 Aligned_cols=253 Identities=23% Similarity=0.446 Sum_probs=213.0
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe--CC
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT--KT 103 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~--~~ 103 (451)
..++|++.+.||+|+||.||+|++..+++.||+|++.... .+.+.+|+.+++.+.+||||+++++++.+ ..
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 106 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVSR 106 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence 3678999999999999999999999999999999997542 25688999999999779999999999987 67
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC-CeEEEeccCCCcchhh
Q 013005 104 KIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG-NLKVSDFGLSALPEQI 182 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~-~lkl~DFGls~~~~~~ 182 (451)
..++||||+.+++|.+++. .+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 107 ~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~- 183 (330)
T 3nsz_A 107 TPALVFEHVNNTDFKQLYQ--TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP- 183 (330)
T ss_dssp CEEEEEECCCCCCHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT-
T ss_pred ceEEEEeccCchhHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC-
Confidence 8999999999999999885 489999999999999999999999999999999999999777 899999999975433
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCC-cHHHHHH-------------HhhccCC
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS-NLLAMYK-------------KVNRRDY 248 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~-~~~~~~~-------------~i~~~~~ 248 (451)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||... +...... .+.....
T Consensus 184 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 184 -GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp -TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred -CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 233456789999999999977555677899999999999999999999543 2211111 1111111
Q ss_pred CC------------------------CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 249 QF------------------------PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 249 ~~------------------------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
.. +..+++.+.+||.+||..||.+|||++|+++||||+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 11 122789999999999999999999999999999998643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=394.72 Aligned_cols=257 Identities=27% Similarity=0.445 Sum_probs=210.1
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
+++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++ ||||+++++++.+....|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 76 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLT 76 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCC-CTTBCCEEEEEECSSCEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc---cccchhHHHHHHHHHhcC-CCCCCeeeeEEeeCCEEE
Confidence 4789999999999999999999999999999999975421 112224557999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 107 LVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
+||||+.| +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 77 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~ 154 (324)
T 3mtl_A 77 LVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-T 154 (324)
T ss_dssp EEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred EEeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC-c
Confidence 99999985 88888864 45999999999999999999999999999999999999999999999999998754322 2
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC-----------------
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD----------------- 247 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~----------------- 247 (451)
......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+....
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 334456889999999998775556778999999999999999999999988776655543310
Q ss_pred --CCC-----------CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 248 --YQF-----------PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 248 --~~~-----------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
+.+ ++.+++.+.+||.+||..||.+|||++|+++||||....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 001 124678899999999999999999999999999998654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=387.53 Aligned_cols=263 Identities=32% Similarity=0.620 Sum_probs=224.7
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE--EeC
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM--ATK 102 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~--~~~ 102 (451)
.+.++|++++.||+|+||.||+|.+..+++.||+|++............+.+.+|+.++++++ ||||+++++++ .+.
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 80 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNEEK 80 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC--
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCC
Confidence 467899999999999999999999999999999999976422111234567899999999995 99999999998 445
Q ss_pred CEEEEEEEecCCCchhHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcc
Q 013005 103 TKIYLVMEYAAGGELFGKLR---RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALP 179 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~---~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~ 179 (451)
...|+||||+.++ |.+.+. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 6899999999987 666554 367999999999999999999999999999999999999999999999999999754
Q ss_pred hhhh-cCcccccCCCCccccceeeeccC-CCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHh
Q 013005 180 EQIK-NGMLHTACGTPAYTAPEVVARRG-YDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKP 257 (451)
Q Consensus 180 ~~~~-~~~~~~~~gt~~y~APEvl~~~~-~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 257 (451)
.... ........||+.|+|||++.+.. +.+.++||||||+++|+|++|..||...+.......+......+|..+++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPP 239 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHH
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHH
Confidence 3322 23344667999999999986533 346679999999999999999999999998888888888888889999999
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 258 ARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 258 ~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
+.+||.+||..||.+|||++++++||||++..
T Consensus 240 l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 240 LSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred HHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 99999999999999999999999999998643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=390.99 Aligned_cols=264 Identities=31% Similarity=0.523 Sum_probs=225.9
Q ss_pred CCCcccccCCeEEc-ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE
Q 013005 20 SKKIPTLLNRYQLG-PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 20 ~~~~~~~~~~y~~~-~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
......+.++|.+. +.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.+.+||||++++++
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR--GQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET--TEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 34456778889987 899999999999999999999999999976532 122345788999999999878999999999
Q ss_pred EEeCCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC---CCCeEEEe
Q 013005 99 MATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR---DGNLKVSD 172 (451)
Q Consensus 99 ~~~~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~---~~~lkl~D 172 (451)
+.+....|+||||+.||+|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEee
Confidence 9999999999999999999999853 67999999999999999999999999999999999999988 78999999
Q ss_pred ccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCC-
Q 013005 173 FGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP- 251 (451)
Q Consensus 173 FGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p- 251 (451)
||++...... ......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+....+..+......++
T Consensus 178 fg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 254 (327)
T 3lm5_A 178 FGMSRKIGHA--CELREIMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE 254 (327)
T ss_dssp GGGCEEC-----------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred CccccccCCc--cccccccCCcCccCCeeecCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc
Confidence 9999754332 23345689999999999977766 5679999999999999999999999888877777766554443
Q ss_pred ---CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 252 ---SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 252 ---~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
..+++.+.+||.+||..||.+|||++++++||||+..
T Consensus 255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 255 ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 3578999999999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-49 Score=386.13 Aligned_cols=257 Identities=25% Similarity=0.432 Sum_probs=210.4
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
.....+.++|++.+.||+|+||+||+|++..+++.||||++..... .........+|+..+.++.+||||+++++++.
T Consensus 50 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~ 127 (311)
T 3p1a_A 50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR--GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE 127 (311)
T ss_dssp SSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC--SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc--ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE
Confidence 3344556889999999999999999999999999999999865422 23334455667777777756999999999999
Q ss_pred eCCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
+.+..|+||||+ +++|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 128 ~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 128 EGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred eCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeee
Confidence 999999999999 6688888764 5699999999999999999999999999999999999999999999999999875
Q ss_pred chhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC--CCCCCCCH
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY--QFPSFVSK 256 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~ 256 (451)
... .......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||..... +..+..... .++..+++
T Consensus 207 ~~~--~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 279 (311)
T 3p1a_A 207 LGT--AGAGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSS 279 (311)
T ss_dssp CC--------CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCH
T ss_pred ccc--CCCCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCH
Confidence 433 223345679999999999865 44 6779999999999999999776655332 222222221 23456899
Q ss_pred hHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 257 PARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
.+.+||.+||..||++|||++++++||||++
T Consensus 280 ~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 280 ELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 9999999999999999999999999999975
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=401.75 Aligned_cols=263 Identities=27% Similarity=0.418 Sum_probs=211.3
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
..-.+.++|++.+.||+|+||.||+|++..+++.||||++... .......+++.+|+.+++.++ ||||+++++++..
T Consensus 20 ~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~ 96 (432)
T 3n9x_A 20 KNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM--FEDLIDCKRILREITILNRLK-SDYIIRLYDLIIP 96 (432)
T ss_dssp GGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST--TTSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCC
T ss_pred CcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch--hcChHHHHHHHHHHHHHHHcC-CCCcceEEEEEec
Confidence 3446788999999999999999999999999999999999753 234455678899999999996 9999999999976
Q ss_pred C-----CEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccC
Q 013005 102 K-----TKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGL 175 (451)
Q Consensus 102 ~-----~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGl 175 (451)
. ...|+||||+. |+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 97 DDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp SCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 6 57999999986 599999986 5699999999999999999999999999999999999999999999999999
Q ss_pred CCcchhhhc---------------------CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCC-----
Q 013005 176 SALPEQIKN---------------------GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYL----- 229 (451)
Q Consensus 176 s~~~~~~~~---------------------~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~----- 229 (451)
+........ ......+||+.|+|||++......+.++||||+||++|+|++|..
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 255 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence 976433211 124677899999999997655555778999999999999998544
Q ss_pred ------CCCCCc-----------------HHHHHHH------------------------hhccCCCCC-------CCCC
Q 013005 230 ------PFDDSN-----------------LLAMYKK------------------------VNRRDYQFP-------SFVS 255 (451)
Q Consensus 230 ------Pf~~~~-----------------~~~~~~~------------------------i~~~~~~~p-------~~~s 255 (451)
+|.+.+ ....... +.......+ +.++
T Consensus 256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 335 (432)
T 3n9x_A 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS 335 (432)
T ss_dssp GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence 443322 0111111 111111111 3479
Q ss_pred HhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 256 KPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 256 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+.+.+||.+||..||.+|||++|+++||||+..
T Consensus 336 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 368 (432)
T 3n9x_A 336 DDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368 (432)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence 999999999999999999999999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=377.63 Aligned_cols=255 Identities=21% Similarity=0.304 Sum_probs=215.7
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
....++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+..+..+.+||||+++++++.+.+
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~ 84 (289)
T 1x8b_A 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA--GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD 84 (289)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT--TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 3456899999999999999999999999999999999986422 23345678899999999956999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCC-------------
Q 013005 104 KIYLVMEYAAGGELFGKLRR-----GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD------------- 165 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~-----~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~------------- 165 (451)
..|+||||++|++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 99999999999999999964 669999999999999999999999999999999999999844
Q ss_pred ------CCeEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHH
Q 013005 166 ------GNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAM 239 (451)
Q Consensus 166 ------~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~ 239 (451)
..+||+|||++..... ....+||+.|+|||++.+....+.++|||||||++|+|++|..|+......
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-- 237 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISS-----PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW-- 237 (289)
T ss_dssp -----CCCEEECCCTTCEETTC-----SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH--
T ss_pred cccCCceEEEEcccccccccCC-----ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH--
Confidence 4799999999875432 234569999999999977655567899999999999999999887655433
Q ss_pred HHHhhcc-CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 240 YKKVNRR-DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 240 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
..+... ...+|..+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 238 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 238 -HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp -HHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred -HHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 223322 345677899999999999999999999999999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=393.48 Aligned_cols=261 Identities=25% Similarity=0.426 Sum_probs=221.0
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC-
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK- 102 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~- 102 (451)
-.+.++|++.+.||+|+||.||+|++..+++.||||++.... .......+.+|+.++++++ ||||+++++++...
T Consensus 23 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 98 (364)
T 3qyz_A 23 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPT 98 (364)
T ss_dssp CCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT---CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSS
T ss_pred ccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc---CcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCC
Confidence 344579999999999999999999999999999999997532 3345567889999999995 99999999999755
Q ss_pred ----CEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 103 ----TKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 103 ----~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
...|+||||+.| +|.+++..+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 99 ~~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 99 IEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp TTTCCCEEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ccccceEEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 479999999975 999999988999999999999999999999999999999999999999999999999999976
Q ss_pred chhhhc--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc----------
Q 013005 179 PEQIKN--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR---------- 246 (451)
Q Consensus 179 ~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~---------- 246 (451)
...... ......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 543322 23456689999999999876665577899999999999999999999887655444433210
Q ss_pred ----------------CC-----CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 247 ----------------DY-----QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 247 ----------------~~-----~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
.. .+.+.+++.+.+||.+||..||.+|||++++++||||+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 00 01244788999999999999999999999999999998753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-49 Score=389.54 Aligned_cols=262 Identities=24% Similarity=0.426 Sum_probs=219.1
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
.-..+++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+.+|+.+++++. ||||+++++++.+.
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 96 (331)
T 4aaa_A 20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKK 96 (331)
T ss_dssp CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS--SCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEET
T ss_pred hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC--CchHHHHHHHHHHHHHhhCC-CCCEeeEEEEeecC
Confidence 3456889999999999999999999999999999999987642 23445667889999999996 99999999999999
Q ss_pred CEEEEEEEecCCCchhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 103 TKIYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~-~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
+..|+||||+++++|.++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999999999999988876 47899999999999999999999999999999999999999999999999999975433
Q ss_pred hhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc---------------
Q 013005 182 IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR--------------- 246 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~--------------- 246 (451)
. .......+||+.|+|||++.+....+.++|||||||++|+|++|..||...+.......+...
T Consensus 177 ~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 177 P-GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred C-ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 2 233456689999999999977655677899999999999999999999987765544433210
Q ss_pred ----CCCCC------------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 247 ----DYQFP------------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 247 ----~~~~p------------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
....| +.+++.+.+||.+||..||.+|||++|+++||||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 11111 2468899999999999999999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=393.44 Aligned_cols=260 Identities=26% Similarity=0.400 Sum_probs=217.0
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe---
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT--- 101 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~--- 101 (451)
...++|++.+.||+|+||.||+|++..+|+.||+|++..... .......+.+|+.+++.++ ||||+++++++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 90 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLK-HENVVNLIEICRTKAS 90 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC--SSSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC--
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc--cccchHHHHHHHHHHHhcc-CCCcccHhheeecccc
Confidence 356899999999999999999999999999999999866532 1222345678999999996 9999999999977
Q ss_pred -----CCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEecc
Q 013005 102 -----KTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFG 174 (451)
Q Consensus 102 -----~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFG 174 (451)
.+..|+||||+.+ +|.+.+.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp ------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccch
Confidence 4578999999986 77776654 679999999999999999999999999999999999999999999999999
Q ss_pred CCCcchhh---hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCC
Q 013005 175 LSALPEQI---KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP 251 (451)
Q Consensus 175 ls~~~~~~---~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p 251 (451)
++...... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||...+.......+......++
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99754321 123345678999999999987766557789999999999999999999999887766665544222111
Q ss_pred CC--------------------------------CCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 252 SF--------------------------------VSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 252 ~~--------------------------------~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+. .++.+.+||.+||..||.+|||++|+++||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 11 26779999999999999999999999999999764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-50 Score=398.05 Aligned_cols=256 Identities=31% Similarity=0.514 Sum_probs=222.0
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchh----hHHHHHHHHHHHHHHHHhcCCCCceEEEEEE
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFL----DAAMEDRIVREVSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~----~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~ 99 (451)
+...++|++.+.||+|+||.||+|++..+++.||||++....... .......+.+|+.+++++. ||||+++++++
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~ 98 (335)
T 3dls_A 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIF 98 (335)
T ss_dssp THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEEEE
T ss_pred cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEE
Confidence 456789999999999999999999999999999999998652111 0112335678999999995 99999999999
Q ss_pred EeCCEEEEEEEecCCC-chhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 100 ATKTKIYLVMEYAAGG-ELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 100 ~~~~~~~lV~E~~~gg-~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
.+.+..|+||||+.+| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 99 ~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 99 ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp ECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 9999999999999776 99999976 579999999999999999999999999999999999999999999999999997
Q ss_pred cchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHh
Q 013005 178 LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKP 257 (451)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 257 (451)
.... .......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.... .........|..+++.
T Consensus 179 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~ 250 (335)
T 3dls_A 179 YLER--GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHPPYLVSKE 250 (335)
T ss_dssp ECCT--TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGTTTCCCCSSCCCHH
T ss_pred ECCC--CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------HHHhhccCCCcccCHH
Confidence 5433 2334567899999999999888887888999999999999999999997632 2233445566778999
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 258 ARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 258 ~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+.+||.+||.+||.+|||++++++||||+..
T Consensus 251 l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 251 LMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 9999999999999999999999999999763
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=382.95 Aligned_cols=256 Identities=35% Similarity=0.718 Sum_probs=224.0
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
..+.++|.+.+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++++. ||||+++++++.+..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 79 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA----FRDSSLENEIAVLKKIK-HENIVTLEDIYESTT 79 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc----cchHHHHHHHHHHHhCC-CCCeeehhhhcccCC
Confidence 4567899999999999999999999999999999999976521 22356889999999995 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEe---CCCCCeEEEeccCCCcc
Q 013005 104 KIYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL---DRDGNLKVSDFGLSALP 179 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~-~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILl---d~~~~lkl~DFGls~~~ 179 (451)
..|+||||++|++|.+++. .+.+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 80 HYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred EEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 9999999999999999886 4789999999999999999999999999999999999999 78899999999998753
Q ss_pred hhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCC----CCCC
Q 013005 180 EQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP----SFVS 255 (451)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 255 (451)
.. ......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+.......+......++ ..++
T Consensus 160 ~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (304)
T 2jam_A 160 QN---GIMSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDIS 235 (304)
T ss_dssp CC---BTTHHHHSCCCBCCTTTBSSCSC-CHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSC
T ss_pred CC---CccccccCCCCccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCC
Confidence 32 23345679999999999977666 5679999999999999999999999888888888777655443 4578
Q ss_pred HhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 256 KPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 256 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+.+.+||.+||..||.+|||++++++||||+..
T Consensus 236 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 236 ESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 999999999999999999999999999999753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=377.48 Aligned_cols=259 Identities=33% Similarity=0.598 Sum_probs=223.3
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhh--HHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLD--AAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
+.++|++.+.||+|+||.||+|.+..+++.||+|++........ ....+.+.+|+.+++++. ||||+++++++.+..
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFENKT 81 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheecCCC
Confidence 45789999999999999999999999999999999976522111 112467889999999996 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC----CeEEEeccCCCc
Q 013005 104 KIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG----NLKVSDFGLSAL 178 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~----~lkl~DFGls~~ 178 (451)
..|+||||+++++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 99999999999999999974 7899999999999999999999999999999999999998887 899999999875
Q ss_pred chhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCC----CCC
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP----SFV 254 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~ 254 (451)
.... ......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+......++ ..+
T Consensus 162 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T 3bhy_A 162 IEAG--NEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT 238 (283)
T ss_dssp CC----------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred ccCC--CcccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccC
Confidence 4331 22345679999999999876665 5679999999999999999999999888888777776665554 457
Q ss_pred CHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 255 SKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 255 s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+..+.+||.+||..||.+|||+.++++||||+..
T Consensus 239 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 8999999999999999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=395.18 Aligned_cols=262 Identities=25% Similarity=0.435 Sum_probs=217.1
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcC-CCCceEEEEEEEe
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN-HPNVLKIQEVMAT 101 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~-HpnIv~l~~~~~~ 101 (451)
+.....+|++.+.||+|+||+||+|.+. +++.||||++.... ......+.+.+|+.++++|.+ ||||+++++++..
T Consensus 51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~ 127 (390)
T 2zmd_A 51 ISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE--ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 127 (390)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred ccccCCceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEeccc--ccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec
Confidence 3444567999999999999999999975 49999999997653 234556789999999999974 6999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
.+.+|+||| +.+++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 128 ~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 128 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp SSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred CCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 999999999 568899999975 6799999999999999999999999999999999999995 5899999999998654
Q ss_pred hhhc-CcccccCCCCccccceeeecc----------CCCCccchhhhhhHHHHHHHhcCCCCCCC-cHHHHHHHhhcc--
Q 013005 181 QIKN-GMLHTACGTPAYTAPEVVARR----------GYDGAVADAWSCGVILFVLLAGYLPFDDS-NLLAMYKKVNRR-- 246 (451)
Q Consensus 181 ~~~~-~~~~~~~gt~~y~APEvl~~~----------~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~-~~~~~~~~i~~~-- 246 (451)
.... ......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||... +.......+...
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~ 285 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 285 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTS
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccc
Confidence 3322 234567899999999998652 23467799999999999999999999864 333444444433
Q ss_pred CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 247 DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 247 ~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
...+|.+.+..+.+||.+||..||.+|||+.++++||||+...
T Consensus 286 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 286 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 3456778899999999999999999999999999999998643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=379.09 Aligned_cols=260 Identities=25% Similarity=0.430 Sum_probs=227.9
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
.....+.|++.+.||+|+||.||+|++..+++.||+|++..... ....+.+.+|+.+++.+. ||||+++++++...
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 92 (303)
T 3a7i_A 17 KADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKD 92 (303)
T ss_dssp EECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC---STTHHHHHHHHHHHHHCC-CTTBCCEEEEEEET
T ss_pred CCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc---HHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecC
Confidence 34566789999999999999999999999999999999976532 223567889999999995 99999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 103 TKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
...|+||||++|++|.+++..+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 93 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 93 TKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp TEEEEEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred CeEEEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 99999999999999999999899999999999999999999999999999999999999999999999999999754332
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhHHHH
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPARSL 261 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 261 (451)
. ......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+... ...++..++..+.+|
T Consensus 173 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 250 (303)
T 3a7i_A 173 Q-IKRNTFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEF 250 (303)
T ss_dssp B-CCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHH
T ss_pred c-cccCccCCCcCccCHHHHhcCCC-CchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHH
Confidence 1 22345679999999999977666 46799999999999999999999988777666555443 335566789999999
Q ss_pred HHhccCCCCCCCCCHHHHHcCccccch
Q 013005 262 IYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 262 i~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
|.+||..||.+|||++++++||||...
T Consensus 251 i~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 251 VEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp HHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 999999999999999999999999754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=379.32 Aligned_cols=260 Identities=25% Similarity=0.360 Sum_probs=216.2
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
...+.++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+.+|+.+++++. ||||+++++++.+.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~ 83 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPP-REKEETLKRFEREVHNSSQLS-HQNIVSMIDVDEED 83 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCS-SCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEEECS
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCc-cccHHHHHHHHHHHHHHhcCC-CCCCceEEEeeeeC
Confidence 3466789999999999999999999999999999999997652 234456678999999999995 99999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 103 TKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
+..|+||||++|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 999999999999999999975 7899999999999999999999999999999999999999999999999999986544
Q ss_pred hhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC-----CCCCCCCH
Q 013005 182 IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY-----QFPSFVSK 256 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~-----~~p~~~s~ 256 (451)
.........+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+......+...... ..+..+++
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242 (294)
T ss_dssp -----------CCSSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred ccccccCccccCccccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence 33334455689999999999987766 5669999999999999999999998877665544443322 23456899
Q ss_pred hHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 257 PARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
.+.++|.+||..||.+||+..+.+.+.|.
T Consensus 243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 243 SLSNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp HHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 99999999999999999955555555554
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=388.97 Aligned_cols=263 Identities=29% Similarity=0.447 Sum_probs=218.9
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
....+.++|++.+.||+|+||.||+|.+..+++.||||++... ...+......+.+|+.+++++. ||||+++++++..
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 83 (311)
T 3ork_A 6 TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRAD-LARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEA 83 (311)
T ss_dssp CCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTT-TTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEEE
T ss_pred CcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcc-ccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeeec
Confidence 3456789999999999999999999999999999999999765 2334455678899999999995 9999999999876
Q ss_pred CC----EEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCC
Q 013005 102 KT----KIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176 (451)
Q Consensus 102 ~~----~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls 176 (451)
.. ..|+||||++|++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 84 ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 54 35999999999999999974 78999999999999999999999999999999999999999999999999999
Q ss_pred Ccchhhhc--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCC---
Q 013005 177 ALPEQIKN--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP--- 251 (451)
Q Consensus 177 ~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p--- 251 (451)
........ ......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.......+
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 242 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHH
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccc
Confidence 76543222 22344679999999999987766 5679999999999999999999998887766655554443322
Q ss_pred -CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 252 -SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 252 -~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
..++..+.+||.+||..||.+||+..+++.|+|++.
T Consensus 243 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 458999999999999999999999999999999975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=386.54 Aligned_cols=262 Identities=26% Similarity=0.454 Sum_probs=214.9
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCC-CCceEEEEEEE
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH-PNVLKIQEVMA 100 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~H-pnIv~l~~~~~ 100 (451)
.+....++|++.+.||+|+||.||+|.+ .+++.||||++.... ......+.+.+|+.+++++.+| |||+++++++.
T Consensus 3 ~i~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 79 (343)
T 3dbq_A 3 CISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE--ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 79 (343)
T ss_dssp CEESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred eeeeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccc--cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe
Confidence 3456678899999999999999999987 578999999997652 2345567889999999999733 99999999999
Q ss_pred eCCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcc
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALP 179 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~ 179 (451)
+....|+||| +.+++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 80 ~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 80 TDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred eCCEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 9999999999 567899999975 6799999999999999999999999999999999999996 678999999999865
Q ss_pred hhhhc-CcccccCCCCccccceeeec----------cCCCCccchhhhhhHHHHHHHhcCCCCCCC-cHHHHHHHhhc--
Q 013005 180 EQIKN-GMLHTACGTPAYTAPEVVAR----------RGYDGAVADAWSCGVILFVLLAGYLPFDDS-NLLAMYKKVNR-- 245 (451)
Q Consensus 180 ~~~~~-~~~~~~~gt~~y~APEvl~~----------~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~-~~~~~~~~i~~-- 245 (451)
..... ......+||+.|+|||++.+ ....+.++|||||||++|+|++|..||... +.......+..
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 237 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 237 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCC
Confidence 43322 23346789999999999864 134467799999999999999999999864 33333333332
Q ss_pred cCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 246 RDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 246 ~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
....+|...+..+.+||.+||..||.+|||+.++++||||+..
T Consensus 238 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 238 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 3446677788999999999999999999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=399.94 Aligned_cols=262 Identities=34% Similarity=0.612 Sum_probs=209.6
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchh----hHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFL----DAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~----~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
.+.++|.+.+.||+|+||+||+|.+..+++.||||++.+..... .......+.+|+.+++++. ||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~ 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFD 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC-CTTBCCCCEEEE
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC-CCCEeeEEEEEe
Confidence 45689999999999999999999999999999999998652111 1122335789999999995 999999999975
Q ss_pred eCCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC---CeEEEeccCC
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG---NLKVSDFGLS 176 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~---~lkl~DFGls 176 (451)
....|+||||+.+|+|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred -cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 4568999999999999998874 7899999999999999999999999999999999999997654 5999999999
Q ss_pred CcchhhhcCcccccCCCCccccceeeec--cCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH-HHHHHhhccCCCCC--
Q 013005 177 ALPEQIKNGMLHTACGTPAYTAPEVVAR--RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL-AMYKKVNRRDYQFP-- 251 (451)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~APEvl~~--~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~-~~~~~i~~~~~~~p-- 251 (451)
..... .....+.+||+.|+|||++.+ ....+.++|||||||++|+|++|..||...... .....+....+.++
T Consensus 290 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~ 367 (419)
T 3i6u_A 290 KILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 367 (419)
T ss_dssp TSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHH
T ss_pred eecCC--CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCch
Confidence 86543 233456789999999999854 233356799999999999999999999764332 34444555544443
Q ss_pred --CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchhH
Q 013005 252 --SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQ 290 (451)
Q Consensus 252 --~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 290 (451)
..+++.+.+||.+||..||.+|||++++++||||+....
T Consensus 368 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 408 (419)
T 3i6u_A 368 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 408 (419)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHH
T ss_pred hhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhH
Confidence 357999999999999999999999999999999987543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=390.31 Aligned_cols=263 Identities=29% Similarity=0.416 Sum_probs=212.9
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchh-hHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFL-DAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
+....++|++.+.||+|+||.||+|.+..+|+.||||++....... .......+.+|+.+++.+. ||||+++++++.+
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGH 83 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECC
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEEee
Confidence 4566789999999999999999999999999999999997542211 1122346789999999995 9999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcc
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALP 179 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~ 179 (451)
.+..|+||||+.+ +|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999999999986 88888865 46999999999999999999999999999999999999999999999999999765
Q ss_pred hhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC-----CC----
Q 013005 180 EQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY-----QF---- 250 (451)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~-----~~---- 250 (451)
... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+....+..+..... .+
T Consensus 163 ~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (346)
T 1ua2_A 163 GSP-NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241 (346)
T ss_dssp TSC-CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred cCC-cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence 332 23345678999999999987666557789999999999999999999998887766665543100 00
Q ss_pred -------------------CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 251 -------------------PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 251 -------------------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
...++..+.+||.+||..||.+|||++|+++||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 13457899999999999999999999999999999764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=392.10 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=208.6
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC-
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT- 103 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~- 103 (451)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+.+|+.+++.+. ||||+++++++....
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 98 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKS 98 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT--SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCCS
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc--CChHHHHHHHHHHHHHHhcC-CCCccceEEeeccccc
Confidence 46789999999999999999999999999999999997642 23455677889999999995 999999999997655
Q ss_pred -----EEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 104 -----KIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 104 -----~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
..|+||||+.+ +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 99 ~~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 99 LEEFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp TTTCCEEEEEEECCSE-EHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred cccccceEEEEEcCCC-CHHHHHh-hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 79999999975 6777775 5699999999999999999999999999999999999999999999999999975
Q ss_pred chhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC----------
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY---------- 248 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~---------- 248 (451)
... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 177 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 177 AGT--SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ---------------CTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred ccc--ccccCCceecCCccCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 432 223445789999999999988766 5669999999999999999999998887766665543211
Q ss_pred ------------CC--------------CCC------CCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchhH
Q 013005 249 ------------QF--------------PSF------VSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQ 290 (451)
Q Consensus 249 ------------~~--------------p~~------~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 290 (451)
.+ |.. .+..+.+||.+||..||.+|||++++++||||+....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 327 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 327 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence 00 100 1467899999999999999999999999999986543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=394.42 Aligned_cols=257 Identities=25% Similarity=0.389 Sum_probs=202.3
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC-
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK- 102 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~- 102 (451)
-.+.++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++ ||||+++++++...
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 101 (367)
T 2fst_X 25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPAR 101 (367)
T ss_dssp EEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCS
T ss_pred cCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCC
Confidence 355689999999999999999999999999999999997532 23445677889999999996 99999999998654
Q ss_pred -----CEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 103 -----TKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 103 -----~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
...|+|+||+ +++|.+++..+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 102 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 102 SLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp SGGGCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred ccccCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 5689999999 7899999988899999999999999999999999999999999999999999999999999997
Q ss_pred cchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc-----------
Q 013005 178 LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR----------- 246 (451)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~----------- 246 (451)
.... .....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+...
T Consensus 181 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 181 HTAD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred cccc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 5432 2345689999999999887555577899999999999999999999988776555544321
Q ss_pred ------------CCCC--------CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 247 ------------DYQF--------PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 247 ------------~~~~--------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.... .+..++.+.+||.+||..||.+|||++++++||||+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 0001 12367889999999999999999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=386.87 Aligned_cols=255 Identities=24% Similarity=0.381 Sum_probs=219.2
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
..++|++.+.||+|+||.||+|++..+++.||||++.... .......+.+.+|+.++++++ ||||+++++++...+..
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 129 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTA 129 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCS-SCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEcccc-ccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCeE
Confidence 3456999999999999999999999999999999997652 233445567899999999995 99999999999999999
Q ss_pred EEEEEecCCCchhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 106 YLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~--~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
|+||||+. |+|.+.+. .+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 130 ~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-- 206 (348)
T 1u5q_A 130 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 206 (348)
T ss_dssp EEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence 99999997 57777774 46899999999999999999999999999999999999999999999999999975432
Q ss_pred cCcccccCCCCccccceeeec--cCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC--CCCCCCCHhHH
Q 013005 184 NGMLHTACGTPAYTAPEVVAR--RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY--QFPSFVSKPAR 259 (451)
Q Consensus 184 ~~~~~~~~gt~~y~APEvl~~--~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~ 259 (451)
....+||+.|+|||++.. ....+.++|||||||++|+|++|..||...+.......+..... ..+..+++.+.
T Consensus 207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 283 (348)
T 1u5q_A 207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR 283 (348)
T ss_dssp ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHH
T ss_pred ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 245689999999999852 23346679999999999999999999998877665555554432 22446799999
Q ss_pred HHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 260 SLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 260 ~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+||.+||..||++|||++++++||||...
T Consensus 284 ~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 284 NFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp HHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 99999999999999999999999999764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=393.76 Aligned_cols=254 Identities=27% Similarity=0.417 Sum_probs=210.7
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe-
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT- 101 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~- 101 (451)
+....++|++++.||+|+||+||+|++..+|+.||||++..+.. ...+|+.+++.+. ||||+++++++..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--------~~~~E~~il~~l~-hpnIv~l~~~~~~~ 72 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR--------YKNRELDIMKVLD-HVNIIKLVDYFYTT 72 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHTTCC-CTTBCCEEEEEEEC
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc--------hHHHHHHHHHHcC-CCCccchhheeeec
Confidence 34567899999999999999999999999999999999976532 1237999999995 9999999999843
Q ss_pred -------------------------------------CCEEEEEEEecCCCchhHHhh-----cCCCCHHHHHHHHHHHH
Q 013005 102 -------------------------------------KTKIYLVMEYAAGGELFGKLR-----RGRLTESAARRYFQQLV 139 (451)
Q Consensus 102 -------------------------------------~~~~~lV~E~~~gg~L~~~l~-----~~~l~e~~~~~~~~ql~ 139 (451)
....++||||++| +|.+.+. .+.+++..++.++.||+
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~ 151 (383)
T 3eb0_A 73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLF 151 (383)
T ss_dssp -------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence 3458999999985 7666554 26799999999999999
Q ss_pred HHHHHHHHCCceecCCCCCeEEeC-CCCCeEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhh
Q 013005 140 SALHFCHQNGVAHRDVKPQNLLLD-RDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCG 218 (451)
Q Consensus 140 ~gL~yLH~~giiHrDLKpeNILld-~~~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlG 218 (451)
.||.|||++||+||||||+|||++ .++.+||+|||++..... .......+||+.|+|||++.+....+.++||||+|
T Consensus 152 ~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 229 (383)
T 3eb0_A 152 RAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP--SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229 (383)
T ss_dssp HHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT--TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred HHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC--CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence 999999999999999999999998 688999999999975433 23345668899999999988766567789999999
Q ss_pred HHHHHHHhcCCCCCCCcHHHHHHHhhcc-----------------CCC------------CCCCCCHhHHHHHHhccCCC
Q 013005 219 VILFVLLAGYLPFDDSNLLAMYKKVNRR-----------------DYQ------------FPSFVSKPARSLIYQLLDPN 269 (451)
Q Consensus 219 vil~~Ll~G~~Pf~~~~~~~~~~~i~~~-----------------~~~------------~p~~~s~~~~~li~~~L~~d 269 (451)
|++|+|++|..||.+.+.......+... ... +|...++.+.+||.+||..|
T Consensus 230 ~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 230 CVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 9999999999999988776655554321 111 34557889999999999999
Q ss_pred CCCCCCHHHHHcCccccch
Q 013005 270 PKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 270 P~~Rpt~~eil~hp~f~~~ 288 (451)
|.+|||+.|+++||||+..
T Consensus 310 P~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 310 PDLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp GGGSCCHHHHHTSGGGHHH
T ss_pred hhhCCCHHHHhcCHHHHHH
Confidence 9999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=385.39 Aligned_cols=263 Identities=25% Similarity=0.407 Sum_probs=219.6
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
.....+.++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++ ||||+++++++.
T Consensus 4 ~~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 79 (353)
T 2b9h_A 4 RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD---KPLFALRTLREIKILKHFK-HENIITIFNIQR 79 (353)
T ss_dssp TCCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS---SHHHHHHHHHHHHHHHHCC-CTTBCCEEEECC
T ss_pred ccccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc---cchHHHHHHHHHHHHHhCc-CCCcCCeeeeec
Confidence 345567899999999999999999999999999999999996542 3345567889999999995 999999999986
Q ss_pred eC-----CEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccC
Q 013005 101 TK-----TKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGL 175 (451)
Q Consensus 101 ~~-----~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGl 175 (451)
.. ...|+||||+. ++|.+++..+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 80 PDSFENFNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp CSCSTTCCCEEEEECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred ccccCccceEEEEEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 54 67999999997 5899999888999999999999999999999999999999999999999999999999999
Q ss_pred CCcchhhhc---------CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc
Q 013005 176 SALPEQIKN---------GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR 246 (451)
Q Consensus 176 s~~~~~~~~---------~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~ 246 (451)
+........ ......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 238 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence 975432111 11234589999999999876555678899999999999999999999987765444333210
Q ss_pred ------------------------CCC--------CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 247 ------------------------DYQ--------FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 247 ------------------------~~~--------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
... .++.+++.+.+||.+||..||.+|||++++++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 000 113578999999999999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=380.06 Aligned_cols=265 Identities=25% Similarity=0.402 Sum_probs=219.1
Q ss_pred CCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE
Q 013005 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 19 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
....+....++|++.+.||+|+||.||+|.+..+++.||||++..... ..+.+.+|+.+++++.+||||++++++
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~~h~~i~~~~~~ 89 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-----EEEEIKQEINMLKKYSHHRNIATYYGA 89 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----TTHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-----cHHHHHHHHHHHHhccCCCCeeeeeeE
Confidence 455667789999999999999999999999999999999999976522 235678999999999669999999999
Q ss_pred EEe------CCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeE
Q 013005 99 MAT------KTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLK 169 (451)
Q Consensus 99 ~~~------~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lk 169 (451)
+.. ....|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp EEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEE
T ss_pred EeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEE
Confidence 977 5689999999999999999974 5799999999999999999999999999999999999999999999
Q ss_pred EEeccCCCcchhhhcCcccccCCCCccccceeeec----cCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhc
Q 013005 170 VSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVAR----RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNR 245 (451)
Q Consensus 170 l~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~----~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~ 245 (451)
|+|||++....... ......+||+.|+|||++.. ....+.++|||||||++|+|++|..||...+.......+..
T Consensus 170 l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 248 (326)
T 2x7f_A 170 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 248 (326)
T ss_dssp ECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred EeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc
Confidence 99999987643321 22345679999999999862 23346679999999999999999999988777666555544
Q ss_pred cCC--CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 246 RDY--QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 246 ~~~--~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
... ..+..++..+.+||.+||..||.+|||++++++||||+...
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 249 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp SCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred CccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 332 22356799999999999999999999999999999998643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=397.41 Aligned_cols=256 Identities=25% Similarity=0.407 Sum_probs=214.9
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhc-----CCCCceEEEEE
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ-----NHPNVLKIQEV 98 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~-----~HpnIv~l~~~ 98 (451)
..+.++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.++ +|+||++++++
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~ 167 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN 167 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-----chHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence 466789999999999999999999999999999999997542 33456778888888885 47899999999
Q ss_pred EEeCCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCC--eEEEec
Q 013005 99 MATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN--LKVSDF 173 (451)
Q Consensus 99 ~~~~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~--lkl~DF 173 (451)
+......|+||||+. ++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+||
T Consensus 168 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 168 FTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp EEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred cccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeec
Confidence 999999999999996 589888864 34999999999999999999999999999999999999999987 999999
Q ss_pred cCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC------
Q 013005 174 GLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD------ 247 (451)
Q Consensus 174 Gls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~------ 247 (451)
|+|.... ....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||...+.......+....
T Consensus 247 G~a~~~~----~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~ 321 (429)
T 3kvw_A 247 GSSCYEH----QRVYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQK 321 (429)
T ss_dssp TTCEETT----CCCCSSCSCGGGCCHHHHHTBCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ccceecC----CcccccCCCCCccChHHHhCCCC-CchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 9996432 33456789999999999988777 567999999999999999999999887765554432110
Q ss_pred --------------CC---------------------------------------CCCCCCHhHHHHHHhccCCCCCCCC
Q 013005 248 --------------YQ---------------------------------------FPSFVSKPARSLIYQLLDPNPKTRM 274 (451)
Q Consensus 248 --------------~~---------------------------------------~p~~~s~~~~~li~~~L~~dP~~Rp 274 (451)
.. ++...++.+.+||.+||..||.+||
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp 401 (429)
T 3kvw_A 322 LLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM 401 (429)
T ss_dssp HHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC
T ss_pred HHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC
Confidence 00 1112377899999999999999999
Q ss_pred CHHHHHcCccccchhH
Q 013005 275 SIEKIMSISWFQKSLQ 290 (451)
Q Consensus 275 t~~eil~hp~f~~~~~ 290 (451)
|++|+++||||++...
T Consensus 402 ta~e~L~Hpw~~~~~~ 417 (429)
T 3kvw_A 402 TPGQALRHPWLRRRLP 417 (429)
T ss_dssp CHHHHHTSTTTC----
T ss_pred CHHHHhCChhhccCCC
Confidence 9999999999987643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=372.95 Aligned_cols=257 Identities=24% Similarity=0.430 Sum_probs=218.5
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe-
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT- 101 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~- 101 (451)
.......|.+.+.||+|+||.||+|.+..++..||+|++.... ......+.+.+|+.+++++. ||||+++++++..
T Consensus 21 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 97 (290)
T 1t4h_A 21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--LTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWEST 97 (290)
T ss_dssp ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEE
T ss_pred cccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchh--hCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeeccc
Confidence 3444556899999999999999999999999999999997642 23455678899999999995 9999999999875
Q ss_pred ---CCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCeEEeC-CCCCeEEEecc
Q 013005 102 ---KTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNG--VAHRDVKPQNLLLD-RDGNLKVSDFG 174 (451)
Q Consensus 102 ---~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~g--iiHrDLKpeNILld-~~~~lkl~DFG 174 (451)
....|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 98 VKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp SSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred cCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 4568999999999999999986 78999999999999999999999999 99999999999998 78999999999
Q ss_pred CCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCC-cHHHHHHHhhccC--CCCC
Q 013005 175 LSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS-NLLAMYKKVNRRD--YQFP 251 (451)
Q Consensus 175 ls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~-~~~~~~~~i~~~~--~~~p 251 (451)
++..... ......+||+.|+|||++.+ . .+.++||||||+++|+|++|..||... +....+..+.... ..++
T Consensus 178 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~-~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (290)
T 1t4h_A 178 LATLKRA---SFAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 252 (290)
T ss_dssp GGGGCCT---TSBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG
T ss_pred Ccccccc---cccccccCCcCcCCHHHHhc-c-CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccC
Confidence 9864322 33445679999999998764 3 467799999999999999999999874 4445555554432 2344
Q ss_pred CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 252 SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 252 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
...++.+.+||.+||..||.+|||++++++||||+.
T Consensus 253 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 567899999999999999999999999999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=375.93 Aligned_cols=260 Identities=23% Similarity=0.350 Sum_probs=201.6
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
+....++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.++...++.+ +||||+++++++.+.
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~~ 78 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN--SQEQKRLLMDLDISMRTV-DCPFTVTFYGALFRE 78 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C--HHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECS
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC--cHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeecc
Confidence 34667899999999999999999999999999999999976421 222233344444446666 599999999999999
Q ss_pred CEEEEEEEecCCCchhHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCeEEeCCCCCeEEEeccCC
Q 013005 103 TKIYLVMEYAAGGELFGKLR-----RGRLTESAARRYFQQLVSALHFCHQN-GVAHRDVKPQNLLLDRDGNLKVSDFGLS 176 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~-----~~~l~e~~~~~~~~ql~~gL~yLH~~-giiHrDLKpeNILld~~~~lkl~DFGls 176 (451)
+..|+||||++| +|.+++. .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 79 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T 3fme_A 79 GDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGIS 157 (290)
T ss_dssp SSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred CCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCc
Confidence 999999999985 7766664 25799999999999999999999998 9999999999999999999999999999
Q ss_pred CcchhhhcCcccccCCCCccccceeee---ccCCCCccchhhhhhHHHHHHHhcCCCCCC-CcHH-HHHHHhhccCCCCC
Q 013005 177 ALPEQIKNGMLHTACGTPAYTAPEVVA---RRGYDGAVADAWSCGVILFVLLAGYLPFDD-SNLL-AMYKKVNRRDYQFP 251 (451)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~APEvl~---~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~-~~~~-~~~~~i~~~~~~~p 251 (451)
...... ......+||+.|+|||++. .....+.++||||+|+++|+|++|..||.. .... .....+.......+
T Consensus 158 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 235 (290)
T 3fme_A 158 GYLVDD--VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP 235 (290)
T ss_dssp --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCC
T ss_pred cccccc--ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcc
Confidence 754332 2234457999999999972 333446779999999999999999999985 2333 33333333333333
Q ss_pred -CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 252 -SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 252 -~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
..+++.+.+||.+||..||++|||++++++||||+..
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 236 ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 3589999999999999999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=386.35 Aligned_cols=273 Identities=34% Similarity=0.619 Sum_probs=211.2
Q ss_pred CCCCCCCCCCCCCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhh--HHHHHHHHHHHHHHHH
Q 013005 8 PSAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLD--AAMEDRIVREVSAMRR 85 (451)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~~Ei~il~~ 85 (451)
|.++.++++++.......+.++|++.+.||+|+||.||+|.+..+++.||+|++........ ......+.+|+.++++
T Consensus 11 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 90 (312)
T 2iwi_A 11 PAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90 (312)
T ss_dssp ----------------------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHH
T ss_pred CCCCCCCCCCCCccchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHh
Confidence 33333344455667778889999999999999999999999999999999999976522111 1123346689999999
Q ss_pred hc---CCCCceEEEEEEEeCCEEEEEEEe-cCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeE
Q 013005 86 LQ---NHPNVLKIQEVMATKTKIYLVMEY-AAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNL 160 (451)
Q Consensus 86 L~---~HpnIv~l~~~~~~~~~~~lV~E~-~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNI 160 (451)
+. +||||+++++++...+..++|||| +.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 91 l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 170 (312)
T 2iwi_A 91 VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENI 170 (312)
T ss_dssp HHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGE
T ss_pred hcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhE
Confidence 83 499999999999999999999999 789999999975 7799999999999999999999999999999999999
Q ss_pred EeC-CCCCeEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHH
Q 013005 161 LLD-RDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAM 239 (451)
Q Consensus 161 Lld-~~~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~ 239 (451)
+++ .++.+||+|||++..... .......||+.|+|||++.+..+.+.++||||||+++|+|++|..||....
T Consensus 171 l~~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---- 243 (312)
T 2iwi_A 171 LIDLRRGCAKLIDFGSGALLHD---EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---- 243 (312)
T ss_dssp EEETTTTEEEECCCSSCEECCS---SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----
T ss_pred EEeCCCCeEEEEEcchhhhccc---CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----
Confidence 999 789999999999875433 234466799999999999887777767999999999999999999997642
Q ss_pred HHHhhccCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 240 YKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 240 ~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
.+......++..++..+.+||.+||..||++|||++++++||||+...
T Consensus 244 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 244 --EILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp --HHHHTCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred --HHhhhccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 233455677888999999999999999999999999999999998643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=386.79 Aligned_cols=259 Identities=24% Similarity=0.397 Sum_probs=219.8
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
.....++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++.+. ||||+++++++.+.
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 103 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSD 103 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC---CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEET
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc---CHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEEEC
Confidence 3456789999999999999999999999999999999997652 3455678899999999995 99999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 103 TKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQN-GVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~-giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
+..|+||||++|++|.+++.. +.+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++....
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred CEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999999999999975 7899999999999999999999996 99999999999999999999999999986443
Q ss_pred hhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHh-----------------
Q 013005 181 QIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKV----------------- 243 (451)
Q Consensus 181 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i----------------- 243 (451)
. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+
T Consensus 184 ~---~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 184 D---SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp H---HC----CCCCTTCCHHHHTTCCC-SHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred c---ccccCCCCCCCeECHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence 2 23345689999999999987666 56799999999999999999999876654432211
Q ss_pred -------------------------hcc-CCCCC-CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 244 -------------------------NRR-DYQFP-SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 244 -------------------------~~~-~~~~p-~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
... ....+ ..++..+.+||.+||..||.+|||++++++||||+...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 111 11222 24688999999999999999999999999999998654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=378.68 Aligned_cols=259 Identities=29% Similarity=0.412 Sum_probs=213.7
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE---
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA--- 100 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~--- 100 (451)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD----PQSVKHALREIKIIRRLD-HDNIVKVFEILGPSG 81 (320)
T ss_dssp EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS----HHHHHHHHHHHHHHHTCC-CTTBCCEEEEECTTS
T ss_pred CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC----hHHHHHHHHHHHHHHhcC-CCCeeEEEEeccccc
Confidence 356789999999999999999999999999999999997542 345567889999999995 999999999873
Q ss_pred -----------eCCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeC-CCCCe
Q 013005 101 -----------TKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLD-RDGNL 168 (451)
Q Consensus 101 -----------~~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld-~~~~l 168 (451)
.....|+||||+. |+|.+++..+++++..++.++.||+.||+|||++||+||||||+|||++ +++.+
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp CBCCC----CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEE
T ss_pred cccccccccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeE
Confidence 4468999999998 5999999989999999999999999999999999999999999999997 56789
Q ss_pred EEEeccCCCcchhhh--cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc
Q 013005 169 KVSDFGLSALPEQIK--NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR 246 (451)
Q Consensus 169 kl~DFGls~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~ 246 (451)
||+|||++....... ........||+.|+|||++.+....+.++|||||||++|+|++|..||...+.......+...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999998654321 133445678999999999876555577899999999999999999999988776655554332
Q ss_pred CC------------------------------CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 247 DY------------------------------QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 247 ~~------------------------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.. ..++.++..+.+||.+||..||.+|||++++++||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 11 1124578999999999999999999999999999999753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=387.07 Aligned_cols=256 Identities=26% Similarity=0.437 Sum_probs=207.8
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC-
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT- 103 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~- 103 (451)
...++|++.+.||+|+||.||+|++..+++.||||++.... .....+.+.+|+.++++++ ||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 78 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLE-HPGIVRYFNAWLETPP 78 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS---TTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECCS
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC---chhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEecc
Confidence 45678999999999999999999999999999999997643 2334567899999999995 999999999985543
Q ss_pred --------------------------------------------------------EEEEEEEecCCCchhHHhhcC---
Q 013005 104 --------------------------------------------------------KIYLVMEYAAGGELFGKLRRG--- 124 (451)
Q Consensus 104 --------------------------------------------------------~~~lV~E~~~gg~L~~~l~~~--- 124 (451)
..|+|||||+||+|.+++...
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 158 (332)
T 3qd2_B 79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158 (332)
T ss_dssp CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence 389999999999999999752
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc-----------CcccccCC
Q 013005 125 -RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN-----------GMLHTACG 192 (451)
Q Consensus 125 -~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~-----------~~~~~~~g 192 (451)
..++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......+|
T Consensus 159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 356777999999999999999999999999999999999999999999999975433211 22345689
Q ss_pred CCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCC-CCCCCCHhHHHHHHhccCCCCC
Q 013005 193 TPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQ-FPSFVSKPARSLIYQLLDPNPK 271 (451)
Q Consensus 193 t~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~~L~~dP~ 271 (451)
|+.|+|||++.+..+ +.++||||+||++|+|++|..|+.. .......+.....+ .+...++.+.+||.+||..||.
T Consensus 239 t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 315 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNY-SHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPT 315 (332)
T ss_dssp CGGGSCHHHHHCCCC-CTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGG
T ss_pred CcCccChHHhcCCCC-cchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCC
Confidence 999999999987766 5679999999999999999877532 12222233222211 1123577889999999999999
Q ss_pred CCCCHHHHHcCccccc
Q 013005 272 TRMSIEKIMSISWFQK 287 (451)
Q Consensus 272 ~Rpt~~eil~hp~f~~ 287 (451)
+|||++++++||||++
T Consensus 316 ~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 316 ERPEATDIIENAIFEN 331 (332)
T ss_dssp GSCCHHHHHHSTTCCC
T ss_pred cCCCHHHHhhchhhhc
Confidence 9999999999999974
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=375.52 Aligned_cols=259 Identities=27% Similarity=0.454 Sum_probs=215.2
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
.......++|++.+.||+|+||.||+|.+..+|+.||+|++..... .+.+.+|+.+++.+. ||||+++++++.
T Consensus 22 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 94 (314)
T 3com_A 22 SLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD------LQEIIKEISIMQQCD-SPHVVKYYGSYF 94 (314)
T ss_dssp --------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC------CHHHHHHHHHHHTCC-CTTBCCEEEEEE
T ss_pred hhhhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH------HHHHHHHHHHHHhCC-CCCCccEEEEEE
Confidence 3345667899999999999999999999999999999999976521 246788999999995 999999999999
Q ss_pred eCCEEEEEEEecCCCchhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 101 TKTKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~--~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
.....|+||||+.+++|.+++. ...+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++..
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 95 KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp ETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred eCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 9999999999999999999986 46899999999999999999999999999999999999999999999999999975
Q ss_pred chhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC---CCCCCCCC
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD---YQFPSFVS 255 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s 255 (451)
.... ........||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.... ...+..++
T Consensus 175 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
T 3com_A 175 LTDT-MAKRNTVIGTPFWMAPEVIQEIGY-NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWS 252 (314)
T ss_dssp CBTT-BSCBCCCCSCGGGCCHHHHSSSCB-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSC
T ss_pred hhhh-ccccCccCCCCCccChhhcCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCC
Confidence 4332 122345679999999999987766 566999999999999999999999877665544443332 23355678
Q ss_pred HhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 256 KPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 256 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
..+.+||.+||..||.+|||++++++||||+..
T Consensus 253 ~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 253 DNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 999999999999999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=376.55 Aligned_cols=263 Identities=27% Similarity=0.431 Sum_probs=215.0
Q ss_pred CCCCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEE
Q 013005 17 PPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQ 96 (451)
Q Consensus 17 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~ 96 (451)
......+....++|++.+.||+|+||+||+|.+ +++.||+|++.... ......+.+.+|+.++++++ ||||++++
T Consensus 26 ~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~-hp~iv~~~ 100 (309)
T 3p86_A 26 AMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQD--FHAERVNEFLREVAIMKRLR-HPNIVLFM 100 (309)
T ss_dssp ------CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCC--CSHHHHHHHHHHHHHHHHCC-CTTBCCEE
T ss_pred CCCcccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCC--CCHHHHHHHHHHHHHHHhCC-CCCEeeEE
Confidence 345566678889999999999999999999986 68899999997653 23445567899999999996 99999999
Q ss_pred EEEEeCCEEEEEEEecCCCchhHHhhcCC----CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCeEEeCCCCCeEE
Q 013005 97 EVMATKTKIYLVMEYAAGGELFGKLRRGR----LTESAARRYFQQLVSALHFCHQNG--VAHRDVKPQNLLLDRDGNLKV 170 (451)
Q Consensus 97 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----l~e~~~~~~~~ql~~gL~yLH~~g--iiHrDLKpeNILld~~~~lkl 170 (451)
+++.+....|+||||+.||+|.+++.... +++..++.++.|++.||+|||++| |+||||||+|||++.++.+||
T Consensus 101 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL 180 (309)
T 3p86_A 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKV 180 (309)
T ss_dssp EEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEE
T ss_pred EEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEE
Confidence 99999999999999999999999997633 999999999999999999999999 999999999999999999999
Q ss_pred EeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhh--ccCC
Q 013005 171 SDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVN--RRDY 248 (451)
Q Consensus 171 ~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~--~~~~ 248 (451)
+|||++...... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+. ....
T Consensus 181 ~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 258 (309)
T 3p86_A 181 CDFGLSRLKAST-FLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL 258 (309)
T ss_dssp CCCC------------------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC
T ss_pred CCCCCCcccccc-ccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 999999754322 122345689999999999987766 567999999999999999999999988777666653 3456
Q ss_pred CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc--Ccccc
Q 013005 249 QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS--ISWFQ 286 (451)
Q Consensus 249 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~--hp~f~ 286 (451)
.+|..+++.+.+||.+||..||.+|||++++++ .++++
T Consensus 259 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 259 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 778889999999999999999999999999987 34443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=374.15 Aligned_cols=260 Identities=30% Similarity=0.539 Sum_probs=223.5
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe--
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT-- 101 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~-- 101 (451)
+...++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 p~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 78 (279)
T 2w5a_A 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS--MTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRT 78 (279)
T ss_dssp -CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGG
T ss_pred CCchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEccc--CCHHHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCC
Confidence 456789999999999999999999999999999999998652 23445678999999999995 9999999998754
Q ss_pred CCEEEEEEEecCCCchhHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCCCeEEeCCCCCeEEE
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR-----GRLTESAARRYFQQLVSALHFCHQNG-----VAHRDVKPQNLLLDRDGNLKVS 171 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~-----~~l~e~~~~~~~~ql~~gL~yLH~~g-----iiHrDLKpeNILld~~~~lkl~ 171 (451)
....|+||||++|++|.+++.. ..+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~ 158 (279)
T 2w5a_A 79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 158 (279)
T ss_dssp GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence 6789999999999999999864 24999999999999999999999999 9999999999999999999999
Q ss_pred eccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC-CC
Q 013005 172 DFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY-QF 250 (451)
Q Consensus 172 DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~-~~ 250 (451)
|||++...... .......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+..... .+
T Consensus 159 dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~ 236 (279)
T 2w5a_A 159 DFGLARILNHD-TSFAKTFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI 236 (279)
T ss_dssp CCCHHHHC----CHHHHHHHSCCTTCCHHHHHCC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred cCchheeeccc-cccccccCCCccccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccC
Confidence 99998643321 111234578999999999977665 5679999999999999999999999888777777766554 56
Q ss_pred CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 251 PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 251 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
|..++..+.++|.+||..||.+|||++++++|+|+...
T Consensus 237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 67789999999999999999999999999999999764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=386.88 Aligned_cols=262 Identities=23% Similarity=0.482 Sum_probs=225.9
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhh-------------HHHHHHHHHHHHHHHHhcC
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLD-------------AAMEDRIVREVSAMRRLQN 88 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~-------------~~~~~~~~~Ei~il~~L~~ 88 (451)
......++|++.+.||+|+||.||+|.+ +++.||+|++........ ....+.+.+|+.++++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~- 101 (348)
T 2pml_X 25 EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK- 101 (348)
T ss_dssp SSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC-
T ss_pred hcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC-
Confidence 3345678999999999999999999998 899999999975421100 011267889999999996
Q ss_pred CCCceEEEEEEEeCCEEEEEEEecCCCchhHH------hhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCC
Q 013005 89 HPNVLKIQEVMATKTKIYLVMEYAAGGELFGK------LRR---GRLTESAARRYFQQLVSALHFCHQ-NGVAHRDVKPQ 158 (451)
Q Consensus 89 HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~------l~~---~~l~e~~~~~~~~ql~~gL~yLH~-~giiHrDLKpe 158 (451)
||||+++++++.+.+..|+||||+++|+|.++ +.. +.+++..++.++.||+.||.|||+ +||+||||||+
T Consensus 102 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~ 181 (348)
T 2pml_X 102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS 181 (348)
T ss_dssp CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence 99999999999999999999999999999998 653 679999999999999999999999 99999999999
Q ss_pred eEEeCCCCCeEEEeccCCCcchhhhcCcccccCCCCccccceeeecc-CCCCccchhhhhhHHHHHHHhcCCCCCCCcH-
Q 013005 159 NLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARR-GYDGAVADAWSCGVILFVLLAGYLPFDDSNL- 236 (451)
Q Consensus 159 NILld~~~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~- 236 (451)
|||++.++.+||+|||++..... ......+||+.|+|||++.+. .+.+.++||||||+++|+|++|..||...+.
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVD---KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBT---TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred hEEEcCCCcEEEecccccccccc---ccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 99999999999999999975432 234567899999999999876 4544479999999999999999999988766
Q ss_pred HHHHHHhhccCCCCC-------------------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 237 LAMYKKVNRRDYQFP-------------------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 237 ~~~~~~i~~~~~~~p-------------------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
......+......+| ..++..+.+||.+||..||.+|||++++++||||+...
T Consensus 259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 677777777766666 56899999999999999999999999999999998643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=398.64 Aligned_cols=255 Identities=16% Similarity=0.213 Sum_probs=206.4
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhc--CCCCceEEE-----
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ--NHPNVLKIQ----- 96 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~--~HpnIv~l~----- 96 (451)
....++|++.+.||+|+||+||+|++..+|+.||||++.... .......+.+.+|+.+++.+. +|||||+++
T Consensus 69 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~ 147 (377)
T 3byv_A 69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTE-RPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 147 (377)
T ss_dssp SCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC--CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCC
T ss_pred CCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeecc-ccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhh
Confidence 344688999999999999999999998999999999998642 223345577899996555553 599999998
Q ss_pred --EEEEeCCE-----------------EEEEEEecCCCchhHHhhc-CCCCH-------HHHHHHHHHHHHHHHHHHHCC
Q 013005 97 --EVMATKTK-----------------IYLVMEYAAGGELFGKLRR-GRLTE-------SAARRYFQQLVSALHFCHQNG 149 (451)
Q Consensus 97 --~~~~~~~~-----------------~~lV~E~~~gg~L~~~l~~-~~l~e-------~~~~~~~~ql~~gL~yLH~~g 149 (451)
+++.+.+. .|+||||+ +|+|.+++.. +.+++ ..++.++.||+.||+|||++|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 226 (377)
T 3byv_A 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 226 (377)
T ss_dssp CSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 77766543 89999999 6799999974 44555 788889999999999999999
Q ss_pred ceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCCCCccccceeeecc-----------CCCCccchhhhhh
Q 013005 150 VAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARR-----------GYDGAVADAWSCG 218 (451)
Q Consensus 150 iiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~-----------~~~~~~sDIwSlG 218 (451)
|+||||||+|||++.++.+||+|||++... .......+| +.|+|||++.+. .+ +.++||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~----~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG 300 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD----GARVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALG 300 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEET----TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheec----CCcccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHH
Confidence 999999999999999999999999999742 223456678 999999999876 45 6779999999
Q ss_pred HHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchhH
Q 013005 219 VILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQ 290 (451)
Q Consensus 219 vil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 290 (451)
|++|+|++|..||...+.......+. ..+..+++.+.+||.+||..||.+|||+.++++||||+....
T Consensus 301 ~il~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 301 LVIYWIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368 (377)
T ss_dssp HHHHHHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHH
T ss_pred HHHHHHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHH
Confidence 99999999999998765443333332 234568999999999999999999999999999999986543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=384.62 Aligned_cols=271 Identities=31% Similarity=0.538 Sum_probs=222.5
Q ss_pred CCCCCCCCCCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchh--hHHHHHHHHHHHHHHHHhc-
Q 013005 11 PPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFL--DAAMEDRIVREVSAMRRLQ- 87 (451)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~~Ei~il~~L~- 87 (451)
.......++......+.++|++.+.||+|+||.||+|.+..+++.||||++....... .......+.+|+.+++++.
T Consensus 26 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 105 (320)
T 3a99_A 26 DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105 (320)
T ss_dssp --------------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS
T ss_pred HhhhhccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhcc
Confidence 3333444566777888999999999999999999999999999999999997652110 0011235668999999996
Q ss_pred CCCCceEEEEEEEeCCEEEEEEEecCC-CchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeC-C
Q 013005 88 NHPNVLKIQEVMATKTKIYLVMEYAAG-GELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLD-R 164 (451)
Q Consensus 88 ~HpnIv~l~~~~~~~~~~~lV~E~~~g-g~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld-~ 164 (451)
.||||+++++++...+..++|||++.+ ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .
T Consensus 106 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~ 185 (320)
T 3a99_A 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN 185 (320)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT
T ss_pred CCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCC
Confidence 379999999999999999999999986 899999874 7899999999999999999999999999999999999999 7
Q ss_pred CCCeEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhh
Q 013005 165 DGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVN 244 (451)
Q Consensus 165 ~~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~ 244 (451)
++.+||+|||++..... ......+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...+ .+.
T Consensus 186 ~~~~kL~Dfg~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~ 256 (320)
T 3a99_A 186 RGELKLIDFGSGALLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EII 256 (320)
T ss_dssp TTEEEECCCTTCEECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHH
T ss_pred CCCEEEeeCcccccccc---ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhh
Confidence 78999999999875432 334456799999999999887777788999999999999999999997643 233
Q ss_pred ccCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchhH
Q 013005 245 RRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQ 290 (451)
Q Consensus 245 ~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 290 (451)
.....++..+++.+.+||.+||..||.+|||++++++||||+....
T Consensus 257 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 257 RGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302 (320)
T ss_dssp HCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred cccccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence 4455677789999999999999999999999999999999987543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=384.75 Aligned_cols=255 Identities=26% Similarity=0.420 Sum_probs=214.2
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
.+.++|.+.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++ ||||+++++++.....
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 115 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASS 115 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSS
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc--cchhHHHHHHHHHHHHHhcC-CCCchhhhhheeccCC
Confidence 46689999999999999999999999999999999997642 23455678889999999996 9999999999987765
Q ss_pred E------EEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 105 I------YLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 105 ~------~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
. |+||||+. ++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 116 ~~~~~~~~lv~e~~~-~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 116 LRNFYDFYLVMPFMQ-TDLQKIMG-MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp STTCCCCEEEEECCC-EEHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred cccceeEEEEEcccc-ccHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 4 99999997 58877764 4599999999999999999999999999999999999999999999999999975
Q ss_pred chhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC-----------
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD----------- 247 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~----------- 247 (451)
... .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 194 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 269 (371)
T 4exu_A 194 ADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 269 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred ccc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence 432 23456889999999998875555778999999999999999999999887665555443210
Q ss_pred ------------C--------CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 248 ------------Y--------QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 248 ------------~--------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
. ..++.+++.+.+||.+||..||.+|||++|+++||||+..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 0 0123468999999999999999999999999999999854
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=386.52 Aligned_cols=256 Identities=21% Similarity=0.377 Sum_probs=219.2
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEc-------CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEE
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSI-------ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l 95 (451)
+....++|++++.||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+++.+.+||||+++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~ 152 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINL 152 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC---BHHHHHHHHHHHHHHHHSCCCTTBCCE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc---CHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 4456789999999999999999999875 345689999997642 334567799999999999559999999
Q ss_pred EEEEEeCCEEEEEEEecCCCchhHHhhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 013005 96 QEVMATKTKIYLVMEYAAGGELFGKLRRG-----------------RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQ 158 (451)
Q Consensus 96 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-----------------~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpe 158 (451)
++++.+.+..|+||||+.||+|.+++... .+++.+++.++.||+.||.|||++||+||||||+
T Consensus 153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 232 (370)
T 2psq_A 153 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 232 (370)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred EEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh
Confidence 99999999999999999999999998742 4799999999999999999999999999999999
Q ss_pred eEEeCCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcH
Q 013005 159 NLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNL 236 (451)
Q Consensus 159 NILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~ 236 (451)
|||++.++.+||+|||++........ .......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999999999999975433221 22334567899999999987666 567999999999999999 9999998877
Q ss_pred HHHHHHhhcc-CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 237 LAMYKKVNRR-DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 237 ~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
......+... ....|..++..+.+||.+||..||.+|||+.+++++
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 312 EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp GGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7766666554 345677889999999999999999999999999875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=375.32 Aligned_cols=260 Identities=27% Similarity=0.412 Sum_probs=217.8
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
.....++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.+. ||||+++++++...
T Consensus 14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELEDYIVEIEILATCD-HPYIVKLLGAYYHD 88 (302)
T ss_dssp SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCC-CTTBCCEEEEEECC
T ss_pred ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC----HHHHHHHHHHHHHHhcCC-CCCEeeeeeeeeeC
Confidence 3466789999999999999999999999999999999986542 223457889999999995 99999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 103 TKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
+..|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++....
T Consensus 89 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 89 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999999999998864 679999999999999999999999999999999999999999999999999875432
Q ss_pred hhhcCcccccCCCCccccceeee----ccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC---CCCCC
Q 013005 181 QIKNGMLHTACGTPAYTAPEVVA----RRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY---QFPSF 253 (451)
Q Consensus 181 ~~~~~~~~~~~gt~~y~APEvl~----~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~ 253 (451)
... ......+||+.|+|||++. .....+.++||||||+++|+|++|..||...+.......+..... ..+..
T Consensus 169 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (302)
T 2j7t_A 169 KTL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSK 247 (302)
T ss_dssp HHH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGG
T ss_pred ccc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccc
Confidence 211 2234567999999999984 233346779999999999999999999998887766666655432 23456
Q ss_pred CCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 254 VSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 254 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
++..+.+||.+||..||.+|||++++++||||+..
T Consensus 248 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 248 WSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp SCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred cCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 78999999999999999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=391.78 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=209.6
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
.......+|++.+.||+|+||+||+|++..+++ ||+|.+...... ..+|+.+++.++ ||||+++++++..
T Consensus 34 ~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~--------~~~E~~il~~l~-h~niv~l~~~~~~ 103 (394)
T 4e7w_A 34 TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF--------KNRELQIMRIVK-HPNVVDLKAFFYS 103 (394)
T ss_dssp SCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS--------CCHHHHHHHTCC-CTTBCCEEEEEEE
T ss_pred CCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch--------HHHHHHHHHhCC-CCCcceEEEEEEe
Confidence 345567789999999999999999999877666 888887654321 236999999995 9999999999965
Q ss_pred CC------EEEEEEEecCCCchhHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeC-CCCCeEE
Q 013005 102 KT------KIYLVMEYAAGGELFGKLR----RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLD-RDGNLKV 170 (451)
Q Consensus 102 ~~------~~~lV~E~~~gg~L~~~l~----~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld-~~~~lkl 170 (451)
.. ..|+||||+.++.+..... .+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||
T Consensus 104 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL 183 (394)
T 4e7w_A 104 NGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKL 183 (394)
T ss_dssp ESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEE
T ss_pred cCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEE
Confidence 43 3889999998764443332 46799999999999999999999999999999999999999 7899999
Q ss_pred EeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc----
Q 013005 171 SDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR---- 246 (451)
Q Consensus 171 ~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~---- 246 (451)
+|||++..... .......+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+...
T Consensus 184 ~DFG~a~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p 261 (394)
T 4e7w_A 184 IDFGSAKILIA--GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261 (394)
T ss_dssp CCCTTCEECCT--TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred eeCCCcccccC--CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999975433 223345688999999999977665677899999999999999999999988766555444321
Q ss_pred -------------CCC------------CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 247 -------------DYQ------------FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 247 -------------~~~------------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
... +++.+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 011 234578999999999999999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=379.79 Aligned_cols=262 Identities=34% Similarity=0.612 Sum_probs=212.8
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcch----hhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKF----LDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
.+.++|++.+.||+|+||.||+|.+..+++.||||++...... ........+.+|+.+++++. ||||+++++++.
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~ 85 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEeeEEc
Confidence 4567999999999999999999999999999999999764211 11223346889999999995 999999999987
Q ss_pred eCCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCC---eEEEeccCC
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN---LKVSDFGLS 176 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~---lkl~DFGls 176 (451)
... .|+||||+.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred CCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 665 8999999999999998875 68999999999999999999999999999999999999987665 999999999
Q ss_pred CcchhhhcCcccccCCCCccccceeeec--cCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH-HHHHHhhccCCCCC--
Q 013005 177 ALPEQIKNGMLHTACGTPAYTAPEVVAR--RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL-AMYKKVNRRDYQFP-- 251 (451)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~APEvl~~--~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~-~~~~~i~~~~~~~p-- 251 (451)
...... ......+||+.|+|||++.. ....+.++|||||||++|+|++|..||...... .....+......++
T Consensus 165 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (322)
T 2ycf_A 165 KILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242 (322)
T ss_dssp EECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHH
T ss_pred eecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCch
Confidence 754321 12234579999999999742 333467799999999999999999999764322 33333444444332
Q ss_pred --CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchhH
Q 013005 252 --SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQ 290 (451)
Q Consensus 252 --~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 290 (451)
..+++.+.+||.+||..||.+|||++++++||||+....
T Consensus 243 ~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~ 283 (322)
T 2ycf_A 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 283 (322)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHH
T ss_pred hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHH
Confidence 457899999999999999999999999999999987543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=376.34 Aligned_cols=256 Identities=23% Similarity=0.402 Sum_probs=214.0
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEE-cCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCC------Cce
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKS-IADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP------NVL 93 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~Hp------nIv 93 (451)
.....+.++|++.+.||+|+||.||+|.+ ..+++.||+|++.... ...+.+.+|+.+++.+. |+ +|+
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~-~~~~~~~~~i~ 80 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-----RYCEAARSEIQVLEHLN-TTDPNSTFRCV 80 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-----HHHHHHHHHHHHHHHHH-HHCTTCTTCBC
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-----chhHHHHHHHHHHHHhh-hcCCCCceeeE
Confidence 44556788999999999999999999998 5688999999996542 34567889999999886 54 599
Q ss_pred EEEEEEEeCCEEEEEEEecCCCchhHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC------
Q 013005 94 KIQEVMATKTKIYLVMEYAAGGELFGKLRRG---RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR------ 164 (451)
Q Consensus 94 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~---~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~------ 164 (451)
++++++...+..|+||||+ +++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 81 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 81 QMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEE
T ss_pred eeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccc
Confidence 9999999999999999999 88999988752 5899999999999999999999999999999999999987
Q ss_pred -------------CCCeEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCC
Q 013005 165 -------------DGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPF 231 (451)
Q Consensus 165 -------------~~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf 231 (451)
++.+||+|||++.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf 234 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDD----EHHSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVF 234 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETT----SCCCSSCSCGGGCCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cCCccccccccccCCCceEeeCcccccCc----cccccccCCccccChHHhhCCCC-CcchhhHHHHHHHHHHHhCCCCC
Confidence 6689999999987532 22345689999999999987766 56799999999999999999999
Q ss_pred CCCcHHHHHHHhhccCCCC--------------------------------------------CCCCCHhHHHHHHhccC
Q 013005 232 DDSNLLAMYKKVNRRDYQF--------------------------------------------PSFVSKPARSLIYQLLD 267 (451)
Q Consensus 232 ~~~~~~~~~~~i~~~~~~~--------------------------------------------p~~~s~~~~~li~~~L~ 267 (451)
...+.......+......+ +...++.+.+||.+||.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp CCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence 9877655444332211111 11124678899999999
Q ss_pred CCCCCCCCHHHHHcCccccch
Q 013005 268 PNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 268 ~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.||.+|||++|+++||||+..
T Consensus 315 ~dP~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 315 YDPAKRITLREALKHPFFDLL 335 (339)
T ss_dssp SSTTTSCCHHHHTTSGGGGGG
T ss_pred cCcccccCHHHHhcCHHHHHH
Confidence 999999999999999999863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=375.95 Aligned_cols=261 Identities=35% Similarity=0.610 Sum_probs=225.5
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
.....+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 91 (287)
T 2wei_A 15 YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA--KNKDTSTILREVELLKKLD-HPNIMKLFEILE 91 (287)
T ss_dssp HHTHHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB--SSSCHHHHHHHHHHHHTCC-CTTBCCEEEEEE
T ss_pred hHHHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHHHHHhcc-CCCccEEEEEEe
Confidence 3345678899999999999999999999999999999999976422 1223467889999999995 999999999999
Q ss_pred eCCEEEEEEEecCCCchhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC---CeEEEeccCC
Q 013005 101 TKTKIYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG---NLKVSDFGLS 176 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~-~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~---~lkl~DFGls 176 (451)
+....|+||||+.+++|.+.+. .+.+++.+++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 92 DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred CCCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999999999998886 47899999999999999999999999999999999999997644 6999999998
Q ss_pred CcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCC----C
Q 013005 177 ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP----S 252 (451)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~ 252 (451)
..... ........||+.|+|||++.+. .+.++||||||+++|+|++|..||...+.......+......++ .
T Consensus 172 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (287)
T 2wei_A 172 TCFQQ--NTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR 247 (287)
T ss_dssp GTBCC--CSSCSCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGT
T ss_pred eeecC--CCccccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhh
Confidence 75432 1223445689999999988653 46779999999999999999999999888888877777655443 3
Q ss_pred CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 253 FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 253 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.+++.+.+||.+||..||.+|||++++++||||++.
T Consensus 248 ~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 248 TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred hcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 579999999999999999999999999999999763
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=381.11 Aligned_cols=264 Identities=33% Similarity=0.574 Sum_probs=187.2
Q ss_pred CCCCCCCCCCcccccCCeEEcc-eEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCC
Q 013005 13 PPPPPPPSKKIPTLLNRYQLGP-LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN 91 (451)
Q Consensus 13 ~~~~~~~~~~~~~~~~~y~~~~-~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~Hpn 91 (451)
+.+.+-|......+.++|.+.+ .||+|+||+||+|++..+++.||||++.... ...+|+..+.++.+|||
T Consensus 13 ~~~~~~p~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~e~~~~~~~~~h~~ 83 (336)
T 3fhr_A 13 EVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---------KARQEVDHHWQASGGPH 83 (336)
T ss_dssp -------CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---------HHHHHHHHHHHHTTSTT
T ss_pred cccccCCCCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---------HHHHHHHHHHHhcCCCC
Confidence 3444445556667889999965 6999999999999999999999999997542 12234443333346999
Q ss_pred ceEEEEEEEe----CCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC
Q 013005 92 VLKIQEVMAT----KTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR 164 (451)
Q Consensus 92 Iv~l~~~~~~----~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~ 164 (451)
|+++++++.. ....|+||||++||+|.+++.. ..+++.+++.++.||+.||.|||++||+||||||+|||++.
T Consensus 84 i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~ 163 (336)
T 3fhr_A 84 IVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTS 163 (336)
T ss_dssp BCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred hHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEe
Confidence 9999999976 5568999999999999999975 36999999999999999999999999999999999999986
Q ss_pred C---CCeEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHH--
Q 013005 165 D---GNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAM-- 239 (451)
Q Consensus 165 ~---~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~-- 239 (451)
+ +.+||+|||++..... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........
T Consensus 164 ~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 239 (336)
T 3fhr_A 164 KEKDAVLKLTDFGFAKETTQ---NALQTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP 239 (336)
T ss_dssp SSTTCCEEECCCTTCEEC-------------------------CHH-HHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cCCCceEEEeccccceeccc---cccccCCCCcCccChhhhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCccchhhhh
Confidence 4 4599999999975432 33456789999999999876665 5679999999999999999999976554332
Q ss_pred --HHHhhccCCCCC----CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 240 --YKKVNRRDYQFP----SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 240 --~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
...+......++ ..+++.+.+||.+||..||.+|||++++++||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 240 GMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp -----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred hHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 222323333333 35799999999999999999999999999999998643
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=385.23 Aligned_cols=263 Identities=25% Similarity=0.368 Sum_probs=204.9
Q ss_pred CCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE
Q 013005 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 19 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
+........++|++.+.||+|+||.||+|.+..+++.||||++....... ....+++..++.+. ||||++++++
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~l~~l~-h~niv~~~~~ 87 (360)
T 3e3p_A 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-----NRELQIMQDLAVLH-HPNIVQLQSY 87 (360)
T ss_dssp SSHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC-----CHHHHHHHHHHHHC-CTTBCCEEEE
T ss_pred hhhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc-----HHHHHHHHHHHhcC-CCCcccHHHh
Confidence 44555677899999999999999999999999999999999986653221 23456777788885 9999999999
Q ss_pred EEeCCE-------EEEEEEecCCCchhH---Hhh-cCCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCCCeEEeCC-
Q 013005 99 MATKTK-------IYLVMEYAAGGELFG---KLR-RGRLTESAARRYFQQLVSALHFCH--QNGVAHRDVKPQNLLLDR- 164 (451)
Q Consensus 99 ~~~~~~-------~~lV~E~~~gg~L~~---~l~-~~~l~e~~~~~~~~ql~~gL~yLH--~~giiHrDLKpeNILld~- 164 (451)
+..... .|+||||+.++.+.. ... ...+++..++.++.|++.||.||| ++||+||||||+|||++.
T Consensus 88 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~ 167 (360)
T 3e3p_A 88 FYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA 167 (360)
T ss_dssp EEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETT
T ss_pred hhccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCC
Confidence 965433 889999998753332 222 367999999999999999999999 999999999999999997
Q ss_pred CCCeEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhh
Q 013005 165 DGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVN 244 (451)
Q Consensus 165 ~~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~ 244 (451)
++.+||+|||++...... ......+||+.|+|||++.+....+.++|||||||++|+|++|..||...+....+..+.
T Consensus 168 ~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 245 (360)
T 3e3p_A 168 DGTLKLCDFGSAKKLSPS--EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV 245 (360)
T ss_dssp TTEEEECCCTTCBCCCTT--SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCcEEEeeCCCceecCCC--CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHH
Confidence 899999999999865432 233456799999999999776656788999999999999999999999888776665553
Q ss_pred ccC--------------------------------CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 245 RRD--------------------------------YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 245 ~~~--------------------------------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
... ...+...++.+.+||.+||..||.+|||+.|+++||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 210 011222567899999999999999999999999999998754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=379.31 Aligned_cols=266 Identities=28% Similarity=0.460 Sum_probs=195.7
Q ss_pred CCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE
Q 013005 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 20 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~ 99 (451)
...+....++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.+++++. ||||+++++++
T Consensus 7 ~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~ 82 (303)
T 2vwi_A 7 ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK---CQTSMDELLKEIQAMSQCH-HPNIVSYYTSF 82 (303)
T ss_dssp ------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCC-CTTBCCEEEEE
T ss_pred ccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh---cchhHHHHHHHHHHHhhcC-CCCEeeEEEEE
Confidence 3345677899999999999999999999998899999999986542 1233467889999999995 99999999999
Q ss_pred EeCCEEEEEEEecCCCchhHHhh---------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEE
Q 013005 100 ATKTKIYLVMEYAAGGELFGKLR---------RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKV 170 (451)
Q Consensus 100 ~~~~~~~lV~E~~~gg~L~~~l~---------~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl 170 (451)
...+..|+||||+.|++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl 162 (303)
T 2vwi_A 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQI 162 (303)
T ss_dssp ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEE
Confidence 99999999999999999999885 245999999999999999999999999999999999999999999999
Q ss_pred EeccCCCcchhhh----cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc
Q 013005 171 SDFGLSALPEQIK----NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR 246 (451)
Q Consensus 171 ~DFGls~~~~~~~----~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~ 246 (451)
+|||++....... .......+||+.|+|||++.+....+.++||||||+++|+|++|..||...+...........
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 242 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc
Confidence 9999986432211 122345679999999999876444467799999999999999999999876554333332222
Q ss_pred CC----------CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 247 DY----------QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 247 ~~----------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
.. ..+..++..+.+||.+||..||.+|||++++++||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 11 12345788999999999999999999999999999998643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=378.97 Aligned_cols=255 Identities=26% Similarity=0.423 Sum_probs=213.5
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
.+.++|.+.+.||+|+||.||+|++..+|+.||||++.... ......+.+.+|+.+++.++ ||||+++++++.....
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 97 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASS 97 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT--SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSS
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc--cchHHHHHHHHHHHHHHhcC-CCCcccHhheEecccc
Confidence 45689999999999999999999999999999999997642 23455677899999999995 9999999999987654
Q ss_pred ------EEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 105 ------IYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 105 ------~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
.|+||||+. ++|.+.+.. ++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 98 ~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 98 LRNFYDFYLVMPFMQ-TDLQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp GGGCCCCEEEEECCS-EEGGGTTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred cccceeEEEEecccc-CCHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 599999997 588877753 599999999999999999999999999999999999999999999999999975
Q ss_pred chhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc------------
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR------------ 246 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~------------ 246 (451)
... .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 176 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 251 (353)
T 3coi_A 176 ADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 251 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred CCC----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence 432 2345678999999999877555577899999999999999999999987765554443210
Q ss_pred ----------------C---CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 247 ----------------D---YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 247 ----------------~---~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
. ...++.+++.+.+||.+||..||.+|||++++++||||+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp SCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0 12234578999999999999999999999999999999754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=368.79 Aligned_cols=258 Identities=22% Similarity=0.335 Sum_probs=220.5
Q ss_pred CCCCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEE
Q 013005 17 PPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQ 96 (451)
Q Consensus 17 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~ 96 (451)
..+...+....++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++++. ||||++++
T Consensus 13 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~-h~~i~~~~ 85 (283)
T 3gen_A 13 GLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS-----EDEFIEEAKVMMNLS-HEKLVQLY 85 (283)
T ss_dssp ---CCTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC-----HHHHHHHHHHHHTCC-CTTBCCEE
T ss_pred CCCCCCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC-----HHHHHHHHHHHhcCC-CCCEeeEE
Confidence 3445677788899999999999999999999874 6778999999765321 246889999999996 99999999
Q ss_pred EEEEeCCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEecc
Q 013005 97 EVMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFG 174 (451)
Q Consensus 97 ~~~~~~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFG 174 (451)
+++.+....|+||||+.+++|.+++.. +.+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg 165 (283)
T 3gen_A 86 GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG 165 (283)
T ss_dssp EEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTT
T ss_pred EEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccc
Confidence 999999999999999999999999975 679999999999999999999999999999999999999999999999999
Q ss_pred CCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhccC-CCCCC
Q 013005 175 LSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRD-YQFPS 252 (451)
Q Consensus 175 ls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~ 252 (451)
++...............+|+.|+|||++.+..+ +.++||||+|+++|+|++ |..||...+.......+.... ...|.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (283)
T 3gen_A 166 LSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 244 (283)
T ss_dssp GGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT
T ss_pred ccccccccccccccCCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCC
Confidence 997654433333445567889999999987766 567999999999999998 999999988887777776653 34566
Q ss_pred CCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 253 FVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 253 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
..++.+.++|.+||..||.+|||++++++|
T Consensus 245 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 245 LASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 789999999999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=387.28 Aligned_cols=255 Identities=22% Similarity=0.385 Sum_probs=207.8
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhc-------CCCCce
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ-------NHPNVL 93 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~-------~HpnIv 93 (451)
.....+.++|++.+.||+|+||+||+|++..+++.||||++... ....+.+.+|+.+++.++ +||||+
T Consensus 30 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv 104 (397)
T 1wak_A 30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-----EHYTETALDEIRLLKSVRNSDPNDPNREMVV 104 (397)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred ehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-----CcchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence 34456678999999999999999999999999999999999754 234567889999999996 278899
Q ss_pred EEEEEEE----eCCEEEEEEEecCCCchhHHhh-c--CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCeEEeCCC
Q 013005 94 KIQEVMA----TKTKIYLVMEYAAGGELFGKLR-R--GRLTESAARRYFQQLVSALHFCHQN-GVAHRDVKPQNLLLDRD 165 (451)
Q Consensus 94 ~l~~~~~----~~~~~~lV~E~~~gg~L~~~l~-~--~~l~e~~~~~~~~ql~~gL~yLH~~-giiHrDLKpeNILld~~ 165 (451)
++++++. +....|+||||+ +++|.+.+. . +.+++..++.++.||+.||.|||++ ||+||||||+|||++.+
T Consensus 105 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~ 183 (397)
T 1wak_A 105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN 183 (397)
T ss_dssp CEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCC
T ss_pred eeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEecc
Confidence 9999987 566899999999 556655554 3 5699999999999999999999999 99999999999999977
Q ss_pred C-------------------------------------------------CeEEEeccCCCcchhhhcCcccccCCCCcc
Q 013005 166 G-------------------------------------------------NLKVSDFGLSALPEQIKNGMLHTACGTPAY 196 (451)
Q Consensus 166 ~-------------------------------------------------~lkl~DFGls~~~~~~~~~~~~~~~gt~~y 196 (451)
+ .+||+|||++..... .....+||+.|
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~----~~~~~~gt~~y 259 (397)
T 1wak_A 184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK----HFTEDIQTRQY 259 (397)
T ss_dssp HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB----CSCSCCSCGGG
T ss_pred chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc----cCccCCCCCcc
Confidence 6 899999999975432 23456899999
Q ss_pred ccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCc------HHHHHHHhhc---c---------------------
Q 013005 197 TAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN------LLAMYKKVNR---R--------------------- 246 (451)
Q Consensus 197 ~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~------~~~~~~~i~~---~--------------------- 246 (451)
+|||++.+..+ +.++|||||||++|+|++|..||...+ .......+.. .
T Consensus 260 ~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 338 (397)
T 1wak_A 260 RSLEVLIGSGY-NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD 338 (397)
T ss_dssp CCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSS
T ss_pred cCChhhcCCCC-CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccc
Confidence 99999988776 567999999999999999999997543 1222211111 0
Q ss_pred ------------------CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCcccc
Q 013005 247 ------------------DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQ 286 (451)
Q Consensus 247 ------------------~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~ 286 (451)
.+..+...+..+.+||.+||..||.+|||++|+++||||+
T Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 339 LKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp BSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred cccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 0111222346788999999999999999999999999996
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=390.15 Aligned_cols=250 Identities=28% Similarity=0.435 Sum_probs=206.5
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC----
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK---- 102 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~---- 102 (451)
..+|++.+.||+|+||.||+|++..+++.||||++..... ...+|+.+|+.|+ ||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHHTCC-CTTBCCEEEEEEEEETTT
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHcC-CCCccceeeEEeccCCCC
Confidence 4479999999999999999999999999999999976532 2347999999995 99999999998532
Q ss_pred --CEEEEEEEecCCCchhHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCC-CCeEEEecc
Q 013005 103 --TKIYLVMEYAAGGELFGKLR-----RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD-GNLKVSDFG 174 (451)
Q Consensus 103 --~~~~lV~E~~~gg~L~~~l~-----~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~-~~lkl~DFG 174 (451)
..+++||||+.+ +|.+.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||
T Consensus 124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccch
Confidence 247799999986 5555443 3679999999999999999999999999999999999999965 568999999
Q ss_pred CCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhc---------
Q 013005 175 LSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNR--------- 245 (451)
Q Consensus 175 ls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~--------- 245 (451)
++..... .......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+.++..
T Consensus 203 ~a~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 203 SAKQLVR--GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp TCEECCT--TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred hhhhccc--CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9975432 22334568999999999997765557789999999999999999999998776555444332
Q ss_pred --------cCCC------------CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 246 --------RDYQ------------FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 246 --------~~~~------------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
..+. +++.+++++.+||.+||..||.+|||+.|+++||||+..
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 1112 234568999999999999999999999999999999754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=365.89 Aligned_cols=253 Identities=22% Similarity=0.373 Sum_probs=220.5
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
.+....++|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.++++++ ||||+++++++.+
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~ 76 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLE 76 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-----CHHHHHHHHHHHHTCC-CTTBCCEEEEECS
T ss_pred cEEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc-----CHHHHHHHHHHHHhCC-CCCEeeEEEEEec
Confidence 44566789999999999999999999985 577899999976532 1246889999999996 9999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcc
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALP 179 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~ 179 (451)
....|+||||+++++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 156 (269)
T 4hcu_A 77 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 156 (269)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred CCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccc
Confidence 9999999999999999999964 56999999999999999999999999999999999999999999999999999765
Q ss_pred hhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHh
Q 013005 180 EQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKP 257 (451)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 257 (451)
............||+.|+|||++.+..+ +.++||||+|+++|+|++ |..||...+.......+... ....|...++.
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T 4hcu_A 157 LDDQYTSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 235 (269)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred cccccccccCcccccccCCHHHhcCCCC-CchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHH
Confidence 4433333445667889999999977666 567999999999999999 99999998888887777665 34556678999
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 258 ARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 258 ~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
+.+++.+||..||.+|||+.++++|
T Consensus 236 ~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 236 VYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999999999999999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-48 Score=384.89 Aligned_cols=262 Identities=23% Similarity=0.368 Sum_probs=218.8
Q ss_pred CCCCCCcccccCCeEEcceEcccCceEEEEEE-----EcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCC
Q 013005 17 PPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAK-----SIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN 91 (451)
Q Consensus 17 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~Hpn 91 (451)
+.....+....++|++++.||+|+||.||+|. +..+++.||||++.... .....+.+.+|+.+++++.+|||
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpn 87 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLN 87 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC---CHHHHHHHHHHHHHHHhhcCCcc
Confidence 33455667788999999999999999999998 45677899999997542 23445678999999999977999
Q ss_pred ceEEEEEEEeCC-EEEEEEEecCCCchhHHhhcCC---------------------------------------------
Q 013005 92 VLKIQEVMATKT-KIYLVMEYAAGGELFGKLRRGR--------------------------------------------- 125 (451)
Q Consensus 92 Iv~l~~~~~~~~-~~~lV~E~~~gg~L~~~l~~~~--------------------------------------------- 125 (451)
|+++++++.+.+ ..|+||||+.||+|.+++....
T Consensus 88 iv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp BCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 999999998755 4899999999999999997421
Q ss_pred ----------------------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 126 ----------------------LTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 126 ----------------------l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 8999999999999999999999999999999999999999999999999997543322
Q ss_pred c-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHH-HHHHhhc-cCCCCCCCCCHhHH
Q 013005 184 N-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLA-MYKKVNR-RDYQFPSFVSKPAR 259 (451)
Q Consensus 184 ~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~-~~~~i~~-~~~~~p~~~s~~~~ 259 (451)
. .......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+... ....+.. .....|..+++.+.
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 326 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY 326 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHH
T ss_pred cchhccccCCCceeEChhhhcCCCC-CchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 2 22345678999999999987666 577999999999999998 999998765433 3333332 34566778999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHcC
Q 013005 260 SLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 260 ~li~~~L~~dP~~Rpt~~eil~h 282 (451)
++|.+||..||.+|||++++++|
T Consensus 327 ~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 327 QTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCCCHHHHHHH
Confidence 99999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=376.71 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=217.6
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCc---EEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGS---IVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~ 99 (451)
.....++|++.+.||+|+||.||+|.+..+++ .||||++.... .....+.+.+|+.++++++ ||||+++++++
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~ 119 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY---TERQRRDFLSEASIMGQFD-HPNIIRLEGVV 119 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC---CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEE
Confidence 35667899999999999999999999986555 59999997542 3345577899999999995 99999999999
Q ss_pred EeCCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 100 ATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 100 ~~~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
.+....|+||||++||+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 120 TRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp CGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 999999999999999999999964 689999999999999999999999999999999999999999999999999997
Q ss_pred cchhhhcC--cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCC
Q 013005 178 LPEQIKNG--MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSF 253 (451)
Q Consensus 178 ~~~~~~~~--~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~ 253 (451)
........ ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+... ....|..
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF-SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMG 278 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTT
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCC
Confidence 65432221 1223456789999999977666 567999999999999999 99999998888777776654 4456677
Q ss_pred CCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 254 VSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 254 ~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+++.+.+||.+||..||.+|||+.++++
T Consensus 279 ~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 279 CPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 8999999999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=388.62 Aligned_cols=259 Identities=17% Similarity=0.179 Sum_probs=198.8
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhc-CCCCceEEE-------E
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ-NHPNVLKIQ-------E 97 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~-~HpnIv~l~-------~ 97 (451)
...+|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+.+|+.+++.|+ +||||++++ +
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d 138 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGA-ENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSD 138 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCS-TTHHHHHHHHHHHHHHHHHHHC----------CBCCCCE
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecc-cccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeeh
Confidence 3456999999999999999999999999999999998763 234455667888977777765 499988755 5
Q ss_pred EEEeC-----------------CEEEEEEEecCCCchhHHhhc--CCCCHHHH------HHHHHHHHHHHHHHHHCCcee
Q 013005 98 VMATK-----------------TKIYLVMEYAAGGELFGKLRR--GRLTESAA------RRYFQQLVSALHFCHQNGVAH 152 (451)
Q Consensus 98 ~~~~~-----------------~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~------~~~~~ql~~gL~yLH~~giiH 152 (451)
++... ..+|+||||+. |+|.+++.. ..+++... ..++.||+.||+|||++||+|
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivH 217 (371)
T 3q60_A 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVH 217 (371)
T ss_dssp EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCcc
Confidence 55443 34899999999 899999974 34444444 566799999999999999999
Q ss_pred cCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCCCCccccceeeec--cCCCCccchhhhhhHHHHHHHhcCCC
Q 013005 153 RDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVAR--RGYDGAVADAWSCGVILFVLLAGYLP 230 (451)
Q Consensus 153 rDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~--~~~~~~~sDIwSlGvil~~Ll~G~~P 230 (451)
|||||+|||++.+|.+||+|||++..... ......+|+.|+|||++.+ ..+ +.++|||||||++|+|++|..|
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCS
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999975432 2224567799999999975 445 6779999999999999999999
Q ss_pred CCCCcHH--HHHHH-----hhccCCCCC--CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchhHH
Q 013005 231 FDDSNLL--AMYKK-----VNRRDYQFP--SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQ 291 (451)
Q Consensus 231 f~~~~~~--~~~~~-----i~~~~~~~p--~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~~ 291 (451)
|...... ..+.. .......++ ..+++.+.+||.+||..||++|||++++++||||+.....
T Consensus 293 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 362 (371)
T 3q60_A 293 FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNE 362 (371)
T ss_dssp TTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHH
T ss_pred CCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHH
Confidence 9875322 11111 111122333 4689999999999999999999999999999999875443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=380.74 Aligned_cols=261 Identities=22% Similarity=0.377 Sum_probs=225.4
Q ss_pred CCCCCcccccCCeEEcceEcccCceEEEEEEEcCC-------CcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCC
Q 013005 18 PPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIAD-------GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP 90 (451)
Q Consensus 18 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~Hp 90 (451)
|+...+....++|.+++.||+|+||.||+|.+..+ +..||+|++.... .......+.+|+.+++++.+||
T Consensus 59 ~~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp 135 (382)
T 3tt0_A 59 PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHK 135 (382)
T ss_dssp CCCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCT
T ss_pred ccCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc---CHHHHHHHHHHHHHHHHhcCCc
Confidence 44555677789999999999999999999997543 3589999997642 3445578899999999996699
Q ss_pred CceEEEEEEEeCCEEEEEEEecCCCchhHHhhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 013005 91 NVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRG-----------------RLTESAARRYFQQLVSALHFCHQNGVAHR 153 (451)
Q Consensus 91 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-----------------~l~e~~~~~~~~ql~~gL~yLH~~giiHr 153 (451)
||+++++++...+..|+||||+.+|+|.+++... .+++.+++.++.||+.||.|||++||+||
T Consensus 136 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 215 (382)
T 3tt0_A 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 215 (382)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred hhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 9999999999999999999999999999999752 49999999999999999999999999999
Q ss_pred CCCCCeEEeCCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCC
Q 013005 154 DVKPQNLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPF 231 (451)
Q Consensus 154 DLKpeNILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf 231 (451)
||||+|||++.++.+||+|||++........ .......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||
T Consensus 216 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~ellt~g~~p~ 294 (382)
T 3tt0_A 216 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPY 294 (382)
T ss_dssp CCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC-CchhHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999985543221 23344567899999999977665 567999999999999999 99999
Q ss_pred CCCcHHHHHHHhhcc-CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 232 DDSNLLAMYKKVNRR-DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 232 ~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
...+.......+... ....|..+++.+.+||.+||..||++|||+++++++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 295 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp TTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 998888877777655 445677789999999999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=382.93 Aligned_cols=257 Identities=28% Similarity=0.420 Sum_probs=214.3
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCC-----ceEE
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN-----VLKI 95 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~Hpn-----Iv~l 95 (451)
.....+.++|++.+.||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.+..|+| |+++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~ 121 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-----AFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-----HHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence 445667899999999999999999999999999999999997542 334567789999998865664 9999
Q ss_pred EEEEEeCCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCCCeEEeC--CCCCe
Q 013005 96 QEVMATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCH--QNGVAHRDVKPQNLLLD--RDGNL 168 (451)
Q Consensus 96 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH--~~giiHrDLKpeNILld--~~~~l 168 (451)
++++...+..|+||||+.+ +|.+++.. +.+++..++.++.|++.||.||| +.||+||||||+|||++ .++.+
T Consensus 122 ~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~ 200 (382)
T 2vx3_A 122 KRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAI 200 (382)
T ss_dssp EEEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCE
T ss_pred eeeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcE
Confidence 9999999999999999965 99998874 45999999999999999999999 57999999999999994 47789
Q ss_pred EEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC
Q 013005 169 KVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY 248 (451)
Q Consensus 169 kl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~ 248 (451)
||+|||++.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+.....
T Consensus 201 kL~DFG~a~~~~----~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 275 (382)
T 2vx3_A 201 KIVDFGSSCQLG----QRIYQYIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275 (382)
T ss_dssp EECCCTTCEETT----CCCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEEeccCceecc----cccccccCCccccChHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999997542 23456789999999999988776 5679999999999999999999998877666555432100
Q ss_pred C-------------------------------------CCCC---------------------------CCHhHHHHHHh
Q 013005 249 Q-------------------------------------FPSF---------------------------VSKPARSLIYQ 264 (451)
Q Consensus 249 ~-------------------------------------~p~~---------------------------~s~~~~~li~~ 264 (451)
. .|.. .++.+.+||.+
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 355 (382)
T 2vx3_A 276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR 355 (382)
T ss_dssp SCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH
Confidence 0 0000 01368899999
Q ss_pred ccCCCCCCCCCHHHHHcCccccch
Q 013005 265 LLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 265 ~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
||..||.+|||++|+++||||+..
T Consensus 356 mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 356 MLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred hcCCChhhCCCHHHHhcCcccccC
Confidence 999999999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=369.47 Aligned_cols=256 Identities=28% Similarity=0.501 Sum_probs=209.2
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe----
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT---- 101 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~---- 101 (451)
+.++|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++++. ||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 77 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLSTILSEVMLLASLN-HQYVVRYYAAWLERRNF 77 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-----HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-----HHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhcch
Confidence 457899999999999999999999999999999999653 234567889999999995 9999999998865
Q ss_pred ---------CCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEE
Q 013005 102 ---------KTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKV 170 (451)
Q Consensus 102 ---------~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl 170 (451)
....|+||||++||+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 78 VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp CC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEE
T ss_pred hhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEE
Confidence 4578999999999999999974 35889999999999999999999999999999999999999999999
Q ss_pred EeccCCCcchhhh-------------cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCC-cH
Q 013005 171 SDFGLSALPEQIK-------------NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS-NL 236 (451)
Q Consensus 171 ~DFGls~~~~~~~-------------~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~-~~ 236 (451)
+|||++....... .......+||+.|+|||++.+.+..+.++||||+||++|+|++ ||... +.
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~ 234 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER 234 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH
Confidence 9999997543211 1223456799999999999776556778999999999999998 66543 33
Q ss_pred HHHHHHhhccCCCCCC----CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchhH
Q 013005 237 LAMYKKVNRRDYQFPS----FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQ 290 (451)
Q Consensus 237 ~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 290 (451)
......+......+|+ ..+..+.+||.+||..||.+|||++++++||||+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (303)
T 1zy4_A 235 VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ 292 (303)
T ss_dssp HHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCH
T ss_pred HHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCCh
Confidence 3455555554444443 45677999999999999999999999999999986543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=377.24 Aligned_cols=255 Identities=24% Similarity=0.403 Sum_probs=209.1
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
....++|++.+.||+|+||+||+|.+..+++.||||++..... ....+.+.+|+.++++++ ||||+++++++....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 80 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETT 80 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG---GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTT
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc---cchHHHHHHHHHHHHhcC-CCCcceEEEEeecCC
Confidence 4567899999999999999999999999999999999975422 122456789999999996 999999999998765
Q ss_pred --EEEEEEEecCCCchhHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEe----CCCCCeEEEec
Q 013005 104 --KIYLVMEYAAGGELFGKLRR----GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL----DRDGNLKVSDF 173 (451)
Q Consensus 104 --~~~lV~E~~~gg~L~~~l~~----~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILl----d~~~~lkl~DF 173 (451)
..|+||||++|++|.+++.. ..+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Df 160 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccC
Confidence 78999999999999999974 239999999999999999999999999999999999999 78888999999
Q ss_pred cCCCcchhhhcCcccccCCCCccccceeeec-------cCCCCccchhhhhhHHHHHHHhcCCCCCCC----cHHHHHHH
Q 013005 174 GLSALPEQIKNGMLHTACGTPAYTAPEVVAR-------RGYDGAVADAWSCGVILFVLLAGYLPFDDS----NLLAMYKK 242 (451)
Q Consensus 174 Gls~~~~~~~~~~~~~~~gt~~y~APEvl~~-------~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~----~~~~~~~~ 242 (451)
|++..... .......+||+.|+|||++.. ....+.++|||||||++|+|++|..||... .......+
T Consensus 161 g~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 238 (319)
T 4euu_A 161 GAARELED--DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (319)
T ss_dssp TTCEECCT--TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH
T ss_pred CCceecCC--CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Confidence 99975433 233445689999999999863 234467799999999999999999999632 22333333
Q ss_pred hhccCC-------------------CCC------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCcc
Q 013005 243 VNRRDY-------------------QFP------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISW 284 (451)
Q Consensus 243 i~~~~~-------------------~~p------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 284 (451)
+..... .+| ..++..+.+||.+||..||++|||++|+++||-
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 332211 111 123567889999999999999999999999974
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=366.34 Aligned_cols=257 Identities=27% Similarity=0.456 Sum_probs=211.3
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
.++|.....||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.+. ||||+++++++...+..|
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 95 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD----SRYSQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIK 95 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC----C---HHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc----hHHHHHHHHHHHHHHhCC-CCCEeeEeeEEEeCCcEE
Confidence 344444459999999999999999999999999997652 234467889999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC-CCCeEEEeccCCCcchh
Q 013005 107 LVMEYAAGGELFGKLRRG----RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR-DGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~~----~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~-~~~lkl~DFGls~~~~~ 181 (451)
+||||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 999999999999999742 4679999999999999999999999999999999999987 89999999999875432
Q ss_pred hhcCcccccCCCCccccceeeeccC-CCCccchhhhhhHHHHHHHhcCCCCCCCcH-H-HHHH-HhhccCCCCCCCCCHh
Q 013005 182 IKNGMLHTACGTPAYTAPEVVARRG-YDGAVADAWSCGVILFVLLAGYLPFDDSNL-L-AMYK-KVNRRDYQFPSFVSKP 257 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~~~-~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~-~-~~~~-~i~~~~~~~p~~~s~~ 257 (451)
. ........||+.|+|||++.+.. ..+.++||||||+++|+|++|..||..... . .... ........+|..+++.
T Consensus 176 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (295)
T 2clq_A 176 I-NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAE 254 (295)
T ss_dssp ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHH
T ss_pred C-CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHH
Confidence 2 12234567999999999986543 246779999999999999999999975322 2 2222 2223345667789999
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 258 ARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 258 ~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
+.+||.+||..||++|||++++++||||+...
T Consensus 255 ~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 255 AKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999999998654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=390.24 Aligned_cols=257 Identities=26% Similarity=0.425 Sum_probs=194.4
Q ss_pred ccccCCeEE-cceEcccCceEEEEEEEc--CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 24 PTLLNRYQL-GPLLGRGSFAKVHKAKSI--ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 24 ~~~~~~y~~-~~~LG~G~~g~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
..+.+.|++ ++.||+|+||+||+|++. .+++.||||++..... ...+.+|+.+|++|+ ||||+++++++.
T Consensus 16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~E~~~l~~l~-hpniv~~~~~~~ 88 (405)
T 3rgf_A 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI------SMSACREIALLRELK-HPNVISLQKVFL 88 (405)
T ss_dssp CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC------CHHHHHHHHHHHHCC-CTTBCCCCEEEE
T ss_pred hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC------CHHHHHHHHHHHhcC-CCCeeeEeeEEe
Confidence 345567887 568999999999999965 5788999999976522 235778999999996 999999999995
Q ss_pred e--CCEEEEEEEecCCCchhHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEe----CC
Q 013005 101 T--KTKIYLVMEYAAGGELFGKLRR----------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL----DR 164 (451)
Q Consensus 101 ~--~~~~~lV~E~~~gg~L~~~l~~----------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILl----d~ 164 (451)
. ....|+||||+.+ +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.
T Consensus 89 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~ 167 (405)
T 3rgf_A 89 SHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPE 167 (405)
T ss_dssp ETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTT
T ss_pred cCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCC
Confidence 4 7789999999975 77777642 249999999999999999999999999999999999999 77
Q ss_pred CCCeEEEeccCCCcchhhhc--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH-----
Q 013005 165 DGNLKVSDFGLSALPEQIKN--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL----- 237 (451)
Q Consensus 165 ~~~lkl~DFGls~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~----- 237 (451)
++.+||+|||++........ ......+||+.|+|||++.+....+.++|||||||++|+|++|..||...+..
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 247 (405)
T 3rgf_A 168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247 (405)
T ss_dssp TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------C
T ss_pred CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccc
Confidence 88999999999986543221 33456789999999999987666678899999999999999999999754431
Q ss_pred ----HHHHHhhcc-CCC-------------------------------------CCCCCCHhHHHHHHhccCCCCCCCCC
Q 013005 238 ----AMYKKVNRR-DYQ-------------------------------------FPSFVSKPARSLIYQLLDPNPKTRMS 275 (451)
Q Consensus 238 ----~~~~~i~~~-~~~-------------------------------------~p~~~s~~~~~li~~~L~~dP~~Rpt 275 (451)
.....+... ... .....++.+.+||.+||..||.+|||
T Consensus 248 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t 327 (405)
T 3rgf_A 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT 327 (405)
T ss_dssp CCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC
T ss_pred cchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC
Confidence 112211110 000 01112678899999999999999999
Q ss_pred HHHHHcCccccch
Q 013005 276 IEKIMSISWFQKS 288 (451)
Q Consensus 276 ~~eil~hp~f~~~ 288 (451)
++|+++||||+..
T Consensus 328 a~e~L~hp~f~~~ 340 (405)
T 3rgf_A 328 SEQAMQDPYFLED 340 (405)
T ss_dssp HHHHHTSGGGTSS
T ss_pred HHHHhcChhhccC
Confidence 9999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=375.68 Aligned_cols=267 Identities=21% Similarity=0.355 Sum_probs=202.6
Q ss_pred CCCCcccccCCeEEcceEcccCceEEEEEEEcCCCc---EEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEE
Q 013005 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGS---IVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95 (451)
Q Consensus 19 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l 95 (451)
.........++|++.+.||+|+||.||+|.+..++. .||||++.... ......+.+.+|+.++++++ ||||+++
T Consensus 14 ~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~ 90 (323)
T 3qup_A 14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADI--IASSDIEEFLREAACMKEFD-HPHVAKL 90 (323)
T ss_dssp --CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHHHHHHHHHHTTCC-CTTBCCC
T ss_pred HhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccc--cCHHHHHHHHHHHHHHHHCC-CCceehh
Confidence 344566778899999999999999999999877665 89999997642 12344678899999999995 9999999
Q ss_pred EEEEEeCCEE------EEEEEecCCCchhHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEe
Q 013005 96 QEVMATKTKI------YLVMEYAAGGELFGKLRRG-------RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL 162 (451)
Q Consensus 96 ~~~~~~~~~~------~lV~E~~~gg~L~~~l~~~-------~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILl 162 (451)
++++...... |+||||+.+|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 91 ~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli 170 (323)
T 3qup_A 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML 170 (323)
T ss_dssp CEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred hceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE
Confidence 9999877655 9999999999999988531 59999999999999999999999999999999999999
Q ss_pred CCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHH
Q 013005 163 DRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMY 240 (451)
Q Consensus 163 d~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~ 240 (451)
+.++.+||+|||++........ .......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.....
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~ 249 (323)
T 3qup_A 171 AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLY-TVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY 249 (323)
T ss_dssp CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCC-CCccchhhHHHHHHHHHhCCCCCccccChHHHH
Confidence 9999999999999975433221 22234457889999999977666 577999999999999999 99999987777666
Q ss_pred HHhhcc-CCCCCCCCCHhHHHHHHhccCCCCCCCCC-------HHHHHcCccccchh
Q 013005 241 KKVNRR-DYQFPSFVSKPARSLIYQLLDPNPKTRMS-------IEKIMSISWFQKSL 289 (451)
Q Consensus 241 ~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt-------~~eil~hp~f~~~~ 289 (451)
..+... ....+..+++.+.+||.+||..||.+||| +++++.|||+....
T Consensus 250 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 250 NYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred HHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 666554 35667789999999999999999999999 88899999997653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=384.88 Aligned_cols=260 Identities=21% Similarity=0.305 Sum_probs=221.7
Q ss_pred ccccCCeEEcceEcccCceEEEEEE-----EcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAK-----SIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
....++|++++.||+|+||+||+|. +..++..||||++.... .......+.+|+.+++++. ||||++++++
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~ 142 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC---SEQDELDFLMEALIISKFN-HQNIVRCIGV 142 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC---CHHHHHHHHHHHHHHHHCC-CTTBCCEEEE
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc---ChhhHHHHHHHHHHHHhCC-CCCCCeEEEE
Confidence 4456899999999999999999999 45578899999996542 2344557889999999995 9999999999
Q ss_pred EEeCCEEEEEEEecCCCchhHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC---C
Q 013005 99 MATKTKIYLVMEYAAGGELFGKLRR--------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG---N 167 (451)
Q Consensus 99 ~~~~~~~~lV~E~~~gg~L~~~l~~--------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~---~ 167 (451)
+.+....|+||||+.||+|.+++.. ..+++.+++.++.||+.||.|||++||+||||||+|||++.+| .
T Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCce
Confidence 9999999999999999999999964 2499999999999999999999999999999999999999655 4
Q ss_pred eEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhc
Q 013005 168 LKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNR 245 (451)
Q Consensus 168 lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~ 245 (451)
+||+|||++........ ......+||+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~ 301 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 99999999975433222 33345678999999999987766 567999999999999998 9999999988888777766
Q ss_pred cC-CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 246 RD-YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 246 ~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.. ...+..++..+.+||.+||..||.+|||+++|+++.|+...
T Consensus 302 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 302 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 54 45567789999999999999999999999999999887654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=371.37 Aligned_cols=260 Identities=29% Similarity=0.460 Sum_probs=215.5
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEc-CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhc--CCCCceEEEEEE
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSI-ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ--NHPNVLKIQEVM 99 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~--~HpnIv~l~~~~ 99 (451)
.....++|++.+.||+|+||.||+|.+. .+++.||+|++..... .......+.+|+.+++.+. +||||+++++++
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~ 83 (326)
T 1blx_A 6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG--EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVC 83 (326)
T ss_dssp CCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC--TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred ccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcc--cccCCchhhHHHHHHHhhhccCCCCeEeeeeee
Confidence 3456689999999999999999999995 6789999999975421 1111234567888777774 599999999998
Q ss_pred E-----eCCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEE
Q 013005 100 A-----TKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVS 171 (451)
Q Consensus 100 ~-----~~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~ 171 (451)
. .....|+||||+. |+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 84 TVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp EEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred eecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEe
Confidence 7 5678999999998 599998864 349999999999999999999999999999999999999999999999
Q ss_pred eccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC----
Q 013005 172 DFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD---- 247 (451)
Q Consensus 172 DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~---- 247 (451)
|||++...... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+....
T Consensus 163 Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 163 DFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239 (326)
T ss_dssp SCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cCcccccccCC--CCccccccccceeCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99999765432 23345689999999999977666 567999999999999999999999887766655543210
Q ss_pred -----------------------CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 248 -----------------------YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 248 -----------------------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
..++..++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 01234578999999999999999999999999999999753
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=378.30 Aligned_cols=263 Identities=23% Similarity=0.403 Sum_probs=210.7
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcc-------hhhHHHHHHHHHHHHHHHHhcCCCCceE
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNK-------FLDAAMEDRIVREVSAMRRLQNHPNVLK 94 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~~~~~~~~~Ei~il~~L~~HpnIv~ 94 (451)
.+..+.++|++.+.||+|+||.||+|.+. +++.||||++..... ..+....+.+.+|+.++++++ ||||++
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~ 93 (362)
T 3pg1_A 16 ELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNILG 93 (362)
T ss_dssp HHHHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBCC
T ss_pred HHHHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCccc
Confidence 34567899999999999999999999974 599999999865321 123345578999999999995 999999
Q ss_pred EEEEEEe-----CCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCC
Q 013005 95 IQEVMAT-----KTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN 167 (451)
Q Consensus 95 l~~~~~~-----~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~ 167 (451)
+++++.. ....|+||||+. |+|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 172 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND 172 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC
Confidence 9999854 347899999998 588887764 46999999999999999999999999999999999999999999
Q ss_pred eEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc-
Q 013005 168 LKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR- 246 (451)
Q Consensus 168 lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~- 246 (451)
+||+|||++..... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||...+.......+...
T Consensus 173 ~kl~Dfg~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 250 (362)
T 3pg1_A 173 ITICDFNLAREDTA--DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV 250 (362)
T ss_dssp EEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred EEEEecCccccccc--ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 99999999974332 223345689999999999877555577899999999999999999999988766655544321
Q ss_pred -----------------------CCC--------CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 247 -----------------------DYQ--------FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 247 -----------------------~~~--------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
... .++..++.+.+||.+||..||.+|||++++++||||+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 001 1234688899999999999999999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=377.74 Aligned_cols=256 Identities=23% Similarity=0.328 Sum_probs=220.9
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEc-----CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEE
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSI-----ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQ 96 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~ 96 (451)
.+....++|++.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.++++++ ||||++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~-hp~iv~~~ 116 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFD-NPNIVKLL 116 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCC-CTTBCCEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc---CHHHHHHHHHHHHHHHhCC-CCCEEEEE
Confidence 34566789999999999999999999987 355899999997542 3445678999999999995 99999999
Q ss_pred EEEEeCCEEEEEEEecCCCchhHHhhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013005 97 EVMATKTKIYLVMEYAAGGELFGKLRR-------------------------GRLTESAARRYFQQLVSALHFCHQNGVA 151 (451)
Q Consensus 97 ~~~~~~~~~~lV~E~~~gg~L~~~l~~-------------------------~~l~e~~~~~~~~ql~~gL~yLH~~gii 151 (451)
+++.+.+..|+||||+++|+|.+++.. ..+++.+++.++.||+.||.|||++||+
T Consensus 117 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iv 196 (343)
T 1luf_A 117 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV 196 (343)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 999999999999999999999999865 5699999999999999999999999999
Q ss_pred ecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCC
Q 013005 152 HRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYL 229 (451)
Q Consensus 152 HrDLKpeNILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~ 229 (451)
||||||+|||++.++.+||+|||++........ .......||+.|+|||++.+..+ +.++||||||+++|+|++ |..
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCC
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCc-CcccccHHHHHHHHHHHhcCCC
Confidence 999999999999999999999999875433221 23345678999999999887666 567999999999999999 999
Q ss_pred CCCCCcHHHHHHHhhccCC-CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 230 PFDDSNLLAMYKKVNRRDY-QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 230 Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
||...+.......+..... .+|..+++.+.+||.+||..||.+|||+.+++++
T Consensus 276 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 276 PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp TTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 9999888877777766543 5677899999999999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=373.15 Aligned_cols=259 Identities=24% Similarity=0.404 Sum_probs=213.2
Q ss_pred CCCcccccCCeEEcceEcccCceEEEEEEEcCCC-cEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCC------c
Q 013005 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADG-SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN------V 92 (451)
Q Consensus 20 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~Hpn------I 92 (451)
......+.++|++.+.||+|+||+||+|.+..++ +.||+|++.... ...+.+.+|+.+++.+. |++ +
T Consensus 11 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~-~~~~~~~~~~ 84 (355)
T 2eu9_A 11 CRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-----KYREAARLEINVLKKIK-EKDKENKFLC 84 (355)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHH-HHCTTSCSCB
T ss_pred cccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-----cchhHHHHHHHHHHHHh-hcCCCCceeE
Confidence 4445567899999999999999999999998777 699999997542 34567888999999996 555 9
Q ss_pred eEEEEEEEeCCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEe-------
Q 013005 93 LKIQEVMATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL------- 162 (451)
Q Consensus 93 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILl------- 162 (451)
+.+++++......|+||||+ +++|.+.+.. ..+++.+++.++.||+.||.|||++||+||||||+|||+
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~ 163 (355)
T 2eu9_A 85 VLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFET 163 (355)
T ss_dssp CCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEE
T ss_pred EEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccc
Confidence 99999999999999999999 5566666653 369999999999999999999999999999999999999
Q ss_pred ------------CCCCCeEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCC
Q 013005 163 ------------DRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLP 230 (451)
Q Consensus 163 ------------d~~~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~P 230 (451)
+.++.+||+|||++.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..|
T Consensus 164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p 238 (355)
T 2eu9_A 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDH----EHHTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTL 238 (355)
T ss_dssp EECCC-CCCEEEESCCCEEECCCTTCEETT----SCCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccccccccccccCCCcEEEeecCcccccc----ccccCCcCCCcccCCeeeecCCC-CCccchHHHHHHHHHHHhCCCC
Confidence 567899999999997532 22345689999999999987766 5679999999999999999999
Q ss_pred CCCCcHHHHHHHhhccCCCCC--------------------------------------------CCCCHhHHHHHHhcc
Q 013005 231 FDDSNLLAMYKKVNRRDYQFP--------------------------------------------SFVSKPARSLIYQLL 266 (451)
Q Consensus 231 f~~~~~~~~~~~i~~~~~~~p--------------------------------------------~~~s~~~~~li~~~L 266 (451)
|...+.......+......+| ...+..+.+||.+||
T Consensus 239 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 318 (355)
T 2eu9_A 239 FQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRML 318 (355)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred CCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHh
Confidence 998776554443322111111 112457889999999
Q ss_pred CCCCCCCCCHHHHHcCccccchhH
Q 013005 267 DPNPKTRMSIEKIMSISWFQKSLQ 290 (451)
Q Consensus 267 ~~dP~~Rpt~~eil~hp~f~~~~~ 290 (451)
..||.+|||++++++||||+....
T Consensus 319 ~~dP~~Rpt~~e~l~hp~f~~~~~ 342 (355)
T 2eu9_A 319 EFDPAQRITLAEALLHPFFAGLTP 342 (355)
T ss_dssp CSSTTTSCCHHHHTTSGGGGGCCH
T ss_pred cCChhhCcCHHHHhcChhhcCCCh
Confidence 999999999999999999987543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=360.59 Aligned_cols=252 Identities=28% Similarity=0.453 Sum_probs=205.8
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
....++|++.+.||+|+||.||+|.+ +++.||+|++............+.+.+|+.+++.++ ||||+++++++.+.+
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 79 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCLKEP 79 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEECCC-
T ss_pred ccchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEecCC
Confidence 34578999999999999999999997 488999999976532222334567889999999996 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCCCeEEeCC--------CCCeEEEe
Q 013005 104 KIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNG---VAHRDVKPQNLLLDR--------DGNLKVSD 172 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~g---iiHrDLKpeNILld~--------~~~lkl~D 172 (451)
..|+||||++|++|.+++..+++++..++.++.|++.||.|||++| |+||||||+|||++. ++.+||+|
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp -CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred ceEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 9999999999999999998889999999999999999999999999 999999999999986 77899999
Q ss_pred ccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC--CCC
Q 013005 173 FGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD--YQF 250 (451)
Q Consensus 173 FGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~--~~~ 250 (451)
||++..... .......||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+.......+.... ...
T Consensus 160 fg~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (271)
T 3dtc_A 160 FGLAREWHR---TTKMSAAGAYAWMAPEVIRASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI 235 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCC-SHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC
T ss_pred CCccccccc---ccccCCCCccceeCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC
Confidence 999975433 22235679999999999877665 567999999999999999999999887776655554443 455
Q ss_pred CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 251 PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 251 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
|..+++.+.++|.+||..||.+|||+.+++++
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 67789999999999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=366.54 Aligned_cols=258 Identities=28% Similarity=0.405 Sum_probs=208.4
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
...+...++|++.+.||+|+||.||+|.+..+++.||+|++... ...+....+.+.+|+.+++++. ||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~ 104 (309)
T 2h34_A 27 SREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSET-LSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGE 104 (309)
T ss_dssp -------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGG-GGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEE
T ss_pred cCCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcc-cccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEe
Confidence 45567789999999999999999999999999999999999765 2234455678999999999995 999999999999
Q ss_pred eCCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcc
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALP 179 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~ 179 (451)
..+..|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 105 IDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp ETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred eCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 99999999999999999999975 78999999999999999999999999999999999999999999999999998765
Q ss_pred hhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC---CCCCCCCH
Q 013005 180 EQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY---QFPSFVSK 256 (451)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~ 256 (451)
...........+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+...+...+..... ..++.+++
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHA-TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPV 263 (309)
T ss_dssp ------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCT
T ss_pred cccccccccccCCCcCccCHHHHcCCCC-CchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCH
Confidence 4433334456689999999999877655 5679999999999999999999998877655555443322 34567899
Q ss_pred hHHHHHHhccCCCCCCCC-CHHHHHc
Q 013005 257 PARSLIYQLLDPNPKTRM-SIEKIMS 281 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~Rp-t~~eil~ 281 (451)
.+.++|.+||..||.+|| |++++++
T Consensus 264 ~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 264 AFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 999999999999999999 8888875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=371.41 Aligned_cols=252 Identities=25% Similarity=0.426 Sum_probs=211.6
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
..++|.+++.||+|+||+||+|.+..+++.||+|++... +....+.+.+|+.++++++ ||||+++++++.+....
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF----DEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC----CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCC-CcCcccEEEEEecCCee
Confidence 468999999999999999999999999999999998543 3455678999999999995 99999999999999999
Q ss_pred EEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh
Q 013005 106 YLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK 183 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~ 183 (451)
|+||||+.||+|.+++.. +.+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999999999975 679999999999999999999999999999999999999999999999999997543221
Q ss_pred cC-------------cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHH-----HHHHhhc
Q 013005 184 NG-------------MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLA-----MYKKVNR 245 (451)
Q Consensus 184 ~~-------------~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~-----~~~~i~~ 245 (451)
.. .....+||+.|+|||++.+..+ +.++||||||+++|+|++|..||....... ......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~- 240 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY-DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL- 240 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH-
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc-
Confidence 11 1125689999999999987666 567999999999999999999986532110 000000
Q ss_pred cCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 246 RDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 246 ~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
....|..+++.+.++|.+||..||++|||++++++ |++.
T Consensus 241 -~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~ 279 (310)
T 3s95_A 241 -DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLET 279 (310)
T ss_dssp -HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred -cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHH
Confidence 11346678899999999999999999999999987 4543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=365.79 Aligned_cols=258 Identities=24% Similarity=0.403 Sum_probs=207.4
Q ss_pred CCCCcccccCCeEEcceEcccCceEEEEEEEcCC---CcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEE
Q 013005 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIAD---GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95 (451)
Q Consensus 19 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l 95 (451)
+........++|++.+.||+|+||.||+|.+..+ +..||+|++.... .....+.+.+|+.+++++. ||||+++
T Consensus 6 s~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~ 81 (281)
T 1mp8_A 6 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT---SDSVREKFLQEALTMRQFD-HPHIVKL 81 (281)
T ss_dssp ---CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT---SHHHHHHHHHHHHHHHTCC-CTTBCCE
T ss_pred cccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHHhCC-CCccceE
Confidence 3455678889999999999999999999998654 4579999986532 3445678899999999995 9999999
Q ss_pred EEEEEeCCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEec
Q 013005 96 QEVMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDF 173 (451)
Q Consensus 96 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DF 173 (451)
++++. .+..|+||||+.+++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df 160 (281)
T 1mp8_A 82 IGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 160 (281)
T ss_dssp EEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-
T ss_pred EEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcc
Confidence 99984 5678999999999999999974 46999999999999999999999999999999999999999999999999
Q ss_pred cCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCC
Q 013005 174 GLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFP 251 (451)
Q Consensus 174 Gls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p 251 (451)
|++...............+|+.|+|||++....+ +.++||||||+++|+|++ |..||...+.......+... ...++
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 239 (281)
T 1mp8_A 161 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 239 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred ccccccCcccccccccCCCcccccChhhcccCCC-CCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCC
Confidence 9998654433233344567889999999977666 567999999999999996 99999987766666666543 34667
Q ss_pred CCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 252 SFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 252 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
..+++.+.++|.+||..||.+|||+.+++++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7899999999999999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=359.74 Aligned_cols=252 Identities=26% Similarity=0.386 Sum_probs=217.7
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
+....++|++.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.+++++. ||||+++++++.+.
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 75 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-----SEDEFFQEAQTMMKLS-HPKLVKFYGVCSKE 75 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSS
T ss_pred eEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-----cHHHHHHHHHHHHhCC-CCCEeeEEEEEccC
Confidence 4556789999999999999999999874 677899999976532 1246889999999996 99999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 103 TKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
...|+||||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 155 (268)
T 3sxs_A 76 YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL 155 (268)
T ss_dssp SSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECC
T ss_pred CceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecc
Confidence 999999999999999999975 459999999999999999999999999999999999999999999999999987544
Q ss_pred hhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhccC-CCCCCCCCHhH
Q 013005 181 QIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRD-YQFPSFVSKPA 258 (451)
Q Consensus 181 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 258 (451)
...........+|+.|+|||++.+..+ +.++||||+|+++|+|++ |..||...+.......+.... ...|...++.+
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 234 (268)
T 3sxs_A 156 DDQYVSSVGTKFPVKWSAPEVFHYFKY-SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTI 234 (268)
T ss_dssp TTCEEECCSCCCCGGGCCHHHHHHSEE-ETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHH
T ss_pred hhhhhcccCCCcCcccCCHHHHhccCC-chhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHH
Confidence 332223344567788999999877666 566999999999999999 999999888877777666554 34456689999
Q ss_pred HHHHHhccCCCCCCCCCHHHHHcC
Q 013005 259 RSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 259 ~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
.++|.+||..||.+|||+.+++++
T Consensus 235 ~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 235 YQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=369.94 Aligned_cols=264 Identities=24% Similarity=0.343 Sum_probs=221.6
Q ss_pred CCCCCCCCCcccccCCeEEcceEcccCceEEEEEEEc-----CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcC
Q 013005 14 PPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSI-----ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN 88 (451)
Q Consensus 14 ~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~ 88 (451)
.........+....++|.+.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++++.
T Consensus 9 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~- 84 (314)
T 2ivs_A 9 AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA---SPSELRDLLSEFNVLKQVN- 84 (314)
T ss_dssp -----CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHTTCC-
T ss_pred ceeccCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCC-
Confidence 3334445566777899999999999999999999983 456899999997542 3445577899999999995
Q ss_pred CCCceEEEEEEEeCCEEEEEEEecCCCchhHHhhcC-------------------------CCCHHHHHHHHHHHHHHHH
Q 013005 89 HPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRG-------------------------RLTESAARRYFQQLVSALH 143 (451)
Q Consensus 89 HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-------------------------~l~e~~~~~~~~ql~~gL~ 143 (451)
||||+++++++.+.+..|+||||+.||+|.+++... .+++.+++.++.||+.||.
T Consensus 85 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 164 (314)
T 2ivs_A 85 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQ 164 (314)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHH
T ss_pred CCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999742 2899999999999999999
Q ss_pred HHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHH
Q 013005 144 FCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILF 222 (451)
Q Consensus 144 yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~ 222 (451)
|||++||+||||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+..+ +.++||||||+++|
T Consensus 165 ~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ 243 (314)
T 2ivs_A 165 YLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLW 243 (314)
T ss_dssp HHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE-CHHHHHHHHHHHHH
T ss_pred HHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCc-CchhhHHHHHHHHH
Confidence 99999999999999999999999999999999975433221 12334567899999999877655 56799999999999
Q ss_pred HHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 223 VLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 223 ~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
+|++ |..||...+.......+... ....|..+++.+.++|.+||..||.+|||+++++++
T Consensus 244 el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 244 EIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999 99999987776666666554 345667789999999999999999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=366.19 Aligned_cols=264 Identities=23% Similarity=0.383 Sum_probs=200.3
Q ss_pred CCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE
Q 013005 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 19 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
.........++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+..+..+++.+ +||||++++++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~ 92 (318)
T 2dyl_A 16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN--KEENKRILMDLDVVLKSH-DCPYIVQCFGT 92 (318)
T ss_dssp SSSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC--HHHHHHHHHHHHHHHHTT-TCTTBCCEEEE
T ss_pred cchhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc--chHHHHHHHHHHHHHHhc-CCCceeeEEEE
Confidence 344556778999999999999999999999999999999999976532 222333344444556666 59999999999
Q ss_pred EEeCCEEEEEEEecCCCchhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCeEEeCCCCCeEEEeccC
Q 013005 99 MATKTKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQN-GVAHRDVKPQNLLLDRDGNLKVSDFGL 175 (451)
Q Consensus 99 ~~~~~~~~lV~E~~~gg~L~~~l~--~~~l~e~~~~~~~~ql~~gL~yLH~~-giiHrDLKpeNILld~~~~lkl~DFGl 175 (451)
+.+.+..|+||||+ ++.+..+.. .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 171 (318)
T 2dyl_A 93 FITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGI 171 (318)
T ss_dssp EECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCC
Confidence 99999999999999 555555554 37899999999999999999999995 999999999999999999999999999
Q ss_pred CCcchhhhcCcccccCCCCccccceeeec----cCCCCccchhhhhhHHHHHHHhcCCCCCC-CcHHHHHHHhhccCC-C
Q 013005 176 SALPEQIKNGMLHTACGTPAYTAPEVVAR----RGYDGAVADAWSCGVILFVLLAGYLPFDD-SNLLAMYKKVNRRDY-Q 249 (451)
Q Consensus 176 s~~~~~~~~~~~~~~~gt~~y~APEvl~~----~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~-~~~~~~~~~i~~~~~-~ 249 (451)
+...... ......+||+.|+|||++.. ....+.++||||||+++|+|++|..||.. .........+..... .
T Consensus 172 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (318)
T 2dyl_A 172 SGRLVDD--KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL 249 (318)
T ss_dssp C----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC
T ss_pred chhccCC--ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC
Confidence 8754332 22345679999999999852 23345679999999999999999999987 344445555444332 3
Q ss_pred CC--CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 250 FP--SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 250 ~p--~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+| ..+++.+.+||.+||..||.+|||++++++||||+..
T Consensus 250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 250 LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 33 3478999999999999999999999999999999764
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=365.67 Aligned_cols=267 Identities=24% Similarity=0.418 Sum_probs=216.1
Q ss_pred CCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcC-CCCceEEEE
Q 013005 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN-HPNVLKIQE 97 (451)
Q Consensus 19 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~-HpnIv~l~~ 97 (451)
....+....++|++.+.||+|+||.||+|.+ .+++.||+|++.... ......+.+.+|+.+++++.+ ||||+++++
T Consensus 19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE--ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp -CCEEEETTEEEEEEEEEECCSSEEEEEEEC-TTCCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CeeeeeeccceEEEEEEecCCCCEEEEEEEc-CCCcEEEEEEecccc--ccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 4566677788999999999999999999997 468999999997652 234556788999999999974 699999999
Q ss_pred EEEeCCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCC
Q 013005 98 VMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176 (451)
Q Consensus 98 ~~~~~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls 176 (451)
++.+....|+||| +.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++
T Consensus 96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~ 173 (313)
T 3cek_A 96 YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA 173 (313)
T ss_dssp EEECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred EeecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccc
Confidence 9999999999999 568899999975 6799999999999999999999999999999999999996 489999999999
Q ss_pred Ccchhhhc-CcccccCCCCccccceeeecc----------CCCCccchhhhhhHHHHHHHhcCCCCCCCc-HHHHHHHhh
Q 013005 177 ALPEQIKN-GMLHTACGTPAYTAPEVVARR----------GYDGAVADAWSCGVILFVLLAGYLPFDDSN-LLAMYKKVN 244 (451)
Q Consensus 177 ~~~~~~~~-~~~~~~~gt~~y~APEvl~~~----------~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~-~~~~~~~i~ 244 (451)
........ ......+||+.|+|||++.+. ...+.++||||||+++|+|++|..||.... .......+.
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 253 (313)
T 3cek_A 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 253 (313)
T ss_dssp CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH
Confidence 86543222 223456799999999998652 234667999999999999999999998643 333333333
Q ss_pred cc--CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchhH
Q 013005 245 RR--DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQ 290 (451)
Q Consensus 245 ~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 290 (451)
.. ...+|...+..+.+||.+||..||.+|||++++++||||+....
T Consensus 254 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 254 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence 32 34567778999999999999999999999999999999987543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=368.36 Aligned_cols=264 Identities=23% Similarity=0.359 Sum_probs=221.4
Q ss_pred CCCCCCCCcccccCCeEEcceEcccCceEEEEEEE-----cCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCC
Q 013005 15 PPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKS-----IADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89 (451)
Q Consensus 15 ~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~H 89 (451)
...|....+....++|++++.||+|+||.||+|.+ ..+++.||+|++.... .....+.+.+|+.+++++.+|
T Consensus 10 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h 86 (313)
T 1t46_A 10 TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNH 86 (313)
T ss_dssp TTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCC
T ss_pred ccCCCccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch---hHHHHHHHHHHHHHHhhcccC
Confidence 34456667778889999999999999999999985 4577899999997652 233457789999999999669
Q ss_pred CCceEEEEEEEeCCEEEEEEEecCCCchhHHhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013005 90 PNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRG-------------------RLTESAARRYFQQLVSALHFCHQNGV 150 (451)
Q Consensus 90 pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-------------------~l~e~~~~~~~~ql~~gL~yLH~~gi 150 (451)
|||+++++++...+..|+||||+++|+|.+++... .+++..++.++.||+.||.|||++||
T Consensus 87 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 166 (313)
T 1t46_A 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC 166 (313)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 99999999999999999999999999999999742 38999999999999999999999999
Q ss_pred eecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cC
Q 013005 151 AHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GY 228 (451)
Q Consensus 151 iHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~ 228 (451)
+||||||+|||++.++.+||+|||++........ .......||+.|+|||++.+..+ +.++||||||+++|+|++ |.
T Consensus 167 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~ 245 (313)
T 1t46_A 167 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGS 245 (313)
T ss_dssp CCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTC
T ss_pred ecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999976543222 12334567889999999877665 577999999999999998 99
Q ss_pred CCCCCCcHHHHHHHhhcc--CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 229 LPFDDSNLLAMYKKVNRR--DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 229 ~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
.||............... ....+..++..+.++|.+||..||.+|||+.+++++
T Consensus 246 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 246 SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp CSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 999876544333332222 234456789999999999999999999999999975
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=364.77 Aligned_cols=257 Identities=23% Similarity=0.377 Sum_probs=224.3
Q ss_pred CCCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEE
Q 013005 18 PPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQE 97 (451)
Q Consensus 18 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~ 97 (451)
|....+....++|++.+.||+|+||.||+|.+..++..||+|++.... ...+.+.+|+.++++++ ||||+++++
T Consensus 3 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~E~~~l~~l~-h~~i~~~~~ 76 (288)
T 3kfa_A 3 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIK-HPNLVQLLG 76 (288)
T ss_dssp TTCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-----THHHHHHHHHHHHHHCC-CTTBCCEEE
T ss_pred CchhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-----HHHHHHHHHHHHHHhCC-CCCEeeEEE
Confidence 445677888999999999999999999999999999999999997642 23467889999999996 999999999
Q ss_pred EEEeCCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEecc
Q 013005 98 VMATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFG 174 (451)
Q Consensus 98 ~~~~~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFG 174 (451)
++.+....|+||||+.|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 77 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg 156 (288)
T 3kfa_A 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 156 (288)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred EEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCc
Confidence 99999999999999999999999974 459999999999999999999999999999999999999999999999999
Q ss_pred CCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCC
Q 013005 175 LSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPS 252 (451)
Q Consensus 175 ls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~ 252 (451)
++...............+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+... ....|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 3kfa_A 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE 235 (288)
T ss_dssp GGGTSCSSSSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCT
T ss_pred cceeccCCccccccCCccccCcCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCC
Confidence 997654333233344567889999999977766 567999999999999999 99999987766666655544 345667
Q ss_pred CCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 253 FVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 253 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.+++.+.+||.+||..||.+|||++++++
T Consensus 236 ~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 236 GCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 78999999999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=377.62 Aligned_cols=260 Identities=23% Similarity=0.440 Sum_probs=210.1
Q ss_pred CCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcC----------
Q 013005 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN---------- 88 (451)
Q Consensus 19 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~---------- 88 (451)
.....+...++|++.+.||+|+||+||+|.+..+++.||||++.... ...+.+.+|+.+++++.+
T Consensus 10 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~ 84 (373)
T 1q8y_A 10 AFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-----VYTEAAEDEIKLLQRVNDADNTKEDSMG 84 (373)
T ss_dssp CCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHTCCSHHHHHH
T ss_pred eecCCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-----cchhhhhHHHHHHHHhhcccccchhccc
Confidence 33344456789999999999999999999999999999999997542 334567889999988852
Q ss_pred CCCceEEEEEEEeCC----EEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCeE
Q 013005 89 HPNVLKIQEVMATKT----KIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQN-GVAHRDVKPQNL 160 (451)
Q Consensus 89 HpnIv~l~~~~~~~~----~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~-giiHrDLKpeNI 160 (451)
||||+++++++.... ..++||||+ +++|.+++.. +.+++..++.++.||+.||.|||++ ||+||||||+||
T Consensus 85 ~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NI 163 (373)
T 1q8y_A 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENV 163 (373)
T ss_dssp HTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGE
T ss_pred cchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHe
Confidence 799999999997654 799999999 8899999864 5699999999999999999999998 999999999999
Q ss_pred EeC------CCCCeEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCC
Q 013005 161 LLD------RDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS 234 (451)
Q Consensus 161 Lld------~~~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~ 234 (451)
|++ ..+.+||+|||++..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...
T Consensus 164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~ 238 (373)
T 1q8y_A 164 LMEIVDSPENLIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPD 238 (373)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEeccCCCcCcceEEEcccccccccCC----CCCCCCCCccccCcHHHhCCCC-CchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 994 344799999999975432 2345689999999999987766 56799999999999999999999864
Q ss_pred cH------HHHHHHhh------------------------------------------ccCCCCCCCCCHhHHHHHHhcc
Q 013005 235 NL------LAMYKKVN------------------------------------------RRDYQFPSFVSKPARSLIYQLL 266 (451)
Q Consensus 235 ~~------~~~~~~i~------------------------------------------~~~~~~p~~~s~~~~~li~~~L 266 (451)
+. ......+. .....++...++.+.+||.+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 318 (373)
T 1q8y_A 239 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 318 (373)
T ss_dssp ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred cccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHh
Confidence 31 11111111 1122334445678899999999
Q ss_pred CCCCCCCCCHHHHHcCccccchh
Q 013005 267 DPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 267 ~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
..||.+|||++++++||||+...
T Consensus 319 ~~dP~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 319 QLDPRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp CSSTTTCBCHHHHHTCGGGTTCT
T ss_pred ccCccccCCHHHHhhChhhhccc
Confidence 99999999999999999998643
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=373.56 Aligned_cols=249 Identities=18% Similarity=0.257 Sum_probs=211.3
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
-.+.++|++.+.||+|+||+||+|.+..+++.||||++..... .+.+.+|+.++++|.+||||+++++++....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 78 (330)
T 2izr_A 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR------APQLHLEYRFYKQLGSGDGIPQVYYFGPCGK 78 (330)
T ss_dssp CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS------SCCHHHHHHHHHHHCSCTTSCCEEEEEEETT
T ss_pred EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc------hHHHHHHHHHHHHhhCCCCCCEEEEEEecCC
Confidence 3456889999999999999999999999999999999975422 1357889999999966999999999999999
Q ss_pred EEEEEEEecCCCchhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCC-----eEEEeccCC
Q 013005 104 KIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN-----LKVSDFGLS 176 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~--~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~-----lkl~DFGls 176 (451)
..|+||||+ |++|.+++. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 79 YNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred ccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 999999999 999999997 368999999999999999999999999999999999999999887 999999999
Q ss_pred CcchhhhcC------cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCC---CcHHHHHHHhhccC
Q 013005 177 ALPEQIKNG------MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDD---SNLLAMYKKVNRRD 247 (451)
Q Consensus 177 ~~~~~~~~~------~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~---~~~~~~~~~i~~~~ 247 (451)
......... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.. ......+..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~ 236 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK 236 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh
Confidence 754332211 1346789999999999988766 5779999999999999999999987 44455555554433
Q ss_pred CCCC-----CCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 248 YQFP-----SFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 248 ~~~p-----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
...+ ...+ .+.++|.+||..||.+||++++|.+
T Consensus 237 ~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 237 RATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 3222 2234 9999999999999999999999987
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=367.75 Aligned_cols=260 Identities=21% Similarity=0.376 Sum_probs=221.5
Q ss_pred CCCCcccccCCeEEcceEcccCceEEEEEEEc-------CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCC
Q 013005 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSI-------ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN 91 (451)
Q Consensus 19 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~Hpn 91 (451)
....+....++|++++.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++++.+|||
T Consensus 26 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~ 102 (334)
T 2pvf_A 26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKN 102 (334)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC---CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC---cHHHHHHHHHHHHHHHHhhcCCC
Confidence 44556677899999999999999999999975 457789999997542 33455678999999999966999
Q ss_pred ceEEEEEEEeCCEEEEEEEecCCCchhHHhhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q 013005 92 VLKIQEVMATKTKIYLVMEYAAGGELFGKLRRG-----------------RLTESAARRYFQQLVSALHFCHQNGVAHRD 154 (451)
Q Consensus 92 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-----------------~l~e~~~~~~~~ql~~gL~yLH~~giiHrD 154 (451)
|+++++++...+..|+||||+.+|+|.+++... .+++.+++.++.||+.||.|||++||+|||
T Consensus 103 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~D 182 (334)
T 2pvf_A 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRD 182 (334)
T ss_dssp BCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred EeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence 999999999999999999999999999999752 389999999999999999999999999999
Q ss_pred CCCCeEEeCCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCC
Q 013005 155 VKPQNLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFD 232 (451)
Q Consensus 155 LKpeNILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~ 232 (451)
|||+|||++.++.+||+|||++........ .......+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.
T Consensus 183 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~ 261 (334)
T 2pvf_A 183 LAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYP 261 (334)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc-ChHHHHHHHHHHHHHHHhCCCCCcC
Confidence 999999999999999999999975433221 12234467889999999877655 567999999999999999 999999
Q ss_pred CCcHHHHHHHhhccC-CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 233 DSNLLAMYKKVNRRD-YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 233 ~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
..+.......+.... ...+..++..+.++|.+||..||.+|||+.+++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 262 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp TCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 988887777666543 45667789999999999999999999999999975
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=378.64 Aligned_cols=258 Identities=24% Similarity=0.408 Sum_probs=220.2
Q ss_pred CCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE
Q 013005 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 19 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
+...+....++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.+|+++. ||||++++++
T Consensus 105 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~-hpniv~~~~~ 180 (377)
T 3cbl_A 105 PKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL---PPDLKAKFLQEARILKQYS-HPNIVRLIGV 180 (377)
T ss_dssp CCCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS---CHHHHTTTTHHHHHHTTCC-CTTBCCEEEE
T ss_pred cccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC---CHHHHHHHHHHHHHHHhCC-CCCEEEEEEE
Confidence 34456667789999999999999999999999899999999987542 2344567889999999995 9999999999
Q ss_pred EEeCCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCC
Q 013005 99 MATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176 (451)
Q Consensus 99 ~~~~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls 176 (451)
+......|+||||++||+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 181 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s 260 (377)
T 3cbl_A 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260 (377)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred EecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCc
Confidence 9999999999999999999999974 46999999999999999999999999999999999999999999999999998
Q ss_pred Ccchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCC
Q 013005 177 ALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSF 253 (451)
Q Consensus 177 ~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~ 253 (451)
........ .......+++.|+|||++....+ +.++|||||||++|+|++ |..||...+.......+... ....|..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 339 (377)
T 3cbl_A 261 REEADGVYAASGGLRQVPVKWTAPEALNYGRY-SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPEL 339 (377)
T ss_dssp EECTTSEEECCSSCCEEEGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTT
T ss_pred eecCCCceeecCCCCCCCcCcCCHhHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 74322111 11122335778999999876665 567999999999999998 99999988777666655543 4566777
Q ss_pred CCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 254 VSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 254 ~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+++.+.+||.+||..||.+|||++++++
T Consensus 340 ~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 8999999999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=365.10 Aligned_cols=258 Identities=20% Similarity=0.284 Sum_probs=222.3
Q ss_pred CCCcccccCCeEEcceEcccCceEEEEEEEc-----CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceE
Q 013005 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSI-----ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94 (451)
Q Consensus 20 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~ 94 (451)
...+....++|++.+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.+. ||||++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~-h~~i~~ 92 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFN-CHHVVR 92 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCC-CTTBCC
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc---CHHHHHHHHHHHHHHHhcC-CCCEee
Confidence 4456777899999999999999999999876 357899999997542 2344567889999999995 999999
Q ss_pred EEEEEEeCCEEEEEEEecCCCchhHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeC
Q 013005 95 IQEVMATKTKIYLVMEYAAGGELFGKLRR-----------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLD 163 (451)
Q Consensus 95 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-----------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld 163 (451)
+++++.+....|+||||+.||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~ 172 (322)
T 1p4o_A 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA 172 (322)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC
T ss_pred eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEc
Confidence 99999999999999999999999999864 4579999999999999999999999999999999999999
Q ss_pred CCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHH
Q 013005 164 RDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYK 241 (451)
Q Consensus 164 ~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~ 241 (451)
.++.+||+|||++........ .......||+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+......
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 251 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCC-CchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence 999999999999975433222 22334567899999999877665 567999999999999999 899999988877777
Q ss_pred HhhccC-CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 242 KVNRRD-YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 242 ~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
.+.... ...+..++..+.+||.+||..||.+|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 252 FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 766544 35667789999999999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=364.11 Aligned_cols=247 Identities=23% Similarity=0.304 Sum_probs=210.6
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCC-------cEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADG-------SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQE 97 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~-------~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~ 97 (451)
...++|++.+.||+|+||.||+|.+..++ ..||+|++.... ....+.+.+|+.++++++ ||||+++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~E~~~l~~l~-h~~iv~~~~ 79 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH----RNYSESFFEAASMMSKLS-HKHLVLNYG 79 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG----GGGHHHHHHHHHHHHTSC-CTTBCCEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc----HHHHHHHHHHHHHHHhCC-CCCEeEEEE
Confidence 45689999999999999999999998877 479999996542 233467889999999996 999999999
Q ss_pred EEEeCCEEEEEEEecCCCchhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCC--------
Q 013005 98 VMATKTKIYLVMEYAAGGELFGKLRRG--RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN-------- 167 (451)
Q Consensus 98 ~~~~~~~~~lV~E~~~gg~L~~~l~~~--~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~-------- 167 (451)
++.+.+..|+||||+.||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 80 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 80 VCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp EECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred EEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccce
Confidence 999999999999999999999999753 3999999999999999999999999999999999999998887
Q ss_pred eEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhc-CCCCCCCcHHHHHHHhhcc
Q 013005 168 LKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAG-YLPFDDSNLLAMYKKVNRR 246 (451)
Q Consensus 168 lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G-~~Pf~~~~~~~~~~~i~~~ 246 (451)
+||+|||++..... .....||+.|+|||++.+....+.++||||||+++|+|++| ..||...+..... .....
T Consensus 160 ~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~~ 233 (289)
T 4fvq_A 160 IKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYED 233 (289)
T ss_dssp EEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHT
T ss_pred eeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhhc
Confidence 99999999864322 12345889999999998755567889999999999999995 5555555544433 33344
Q ss_pred CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 247 DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 247 ~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
...+|...++.+.+||.+||..||.+|||++++++|
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 234 RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 566777789999999999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=361.03 Aligned_cols=252 Identities=16% Similarity=0.240 Sum_probs=212.9
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
...+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .+.+.+|+.+++.+.+|+||+++++++...
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 78 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEG 78 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc------cHHHHHHHHHHHHHhcCCCCCeEEeecCCC
Confidence 34567889999999999999999999999999999999875421 235778999999997799999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCC-----eEEEeccC
Q 013005 103 TKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN-----LKVSDFGL 175 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~-----lkl~DFGl 175 (451)
...|+||||+ +++|.+++.. .++++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 79 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 79 LHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred ceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 9999999999 9999999974 46999999999999999999999999999999999999988776 99999999
Q ss_pred CCcchhhhc------CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCC---cHHHHHHHhhcc
Q 013005 176 SALPEQIKN------GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS---NLLAMYKKVNRR 246 (451)
Q Consensus 176 s~~~~~~~~------~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~---~~~~~~~~i~~~ 246 (451)
+........ ......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||... .....+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 975443222 12356689999999999877666 67799999999999999999999873 344444444332
Q ss_pred CC-----CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 247 DY-----QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 247 ~~-----~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
.. ..+..+++.+.+||.+||..||++|||+++|++.
T Consensus 237 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 237 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 21 1234688999999999999999999999999864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=372.52 Aligned_cols=260 Identities=23% Similarity=0.359 Sum_probs=215.7
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEc-----CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEE
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSI-----ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l 95 (451)
..+....++|++++.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++++.+||||+++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~ 114 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNL 114 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 345566789999999999999999999973 466789999997542 233456789999999999569999999
Q ss_pred EEEEEeCCEEEEEEEecCCCchhHHhhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013005 96 QEVMATKTKIYLVMEYAAGGELFGKLRRG------------------------RLTESAARRYFQQLVSALHFCHQNGVA 151 (451)
Q Consensus 96 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~------------------------~l~e~~~~~~~~ql~~gL~yLH~~gii 151 (451)
++++...+..|+||||+++|+|.+++... .+++..++.++.||+.||.|||++||+
T Consensus 115 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 194 (344)
T 1rjb_A 115 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV 194 (344)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 99999999999999999999999999742 279999999999999999999999999
Q ss_pred ecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCC
Q 013005 152 HRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYL 229 (451)
Q Consensus 152 HrDLKpeNILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~ 229 (451)
||||||+|||++.++.+||+|||++........ .......||+.|+|||++.+..+ +.++|||||||++|+|++ |..
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCC
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC-ChhHhHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999986543222 12334567889999999877665 567999999999999998 999
Q ss_pred CCCCCcHHHHHHHhhcc--CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCcc
Q 013005 230 PFDDSNLLAMYKKVNRR--DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISW 284 (451)
Q Consensus 230 Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 284 (451)
||...+.......+... ....|..+++.+.+||.+||..||.+|||+.++++|..
T Consensus 274 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 274 PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp SSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 99876544333333322 34556778999999999999999999999999998743
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=355.24 Aligned_cols=248 Identities=19% Similarity=0.314 Sum_probs=215.2
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
.....++|++.+.||+|+||.||+|.+ +++.||+|++.... ......+.+.+|+.++++++ ||||+++++++.+.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 79 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRD--WSTRKSRDFNEECPRLRIFS-HPNVLPVLGACQSP 79 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTT--CCHHHHHHHHHHGGGGCCCS-CTTEECEEEEECTT
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccc--cCHHHHHHHHHHHHHHHhcC-CCchhheEEEEccC
Confidence 456678999999999999999999997 48899999997652 23345567999999999995 99999999999877
Q ss_pred --CEEEEEEEecCCCchhHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCeEEeCCCCCeEEEeccC
Q 013005 103 --TKIYLVMEYAAGGELFGKLRRG---RLTESAARRYFQQLVSALHFCHQNG--VAHRDVKPQNLLLDRDGNLKVSDFGL 175 (451)
Q Consensus 103 --~~~~lV~E~~~gg~L~~~l~~~---~l~e~~~~~~~~ql~~gL~yLH~~g--iiHrDLKpeNILld~~~~lkl~DFGl 175 (451)
...|+||||++||+|.+++... .+++.+++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~ 159 (271)
T 3kmu_A 80 PAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADV 159 (271)
T ss_dssp TSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGS
T ss_pred CCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccc
Confidence 7899999999999999999863 4899999999999999999999999 99999999999999999999999998
Q ss_pred CCcchhhhcCcccccCCCCccccceeeeccCCCCc--cchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc--CCCCC
Q 013005 176 SALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGA--VADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR--DYQFP 251 (451)
Q Consensus 176 s~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~--~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p 251 (451)
+... .....+||+.|+|||++.+..+... ++||||||+++|+|++|..||...+.......+... ...+|
T Consensus 160 ~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (271)
T 3kmu_A 160 KFSF------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP 233 (271)
T ss_dssp CCTT------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCC
T ss_pred eeee------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCC
Confidence 7632 2234578999999999977655432 699999999999999999999988877665555443 34567
Q ss_pred CCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 252 SFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 252 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
..+++.+.++|.+||..||++|||++++++
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 234 PGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 789999999999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=356.21 Aligned_cols=251 Identities=26% Similarity=0.405 Sum_probs=209.6
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHH---HHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAME---DRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~---~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
....++|++.+.||+|+||.||+|++..+++.||+|++............ +.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~ 93 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLMH 93 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEEET
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhheeec
Confidence 45668999999999999999999999999999999999765332222222 67889999999995 999999999987
Q ss_pred eCCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCeEEeCCCCC-----eEEE
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNG--VAHRDVKPQNLLLDRDGN-----LKVS 171 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~g--iiHrDLKpeNILld~~~~-----lkl~ 171 (451)
+.. ++||||+.+|+|.+.+.. ..+++..++.++.|++.||+|||++| |+||||||+|||++.++. +||+
T Consensus 94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 665 799999999999998854 57999999999999999999999999 999999999999988876 9999
Q ss_pred eccCCCcchhhhcCcccccCCCCccccceeeec-cCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH--HHHHHhhc--c
Q 013005 172 DFGLSALPEQIKNGMLHTACGTPAYTAPEVVAR-RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL--AMYKKVNR--R 246 (451)
Q Consensus 172 DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~-~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~--~~~~~i~~--~ 246 (451)
|||++.... ......+||+.|+|||++.. ....+.++|||||||++|+|++|..||...+.. .....+.. .
T Consensus 172 Dfg~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 247 (287)
T 4f0f_A 172 DFGLSQQSV----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247 (287)
T ss_dssp CCTTCBCCS----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred CCCcccccc----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence 999997432 23445689999999999843 223367799999999999999999999865432 22333332 2
Q ss_pred CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 247 DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 247 ~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
...++..+++.+.+||.+||..||.+|||++++++
T Consensus 248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 34567788999999999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=366.83 Aligned_cols=262 Identities=25% Similarity=0.392 Sum_probs=219.9
Q ss_pred CCCCCCcccccCCeEEcceEcccCceEEEEEEEcCCCc-----EEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCC
Q 013005 17 PPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGS-----IVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN 91 (451)
Q Consensus 17 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~Hpn 91 (451)
.+....+....++|++.+.||+|+||.||+|.+..+++ .||+|++.... .....+.+.+|+.+++++.+|||
T Consensus 35 ~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~ 111 (333)
T 2i1m_A 35 LPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA---HADEKEALMSELKIMSHLGQHEN 111 (333)
T ss_dssp SCCCGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred ccccccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc---ChHHHHHHHHHHHHHHhhcCCCC
Confidence 34455677788999999999999999999999977664 79999997642 23455778999999999955999
Q ss_pred ceEEEEEEEeCCEEEEEEEecCCCchhHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q 013005 92 VLKIQEVMATKTKIYLVMEYAAGGELFGKLRR---------------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVK 156 (451)
Q Consensus 92 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~---------------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLK 156 (451)
|+++++++.+.+..|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+|||||
T Consensus 112 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 191 (333)
T 2i1m_A 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVA 191 (333)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred eeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcc
Confidence 99999999999999999999999999998853 358999999999999999999999999999999
Q ss_pred CCeEEeCCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCC
Q 013005 157 PQNLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDS 234 (451)
Q Consensus 157 peNILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~ 234 (451)
|+|||++.++.+||+|||++........ .......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||...
T Consensus 192 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~ 270 (333)
T 2i1m_A 192 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGLNPYPGI 270 (333)
T ss_dssp GGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred cceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCC-ChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence 9999999999999999999986543222 12334567889999999877666 577999999999999998 99999876
Q ss_pred cHHHHHHHhhcc--CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 235 NLLAMYKKVNRR--DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 235 ~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
........+... ....|...++.+.++|.+||..||.+|||+++++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 271 LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp CSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 544333333322 334566789999999999999999999999999873
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=354.27 Aligned_cols=251 Identities=22% Similarity=0.366 Sum_probs=218.2
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
....++|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.++++++ ||||+++++++.+.+
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 76 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQA 76 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSS
T ss_pred EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-----CHHHHHHHHHHHHhCC-CCCEeeEEEEEccCC
Confidence 445689999999999999999999985 678999999976532 1256889999999995 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 104 KIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
..|+||||+++++|.+++.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 77 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 77 PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp SCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccc
Confidence 99999999999999999975 5699999999999999999999999999999999999999999999999999876533
Q ss_pred hhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhccC-CCCCCCCCHhHH
Q 013005 182 IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRD-YQFPSFVSKPAR 259 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 259 (451)
..........||+.|+|||++.+..+ +.++||||+|+++|+|++ |..||...+.......+.... ...|...+..+.
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 235 (267)
T 3t9t_A 157 DQYTSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVY 235 (267)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHH
T ss_pred ccccccccccccccccChhhhcCCCc-cchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHH
Confidence 32233345567889999999977666 567999999999999999 999999988887777776653 345667899999
Q ss_pred HHHHhccCCCCCCCCCHHHHHcC
Q 013005 260 SLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 260 ~li~~~L~~dP~~Rpt~~eil~h 282 (451)
+++.+||..||.+|||+++++++
T Consensus 236 ~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 236 QIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=365.59 Aligned_cols=264 Identities=23% Similarity=0.390 Sum_probs=196.0
Q ss_pred CCCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHH-HHHHhcCCCCceEEE
Q 013005 18 PPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVS-AMRRLQNHPNVLKIQ 96 (451)
Q Consensus 18 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~-il~~L~~HpnIv~l~ 96 (451)
.+...+....++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+. +++.+ +||||++++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~~~-~h~niv~~~ 87 (327)
T 3aln_A 12 SPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSS-DCPYIVQFY 87 (327)
T ss_dssp CCCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC---CHHHHHHHHHHHHHHHSSC-CCTTBCCEE
T ss_pred ChHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc---CchHHHHHHHHHHHHHHcC-CCCcEeeee
Confidence 345666777899999999999999999999999999999999997642 2233445666666 45555 699999999
Q ss_pred EEEEeCCEEEEEEEecCCCchhHHhh------cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCeEEeCCCCCeE
Q 013005 97 EVMATKTKIYLVMEYAAGGELFGKLR------RGRLTESAARRYFQQLVSALHFCHQN-GVAHRDVKPQNLLLDRDGNLK 169 (451)
Q Consensus 97 ~~~~~~~~~~lV~E~~~gg~L~~~l~------~~~l~e~~~~~~~~ql~~gL~yLH~~-giiHrDLKpeNILld~~~~lk 169 (451)
+++...+..|+||||+.+ +|.+++. .+.+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~k 166 (327)
T 3aln_A 88 GALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIK 166 (327)
T ss_dssp EEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEE
T ss_pred eEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEE
Confidence 999999999999999986 7777664 46799999999999999999999999 999999999999999999999
Q ss_pred EEeccCCCcchhhhcCcccccCCCCccccceeee----ccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH-HHHHHhh
Q 013005 170 VSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVA----RRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL-AMYKKVN 244 (451)
Q Consensus 170 l~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~----~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~-~~~~~i~ 244 (451)
|+|||++...... ......+||+.|+|||++. +..+ +.++||||||+++|+|++|..||...+.. .....+.
T Consensus 167 l~Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 243 (327)
T 3aln_A 167 LCDFGISGQLVDS--IAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV 243 (327)
T ss_dssp ECCCSSSCC--------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC
T ss_pred EccCCCceecccc--cccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh
Confidence 9999999764332 2233457999999999983 3334 56799999999999999999999875432 2222222
Q ss_pred ccC-CCCC----CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 245 RRD-YQFP----SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 245 ~~~-~~~p----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
... ..++ ..+++.+.+||.+||..||.+|||+.++++||||....
T Consensus 244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 222 1222 35789999999999999999999999999999997643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=358.86 Aligned_cols=256 Identities=30% Similarity=0.559 Sum_probs=204.9
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
.....++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+....+.+.+|+.+++++. ||||+++++++...
T Consensus 27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 104 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFD-LMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIED 104 (310)
T ss_dssp TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTS-SCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEET
T ss_pred ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhh-ccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcC
Confidence 3456789999999999999999999999999999999997642 233455678899999999995 99999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 103 TKIYLVMEYAAGGELFGKLRR-----GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~-----~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
+..|+||||+.+++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR 184 (310)
T ss_dssp TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----
T ss_pred CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEecccee
Confidence 999999999999999998852 569999999999999999999999999999999999999999999999999987
Q ss_pred cchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCC--cHHHHHHHhhccCCC-C-CCC
Q 013005 178 LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS--NLLAMYKKVNRRDYQ-F-PSF 253 (451)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~--~~~~~~~~i~~~~~~-~-p~~ 253 (451)
...... .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||... +.......+...... . +..
T Consensus 185 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (310)
T 2wqm_A 185 FFSSKT-TAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDH 262 (310)
T ss_dssp ---------------CCSSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTT
T ss_pred eecCCC-ccccccCCCeeEeChHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccc
Confidence 543321 22345679999999999877665 56799999999999999999999754 334444555443332 2 245
Q ss_pred CCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 254 VSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 254 ~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
+++.+.+||.+||..||.+|||+++++++
T Consensus 263 ~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 263 YSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 78999999999999999999999999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=381.48 Aligned_cols=254 Identities=23% Similarity=0.381 Sum_probs=218.6
Q ss_pred CCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE
Q 013005 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 19 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
....+....++|++.+.||+|+||+||+|.+. ++..||||++..... ..+.+.+|+.+|++++ ||||++++++
T Consensus 179 ~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~-h~~iv~l~~~ 251 (454)
T 1qcf_A 179 EKDAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM-----SVEAFLAEANVMKTLQ-HDKLVKLHAV 251 (454)
T ss_dssp CTTCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB-----CHHHHHHHHHHHTTCC-CTTBCCEEEE
T ss_pred cccceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc-----cHHHHHHHHHHHhhCC-CCCEeeEEEE
Confidence 35667778899999999999999999999974 577899999976432 2457889999999995 9999999999
Q ss_pred EEeCCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccC
Q 013005 99 MATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGL 175 (451)
Q Consensus 99 ~~~~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGl 175 (451)
+. ....|+||||+.+|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 252 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 330 (454)
T 1qcf_A 252 VT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 330 (454)
T ss_dssp EC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred Ee-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCC
Confidence 86 6678999999999999999974 3799999999999999999999999999999999999999999999999999
Q ss_pred CCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCC
Q 013005 176 SALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSF 253 (451)
Q Consensus 176 s~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~ 253 (451)
+...............+|+.|+|||++....+ +.++|||||||++|+|++ |..||.+.+.......+... ....|..
T Consensus 331 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~ 409 (454)
T 1qcf_A 331 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPEN 409 (454)
T ss_dssp GGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTT
T ss_pred ceEcCCCceeccCCCcccccccCHHHhccCCC-CcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 98654322222334557889999999977666 567999999999999999 99999998887777766554 3455677
Q ss_pred CCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 254 VSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 254 ~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+++.+.+||.+||..||.+|||+++|++
T Consensus 410 ~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 410 CPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 8999999999999999999999999975
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=360.62 Aligned_cols=252 Identities=21% Similarity=0.357 Sum_probs=207.4
Q ss_pred ccccCCeEEcceEcccCceEEEEEE----EcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAK----SIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~ 99 (451)
....++|++.+.||+|+||+||+|+ +..+++.||||++... .....+.+.+|+.++++++ ||||+++++++
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~ 80 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQ-HDNIVKYKGVC 80 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC----CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEE
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC----CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEE
Confidence 4567899999999999999999998 5678999999999754 2344567899999999996 99999999998
Q ss_pred Ee--CCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccC
Q 013005 100 AT--KTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGL 175 (451)
Q Consensus 100 ~~--~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGl 175 (451)
.. ....|+||||+++|+|.+++.. .++++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 81 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp CHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred ecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 54 4568999999999999999975 4599999999999999999999999999999999999999999999999999
Q ss_pred CCcchhhhc--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH----------------
Q 013005 176 SALPEQIKN--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL---------------- 237 (451)
Q Consensus 176 s~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~---------------- 237 (451)
+........ .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCC-ChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 986543222 22334567888999999987766 56799999999999999999998754321
Q ss_pred HHHHHhh-ccCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 238 AMYKKVN-RRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 238 ~~~~~i~-~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.....+. ......|..+++.+.+||.+||..||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1111222 2344567789999999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=356.17 Aligned_cols=256 Identities=21% Similarity=0.305 Sum_probs=217.4
Q ss_pred cccccCCeEEcc-eEcccCceEEEEEEEc--CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE
Q 013005 23 IPTLLNRYQLGP-LLGRGSFAKVHKAKSI--ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 23 ~~~~~~~y~~~~-~LG~G~~g~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~ 99 (451)
+....++|.+.+ .||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++++. ||||+++++++
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~ 79 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLD-NPYIVRLIGVC 79 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc---chhHHHHHHHHHHHHHhCC-CCCEeEEEEEe
Confidence 445567888887 9999999999999854 468899999997642 3445678899999999995 99999999999
Q ss_pred EeCCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 100 ATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 100 ~~~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
..+..|+||||+.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 80 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 158 (287)
T 1u59_A 80 -QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK 158 (287)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred -cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECccccee
Confidence 55679999999999999999963 569999999999999999999999999999999999999999999999999997
Q ss_pred cchhhhc--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCC
Q 013005 178 LPEQIKN--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSF 253 (451)
Q Consensus 178 ~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~ 253 (451)
....... .......||+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+... ...+|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 237 (287)
T 1u59_A 159 ALGADDSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE 237 (287)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTT
T ss_pred eeccCcceeeccccccccccccCHHHhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCC
Confidence 5433221 22334567899999999876665 567999999999999998 99999987777666666554 3567778
Q ss_pred CCHhHHHHHHhccCCCCCCCCCHHHHHcCcc
Q 013005 254 VSKPARSLIYQLLDPNPKTRMSIEKIMSISW 284 (451)
Q Consensus 254 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 284 (451)
+++.+.++|.+||..||.+|||+.+++++.+
T Consensus 238 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 238 CPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 9999999999999999999999999998754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=366.28 Aligned_cols=252 Identities=24% Similarity=0.386 Sum_probs=214.7
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEE--EEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIV--AIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~v--AiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
...++|++.+.||+|+||.||+|++..++..+ |+|.+.... .....+.+.+|+.+++++.+||||+++++++.+.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 98 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 98 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc---chHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence 34589999999999999999999998888865 999987532 2334567889999999996699999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCC
Q 013005 103 TKIYLVMEYAAGGELFGKLRRG-----------------RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD 165 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~~-----------------~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~ 165 (451)
+..|+||||+++|+|.+++... .+++.+++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 178 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC
Confidence 9999999999999999999753 59999999999999999999999999999999999999999
Q ss_pred CCeEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhh
Q 013005 166 GNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVN 244 (451)
Q Consensus 166 ~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~ 244 (451)
+.+||+|||++..... ........+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+.
T Consensus 179 ~~~kL~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp GCEEECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred CeEEEcccCcCccccc--cccccCCCCCccccChhhhccccC-CchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 9999999999864322 122234567889999999876655 567999999999999998 999999998888877776
Q ss_pred cc-CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 245 RR-DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 245 ~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
.. ....|..+++.+.+||.+||..||.+|||+++++++
T Consensus 256 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 65 345666789999999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=363.59 Aligned_cols=258 Identities=22% Similarity=0.369 Sum_probs=216.1
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEE-----cCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEE
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKS-----IADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l 95 (451)
..+....++|++.+.||+|+||.||+|.+ ..+++.||+|++.... .....+.+.+|+.+++++.+||||+++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC---CcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34566788999999999999999999985 3567899999997642 234456789999999999779999999
Q ss_pred EEEEEeCC-EEEEEEEecCCCchhHHhhcCC-----------------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 013005 96 QEVMATKT-KIYLVMEYAAGGELFGKLRRGR-----------------LTESAARRYFQQLVSALHFCHQNGVAHRDVKP 157 (451)
Q Consensus 96 ~~~~~~~~-~~~lV~E~~~gg~L~~~l~~~~-----------------l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKp 157 (451)
++++...+ ..|+||||++||+|.+++.... +++..++.++.||+.||.|||++||+||||||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp 176 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 176 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCcc
Confidence 99987654 5999999999999999997532 89999999999999999999999999999999
Q ss_pred CeEEeCCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCc
Q 013005 158 QNLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSN 235 (451)
Q Consensus 158 eNILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~ 235 (451)
+||+++.++.+||+|||++........ .......||+.|+|||++.+..+ +.++||||||+++|+|++ |..||....
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc-cchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999999999999999999975433222 22234568899999999977666 567999999999999998 999998755
Q ss_pred HH-HHHHHhhc-cCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 236 LL-AMYKKVNR-RDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 236 ~~-~~~~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
.. .....+.. .....|..+++.+.++|.+||..||.+|||+.++++|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33 33333333 2356677889999999999999999999999999987
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=366.93 Aligned_cols=252 Identities=20% Similarity=0.331 Sum_probs=205.9
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEE----EEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIV----AIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~v----AiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
...++|++.+.||+|+||+||+|++..+++.+ |+|.+.... .....+.+.+|+.++++++ ||||+++++++.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 87 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVD-NPHVCRLLGICL 87 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCC-BTTBCCEEEEEE
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc---CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEe
Confidence 44678999999999999999999998888765 667664321 2234567889999999995 999999999998
Q ss_pred eCCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
+.. .++|+||+.+|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++..
T Consensus 88 ~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 88 TST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp SSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred cCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 755 7899999999999999974 6799999999999999999999999999999999999999999999999999875
Q ss_pred chhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCC
Q 013005 179 PEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVS 255 (451)
Q Consensus 179 ~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s 255 (451)
...... .......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+... ....|...+
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBC
T ss_pred ccCCcccccccCCCccccccChHHhccCCC-CchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCC
Confidence 433222 22234457889999999987766 577999999999999999 99999987766665555543 345677789
Q ss_pred HhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 256 KPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 256 ~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
..+.+++.+||..||.+|||+.+++++
T Consensus 246 ~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 246 IDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999999976
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=365.18 Aligned_cols=260 Identities=21% Similarity=0.296 Sum_probs=215.9
Q ss_pred ccccCCeEEcceEcccCceEEEEEE-----EcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAK-----SIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
....++|++.+.||+|+||.||+|. +..++..||||++.... .......+.+|+.+++++. ||||++++++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~ 101 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC---SEQDELDFLMEALIISKFN-HQNIVRCIGV 101 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC---CHHHHHHHHHHHHHHHHCC-CTTBCCEEEE
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc---chhhHHHHHHHHHHHhhCC-CCCCCeEEEE
Confidence 4567899999999999999999998 55678899999996442 2344567889999999995 9999999999
Q ss_pred EEeCCEEEEEEEecCCCchhHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCC---CC
Q 013005 99 MATKTKIYLVMEYAAGGELFGKLRRG--------RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD---GN 167 (451)
Q Consensus 99 ~~~~~~~~lV~E~~~gg~L~~~l~~~--------~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~---~~ 167 (451)
+......|+||||++|++|.+++... .+++.+++.++.||+.||.|||++||+||||||+|||++.+ ..
T Consensus 102 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 102 SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred EcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcce
Confidence 99999999999999999999999742 38999999999999999999999999999999999999844 46
Q ss_pred eEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhc
Q 013005 168 LKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNR 245 (451)
Q Consensus 168 lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~ 245 (451)
+||+|||++........ .......||+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+..
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 260 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence 99999999864332221 22344568999999999877665 567999999999999998 9999998887777766655
Q ss_pred c-CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 246 R-DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 246 ~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
. ....+..++..+.++|.+||..||.+|||+++++++.|+...
T Consensus 261 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 261 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 4 345667789999999999999999999999999999987654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=364.89 Aligned_cols=257 Identities=22% Similarity=0.277 Sum_probs=206.7
Q ss_pred CCCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEE
Q 013005 18 PPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQE 97 (451)
Q Consensus 18 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~ 97 (451)
.+...+-...++|++.+.||+|+||+||+|++. ++.||||++.... .......+|+.++++++ ||||+++++
T Consensus 14 ~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~-hpniv~~~~ 85 (322)
T 3soc_A 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-----KQSWQNEYEVYSLPGMK-HENILQFIG 85 (322)
T ss_dssp CCCCCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-----HHHHHHHHHHHTSTTCC-CTTBCCEEE
T ss_pred cCccccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-----hHHHHHHHHHHHHhcCC-CCCchhhcc
Confidence 345566677889999999999999999999864 7999999996542 22345567999999995 999999999
Q ss_pred EEEeCC----EEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC----------CceecCCCCCeEEeC
Q 013005 98 VMATKT----KIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQN----------GVAHRDVKPQNLLLD 163 (451)
Q Consensus 98 ~~~~~~----~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~----------giiHrDLKpeNILld 163 (451)
++.... ..|+||||+++|+|.+++..+.+++..++.++.|++.||.|||++ ||+||||||+|||++
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~ 165 (322)
T 3soc_A 86 AEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK 165 (322)
T ss_dssp EEEEECSSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC
T ss_pred eeccCCCCCceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC
Confidence 998744 479999999999999999988999999999999999999999999 999999999999999
Q ss_pred CCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccC----CCCccchhhhhhHHHHHHHhcCCCCCCC----
Q 013005 164 RDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRG----YDGAVADAWSCGVILFVLLAGYLPFDDS---- 234 (451)
Q Consensus 164 ~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~----~~~~~sDIwSlGvil~~Ll~G~~Pf~~~---- 234 (451)
.++.+||+|||++........ ......+||+.|+|||++.+.. ..+.++|||||||++|+|++|..||...
T Consensus 166 ~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 245 (322)
T 3soc_A 166 NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245 (322)
T ss_dssp TTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCC
T ss_pred CCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchh
Confidence 999999999999975443222 2334568999999999987632 2245689999999999999999999653
Q ss_pred ------------cHHHHHHHhhccCC--CCCCC-----CCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 235 ------------NLLAMYKKVNRRDY--QFPSF-----VSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 235 ------------~~~~~~~~i~~~~~--~~p~~-----~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
........+..... .++.. .++.+.+||.+||..||++|||+.++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22222222222211 11111 23458999999999999999999999863
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=354.93 Aligned_cols=255 Identities=22% Similarity=0.322 Sum_probs=212.0
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEcC---CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIA---DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
......++|++.+.||+|+||.||+|.+.. ++..||+|++.... .....+.+.+|+.+++.++ ||||++++++
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~ 81 (281)
T 3cc6_A 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC---TLDNKEKFMSEAVIMKNLD-HPHIVKLIGI 81 (281)
T ss_dssp CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS---CHHHHHHHHHHHHHHHHHC-CTTBCCEEEE
T ss_pred cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc---CchHHHHHHHHHHHHHhCC-CCCcceEEEE
Confidence 456678899999999999999999998654 34569999997652 2344578899999999995 9999999999
Q ss_pred EEeCCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCC
Q 013005 99 MATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176 (451)
Q Consensus 99 ~~~~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls 176 (451)
+.+ ...|+||||+.+++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 82 ~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 160 (281)
T 3cc6_A 82 IEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160 (281)
T ss_dssp ECS-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred EcC-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCC
Confidence 865 456899999999999999974 56999999999999999999999999999999999999999999999999999
Q ss_pred CcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCC
Q 013005 177 ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFV 254 (451)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~ 254 (451)
...............+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+... ....|..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (281)
T 3cc6_A 161 RYIEDEDYYKASVTRLPIKWMSPESINFRRF-TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLC 239 (281)
T ss_dssp GCC---------CCCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTC
T ss_pred cccccccccccccCCCCcceeCchhhccCCC-CchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCC
Confidence 7654433333345567899999999876665 567999999999999998 99999876555555544433 34566778
Q ss_pred CHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 255 SKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 255 s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
++.+.++|.+||..||.+|||+.+++++
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 240 PPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 9999999999999999999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=386.10 Aligned_cols=255 Identities=23% Similarity=0.367 Sum_probs=220.9
Q ss_pred CCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE
Q 013005 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 20 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~ 99 (451)
...+....++|++.+.||+|+||.||+|.+..++..||||++..... ..+.+.+|+.+|++++ ||||+++++++
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~-hpniv~l~~~~ 285 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIK-HPNLVQLLGVC 285 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-----CHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-----chHHHHHHHHHHHhcC-CCCEeeEEEEE
Confidence 45566777899999999999999999999998899999999976532 2456889999999995 99999999999
Q ss_pred EeCCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCC
Q 013005 100 ATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176 (451)
Q Consensus 100 ~~~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls 176 (451)
......|+||||+.+|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 286 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 365 (495)
T 1opk_A 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLS 365 (495)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred ecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccc
Confidence 999999999999999999999974 45999999999999999999999999999999999999999999999999999
Q ss_pred CcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCC
Q 013005 177 ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFV 254 (451)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~ 254 (451)
...............+|+.|+|||++....+ +.++|||||||++|+|++ |..||...+....+..+... ....|..+
T Consensus 366 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (495)
T 1opk_A 366 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC 444 (495)
T ss_dssp ECCTTCCEECCTTCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTC
T ss_pred eeccCCceeecCCCcCCcceeCHhHHhcCCC-CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 7654322222334556789999999977666 567999999999999999 99999987766666655543 34567789
Q ss_pred CHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 255 SKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 255 s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
++.+.+||.+||..||.+|||+.+|++
T Consensus 445 ~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 445 PEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 999999999999999999999999976
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=369.03 Aligned_cols=251 Identities=21% Similarity=0.348 Sum_probs=209.5
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcE----EEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSI----VAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
..++|++.+.||+|+||+||+|.+..+++. ||+|.+..... ......+.+|+.+++++. ||||+++++++.
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~- 85 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG---RQSFQAVTDHMLAIGSLD-HAHIVRLLGLCP- 85 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS---CSCBCSCCHHHHHHHTCC-CTTBCCEEEEEC-
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc---HHHHHHHHHHHHHHhcCC-CCCcCeEEEEEc-
Confidence 357899999999999999999999888876 67777643311 112235678899999995 999999999886
Q ss_pred CCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcc
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALP 179 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~ 179 (451)
....|+||||+.+|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 5668999999999999999975 57999999999999999999999999999999999999999999999999999765
Q ss_pred hhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCH
Q 013005 180 EQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSK 256 (451)
Q Consensus 180 ~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 256 (451)
..... .......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+... ....|..++.
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKY-THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTI 244 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCT
T ss_pred CcccccccccCCCCcccccChHHhccCCC-ChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcH
Confidence 43322 23345678889999999977666 567999999999999999 99999987766666665554 4556677899
Q ss_pred hHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 257 PARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
.+.++|.+||..||.+|||+.+++++
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 245 DVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999987
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=371.55 Aligned_cols=253 Identities=23% Similarity=0.388 Sum_probs=205.4
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEc---CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSI---ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
....++|++.+.||+|+||.||+|++. .++..||||++.... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 116 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEASIMGQFD-HPNIIRLEGVVT 116 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEC
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe
Confidence 445678999999999999999999876 467789999997542 3345577999999999995 999999999999
Q ss_pred eCCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
.....|+||||++||+|.+++.. ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 117 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 117 KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred eCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 99999999999999999999975 4799999999999999999999999999999999999999999999999999986
Q ss_pred chhhhcCc--ccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCC
Q 013005 179 PEQIKNGM--LHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFV 254 (451)
Q Consensus 179 ~~~~~~~~--~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~ 254 (451)
........ .....+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+... ....+..+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~ 275 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF-TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC 275 (373)
T ss_dssp -----------------CTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTC
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCc-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 54322211 122345788999999987766 567999999999999997 99999988877777666544 34455678
Q ss_pred CHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 255 SKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 255 s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+..+.+||.+||..||.+|||++++++
T Consensus 276 ~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 276 PAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp BHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 999999999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=369.79 Aligned_cols=254 Identities=16% Similarity=0.178 Sum_probs=198.0
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCC-----CcEEEEEEeecCcchhhHH-------HHHHHHHHHHHHHHhcCCCCc
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIAD-----GSIVAIKTIEKNNKFLDAA-------MEDRIVREVSAMRRLQNHPNV 92 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~-------~~~~~~~Ei~il~~L~~HpnI 92 (451)
...++|++++.||+|+||.||+|.+..+ ++.||||++.......... ....+.+|+..++.+. ||||
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~~i 110 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLK-YLGV 110 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCS-CCCS
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhcc-CCCC
Confidence 4556999999999999999999998765 5889999997653211000 0112334555566664 9999
Q ss_pred eEEEEEEEeC----CEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeC--C
Q 013005 93 LKIQEVMATK----TKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLD--R 164 (451)
Q Consensus 93 v~l~~~~~~~----~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld--~ 164 (451)
+++++++... ...|+||||+ |++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++ .
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 9999998764 5689999999 9999999975 6799999999999999999999999999999999999999 8
Q ss_pred CCCeEEEeccCCCcchhhhc------CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHH
Q 013005 165 DGNLKVSDFGLSALPEQIKN------GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLA 238 (451)
Q Consensus 165 ~~~lkl~DFGls~~~~~~~~------~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~ 238 (451)
++.+||+|||++........ ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.....
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 89999999999975443222 11234569999999999987766 677999999999999999999998532111
Q ss_pred HHHHhhc----cC-------CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 239 MYKKVNR----RD-------YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 239 ~~~~i~~----~~-------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.+..... .. .-.+..+++.+.+++.+||..||.+|||+++|++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1111000 00 0012457899999999999999999999999987
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=354.98 Aligned_cols=255 Identities=21% Similarity=0.310 Sum_probs=213.5
Q ss_pred CcccccCCeEEcc-eEcccCceEEEEEEE--cCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE
Q 013005 22 KIPTLLNRYQLGP-LLGRGSFAKVHKAKS--IADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 22 ~~~~~~~~y~~~~-~LG~G~~g~Vy~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
.+....++|.+.+ .||+|+||.||+|.+ ..+++.||||++.... ......+.+.+|+.+++.+. ||||++++++
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~ 86 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLD-NPYIVRMIGI 86 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCC-CTTBCCEEEE
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc--cCHHHHHHHHHHHHHHHhCC-CCCEEEEEEE
Confidence 4445568999998 999999999999954 5678899999997642 23344678999999999995 9999999999
Q ss_pred EEeCCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 99 MATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 99 ~~~~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
+ ..+..|+||||+.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 87 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 87 C-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp E-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred E-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 9 56778999999999999999975 669999999999999999999999999999999999999999999999999987
Q ss_pred cchhhhc--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCC
Q 013005 178 LPEQIKN--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSF 253 (451)
Q Consensus 178 ~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~ 253 (451)
....... .......||+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+... ...+|..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 244 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG 244 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCC-ChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 5433221 11223456789999999877665 567999999999999999 99999998877777666554 3456778
Q ss_pred CCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 254 VSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 254 ~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+++.+.++|.+||..||.+|||+.++++
T Consensus 245 ~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 245 CPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=356.97 Aligned_cols=253 Identities=21% Similarity=0.342 Sum_probs=208.2
Q ss_pred ccccCCeEEcceEcccCceEEEEEE----EcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAK----SIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~ 99 (451)
.....+|++.+.||+|+||.||+|+ +..+++.||+|++.... .....+.+.+|+.+++.++ ||||+++++++
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~ 92 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLY-HENIVKYKGIC 92 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCC-CTTBCCEEEEE
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc---cchhHHHHHHHHHHHHhCC-CCCeeeeeeEE
Confidence 3445679999999999999999998 56789999999997542 1223467889999999995 99999999999
Q ss_pred EeC--CEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccC
Q 013005 100 ATK--TKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGL 175 (451)
Q Consensus 100 ~~~--~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGl 175 (451)
... ...|+||||+++|+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 93 TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp EC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred ecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccc
Confidence 876 678999999999999999953 6799999999999999999999999999999999999999999999999999
Q ss_pred CCcchhhhc--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCc---------------HHH
Q 013005 176 SALPEQIKN--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN---------------LLA 238 (451)
Q Consensus 176 s~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~---------------~~~ 238 (451)
+........ .......||+.|+|||++.+..+ +.++||||+|+++|+|++|..|+.... ...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKF-YIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCC-CcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 976543222 23345678999999999877666 467999999999999999999864321 112
Q ss_pred HHHHhhc-cCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 239 MYKKVNR-RDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 239 ~~~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
....+.. .....|..+++.+.+||.+||..||.+|||++++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 2222222 244567789999999999999999999999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=352.94 Aligned_cols=236 Identities=32% Similarity=0.568 Sum_probs=195.8
Q ss_pred CCcccccCCeEEc-ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE
Q 013005 21 KKIPTLLNRYQLG-PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 21 ~~~~~~~~~y~~~-~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~ 99 (451)
.....+.++|.+. +.||+|+||.||+|.+..+++.||+|++... ....+|+.++.++.+||||+++++++
T Consensus 10 ~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~~i~~~~~~~ 80 (299)
T 3m2w_A 10 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVY 80 (299)
T ss_dssp CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred CcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---------HHHHHHHHHHHHhccCCCchhHHhhh
Confidence 3456788889887 7899999999999999999999999999653 24567888886665799999999999
Q ss_pred Ee----CCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC---CCCeE
Q 013005 100 AT----KTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR---DGNLK 169 (451)
Q Consensus 100 ~~----~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~---~~~lk 169 (451)
.. ....|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~k 160 (299)
T 3m2w_A 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 160 (299)
T ss_dssp EEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEE
T ss_pred hhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEE
Confidence 87 7789999999999999999975 36999999999999999999999999999999999999998 78899
Q ss_pred EEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHH----hhc
Q 013005 170 VSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKK----VNR 245 (451)
Q Consensus 170 l~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~----i~~ 245 (451)
|+|||++.... +..+ +.++|||||||++|+|++|..||...+....... +..
T Consensus 161 l~Dfg~a~~~~-----------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 216 (299)
T 3m2w_A 161 LTDFGFAKETT-----------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 216 (299)
T ss_dssp ECCCTTCEECT-----------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCT
T ss_pred Eeccccccccc-----------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhh
Confidence 99999985321 1123 5669999999999999999999987654443222 222
Q ss_pred cCCCCC----CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 246 RDYQFP----SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 246 ~~~~~p----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
....+| ..+++.+.+||.+||..||.+|||++++++||||+...
T Consensus 217 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 217 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 233344 45899999999999999999999999999999998754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=369.65 Aligned_cols=260 Identities=22% Similarity=0.298 Sum_probs=211.7
Q ss_pred CCCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEE
Q 013005 18 PPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQE 97 (451)
Q Consensus 18 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~ 97 (451)
.+...+....++|++.+.||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|+.+++.++ ||||+++++
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~-h~~iv~~~~ 102 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES----SQGIEEFETEIETLSFCR-HPHLVSLIG 102 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC----SSHHHHHHHHHHGGGSCC-CTTBCCEEE
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC----hHHHHHHHHHHHHHHhCC-CCCEeeEEE
Confidence 35667778899999999999999999999995 578999999987542 223567889999999995 999999999
Q ss_pred EEEeCCEEEEEEEecCCCchhHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEe
Q 013005 98 VMATKTKIYLVMEYAAGGELFGKLRRG-----RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSD 172 (451)
Q Consensus 98 ~~~~~~~~~lV~E~~~gg~L~~~l~~~-----~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~D 172 (451)
++...+..|+||||++||+|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~D 182 (321)
T 2qkw_B 103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITD 182 (321)
T ss_dssp ECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECC
T ss_pred EEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEee
Confidence 999999999999999999999998642 489999999999999999999999999999999999999999999999
Q ss_pred ccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH------HH-HHHhh
Q 013005 173 FGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL------AM-YKKVN 244 (451)
Q Consensus 173 FGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~------~~-~~~i~ 244 (451)
||++........ ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .. .....
T Consensus 183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 261 (321)
T 2qkw_B 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRL-TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261 (321)
T ss_dssp CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBC-CTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred cccccccccccccccccccCCCccccCHHHhcCCCC-CcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence 999875432222 22344568999999999877666 56799999999999999999999754321 11 01111
Q ss_pred ccC------C----CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCcc
Q 013005 245 RRD------Y----QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISW 284 (451)
Q Consensus 245 ~~~------~----~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 284 (451)
... . ..++..+..+.+++.+||..||++|||+.+++++..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 111 0 111223567889999999999999999999998643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=367.62 Aligned_cols=256 Identities=18% Similarity=0.199 Sum_probs=200.6
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcC---CCcEEEEEEeecCcchhhH-------HHHHHHHHHHHHHHHhcCCCCce
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIA---DGSIVAIKTIEKNNKFLDA-------AMEDRIVREVSAMRRLQNHPNVL 93 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~-------~~~~~~~~Ei~il~~L~~HpnIv 93 (451)
....++|++.+.||+|+||.||+|.+.. ++..+|+|++......... .....+.+|+..++.+. ||||+
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni~ 111 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGIP 111 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCcc
Confidence 4556799999999999999999999987 7889999999865321111 01123667888888885 99999
Q ss_pred EEEEEEEe----CCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC--
Q 013005 94 KIQEVMAT----KTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG-- 166 (451)
Q Consensus 94 ~l~~~~~~----~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~-- 166 (451)
++++++.. ....|+||||+ |++|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred eeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence 99999988 78899999999 9999999975 5899999999999999999999999999999999999999887
Q ss_pred CeEEEeccCCCcchhhhc------CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCC--CcHHH
Q 013005 167 NLKVSDFGLSALPEQIKN------GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDD--SNLLA 238 (451)
Q Consensus 167 ~lkl~DFGls~~~~~~~~------~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~--~~~~~ 238 (451)
.+||+|||++........ ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.. .+...
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 999999999975433221 12245689999999999887655 6779999999999999999999964 23222
Q ss_pred HHHHhhccCCCCC---------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 239 MYKKVNRRDYQFP---------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 239 ~~~~i~~~~~~~p---------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
...........+| ..+++.+.++|.+||..||++|||+++|++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 2221111111122 2688999999999999999999999999873
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=350.93 Aligned_cols=252 Identities=23% Similarity=0.367 Sum_probs=215.5
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
..+....++|++.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.+++++. ||||+++++++.
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~ 78 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-----SPDAFLAEANLMKQLQ-HQRLVRLYAVVT 78 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-----CHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc-----cHHHHHHHHHHHHhCC-CcCcceEEEEEc
Confidence 456677889999999999999999999974 677899999976421 1356889999999995 999999999986
Q ss_pred eCCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
.+..|+||||+.|++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 79 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 79 -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 157 (279)
T ss_dssp -SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred -CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccc
Confidence 4568999999999999999975 279999999999999999999999999999999999999999999999999997
Q ss_pred cchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCC
Q 013005 178 LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVS 255 (451)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s 255 (451)
..............+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+... ....+..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (279)
T 1qpc_A 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP 236 (279)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred cccCcccccccCCCCccCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCccccc
Confidence 654322223334567889999999876655 567999999999999999 99999988877777766554 344566789
Q ss_pred HhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 256 KPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 256 ~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+.+.++|.+||..||++|||++++++
T Consensus 237 ~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 237 EELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhccChhhCCCHHHHHH
Confidence 99999999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=353.86 Aligned_cols=248 Identities=21% Similarity=0.256 Sum_probs=204.6
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCC-ceEEEEEEEeCC
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN-VLKIQEVMATKT 103 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~Hpn-Iv~l~~~~~~~~ 103 (451)
.+.++|++.+.||+|+||.||+|++..+++.||+|++..... .+.+.+|+.+++.+. |++ +..+..+.....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~-~~~~i~~~~~~~~~~~ 78 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQ-GGVGIPTIRWCGAEGD 78 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS------CCHHHHHHHHHHHHT-TSTTCCCEEEEEEETT
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc------hhHHHHHHHHHHHhh-cCCCCCccccccCCCC
Confidence 457899999999999999999999999999999999876532 135788999999997 555 555555557788
Q ss_pred EEEEEEEecCCCchhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEe---CCCCCeEEEeccCCCc
Q 013005 104 KIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL---DRDGNLKVSDFGLSAL 178 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~--~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILl---d~~~~lkl~DFGls~~ 178 (451)
..|+||||+ +++|.+++. .+.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 79 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 999999999 899999997 4679999999999999999999999999999999999999 4889999999999975
Q ss_pred chhhhc------CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCc---HHHHHHHhhccCCC
Q 013005 179 PEQIKN------GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN---LLAMYKKVNRRDYQ 249 (451)
Q Consensus 179 ~~~~~~------~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~---~~~~~~~i~~~~~~ 249 (451)
...... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+ ....+..+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence 443222 12345689999999999987665 577999999999999999999997632 22233333322222
Q ss_pred C-----CCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 250 F-----PSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 250 ~-----p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
. +..+++.+.+||.+||..||.+|||++++++
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 2 3568999999999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=355.56 Aligned_cols=257 Identities=23% Similarity=0.378 Sum_probs=199.0
Q ss_pred CCCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEE
Q 013005 18 PPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQE 97 (451)
Q Consensus 18 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~ 97 (451)
+.........++|++.+.||+|+||.||+|.+. ..||+|++.... ......+.+.+|+.+++++. ||||+++++
T Consensus 14 ~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~ 87 (289)
T 3og7_A 14 DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA--PTPQQLQAFKNEVGVLRKTR-HVNILLFMG 87 (289)
T ss_dssp ----CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS--CCHHHHHHHHHHHHHHTTCC-CTTBCCEEE
T ss_pred CCCCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC--CCHHHHHHHHHHHHHHHhCC-CCcEEEEEe
Confidence 345666788889999999999999999999853 359999997652 23455678999999999996 999999999
Q ss_pred EEEeCCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccC
Q 013005 98 VMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGL 175 (451)
Q Consensus 98 ~~~~~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGl 175 (451)
+. .....++||||+.|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (289)
T 3og7_A 88 YS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGL 166 (289)
T ss_dssp EE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred ec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEcccee
Confidence 65 56678999999999999999963 6799999999999999999999999999999999999999999999999999
Q ss_pred CCcchhhh-cCcccccCCCCccccceeeec--cCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH-HHHHHhhccCCC--
Q 013005 176 SALPEQIK-NGMLHTACGTPAYTAPEVVAR--RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL-AMYKKVNRRDYQ-- 249 (451)
Q Consensus 176 s~~~~~~~-~~~~~~~~gt~~y~APEvl~~--~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~-~~~~~i~~~~~~-- 249 (451)
+....... .......+||+.|+|||++.. ....+.++||||||+++|+|++|..||...+.. .....+......
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (289)
T 3og7_A 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246 (289)
T ss_dssp -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC
T ss_pred ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc
Confidence 97544322 233445679999999999862 223356799999999999999999999875443 444444333222
Q ss_pred ---CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 250 ---FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 250 ---~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.+..+++.+.+||.+||..||.+|||++++++
T Consensus 247 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 23457899999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=360.50 Aligned_cols=258 Identities=27% Similarity=0.419 Sum_probs=192.3
Q ss_pred CCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE
Q 013005 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 20 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~ 99 (451)
...+.....+|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++++.+||||+++++++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 95 (337)
T 3ll6_A 20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE----EEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95 (337)
T ss_dssp TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS----HHHHHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc----hHHHHHHHHHHHHHHHhccCCChhhccccc
Confidence 4455566679999999999999999999999999999999986542 344567889999999997799999999998
Q ss_pred E--------eCCEEEEEEEecCCCchhHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCeEEeCCC
Q 013005 100 A--------TKTKIYLVMEYAAGGELFGKLRR----GRLTESAARRYFQQLVSALHFCHQNG--VAHRDVKPQNLLLDRD 165 (451)
Q Consensus 100 ~--------~~~~~~lV~E~~~gg~L~~~l~~----~~l~e~~~~~~~~ql~~gL~yLH~~g--iiHrDLKpeNILld~~ 165 (451)
. .....|+||||+. |+|.+++.. +.+++.+++.++.||+.||.|||++| |+||||||+|||++.+
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~ 174 (337)
T 3ll6_A 96 SIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ 174 (337)
T ss_dssp EECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT
T ss_pred cccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC
Confidence 4 3456899999996 688887753 67999999999999999999999999 9999999999999999
Q ss_pred CCeEEEeccCCCcchhhhc-----------CcccccCCCCccccceeee--ccCCCCccchhhhhhHHHHHHHhcCCCCC
Q 013005 166 GNLKVSDFGLSALPEQIKN-----------GMLHTACGTPAYTAPEVVA--RRGYDGAVADAWSCGVILFVLLAGYLPFD 232 (451)
Q Consensus 166 ~~lkl~DFGls~~~~~~~~-----------~~~~~~~gt~~y~APEvl~--~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~ 232 (451)
+.+||+|||++........ ......+||+.|+|||++. .....+.++|||||||++|+|++|..||.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 254 (337)
T 3ll6_A 175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254 (337)
T ss_dssp SCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 9999999999975433211 1112567999999999983 22334677999999999999999999998
Q ss_pred CCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCcc
Q 013005 233 DSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISW 284 (451)
Q Consensus 233 ~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 284 (451)
........... .....+...+..+.+||.+||..||.+|||++++++|.+
T Consensus 255 ~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 255 DGAKLRIVNGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp -------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred chhHHHhhcCc--ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 65544332221 122334557888999999999999999999999999754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=357.18 Aligned_cols=260 Identities=21% Similarity=0.317 Sum_probs=208.6
Q ss_pred CCCCcccccCCeEEcceEcccCceEEEEEEEcC---CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEE
Q 013005 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIA---DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95 (451)
Q Consensus 19 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l 95 (451)
....+....++|.+++.||+|+||.||+|.+.. ++..||+|++.... ......+.+.+|+.++++++ ||||+++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~ 101 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN--SSQREIEEFLSEAACMKDFS-HPNVIRL 101 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C--CCHHHHHHHHHHHHHHHTCC-CTTBCCC
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc--cchhHHHHHHHHHHHHhcCC-CCCeeee
Confidence 345556667899999999999999999998765 55689999997642 23344567899999999996 9999999
Q ss_pred EEEEEeCC-----EEEEEEEecCCCchhHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeC
Q 013005 96 QEVMATKT-----KIYLVMEYAAGGELFGKLR-------RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLD 163 (451)
Q Consensus 96 ~~~~~~~~-----~~~lV~E~~~gg~L~~~l~-------~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld 163 (451)
++++.... ..|+||||+.+|+|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 102 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~ 181 (313)
T 3brb_A 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR 181 (313)
T ss_dssp CEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEEC
T ss_pred eEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc
Confidence 99997655 4599999999999999883 24699999999999999999999999999999999999999
Q ss_pred CCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHH
Q 013005 164 RDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYK 241 (451)
Q Consensus 164 ~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~ 241 (451)
.++.+||+|||++........ .......+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...+......
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 260 (313)
T 3brb_A 182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD 260 (313)
T ss_dssp TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCc-cchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH
Confidence 999999999999975433221 22234567889999999977665 567999999999999999 999998877766666
Q ss_pred Hhhcc-CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 242 KVNRR-DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 242 ~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
.+... ....|..+++.+.++|.+||..||.+|||+.+++++
T Consensus 261 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 261 YLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 65544 456677789999999999999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=354.49 Aligned_cols=249 Identities=21% Similarity=0.274 Sum_probs=200.3
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
.+.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.+.+|++|..+..+......
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc------chHHHHHHHHHHHhcCCCCCCeeeeecCCCCc
Confidence 456899999999999999999999999999999998765422 23477899999999744445555555678889
Q ss_pred EEEEEEecCCCchhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEe---CCCCCeEEEeccCCCcc
Q 013005 105 IYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL---DRDGNLKVSDFGLSALP 179 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~--~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILl---d~~~~lkl~DFGls~~~ 179 (451)
.|+||||+ +++|.+++. .+.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred eEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99999999 999999997 4679999999999999999999999999999999999999 78899999999999754
Q ss_pred hhhhc------CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcH---HHHHHHhhccCCCC
Q 013005 180 EQIKN------GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNL---LAMYKKVNRRDYQF 250 (451)
Q Consensus 180 ~~~~~------~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~---~~~~~~i~~~~~~~ 250 (451)
..... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+. ...+..+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 43222 12345689999999999987765 6779999999999999999999976321 12223322222222
Q ss_pred C-----CCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 251 P-----SFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 251 p-----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
| ..+++.+.+||.+||..||++|||++++++
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 2 567899999999999999999999999987
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=358.66 Aligned_cols=254 Identities=22% Similarity=0.349 Sum_probs=210.8
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCC----cEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADG----SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~ 99 (451)
....++|.+.+.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+.+++++. ||||+++++++
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~ 115 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVI 115 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEE
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC---CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEE
Confidence 455678999999999999999999876553 469999997542 2344567889999999995 99999999999
Q ss_pred EeCCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 100 ATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 100 ~~~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
......|+||||+.+|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 999999999999999999999974 679999999999999999999999999999999999999999999999999997
Q ss_pred cchhhhcC--cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCC
Q 013005 178 LPEQIKNG--MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSF 253 (451)
Q Consensus 178 ~~~~~~~~--~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~ 253 (451)
........ ......+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+... ....+..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 274 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD 274 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred hhccccccccccCCCCccccccCchhcccCCC-CchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCccc
Confidence 65432221 1223456889999999977666 567999999999999998 99999988877777776654 3455667
Q ss_pred CCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 254 VSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 254 ~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
++..+.++|.+||..||.+|||+.+++++
T Consensus 275 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 275 CPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 89999999999999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=376.23 Aligned_cols=253 Identities=24% Similarity=0.368 Sum_probs=212.0
Q ss_pred CCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE
Q 013005 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 20 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~ 99 (451)
...+....++|++.+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.+|++++ ||||+++++++
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~-hp~iv~~~~~~ 248 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLR-HEKLVQLYAVV 248 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS-----CHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC-----CHHHHHHHHHHHHhCC-CCCEeeEEEEE
Confidence 45667778899999999999999999999854 56799999976421 1356889999999995 99999999998
Q ss_pred EeCCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCC
Q 013005 100 ATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176 (451)
Q Consensus 100 ~~~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls 176 (451)
.+ ...|+||||+.+|+|.+++.. ..+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 249 ~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a 327 (452)
T 1fmk_A 249 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 327 (452)
T ss_dssp CS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred cC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccc
Confidence 76 678999999999999999963 46999999999999999999999999999999999999999999999999999
Q ss_pred CcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCC
Q 013005 177 ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFV 254 (451)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~ 254 (451)
...............+|+.|+|||++....+ +.++|||||||++|+|++ |..||.+.+..+....+..+ ....|..+
T Consensus 328 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~ 406 (452)
T 1fmk_A 328 RLIEDNEYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 406 (452)
T ss_dssp C--------------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTS
T ss_pred eecCCCceecccCCcccccccCHhHHhcCCC-CccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 8654322222334557889999999877666 567999999999999999 99999988877777766554 34567789
Q ss_pred CHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 255 SKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 255 s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
++.+.+||.+||..||++|||+++|++
T Consensus 407 ~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 407 PESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=352.88 Aligned_cols=248 Identities=25% Similarity=0.418 Sum_probs=211.8
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe--
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT-- 101 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~-- 101 (451)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++.... +.+.+|+.+++++. ||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 77 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLD-HVNIVHYNGCWDGFD 77 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGGHHHHHHHHHCC-CTTBCCEEEEEEEEE
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHhCC-CCCEEEEeeeEeccc
Confidence 345678999999999999999999999999999999997653 24668999999995 9999999999864
Q ss_pred --------------CCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC
Q 013005 102 --------------KTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR 164 (451)
Q Consensus 102 --------------~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~ 164 (451)
....|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVD 157 (284)
T ss_dssp EC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE
T ss_pred cCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcC
Confidence 4568999999999999999963 57999999999999999999999999999999999999999
Q ss_pred CCCeEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhh
Q 013005 165 DGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVN 244 (451)
Q Consensus 165 ~~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~ 244 (451)
++.+||+|||++...... ......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||... ......+.
T Consensus 158 ~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~ 232 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKND--GKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFET--SKFFTDLR 232 (284)
T ss_dssp TTEEEECCCTTCEESSCC--SCCCCCCSCCTTSCHHHHHCSCC-CTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHH
T ss_pred CCCEEECcchhheecccc--ccccccCCcccccChhhhccCCC-cchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhh
Confidence 999999999998754332 23345679999999999977666 56799999999999999999997532 22333333
Q ss_pred ccCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 245 RRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 245 ~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
. ..++..++..+.++|.+||..||.+|||+.++++|+|...
T Consensus 233 ~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 233 D--GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp T--TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred c--ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 3 2356678999999999999999999999999999988754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=363.89 Aligned_cols=252 Identities=20% Similarity=0.330 Sum_probs=206.4
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEE----EEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIV----AIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~v----AiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
...++|++.+.||+|+||.||+|.+..+++.+ |+|.+.... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~---~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~ 87 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVD-NPHVCRLLGICL 87 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS---SCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEE
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc---CHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEe
Confidence 44689999999999999999999998888765 566554321 1223467889999999995 999999999998
Q ss_pred eCCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
... .++|+||+.+|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 88 ~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 88 TST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp SSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred cCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 765 8899999999999999974 6799999999999999999999999999999999999999999999999999986
Q ss_pred chhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCC
Q 013005 179 PEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVS 255 (451)
Q Consensus 179 ~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s 255 (451)
...... .......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+... ....|..++
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBC
T ss_pred ccCccccccccCCCccccccCHHHHcCCCC-ChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCC
Confidence 543222 22334567889999999987766 567999999999999999 99999987776666655544 345677789
Q ss_pred HhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 256 KPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 256 ~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
..+.+||.+||..||.+|||+.++++.
T Consensus 246 ~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 246 IDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999999999973
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=351.55 Aligned_cols=248 Identities=26% Similarity=0.391 Sum_probs=198.8
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHH--hcCCCCceEEEEEEEe
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR--LQNHPNVLKIQEVMAT 101 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~--L~~HpnIv~l~~~~~~ 101 (451)
..+.++|++.+.||+|+||+||+|.+ +++.||||++.... ...+.+|..++.. + +||||+++++++..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~l-~h~niv~~~~~~~~ 73 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD-------EKSWFRETELYNTVML-RHENILGFIASDMT 73 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG-------HHHHHHHHHHHHHTCC-CCTTBCCEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc-------chhhHHHHHHHHHhhc-cCcCeeeEEEeecc
Confidence 45678999999999999999999986 78999999996542 2344566666666 5 59999999998654
Q ss_pred ----CCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCceecCCCCCeEEeCCCCCeE
Q 013005 102 ----KTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCH--------QNGVAHRDVKPQNLLLDRDGNLK 169 (451)
Q Consensus 102 ----~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH--------~~giiHrDLKpeNILld~~~~lk 169 (451)
....|+||||+++|+|.++++.+.+++..++.++.|++.||+||| ++||+||||||+|||++.++.+|
T Consensus 74 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 74 SRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EETTEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred ccCCCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence 356899999999999999999889999999999999999999999 99999999999999999999999
Q ss_pred EEeccCCCcchhhhc---CcccccCCCCccccceeeeccCCC-----CccchhhhhhHHHHHHHhc----------CCCC
Q 013005 170 VSDFGLSALPEQIKN---GMLHTACGTPAYTAPEVVARRGYD-----GAVADAWSCGVILFVLLAG----------YLPF 231 (451)
Q Consensus 170 l~DFGls~~~~~~~~---~~~~~~~gt~~y~APEvl~~~~~~-----~~~sDIwSlGvil~~Ll~G----------~~Pf 231 (451)
|+|||++........ ......+||+.|+|||++.+.... +.++|||||||++|+|++| ..||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 999999975433222 123345899999999998765322 3579999999999999999 8888
Q ss_pred CCC-----cHHHHHHHhhc--cCCCCCC-----CCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 232 DDS-----NLLAMYKKVNR--RDYQFPS-----FVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 232 ~~~-----~~~~~~~~i~~--~~~~~p~-----~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
... ........... .....|. ..++.+.+||.+||..||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 542 22222222221 1222222 13467999999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=357.49 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=204.7
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE---
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA--- 100 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~--- 100 (451)
....++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++.+. ||||+++++++.
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 99 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFN-HPNILRLVAYCLRER 99 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC----CHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEEecc
Confidence 34567899999999999999999999999999999998654 2345567889999999995 999999999986
Q ss_pred -eCCEEEEEEEecCCCchhHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEecc
Q 013005 101 -TKTKIYLVMEYAAGGELFGKLRR-----GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFG 174 (451)
Q Consensus 101 -~~~~~~lV~E~~~gg~L~~~l~~-----~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFG 174 (451)
.....|+||||+.+|+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecC
Confidence 34578999999999999998863 569999999999999999999999999999999999999999999999999
Q ss_pred CCCcchhhhc--------CcccccCCCCccccceeeeccCC--CCccchhhhhhHHHHHHHhcCCCCCCCcHH--HHHHH
Q 013005 175 LSALPEQIKN--------GMLHTACGTPAYTAPEVVARRGY--DGAVADAWSCGVILFVLLAGYLPFDDSNLL--AMYKK 242 (451)
Q Consensus 175 ls~~~~~~~~--------~~~~~~~gt~~y~APEvl~~~~~--~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~--~~~~~ 242 (451)
++........ .......||+.|+|||++..... .+.++||||||+++|+|++|..||...... .....
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 259 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence 9864321111 11124568999999999865442 356799999999999999999999531110 11111
Q ss_pred hh-ccCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 243 VN-RRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 243 i~-~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
+. ......+..++..+.+||.+||..||.+|||+++++++
T Consensus 260 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 260 VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 11 12233445689999999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=375.83 Aligned_cols=258 Identities=22% Similarity=0.277 Sum_probs=200.4
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
..-..+|.+.+.||+|+||+|+.. ...+++.||||++..... ..+.+|+.+++.+.+|||||++++++.+..
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~-------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 91 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF-------SFADREVQLLRESDEHPNVIRYFCTEKDRQ 91 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTE-------EECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred EEccEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHH-------HHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 333456999999999999997643 347899999999975422 124579999999966999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC-----CCCeEEEeccCC
Q 013005 104 KIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR-----DGNLKVSDFGLS 176 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~-----~~~lkl~DFGls 176 (451)
..|+|||||. |+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++. ...+||+|||++
T Consensus 92 ~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 92 FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9999999996 599999975 34666778899999999999999999999999999999953 235889999999
Q ss_pred Ccchhhhc--CcccccCCCCccccceeeecc--CCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhccCCCC-
Q 013005 177 ALPEQIKN--GMLHTACGTPAYTAPEVVARR--GYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRDYQF- 250 (451)
Q Consensus 177 ~~~~~~~~--~~~~~~~gt~~y~APEvl~~~--~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~~~~~- 250 (451)
........ ......+||+.|+|||++.+. ...+.++|||||||++|+|++ |..||...........+.......
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~ 250 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL 250 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTS
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcccc
Confidence 76543221 233457899999999998742 233567999999999999999 999997665544443333222221
Q ss_pred --CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchhH
Q 013005 251 --PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQ 290 (451)
Q Consensus 251 --p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 290 (451)
+...+..+.+||.+||..||.+|||++++++||||.....
T Consensus 251 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~ 292 (432)
T 3p23_A 251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292 (432)
T ss_dssp CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHH
T ss_pred CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHH
Confidence 1224566899999999999999999999999999986443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=353.49 Aligned_cols=257 Identities=26% Similarity=0.385 Sum_probs=206.6
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEcC-CCc--EEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEE
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIA-DGS--IVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQE 97 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-~~~--~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~ 97 (451)
.......++|++.+.||+|+||.||+|.+.. +++ .||+|++.... .......+.+.+|+.+++++. ||||+++++
T Consensus 11 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~ 88 (291)
T 1u46_A 11 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDV-LSQPEAMDDFIREVNAMHSLD-HRNLIRLYG 88 (291)
T ss_dssp CCEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCC-CTTBCCEEE
T ss_pred cccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCc-cCCHHHHHHHHHHHHHHHhCC-CCCcccEEE
Confidence 3345567899999999999999999998643 333 69999987642 223345678899999999995 999999999
Q ss_pred EEEeCCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccC
Q 013005 98 VMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGL 175 (451)
Q Consensus 98 ~~~~~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGl 175 (451)
++.+.. .++||||+.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 89 ~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 167 (291)
T 1u46_A 89 VVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGL 167 (291)
T ss_dssp EECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred EEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccc
Confidence 998765 8999999999999999874 6799999999999999999999999999999999999999999999999999
Q ss_pred CCcchhhhc--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhccC--CCC
Q 013005 176 SALPEQIKN--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRD--YQF 250 (451)
Q Consensus 176 s~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~~--~~~ 250 (451)
+........ .......+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+.... ...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (291)
T 1u46_A 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 246 (291)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC
T ss_pred cccccccccchhhhccCCCCceeeCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC
Confidence 875433221 12234567889999999877665 567999999999999999 999999988888777776543 344
Q ss_pred CCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 251 PSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 251 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+..++..+.++|.+||..||.+|||+.++++
T Consensus 247 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 247 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 5678999999999999999999999999997
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=356.79 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=209.3
Q ss_pred ccccCCe-EEcceEcccCceEEEEEE----EcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE
Q 013005 24 PTLLNRY-QLGPLLGRGSFAKVHKAK----SIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 24 ~~~~~~y-~~~~~LG~G~~g~Vy~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
..+.++| ++++.||+|+||+||++. +..+++.||||++.... .....+.+.+|+.+++++. ||||++++++
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~ 101 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA---GPQHRSGWKQEIDILRTLY-HEHIIKYKGC 101 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHCC-CTTBCCEEEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc---ChHHHHHHHHHHHHHHhCC-CcchhhEEEE
Confidence 3455666 999999999999998775 34578999999997652 3345677899999999996 9999999999
Q ss_pred EEe--CCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCC
Q 013005 99 MAT--KTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176 (451)
Q Consensus 99 ~~~--~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls 176 (451)
+.+ ....|+||||+++|+|.+++....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 102 CEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181 (318)
T ss_dssp EEETTTTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred EecCCCceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccc
Confidence 987 468999999999999999999888999999999999999999999999999999999999999999999999999
Q ss_pred Ccchhhhc--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH---------------HH
Q 013005 177 ALPEQIKN--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL---------------AM 239 (451)
Q Consensus 177 ~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~---------------~~ 239 (451)
........ .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...... ..
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 260 (318)
T 3lxp_A 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKF-YYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260 (318)
T ss_dssp EECCTTCSEEEC---CCCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred ccccccccccccccCCCCCceeeChHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence 76543221 22345568899999999977666 46799999999999999999999754321 11
Q ss_pred HHHhhc-cCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 240 YKKVNR-RDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 240 ~~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
...+.. .....+..++..+.+||.+||..||.+|||++++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 122222 234566778999999999999999999999999985
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=350.55 Aligned_cols=256 Identities=21% Similarity=0.332 Sum_probs=210.1
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEcCC---CcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEE
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIAD---GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQE 97 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~ 97 (451)
..++....+|++.+.||+|+||.||+|.+..+ ...+|+|.+.... .....+.+.+|+.+++++. ||||+++++
T Consensus 18 ~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~ 93 (298)
T 3f66_A 18 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT---DIGEVSQFLTEGIIMKDFS-HPNVLSLLG 93 (298)
T ss_dssp GBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC---SHHHHHHHHHHHHHHHTCC-CTTBCCCCE
T ss_pred eecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC---CHHHHHHHHHHHHHHHhCC-CCCEeeeee
Confidence 33455667899999999999999999997543 3468999987542 3445677899999999995 999999999
Q ss_pred EE-EeCCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEecc
Q 013005 98 VM-ATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFG 174 (451)
Q Consensus 98 ~~-~~~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFG 174 (451)
++ ...+..|+||||+.+|+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg 173 (298)
T 3f66_A 94 ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFG 173 (298)
T ss_dssp EECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCG
T ss_pred EEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccc
Confidence 85 556688999999999999999974 568999999999999999999999999999999999999999999999999
Q ss_pred CCCcchhhhc---CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhccC-CC
Q 013005 175 LSALPEQIKN---GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRD-YQ 249 (451)
Q Consensus 175 ls~~~~~~~~---~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~~-~~ 249 (451)
++........ .......||+.|+|||++.+..+ +.++||||||+++|+|++ |.+||...+.......+.... ..
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
T 3f66_A 174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 252 (298)
T ss_dssp GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCC
T ss_pred ccccccccchhccccccCCCCCccccChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCC
Confidence 9975433221 22334567889999999977666 567999999999999999 677777766555555554443 34
Q ss_pred CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 250 FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 250 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.|..++..+.++|.+||..||.+|||+.++++
T Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 253 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 46678999999999999999999999999987
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=372.00 Aligned_cols=247 Identities=24% Similarity=0.430 Sum_probs=211.2
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
..+....++|++.+.||+|+||.||+|.+ +++.||||+++... ..+.+.+|+.+|++++ ||||+++++++.
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 256 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA------TAQAFLAEASVMTQLR-HSNLVQLLGVIV 256 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT------TSHHHHHHHHHHHTCC-CTTBCCEEEEEE
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch------HHHHHHHHHHHHHhcc-CCCEEEEEEEEE
Confidence 34556778999999999999999999986 47899999997642 2356889999999995 999999999987
Q ss_pred eCC-EEEEEEEecCCCchhHHhhc-C--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCC
Q 013005 101 TKT-KIYLVMEYAAGGELFGKLRR-G--RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176 (451)
Q Consensus 101 ~~~-~~~lV~E~~~gg~L~~~l~~-~--~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls 176 (451)
... ..|+||||+.+|+|.+++.. + .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 257 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a 336 (450)
T 1k9a_A 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336 (450)
T ss_dssp CTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence 655 79999999999999999974 3 3799999999999999999999999999999999999999999999999998
Q ss_pred CcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCC
Q 013005 177 ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFV 254 (451)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~ 254 (451)
..... ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+ ....|..+
T Consensus 337 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~ 411 (450)
T 1k9a_A 337 KEASS----TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC 411 (450)
T ss_dssp EECC----------CCCTTTSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTC
T ss_pred ccccc----cccCCCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcC
Confidence 74322 1233467899999999987766 567999999999999998 99999887666666665544 45677789
Q ss_pred CHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 255 SKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 255 s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
++.+.+||.+||..||.+|||+.++++
T Consensus 412 ~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 412 PPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=358.23 Aligned_cols=250 Identities=22% Similarity=0.367 Sum_probs=210.5
Q ss_pred cCCeEEcceEcccCceEEEEEE----EcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE--
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAK----SIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA-- 100 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~-- 100 (451)
.++|++.+.||+|+||.||+|+ +..+++.||+|++.... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG----PDQQRDFQREIQILKALH-SDFIVKYRGVSYGP 96 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC----HHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC----HHHHHHHHHHHHHHHhcC-CCceeEEEEEEecC
Confidence 4699999999999999999998 56789999999997642 344567899999999995 999999999986
Q ss_pred eCCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
+....|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 56679999999999999999974 5699999999999999999999999999999999999999999999999999975
Q ss_pred chhhhc--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH---------------HHHH
Q 013005 179 PEQIKN--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL---------------AMYK 241 (451)
Q Consensus 179 ~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~---------------~~~~ 241 (451)
...... .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...... ....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 433221 12344568899999999877665 56799999999999999999999654322 2222
Q ss_pred Hhhc-cCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 242 KVNR-RDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 242 ~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
.+.. .....+..+++.+.+||.+||..||.+|||+++++++
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2222 2345667789999999999999999999999999765
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=349.45 Aligned_cols=248 Identities=24% Similarity=0.416 Sum_probs=205.4
Q ss_pred CCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE
Q 013005 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 20 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~ 99 (451)
...+....++|++.+.||+|+||.||+|.+ +++.||+|++.... ..+.+.+|+.++++++ ||||+++++++
T Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~-h~~iv~~~~~~ 83 (278)
T 1byg_A 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA------TAQAFLAEASVMTQLR-HSNLVQLLGVI 83 (278)
T ss_dssp --CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--------HHHHHTHHHHTTCC-CTTBCCEEEEE
T ss_pred hccccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh------HHHHHHHHHHHHHhCC-CCCEeeEEEEE
Confidence 344567789999999999999999999986 58899999997542 2457889999999995 99999999997
Q ss_pred Ee-CCEEEEEEEecCCCchhHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccC
Q 013005 100 AT-KTKIYLVMEYAAGGELFGKLRRG---RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGL 175 (451)
Q Consensus 100 ~~-~~~~~lV~E~~~gg~L~~~l~~~---~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGl 175 (451)
.. .+..|+||||+++++|.+++... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~ 163 (278)
T 1byg_A 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 163 (278)
T ss_dssp CCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred EcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccc
Confidence 54 45789999999999999999752 389999999999999999999999999999999999999999999999999
Q ss_pred CCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCC
Q 013005 176 SALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSF 253 (451)
Q Consensus 176 s~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~ 253 (451)
+..... ......+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+... ....+..
T Consensus 164 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (278)
T 1byg_A 164 TKEASS----TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 238 (278)
T ss_dssp ----------------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTT
T ss_pred cccccc----cccCCCccccccCHHHhCCCCC-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCccc
Confidence 875432 1234467899999999877666 567999999999999998 99999987766666666544 4456778
Q ss_pred CCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 254 VSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 254 ~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+++.+.++|.+||..||.+|||+.++++
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 239 CPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 8999999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=370.48 Aligned_cols=253 Identities=25% Similarity=0.348 Sum_probs=195.5
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
+.+.|.+.+.||+|+||+||.+. ..+|+.||||++.... .+.+.+|+.+++++.+||||+++++++.+....
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~-------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 84 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF-------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFL 84 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred hhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH-------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeE
Confidence 44566778899999999998764 4689999999986542 245678999999876699999999999999999
Q ss_pred EEEEEecCCCchhHHhhcCCC--------CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCC------------
Q 013005 106 YLVMEYAAGGELFGKLRRGRL--------TESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD------------ 165 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~~~l--------~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~------------ 165 (451)
|+|||||. |+|.+++..... ++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 85 ~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~ 163 (434)
T 2rio_A 85 YIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE 163 (434)
T ss_dssp EEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred EEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCC
Confidence 99999996 599999975432 233457899999999999999999999999999999754
Q ss_pred -CCeEEEeccCCCcchhhhc---CcccccCCCCccccceeeec------cCCCCccchhhhhhHHHHHHHh-cCCCCCCC
Q 013005 166 -GNLKVSDFGLSALPEQIKN---GMLHTACGTPAYTAPEVVAR------RGYDGAVADAWSCGVILFVLLA-GYLPFDDS 234 (451)
Q Consensus 166 -~~lkl~DFGls~~~~~~~~---~~~~~~~gt~~y~APEvl~~------~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~ 234 (451)
+.+||+|||++........ ......+||+.|+|||++.+ ....+.++|||||||++|+|++ |..||...
T Consensus 164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 4799999999976543221 12345689999999999865 2344677999999999999999 99999765
Q ss_pred cHHHHHHHhhccCCCCCC-------CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 235 NLLAMYKKVNRRDYQFPS-------FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 235 ~~~~~~~~i~~~~~~~p~-------~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
.... ..+.......+. .+++.+.+||.+||..||.+|||+.++++||||....
T Consensus 244 ~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~~ 303 (434)
T 2rio_A 244 YSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKS 303 (434)
T ss_dssp TTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCHH
T ss_pred hhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCcH
Confidence 4332 222222222221 2357899999999999999999999999999997643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=347.26 Aligned_cols=253 Identities=22% Similarity=0.341 Sum_probs=210.3
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCc---EEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGS---IVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
...-.|.+.+.||+|+||.||+|.+..++. .||+|++.... .....+.+.+|+.+++.+. ||||+++++++.+
T Consensus 18 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 93 (298)
T 3pls_A 18 HERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT---EMQQVEAFLREGLLMRGLN-HPNVLALIGIMLP 93 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC---SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECC
T ss_pred ccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc---cHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEec
Confidence 334467788999999999999999766554 79999997542 3345678899999999995 9999999999976
Q ss_pred CCEE-EEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 102 KTKI-YLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 102 ~~~~-~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
.+.. |+||||+.+|+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 94 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 94 PEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp SSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred CCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 6655 999999999999999975 5799999999999999999999999999999999999999999999999999975
Q ss_pred chhhh---cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCC
Q 013005 179 PEQIK---NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSF 253 (451)
Q Consensus 179 ~~~~~---~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~ 253 (451)
..... ........||+.|+|||.+.+..+ +.++||||||+++|+|++ |.+||...+.......+... ....+..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRF-TTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEY 252 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTT
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCC-ChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCcc
Confidence 43322 133345678999999999977666 567999999999999999 55556655555555554443 3456677
Q ss_pred CCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 254 VSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 254 ~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
+++.+.++|.+||..||.+|||++++++.
T Consensus 253 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 253 CPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 89999999999999999999999999873
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=359.34 Aligned_cols=246 Identities=17% Similarity=0.220 Sum_probs=202.6
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCC--------CcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceE--
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIAD--------GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK-- 94 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~--------~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~-- 94 (451)
...++|++.+.||+|+||.||+|++..+ ++.||+|++... +.+.+|+.++++++ ||||++
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~-h~niv~~~ 108 (352)
T 2jii_A 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAA-KPLQVNKW 108 (352)
T ss_dssp TTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHC-CHHHHHHH
T ss_pred ccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhc-ccchhhhh
Confidence 3358999999999999999999999874 889999999754 25778999999996 999887
Q ss_pred -------------EEEEEEe-CCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 013005 95 -------------IQEVMAT-KTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKP 157 (451)
Q Consensus 95 -------------l~~~~~~-~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKp 157 (451)
+++++.. ....|+||||+ +++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||
T Consensus 109 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp 187 (352)
T 2jii_A 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTA 187 (352)
T ss_dssp HHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCG
T ss_pred hhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCH
Confidence 6777766 78899999999 9999999975 6799999999999999999999999999999999
Q ss_pred CeEEeCCCC--CeEEEeccCCCcchhhhc------CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCC
Q 013005 158 QNLLLDRDG--NLKVSDFGLSALPEQIKN------GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYL 229 (451)
Q Consensus 158 eNILld~~~--~lkl~DFGls~~~~~~~~------~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~ 229 (451)
+|||++.++ .+||+|||++........ ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..
T Consensus 188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~ 266 (352)
T 2jii_A 188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFL 266 (352)
T ss_dssp GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCC
T ss_pred HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCC
Confidence 999999998 899999999976543322 12244589999999999877665 667999999999999999999
Q ss_pred CCCCC--cHHHHHHH---hhccCCCCC------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 230 PFDDS--NLLAMYKK---VNRRDYQFP------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 230 Pf~~~--~~~~~~~~---i~~~~~~~p------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
||... +....... +......++ ..+++.+.+||.+||..||.+|||++++++.
T Consensus 267 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 267 PWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp TTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred CcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 99864 33322222 222222222 2468999999999999999999999999873
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=360.51 Aligned_cols=260 Identities=25% Similarity=0.369 Sum_probs=210.1
Q ss_pred CCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE
Q 013005 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 19 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
+...+....++|++.+.||+|+||.||+|.+ .+++.||||++..... ......+.+|+.+++.+. ||||++++++
T Consensus 21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~ 95 (326)
T 3uim_A 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERT---QGGELQFQTEVEMISMAV-HRNLLRLRGF 95 (326)
T ss_dssp CTHHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC--------CCCHHHHHHHGGGTCC-CTTBCCCCEE
T ss_pred cHHHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccC---chHHHHHHHHHHHHHhcc-CCCccceEEE
Confidence 4556677889999999999999999999984 5789999999976421 112235889999999995 9999999999
Q ss_pred EEeCCEEEEEEEecCCCchhHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCCCeEEeCCCCCeEE
Q 013005 99 MATKTKIYLVMEYAAGGELFGKLRRG-----RLTESAARRYFQQLVSALHFCHQN---GVAHRDVKPQNLLLDRDGNLKV 170 (451)
Q Consensus 99 ~~~~~~~~lV~E~~~gg~L~~~l~~~-----~l~e~~~~~~~~ql~~gL~yLH~~---giiHrDLKpeNILld~~~~lkl 170 (451)
+.+.+..|+||||+.+|+|.+++... .+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 99999999999999999999999742 399999999999999999999999 9999999999999999999999
Q ss_pred EeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCc--------HHHHHHH
Q 013005 171 SDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN--------LLAMYKK 242 (451)
Q Consensus 171 ~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~--------~~~~~~~ 242 (451)
+|||++..............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... .......
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 9999997654433344455679999999999877665 677999999999999999999995211 1111111
Q ss_pred hhcc-C------C----CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCcc
Q 013005 243 VNRR-D------Y----QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISW 284 (451)
Q Consensus 243 i~~~-~------~----~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 284 (451)
.... . . .++...+..+.+++.+||..||.+|||+.++++|-+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 1110 0 0 111123467899999999999999999999998754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=369.93 Aligned_cols=253 Identities=24% Similarity=0.402 Sum_probs=205.5
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
....++|++.+.||+|+||+||+|++..+++.||||++..... ....+.+.+|+.++++++ ||||+++++++....
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 80 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETT 80 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG---GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTT
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc---cchHHHHHHHHHHHHhcC-CCCCCeEEEeeccCC
Confidence 4567899999999999999999999999999999999975421 122456779999999995 999999999998755
Q ss_pred --EEEEEEEecCCCchhHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEe----CCCCCeEEEec
Q 013005 104 --KIYLVMEYAAGGELFGKLRR----GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL----DRDGNLKVSDF 173 (451)
Q Consensus 104 --~~~lV~E~~~gg~L~~~l~~----~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILl----d~~~~lkl~DF 173 (451)
..|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DF 160 (396)
T 4eut_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (396)
T ss_dssp TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecC
Confidence 78999999999999999974 239999999999999999999999999999999999999 77888999999
Q ss_pred cCCCcchhhhcCcccccCCCCccccceeeecc-------CCCCccchhhhhhHHHHHHHhcCCCCCC----CcHHHHHHH
Q 013005 174 GLSALPEQIKNGMLHTACGTPAYTAPEVVARR-------GYDGAVADAWSCGVILFVLLAGYLPFDD----SNLLAMYKK 242 (451)
Q Consensus 174 Gls~~~~~~~~~~~~~~~gt~~y~APEvl~~~-------~~~~~~sDIwSlGvil~~Ll~G~~Pf~~----~~~~~~~~~ 242 (451)
|++...... ......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.. ........+
T Consensus 161 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 238 (396)
T 4eut_A 161 GAARELEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (396)
T ss_dssp GGCEECCCG--GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred CCceEccCC--CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence 999754332 233456899999999998652 2335679999999999999999999963 222333333
Q ss_pred hhccCC-------------------CCC------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 243 VNRRDY-------------------QFP------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 243 i~~~~~-------------------~~p------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
+..... .+| ..++..+.++|.+||..||++|||+++++++
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 332211 111 1234578899999999999999999998654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=355.38 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=199.1
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHh-cCCCCceEEEEEEE
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL-QNHPNVLKIQEVMA 100 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L-~~HpnIv~l~~~~~ 100 (451)
....+.++|++.+.||+|+||.||+|.+ +++.||||++.... .....+|..++..+ .+||||+++++++.
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 101 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE-------EASWFRETEIYQTVLMRHENILGFIAADI 101 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred cccccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc-------cchhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence 3456678999999999999999999987 48999999996542 12233444444443 15999999999998
Q ss_pred eC----CEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCeEEeCCCCCe
Q 013005 101 TK----TKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQN--------GVAHRDVKPQNLLLDRDGNL 168 (451)
Q Consensus 101 ~~----~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~--------giiHrDLKpeNILld~~~~l 168 (451)
.. ...|+||||+++|+|.+++....+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+
T Consensus 102 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 102 KGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp ESCGGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred cCCCCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence 87 7899999999999999999988999999999999999999999999 99999999999999999999
Q ss_pred EEEeccCCCcchhhhcC---cccccCCCCccccceeeeccCCCCc-----cchhhhhhHHHHHHHhc----------CCC
Q 013005 169 KVSDFGLSALPEQIKNG---MLHTACGTPAYTAPEVVARRGYDGA-----VADAWSCGVILFVLLAG----------YLP 230 (451)
Q Consensus 169 kl~DFGls~~~~~~~~~---~~~~~~gt~~y~APEvl~~~~~~~~-----~sDIwSlGvil~~Ll~G----------~~P 230 (451)
||+|||++......... .....+||+.|+|||++.+..+... ++|||||||++|+|++| ..|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 99999999654332221 1235689999999999876655433 48999999999999999 777
Q ss_pred CCCC-----cHHHHHHHhhc--cCCCCCC-----CCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 231 FDDS-----NLLAMYKKVNR--RDYQFPS-----FVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 231 f~~~-----~~~~~~~~i~~--~~~~~p~-----~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
|... ........+.. ....+|. .+++.+.+||.+||..||.+|||+.++++|
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 7542 22222222221 1223332 245668999999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=376.53 Aligned_cols=254 Identities=24% Similarity=0.367 Sum_probs=217.9
Q ss_pred CCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE
Q 013005 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 19 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
....+....++|++.+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.+|++|+ ||||++++++
T Consensus 258 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~-hpniv~~~~~ 330 (535)
T 2h8h_A 258 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLR-HEKLVQLYAV 330 (535)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS-----CHHHHHHHHHHHHHCC-CTTBCCEEEE
T ss_pred CccceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC-----CHHHHHHHHHHHHhCC-CCCEeeEEEE
Confidence 355667788899999999999999999999854 56799999976421 1356889999999996 9999999999
Q ss_pred EEeCCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccC
Q 013005 99 MATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGL 175 (451)
Q Consensus 99 ~~~~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGl 175 (451)
+.+ ...|+||||+.+|+|.+++.. ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 331 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 409 (535)
T 2h8h_A 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 409 (535)
T ss_dssp ECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred Eee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEccccc
Confidence 876 678999999999999999963 4699999999999999999999999999999999999999999999999999
Q ss_pred CCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCC
Q 013005 176 SALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSF 253 (451)
Q Consensus 176 s~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~ 253 (451)
+...............+++.|+|||++....+ +.++|||||||+||+|++ |..||.+....+....+... ....|..
T Consensus 410 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~ 488 (535)
T 2h8h_A 410 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 488 (535)
T ss_dssp TTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred ceecCCCceecccCCcCcccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 98654322222234557889999999877665 567999999999999999 99999988877777776554 3456778
Q ss_pred CCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 254 VSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 254 ~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
++..+.+||.+||..||++|||+++|++
T Consensus 489 ~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 489 CPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=359.50 Aligned_cols=249 Identities=15% Similarity=0.202 Sum_probs=199.6
Q ss_pred CCCcccccCCeEEcceEcccCceEEEEE-----EEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcC--CCCc
Q 013005 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKA-----KSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN--HPNV 92 (451)
Q Consensus 20 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a-----~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~--HpnI 92 (451)
...+....++|.+.+.||+|+||+||+| .+..+++.||+|++.... ...+.+|+.+++.+.. |+||
T Consensus 57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~e~~~~~~l~~~~~~~i 129 (365)
T 3e7e_A 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-------PWEFYIGTQLMERLKPSMQHMF 129 (365)
T ss_dssp SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-------HHHHHHHHHHHHHSCGGGGGGB
T ss_pred ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-------hhHHHHHHHHHHHhhhhhhhhh
Confidence 3444556788999999999999999999 467789999999997652 2356677777777742 8999
Q ss_pred eEEEEEEEeCCEEEEEEEecCCCchhHHhh------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC--
Q 013005 93 LKIQEVMATKTKIYLVMEYAAGGELFGKLR------RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR-- 164 (451)
Q Consensus 93 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~------~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~-- 164 (451)
+++++++...+..|+||||++||+|.+++. .+.+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 130 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~ 209 (365)
T 3e7e_A 130 MKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGF 209 (365)
T ss_dssp CCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGG
T ss_pred hhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccc
Confidence 999999999999999999999999999995 356999999999999999999999999999999999999998
Q ss_pred ---------CCCeEEEeccCCCcchhhh-cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCC
Q 013005 165 ---------DGNLKVSDFGLSALPEQIK-NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS 234 (451)
Q Consensus 165 ---------~~~lkl~DFGls~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~ 234 (451)
++.+||+|||+|....... .......+||+.|+|||++.+..| +.++|||||||++|+|++|+.||...
T Consensus 210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp TCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred cCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC-CccccHHHHHHHHHHHHhCCCccccC
Confidence 8999999999997543222 234456789999999999988776 56799999999999999999999643
Q ss_pred cHHHHHHHhhccCCCCC-CCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 235 NLLAMYKKVNRRDYQFP-SFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 235 ~~~~~~~~i~~~~~~~p-~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.... . .....++ .+.++.+.+++.+||..+|.+|++..+.+.
T Consensus 289 ~~~~----~-~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 289 EGGE----C-KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp ETTE----E-EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred CCCc----e-eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 2210 0 0011111 235778899999999999999965444443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=354.67 Aligned_cols=258 Identities=21% Similarity=0.326 Sum_probs=212.0
Q ss_pred CCCCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEE
Q 013005 17 PPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQ 96 (451)
Q Consensus 17 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~ 96 (451)
......+....++|++.+.||+|+||.||+|.+.. .+|+|++..... .....+.+.+|+.++++++ ||||++++
T Consensus 22 ~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~ 95 (319)
T 2y4i_B 22 SIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD--NEDQLKAFKREVMAYRQTR-HENVVLFM 95 (319)
T ss_dssp CCCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC--CCCCCCCCCTTGGGGTTCC-CTTBCCCC
T ss_pred ccccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC--CHHHHHHHHHHHHHHhcCC-CCCEeEEE
Confidence 34456777889999999999999999999998753 499999975421 1122345678999999995 99999999
Q ss_pred EEEEeCCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEecc
Q 013005 97 EVMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFG 174 (451)
Q Consensus 97 ~~~~~~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFG 174 (451)
+++.+....|+||||+.|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||
T Consensus 96 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 96 GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp EEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCS
T ss_pred EEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecC
Confidence 999999999999999999999999986 3699999999999999999999999999999999999998 6799999999
Q ss_pred CCCcchhh----hcCcccccCCCCccccceeeecc--------CCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHH
Q 013005 175 LSALPEQI----KNGMLHTACGTPAYTAPEVVARR--------GYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKK 242 (451)
Q Consensus 175 ls~~~~~~----~~~~~~~~~gt~~y~APEvl~~~--------~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~ 242 (451)
++...... .........||+.|+|||++... ...+.++||||||+++|+|++|..||...+.......
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 254 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ 254 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 98754321 12334456799999999998652 2346779999999999999999999999888777766
Q ss_pred hhccCCCC--CCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 243 VNRRDYQF--PSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 243 i~~~~~~~--p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+....... +..++..+.++|.+||..||.+|||+.++++
T Consensus 255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 255 MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp HHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred hccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 65543322 2357899999999999999999999999987
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=350.98 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=201.2
Q ss_pred eEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEE
Q 013005 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVM 109 (451)
Q Consensus 30 y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~ 109 (451)
|..++.||+|+||.||+|.+ +++.||+|++............+.+.+|+.++++++ ||||+++++++.+.+..|+||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEecCCceEEEE
Confidence 33458999999999999984 688999999976432233445678999999999995 999999999999999999999
Q ss_pred EecCCCchhHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 110 EYAAGGELFGKLRR----GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 110 E~~~gg~L~~~l~~----~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence 99999999998862 46999999999999999999999999999999999999999999999999998754332221
Q ss_pred -cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH----HHHHHhhccC-----------CC
Q 013005 186 -MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL----AMYKKVNRRD-----------YQ 249 (451)
Q Consensus 186 -~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~----~~~~~i~~~~-----------~~ 249 (451)
.....+||+.|+|||++.+. .+.++||||||+++|+|++|..||...... .....+.... ..
T Consensus 190 ~~~~~~~g~~~y~aPE~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND 267 (307)
T ss_dssp EECSSCCSCGGGCCHHHHTTE--ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC
T ss_pred ccccccCCCcCcCChHHhcCC--CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc
Confidence 23345799999999988653 366799999999999999999999864322 1112211111 11
Q ss_pred CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 250 FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 250 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
.+...+..+.+++.+||..||.+|||+.+++++
T Consensus 268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 122345678999999999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=347.42 Aligned_cols=241 Identities=32% Similarity=0.510 Sum_probs=197.1
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
..++|++.+.||+|+||.||+|.+ +++.||+|++.... ..+.+.+|+.++++++ ||||+++++++.+ ..
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~ 74 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESES------ERKAFIVELRQLSRVN-HPNIVKLYGACLN--PV 74 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTT------HHHHHHHHHHHHHHCC-CTTBCCEEEBCTT--TT
T ss_pred CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChh------HHHHHHHHHHHHhcCC-CCCcCeEEEEEcC--Cc
Confidence 457899999999999999999986 47899999986432 2457889999999995 9999999998763 47
Q ss_pred EEEEEecCCCchhHHhhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCCCeEEeCCCCC-eEEEeccCCC
Q 013005 106 YLVMEYAAGGELFGKLRRG----RLTESAARRYFQQLVSALHFCHQ---NGVAHRDVKPQNLLLDRDGN-LKVSDFGLSA 177 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~~----~l~e~~~~~~~~ql~~gL~yLH~---~giiHrDLKpeNILld~~~~-lkl~DFGls~ 177 (451)
|+||||++||+|.+++... .+++..+..++.|++.||.|||+ +||+||||||+|||++.++. +||+|||++.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence 9999999999999999753 37899999999999999999999 89999999999999998887 7999999987
Q ss_pred cchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCc--HHHHHHHh-hccCCCCCCCC
Q 013005 178 LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN--LLAMYKKV-NRRDYQFPSFV 254 (451)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~--~~~~~~~i-~~~~~~~p~~~ 254 (451)
.... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.... .......+ .......+..+
T Consensus 155 ~~~~----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (307)
T 2eva_A 155 DIQT----HMTNNKGSAAWMAPEVFEGSNY-SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 229 (307)
T ss_dssp --------------CCTTSSCHHHHTCCCC-CTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTC
T ss_pred cccc----ccccCCCCCceEChhhhCCCCC-CcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCccccc
Confidence 4432 2234579999999999977665 567999999999999999999997532 22222222 23344556678
Q ss_pred CHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 255 SKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 255 s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
++.+.++|.+||..||.+|||+++++++
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9999999999999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=378.23 Aligned_cols=243 Identities=21% Similarity=0.333 Sum_probs=204.4
Q ss_pred ceEcccCceEEEEEEE--cCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEe
Q 013005 34 PLLGRGSFAKVHKAKS--IADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEY 111 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~ 111 (451)
+.||+|+||.||+|.+ ..+++.||||++.... .+....+.+.+|+.+|++|+ |||||++++++.. ...|+||||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~-~~~~lv~E~ 450 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESWMLVMEM 450 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG--GCGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEES-SSEEEEEEC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc--CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec-CCEEEEEEc
Confidence 4799999999999954 4567899999997642 23344577999999999996 9999999999864 558999999
Q ss_pred cCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc--Cccc
Q 013005 112 AAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN--GMLH 188 (451)
Q Consensus 112 ~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~--~~~~ 188 (451)
+.+|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ....
T Consensus 451 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 451 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred cCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 999999999975 6799999999999999999999999999999999999999999999999999875433221 2223
Q ss_pred ccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhHHHHHHhcc
Q 013005 189 TACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPARSLIYQLL 266 (451)
Q Consensus 189 ~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L 266 (451)
...||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+... ...+|..+++.+.+||.+||
T Consensus 531 ~~~~t~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl 609 (635)
T 4fl3_A 531 HGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCW 609 (635)
T ss_dssp ----CGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred CCCCceeeeChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHc
Confidence 4457889999999977666 567999999999999998 99999998888777777654 34667789999999999999
Q ss_pred CCCCCCCCCHHHHHc
Q 013005 267 DPNPKTRMSIEKIMS 281 (451)
Q Consensus 267 ~~dP~~Rpt~~eil~ 281 (451)
..||++|||+++|++
T Consensus 610 ~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 610 TYDVENRPGFAAVEL 624 (635)
T ss_dssp CSSTTTSCCHHHHHH
T ss_pred CCCHhHCcCHHHHHH
Confidence 999999999999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=376.26 Aligned_cols=250 Identities=22% Similarity=0.320 Sum_probs=207.2
Q ss_pred ccCCeEEcc-eEcccCceEEEEEEEc--CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 26 LLNRYQLGP-LLGRGSFAKVHKAKSI--ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 26 ~~~~y~~~~-~LG~G~~g~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
..+++.+.+ .||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+|++++ |||||++++++..
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~- 407 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA- 407 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC---SSTTHHHHHHHHHHHTTCC-CTTBCCEEEEEES-
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC---ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEecc-
Confidence 345666666 8999999999999875 356689999997642 1233567889999999995 9999999999976
Q ss_pred CEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 103 TKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
+..|+||||+.+|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 569999999999999999964 569999999999999999999999999999999999999999999999999998653
Q ss_pred hhhc--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCH
Q 013005 181 QIKN--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSK 256 (451)
Q Consensus 181 ~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 256 (451)
.... .......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+....+..+ ...+|..+++
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~ 566 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP 566 (613)
T ss_dssp --------------CCTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCH
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCH
Confidence 3222 11223446789999999977666 567999999999999998 99999988777777776654 3567788999
Q ss_pred hHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 257 PARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.+.+||.+||..||.+|||+.+|++
T Consensus 567 ~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 567 ELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999999865
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=351.19 Aligned_cols=251 Identities=22% Similarity=0.316 Sum_probs=191.5
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe-
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT- 101 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~- 101 (451)
.....++|++.+.||+|+||.||+|.+ +++.||||++..... .......|+..+..+ +||||+++++.+..
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR-----QNFINEKNIYRVPLM-EHDNIARFIVGDERV 79 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH-----HHHHHHHHHHTSTTC-CCTTBCCEEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch-----hhHHHHHHHHHHHhc-cCcchhhheeccccc
Confidence 345679999999999999999999975 789999999975421 111122344334446 59999999986542
Q ss_pred ----CCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CceecCCCCCeEEeCCCCCe
Q 013005 102 ----KTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQN---------GVAHRDVKPQNLLLDRDGNL 168 (451)
Q Consensus 102 ----~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~---------giiHrDLKpeNILld~~~~l 168 (451)
...+|+||||+++|+|.+++.....++..++.++.||+.||.|||++ ||+||||||+|||++.++.+
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence 33679999999999999999988889999999999999999999999 99999999999999999999
Q ss_pred EEEeccCCCcchhh-------hcCcccccCCCCccccceeeecc------CCCCccchhhhhhHHHHHHHhcCCCCCCCc
Q 013005 169 KVSDFGLSALPEQI-------KNGMLHTACGTPAYTAPEVVARR------GYDGAVADAWSCGVILFVLLAGYLPFDDSN 235 (451)
Q Consensus 169 kl~DFGls~~~~~~-------~~~~~~~~~gt~~y~APEvl~~~------~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~ 235 (451)
||+|||++...... ........+||+.|+|||++.+. ...+.++|||||||++|+|++|..||....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 99999999754321 11223456799999999998752 223467999999999999999977763211
Q ss_pred ------------------HHHHHHHhh--ccCCCCCCC------CCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 236 ------------------LLAMYKKVN--RRDYQFPSF------VSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 236 ------------------~~~~~~~i~--~~~~~~p~~------~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.......+. .....+|.. .++.+.+||.+||..||++|||++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 111111111 112233333 2347999999999999999999999965
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=361.11 Aligned_cols=252 Identities=22% Similarity=0.337 Sum_probs=200.1
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCC---cEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE-e
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADG---SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA-T 101 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~-~ 101 (451)
....|++.+.||+|+||+||+|.+..++ ..||+|.+.... .....+.+.+|+.++++++ ||||+++++++. .
T Consensus 87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~ 162 (373)
T 3c1x_A 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT---DIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRS 162 (373)
T ss_dssp TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS---CSHHHHHHHHHHTTSTTCC-CTTBCCCCEEECCC
T ss_pred hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC---CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcC
Confidence 3446889999999999999999875433 468999986532 3345678899999999995 999999999864 4
Q ss_pred CCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcc
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALP 179 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~ 179 (451)
.+..|+||||+.+|+|.+++.. ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccc
Confidence 5688999999999999999975 46899999999999999999999999999999999999999999999999999754
Q ss_pred hhhhc---CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCC
Q 013005 180 EQIKN---GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFV 254 (451)
Q Consensus 180 ~~~~~---~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~ 254 (451)
..... .......+|+.|+|||++.+..+ +.++|||||||++|+|++ |.+||...+.......+... ....|..+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~ 321 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 321 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTC
T ss_pred cccccccccccCCCCCcccccChHHhcCCCC-CcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 33221 11234467889999999987666 567999999999999999 78888776554444444433 34456778
Q ss_pred CHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 255 SKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 255 s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
+..+.++|.+||..||.+|||+++++++
T Consensus 322 ~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 322 PDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=350.28 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=205.4
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHh-cCCCCceEEEEEEEe
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL-QNHPNVLKIQEVMAT 101 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L-~~HpnIv~l~~~~~~ 101 (451)
...+.++|++.+.||+|+||.||+|.+ +++.||||++.... ...+.+|+.+++.+ .+||||+++++++..
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-------ERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG-------HHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh-------HHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 345668999999999999999999987 58999999996532 24567888888873 259999999999987
Q ss_pred CC----EEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCceecCCCCCeEEeCCCCCeE
Q 013005 102 KT----KIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCH--------QNGVAHRDVKPQNLLLDRDGNLK 169 (451)
Q Consensus 102 ~~----~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH--------~~giiHrDLKpeNILld~~~~lk 169 (451)
.. ..|+||||+.+|+|.+++.+.++++.+++.++.|++.||.||| ++||+||||||+|||++.++.+|
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEE
T ss_pred cCCccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEE
Confidence 76 8999999999999999999889999999999999999999999 89999999999999999999999
Q ss_pred EEeccCCCcchhhhcC---cccccCCCCccccceeeeccCCC-----CccchhhhhhHHHHHHHhc----------CCCC
Q 013005 170 VSDFGLSALPEQIKNG---MLHTACGTPAYTAPEVVARRGYD-----GAVADAWSCGVILFVLLAG----------YLPF 231 (451)
Q Consensus 170 l~DFGls~~~~~~~~~---~~~~~~gt~~y~APEvl~~~~~~-----~~~sDIwSlGvil~~Ll~G----------~~Pf 231 (451)
|+|||++......... .....+||+.|+|||++.+.... +.++|||||||++|+|++| ..||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 9999999754432211 23456899999999998765322 2569999999999999999 7898
Q ss_pred CCC-----cHHHHHHHhhccC--CCCCC-----CCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 232 DDS-----NLLAMYKKVNRRD--YQFPS-----FVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 232 ~~~-----~~~~~~~~i~~~~--~~~p~-----~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
... ........+.... ..+|. ..+..+.+||.+||..||.+|||++++++|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 653 3344444443322 22232 123578899999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=349.33 Aligned_cols=254 Identities=21% Similarity=0.348 Sum_probs=208.3
Q ss_pred CcccccCCeEEcceEcccCceEEEEEE----EcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEE
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAK----SIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQE 97 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~ 97 (451)
......++|++.+.||+|+||.||+|. +..+++.||+|++.... ....+.+.+|+.++++++ ||||+++++
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~-h~~iv~~~~ 109 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLRDFEREIEILKSLQ-HDNIVKYKG 109 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC----SHHHHHHHHHHHHHHTCC-CTTBCCEEE
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC----HHHHHHHHHHHHHHHhCC-CCCeeeEEE
Confidence 345567889999999999999999998 45689999999997642 344567899999999995 999999999
Q ss_pred EEEeCC--EEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEec
Q 013005 98 VMATKT--KIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDF 173 (451)
Q Consensus 98 ~~~~~~--~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DF 173 (451)
++...+ ..|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 110 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Df 189 (326)
T 2w1i_A 110 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 189 (326)
T ss_dssp EECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred EEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecC
Confidence 986543 78999999999999999975 46999999999999999999999999999999999999999999999999
Q ss_pred cCCCcchhhhc--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH--------------
Q 013005 174 GLSALPEQIKN--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL-------------- 237 (451)
Q Consensus 174 Gls~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~-------------- 237 (451)
|++........ .......+|+.|+|||++.+..+ +.++||||||+++|+|++|..||......
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 268 (326)
T 2w1i_A 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268 (326)
T ss_dssp TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH
T ss_pred cchhhccccccccccccCCCCceeEECchhhcCCCC-CchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh
Confidence 99975433221 11234567888999999877665 56799999999999999999998643211
Q ss_pred --HHHHHhhc-cCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 238 --AMYKKVNR-RDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 238 --~~~~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.....+.. .....|..++..+.+||.+||..||.+|||+.++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 269 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11122221 234566778999999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=363.13 Aligned_cols=250 Identities=21% Similarity=0.285 Sum_probs=209.9
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
+.+.++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.|.+|++|..+..+.....
T Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~ 76 (483)
T 3sv0_A 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------PQLLYESKIYRILQGGTGIPNVRWFGVEGD 76 (483)
T ss_dssp CEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS------CCHHHHHHHHHHTTTSTTCCCEEEEEEETT
T ss_pred CCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCC
Confidence 35678999999999999999999999999999999998765321 247789999999986688888888888899
Q ss_pred EEEEEEEecCCCchhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEe---CCCCCeEEEeccCCCc
Q 013005 104 KIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLL---DRDGNLKVSDFGLSAL 178 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~--~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILl---d~~~~lkl~DFGls~~ 178 (451)
..|+||||+ +++|.+++. .+.+++.+++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..
T Consensus 77 ~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 999999999 999999997 4689999999999999999999999999999999999999 6889999999999975
Q ss_pred chhhhc------CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCC---cHHHHHHHhhccCC-
Q 013005 179 PEQIKN------GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS---NLLAMYKKVNRRDY- 248 (451)
Q Consensus 179 ~~~~~~------~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~---~~~~~~~~i~~~~~- 248 (451)
...... ......+||+.|+|||++.+..+ +.++|||||||+||+|++|..||... .....+.++.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA 234 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence 443221 12236789999999999987766 56799999999999999999999863 33344444333221
Q ss_pred ----CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 249 ----QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 249 ----~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.++..++.++.+||.+||..||.+||++++|++
T Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 223567899999999999999999999998876
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=356.96 Aligned_cols=247 Identities=17% Similarity=0.255 Sum_probs=198.8
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcch----hhHHHHHHHHHHHHHHHHhc--------CCCCc
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKF----LDAAMEDRIVREVSAMRRLQ--------NHPNV 92 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~~~~~~~~~Ei~il~~L~--------~HpnI 92 (451)
...++|++.+.||+|+||+||+|++ +|+.||||++...... ......+.+.+|+.+++.++ +||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 4468899999999999999999997 7899999999865311 11223357889999999986 58888
Q ss_pred eEEEEEEE------------------------------eCCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHH
Q 013005 93 LKIQEVMA------------------------------TKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSAL 142 (451)
Q Consensus 93 v~l~~~~~------------------------------~~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL 142 (451)
+++.+++. +....|+||||+.+|++.+.+.++.+++.+++.++.||+.||
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 88888753 267899999999999888888778899999999999999999
Q ss_pred HHHH-HCCceecCCCCCeEEeCCCC--------------------CeEEEeccCCCcchhhhcCcccccCCCCcccccee
Q 013005 143 HFCH-QNGVAHRDVKPQNLLLDRDG--------------------NLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEV 201 (451)
Q Consensus 143 ~yLH-~~giiHrDLKpeNILld~~~--------------------~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEv 201 (451)
+||| ++||+||||||+|||++.++ .+||+|||+|+.... ...+||+.|+|||+
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTTCSGG
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecccChhh
Confidence 9999 99999999999999999887 899999999985432 24589999999999
Q ss_pred eeccCCCCccchhhhhhHH-HHHHHhcCCCCCCCcH-HHHHHHhhcc-CC--CC----CCCCCHhHHHHHHhccCCCCCC
Q 013005 202 VARRGYDGAVADAWSCGVI-LFVLLAGYLPFDDSNL-LAMYKKVNRR-DY--QF----PSFVSKPARSLIYQLLDPNPKT 272 (451)
Q Consensus 202 l~~~~~~~~~sDIwSlGvi-l~~Ll~G~~Pf~~~~~-~~~~~~i~~~-~~--~~----p~~~s~~~~~li~~~L~~dP~~ 272 (451)
+.+.. +.++||||+|++ .+++++|..||..... ......+... .. .. ++.+++++.+||.+||..|
T Consensus 249 ~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--- 323 (336)
T 2vuw_A 249 FTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--- 323 (336)
T ss_dssp GCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS---
T ss_pred hcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC---
Confidence 97655 677999998776 7789999999954321 1122222211 11 11 1236788999999999987
Q ss_pred CCCHHHHH-cCcccc
Q 013005 273 RMSIEKIM-SISWFQ 286 (451)
Q Consensus 273 Rpt~~eil-~hp~f~ 286 (451)
|++|++ +||||+
T Consensus 324 --sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 --SATDLLCQHSLFK 336 (336)
T ss_dssp --SHHHHHHHCGGGC
T ss_pred --CHHHHHhcCCCcC
Confidence 999999 999995
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=375.21 Aligned_cols=255 Identities=24% Similarity=0.401 Sum_probs=214.0
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEcCC---CcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEE
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIAD---GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
......++|++++.||+|+||+||+|.+..+ +..||+|.+.... .....+.+.+|+.+++++. ||||++++++
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~ 459 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT---SDSVREKFLQEALTMRQFD-HPHIVKLIGV 459 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT---CHHHHHHHHHHHHHHHHCC-CTTBCCEEEE
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC---CHHHHHHHHHHHHHHHhCC-CCCCCeEEEE
Confidence 3445568899999999999999999998654 4579999986532 3445678899999999995 9999999999
Q ss_pred EEeCCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCC
Q 013005 99 MATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176 (451)
Q Consensus 99 ~~~~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls 176 (451)
+. .+..|+||||+++|+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 460 ~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 460 IT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp EC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred Ee-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCC
Confidence 85 4568999999999999999974 46999999999999999999999999999999999999999999999999999
Q ss_pred CcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCC
Q 013005 177 ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFV 254 (451)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~ 254 (451)
...............||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+... ....|..+
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 617 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 617 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTC
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCC-CchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 8654333223334567889999999977766 567999999999999997 99999998887777776654 35677889
Q ss_pred CHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 255 SKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 255 s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
++.+.+||.+||..||.+|||+.++++.
T Consensus 618 ~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 618 PPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999999864
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=338.82 Aligned_cols=231 Identities=17% Similarity=0.203 Sum_probs=191.7
Q ss_pred CCCCcc-cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEE
Q 013005 19 PSKKIP-TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQE 97 (451)
Q Consensus 19 ~~~~~~-~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~ 97 (451)
...... .+.++|++.+.||+|+||.||+|.+..+++.||||++.... ..+....+.+.+|+.++.++. ||||+++++
T Consensus 21 ~~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~ 98 (286)
T 3uqc_A 21 QLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQG-VLPDDVLQETLSRTLRLSRID-KPGVARVLD 98 (286)
T ss_dssp CCCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTC-CSCHHHHHHHHHHHHHHHTCC-CTTBCCEEE
T ss_pred cCCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECccc-ccCHHHHHHHHHHHHHHhcCC-CCCcceeeE
Confidence 334444 56788999999999999999999999999999999998652 233455678899999999995 999999999
Q ss_pred EEEeCCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 98 VMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 98 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
++.+.+..|+||||++|++|.++++.+. ...++..++.||+.||+|||++||+||||||+|||++.+|.+||+++|
T Consensus 99 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~--- 174 (286)
T 3uqc_A 99 VVHTRAGGLVVAEWIRGGSLQEVADTSP-SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA--- 174 (286)
T ss_dssp EEEETTEEEEEEECCCEEEHHHHHTTCC-CHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC---
T ss_pred EEEECCcEEEEEEecCCCCHHHHHhcCC-ChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc---
Confidence 9999999999999999999999997664 566789999999999999999999999999999999999999998544
Q ss_pred cchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHH---HhhccCC----CC
Q 013005 178 LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYK---KVNRRDY----QF 250 (451)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~---~i~~~~~----~~ 250 (451)
|++| .+.++|||||||++|+|++|..||...+...... +...... ..
T Consensus 175 ------------------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T 3uqc_A 175 ------------------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADI 228 (286)
T ss_dssp ------------------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHH
T ss_pred ------------------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhc
Confidence 3332 3667999999999999999999998755322110 1111111 12
Q ss_pred CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 251 PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 251 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
+..+++.+.+||.+||..||.+| |+.++++.
T Consensus 229 ~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 229 DRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred ccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 35689999999999999999999 99999873
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=363.34 Aligned_cols=254 Identities=17% Similarity=0.194 Sum_probs=196.2
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCce---------E-
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVL---------K- 94 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv---------~- 94 (451)
.....|.+++.||+|+||+||+|.+..+|+.||||++..... ......+.+.+|+.+++.+.+++|.. .
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCC-ccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence 344568899999999999999999999999999999974422 22233567899999999886223211 1
Q ss_pred -----------EEEEEEe-----CCEEEEEEEecCCCchhHHhh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013005 95 -----------IQEVMAT-----KTKIYLVMEYAAGGELFGKLR--------RGRLTESAARRYFQQLVSALHFCHQNGV 150 (451)
Q Consensus 95 -----------l~~~~~~-----~~~~~lV~E~~~gg~L~~~l~--------~~~l~e~~~~~~~~ql~~gL~yLH~~gi 150 (451)
+..++.. ....+++|+++ +++|.+++. .+.+++..+..++.||+.||+|||++||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 232 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 232 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 1111111 22467777766 579988884 2347888999999999999999999999
Q ss_pred eecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCCCCccccceeee----------ccCCCCccchhhhhhHH
Q 013005 151 AHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVA----------RRGYDGAVADAWSCGVI 220 (451)
Q Consensus 151 iHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~----------~~~~~~~~sDIwSlGvi 220 (451)
+||||||+|||++.++.+||+|||++..... ...+.+| +.|+|||++. +..+ +.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTE----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCC----ccccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHH
Confidence 9999999999999999999999999875433 2456788 9999999983 3333 567999999999
Q ss_pred HHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchhH
Q 013005 221 LFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQ 290 (451)
Q Consensus 221 l~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 290 (451)
+|+|++|+.||...+.......+.. ....+++.+.+||.+||..||.+|||+.++++||||+....
T Consensus 307 l~elltg~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~ 372 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSEWIFR----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 372 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSGGGGS----SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred HHHHHHCCCCCCCcchhhhHHHHHh----hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHH
Confidence 9999999999987664433333322 22457899999999999999999999999999999987543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=382.22 Aligned_cols=259 Identities=26% Similarity=0.413 Sum_probs=207.2
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe--
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT-- 101 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~-- 101 (451)
+...++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.+++++. ||||+++++++..
T Consensus 10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~---~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~ 85 (676)
T 3qa8_A 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL---SPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQ 85 (676)
T ss_dssp -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC---CHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTC
T ss_pred CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC---CHHHHHHHHHHHHHHHhCC-CCCCCceeeeecccc
Confidence 344589999999999999999999999999999999987542 3455677899999999995 9999999999765
Q ss_pred ----CCEEEEEEEecCCCchhHHhhc-C---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCC---eEE
Q 013005 102 ----KTKIYLVMEYAAGGELFGKLRR-G---RLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN---LKV 170 (451)
Q Consensus 102 ----~~~~~lV~E~~~gg~L~~~l~~-~---~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~---lkl 170 (451)
.+..|+||||++||+|.+++.. + .+++..++.++.|++.||+|||++||+||||||+|||++.++. +||
T Consensus 86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL 165 (676)
T 3qa8_A 86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKI 165 (676)
T ss_dssp CCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred cccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEE
Confidence 6778999999999999999975 2 5999999999999999999999999999999999999997775 999
Q ss_pred EeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHh-------
Q 013005 171 SDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKV------- 243 (451)
Q Consensus 171 ~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i------- 243 (451)
+|||++..... .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||........+...
T Consensus 166 ~DFG~a~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 166 IDLGYAKELDQ--GELCTEFVGTLQYLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242 (676)
T ss_dssp CSCCCCCBTTS--CCCCCCCCSCCTTCSSCSSCCSCC-STTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred ccccccccccc--ccccccccCCcccCChHHhccCCC-CchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch
Confidence 99999986533 233455789999999999987766 56799999999999999999999765433221100
Q ss_pred -------hccCCCC------C----CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 244 -------NRRDYQF------P----SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 244 -------~~~~~~~------p----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
..+...+ | ..+++.+.+||.+||..||.+|||++++++||||+...
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~ 305 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence 0111111 1 22567899999999999999999999999999997643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=368.94 Aligned_cols=243 Identities=22% Similarity=0.358 Sum_probs=201.9
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcC-CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIA-DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
..+.++|++.+.||+|+||.||+|.+.. +++.||||++.... .......+.+|+.+++++. ||||+++++++...
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG---DAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHT 151 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC---CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEEE
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC---CHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEeec
Confidence 4566899999999999999999999976 78999999986542 2345567889999999995 99999999999876
Q ss_pred CE-----EEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 103 TK-----IYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 103 ~~-----~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
+. .|+||||++|++|.+++.. .+++.+++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++.
T Consensus 152 ~~~~~~~~~lv~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 152 DRHGDPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp CTTSCEEEEEEEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CCCCCceeEEEEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccch
Confidence 65 7999999999999987765 89999999999999999999999999999999999999875 99999999997
Q ss_pred cchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCC-CC-CCCC
Q 013005 178 LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQ-FP-SFVS 255 (451)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p-~~~s 255 (451)
.... ....+||+.|+|||++.+. + +.++|||||||++|+|++|..||...... .... .+ ...+
T Consensus 230 ~~~~-----~~~~~gt~~y~aPE~~~~~-~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~ 294 (681)
T 2pzi_A 230 RINS-----FGYLYGTPGFQAPEIVRTG-P-TVATDIYTVGRTLAALTLDLPTRNGRYVD--------GLPEDDPVLKTY 294 (681)
T ss_dssp ETTC-----CSCCCCCTTTSCTTHHHHC-S-CHHHHHHHHHHHHHHHHSCCCEETTEECS--------SCCTTCHHHHHC
T ss_pred hccc-----CCccCCCccccCHHHHcCC-C-CCceehhhhHHHHHHHHhCCCCCcccccc--------cccccccccccC
Confidence 5432 2456899999999998654 3 67899999999999999999998753210 0000 00 1135
Q ss_pred HhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 256 KPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 256 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
+.+.+||.+||.+||.+||+..+.+.|+|+..
T Consensus 295 ~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 295 DSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 78999999999999999999999999999864
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=317.75 Aligned_cols=233 Identities=15% Similarity=0.054 Sum_probs=162.1
Q ss_pred eEcccCceEEEEEEEcCCCcEEEEEEeecCcc------hhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEE
Q 013005 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNK------FLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLV 108 (451)
Q Consensus 35 ~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV 108 (451)
..+.|+.|.+..++....|+.||+|++.+... .......+.+.+|+.+|+++.+|+||++++++++++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46778888888888778899999999976521 122344567999999999998899999999999999999999
Q ss_pred EEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcc
Q 013005 109 MEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGML 187 (451)
Q Consensus 109 ~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~ 187 (451)
|||++|++|.+++.+ +++++. .++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+..... ....
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~-~~~~ 396 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD-CSWP 396 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----CCS
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC-Cccc
Confidence 999999999999986 667654 58999999999999999999999999999999999999999999765432 2345
Q ss_pred cccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccC
Q 013005 188 HTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLD 267 (451)
Q Consensus 188 ~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 267 (451)
.+.|||+.|+|||++.+.. ...+|+||+|++++.|.++..|+. ..+.. .|.. ...+..+...++.
T Consensus 397 ~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~~~~~--------~~l~~----~~~~-~~~~~~l~~~l~~ 461 (569)
T 4azs_A 397 TNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPWSNWL--------YAVWQ----EPVE-RWNFVLLLALFEK 461 (569)
T ss_dssp HHHHHHHHHHHHHHC-------------------CCCCTTHHHHH--------HHHHT----SCGG-GCSHHHHHHHHHT
T ss_pred cCceechhhccHHHhCCCC--CCcccccccccchhhhccccchhH--------HHhhc----CCCC-CCcHHHHHHHHhC
Confidence 5679999999999987642 345899999999998877755431 11111 1110 1124566677777
Q ss_pred CCCCCCCCHHHHHcCcccc
Q 013005 268 PNPKTRMSIEKIMSISWFQ 286 (451)
Q Consensus 268 ~dP~~Rpt~~eil~hp~f~ 286 (451)
.+|..|+.......++|..
T Consensus 462 ~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 462 KAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp GGGSCCGGGSSCCHHHHHH
T ss_pred CCCCCCCChhhhccchhHH
Confidence 8888888777766777764
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=248.68 Aligned_cols=122 Identities=26% Similarity=0.532 Sum_probs=108.3
Q ss_pred CCCCCChhhhhccCCCCCCCCcccccc---ccccceeeCCCHHHHHHHHHHHHHHcCcEEEEecCe--EEee---eccCc
Q 013005 320 DIVSMNAFDIISLSSGLDLSGLFEAKK---RKEKRFTTKEKTERVVEKVKEVGERLGYVVEKGKGD--VVGL---GKLGK 391 (451)
Q Consensus 320 ~~~~~~~~~~~~~s~~~~~~~~~~~~~---~~~~rf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~---~~~~~ 391 (451)
.|..+||||+||+|+|+|||+||+... +++|||+|+.++++|+++|+++|+++||.|++++.. +++. ++ |.
T Consensus 3 ~p~~lNAFdiIs~S~g~dLSgLFe~~~~~~~r~tRF~s~~~a~~ii~klEe~a~~lg~~V~kk~~~vkl~~~~~grk-G~ 81 (143)
T 2ehb_D 3 GPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNFKTRLEGLSSIKA-GQ 81 (143)
T ss_dssp CCEECCHHHHHTTCTTTCGGGGGCSCCCSCCCCCEEEECSCHHHHHHHHHHHHHHTTEEEEESSSEEEEEECCSSGG-GC
T ss_pred CccccCHHHHHHHCcCCCchhhhccccccccccceEEeCCCHHHHHHHHHHHHHhcCcEEEEcCcEEEEEEecCCCc-ce
Confidence 456799999999999999999998753 789999999999999999999999999999987765 5555 56 99
Q ss_pred EEEEEEEEeeecCCeEEEEEEecCCCCCCCcchhhHhhhHHHHhhhhcCceecccCCC
Q 013005 392 MVLLVEVLMEIAPETFVVGVKVVDNSVCGRVALEFDEGDWNELQAGLGDIVLSWHTSD 449 (451)
Q Consensus 392 ~~~~~~~~~~~~~~~~~v~~~~~~g~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (451)
|++.+||| ||+|+++||||||++|| ++||++||+ +||++|+||||+|+++.
T Consensus 82 l~v~~EVf-evapsl~vVEvrks~GD-----~lEy~k~~~-~Lr~~L~diV~~~~~~~ 132 (143)
T 2ehb_D 82 LAVVIEIY-EVAPSLFMVDVRKAAGE-----TLEYHKFYK-KLCSKLENIIWRATEGI 132 (143)
T ss_dssp CEEEEEEE-EEETTEEEEEEEEEESC-----HHHHHHHHH-HHHHHSTTTBCC-----
T ss_pred EEEEEEEE-EecCCEEEEEEEecCCC-----hHHHHHHHH-HHHHHhhcceecCCCCC
Confidence 99999999 99999999999999999 999999887 99999999999999853
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=236.11 Aligned_cols=116 Identities=29% Similarity=0.342 Sum_probs=102.0
Q ss_pred CCCCChhhhhccCCCCCCCCccccc--cccccceeeCCCHHHHHHHHHHHHHHcCcEEEEecCeEEee---eccCcEEEE
Q 013005 321 IVSMNAFDIISLSSGLDLSGLFEAK--KRKEKRFTTKEKTERVVEKVKEVGERLGYVVEKGKGDVVGL---GKLGKMVLL 395 (451)
Q Consensus 321 ~~~~~~~~~~~~s~~~~~~~~~~~~--~~~~~rf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 395 (451)
+..+||||+||+|+|+|||+||+.. .+++|||+|+.+|++|+++||++|+++||+|++++.+ ++. ++ |.|++.
T Consensus 3 ~~~lNAFdiIs~S~g~dLSgLFe~~~~~~r~tRF~S~~~a~~ii~klEe~a~~lg~~v~kk~~~-~~~~~g~k-G~l~v~ 80 (123)
T 2zfd_B 3 ARRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVAKKETW-GMKIEGQK-GNFAMV 80 (123)
T ss_dssp -CCCCHHHHHHTSTTSSSGGGGGGGCSSCCCEEEEESSCHHHHHHHHHHHHHHTTCEEEEEETT-EEEEEEGG-GTEEEE
T ss_pred cccccHHHHHHHCcCCCchHhcCcccccccceEEEeCCCHHHHHHHHHHHHHHCCCEEEEcCCc-cccccCCC-ccEEEE
Confidence 4569999999999999999999763 3678999999999999999999999999999988764 222 66 999999
Q ss_pred EEEEeeecCCeEEEEEEecCCCCCCCcchhhHhhhHHHHhhhhcCceec
Q 013005 396 VEVLMEIAPETFVVGVKVVDNSVCGRVALEFDEGDWNELQAGLGDIVLS 444 (451)
Q Consensus 396 ~~~~~~~~~~~~~v~~~~~~g~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 444 (451)
+||| ||+|+++||||||++|| ++||++||.++||++|+||||+
T Consensus 81 ~EVf-ev~p~l~vVEvrks~GD-----~lEy~~~~~~~L~~~L~diV~~ 123 (123)
T 2zfd_B 81 VEIN-QLTDELVMIEVRKRQRA-----AASGRDLWTDTLRPFFVELVHE 123 (123)
T ss_dssp EEEE-ECSSSCEEEEEEEEESC-----C---CCHHHHTHHHHHHHTBC-
T ss_pred EEEE-EecCCEEEEEEEecCCC-----hHHHHHHHHHHHHHHHhhhhcC
Confidence 9999 99999999999999999 9999999988999999999984
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.2e-29 Score=261.41 Aligned_cols=188 Identities=19% Similarity=0.216 Sum_probs=144.4
Q ss_pred EEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcch----hhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 31 QLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKF----LDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 31 ~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
...+.||+|+||+||+|. ..+..+++|........ ......+++.+|+.++++++ ||||+++..+....+..|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEETTTTE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEeCCccE
Confidence 346689999999999994 56889999987543111 12223556899999999996 999995555555677789
Q ss_pred EEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC-
Q 013005 107 LVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG- 185 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~- 185 (451)
+||||++|++|.+++.. +..++.|++.||.|||++||+||||||+|||++. ++||+|||+|+........
T Consensus 416 lVmE~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED-------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp EEEECCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred EEEECCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 99999999999999876 6789999999999999999999999999999998 9999999999865432221
Q ss_pred -----cccccCCCCccccceeeec--cCCCCccchhhhhhHHHHHHHhcCCCC
Q 013005 186 -----MLHTACGTPAYTAPEVVAR--RGYDGAVADAWSCGVILFVLLAGYLPF 231 (451)
Q Consensus 186 -----~~~~~~gt~~y~APEvl~~--~~~~~~~sDIwSlGvil~~Ll~G~~Pf 231 (451)
...+.+||+.|+|||++.. .+|. ..+|+||..+-..+...++.+|
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHHHHHTCSCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHHHHHhcccc
Confidence 1246789999999999976 5563 4579999988888777776665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.6e-26 Score=219.49 Aligned_cols=144 Identities=19% Similarity=0.254 Sum_probs=115.4
Q ss_pred cceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhh------H--------HHHHHHHHHHHHHHHhcCCCCceEEEEE
Q 013005 33 GPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLD------A--------AMEDRIVREVSAMRRLQNHPNVLKIQEV 98 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~------~--------~~~~~~~~Ei~il~~L~~HpnIv~l~~~ 98 (451)
++.||+|+||.||+|.+ .+|+.||+|++........ . .....+.+|+.+++++. | ++++++
T Consensus 95 ~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~---~~v~~~ 169 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-G---LAVPKV 169 (282)
T ss_dssp EEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-T---SSSCCE
T ss_pred cCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-C---CCcCeE
Confidence 39999999999999999 8899999999965321000 0 23567899999999996 4 444444
Q ss_pred EEeCCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 99 MATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 99 ~~~~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
+.. +..|+||||++|++|.+ +.. .+...++.|++.||.|||++||+||||||+|||++ ++.+||+|||+|.
T Consensus 170 ~~~-~~~~lvmE~~~g~~L~~-l~~-----~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~- 240 (282)
T 1zar_A 170 YAW-EGNAVLMELIDAKELYR-VRV-----ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV- 240 (282)
T ss_dssp EEE-ETTEEEEECCCCEEGGG-CCC-----SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE-
T ss_pred Eec-cceEEEEEecCCCcHHH-cch-----hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe-
Confidence 443 45699999999999988 422 33567999999999999999999999999999999 9999999999985
Q ss_pred chhhhcCcccccCCCCccccceeee
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVA 203 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~ 203 (451)
.+..+.|||.+.
T Consensus 241 -------------~~~~~~a~e~l~ 252 (282)
T 1zar_A 241 -------------EVGEEGWREILE 252 (282)
T ss_dssp -------------ETTSTTHHHHHH
T ss_pred -------------ECCCCCHHHHHH
Confidence 245678999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=8.1e-22 Score=188.80 Aligned_cols=140 Identities=19% Similarity=0.235 Sum_probs=109.2
Q ss_pred eEEcceEcccCceEEEEEEEcCCCcE--EEEEEeecCcchh--------------------hHHHHHHHHHHHHHHHHhc
Q 013005 30 YQLGPLLGRGSFAKVHKAKSIADGSI--VAIKTIEKNNKFL--------------------DAAMEDRIVREVSAMRRLQ 87 (451)
Q Consensus 30 y~~~~~LG~G~~g~Vy~a~~~~~~~~--vAiK~i~~~~~~~--------------------~~~~~~~~~~Ei~il~~L~ 87 (451)
|++.+.||+|+||.||+|.+..+|+. ||||++....... .......+.+|+.+++.|.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78899999999999999998778999 9999975431110 1122346889999999996
Q ss_pred CCCCc--eEEEEEEEeCCEEEEEEEecCC-C----chhHHhhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCe
Q 013005 88 NHPNV--LKIQEVMATKTKIYLVMEYAAG-G----ELFGKLRRGRLTESAARRYFQQLVSALHFCH-QNGVAHRDVKPQN 159 (451)
Q Consensus 88 ~HpnI--v~l~~~~~~~~~~~lV~E~~~g-g----~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH-~~giiHrDLKpeN 159 (451)
|++| +.+++. ...++||||+.+ | .|.+.... .++..+..++.|++.||.||| ++||+||||||+|
T Consensus 129 -~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 129 -EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp -HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred -hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 7754 444442 246899999942 4 56555432 345678899999999999999 9999999999999
Q ss_pred EEeCCCCCeEEEeccCCCc
Q 013005 160 LLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 160 ILld~~~~lkl~DFGls~~ 178 (451)
||++. .++|+|||+|..
T Consensus 202 ILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp EEESS--SEEECCCTTCEE
T ss_pred EEEcC--cEEEEECccccc
Confidence 99988 999999999863
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2e-18 Score=173.51 Aligned_cols=139 Identities=14% Similarity=0.180 Sum_probs=101.9
Q ss_pred eEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcch----------------hhH--HHHHHHHHHHHHHHHhcCCCC
Q 013005 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKF----------------LDA--AMEDRIVREVSAMRRLQNHPN 91 (451)
Q Consensus 30 y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~----------------~~~--~~~~~~~~Ei~il~~L~~Hpn 91 (451)
|++++.||+|++|.||+|.+ .+|+.||||+++..... .+. .......+|...|.+|. +++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~-~~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY-EEG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH-HTT
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH-hcC
Confidence 89999999999999999997 57999999997542100 000 01112356788888884 444
Q ss_pred ceEEEEEEEeCCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCC----
Q 013005 92 VLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN---- 167 (451)
Q Consensus 92 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~---- 167 (451)
+. ....+.... .+|||||++|++|..+.. .+.+..++.||+.+|.|||++||+||||||+|||++++|.
T Consensus 175 v~-vp~p~~~~~-~~LVME~i~G~~L~~l~~-----~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~ 247 (397)
T 4gyi_A 175 FP-VPEPIAQSR-HTIVMSLVDALPMRQVSS-----VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP 247 (397)
T ss_dssp CS-CCCEEEEET-TEEEEECCSCEEGGGCCC-----CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred CC-CCeeeeccC-ceEEEEecCCccHhhhcc-----cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence 32 222222222 379999999998876532 2346788999999999999999999999999999988773
Q ss_pred ------eEEEeccCCC
Q 013005 168 ------LKVSDFGLSA 177 (451)
Q Consensus 168 ------lkl~DFGls~ 177 (451)
+.|+||+-+-
T Consensus 248 ~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 248 SSITLTPIIIXFPQMV 263 (397)
T ss_dssp TSEEEEEEECCCTTCE
T ss_pred cccccceEEEEeCCcc
Confidence 8999998653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.9e-13 Score=130.02 Aligned_cols=144 Identities=19% Similarity=0.164 Sum_probs=116.8
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
..++.|++...+|.|+.+.||++.. .+..+++|+...... .....+.+|+.+++.|..+..+.+++++..+.+.
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~----~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~ 84 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK----GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT----TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC----CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence 4567899999999999999999973 478999999865311 1123588999999999767888999999999999
Q ss_pred EEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 013005 105 IYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQ------------------------------------- 147 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~------------------------------------- 147 (451)
.|+||||++|.+|.+... +......++.++.++|..||+
T Consensus 85 ~~lv~e~i~G~~l~~~~~----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEYE----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEEECCSSEEHHHHCC----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred eEEEEEecCCeehhhccC----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999999999877632 223345788999999999999
Q ss_pred ----------------------CCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 148 ----------------------NGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 148 ----------------------~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
..++|+|++|.|||+++++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4489999999999998765667999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.33 E-value=3.8e-12 Score=120.04 Aligned_cols=141 Identities=16% Similarity=0.150 Sum_probs=105.9
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCC-ceEEEEEEE
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN-VLKIQEVMA 100 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~Hpn-Iv~l~~~~~ 100 (451)
.+......|.+....+.|..+.||++. ..+|..+++|+.... . ...+.+|+.+++.|..+.- +.+++.+..
T Consensus 14 ~l~~~~~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~-~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~ 85 (264)
T 1nd4_A 14 AWVERLFGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG-A------LNELQDEAARLSWLATTGVPCAAVLDVVT 85 (264)
T ss_dssp GGTTTTTTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC-T------TSCHHHHHHHHHHHHTTTCCBCCEEEEEE
T ss_pred HHHHhcCCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc-c------chhhhHHHHHHHHHHhCCCCCCeEEEecc
Confidence 345556677776555577779999996 456788999997543 1 1357789999999975522 567899888
Q ss_pred eCCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC-------------------------------
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNG------------------------------- 149 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~g------------------------------- 149 (451)
..+..|+||||++|.+|. .. ..+ ...++.++...|..||+..
T Consensus 86 ~~~~~~~v~e~i~G~~l~--~~--~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (264)
T 1nd4_A 86 EAGRDWLLLGEVPGQDLL--SS--HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDL 158 (264)
T ss_dssp CSSCEEEEEECCSSEETT--TS--CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSC
T ss_pred CCCCCEEEEEecCCcccC--cC--cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhh
Confidence 888899999999998884 21 111 2356777788888888643
Q ss_pred ---------------------------ceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 150 ---------------------------VAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 150 ---------------------------iiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
++|+|++|.|||+++++.+.|+|||.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 159 DEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.17 E-value=8.9e-11 Score=116.95 Aligned_cols=142 Identities=18% Similarity=0.281 Sum_probs=107.5
Q ss_pred EcceEcccCceEEEEEEEcCCCcEEEEEEee--cCcchhhHHHHHHHHHHHHHHHHhcC-CCCceEEEEEEEeC---CEE
Q 013005 32 LGPLLGRGSFAKVHKAKSIADGSIVAIKTIE--KNNKFLDAAMEDRIVREVSAMRRLQN-HPNVLKIQEVMATK---TKI 105 (451)
Q Consensus 32 ~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~--~~~~~~~~~~~~~~~~Ei~il~~L~~-HpnIv~l~~~~~~~---~~~ 105 (451)
-.+.|+.|.++.||++.. .+..+++|+.. .... ......+.+|..+++.|.. +..+++++.++.+. +..
T Consensus 42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~---~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKL---LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp EEEECCC-CCSCEEEEEC--SSCEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCC---CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 456789999999999874 34678889875 3211 1123568899999999963 34578889888766 458
Q ss_pred EEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 013005 106 YLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQ-------------------------------------- 147 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~-------------------------------------- 147 (451)
|+||||++|..+.+... ..++..+...++.+++..|..||+
T Consensus 117 ~~vme~v~G~~l~~~~~-~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQSL-PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEEECCCCBCCCCTTC-TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEEecCCeecCCCcc-ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999999988754221 347888899999999999999997
Q ss_pred --------------------CCceecCCCCCeEEeCCCCC--eEEEeccCCCcc
Q 013005 148 --------------------NGVAHRDVKPQNLLLDRDGN--LKVSDFGLSALP 179 (451)
Q Consensus 148 --------------------~giiHrDLKpeNILld~~~~--lkl~DFGls~~~ 179 (451)
..++|+|++|.|||++.++. +.|+||+.+...
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 35899999999999998764 699999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.10 E-value=2.9e-11 Score=117.68 Aligned_cols=185 Identities=17% Similarity=0.206 Sum_probs=124.0
Q ss_pred cceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCC--ceEEEEEEEeCC---EEEE
Q 013005 33 GPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN--VLKIQEVMATKT---KIYL 107 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~Hpn--Iv~l~~~~~~~~---~~~l 107 (451)
.+.++.|....||++. ..+++|+.... .....+.+|..+++.|..+.. +.+++....... ..|+
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~ 93 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFA 93 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceE
Confidence 3568999999999873 45888986422 335678899999999854433 344554433332 4589
Q ss_pred EEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 013005 108 VMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQ---------------------------------------- 147 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~---------------------------------------- 147 (451)
|||+++|..|..... ..++..+...++.|+...+..||+
T Consensus 94 vm~~i~G~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 94 GFTKIKGVPLTPLLL-NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EEECCCCEECCHHHH-HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EEcccCCeECCcccc-ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 999999988865332 357888888999999999999996
Q ss_pred ------------------CCceecCCCCCeEEeCC--CCCeEEEeccCCCcchhhhc-Cccccc---CCCC---------
Q 013005 148 ------------------NGVAHRDVKPQNLLLDR--DGNLKVSDFGLSALPEQIKN-GMLHTA---CGTP--------- 194 (451)
Q Consensus 148 ------------------~giiHrDLKpeNILld~--~~~lkl~DFGls~~~~~~~~-~~~~~~---~gt~--------- 194 (451)
..++|+|++|.||++++ .+.+.|+||+.+........ ...... .+..
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 13699999999999998 45688999999875432111 000000 0000
Q ss_pred cccc-ceeeeccCCCCccchhhhhhHHHHHHHhcCCCCC
Q 013005 195 AYTA-PEVVARRGYDGAVADAWSCGVILFVLLAGYLPFD 232 (451)
Q Consensus 195 ~y~A-PEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~ 232 (451)
.... |+...... .-.+.|++|.++|.+.+|..+|.
T Consensus 253 ~~~~~~~~~~r~~---~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 253 KHKDIPTVLEKYR---MKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp TCSCHHHHHHHHH---HHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCCcHHHHHHHH---HHHHHHHHHHHHHHHHcCCHHHH
Confidence 0111 22211111 11589999999999999988763
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A | Back alignment and structure |
|---|
Probab=99.02 E-value=1.3e-09 Score=91.14 Aligned_cols=82 Identities=11% Similarity=0.094 Sum_probs=71.3
Q ss_pred ceeeCCCHHHHHHHHHHHHHHcCcEEEEecCe-EEeee----ccCcEEEEEEEEeeec-CCeEEEEEEecCCCCCCCcch
Q 013005 351 RFTTKEKTERVVEKVKEVGERLGYVVEKGKGD-VVGLG----KLGKMVLLVEVLMEIA-PETFVVGVKVVDNSVCGRVAL 424 (451)
Q Consensus 351 rf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~-~~~~~v~~~~~~g~~~~~~~~ 424 (451)
..||+.+|++|+..|+.+++.+|+.|++++.+ +.+.. ..+.+.|.+||| ++. +++++|+|+|.+|| ++
T Consensus 32 ~tTS~~~P~eIm~eI~rvL~~~gi~~~~~g~y~l~C~~~~~~~~~~v~fElEVc-kl~~~~l~gV~~kRi~Gd-----~~ 105 (120)
T 3ose_A 32 KTTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVC-KLPRLSLNGVRFKRISGT-----SI 105 (120)
T ss_dssp CCEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEESCTTTTCCEEEEEEEE-EEGGGTEEEEEEEEEESC-----HH
T ss_pred cCcccCCHHHHHHHHHHHHHHCCCEEEEcCCEEEEEEecCCCCCccEEEEEEEE-EecCCCceeEEEEecCCC-----HH
Confidence 45789999999999999999999999987655 66651 115799999999 995 89999999999999 99
Q ss_pred hhHhhhHHHHhhhhc
Q 013005 425 EFDEGDWNELQAGLG 439 (451)
Q Consensus 425 ~~~~~~~~~~~~~l~ 439 (451)
.|+++|. +|.++|+
T Consensus 106 ~yk~lc~-~il~~L~ 119 (120)
T 3ose_A 106 AFKNIAS-KIANELK 119 (120)
T ss_dssp HHHHHHH-HHHHHCC
T ss_pred HHHHHHH-HHHHHhc
Confidence 9999998 8887774
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.68 E-value=2.5e-07 Score=89.99 Aligned_cols=134 Identities=17% Similarity=0.155 Sum_probs=96.8
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCC--CceEEEEEEE-eCCEEEEEEE
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP--NVLKIQEVMA-TKTKIYLVME 110 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~Hp--nIv~l~~~~~-~~~~~~lV~E 110 (451)
+.++.|....||+. +..+++|+... ......+.+|..+|+.|..|- .+.+++.+.. ..+..|+|||
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~~~------~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFPKS------QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEESS------HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eecCCCcceeEEEE-----CCEEEEEecCC------chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 45788999999988 46688898532 234567899999999997442 2556666654 4556889999
Q ss_pred ecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC------------------------------------------
Q 013005 111 YAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQN------------------------------------------ 148 (451)
Q Consensus 111 ~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~------------------------------------------ 148 (451)
|++|..+....- ..++..+...++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~-~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 94 KVQGQILGEDGM-AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CCCSEECHHHHH-TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ccCCeECchhhh-hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 999988865321 2345666666666666666666643
Q ss_pred ------------------CceecCCCCCeEEeCC---CCCe-EEEeccCCCcc
Q 013005 149 ------------------GVAHRDVKPQNLLLDR---DGNL-KVSDFGLSALP 179 (451)
Q Consensus 149 ------------------giiHrDLKpeNILld~---~~~l-kl~DFGls~~~ 179 (451)
.++|+|++|.|||++. ++.+ .|+||+.+...
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2489999999999987 4565 89999988653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.67 E-value=2.3e-07 Score=88.05 Aligned_cols=141 Identities=17% Similarity=0.212 Sum_probs=100.3
Q ss_pred cCCeEEcceEcccCc-eEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 27 LNRYQLGPLLGRGSF-AKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~-g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
...|+... +..|.. +.||+......+..+++|+-... ....+.+|..+|+.|..+--+.+++.+..+.+..
T Consensus 24 l~g~~~~~-~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~ 95 (272)
T 4gkh_A 24 LYGYRWAR-DNVGQSGATIYRLYGKPNAPELFLKHGKGS-------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDA 95 (272)
T ss_dssp HTTCEEEE-EECSSSSCEEEEEECCTTCCCEEEEEEETH-------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred ccCCeEEE-ccCCCcCCeEEEEEecCCCeEEEEEECCCC-------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeE
Confidence 33454433 344544 47998876666778999986432 2456788999999997555577889999999999
Q ss_pred EEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-------------------------------------
Q 013005 106 YLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQN------------------------------------- 148 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~------------------------------------- 148 (451)
|+|||+++|.++.+..... ......+..++...|.-||+.
T Consensus 96 ~lvme~l~G~~~~~~~~~~---~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (272)
T 4gkh_A 96 WLLTTAIPGKTAFQVLEEY---PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN 172 (272)
T ss_dssp EEEEECCCSEEHHHHHHHC---GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred EEEEEeeCCccccccccCC---HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence 9999999998876654321 122334555555555555531
Q ss_pred ---------------------CceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 149 ---------------------GVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 149 ---------------------giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
.++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 168999999999999877778999998864
|
| >1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1 | Back alignment and structure |
|---|
Probab=98.60 E-value=6.3e-08 Score=80.85 Aligned_cols=81 Identities=10% Similarity=0.050 Sum_probs=69.9
Q ss_pred eeeCCCHHHHHHHHHHHHHHcCcEEEEecCe-EEeeec----cCcEEEEEEEEeeec-CCeEEEEEEecCCCCCCCcchh
Q 013005 352 FTTKEKTERVVEKVKEVGERLGYVVEKGKGD-VVGLGK----LGKMVLLVEVLMEIA-PETFVVGVKVVDNSVCGRVALE 425 (451)
Q Consensus 352 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~-~~~~~v~~~~~~g~~~~~~~~~ 425 (451)
.||+.+|++|+..|..+++++|+.|++++++ +.+... ...+.|.+||| .|. .+++.|+|||.+|| ++.
T Consensus 33 tTSsk~P~eIm~EI~rvL~~~~i~~k~~~~y~L~C~~~~~~~~~~vkfEiEVc-Kvp~l~l~GI~fKRisGd-----~w~ 106 (126)
T 1v5s_A 33 QGSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVC-KLPRLSLNGVRFKRISGT-----SIA 106 (126)
T ss_dssp CCCCSSHHHHHHHHHHHHHHTTEEEEEEETTEEEEEECSSSTTTCEEEEEECC-CCTTTCSCCCEEEEEESC-----HHH
T ss_pred eecCCCHHHHHHHHHHHHHHcCCcEEEECCEEEEEEECCCCCCceEEEEEEEE-EecCCCceeEEEeeccCc-----hhH
Confidence 5678899999999999999999999986666 666421 14799999999 994 78999999999999 999
Q ss_pred hHhhhHHHHhhhhc
Q 013005 426 FDEGDWNELQAGLG 439 (451)
Q Consensus 426 ~~~~~~~~~~~~l~ 439 (451)
|+++|. +|...|+
T Consensus 107 YK~lc~-~IL~eLk 119 (126)
T 1v5s_A 107 FKNIAS-KIANELK 119 (126)
T ss_dssp HHHHHH-HHHHHTT
T ss_pred HHHHHH-HHHHHHh
Confidence 999998 7877776
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=1.1e-06 Score=88.29 Aligned_cols=81 Identities=22% Similarity=0.176 Sum_probs=51.1
Q ss_pred cceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhH---HHHHHHHHHHHHHHHhcCC-CC-ceEEEEEEEeCCEEEE
Q 013005 33 GPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDA---AMEDRIVREVSAMRRLQNH-PN-VLKIQEVMATKTKIYL 107 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~~~Ei~il~~L~~H-pn-Iv~l~~~~~~~~~~~l 107 (451)
.+.||.|..+.||++....++..+++|........... ...+++..|..+++.+..+ |. +.+++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 56789999999999976556789999987532110000 1124567788899888543 33 4456644 3455689
Q ss_pred EEEecCCC
Q 013005 108 VMEYAAGG 115 (451)
Q Consensus 108 V~E~~~gg 115 (451)
|||+++|.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=1.1e-06 Score=86.86 Aligned_cols=84 Identities=10% Similarity=0.097 Sum_probs=57.3
Q ss_pred EcceE-cccCceEEEEEEEc--C----CCcEEEEEEeecCcc--hhhHHHHHHHHHHHHHHHHhcCC--CCceEEEEEEE
Q 013005 32 LGPLL-GRGSFAKVHKAKSI--A----DGSIVAIKTIEKNNK--FLDAAMEDRIVREVSAMRRLQNH--PNVLKIQEVMA 100 (451)
Q Consensus 32 ~~~~L-G~G~~g~Vy~a~~~--~----~~~~vAiK~i~~~~~--~~~~~~~~~~~~Ei~il~~L~~H--pnIv~l~~~~~ 100 (451)
..+.| +.|....+|+.... . ++..+++|+...... ... ...+.+|..+++.|..+ -.+.+++.+..
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~ 100 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIET 100 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEEC
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEcc
Confidence 45678 88999999988642 0 266889998754310 000 13567888889888654 35677888766
Q ss_pred eC---CEEEEEEEecCCCchh
Q 013005 101 TK---TKIYLVMEYAAGGELF 118 (451)
Q Consensus 101 ~~---~~~~lV~E~~~gg~L~ 118 (451)
+. +..|+||||++|..+.
T Consensus 101 ~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 101 TGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSTTTSSCEEEEECCCCBCCC
T ss_pred CCCccCCceEEEEecCCCChh
Confidence 54 3578999999987654
|
| >4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=6.5e-06 Score=66.33 Aligned_cols=86 Identities=14% Similarity=0.152 Sum_probs=69.5
Q ss_pred eeeCCCHHHHHHHHHHHHHHcCcEEEEecCe-EEeeec----cCcEEEEEEEEeeecCCeEEEEEEecCCC---CCCCcc
Q 013005 352 FTTKEKTERVVEKVKEVGERLGYVVEKGKGD-VVGLGK----LGKMVLLVEVLMEIAPETFVVGVKVVDNS---VCGRVA 423 (451)
Q Consensus 352 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~~~v~~~~~~g~---~~~~~~ 423 (451)
..|...|.+|+..|..+++.+|+.|++.+.+ +.+..+ +..+.|.+++| .+.+..+|+||++..|| ..|-.+
T Consensus 12 IrS~~~P~eiM~eIyraLk~lg~~Wk~~~~Y~lkcR~~~~~~~~~vK~~lQLY-kv~~~~YLLDfq~i~g~~~~~~~~~~ 90 (106)
T 4eai_A 12 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLY-QVDSRTYLLDFRSIDDGGGGGGGSHT 90 (106)
T ss_dssp EEECSCHHHHHHHHHHHHHHHTCEEEEEETTEEEEEEECTTTCCEEEEEEEEE-ECSSSCEEEEEEECCSSCCCSSSCHH
T ss_pred ceeCCCHHHHHHHHHHHHHHcCCEEeeCCceEEEEEEcCCCCCceeEEEEEEE-EecCCcEEEEEEeccCCCCCCCCcCc
Confidence 5678889999999999999999999987776 766522 13589999999 99889999999999994 111127
Q ss_pred hhhHhhhHHHHhhhhc
Q 013005 424 LEFDEGDWNELQAGLG 439 (451)
Q Consensus 424 ~~~~~~~~~~~~~~l~ 439 (451)
++|-++|. .+-.+|.
T Consensus 91 ~~F~d~ca-~li~~la 105 (106)
T 4eai_A 91 IEFFEMCA-NLIKILA 105 (106)
T ss_dssp HHHHHHHH-HHHHHCC
T ss_pred EeHHHHHH-HHHHHHh
Confidence 99999998 7766664
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.10 E-value=1.2e-05 Score=78.31 Aligned_cols=134 Identities=16% Similarity=0.194 Sum_probs=78.0
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCC-CCceEEEE------EEEeCCEEE
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH-PNVLKIQE------VMATKTKIY 106 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~H-pnIv~l~~------~~~~~~~~~ 106 (451)
+.|+.|..+.||++.. .+ ..+++|+..... ..+..|..+++.|..+ -.+++++. +....+..|
T Consensus 38 ~~l~gG~~n~~~~v~~-~~-~~~vlk~~~~~~--------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 38 DVIQGNQMALVWKVHT-DS-GAVCLKRIHRPE--------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp EECC----CEEEEEEE-TT-EEEEEEEECSCH--------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred eeccccccCcEEEEEe-CC-CCEEEEecCCCH--------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 4567778899999975 33 458999986531 2233455556655421 12333332 123467889
Q ss_pred EEEEecCCCchh--------------HHhhc--CCC--C-----------HHH---------------------------
Q 013005 107 LVMEYAAGGELF--------------GKLRR--GRL--T-----------ESA--------------------------- 130 (451)
Q Consensus 107 lV~E~~~gg~L~--------------~~l~~--~~l--~-----------e~~--------------------------- 130 (451)
++|||++|..+. ..++. ..+ + +..
T Consensus 108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 187 (346)
T 2q83_A 108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL 187 (346)
T ss_dssp EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence 999999986542 11111 111 1 100
Q ss_pred ----HHHHHHHHHHHHHHHHH-------------CCceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 131 ----ARRYFQQLVSALHFCHQ-------------NGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 131 ----~~~~~~ql~~gL~yLH~-------------~giiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
...+..++..++.+|++ .+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11112233445666652 579999999999999888899999999875
|
| >2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C* | Back alignment and structure |
|---|
Probab=98.02 E-value=4.4e-05 Score=65.22 Aligned_cols=66 Identities=9% Similarity=0.162 Sum_probs=56.3
Q ss_pred ceeeCCCHHHHHHHHHHHHHHcCcEEEEecCe-EEeeeccC----cEEEEEEEEeeecCCeEEEEEEecCCC
Q 013005 351 RFTTKEKTERVVEKVKEVGERLGYVVEKGKGD-VVGLGKLG----KMVLLVEVLMEIAPETFVVGVKVVDNS 417 (451)
Q Consensus 351 rf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~~~v~~~~~~g~ 417 (451)
...|...|.+|+..|..+++.||+.|++.+.+ +.++.+++ .+.|.+++| ++.++.+||||++..||
T Consensus 8 GIrSrs~P~eIM~EVyRALk~Lg~eWK~~~pY~IkcRw~~~~~~~~vKm~LQLY-kv~~~~YLLDFk~l~g~ 78 (157)
T 2v8q_A 8 GIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLY-QVDSRTYLLDFRSIDDE 78 (157)
T ss_dssp SEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEE-ECSSSCEEEEEEEECCC
T ss_pred ecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCceEEEEEEEE-EecCCCEEEEEEecCCC
Confidence 45577899999999999999999999988777 76652212 489999999 99999999999999988
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.92 E-value=8.4e-05 Score=72.43 Aligned_cols=76 Identities=14% Similarity=0.151 Sum_probs=60.4
Q ss_pred cceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCC--CCceEEEEEEEeCCEEEEEEE
Q 013005 33 GPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH--PNVLKIQEVMATKTKIYLVME 110 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~H--pnIv~l~~~~~~~~~~~lV~E 110 (451)
.+.|+.|....+|+... ++..+++|+.... ....+.+|...|+.|..+ ..+++++.+....+..|+|||
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS-------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG-------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc-------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 45789999999999973 5678899987543 135678899999988643 567888988888889999999
Q ss_pred ecCCCch
Q 013005 111 YAAGGEL 117 (451)
Q Consensus 111 ~~~gg~L 117 (451)
|++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.86 E-value=9.1e-05 Score=67.79 Aligned_cols=133 Identities=20% Similarity=0.160 Sum_probs=89.6
Q ss_pred chhHHhh--cCCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccccCC
Q 013005 116 ELFGKLR--RGRLTESAARRYFQQLVSALHFC-HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACG 192 (451)
Q Consensus 116 ~L~~~l~--~~~l~e~~~~~~~~ql~~gL~yL-H~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~~~g 192 (451)
+|.+++. .++++|+++|.++.|.+.+|.-+ +.+.-..+=+.|..|++..+|++.+.+ +.+. ..
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------~~ 99 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------AG 99 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------cc
Confidence 7888886 47899999999999999998776 222223445668999999999998764 2111 12
Q ss_pred CCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhccCC----
Q 013005 193 TPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQLLDP---- 268 (451)
Q Consensus 193 t~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~---- 268 (451)
...+.|||... ...+.+.=|||||+++|.-+--.+| ..-+..+|+++.+||..|..-
T Consensus 100 ~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~-----------------e~eE~eLS~~LE~LL~~Mt~~~~d~ 160 (229)
T 2yle_A 100 EPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK-----------------ENEERELSPPLEQLIDHMANTVEAD 160 (229)
T ss_dssp -------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC-----------------TTEEECCCHHHHHHHHHHTTCCC--
T ss_pred ccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC-----------------cccchhhCHHHHHHHHHHHhccccc
Confidence 34577888753 2335667999999999987743333 122345899999999999866
Q ss_pred ---------------------CCCCCCCHHHHHc
Q 013005 269 ---------------------NPKTRMSIEKIMS 281 (451)
Q Consensus 269 ---------------------dP~~Rpt~~eil~ 281 (451)
.+..|+++++|++
T Consensus 161 ~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 161 GSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp ------------------CCSCCCCCCSHHHHHH
T ss_pred ccccccccccccccccccccccccCcCCHHHHHH
Confidence 2467788888775
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.86 E-value=4e-05 Score=77.69 Aligned_cols=33 Identities=18% Similarity=0.292 Sum_probs=28.5
Q ss_pred HCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 147 QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 147 ~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
...++|+|++|.|||++.++ +.|+||+.+....
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~ 263 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP 263 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence 45799999999999998876 9999999987543
|
| >4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=97.75 E-value=0.0002 Score=59.18 Aligned_cols=65 Identities=11% Similarity=0.124 Sum_probs=53.2
Q ss_pred eeeCCCHHHHHHHHHHHHHHcCcEEEEecCe-EEeeec----cCcEEEEEEEEeeecCCeEEEEEEecCCC
Q 013005 352 FTTKEKTERVVEKVKEVGERLGYVVEKGKGD-VVGLGK----LGKMVLLVEVLMEIAPETFVVGVKVVDNS 417 (451)
Q Consensus 352 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~~~v~~~~~~g~ 417 (451)
..|...|.+|+..|..+++.||+.|++.+.+ +.++.+ +..+.|.+++| ++.+..+|+||+...||
T Consensus 12 IrS~~~P~eIM~EVyrALk~Lg~eWK~~~pY~vkcR~~n~~~~~~vKm~LQLY-qv~~~~YLLDfk~~~~~ 81 (130)
T 4eag_A 12 IRSQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKTGKFSKMSLQLY-QVDAKSYLLDFKSLTND 81 (130)
T ss_dssp BCCCSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEE-ESSSSCEEEEEEECC--
T ss_pred eecCCCHHHHHHHHHHHHHHCCCEEeeCCCEEEEEEecCCCCCceeEEEEEEE-EecCCcEEEEeccCCcc
Confidence 3567779999999999999999999988776 666522 13578999999 99999999999999998
|
| >2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A* | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00016 Score=62.48 Aligned_cols=70 Identities=9% Similarity=0.126 Sum_probs=59.1
Q ss_pred ccccceeeCCCHHHHHHHHHHHHHHcCcEEEEecCe-EEeeeccC----cEEEEEEEEeeecCCeEEEEEEecCCC
Q 013005 347 RKEKRFTTKEKTERVVEKVKEVGERLGYVVEKGKGD-VVGLGKLG----KMVLLVEVLMEIAPETFVVGVKVVDNS 417 (451)
Q Consensus 347 ~~~~rf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~~~v~~~~~~g~ 417 (451)
+..-...|+..|.+|+..|..+++.||+.|++.+.+ +.++.+++ .+.|.+++| ++.++.+||||++..||
T Consensus 18 kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~i~pY~IkcRw~~~~~~~~vKmeLQLY-Kv~~~~YLLDFk~l~Gd 92 (173)
T 2y8l_A 18 AWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLY-QVDSRTYLLDFRSIDDE 92 (173)
T ss_dssp EEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEE-ECSSSCEEEEEEEECCC
T ss_pred eeeeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCeeEEEEEEEE-EEcCCCEEEEEEecCCC
Confidence 334556788899999999999999999999998777 76652212 488999999 99999999999999999
|
| >2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A* | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00012 Score=61.98 Aligned_cols=89 Identities=12% Similarity=0.003 Sum_probs=67.7
Q ss_pred ccceeeCCCHHHHHHHHHHHHHHcCcEEEEe---------cCe-EEeee-cc--------CcEEEEEEEEeeecCCeEEE
Q 013005 349 EKRFTTKEKTERVVEKVKEVGERLGYVVEKG---------KGD-VVGLG-KL--------GKMVLLVEVLMEIAPETFVV 409 (451)
Q Consensus 349 ~~rf~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~-~~~~~-~~--------~~~~~~~~~~~~~~~~~~~v 409 (451)
.--..|...|.+|+..|..+++.||+.|++. +.+ +.++. +. ..+.|.+++| +|.++.+||
T Consensus 14 hlGIRSrs~P~eIM~EVyrALk~Lg~eWk~~~~~~~~~~~~~y~Ik~R~~~~~~~~~~~~~~vkm~iQLY-qv~~~~YLl 92 (137)
T 2qrd_A 14 HFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLY-EVMPGCFML 92 (137)
T ss_dssp EESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEE-EEETTEEEE
T ss_pred ccccccCCCHHHHHHHHHHHHHHCCCEEEeccccccccCCCceEEEEEEecCCCccccCCceEEEEEEEE-EecCCcEEE
Confidence 3345677899999999999999999999977 444 66652 21 2488899999 999999999
Q ss_pred EEEecCCCC--------------CCCcchhhHhhhHHHHhhhhc
Q 013005 410 GVKVVDNSV--------------CGRVALEFDEGDWNELQAGLG 439 (451)
Q Consensus 410 ~~~~~~g~~--------------~~~~~~~~~~~~~~~~~~~l~ 439 (451)
||+...|+. -|--+++|-.+|. .|-.+|.
T Consensus 93 DFk~~~~~~~~~~~~~~~~~~~~~~~s~~~Fldlca-~Li~eLa 135 (137)
T 2qrd_A 93 DVKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCA-MLVCKLF 135 (137)
T ss_dssp EEEEEEEEESCC-------------CCCTTHHHHHH-HHHHHHH
T ss_pred EEEecCCccccccCccccccCCccccccccHHHHHH-HHHHHHh
Confidence 999999871 1222378888887 7766654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00011 Score=70.67 Aligned_cols=132 Identities=14% Similarity=0.097 Sum_probs=76.4
Q ss_pred cceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEec
Q 013005 33 GPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYA 112 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~ 112 (451)
.+.|+.|....+|+. ..+++|+...... ......+|..+++.+..+.-..+++.. +...-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~-----~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE-----EYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC---------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc-----ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeec
Confidence 678999999999999 4588898754311 011234688888877644333566654 333457899999
Q ss_pred -CCCchhH---------------Hh---hcCC--C----C-HHHHHHHHHH--------------HHHHHHHHH----H-
Q 013005 113 -AGGELFG---------------KL---RRGR--L----T-ESAARRYFQQ--------------LVSALHFCH----Q- 147 (451)
Q Consensus 113 -~gg~L~~---------------~l---~~~~--l----~-e~~~~~~~~q--------------l~~gL~yLH----~- 147 (451)
+|.++.. .+ +... + . ...+..+..+ +...+..+. .
T Consensus 90 ~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~ 169 (301)
T 3dxq_A 90 AGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAH 169 (301)
T ss_dssp TTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSS
T ss_pred CCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhc
Confidence 6654421 01 1100 1 1 1112222111 111122221 1
Q ss_pred ---CCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 148 ---NGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 148 ---~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
..++|+|+.|.||+ ..++.+.|+||..+..
T Consensus 170 ~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 170 PLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 13799999999999 5667899999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00014 Score=70.95 Aligned_cols=135 Identities=16% Similarity=0.161 Sum_probs=71.9
Q ss_pred ceEcccCceE-EEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCC-CceEEEEEEEeCCEEEEEEEe
Q 013005 34 PLLGRGSFAK-VHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP-NVLKIQEVMATKTKIYLVMEY 111 (451)
Q Consensus 34 ~~LG~G~~g~-Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~Hp-nIv~l~~~~~~~~~~~lV~E~ 111 (451)
+.|+.|.... +|+.. ..++..+++|...... .+.+..|+.+++.|..+. .+.+++.+....+ +++||+
T Consensus 24 ~~l~gg~s~~~~~r~~-~~~~~~~vlk~~~~~~-------~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~ 93 (333)
T 3csv_A 24 TPLAGDASSRRYQRLR-SPTGAKAVLMDWSPEE-------GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED 93 (333)
T ss_dssp CC--------CCEEEE-CTTCCEEEEEECCTTT-------TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred eECCCCCCCceEEEEE-cCCCCeEEEEECCCCC-------CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence 4565565554 56664 2336778887654321 023456777787776432 2456666533333 789999
Q ss_pred cCCCchhHHhhcC------------------------C---CCHHHHH-------H-HH------------HHHHHHHHH
Q 013005 112 AAGGELFGKLRRG------------------------R---LTESAAR-------R-YF------------QQLVSALHF 144 (451)
Q Consensus 112 ~~gg~L~~~l~~~------------------------~---l~e~~~~-------~-~~------------~ql~~gL~y 144 (451)
+.+..+.+.+... . ++..... . +. ..+...+..
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 9776554332211 1 1121110 0 00 011122233
Q ss_pred H------HHCCceecCCCCCeEEeCCC----CCeEEEeccCCCc
Q 013005 145 C------HQNGVAHRDVKPQNLLLDRD----GNLKVSDFGLSAL 178 (451)
Q Consensus 145 L------H~~giiHrDLKpeNILld~~----~~lkl~DFGls~~ 178 (451)
+ +...++|+|+.|.||+++.+ +.+.|+||+.+..
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3 12469999999999999875 6799999998864
|
| >3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} SCOP: d.129.6.2 PDB: 3tdh_A* 3te5_A* 2qlv_A | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00057 Score=59.70 Aligned_cols=85 Identities=16% Similarity=0.111 Sum_probs=63.0
Q ss_pred eeeCCCHHHHHHHHHHHHHHcCcEEEEec---Ce-EEeeecc-------------CcEEEEEEEEeeecCCeEEEEEEec
Q 013005 352 FTTKEKTERVVEKVKEVGERLGYVVEKGK---GD-VVGLGKL-------------GKMVLLVEVLMEIAPETFVVGVKVV 414 (451)
Q Consensus 352 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-~~~~~~~-------------~~~~~~~~~~~~~~~~~~~v~~~~~ 414 (451)
..|...+.+|+..|..+++.||+.|++.+ .+ |.++.+. ..+.|.+++| ++.++.+||||+ +
T Consensus 55 IrS~~~P~eIM~EVyrALk~Lg~~WKk~~~~~pY~IkcRw~~~~~~~~~~~~~~p~~vKmeLQLY-kv~~~~YLLDfk-~ 132 (179)
T 3t4n_A 55 IRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLF-QIETNNYLVDFK-F 132 (179)
T ss_dssp EEECSCHHHHHHHHHHHHHHHTCEEECCCGGGTTEEEEEECC-----------CCCEEEEEEEEE-EEETTEEEEEEE-E
T ss_pred cccCCCHHHHHHHHHHHHHHcCCEEeeCCCCCceEEEEEEeCCCCcccccccCCCceeEEEEEEE-EecCCceEEEEE-e
Confidence 56788999999999999999999999865 44 5554110 2488999999 999999999999 7
Q ss_pred CCC-----------------CCCCcchhhHhhhHHHHhhhhc
Q 013005 415 DNS-----------------VCGRVALEFDEGDWNELQAGLG 439 (451)
Q Consensus 415 ~g~-----------------~~~~~~~~~~~~~~~~~~~~l~ 439 (451)
.|- ...-..+.|-.+|. .|--+|.
T Consensus 133 ~G~e~~~~~~~~~~~~~~~e~~~~s~~pFLdlca-~LI~eLa 173 (179)
T 3t4n_A 133 DGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTT-KLIMELA 173 (179)
T ss_dssp EEEECC----------------CCCCHHHHHHHH-HHHHHHH
T ss_pred ccccccccccccccccccccccccCCccHHHHHH-HHHHHHH
Confidence 770 00001577888887 6655553
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00028 Score=68.33 Aligned_cols=138 Identities=11% Similarity=0.063 Sum_probs=79.2
Q ss_pred cceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCC-CceEEEEE------EEeCCEE
Q 013005 33 GPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP-NVLKIQEV------MATKTKI 105 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~Hp-nIv~l~~~------~~~~~~~ 105 (451)
.+.|+.|....+|+... .+| .+++|+..... ..+.+..|..+++.|..+. .+.+++.. ....+..
T Consensus 27 ~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~------~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV------EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp EEEECC---EEEEEEEE-SSC-CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred eeccCCCcccceEEEEe-CCc-cEEEEEeCCCC------CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 45677898899999974 334 68899986520 1234567888888776331 12333321 1234678
Q ss_pred EEEEEecCCCchhH--------------Hhhc--CCC--------CHHHHHHH---------------HHHHHHHHHHHH
Q 013005 106 YLVMEYAAGGELFG--------------KLRR--GRL--------TESAARRY---------------FQQLVSALHFCH 146 (451)
Q Consensus 106 ~lV~E~~~gg~L~~--------------~l~~--~~l--------~e~~~~~~---------------~~ql~~gL~yLH 146 (451)
+++++|++|..+.. .++. ..+ ....-... -..+...++.++
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 99999999865311 1111 011 11100000 011344455555
Q ss_pred H-------CCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 147 Q-------NGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 147 ~-------~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
+ .+++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3 3699999999999998776568999998753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00035 Score=69.92 Aligned_cols=137 Identities=16% Similarity=0.150 Sum_probs=84.9
Q ss_pred cceEcccCceEEEEEEEcC-------CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 33 GPLLGRGSFAKVHKAKSIA-------DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
.+.|..|....+|++.... ++..+.+|+.-.. . .......+|..+++.|..+.-..++++.+.+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~---- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--L---QGVDSLVLESVMFAILAERSLGPQLYGVFPE---- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC--------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--c---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----
Confidence 3467778888999987532 3578999986321 0 1124456899999988755445677776543
Q ss_pred EEEEEecCCCchhH--------------Hh---hcC-----C-C--CHHHHHHHHHHHHH-------------------H
Q 013005 106 YLVMEYAAGGELFG--------------KL---RRG-----R-L--TESAARRYFQQLVS-------------------A 141 (451)
Q Consensus 106 ~lV~E~~~gg~L~~--------------~l---~~~-----~-l--~e~~~~~~~~ql~~-------------------g 141 (451)
.+||||++|..|.. .+ +.. + . -..++.+|..++-. .
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 28999999865421 11 111 1 1 13556666655432 2
Q ss_pred HHHHH----HC----CceecCCCCCeEEeCCC----CCeEEEeccCCCc
Q 013005 142 LHFCH----QN----GVAHRDVKPQNLLLDRD----GNLKVSDFGLSAL 178 (451)
Q Consensus 142 L~yLH----~~----giiHrDLKpeNILld~~----~~lkl~DFGls~~ 178 (451)
+..|. .. .++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 33333 22 48999999999999876 7899999998864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0016 Score=62.08 Aligned_cols=80 Identities=15% Similarity=0.131 Sum_probs=55.7
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCC--CceEEEEEEEeCCEEE
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP--NVLKIQEVMATKTKIY 106 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~Hp--nIv~l~~~~~~~~~~~ 106 (451)
+..-.+.+|.|..+.||+... .+|+.|.+|+...... .....+.+|...|+.|.... -+++++.+ +. .+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~----~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~ 86 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP----ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RT 86 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC----CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc----chhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ce
Confidence 445577899999999999974 6889999998754321 11235778999999985332 24455554 22 37
Q ss_pred EEEEecCCCch
Q 013005 107 LVMEYAAGGEL 117 (451)
Q Consensus 107 lV~E~~~gg~L 117 (451)
+||||+.++..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 89999987643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00079 Score=68.41 Aligned_cols=75 Identities=13% Similarity=0.091 Sum_probs=50.9
Q ss_pred cceEcccCceEEEEEEEcC-------CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 33 GPLLGRGSFAKVHKAKSIA-------DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
.+.|+.|....||++.... ++..+++|+.... . . .+.+.+|..+++.|..+.-.+++++.+.+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-C--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 4568889999999997642 2578999998431 1 1 12344789999988755434677776542
Q ss_pred EEEEEecCCCch
Q 013005 106 YLVMEYAAGGEL 117 (451)
Q Consensus 106 ~lV~E~~~gg~L 117 (451)
.+|+||++|..|
T Consensus 148 g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 GRLEEYIPSRPL 159 (429)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEeCCccc
Confidence 289999987443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0012 Score=63.94 Aligned_cols=136 Identities=15% Similarity=0.131 Sum_probs=78.9
Q ss_pred ceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCC-CceEEEEE-----EEeCCEEEE
Q 013005 34 PLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHP-NVLKIQEV-----MATKTKIYL 107 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~Hp-nIv~l~~~-----~~~~~~~~l 107 (451)
..|+ |....||+... .+|+.+++|+...... ..+.+..|..+++.|..+. .+++++.. ....+..++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~-----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW-----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA 104 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS-----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC-----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence 3466 88889998753 4566899999864311 1235667888888875331 13444432 223567789
Q ss_pred EEEecCCCchh-----------HH---hhc----C------CCCHHH----HHH------------------HHHHHHHH
Q 013005 108 VMEYAAGGELF-----------GK---LRR----G------RLTESA----ARR------------------YFQQLVSA 141 (451)
Q Consensus 108 V~E~~~gg~L~-----------~~---l~~----~------~l~e~~----~~~------------------~~~ql~~g 141 (451)
+||+++|..+. .. ++. . .++... .+. .+.+++..
T Consensus 105 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 184 (328)
T 1zyl_A 105 VFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAA 184 (328)
T ss_dssp EEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHH
T ss_pred EEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHH
Confidence 99999885431 00 110 0 011111 011 11122222
Q ss_pred HHHH----HHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 142 LHFC----HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 142 L~yL----H~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
+.-+ ....++|+|++|.|||++ + .+.|+||+.+..
T Consensus 185 l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 185 VTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 2221 123589999999999998 4 899999998753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0015 Score=64.59 Aligned_cols=76 Identities=9% Similarity=0.022 Sum_probs=45.8
Q ss_pred cceEcccCceEEEEEEEcC--------CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 33 GPLLGRGSFAKVHKAKSIA--------DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~--------~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
...|+.|....+|+..... .+..+++|+....... ......|..+++.|..+.-..++++.. .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-----~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-----LYNTISEFEVYKTMSKYKIAPQLLNTF--NG- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-----TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-----eecHHHHHHHHHHHHhcCCCCceEEec--CC-
Confidence 4567888889999997532 1368999987543111 012357888888886443345677554 22
Q ss_pred EEEEEEecCCCch
Q 013005 105 IYLVMEYAAGGEL 117 (451)
Q Consensus 105 ~~lV~E~~~gg~L 117 (451)
++||||++|..+
T Consensus 110 -~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 -GRIEEWLYGDPL 121 (369)
T ss_dssp -EEEEECCCSEEC
T ss_pred -cEEEEEecCCcC
Confidence 689999998543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0028 Score=62.07 Aligned_cols=31 Identities=19% Similarity=0.417 Sum_probs=27.7
Q ss_pred CceecCCCCCeEEeCCCCCeEEEeccCCCcc
Q 013005 149 GVAHRDVKPQNLLLDRDGNLKVSDFGLSALP 179 (451)
Q Consensus 149 giiHrDLKpeNILld~~~~lkl~DFGls~~~ 179 (451)
.++|+|+.|.||+++.++.+.|+||+.+...
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 5899999999999998889999999987643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.011 Score=60.50 Aligned_cols=76 Identities=17% Similarity=0.089 Sum_probs=49.0
Q ss_pred cceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEec
Q 013005 33 GPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYA 112 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~~ 112 (451)
.+.|+.|-...+|++....++..+++|+....... .. .-.+|..+++.|..+.-..++++.+. + .+||||+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~----~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE----II-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS----CS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh----hc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence 45688899999999986444578999987432110 00 11578899999975443457777763 2 2499999
Q ss_pred CCCch
Q 013005 113 AGGEL 117 (451)
Q Consensus 113 ~gg~L 117 (451)
+|..|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 88544
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.08 E-value=0.012 Score=59.63 Aligned_cols=136 Identities=15% Similarity=0.138 Sum_probs=84.2
Q ss_pred cceEcccCceEEEEEEEcCC-------CcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 33 GPLLGRGSFAKVHKAKSIAD-------GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
.+.|..|....+|+...... +..+++|+...... ..-...+|..+++.|..+.-..++++.+. +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-----~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~-- 145 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-----KFYDSKVELDVFRYLSNINIAPNIIADFP--E-- 145 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC------CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-----hhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--
Confidence 45677788999999986421 57899999754211 01123578888888865544556675432 2
Q ss_pred EEEEEecCCCchhH--------------Hh---hc----C-CC---------CHHHHHHHHHHH----------------
Q 013005 106 YLVMEYAAGGELFG--------------KL---RR----G-RL---------TESAARRYFQQL---------------- 138 (451)
Q Consensus 106 ~lV~E~~~gg~L~~--------------~l---~~----~-~l---------~e~~~~~~~~ql---------------- 138 (451)
++|+||++|..|.. .+ +. . .+ -..++.++..++
T Consensus 146 ~~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~ 225 (424)
T 3mes_A 146 GRIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELY 225 (424)
T ss_dssp EEEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHH
T ss_pred CEEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccH
Confidence 78999999865421 01 10 0 01 134444444332
Q ss_pred ---HHHHHHHHH------------------------CCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 139 ---VSALHFCHQ------------------------NGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 139 ---~~gL~yLH~------------------------~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
...+..|.+ ..++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 226 ~~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 226 SKILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 222333321 14899999999999 7888999999999874
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.07 E-value=0.27 Score=49.01 Aligned_cols=29 Identities=31% Similarity=0.509 Sum_probs=25.4
Q ss_pred ceecCCCCCeEEe------CCCCCeEEEeccCCCc
Q 013005 150 VAHRDVKPQNLLL------DRDGNLKVSDFGLSAL 178 (451)
Q Consensus 150 iiHrDLKpeNILl------d~~~~lkl~DFGls~~ 178 (451)
++|+|+.+.|||+ ++++.+.++||-+|+.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567899999999874
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=87.96 E-value=1.1 Score=40.85 Aligned_cols=113 Identities=16% Similarity=0.177 Sum_probs=79.9
Q ss_pred CCCCceEEEEEEEeCCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHH-HHHHCCceecCCCCCeEEeCCCC
Q 013005 88 NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALH-FCHQNGVAHRDVKPQNLLLDRDG 166 (451)
Q Consensus 88 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~-yLH~~giiHrDLKpeNILld~~~ 166 (451)
.||++ -..+-.+.+.+.+.++.-+++.=+..+ ..++..+.++++.+|+.... ++ ..-+|-=|+|+||++|.++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i--~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~~ 121 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI--RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRAL 121 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH--HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTTC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH--HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCCC
Confidence 58888 555567788888888876555445555 35788899999988887655 33 4457788999999999999
Q ss_pred CeEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhh-hhhHHHHHHHhcCCCC
Q 013005 167 NLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAW-SCGVILFVLLAGYLPF 231 (451)
Q Consensus 167 ~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIw-SlGvil~~Ll~G~~Pf 231 (451)
.++|.-.|+-. -++|.- ....|.| ++=|++..++.++..|
T Consensus 122 ~p~i~hRGi~~------------------~lpP~e-------~~ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 122 EPFFLHVGVKE------------------SLPPDE-------WDDERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp CEEESCCEETT------------------TBSSCS-------CCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred cEEEEEcCCcc------------------cCCCCC-------CCHHHHHHHHHHHHHHHHcCCCCH
Confidence 99998777632 223321 1224555 3667888888887776
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.56 E-value=1.7 Score=39.42 Aligned_cols=114 Identities=14% Similarity=0.224 Sum_probs=79.2
Q ss_pred CCCCceEEEEEEEeCCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCC
Q 013005 88 NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN 167 (451)
Q Consensus 88 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~ 167 (451)
.||+.+.. .+-.+.+.+.+.++.-+.+.=+..++ .++..+.++++.+|+....++ ..-+|-=|+|+||++|.++.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik--~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~~~ 117 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK--SFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRDGL 117 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG--GSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTTSC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH--hcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCCCC
Confidence 48999876 57677777777776654333333333 478888999999999877444 34477889999999999999
Q ss_pred eEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhh-hhhHHHHHHHhcCCCC
Q 013005 168 LKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAW-SCGVILFVLLAGYLPF 231 (451)
Q Consensus 168 lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIw-SlGvil~~Ll~G~~Pf 231 (451)
+++.--|+-.. ++|. .....|.| .+=|++..++.++..|
T Consensus 118 p~i~~RGik~~------------------l~P~-------~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 118 PIAKTRGLQNV------------------VDPL-------PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp EEESCCEETTT------------------BSCC-------CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred EEEEEccCccC------------------CCCC-------CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 99987776321 1222 11223554 3668888899998887
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 451 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-85 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-79 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-79 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-79 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-78 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-77 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-77 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-75 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-75 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-74 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-73 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-73 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-71 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-71 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-71 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-69 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-69 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-69 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-68 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-68 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-68 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-68 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-65 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-64 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-62 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-62 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-62 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-60 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-60 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-60 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-59 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-59 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-59 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-59 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-59 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-59 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-58 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-58 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-58 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-56 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-56 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-56 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-56 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-55 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-55 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-55 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-55 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-52 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-52 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-48 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-38 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-20 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 260 bits (665), Expect = 3e-85
Identities = 90/263 (34%), Positives = 144/263 (54%), Gaps = 7/263 (2%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
L +++G LG+G F V+ A+ I+A+K + K + A +E ++ REV L
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 63
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFC 145
HPN+L++ T++YL++EYA G ++ +L++ + E Y +L +AL +C
Sbjct: 64 -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 122
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARR 205
H V HRD+KP+NLLL G LK++DFG S + T CGT Y PE++ R
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGR 179
Query: 206 GYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQL 265
+D V D WS GV+ + L G PF+ + YK+++R ++ FP FV++ AR LI +L
Sbjct: 180 MHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 238
Query: 266 LDPNPKTRMSIEKIMSISWFQKS 288
L NP R + +++ W +
Sbjct: 239 LKHNPSQRPMLREVLEHPWITAN 261
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 246 bits (628), Expect = 2e-79
Identities = 83/271 (30%), Positives = 141/271 (52%), Gaps = 8/271 (2%)
Query: 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVR 78
P KK P ++ G +LG GSF+ V A+ +A AIK +EK + + R
Sbjct: 2 PRKKRP---EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR-HIIKENKVPYVTR 57
Query: 79 EVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQ 137
E M RL +HP +K+ K+Y + YA GEL +R+ G E+ R Y +
Sbjct: 58 ERDVMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 116
Query: 138 LVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL-PEQIKNGMLHTACGTPAY 196
+VSAL + H G+ HRD+KP+N+LL+ D +++++DFG + + + K ++ GT Y
Sbjct: 117 IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
Query: 197 TAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSK 256
+PE++ + + +D W+ G I++ L+AG PF N +++K+ + +Y FP
Sbjct: 177 VSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP 235
Query: 257 PARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287
AR L+ +LL + R+ E++ +
Sbjct: 236 KARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (625), Expect = 3e-79
Identities = 86/270 (31%), Positives = 140/270 (51%), Gaps = 9/270 (3%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
+ + L LG G++ +V A + VA+K ++ + I +E+ + L
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKML 60
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFC 145
NH NV+K YL +EY +GGELF ++ + E A+R+F QL++ + +
Sbjct: 61 -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS-ALPEQIKNGMLHTACGTPAYTAPEVVAR 204
H G+ HRD+KP+NLLLD NLK+SDFGL+ + +L+ CGT Y APE++ R
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 205 RGYDGAVADAWSCGVILFVLLAGYLPFD-DSNLLAMYKKVNRRDYQFPSF--VSKPARSL 261
R + D WSCG++L +LAG LP+D S+ Y + + + +L
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239
Query: 262 IYQLLDPNPKTRMSIEKIMSISWFQKSLQQ 291
++++L NP R++I I W+ K L++
Sbjct: 240 LHKILVENPSARITIPDIKKDRWYNKPLKK 269
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 246 bits (630), Expect = 7e-79
Identities = 76/297 (25%), Positives = 141/297 (47%), Gaps = 16/297 (5%)
Query: 16 PPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDR 75
P P K ++ + Y + LG G+F VH+ A G + K I +
Sbjct: 17 PQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYT 72
Query: 76 IVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARR 133
+ E+S M +L +HP ++ + + K ++ L++E+ +GGELF ++ +++E+
Sbjct: 73 VKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN 131
Query: 134 YFQQLVSALHFCHQNGVAHRDVKPQNLLLD--RDGNLKVSDFGLSALPEQIKNGMLHTAC 191
Y +Q L H++ + H D+KP+N++ + + ++K+ DFGL+ + + ++
Sbjct: 132 YMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA--TKLNPDEIVKVTT 189
Query: 192 GTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP 251
T + APE+V R D W+ GV+ +VLL+G PF + L + V R D++F
Sbjct: 190 ATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD 248
Query: 252 ----SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSLFEL 304
S VS A+ I LL P+ R+++ + W + R S ++
Sbjct: 249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKI 305
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 244 bits (623), Expect = 6e-78
Identities = 77/280 (27%), Positives = 133/280 (47%), Gaps = 16/280 (5%)
Query: 16 PPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDR 75
P P K +L+ Y + LG G+F VH+ A G+ A K + ++ + ++
Sbjct: 14 PQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE----SDKET 69
Query: 76 IVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL--RRGRLTESAARR 133
+ +E+ M L HP ++ + + ++ ++ E+ +GGELF K+ +++E A
Sbjct: 70 VRKEIQTMSVL-RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVE 128
Query: 134 YFQQLVSALHFCHQNGVAHRDVKPQNLLL--DRDGNLKVSDFGLSALPEQIKNGMLHTAC 191
Y +Q+ L H+N H D+KP+N++ R LK+ DFGL+A + +
Sbjct: 129 YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--PKQSVKVTT 186
Query: 192 GTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP 251
GT + APEV + D WS GV+ ++LL+G PF N + V D+
Sbjct: 187 GTAEFAAPEVAEGKPVGYYT-DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD 245
Query: 252 ----SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287
S +S+ + I +LL +P TRM+I + + W
Sbjct: 246 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 285
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (616), Expect = 1e-77
Identities = 73/264 (27%), Positives = 128/264 (48%), Gaps = 10/264 (3%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
+Y +G+G+ V+ A +A G VAI+ + + ++ I+ E+ MR
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMREN- 74
Query: 88 NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQ 147
+PN++ + ++++VMEY AGG L + + E ++ + AL F H
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 148 NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGY 207
N V HRD+K N+LL DG++K++DFG A + T GTP + APEVV R+ Y
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 208 DGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR---DYQFPSFVSKPARSLIYQ 264
V D WS G++ ++ G P+ + N L + + Q P +S R + +
Sbjct: 194 GPKV-DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252
Query: 265 LLDPNPKTRMSIEKIMSISWFQKS 288
LD + + R S ++++ + + +
Sbjct: 253 CLDMDVEKRGSAKELLQHQFLKIA 276
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 239 bits (611), Expect = 5e-77
Identities = 82/274 (29%), Positives = 138/274 (50%), Gaps = 17/274 (6%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAA-----MEDRIVREVSAM 83
Y+ +LGRG + V + A+K I+ +A + + ++EV +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 84 RRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSAL 142
R++ HPN++++++ T T +LV + GELF L + L+E R+ + L+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 143 HFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVV 202
H+ + HRD+KP+N+LLD D N+K++DFG S + L CGTP+Y APE++
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTPSYLAPEII 181
Query: 203 ARRGYD-----GAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS----F 253
D G D WS GVI++ LLAG PF + M + + +YQF S
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 241
Query: 254 VSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287
S + L+ + L P+ R + E+ ++ +FQ+
Sbjct: 242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (601), Expect = 2e-75
Identities = 68/269 (25%), Positives = 130/269 (48%), Gaps = 17/269 (6%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN 88
+++ LG G+F KV+KA++ + A K I+ ++ + + E+ + +
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE----EELEDYMVEIDILASC-D 67
Query: 89 HPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL--RRGRLTESAARRYFQQLVSALHFCH 146
HPN++K+ + + +++++E+ AGG + + LTES + +Q + AL++ H
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 147 QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVA--- 203
N + HRD+K N+L DG++K++DFG+SA + + GTP + APEVV
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR-TIQRRDSFIGTPYWMAPEVVMCET 186
Query: 204 --RRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY---QFPSFVSKPA 258
R YD D WS G+ L + P + N + + K+ + + PS S
Sbjct: 187 SKDRPYDYKA-DVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245
Query: 259 RSLIYQLLDPNPKTRMSIEKIMSISWFQK 287
+ + + L+ N R + +++ +
Sbjct: 246 KDFLKKCLEKNVDARWTTSQLLQHPFVTV 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 235 bits (601), Expect = 3e-75
Identities = 95/288 (32%), Positives = 158/288 (54%), Gaps = 15/288 (5%)
Query: 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREV 80
K+ + + Y +LG G+F++V A+ +VAIK I K E + E+
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKA---LEGKEGSMENEI 58
Query: 81 SAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLV 139
+ + ++ HPN++ + ++ + +YL+M+ +GGELF ++ +G TE A R Q++
Sbjct: 59 AVLHKI-KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL 117
Query: 140 SALHFCHQNGVAHRDVKPQNLLL---DRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAY 196
A+ + H G+ HRD+KP+NLL D D + +SDFGLS + + +L TACGTP Y
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPGY 175
Query: 197 TAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS---- 252
APEV+A++ Y AV D WS GVI ++LL GY PF D N +++++ + +Y+F S
Sbjct: 176 VAPEVLAQKPYSKAV-DCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD 234
Query: 253 FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESS 300
+S A+ I L++ +P+ R + E+ + W + Q S
Sbjct: 235 DISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVS 282
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (596), Expect = 3e-74
Identities = 77/263 (29%), Positives = 137/263 (52%), Gaps = 5/263 (1%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
+ + L +LG+GSF KV A+ AIK ++K+ +D +E + E +
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVE-CTMVEKRVLSLA 59
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFC 145
HP + + TK ++ VMEY GG+L ++ + S A Y +++ L F
Sbjct: 60 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARR 205
H G+ +RD+K N+LLD+DG++K++DFG+ + + +T CGTP Y APE++ +
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGDAKTNTFCGTPDYIAPEILLGQ 178
Query: 206 GYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQL 265
Y+ +V D WS GV+L+ +L G PF + ++ + + +P ++ K A+ L+ +L
Sbjct: 179 KYNHSV-DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 237
Query: 266 LDPNPKTRMSIEK-IMSISWFQK 287
P+ R+ + I F++
Sbjct: 238 FVREPEKRLGVRGDIRQHPLFRE 260
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 5e-73
Identities = 83/273 (30%), Positives = 134/273 (49%), Gaps = 15/273 (5%)
Query: 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKN--NKFLDAAMEDRIVREVSAM 83
L ++YQ+GPLLG G F V+ ++D VAIK +EK+ + + + R+ EV +
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 84 RRLQ-NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL--RRGRLTESAARRYFQQLVS 140
+++ V+++ + L++E + RG L E AR +F Q++
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 141 ALHFCHQNGVAHRDVKPQNLLLDRD-GNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAP 199
A+ CH GV HRD+K +N+L+D + G LK+ DFG AL +K+ + GT Y+ P
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL---LKDTVYTDFDGTRVYSPP 178
Query: 200 EVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPAR 259
E + Y G A WS G++L+ ++ G +PF+ ++ R F VS +
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQ 232
Query: 260 SLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQ 292
LI L P R + E+I + W Q L Q
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 229 bits (585), Expect = 9e-73
Identities = 65/265 (24%), Positives = 117/265 (44%), Gaps = 14/265 (5%)
Query: 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQN 88
+ +G GSF V+ A+ + + +VAIK + + K I++EV +++L
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKL-R 73
Query: 89 HPNVLKIQEVMATKTKIYLVMEYAAGGELF-GKLRRGRLTESAARRYFQQLVSALHFCHQ 147
HPN ++ + + +LVMEY G ++ + L E + L + H
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 148 NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVA---R 204
+ + HRDVK N+LL G +K+ DFG +++ ++ GTP + APEV+
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVILAMDE 188
Query: 205 RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQF--PSFVSKPARSLI 262
YDG V D WS G+ L P + N ++ + + + S+ R+ +
Sbjct: 189 GQYDGKV-DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247
Query: 263 YQLLDPNPKTRMSIEKIMSISWFQK 287
L P+ R + E ++ + +
Sbjct: 248 DSCLQKIPQDRPTSEVLLKHRFVLR 272
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (578), Expect = 1e-71
Identities = 61/274 (22%), Positives = 119/274 (43%), Gaps = 17/274 (6%)
Query: 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRR 85
L +Y + LGRG F VH+ + K ++ + + +E+S +
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-----QVLVKKEISILNI 57
Query: 86 LQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALH 143
H N+L + E + ++ ++ E+ +G ++F ++ L E Y Q+ AL
Sbjct: 58 A-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 144 FCHQNGVAHRDVKPQNLLLDRDGN--LKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEV 201
F H + + H D++P+N++ + +K+ +FG + + P Y APEV
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--GDNFRLLFTAPEYYAPEV 174
Query: 202 VARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS----FVSKP 257
A D WS G +++VLL+G PF + + + +Y F +S
Sbjct: 175 HQHDVVSTAT-DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233
Query: 258 ARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQ 291
A + +LL K+RM+ + + W ++ +++
Sbjct: 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (573), Expect = 2e-71
Identities = 79/268 (29%), Positives = 128/268 (47%), Gaps = 18/268 (6%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89
Y++ +G GS+ + K + +DG I+ K ++ + A + +V EV+ +R L H
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY--GSMTEAEKQMLVSEVNLLREL-KH 62
Query: 90 PNVLKIQEVM--ATKTKIYLVMEYAAGGELFGKLR-----RGRLTESAARRYFQQLVSAL 142
PN+++ + + T T +Y+VMEY GG+L + R L E R QL AL
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 143 HFCHQ-----NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYT 197
CH+ + V HRD+KP N+ LD N+K+ DFGL+ + GTP Y
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFVGTPYYM 181
Query: 198 APEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY-QFPSFVSK 256
+PE + R Y+ D WS G +L+ L A PF + + K+ + + P S
Sbjct: 182 SPEQMNRMSYNEKS-DIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 240
Query: 257 PARSLIYQLLDPNPKTRMSIEKIMSISW 284
+I ++L+ R S+E+I+
Sbjct: 241 ELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (573), Expect = 9e-71
Identities = 65/307 (21%), Positives = 122/307 (39%), Gaps = 54/307 (17%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
+ ++ LG G+ V K G ++A K I + + A+ ++I+RE+ +
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---HLEIKPAIRNQIIRELQVLHEC- 61
Query: 88 NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLVSALHFCH 146
N P ++ + +I + ME+ GG L L + GR+ E + ++ L +
Sbjct: 62 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 147 Q-NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARR 205
+ + + HRDVKP N+L++ G +K+ DFG+S Q+ + M ++ GT +Y +PE +
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFVGTRSYMSPERLQGT 178
Query: 206 GYDGAVADAWSCGVILFVLLAGYLPFDDSN---LLAMYKKVNRRDYQF------------ 250
Y D WS G+ L + G P + L M+ D
Sbjct: 179 HYSVQS-DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 251 -----------------------------PSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281
S + + + L NP R ++++M
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
Query: 282 ISWFQKS 288
++ ++S
Sbjct: 298 HAFIKRS 304
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 223 bits (568), Expect = 1e-69
Identities = 67/271 (24%), Positives = 124/271 (45%), Gaps = 15/271 (5%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
+N + + ++GRG F +V+ + G + A+K ++K + E + E + +
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK-RIKMKQGETLALNERIMLSLV 61
Query: 87 Q--NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALH 143
+ P ++ + T K+ +++ GG+L L + G +E+ R Y +++ L
Sbjct: 62 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 144 FCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVA 203
H V +RD+KP N+LLD G++++SD GL+ H + GT Y APEV+
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC---DFSKKKPHASVGTHGYMAPEVLQ 178
Query: 204 RRGYDGAVADAWSCGVILFVLLAGYLPFDDSN---LLAMYKKVNRRDYQFPSFVSKPARS 260
+ + AD +S G +LF LL G+ PF + + + P S RS
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238
Query: 261 LIYQLLDPNPKTRMS-----IEKIMSISWFQ 286
L+ LL + R+ +++ +F+
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (560), Expect = 3e-69
Identities = 89/276 (32%), Positives = 135/276 (48%), Gaps = 15/276 (5%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKN--NKFLDAAMEDRIVREVSAMRR 85
+ Y G LG G FA V K + + G A K I+K + I REVS ++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 86 LQNHPNVLKIQEVMATKTKIYLVMEYAAGGELF-GKLRRGRLTESAARRYFQQLVSALHF 144
+ HPNV+ + EV KT + L++E AGGELF + LTE A + +Q+++ +++
Sbjct: 70 I-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128
Query: 145 CHQNGVAHRDVKPQNLLLDRDG----NLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPE 200
H +AH D+KP+N++L +K+ DFGL+ + GTP + APE
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFKNIFGTPEFVAPE 186
Query: 201 VVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP----SFVSK 256
+V AD WS GVI ++LL+G PF V+ +Y+F S S
Sbjct: 187 IVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245
Query: 257 PARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQ 292
A+ I +LL +PK RM+I+ + W + QQ
Sbjct: 246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 281
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 219 bits (559), Expect = 7e-69
Identities = 80/267 (29%), Positives = 148/267 (55%), Gaps = 13/267 (4%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
L +Q+ LG GSF +VH +S +G A+K ++K + + E + +
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKE-IVVRLKQVEHTNDERLMLSIV 61
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGELFG-KLRRGRLTESAARRYFQQLVSALHFC 145
HP ++++ +I+++M+Y GGELF + R A+ Y ++ AL +
Sbjct: 62 -THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARR 205
H + +RD+KP+N+LLD++G++K++DFG + + + +T CGTP Y APEVV+ +
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFA----KYVPDVTYTLCGTPDYIAPEVVSTK 176
Query: 206 GYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQL 265
Y+ ++ D WS G++++ +LAGY PF DSN + Y+K+ + +FP F ++ + L+ +L
Sbjct: 177 PYNKSI-DWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL 235
Query: 266 LDPNPKTRM-----SIEKIMSISWFQK 287
+ + R+ E + + WF++
Sbjct: 236 ITRDLSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (555), Expect = 1e-68
Identities = 60/274 (21%), Positives = 109/274 (39%), Gaps = 19/274 (6%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
+ +G +G GSF V+K K VA+K + EV +R+
Sbjct: 8 GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTA--PTPQQLQAFKNEVGVLRKT- 61
Query: 88 NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFC 145
H N+L T ++ +V ++ G L+ L + +Q + +
Sbjct: 62 RHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL-PEQIKNGMLHTACGTPAYTAPEVVAR 204
H + HRD+K N+ L D +K+ DFGL+ + + G+ + APEV+
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 205 RGYD--GAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSF------VSK 256
+ + +D ++ G++L+ L+ G LP+ + N + R Y P K
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240
Query: 257 PARSLIYQLLDPNPKTRMSIEKIMS-ISWFQKSL 289
+ L+ + L R +I++ I +SL
Sbjct: 241 AMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 2e-68
Identities = 91/301 (30%), Positives = 143/301 (47%), Gaps = 31/301 (10%)
Query: 22 KIPTLLNRYQ-LGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREV 80
K +++ Y+ +LG G KV + + A+K ++ K REV
Sbjct: 5 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR---------REV 55
Query: 81 SAMRRLQNHPNVLKIQEV----MATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARR 133
R P++++I +V A + + +VME GGELF +++ TE A
Sbjct: 56 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 115
Query: 134 YFQQLVSALHFCHQNGVAHRDVKPQNLLLDR---DGNLKVSDFGLSALPEQIKNGMLHTA 190
+ + A+ + H +AHRDVKP+NLL + LK++DFG + + L T
Sbjct: 116 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTP 173
Query: 191 CGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLA----MYKKVNRR 246
C TP Y APEV+ YD + D WS GVI+++LL GY PF ++ LA M ++
Sbjct: 174 CYTPYYVAPEVLGPEKYDKSC-DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 232
Query: 247 DYQFP----SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSLF 302
Y+FP S VS+ + LI LL P RM+I + M+ W +S + + S +
Sbjct: 233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVL 292
Query: 303 E 303
+
Sbjct: 293 K 293
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 4e-68
Identities = 89/266 (33%), Positives = 140/266 (52%), Gaps = 10/266 (3%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
+N + LLG+G+F KV + A G A+K + K + V E ++
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKE-VIIAKDEVAHTVTESRVLQNT 62
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRG-RLTESAARRYFQQLVSALHFC 145
HP + ++ T ++ VMEYA GGELF L R TE AR Y ++VSAL +
Sbjct: 63 -RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARR 205
H V +RD+K +NL+LD+DG++K++DFGL + T CGTP Y APEV+
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFCGTPEYLAPEVLEDN 180
Query: 206 GYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQL 265
Y AV D W GV+++ ++ G LPF + + +++ + + +FP +S A+SL+ L
Sbjct: 181 DYGRAV-DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGL 239
Query: 266 LDPNPKTRMS-----IEKIMSISWFQ 286
L +PK R+ +++M +F
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRFFL 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 6e-68
Identities = 64/268 (23%), Positives = 115/268 (42%), Gaps = 19/268 (7%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89
+ +GRGSF V+K VA ++ + L + R E ++ L H
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQD--RKLTKSERQRFKEEAEMLKGL-QH 67
Query: 90 PNVLKIQEVMATKTK----IYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHF 144
PN+++ + + K I LV E G L L+R + R + +Q++ L F
Sbjct: 68 PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 127
Query: 145 CHQNG--VAHRDVKPQNLLL-DRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEV 201
H + HRD+K N+ + G++K+ D GL+ L GTP + APE+
Sbjct: 128 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEM 184
Query: 202 VARRGYDGAVADAWSCGVILFVLLAGYLPFDDS-NLLAMYKKVNR--RDYQFPSFVSKPA 258
YD +V D ++ G+ + + P+ + N +Y++V + F
Sbjct: 185 Y-EEKYDESV-DVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242
Query: 259 RSLIYQLLDPNPKTRMSIEKIMSISWFQ 286
+ +I + N R SI+ +++ ++FQ
Sbjct: 243 KEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 211 bits (538), Expect = 3e-65
Identities = 88/275 (32%), Positives = 144/275 (52%), Gaps = 14/275 (5%)
Query: 19 PSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVR 78
PS+ L +++ LG GSF +V K G+ A+K ++K K + + +
Sbjct: 33 PSQNTAQL-DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ-KVVKLKQIEHTLN 90
Query: 79 EVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQ 137
E ++ + N P ++K++ + +Y+VMEY AGGE+F L R GR +E AR Y Q
Sbjct: 91 EKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 138 LVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYT 197
+V + H + +RD+KP+NLL+D+ G ++V+DFG + + G T CGTP
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA----KRVKGRTWTLCGTPEAL 205
Query: 198 APEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKP 257
APE++ +GY+ AV D W+ GV+++ + AGY PF + +Y+K+ +FPS S
Sbjct: 206 APEIILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSD 264
Query: 258 ARSLIYQLLDPNPKTRM-----SIEKIMSISWFQK 287
+ L+ LL + R + I + WF
Sbjct: 265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 207 bits (527), Expect = 1e-64
Identities = 77/264 (29%), Positives = 122/264 (46%), Gaps = 15/264 (5%)
Query: 24 PTLL-NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSA 82
P+ L +RY+LG +LG G ++VH A+ + VA+K + + D + R RE
Sbjct: 2 PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD-LARDPSFYLRFRREAQN 60
Query: 83 MRRLQNHPNVLKIQEVMATKTK----IYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQ 137
L NHP ++ + + +T Y+VMEY G L + G +T A
Sbjct: 61 AAAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIAD 119
Query: 138 LVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM--LHTACGTPA 195
AL+F HQNG+ HRDVKP N+++ +KV DFG++ N + GT
Sbjct: 120 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 196 YTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSF-- 253
Y +PE D D +S G +L+ +L G PF + +++ + R D PS
Sbjct: 180 YLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 238
Query: 254 --VSKPARSLIYQLLDPNPKTRMS 275
+S +++ + L NP+ R
Sbjct: 239 EGLSADLDAVVLKALAKNPENRYQ 262
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 2e-62
Identities = 67/297 (22%), Positives = 114/297 (38%), Gaps = 41/297 (13%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
RY +G G++ V A + VAIK I R +RE+ + R
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRF- 63
Query: 88 NHPNVLKIQEVMATKT----KIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALH 143
H N++ I +++ T K ++ + G +L+ L+ L+ + Q++ L
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLK 123
Query: 144 FCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL--PEQIKNGMLHTACGTPAYTAPEV 201
+ H V HRD+KP NLLL+ +LK+ DFGL+ + P+ G L T Y APE+
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 202 VARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSF-------- 253
+ D WS G IL +L+ F + L +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 254 -----------------------VSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287
A L+ ++L NP R+ +E+ ++ + ++
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 2e-62
Identities = 58/288 (20%), Positives = 113/288 (39%), Gaps = 37/288 (12%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSI-----VAIKTIEKNNKFLDAAMEDRIVREVSA 82
+ G +LG G+F KV A + VA+K +++ D++ + ++ E+
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKM 93
Query: 83 MRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR------------------- 123
M +L +H N++ + IYL+ EY G+L LR
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 124 -----GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS-A 177
LT + Q+ + F HRD+ +N+L+ +K+ DFGL+
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 178 LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNL 236
+ + A + APE + Y D WS G++L+ + + G P+ +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKS-DVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 237 LAMYKKVNRRDYQF--PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282
A + K+ + ++ P + ++ ++ + + R S + S
Sbjct: 273 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 2e-62
Identities = 62/261 (23%), Positives = 110/261 (42%), Gaps = 20/261 (7%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
+ +L +G+G F V G+ VA+K I+ + A + E S M +L
Sbjct: 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQL 57
Query: 87 QNHPNVLKIQEVMA-TKTKIYLVMEYAAGGELFGKLR---RGRLTESAARRYFQQLVSAL 142
H N++++ V+ K +Y+V EY A G L LR R L ++ + A+
Sbjct: 58 -RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 143 HFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVV 202
+ N HRD+ +N+L+ D KVSDFGL+ + + T +TAPE +
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT----KEASSTQDTGKLPVKWTAPEAL 172
Query: 203 ARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNR-RDYQFPSFVSKPARS 260
+ + D WS G++L+ + + G +P+ L + +V + P
Sbjct: 173 REKKFSTKS-DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 231
Query: 261 LIYQLLDPNPKTRMSIEKIMS 281
++ + R S ++
Sbjct: 232 VMKNCWHLDAAMRPSFLQLRE 252
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 3e-62
Identities = 82/276 (29%), Positives = 145/276 (52%), Gaps = 16/276 (5%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIAD---GSIVAIKTIEKNNKFLDAAMEDRIVREVSAM 83
+ ++L +LG G++ KV + I+ G + A+K ++K A + E +
Sbjct: 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82
Query: 84 RRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRG-RLTESAARRYFQQLVSAL 142
++ P ++ + T+TK++L+++Y GGELF L + R TE + Y ++V AL
Sbjct: 83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 142
Query: 143 HFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVV 202
H+ G+ +RD+K +N+LLD +G++ ++DFGLS + + CGT Y AP++V
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 203 --ARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN----LLAMYKKVNRRDYQFPSFVSK 256
G+D AV D WS GV+++ LL G PF + +++ + + +P +S
Sbjct: 203 RGGDSGHDKAV-DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 261
Query: 257 PARSLIYQLLDPNPKTRMS-----IEKIMSISWFQK 287
A+ LI +LL +PK R+ ++I +FQK
Sbjct: 262 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 2e-60
Identities = 72/282 (25%), Positives = 112/282 (39%), Gaps = 32/282 (11%)
Query: 35 LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKF-LDAAMEDRIVREVSAMRRLQNHPNVL 93
LG G FA V+KA+ IVAIK I+ ++ + +RE+ ++ L +HPN++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNII 63
Query: 94 KIQEVMATKTKIYLVMEYAAGGEL-FGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAH 152
+ + K+ I LV ++ K LT S + Y + L + HQ+ + H
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123
Query: 153 RDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVA 212
RD+KP NLLLD +G LK++DFGL+ H T Y APE++ G
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ-VVTRWYRAPELLFGARMYGVGV 182
Query: 213 DAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP--------------------- 251
D W+ G IL LL + L ++
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242
Query: 252 -------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQ 286
S LI L NP R++ + + + +F
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 2e-60
Identities = 56/256 (21%), Positives = 103/256 (40%), Gaps = 12/256 (4%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH 89
LG G F V K VAIK I++ + ED + E M L +H
Sbjct: 6 LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKE-----GSMSEDEFIEEAKVMMNL-SH 58
Query: 90 PNVLKIQEVMATKTKIYLVMEYAAGGELFGKL--RRGRLTESAARRYFQQLVSALHFCHQ 147
++++ V + I+++ EY A G L L R R + + A+ +
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 148 NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGY 207
HRD+ +N L++ G +KVSDFGLS + + ++ PEV+ +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 208 DGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKV-NRRDYQFPSFVSKPARSLIYQL 265
D W+ GV+++ + + G +P++ + + P S+ +++Y
Sbjct: 179 SSKS-DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC 237
Query: 266 LDPNPKTRMSIEKIMS 281
R + + ++S
Sbjct: 238 WHEKADERPTFKILLS 253
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 196 bits (498), Expect = 4e-60
Identities = 63/288 (21%), Positives = 119/288 (41%), Gaps = 16/288 (5%)
Query: 10 APPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLD 69
A P P ++ + LG G + +V++ VA+KT+++ D
Sbjct: 1 AMDPSSPNYDKWEME--RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-----D 53
Query: 70 AAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL---RRGRL 126
+ ++E + M+ + HPN++++ V + Y++ E+ G L L R +
Sbjct: 54 TMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV 112
Query: 127 TESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM 186
+ Q+ SA+ + + HRD+ +N L+ + +KV+DFGLS L
Sbjct: 113 SAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172
Query: 187 LHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLL-AGYLPFDDSNLLAMYKKVNR 245
A +TAPE +A + W+ GV+L+ + G P+ +L +Y+ + +
Sbjct: 173 HAGAKFPIKWTAPESLAYNKFSIKSDV-WAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 231
Query: 246 R-DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQ 292
+ P + L+ NP R S +I F+ Q+
Sbjct: 232 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIH--QAFETMFQES 277
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 6e-60
Identities = 62/296 (20%), Positives = 118/296 (39%), Gaps = 26/296 (8%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
N + ++G G+F +V KA+ DG + I++ ++ E+ + +L
Sbjct: 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAA-IKRMKEYASKDDHRDFAGELEVLCKL 67
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR-----------------GRLTES 129
+HPN++ + + +YL +EYA G L LR+ L+
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 130 AARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHT 189
+ + + + Q HRD+ +N+L+ + K++DFGLS E
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--YVKKTM 185
Query: 190 ACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNR-RD 247
+ A E + Y D WS GV+L+ +++ G P+ +Y+K+ +
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244
Query: 248 YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKRGQESSLFE 303
+ P L+ Q P R S +I+ + ++RK ++L+E
Sbjct: 245 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS---LNRMLEERKTYVNTTLYE 297
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 9e-60
Identities = 66/273 (24%), Positives = 124/273 (45%), Gaps = 15/273 (5%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIAD---GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMR 84
R +LG +G G F VH+ ++ VAIKT + ++ ++ ++E MR
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT---SDSVREKFLQEALTMR 63
Query: 85 RLQNHPNVLKIQEVMATKTKIYLVMEYAAGGEL--FGKLRRGRLTESAARRYFQQLVSAL 142
+ +HP+++K+ V+ T+ ++++ME GEL F ++R+ L ++ Y QL +AL
Sbjct: 64 QF-DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 121
Query: 143 HFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVV 202
+ HRD+ +N+L+ + +K+ DFGLS E + APE +
Sbjct: 122 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 203 ARRGYDGAVADAWSCGVILF-VLLAGYLPFDDSNLLAMYKKV-NRRDYQFPSFVSKPARS 260
R + A D W GV ++ +L+ G PF + ++ N P S
Sbjct: 182 NFRRFTSAS-DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 240
Query: 261 LIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQR 293
L+ + +P R ++ + L++++
Sbjct: 241 LMTKCWAYDPSRRPRFTELKAQ--LSTILEEEK 271
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-59
Identities = 61/265 (23%), Positives = 108/265 (40%), Gaps = 12/265 (4%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIAD---GSIVAIKTIEKNNKFLDAAMEDRIVREVSAM 83
+L LG GSF V + + A VA+K ++ + D +REV+AM
Sbjct: 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPD-VLSQPEAMDDFIREVNAM 65
Query: 84 RRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL--RRGRLTESAARRYFQQLVSA 141
L +H N++++ V+ T + +V E A G L +L +G RY Q+
Sbjct: 66 HSL-DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 142 LHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS-ALPEQIKNGMLHTACGTPAYTAPE 200
+ + HRD+ +NLLL +K+ DFGL ALP+ + ++ P
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 201 VVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRDYQF--PSFVSKP 257
+ +D W GV L+ + G P+ N + K+++ + P +
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243
Query: 258 ARSLIYQLLDPNPKTRMSIEKIMSI 282
+++ Q P+ R + +
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-59
Identities = 68/305 (22%), Positives = 118/305 (38%), Gaps = 47/305 (15%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
+++Y+ +G+G+F +V KA+ G VA+K + N+ +RE+ ++ L
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLL 66
Query: 87 QNHPNVLKIQEVMATKT--------KIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQ 137
H NV+ + E+ TK IYLV ++ + T S +R Q
Sbjct: 67 -KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 125
Query: 138 LVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG---MLHTACGTP 194
L++ L++ H+N + HRD+K N+L+ RDG LK++DFGL+ KN T
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 195 AYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFV 254
Y PE++ G D W G I+ + + +++ V
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245
Query: 255 --------------------------------SKPARSLIYQLLDPNPKTRMSIEKIMSI 282
A LI +LL +P R+ + ++
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305
Query: 283 SWFQK 287
+F
Sbjct: 306 DFFWS 310
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-59
Identities = 57/260 (21%), Positives = 112/260 (43%), Gaps = 14/260 (5%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
+L LG G F +V + VA+K++++ + D + E + M++L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQ-----GSMSPDAFLAEANLMKQL- 65
Query: 88 NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHF 144
H ++++ V+ T+ IY++ EY G L L+ +LT + Q+ + F
Sbjct: 66 QHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 145 CHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVAR 204
+ HRD++ N+L+ + K++DFGL+ L E + A +TAPE +
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 205 RGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNR-RDYQFPSFVSKPARSLI 262
+ D WS G++L ++ G +P+ + + + R P + L+
Sbjct: 185 GTFTIKS-DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLM 243
Query: 263 YQLLDPNPKTRMSIEKIMSI 282
P+ R + + + S+
Sbjct: 244 RLCWKERPEDRPTFDYLRSV 263
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 2e-59
Identities = 56/255 (21%), Positives = 98/255 (38%), Gaps = 14/255 (5%)
Query: 36 LGRGSFAKVHKA--KSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVL 93
LG G+F V + + VAIK + + + A + ++RE M +L ++P ++
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVL---KQGTEKADTEEMMREAQIMHQL-DNPYIV 72
Query: 94 KIQEVMATKTKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVA 151
++ V + LVME A GG L L R + S Q+ + + +
Sbjct: 73 RLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131
Query: 152 HRDVKPQNLLLDRDGNLKVSDFGLSAL--PEQIKNGMLHTACGTPAYTAPEVVARRGYDG 209
HRD+ +N+LL K+SDFGLS + + APE + R +
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 210 AVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRDY-QFPSFVSKPARSLIYQLLD 267
D WS GV ++ L+ G P+ + + + + P +L+
Sbjct: 192 RS-DVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWI 250
Query: 268 PNPKTRMSIEKIMSI 282
+ R +
Sbjct: 251 YKWEDRPDFLTVEQR 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 4e-59
Identities = 54/257 (21%), Positives = 108/257 (42%), Gaps = 12/257 (4%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
+ +G G F VH + + VAIKTI + A E+ + E M +L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIRE-----GAMSEEDFIEEAEVMMKL- 57
Query: 88 NHPNVLKIQEVMATKTKIYLVMEYAAGGEL--FGKLRRGRLTESAARRYFQQLVSALHFC 145
+HP ++++ V + I LV E+ G L + + +RG + + +
Sbjct: 58 SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARR 205
+ V HRD+ +N L+ + +KVSDFG++ + + +PEV +
Sbjct: 118 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 206 GYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNR-RDYQFPSFVSKPARSLIY 263
Y D WS GV+++ + + G +P+++ + + + ++ P S ++
Sbjct: 178 RYSSKS-DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 236
Query: 264 QLLDPNPKTRMSIEKIM 280
P+ R + +++
Sbjct: 237 HCWKERPEDRPAFSRLL 253
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 193 bits (491), Expect = 4e-59
Identities = 68/291 (23%), Positives = 127/291 (43%), Gaps = 35/291 (12%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
+ +Y +G G++ V+KA++ G A+K I + D + +RE+S ++ L
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRL--EKEDEGIPSTTIREISILKEL 57
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGELFG-KLRRGRLTESAARRYFQQLVSALHFC 145
H N++K+ +V+ TK ++ LV E+ + G L A+ + QL++ + +C
Sbjct: 58 -KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARR 205
H V HRD+KPQNLL++R+G LK++DFGL+ T Y AP+V+
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIVTLWYRAPDVLMGS 175
Query: 206 GYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY----------------- 248
D WS G I ++ G F + ++ R
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 249 ------------QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287
F + + L+ ++L +P R++ ++ + ++F++
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 5e-59
Identities = 52/265 (19%), Positives = 109/265 (41%), Gaps = 14/265 (5%)
Query: 36 LGRGSFAKVHKA--KSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVL 93
LG G+F V K + VA+K + N+ D A++D ++ E + M++L ++P ++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKIL--KNEANDPALKDELLAEANVMQQL-DNPYIV 71
Query: 94 KIQEVMATKTKIYLVMEYAAGGELFGKL-RRGRLTESAARRYFQQLVSALHFCHQNGVAH 152
++ + + LVME A G L L + + + Q+ + + ++ H
Sbjct: 72 RMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 153 RDVKPQNLLLDRDGNLKVSDFGLSAL--PEQIKNGMLHTACGTPAYTAPEVVARRGYDGA 210
RD+ +N+LL K+SDFGLS ++ + APE + +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 190
Query: 211 VADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRDY-QFPSFVSKPARSLIYQLLDP 268
D WS GV+++ + G P+ + + + + P+ + L+
Sbjct: 191 S-DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249
Query: 269 NPKTRMSIEKIMSI--SWFQKSLQQ 291
+ + R + +++ + +
Sbjct: 250 DVENRPGFAAVELRLRNYYYDVVNE 274
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 9e-59
Identities = 69/304 (22%), Positives = 123/304 (40%), Gaps = 45/304 (14%)
Query: 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREV 80
K + Y+ +G G++ V A G+ VAIK + + F R RE+
Sbjct: 11 KTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--PFQSELFAKRAYREL 68
Query: 81 SAMRRLQNHPNVLKIQEVMATK------TKIYLVMEYAAGGELFGKLRRGRLTESAARRY 134
++ + H NV+ + +V T YLVM + G +L ++ +L E +
Sbjct: 69 RLLKHM-RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFL 126
Query: 135 FQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTP 194
Q++ L + H G+ HRD+KP NL ++ D LK+ DFGL+ + + T
Sbjct: 127 VYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVVTR 182
Query: 195 AYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSF- 253
Y APEV+ D WS G I+ ++ G F S+ L K++ + P+
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242
Query: 254 ------------------------------VSKPARSLIYQLLDPNPKTRMSIEKIMSIS 283
S A +L+ ++L + + R++ + ++
Sbjct: 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 302
Query: 284 WFQK 287
+F+
Sbjct: 303 YFES 306
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-58
Identities = 73/292 (25%), Positives = 129/292 (44%), Gaps = 35/292 (11%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
+ +Q +G G++ V+KA++ G +VA+K I + + + +RE+S ++ L
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKEL 58
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGG--ELFGKLRRGRLTESAARRYFQQLVSALHF 144
NHPN++K+ +V+ T+ K+YLV E+ + + + Y QL+ L F
Sbjct: 59 -NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 145 CHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVAR 204
CH + V HRD+KPQNLL++ +G +K++DFGL+ T Y APE++
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLG 176
Query: 205 RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSF----------- 253
Y D WS G I ++ F + + ++ R
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 254 ------------------VSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287
+ + RSL+ Q+L +P R+S + ++ +FQ
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-58
Identities = 75/296 (25%), Positives = 129/296 (43%), Gaps = 42/296 (14%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIAD-GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
+Y+ +G G++ KV KA+ + + G VA+K + + + M +REV+ +R L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV--RVQTGEEGMPLSTIREVAVLRHL 64
Query: 87 Q--NHPNVLKIQEVMAT-----KTKIYLVMEYAAGG--ELFGKLRRGRLTESAARRYFQQ 137
+ HPNV+++ +V +TK+ LV E+ K+ + + Q
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 138 LVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYT 197
L+ L F H + V HRD+KPQN+L+ G +K++DFGL+ + L + T Y
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYR 182
Query: 198 APEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKV-------------- 243
APEV+ + Y V D WS G I + F S+ + K+
Sbjct: 183 APEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 244 -------------NRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQ 286
+ +F + + + + L+ + L NP R+S +S +FQ
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (487), Expect = 2e-58
Identities = 59/274 (21%), Positives = 115/274 (41%), Gaps = 18/274 (6%)
Query: 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGS---IVAIKTIEKNNKFLDAAMEDRI 76
+K+I ++ ++ ++G G F +V G VAIKT++
Sbjct: 20 AKEID--ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG---YTEKQRRDF 74
Query: 77 VREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGEL--FGKLRRGRLTESAARRY 134
+ E S M + +HPNV+ ++ V+ T + ++ E+ G L F + G+ T
Sbjct: 75 LSEASIMGQF-DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGM 133
Query: 135 FQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTA---- 190
+ + + + + HRD+ +N+L++ + KVSDFGLS E + +T+
Sbjct: 134 LRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGG 193
Query: 191 CGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKV-NRRDY 248
+TAPE + R + A D WS G++++ +++ G P+ D + +
Sbjct: 194 KIPIRWTAPEAIQYRKFTSAS-DVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL 252
Query: 249 QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282
P L+ + R +I++
Sbjct: 253 PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 6e-58
Identities = 62/273 (22%), Positives = 111/273 (40%), Gaps = 16/273 (5%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
+L LG+G F +V + VAIKT++ + ++E M++L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKP-----GTMSPEAFLQEAQVMKKL- 69
Query: 88 NHPNVLKIQEVMATKTKIYLVMEYAAGGELF---GKLRRGRLTESAARRYFQQLVSALHF 144
H ++++ V+ ++ IY+V EY + G L L Q+ S + +
Sbjct: 70 RHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128
Query: 145 CHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVAR 204
+ HRD++ N+L+ + KV+DFGL+ L E + A +TAPE
Sbjct: 129 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
Query: 205 RGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNR-RDYQFPSFVSKPARSLI 262
+ D WS G++L L G +P+ + +V R P + L+
Sbjct: 189 GRFTIKS-DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM 247
Query: 263 YQLLDPNPKTRMSIEKIMSI--SWFQKSLQQQR 293
Q P+ R + E + + +F + Q +
Sbjct: 248 CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 6e-58
Identities = 59/307 (19%), Positives = 109/307 (35%), Gaps = 34/307 (11%)
Query: 12 PPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIA-----DGSIVAIKTIEKNNK 66
P P + P NR G LG G+F KV +A + VA+K +
Sbjct: 9 PTQLPYDHKWEFP--RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML---KP 63
Query: 67 FLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRR--- 123
+ ++ E+ + L NH N++ + ++ EY G+L LRR
Sbjct: 64 SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123
Query: 124 ----------------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN 167
L + Q+ + F HRD+ +N+LL
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI 183
Query: 168 LKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA- 226
K+ DFGL+ + N ++ P +D WS G+ L+ L +
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243
Query: 227 GYLPFDDSNLLAMYKKVNRRDYQ--FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISW 284
G P+ + + + K+ + ++ P ++ D +P R + ++I+
Sbjct: 244 GSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV--QL 301
Query: 285 FQKSLQQ 291
+K + +
Sbjct: 302 IEKQISE 308
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 2e-56
Identities = 58/292 (19%), Positives = 116/292 (39%), Gaps = 33/292 (11%)
Query: 16 PPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIA-------DGSIVAIKTIEKNNKFL 68
P P ++P +R LG LG G+F +V A++I + VA+K ++ +
Sbjct: 3 PEDPRWELP--RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---A 57
Query: 69 DAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLR------ 122
++ E+ M+ + H N++ + +Y+++EYA+ G L L+
Sbjct: 58 TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 117
Query: 123 -----------RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVS 171
+L+ Q+ + + HRD+ +N+L+ D +K++
Sbjct: 118 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 177
Query: 172 DFGLS-ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYL 229
DFGL+ + + APE + R Y D WS GV+L+ + G
Sbjct: 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGGS 236
Query: 230 PFDDSNLLAMYKKV-NRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIM 280
P+ + ++K + PS + ++ P R + ++++
Sbjct: 237 PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 2e-56
Identities = 71/292 (24%), Positives = 122/292 (41%), Gaps = 35/292 (11%)
Query: 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRL 86
+ +Y+ +G G++ V KAK+ IVA+K + ++ D + +RE+ ++ L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKEL 58
Query: 87 QNHPNVLKIQEVMATKTKIYLVMEYAAGGEL-FGKLRRGRLTESAARRYFQQLVSALHFC 145
H N++++ +V+ + K+ LV E+ + G L + + QL+ L FC
Sbjct: 59 -KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 146 HQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARR 205
H V HRD+KPQNLL++R+G LK+++FGL+ T Y P+V+
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVVTLWYRPPDVLFGA 176
Query: 206 GYDGAVADAWSCGVILFVLLAGYLP-FDDSNLLAMYKKVNRRDYQFPSF----------- 253
D WS G I L P F +++ K++ R
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 254 ------------------VSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287
++ R L+ LL NP R+S E+ + +F
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (474), Expect = 6e-56
Identities = 63/303 (20%), Positives = 121/303 (39%), Gaps = 43/303 (14%)
Query: 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREV 80
K I + RYQ +G G++ V A G VA+K + + F R RE+
Sbjct: 11 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--PFQSIIHAKRTYREL 68
Query: 81 SAMRRLQNHPNVLKIQEVMATKTKI-----YLVMEYAAGGELFGKLRRGRLTESAARRYF 135
++ + H NV+ + +V + ++ + G +L ++ +LT+ +
Sbjct: 69 RLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 127
Query: 136 QQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPA 195
Q++ L + H + HRD+KP NL ++ D LK+ DFGL+ + + + T
Sbjct: 128 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYVATRW 183
Query: 196 YTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSF-- 253
Y APE++ + D WS G I+ LL G F ++ + K + R +
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 254 -----------------------------VSKPARSLIYQLLDPNPKTRMSIEKIMSISW 284
+ A L+ ++L + R++ + ++ ++
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303
Query: 285 FQK 287
F +
Sbjct: 304 FAQ 306
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (470), Expect = 8e-56
Identities = 58/288 (20%), Positives = 109/288 (37%), Gaps = 38/288 (13%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKS-----IADGSIVAIKTIEKNNKFLDAAMEDRIVREVSA 82
N + +G G+F +V +A++ ++VA+K +++ A M+ RE +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAAL 69
Query: 83 MRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGR----------------- 125
M ++PN++K+ V A + L+ EY A G+L LR
Sbjct: 70 MAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128
Query: 126 --------LTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS- 176
L+ + +Q+ + + + + HRD+ +N L+ + +K++DFGLS
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 188
Query: 177 ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYL-PFDDSN 235
+ + PE + Y D W+ GV+L+ + + L P+
Sbjct: 189 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTES-DVWAYGVVLWEIFSYGLQPYYGMA 247
Query: 236 LLAMYKKVNRRDY-QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282
+ V + P +L+ P R S I I
Sbjct: 248 HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 295
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 185 bits (470), Expect = 2e-55
Identities = 61/300 (20%), Positives = 122/300 (40%), Gaps = 52/300 (17%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
+ YQL LGRG +++V +A +I + V +K ++ K +I RE+ + L+
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK-------KKIKREIKILENLR 87
Query: 88 NHPNVLKIQEVMATKTK--IYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFC 145
PN++ + +++ LV E+ + + LT+ R Y +++ AL +C
Sbjct: 88 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYC 145
Query: 146 HQNGVAHRDVKPQNLLLDRDGN-LKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVAR 204
H G+ HRDVKP N+++D + L++ D+GL+ + + + PE++
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP--GQEYNVRVASRYFKGPELLVD 203
Query: 205 RGYDGAVADAWSCGVILFVLLAGYLPFDDSN--------------LLAMYKKVNRRDYQF 250
D WS G +L ++ PF + +Y +++ + +
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 251 P------------------------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQ 286
VS A + +LL + ++R++ + M +F
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 2e-55
Identities = 77/319 (24%), Positives = 135/319 (42%), Gaps = 57/319 (17%)
Query: 9 SAPPPPPPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFL 68
A P P P + Y ++G GSF V++AK G +VAIK + ++ +F
Sbjct: 7 VATPGQGPDRPQEV------SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK 60
Query: 69 DAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT------KTKIYLVMEYAAGGEL----F 118
+ RE+ MR+L +H N+++++ + + + LV++Y
Sbjct: 61 N--------RELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 111
Query: 119 GKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGN-LKVSDFGLSA 177
+ L + Y QL +L + H G+ HRD+KPQNLLLD D LK+ DFG +
Sbjct: 112 YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171
Query: 178 LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL 237
+ ++ + + Y APE++ + D WS G +L LL G F + +
Sbjct: 172 --QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 229
Query: 238 AMYKKV-----------------NRRDYQFPSFVSKP------------ARSLIYQLLDP 268
++ N +++FP + P A +L +LL+
Sbjct: 230 DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEY 289
Query: 269 NPKTRMSIEKIMSISWFQK 287
P R++ + + S+F +
Sbjct: 290 TPTARLTPLEACAHSFFDE 308
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 2e-55
Identities = 48/258 (18%), Positives = 104/258 (40%), Gaps = 9/258 (3%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKN-NKFLDAAMEDRIVREVSAMRRLQN 88
++ +LG G+F V+K I +G V I K + I+ E M + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-D 69
Query: 89 HPNVLKIQEVMATKTKIYLVMEYAAGGELFGKL--RRGRLTESAARRYFQQLVSALHFCH 146
+P+V ++ + T T + L+ + G L + + + + Q+ +++
Sbjct: 70 NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 147 QNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA-LPEQIKNGMLHTACGTPAYTAPEVVARR 205
+ HRD+ +N+L+ ++K++DFGL+ L + K + A E + R
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 206 GYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRDY-QFPSFVSKPARSLIY 263
Y WS GV ++ L+ G P+D + + + + P + ++
Sbjct: 189 IYTHQSDV-WSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMV 247
Query: 264 QLLDPNPKTRMSIEKIMS 281
+ + +R +++
Sbjct: 248 KCWMIDADSRPKFRELII 265
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 183 bits (466), Expect = 3e-55
Identities = 55/283 (19%), Positives = 92/283 (32%), Gaps = 27/283 (9%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
NRY+LG +G GSF ++ IA G VAIK K ++ E + +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQ 60
Query: 88 NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGR-LTESAARRYFQQLVSALHFCH 146
+ I+ A +VME R + Q++S + + H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 147 QNGVAHRDVKPQNLL---LDRDGNLKVSDFGLS------ALPEQIKNGMLHTACGTPAYT 197
HRDVKP N L + + + DFGL+ + I GT Y
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 198 APEVVARRGYDGAVADAWSCGVILFVLLAGYLPFD---DSNLLAMYKKVNRRDYQFP--- 251
+ D S G +L G LP+ + Y++++ + P
Sbjct: 181 SINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 252 --SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQ 292
+ + + + + F+ +Q
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL--FRNLFHRQ 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 180 bits (457), Expect = 4e-54
Identities = 45/286 (15%), Positives = 94/286 (32%), Gaps = 29/286 (10%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
Y++G +G GSF + + ++ + VAIK + + ++ E + L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLA 58
Query: 88 NHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGR-LTESAARRYFQQLVSALHFCH 146
+ + LV++ GR + +Q+++ + H
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 147 QNGVAHRDVKPQNLLLDR-----DGNLKVSDFGLSAL------PEQIKNGMLHTACGTPA 195
+ + +RD+KP N L+ R + V DFG+ + I GT
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 196 YTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS---NLLAMYKKVNRRDYQFP- 251
Y + R D + G + L G LP+ Y+++ + P
Sbjct: 179 YMSINTHLGREQSRRD-DLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 252 ----SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQR 293
+ + ++ + + + + F K L++
Sbjct: 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL--FSKVLERLN 281
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 3e-52
Identities = 59/270 (21%), Positives = 110/270 (40%), Gaps = 16/270 (5%)
Query: 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGS---IVAIKTIEKNNKFLDAAMEDRIVRE 79
I ++GRG F V+ + + A+K++ N+ D + + E
Sbjct: 22 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTE 78
Query: 80 VSAMRRLQNHPNVLKIQEV-MATKTKIYLVMEYAAGGEL--FGKLRRGRLTESAARRYFQ 136
M+ +HPNVL + + + ++ +V+ Y G+L F + T +
Sbjct: 79 GIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL 137
Query: 137 QLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHT---ACGT 193
Q+ + F HRD+ +N +LD +KV+DFGL+ + +H A
Sbjct: 138 QVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 197
Query: 194 PAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKV-NRRDYQFP 251
+ A E + + + D WS GV+L+ L+ G P+ D N + + R P
Sbjct: 198 VKWMALESLQTQKFTTKS-DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 256
Query: 252 SFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281
+ P ++ + P + R S +++S
Sbjct: 257 EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 7e-52
Identities = 56/265 (21%), Positives = 109/265 (41%), Gaps = 15/265 (5%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGS----IVAIKTIEKNNKFLDAAMEDRIVREVSAM 83
+ ++G G F +V+K VAIKT++ + E M
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRVDFLGEAGIM 63
Query: 84 RRLQNHPNVLKIQEVMATKTKIYLVMEYAAGG--ELFGKLRRGRLTESAARRYFQQLVSA 141
+ +H N+++++ V++ + ++ EY G + F + + G + + + +
Sbjct: 64 GQF-SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 122
Query: 142 LHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHT--ACGTPAYTAP 199
+ + HRD+ +N+L++ + KVSDFGLS + E T +TAP
Sbjct: 123 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 200 EVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKP 257
E ++ R + A D WS G++++ ++ G P+ + + + K +N P
Sbjct: 183 EAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA 241
Query: 258 ARSLIYQLLDPNPKTRMSIEKIMSI 282
L+ Q R I+SI
Sbjct: 242 IYQLMMQCWQQERARRPKFADIVSI 266
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-50
Identities = 70/327 (21%), Positives = 121/327 (37%), Gaps = 56/327 (17%)
Query: 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMR 84
T+L RYQ +G G+ V A VAIK + + F + R RE+ M+
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR--PFQNQTHAKRAYRELVLMK 71
Query: 85 RLQNHPNVLKIQEVMATK------TKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQL 138
+ NH N++ + V + +YLVME ++ + L Q+
Sbjct: 72 CV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC--QVIQMELDHERMSYLLYQM 128
Query: 139 VSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHTACGTPAYTA 198
+ + H G+ HRD+KP N+++ D LK+ DFGL+ + M+ T Y A
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRA 186
Query: 199 PEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKV--------------- 243
PEV+ GY V D WS G I+ ++ + F + + + KV
Sbjct: 187 PEVILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 244 ---------------------------NRRDYQFPSFVSKPARSLIYQLLDPNPKTRMSI 276
D + + AR L+ ++L +P R+S+
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 277 EKIMSISWFQKSLQQQRKRGQESSLFE 303
+ + + +++
Sbjct: 306 DDALQHPYINVWYDPAEVEAPPPQIYD 332
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 1e-49
Identities = 59/294 (20%), Positives = 115/294 (39%), Gaps = 34/294 (11%)
Query: 16 PPPPSK-KIPTLLNRYQLGPLLGRGSFAKVHKAKS-----IADGSIVAIKTIEKNNKFLD 69
P SK + P +R +LG LGRG+F +V +A + A VA+K +++
Sbjct: 2 PYDASKWEFP--RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---T 56
Query: 70 AAMEDRIVREVSAMRRLQNHPNVLKIQEVMA-TKTKIYLVMEYAAGGELFGKLR------ 122
+ ++ E+ + + +H NV+ + + +++E+ G L LR
Sbjct: 57 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 116
Query: 123 -----------RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVS 171
+ LT Y Q+ + F HRD+ +N+LL +K+
Sbjct: 117 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 176
Query: 172 DFGLSA-LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGY-L 229
DFGL+ + + A + APE + R Y +D WS GV+L+ + +
Sbjct: 177 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGAS 235
Query: 230 PFDDSNLLAMYKKVNRRDY--QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281
P+ + + + + + P + + + P R + +++
Sbjct: 236 PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-49
Identities = 54/273 (19%), Positives = 102/273 (37%), Gaps = 24/273 (8%)
Query: 28 NRYQLGPLLGRGSFAKVHKAK-----SIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSA 82
+ + LG+GSF V++ + VAIKT+ + + E S
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASV 76
Query: 83 MRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGR-----------LTESAA 131
M+ N +V+++ V++ ++ME G+L LR R + S
Sbjct: 77 MKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 132 RRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGL-SALPEQIKNGMLHTA 190
+ ++ + + + N HRD+ +N ++ D +K+ DFG+ + E
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 191 CGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAG-YLPFDDSNLLAMYKKVNRRDY- 248
+ +PE + + WS GV+L+ + P+ + + + V
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDV-WSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254
Query: 249 QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281
P L+ NPK R S +I+S
Sbjct: 255 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 7e-48
Identities = 57/295 (19%), Positives = 105/295 (35%), Gaps = 50/295 (16%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
L +G+G F +V + K G VA+K + E+ L
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-----RSWFREAEIYQTVML- 54
Query: 88 NHPNVLKI----QEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALH 143
H N+L + T T+++LV +Y G LF L R +T + S L
Sbjct: 55 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA 114
Query: 144 FCHQ--------NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM---LHTACG 192
H +AHRD+K +N+L+ ++G ++D GL+ + + + + G
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 193 TPAYTAPEVV-----ARRGYDGAVADAWSCGVILFVLLAGYLPFD--------------- 232
T Y APEV+ + AD ++ G++ + +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234
Query: 233 DSNLLAMYKKVNRRDYQ-------FPSFVSKPARSLIYQLLDPNPKTRMSIEKIM 280
D ++ M K V + + + ++ + N R++ +I
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 139 bits (351), Expect = 5e-38
Identities = 60/339 (17%), Positives = 121/339 (35%), Gaps = 81/339 (23%)
Query: 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ 87
RY L LG G F+ V AK + + + VA+K + + + +AA E+ ++R+
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE-----DEIKLLQRVN 67
Query: 88 ----------NHPNVLKIQEVMAT--KTKIYLVMEYAAGG----ELFGKLRRGRLTESAA 131
++LK+ + +++VM + G L K +
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 132 RRYFQQLVSALHFC-HQNGVAHRDVKPQNLLLDRDG------NLKVSDFGLSALPEQIKN 184
++ +QL+ L + + G+ H D+KP+N+L++ +K++D G + ++
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--- 184
Query: 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYK--- 241
+ T Y +PEV+ + D WS ++F L+ G F+ + K
Sbjct: 185 -HYTNSIQTREYRSPEVLLGAPWGCGA-DIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242
Query: 242 ---------------------------------------------KVNRRDYQFPSFVSK 256
V Y+F +K
Sbjct: 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAK 302
Query: 257 PARSLIYQLLDPNPKTRMSIEKIMSISWFQKSLQQQRKR 295
+ +L +P+ R +++ W + +L + R
Sbjct: 303 EISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIR 341
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 85.6 bits (211), Expect = 5e-20
Identities = 24/161 (14%), Positives = 49/161 (30%), Gaps = 27/161 (16%)
Query: 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVRE---------- 79
+G L+G G + V S +K + + E R +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 80 ----VSAMRRLQNHPNVLKIQEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYF 135
A+++L V K+ ++ME R+
Sbjct: 61 ARNEFRALQKL-QGLAVPKVYAWE----GNAVLMELIDAK------ELYRVRVENPDEVL 109
Query: 136 QQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176
++ + + G+ H D+ N+L+ + + + DF S
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQS 149
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 451 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1ul7a_ | 102 | Map/microtubule affinity-regulating kinase 3 {Mous | 99.28 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.6 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.1 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.08 | |
| d2v8qa1 | 153 | 5'-AMP-activated protein kinase catalytic subunit | 97.7 | |
| d2qrda1 | 127 | Snf1-like protein kinase ssp2 {Schizosaccharomyces | 97.07 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.0 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.67 | |
| d2qlva1 | 171 | Carbon catabolite-derepressing protein kinase SNF1 | 96.52 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.19 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-63 Score=478.44 Aligned_cols=255 Identities=35% Similarity=0.675 Sum_probs=234.3
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
+++|++++.||+|+||+||+|+++.+++.||+|++.+. ...+....+.+.+|+.++++++ |||||++++++.+.+..|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVY 82 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH-HHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchH-HccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEEECCEEE
Confidence 57899999999999999999999999999999999765 2223344567899999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 107 LVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
+|||||+||+|.+++.+ +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..... .
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~---~ 159 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---S 159 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC---C
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC---C
Confidence 99999999999999975 7899999999999999999999999999999999999999999999999999975432 3
Q ss_pred cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhc
Q 013005 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQL 265 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 265 (451)
.....+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+.+....+..+.+..+.+|..+|+++.+||.+|
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 238 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 238 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCcccCHHHHcCCCC-CchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHH
Confidence 3456789999999999988777 567999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCHHHHHcCccccc
Q 013005 266 LDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 266 L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
|.+||++|||++|+++||||+.
T Consensus 239 L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 239 LKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp TCSSGGGSCCHHHHHTCHHHHH
T ss_pred ccCCHhHCcCHHHHHcCcCcCC
Confidence 9999999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-63 Score=478.30 Aligned_cols=259 Identities=32% Similarity=0.608 Sum_probs=223.7
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
..++|++++.||+|+||+||+|+++.+|+.||||++++... ....+.+.+|+.+|++++ |||||++++++.+.+..
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~~~~~ 78 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQ 78 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCC-CTTBCCEEEEEEETTEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---chHHHHHHHHHHHHHhCC-CCCEeeEeeeeccCcee
Confidence 36789999999999999999999999999999999986531 233457899999999995 99999999999999999
Q ss_pred EEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh-
Q 013005 106 YLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK- 183 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~- 183 (451)
|+|||||+||+|++++.+ +.+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|.......
T Consensus 79 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999999999999975 689999999999999999999999999999999999999999999999999998654332
Q ss_pred cCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH-HHHHHhhccCCCCC--CCCCHhHHH
Q 013005 184 NGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL-AMYKKVNRRDYQFP--SFVSKPARS 260 (451)
Q Consensus 184 ~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~-~~~~~i~~~~~~~p--~~~s~~~~~ 260 (451)
.....+.+||+.|+|||++.+..+++.++|||||||++|+|++|+.||...+.. ..+..+.......+ ..+|+++.+
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 238 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 238 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHH
Confidence 244567899999999999998888888899999999999999999999765433 33444433333222 357999999
Q ss_pred HHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 261 LIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 261 li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
||.+||+.||++|||++|+++||||++.
T Consensus 239 li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 239 LLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 9999999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-62 Score=475.16 Aligned_cols=257 Identities=31% Similarity=0.590 Sum_probs=229.5
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
++|++++.||+|+||+||+|++..+|+.||||++++. ...+....+.+.+|+.+|++++ |||||++++++.+.+.+|+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR-HIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH-HHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEECSSEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehH-HccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEEECCEEEE
Confidence 6899999999999999999999999999999999764 2223334567899999999995 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhh-cC
Q 013005 108 VMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIK-NG 185 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~-~~ 185 (451)
|||||+||+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++++|.+||+|||+|....... ..
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 9999999999998874 899999999999999999999999999999999999999999999999999998654332 23
Q ss_pred cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhc
Q 013005 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQL 265 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 265 (451)
...+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+....+.++....+.+|..+++++.+||.+|
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 244 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 244 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTT
T ss_pred ccccccCCccccCceeeccCCC-CcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHH
Confidence 4456789999999999988877 567999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCHHH------HHcCccccc
Q 013005 266 LDPNPKTRMSIEK------IMSISWFQK 287 (451)
Q Consensus 266 L~~dP~~Rpt~~e------il~hp~f~~ 287 (451)
|..||.+|||++| |++||||+.
T Consensus 245 L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 245 LVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp SCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred ccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 9999999999987 688999965
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-61 Score=471.20 Aligned_cols=256 Identities=29% Similarity=0.482 Sum_probs=226.8
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
..++|++.+.||+|+||+||+|++..+|+.||||++..... ...+.+.+|+.+|++++ |||||++++++.+.+.+
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~ 92 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENK-NPNIVNYLDSYLVGDEL 92 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC----hHHHHHHHHHHHHHhCC-CCCEeeEeEEEEECCEE
Confidence 34689999999999999999999999999999999976532 12357899999999995 99999999999999999
Q ss_pred EEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 106 YLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
|+|||||+||+|.+++.++.+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|...... ..
T Consensus 93 ~ivmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-~~ 171 (293)
T d1yhwa1 93 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QS 171 (293)
T ss_dssp EEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST-TC
T ss_pred EEEEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc-cc
Confidence 99999999999999998889999999999999999999999999999999999999999999999999999765332 23
Q ss_pred cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc---CCCCCCCCCHhHHHHH
Q 013005 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR---DYQFPSFVSKPARSLI 262 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li 262 (451)
.....+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+.+.......+... ....|..+|+.+++||
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 250 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 250 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHH
T ss_pred cccccccCCCccChhhhcCCCC-CchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHH
Confidence 4466789999999999988777 56799999999999999999999988776655554433 3345667899999999
Q ss_pred HhccCCCCCCCCCHHHHHcCccccch
Q 013005 263 YQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 263 ~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.+||.+||.+|||++|+++||||+..
T Consensus 251 ~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 251 NRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHccCChhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999999753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-61 Score=476.71 Aligned_cols=259 Identities=34% Similarity=0.603 Sum_probs=237.0
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
-+++|++++.||+|+||+||+|+++.+|+.||||++++. ........+.+.+|+.+|+++. ||||+++++++.+...+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~-~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~ 80 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKE-VIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH-HHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchh-hccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeecccccc
Confidence 468899999999999999999999999999999999865 2223334567889999999995 99999999999999999
Q ss_pred EEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 106 YLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
|+|||||+||+|.+++.+ +.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... .
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~-~ 159 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-G 159 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-T
T ss_pred ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC-C
Confidence 999999999999999975 78999999999999999999999999999999999999999999999999999854332 2
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHh
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQ 264 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 264 (451)
....+.|||+.|+|||++.+.+| +.++|||||||++|+|++|+.||.+.+...++..+....+.+|..+|+++.+||++
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y-~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 238 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred cccccceeCHHHhhhhhccCCCC-ChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHh
Confidence 34567899999999999998888 56799999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCC-----HHHHHcCccccch
Q 013005 265 LLDPNPKTRMS-----IEKIMSISWFQKS 288 (451)
Q Consensus 265 ~L~~dP~~Rpt-----~~eil~hp~f~~~ 288 (451)
||.+||.+|++ ++++++||||+..
T Consensus 239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred hccCCchhhcccccccHHHHHcCcccccC
Confidence 99999999994 9999999999864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-60 Score=467.52 Aligned_cols=258 Identities=34% Similarity=0.696 Sum_probs=213.9
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
...+.++|++.+.||+|+||+||+|+++.+++.||||++.+... ......+.+|+.+|++++ |||||++++++.+.
T Consensus 4 ~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 79 (307)
T d1a06a_ 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL---EGKEGSMENEIAVLHKIK-HPNIVALDDIYESG 79 (307)
T ss_dssp CSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred CCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHh---hhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC
Confidence 34567889999999999999999999999999999999986532 223456889999999995 99999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeC---CCCCeEEEeccCCCc
Q 013005 103 TKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLD---RDGNLKVSDFGLSAL 178 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld---~~~~lkl~DFGls~~ 178 (451)
+.+|+|||||+||+|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++ +++.+||+|||+|..
T Consensus 80 ~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 80 GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred CEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 999999999999999999974 7899999999999999999999999999999999999994 578999999999986
Q ss_pred chhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCC----CCC
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP----SFV 254 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~ 254 (451)
... .....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+....+..+......++ +.+
T Consensus 160 ~~~--~~~~~~~~GT~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (307)
T d1a06a_ 160 EDP--GSVLSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 236 (307)
T ss_dssp ---------------CTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTS
T ss_pred ccC--CCeeeeeeeCccccCcHHHcCCCC-CcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCC
Confidence 533 234557789999999999988877 5679999999999999999999999998888888887766544 468
Q ss_pred CHhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 255 SKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 255 s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
|+++.+||.+||.+||++|||++|+++||||+.
T Consensus 237 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 237 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 999999999999999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.9e-60 Score=465.67 Aligned_cols=256 Identities=32% Similarity=0.661 Sum_probs=233.8
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
+++|++++.||+|+||+||+|+++.+|+.||||++++.. ..+....+.+.+|+.+|++++ |||||++++++.+.+.+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~ 80 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEI-VVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIF 80 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHH-ccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEeeCCeee
Confidence 568999999999999999999999999999999997642 222334567899999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 107 LVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
+|||||.||+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.... .
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~----~ 156 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----D 156 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS----S
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEec----c
Confidence 99999999999998875 679999999999999999999999999999999999999999999999999997543 2
Q ss_pred cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhc
Q 013005 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQL 265 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 265 (451)
...+.+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+....+.++......+|+.+++++.++|.+|
T Consensus 157 ~~~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 235 (316)
T d1fota_ 157 VTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL 235 (316)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 34567999999999999888775 57999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCC-----CHHHHHcCccccchh
Q 013005 266 LDPNPKTRM-----SIEKIMSISWFQKSL 289 (451)
Q Consensus 266 L~~dP~~Rp-----t~~eil~hp~f~~~~ 289 (451)
|..||.+|+ |+++|++||||+...
T Consensus 236 L~~dp~~R~~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 236 ITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred hhhCHHhccccchhhHHHHHcCcccccCC
Confidence 999999996 999999999998753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-60 Score=460.96 Aligned_cols=255 Identities=26% Similarity=0.422 Sum_probs=222.9
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
+.|++++.||+|+||+||+|++..+++.||||++++... ...+.+.+|+.+|++|+ |||||++++++.+.+..|+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~----~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE----EELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS----GGGGGTHHHHHHHHHCC-CTTBCCEEEEEEETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH----HHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCeEEE
Confidence 579999999999999999999999999999999976522 22456889999999995 9999999999999999999
Q ss_pred EEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 108 VMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 108 V~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
|||||+||+|.+++.+ +.+++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|....... .
T Consensus 87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~ 165 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 165 (288)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-H
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-c
Confidence 9999999999998753 579999999999999999999999999999999999999999999999999997543321 2
Q ss_pred cccccCCCCccccceeeec----cCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC---CCCCCCCHhH
Q 013005 186 MLHTACGTPAYTAPEVVAR----RGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY---QFPSFVSKPA 258 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~----~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~ 258 (451)
...+.+||+.|+|||++.. ....+.++|||||||++|+|++|+.||.+.+..+.+.++..... ..|..+|+++
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 245 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHH
Confidence 3456789999999999842 22235779999999999999999999998887777777766543 3455689999
Q ss_pred HHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 259 RSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 259 ~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.+||.+||++||++|||++|+++||||+..
T Consensus 246 ~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 246 KDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.6e-59 Score=468.63 Aligned_cols=259 Identities=28% Similarity=0.562 Sum_probs=232.0
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
...++++|++++.||+|+||+||+|++..+|+.||||++.+.. ....+.+.+|+.+|++|+ |||||++++++.+.
T Consensus 21 ~~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~ 95 (350)
T d1koaa2 21 HDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDD 95 (350)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS----HHHHHHHHHHHHHHHHTC-CTTBCCEEEEEEET
T ss_pred CCCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc----hhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC
Confidence 3467899999999999999999999999999999999997652 234567899999999995 99999999999999
Q ss_pred CEEEEEEEecCCCchhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC--CCCeEEEeccCCCc
Q 013005 103 TKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR--DGNLKVSDFGLSAL 178 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~--~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~--~~~lkl~DFGls~~ 178 (451)
+.+|+|||||+||+|.+++. .+++++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|..
T Consensus 96 ~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 96 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp TEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 99999999999999999985 367999999999999999999999999999999999999964 57899999999975
Q ss_pred chhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCC----CC
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS----FV 254 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~ 254 (451)
... .....+.+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+.+..+.+..+....+.++. .+
T Consensus 176 ~~~--~~~~~~~~gT~~Y~aPEv~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 252 (350)
T d1koaa2 176 LDP--KQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 252 (350)
T ss_dssp CCT--TSCEEEECSCTTTCCHHHHHTCCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGC
T ss_pred ccc--ccccceecCcccccCHHHHcCCCC-ChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCC
Confidence 433 234456789999999999988877 56799999999999999999999999999999888887766553 48
Q ss_pred CHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 255 SKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 255 s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
|+++.+||.+||..||.+|||++|+++||||+...
T Consensus 253 s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 253 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999999999999998653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-60 Score=456.62 Aligned_cols=254 Identities=30% Similarity=0.541 Sum_probs=214.8
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe--CCE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT--KTK 104 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~--~~~ 104 (451)
.++|++.+.||+|+||+||+|+++.||+.||+|+++... .+....+.+.+|+.+|++++ |||||++++++.+ .+.
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS--MTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTT--SCHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC----C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhh--CCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCCCE
Confidence 578999999999999999999999999999999998753 23445677899999999995 9999999999864 456
Q ss_pred EEEEEEecCCCchhHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCCCeEEeCCCCCeEEEecc
Q 013005 105 IYLVMEYAAGGELFGKLRR-----GRLTESAARRYFQQLVSALHFCHQNG-----VAHRDVKPQNLLLDRDGNLKVSDFG 174 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~-----~~l~e~~~~~~~~ql~~gL~yLH~~g-----iiHrDLKpeNILld~~~~lkl~DFG 174 (451)
+|+|||||+||+|.+++.+ +.+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG 159 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 159 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence 8999999999999998852 57999999999999999999999976 9999999999999999999999999
Q ss_pred CCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC-CCCCC
Q 013005 175 LSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY-QFPSF 253 (451)
Q Consensus 175 ls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~ 253 (451)
+|...... .....+.+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+.+..+...++..... .+|..
T Consensus 160 ~a~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 237 (269)
T d2java1 160 LARILNHD-TSFAKAFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 237 (269)
T ss_dssp HHHHC------------CCCSCCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred ceeecccC-CCccccCCCCcccCCHHHHcCCCC-ChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 99765432 233456789999999999988777 5679999999999999999999999998888888877665 46677
Q ss_pred CCHhHHHHHHhccCCCCCCCCCHHHHHcCccc
Q 013005 254 VSKPARSLIYQLLDPNPKTRMSIEKIMSISWF 285 (451)
Q Consensus 254 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f 285 (451)
+|+++.+||.+||..||.+|||++||++|||+
T Consensus 238 ~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 99999999999999999999999999999995
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.8e-59 Score=467.29 Aligned_cols=257 Identities=28% Similarity=0.582 Sum_probs=231.0
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
..+.++|++++.||+|+||+||+|++..+|+.||||++++.. ....+.+.+|+.+|++|. |||||++++++.+++
T Consensus 25 ~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKY 99 (352)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSS
T ss_pred CCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc----hhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence 346789999999999999999999999999999999997653 223467889999999995 999999999999999
Q ss_pred EEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeC--CCCCeEEEeccCCCcc
Q 013005 104 KIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLD--RDGNLKVSDFGLSALP 179 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld--~~~~lkl~DFGls~~~ 179 (451)
.+|+|||||+||+|.+.+.. .++++.+++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||+|...
T Consensus 100 ~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceec
Confidence 99999999999999998764 4699999999999999999999999999999999999998 5789999999999865
Q ss_pred hhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCC----CCCC
Q 013005 180 EQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP----SFVS 255 (451)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 255 (451)
.. .....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+....+..+....+.+| ..+|
T Consensus 180 ~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 256 (352)
T d1koba_ 180 NP--DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS 256 (352)
T ss_dssp CT--TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred CC--CCceeeccCcccccCHHHHcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence 43 344567889999999999988777 5679999999999999999999999999988888888776655 4589
Q ss_pred HhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 256 KPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 256 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+++.+||.+||..||.+|||++|+++||||+..
T Consensus 257 ~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 257 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-59 Score=455.00 Aligned_cols=260 Identities=35% Similarity=0.576 Sum_probs=230.8
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchh--hHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFL--DAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
.+.++|++++.||+|+||+||+|+++.+|+.||||++++..... .....+.+.+|+.+|++|+ |||||++++++.+.
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~ 85 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYENK 85 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC
Confidence 35678999999999999999999999999999999997653211 1123567899999999995 99999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC----CeEEEeccCCC
Q 013005 103 TKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG----NLKVSDFGLSA 177 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~----~lkl~DFGls~ 177 (451)
+.+|+|||||+||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|.
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 999999999999999999975 7899999999999999999999999999999999999998876 59999999997
Q ss_pred cchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCC----CC
Q 013005 178 LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFP----SF 253 (451)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~ 253 (451)
.... .....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+..+.+..+......++ +.
T Consensus 166 ~~~~--~~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (293)
T d1jksa_ 166 KIDF--GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242 (293)
T ss_dssp ECTT--SCBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred hcCC--CccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCC
Confidence 6533 234456789999999999987766 6779999999999999999999999999998888888777665 46
Q ss_pred CCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 254 VSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 254 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
+|+.+.+||++||.+||.+|||++|+++||||+..
T Consensus 243 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 89999999999999999999999999999999853
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-59 Score=448.15 Aligned_cols=253 Identities=25% Similarity=0.464 Sum_probs=218.0
Q ss_pred ccCCe-EEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe---
Q 013005 26 LLNRY-QLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT--- 101 (451)
Q Consensus 26 ~~~~y-~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~--- 101 (451)
..++| ++.+.||+|+||+||+|++..+++.||+|++.... ......+.+.+|+.+|++++ |||||++++++.+
T Consensus 6 ~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~--~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~ 82 (270)
T d1t4ha_ 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--LTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVK 82 (270)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESS
T ss_pred CCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh--CCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccc
Confidence 34566 67889999999999999999999999999997642 23445678999999999996 9999999999865
Q ss_pred -CCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCeEEeC-CCCCeEEEeccCC
Q 013005 102 -KTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNG--VAHRDVKPQNLLLD-RDGNLKVSDFGLS 176 (451)
Q Consensus 102 -~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~g--iiHrDLKpeNILld-~~~~lkl~DFGls 176 (451)
...+|+|||||+||+|.+++.+ +.+++.+++.++.||+.||+|||++| |+||||||+|||++ +++.+||+|||+|
T Consensus 83 ~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 83 GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred cCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 4568999999999999999975 78999999999999999999999998 99999999999996 5789999999999
Q ss_pred CcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCC-cHHHHHHHhhccCC--CCCCC
Q 013005 177 ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS-NLLAMYKKVNRRDY--QFPSF 253 (451)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~-~~~~~~~~i~~~~~--~~p~~ 253 (451)
+.... ....+.+||+.|+|||++.+ .| +.++|||||||++|+|++|+.||... +...++..+..... .++..
T Consensus 163 ~~~~~---~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (270)
T d1t4ha_ 163 TLKRA---SFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 237 (270)
T ss_dssp GGCCT---TSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred eeccC---CccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCcc
Confidence 75332 34457799999999999864 45 67799999999999999999999764 45566666665433 34456
Q ss_pred CCHhHHHHHHhccCCCCCCCCCHHHHHcCcccc
Q 013005 254 VSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQ 286 (451)
Q Consensus 254 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~ 286 (451)
.++++.+||.+||.+||++|||++|+++||||+
T Consensus 238 ~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 238 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 889999999999999999999999999999996
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-58 Score=447.92 Aligned_cols=259 Identities=31% Similarity=0.554 Sum_probs=230.1
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcch-----hhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKF-----LDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
.++|++.+.||+|+||+||+|++..+|+.||||++++.... ......+.+.+|+.++++|..|||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 57999999999999999999999999999999999875321 1234456788999999999779999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 102 KTKIYLVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~-~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
++..|||||||+||+|.+++. ++.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 999999999999999999996 4889999999999999999999999999999999999999999999999999997654
Q ss_pred hhhcCcccccCCCCccccceeeecc-----CCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCC---
Q 013005 181 QIKNGMLHTACGTPAYTAPEVVARR-----GYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS--- 252 (451)
Q Consensus 181 ~~~~~~~~~~~gt~~y~APEvl~~~-----~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~--- 252 (451)
. .......+||+.|+|||++.+. ...+.++||||+||++|+|++|+.||.+.+.......+......++.
T Consensus 162 ~--~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (277)
T d1phka_ 162 P--GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239 (277)
T ss_dssp T--TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG
T ss_pred C--CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 3 2234567899999999998642 23467899999999999999999999999988888888877665443
Q ss_pred -CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 253 -FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 253 -~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
.+|+++.+||.+||++||++|||++|+++||||++
T Consensus 240 ~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 58999999999999999999999999999999975
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-59 Score=466.60 Aligned_cols=256 Identities=33% Similarity=0.636 Sum_probs=234.2
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
+++|++++.||+|+||+||+|+++.+|+.||||++++. ...+....+.+.+|+.+|+.+. |||||++++++.+....|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~-~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ-KVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH-HHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchH-HccCHHHHHHHHHHHHHHHHcC-CCcEeecccccccccccc
Confidence 58999999999999999999999999999999999764 2223334567889999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 107 LVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
+||||+.||+|...+.+ +.+++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|.... .
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~----~ 193 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----G 193 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS----S
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecc----c
Confidence 99999999999999875 789999999999999999999999999999999999999999999999999997543 2
Q ss_pred cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHhc
Q 013005 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQL 265 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 265 (451)
...+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|+.||.+.+....+.++......+|..+++++.+||++|
T Consensus 194 ~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 272 (350)
T d1rdqe_ 194 RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNL 272 (350)
T ss_dssp CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHH
T ss_pred ccccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHH
Confidence 34567899999999999888774 66999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCC-----CHHHHHcCccccchh
Q 013005 266 LDPNPKTRM-----SIEKIMSISWFQKSL 289 (451)
Q Consensus 266 L~~dP~~Rp-----t~~eil~hp~f~~~~ 289 (451)
|..||.+|+ |+++|++||||+...
T Consensus 273 L~~dP~kR~~~~r~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 273 LQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp SCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred hhhCHHhccccccccHHHHHcCccccCCC
Confidence 999999995 999999999998643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-59 Score=457.88 Aligned_cols=254 Identities=24% Similarity=0.364 Sum_probs=223.2
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~l 107 (451)
..|++.+.||+|+||+||+|++..+++.||||++.+.. ..+....+.+.+|+.+|++|+ |||||++++++.+.+..|+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~i 92 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWL 92 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCS-SCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhh-ccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEECCEEEE
Confidence 35999999999999999999999999999999998763 334455677999999999995 9999999999999999999
Q ss_pred EEEecCCCchhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCc
Q 013005 108 VMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGM 186 (451)
Q Consensus 108 V~E~~~gg~L~~~l~-~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~ 186 (451)
|||||.||+|..++. ++++++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.... .
T Consensus 93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~-----~ 167 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----P 167 (309)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS-----S
T ss_pred EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC-----C
Confidence 999999999987665 4789999999999999999999999999999999999999999999999999997543 2
Q ss_pred ccccCCCCccccceeeecc--CCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCC--CCCCCCHhHHHHH
Q 013005 187 LHTACGTPAYTAPEVVARR--GYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQ--FPSFVSKPARSLI 262 (451)
Q Consensus 187 ~~~~~gt~~y~APEvl~~~--~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~li 262 (451)
....+||+.|+|||++.+. +.++.++|||||||++|+|++|..||.+.+......++...... .+..+|+.+.+||
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li 247 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHH
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence 3467899999999998642 23356799999999999999999999988877777666655433 2345899999999
Q ss_pred HhccCCCCCCCCCHHHHHcCccccch
Q 013005 263 YQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 263 ~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.+||..||.+|||++|+++||||.+.
T Consensus 248 ~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 248 DSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 99999999999999999999999753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-60 Score=465.47 Aligned_cols=257 Identities=24% Similarity=0.412 Sum_probs=217.1
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
...++|++.+.||+|+||+||+|++..+|+.||+|++++.. +....+.+.+|+.+|++++ |||||++++++.+.+.
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 78 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGE 78 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC---CTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEECSSE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh---CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCE
Confidence 45789999999999999999999999999999999997652 2344567899999999995 9999999999999999
Q ss_pred EEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCeEEeCCCCCeEEEeccCCCcchhh
Q 013005 105 IYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQ-NGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQI 182 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~-~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~ 182 (451)
+|+||||++||+|.+++.+ +.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|.....
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 157 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 157 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence 9999999999999999974 789999999999999999999997 4999999999999999999999999999985433
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHH---------------------
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYK--------------------- 241 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~--------------------- 241 (451)
....+.+||+.|+|||++.+..| +.++||||+||++|+|++|+.||.+.+......
T Consensus 158 --~~~~~~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 158 --SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp --HTC---CCSSCCCCHHHHHCSCC-CTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred --CccccccCCccccCchHHcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 23456799999999999998877 466999999999999999999997654221100
Q ss_pred ---------------------Hhhcc-CCCCCC-CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 242 ---------------------KVNRR-DYQFPS-FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 242 ---------------------~i~~~-~~~~p~-~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
.+... ....|. .+|.++.+||.+||..||.+|||++|+++||||++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 00000 111221 3588999999999999999999999999999998643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-59 Score=460.03 Aligned_cols=258 Identities=29% Similarity=0.547 Sum_probs=230.5
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHH-HhcCCCCceEEEEEEEeCCEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMR-RLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~-~L~~HpnIv~l~~~~~~~~~~ 105 (451)
+++|++++.||+|+||+||+|+++.+|+.||||++++.. .......+.+.+|+.++. .+ +|||||++++++.+++..
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~-~~~~~~~~~~~~e~~~l~~~~-~hp~Iv~~~~~~~~~~~~ 78 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDV-VLMDDDVECTMVEKRVLSLAW-EHPFLTHMFCTFQTKENL 78 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHH-HHHTTCHHHHHHHHHHHHHHT-TCTTBCCEEEEEECSSEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhh-ccChHHHHHHHHHHHHHHHhC-CCCcEEEEEEEEccCCce
Confidence 478999999999999999999999999999999997652 222223445666777665 46 599999999999999999
Q ss_pred EEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 106 YLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
|+|||||+||+|.+++.. +++++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||++...... .
T Consensus 79 yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-~ 157 (320)
T d1xjda_ 79 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-D 157 (320)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-T
T ss_pred eEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc-c
Confidence 999999999999999975 78999999999999999999999999999999999999999999999999999754332 2
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHHHHHHh
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPARSLIYQ 264 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 264 (451)
......+||+.|+|||++.+.+|+ .++|||||||++|+|++|+.||.+.+...++.++....+.+|..+|+++.+||++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 236 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK 236 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 344567899999999999988875 6799999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCHH-HHHcCccccch
Q 013005 265 LLDPNPKTRMSIE-KIMSISWFQKS 288 (451)
Q Consensus 265 ~L~~dP~~Rpt~~-eil~hp~f~~~ 288 (451)
||..||.+|||+. ++++||||+.-
T Consensus 237 ~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 237 LFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp HSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred hcccCCCCCcCHHHHHHhCchhccC
Confidence 9999999999995 89999999863
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-58 Score=456.29 Aligned_cols=255 Identities=24% Similarity=0.472 Sum_probs=229.9
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
.+.++|++++.||+|+||+||+|+++.+++.||||++++.. .....+.+|+.+|++++ |||||++++++.+.+.
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~ 75 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIAR-HRNILHLHESFESMEE 75 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-----ccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCE
Confidence 57899999999999999999999999999999999997652 22356889999999996 9999999999999999
Q ss_pred EEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCC--CCeEEEeccCCCcch
Q 013005 105 IYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD--GNLKVSDFGLSALPE 180 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~--~~lkl~DFGls~~~~ 180 (451)
+|+|||||+||+|.+++.. +++++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 76 ~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 9999999999999999974 379999999999999999999999999999999999999854 489999999997543
Q ss_pred hhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCC----CCCH
Q 013005 181 QIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS----FVSK 256 (451)
Q Consensus 181 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 256 (451)
. .....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||...+....+..+....+.++. .+|+
T Consensus 156 ~--~~~~~~~~~t~~y~ape~~~~~~~-~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T d1tkia_ 156 P--GDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp T--TCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred c--CCcccccccccccccchhccCCCC-CchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCH
Confidence 2 234566789999999999887766 56799999999999999999999999999999999888877764 6899
Q ss_pred hHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 257 PARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
++.+||.+||..||.+|||++|+++||||++.
T Consensus 233 ~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 99999999999999999999999999999764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.7e-58 Score=461.23 Aligned_cols=259 Identities=26% Similarity=0.432 Sum_probs=222.1
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHH---HHHHHHhcCCCCceEEEEEEEeC
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVRE---VSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~E---i~il~~L~~HpnIv~l~~~~~~~ 102 (451)
-+++|++.+.||+|+||+||+|++..||+.||||++++.. .........+.+| +.+++.+ +|||||++++++.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~~ 79 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR-IKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTP 79 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-HHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECS
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHH-cchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEEC
Confidence 3678999999999999999999999999999999997642 1122222334444 5555555 499999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 103 TKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
+.+|+|||||+||+|.+++.+ +.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 999999999999999999974 7899999999999999999999999999999999999999999999999999975432
Q ss_pred hhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCc---HHHHHHHhhccCCCCCCCCCHhH
Q 013005 182 IKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSN---LLAMYKKVNRRDYQFPSFVSKPA 258 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~ 258 (451)
......+||+.|+|||++.+...++.++|||||||+||+|++|+.||...+ .......+......+|..+|+++
T Consensus 160 ---~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 236 (364)
T d1omwa3 160 ---KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236 (364)
T ss_dssp ---SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHH
T ss_pred ---CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHH
Confidence 344567899999999999765555677999999999999999999997643 34455566666778888899999
Q ss_pred HHHHHhccCCCCCCCCC-----HHHHHcCccccchh
Q 013005 259 RSLIYQLLDPNPKTRMS-----IEKIMSISWFQKSL 289 (451)
Q Consensus 259 ~~li~~~L~~dP~~Rpt-----~~eil~hp~f~~~~ 289 (451)
.+||.+||..||.+||| ++++++||||+...
T Consensus 237 ~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp HHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred HHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence 99999999999999999 79999999998643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-58 Score=444.63 Aligned_cols=255 Identities=33% Similarity=0.575 Sum_probs=221.6
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchh--hHHHHHHHHHHHHHHHHhc-CCCCceEEEEEEEeC
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFL--DAAMEDRIVREVSAMRRLQ-NHPNVLKIQEVMATK 102 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~~Ei~il~~L~-~HpnIv~l~~~~~~~ 102 (451)
+.++|++++.||+|+||+||+|++..+|+.||||++++..... ......++.+|+.+|+++. .|||||++++++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 4578999999999999999999999999999999997642110 0111234668999999995 389999999999999
Q ss_pred CEEEEEEEecCC-CchhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCC-CCeEEEeccCCCcc
Q 013005 103 TKIYLVMEYAAG-GELFGKLR-RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD-GNLKVSDFGLSALP 179 (451)
Q Consensus 103 ~~~~lV~E~~~g-g~L~~~l~-~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~-~~lkl~DFGls~~~ 179 (451)
+..|+||||+.+ +++.+++. .+.+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|...
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 999999999986 57788776 4789999999999999999999999999999999999999854 78999999999754
Q ss_pred hhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCCCCCHhHH
Q 013005 180 EQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPSFVSKPAR 259 (451)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 259 (451)
.. ....+.+||+.|+|||++.+..+++.++|||||||++|+|++|+.||...+ .+......++..+|+++.
T Consensus 162 ~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~s~~~~ 232 (273)
T d1xwsa_ 162 KD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQ 232 (273)
T ss_dssp CS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHHH
T ss_pred cc---ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCCCCHHHH
Confidence 32 344567899999999999888888888999999999999999999997643 345667788899999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 260 SLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 260 ~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
+||.+||..||++|||++|+++||||++..
T Consensus 233 ~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 233 HLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 999999999999999999999999998753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-57 Score=450.35 Aligned_cols=253 Identities=33% Similarity=0.602 Sum_probs=216.1
Q ss_pred ccccCCeEEcc-eEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe-
Q 013005 24 PTLLNRYQLGP-LLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT- 101 (451)
Q Consensus 24 ~~~~~~y~~~~-~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~- 101 (451)
..+.++|++.. .||+|+||+||+|++..+++.||||+++.. ..+.+|+.++.++.+|||||++++++.+
T Consensus 7 ~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~ 77 (335)
T d2ozaa1 7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENL 77 (335)
T ss_dssp SCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 45678999875 699999999999999999999999999754 3467899988777679999999999976
Q ss_pred ---CCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC---CCCeEEEe
Q 013005 102 ---KTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR---DGNLKVSD 172 (451)
Q Consensus 102 ---~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~---~~~lkl~D 172 (451)
...+|+|||||+||+|++++.+ .++++.+++.++.||+.||+|||++||+||||||+|||++. .+.+||+|
T Consensus 78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence 4679999999999999999975 36999999999999999999999999999999999999985 46799999
Q ss_pred ccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH----HHHHHhhccCC
Q 013005 173 FGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL----AMYKKVNRRDY 248 (451)
Q Consensus 173 FGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~----~~~~~i~~~~~ 248 (451)
||+|+.... .....+.+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+.+.. .+...+....+
T Consensus 158 FG~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~y-~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~ 234 (335)
T d2ozaa1 158 FGFAKETTS--HNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234 (335)
T ss_dssp CTTCEECCC--CCCCCCCSCCCSSCCCCCCCGGGG-SHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS
T ss_pred cceeeeccC--CCccccccCCcccCCcHHHcCCCC-CHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC
Confidence 999975433 234567789999999999988877 46799999999999999999999765432 34445555566
Q ss_pred CCCC----CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 249 QFPS----FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 249 ~~p~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
.+|. .+|+++.+||++||..||++|||++|+++||||++.
T Consensus 235 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 6664 379999999999999999999999999999999754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-57 Score=441.89 Aligned_cols=254 Identities=28% Similarity=0.390 Sum_probs=213.5
Q ss_pred EcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchh-hHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEE
Q 013005 32 LGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFL-DAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVME 110 (451)
Q Consensus 32 ~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E 110 (451)
.++.||+|+||+||+|++..+|+.||||+++...... .....+.+.+|+.+|++++ |||||++++++.+++.+|+|||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCCEEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeeccCCceeehhh
Confidence 4678999999999999999999999999997653221 1223457889999999995 9999999999999999999999
Q ss_pred ecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcCcccc
Q 013005 111 YAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNGMLHT 189 (451)
Q Consensus 111 ~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~~~~~ 189 (451)
|+.|+++..+... +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...... .....+
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~-~~~~~~ 159 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-NRAYTH 159 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-CCCCCC
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC-cccccc
Confidence 9999888877764 67999999999999999999999999999999999999999999999999999754332 234456
Q ss_pred cCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCC--------------------C
Q 013005 190 ACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDY--------------------Q 249 (451)
Q Consensus 190 ~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~--------------------~ 249 (451)
.+||+.|+|||++....+++.++||||+||++|+|++|..||.+.+..+...++..... .
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence 78999999999998776668889999999999999999999999887776666542100 0
Q ss_pred C--------CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 250 F--------PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 250 ~--------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
. .+.+++++.+||.+||..||++|||++|+|+||||+.
T Consensus 240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 0 1246789999999999999999999999999999975
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-57 Score=439.01 Aligned_cols=258 Identities=29% Similarity=0.482 Sum_probs=216.7
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
+++|++++.||+|+||+||+|++..+|+.||||++.... ......+++.+|+.+|+++. |||||++++++.+.+.+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~~~~~~ 77 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLY 77 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh--cChHHHHHHHHHHHHHHhCC-CCcEEEecccccccccee
Confidence 479999999999999999999999999999999997542 22334567889999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 107 LVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~--~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
+||||+.++.+..... .+.+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|..... ..
T Consensus 78 iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~-~~ 156 (298)
T d1gz8a_ 78 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PV 156 (298)
T ss_dssp EEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC-CS
T ss_pred EEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC-Cc
Confidence 9999998765544433 36799999999999999999999999999999999999999999999999999865432 12
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc------------------
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR------------------ 246 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~------------------ 246 (451)
......+||+.|+|||++....+.+.++||||+||++|+|++|+.||.+.+......++...
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 34456689999999999988888888999999999999999999999988766555443221
Q ss_pred CCCCC-----------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 247 DYQFP-----------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 247 ~~~~p-----------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
...++ +.+++++.+||++||.+||++|||++|+++||||+.-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 00111 2357889999999999999999999999999999754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.5e-56 Score=430.99 Aligned_cols=260 Identities=23% Similarity=0.361 Sum_probs=223.7
Q ss_pred CCCCCCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceE
Q 013005 15 PPPPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLK 94 (451)
Q Consensus 15 ~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~ 94 (451)
|+.|...++....++|++.+.||+|+||+||+|++..+++.||||+++.+.. ..+++.+|+.+|++|+ |||||+
T Consensus 4 p~~p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~E~~il~~l~-HpnIv~ 77 (287)
T d1opja_ 4 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIK-HPNLVQ 77 (287)
T ss_dssp TTSTTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-----CHHHHHHHHHHHHHCC-CTTBCC
T ss_pred CCCCCCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-----hHHHHHHHHHHHHhCC-CCCEec
Confidence 3344556677778899999999999999999999999999999999976532 2356889999999995 999999
Q ss_pred EEEEEEeCCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEE
Q 013005 95 IQEVMATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVS 171 (451)
Q Consensus 95 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~ 171 (451)
+++++.+.+..|+|||||++|+|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||||.++++||+
T Consensus 78 ~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~ 157 (287)
T d1opja_ 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 157 (287)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred CCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEc
Confidence 99999999999999999999999999864 578999999999999999999999999999999999999999999999
Q ss_pred eccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCC-CCCCcHHHHHHHhhcc-CCC
Q 013005 172 DFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLP-FDDSNLLAMYKKVNRR-DYQ 249 (451)
Q Consensus 172 DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~P-f~~~~~~~~~~~i~~~-~~~ 249 (451)
|||+|+..............||+.|+|||++.+..| +.++||||+||++|+|++|..| |...+....+..+... ...
T Consensus 158 DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~ 236 (287)
T d1opja_ 158 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 236 (287)
T ss_dssp CCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred cccceeecCCCCceeeccccccccccChHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCC
Confidence 999998654433333334568999999999988777 5779999999999999996555 5566666666666543 456
Q ss_pred CCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 250 FPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 250 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
+|..+++.+.+||.+||..||++|||+++|++
T Consensus 237 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 77789999999999999999999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.2e-55 Score=428.40 Aligned_cols=256 Identities=27% Similarity=0.440 Sum_probs=216.7
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
+++|++.+.||+|+||+||+|++. +|+.||||+++.... +....+++.+|+.+|++++ |||||++++++.+.+..|
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~ 76 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE--DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLV 76 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCC-CCcEEeeeeecccCCcee
Confidence 479999999999999999999984 889999999976532 2334567899999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 107 LVMEYAAGGELFGKLR-RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~-~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
++|||+.++.+..+.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...... ..
T Consensus 77 i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~-~~ 155 (286)
T d1ob3a_ 77 LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP-VR 155 (286)
T ss_dssp EEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC-cc
Confidence 9999999888887776 478999999999999999999999999999999999999999999999999998754321 12
Q ss_pred cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC------------------
Q 013005 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD------------------ 247 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~------------------ 247 (451)
.....+||+.|+|||++.+..+.+.++||||+||++|+|++|+.||.+.+..+...++....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 33455799999999999888887889999999999999999999999887766555442200
Q ss_pred -----------CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 248 -----------YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 248 -----------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
..++..+++.+.+||++||.+||++|||++|+++||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0123446889999999999999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-55 Score=430.16 Aligned_cols=257 Identities=28% Similarity=0.448 Sum_probs=213.9
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCC-CcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhc--CCCCceEEEEEEEe-
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIAD-GSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ--NHPNVLKIQEVMAT- 101 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~-~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~--~HpnIv~l~~~~~~- 101 (451)
..++|++++.||+|+||+||+|++..+ ++.||||++..... .......+.+|+.+|+.|. +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG--EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC--TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhc--cchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 357999999999999999999999766 66799999975421 1112234567888888774 59999999999853
Q ss_pred ----CCEEEEEEEecCCCchhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccC
Q 013005 102 ----KTKIYLVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGL 175 (451)
Q Consensus 102 ----~~~~~lV~E~~~gg~L~~~l~--~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGl 175 (451)
....|++|||+.++.+..... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhh
Confidence 357899999999987765543 36799999999999999999999999999999999999999999999999999
Q ss_pred CCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc---------
Q 013005 176 SALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR--------- 246 (451)
Q Consensus 176 s~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~--------- 246 (451)
+..... .......+||+.|+|||++.+..| +.++||||+||++|+|++|+.||.+.+......++...
T Consensus 163 ~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 163 ARIYSF--QMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCCCCG--GGGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhcc--cccCCCcccChhhcCcchhcCCCC-ChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 876543 234567889999999999988877 56799999999999999999999998877666655321
Q ss_pred ------------------CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 247 ------------------DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 247 ------------------~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
...++..+++.+.+||.+||.+||++|||++|+++||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 00123457889999999999999999999999999999975
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.7e-55 Score=424.20 Aligned_cols=258 Identities=28% Similarity=0.443 Sum_probs=214.1
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC-
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT- 103 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~- 103 (451)
.+.++|++.+.||+|+||+||+|++..+|+.||||++.+. ...+....+.+.+|+.+++.++ |||||++++++...+
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD-LARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETP 81 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECST-TTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEECS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchh-hccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeeccC
Confidence 4678899999999999999999999999999999999875 3344566678999999999995 999999999997654
Q ss_pred ---EEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcc
Q 013005 104 ---KIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALP 179 (451)
Q Consensus 104 ---~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~ 179 (451)
.+|+|||||+||+|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++..+|+|||++...
T Consensus 82 ~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 82 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence 48999999999999998864 78999999999999999999999999999999999999999999999999998644
Q ss_pred hhhhc--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCC----CCC
Q 013005 180 EQIKN--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQF----PSF 253 (451)
Q Consensus 180 ~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~----p~~ 253 (451)
..... ....+.+||+.|+|||++.+..| +.++||||+||++|+|++|..||.+.+..+...++....... ++.
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240 (277)
T ss_dssp C----------------TTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSS
T ss_pred ccccccccccccccCcccccCHHHHcCCCC-CcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccC
Confidence 32222 34456789999999999987776 567999999999999999999999988887776666554433 346
Q ss_pred CCHhHHHHHHhccCCCCCCCC-CHHHHHcCcccc
Q 013005 254 VSKPARSLIYQLLDPNPKTRM-SIEKIMSISWFQ 286 (451)
Q Consensus 254 ~s~~~~~li~~~L~~dP~~Rp-t~~eil~hp~f~ 286 (451)
+|+.+.+||.+||.+||.+|| |++++ .|+|.+
T Consensus 241 ~s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~r 273 (277)
T d1o6ya_ 241 LSADLDAVVLKALAKNPENRYQTAAEM-RADLVR 273 (277)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCHhHHHHH-HHHHHH
Confidence 899999999999999999999 56655 466654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-55 Score=434.30 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=215.6
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC--
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT-- 103 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~-- 103 (451)
+-++|++++.||+|+||+||+|++..+|+.||||++.+.. .+....+.+.+|+.+|++++ |||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETL 92 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSST
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh--cChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccCccc
Confidence 5789999999999999999999999999999999997642 34456678999999999995 999999999997654
Q ss_pred ----EEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcc
Q 013005 104 ----KIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALP 179 (451)
Q Consensus 104 ----~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~ 179 (451)
.+|+||||+ |.+|...++.+++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...
T Consensus 93 ~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 93 DDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cccceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence 579999999 668888888899999999999999999999999999999999999999999999999999999754
Q ss_pred hhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccC------------
Q 013005 180 EQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRD------------ 247 (451)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~------------ 247 (451)
. ......+||+.|+|||++.+..+.+.++||||+||++|+|++|+.||.+.+.......+....
T Consensus 172 ~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 172 D----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp C----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred C----CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 3 334567899999999999887777888999999999999999999999877655443332110
Q ss_pred -------------------CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 248 -------------------YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 248 -------------------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
......+++.+.+||++||..||++|||++|+|+||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 01234578999999999999999999999999999999863
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-55 Score=432.59 Aligned_cols=257 Identities=23% Similarity=0.374 Sum_probs=216.4
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEcCCCc-----EEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEE
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGS-----IVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQ 96 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~ 96 (451)
++....++|++++.||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.+|.++.+|||||+++
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~l~ 107 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLL 107 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc---CHHHHHHHHHHHHHHHHhcCCCcEeEEE
Confidence 344556899999999999999999999876554 69999986542 2334567889999999996699999999
Q ss_pred EEEEeCCEEEEEEEecCCCchhHHhhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 013005 97 EVMATKTKIYLVMEYAAGGELFGKLRRG------------------------RLTESAARRYFQQLVSALHFCHQNGVAH 152 (451)
Q Consensus 97 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~------------------------~l~e~~~~~~~~ql~~gL~yLH~~giiH 152 (451)
+++.+.+..|+|||||+||+|.++++.. .+++.+++.++.|++.||+|||++||+|
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiH 187 (325)
T d1rjba_ 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 187 (325)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 9999999999999999999999999642 3899999999999999999999999999
Q ss_pred cCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC-cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCC
Q 013005 153 RDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG-MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLP 230 (451)
Q Consensus 153 rDLKpeNILld~~~~lkl~DFGls~~~~~~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~P 230 (451)
|||||+|||++.++++||+|||+|+........ ...+.+||+.|+|||++.+..| +.++|||||||++|+|++ |..|
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCS
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC-CcceeccchhHHHHHHHhCCCCC
Confidence 999999999999999999999999865543332 2345678999999999987776 567999999999999997 8999
Q ss_pred CCCCcHHHHHHHhhcc--CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 231 FDDSNLLAMYKKVNRR--DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 231 f~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
|.+.+......++... ..+.|..+|+.+.+||.+||+.||++|||++||++|
T Consensus 267 f~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 267 YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp STTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9876555444444433 345677899999999999999999999999999976
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-54 Score=430.00 Aligned_cols=260 Identities=25% Similarity=0.418 Sum_probs=215.8
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC--
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT-- 103 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~-- 103 (451)
+.++|++++.||+|+||+||+|++..+|+.||||++++.+ .....+++.+|+.+|++|+ ||||+++++++....
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~~~~ 81 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIE 81 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT---CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTT
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc---ChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeecccc
Confidence 4578999999999999999999999999999999997653 3445667899999999995 999999999997653
Q ss_pred --EEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 104 --KIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 104 --~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
..+++++|+.||+|.+++..+++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 82 ~~~~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 82 QMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp TCCCEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred ccceEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 234445567799999999988999999999999999999999999999999999999999999999999999975433
Q ss_pred hhc--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc-------------
Q 013005 182 IKN--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR------------- 246 (451)
Q Consensus 182 ~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~------------- 246 (451)
... ......+||+.|+|||++....+++.++||||+||++|+|++|..||...+...........
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 222 34567889999999999977777788899999999999999999999887655443332110
Q ss_pred -----------CC-------CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 247 -----------DY-------QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 247 -----------~~-------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
.. ...+.+++.+.+||.+||..||.+|||++|+++||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 00 01234688999999999999999999999999999998653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=419.17 Aligned_cols=259 Identities=22% Similarity=0.355 Sum_probs=221.4
Q ss_pred CCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE
Q 013005 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 20 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~ 99 (451)
...+....++|++++.||+|+||+||+|++. ++..||||+++.... ..+.+.+|+.+|++++ |||||++++++
T Consensus 5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~-----~~~~~~~E~~~l~~l~-HpnIv~~~g~~ 77 (272)
T d1qpca_ 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-----SPDAFLAEANLMKQLQ-HQRLVRLYAVV 77 (272)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-----CHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred CCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC-----CHHHHHHHHHHHHhCC-CCCEeEEEeee
Confidence 4556666789999999999999999999974 678899999976532 1356899999999995 99999999987
Q ss_pred EeCCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCC
Q 013005 100 ATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLS 176 (451)
Q Consensus 100 ~~~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls 176 (451)
.+ +..|+||||+++|+|.+++.. .++++.++..++.||+.||.|||++||+||||||+||||++++.+||+|||+|
T Consensus 78 ~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla 156 (272)
T d1qpca_ 78 TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156 (272)
T ss_dssp CS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred cc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccce
Confidence 54 567999999999999997753 46999999999999999999999999999999999999999999999999999
Q ss_pred CcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhc-CCCCCCCcHHHHHHHhhcc-CCCCCCCC
Q 013005 177 ALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAG-YLPFDDSNLLAMYKKVNRR-DYQFPSFV 254 (451)
Q Consensus 177 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G-~~Pf~~~~~~~~~~~i~~~-~~~~p~~~ 254 (451)
+..............||+.|+|||++.+..| +.++|||||||++|+|+|| .+||...+.......+... ....|..+
T Consensus 157 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~ 235 (272)
T d1qpca_ 157 RLIEDNEYTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 235 (272)
T ss_dssp EECSSSCEECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred EEccCCccccccccCCcccccChHHHhCCCC-CchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccC
Confidence 8655433334456689999999999987666 5779999999999999995 5666777777777777654 45567789
Q ss_pred CHhHHHHHHhccCCCCCCCCCHHHHHc--Cccccc
Q 013005 255 SKPARSLIYQLLDPNPKTRMSIEKIMS--ISWFQK 287 (451)
Q Consensus 255 s~~~~~li~~~L~~dP~~Rpt~~eil~--hp~f~~ 287 (451)
++++.+||.+||..||++|||+++|++ |+||..
T Consensus 236 ~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 999999999999999999999999998 788853
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-55 Score=430.40 Aligned_cols=262 Identities=30% Similarity=0.522 Sum_probs=226.2
Q ss_pred ccCCeEEcceEcccCceEEEEEEEc---CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSI---ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
-+++|++++.||+|+||+||+|++. .+|+.||||++++.....+....+.+.+|+.+|+++++||||+++++++.+.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 3588999999999999999999874 4789999999976532222233456889999999998569999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 103 TKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
...|++|||+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 999999999999999999975 7899999999999999999999999999999999999999999999999999976555
Q ss_pred hhcCcccccCCCCccccceeeeccC-CCCccchhhhhhHHHHHHHhcCCCCCCCc----HHHHHHHhhccCCCCCCCCCH
Q 013005 182 IKNGMLHTACGTPAYTAPEVVARRG-YDGAVADAWSCGVILFVLLAGYLPFDDSN----LLAMYKKVNRRDYQFPSFVSK 256 (451)
Q Consensus 182 ~~~~~~~~~~gt~~y~APEvl~~~~-~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~ 256 (451)
.......+.+||+.|+|||.+.... +.+.++|||||||+||+|++|..||...+ ..............+|..+|+
T Consensus 182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 261 (322)
T d1vzoa_ 182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 261 (322)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCH
Confidence 4455566788999999999987654 45677999999999999999999997643 334445555666778888999
Q ss_pred hHHHHHHhccCCCCCCCC-----CHHHHHcCccccc
Q 013005 257 PARSLIYQLLDPNPKTRM-----SIEKIMSISWFQK 287 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~Rp-----t~~eil~hp~f~~ 287 (451)
++.+||.+||.+||.+|| |++|+++||||+.
T Consensus 262 ~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 262 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 999999999999999999 5899999999976
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=426.77 Aligned_cols=259 Identities=25% Similarity=0.369 Sum_probs=213.6
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe-----
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT----- 101 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~----- 101 (451)
+++|++++.||+|+||+||+|++..+|+.||||++.+... ......++.+|+.+|++++ ||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLK-HENVVNLIEICRTKASPY 85 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C--TTSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC-----
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHHhc-CCCccceEeeeecccccc
Confidence 6999999999999999999999999999999999876532 2233456789999999995 9999999999854
Q ss_pred ---CCEEEEEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 102 ---KTKIYLVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 102 ---~~~~~lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
....|+||||+.++.+...... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 4468999999988777655543 689999999999999999999999999999999999999999999999999996
Q ss_pred cchhh---hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCCCCC--
Q 013005 178 LPEQI---KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQFPS-- 252 (451)
Q Consensus 178 ~~~~~---~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~-- 252 (451)
..... ......+.+||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+.......+......+++
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 54322 2234456789999999999987766678899999999999999999999988776665554332111110
Q ss_pred ------------------------------CCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 253 ------------------------------FVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 253 ------------------------------~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
..++.+.+||.+||.+||++|||++|+++||||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 026678899999999999999999999999999853
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=416.83 Aligned_cols=248 Identities=22% Similarity=0.388 Sum_probs=206.7
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
.++|++++.||+|+||+||+|++. +++.||||+++.... ..+.+.+|+.++++++ |||||++++++...+..|
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~ 76 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPIC 76 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS-----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC-----cHHHHHHHHHHHHhcC-CCCcccccceeccCCceE
Confidence 358999999999999999999974 678899999976532 1356889999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 107 LVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
+||||+++|+|.+++.. ..+++..++.++.|++.||+|||+++|+||||||+|||+|.++++||+|||+|+.......
T Consensus 77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 99999999999998864 5689999999999999999999999999999999999999999999999999986654443
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhHHHHH
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPARSLI 262 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li 262 (451)
......+||+.|+|||++.+..| +.++||||+||++|+|+| |.+||...+.......+..+ ....|...++++.+||
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 235 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM 235 (263)
T ss_dssp --------CTTSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred eeecceecCcccCChHHhcCCCC-CchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHH
Confidence 44455789999999999988777 567999999999999999 57778777877777777665 3455677899999999
Q ss_pred HhccCCCCCCCCCHHHHHcC
Q 013005 263 YQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 263 ~~~L~~dP~~Rpt~~eil~h 282 (451)
.+||..||++|||+++|++|
T Consensus 236 ~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 236 NHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=420.04 Aligned_cols=254 Identities=22% Similarity=0.362 Sum_probs=206.9
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
.+....++|++++.||+|+||+||+|+. +..||||+++.... +....+.+.+|+.+|++++ |||||++++++.
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~- 74 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTR-HVNILLFMGYST- 74 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSC--CTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEC-
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCC-CCCEeeeeEEEe-
Confidence 3455678999999999999999999974 34699999976522 2344578999999999995 999999999865
Q ss_pred CCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcc
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALP 179 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~ 179 (451)
.+.+|+|||||+||+|.+++.. +++++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|...
T Consensus 75 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 75 APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeec
Confidence 4568999999999999999963 67999999999999999999999999999999999999999999999999999865
Q ss_pred hhhhc-CcccccCCCCccccceeeeccC--CCCccchhhhhhHHHHHHHhcCCCCCCCcHH-HHHHHhhccCC-----CC
Q 013005 180 EQIKN-GMLHTACGTPAYTAPEVVARRG--YDGAVADAWSCGVILFVLLAGYLPFDDSNLL-AMYKKVNRRDY-----QF 250 (451)
Q Consensus 180 ~~~~~-~~~~~~~gt~~y~APEvl~~~~--~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~-~~~~~i~~~~~-----~~ 250 (451)
..... ....+.+||+.|+|||++.... ..+.++|||||||++|+|++|+.||.+.+.. .....+..... ..
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 234 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGS
T ss_pred cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhc
Confidence 44322 3445678999999999986432 2367799999999999999999999875544 34444433321 23
Q ss_pred CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 251 PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 251 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
+..+++.+.+||.+||..||.+|||+++|+++
T Consensus 235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 55689999999999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-54 Score=417.76 Aligned_cols=255 Identities=22% Similarity=0.343 Sum_probs=217.5
Q ss_pred ccCCeEEcce-EcccCceEEEEEEEcC--CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 26 LLNRYQLGPL-LGRGSFAKVHKAKSIA--DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 26 ~~~~y~~~~~-LG~G~~g~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
.-++|.+.+. ||+|+||+||+|.+.. ++..||||+++... .....+.+.+|+.+|++++ |||||++++++.+
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~- 80 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA- 80 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEES-
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc---CHHHHHHHHHHHHHHHhCC-CCCEeeEeeeecc-
Confidence 3467888885 9999999999998754 45589999997542 3445678999999999995 9999999999865
Q ss_pred CEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 103 TKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
+.+|+|||||+||+|.+++.. +.+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 468999999999999998753 679999999999999999999999999999999999999999999999999998654
Q ss_pred hhhc--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCH
Q 013005 181 QIKN--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSK 256 (451)
Q Consensus 181 ~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 256 (451)
.... ......+||+.|+|||++.+..+ +.++|||||||++|||+| |..||.+.+..+....+..+ ...+|+.+|+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~ 239 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP 239 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCH
T ss_pred ccccccccccccccCccccChHHHhCCCC-CccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCH
Confidence 3222 33345679999999999987766 567999999999999998 99999988777777777664 3567888999
Q ss_pred hHHHHHHhccCCCCCCCCCHHHH---HcCcccc
Q 013005 257 PARSLIYQLLDPNPKTRMSIEKI---MSISWFQ 286 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~Rpt~~ei---l~hp~f~ 286 (451)
++.+||.+||..||++|||+.+| |+|+|+.
T Consensus 240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999888 5667663
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-54 Score=411.82 Aligned_cols=248 Identities=23% Similarity=0.382 Sum_probs=220.8
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
.++|++++.||+|+||+||+|++ .+++.||||++++.... .+.+.+|+.++++++ ||||+++++++.++..+|
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-----~~~~~~Ev~~~~~l~-HpnIv~~~g~~~~~~~~~ 75 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMS-----EDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIF 75 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSC-----HHHHHHHHHHHHTCC-CTTBCCEEEEECCSSSEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCC-----HHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceE
Confidence 36899999999999999999997 57889999999875321 246889999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 107 LVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~--~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
+||||+.+|+|..++. ...+++..+++++.|+++||+|||++||+||||||+|||++.++.+||+|||+|........
T Consensus 76 iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp EEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred EEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 9999999999999875 36799999999999999999999999999999999999999999999999999986554444
Q ss_pred CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhHHHHH
Q 013005 185 GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPARSLI 262 (451)
Q Consensus 185 ~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li 262 (451)
......+||+.|+|||++.+..| +.++|||||||++|+|+| |+.||...+..+...++... ....|...++.+.+||
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~-~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 234 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM 234 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred eeecccCCCCCcCCcHHhcCCCC-CcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHH
Confidence 44455789999999999988777 467999999999999998 89999999988888888765 3456777899999999
Q ss_pred HhccCCCCCCCCCHHHHHcC
Q 013005 263 YQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 263 ~~~L~~dP~~Rpt~~eil~h 282 (451)
.+||+.||++|||+++|++|
T Consensus 235 ~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 235 YSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHTTCSSGGGSCCHHHHHHH
T ss_pred HHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999987
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=418.58 Aligned_cols=248 Identities=21% Similarity=0.336 Sum_probs=208.7
Q ss_pred ceEcccCceEEEEEEEc--CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEEEEEEe
Q 013005 34 PLLGRGSFAKVHKAKSI--ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIYLVMEY 111 (451)
Q Consensus 34 ~~LG~G~~g~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~lV~E~ 111 (451)
+.||+|+||+||+|.+. .+++.||||++.... .+....+.+.+|+.+|++|+ |||||++++++.+ +..|+||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~~-~~~~lvmE~ 88 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESWMLVMEM 88 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEES-SSEEEEEEC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh--CCHHHHHHHHHHHHHHHhCC-CCCCceEEEEecc-CCEEEEEEc
Confidence 47999999999999764 456789999996542 23455678999999999995 9999999999865 457899999
Q ss_pred cCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc--Cccc
Q 013005 112 AAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN--GMLH 188 (451)
Q Consensus 112 ~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~--~~~~ 188 (451)
|++|+|.+++.+ +.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....... ....
T Consensus 89 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 89 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 999999999975 6799999999999999999999999999999999999999999999999999975433222 2233
Q ss_pred ccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCCCCHhHHHHHHhcc
Q 013005 189 TACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSFVSKPARSLIYQLL 266 (451)
Q Consensus 189 ~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L 266 (451)
...||+.|+|||++.+..| +.++|||||||++|+|++ |..||.+.+..+....+..+ ...+|..+|+++.+||.+||
T Consensus 169 ~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl 247 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCW 247 (277)
T ss_dssp --CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred ccCCCceecCchhhcCCCC-CchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHc
Confidence 4579999999999987766 567999999999999997 89999998888877777664 45678889999999999999
Q ss_pred CCCCCCCCCHHHHH---cCcccc
Q 013005 267 DPNPKTRMSIEKIM---SISWFQ 286 (451)
Q Consensus 267 ~~dP~~Rpt~~eil---~hp~f~ 286 (451)
..||.+|||+++|+ +|+|+.
T Consensus 248 ~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 248 TYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCHhHCcCHHHHHHHhhCHHhh
Confidence 99999999999984 565553
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.3e-54 Score=418.47 Aligned_cols=253 Identities=22% Similarity=0.389 Sum_probs=207.5
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCc---EEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGS---IVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT 101 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~ 101 (451)
...++|++.+.||+|+||+||+|++..+++ .||||.+.... .....+.+.+|+.+|++|+ |||||++++++.+
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~ 98 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTK 98 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc---CHHHHHHHHHHHHHHHhCC-CCCCccEEEEEee
Confidence 345789999999999999999999877664 68999886542 3345567999999999995 9999999999999
Q ss_pred CCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcc
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALP 179 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~ 179 (451)
.+..|+|||||+||+|.+++.. +.+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+..
T Consensus 99 ~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 99 STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEc
Confidence 9999999999999999998864 57999999999999999999999999999999999999999999999999999865
Q ss_pred hhhhcC----cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhcc-CCCCCCC
Q 013005 180 EQIKNG----MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRR-DYQFPSF 253 (451)
Q Consensus 180 ~~~~~~----~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~ 253 (451)
...... ......||+.|+|||++.+..| +.++|||||||++|+|+| |..||.+.+.......+..+ ..+.|..
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 257 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMD 257 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCC-CcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 432221 1122467999999999987766 567999999999999998 89999998888887777654 3456777
Q ss_pred CCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 254 VSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 254 ~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
+++.+.+||.+||..||.+|||+.||+++
T Consensus 258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999999999874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=412.39 Aligned_cols=257 Identities=27% Similarity=0.446 Sum_probs=220.7
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
+++|++++.||+|+||+||+|++..+++.||||+++... .......++.+|+.+|+.++ ||||+++++++.+....+
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~ 77 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLT 77 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC--SSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh--CChHHHHHHHHHHHHHHhcC-cCCEEeecccccccccee
Confidence 479999999999999999999999999999999997653 23445678999999999995 999999999999999999
Q ss_pred EEEEecCCCchhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhcC
Q 013005 107 LVMEYAAGGELFGKLRR-GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKNG 185 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~-~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~~ 185 (451)
+|+|++.|++|..++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|...... ..
T Consensus 78 iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~-~~ 156 (292)
T d1unla_ 78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VR 156 (292)
T ss_dssp EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC-CS
T ss_pred EEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCC-Cc
Confidence 99999999999888775 78999999999999999999999999999999999999999999999999999754332 22
Q ss_pred cccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCC-CCcHHHHHHHhhcc------------------
Q 013005 186 MLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFD-DSNLLAMYKKVNRR------------------ 246 (451)
Q Consensus 186 ~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~-~~~~~~~~~~i~~~------------------ 246 (451)
......+++.|.|||++....+.+.++||||+||++|+|++|..||. ..+......++...
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 33455688999999999888777888999999999999999999864 44555544443211
Q ss_pred -----------CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 247 -----------DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 247 -----------~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
....+..+++.+.+||++||..||.+|||++|+|+||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 01123346889999999999999999999999999999975
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.7e-53 Score=421.16 Aligned_cols=251 Identities=24% Similarity=0.439 Sum_probs=210.5
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe--CC
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT--KT 103 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~--~~ 103 (451)
..++|++++.||+|+||+||+|++..+|+.||||++++.. .+++.+|+.+|+.+.+||||+++++++.. ..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~ 105 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVSR 105 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence 4578999999999999999999999999999999997642 24678999999999779999999999974 45
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC-CeEEEeccCCCcchhh
Q 013005 104 KIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG-NLKVSDFGLSALPEQI 182 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~-~lkl~DFGls~~~~~~ 182 (451)
.+|+|||||.+++|.... +.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|.....
T Consensus 106 ~~~~v~e~~~~~~L~~~~--~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~- 182 (328)
T d3bqca1 106 TPALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP- 182 (328)
T ss_dssp SEEEEEECCCSCBGGGTT--TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT-
T ss_pred ceeEEEeecCCCcHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC-
Confidence 699999999999998764 4699999999999999999999999999999999999998765 599999999975543
Q ss_pred hcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcH-HHHHHHhh-------------ccCC
Q 013005 183 KNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNL-LAMYKKVN-------------RRDY 248 (451)
Q Consensus 183 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~-~~~~~~i~-------------~~~~ 248 (451)
.......+||+.|+|||++.+....+.++||||+||++|+|++|..||..... ......+. ....
T Consensus 183 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 183 -GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp -TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred -CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 23456678999999999988776667889999999999999999999976432 12111110 0000
Q ss_pred ------------------------CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccc
Q 013005 249 ------------------------QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQK 287 (451)
Q Consensus 249 ------------------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 287 (451)
.....+++++.+||++||..||++|||++|+|+||||+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 011236889999999999999999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-54 Score=427.43 Aligned_cols=256 Identities=23% Similarity=0.363 Sum_probs=217.7
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC---
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK--- 102 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~--- 102 (451)
+.++|++++.||+|+||+||+|++..+|+.||||++.+.. .+....+++.+|+.+|++|+ |||||++++++...
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~~~~ 92 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSL 92 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT--SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSST
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh--cChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeecccc
Confidence 3579999999999999999999999999999999998652 23445567889999999995 99999999998633
Q ss_pred --CEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 103 --TKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 103 --~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
...+++|+|+.||+|.+++..+++++.+++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+|....
T Consensus 93 ~~~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 93 EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp TTCCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred ccCceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC
Confidence 345667788889999999988899999999999999999999999999999999999999999999999999997543
Q ss_pred hhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhccCCC-----------
Q 013005 181 QIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRRDYQ----------- 249 (451)
Q Consensus 181 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~~~~----------- 249 (451)
. ...+.+||+.|+|||++.+..+.+.++||||+||++|+|++|..||.+.+.......+......
T Consensus 173 ~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 173 D----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp G----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred c----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence 3 3456789999999999888888888899999999999999999999988776665555332111
Q ss_pred ------------C--------CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 250 ------------F--------PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 250 ------------~--------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
. ...+++.+.+||++||..||.+|||++|+|+||||++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 1 12468899999999999999999999999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-54 Score=412.96 Aligned_cols=253 Identities=24% Similarity=0.405 Sum_probs=207.5
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCC---cEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEE
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADG---SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMA 100 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~ 100 (451)
...-++|++++.||+|+||+||+|++..++ ..||||.++.. ......+.+.+|+.+|++++ |||||++++++.
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~ 78 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT 78 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc---cCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe
Confidence 345679999999999999999999986543 56889988643 23455678999999999995 999999999985
Q ss_pred eCCEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 101 TKTKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 101 ~~~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
.+..|+||||+++|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+.
T Consensus 79 -~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 79 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred -cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhhee
Confidence 5678999999999999998753 6799999999999999999999999999999999999999999999999999986
Q ss_pred chhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhccC-CCCCCCCCH
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRD-YQFPSFVSK 256 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~ 256 (451)
............+||+.|+|||++.+..| +.++|||||||++|+|++ |.+||.+.+..+.+.++..+. .++|+.+|+
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~-~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~ 236 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 236 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred ccCCcceeccceecCcccchhhHhccCCC-CCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 55433344456678999999999987776 567999999999999987 899999888887777776654 567888999
Q ss_pred hHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 257 PARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
.+.+||.+||..||++|||+++|++|
T Consensus 237 ~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 237 TLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-53 Score=412.86 Aligned_cols=262 Identities=23% Similarity=0.354 Sum_probs=215.8
Q ss_pred CCCCCCcccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEE
Q 013005 17 PPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQ 96 (451)
Q Consensus 17 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~ 96 (451)
..+...+....++|++++.||+|+||+||+|++..+ +.||||+++.... ..+.+.+|+.+|++++ |||||+++
T Consensus 6 ~~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~-----~~~~~~~E~~~l~~l~-h~nIv~~~ 78 (285)
T d1fmka3 6 GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-----SPEAFLQEAQVMKKLR-HEKLVQLY 78 (285)
T ss_dssp SSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS-----CHHHHHHHHHHHHHCC-CTTBCCEE
T ss_pred CCCCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC-----CHHHHHHHHHHHHhcc-cCCEeEEE
Confidence 334556667789999999999999999999998654 5799999976532 1356899999999995 99999999
Q ss_pred EEEEeCCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEec
Q 013005 97 EVMATKTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDF 173 (451)
Q Consensus 97 ~~~~~~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DF 173 (451)
+++.+ +..|+||||+++|+|..++.. +.+++.+++.++.||+.||+|||++||+||||||+|||||.++.+||+||
T Consensus 79 g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~Df 157 (285)
T d1fmka3 79 AVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF 157 (285)
T ss_dssp EEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred EEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEccc
Confidence 99854 567999999999999988853 57999999999999999999999999999999999999999999999999
Q ss_pred cCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhc-CCCCCCCcHHHHHHHhhcc-CCCCC
Q 013005 174 GLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAG-YLPFDDSNLLAMYKKVNRR-DYQFP 251 (451)
Q Consensus 174 Gls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G-~~Pf~~~~~~~~~~~i~~~-~~~~p 251 (451)
|+|+.............+||+.|+|||++.+..+ +.++||||+||++|+|++| .+||...+..+....+... ..+.|
T Consensus 158 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~ 236 (285)
T d1fmka3 158 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP 236 (285)
T ss_dssp CTTC--------------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred chhhhccCCCceeeccccccccccChHHHhCCCC-CcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCC
Confidence 9998654433344455789999999999987777 5779999999999999995 5556667777777776654 45678
Q ss_pred CCCCHhHHHHHHhccCCCCCCCCCHHHHHc--Cccccc
Q 013005 252 SFVSKPARSLIYQLLDPNPKTRMSIEKIMS--ISWFQK 287 (451)
Q Consensus 252 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~--hp~f~~ 287 (451)
..+++++.+||.+||+.||++|||+++|++ ++||..
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 889999999999999999999999999987 778764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-53 Score=422.83 Aligned_cols=249 Identities=28% Similarity=0.420 Sum_probs=209.2
Q ss_pred CeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe------C
Q 013005 29 RYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT------K 102 (451)
Q Consensus 29 ~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~------~ 102 (451)
+|..++.||+|+||+||+|++..+|+.||||++.+... ...+|+.+|++|+ ||||+++++++.. .
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--------~~~~Ei~il~~l~-h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--------SCCHHHHHHHHCC-CTTBCCEEEEEEEC--CCSC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch--------HHHHHHHHHHhcC-CCCCCcEEEEEEecCccCCc
Confidence 79999999999999999999999999999999987632 2347999999995 9999999999854 3
Q ss_pred CEEEEEEEecCCCchhHHh---h-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCC-CeEEEeccCCC
Q 013005 103 TKIYLVMEYAAGGELFGKL---R-RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDG-NLKVSDFGLSA 177 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l---~-~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~-~lkl~DFGls~ 177 (451)
.++|||||||+++.+.... . ...+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchh
Confidence 4589999999876444333 2 35799999999999999999999999999999999999999875 89999999997
Q ss_pred cchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc-----------
Q 013005 178 LPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR----------- 246 (451)
Q Consensus 178 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~----------- 246 (451)
.... .....+.+||+.|+|||++.+..+++.++||||+||++|+|++|+.||...+....+.++.+.
T Consensus 172 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 172 QLVR--GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp ECCT--TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred hccC--CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 5433 234556789999999999887666678899999999999999999999988776655544210
Q ss_pred ------CCCC------------CCCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccch
Q 013005 247 ------DYQF------------PSFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKS 288 (451)
Q Consensus 247 ------~~~~------------p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 288 (451)
...+ .+..++++.+||.+||..||++|||+.|+++||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 1111 23468899999999999999999999999999999764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=417.91 Aligned_cols=256 Identities=26% Similarity=0.412 Sum_probs=204.1
Q ss_pred ccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe----
Q 013005 26 LLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT---- 101 (451)
Q Consensus 26 ~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~---- 101 (451)
+.++|++++.||+|+||+||+|++..||+.||||++.+.. .+.....++.+|+.++++++ |||||++++++..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~--~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~~~ 91 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTL 91 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT--SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCST
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh--cCHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeccccc
Confidence 5689999999999999999999999999999999998653 23455667899999999995 9999999999953
Q ss_pred --CCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcc
Q 013005 102 --KTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALP 179 (451)
Q Consensus 102 --~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~ 179 (451)
...+|+|||||.|+.+... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++...
T Consensus 92 ~~~~~~~iv~Ey~~~~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 92 EEFQDVYLVMELMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp TTCCEEEEEEECCSEEHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred ccCceeEEEEeccchHHHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcc
Confidence 4789999999987655433 357999999999999999999999999999999999999999999999999998754
Q ss_pred hhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHHHhhcc-------------
Q 013005 180 EQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYKKVNRR------------- 246 (451)
Q Consensus 180 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~~i~~~------------- 246 (451)
.. .......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+......++...
T Consensus 170 ~~--~~~~~~~~~t~~y~aPE~l~~~~~-~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 170 GT--SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp -------------CCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred cc--ccccccccccccccChhhhcCCCC-CCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 33 233456689999999999988766 56699999999999999999999887766554443211
Q ss_pred ---------CCCC--------------C------CCCCHhHHHHHHhccCCCCCCCCCHHHHHcCccccchh
Q 013005 247 ---------DYQF--------------P------SFVSKPARSLIYQLLDPNPKTRMSIEKIMSISWFQKSL 289 (451)
Q Consensus 247 ---------~~~~--------------p------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 289 (451)
.... + ...++++.+||++||..||++|||++|+|+||||+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 0000 0 01356789999999999999999999999999998743
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-52 Score=401.41 Aligned_cols=250 Identities=22% Similarity=0.333 Sum_probs=206.0
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCC----cEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADG----SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
.+.|++.+.||+|+||+||+|....++ ..||||++.... .......+.+|+.++++|+ |||||++++++.+.
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKY 81 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc---ChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEecC
Confidence 467999999999999999999876654 479999997542 3344567899999999995 99999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcch
Q 013005 103 TKIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPE 180 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~ 180 (451)
...|+||||+.+|++.+.+.. +.+++.++..++.|++.||+|||++||+||||||+||||+.++.+||+|||+|+...
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 999999999999999998864 679999999999999999999999999999999999999999999999999998654
Q ss_pred hhhc--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhc-CCCCCCCcHHHHHHHhhcc-CCCCCCCCCH
Q 013005 181 QIKN--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAG-YLPFDDSNLLAMYKKVNRR-DYQFPSFVSK 256 (451)
Q Consensus 181 ~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G-~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 256 (451)
.... .......||+.|+|||++.+..| +.++|||||||++|+|++| .+||...+....+..+..+ ..+.|..++.
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 240 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 240 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred CCCccceEeccCCCCccccCHHHHccCCC-CCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHH
Confidence 3322 22334578999999999987766 5679999999999999995 5556666777777766654 3456677899
Q ss_pred hHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 257 PARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.+.+||.+||..||++|||+.+|++
T Consensus 241 ~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 241 AIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 9999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-52 Score=404.13 Aligned_cols=258 Identities=22% Similarity=0.382 Sum_probs=220.2
Q ss_pred CCCcccccCCeEEcceEcccCceEEEEEEEcCCC-------cEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCc
Q 013005 20 SKKIPTLLNRYQLGPLLGRGSFAKVHKAKSIADG-------SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNV 92 (451)
Q Consensus 20 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~-------~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnI 92 (451)
..++....++|++++.||+|+||.||+|+...++ ..||||+++++. .......+.+|...+.++.+||||
T Consensus 5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~e~~~l~~~~~HpnI 81 (299)
T d1fgka_ 5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNI 81 (299)
T ss_dssp CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC---CHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc---ChHHHHHHHHHHHHHHHhcCCCeE
Confidence 3447778899999999999999999999876554 479999997653 234456788999999999679999
Q ss_pred eEEEEEEEeCCEEEEEEEecCCCchhHHhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q 013005 93 LKIQEVMATKTKIYLVMEYAAGGELFGKLRR-----------------GRLTESAARRYFQQLVSALHFCHQNGVAHRDV 155 (451)
Q Consensus 93 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-----------------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDL 155 (451)
|++++++.++...|+||||+++|+|.+++.. ..+++.++..++.||+.||+|||++||+||||
T Consensus 82 v~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDi 161 (299)
T d1fgka_ 82 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDL 161 (299)
T ss_dssp CCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeee
Confidence 9999999999999999999999999999963 24899999999999999999999999999999
Q ss_pred CCCeEEeCCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCC
Q 013005 156 KPQNLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDD 233 (451)
Q Consensus 156 KpeNILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~ 233 (451)
||+|||++.++.+||+|||++........ ......+||+.|+|||.+.+..| +.++|||||||++|+|++ |.+||.+
T Consensus 162 Kp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y-~~k~DiwS~Gvvl~ell~~g~~p~~~ 240 (299)
T d1fgka_ 162 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPG 240 (299)
T ss_dssp SGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCC-CchhhhHHhHHHHHHhccCCCCCCCC
Confidence 99999999999999999999987654332 33455789999999999988777 577999999999999998 7999999
Q ss_pred CcHHHHHHHhhcc-CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 234 SNLLAMYKKVNRR-DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 234 ~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.+....+..+..+ ....|..+++.+.+||.+||+.||++|||+.||++
T Consensus 241 ~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 241 VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 8888888777654 45677889999999999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=407.83 Aligned_cols=258 Identities=21% Similarity=0.345 Sum_probs=206.7
Q ss_pred CCcccccCCeEEcceEcccCceEEEEEEEcC-----CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEE
Q 013005 21 KKIPTLLNRYQLGPLLGRGSFAKVHKAKSIA-----DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKI 95 (451)
Q Consensus 21 ~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l 95 (451)
.++....++|++++.||+|+||+||+|.+.. +++.||||+++... .....+.+.+|+.++.++.+||||+++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---CcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 3455566899999999999999999999754 45689999997542 234456788888899988789999999
Q ss_pred EEEEEe-CCEEEEEEEecCCCchhHHhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 013005 96 QEVMAT-KTKIYLVMEYAAGGELFGKLRR-----------------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKP 157 (451)
Q Consensus 96 ~~~~~~-~~~~~lV~E~~~gg~L~~~l~~-----------------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKp 157 (451)
++++.. ....|+|||||++|+|.+++.. ..+++.+++.++.||+.||+|||++||+||||||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp 162 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 162 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCc
Confidence 998765 4568999999999999999853 2489999999999999999999999999999999
Q ss_pred CeEEeCCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhc-CCCCCCCc
Q 013005 158 QNLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAG-YLPFDDSN 235 (451)
Q Consensus 158 eNILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G-~~Pf~~~~ 235 (451)
+||||+.++++||+|||+|+....... ......+||+.|+|||++.+..| +.++|||||||++|+|++| ..||...+
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999975443222 33445689999999999988766 6779999999999999986 56787655
Q ss_pred HHH-HHHHhhc-cCCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 236 LLA-MYKKVNR-RDYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 236 ~~~-~~~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
... ....+.. .....|..+++++.+||.+||..||++|||++||++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 242 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 433 3333333 3456677899999999999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-52 Score=409.86 Aligned_cols=251 Identities=20% Similarity=0.333 Sum_probs=208.3
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCc----EEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGS----IVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
++|++++.||+|+||+||+|.+..+|+ .||+|.+.... +....+.+.+|+.++++++ |||||++++++.+.
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVD-NPHVCRLLGICLTS- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc---CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC-
Confidence 579999999999999999999988886 47788775431 2234567899999999995 99999999999765
Q ss_pred EEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 104 KIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
..++++||+.+|+|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 56788999999999988864 6799999999999999999999999999999999999999999999999999976543
Q ss_pred hhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhccC-CCCCCCCCHhH
Q 013005 182 IKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRD-YQFPSFVSKPA 258 (451)
Q Consensus 182 ~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 258 (451)
... .......||+.|+|||++.+..| +.++|||||||++|+|+| |..||.+.+..+....+..+. ...|+.+++.+
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~ 242 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 242 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHH
T ss_pred ccccccccccccCccccChHHHhcCCC-ChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHH
Confidence 222 22334568999999999988776 577999999999999998 899999887777766666543 56777899999
Q ss_pred HHHHHhccCCCCCCCCCHHHHHcCcc
Q 013005 259 RSLIYQLLDPNPKTRMSIEKIMSISW 284 (451)
Q Consensus 259 ~~li~~~L~~dP~~Rpt~~eil~hp~ 284 (451)
.+||.+||..||.+|||+.+|++|..
T Consensus 243 ~~li~~cl~~dP~~RPs~~eil~~l~ 268 (317)
T d1xkka_ 243 YMIMVKCWMIDADSRPKFRELIIEFS 268 (317)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHhCCCChhhCcCHHHHHHHHH
Confidence 99999999999999999999999843
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-51 Score=401.70 Aligned_cols=252 Identities=22% Similarity=0.304 Sum_probs=217.2
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcC-----CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIA-----DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVM 99 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~ 99 (451)
...++|++.+.||+|+||+||+|+... +++.||||+++... .....+.+.+|+.+|++++ ||||+++++++
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~il~~l~-h~niv~~~~~~ 85 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFD-NPNIVKLLGVC 85 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEE
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc---ChHHHHHHHHHHHHHHhcC-CCCcccceeee
Confidence 345789999999999999999998753 56789999997542 3445678999999999995 99999999999
Q ss_pred EeCCEEEEEEEecCCCchhHHhhcC-------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q 013005 100 ATKTKIYLVMEYAAGGELFGKLRRG-------------------------RLTESAARRYFQQLVSALHFCHQNGVAHRD 154 (451)
Q Consensus 100 ~~~~~~~lV~E~~~gg~L~~~l~~~-------------------------~l~e~~~~~~~~ql~~gL~yLH~~giiHrD 154 (451)
......+++|||+.+|+|.+++... .+++.++..++.||+.||+|||++||+|||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 9999999999999999999988531 388999999999999999999999999999
Q ss_pred CCCCeEEeCCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcC-CCCC
Q 013005 155 VKPQNLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGY-LPFD 232 (451)
Q Consensus 155 LKpeNILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~-~Pf~ 232 (451)
|||+|||+|.++++||+|||+|........ ....+.+||+.|+|||.+.+..| +.++|||||||++|+|++|. .||.
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCC-ChhhhhccchhhHHHHHccCCCCCC
Confidence 999999999999999999999975433322 33456789999999999988777 46799999999999999985 6898
Q ss_pred CCcHHHHHHHhhccCC-CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 233 DSNLLAMYKKVNRRDY-QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 233 ~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
..+..+....+..... ..|..+++++.+||.+||..||++|||+.||++
T Consensus 245 ~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 245 GMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8888888888776654 467789999999999999999999999999965
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-52 Score=399.02 Aligned_cols=251 Identities=26% Similarity=0.403 Sum_probs=203.9
Q ss_pred cCCeEEcceEcccCceEEEEEEEcC-CC--cEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIA-DG--SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~-~~--~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
.++|++.+.||+|+||+||+|+... ++ ..||||++++.. ..+....+.+.+|+.+|++++ |||||++++++.+ .
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~-~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDV-LSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLT-P 83 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS-S
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhh-cCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEee-c
Confidence 4679999999999999999998643 33 378999997652 233455678999999999995 9999999999965 4
Q ss_pred EEEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchh
Q 013005 104 KIYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~ 181 (451)
..++||||+++|++.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 67899999999999987753 6799999999999999999999999999999999999999999999999999986533
Q ss_pred hhc--CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhccCC--CCCCCCCH
Q 013005 182 IKN--GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNRRDY--QFPSFVSK 256 (451)
Q Consensus 182 ~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~ 256 (451)
... ......+||+.|+|||++.+..+ +.++|||||||++|+|+| |..||.+.+..+...++..... +.|..+|+
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 242 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred CCCcceecCccccCcccCCHHHHhCCCC-CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccH
Confidence 222 22334568889999999987665 677999999999999998 8999999999988888876644 44567899
Q ss_pred hHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 257 PARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
.+.+||.+||..||++|||+++|++
T Consensus 243 ~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 243 DIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999999963
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=402.98 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=215.1
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCc--EEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeC
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGS--IVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATK 102 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~ 102 (451)
+..++|++.+.||+|+||+||+|++..++. .||||.++... .....+.+.+|+.+|+++.+|||||++++++.++
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 83 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 83 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc---ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence 345899999999999999999999988876 46777775431 2334567899999999996699999999999999
Q ss_pred CEEEEEEEecCCCchhHHhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCC
Q 013005 103 TKIYLVMEYAAGGELFGKLRR-----------------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD 165 (451)
Q Consensus 103 ~~~~lV~E~~~gg~L~~~l~~-----------------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~ 165 (451)
+..|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence 999999999999999999853 469999999999999999999999999999999999999999
Q ss_pred CCeEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcC-CCCCCCcHHHHHHHhh
Q 013005 166 GNLKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGY-LPFDDSNLLAMYKKVN 244 (451)
Q Consensus 166 ~~lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~-~Pf~~~~~~~~~~~i~ 244 (451)
+.+||+|||+|...... ......+||+.|+|||.+.+..| +.++|||||||++|+|++|. +||.+.+..+++..+.
T Consensus 164 ~~~kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~ 240 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240 (309)
T ss_dssp GCEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred CceEEcccccccccccc--ccccceecCCcccchHHhccCCC-CccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 99999999999754332 22345679999999999988777 56799999999999999964 6798889888888876
Q ss_pred cc-CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 245 RR-DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 245 ~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
.+ .+..|..+++++.+||.+||..||++|||+++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 64 456677899999999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-51 Score=401.03 Aligned_cols=261 Identities=23% Similarity=0.361 Sum_probs=219.9
Q ss_pred CCCCCCcccccCCeEEcceEcccCceEEEEEEEc-----CCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCC
Q 013005 17 PPPSKKIPTLLNRYQLGPLLGRGSFAKVHKAKSI-----ADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPN 91 (451)
Q Consensus 17 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~Hpn 91 (451)
-|...++....++|++++.||+|+||.||+|+.. .+++.||||+++... .......+.+|+.+++++.+|||
T Consensus 12 ~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~~~~~l~~Hpn 88 (311)
T d1t46a_ 12 LPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMN 88 (311)
T ss_dssp SCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc---CHHHHHHHHHHHHHHHhccCCCC
Confidence 3344467777899999999999999999999863 467799999997653 23445678899999999977999
Q ss_pred ceEEEEEEEeCCEEEEEEEecCCCchhHHhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 013005 92 VLKIQEVMATKTKIYLVMEYAAGGELFGKLRRG-------------------RLTESAARRYFQQLVSALHFCHQNGVAH 152 (451)
Q Consensus 92 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-------------------~l~e~~~~~~~~ql~~gL~yLH~~giiH 152 (451)
||++++++.+....|+|||||++|+|.++++.. .+++..++.++.||+.||+|||++|++|
T Consensus 89 Iv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivH 168 (311)
T d1t46a_ 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIH 168 (311)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 999999999999999999999999999998642 4899999999999999999999999999
Q ss_pred cCCCCCeEEeCCCCCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCC
Q 013005 153 RDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLP 230 (451)
Q Consensus 153 rDLKpeNILld~~~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~P 230 (451)
|||||+|||++.++.+||+|||++........ ......+||+.|+|||++.+..+ +.++|||||||++|+|+| |.+|
T Consensus 169 rDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~ 247 (311)
T d1t46a_ 169 RDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSP 247 (311)
T ss_dssp SCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCS
T ss_pred cccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCC
Confidence 99999999999999999999999986544332 23345689999999999977655 677999999999999998 6777
Q ss_pred CCCCcHHHHHHHhhcc--CCCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 231 FDDSNLLAMYKKVNRR--DYQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 231 f~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
|...+....+.++... ....|..+++.+.+||.+||.+||.+|||+++|++
T Consensus 248 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 248 YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp STTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7666554444444332 34456678999999999999999999999999996
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=395.25 Aligned_cols=246 Identities=24% Similarity=0.419 Sum_probs=207.9
Q ss_pred cccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe-
Q 013005 23 IPTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT- 101 (451)
Q Consensus 23 ~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~- 101 (451)
+....++|++++.||+|+||.||+|++ +|+.||||+++++. ..+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~------~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~ 72 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA------TAQAFLAEASVMTQLR-HSNLVQLLGVIVEE 72 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--------HHHHHTHHHHTTCC-CTTBCCEEEEECCC
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH------HHHHHHHHHHHHHhCC-CCCEeeEEEEEEec
Confidence 456678999999999999999999997 57889999997642 2356889999999995 9999999998854
Q ss_pred CCEEEEEEEecCCCchhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 102 KTKIYLVMEYAAGGELFGKLRR---GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 102 ~~~~~lV~E~~~gg~L~~~l~~---~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
.+.+|+||||+++|+|.+++.+ ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..
T Consensus 73 ~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~ 152 (262)
T d1byga_ 73 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 152 (262)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred CCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeeccccccee
Confidence 5668999999999999999864 3499999999999999999999999999999999999999999999999999975
Q ss_pred chhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHh-cCCCCCCCcHHHHHHHhhc-cCCCCCCCCCH
Q 013005 179 PEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLA-GYLPFDDSNLLAMYKKVNR-RDYQFPSFVSK 256 (451)
Q Consensus 179 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~-G~~Pf~~~~~~~~~~~i~~-~~~~~p~~~s~ 256 (451)
... ...+.++|+.|+|||++.+..+ +.++|||||||++|+|+| |.+||...+.......+.. ...++|..+++
T Consensus 153 ~~~----~~~~~~~~~~y~aPE~l~~~~~-t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (262)
T d1byga_ 153 ASS----TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP 227 (262)
T ss_dssp -------------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCH
T ss_pred cCC----CCccccccccCCChHHHhCCCC-ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCH
Confidence 432 3345678999999999988766 677999999999999998 7999988887777777765 34577888999
Q ss_pred hHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 257 PARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 257 ~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
.+.+||.+||..||.+|||+.+|+++
T Consensus 228 ~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 228 AVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 99999999999999999999999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=396.34 Aligned_cols=255 Identities=20% Similarity=0.283 Sum_probs=220.8
Q ss_pred CcccccCCeEEcceEcccCceEEEEEEEcC-----CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEE
Q 013005 22 KIPTLLNRYQLGPLLGRGSFAKVHKAKSIA-----DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQ 96 (451)
Q Consensus 22 ~~~~~~~~y~~~~~LG~G~~g~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~ 96 (451)
.+....++|++++.||+|+||+||+|.+.. +++.||||++++.. .......+.+|+.+++++. |||||+++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~---~~~~~~~~~~E~~il~~l~-h~nIv~~~ 89 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFN-CHHVVRLL 89 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCC-CTTBCCEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc---ChHHHHHHHHHHHHHHHcC-CCCEeeee
Confidence 456667999999999999999999998753 35789999997542 3344567899999999995 99999999
Q ss_pred EEEEeCCEEEEEEEecCCCchhHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCC
Q 013005 97 EVMATKTKIYLVMEYAAGGELFGKLRR-----------GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRD 165 (451)
Q Consensus 97 ~~~~~~~~~~lV~E~~~gg~L~~~l~~-----------~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~ 165 (451)
+++......++||||+.+|+|.+++.. ..+++..+..++.|+++||.|||+++|+||||||+|||+|.+
T Consensus 90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 169 (308)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCC
Confidence 999999999999999999999998752 237899999999999999999999999999999999999999
Q ss_pred CCeEEEeccCCCcchhhhc-CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhc-CCCCCCCcHHHHHHHh
Q 013005 166 GNLKVSDFGLSALPEQIKN-GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAG-YLPFDDSNLLAMYKKV 243 (451)
Q Consensus 166 ~~lkl~DFGls~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G-~~Pf~~~~~~~~~~~i 243 (451)
+++||+|||+|........ ......+||+.|+|||.+.+..+ +.++|||||||++|+|++| ..||.+.+..+.+..+
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~-~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i 248 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCC-CcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999986544333 23344579999999999988776 4679999999999999998 5889988888888877
Q ss_pred hccC-CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 244 NRRD-YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 244 ~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
..+. ...|..+++.+.+||.+||+.||++|||+++|++
T Consensus 249 ~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 249 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 6644 4567789999999999999999999999999997
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=382.59 Aligned_cols=247 Identities=22% Similarity=0.332 Sum_probs=203.4
Q ss_pred EEcceEcccCceEEEEEEEcCCC---cEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEe-CCEEE
Q 013005 31 QLGPLLGRGSFAKVHKAKSIADG---SIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMAT-KTKIY 106 (451)
Q Consensus 31 ~~~~~LG~G~~g~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~-~~~~~ 106 (451)
.+.+.||+|+||+||+|++..++ ..||||.+++.. +....+++.+|+.+|++|+ |||||++++++.. +...|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT---DIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC---CHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEETTTEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc---CHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEecCCceE
Confidence 34678999999999999986543 369999997542 3455678999999999996 9999999999765 56899
Q ss_pred EEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccCCCcchhhhc
Q 013005 107 LVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGLSALPEQIKN 184 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGls~~~~~~~~ 184 (451)
+|||||++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||+|+++.+||+|||++........
T Consensus 106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999999998875 4688899999999999999999999999999999999999999999999999986543222
Q ss_pred ---CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCC-cHHHHHHHhhc-cCCCCCCCCCHhHH
Q 013005 185 ---GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS-NLLAMYKKVNR-RDYQFPSFVSKPAR 259 (451)
Q Consensus 185 ---~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~-~~~~~~~~i~~-~~~~~p~~~s~~~~ 259 (451)
.......||+.|+|||++.+..+ +.++||||||+++|+|++|..||... +.......+.. .....|..+++.+.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~ 264 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 264 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHH
T ss_pred ccceecccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHH
Confidence 12234568999999999887766 67799999999999999987777653 33344444433 34566778999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHcC
Q 013005 260 SLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 260 ~li~~~L~~dP~~Rpt~~eil~h 282 (451)
+||.+||..||++|||+.||++|
T Consensus 265 ~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 265 EVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-48 Score=379.66 Aligned_cols=252 Identities=20% Similarity=0.234 Sum_probs=200.7
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEEE
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKIY 106 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~~ 106 (451)
.++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+.+++.+.+|++|+.++.+..+.+..+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT------SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc------CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence 3689999999999999999999999999999999876532 1346789999999975666777778888999999
Q ss_pred EEEEecCCCchhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC---CCCeEEEeccCCCcchh
Q 013005 107 LVMEYAAGGELFGKLR--RGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR---DGNLKVSDFGLSALPEQ 181 (451)
Q Consensus 107 lV~E~~~gg~L~~~l~--~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~---~~~lkl~DFGls~~~~~ 181 (451)
+||||+.+ +|.+.+. .+.+++..+..++.|++.||+|||++||+||||||+|||++. +..+||+|||+|.....
T Consensus 80 ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 80 MVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 99999955 5555543 368999999999999999999999999999999999999864 45799999999986543
Q ss_pred hhc------CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHHHHHH---HhhccC-----
Q 013005 182 IKN------GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLLAMYK---KVNRRD----- 247 (451)
Q Consensus 182 ~~~------~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~~~~~---~i~~~~----- 247 (451)
... ....+.+||+.|+|||++.+.++ +.++|||||||++|+|++|..||.......... +.....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCC-CHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCC-CChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 221 22345689999999999988776 567999999999999999999998754433222 211111
Q ss_pred CCCCCCCCHhHHHHHHhccCCCCCCCCCHHHH---HcCcccc
Q 013005 248 YQFPSFVSKPARSLIYQLLDPNPKTRMSIEKI---MSISWFQ 286 (451)
Q Consensus 248 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~ei---l~hp~f~ 286 (451)
...+..+|+++.+||.+||..||++||++++| ++|+|.+
T Consensus 238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 12235688999999999999999999998755 5566543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.8e-48 Score=374.83 Aligned_cols=249 Identities=16% Similarity=0.241 Sum_probs=207.5
Q ss_pred cccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCE
Q 013005 25 TLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTK 104 (451)
Q Consensus 25 ~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~ 104 (451)
++.++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+.+++.|.+|+||+.+++++.....
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 75 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 75 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC------cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCc
Confidence 456899999999999999999999999999999999876422 13467889999999877999999999999999
Q ss_pred EEEEEEecCCCchhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCC-----CCCeEEEeccCCC
Q 013005 105 IYLVMEYAAGGELFGKLRR--GRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDR-----DGNLKVSDFGLSA 177 (451)
Q Consensus 105 ~~lV~E~~~gg~L~~~l~~--~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~-----~~~lkl~DFGls~ 177 (451)
.|+||||+ |++|.+++.. ..+++.++..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 76 ~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 76 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred cEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99999999 6799888864 57999999999999999999999999999999999999974 5789999999997
Q ss_pred cchhhhc------CcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCC---cHHHHHHHhhccCC
Q 013005 178 LPEQIKN------GMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDS---NLLAMYKKVNRRDY 248 (451)
Q Consensus 178 ~~~~~~~------~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~---~~~~~~~~i~~~~~ 248 (451)
....... ....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+. +....+.++.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCC-ChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence 6433211 22345689999999999988766 57799999999999999999999753 33333333332111
Q ss_pred -----CCCCCCCHhHHHHHHhccCCCCCCCCCHHHHHc
Q 013005 249 -----QFPSFVSKPARSLIYQLLDPNPKTRMSIEKIMS 281 (451)
Q Consensus 249 -----~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 281 (451)
..++.+|+++.+++..|+..+|++||+++.+.+
T Consensus 234 ~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 234 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 223568899999999999999999999887754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=374.09 Aligned_cols=248 Identities=22% Similarity=0.303 Sum_probs=194.3
Q ss_pred cCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC---
Q 013005 27 LNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT--- 103 (451)
Q Consensus 27 ~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~--- 103 (451)
..+|.+.+.||+|+||.||+|+. +|+.||||+++... .......+|+..+.+++ |||||++++++.+.+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~-HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhHHHHHHHHHHHhhCC-CCcCcceEEEEEeCCCcc
Confidence 46799999999999999999985 68999999996542 11222335555566774 999999999997654
Q ss_pred -EEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHH--------CCceecCCCCCeEEeCCCCCeEEEecc
Q 013005 104 -KIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQ--------NGVAHRDVKPQNLLLDRDGNLKVSDFG 174 (451)
Q Consensus 104 -~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~--------~giiHrDLKpeNILld~~~~lkl~DFG 174 (451)
.+|+||||+++|+|.+++++.++++.++..++.|++.||.|||+ +||+||||||+|||||.++++||+|||
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred eEEEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 68999999999999999998899999999999999999999996 599999999999999999999999999
Q ss_pred CCCcchhhhc---CcccccCCCCccccceeeeccCC-----CCccchhhhhhHHHHHHHhcCCCCCC-------------
Q 013005 175 LSALPEQIKN---GMLHTACGTPAYTAPEVVARRGY-----DGAVADAWSCGVILFVLLAGYLPFDD------------- 233 (451)
Q Consensus 175 ls~~~~~~~~---~~~~~~~gt~~y~APEvl~~~~~-----~~~~sDIwSlGvil~~Ll~G~~Pf~~------------- 233 (451)
++........ ......+||+.|+|||++.+... .+.++|||||||+||+|++|..||..
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 9986543222 23446789999999999865432 25579999999999999999888742
Q ss_pred --CcHHHHHHHhhccCC--CCCCC-----CCHhHHHHHHhccCCCCCCCCCHHHHHcC
Q 013005 234 --SNLLAMYKKVNRRDY--QFPSF-----VSKPARSLIYQLLDPNPKTRMSIEKIMSI 282 (451)
Q Consensus 234 --~~~~~~~~~i~~~~~--~~p~~-----~s~~~~~li~~~L~~dP~~Rpt~~eil~h 282 (451)
............... .+|.. ....+.+|+.+||..||.+|||+.||+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 122333333332222 22222 12358899999999999999999999874
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.2e-46 Score=372.06 Aligned_cols=251 Identities=22% Similarity=0.427 Sum_probs=196.6
Q ss_pred CCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhc----------CCCCceEEEE
Q 013005 28 NRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQ----------NHPNVLKIQE 97 (451)
Q Consensus 28 ~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~----------~HpnIv~l~~ 97 (451)
++|++++.||+|+||+||+|++..+|+.||||++++.. ...+.+.+|+.+++.+. +||||+++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence 57999999999999999999999999999999997652 23356778888888774 2688999998
Q ss_pred EEEe--CCEEEEEEEecCCCchhHHh-h---cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCeEEeCCCCC---
Q 013005 98 VMAT--KTKIYLVMEYAAGGELFGKL-R---RGRLTESAARRYFQQLVSALHFCHQ-NGVAHRDVKPQNLLLDRDGN--- 167 (451)
Q Consensus 98 ~~~~--~~~~~lV~E~~~gg~L~~~l-~---~~~l~e~~~~~~~~ql~~gL~yLH~-~giiHrDLKpeNILld~~~~--- 167 (451)
++.. ....+++|+++..+...... . ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred EeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccc
Confidence 8754 46777888777665443322 1 3679999999999999999999998 89999999999999987664
Q ss_pred ---eEEEeccCCCcchhhhcCcccccCCCCccccceeeeccCCCCccchhhhhhHHHHHHHhcCCCCCCCcHH------H
Q 013005 168 ---LKVSDFGLSALPEQIKNGMLHTACGTPAYTAPEVVARRGYDGAVADAWSCGVILFVLLAGYLPFDDSNLL------A 238 (451)
Q Consensus 168 ---lkl~DFGls~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~sDIwSlGvil~~Ll~G~~Pf~~~~~~------~ 238 (451)
++++|||.|.... ......+||+.|+|||++....|+ .++||||+||++++|++|+.||...+.. .
T Consensus 168 ~~~~kl~dfg~s~~~~----~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYD----EHYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEEECCCTTCEETT----BCCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cceeeEeecccccccc----cccccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 9999999987432 233567899999999999888774 6799999999999999999999753221 0
Q ss_pred HHHHhh------------------------------------------ccCCCCCCCCCHhHHHHHHhccCCCCCCCCCH
Q 013005 239 MYKKVN------------------------------------------RRDYQFPSFVSKPARSLIYQLLDPNPKTRMSI 276 (451)
Q Consensus 239 ~~~~i~------------------------------------------~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~ 276 (451)
...... .....++...++.+.+||.+||..||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 110000 00111122246788999999999999999999
Q ss_pred HHHHcCccccch
Q 013005 277 EKIMSISWFQKS 288 (451)
Q Consensus 277 ~eil~hp~f~~~ 288 (451)
+|+|+||||+..
T Consensus 323 ~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 323 GGLVNHPWLKDT 334 (362)
T ss_dssp HHHHTCGGGTTC
T ss_pred HHHhcCcccCCC
Confidence 999999999853
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=1.3e-25 Score=203.22 Aligned_cols=136 Identities=18% Similarity=0.242 Sum_probs=108.4
Q ss_pred eEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcc--------------hhhHHHHHHHHHHHHHHHHhcCCCCceEE
Q 013005 30 YQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNK--------------FLDAAMEDRIVREVSAMRRLQNHPNVLKI 95 (451)
Q Consensus 30 y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~--------------~~~~~~~~~~~~Ei~il~~L~~HpnIv~l 95 (451)
+.+++.||+|+||+||+|.+ .+|+.||||+++.... ...........+|...+.++. |++++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCCE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCcceE
Confidence 46899999999999999998 5799999998753211 001122344567888999995 9999998
Q ss_pred EEEEEeCCEEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCeEEeCCCCCeEEEeccC
Q 013005 96 QEVMATKTKIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCHQNGVAHRDVKPQNLLLDRDGNLKVSDFGL 175 (451)
Q Consensus 96 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH~~giiHrDLKpeNILld~~~~lkl~DFGl 175 (451)
+++.. .+++|||+++..+.. +++..+..++.|++.+|.|||++||+||||||+|||++++ .++|+|||+
T Consensus 80 ~~~~~----~~lvme~~~~~~~~~------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 80 YAWEG----NAVLMELIDAKELYR------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEEET----TEEEEECCCCEEGGG------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred EEecC----CEEEEEeeccccccc------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 87632 279999999876543 4556678899999999999999999999999999999865 599999999
Q ss_pred CCc
Q 013005 176 SAL 178 (451)
Q Consensus 176 s~~ 178 (451)
|..
T Consensus 149 a~~ 151 (191)
T d1zara2 149 SVE 151 (191)
T ss_dssp CEE
T ss_pred ccc
Confidence 864
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.28 E-value=6.3e-12 Score=99.83 Aligned_cols=81 Identities=11% Similarity=0.101 Sum_probs=70.6
Q ss_pred ceeeCCCHHHHHHHHHHHHHHcCcEEEEecCe-EEee-----eccCcEEEEEEEEeeec-CCeEEEEEEecCCCCCCCcc
Q 013005 351 RFTTKEKTERVVEKVKEVGERLGYVVEKGKGD-VVGL-----GKLGKMVLLVEVLMEIA-PETFVVGVKVVDNSVCGRVA 423 (451)
Q Consensus 351 rf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~~~~~~-~~~~~v~~~~~~g~~~~~~~ 423 (451)
..||+.+|++|+.+|+++++.+|+.|++++++ +.+. ++ +.|.|.+||| ++. +++++|+|||.+|| +
T Consensus 14 ~tTS~~~P~eIm~eI~rvL~~lgv~~~~~g~y~l~c~~~~~~~~-~~v~fEieV~-kv~~~~l~gv~~kR~~Gd-----~ 86 (102)
T d1ul7a_ 14 KTTSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAE-NLVQWEMEVC-KLPRLSLNGVRFKRISGT-----S 86 (102)
T ss_dssp CCCBCSCHHHHHHHHHHHHHHTTCEEEECSTTCEEEEECSSCGG-GCEEEEEEEE-ECSSSSSEEEEEEEEESC-----H
T ss_pred ecCcCCCHHHHHHHHHHHHHHcCcEEEEcCCEEEEEEecCCCCC-ceEEEEEEEE-EcCCCceEEEEEEEccCC-----H
Confidence 45899999999999999999999999877655 5554 33 6799999999 995 79999999999999 9
Q ss_pred hhhHhhhHHHHhhhhc
Q 013005 424 LEFDEGDWNELQAGLG 439 (451)
Q Consensus 424 ~~~~~~~~~~~~~~l~ 439 (451)
++|+++|. +|...|+
T Consensus 87 ~~yk~l~~-~il~~l~ 101 (102)
T d1ul7a_ 87 IAFKNIAS-KIANELK 101 (102)
T ss_dssp HHHHHHHH-HHHHHCC
T ss_pred HHHHHHHH-HHHHhcc
Confidence 99999998 7777664
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.60 E-value=7.9e-08 Score=88.48 Aligned_cols=145 Identities=18% Similarity=0.155 Sum_probs=99.1
Q ss_pred ccccCCeEEcceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCC
Q 013005 24 PTLLNRYQLGPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKT 103 (451)
Q Consensus 24 ~~~~~~y~~~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~ 103 (451)
..+.+.|+..+..+.++.+.||+.. .++..+.+|....... .....+.+|...++.|..+--+.+++.+..+.+
T Consensus 10 ~~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~----~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~ 83 (263)
T d1j7la_ 10 KKLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK----GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp HHHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT----TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred HHhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc----cchhhHHHHHHHHHHHhccCCCCcEEEEEecCC
Confidence 4456788887776666678999886 4667788898764421 112346788888888865555678888888899
Q ss_pred EEEEEEEecCCCchhHHhhcCCCCHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 013005 104 KIYLVMEYAAGGELFGKLRRGRLTESAARRYFQQLVSALHFCH------------------------------------- 146 (451)
Q Consensus 104 ~~~lV~E~~~gg~L~~~l~~~~l~e~~~~~~~~ql~~gL~yLH------------------------------------- 146 (451)
..|+||++++|..+........- ...++.++...+..||
T Consensus 84 ~~~lv~~~l~G~~~~~~~~~~~~----~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYEDEQS----PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEEECCSSEEHHHHTTTCSC----HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred ceEEEEEeccccccccccccccc----HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 99999999999877554322111 1122233333333333
Q ss_pred ----------------HC------CceecCCCCCeEEeCCCCCeEEEeccCCCc
Q 013005 147 ----------------QN------GVAHRDVKPQNLLLDRDGNLKVSDFGLSAL 178 (451)
Q Consensus 147 ----------------~~------giiHrDLKpeNILld~~~~lkl~DFGls~~ 178 (451)
+. .++|+|+.|.|||+++++...|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 21 278999999999998776667999998763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.10 E-value=8e-06 Score=74.15 Aligned_cols=141 Identities=15% Similarity=0.164 Sum_probs=86.4
Q ss_pred CCeEEcceEcccC-ceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCC-CCceEEEEEEEeCCEE
Q 013005 28 NRYQLGPLLGRGS-FAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH-PNVLKIQEVMATKTKI 105 (451)
Q Consensus 28 ~~y~~~~~LG~G~-~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~H-pnIv~l~~~~~~~~~~ 105 (451)
..+.... +..|. -+.||+... .++..+.+|...... ...+..|...++.|..+ -.+.+++.+..+.+..
T Consensus 11 ~g~~~~~-~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~-------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~ 81 (255)
T d1nd4a_ 11 FGYDWAQ-QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD 81 (255)
T ss_dssp TTCEEEE-CSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred cCCceEE-cCCcccCCeEEEEEe-CCCCEEEEEeCCccC-------HhHHHHHHHHHHHHHhcCCCCCceeeecccccce
Confidence 3444433 34444 478999874 567778889865432 12467788888877643 2256788888888899
Q ss_pred EEEEEecCCCchhHH--------------hhc-CC-------C--CHHHHH-----HH---------------HHHHHHH
Q 013005 106 YLVMEYAAGGELFGK--------------LRR-GR-------L--TESAAR-----RY---------------FQQLVSA 141 (451)
Q Consensus 106 ~lV~E~~~gg~L~~~--------------l~~-~~-------l--~e~~~~-----~~---------------~~ql~~g 141 (451)
|+||++++|.++... +.+ .. + ...... .+ .......
T Consensus 82 ~~v~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 82 WLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp EEEEECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred EEEEEeeeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 999999998665321 100 00 0 000000 00 0011222
Q ss_pred HHHHHHC-------CceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 142 LHFCHQN-------GVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 142 L~yLH~~-------giiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
+..+.+. .++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 3333332 27999999999999887667899999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.08 E-value=2.5e-06 Score=83.60 Aligned_cols=83 Identities=20% Similarity=0.138 Sum_probs=51.8
Q ss_pred cceEcccCceEEEEEEEcCCCcEEEEEEeecCcchhh---HHHHHHHHHHHHHHHHhcCC--CCceEEEEEEEeCCEEEE
Q 013005 33 GPLLGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLD---AAMEDRIVREVSAMRRLQNH--PNVLKIQEVMATKTKIYL 107 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~~Ei~il~~L~~H--pnIv~l~~~~~~~~~~~l 107 (451)
.+.||.|....||++.+..+++.+++|.-...-+... ....++...|...|+.+..+ ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4568999999999998777788999997543211100 01223556788888877544 335566644 4555678
Q ss_pred EEEecCCCch
Q 013005 108 VMEYAAGGEL 117 (451)
Q Consensus 108 V~E~~~gg~L 117 (451)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.70 E-value=9e-05 Score=60.75 Aligned_cols=65 Identities=9% Similarity=0.177 Sum_probs=56.6
Q ss_pred eeeCCCHHHHHHHHHHHHHHcCcEEEEecCe-EEeeec----cCcEEEEEEEEeeecCCeEEEEEEecCCC
Q 013005 352 FTTKEKTERVVEKVKEVGERLGYVVEKGKGD-VVGLGK----LGKMVLLVEVLMEIAPETFVVGVKVVDNS 417 (451)
Q Consensus 352 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~~~v~~~~~~g~ 417 (451)
+.|+..+.+|+..|..+++.||+.|++.+.+ +.++.+ ...+.|.+++| +|.++.||||||...|+
T Consensus 5 IrS~s~P~dIM~eVyrALk~L~~eWk~~~~y~ir~R~~~~~~~~~~Km~lQLY-qv~~~~YLLDfk~i~~~ 74 (153)
T d2v8qa1 5 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLY-QVDSRTYLLDFRSIDDE 74 (153)
T ss_dssp EEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEE-ECSSSCEEEEEEEECCC
T ss_pred cccCCCHHHHHHHHHHHHHHcCCeEEecCceEEEEEEECCCCCceeEEEEEEE-EEcCCceEEEeeecCcc
Confidence 4578899999999999999999999988777 776622 14688999999 99999999999999998
|
| >d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Snf1-like protein kinase ssp2 species: Schizosaccharomyces pombe [TaxId: 4896]
Probab=97.07 E-value=0.00094 Score=53.39 Aligned_cols=60 Identities=15% Similarity=0.160 Sum_probs=49.0
Q ss_pred eeeCCCHHHHHHHHHHHHHHcCcEEEEecC---------e-EEeeec---------cCcEEEEEEEEeeecCCeEEEEEE
Q 013005 352 FTTKEKTERVVEKVKEVGERLGYVVEKGKG---------D-VVGLGK---------LGKMVLLVEVLMEIAPETFVVGVK 412 (451)
Q Consensus 352 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~-~~~~~~---------~~~~~~~~~~~~~~~~~~~~v~~~ 412 (451)
.-|...|-+|+-.|..|.++||+.|++-++ + +.++.+ +..+.|.+++| +|.++.+|||||
T Consensus 7 IRSrs~P~eiM~eVYrALk~Lg~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~~~~~~~vkm~iQLY-qve~~~YLlDFK 85 (127)
T d2qrda1 7 VRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLY-EVMPGCFMLDVK 85 (127)
T ss_dssp EEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEE-EEETTEEEEEEE
T ss_pred cccCCChHHHHHHHHHHHHHcCCEEeecCcccccccCCceEEEEEeecCCccccCCCceEEEEEEEE-EEcCCcEEEEEc
Confidence 357889999999999999999999987664 2 555411 12478899999 999999999998
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.00 E-value=0.0014 Score=63.25 Aligned_cols=75 Identities=13% Similarity=0.090 Sum_probs=52.1
Q ss_pred cceEcccCceEEEEEEEcC-------CCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCceEEEEEEEeCCEE
Q 013005 33 GPLLGRGSFAKVHKAKSIA-------DGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNVLKIQEVMATKTKI 105 (451)
Q Consensus 33 ~~~LG~G~~g~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnIv~l~~~~~~~~~~ 105 (451)
++.|+.|-.-.+|++.... ..+.|.+++.-.... .....+|..+++.+..+.-..++++++.+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~------~idr~~E~~i~~~ls~~gl~Pkll~~~~~---- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET------ESHLVAESVIFTLLSERHLGPKLYGIFSG---- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC------HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch------hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence 4578889999999997643 245788888753211 12355789999998766445578887643
Q ss_pred EEEEEecCCCch
Q 013005 106 YLVMEYAAGGEL 117 (451)
Q Consensus 106 ~lV~E~~~gg~L 117 (451)
.+|+||++|..|
T Consensus 117 g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 GRLEEYIPSRPL 128 (395)
T ss_dssp EEEECCCCEEEC
T ss_pred ceEEEEeccccC
Confidence 579999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.67 E-value=0.0024 Score=59.82 Aligned_cols=69 Identities=16% Similarity=0.161 Sum_probs=45.4
Q ss_pred ceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCCCCc--eEEE-----EEEEeCCEEEEEEEecC
Q 013005 41 FAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNHPNV--LKIQ-----EVMATKTKIYLVMEYAA 113 (451)
Q Consensus 41 ~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~HpnI--v~l~-----~~~~~~~~~~lV~E~~~ 113 (451)
--.||++.. ++|+.|++|+.+.... ..+++..|...+..|..+ +| +... ..+......+.+++++.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~-----s~~~i~~E~~~l~~L~~~-gipv~~p~~~~g~~~~~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERW-----TADQILEEHQFALQLVND-EVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 107 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTS-----CHHHHHHHHHHHHHHHHT-TCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCC-----CHHHHHHHHHHHHHHHhc-CCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence 468999974 6889999999865421 134577788888887622 22 1111 12345677899999998
Q ss_pred CCc
Q 013005 114 GGE 116 (451)
Q Consensus 114 gg~ 116 (451)
|..
T Consensus 108 G~~ 110 (325)
T d1zyla1 108 GRQ 110 (325)
T ss_dssp CEE
T ss_pred CcC
Confidence 743
|
| >d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Carbon catabolite-derepressing protein kinase SNF1 species: Saccharomyces cerevisiae [TaxId: 4932]
Probab=96.52 E-value=0.0043 Score=52.02 Aligned_cols=63 Identities=14% Similarity=0.123 Sum_probs=47.5
Q ss_pred cceeeCCCHHHHHHHHHHHHHHcCcEEEEecC---e-EEeeec-------------cCcEEEEEEEEeeecCCeEEEEEE
Q 013005 350 KRFTTKEKTERVVEKVKEVGERLGYVVEKGKG---D-VVGLGK-------------LGKMVLLVEVLMEIAPETFVVGVK 412 (451)
Q Consensus 350 ~rf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-~~~~~~-------------~~~~~~~~~~~~~~~~~~~~v~~~ 412 (451)
--.-|...|-+|+-.|..++++||+.|++.+. + +.++.+ ...+.|.+++| +|.++.+|||||
T Consensus 48 fGIRSrs~P~eiM~evykALk~Lg~eWk~~~~~~~~~ir~Rwk~~~~~~~~~~~~~~~~vk~~iQLY-qv~~~~YLlDFK 126 (171)
T d2qlva1 48 FGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLF-QIETNNYLVDFK 126 (171)
T ss_dssp ESEEECSCHHHHHHHHHHHHHHHTCEECCCC---CCEEEEEEC--------------CEEEEEEEEE-C---CCEEEEEE
T ss_pred eecccCCCHHHHHHHHHHHHHHcCCEEeecCCCCceEEEEEeecCCCcccccCCCCCceEEEEEEEE-EEcCCceEEEEe
Confidence 34579999999999999999999999987653 3 554421 02478999999 999999999998
Q ss_pred e
Q 013005 413 V 413 (451)
Q Consensus 413 ~ 413 (451)
-
T Consensus 127 ~ 127 (171)
T d2qlva1 127 F 127 (171)
T ss_dssp E
T ss_pred c
Confidence 5
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.19 E-value=0.0044 Score=57.37 Aligned_cols=147 Identities=16% Similarity=0.202 Sum_probs=77.9
Q ss_pred cccccCCeEEcce-----EcccCceEEEEEEEcCCCcEEEEEEeecCcchhhHHHHHHHHHHHHHHHHhcCC----CCce
Q 013005 23 IPTLLNRYQLGPL-----LGRGSFAKVHKAKSIADGSIVAIKTIEKNNKFLDAAMEDRIVREVSAMRRLQNH----PNVL 93 (451)
Q Consensus 23 ~~~~~~~y~~~~~-----LG~G~~g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~~Ei~il~~L~~H----pnIv 93 (451)
+..+..+|.+++. |..|.--+.|+... .+| .+++|+..... ..+.+..|+..+..|..+ |..+
T Consensus 8 l~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t-~~g-~yVLri~~~~~------~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 8 LRNFLTQYDVGSLTSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV------EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp HHHHHTTBCCCCEEEEEEECC---EEEEEEEE-SSC-CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred HHHHHHhCCCCCceEeecCCCCcccCeEEEEE-CCC-cEEEEEcCCCC------CHHHHHHHHHHHHhhhhccccccccc
Confidence 3444556655443 45677788899874 344 48999986431 123455677777777522 2222
Q ss_pred EE---EEEEEeCCEEEEEEEecCCCchhH--------------Hhh---c-------CCCCHHH----------------
Q 013005 94 KI---QEVMATKTKIYLVMEYAAGGELFG--------------KLR---R-------GRLTESA---------------- 130 (451)
Q Consensus 94 ~l---~~~~~~~~~~~lV~E~~~gg~L~~--------------~l~---~-------~~l~e~~---------------- 130 (451)
.. ..+.........++.+..|..... .++ . .......
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 11 011223456677777776643310 000 0 0011111
Q ss_pred --HHHHHHHHHHHHHHHHH----CCceecCCCCCeEEeCCCCCeEEEeccCCC
Q 013005 131 --ARRYFQQLVSALHFCHQ----NGVAHRDVKPQNLLLDRDGNLKVSDFGLSA 177 (451)
Q Consensus 131 --~~~~~~ql~~gL~yLH~----~giiHrDLKpeNILld~~~~lkl~DFGls~ 177 (451)
....+..+...+.-.+. .|++|+|+.+.||+++.+...-|.||+.++
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 11122222222222222 379999999999999988777999999875
|